Citrus Sinensis ID: 008698

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------
Protein Sequence
MTLLMEKKLVPLQCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK
Secondary Structure (PSIPRED)
ccccccccEEEHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccEEEEEEcccccHHHHHHHHHHccccccccccHHHHHHHHHHHccccccEEEccEEEEEcccccEEEEccccccccccccccEEEccccccccccccccccEEEccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccHHHHHHHHccccccccccccccccccEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEEEEEEcccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccEEEEEEEcccccccHHHHHccccccccccccHHHHHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHcccccccccc
Secondary Structure Prediction (SSPRO)
ccEEHHcccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccEcccccccEEEEEccccccccccHHcccccccccccccccccHHHHHccccccccEEcccccccccccEEccccccccccHHcccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEcHHHHHHHHccccHHccEccccccccEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcccHccEEccccccccHccccHHEEcccccccEEEEEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHcccHHHHccHHHcccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccc
Coil and Loop (DISEMBL)
mtllmekklvpLQCFLLLVAYYVLQLVASdtisnqssngQLAASmnkdwkapcppdwiineekskcfgyignfrswdesETYCKEIGGHLAALTSYEEEHSAQklcgknvngcwvggrsinttvglswkwsdnmsKWNESIHAVgsfnssctslpchvhaTVDLctlvsngsrslvtercntshpficmvehenkcyylHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKrrrksrklsnpaasalvppswkvfttEELRSITKNFsegnrllgdsktggtysgilpdgsrVAVKRLKRSSFQRKKEFYSEIGRfarlhhpnlvavkgccydhgdryIVYEFVVngpldrwlhhiprggrsLDWAMRMKVATTLAQGIAFlhdkvkphvvhrdirasnvlldeefGAHLmgvglskfvpwevMQERTvmaggtygylapefvyrnelttksdvYSFGVLLLEIVsgrrpaqavdsVCWQSIFEWATPLVQSHRYLELLDPLIsslssdipeagVVQKVVDLVYACtqhvpsmrprmSHVVHQLqqlaqppvtk
Flexible Loop (DISEMBL)
mtllmekkLVPLQCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYrrskrrrksrklsnpaasalvppswkvftTEELRSITKnfsegnrllgdsktggtysgilpdgsrvavkrlkrssfqrkKEFYSEigrfarlhhpnLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQlqqlaqppvtk
Low Complexity Region (SEG)
MTLLMEKKLVPLQCFlllvayyvlqlvaSDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYrrskrrrksrkLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYlelldplisslssdipeAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK
Disordered region (IsUnstruct)
*****EKKLVPLQCFLLLVAYYVLQLVASDTI***************DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYR**********************SWKVFTTEELRSIT******************YSGIL*****VAV*******FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVP***********************
Disordered Region (DISOPRED)
*TLLM*KKLVPLQCFLLLVAYYVLQLVASDTIS*****************APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSL*******************************ITLGVVSGLILLTTFAIVIWLL**************************WKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK********EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA*P****
Disordered Region (DISEMBL)
MTLLMEKKLVPLQCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRR*****************LVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ*********
Disordered Region (DISPRO)
MTLLMEKKLVPLQCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKC****CHREYLITLGVVSGLILLTTFAIVIWLLAYRRSK*******************SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA******
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTLLMEKKLVPLQCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	557	2.2.26 [Sep-21-2011]
Q9C823	552	C-type lectin receptor-li	yes	no	0.971	0.980	0.663	0.0
Q9LSC2	361	PTI1-like tyrosine-protei	no	no	0.538	0.831	0.390	9e-55
Q9SX31	708	Proline-rich receptor-lik	no	no	0.612	0.481	0.338	2e-54
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.603	0.493	0.333	7e-54
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.614	0.666	0.351	8e-54
Q9LV48	652	Proline-rich receptor-lik	no	no	0.543	0.464	0.384	1e-53
Q9C660	762	Proline-rich receptor-lik	no	no	0.522	0.381	0.372	2e-53
C0LGG9	1035	Probable LRR receptor-lik	no	no	0.614	0.330	0.36	3e-53
Q9LS95	700	Putative proline-rich rec	no	no	0.508	0.404	0.405	1e-52
C0LGG8	1038	Probable LRR receptor-lik	no	no	0.527	0.283	0.387	3e-52

>sp|Q9C823|Y1523_ARATH C-type lectin receptor-like tyrosine-protein kinase At1g52310 OS=Arabidopsis thaliana GN=At1g52310 PE=2 SV=1

 Score =  708 bits (1827), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/556 (66%), Positives = 437/556 (78%), Gaps = 15/556 (2%)

Query: 5   MEKKLVPL--QCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNK-DWKAPCPPDWIINE 61
           ME K V    Q   L+    +L L + DTIS +S+  Q A    K      CPPDWII  
Sbjct: 1   MELKWVSCRKQSLFLISCLALLCLASLDTISCEST--QNATDFKKRSQTVSCPPDWIIGP 58

Query: 62  EKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSIN 121
            ++KC+ Y  N  SW++SE +C+  GGHLA+L S +E    QKLC  NV+ CW+GGRS+N
Sbjct: 59  NQTKCYAYFKNSTSWEKSEMFCRTYGGHLASLASSKELSFVQKLCNGNVSSCWIGGRSMN 118

Query: 122 T-TVGLSWKWSD-NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTER 179
           + T G  W WSD    +WN+S+       + C +         ++C  V+NGS S+  ER
Sbjct: 119 SSTSGFRWSWSDPKTPQWNQSMFPKVPIRTRCGNGNGSSSCRANICIAVTNGSSSIFGER 178

Query: 180 CNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKS 239
           CN SH F+C V+ + KC   +CH+ YL+ L VVSGLIL TTFAI++WLL Y+RSK+RRKS
Sbjct: 179 CNASHAFVCAVDSDIKCR--NCHK-YLVILAVVSGLILFTTFAIILWLLVYKRSKKRRKS 235

Query: 240 RKLSNPAASALVPPS-WKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAV 298
           RK+SNPA+S+ V P  WK+FT+EELRS+TKNFSE NRL GD+KTGGTYSG L DG++VAV
Sbjct: 236 RKVSNPASSSSVVPPSWKIFTSEELRSMTKNFSEANRLAGDAKTGGTYSGGLSDGTKVAV 295

Query: 299 KRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH 358
           KRLKRSSFQRKKEFYSEI R A+L+HPN+VA+KGCCYDHG+R+IVYEF+ +GPLDRWLHH
Sbjct: 296 KRLKRSSFQRKKEFYSEIRRAAKLYHPNVVAIKGCCYDHGERFIVYEFIASGPLDRWLHH 355

Query: 359 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418
           +PRGGRSLDW MR+ +ATTLAQGIAFLHDKVKP VVHRDIRASNVLLDEEFGAHLMGVGL
Sbjct: 356 VPRGGRSLDWNMRLNIATTLAQGIAFLHDKVKPQVVHRDIRASNVLLDEEFGAHLMGVGL 415

Query: 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD 478
           SKFVPWEVMQERTVMAGGTYGYLAPE+VYRNELTTKSDVYSFGVLLLEIVSGRRP QAV+
Sbjct: 416 SKFVPWEVMQERTVMAGGTYGYLAPEYVYRNELTTKSDVYSFGVLLLEIVSGRRPTQAVN 475

Query: 479 -SVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR 537
            SV WQSIFEWATPLVQ++R+LE+LDP+I   +  +PEA VVQKVVDLVY+CTQ+VPSMR
Sbjct: 476 SSVGWQSIFEWATPLVQANRWLEILDPVI---TCGLPEACVVQKVVDLVYSCTQNVPSMR 532

Query: 538 PRMSHVVHQLQQLAQP 553
           PRMSHVVHQLQQL QP
Sbjct: 533 PRMSHVVHQLQQLVQP 548

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 1

>sp|Q9LSC2|Y3589_ARATH PTI1-like tyrosine-protein kinase At3g15890 OS=Arabidopsis thaliana GN=At3g15890 PE=1 SV=1

 Score =  215 bits (547), Expect = 9e-55,   Method: Compositional matrix adjust.
 Identities = 119/305 (39%), Positives = 176/305 (57%), Gaps = 5/305 (1%)

Query: 253 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEF 312
           PSW+VF+ +EL + T +F+  N+L G+ + G  Y G L DGS++AVKRLK  S + + +F
Sbjct: 22  PSWRVFSLKELHAATNSFNYDNKL-GEGRFGSVYWGQLWDGSQIAVKRLKEWSNREEIDF 80

Query: 313 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
             E+   AR+ H NL++V+G C +  +R +VYE++ N  L   LH        LDW  RM
Sbjct: 81  AVEVEILARIRHKNLLSVRGYCAEGQERLLVYEYMQNLSLVSHLHGQHSAECLLDWTKRM 140

Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
           K+A + AQ IA+LHD   PH+VH D+RASNVLLD EF A +   G  K +P +   +   
Sbjct: 141 KIAISSAQAIAYLHDHATPHIVHGDVRASNVLLDSEFEARVTDFGYGKLMPDDDTGDGAT 200

Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 492
            A    GY++PE     + +  SDVYSFG+LL+ +VSG+RP + ++    + I EW  PL
Sbjct: 201 KAKSNNGYISPECDASGKESETSDVYSFGILLMVLVSGKRPLERLNPTTTRCITEWVLPL 260

Query: 493 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
           V    + E++D  +S        A  ++KVV +   C Q  P  RP MS VV  L   ++
Sbjct: 261 VYERNFGEIVDKRLSEEHV----AEKLKKVVLVGLMCAQTDPDKRPTMSEVVEMLVNESK 316

Query: 553 PPVTK 557
             +++
Sbjct: 317 EKISE 321

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1

 Score =  213 bits (543), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 132/390 (33%), Positives = 207/390 (53%), Gaps = 49/390 (12%)

Query: 206 LITLGVVSGLILLTTFAIVIWLLAYRRSKR-------------------------RRKS- 239
           ++ + V   L++ T F I +W L  +R KR                         R +S 
Sbjct: 281 VVGISVAVALVVFTLFGIFVWCL-RKREKRLSAVSGGDVTPSPMSSTARSDSAFFRMQSS 339

Query: 240 -------RKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD 292
                  R  S  + S  +  S  +F+ EEL   T  FS+ N LLG+   G  Y GILPD
Sbjct: 340 APVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQEN-LLGEGGFGCVYKGILPD 398

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           G  VAVK+LK    Q  +EF +E+   +R+HH +LV++ G C     R ++Y++V N  L
Sbjct: 399 GRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDL 458

Query: 353 DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
              LH    G +S LDWA R+K+A   A+G+A+LH+   P ++HRDI++SN+LL++ F A
Sbjct: 459 YFHLH----GEKSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDA 514

Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
            +   GL++    +     T    GT+GY+APE+    +LT KSDV+SFGV+LLE+++GR
Sbjct: 515 RVSDFGLARLA-LDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 573

Query: 472 RPAQAVDSVCWQSIFEWATPL----VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVY 527
           +P      +  +S+ EWA PL    +++  +  L DP    L  +  E+ +  ++++   
Sbjct: 574 KPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADP---KLGGNYVESEMF-RMIEAAG 629

Query: 528 ACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 557
           AC +H+ + RPRM  +V   + LA   +T 
Sbjct: 630 ACVRHLATKRPRMGQIVRAFESLAAEDLTN 659

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  212 bits (539), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 131/393 (33%), Positives = 206/393 (52%), Gaps = 57/393 (14%)

Query: 206 LITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKS-----------RKLSNPAASALV--- 251
           ++ +GV+ GL+ L+ F + +W       KR+RK               S+P  S +V   
Sbjct: 238 IVAIGVIVGLVFLSLFVMGVWFT----RKRKRKDPGTFVGYTMPPSAYSSPQGSDVVLFN 293

Query: 252 -----PPSWKV----------------------FTTEELRSITKNFSEGNRLLGDSKTGG 284
                PP  +                       F+ +EL  +T  FSE N LLG+   G 
Sbjct: 294 SRSSAPPKMRSHSGSDYMYASSDSGMVSNQRSWFSYDELSQVTSGFSEKN-LLGEGGFGC 352

Query: 285 TYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344
            Y G+L DG  VAVK+LK    Q ++EF +E+   +R+HH +LV + G C     R +VY
Sbjct: 353 VYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVY 412

Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
           ++V N  L   LH    G   + W  R++VA   A+GIA+LH+   P ++HRDI++SN+L
Sbjct: 413 DYVPNNTLHYHLHA--PGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNIL 470

Query: 405 LDEEFGAHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
           LD  F A +   GL+K     ++    +    GT+GY+APE+    +L+ K+DVYS+GV+
Sbjct: 471 LDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVI 530

Query: 464 LLEIVSGRRPAQAVDSVCWQSIFEWATPL----VQSHRYLELLDPLISSLSSDIPEAGVV 519
           LLE+++GR+P      +  +S+ EWA PL    +++  + EL+DP +    + IP  G +
Sbjct: 531 LLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLG--KNFIP--GEM 586

Query: 520 QKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
            ++V+   AC +H  + RP+MS VV  L  L +
Sbjct: 587 FRMVEAAAACVRHSAAKRPKMSQVVRALDTLEE 619

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  211 bits (538), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 122/347 (35%), Positives = 193/347 (55%), Gaps = 5/347 (1%)

Query: 207 ITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSI 266
           ++ G V G+ +     ++  +    + KR R  + L  P    L       FT  EL   
Sbjct: 121 LSTGAVVGISIGGGVFVLTLIFFLCKKKRPRDDKALPAPIGLVL-GIHQSTFTYGELARA 179

Query: 267 TKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN 326
           T  FSE N LLG+   G  Y GIL +G+ VAVK+LK  S Q +KEF +E+   +++HH N
Sbjct: 180 TNKFSEAN-LLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRN 238

Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
           LV++ G C     R +VYEFV N  L+  LH   +G  +++W++R+K+A + ++G+++LH
Sbjct: 239 LVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHG--KGRPTMEWSLRLKIAVSSSKGLSYLH 296

Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
           +   P ++HRDI+A+N+L+D +F A +   GL+K +  +     +    GT+GYLAPE+ 
Sbjct: 297 ENCNPKIIHRDIKAANILIDFKFEAKVADFGLAK-IALDTNTHVSTRVMGTFGYLAPEYA 355

Query: 447 YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506
              +LT KSDVYSFGV+LLE+++GRRP  A +     S+ +WA PL+         + L 
Sbjct: 356 ASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALEESNFEGLA 415

Query: 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
               ++  +   + ++V    AC ++    RPRM  VV  L+    P
Sbjct: 416 DIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGNISP 462

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  211 bits (537), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 118/307 (38%), Positives = 178/307 (57%), Gaps = 4/307 (1%)

Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRL 301
           L  P+   ++  S   FT EEL   T  FSE N LLG    G  + GILP G  VAVK+L
Sbjct: 252 LPPPSPGLVLGFSKSTFTYEELSRATNGFSEAN-LLGQGGFGYVHKGILPSGKEVAVKQL 310

Query: 302 KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPR 361
           K  S Q ++EF +E+   +R+HH +LV++ G C     R +VYEFV N  L+  LH   +
Sbjct: 311 KAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG--K 368

Query: 362 GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421
           G  +++W+ R+K+A   A+G+++LH+   P ++HRDI+ASN+L+D +F A +   GL+K 
Sbjct: 369 GRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK- 427

Query: 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC 481
           +  +     +    GT+GYLAPE+    +LT KSDV+SFGV+LLE+++GRRP  A +   
Sbjct: 428 IASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYV 487

Query: 482 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541
             S+ +WA PL+         + L  S   +  +   + ++V    AC +H    RPRMS
Sbjct: 488 DDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMS 547

Query: 542 HVVHQLQ 548
            +V  L+
Sbjct: 548 QIVRALE 554

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2

 Score =  211 bits (536), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 176/303 (58%), Gaps = 12/303 (3%)

Query: 254 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFY 313
           S ++F+ EEL   T  FS+ N LLG+   G  Y G+LPD   VAVK+LK    Q  +EF 
Sbjct: 414 SRELFSYEELVIATNGFSDEN-LLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFK 472

Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
           +E+   +R+HH NL+++ G C     R ++Y++V N  L  + H    G   LDWA R+K
Sbjct: 473 AEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNL--YFHLHAAGTPGLDWATRVK 530

Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
           +A   A+G+A+LH+   P ++HRDI++SN+LL+  F A +   GL+K    +     T  
Sbjct: 531 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLA-LDCNTHITTR 589

Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV 493
             GT+GY+APE+    +LT KSDV+SFGV+LLE+++GR+P  A   +  +S+ EWA PL+
Sbjct: 590 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 649

Query: 494 ----QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
               ++  +  L DP +      +     + ++++   AC +H  + RPRMS +V     
Sbjct: 650 SNATETEEFTALADPKLGRNYVGV----EMFRMIEAAAACIRHSATKRPRMSQIVRAFDS 705

Query: 550 LAQ 552
           LA+
Sbjct: 706 LAE 708

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2

 Score =  210 bits (534), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 126/350 (36%), Positives = 190/350 (54%), Gaps = 8/350 (2%)

Query: 210 GVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKN 269
           GVV+G+++    A  + +L   R       +++        +      FT ++++  T N
Sbjct: 607 GVVAGIVIAACVAFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNN 666

Query: 270 FSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA 329
           F   N++ G+   G  Y G+L DG  +AVK+L   S Q  +EF +EIG  + L HPNLV 
Sbjct: 667 FDPENKI-GEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVK 725

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           + GCC +  +  +VYE++ N  L R L    +    LDW+ R KV   +A+G+A+LH++ 
Sbjct: 726 LYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEES 785

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
           +  +VHRDI+A+NVLLD    A +   GL+K    E     T +A GT GY+APE+  R 
Sbjct: 786 RLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIA-GTIGYMAPEYAMRG 844

Query: 450 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509
            LT K+DVYSFGV+ LEIVSG+          +  + +WA  L +    LEL+DP + + 
Sbjct: 845 YLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDPDLGT- 903

Query: 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ--LAQPPVTK 557
           S    EA    +++++   CT   P++RP MS VV  LQ     QPP+ K
Sbjct: 904 SFSKKEA---MRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKVQPPLVK 950

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2

 Score =  208 bits (529), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 120/296 (40%), Positives = 176/296 (59%), Gaps = 13/296 (4%)

Query: 257 VFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEI 316
            FT +EL + T+ FS+ +RLLG    G  + GILP+G  +AVK LK  S Q ++EF +E+
Sbjct: 324 TFTYDELAAATQGFSQ-SRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEV 382

Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
              +R+HH  LV++ G C   G R +VYEF+ N  L+  LH   + G+ LDW  R+K+A 
Sbjct: 383 DIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHG--KSGKVLDWPTRLKIAL 440

Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG 436
             A+G+A+LH+   P ++HRDI+ASN+LLDE F A +   GL+K     V    T +  G
Sbjct: 441 GSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIM-G 499

Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL---- 492
           T+GYLAPE+    +LT +SDV+SFGV+LLE+V+GRRP      +   S+ +WA P+    
Sbjct: 500 TFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEM-EDSLVDWARPICLNA 558

Query: 493 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
            Q   Y EL+DP + +      E   + ++V    A  +H    RP+MS +V  L+
Sbjct: 559 AQDGDYSELVDPRLENQY----EPHEMAQMVACAAAAVRHSARRRPKMSQIVRALE 610

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1

 Score =  206 bits (524), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 117/302 (38%), Positives = 173/302 (57%), Gaps = 8/302 (2%)

Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIG 317
           FT ++++  T NF   N++ G+   G  Y G+L DG  +AVK+L   S Q  +EF +EIG
Sbjct: 657 FTLKQIKRATNNFDPENKI-GEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIG 715

Query: 318 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
             + L HPNLV + GCC +  +  +VYE++ N  L R L    +    LDW+ R K+   
Sbjct: 716 MISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIG 775

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           +A+G+A+LH++ +  +VHRDI+A+NVLLD    A +   GL+K    E     T +A GT
Sbjct: 776 IAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIA-GT 834

Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497
            GY+APE+  R  LT K+DVYSFGV+ LEIVSG+          +  + +WA  L +   
Sbjct: 835 IGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGS 894

Query: 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ--LAQPPV 555
            LEL+DP + + S    EA    +++++   CT   P++RP MS VV  L+     QPP+
Sbjct: 895 LLELVDPDLGT-SFSKKEA---MRMLNIALLCTNPSPTLRPPMSSVVSMLEGKIKVQPPL 950

Query: 556 TK 557
            K
Sbjct: 951 VK 952

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	557
225455058	542	PREDICTED: C-type lectin receptor-like t	0.973	1.0	0.793	0.0
255556651	552	kinase, putative [Ricinus communis] gi|2	0.982	0.990	0.779	0.0
224137796	516	predicted protein [Populus trichocarpa]	0.895	0.967	0.810	0.0
449503381	557	PREDICTED: C-type lectin receptor-like t	0.985	0.985	0.703	0.0
449454927	557	PREDICTED: C-type lectin receptor-like t	0.983	0.983	0.702	0.0
297745082	517	unnamed protein product [Vitis vinifera]	0.906	0.976	0.727	0.0
356532800	545	PREDICTED: C-type lectin receptor-like t	0.937	0.957	0.709	0.0
356558437	547	PREDICTED: C-type lectin receptor-like t	0.937	0.954	0.711	0.0
357134621	557	PREDICTED: C-type lectin receptor-like t	0.885	0.885	0.709	0.0
115434006	555	Os01g0104000 [Oryza sativa Japonica Grou	0.885	0.888	0.713	0.0

>gi|225455058|ref|XP_002263812.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Vitis vinifera]

 Score =  885 bits (2288), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/553 (79%), Positives = 479/553 (86%), Gaps = 11/553 (1%)

Query: 5   MEKKLVPLQCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKS 64
           ME KLV LQ  LL+++  V QL ASD I ++S       S+    +A CPPDWI   +K+
Sbjct: 1   MEGKLVRLQFPLLVISCLVFQLRASDAILHESRR-----SLESRKEALCPPDWITGPDKN 55

Query: 65  KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
           KCF YIGN +SWD SE YCK +GGHLAALTS++E  S Q LCG++ NGCWVGGR +N+T 
Sbjct: 56  KCFRYIGNPQSWDVSEAYCKSLGGHLAALTSFQELSSVQNLCGESNNGCWVGGRGVNSTF 115

Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH 184
           G  WKWSDN S WNESI        +CT+  CH+  +VD CTLV+NGS  L+ ERCN SH
Sbjct: 116 GAGWKWSDNTSHWNESIFP------NCTNSSCHIKNSVDSCTLVTNGSTFLIGERCNMSH 169

Query: 185 PFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSN 244
             ICM++ ENKCY++HCH+EYLI L VVSGLIL TT A+VIWLLAYRRSKRRR+SRKLSN
Sbjct: 170 ASICMIDIENKCYHMHCHKEYLIILAVVSGLILSTTLAVVIWLLAYRRSKRRRRSRKLSN 229

Query: 245 PAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS 304
           PAASALVPPSWKVFT EELRSITKNFSEGNRLLGD+KTGGTYSG+LPDGSRVAVKRLKRS
Sbjct: 230 PAASALVPPSWKVFTNEELRSITKNFSEGNRLLGDAKTGGTYSGLLPDGSRVAVKRLKRS 289

Query: 305 SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR 364
           +FQRKKEFYSEIGR ARLHHPNLVAVKGCCYDHGDRYIVYEF++NGPLDRWLHHIPRGGR
Sbjct: 290 TFQRKKEFYSEIGRVARLHHPNLVAVKGCCYDHGDRYIVYEFIINGPLDRWLHHIPRGGR 349

Query: 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
           SLDWAMRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV W
Sbjct: 350 SLDWAMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVSW 409

Query: 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS 484
           EVM + TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV WQS
Sbjct: 410 EVMHQGTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVGWQS 469

Query: 485 IFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
           IFEWATPLVQSHRY ELLDPLISS S+DIPEAGV+QKVVDLVYACTQHVPSMRPRMSHVV
Sbjct: 470 IFEWATPLVQSHRYPELLDPLISSSSADIPEAGVIQKVVDLVYACTQHVPSMRPRMSHVV 529

Query: 545 HQLQQLAQPPVTK 557
           HQLQQLAQPP+ K
Sbjct: 530 HQLQQLAQPPIAK 542

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255556651|ref|XP_002519359.1| kinase, putative [Ricinus communis] gi|223541426|gb|EEF42976.1| kinase, putative [Ricinus communis]

 Score =  853 bits (2205), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 427/548 (77%), Positives = 466/548 (85%), Gaps = 1/548 (0%)

Query: 5   MEKKLVPLQCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKS 64
           M+ KL  LQ  +LL+A  VL  VA + ISN + +  L AS N+  K  C   W I+  K 
Sbjct: 1   MDLKLTHLQFSVLLIAV-VLSFVAPENISNDTIHSPLIASRNESNKGWCHSGWDISPNKK 59

Query: 65  KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
           KC  Y    +SWD+SE  C   GGHLAALTS +E   A++LCG+ V+GCWVG R IN+TV
Sbjct: 60  KCLKYFEKSKSWDDSEALCASYGGHLAALTSSQELTFAKQLCGQIVDGCWVGERVINSTV 119

Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH 184
           G +WKW DN S WNESI +  SF+S CT+L CH +AT + CTLV+N +  LV ERCN SH
Sbjct: 120 GSNWKWFDNTSYWNESILSGASFDSKCTNLSCHNNATAEFCTLVNNRTTHLVDERCNKSH 179

Query: 185 PFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSN 244
            FICM++ ENKCY++HCHREYLI L VVSGLIL T  A+VIWLLAYRRS++RRKSRKLSN
Sbjct: 180 VFICMLDAENKCYHMHCHREYLIILAVVSGLILCTALAVVIWLLAYRRSRKRRKSRKLSN 239

Query: 245 PAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS 304
           PAASALVPPSWKVFT EELRSITKNFSEGNRL GD+KTGGTYSG+LPDGSRVAVKRLKRS
Sbjct: 240 PAASALVPPSWKVFTNEELRSITKNFSEGNRLPGDAKTGGTYSGLLPDGSRVAVKRLKRS 299

Query: 305 SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR 364
           SFQRKKEFYSEIGR ARLHHPNLVA+KGCCYDHGDRYIVYEFVVNGPLDRWLHHI RGGR
Sbjct: 300 SFQRKKEFYSEIGRVARLHHPNLVAIKGCCYDHGDRYIVYEFVVNGPLDRWLHHISRGGR 359

Query: 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
           SLDW MRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW
Sbjct: 360 SLDWTMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 419

Query: 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS 484
           EVM E TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV+GRRPAQAVDSV WQS
Sbjct: 420 EVMHEGTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVTGRRPAQAVDSVGWQS 479

Query: 485 IFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
           IFEWATPLVQ+HRY ELLDPLI S SS+IPE GV+QKVVDLVYACTQHVPSMRPRMSHVV
Sbjct: 480 IFEWATPLVQAHRYPELLDPLIYSSSSEIPEPGVIQKVVDLVYACTQHVPSMRPRMSHVV 539

Query: 545 HQLQQLAQ 552
           HQLQQLAQ
Sbjct: 540 HQLQQLAQ 547

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224137796|ref|XP_002326442.1| predicted protein [Populus trichocarpa] gi|222833764|gb|EEE72241.1| predicted protein [Populus trichocarpa]

 Score =  825 bits (2132), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 406/501 (81%), Positives = 439/501 (87%), Gaps = 2/501 (0%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP  W I+  KSKCF  I  F+SW+ESE  C   GGH+A LTS EE   AQKLCG+  NG
Sbjct: 18  CPSGWAISPNKSKCFKLIRRFKSWNESENRCMHYGGHVAGLTSSEELSFAQKLCGQTANG 77

Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
           CW GGR +N+T+G  WKWSD+ S  N+SI     F  +CTSL C      DLCT+V NG+
Sbjct: 78  CWAGGRVMNSTIGFIWKWSDSTSHMNQSI-VPEPFPLNCTSLSCRNSIAADLCTVV-NGT 135

Query: 173 RSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRR 232
             LV ERCN+SH FICM++ E KCY++HCHREYLI L VVSGLIL TT A+VIWLLAYRR
Sbjct: 136 ADLVAERCNSSHAFICMLDVEKKCYHMHCHREYLIILAVVSGLILCTTLAVVIWLLAYRR 195

Query: 233 SKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD 292
           SK+RRKSRKLSNPAASALVPPSWKVFT EELRSITKNFSEGNRLLGD+KTGGTYSG LPD
Sbjct: 196 SKKRRKSRKLSNPAASALVPPSWKVFTNEELRSITKNFSEGNRLLGDAKTGGTYSGFLPD 255

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           GSRVAVKRLKRSSFQRKKEFYSEIGR ARLHHPNLVA+KGCCYDHGDRYIVYEF++NGPL
Sbjct: 256 GSRVAVKRLKRSSFQRKKEFYSEIGRVARLHHPNLVAIKGCCYDHGDRYIVYEFILNGPL 315

Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
           DRWLHH+PRGGRSLDWAMRMK+ATTLAQGIAFLHDKVKPHVVHRDIRAS+VLLDEEFGAH
Sbjct: 316 DRWLHHVPRGGRSLDWAMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASSVLLDEEFGAH 375

Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 472
           LMGVGLSKF+PWEVM ERT+MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR
Sbjct: 376 LMGVGLSKFMPWEVMHERTMMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 435

Query: 473 PAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 532
           P QAVDSV WQSIFEWATPLVQ+HRY ELLDPLI+  SSD+PEAGV+QKVVDLVYACTQH
Sbjct: 436 PMQAVDSVGWQSIFEWATPLVQAHRYPELLDPLITPPSSDVPEAGVIQKVVDLVYACTQH 495

Query: 533 VPSMRPRMSHVVHQLQQLAQP 553
           VPSMRPRMSHVVHQLQQLAQP
Sbjct: 496 VPSMRPRMSHVVHQLQQLAQP 516

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449503381|ref|XP_004161974.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Cucumis sativus]

 Score =  803 bits (2074), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 391/556 (70%), Positives = 461/556 (82%), Gaps = 7/556 (1%)

Query: 9   LVPLQCFLLLVAYYVL----QLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKS 64
           + P +   L ++ +VL    ++  SDT+ N+S  G    S  +  K  CP  WII+  K+
Sbjct: 1   MAPTEVKTLFLSLFVLIWLSRMGVSDTMFNESGIGYSVVSRKEISKGRCPHGWIISPSKT 60

Query: 65  KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
           KCFG++ + +SW++SET C   GG+LAAL +Y+E   AQ LC   + GCWVGGR+ N+  
Sbjct: 61  KCFGFMSSPKSWNDSETQCNSFGGNLAALVTYQEFSYAQNLCNGTLGGCWVGGRAFNSLN 120

Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRS--LVTERCNT 182
              WKWSDN+SKWN+SI    +  S+C +  CH + +V+ CTL+  G  +  L  E+CN+
Sbjct: 121 DFVWKWSDNVSKWNDSIFPSATLQSNCKNASCHRNDSVETCTLIFGGPATPFLRDEKCNS 180

Query: 183 SHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKL 242
           SHPFICM+  +++C+ +HCH+EYL+ L VVSGLI  TT A+VIWLLA++RSK+RR+SRK 
Sbjct: 181 SHPFICMINLDDRCHRMHCHKEYLVILAVVSGLIFCTTLAVVIWLLAHKRSKKRRRSRKP 240

Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
           SNPAASALVPP W+VFT EELRS+TKNFSEGNRLLGD+KTGGTYSG+LPDGSRVA+KRLK
Sbjct: 241 SNPAASALVPPLWRVFTKEELRSMTKNFSEGNRLLGDAKTGGTYSGLLPDGSRVAIKRLK 300

Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
           +SSFQRKKEF+SEI R ARL HPNLVA+KGCCYDHGDRYIVYEF+VNGPLDRWLHH+PRG
Sbjct: 301 KSSFQRKKEFHSEIARVARLRHPNLVALKGCCYDHGDRYIVYEFIVNGPLDRWLHHVPRG 360

Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
           GRSLDW MRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK V
Sbjct: 361 GRSLDWTMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKLV 420

Query: 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW 482
            +EVM ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV+GRRPAQAVDSV W
Sbjct: 421 AYEVMHERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVTGRRPAQAVDSVGW 480

Query: 483 QSIFEWATPLVQSHRYLELLDPLISSLS-SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541
           QSIFEWATPLVQ+HRYL+LLDP I++ S S+IPEAG+VQKVVDLVYACTQHVPSMRPRMS
Sbjct: 481 QSIFEWATPLVQAHRYLDLLDPHITATSTSEIPEAGIVQKVVDLVYACTQHVPSMRPRMS 540

Query: 542 HVVHQLQQLAQPPVTK 557
           HVVHQLQQLA  P+T+
Sbjct: 541 HVVHQLQQLAPSPLTR 556

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449454927|ref|XP_004145205.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Cucumis sativus] gi|449473071|ref|XP_004153775.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Cucumis sativus]

 Score =  799 bits (2063), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 390/555 (70%), Positives = 459/555 (82%), Gaps = 7/555 (1%)

Query: 9   LVPLQCFLLLVAYYVL----QLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKS 64
           + P +   L ++ +VL    ++  SDT+ N+S  G    S  +  K  CP  WII+  K+
Sbjct: 1   MAPTEVKTLFLSLFVLIWLSRMGVSDTMFNESGIGYSVVSRKEISKGRCPHGWIISPSKT 60

Query: 65  KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
           KCFG++ + +SW++SET C   GG+LAAL +Y+E   AQ LC   + GCWVGGR+ N+  
Sbjct: 61  KCFGFMSSPKSWNDSETQCNSFGGNLAALVTYQEFSYAQNLCNGTLGGCWVGGRAFNSLN 120

Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRS--LVTERCNT 182
              WKWSDN+SKWN+SI    +  S+C +  C  + +V+ CTL+  G  +  L  E+CN+
Sbjct: 121 DFVWKWSDNVSKWNDSIFPSATLQSNCKNASCLRNDSVETCTLIFGGPATPFLRDEKCNS 180

Query: 183 SHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKL 242
           SHPFICM+  +++C+ +HCH+EYL+ L VVSGLI  TT A+VIWLLA++RSK+RR+SRK 
Sbjct: 181 SHPFICMINLDDRCHRMHCHKEYLVILAVVSGLIFCTTLAVVIWLLAHKRSKKRRRSRKP 240

Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
           SNPAASALVPP W+VFT EELRS+TKNFSEGNRLLGD+KTGGTYSG+LPDGSRVA+KRLK
Sbjct: 241 SNPAASALVPPLWRVFTKEELRSMTKNFSEGNRLLGDAKTGGTYSGLLPDGSRVAIKRLK 300

Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
           +SSFQRKKEF+SEI R ARL HPNLVA+KGCCYDHGDRYIVYEF+VNGPLDRWLHH+PRG
Sbjct: 301 KSSFQRKKEFHSEIARVARLRHPNLVALKGCCYDHGDRYIVYEFIVNGPLDRWLHHVPRG 360

Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
           GRSLDW MRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK V
Sbjct: 361 GRSLDWTMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKLV 420

Query: 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW 482
            +EVM ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV+GRRPAQAVDSV W
Sbjct: 421 AYEVMHERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVTGRRPAQAVDSVGW 480

Query: 483 QSIFEWATPLVQSHRYLELLDPLISSLS-SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541
           QSIFEWATPLVQ+HRYL+LLDP I++ S S+IPEAG+VQKVVDLVYACTQHVPSMRPRMS
Sbjct: 481 QSIFEWATPLVQAHRYLDLLDPHITATSTSEIPEAGIVQKVVDLVYACTQHVPSMRPRMS 540

Query: 542 HVVHQLQQLAQPPVT 556
           HVVHQLQQLA  P+T
Sbjct: 541 HVVHQLQQLAPSPLT 555

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297745082|emb|CBI38674.3| unnamed protein product [Vitis vinifera]

 Score =  797 bits (2058), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/555 (72%), Positives = 443/555 (79%), Gaps = 50/555 (9%)

Query: 3   LLMEKKLVPLQCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEE 62
           + ME KLV LQ  LL+++  V QL ASD I ++S       S+    +A CPPDWI   +
Sbjct: 13  VFMEGKLVRLQFPLLVISCLVFQLRASDAILHESRR-----SLESRKEALCPPDWITGPD 67

Query: 63  KSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINT 122
           K+KCF YIGN +SWD SE YCK +GGHLAALTS++E  S Q LCG++ NGCWVGGR +N+
Sbjct: 68  KNKCFRYIGNPQSWDVSEAYCKSLGGHLAALTSFQELSSVQNLCGESNNGCWVGGRGVNS 127

Query: 123 TVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNT 182
           T G  WKWSDN S WNESI        +CT+  CH+  +VD CTLV+NGS  L+ ERCN 
Sbjct: 128 TFGAGWKWSDNTSHWNESIFP------NCTNSSCHIKNSVDSCTLVTNGSTFLIGERCNM 181

Query: 183 SHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKL 242
           SH  ICM++ ENKCY++HCH+EYLI L VVSGLIL TT A+VIWLLAYRRSKRRR+SRKL
Sbjct: 182 SHASICMIDIENKCYHMHCHKEYLIILAVVSGLILSTTLAVVIWLLAYRRSKRRRRSRKL 241

Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
           SNPAASALVPPSWKVFT EELRSITKNFSEGNRLLGD+KTGGTYSG+LPDGSRVAVKRLK
Sbjct: 242 SNPAASALVPPSWKVFTNEELRSITKNFSEGNRLLGDAKTGGTYSGLLPDGSRVAVKRLK 301

Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
           RS+FQRKKEFYSEIGR ARLHHPNLVAVKGCCYDHGDRYIVYEF++NGPLDRWLHHIPRG
Sbjct: 302 RSTFQRKKEFYSEIGRVARLHHPNLVAVKGCCYDHGDRYIVYEFIINGPLDRWLHHIPRG 361

Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
           GRSLDWAMRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV
Sbjct: 362 GRSLDWAMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 421

Query: 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW 482
            WEVM + TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV W
Sbjct: 422 SWEVMHQGTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVGW 481

Query: 483 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH 542
           QSIFEWATPL                                       HVPSMRPRMSH
Sbjct: 482 QSIFEWATPL---------------------------------------HVPSMRPRMSH 502

Query: 543 VVHQLQQLAQPPVTK 557
           VVHQLQQLAQPP+ K
Sbjct: 503 VVHQLQQLAQPPIAK 517

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356532800|ref|XP_003534958.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Glycine max]

 Score =  752 bits (1942), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/530 (70%), Positives = 437/530 (82%), Gaps = 8/530 (1%)

Query: 27  VASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI 86
           +AS+   N++  G    S+N+D K PCP  W+++  K+KCF ++G  +SW++SET C + 
Sbjct: 20  LASNATLNETC-GYFDGSLNRDPKVPCPIGWVMDPNKTKCFLHVGRPQSWNDSETCCSKY 78

Query: 87  GGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGS 146
           GGHL +LTS +E   AQ LCG+++N CW+GG+ +N+T G  W WS+N S WN SI ++ +
Sbjct: 79  GGHLVSLTSLQELQFAQSLCGESINSCWIGGQRLNSTAGYQWMWSNN-SPWNNSIFSMVN 137

Query: 147 FNSSC--TSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHRE 204
               C  T   CH ++T +LCT+V+N S SL+TERC+  H  +C+++ + K   +H  RE
Sbjct: 138 VPPHCNGTGPSCHRNSTDNLCTVVTNNSNSLITERCDNPHASLCILDIDTKRNQMHRRRE 197

Query: 205 YLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELR 264
           YLI L VVS LIL TT ++V+WLL Y+R K+RR+SRKLS P AS    PSWKVFT EELR
Sbjct: 198 YLIILTVVSTLILSTTLSVVVWLLVYKRGKKRRRSRKLSIPGASL---PSWKVFTKEELR 254

Query: 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH 324
           SITKNFSEGNRL+GD+KTGGTYSG+L DGS+VAVKRLKRSSFQRKKEFYSEI R ARL H
Sbjct: 255 SITKNFSEGNRLVGDAKTGGTYSGVLSDGSKVAVKRLKRSSFQRKKEFYSEISRVARLRH 314

Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
           PNLVAV GCCYDHGDRYIVYEFV NGPLD+WLHHIPRGGR+LDWAMRMK+ATTLAQGIAF
Sbjct: 315 PNLVAVMGCCYDHGDRYIVYEFVANGPLDKWLHHIPRGGRNLDWAMRMKIATTLAQGIAF 374

Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           LHDKVKP VVHRDIRASNVLLDEEFGA LMGVGLSKFVP+EVM ERTVMAGGTYGYLAPE
Sbjct: 375 LHDKVKPQVVHRDIRASNVLLDEEFGAQLMGVGLSKFVPYEVMHERTVMAGGTYGYLAPE 434

Query: 445 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504
           FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV WQSIFEWATPLVQ+HRY ELLD 
Sbjct: 435 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVGWQSIFEWATPLVQAHRYHELLDL 494

Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
            I+S SS IPEA  +QKVVDLVY+CTQHVPSMRPRMSHVVHQLQQ+AQPP
Sbjct: 495 HITS-SSIIPEASTIQKVVDLVYSCTQHVPSMRPRMSHVVHQLQQIAQPP 543

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356558437|ref|XP_003547513.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Glycine max]

 Score =  743 bits (1918), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/530 (71%), Positives = 430/530 (81%), Gaps = 8/530 (1%)

Query: 27  VASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI 86
           +AS+   N++  G    S+N+D K PCP  WI++  K+KCF ++G  +SW++SET C + 
Sbjct: 20  LASNATLNETC-GYFDGSLNRDPKVPCPIGWIMDPNKTKCFLHVGRPQSWNDSETCCSKY 78

Query: 87  GGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGS 146
           GGHL +LTS  E   AQ LCG+++N CWVGG+ +N T G  W WSDN S WN SI ++  
Sbjct: 79  GGHLVSLTSLPELQFAQGLCGESINSCWVGGQRVNATAGNQWMWSDN-SPWNNSIFSMVE 137

Query: 147 FNSSC--TSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHRE 204
               C  T   CH ++T +LCT+V+N S SL TERCN  H  +C+++ + KC  +H  RE
Sbjct: 138 VPPHCNGTGPSCHRNSTDNLCTVVTNNSNSLTTERCNNPHASLCILDIDTKCNQMHRRRE 197

Query: 205 YLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELR 264
           Y I L VVS LIL TT A+V+WLL Y+R K+RR+SRKLS P AS    PSWKVFT EELR
Sbjct: 198 YFIILTVVSALILSTTLAVVVWLLVYKRGKKRRRSRKLSIPGASL---PSWKVFTKEELR 254

Query: 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH 324
           SITKNFSEGNRL+GD+KTGGTYSG++ DGS+VAVKRLKRS+FQRKKEFYSEIGR ARL H
Sbjct: 255 SITKNFSEGNRLVGDTKTGGTYSGVVSDGSKVAVKRLKRSNFQRKKEFYSEIGRVARLRH 314

Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
           PNLVAV GCCYDHGDRYIVYEFV NGPLD+WLHHIPRGGRSLDWAMRMK+ATTLAQGIAF
Sbjct: 315 PNLVAVMGCCYDHGDRYIVYEFVANGPLDKWLHHIPRGGRSLDWAMRMKIATTLAQGIAF 374

Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           LHDKVKP VVHRDIR SNVLLDEEFGA LMGVGLSKFVP+EVM ERTVMAGGTYGYLAPE
Sbjct: 375 LHDKVKPQVVHRDIRTSNVLLDEEFGARLMGVGLSKFVPYEVMHERTVMAGGTYGYLAPE 434

Query: 445 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504
           FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV WQSIFEWATPLVQ+HRY ELLD 
Sbjct: 435 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVGWQSIFEWATPLVQAHRYHELLDL 494

Query: 505 LIS-SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            I+ S SS IPEA  +QKVVDLVY+CTQHVPSMRPRMSHV HQLQQ+ QP
Sbjct: 495 HITSSSSSIIPEASTIQKVVDLVYSCTQHVPSMRPRMSHVFHQLQQITQP 544

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357134621|ref|XP_003568915.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Brachypodium distachyon]

 Score =  729 bits (1883), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/502 (70%), Positives = 416/502 (82%), Gaps = 9/502 (1%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP  W I+ ++ KCF +I +  SWD SE  C+   GHLAAL+S ++ + A+ LCG + +G
Sbjct: 30  CPQGWQISPDRVKCFMHISSSLSWDGSEALCRNFSGHLAALSSVQDLNFAKSLCGASSSG 89

Query: 113 CWVGGR----SINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
           CWVGGR    S NTT  + WKWSD+ S WN+++      +++C S  C +  + D+CTLV
Sbjct: 90  CWVGGRRYNTSSNTTSVVGWKWSDDSSFWNQTVFPGEPSHANCNSTHCGLATSYDICTLV 149

Query: 169 SNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLL 228
           +N   +L   +C  SH  ICM+ HE++CY+ HCH+EY I L VVSGLIL TT A+V+WLL
Sbjct: 150 TNKHAALTGRKCGESHGLICMINHEDRCYHDHCHKEYFIVLIVVSGLILSTTLAVVVWLL 209

Query: 229 AYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSG 288
            YRRSK+RR+SR+ S  +A+ALVPP WKVFT EELRSITKNFSEGNRL G++KTGGTYSG
Sbjct: 210 VYRRSKKRRRSREASGTSATALVPPLWKVFTGEELRSITKNFSEGNRLPGNAKTGGTYSG 269

Query: 289 ILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
           I+PDGS+VA+KRLKRSS QRKK+FYSEI R A+L+HPNLVAVKGCCYDHGDR+IVYEFV 
Sbjct: 270 IMPDGSKVAIKRLKRSSLQRKKDFYSEISRVAKLYHPNLVAVKGCCYDHGDRFIVYEFVA 329

Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
           NGPLD WLHHIPRGGRSLDW  RM+VATTLAQGIAFLHDKVKP VVHRDIRASNVLLDEE
Sbjct: 330 NGPLDVWLHHIPRGGRSLDWVTRMRVATTLAQGIAFLHDKVKPQVVHRDIRASNVLLDEE 389

Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
           FG+HLMGVGLSKFVPWEVM ERTV A  TYGYLAPEF+YRNELTTKSDVYSFGVLLLEI+
Sbjct: 390 FGSHLMGVGLSKFVPWEVMHERTVKA-ATYGYLAPEFIYRNELTTKSDVYSFGVLLLEII 448

Query: 469 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYA 528
           SGRRPAQ+V+SV WQ+IFEWATPLVQSHRYLELLDPLI    +D+PE GV+QKVVDLVY+
Sbjct: 449 SGRRPAQSVESVGWQTIFEWATPLVQSHRYLELLDPLI----NDLPEVGVIQKVVDLVYS 504

Query: 529 CTQHVPSMRPRMSHVVHQLQQL 550
           CTQHVPS+RPRMSHVVHQLQQL
Sbjct: 505 CTQHVPSVRPRMSHVVHQLQQL 526

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115434006|ref|NP_001041761.1| Os01g0104000 [Oryza sativa Japonica Group] gi|52075662|dbj|BAD44832.1| putative protein kinase [Oryza sativa Japonica Group] gi|113531292|dbj|BAF03675.1| Os01g0104000 [Oryza sativa Japonica Group] gi|125568686|gb|EAZ10201.1| hypothetical protein OsJ_00032 [Oryza sativa Japonica Group]

 Score =  726 bits (1873), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/499 (71%), Positives = 408/499 (81%), Gaps = 6/499 (1%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKNVN 111
           CP  W I     KCF YI    SWD SE  C+     HLAAL+S ++ + A+ LCG + +
Sbjct: 32  CPDGWQITPALDKCFIYIPTPLSWDRSEALCRNNFTAHLAALSSLQDLNLAKSLCGPSPS 91

Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
           GCWVGG   NT    +WKWSD+ S WN++        ++C++  C +  T D CTLV+N 
Sbjct: 92  GCWVGGHRNNTASAFAWKWSDDSSSWNDTAFPADPLRANCSTTGCALATTNDACTLVTNT 151

Query: 172 SRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYR 231
             +L  +RC+ SH  ICM+ HE++CY+ HCH+EY I L VVSG ILLTT A+V+WLL YR
Sbjct: 152 HAALTAKRCSDSHGLICMINHEDRCYHDHCHKEYFIVLVVVSGFILLTTLAVVVWLLVYR 211

Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILP 291
           RSKRRR+SR+ S+ +A+ALVPP WKVFT+EELRSITKNFSEGNRL G++KTGGTYSGILP
Sbjct: 212 RSKRRRRSREGSSTSATALVPPLWKVFTSEELRSITKNFSEGNRLPGNAKTGGTYSGILP 271

Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           DGSRVA+KRLKRSS QRKK+FYSEIGR A+L+HPNLVAVKGCCYDHGDR+IVYEFV NGP
Sbjct: 272 DGSRVAIKRLKRSSLQRKKDFYSEIGRVAKLYHPNLVAVKGCCYDHGDRFIVYEFVANGP 331

Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
           LD WLHH+PRGGR LDW MRM+VATTLAQGIAFLHDKVKP VVHRDIRASNVLLDEEFG+
Sbjct: 332 LDVWLHHVPRGGRCLDWPMRMRVATTLAQGIAFLHDKVKPQVVHRDIRASNVLLDEEFGS 391

Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
           HLMGVGLSKFVPWEVM ERTV A  TYGYLAPEF+YRNELTTKSDVYSFGVLLLEI+SGR
Sbjct: 392 HLMGVGLSKFVPWEVMHERTVKA-ATYGYLAPEFIYRNELTTKSDVYSFGVLLLEIISGR 450

Query: 472 RPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQ 531
           RP Q+V+SV WQ+IFEWATPLVQSHRYLELLDPLI  L    P+ GV+QKVVDLVYACTQ
Sbjct: 451 RPTQSVESVGWQTIFEWATPLVQSHRYLELLDPLIQEL----PDVGVIQKVVDLVYACTQ 506

Query: 532 HVPSMRPRMSHVVHQLQQL 550
           HVPS+RPRMSHVVHQLQQL
Sbjct: 507 HVPSVRPRMSHVVHQLQQL 525

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	557
TAIR|locus:2018189	552	AT1G52310 [Arabidopsis thalian	0.926	0.934	0.654	1.2e-184
TAIR|locus:2026925	708	PERK9 "proline-rich extensin-l	0.526	0.413	0.374	2.6e-53
TAIR|locus:2159873	681	PERK8 "proline-rich extensin-l	0.527	0.431	0.37	1.4e-52
TAIR|locus:2028756	762	PERK10 "proline-rich extensin-	0.535	0.391	0.378	6.5e-51
TAIR|locus:2091722	652	PERK1 "proline-rich extensin-l	0.543	0.464	0.377	8.3e-51
UNIPROTKB|Q9ARH1	647	Q9ARH1 "Receptor protein kinas	0.543	0.468	0.374	1.1e-50
TAIR|locus:2093900	361	AT3G15890 [Arabidopsis thalian	0.520	0.803	0.396	4.6e-50
TAIR|locus:2093999	700	PERK6 "proline-rich extensin-l	0.513	0.408	0.388	7.4e-50
TAIR|locus:2026846	710	PERK13 "proline-rich extensin-	0.527	0.414	0.384	9.5e-50
TAIR|locus:2125692	731	PERK14 "proline-rich extensin-	0.540	0.411	0.375	3.4e-49

TAIR|locus:2018189 AT1G52310 [Arabidopsis thaliana (taxid:3702)]

 Score = 1791 (635.5 bits), Expect = 1.2e-184, P = 1.2e-184
 Identities = 346/529 (65%), Positives = 407/529 (76%)

Query:    30 DTISNQSSNGQLAASMNK-DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGG 88
             DTIS +S+  Q A    K      CPPDWII   ++KC+ Y  N  SW++SE +C+  GG
Sbjct:    28 DTISCEST--QNATDFKKRSQTVSCPPDWIIGPNQTKCYAYFKNSTSWEKSEMFCRTYGG 85

Query:    89 HLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINT-TVGLSWKWSDNMS-KWNESIHAVGS 146
             HLA+L S +E    QKLC  NV+ CW+GGRS+N+ T G  W WSD  + +WN+S+     
Sbjct:    86 HLASLASSKELSFVQKLCNGNVSSCWIGGRSMNSSTSGFRWSWSDPKTPQWNQSMFPKVP 145

Query:   147 FNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYL 206
               + C +         ++C  V+NGS S+  ERCN SH F+C V+ + KC   +CH+ YL
Sbjct:   146 IRTRCGNGNGSSSCRANICIAVTNGSSSIFGERCNASHAFVCAVDSDIKCR--NCHK-YL 202

Query:   207 ITLGVVSGLILLTTFAIVIWLLAYXXXXXXXXXXXLSNPAASA-LVPPSWKVFTTEELRS 265
             + L VVSGLIL TTFAI++WLL Y           +SNPA+S+ +VPPSWK+FT+EELRS
Sbjct:   203 VILAVVSGLILFTTFAIILWLLVYKRSKKRRKSRKVSNPASSSSVVPPSWKIFTSEELRS 262

Query:   266 ITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP 325
             +TKNFSE NRL GD+KTGGTYSG L DG++VAVKRLKRSSFQRKKEFYSEI R A+L+HP
Sbjct:   263 MTKNFSEANRLAGDAKTGGTYSGGLSDGTKVAVKRLKRSSFQRKKEFYSEIRRAAKLYHP 322

Query:   326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             N+VA+KGCCYDHG+R+IVYEF+ +GPLDRWLHH+PRGGRSLDW MR+ +ATTLAQGIAFL
Sbjct:   323 NVVAIKGCCYDHGERFIVYEFIASGPLDRWLHHVPRGGRSLDWNMRLNIATTLAQGIAFL 382

Query:   386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
             HDKVKP VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE+
Sbjct:   383 HDKVKPQVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEY 442

Query:   446 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSIFEWATPLVQSHRYXXXXXX 504
             VYRNELTTKSDVYSFGVLLLEIVSGRRP QAV+S V WQSIFEWATPLVQ++R+      
Sbjct:   443 VYRNELTTKSDVYSFGVLLLEIVSGRRPTQAVNSSVGWQSIFEWATPLVQANRWLEILDP 502

Query:   505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
                        A VVQKVVDLVY+CTQ+VPSMRPRMSHVVHQLQQL QP
Sbjct:   503 VITCGLPE---ACVVQKVVDLVYSCTQNVPSMRPRMSHVVHQLQQLVQP 548

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006346 "methylation-dependent chromatin silencing" evidence=RCA

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010048 "vernalization response" evidence=RCA

GO:0010050 "vegetative phase change" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0016246 "RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 525 (189.9 bits), Expect = 2.6e-53, Sum P(2) = 2.6e-53
 Identities = 113/302 (37%), Positives = 173/302 (57%)

Query:   257 VFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEI 316
             +F+ EEL   T  FS+ N LLG+   G  Y GILPDG  VAVK+LK    Q  +EF +E+
Sbjct:   364 LFSYEELVKATNGFSQEN-LLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEV 422

Query:   317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS-LDWAMRMKVA 375
                +R+HH +LV++ G C     R ++Y++V N  L   LH    G +S LDWA R+K+A
Sbjct:   423 ETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLH----GEKSVLDWATRVKIA 478

Query:   376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435
                A+G+A+LH+   P ++HRDI++SN+LL++ F A +   GL++    +     T    
Sbjct:   479 AGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLA-LDCNTHITTRVI 537

Query:   436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495
             GT+GY+APE+    +LT KSDV+SFGV+LLE+++GR+P      +  +S+ EWA PL+ S
Sbjct:   538 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLI-S 596

Query:   496 HRYXXXXXXXXXXXXXXXXXA-GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
             H                       + ++++   AC +H+ + RPRM  +V   + LA   
Sbjct:   597 HAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAED 656

Query:   555 VT 556
             +T
Sbjct:   657 LT 658

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 509 (184.2 bits), Expect = 1.4e-52, Sum P(2) = 1.4e-52
 Identities = 111/300 (37%), Positives = 168/300 (56%)

Query:   254 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFY 313
             SW  F+ +EL  +T  FSE N LLG+   G  Y G+L DG  VAVK+LK    Q ++EF 
Sbjct:   325 SW--FSYDELSQVTSGFSEKN-LLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFK 381

Query:   314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
             +E+   +R+HH +LV + G C     R +VY++V N  L   LH  P G   + W  R++
Sbjct:   382 AEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLH-AP-GRPVMTWETRVR 439

Query:   374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP-WEVMQERTV 432
             VA   A+GIA+LH+   P ++HRDI++SN+LLD  F A +   GL+K     ++    + 
Sbjct:   440 VAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVST 499

Query:   433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 492
                GT+GY+APE+    +L+ K+DVYS+GV+LLE+++GR+P      +  +S+ EWA PL
Sbjct:   500 RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPL 559

Query:   493 VQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
             +                       G + ++V+   AC +H  + RP+MS VV  L  L +
Sbjct:   560 LGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEE 619

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005199 "structural constituent of cell wall" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 530 (191.6 bits), Expect = 6.5e-51, P = 6.5e-51
 Identities = 115/304 (37%), Positives = 173/304 (56%)

Query:   254 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFY 313
             S ++F+ EEL   T  FS+ N LLG+   G  Y G+LPD   VAVK+LK    Q  +EF 
Sbjct:   414 SRELFSYEELVIATNGFSDEN-LLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFK 472

Query:   314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
             +E+   +R+HH NL+++ G C     R ++Y++V N  L   LH    G   LDWA R+K
Sbjct:   473 AEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLH--AAGTPGLDWATRVK 530

Query:   374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
             +A   A+G+A+LH+   P ++HRDI++SN+LL+  F A +   GL+K    +     T  
Sbjct:   531 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLA-LDCNTHITTR 589

Query:   434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV 493
               GT+GY+APE+    +LT KSDV+SFGV+LLE+++GR+P  A   +  +S+ EWA PL+
Sbjct:   590 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 649

Query:   494 QSHRYXXXXXXXXXXXXXXXXXAGVVQ-KVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
              S+                    GV   ++++   AC +H  + RPRMS +V     LA+
Sbjct:   650 -SNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLAE 708

Query:   553 PPVT 556
               +T
Sbjct:   709 EDLT 712

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 528 (190.9 bits), Expect = 8.3e-51, P = 8.3e-51
 Identities = 116/307 (37%), Positives = 172/307 (56%)

Query:   242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRL 301
             L  P+   ++  S   FT EEL   T  FSE N LLG    G  + GILP G  VAVK+L
Sbjct:   252 LPPPSPGLVLGFSKSTFTYEELSRATNGFSEAN-LLGQGGFGYVHKGILPSGKEVAVKQL 310

Query:   302 KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPR 361
             K  S Q ++EF +E+   +R+HH +LV++ G C     R +VYEFV N  L+  LH   +
Sbjct:   311 KAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG--K 368

Query:   362 GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421
             G  +++W+ R+K+A   A+G+++LH+   P ++HRDI+ASN+L+D +F A +   GL+K 
Sbjct:   369 GRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKI 428

Query:   422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC 481
                +     +    GT+GYLAPE+    +LT KSDV+SFGV+LLE+++GRRP  A +   
Sbjct:   429 AS-DTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYV 487

Query:   482 WQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMS 541
               S+ +WA PL+                         + ++V    AC +H    RPRMS
Sbjct:   488 DDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMS 547

Query:   542 HVVHQLQ 548
              +V  L+
Sbjct:   548 QIVRALE 554

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)]

 Score = 527 (190.6 bits), Expect = 1.1e-50, P = 1.1e-50
 Identities = 115/307 (37%), Positives = 171/307 (55%)

Query:   242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRL 301
             L  P+   ++  S   FT EEL   T  FSE N LLG    G  + G+LP G  VAVK+L
Sbjct:   247 LPPPSPGLVLGFSKSTFTYEELARATNGFSEAN-LLGQGGFGYVHKGVLPSGKEVAVKQL 305

Query:   302 KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPR 361
             K  S Q ++EF +E+   +R+HH +LV++ G C     R +VYEFV N  L+  LH    
Sbjct:   306 KVGSGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHG--E 363

Query:   362 GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421
             G  +++W+ R+K+A   A+G+++LH+   P ++HRDI+ASN+L+D +F A +   GL+K 
Sbjct:   364 GRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKI 423

Query:   422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC 481
                +     +    GT+GYLAPE+    +LT KSDV+SFGV+LLE+++GRRP  A +   
Sbjct:   424 AS-DTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYV 482

Query:   482 WQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMS 541
               S+ +WA PL+                         + ++V    AC +H    RPRMS
Sbjct:   483 DDSLVDWARPLLNRASEQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMS 542

Query:   542 HVVHQLQ 548
              +V  L+
Sbjct:   543 QIVRALE 549

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005887 "integral to plasma membrane" evidence=IDA

TAIR|locus:2093900 AT3G15890 [Arabidopsis thaliana (taxid:3702)]

 Score = 521 (188.5 bits), Expect = 4.6e-50, P = 4.6e-50
 Identities = 117/295 (39%), Positives = 165/295 (55%)

Query:   253 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEF 312
             PSW+VF+ +EL + T +F+  N+L G+ + G  Y G L DGS++AVKRLK  S + + +F
Sbjct:    22 PSWRVFSLKELHAATNSFNYDNKL-GEGRFGSVYWGQLWDGSQIAVKRLKEWSNREEIDF 80

Query:   313 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
               E+   AR+ H NL++V+G C +  +R +VYE++ N  L   LH        LDW  RM
Sbjct:    81 AVEVEILARIRHKNLLSVRGYCAEGQERLLVYEYMQNLSLVSHLHGQHSAECLLDWTKRM 140

Query:   373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
             K+A + AQ IA+LHD   PH+VH D+RASNVLLD EF A +   G  K +P +   +   
Sbjct:   141 KIAISSAQAIAYLHDHATPHIVHGDVRASNVLLDSEFEARVTDFGYGKLMPDDDTGDGAT 200

Query:   433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 492
              A    GY++PE     + +  SDVYSFG+LL+ +VSG+RP + ++    + I EW  PL
Sbjct:   201 KAKSNNGYISPECDASGKESETSDVYSFGILLMVLVSGKRPLERLNPTTTRCITEWVLPL 260

Query:   493 VQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
             V    Y                 A  ++KVV +   C Q  P  RP MS VV  L
Sbjct:   261 V----YERNFGEIVDKRLSEEHVAEKLKKVVLVGLMCAQTDPDKRPTMSEVVEML 311

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 519 (187.8 bits), Expect = 7.4e-50, P = 7.4e-50
 Identities = 113/291 (38%), Positives = 167/291 (57%)

Query:   258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIG 317
             FT +EL + T+ FS+ +RLLG    G  + GILP+G  +AVK LK  S Q ++EF +E+ 
Sbjct:   325 FTYDELAAATQGFSQ-SRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVD 383

Query:   318 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
               +R+HH  LV++ G C   G R +VYEF+ N  L+  LH   + G+ LDW  R+K+A  
Sbjct:   384 IISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHG--KSGKVLDWPTRLKIALG 441

Query:   378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
              A+G+A+LH+   P ++HRDI+ASN+LLDE F A +   GL+K     V    T + G T
Sbjct:   442 SAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMG-T 500

Query:   438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497
             +GYLAPE+    +LT +SDV+SFGV+LLE+V+GRRP      +   S+ +WA P+  +  
Sbjct:   501 FGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEM-EDSLVDWARPICLNAA 559

Query:   498 YXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
                                  + ++V    A  +H    RP+MS +V  L+
Sbjct:   560 QDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALE 610

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 518 (187.4 bits), Expect = 9.5e-50, P = 9.5e-50
 Identities = 116/302 (38%), Positives = 173/302 (57%)

Query:   248 SALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ 307
             SA++      FT EEL  IT+ FS+ N +LG+   G  Y G L DG  VAVK+LK  S Q
Sbjct:   331 SAVMGSGQTHFTYEELTDITEGFSKHN-ILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQ 389

Query:   308 RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS-L 366
               +EF +E+   +R+HH +LV++ G C    +R ++YE+V N  L+   HH+   GR  L
Sbjct:   390 GDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLE---HHLHGKGRPVL 446

Query:   367 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426
             +WA R+++A   A+G+A+LH+   P ++HRDI+++N+LLD+EF A +   GL+K      
Sbjct:   447 EWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQ 506

Query:   427 MQERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI 485
                 T VM  GT+GYLAPE+    +LT +SDV+SFGV+LLE+++GR+P      +  +S+
Sbjct:   507 THVSTRVM--GTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESL 564

Query:   486 FEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545
              EWA PL+                         V ++++   AC +H    RPRM  VV 
Sbjct:   565 VEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVR 624

Query:   546 QL 547
              L
Sbjct:   625 AL 626

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2125692 PERK14 "proline-rich extensin-like receptor kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 513 (185.6 bits), Expect = 3.4e-49, P = 3.4e-49
 Identities = 116/309 (37%), Positives = 175/309 (56%)

Query:   243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
             +N  A  +  PS  +F+ EEL   T  FSE N LLG+   G  + G+L +G+ VAVK+LK
Sbjct:   363 NNSVAKNISMPSG-MFSYEELSKATGGFSEEN-LLGEGGFGYVHKGVLKNGTEVAVKQLK 420

Query:   303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
               S+Q ++EF +E+   +R+HH +LV++ G C +   R +VYEFV    L+  LH     
Sbjct:   421 IGSYQGEREFQAEVDTISRVHHKHLVSLVGYCVNGDKRLLVYEFVPKDTLEFHLHE--NR 478

Query:   363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
             G  L+W MR+++A   A+G+A+LH+   P ++HRDI+A+N+LLD +F A +   GL+KF 
Sbjct:   479 GSVLEWEMRLRIAVGAAKGLAYLHEDCSPTIIHRDIKAANILLDSKFEAKVSDFGLAKFF 538

Query:   423 PWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
               +     T ++    GT+GY+APE+    ++T KSDVYSFGV+LLE+++GR    A DS
Sbjct:   539 S-DTNSSFTHISTRVVGTFGYMAPEYASSGKVTDKSDVYSFGVVLLELITGRPSIFAKDS 597

Query:   480 VCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPR 539
                QS+ +WA PL+                         +  +     AC +    +RPR
Sbjct:   598 STNQSLVDWARPLLTKAISGESFDFLVDSRLEKNYDTTQMANMAACAAACIRQSAWLRPR 657

Query:   540 MSHVVHQLQ 548
             MS VV  L+
Sbjct:   658 MSQVVRALE 666

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9C823	Y1523_ARATH	2, ., 7, ., 1, 0, ., 1	0.6636	0.9712	0.9800	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pg.C_290027 hypothetical protein (517 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	557
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-37
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-36
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-36
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-34
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-34
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-33
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-26
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-22
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-21
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-21
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-17
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-16
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-15
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-15
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-14
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-14
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-13
smart00034	124	smart00034, CLECT, C-type lectin (CTL) or carbohyd	4e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-12
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-12
cd00037	116	cd00037, CLECT, C-type lectin (CTL)/C-type lectin-	4e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-11
cd03594	129	cd03594, CLECT_REG-1_like, C-type lectin-like doma	8e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-10
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-10
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-09
cd03590	126	cd03590, CLECT_DC-SIGN_like, C-type lectin-like do	3e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-09
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-09
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	9e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-08
cd03593	116	cd03593, CLECT_NK_receptors_like, C-type lectin-li	6e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-07
pfam00059	108	pfam00059, Lectin_C, Lectin C-type domain	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-07
cd03603	118	cd03603, CLECT_VCBS, A bacterial subgroup of the C	4e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-07
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-07
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-06
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-06
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-05
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-05
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-05
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-04
cd03589	137	cd03589, CLECT_CEL-1_like, C-type lectin-like doma	2e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-04
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-04
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-04
cd03588	124	cd03588, CLECT_CSPGs, C-type lectin-like domain (C	4e-04
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-04
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-04
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-04
PHA02642	216	PHA02642, PHA02642, C-type lectin-like protein; Pr	6e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	7e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	0.001
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.001
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.001
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.001
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	0.002
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	0.002
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	0.002
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	0.003
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.003
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	0.004

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  138 bits (349), Expect = 4e-37
 Identities = 76/275 (27%), Positives = 121/275 (44%), Gaps = 36/275 (13%)

Query: 284 GTYSGILPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342
           G   G     + VAVK LK   S + +K+F  E     +L HPN+V + G C +    Y+
Sbjct: 14  GKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYL 73

Query: 343 VYEFVVNGPLDRWL-----HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
           V E++  G L  +L             +L     +  A  +A+G+ +L  K     VHRD
Sbjct: 74  VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRD 130

Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY---GYLAPEFVYRNELTTK 454
           + A N L+ E+    +   GLS+ V  +   +      G      ++APE +     T+K
Sbjct: 131 LAARNCLVGEDLVVKISDFGLSRDVYDD---DYYRKKTGGKLPIRWMAPESLKDGIFTSK 187

Query: 455 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513
           SDV+SFGVLL EI + G  P   +     + + E+   L + +R   L  P         
Sbjct: 188 SDVWSFGVLLWEIFTLGATPYPGLS---NEEVLEY---LRKGYR---LPKPEYCP----- 233

Query: 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
                  ++ +L+ +C Q  P  RP  S +V +L+
Sbjct: 234 ------DELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  137 bits (347), Expect = 7e-37
 Identities = 78/277 (28%), Positives = 122/277 (44%), Gaps = 49/277 (17%)

Query: 284 GTYSGILPDGS-RVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
           GT  G       +VAVK LK  + +  ++EF  E     +L HPN+V + G C      Y
Sbjct: 18  GTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLY 77

Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           IV E++  G L  +L    + G  L     +++A  +A+G+ +L  K   + VHRD+ A 
Sbjct: 78  IVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK---NFVHRDLAAR 131

Query: 402 NVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYG---YLAPEFVYRNEL 451
           N L+ E        F       GLS+ +  +   +     GG      ++APE +   + 
Sbjct: 132 NCLVTENLVVKISDF-------GLSRDIYED---DYYRKRGGGKLPIKWMAPESLKDGKF 181

Query: 452 TTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
           T+KSDV+SFGVLL EI + G +P   +     + + E    L   +R   L  P      
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQPYPGMS---NEEVLEL---LEDGYR---LPRPENCP-- 230

Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
                     ++ +L+  C  + P  RP  S +V  L
Sbjct: 231 ---------DELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  134 bits (341), Expect = 5e-36
 Identities = 72/270 (26%), Positives = 112/270 (41%), Gaps = 35/270 (12%)

Query: 284 GTYSGILPDGS-RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
           GT  G        VAVK LK   S Q+ +EF  E     +L HPN+V + G C +     
Sbjct: 18  GTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77

Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           IV E++  G L  +L       + L  +  +  A  +A+G+ +L  K   + +HRD+ A 
Sbjct: 78  IVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAAR 132

Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVY 458
           N L+ E     +   GLS+ +      +      G      ++APE +   + T+KSDV+
Sbjct: 133 NCLVGENLVVKISDFGLSRDLY----DDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVW 188

Query: 459 SFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG 517
           SFGVLL EI + G  P   +       + E+    ++    L                  
Sbjct: 189 SFGVLLWEIFTLGEEPYPGMS---NAEVLEY----LKKGYRLP-------------KPPN 228

Query: 518 VVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
              ++  L+  C    P  RP  S +V  L
Sbjct: 229 CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  134 bits (339), Expect = 8e-36
 Identities = 73/270 (27%), Positives = 117/270 (43%), Gaps = 36/270 (13%)

Query: 284 GTYSGILPDGSR-VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
           G   G        VAVK LK  +S Q+ +EF  E     +L HPN+V + G C +    Y
Sbjct: 18  GKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLY 77

Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           IV E++  G L  +L    +    L  +  +  A  +A+G+ +L  K   + +HRD+ A 
Sbjct: 78  IVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAAR 131

Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVY 458
           N L+ E     +   GLS+ +      +      G      ++APE +   + T+KSDV+
Sbjct: 132 NCLVGENLVVKISDFGLSRDLY----DDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVW 187

Query: 459 SFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG 517
           SFGVLL EI + G +P   +     + + E+    +++   L                  
Sbjct: 188 SFGVLLWEIFTLGEQPYPGMS---NEEVLEY----LKNGYRLP-------------QPPN 227

Query: 518 VVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
              ++ DL+  C    P  RP  S +V  L
Sbjct: 228 CPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  131 bits (331), Expect = 1e-34
 Identities = 63/248 (25%), Positives = 102/248 (41%), Gaps = 28/248 (11%)

Query: 292 DGSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
            G  VA+K +K+   ++ +E    EI    +L HPN+V +     D    Y+V E+   G
Sbjct: 23  TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGG 82

Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L   L    RG  S D A        +   + +LH K    +VHRD++  N+LLDE+  
Sbjct: 83  DLFDLLKK--RGRLSEDEA--RFYLRQILSALEYLHSK---GIVHRDLKPENILLDEDGH 135

Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
             L   GL++ +         V   GT  Y+APE +         D++S GV+L E+++G
Sbjct: 136 VKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTG 192

Query: 471 RRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACT 530
           + P    D +    +F+     +   +                PE  +  +  DL+    
Sbjct: 193 KPPFPGDDQL--LELFK----KIGKPKP-----------PFPPPEWDISPEAKDLIRKLL 235

Query: 531 QHVPSMRP 538
              P  R 
Sbjct: 236 VKDPEKRL 243

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  127 bits (322), Expect = 6e-34
 Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 11/179 (6%)

Query: 292 DGSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
            G +VA+K +K+       E    EI    +L+HPN+V + G   D    Y+V E+   G
Sbjct: 17  TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76

Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L   L         L     +++   + +G+ +LH      ++HRD++  N+LLD + G
Sbjct: 77  SLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNG 130

Query: 411 -AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLLEI 467
              L   GLSK +  +    +T++  GT  Y+APE  + +   + KSD++S GV+L E+
Sbjct: 131 KVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  128 bits (323), Expect = 1e-33
 Identities = 79/279 (28%), Positives = 114/279 (40%), Gaps = 35/279 (12%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--FYSEIGRFARLHHPNLVAVK 331
           R LG    G  Y       G  VAVK LK+ S + KK+     EI    RL HPN+V + 
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
               D    Y+V E+   G L  +L      G  L      K+A  + +G+ +LH     
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHSN--- 117

Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV-YRNE 450
            ++HRD++  N+LLDE     +   GL+K               GT  Y+APE +   N 
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKK--LLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS-- 508
              K DV+S GV+L E+++G+ P    + +             Q      +L P +    
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILD------------QLQLIRRILGPPLEFDE 223

Query: 509 --LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545
              SS   EA       DL+  C    PS RP    ++ 
Sbjct: 224 PKWSSGSEEA------KDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  108 bits (273), Expect = 1e-26
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 12/204 (5%)

Query: 275 RLLGDSKTGGTYSGILPD-GSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVK 331
            LLG    G  Y  +  D G  +AVK   L   S +  +    EI   + L HPN+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 332 GCCYD--HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           G   D       I  E+V  G L      + + G+ L   +  K    + +G+A+LH   
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLS---SLLKKFGK-LPEPVIRKYTRQILEGLAYLHSN- 120

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
              +VHRDI+ +N+L+D +    L   G +K +      E T    GT  ++APE +   
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 450 ELTTKSDVYSFGVLLLEIVSGRRP 473
           E    +D++S G  ++E+ +G+ P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  108 bits (271), Expect = 2e-26
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 10/198 (5%)

Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           +G    G  Y       G  VA+K +K  S ++K++  +EI    +  HPN+V   G   
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
              + +IV EF   G L   L       ++L  +    V   L +G+ +LH      ++H
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIH 121

Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
           RDI+A+N+LL  +    L+  GLS  +     + R  M  GT  ++APE +       K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMV-GTPYWMAPEVINGKPYDYKA 178

Query: 456 DVYSFGVLLLEIVSGRRP 473
           D++S G+  +E+  G+ P
Sbjct: 179 DIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 7e-26
 Identities = 67/201 (33%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
            +G  + G    G    G +VAVK LK  S    + F +E      L HPNLV + G   
Sbjct: 13  TIGKGEFGDVMLGDY-RGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YIV E++  G L  +L    RG   +  A ++  A  + +G+ +L +K   + VH
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVH 125

Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A NVL+ E+  A +   GL+K       +       G     + APE +   + +T
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFST 178

Query: 454 KSDVYSFGVLLLEIVS-GRRP 473
           KSDV+SFG+LL EI S GR P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  106 bits (265), Expect = 1e-25
 Identities = 82/278 (29%), Positives = 126/278 (45%), Gaps = 33/278 (11%)

Query: 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+       VAVK LK  +    +EF  E      + HPNLV + G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 127

Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512
           KSDV++FGVLL EI + G  P   +D                S  Y ELL+        +
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGID---------------LSQVY-ELLE---KGYRME 225

Query: 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
            PE G   KV +L+ AC Q  PS RP  + +    + +
Sbjct: 226 RPE-GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  102 bits (256), Expect = 2e-24
 Identities = 58/198 (29%), Positives = 103/198 (52%), Gaps = 13/198 (6%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           R LG    G  + G+  +  RVA+K LK     ++++F  E+    RL H +L+++   C
Sbjct: 12  RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 YI+ E +  G L  +L   P  G+ L  A  + +A  +A+G+A+L ++   + +
Sbjct: 72  SVGEPVYIITELMEKGSLLAFLRS-PE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSI 126

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNEL 451
           HRD+ A N+L+ E+    +   GL++     +++E   ++      Y + APE       
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLAR-----LIKEDVYLSSDKKIPYKWTAPEAASHGTF 181

Query: 452 TTKSDVYSFGVLLLEIVS 469
           +TKSDV+SFG+LL E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 5e-24
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 12/202 (5%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           R LG  + G  + G+  + + VAVK LK  +    K+F +E     +L HP L+ +   C
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 YIV E +  G L  +L      GR+L     + +A  +A G+A+L  +   + +
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQ---NYI 125

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELT 452
           HRD+ A NVL+ E     +   GL++ +  ++ + R    G  +   + APE    N  +
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE---GAKFPIKWTAPEAALYNRFS 182

Query: 453 TKSDVYSFGVLLLEIVS-GRRP 473
            KSDV+SFG+LL EIV+ GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  103 bits (257), Expect = 6e-24
 Identities = 77/280 (27%), Positives = 121/280 (43%), Gaps = 28/280 (10%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARL-HHPNLVAV 330
           R LG+   G  Y     D   VA+K L +    + KE   F  EI   A L H PN+V +
Sbjct: 6   RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
                D G  Y+V E+V  G L+  L  I R G   +      +   +   + +LH K  
Sbjct: 64  YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL-FILAQILSALEYLHSK-- 120

Query: 391 PHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEV----MQERTVMAGGTYGYLAPEF 445
             ++HRDI+  N+LLD +     L+  GL+K +P       +      + GT GY+APE 
Sbjct: 121 -GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179

Query: 446 VYRNEL---TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL-EL 501
           +    L   ++ SD++S G+ L E+++G  P +   +    S         Q+ + + EL
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS---------QTLKIILEL 230

Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541
             P ++S  S      + +   DL+       P  R   S
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSS 270

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  100 bits (252), Expect = 1e-23
 Identities = 67/267 (25%), Positives = 123/267 (46%), Gaps = 23/267 (8%)

Query: 293 GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVN 349
           G +VAVK L  S   Q + +F  EI     L H N+V  KG C   G R   ++ E++ +
Sbjct: 33  GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92

Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
           G L     ++ R    ++    +  ++ + +G+ +L  +     +HRD+ A N+L++ E 
Sbjct: 93  GSLR---DYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESED 146

Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLL 464
              +   GL+K +P    +++        G     + APE +  ++ ++ SDV+SFGV L
Sbjct: 147 LVKISDFGLAKVLP----EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202

Query: 465 LEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVD 524
            E+ +   P+Q+  +   + I      ++ + R LELL      L           +V D
Sbjct: 203 YELFTYGDPSQSPPAEFLRMIGIAQGQMIVT-RLLELLKE-GERLP---RPPSCPDEVYD 257

Query: 525 LVYACTQHVPSMRPRMSHVVHQLQQLA 551
           L+  C +  P  RP  + ++  + +L 
Sbjct: 258 LMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  103 bits (259), Expect = 4e-23
 Identities = 91/347 (26%), Positives = 162/347 (46%), Gaps = 38/347 (10%)

Query: 211 VVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKV--FTTEELRSITK 268
           +   L      A+V +   + R +   + +++ N   +      W++  F ++  +SIT 
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGT------WELQFFDSKVSKSITI 685

Query: 269 N-----FSEGNRLLGDSKTGGTYSG-ILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
           N       E N ++   K G +Y G  + +G +  VK +   +        SEI    +L
Sbjct: 686 NDILSSLKEEN-VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKL 740

Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
            HPN+V + G C      Y+++E++    L   L       R+L W  R K+A  +A+ +
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKAL 793

Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
            FLH +  P VV  ++    +++D +   HL  + L    P  +  +          Y+A
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL----PGLLCTDTKCFISS--AYVA 846

Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL- 501
           PE     ++T KSD+Y FG++L+E+++G+ PA A   V   SI EWA     S  +L++ 
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWAR-YCYSDCHLDMW 904

Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
           +DP I    S + +  +V+ V++L   CT   P+ RP  + V+  L+
Sbjct: 905 IDPSIRGDVS-VNQNEIVE-VMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 97.3 bits (242), Expect = 2e-22
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 19/263 (7%)

Query: 293 GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVN 349
           G  VAVK LKR    Q    +  EI     L+H N+V  KGCC + G +   ++ E+V  
Sbjct: 33  GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV-- 90

Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
            PL     ++P+    L+ A  +  A  + +G+A+LH +   H +HRD+ A NVLLD + 
Sbjct: 91  -PLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDR 144

Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
              +   GL+K VP      R    G +   + A E +  N+ +  SDV+SFGV L E++
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Query: 469 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS-SLSSDIPEAGVVQKVVDLVY 527
           +     Q+     ++ +       +   R +ELL+  +      + P     Q+V  L+ 
Sbjct: 205 THCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCP-----QEVYILMK 258

Query: 528 ACTQHVPSMRPRMSHVVHQLQQL 550
            C +     RP    ++  L+++
Sbjct: 259 NCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 95.9 bits (239), Expect = 3e-22
 Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 48/283 (16%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVK 331
             +G    G  Y+ + L  G  +AVK  R++ +  +  KE   E+     L HPNLV   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
           G        YI  E+   G L+  L H    GR LD  +       L +G+A+LH     
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH--- 118

Query: 392 HVVHRDIRASNVLLDE-------EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
            +VHRDI+ +N+ LD        +FG  +  +  +     E +Q       GT  Y+APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVK-LKNNTTTMGEEVQSLA----GTPAYMAPE 173

Query: 445 FVYRNELTTK---SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA---TPLVQSHRY 498
            +   +       +D++S G ++LE+ +G+RP   +D+  +Q +F       P +     
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGAGHKPPI----- 227

Query: 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541
                P    LS +           D +  C +  P  RP  S
Sbjct: 228 -----PDSLQLSPE---------GKDFLDRCLESDPKKRPTAS 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 19/211 (9%)

Query: 269 NFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHP 325
           N+  G+ L+G    G  Y G+ L  G  VA+K++     + +  K    EI     L HP
Sbjct: 1   NYQLGD-LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP 59

Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GI 382
           N+V   G        YI+ E+  NG L + +        SL       VA  + Q   G+
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGL 112

Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
           A+LH++    V+HRDI+A+N+L  ++    L   G++  +      + +V+  GT  ++A
Sbjct: 113 AYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV--GTPYWMA 167

Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           PE +  +  +T SD++S G  ++E+++G  P
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 92.4 bits (230), Expect = 6e-21
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 20/207 (9%)

Query: 274 NRLLGDSKTG----GTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA 329
            R LG  + G    GT++G       VAVK LK  +    + F  E     +L H  LV 
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTK----VAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQ 65

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           +   C +    YIV E++  G L  +L      G+ L     + +A  +A+G+A+L  + 
Sbjct: 66  LYAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR- 122

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVY 447
             + +HRD+ A N+L+ E     +   GL++ +  +   E T   G  +   + APE   
Sbjct: 123 --NYIHRDLAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAAN 177

Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRP 473
               T KSDV+SFG+LL EIV+ GR P
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 89.9 bits (224), Expect = 4e-20
 Identities = 47/191 (24%), Positives = 86/191 (45%), Gaps = 15/191 (7%)

Query: 292 DGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
           DG    +K   L   S + +++  +E+    +L+HPN++       + G   IV E+   
Sbjct: 24  DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83

Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
           G L + +    + G+       +     L   + +LH +    ++HRDI+  N+ L    
Sbjct: 84  GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNG 140

Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNE-LTTKSDVYSFGVLLL 465
              L   G+SK     V+     +A    GT  YL+PE + +N+    KSD++S G +L 
Sbjct: 141 LVKLGDFGISK-----VLSSTVDLAKTVVGTPYYLSPE-LCQNKPYNYKSDIWSLGCVLY 194

Query: 466 EIVSGRRPAQA 476
           E+ + + P + 
Sbjct: 195 ELCTLKHPFEG 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 89.6 bits (222), Expect = 5e-20
 Identities = 67/256 (26%), Positives = 121/256 (47%), Gaps = 33/256 (12%)

Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           VA+K +K  S   + EF  E     +L H  LV + G C      YIV E++ NG L   
Sbjct: 31  VAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL--- 86

Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415
           L+++   G+    +  +++   + +G+A+L  K     +HRD+ A N L+D++    +  
Sbjct: 87  LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSD 143

Query: 416 VGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRR 472
            GLS++V   +  E T   G  +   +  PE +  ++ ++KSDV++FGVL+ E+ S G+ 
Sbjct: 144 FGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200

Query: 473 PAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 532
           P +  ++       E    + Q  R   L  P ++S           +KV  ++Y+C   
Sbjct: 201 PYERFNNS------ETVEKVSQGLR---LYRPHLAS-----------EKVYAIMYSCWHE 240

Query: 533 VPSMRPRMSHVVHQLQ 548
               RP    ++  ++
Sbjct: 241 KAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 61/262 (23%), Positives = 112/262 (42%), Gaps = 47/262 (17%)

Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           VA+K ++  +   + +F  E     +L HPNLV + G C      +IV E++ NG L  +
Sbjct: 31  VAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNY 89

Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415
           L        +      + + + + + + +L        +HRD+ A N L+ E+    +  
Sbjct: 90  LRERKGKLGT---EWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSD 143

Query: 416 VGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GR 471
            GL+++    V+ ++   + GT     +  PE    +  ++KSDV+SFGVL+ E+ S G+
Sbjct: 144 FGLARY----VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199

Query: 472 RP------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDL 525
            P      ++ V+SV                    L  P ++             +V  +
Sbjct: 200 MPYERFSNSEVVESV---------------SAGYRLYRPKLAP-----------TEVYTI 233

Query: 526 VYACTQHVPSMRPRMSHVVHQL 547
           +Y+C    P  RP    ++ QL
Sbjct: 234 MYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)

Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G  + G     ++VA+K LK+ S    + F +E     +L HP LV +      
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+  K   + +HR
Sbjct: 73  E-PIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHR 126

Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL EIV+ GR P
Sbjct: 184 SDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 85.8 bits (212), Expect = 8e-19
 Identities = 72/258 (27%), Positives = 119/258 (46%), Gaps = 34/258 (13%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           G +VAVK +K       + F  E     +LHH NLV + G    H   YIV E +  G L
Sbjct: 29  GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL-HNGLYIVMELMSKGNL 85

Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
             +L    RG   +     ++ +  +A+G+ +L  K    +VHRD+ A N+L+ E+  A 
Sbjct: 86  VNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAK 140

Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GR 471
           +   GL++     V   +  +      + APE +   + ++KSDV+S+GVLL E+ S GR
Sbjct: 141 VSDFGLARVGSMGVDNSKLPVK-----WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195

Query: 472 RPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQ 531
            P   +      S+ E    + + +R    ++P         PE G    V  L+ +C +
Sbjct: 196 APYPKM------SLKEVKECVEKGYR----MEP---------PE-GCPADVYVLMTSCWE 235

Query: 532 HVPSMRPRMSHVVHQLQQ 549
             P  RP    +  +L++
Sbjct: 236 TEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 74/291 (25%), Positives = 130/291 (44%), Gaps = 38/291 (13%)

Query: 275 RLLGDSKTGGTYSGIL--PDGS--RVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLV 328
           ++LG+ + G    G L   DGS  +VAVK +K         +EF SE        HPN++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 329 AVKGCCYDHGDR------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM--KVATTLAQ 380
            + G C++           ++  F+ +G L  +L +   GG      ++   K    +A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
           G+ +L ++   + +HRD+ A N +L E+    +   GLSK +       +  +A     +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181

Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499
           +A E +     T+KSDV++FGV + EI + G+ P                 P V++H   
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP----------------YPGVENH--- 222

Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           E+ D L        PE   + ++ DL+Y+C +  P  RP  + +   L+ +
Sbjct: 223 EIYDYLRHGNRLKQPE-DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 74/275 (26%), Positives = 130/275 (47%), Gaps = 35/275 (12%)

Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G  + G  + G   +  +VA+K + R     +++F  E     +L HP LV + G C +
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                +V+EF+ +G L  +L    RG  S +  + M     + +G+A+L      +V+HR
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRA-QRGKFSQETLLGM--CLDVCEGMAYLESS---NVIHR 124

Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 453
           D+ A N L+ E     +   G+++F    V+ ++   + GT     + +PE    ++ ++
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRF----VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512
           KSDV+SFGVL+ E+ S G+ P +       +S  E    +    R   L  P ++S    
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYEN------RSNSEVVETINAGFR---LYKPRLAS---- 227

Query: 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
                  Q V +L+  C +  P  RP  S ++HQL
Sbjct: 228 -------QSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 82/299 (27%), Positives = 127/299 (42%), Gaps = 56/299 (18%)

Query: 275 RLLGDSKTGGTYSG----ILPDGS---RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPN 326
             LG    G  Y G    IL  GS   RVAVK L++ ++ Q KKEF  E    +  +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS-------LDWAMRMKVATTLA 379
           +V + G C  +  +YI+ E +  G L   L ++ R  R        L     + +   +A
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDL---LSYL-RDARVERFGPPLLTLKELLDICLDVA 116

Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV-----GLSKFV----PWEVMQER 430
           +G  +L      H +HRD+ A N L+ E+       V     GL++ +     +    E 
Sbjct: 117 KGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173

Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA 489
            +       ++APE +   + TT+SDV+SFGVL+ EI++ G++P  A             
Sbjct: 174 LL----PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA------------- 216

Query: 490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
                     E+L  + +      PE     K+  L+  C    PS RP    +   LQ
Sbjct: 217 ------LNNQEVLQHVTAGGRLQKPE-NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 14/207 (6%)

Query: 274 NRLLGDSKTGGTYSGILPDGSR----VAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLV 328
            +++G  + G    G L    +    VA+K LK  SS +++ +F +E     +  HPN++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            ++G         I+ E++ NG LD++L      G+       + +   +A G+ +L + 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGK-FTVGQLVGMLRGIASGMKYLSEM 125

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 447
                VHRD+ A N+L++      +   GLS+ +  +     T   G     + APE + 
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE-DSEATYTTKGGKIPIRWTAPEAIA 181

Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRP 473
             + T+ SDV+SFG+++ E++S G RP
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 19/219 (8%)

Query: 282 TGGTYSGIL--PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338
             G  S +L  P G  +AVK ++       +K+   E+    + + P +V   G  Y++G
Sbjct: 13  NSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72

Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
           D  I  E++  G LD+ L         +   +  K+A  + +G+ +LH+K    ++HRD+
Sbjct: 73  DISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRDV 127

Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKS 455
           + SN+L++      L   G+S        Q    +A    GT  Y+APE +  N+ + KS
Sbjct: 128 KPSNILVNSRGQIKLCDFGVSG-------QLVNSLAKTFVGTSSYMAPERIQGNDYSVKS 180

Query: 456 DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 494
           D++S G+ L+E+ +GR P    +      IFE    +V 
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVN 218

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 84/285 (29%), Positives = 133/285 (46%), Gaps = 51/285 (17%)

Query: 289 ILPDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 344
           I  DG R+  A+KR+K  +S    ++F  E+    +L HHPN++ + G C   G  Y+  
Sbjct: 28  IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87

Query: 345 EFVVNGPLDRWLHHIPRGGRSLD----WAMRMKVATTL------------AQGIAFLHDK 388
           E+  +G L  +L    R  R L+    +A+    A+TL            A+G+ +L  K
Sbjct: 88  EYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 143

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
                +HRD+ A N+L+ E + A +   GLS+    EV  ++T M      ++A E +  
Sbjct: 144 ---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT-MGRLPVRWMAIESLNY 197

Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507
           +  TT SDV+S+GVLL EIVS G  P       C  +  E    L Q +R       L  
Sbjct: 198 SVYTTNSDVWSYGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYR-------LEK 244

Query: 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
            L+ D        +V DL+  C +  P  RP  + ++  L ++ +
Sbjct: 245 PLNCD-------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 29/220 (13%)

Query: 277 LGDSKTGGTYSGIL--PDG----SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVA 329
           LG+   G  Y G L  P+     + VA+K LK +   + ++EF  E    + L HPN+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWL-HHIP-----------RGGRSLDWAMRMKVATT 377
           + G C       +++E++ +G L  +L  + P               SLD +  + +A  
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMA 434
           +A G+ +L      H VHRD+ A N L+ E     +   GLS+ +    +  +Q ++++ 
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
                ++ PE +   + TT+SD++SFGV+L EI S G +P
Sbjct: 190 ---VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 77/293 (26%), Positives = 122/293 (41%), Gaps = 47/293 (16%)

Query: 275 RLLGDSKTG----GTYSGILPDGSR--VAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNL 327
           R LG    G    G Y G   D     VAVK L  S  ++ +  F  E    ++ +H N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLDWAMR--MKVATTLAQGIAF 384
           V + G  ++   R+I+ E +  G L  +L    PR  R     M+  +  A  +A+G  +
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFG----AHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
           L +    H +HRDI A N LL  + G    A +   G+++    ++ +      GG    
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR----DIYRASYYRKGGRAML 183

Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS 495
              ++ PE       T+K+DV+SFGVLL EI S G  P                      
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP-------------------YPG 224

Query: 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
               E+++ +      D P  G    V  ++  C QH P  RP  + ++ ++Q
Sbjct: 225 RTNQEVMEFVTGGGRLDPP-KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 69/265 (26%), Positives = 115/265 (43%), Gaps = 37/265 (13%)

Query: 295 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           +VAVK LK ++   ++E   SE+   + L +H N+V + G C   G   ++ E+   G L
Sbjct: 67  KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126

Query: 353 DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
             +L    R   S L     +  +  +A+G+AFL  K   + +HRD+ A NVLL      
Sbjct: 127 LNFLR---RKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIV 180

Query: 412 HLMGVGLSKFVPWEVMQERT-VMAGGTY---GYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
            +   GL++    ++M +   V+ G       ++APE ++    T +SDV+S+G+LL EI
Sbjct: 181 KICDFGLAR----DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Query: 468 VS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV 526
            S G  P   +               V S  Y      +        PE     ++ D++
Sbjct: 237 FSLGSNPYPGM--------------PVDSKFY----KLIKEGYRMAQPEHA-PAEIYDIM 277

Query: 527 YACTQHVPSMRPRMSHVVHQLQQLA 551
             C    P  RP    +V  + +  
Sbjct: 278 KTCWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 47/282 (16%)

Query: 284 GTYSGILPD--GSRVAVKRL-KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
           G   G++     +RVA+K + + +S + + EF +E       +  ++V + G        
Sbjct: 25  GLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84

Query: 341 YIVYEFVVNGPLDRWL--------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
            +V E +  G L  +L        ++   G  +L   ++M  A  +A G+A+L  K    
Sbjct: 85  LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM--AAEIADGMAYLAAK---K 139

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVY 447
            VHRD+ A N ++ E+    +   G+++ +      E      G  G L     APE + 
Sbjct: 140 FVHRDLAARNCMVAEDLTVKIGDFGMTRDI-----YETDYYRKGGKGLLPVRWMAPESLK 194

Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506
               TTKSDV+SFGV+L E+ +   +P Q + +       E     V    +L+L     
Sbjct: 195 DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-------EEVLKFVIDGGHLDL----- 242

Query: 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
                  PE     K+++L+  C Q+ P MRP    +V  L+
Sbjct: 243 -------PE-NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 19/158 (12%)

Query: 323 HHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHI-PRGGRSLDWAMRMKVATTLA 379
             P +V   G   D       I  E+   G LD     +  RGGR  +  +  K+A ++ 
Sbjct: 57  KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-GKIAESVL 115

Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAG--- 435
           +G+++LH +    ++HRDI+ SN+LL  +    L   G+S + V          +AG   
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--------NSLAGTFT 164

Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           GT  Y+APE +     +  SDV+S G+ LLE+   R P
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 12/202 (5%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           + LG  + G  + G   + ++VAVK LK  +    + F  E      L H  LV +    
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 YI+ E++  G L  +L      G  +     +  +  +A+G+A++  K   + +
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLK--SDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 125

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELT 452
           HRD+RA+NVL+ E     +   GL++ +      E T   G  +   + APE +     T
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSFT 182

Query: 453 TKSDVYSFGVLLLEIVS-GRRP 473
            KSDV+SFG+LL EIV+ G+ P
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 82/295 (27%), Positives = 134/295 (45%), Gaps = 44/295 (14%)

Query: 276 LLGDSKTGGTYSGILP-DGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAV 330
           ++G+   G     ++  DG ++  A+K LK  +S    ++F  E+    +L HHPN++ +
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 331 KGCCYDHGDRYIVYEFVVNGPL------DRWLHHIPRGGR------SLDWAMRMKVATTL 378
            G C + G  YI  E+   G L       R L   P   +      +L     ++ A+ +
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
           A G+ +L +K     +HRD+ A NVL+ E   + +   GLS+    EV  ++T M     
Sbjct: 129 ATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKT-MGRLPV 182

Query: 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
            ++A E +  +  TTKSDV+SFGVLL EIVS G  P       C  +  E    L Q +R
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYR 236

Query: 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                         + P      +V +L+  C +  P  RP  + +  QL ++ +
Sbjct: 237 M-------------EKPR-NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.0 bits (194), Expect = 2e-16
 Identities = 76/295 (25%), Positives = 128/295 (43%), Gaps = 44/295 (14%)

Query: 276 LLGDSKTGGTYSGILP-DGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAV 330
           ++G+   G      +  DG R+  A+KR+K  +S    ++F  E+    +L HHPN++ +
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 331 KGCCYDHGDRYIVYEFVVNGPL------DRWLHHIPRGGR------SLDWAMRMKVATTL 378
            G C   G  Y+  E+  +G L       R L   P          +L     +  A  +
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
           A+G+ +L  K     +HRD+ A N+L+ E + A +   GLS+    + +  +  M     
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 175

Query: 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
            ++A E +  +  TT SDV+S+GVLL EIVS G  P       C  +  E    L Q +R
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYR 229

Query: 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
             +                    +V DL+  C +  P  RP  + ++  L ++ +
Sbjct: 230 LEK--------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 72/260 (27%), Positives = 116/260 (44%), Gaps = 34/260 (13%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFVVNGP 351
           G++VAVK +K  +    + F +E     +L H NLV + G    + G  YIV E++  G 
Sbjct: 29  GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86

Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
           L  +L    RG   L     +K +  + + + +L      + VHRD+ A NVL+ E+  A
Sbjct: 87  LVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVA 141

Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 470
            +   GL+K       Q+   +      + APE +   + +TKSDV+SFG+LL EI S G
Sbjct: 142 KVSDFGLTKEA--SSTQDTGKLP---VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196

Query: 471 RRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACT 530
           R P   +             PL       +++  +      D P+ G    V D++  C 
Sbjct: 197 RVPYPRI-------------PLK------DVVPRVEKGYKMDAPD-GCPPVVYDVMKQCW 236

Query: 531 QHVPSMRPRMSHVVHQLQQL 550
               + RP    +  QL+ +
Sbjct: 237 HLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 64/256 (25%), Positives = 121/256 (47%), Gaps = 33/256 (12%)

Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +VA+K +   +   +++F  E     +L HP LV + G C      YIV EF+ NG L  
Sbjct: 30  KVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88

Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414
           +L    +G  S D  M + +   + +G+ +L    +   +HRD+ A N L+       + 
Sbjct: 89  YLRQ-RQGKLSKD--MLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVS 142

Query: 415 GVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GR 471
             G++++V   +  E T  +G  +   +  PE    ++ ++KSDV+SFGVL+ E+ + G+
Sbjct: 143 DFGMTRYV---LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199

Query: 472 RPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQ 531
            P +       +S +E    + +  R   L  P ++S++           V +++Y+C  
Sbjct: 200 MPFEK------KSNYEVVEMISRGFR---LYRPKLASMT-----------VYEVMYSCWH 239

Query: 532 HVPSMRPRMSHVVHQL 547
             P  RP  + ++  +
Sbjct: 240 EKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 36/211 (17%)

Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           +G+  +G  Y       G  VA+K+++    Q K+   +EI       HPN+V       
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK------VATTLAQGIAFLHDKV 389
              + ++V E++  G L   +             +RM       V   + QG+ +LH + 
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNF---------VRMNEPQIAYVCREVLQGLEYLHSQ- 135

Query: 390 KPHVVHRDIRASNVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
             +V+HRDI++ N+LL ++       FG       L+K        +R  + G  Y ++A
Sbjct: 136 --NVIHRDIKSDNILLSKDGSVKLADFG---FAAQLTKEK-----SKRNSVVGTPY-WMA 184

Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           PE + R +   K D++S G++ +E+  G  P
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 68/263 (25%), Positives = 126/263 (47%), Gaps = 17/263 (6%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   +V E++  G
Sbjct: 33  GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92

Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    LD    +  A+ + +G+ +L  K     VHRD+   N+L++ E  
Sbjct: 93  SLRDYLQ---KHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENR 146

Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGT--YGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
             +   GL+K +P +    +    G +  + Y APE +  ++ +  SDV+SFGV+L E+ 
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELF 205

Query: 469 SGRRPAQAVDSVCWQSI-FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVY 527
           +    + +  +   + +  +    ++  H    L++ L ++     P  G   ++  ++ 
Sbjct: 206 TYSDKSCSPPAEFMRMMGNDKQGQMIVYH----LIELLKNNGRLPAPP-GCPAEIYAIMK 260

Query: 528 ACTQHVPSMRPRMSHVVHQLQQL 550
            C  + PS RP  S +  Q++ +
Sbjct: 261 ECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 39/286 (13%)

Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNLVA 329
           +++G  + G  + GIL    R    VA+K LK    ++++ +F SE     +  H N++ 
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           ++G         I+ E++ NG LD++L        S      ++    +A G+ +L D  
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDM- 126

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYLAPEFV 446
             + VHRD+ A N+L++      +   GLS+ +  E   E T    G      + APE +
Sbjct: 127 --NYVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 447 YRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDP 504
              + T+ SDV+SFG+++ E++S G RP        W  S  E    +    R   L  P
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPY-------WDMSNHEVMKAINDGFR---LPAP 232

Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           +      D P A     V  L+  C Q   + RPR   +V+ L +L
Sbjct: 233 M------DCPSA-----VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 14/205 (6%)

Query: 277 LGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGC 333
           +G    G  +  +     RV A+K++  S   R  ++E   E    A+L    ++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKVKP 391
             D G   IV E+  NG L + L    + GR L  D   R  +   L  G+A LH K   
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKM--QRGRPLPEDQVWRFFIQILL--GLAHLHSK--- 120

Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
            ++HRDI++ N+ LD      +  +G++K +        T++  GT  YL+PE       
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV--GTPYYLSPELCEDKPY 178

Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQA 476
             KSDV++ GV+L E  +G+ P  A
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 37/215 (17%)

Query: 277 LGDSKTGGTYSGI--LPDGSR--VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVK 331
           LG    G    G+  +  G    VAVK LK+      KKEF  E    A+L HP +V + 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 332 GCCYDHGDRYI-VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
           G C   G+  + V E    GPL ++L    +  R +  +   ++A  +A G+A+L  K  
Sbjct: 63  GVC--KGEPLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLESK-- 114

Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----------G 439
            H VHRD+ A NVLL     A +   G+S          R + AG  Y            
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMS----------RALGAGSDYYRATTAGRWPLK 163

Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
           + APE +   + ++KSDV+S+GV L E  S G +P
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 13/196 (6%)

Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
            L+HP LV +     D  + Y+V + ++ G L R+  H+ +  +  +  ++  +   +  
Sbjct: 56  ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDL-RY--HLSQKVKFSEEQVKFWICE-IVL 111

Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
            + +LH K    ++HRDI+  N+LLDE+   H+    ++  V  + +   T    GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGY 165

Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC---WQSIFEWATPLVQSHR 497
           +APE + R   +   D +S GV   E + G+RP +          ++  E A  L  +  
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW 225

Query: 498 YLELLDPLISSLSSDI 513
             E +D +   L  D 
Sbjct: 226 STEAIDAINKLLERDP 241

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 76.4 bits (189), Expect = 1e-15
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 12/186 (6%)

Query: 297 AVKRL-KRSSFQRKKEFYSEIGRF--ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           A+K L K+   +RK+  ++   R   +R++HP +V +          Y+V E+   G L 
Sbjct: 22  AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL- 80

Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
               H+ + GR  +   R   A  +   + +LH      +++RD++  N+LLD +    L
Sbjct: 81  --FSHLSKEGRFSEERARFYAAE-IVLALEYLHSL---GIIYRDLKPENILLDADGHIKL 134

Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
              GL+K +  E  +  T    GT  YLAPE +         D +S GVLL E+++G+ P
Sbjct: 135 TDFGLAKELSSEGSRTNTFC--GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Query: 474 AQAVDS 479
             A D 
Sbjct: 193 FYAEDR 198

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 65/239 (27%), Positives = 114/239 (47%), Gaps = 28/239 (11%)

Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF-----QRKKEFYS----EIGRFARLHHP 325
           L+G    G  Y G+    G  +AVK+++  S       RK+        EI     L H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
           N+V   G   D     I  E+V  G +   L++      +L   +R  V   L +G+ +L
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VRNFVRQIL-KGLNYL 122

Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM-----QERTVMAGGTYGY 440
           H++    ++HRDI+ +N+L+D + G  +   G+SK +    +       R  + G  + +
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF-W 178

Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF---EWATPLVQSH 496
           +APE V +   T K+D++S G L++E+++G+ P      +  Q+IF   E A+P + S+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIFKIGENASPEIPSN 235

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGC 333
             +G    G  Y G+L   + VAVK  + +     K  + +     + + HPN+V + G 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
           C      YIV E V  G L   L  + +    L     ++++   A G+ +L  K   + 
Sbjct: 61  CVQKQPIYIVMELVPGGSL---LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NC 114

Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG-----------YLA 442
           +HRD+ A N L+ E     +   G+S+       +E     GG Y            + A
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR-------EE----EGGIYTVSDGLKQIPIKWTA 163

Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSG 470
           PE +     T++SDV+S+G+LL E  S 
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 78/295 (26%), Positives = 132/295 (44%), Gaps = 49/295 (16%)

Query: 277 LGDSKTGGTYSG--ILP---DGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAV 330
           LG+   G  Y G   LP       VA+K LK  ++ Q+  EF  E    A LHHPN+V +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWL----HHIPRG---------GRSLDWAMRMKVATT 377
            G         +++E++  G L  +L     H   G           SLD    + +A  
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMA 434
           +A G+ +L        VH+D+ A N+L+ E+    +  +GLS+ +    +  +Q ++++ 
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++ PE +   + ++ SD++SFGV+L EI S G +P     +   Q + E    +V
Sbjct: 190 ---IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE----MV 239

Query: 494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
           +  + L          S D P      ++  L+  C Q  PS RPR   +  +L+
Sbjct: 240 RKRQLL--------PCSEDCPP-----RMYSLMTECWQEGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 43/277 (15%)

Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRL------KRSSFQRKKEFYSEIGRFARLHHPNLVA 329
           +LG    G  Y G+   G  +AVK++        ++ +  ++   E+     L H N+V 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
             G C D     I  EFV  G +   L+   R G   +     K    +  G+A+LH+  
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILN---RFGPLPEPVFC-KYTKQILDGVAYLHNN- 121

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW--------EVMQERTVMAGGTYGYL 441
              VVHRDI+ +NV+L       L+  G ++ + W         +++    M G  Y ++
Sbjct: 122 --CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS---MHGTPY-WM 175

Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501
           APE +  +    KSD++S G  + E+ +G+ P  ++D +   ++F      + +HR   L
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--AAMF-----YIGAHR--GL 226

Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
           +  L  S S+           +D V +C       RP
Sbjct: 227 MPRLPDSFSAA---------AIDFVTSCLTRDQHERP 254

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 76.3 bits (187), Expect = 3e-15
 Identities = 70/271 (25%), Positives = 119/271 (43%), Gaps = 41/271 (15%)

Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           VAVK LK +S   +K+F+ E      L H ++V   G C +     +V+E++ +G L+++
Sbjct: 38  VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97

Query: 356 LH-HIPRG--------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
           L  H P             L  +  + +A  +A G+ +L  +   H VHRD+   N L+ 
Sbjct: 98  LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVG 154

Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGV 462
           E     +   G+S+    +V        GG       ++ PE +   + TT+SDV+S GV
Sbjct: 155 ENLLVKIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 210

Query: 463 LLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQK 521
           +L EI + G++P        W  +              E+++ +        P     ++
Sbjct: 211 VLWEIFTYGKQP--------WYQLSN-----------NEVIECITQGRVLQRPRT-CPKE 250

Query: 522 VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
           V DL+  C Q  P MR  +  +   LQ LA+
Sbjct: 251 VYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 28/205 (13%)

Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCC 334
           LLG    G  + G L D + VAVK  K    Q  K +F SE     +  HPN+V + G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 YIV E V  G    +L  + +    L     +K A   A G+A+L  K   + +
Sbjct: 62  TQRQPIYIVMELVPGGD---FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG----------YLAPE 444
           HRD+ A N L+ E     +   G+S+       QE      G Y           + APE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-------QED----DGIYSSSGLKQIPIKWTAPE 164

Query: 445 FVYRNELTTKSDVYSFGVLLLEIVS 469
            +     +++SDV+S+G+LL E  S
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 29/219 (13%)

Query: 277 LGDSKTGGTY----SGILPDGSR--VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV 330
           LG+   G  +      +LP+  +  VAVK LK +S   +++F  E      L H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLH------HIPRGGR-----SLDWAMRMKVATTLA 379
            G C +     +V+E++ +G L+R+L        I  GG       L     + +A+ +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG--- 436
            G+ +L      H VHRD+   N L+ +     +   G+S+    ++        GG   
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRTM 185

Query: 437 -TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
               ++ PE +   + TT+SD++SFGV+L EI + G++P
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG+ + G  + G     ++VAVK LK  +    + F  E     +L H  LV +     +
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
               YIV E++  G L   L  +  G GR+L     + +A  +A G+A++    + + +H
Sbjct: 73  E-PIYIVTEYMSKGSL---LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125

Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+R++N+L+ +     +   GL++ +      E T   G  +   + APE       T 
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 454 KSDVYSFGVLLLEIVS-GRRP 473
           KSDV+SFG+LL E+V+ GR P
Sbjct: 183 KSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 17/190 (8%)

Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           S VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y+V E+  +G 
Sbjct: 43  STVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGN 102

Query: 352 LDRWLH-HIPRG-----------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
           L  +L    P G             +L     +  A  +A+G+ FL  K     +HRD+ 
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLA 159

Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
           A NVL+ E+    +   GL++ +       +T        ++APE ++    T +SDV+S
Sbjct: 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 219

Query: 460 FGVLLLEIVS 469
           FGVLL EI +
Sbjct: 220 FGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 12/181 (6%)

Query: 296 VAVKRL-KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           V VK L K      + EF  E+  F +L H N+V + G C +    Y++ E+   G L +
Sbjct: 38  VLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQ 97

Query: 355 WL-----HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
           +L              L    ++ + T +A G+  L        VHRD+ A N L+  + 
Sbjct: 98  FLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQR 154

Query: 410 GAHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
              +  + LSK V   E  + R  +      +LAPE V  ++ +TKSDV+SFGVL+ E+ 
Sbjct: 155 EVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212

Query: 469 S 469
           +
Sbjct: 213 T 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 4e-15
 Identities = 69/294 (23%), Positives = 130/294 (44%), Gaps = 48/294 (16%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLV 328
           ++LG    G  Y G+ +P+G +    VA+K L+  +  +  KE   E    A + HP++V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 329 AVKGCCYDHGDRY-IVYEFVVNGPLDRWLH-HIPRGGRS--LDWAMRMKVATTLAQGIAF 384
            + G C     +  ++ + +  G L  ++  H    G    L+W         +A+G+++
Sbjct: 73  RLLGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC------VQIAKGMSY 124

Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYL 441
           L +K    +VHRD+ A NVL+       +   GL+K +    + E+   A G      ++
Sbjct: 125 LEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD---VDEKEYHAEGGKVPIKWM 178

Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500
           A E +     T KSDV+S+GV + E+++ G +P + + +V    + E    L Q      
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ------ 232

Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
              P I ++            V  ++  C       RP    ++++  ++A+ P
Sbjct: 233 ---PPICTID-----------VYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 40/273 (14%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLK-----RSSFQRKKEFYSEIGRFARLHHPNLV 328
            LLG    G  Y G+ L DG   AVK +      ++  +  K+   EI   ++L HPN+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
              G   +  + YI  E V  G L + L    + G   +  +R+     L  G+ +LHD+
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILL-GLEYLHDR 121

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV--MAGGTYGYLAPEFV 446
              + VHRDI+ +N+L+D      L   G++K    +V++        G  Y ++APE +
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK----QVVEFSFAKSFKGSPY-WMAPEVI 173

Query: 447 YR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505
            +       +D++S G  +LE+ +G+ P   ++ V   ++F+              L P+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKIGRSKE--------LPPI 223

Query: 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
              LS    EA       D +  C Q  PS+RP
Sbjct: 224 PDHLS---DEAK------DFILKCLQRDPSLRP 247

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 24/199 (12%)

Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           D   VAVK LK  +   +K+F  E      L H ++V   G C D     +V+E++ +G 
Sbjct: 34  DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 93

Query: 352 LDRWLH-HIP-----------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
           L+++L  H P           +    L  +  + +A+ +A G+ +L  +   H VHRD+ 
Sbjct: 94  LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLA 150

Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG----TYGYLAPEFVYRNELTTKS 455
             N L+       +   G+S+    +V        GG       ++ PE +   + TT+S
Sbjct: 151 TRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206

Query: 456 DVYSFGVLLLEIVS-GRRP 473
           DV+SFGV+L EI + G++P
Sbjct: 207 DVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 15/201 (7%)

Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     ++VA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
               YIV EF+  G L   L  +  G G+ L     + +A  +A G+A++    + + +H
Sbjct: 73  E-PIYIVTEFMGKGSL---LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125

Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+RA+N+L+ +     +   GL++ +      E T   G  +   + APE       T 
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 454 KSDVYSFGVLLLEIVS-GRRP 473
           KSDV+SFG+LL E+V+ GR P
Sbjct: 183 KSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 74.2 bits (183), Expect = 9e-15
 Identities = 65/274 (23%), Positives = 111/274 (40%), Gaps = 43/274 (15%)

Query: 291 PDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR-LH---HPNLVAVKGCCYDHGDRYIVYEF 346
           P G   A+K++        +EF  ++ R  + L     P +V   G  Y  G+  IV E+
Sbjct: 24  PTGKIYALKKIH---VDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80

Query: 347 VVNGPLDRWL---HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
           +  G L   L     IP         +   +A  + +G+ +LH K   H++HRDI+ SN+
Sbjct: 81  MDGGSLADLLKKVGKIPE-------PVLAYIARQILKGLDYLHTKR--HIIHRDIKPSNL 131

Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
           L++ +    +   G+SK +  E   ++     GT  Y++PE +     +  +D++S G+ 
Sbjct: 132 LINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189

Query: 464 LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVV 523
           LLE   G+ P        +                 EL+  +       +P      +  
Sbjct: 190 LLECALGKFPFLPPGQPSF----------------FELMQAICDGPPPSLPAEEFSPEFR 233

Query: 524 DLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 557
           D + AC Q  P  RP       +L Q   P + K
Sbjct: 234 DFISACLQKDPKKRPS----AAELLQH--PFIKK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)

Query: 275 RLLGDSKTGGTYSG----ILPDGSR--VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNL 327
           R LG+   G  + G    + P+  +  VAVK LK ++    +K+F  E        H N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRS---------LDWAMRMKVATT 377
           V   G C +     +V+E++ +G L+++L  H P              L  +  +++A  
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           +A G+ +L  +   H VHRD+   N L+  +    +   G+S+    +V        GG 
Sbjct: 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGH 183

Query: 438 ----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
                 ++ PE +   + TT+SDV+SFGV+L EI + G++P
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 18/220 (8%)

Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
           E+LR+I       K ++   ++ G   +G  Y+ I +  G  VA+K++      +K+   
Sbjct: 6   EKLRTIVSVGDPKKKYTRFEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII 64

Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
           +EI       HPN+V          + ++V E++  G L   +         +D      
Sbjct: 65  NEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 119

Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
           V     Q + FLH      V+HRDI++ N+LL  +    L   G    +  E   +R+ M
Sbjct: 120 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM 175

Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
            G  Y ++APE V R     K D++S G++ +E+V G  P
Sbjct: 176 VGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 56/182 (30%), Positives = 91/182 (50%), Gaps = 12/182 (6%)

Query: 293 GSRVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI--VYEFVVN 349
           G +VAVK LK  S      +   EI     L+H N+V  KG C + G   I  + EF+ +
Sbjct: 33  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92

Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
           G L  +L   PR    ++   ++K A  + +G+ +L  +     VHRD+ A NVL++ E 
Sbjct: 93  GSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 146

Query: 410 GAHLMGVGLSKFVPW--EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
              +   GL+K +    E    +  +    + Y APE + +++    SDV+SFGV L E+
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYEL 205

Query: 468 VS 469
           ++
Sbjct: 206 LT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 66/261 (25%), Positives = 110/261 (42%), Gaps = 33/261 (12%)

Query: 290 LPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
           L DG  VA+K+++       K   +   EI    +L HPN++       ++ +  IV E 
Sbjct: 24  LLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83

Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
              G L R + H  +  R +      K    L   +  +H K    ++HRDI+ +NV + 
Sbjct: 84  ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFIT 140

Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
                 L  +GL +F   +     +++  GT  Y++PE ++ N    KSD++S G LL E
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198

Query: 467 IVSGRRP----AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 522
           + + + P       + S+C + I +   P + +  Y E L                    
Sbjct: 199 MAALQSPFYGDKMNLYSLC-KKIEKCDYPPLPADHYSEELR------------------- 238

Query: 523 VDLVYACTQHVPSMRPRMSHV 543
            DLV  C    P  RP +S+V
Sbjct: 239 -DLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 60/258 (23%), Positives = 108/258 (41%), Gaps = 30/258 (11%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFAR---------LHH---PNLVAVKGCCYDHGDR 340
           GS   VK +   +   KK  +       R         +H    P +V+  G   +  + 
Sbjct: 19  GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78

Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
            +  EF+  G LDR    I + G  +   +  K+A  + +G+ +L++     ++HRDI+ 
Sbjct: 79  CMCMEFMDCGSLDR----IYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKP 132

Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
           SN+L++      L   G+S     E++        GT  Y++PE +   + T KSDV+S 
Sbjct: 133 SNILVNSRGQIKLCDFGVSG----ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSL 188

Query: 461 GVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQ 520
           G+ ++E+  G+ P        +                L+LL  ++      +P +   +
Sbjct: 189 GISIIELALGKFP--------FAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240

Query: 521 KVVDLVYACTQHVPSMRP 538
            + D V AC    P+ RP
Sbjct: 241 DLRDFVDACLLKDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 44/213 (20%)

Query: 288 GILP--DGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344
           G+LP    + VAVK LK  +S   + +F  E    A   HPN+V + G C       +++
Sbjct: 28  GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87

Query: 345 EFVVNGPLD--------RWLHHIPRGGRS----------LDWAMRMKVATTLAQGIAFLH 386
           E++  G L+        R    +     S          L    ++ +A  +A G+A+L 
Sbjct: 88  EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS 147

Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG------- 439
           ++     VHRD+   N L+ E     +   GLS          R + +   Y        
Sbjct: 148 ER---KFVHRDLATRNCLVGENMVVKIADFGLS----------RNIYSADYYKASENDAI 194

Query: 440 ---YLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              ++ PE ++ N  TT+SDV+++GV+L EI S
Sbjct: 195 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 73.6 bits (180), Expect = 2e-14
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 18/220 (8%)

Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
           E+LR+I       K ++   ++ G   +G  ++ I +  G  VA+K++      +K+   
Sbjct: 6   EKLRTIVSIGDPKKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII 64

Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
           +EI     L +PN+V          + ++V E++  G L   +         +D A    
Sbjct: 65  NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-----CMDEAQIAA 119

Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
           V     Q + FLH      V+HRDI++ NVLL  +    L   G    +  E   +R+ M
Sbjct: 120 VCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTM 175

Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
            G  Y ++APE V R     K D++S G++ +E+V G  P
Sbjct: 176 VGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 72.3 bits (177), Expect = 5e-14
 Identities = 67/283 (23%), Positives = 123/283 (43%), Gaps = 45/283 (15%)

Query: 290 LPDGSRVAVKRLKRSSFQRK-KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
               + VAVK LK ++   + ++  SE     +++HP+++ + G C   G   ++ E+  
Sbjct: 27  RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 86

Query: 349 NGPLDRWLH--------HIPRGG------------RSLDWAMRMKVATTLAQGIAFLHDK 388
            G L  +L         ++   G            R+L     +  A  +++G+ +L + 
Sbjct: 87  YGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM 146

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
               +VHRD+ A NVL+ E     +   GLS+ V  E    +         ++A E ++ 
Sbjct: 147 ---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD 203

Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507
           +  TT+SDV+SFGVLL EIV+ G  P                 P +   R   LL    +
Sbjct: 204 HIYTTQSDVWSFGVLLWEIVTLGGNP----------------YPGIAPERLFNLLK---T 244

Query: 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
               + PE    +++ +L+  C +  P  RP  + +  +L+++
Sbjct: 245 GYRMERPE-NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 54/188 (28%), Positives = 97/188 (51%), Gaps = 24/188 (12%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
           G +VAVK++     QR++  ++E+       HPN+V +    Y  GD  ++V EF+  G 
Sbjct: 44  GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS-YLVGDELWVVMEFLEGGA 102

Query: 352 LDRWLHHIPRGGRSLDWAMRM---KVATT---LAQGIAFLHDKVKPHVVHRDIRASNVLL 405
           L   + H            RM   ++AT    + + ++FLH +    V+HRDI++ ++LL
Sbjct: 103 LTDIVTH-----------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILL 148

Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
             +    L   G    V  EV + ++++  GT  ++APE + R    T+ D++S G++++
Sbjct: 149 TSDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVI 206

Query: 466 EIVSGRRP 473
           E+V G  P
Sbjct: 207 EMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 32/197 (16%)

Query: 296 VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           VAVK L+   S   +++F  E+   +RL  PN+  + G C       ++ E++ NG L++
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 355 WLH-HIPR------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
           +L  H+          +SL ++  + +AT +A G+ +L      + VHRD+   N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGK 165

Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG----------YLAPEFVYRNELTTKSDV 457
            +   +   G+S          R + +   Y           ++A E V   + TTKSDV
Sbjct: 166 NYTIKIADFGMS----------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215

Query: 458 YSFGVLLLEIVS-GRRP 473
           ++FGV L EI++  R  
Sbjct: 216 WAFGVTLWEILTLCREQ 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 67/254 (26%), Positives = 119/254 (46%), Gaps = 30/254 (11%)

Query: 291 PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVV 348
           P G+ +AVKR++ + + Q +K    ++    R +  P  V   G  +  GD +I  E V+
Sbjct: 24  PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME-VM 82

Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
           +  LD++   +   G ++   +  K+A ++ + + +LH K+   V+HRD++ SNVL++  
Sbjct: 83  DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRN 140

Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVLL 464
               L   G+S ++   V   +T+ A G   Y+APE +     +     KSDV+S G+ +
Sbjct: 141 GQVKLCDFGISGYLVDSVA--KTIDA-GCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197

Query: 465 LEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVD 524
           +E+ +GR P              W TP  Q  + +E  +P     S  +P      +  D
Sbjct: 198 IELATGRFPYD-----------SWKTPFQQLKQVVE--EP-----SPQLPAEKFSPEFQD 239

Query: 525 LVYACTQHVPSMRP 538
            V  C +     RP
Sbjct: 240 FVNKCLKKNYKERP 253

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 29/263 (11%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           G +VAVK++     QR++  ++E+      HH N+V +        + ++V EF+  G L
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106

Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
              + H       ++      V  ++ + +++LH++    V+HRDI++ ++LL  +    
Sbjct: 107 TDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIK 158

Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 472
           L   G    V  EV + ++++  GT  ++APE + R    T+ D++S G++++E++ G  
Sbjct: 159 LSDFGFCAQVSKEVPKRKSLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216

Query: 473 PAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 532
           P              +  P +Q+ R +   D L   +      + V++  +DL+      
Sbjct: 217 PY-------------FNEPPLQAMRRIR--DNLPPRVKDSHKVSSVLRGFLDLMLV---R 258

Query: 533 VPSMRPRMSHVV-HQLQQLAQPP 554
            PS R     ++ H   +LA PP
Sbjct: 259 EPSQRATAQELLQHPFLKLAGPP 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 64/276 (23%), Positives = 115/276 (41%), Gaps = 35/276 (12%)

Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVKR--LKRSSFQRKKE--------FYSEIGRFARLHH 324
           L+G    G  Y  + +  G  +AVK+  L  +   R             SEI     L H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
            N+V   G         I  E+V  G +   L      GR  +  +       + +G+A+
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR---TYGR-FEEQLVRFFTEQVLEGLAY 123

Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           LH K    ++HRD++A N+L+D +    +   G+SK        ++ +   G+  ++APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 445 FV--YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502
            +  Y    + K D++S G ++LE+ +GRRP    +++   ++F+      +        
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKLGN---KRSA----- 230

Query: 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
            P+   +S ++         +D + AC    P  RP
Sbjct: 231 PPIPPDVSMNLSPVA-----LDFLNACFTINPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 71.9 bits (176), Expect = 8e-14
 Identities = 76/297 (25%), Positives = 124/297 (41%), Gaps = 45/297 (15%)

Query: 275 RLLGDSKTGGTYSGILPD------GSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNL 327
           R LG    G  Y G   D       +RVAVK +  S+  R++ EF +E          ++
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71

Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI------PRGGRSLDWAMRMKVATTLAQG 381
           V + G         +V E + +G L  +L  +        G         +++A  +A G
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---- 437
           +A+L+ K     VHRD+ A N ++  +F   +   G+++    ++ +      GG     
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184

Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH 496
             ++APE +     TT SD++SFGV+L EI S   +P Q + +       E     V   
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVLKFVMDG 237

Query: 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            YL            D P+    ++V DL+  C Q  P MRP    +V+ L+    P
Sbjct: 238 GYL------------DQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 71.8 bits (177), Expect = 8e-14
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 19/183 (10%)

Query: 296 VAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
            A+K L ++   + K+     +E      + HP LV + G   D  + Y+V E+V  G L
Sbjct: 29  YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL 88

Query: 353 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
                H+ + GR     A        LA  + +LH      +V+RD++  N+LLD +   
Sbjct: 89  ---FSHLRKSGRFPEPVARFYAAQVVLA--LEYLHSL---DIVYRDLKPENLLLDSDGYI 140

Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSG 470
            +   G +K V       RT    GT  YLAPE +  ++   K+ D ++ G+L+ E+++G
Sbjct: 141 KITDFGFAKRVK-----GRTYTLCGTPEYLAPE-IILSKGYGKAVDWWALGILIYEMLAG 194

Query: 471 RRP 473
             P
Sbjct: 195 YPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 71.5 bits (176), Expect = 8e-14
 Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 29/200 (14%)

Query: 296 VAVKRLKRSSFQR-KKEFYSEIGR--FARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
            A+K L +    + KK  Y +I +    RL  HP ++ +     D  + Y V E+  NG 
Sbjct: 29  YAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGE 88

Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--- 408
           L   L +I + G SLD       A  +   + +LH K    ++HRD++  N+LLD++   
Sbjct: 89  L---LQYIRKYG-SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHI 141

Query: 409 ----FGA-----------HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 453
               FG               G   +     E  + R     GT  Y++PE +       
Sbjct: 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK 201

Query: 454 KSDVYSFGVLLLEIVSGRRP 473
            SD+++ G ++ ++++G+ P
Sbjct: 202 SSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)

Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 73  E-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 184 SDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 61/249 (24%), Positives = 111/249 (44%), Gaps = 16/249 (6%)

Query: 292 DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
           DG  VA+K+++       + + +   EI    +L+HPN++       +  +  IV E   
Sbjct: 26  DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 85

Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
            G L R + H  +  R +      K    L   +  +H +    V+HRDI+ +NV +   
Sbjct: 86  AGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT 142

Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
               L  +GL +F   +     +++  GT  Y++PE ++ N    KSD++S G LL E+ 
Sbjct: 143 GVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200

Query: 469 SGRRP----AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVD 524
           + + P       + S+C + I +   P + S  Y E L  L++   +  PE    +  + 
Sbjct: 201 ALQSPFYGDKMNLYSLC-KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEK---RPDIT 256

Query: 525 LVYACTQHV 533
            VY   + +
Sbjct: 257 YVYDVAKRM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.9 bits (173), Expect = 2e-13
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 18/220 (8%)

Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
           E+LRSI       K ++   ++ G   +G  Y+ I +  G  VA+K++      +K+   
Sbjct: 6   EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII 64

Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
           +EI       +PN+V          + ++V E++  G L   +         +D      
Sbjct: 65  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 119

Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
           V     Q + FLH      V+HRDI++ N+LL  +    L   G    +  E   +R+ M
Sbjct: 120 VCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM 175

Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
            G  Y ++APE V R     K D++S G++ +E+V G  P
Sbjct: 176 VGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 11/156 (7%)

Query: 324 HPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
           HP L  +   C+   DR + V E+V  G L   + HI R GR  D       A  +  G+
Sbjct: 55  HPFLTQLH-SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGR-FDEPRARFYAAEIVLGL 109

Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
            FLH++    +++RD++  NVLLD E    +   G+ K      +   T    GT  Y+A
Sbjct: 110 QFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC--GTPDYIA 164

Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD 478
           PE +         D ++ GVLL E+++G+ P +  D
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 63/268 (23%), Positives = 114/268 (42%), Gaps = 33/268 (12%)

Query: 290 LPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
           L D   VA+K+++       + +++   EI    +L+HPN++       +  +  IV E 
Sbjct: 24  LLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83

Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
              G L + + +  +  R +      K    L   +  +H +    V+HRDI+ +NV + 
Sbjct: 84  ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFIT 140

Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
                 L  +GL +F   +     +++  GT  Y++PE ++ N    KSD++S G LL E
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198

Query: 467 IVSGRRP----AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 522
           + + + P       + S+C Q I +   P            PL        P     +K+
Sbjct: 199 MAALQSPFYGDKMNLFSLC-QKIEQCDYP------------PL--------PTEHYSEKL 237

Query: 523 VDLVYACTQHVPSMRPRMSHVVHQLQQL 550
            +LV  C    P  RP + +V    +Q+
Sbjct: 238 RELVSMCIYPDPDQRPDIGYVHQIAKQM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|214480 smart00034, CLECT, C-type lectin (CTL) or carbohydrate-recognition domain (CRD)

 Score = 66.1 bits (161), Expect = 4e-13
 Identities = 32/138 (23%), Positives = 60/138 (43%), Gaps = 17/138 (12%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP  WI    K  C+ +    ++W++++ +C+ +GGHLA++ S  E      L   + + 
Sbjct: 1   CPSGWISYGGK--CYKFSTEKKTWEDAQAFCQSLGGHLASIHSEAENDFVASLLKNSGSS 58

Query: 113 --CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
              W+G    ++    SW+WSD  S          S+++     P   + +   C ++S 
Sbjct: 59  DYYWIGLSDPDSNG--SWQWSDG-SGPV-------SYSNWAPGEP---NNSSGDCVVLST 105

Query: 171 GSRSLVTERCNTSHPFIC 188
                    C +  PF+C
Sbjct: 106 SGGKWNDVSCTSKLPFVC 123

Many of these domains function as calcium-dependent carbohydrate binding modules. Length = 124

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 13/203 (6%)

Query: 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
            + LG  + G  +       ++VAVK +K  S    + F +E      L H  LV +   
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
                  YI+ EF+  G L  +L      G        +  +  +A+G+AF+  +   + 
Sbjct: 70  VTKE-PIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 123

Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNEL 451
           +HRD+RA+N+L+       +   GL++ +      E T   G  +   + APE +     
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF 180

Query: 452 TTKSDVYSFGVLLLEIVS-GRRP 473
           T KSDV+SFG+LL+EIV+ GR P
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 43/289 (14%)

Query: 275 RLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 329
           R++G    G  Y G L   DG ++  AVK L R +  +  ++F  E        HPN+++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 330 VKGCCY-DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
           + G C    G   +V  ++ +G L    + I     +      +     +A+G+ +L  K
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEF 445
                VHRD+ A N +LDE F   +   GL++ +    +  +   T  A     ++A E 
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT-GAKLPVKWMALES 173

Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE---L 501
           +   + TTKSDV+SFGVLL E+++ G  P   VDS      F+    L+Q  R L+    
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLLQGRRLLQPEYC 227

Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
            DPL                   ++ +C    P MRP  S +V +++Q+
Sbjct: 228 PDPLYE-----------------VMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 60/258 (23%), Positives = 110/258 (42%), Gaps = 29/258 (11%)

Query: 292 DGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
           D S V  K   L R S + +++  +EI   + L HPN++A      D     I  E+   
Sbjct: 24  DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83

Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
           G L   +    + G+  +  M +     +   ++++H   K  ++HRDI+  N+ L +  
Sbjct: 84  GTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAG 138

Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              L   G+SK +  E     TV+  GT  Y++PE     +   KSD+++ G +L E+++
Sbjct: 139 LIKLGDFGISKILGSEYSMAETVV--GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196

Query: 470 GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYAC 529
            +R             F+   P       L L+  ++    + +       +++ LV++ 
Sbjct: 197 LKR------------TFDATNP-------LNLVVKIVQGNYTPVVS-VYSSELISLVHSL 236

Query: 530 TQHVPSMRPRMSHVVHQL 547
            Q  P  RP    V+ Q 
Sbjct: 237 LQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 51/199 (25%), Positives = 97/199 (48%), Gaps = 13/199 (6%)

Query: 277 LGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           +G+  TG    + +   G  VAVK++     QR++  ++E+       H N+V +    Y
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-Y 86

Query: 336 DHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
             GD  ++V EF+  G L   + H       ++      V   + + ++ LH +    V+
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVI 138

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRDI++ ++LL  +    L   G    V  EV + ++++  GT  ++APE + R     +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPELISRLPYGPE 196

Query: 455 SDVYSFGVLLLEIVSGRRP 473
            D++S G++++E+V G  P
Sbjct: 197 VDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 14/211 (6%)

Query: 274 NRLLGDSKTGGTYSGI--LPDGSR--VAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLV 328
            R +G+ + G  Y G+   P+  +  VAVK  K  +    +E F  E     +  HP++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            + G   ++   +IV E    G L  +L        SLD A  +  +  L+  +A+L  K
Sbjct: 71  KLIGVITEN-PVWIVMELAPLGELRSYLQ---VNKYSLDLASLILYSYQLSTALAYLESK 126

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
                VHRDI A NVL+       L   GLS+++  E   + +        ++APE +  
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESINF 182

Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVD 478
              T+ SDV+ FGV + EI+  G +P Q V 
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 68.2 bits (167), Expect = 8e-13
 Identities = 50/200 (25%), Positives = 97/200 (48%), Gaps = 14/200 (7%)

Query: 284 GTYSGI-----LPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           G+Y  +     L D    A+K +   S   + +++  +EI   A ++HPN+++ K    D
Sbjct: 11  GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD 70

Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                IV E+   G L + +    +  + +      ++   L +G+  LH++    ++HR
Sbjct: 71  GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHR 127

Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
           D++++N+LL       +  +G+SK +  +    +T +  GT  Y+APE       + KSD
Sbjct: 128 DLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI--GTPHYMAPEVWKGRPYSYKSD 183

Query: 457 VYSFGVLLLEIVSGRRPAQA 476
           ++S G LL E+ +   P +A
Sbjct: 184 IWSLGCLLYEMATFAPPFEA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 13/178 (7%)

Query: 334 CYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
           C+   DR Y V E+V  G L   ++ I + GR       +  A  +A G+ FLH K    
Sbjct: 69  CFQTMDRLYFVMEYVNGGDL---MYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHSK---G 121

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
           +++RD++  NV+LD E    +   G+ K   W+ +  +T    GT  Y+APE +      
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC--GTPDYIAPEIIAYQPYG 179

Query: 453 TKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSIFEW--ATPLVQSHRYLELLDPLIS 507
              D ++FGVLL E+++G+ P +  D    +QSI E   A P   S   + +   L++
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 68.6 bits (168), Expect = 9e-13
 Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 13/186 (6%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           G   A K ++  S +  ++F  EI   +   HPN+V +    +     +I+ EF   G L
Sbjct: 30  GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGAL 89

Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
           D  +  + RG   L       V   + + + FLH      V+HRD++A N+LL  +    
Sbjct: 90  DSIMLELERG---LTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVK 143

Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YR-NELTTKSDVYSFGVLLLEI 467
           L   G+S       +Q+R    G  Y ++APE V    ++ N    K+D++S G+ L+E+
Sbjct: 144 LADFGVSAKNKST-LQKRDTFIGTPY-WMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201

Query: 468 VSGRRP 473
                P
Sbjct: 202 AQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 11/203 (5%)

Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK-KEFYSEIGRFARLHHPNLVAVKGCC 334
           +G   T   Y+ I LP+  +VA+KR+     Q    E   E+   ++ +HPN+V      
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 335 YDHGDRYIVYEFVVNGP-LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
               + ++V  ++  G  LD      PRGG  LD A+   V   + +G+ +LH   +   
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 394 VHRDIRASNVLLDEEFGAHL--MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNE 450
           +HRDI+A N+LL E+    +   GV  S     +  ++      GT  ++APE +   + 
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183

Query: 451 LTTKSDVYSFGVLLLEIVSGRRP 473
              K+D++SFG+  +E+ +G  P
Sbjct: 184 YDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 68.6 bits (167), Expect = 1e-12
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 18/220 (8%)

Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
           E+LRSI       K ++   ++ G   +G  Y+ + +  G  VA++++      +K+   
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65

Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
           +EI       +PN+V          + ++V E++  G L   +         +D      
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 120

Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
           V     Q + FLH      V+HRDI++ N+LL  +    L   G    +  E   +R+ M
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM 176

Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
            G  Y ++APE V R     K D++S G++ +E++ G  P
Sbjct: 177 VGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 23/211 (10%)

Query: 276 LLGDSKTGGTYSGIL-PDGSR---VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAV 330
           ++G  + G    G L   G R   VA+K LK   + +++++F SE     +  HPN++ +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA----FLH 386
           +G         I+ EF+ NG LD +L       R  D    +     + +GIA    +L 
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFL-------RQNDGQFTVIQLVGMLRGIAAGMKYLS 123

Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER-TVMAGGTYG--YLAP 443
           +    + VHRD+ A N+L++      +   GLS+F+  +      T   GG     + AP
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
           E +   + T+ SDV+S+G+++ E++S G RP
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 22/199 (11%)

Query: 291 PDGSRVAVKRLKRSSFQRKKEFY--SEIGRFARLHHPNLVAVKGCCYDHG-DR-----YI 342
            DG  +  K +   +   K++    SE+     L HPN+V      YD   DR     YI
Sbjct: 23  SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY----YDRIIDRSNQTLYI 78

Query: 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRA 400
           V E+   G L + +    +  + ++     ++ T L   +   H++  P   V+HRD++ 
Sbjct: 79  VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKP 138

Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKSDV 457
           +N+ LD      L   GL+K     ++   +  A    GT  Y++PE +       KSD+
Sbjct: 139 ANIFLDANNNVKLGDFGLAK-----ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDI 193

Query: 458 YSFGVLLLEIVSGRRPAQA 476
           +S G L+ E+ +   P  A
Sbjct: 194 WSLGCLIYELCALSPPFTA 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 21/204 (10%)

Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            LG+   G  Y  I    G  VA+K   ++    +  KE    I    +   P +V   G
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYIVKYYG 65

Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKV 389
             + + D +IV E+   G +      +    ++L      ++A  L Q   G+ +LH   
Sbjct: 66  SYFKNTDLWIVMEYCGAGSV---SDIMKITNKTLTEE---EIAAILYQTLKGLEYLHSN- 118

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
               +HRDI+A N+LL+EE  A L   G+S  +   + +  TV+  GT  ++APE +   
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI--GTPFWMAPEVIQEI 174

Query: 450 ELTTKSDVYSFGVLLLEIVSGRRP 473
               K+D++S G+  +E+  G+ P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 18/186 (9%)

Query: 292 DGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
            G  VA+K++K         K    EI     L+HPN++ +       GD Y+V+EF   
Sbjct: 23  TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF--- 79

Query: 350 GPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
             +D  L+ + +   R L  ++       L QG+AF H      ++HRD++  N+L++ E
Sbjct: 80  --MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTE 134

Query: 409 FGAHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLL 465
               L   GL++    P        V    T  Y APE +  ++  +T  D++S G +  
Sbjct: 135 GVLKLADFGLARSFGSPVRPYTHYVV----TRWYRAPELLLGDKGYSTPVDIWSVGCIFA 190

Query: 466 EIVSGR 471
           E++S R
Sbjct: 191 ELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 23/211 (10%)

Query: 275 RLLGDSKTGGTYSGILP-DGSR---VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVA 329
           +++G  + G   SG L   G R   VA+K LK    ++ +++F SE     +  HPN++ 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           ++G         IV E++ NG LD +L    +          + +   +A G+ +L D  
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIASGMKYLSDM- 125

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG------YLAP 443
               VHRD+ A N+L++      +   GLS+     V+++    A  T G      + AP
Sbjct: 126 --GYVHRDLAARNILVNSNLVCKVSDFGLSR-----VLEDDPEAAYTTRGGKIPIRWTAP 178

Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
           E +   + T+ SDV+S+G+++ E++S G RP
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 17/219 (7%)

Query: 275 RLLGDSKTGGTYSGILPDGS---RVAVKRLKRSSFQRKK--EFYSEIGRFARLHHPNLVA 329
           + LG+ + G    G L       +VAVK +K +   R +  +F SE        HPN++ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 330 VKGCCYDHGDR------YIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKVATTLAQG 381
           + G C    +        ++  F+ +G L  +L +   G     L   M +K  T +A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +L  K     +HRD+ A N +L+E     +   GLSK +       +  +A     ++
Sbjct: 125 MEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
           A E +     TTKSDV+SFGV + EI + G+ P   V++
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 33/234 (14%)

Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
           P +V   G  Y  G+  I  E +  G LD+ L    R    +   +  K++  + +G+ +
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPENILGKISIAVLRGLTY 114

Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYL 441
           L +K K  ++HRD++ SN+L++      L   G+S        Q    MA    GT  Y+
Sbjct: 115 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG-------QLIDSMANSFVGTRSYM 165

Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF-------EWATPLV- 493
           +PE +     T +SD++S G+ L+E+  GR P    D+   +++F       E       
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP 225

Query: 494 ---------QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
                    +     ELLD +++     +P      +  D V  C +  P  R 
Sbjct: 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA 279

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 57/195 (29%), Positives = 86/195 (44%), Gaps = 8/195 (4%)

Query: 277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           +G    G  +SG L  D + VAVK  + +     K +F  E     +  HPN+V + G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 YIV E V  G    +L      G  L     +++    A G+ +L  K   H +
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCI 116

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD+ A N L+ E+    +   G+S+     V      M      + APE +     +++
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 455 SDVYSFGVLLLEIVS 469
           SDV+SFG+LL E  S
Sbjct: 177 SDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 74/291 (25%), Positives = 124/291 (42%), Gaps = 38/291 (13%)

Query: 275 RLLGDSKTGGTYSGILP--DGS--RVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLV 328
           R+LG  + G      L   DGS  +VAVK LK   F     +EF  E        HPN++
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 329 AVKGCCYDHGDR------YIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATTLAQ 380
            + G       +       ++  F+ +G L  +L    I     +L     ++    +A 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
           G+ +L  K   + +HRD+ A N +L+E     +   GLSK +       +   +     +
Sbjct: 125 GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499
           LA E +  N  TT SDV++FGV + EI++ G+ P   V++     I+ +   L++ +R  
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY---LIKGNRLK 235

Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           +  D L              + V +L+  C    P  RP   H+  QL+ +
Sbjct: 236 QPPDCL--------------EDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 68/274 (24%), Positives = 117/274 (42%), Gaps = 42/274 (15%)

Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 51  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110

Query: 352 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
           L  +L                +P     L +   +  A  +A+G+ +L  K     +HRD
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPE--EQLSFKDLVSCAYQVARGMEYLASK---KCIHRD 165

Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225

Query: 458 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEA 516
           +SFGVLL EI + G  P   V       + E    L + HR              D P +
Sbjct: 226 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHRM-------------DKP-S 265

Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 266 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|153057 cd00037, CLECT, C-type lectin (CTL)/C-type lectin-like (CTLD) domain

 Score = 62.6 bits (152), Expect = 4e-12
 Identities = 32/130 (24%), Positives = 56/130 (43%), Gaps = 22/130 (16%)

Query: 65  KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEE-EHSAQKLCGKNVNGCWVGGRSINTT 123
            C+ +     +W+E++ YC+ +GGHLA++ S EE +  A  L   + +  W+G   +++ 
Sbjct: 1   SCYKFSTEKLTWEEAQEYCRSLGGHLASIHSEEENDFLASLLKKSSSSDVWIGLNDLSS- 59

Query: 124 VGLSWKWSD-----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTE 178
              +WKWSD     + + W       G  +  C               L S+        
Sbjct: 60  -EGTWKWSDGSPLVDYTNWAPGEPNPGG-SEDCV-------------VLSSSSDGKWNDV 104

Query: 179 RCNTSHPFIC 188
            C++  PFIC
Sbjct: 105 SCSSKLPFIC 114

CLECT: C-type lectin (CTL)/C-type lectin-like (CTLD) domain; protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. This group is chiefly comprised of eukaryotic CTLDs, but contains some, as yet functionally uncharacterized, bacterial CTLDs. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces, including CaCO3 and ice. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. For example: mannose-binding lectin and lung surfactant proteins A and D bind carbohydrates on surfaces (e.g. pathogens, allergens, necrotic, and apoptotic cells) and mediate functions associated with killing and phagocytosis; P (platlet)-, E (endothelial)-, and L (leukocyte)- selectins (sels) mediate the initial attachment, tethering, and rolling of lymphocytes on inflamed vascular walls enabling subsequent lymphocyte adhesion and transmigration. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. Several CTLDs bind to protein ligands, and only some of these binding interactions are Ca2+-dependent; including the CTLDs of Coagulation Factors IX/X (IX/X) and Von Willebrand Factor (VWF) binding proteins, and natural killer cell receptors. C-type lectins, such as lithostathine, and some type II antifreeze glycoproteins function in a Ca2+-independent manner to bind inorganic surfaces. Many proteins in this group contain a single CTLD; these CTLDs associate with each other through several different surfaces to form dimers, trimers, or tetramers, from which ligand-binding sites project in different orientations. Various vertebrate type 1 transmembrane proteins including macrophage mannose receptor, endo180, phospholipase A2 receptor, and dendritic and epithelial cell receptor (DEC205) have extracellular domains containing 8 or more CTLDs; these CTLDs remain in the parent model. In some members (IX/X and VWF binding proteins), a loop extends to the adjoining domain to form a loop-swapped dimer. A similar conformation is seen in the macrophage mannose receptor CRD4's putative non-sugar bound form of the domain in the acid environment of the endosome. Lineage specific expansions of CTLDs have occurred in several animal lineages including Drosophila melanogaster and Caenorhabditis elegans; these CTLDs also remain in the parent model. Length = 116

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 22/200 (11%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH----HPNLVAVKGCCYDHGDR-YIVYEFV 347
           G   A+K LK+S    K +  +     A +      P  VA     +   D  Y+V E++
Sbjct: 21  GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY-VAKLYYSFQSKDYLYLVMEYL 79

Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
             G     +  +  GG   DWA   +    +  G+  LH +    ++HRDI+  N+L+D+
Sbjct: 80  NGGDCASLIKTL--GGLPEDWAK--QYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQ 132

Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
                L   GLS+     +  ++ V   GT  YLAPE +        SD +S G ++ E 
Sbjct: 133 TGHLKLTDFGLSRNG---LENKKFV---GTPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186

Query: 468 VSGRRP--AQAVDSVCWQSI 485
           + G  P  A+  D+V + +I
Sbjct: 187 LFGYPPFHAETPDAV-FDNI 205

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.8 bits (163), Expect = 6e-12
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 46/208 (22%)

Query: 291 PD-GSRVAVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           PD G   A+K LK+++ + +    +++ R   A ++HP +V +       G  Y++ +F+
Sbjct: 21  PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80

Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--------------- 392
                        RGG          + T L++ + F  + VK +               
Sbjct: 81  -------------RGG---------DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--QERTVMAGGTYGYLAPEFVYRNE 450
           +++RD++  N+LLDEE    L   GLSK    E +  +++     GT  Y+APE V R  
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPEVVNRRG 174

Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVD 478
            T  +D +SFGVL+ E+++G  P Q  D
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKD 202

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 66.5 bits (162), Expect = 6e-12
 Identities = 51/193 (26%), Positives = 94/193 (48%), Gaps = 25/193 (12%)

Query: 296 VAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           VAVK L+  ++   + +F  E+   +RL  PN++ + G C D     ++ E++ NG L++
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 355 WL--HHIPRG-------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
           +L  HH+                  ++ ++  + VA  +A G+ +L      + VHRD+ 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLA 165

Query: 400 ASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
             N L+ E     +   G+S+ +    +  +Q R V+      ++A E +   + TT SD
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP---IRWMAWECILMGKFTTASD 222

Query: 457 VYSFGVLLLEIVS 469
           V++FGV L EI+ 
Sbjct: 223 VWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 72/269 (26%), Positives = 120/269 (44%), Gaps = 28/269 (10%)

Query: 293 GSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           G  VA+K+   S   +  KK    EI    +L H NLV +          Y+V+EFV + 
Sbjct: 26  GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85

Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            LD  L   P G   LD +   K    + +GI F H     +++HRDI+  N+L+ +   
Sbjct: 86  VLDD-LEKYPNG---LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGV 138

Query: 411 AHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEI 467
             L   G ++ +  P EV  +       T  Y APE +  +    ++ D+++ G L+ E+
Sbjct: 139 VKLCDFGFARTLAAPGEVYTDYV----ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEM 194

Query: 468 VSGRRPAQAVDSVCWQ--SIFEWATPLVQSHRYLELLDPLISSLS-SDIPEAGVVQK--- 521
           ++G  P    DS   Q   I +    L+  H+ +   +PL + +   ++ E   ++K   
Sbjct: 195 LTG-EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFP 253

Query: 522 -----VVDLVYACTQHVPSMRPRMSHVVH 545
                V+DL   C +  P  RP  S ++H
Sbjct: 254 KLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 57/186 (30%), Positives = 84/186 (45%), Gaps = 19/186 (10%)

Query: 293 GSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVV 348
           G   A+K LK+    + K+      E      L HP +V +  C +   +R Y + EFVV
Sbjct: 43  GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM-CSFQDENRVYFLLEFVV 101

Query: 349 NGPLDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
            G L     H+ + GR   D A        LA    +LH K    +++RD++  N+LLD 
Sbjct: 102 GGEL---FTHLRKAGRFPNDVAKFYHAELVLA--FEYLHSK---DIIYRDLKPENLLLDN 153

Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
           +    +   G +K VP     +RT    GT  YLAPE +         D ++ GVLL E 
Sbjct: 154 KGHVKVTDFGFAKKVP-----DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208

Query: 468 VSGRRP 473
           ++G  P
Sbjct: 209 IAGYPP 214

Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.2 bits (161), Expect = 9e-12
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 11/171 (6%)

Query: 319 FARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
            A    P  +     C+   DR Y V E+V  G L   ++HI + G+       +  A  
Sbjct: 54  LALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGK-FKEPQAVFYAAE 109

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           ++ G+ FLH +    +++RD++  NV+LD E    +   G+ K    + +  RT    GT
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC--GT 164

Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSIFE 487
             Y+APE +         D +++GVLL E+++G+ P    D    +QSI E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 61/261 (23%), Positives = 118/261 (45%), Gaps = 44/261 (16%)

Query: 293 GSRVAVKRLK--RSSFQRKKEFYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
           G+ +AVK++   R++   ++E       EI   ARL+HP+++ + G   +     +  E+
Sbjct: 25  GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84

Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
           +  G +   L        +   A+ +     L +G+++LH+     ++HRD++ +N+L+D
Sbjct: 85  MAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLID 137

Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAG-------GTYGYLAPEFVYRNELTTKS-DVY 458
              G  L    ++ F     +  +   AG       GT  ++APE V R E   +S DV+
Sbjct: 138 ST-GQRLR---IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE-VLRGEQYGRSCDVW 192

Query: 459 SFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS-DIPEAG 517
           S G +++E+ + + P              W      +H  L L+  + S+ ++  IPE  
Sbjct: 193 SVGCVIIEMATAKPP--------------WNAEKHSNH--LALIFKIASATTAPSIPEH- 235

Query: 518 VVQKVVDLVYACTQHVPSMRP 538
           +   + D+   C +  P  RP
Sbjct: 236 LSPGLRDVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 44/181 (24%), Positives = 89/181 (49%), Gaps = 10/181 (5%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           G +VAVK +     QR++  ++E+       H N+V +        + +++ EF+  G L
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105

Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
              +         L+      V  ++ Q + +LH +    V+HRDI++ ++LL  +    
Sbjct: 106 TDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVK 157

Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 472
           L   G    +  +V + ++++  GT  ++APE + R    T+ D++S G++++E+V G  
Sbjct: 158 LSDFGFCAQISKDVPKRKSLV--GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215

Query: 473 P 473
           P
Sbjct: 216 P 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 51/156 (32%), Positives = 73/156 (46%), Gaps = 15/156 (9%)

Query: 324 HPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
           HP L  +  CC+   DR + V EFV  G L   + HI +  R  D A     A  +   +
Sbjct: 55  HPFLTQLY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKS-RRFDEARARFYAAEITSAL 109

Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGY 440
            FLHDK    +++RD++  NVLLD E    L   G+ K    E +      +   GT  Y
Sbjct: 110 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDY 162

Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           +APE +         D ++ GVLL E++ G  P +A
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 16/204 (7%)

Query: 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LGD   G  Y     + G+  A K ++  S +  +++  EI   A  +HP +V + G  Y
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
             G  +I+ EF   G +D  +  + RG   L       +   + + + +LH      ++H
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSM---KIIH 133

Query: 396 RDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT- 453
           RD++A NVLL  +    L   G+S K V  + +Q R    G  Y ++APE V    +   
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNV--KTLQRRDSFIGTPY-WMAPEVVMCETMKDT 190

Query: 454 ----KSDVYSFGVLLLEIVSGRRP 473
               K+D++S G+ L+E+     P
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 11/157 (7%)

Query: 333 CCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
            C+   DR Y V E+V  G L   ++HI + G+       +  A  +A G+ FLH K   
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHSK--- 120

Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
            +++RD++  NV+LD E    +   G+ K   +     RT    GT  Y+APE +     
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC--GTPDYIAPEIIAYQPY 178

Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSIFE 487
               D ++FGVLL E+++G+ P    D    +QSI E
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 45/195 (23%), Positives = 79/195 (40%), Gaps = 26/195 (13%)

Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVV 348
           G   A+K +K++   RK    +  +E    ++   P +V +    +      Y+V E++ 
Sbjct: 18  GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLP 76

Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
            G L   L ++     SLD  +       +   + +LH      ++HRD++  N+L+D  
Sbjct: 77  GGDLASLLENV----GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSN 129

Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAG----------GTYGYLAPEFVYRNELTTKSDVY 458
               L   GLSK      +  R +             GT  Y+APE +     +   D +
Sbjct: 130 GHLKLTDFGLSKVG----LVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWW 185

Query: 459 SFGVLLLEIVSGRRP 473
           S G +L E + G  P
Sbjct: 186 SLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 48/275 (17%)

Query: 296 VAVKRLKRSSFQR-------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
           VAVK LK  + ++       + E    IG+     H N++ + G C   G  Y++ E+  
Sbjct: 50  VAVKMLKDDATEKDLSDLVSEMEMMKMIGK-----HKNIINLLGACTQDGPLYVIVEYAS 104

Query: 349 NGPLDRWLH-HIPRG-------GRSLDWAMRMK--VATT--LAQGIAFLHDKVKPHVVHR 396
            G L  +L    P G        R  D  M  K  V+ T  +A+G+ +L  +     +HR
Sbjct: 105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHR 161

Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
           D+ A NVL+ E     +   GL++ V      ++T        ++APE ++    T +SD
Sbjct: 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 221

Query: 457 VYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 515
           V+SFGVL+ EI + G  P   +       + E    L + HR              D P 
Sbjct: 222 VWSFGVLMWEIFTLGGSPYPGI------PVEELFKLLKEGHRM-------------DKP- 261

Query: 516 AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           A    ++  ++  C   +PS RP    +V  L ++
Sbjct: 262 ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)

Query: 283 GGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH----PNLVAVKGCCYDHG 338
           GG  + +    S + + R K    + K    ++I R  ++ H    P +V   G  Y  G
Sbjct: 18  GGVVTKVQHKPSGLIMAR-KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76

Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
           +  I  E +  G LD+ L    +  + +   +  KV+  + +G+A+L +K    ++HRD+
Sbjct: 77  EISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDV 130

Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVY 458
           + SN+L++      L   G+S     +++        GT  Y++PE +     + +SD++
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 186

Query: 459 SFGVLLLEIVSGRRPAQAVDSVCWQSIF 486
           S G+ L+E+  GR P    D+   ++IF
Sbjct: 187 SMGLSLVELAIGRYPIPPPDAKELEAIF 214

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 19/211 (9%)

Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGC 333
           ++G+   G  Y       G  VA+K +       ++E   E     +  +HPN+    G 
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 334 CY------DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
                   +    ++V E    G +   +  + + G+ L       +     +G+A+LH+
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE 131

Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
                V+HRDI+  N+LL +     L+  G+S  +   + +  T +  GT  ++APE + 
Sbjct: 132 N---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI--GTPYWMAPEVIA 186

Query: 448 RNE-----LTTKSDVYSFGVLLLEIVSGRRP 473
            +E        +SDV+S G+  +E+  G+ P
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 48/185 (25%), Positives = 92/185 (49%), Gaps = 19/185 (10%)

Query: 292 DGSRVAVKRLKRSSFQRKK--EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
           DG +  +K +  S    K+  E   E+   + + HPN+V  +    ++G+ YIV ++   
Sbjct: 24  DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83

Query: 350 GPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
           G L + ++   RG      + LDW +++ +A      +  +HD+    ++HRDI++ N+ 
Sbjct: 84  GDLYKKINA-QRGVLFPEDQILDWFVQICLA------LKHVHDR---KILHRDIKSQNIF 133

Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
           L ++    L   G+++ +   V   RT +  GT  YL+PE         KSD+++ G +L
Sbjct: 134 LTKDGTIKLGDFGIARVLNSTVELARTCI--GTPYYLSPEICENRPYNNKSDIWALGCVL 191

Query: 465 LEIVS 469
            E+ +
Sbjct: 192 YEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 50/190 (26%), Positives = 93/190 (48%), Gaps = 26/190 (13%)

Query: 296 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           VAVK L+    +  + +F  EI   +RL +PN++ + G C       ++ E++ NG L++
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 355 WL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
           +L            ++IP    S+  A  + +A  +A G+ +L      + VHRD+   N
Sbjct: 107 FLSQREIESTFTHANNIP----SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRN 159

Query: 403 VLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
            L+   +   +   G+S+ +    +  +Q R V+      ++A E +   + TT SDV++
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLP---IRWMAWESILLGKFTTASDVWA 216

Query: 460 FGVLLLEIVS 469
           FGV L E+ +
Sbjct: 217 FGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 55/231 (23%), Positives = 101/231 (43%), Gaps = 28/231 (12%)

Query: 296 VAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           VA+K++  S  Q   + ++   E+    +L HPN +  +GC       ++V E+ +    
Sbjct: 43  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 102

Query: 353 DRW-LHHIPRGGRSLDWAMRMKVATTL---AQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
           D   +H  P           +++A       QG+A+LH     +++HRD++A N+LL E 
Sbjct: 103 DLLEVHKKP--------LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP 151

Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLL 465
                  V L  F    +M       G  Y ++APE +      +   K DV+S G+  +
Sbjct: 152 -----GLVKLGDFGSASIMAPANXFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCI 205

Query: 466 EIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 515
           E+   + P   ++++     I +  +P +QS  + E     + S    IP+
Sbjct: 206 ELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQ 256

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 62/226 (27%), Positives = 91/226 (40%), Gaps = 39/226 (17%)

Query: 277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRK---------KEFYSEIGRFARLHHPN 326
           LG       Y G+L        V   +  S   K           F+      ++L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
           LV + G C    +  +V E+V  GPLD +LH       SL W  ++ VA  LA  + +L 
Sbjct: 63  LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREK-NNVSLHW--KLDVAKQLASALHYLE 118

Query: 387 DKVKPHVVHRDIRASNVLL---DEEFGAHLM------GVGLSKFVPWEVMQERTVMAGGT 437
           DK    +VH ++   N+L+       G          G+ ++  +  E   ER       
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT-VLSREERVERI------ 168

Query: 438 YGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
             ++APE   RN    LT  +D +SFG  LLEI S G  P   + S
Sbjct: 169 -PWIAPEC-IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 38/262 (14%)

Query: 292 DGSRVAVKRL--KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFVV 348
           DG +  +K+L  + +S + +K    E    ++L HPN+VA +     + G  YIV  F  
Sbjct: 24  DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83

Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
            G L   L    + G+ L     ++    +A  + +LH+K   H++HRD++  NV L   
Sbjct: 84  GGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRT 138

Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
               +  +G+++     V++ +  MA    GT  Y++PE         KSDV++ G  + 
Sbjct: 139 NIIKVGDLGIAR-----VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVY 193

Query: 466 EIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE-LLDPLISSLSSDIPEAGVVQKVVD 524
           E+ + +    A D             LV  +R +E  L P+    S   PE G      +
Sbjct: 194 EMATLKHAFNAKD----------MNSLV--YRIIEGKLPPMPKDYS---PELG------E 232

Query: 525 LVYACTQHVPSMRPRMSHVVHQ 546
           L+       P  RP +  ++ Q
Sbjct: 233 LIATMLSKRPEKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 67/294 (22%), Positives = 127/294 (43%), Gaps = 47/294 (15%)

Query: 275 RLLGDSKTGGTYSGIL-------PDGSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPN 326
           R LG    G  Y GI        P+ +RVA+K +  ++  R++ EF +E       +  +
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-----PRGGRSLDWAMRM-KVATTLAQ 380
           +V + G         ++ E +  G L  +L  +         ++     +M ++A  +A 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
           G+A+L+       VHRD+ A N ++ E+F   +   G+++    ++ +      GG    
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 183

Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS 495
              +++PE +     TT SDV+SFGV+L EI +   +P Q + +       E     V  
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVLRFVME 236

Query: 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
              L+  D        + P+      + +L+  C Q+ P MRP    ++  +++
Sbjct: 237 GGLLDKPD--------NCPDM-----LFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 68/292 (23%), Positives = 125/292 (42%), Gaps = 44/292 (15%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           ++LG    G  Y G+ +P+G +    VA+K L+  +S +  KE   E    A + +P++ 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKVATTLAQGIAFLH 386
            + G C     + I         LD    H    G    L+W ++      +A+G+ +L 
Sbjct: 73  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLE 126

Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYLAP 443
           ++    +VHRD+ A NVL+       +   GL+K +  +   E+   A G      ++A 
Sbjct: 127 ER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD---EKEYHAEGGKVPIKWMAL 180

Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502
           E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L Q        
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-------- 232

Query: 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
            P I ++            V  ++  C       RP+   ++ +  ++A+ P
Sbjct: 233 -PPICTI-----------DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|153064 cd03594, CLECT_REG-1_like, C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2)

 Score = 59.3 bits (144), Expect = 8e-11
 Identities = 35/146 (23%), Positives = 51/146 (34%), Gaps = 29/146 (19%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEE-----EH-SAQK 104
           CP  W+    K  C+GY     SW ++E +C++   G HLA++ S  E        S+ +
Sbjct: 1   CPKGWL--PYKGNCYGYFRQPLSWSDAELFCQKYGPGAHLASIHSPAEAAAIASLISSYQ 58

Query: 105 LCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNS--SCTSLPCHVHATV 162
              + V   W+G           W+WSD       S      +     C  L        
Sbjct: 59  KAYQPV---WIGLHDPQQ--SRGWEWSDGSKLDYRSWDRNPPYARGGYCAELSR------ 107

Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
                 S G        C   +PFIC
Sbjct: 108 ------STGFLKWNDANCEERNPFIC 127

CLECT_REG-1_like: C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. REG-1 is a proliferating factor which participates in various kinds of tissue regeneration including pancreatic beta-cell regeneration, regeneration of intestinal mucosa, regeneration of motor neurons, and perhaps in tissue regeneration of damaged heart. REG-1 may play a role on the pathophysiology of Alzheimer's disease and in the development of gastric cancers. Its expression is correlated with reduced survival from early-stage colorectal cancer. REG-1 also binds and aggregates several bacterial strains from the intestinal flora and it has been suggested that it is involved in the control of the intestinal bacterial ecosystem. Rat lithostathine has calcium carbonate crystal inhibitor activity in vitro. REG-IV is unregulated in pancreatic, gastric, hepatocellular, and prostrate adenocarcinomas. REG-IV activates the EGF receptor/Akt/AP-1 signaling pathway in colorectal carcinoma. Ansocalcin, SCA-1 and -2 are found at high concentration in the calcified egg shell layer of goose and ostrich, respectively and tend to form aggregates. Ansocalcin nucleates calcite crystal aggregates in vitro. Length = 129

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 22/206 (10%)

Query: 284 GTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCY-- 335
           GTY  +       DGS  AVK L   S    +E  +E      L +HPN+V   G  Y  
Sbjct: 33  GTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91

Query: 336 DH---GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
           D    G  ++V E    G +   +  +   G+ LD AM   +      G+  LH+     
Sbjct: 92  DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---R 148

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV-----Y 447
           ++HRD++ +N+LL  E G  L+  G+S  +    ++  T +  GT  ++APE +     Y
Sbjct: 149 IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEVIACEQQY 206

Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRP 473
                 + DV+S G+  +E+  G  P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.1 bits (151), Expect = 9e-11
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 19/214 (8%)

Query: 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLK--RSSFQRKKEFYS---EIGRFARL 322
           N+  G +LLG    G  Y     D G  +AVK++     S + KKE  +   EI     L
Sbjct: 3   NWRRG-KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
            H  +V   GC  D     I  E++  G +      +   G +L   +  K    + +G+
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVK---DQLKAYG-ALTETVTRKYTRQILEGV 117

Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE---RTVMAGGTYG 439
            +LH      +VHRDI+ +N+L D      L   G SK +          ++V   GT  
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT--GTPY 172

Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           +++PE +       K+DV+S G  ++E+++ + P
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 55/234 (23%), Positives = 103/234 (44%), Gaps = 34/234 (14%)

Query: 296 VAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           VA+K++  S   S ++ ++   E+    R+ HPN +  KGC       ++V E+ +    
Sbjct: 53  VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSAS 112

Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE----- 407
           D    H     + L       +     QG+A+LH     +++HRDI+A N+LL E     
Sbjct: 113 DLLEVH----KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVK 165

Query: 408 --EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGV 462
             +FG+  +    + FV             GT  ++APE +      +   K DV+S G+
Sbjct: 166 LADFGSASIASPANSFV-------------GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 212

Query: 463 LLLEIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 515
             +E+   + P   ++++     I +  +P +QS+ + +     + S    IP+
Sbjct: 213 TCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQ 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 70/277 (25%), Positives = 114/277 (41%), Gaps = 52/277 (18%)

Query: 296 VAVKRLKR-------SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
           VAVK LK        S    + E    IG+     H N++ + G C   G  Y++ E+  
Sbjct: 47  VAVKMLKDDATDKDLSDLVSEMEMMKMIGK-----HKNIINLLGACTQDGPLYVLVEYAS 101

Query: 349 NGPLDRWLHHIPRGGRSLDWAMR--------------MKVATTLAQGIAFLHDKVKPHVV 394
            G L  +L    R    +D++                +  A  +A+G+ +L  +     +
Sbjct: 102 KGNLREYLR--ARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCI 156

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD+ A NVL+ E+    +   GL++ V      ++T        ++APE ++    T +
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 216

Query: 455 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513
           SDV+SFGVLL EI + G  P   +       + E    L + HR              D 
Sbjct: 217 SDVWSFGVLLWEIFTLGGSPYPGI------PVEELFKLLKEGHRM-------------DK 257

Query: 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           P A    ++  ++  C   VPS RP    +V  L ++
Sbjct: 258 P-ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 26/236 (11%)

Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRY--IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
           EI     L H  +V   GC  D  ++   I  E++  G +   L    +   +L  ++  
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTR 109

Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
           K    + +G+++LH  +   +VHRDI+ +N+L D      L   G SK +    M    +
Sbjct: 110 KYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166

Query: 433 MA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP 491
            +  GT  +++PE +       K+DV+S G  ++E+++ + P    +++   +IF+ AT 
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA--AIFKIAT- 223

Query: 492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
                       P    L S I E    +  +  ++   +H PS    + H   QL
Sbjct: 224 -----------QPTNPQLPSHISEHA--RDFLGCIFVEARHRPSAEELLRHPFAQL 266

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 66/262 (25%), Positives = 104/262 (39%), Gaps = 32/262 (12%)

Query: 296 VAVKRLK--RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VA+K+ K        KK    E+    +L H N+V +K      G  Y+V+E+V    L+
Sbjct: 29  VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE 88

Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
             L   P G   L           L Q IA+ H     +++HRDI+  N+L+ E     L
Sbjct: 89  L-LEASPGG---LPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKL 141

Query: 414 MGVGLSKFVPWEVMQERTVMAGGTY----GYLAPEFVYRNELTTKS-DVYSFGVLLLEIV 468
              G ++      ++ R       Y     Y APE +  +    K  DV++ G ++ E++
Sbjct: 142 CDFGFARA-----LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL 196

Query: 469 SGRRPAQAVDSVCWQ--SIFEWATPLVQSHRYLELLDPLISSLS----SDI------PEA 516
            G  P    DS   Q   I +   PL  SH+ L   +P  + ++    S           
Sbjct: 197 DG-EPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPG 255

Query: 517 GVVQKVVDLVYACTQHVPSMRP 538
            V    +D + AC +  P  R 
Sbjct: 256 KVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 55/213 (25%), Positives = 105/213 (49%), Gaps = 20/213 (9%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRV----AVKRLKRSSFQRKK-EFYSEIGRFARLHHPNLV 328
           ++LG    G  Y GI +P+G  V    A+K L  ++  +   EF  E    A + HP+LV
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRSL--DWAMRMKVATTLAQGIAFL 385
            + G C     + +V + + +G L  ++H H    G  L  +W ++      +A+G+ +L
Sbjct: 73  RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 125

Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
            ++    +VHRD+ A NVL+       +   GL++ +  +  +           ++A E 
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182

Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 477
           ++  + T +SDV+S+GV + E+++ G +P   +
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 29/228 (12%)

Query: 284 GTYSGILPDGSR-VAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC-YDHGDR 340
           G      P     V VK +K  +S  +      E      L H N++ +   C  D    
Sbjct: 25  GILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84

Query: 341 YIVYEFVVNGPLDRWLH---HIPR-GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
           +++Y ++  G L  +L           ++L     + +A  +A G+++LH +    V+H+
Sbjct: 85  FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHK 141

Query: 397 DIRASNVLLDEEFGAHLMGVGLSK-FVPWEVM-----QERTVMAGGTYGYLAPEFVYRNE 450
           DI A N ++DEE    +    LS+   P +       + R V       ++A E +   E
Sbjct: 142 DIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK------WMALESLVNKE 195

Query: 451 LTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
            ++ SDV+SFGVLL E+++ G+ P   +D       FE A  L   +R
Sbjct: 196 YSSASDVWSFGVLLWELMTLGQTPYVEID------PFEMAAYLKDGYR 237

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 47/206 (22%)

Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           RV +K L  S       F+      +++ H +L  V G C    +  +V EFV +GPLD 
Sbjct: 46  RVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDV 105

Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD----EEFG 410
            L    +G   + W  ++ VA  LA  +++L DK   ++VH ++ A N+LL      E  
Sbjct: 106 CLRK-EKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGT 159

Query: 411 AHLM-----GVGLSKF--------VPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSD 456
           +  +     GV  +          +PW                +APE V   N L+T +D
Sbjct: 160 SPFIKLSDPGVSFTALSREERVERIPW----------------IAPECVPGGNSLSTAAD 203

Query: 457 VYSFGVLLLEI-------VSGRRPAQ 475
            +SFG  LLEI       +  R P++
Sbjct: 204 KWSFGTTLLEICFDGEVPLKERTPSE 229

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 57/195 (29%), Positives = 90/195 (46%), Gaps = 24/195 (12%)

Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           V +K L +S     + F+      ++L H +LV   G C    +  +V E+V  G LD +
Sbjct: 30  VLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTY 89

Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH--- 412
           L    +    ++ + +++VA  LA  + FL DK    + H ++ A NVLL  E       
Sbjct: 90  LK---KNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGN 143

Query: 413 -----LMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLL 465
                L   G+S  V P E++ ER         ++ PE +     L+  +D +SFG  L 
Sbjct: 144 PPFIKLSDPGISITVLPKEILLERI-------PWVPPECIENPQNLSLAADKWSFGTTLW 196

Query: 466 EIVSG-RRPAQAVDS 479
           EI SG  +P  A+DS
Sbjct: 197 EIFSGGDKPLSALDS 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 61/275 (22%), Positives = 111/275 (40%), Gaps = 44/275 (16%)

Query: 286 YSGILPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRY- 341
           Y GI  +   V ++  K+     K       +EI    R+   N++ + G   D  D   
Sbjct: 37  YKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 342 ---IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-KPHVVHRD 397
              ++ E+   G L   L       + L +  ++ +A    +G+  L+    KP+   ++
Sbjct: 96  RLSLILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY---KN 148

Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
           + + + L+ E +   ++  GL K +     +    M   +Y  L   F   +E T K D+
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIF---SEYTIKDDI 205

Query: 458 YSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS---SLSSDIP 514
           YS GV+L EI +G+ P            FE  T         E+ D +I+   SL   + 
Sbjct: 206 YSLGVVLWEIFTGKIP------------FENLT-------TKEIYDLIINKNNSLKLPLD 246

Query: 515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
               ++ +V+   ACT H    RP +  +++ L  
Sbjct: 247 CPLEIKCIVE---ACTSHDSIKRPNIKEILYNLSL 278

Length = 283

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 18/197 (9%)

Query: 296 VAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           VA+KR ++S   ++K+    +SE      ++HP  V + G   D    Y+V EFV+ G  
Sbjct: 59  VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118

Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP-HVVHRDIRASNVLLDEEFGA 411
             +L    R            V    A  I  + + ++  ++V+RD++  N+LLD++   
Sbjct: 119 FTFLRRNKR--------FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFI 170

Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
            +   G +K     V+  RT    GT  Y+APE +        +D ++ G+ + EI+ G 
Sbjct: 171 KMTDFGFAK-----VVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGC 225

Query: 472 RPAQAVDS-VCWQSIFE 487
            P  A +  + +Q I E
Sbjct: 226 PPFYANEPLLIYQKILE 242

Length = 340

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 65/277 (23%), Positives = 115/277 (41%), Gaps = 48/277 (17%)

Query: 294 SRVAVKRLKRSSFQR-------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
             VAVK LK ++  +       + E    IG+     H N++ + G C   G  Y++ E+
Sbjct: 45  VTVAVKMLKDNATDKDLADLISEMELMKLIGK-----HKNIINLLGVCTQEGPLYVIVEY 99

Query: 347 VVNGPLDRWLH--------HIPRGGRSLDWAMRMK----VATTLAQGIAFLHDKVKPHVV 394
              G L  +L         +     +  +  +  K     A  +A+G+ +L  +     +
Sbjct: 100 AAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCI 156

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD+ A NVL+ E+    +   GL++ V      ++T        ++APE ++    T +
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ 216

Query: 455 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513
           SDV+SFG+L+ EI + G  P   +       + E    L + HR              D 
Sbjct: 217 SDVWSFGILMWEIFTLGGSPYPGI------PVEELFKLLREGHRM-------------DK 257

Query: 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           P +    ++  L+  C   VP+ RP    +V  L ++
Sbjct: 258 P-SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 63.3 bits (154), Expect = 3e-10
 Identities = 57/229 (24%), Positives = 106/229 (46%), Gaps = 28/229 (12%)

Query: 293 GSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV--KGCCYDHGDRYIVYEFV 347
           G  VA+K L+  + + + +   F  E    ARL+HPN+VA+   G     G  + V+E+V
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYV 61

Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-- 405
                 R L  +     +L      ++   +   +A  H++    +VHRD++  N+++  
Sbjct: 62  PG----RTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQ 114

Query: 406 -DEEFGAHLMGVGLSKFVP--WEVMQERTVMAG---GTYGYLAPEFVYRNE-LTTKSDVY 458
                 A ++  G+   +P   +             GT  Y APE + R E +T  SD+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLY 173

Query: 459 SFGVLLLEIVSGRRPAQ--AVDSVCWQ--SIFEWATP-LVQSHRYLELL 502
           ++G++ LE ++G+R  Q  +V  + +Q  S  + + P  +  H   ++L
Sbjct: 174 AWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVL 222

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 59/264 (22%), Positives = 108/264 (40%), Gaps = 29/264 (10%)

Query: 277 LGDSKTGGTYSGILPDGSRV-AVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           LG    G  Y        R+ AVK +    + + +K+  SE+    +   P ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
           +      I  EF+  G LD +        R +   +  ++A  + +G+ +L       ++
Sbjct: 69  FVENRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL---KIL 117

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD++ SN+L++      L   G+S     +++        GT  Y+APE +   +    
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGIH 173

Query: 455 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514
           SDV+S G+  +E+  GR P        +  I +    L+     L+LL  ++      +P
Sbjct: 174 SDVWSLGISFMELALGRFP--------YPQIQKNQGSLMP----LQLLQCIVDEDPPVLP 221

Query: 515 EAGVVQKVVDLVYACTQHVPSMRP 538
                +K V  +  C +  P  RP
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 13/186 (6%)

Query: 292 DGSRV-AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           D  R+ A+K ++++    + E     +E    A+++ P +V +K         Y+V  F+
Sbjct: 16  DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI 75

Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
             G L    HH+ R GR      R   A  L   +  LH   K +V++RD++  N+LLD 
Sbjct: 76  NGGEL---FHHLQREGRFDLSRARFYTAELLC-ALENLH---KFNVIYRDLKPENILLDY 128

Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
           +    L   GL K    +   ++T    GT  YLAPE +  +  T   D ++ GVLL E+
Sbjct: 129 QGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEM 186

Query: 468 VSGRRP 473
           ++G  P
Sbjct: 187 LTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 63/302 (20%)

Query: 277 LGDSKTGGTYSGIL------PDGSRVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVA 329
           LG+ + G  Y G L           VA+K LK ++    ++EF  E    +RL HPN+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWL----HHIPRGGRSLDWAMR--------MKVATT 377
           + G         +++ +  +  L  +L     H   G    D  ++        + + T 
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           +A G+ FL      HVVH+D+   NVL+ ++    +  +GL           R V A   
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLF----------REVYAADY 179

Query: 438 YG----------YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 486
           Y           +++PE +   + +  SD++S+GV+L E+ S G +P     +   Q + 
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVI 236

Query: 487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546
           E    ++++ + L   D        D P       V  L+  C    PS RPR   +  +
Sbjct: 237 E----MIRNRQVLPCPD--------DCPAW-----VYTLMLECWNEFPSRRPRFKDIHSR 279

Query: 547 LQ 548
           L+
Sbjct: 280 LR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 24/217 (11%)

Query: 269 NFSEGNR--LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP 325
            + E     +LG    G  Y+   L    R+A+K +     +  +  + EI   + L H 
Sbjct: 6   EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT------TLA 379
           N+V   G   ++G   I  E V  G L   L       RS    ++    T       + 
Sbjct: 66  NIVQYLGSDSENGFFKIFMEQVPGGSLSALL-------RSKWGPLKDNEQTIIFYTKQIL 118

Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTY 438
           +G+ +LHD     +VHRDI+  NVL++   G   +   G SK +    +   T    GT 
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTL 173

Query: 439 GYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRP 473
            Y+APE + +        +D++S G  ++E+ +G+ P
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.7 bits (147), Expect = 6e-10
 Identities = 60/196 (30%), Positives = 87/196 (44%), Gaps = 17/196 (8%)

Query: 292 DGSRV-AVKRLKRSSFQRKKEFYSEIG------RFARLHHPNLVAVKGCCYDHGDRYIVY 344
           D  R+ A+K L +     KKE    IG      R      P +V +K       D Y+V 
Sbjct: 16  DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT 75

Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
           +++  G L  W  H+ + GR  +   +  +A  L   +  LH   K  +V+RD++  N+L
Sbjct: 76  DYMSGGEL-FW--HLQKEGRFSEDRAKFYIAE-LVLALEHLH---KYDIVYRDLKPENIL 128

Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVL 463
           LD      L   GLSK        + T    GT  YLAPE +   +  TK  D +S GVL
Sbjct: 129 LDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL 186

Query: 464 LLEIVSGRRPAQAVDS 479
           + E+  G  P  A D+
Sbjct: 187 VFEMCCGWSPFYAEDT 202

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 66/293 (22%), Positives = 121/293 (41%), Gaps = 46/293 (15%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           ++LG    G  Y GI +PDG      VA+K L+  +S +  KE   E    A +  P + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKVATTLAQGIAFLH 386
            + G C     + +         LD    +  R G    L+W ++      +A+G+++L 
Sbjct: 73  RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126

Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYLAP 443
           +     +VHRD+ A NVL+       +   GL++ +    + E    A G      ++A 
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD---IDETEYHADGGKVPIKWMAL 180

Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502
           E +     T +SDV+S+GV + E+++ G +P                   + +    +LL
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG----------------IPAREIPDLL 224

Query: 503 DPLISSLSSDIPEAGVVQKVVDLVYA-CTQHVPSMRPRMSHVVHQLQQLAQPP 554
           +         +P+  +    V ++   C       RPR   +V +  ++A+ P
Sbjct: 225 EK-----GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 9/159 (5%)

Query: 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIP-RGGRSLDWAMRMKVATT 377
            A++ HPN+VA K      G  YIV E+   G L   +  I  + G+       ++    
Sbjct: 52  LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL---MQKIKLQRGKLFPEDTILQWFVQ 108

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           +  G+  +H+K    V+HRDI++ N+ L +     L   G ++ +        T +  GT
Sbjct: 109 MCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--GT 163

Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
             Y+ PE         KSD++S G +L E+ + + P QA
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 44/162 (27%), Positives = 81/162 (50%), Gaps = 10/162 (6%)

Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
           P +V   G  Y  G+  I  E +  G LD+ L    + GR +   +  KV+  + +G+ +
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGR-IPEQILGKVSIAVIKGLTY 118

Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           L +K K  ++HRD++ SN+L++      L   G+S     +++        GT  Y++PE
Sbjct: 119 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPE 172

Query: 445 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 486
            +     + +SD++S G+ L+E+  GR P    D+   + +F
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 60.2 bits (146), Expect = 8e-10
 Identities = 87/345 (25%), Positives = 140/345 (40%), Gaps = 75/345 (21%)

Query: 245 PAASALVPPSWKVFTTEELRSITKNFSEGNRL--LGDSKTGGTYSGIL--PDGSRVAVKR 300
           P  S+    S     +    S  K+ SE  R+  +G S  GGT   ++  P G   A+K 
Sbjct: 48  PPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIG-SGAGGTVYKVIHRPTGRLYALKV 106

Query: 301 L---KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEFVVNGPLDRWL 356
           +      + +R  +   EI     ++HPN+V      +DH G+  ++ EF+  G L+   
Sbjct: 107 IYGNHEDTVRR--QICREIEILRDVNHPNVVKCHDM-FDHNGEIQVLLEFMDGGSLEG-- 161

Query: 357 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416
            HI       D      VA  +  GIA+LH   + H+VHRDI+ SN+L++      +   
Sbjct: 162 THIADEQFLAD------VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADF 212

Query: 417 GLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTT------KSDVYSFGVLLLEIV 468
           G+S+ +  + M     +V   GT  Y++PE +   +L          D++S GV +LE  
Sbjct: 213 GVSRILA-QTMDPCNSSV---GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFY 267

Query: 469 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS-SDIPEA--GVVQKVVDL 525
            GR P      V  Q   +WA+              L+ ++  S  PEA     ++    
Sbjct: 268 LGRFPF----GVGRQG--DWAS--------------LMCAICMSQPPEAPATASREFRHF 307

Query: 526 VYACTQHVPSMRPRMSHVVH----------------QLQQLAQPP 554
           +  C Q  P+ R     ++                  L QL  PP
Sbjct: 308 ISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPPP 352

Length = 353

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.1 bits (145), Expect = 9e-10
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 13/159 (8%)

Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
           +HP LV +  C       + V E+V  G L   + H+ R  +  +   R   A  ++  +
Sbjct: 54  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 109

Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGY 440
            +LH++    +++RD++  NVLLD E    L   G+ K    E ++  + T    GT  Y
Sbjct: 110 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTSTFCGTPNY 162

Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
           +APE +   +     D ++ GVL+ E+++GR P   V S
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 201

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 53/190 (27%), Positives = 78/190 (41%), Gaps = 27/190 (14%)

Query: 296 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-- 352
           VAVK LK         +F  E      L H NL+ + G    H    +V E    G L  
Sbjct: 26  VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTH-PLMMVTELAPLGSLLD 84

Query: 353 ---DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
                 L H        D+A++      +A G+ +L  K     +HRD+ A N+LL  + 
Sbjct: 85  RLRKDALGHFLIS-TLCDYAVQ------IANGMRYLESK---RFIHRDLAARNILLASDD 134

Query: 410 GAHLMGVGLSKFVPWE----VMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
              +   GL + +P      VM+E   V     + + APE +     +  SDV+ FGV L
Sbjct: 135 KVKIGDFGLMRALPQNEDHYVMEEHLKV----PFAWCAPESLRTRTFSHASDVWMFGVTL 190

Query: 465 LEIVS-GRRP 473
            E+ + G  P
Sbjct: 191 WEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 12/153 (7%)

Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
            + HP ++ +    +D    Y++ E+V  G L  +L    R       +  +  A+ +  
Sbjct: 57  EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL----RNSGRFSNSTGLFYASEIVC 112

Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
            + +LH K    +V+RD++  N+LLD+E    L   G +K +     ++RT    GT  Y
Sbjct: 113 ALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTLCGTPEY 164

Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           LAPE +         D ++ G+L+ E++ G  P
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 6/102 (5%)

Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
           A  +  G+  LH +    +V+RD++  NVLLD+     +  +GL+  +      ++    
Sbjct: 101 AAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK---GGKKIKGR 154

Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
            GT GY+APE +         D ++ G  L E+++GR P + 
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 13/160 (8%)

Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF+ +  L +++   P  G  L   +    
Sbjct: 49  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSY 105

Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 106 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 162

Query: 433 MAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +   +  +T  D++S G +  E+V+ R
Sbjct: 163 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 15/156 (9%)

Query: 324 HPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
           HP L A+  CC+   DR + V E+V  G L   +  I R  R  D       A  +   +
Sbjct: 55  HPFLTALH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRS-RKFDEPRSRFYAAEVTLAL 109

Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGY 440
            FLH   +  V++RD++  N+LLD E    L   G+ K    E +     T    GT  Y
Sbjct: 110 MFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK----EGILNGVTTTTFCGTPDY 162

Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           +APE +   E     D ++ GVL+ E+++G+ P +A
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 53/184 (28%), Positives = 88/184 (47%), Gaps = 18/184 (9%)

Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L HPN+V ++         Y+++EF ++  L ++L  +P  G+ +D A  +K 
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQESRLYLIFEF-LSMDLKKYLDSLP-KGQYMD-AELVKS 105

Query: 375 AT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERT 431
               + QGI F H +    V+HRD++  N+L+D +    L   GL++   +P  V     
Sbjct: 106 YLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV 162

Query: 432 VMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ--SIFE- 487
           V    T  Y APE +  +   +T  D++S G +  E+ + ++P    DS   Q   IF  
Sbjct: 163 V----TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRIFRI 217

Query: 488 WATP 491
             TP
Sbjct: 218 LGTP 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 13/140 (9%)

Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
           + V E++  G L   + HI    +  D       A  +  G+ FLH K    +V+RD++ 
Sbjct: 72  FFVMEYLNGGDL---MFHIQSCHK-FDLPRATFYAAEIICGLQFLHSK---GIVYRDLKL 124

Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVM--QERTVMAGGTYGYLAPEFVYRNELTTKSDVY 458
            N+LLD +    +   G+ K    E M    +T    GT  Y+APE +   +  T  D +
Sbjct: 125 DNILLDTDGHIKIADFGMCK----ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWW 180

Query: 459 SFGVLLLEIVSGRRPAQAVD 478
           SFGVLL E++ G+ P    D
Sbjct: 181 SFGVLLYEMLIGQSPFHGHD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|153060 cd03590, CLECT_DC-SIGN_like, C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR)

 Score = 54.6 bits (132), Expect = 3e-09
 Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 7/82 (8%)

Query: 53  CPPDWIINEEKSKCFGYIGNFR-SWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
           CP +W     +S C+ +    + SW+ES  +C+++G HL  + S EE+    K+   N +
Sbjct: 1   CPTNWK--SFQSSCY-FFSTEKKSWEESRQFCEDMGAHLVIINSQEEQEFISKILSGNRS 57

Query: 112 GCWVGGRSINTTVGLSWKWSDN 133
             W+G     T  G  WKW D 
Sbjct: 58  -YWIGLSDEETE-G-EWKWVDG 76

CLECT_DC-SIGN_like: C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR). This group also contains proteins similar to hepatic asialoglycoprotein receptor (ASGP-R) and langerin in human. These proteins are type II membrane proteins with a CTLD ectodomain. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. DC-SIGN is thought to mediate the initial contact between dendritic cells and resting T cells, and may also mediate the rolling of DCs on epithelium. DC-SIGN and DC-SIGNR bind to oligosaccharides present on human tissues, as well as, on pathogens including parasites, bacteria, and viruses. DC-SIGN and DC-SIGNR bind to HIV enhancing viral infection of T cells. DC-SIGN and DC-SIGNR are homotetrameric, and contain four CTLDs stabilized by a coiled coil of alpha helices. The hepatic ASGP-R is an endocytic recycling receptor which binds and internalizes desialylated glycoproteins having a terminal galactose or N-acetylgalactosamine residues on their N-linked carbohydrate chains, via the clathrin-coated pit mediated endocytic pathway, and delivers them to lysosomes for degradation. It has been proposed that glycoproteins bearing terminal Sia (sialic acid) alpha2, 6GalNAc and Sia alpha2, 6Gal are endogenous ligands for ASGP-R and that ASGP-R participates in regulating the relative concentration of serum glycoproteins bearing alpha 2,6-linked Sia. The human ASGP-R is a hetero-oligomer composed of two subunits, both of which are found within this group. Langerin is expressed in a subset of dendritic leukocytes, the Langerhans cells (LC). Langerin induces the formation of Birbeck Granules (BGs) and associates with these BGs following internalization. Langerin binds, in a calcium-dependent manner, to glyco-conjugates containing mannose and related sugars mediating their uptake and degradation. Langerin molecules oligomerize as trimers with three CTLDs held together by a coiled-coil of alpha helices. Length = 126

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 46/192 (23%), Positives = 87/192 (45%), Gaps = 24/192 (12%)

Query: 292 DGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
           D     +K   L +   + K+    E+   A++ HPN+V       ++G  +IV E+   
Sbjct: 24  DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83

Query: 350 GPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
           G L + ++   RG      + L W ++      ++ G+  +HD+    ++HRDI++ N+ 
Sbjct: 84  GDLMKRINR-QRGVLFSEDQILSWFVQ------ISLGLKHIHDR---KILHRDIKSQNIF 133

Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMA---GGTYGYLAPEFVYRNELTTKSDVYSFG 461
           L +    + M   L  F     + +   +A    GT  YL+PE         K+D++S G
Sbjct: 134 LSK----NGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLG 189

Query: 462 VLLLEIVSGRRP 473
            +L E+ + + P
Sbjct: 190 CVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 22/212 (10%)

Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKR-------SSFQRKKEFYSEIGRFARLHHPNL 327
           L+G    G  Y G  +P G  VA+K +         S  QR+    S++ +      PN+
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP---PNI 64

Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
               G        +I+ E+   G +   +   P   + +   +R      +   + ++H 
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIH- 118

Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
             K  V+HRDI+A+N+L+       L   G++  +  +   +R+   G  Y ++APE + 
Sbjct: 119 --KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN-QNSSKRSTFVGTPY-WMAPEVIT 174

Query: 448 R-NELTTKSDVYSFGVLLLEIVSGRRPAQAVD 478
                 TK+D++S G+ + E+ +G  P   VD
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 47/185 (25%), Positives = 93/185 (50%), Gaps = 17/185 (9%)

Query: 296 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           VAVK L+  + +  + +F  EI   +RL  PN++ +   C       ++ E++ NG L++
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 355 WL--HHIPRGG-----RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
           +L  H            ++ ++  + +AT +A G+ +L      + VHRD+   N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK 165

Query: 408 EFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
            +   +   G+S+ +    +  +Q R V+      +++ E +   + TT SDV++FGV L
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLP---IRWMSWESILLGKFTTASDVWAFGVTL 222

Query: 465 LEIVS 469
            EI++
Sbjct: 223 WEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 15/206 (7%)

Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVA 329
           R+LG  + G    G L   S+    VA+  L+   S ++++ F +E     +  H N+V 
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           ++G         IV E++ NG LD +L    +    L     M +   LA G+ +L +  
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLASGMKYLSEM- 126

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG-YLAPEFVYR 448
               VH+ + A  VL++ +    + G    +    E +   T M+G +   + APE +  
Sbjct: 127 --GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY--TTMSGKSPVLWAAPEAIQY 182

Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRP 473
           +  ++ SDV+SFG+++ E++S G RP
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 20/227 (8%)

Query: 296 VAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           VAVK++  S  Q   + ++   E+    +L HPN +  KGC       ++V E+ +    
Sbjct: 49  VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSAS 108

Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
           D    H     + L       +     QG+A+LH       +HRDI+A N+LL E     
Sbjct: 109 DLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEP---- 157

Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVS 469
              V L+ F             G  Y ++APE +      +   K DV+S G+  +E+  
Sbjct: 158 -GQVKLADFGSASKSSPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 215

Query: 470 GRRPAQAVDSV-CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 515
            + P   ++++     I +  +P +QS+ + +     +      IP+
Sbjct: 216 RKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQ 262

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 57.5 bits (139), Expect = 6e-09
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 13/152 (8%)

Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HP LV +  C       + V EFV  G L   + H+ R  +  +   R   +  ++  + 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARF-YSAEISLALN 110

Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYL 441
           FLH++    +++RD++  NVLLD E    L   G+ K    E ++  + T    GT  Y+
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTTSTFCGTPNYI 163

Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +   +     D ++ GVL+ E+++GR P
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 13/120 (10%)

Query: 362 GGRSLDWAM-----RMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
           GG +LD          ++AT L +   G+ +LH + K   +HRDI+A+NVLL E+    L
Sbjct: 86  GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKL 142

Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
              G++  +    ++  T +  GT  ++APE + ++   +K+D++S G+  +E+  G  P
Sbjct: 143 ADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 13/152 (8%)

Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           +P LV +  C       ++V E+V  G L   + H+ R  R L        A  +   + 
Sbjct: 55  NPFLVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQ-RKLPEEHARFYAAEICIALN 110

Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYL 441
           FLH++    +++RD++  NVLLD +    L   G+ K    E +   + T    GT  Y+
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK----EGLGPGDTTSTFCGTPNYI 163

Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +   E     D ++ GVL+ E+++GR P
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 56.8 bits (138), Expect = 7e-09
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 46/212 (21%)

Query: 284 GTYSGI-----LPDGSRVAVKRLKRSSFQRKKEFYS-----EIGRFARLHHPNLVAVKGC 333
           GTY  +        G  VA+K+++    + +KE +      EI    +L HPN+V +K  
Sbjct: 10  GTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 334 CYDH--GDRYIVYEFV---VNGPLDRWLHHIPRGG-RSLDWAMRMKVATTLAQGIAFLHD 387
                 G  Y+V+E++   + G LD           +     M+      L +G+ +LH 
Sbjct: 67  VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY---MKQ-----LLEGLQYLHS 118

Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF---VPWEVMQERTVMAGGTYGYLAPE 444
                ++HRDI+ SN+L++ +    L   GL++            R +    T  Y  PE
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI----TLWYRPPE 171

Query: 445 -----FVYRNELTTKSDVYSFGVLLLEIVSGR 471
                  Y      + D++S G +L E+  G+
Sbjct: 172 LLLGATRY----GPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.7 bits (139), Expect = 8e-09
 Identities = 53/183 (28%), Positives = 81/183 (44%), Gaps = 41/183 (22%)

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT-VMAGG 436
           +A+G+ FL  K   + VHRD+ A NVLL +     +   GL++    ++M +   V  G 
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLAR----DIMHDSNYVSKGS 298

Query: 437 TY---GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS---GRRPAQAVDSVCWQSI---FE 487
           T+    ++APE ++ N  TT SDV+S+G+LL EI S      P   VDS  +  I   + 
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358

Query: 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
            A P    H                       Q+V D++  C    P  RP   H+   +
Sbjct: 359 MAKP---DH---------------------ATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394

Query: 548 QQL 550
           + L
Sbjct: 395 ESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 14/203 (6%)

Query: 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LGD   G  Y     + G   A K +   S +  +++  EI   A   HPN+V +    Y
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
              + +I+ EF   G +D  +  +    R L       V     + + +LH+     ++H
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126

Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNE 450
           RD++A N+L   +    L   G+S       +Q R    G  Y ++APE V         
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRP 184

Query: 451 LTTKSDVYSFGVLLLEIVSGRRP 473
              K+DV+S G+ L+E+     P
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 56.1 bits (135), Expect = 9e-09
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 20/186 (10%)

Query: 296 VAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK  +     K E   E     +L +P +V + G C +     +V E    GPL+
Sbjct: 25  VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLN 83

Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
           ++L       + +      ++   ++ G+ +L +    + VHRD+ A NVLL  +  A +
Sbjct: 84  KFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKI 136

Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
              GLSK     +  +       T+G     + APE +   + ++KSDV+SFGVL+ E  
Sbjct: 137 SDFGLSK----ALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAF 192

Query: 469 S-GRRP 473
           S G++P
Sbjct: 193 SYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.1 bits (135), Expect = 9e-09
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 35/213 (16%)

Query: 277 LGDSKTGGTYSGILPDGS-------------RVAVKRLKRSSFQRKKEFYSEIGRFARLH 323
           LG       Y+GIL                 +V +K L  S       F+       ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           H ++V + G C    +  +V EFV  GPLD ++H   R    L    + KVA  LA  ++
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALS 119

Query: 384 FLHDKVKPHVVHRDIRASNVLL-----DEEFGAHLMGVGLSK-FVPWEVM--QERTVMAG 435
           +L DK    +VH ++   N+LL     D E G     + LS   +P  V+  QE      
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPF---IKLSDPGIPITVLSRQECV---- 169

Query: 436 GTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEI 467
               ++APE V  ++ L+  +D +SFG  L EI
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 51/187 (27%), Positives = 81/187 (43%), Gaps = 50/187 (26%)

Query: 351 PLDRWLHHIPRGGR---------SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           P D++L   P   R         +L +   +  +  +A G+ FL  K   + VHRD+ A 
Sbjct: 212 PYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268

Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDV 457
           NVL+ E     +   GL++    ++M++   ++ G+      ++APE ++ N  TT SDV
Sbjct: 269 NVLICEGKLVKICDFGLAR----DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDV 324

Query: 458 YSFGVLLLEIVS---------------------GRR---PAQAVDSV------CWQSIFE 487
           +SFG+LL EI +                     G R   PA A D +      CW+  FE
Sbjct: 325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFE 384

Query: 488 WATPLVQ 494
                 Q
Sbjct: 385 IRPDFSQ 391

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 45/147 (30%), Positives = 68/147 (46%), Gaps = 20/147 (13%)

Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
           H++HRDI+++N+LL       L   G SK     V  +      GT  Y+APE   R   
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222

Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511
           + K+D++S GVLL E+++ +RP    D    + +         + RY    DPL  S+S 
Sbjct: 223 SKKADMFSLGVLLYELLTLKRP---FDGENMEEVMHKTL----AGRY----DPLPPSIS- 270

Query: 512 DIPEAGVVQKVVDLVYACTQHVPSMRP 538
             PE      + ++V A     P  RP
Sbjct: 271 --PE------MQEIVTALLSSDPKRRP 289

Length = 496

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 12/136 (8%)

Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           +V   +  G L   ++H+   G   +    +  A  +  G+  LH   +  +V+RD++  
Sbjct: 77  LVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPE 131

Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYS 459
           N+LLD+     +  +GL+  VP     E   + G  GT GY+APE V     T   D ++
Sbjct: 132 NILLDDHGHIRISDLGLAVHVP-----EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 186

Query: 460 FGVLLLEIVSGRRPAQ 475
            G LL E+++G+ P Q
Sbjct: 187 LGCLLYEMIAGQSPFQ 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 22/206 (10%)

Query: 284 GTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGR----FARLHHPNLVAVKGCC 334
           G++  +L      DGS  AVK L++ +  +KKE    +         L HP LV +    
Sbjct: 6   GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF 65

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 Y V ++V  G L     H+ R    L+   R   A  +A  I +LH     +++
Sbjct: 66  QTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARF-YAAEVASAIGYLHSL---NII 118

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELT 452
           +RD++  N+LLD +    L   GL K    E ++  E T    GT  YLAPE + +    
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 453 TKSDVYSFGVLLLEIVSGRRPAQAVD 478
              D +  G +L E++ G  P  + D
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 32/227 (14%)

Query: 275 RLLGDSKTGGTYSGILPDGSR-VAVKRLKR--SSFQR-KKEFYSEIGRFARLHHPNLVAV 330
           RL+G    G  Y    P  SR VA+K+++   S     KK F  E    A L HP +V V
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVAT------TLAQGI 382
              C D    Y    ++    L   L  +     SL  + A +  V         +   I
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSV-WQKESLSKELAEKTSVGAFLSIFHKICATI 126

Query: 383 AFLHDKVKPHVVHRDIRASNVLLDE-------EFGAHLMGVG-------LSKFVPWEVMQ 428
            ++H K    V+HRD++  N+LL         ++GA +           +          
Sbjct: 127 EYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 429 ERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
             T+     GT  Y+APE +     +  +D+Y+ GV+L ++++   P
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 41/134 (30%), Positives = 65/134 (48%), Gaps = 11/134 (8%)

Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
           + V E++  G L   + HI   GR  +   R   A  +  G+ FLH K    +++RD++ 
Sbjct: 72  FFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIIC-GLQFLHKK---GIIYRDLKL 124

Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYS 459
            NVLLD++    +   G+ K     +  E       GT  Y+APE +   +     D +S
Sbjct: 125 DNVLLDKDGHIKIADFGMCKE---NMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWS 181

Query: 460 FGVLLLEIVSGRRP 473
           FGVLL E++ G+ P
Sbjct: 182 FGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 51/221 (23%), Positives = 93/221 (42%), Gaps = 35/221 (15%)

Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVK 331
           GN   G    G  + G+    +RV VK L+ S+    +  F  E+  +  L+HPN++   
Sbjct: 4   GNGWFGKVLLGEAHRGM--SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM--------KVATTLAQGIA 383
           G C +     +V EF   G L  +L       RS    +          ++A  +A G+ 
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYL-------RSNRGMVAQMAQKDVLQRMACEVASGLL 114

Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHL--MGVGLSKFVP-WEVMQERTVMAGGTYGY 440
           +LH   +   +H D+   N  L  +    +   G+ L ++   + + ++   +      +
Sbjct: 115 WLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP---LRW 168

Query: 441 LAPEFV-------YRNELTTKSDVYSFGVLLLEIVS-GRRP 473
           LAPE V          + T KS+++S GV + E+ +   +P
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 21/160 (13%)

Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
           A  + K +  ++HRD++ SN+LLD      L   G+S  +   + + R     G   Y+A
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA---GCRPYMA 175

Query: 443 PEFV---YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499
           PE +    R+    +SDV+S G+ L E+ +G+ P        W S+F+  T +V+     
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK-----WNSVFDQLTQVVKG---- 226

Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR 539
              DP I  LS+   E       V+ +  C     S RP+
Sbjct: 227 ---DPPI--LSNS-EEREFSPSFVNFINLCLIKDESKRPK 260

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 26/228 (11%)

Query: 263 LRSITKNFSEG-NRLLGDSKTGGTYSGILPDGSRVAVKR--LKRSSFQRKKEFYSEIGRF 319
           L  I K F +     L   K   T          VAVK+  L   S +  K    EI   
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTL---------VAVKKINLDSCSKEDLKLLQQEIITS 53

Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMRMKVATTL 378
            +L HPN++          + Y+V   +  G  +  L  H P G   L  A  +K    +
Sbjct: 54  RQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK---DV 110

Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
              + ++H K     +HR ++AS++LL  +    L G+  S  +     ++R V      
Sbjct: 111 LNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167

Query: 439 G-----YLAPEFVYRNEL--TTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
                 +L+PE + +N      KSD+YS G+   E+ +G  P + + +
Sbjct: 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 10/175 (5%)

Query: 299 KRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH 358
           KRLK+ S ++      EI    +++ P +V +           +V   +  G L   +++
Sbjct: 29  KRLKKKSGEKMALLEKEI--LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN 86

Query: 359 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418
           +  G R L+    +  +  +  GI  LH      +V+RD++  NVLLD++    L  +GL
Sbjct: 87  V--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGL 141

Query: 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           +  +      +      GT GY+APE +     +   D ++ G  + E+V+GR P
Sbjct: 142 AVELK---DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 39/123 (31%), Positives = 66/123 (53%), Gaps = 14/123 (11%)

Query: 364 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423
             LD    ++ ++ +AQG+ FL  K   + +HRD+ A NVLL +   A +   GL++   
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLAR--- 260

Query: 424 WEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRR--PAQA 476
            ++M +   +  G       ++APE ++    T +SDV+S+G+LL EI S G+   P   
Sbjct: 261 -DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319

Query: 477 VDS 479
           V+S
Sbjct: 320 VNS 322

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 5/97 (5%)

Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
            G+  LH +    +++RD++  NVLLD +    +  +GL+  V  +  Q +T    GT G
Sbjct: 108 SGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPG 162

Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           ++APE +   E     D ++ GV L E+++ R P +A
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 43/138 (31%), Positives = 64/138 (46%), Gaps = 9/138 (6%)

Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
           + V EF+  G L   + HI   GR  D       A  +  G+ FLH K    +++RD++ 
Sbjct: 72  FFVMEFLNGGDL---MFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKL 124

Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
            NV+LD +    +   G+ K         R     GT  Y+APE +   + T   D +SF
Sbjct: 125 DNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182

Query: 461 GVLLLEIVSGRRPAQAVD 478
           GVLL E++ G+ P    D
Sbjct: 183 GVLLYEMLIGQSPFHGDD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 18/225 (8%)

Query: 275 RLLGDSKTGGTYSGILPD-GSRVAVKRL--KRSSFQRKKEFYS---EIGRFARLHHPNLV 328
           +LLG    G  Y     D G  +AVK++     S +  KE  +   EI     L H  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 329 AVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
              GC  D  ++   I  E++  G +   L    +   +L   +  +    + QG+++LH
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSYLH 123

Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEF 445
             +   +VHRDI+ +N+L D      L   G SK +    M    + +  GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180

Query: 446 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 490
           +       K+DV+S    ++E+++ + P    +++   +IF+ AT
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKIAT 223

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 55/187 (29%), Positives = 90/187 (48%), Gaps = 22/187 (11%)

Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHH----PNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           VA+K LK    + +K    E+ R A + H    P +V + G C +     +V E    GP
Sbjct: 25  VAIKVLKN---ENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGP 80

Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEE 408
           L+++L      G+  D      V   + Q   G+ +L  K   + VHRD+ A NVLL  +
Sbjct: 81  LNKFL-----SGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQ 131

Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGG-TYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
             A +   GLSK +  +    +   AG     + APE +   + +++SDV+S+G+ + E 
Sbjct: 132 HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEA 191

Query: 468 VS-GRRP 473
            S G++P
Sbjct: 192 FSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 19/211 (9%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVA---- 329
            ++G+   G  Y G      ++A  ++   +   ++E   EI    +  HH N+      
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 330 -VKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
            +K     H D+ ++V EF   G +   + +        DW     +   + +G+A LH 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA 139

Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
                V+HRDI+  NVLL E     L+  G+S  +   V +  T +  GT  ++APE + 
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIA 194

Query: 448 RNE-----LTTKSDVYSFGVLLLEIVSGRRP 473
            +E        +SD++S G+  +E+  G  P
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 57/236 (24%), Positives = 102/236 (43%), Gaps = 28/236 (11%)

Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSR----VAVKRLK-RSSFQRK 309
           ++    ELR +        +LLG    G  + GI +P+G      VA+K ++ RS  Q  
Sbjct: 2   RILKETELRKL--------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53

Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
           +E    +     L H  +V + G C       +V +     PL   L H+ +   SLD  
Sbjct: 54  QEITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLS---PLGSLLDHVRQHRDSLDPQ 109

Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429
             +     +A+G+ +L +     +VHR++ A N+LL  +    +   G++  +  +  + 
Sbjct: 110 RLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166

Query: 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-------GRRPAQAVD 478
                     ++A E +     T +SDV+S+GV + E++S       G RP +  D
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 53/185 (28%), Positives = 76/185 (41%), Gaps = 20/185 (10%)

Query: 297 AVKRLKRSSFQRKKE---FYSEIGRF---ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           A+K LK+     + E      E   F       HP LV +  C         V E+   G
Sbjct: 28  AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87

Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L   + HI     S   A+       L  G+ +LH+     +V+RD++  N+LLD E  
Sbjct: 88  DL---MMHIHTDVFSEPRAVFYAACVVL--GLQYLHEN---KIVYRDLKLDNLLLDTEGF 139

Query: 411 AHLMGVGLSKFVPWEVM--QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
             +   GL K    E M   +RT    GT  +LAPE +     T   D +  GVL+ E++
Sbjct: 140 VKIADFGLCK----EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195

Query: 469 SGRRP 473
            G  P
Sbjct: 196 VGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|153063 cd03593, CLECT_NK_receptors_like, C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs)

 Score = 50.8 bits (122), Expect = 6e-08
 Identities = 34/137 (24%), Positives = 51/137 (37%), Gaps = 22/137 (16%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP DWI    K  C+ +    ++W+ES+  C      L  +   EE    Q   G   + 
Sbjct: 1   CPKDWICYGNK--CYYFSMEKKTWNESKEACSSKNSSLLKIDDEEELEFLQSQIGS--SS 56

Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
            W+G     +     WKW D  S  N   +  GS  S               C  +S+  
Sbjct: 57  YWIGLSREKS--EKPWKWIDG-SPLNNLFNIRGSTKS-------------GNCAYLSST- 99

Query: 173 RSLVTERCNTSHPFICM 189
             + +E C+T   +IC 
Sbjct: 100 -GIYSEDCSTKKRWICE 115

CLECT_NK_receptors_like: C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs), including proteins similar to oxidized low density lipoprotein (OxLDL) receptor (LOX-1), CD94, CD69, NKG2-A and -D, osteoclast inhibitory lectin (OCIL), dendritic cell-associated C-type lectin-1 (dectin-1), human myeloid inhibitory C-type lectin-like receptor (MICL), mast cell-associated functional antigen (MAFA), killer cell lectin-like receptors: subfamily F, member 1 (KLRF1) and subfamily B, member 1 (KLRB1), and lys49 receptors. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. NKRs are variously associated with activation or inhibition of natural killer (NK) cells. Activating NKRs stimulate cytolysis by NK cells of virally infected or transformed cells; inhibitory NKRs block cytolysis upon recognition of markers of healthy self cells. Most Lys49 receptors are inhibitory; some are stimulatory. OCIL inhibits NK cell function via binding to the receptor NKRP1D. Murine OCIL in addition to inhibiting NK cell function inhibits osteoclast differentiation. MAFA clusters with the type I Fc epsilon receptor (FcepsilonRI) and inhibits the mast cells secretory response to FcepsilonRI stimulus. CD72 is a negative regulator of B cell receptor signaling. NKG2D is an activating receptor for stress-induced antigens; human NKG2D ligands include the stress induced MHC-I homologs, MICA, MICB, and ULBP family of glycoproteins Several NKRs have a carbohydrate-binding capacity which is not mediated through calcium ions (e.g. OCIL binds a range of high molecular weight sulfated glycosaminoglycans including dextran sulfate, fucoidan, and gamma-carrageenan sugars). Dectin-1 binds fungal beta-glucans and in involved in the innate immune responses to fungal pathogens. MAFA binds saccharides having terminal alpha-D mannose residues in a calcium-dependent manner. LOX-1 is the major receptor for OxLDL in endothelial cells and thought to play a role in the pathology of atherosclerosis. Some NKRs exist as homodimers (e.g.Lys49, NKG2D, CD69, LOX-1) and some as heterodimers (e.g. CD94/NKG2A). Dectin-1 can function as a monomer in vitro. Length = 116

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 52/232 (22%), Positives = 94/232 (40%), Gaps = 36/232 (15%)

Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
           ++   EI   ++   P +    G        +I+ E++  G     L   P     LD  
Sbjct: 47  EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDET 101

Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQ 428
               +   + +G+ +LH + K   +HRDI+A+NVLL E     L   G++ +    ++ +
Sbjct: 102 QIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158

Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
              V   GT  ++APE + ++   +K+D++S G+  +E+  G  P               
Sbjct: 159 NTFV---GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP--------------- 200

Query: 489 ATPLVQSHRYLELLDPLISSLSSDIP--EAGVVQKVVDLVYACTQHVPSMRP 538
                  H  L  +  L     ++ P  E    + + + V AC    PS RP
Sbjct: 201 -------HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 32/103 (31%), Positives = 58/103 (56%), Gaps = 8/103 (7%)

Query: 374 VATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430
           +AT L +   G+ +LH + K   +HRDI+A+NVLL E+    L   G++  +    ++  
Sbjct: 103 IATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159

Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           T +  GT  ++APE + ++    K+D++S G+  +E+  G  P
Sbjct: 160 TFV--GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 17/205 (8%)

Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR-LHHPNLVAVK 331
           GN   G       Y+      +RV VK LK ++  +++  + + G   R L HPN++   
Sbjct: 4   GNGWFGKVLLSEIYTD--TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
           G C +     +V+E+   G L  +L       R+    +  ++A  +A G+  +H   K 
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KH 118

Query: 392 HVVHRDIRASNVLLDEEFGAHL--MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV--- 446
           + +H D+   N  L  +    +   G+G S++    +  E          +LAPE V   
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV--PLRWLAPELVGEF 176

Query: 447 ----YRNELTTKSDVYSFGVLLLEI 467
                  E T  S+V++ GV L E+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 47/194 (24%), Positives = 86/194 (44%), Gaps = 19/194 (9%)

Query: 291 PDGSRVAVKRLKRSS-FQRKKE--FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
                 A+K +K+    +  ++   +SE       +HP +V +     D    Y++ E+ 
Sbjct: 16  SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC 75

Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
           + G L   L      G   ++  R  +A   LA    +LH++    +++RD++  N+LLD
Sbjct: 76  LGGELWTILRDR---GLFDEYTARFYIACVVLA--FEYLHNR---GIIYRDLKPENLLLD 127

Query: 407 EEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
                 L+  G +K      ++  ++T    GT  Y+APE +         D +S G+LL
Sbjct: 128 SNGYVKLVDFGFAK-----KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILL 182

Query: 465 LEIVSGRRPAQAVD 478
            E+++GR P    D
Sbjct: 183 YELLTGRPPFGEDD 196

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 12/136 (8%)

Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
           +++ ++V  G L     H+ +     +  +R+ +A  +   +  LH   +  +++RDI+ 
Sbjct: 81  HLILDYVNGGEL---FTHLYQREHFTESEVRVYIAE-IVLALDHLH---QLGIIYRDIKL 133

Query: 401 SNVLLDEEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS--DV 457
            N+LLD E    L   GLSK F+  E  +ER     GT  Y+APE +           D 
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEE--EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191

Query: 458 YSFGVLLLEIVSGRRP 473
           +S GVL  E+++G  P
Sbjct: 192 WSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|215684 pfam00059, Lectin_C, Lectin C-type domain

 Score = 49.3 bits (118), Expect = 2e-07
 Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 11/116 (9%)

Query: 74  RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133
           ++W E+E  C+++GGHL ++ S EE+     L   +    W+G   INT    +W W+D 
Sbjct: 3   KTWAEAEAACQKLGGHLVSIQSAEEQDFLTSLVKASNTYAWIGLTDINT--EGTWVWTDG 60

Query: 134 MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189
            S  N +  A G  N+   +  C V        + ++ +     E C +   ++C 
Sbjct: 61  -SPVNYTNWAPGEPNNKGGNEDC-VE-------IYTDTNGKWNDEPCGSKRLYVCE 107

This family includes both long and short form C-type. Length = 108

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 27/178 (15%)

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           +A+G+ FL  +     +HRD+ A N+LL E     +   GL++ +  +    R   A   
Sbjct: 188 VAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS---GRRPAQAVDSVCWQSIFEWATPLVQ 494
             ++APE ++    T +SDV+SFGVLL EI S      P   +D        E+   L +
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKE 297

Query: 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
             R   +  P  ++     PE  + Q ++D    C    PS RP  S +V  L  L Q
Sbjct: 298 GTR---MRAPDYTT-----PE--MYQTMLD----CWHGEPSQRPTFSELVEHLGNLLQ 341

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 61/275 (22%), Positives = 112/275 (40%), Gaps = 53/275 (19%)

Query: 296 VAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           VA+K++    + S ++ ++   E+    +L HPN +  KGC       ++V E+ +    
Sbjct: 43  VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSAS 102

Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE----- 407
           D    H  +  + ++ A    +     QG+A+LH   +   +HRDI+A N+LL E     
Sbjct: 103 DILEVH-KKPLQEVEIA---AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVK 155

Query: 408 --EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGV 462
             +FG+  +    + FV             GT  ++APE +      +   K DV+S G+
Sbjct: 156 LADFGSASLVSPANSFV-------------GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202

Query: 463 LLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 522
             +E+   R+P                 PL  +   +  L  +  + S  +         
Sbjct: 203 TCIELAE-RKP-----------------PLF-NMNAMSALYHIAQNDSPTLSSNDWSDYF 243

Query: 523 VDLVYACTQHVPSMRPRMSHVV-HQLQQLAQPPVT 556
            + V +C Q +P  RP    ++ H+     +PP  
Sbjct: 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTV 278

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 33/83 (39%), Positives = 48/83 (57%), Gaps = 4/83 (4%)

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
           +V+RDI+  N+LLD E    L   GLSK F+  E  +ERT    GT  Y+APE +     
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE--KERTYSFCGTIEYMAPEIIRGKGG 183

Query: 452 TTKS-DVYSFGVLLLEIVSGRRP 473
             K+ D +S G+L+ E+++G  P
Sbjct: 184 HGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 32/118 (27%), Positives = 65/118 (55%), Gaps = 9/118 (7%)

Query: 357 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416
           +H+ + G   +  MR   AT +  G+  +H++    VV+RD++ +N+LLDE     +  +
Sbjct: 86  YHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141

Query: 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRP 473
           GL+     +  +++   + GT+GY+APE + +     + +D +S G +L +++ G  P
Sbjct: 142 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           +A+G+ FL  +     +HRD+ A N+LL E     +   GL++ +  +    R   A   
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             ++APE ++    TT+SDV+SFGVLL EI S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 19/210 (9%)

Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCC 334
           L+G+   G  Y G      ++A  ++   +   ++E   EI    +  HH N+    G  
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 335 YDHG------DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
                       ++V EF   G +   + +    G +L       +   + +G++ LH  
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLH-- 128

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
            +  V+HRDI+  NVLL E     L+  G+S  +   V +  T +  GT  ++APE +  
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIAC 185

Query: 449 NE-----LTTKSDVYSFGVLLLEIVSGRRP 473
           +E        KSD++S G+  +E+  G  P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP-WEVMQERTVMAGGTYGYLAP 443
           L D  +  +V+RD++  N+LLD+     +  +GL+  +P  E ++ R     GT GY+AP
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAP 170

Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           E +   + T   D +  G L+ E++ G+ P
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 20/235 (8%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVVN 349
           G   A+K LK+     K E    +     L    HP L A+K     H     V E+   
Sbjct: 20  GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79

Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
           G L     H+ R  R             +   + +LH   + +VV+RD++  N++LD++ 
Sbjct: 80  GEL---FFHLSRE-RVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDG 133

Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
              +   GL K    E +++   M    GT  YLAPE +  N+     D +  GV++ E+
Sbjct: 134 HIKITDFGLCK----EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 189

Query: 468 VSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 522
           + GR P    D    + +FE    L++  R+   L P   SL S + +    Q++
Sbjct: 190 MCGRLPFYNQDH---EKLFELI--LMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 11/187 (5%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAVKGCCYDHGDRYIVYEFVVNG 350
           G   A KRL++   +++K     +     L   N   V      Y+  D   +   ++NG
Sbjct: 25  GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84

Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
             D   H    G    +    +  A  +  G+  LH   + + V+RD++  N+LLD+   
Sbjct: 85  G-DLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGH 140

Query: 411 AHLMGVGLSKFVP-WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +  +GL+  +P  E ++ R     GT GY+APE +     T   D +  G L+ E++ 
Sbjct: 141 IRISDLGLAVKIPEGESIRGRV----GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE 196

Query: 470 GRRPAQA 476
           G+ P + 
Sbjct: 197 GQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|153073 cd03603, CLECT_VCBS, A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins

 Score = 48.6 bits (116), Expect = 4e-07
 Identities = 21/70 (30%), Positives = 31/70 (44%), Gaps = 7/70 (10%)

Query: 75  SWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN- 133
           +W+ ++T  + +GGHL  + S EE        G      W+G  S   T G +WKWSD  
Sbjct: 11  TWEAAQTLAESLGGHLVTINSAEENDWLLSNFGGYGAS-WIGA-SDAATEG-TWKWSDGE 67

Query: 134 ---MSKWNES 140
               + W   
Sbjct: 68  ESTYTNWGSG 77

CLECT_VCBS: A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces including CaCO3 and ice. Bacterial CTLDs within this group are functionally uncharacterized. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. CTLDs associate with each other through several different surfaces to form dimers, trimers, or tetramers from which ligand-binding sites project in different orientations. In some CTLDs a loop extends to the adjoining domain to form a loop-swapped dimer. Length = 118

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 24/210 (11%)

Query: 277 LGDSKTGGTYSGI-LPDGSR-VAVKRLKRSSFQRKKEFYSEIGRFARL------HHPNLV 328
           +G+   G  +    L +G R VA+KR++  + +      S I   A L       HPN+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-STIREVAVLRHLETFEHPNVV 67

Query: 329 AV-KGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
            +   C     DR     +V+E V +  L  +L  +P  G   +    M     L +G+ 
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF--QLLRGLD 124

Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 443
           FLH      VVHRD++  N+L+       L   GL++   +++     V+   T  Y AP
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYRAP 178

Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           E + ++   T  D++S G +  E+   R+P
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 18/225 (8%)

Query: 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLK--RSSFQRKKEFYS---EIGRFARLHHPNLV 328
           +LLG    G  Y     D G  +AVK+++    S +  KE  +   EI     L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 329 AVKGCCYDHGDRY--IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
              GC  D  +R   I  E +  G +   L    +   +L   +  K    + +G+++LH
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLH 123

Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEF 445
             +   +VHRDI+ +N+L D      L   G SK +    +    + +  GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 446 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 490
           +       K+D++S G  ++E+++ + P    +++   +IF+ AT
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--AIFKIAT 223

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 50/228 (21%), Positives = 93/228 (40%), Gaps = 34/228 (14%)

Query: 321 RLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLD----WAMRMKVA 375
           +L HPN+V      +   DR YIV + +   PL    + +    +       W + +++ 
Sbjct: 65  QLRHPNIVRYYKT-FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435
             L     +LH + +  +VHRD+  +N++L E+    +   GL+K    +  + +     
Sbjct: 124 LALR----YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVV 174

Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495
           GT  Y  PE V       K+DV++FG +L ++ +                     P   S
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-------------------LQPPFYS 215

Query: 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
              L L   ++ ++   +PE    + V D++ +C       RP +  V
Sbjct: 216 TNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 53/168 (31%), Positives = 81/168 (48%), Gaps = 14/168 (8%)

Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++   P  G  LD  +    
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEF-LDLDLKKYMDSSPLTG--LDPPLIKSY 104

Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK-F-VPWEVMQERTV 432
              L QGIA+ H      V+HRD++  N+L+D E    L   GL++ F VP        V
Sbjct: 105 LYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV 161

Query: 433 MAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
               T  Y APE +  +   +T  D++S G +  E+V+ RRP    DS
Sbjct: 162 ----TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPLFPGDS 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.8 bits (124), Expect = 5e-07
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           +A+G+ FL  +     +HRD+ A N+LL E     +   GL++ +  +    R   A   
Sbjct: 182 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             ++APE ++    TT+SDV+SFGVLL EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 56/192 (29%), Positives = 90/192 (46%), Gaps = 25/192 (13%)

Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVY 344
             +VA+K++  ++F  +   K    EI     L H N++A+K            D YIVY
Sbjct: 30  NEKVAIKKIA-NAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88

Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
           E      +D  LH I R  ++L           L +G+ ++H     +V+HRD++ SN+L
Sbjct: 89  EL-----MDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLL 140

Query: 405 LDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFG 461
           L+      +   GL++      + M E  V    T  Y APE +   +E TT  DV+S G
Sbjct: 141 LNANCDLKICDFGLARTTSEKGDFMTEYVV----TRWYRAPELLLNCSEYTTAIDVWSVG 196

Query: 462 VLLLEIVSGRRP 473
            +  E++ GR+P
Sbjct: 197 CIFAELL-GRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 17/188 (9%)

Query: 292 DGSRVAVKRLKRSSFQRKKE---FYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFV 347
           DG   AVK L++ +  +KKE     +E     + + HP LV +          Y V ++V
Sbjct: 19  DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78

Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
             G L     H+ R     +   R   A  +A  + +LH     ++++RD++  N+LLD 
Sbjct: 79  NGGEL---FFHLQRERSFPEPRARF-YAAEIASALGYLHSL---NIIYRDLKPENILLDS 131

Query: 408 EFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
           +    L   GL K    E ++  + T    GT  YLAPE + +       D +  G +L 
Sbjct: 132 QGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLY 187

Query: 466 EIVSGRRP 473
           E++ G  P
Sbjct: 188 EMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 17/183 (9%)

Query: 297 AVKRLKRSSFQRKKE---FYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           AVK L++ +  +KKE     SE     + + HP LV +          Y V +++  G L
Sbjct: 24  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83

Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
               +H+ R    L+   R   A  +A  + +LH     ++V+RD++  N+LLD +    
Sbjct: 84  ---FYHLQRERCFLEPRARF-YAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIV 136

Query: 413 LMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
           L   GL K    E ++     +   GT  YLAPE +++       D +  G +L E++ G
Sbjct: 137 LTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Query: 471 RRP 473
             P
Sbjct: 193 LPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 15/167 (8%)

Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
           +E      L HPN++       +     IV E+   G L  ++    R    LD    + 
Sbjct: 48  NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILH 105

Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER--- 430
               +   +  +H K+   ++HRD++  N+LLD+    H M V +  F   +++  +   
Sbjct: 106 FFVQILLALHHVHTKL---ILHRDLKTQNILLDK----HKMVVKIGDFGISKILSSKSKA 158

Query: 431 -TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
            TV+  GT  Y++PE         KSD+++ G +L E+ S +R  +A
Sbjct: 159 YTVV--GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 50.8 bits (122), Expect = 8e-07
 Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 49/262 (18%)

Query: 293 GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI-VYEFVVN 349
           G +VA+K++  +       K    E+       H N++A++      G  +  VY  VV 
Sbjct: 30  GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY--VVM 87

Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-- 407
             ++  LHHI    + L           L +G+ ++H     +V+HRD++ SN+L++E  
Sbjct: 88  DLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDC 144

Query: 408 -----EFGAHLMGVGLSKFVPWEV---MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVY 458
                +FG   M  GLS   P E    M E       T  Y APE +    E TT  D++
Sbjct: 145 ELRIGDFG---MARGLSSS-PTEHKYFMTEYV----ATRWYRAPELLLSLPEYTTAIDMW 196

Query: 459 SFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGV 518
           S G +  E++ GRR            +F     + Q       L  ++S L S  P   V
Sbjct: 197 SVGCIFAEML-GRRQ-----------LFPGKNYVHQ-------LKLILSVLGS--PSEEV 235

Query: 519 VQKV-VDLVYACTQHVPSMRPR 539
           + ++  D V    Q++P  +P 
Sbjct: 236 LNRIGSDRVRKYIQNLPRKQPV 257

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 28/205 (13%)

Query: 283 GGTYSGI-----LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
            GTY  +     +  G  VA+K +K       +    EI       HPN+VA  G  Y  
Sbjct: 13  SGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-YLR 71

Query: 338 GDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVA----TTLAQGIAFLHDKVKPH 392
            D+ +IV E+   G L   ++ + RG  S       ++A     TL +G+A+LH+     
Sbjct: 72  RDKLWIVMEYCGGGSLQD-IYQVTRGPLSEL-----QIAYVCRETL-KGLAYLHET---G 121

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
            +HRDI+ +N+LL E+    L   G+S  +    + +R    G  Y ++APE V   E  
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIAKRKSFIGTPY-WMAPE-VAAVERK 178

Query: 453 ----TKSDVYSFGVLLLEIVSGRRP 473
                K D+++ G+  +E+   + P
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 37/163 (22%), Positives = 74/163 (45%), Gaps = 12/163 (7%)

Query: 357 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416
           +H+ + G   +  MR   A  +  G+  +H++    VV+RD++ +N+LLDE     +  +
Sbjct: 86  YHLSQHGVFSEAEMRF-YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141

Query: 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQ 475
           GL+     +  +++   + GT+GY+APE + +     + +D +S G +L +++ G  P +
Sbjct: 142 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197

Query: 476 ---AVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 515
                D      +       +      EL   L   L  D+  
Sbjct: 198 QHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 14/169 (8%)

Query: 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
           +LD    +  +  +A+G++FL  K   + +HRD+ A N+LL       +   GL++    
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR---- 262

Query: 425 EVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS---GRRPAQAV 477
           ++  +   +  G       ++APE ++    T +SDV+S+G+LL EI S      P   V
Sbjct: 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322

Query: 478 DSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV 526
           DS  ++ I E    L       E+ D + S   +D  +    +++V L+
Sbjct: 323 DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 34/222 (15%)

Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
           P +V   G  +  G  Y+  E++  G LD+            +  +R ++   + +G+ F
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLKF 117

Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           L ++   +++HRD++ +NVL++      L   G+S  +   + +       G   Y+APE
Sbjct: 118 LKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPE 171

Query: 445 FVY------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 498
            +           T +SDV+S G+ +LE+  GR P        + +IF   + +V     
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP---YPPETYANIFAQLSAIVDG--- 225

Query: 499 LELLDP--LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
               DP  L S  S D           D V  C   +P+ RP
Sbjct: 226 ----DPPTLPSGYSDD---------AQDFVAKCLNKIPNRRP 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 53/188 (28%), Positives = 82/188 (43%), Gaps = 18/188 (9%)

Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HP L A+K     H     V E+   G L     H+ R     +   R   A  +   + 
Sbjct: 54  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALE 109

Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 441
           +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M    GT  YL
Sbjct: 110 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYL 162

Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501
           APE +  N+     D +  GV++ E++ GR P    D    + +FE    L++  R+   
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELI--LMEEIRFPRT 217

Query: 502 LDPLISSL 509
           L P   SL
Sbjct: 218 LSPEAKSL 225

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 49.4 bits (119), Expect = 2e-06
 Identities = 38/168 (22%), Positives = 73/168 (43%), Gaps = 42/168 (25%)

Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA- 379
            L HPN+V +    +     Y+V+E+  +  L ++L   P         +   +  ++  
Sbjct: 54  ELKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGP-------LSPNLIKSIMY 105

Query: 380 ---QGIAFLHDKVKPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQ 428
              +G+A+ H      ++HRD++  N+L++ +       FG A   G+ L  +   EV+ 
Sbjct: 106 QLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH-EVV- 160

Query: 429 ERTVMAGGTYGYLAPE-----FVYRNELTTKSDVYSFGVLLLEIVSGR 471
                   T  Y APE       Y    +T  D++S G +  E+++G+
Sbjct: 161 --------TLWYRAPEILLGSKHY----STAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 26/167 (15%)

Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRSLDWAMRMK 373
           EI     L H N+V +    +      +V+E++ +  L +++  H  RG   LD      
Sbjct: 48  EISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGA--LDPNTVKS 104

Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-------EFG-AHLMGVGLSKFVPWE 425
               L +GIAF H+     V+HRD++  N+L+++       +FG A   G+ ++ F   E
Sbjct: 105 FTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN-E 160

Query: 426 VMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGR 471
           V+         T  Y AP+ +  +   +T  D++S G ++ E+++GR
Sbjct: 161 VV---------TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 36/161 (22%)

Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIR 399
           Y+V E++  G L   L  I +     + A R  +A   LA  +  +H   K   +HRDI+
Sbjct: 77  YLVMEYMPGGDLMNLL--IRKDVFPEETA-RFYIAELVLA--LDSVH---KLGFIHRDIK 128

Query: 400 ASNVLLDEE-------FG-----------------AHLMGVGLSKFVPWEVMQERTVMAG 435
             N+L+D +       FG                 +H +    +  V     ++R V A 
Sbjct: 129 PDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRAN 188

Query: 436 ---GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
              GT  Y+APE +       + D +S GV+L E++ G  P
Sbjct: 189 STVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 31/103 (30%), Positives = 53/103 (51%), Gaps = 8/103 (7%)

Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP-WEVMQERTVM 433
           A  +  G+  LH   +  +V+RD++  N+LLD+     +  +GL+  +P  E ++ R   
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-- 162

Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
             GT GY+APE V     T   D +  G L+ E++ G+ P + 
Sbjct: 163 --GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 7/90 (7%)

Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K K  V+HRD++ SN+LLD      L   G+S  +     + R+    G   Y+APE + 
Sbjct: 131 KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS---AGCAAYMAPERID 187

Query: 448 RNELTTK----SDVYSFGVLLLEIVSGRRP 473
             +   K    +DV+S G+ L+E+ +G+ P
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 23/218 (10%)

Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARL 322
           RS  K++  GN ++G+   G  Y  I  D S +VA+K++ +    + +E          L
Sbjct: 62  RSPNKSYKLGN-IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNL 116

Query: 323 HHPNLVAVKGCCYDHGDRY--------IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           +H N++ +K   Y    +         +V EF+    + +++ H  R   +L   +    
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLY 175

Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWEVMQERTVM 433
           +  L + +A++H K    + HRD++  N+L+D       L   G +K +   +  +R+V 
Sbjct: 176 SYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL---LAGQRSVS 229

Query: 434 AGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSG 470
              +  Y APE +      TT  D++S G ++ E++ G
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 47.8 bits (114), Expect = 6e-06
 Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 66/266 (24%)

Query: 301 LKRSSFQRKKEFY-----SEIGRFARLHHPNLVAVKGCCYDHGDR----------YIVYE 345
           LK+     +KE +      EI    +L+H N+V +K    D  D           Y+V+E
Sbjct: 37  LKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFE 96

Query: 346 FV---VNGPLDRWLHHIPRGG-RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           ++   + G L+  L H      +S      MK    L +G+ + H K   + +HRDI+ S
Sbjct: 97  YMDHDLMGLLESGLVHFSEDHIKSF-----MK---QLLEGLNYCHKK---NFLHRDIKCS 145

Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQER----TVMAGGTYGYLAPEFVYRNELTTKS-D 456
           N+LL+ +    L   GL++   +   + R     V+   T  Y  PE +   E    + D
Sbjct: 146 NILLNNKGQIKLADFGLARL--YNSEESRPYTNKVI---TLWYRPPELLLGEERYGPAID 200

Query: 457 VYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEA 516
           V+S G +L E+ + +                   P+ Q+++ L  L+ LIS L    P  
Sbjct: 201 VWSCGCILGELFTKK-------------------PIFQANQELAQLE-LISRLCGS-PCP 239

Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSH 542
            V   V+ L Y  T     M+P+  +
Sbjct: 240 AVWPDVIKLPYFNT-----MKPKKQY 260

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.5 bits (115), Expect = 7e-06
 Identities = 47/190 (24%), Positives = 88/190 (46%), Gaps = 27/190 (14%)

Query: 291 PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV------- 343
           P   R+  KR+K  S +   +  +EI    RL+H N++ ++       + Y++       
Sbjct: 190 PKCERLIAKRVKAGS-RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFD 248

Query: 344 -YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
            Y F+ +   D W        R L    R  +   L   + ++HDK    ++HRDI+  N
Sbjct: 249 LYSFMYDEAFD-W------KDRPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLEN 297

Query: 403 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA---PEFVYRNELTTKSDVYS 459
           + L+ + G  ++G      +P+E  +ER     G  G +A   PE +  +     +D++S
Sbjct: 298 IFLNCD-GKIVLG-DFGTAMPFE--KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWS 353

Query: 460 FGVLLLEIVS 469
            G++LL+++S
Sbjct: 354 CGLILLDMLS 363

Length = 501

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 53/186 (28%), Positives = 78/186 (41%), Gaps = 13/186 (6%)

Query: 292 DGSRVAVKRL-KRSSFQRKKEFYSEIGR---FARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           DG   AVK L K+    RK++ +    R      + HP LV +          Y V +FV
Sbjct: 19  DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78

Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
             G L     H+ R  RS         A  +A  + +LH     ++V+RD++  N+LLD 
Sbjct: 79  NGGEL---FFHLQRE-RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDS 131

Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
           +    L   GL K        + T    GT  YLAPE + +       D +  G +L E+
Sbjct: 132 QGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEM 189

Query: 468 VSGRRP 473
           + G  P
Sbjct: 190 LYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 47.6 bits (114), Expect = 8e-06
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 46/197 (23%)

Query: 296 VAVKRLKRSSFQRKKEFYS-----EIGRFARLHHPNLVAVK----GCCYDHGDRYIVYEF 346
           VA+K+LK    +++KE +      EI    +L HPN+V VK    G   +    Y+V E+
Sbjct: 33  VALKKLK---MEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS--NLDKIYMVMEY 87

Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNV 403
           V +  L   +  + +           +V   + Q   G+A LHD     ++HRD++ SN+
Sbjct: 88  VEH-DLKSLMETMKQPFLQ------SEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNL 137

Query: 404 LLDE-------EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNELTTK 454
           LL+        +FG A   G  L  +    V          T  Y APE +    E +T 
Sbjct: 138 LLNNRGILKICDFGLAREYGSPLKPYTQLVV----------TLWYRAPELLLGAKEYSTA 187

Query: 455 SDVYSFGVLLLEIVSGR 471
            D++S G +  E+++ +
Sbjct: 188 IDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 31/84 (36%), Positives = 44/84 (52%), Gaps = 5/84 (5%)

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
           +++RDI+  N+LLD      L   GLSK F   EV  ER     GT  Y+AP+ V   + 
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDG 183

Query: 452 --TTKSDVYSFGVLLLEIVSGRRP 473
                 D +S GVL+ E+++G  P
Sbjct: 184 GHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (113), Expect = 9e-06
 Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
            G+ +LH++ K   +HRDI+A+N+LL EE    L   G+S  +    M +R    G  + 
Sbjct: 109 LGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLT-STMSKRNTFVGTPF- 163

Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           ++APE + ++    K+D++S G+  +E+  G  P
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 23/201 (11%)

Query: 284 GTYSGI-----LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338
           GTY  +     +  G   A+K +K    +       EI       H N+VA  G      
Sbjct: 20  GTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79

Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
             +I  EF   G L   ++H+         A    V+    QG+ +LH K K   +HRDI
Sbjct: 80  KLWICMEFCGGGSLQD-IYHVTGPLSESQIAY---VSRETLQGLYYLHSKGK---MHRDI 132

Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF--VYR----NELT 452
           + +N+LL +     L   G+S  +   + + ++ +  GT  ++APE   V R    N+L 
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFI--GTPYWMAPEVAAVERKGGYNQLC 190

Query: 453 TKSDVYSFGVLLLEIVSGRRP 473
              D+++ G+  +E+   + P
Sbjct: 191 ---DIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 27/210 (12%)

Query: 275 RLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPN 326
           +LLG     GT+  ++       G   A+K LK+     K E     +E        HP 
Sbjct: 1   KLLGK----GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPF 56

Query: 327 LVAVKGCCYDHGDRY-IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
           L ++K   +   DR   V E+V  G L     H+ R  R             +   + +L
Sbjct: 57  LTSLK-YSFQTKDRLCFVMEYVNGGEL---FFHLSRE-RVFSEDRTRFYGAEIVSALDYL 111

Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAP 443
           H      +V+RD++  N++LD++    +   GL K    E + +   M    GT  YLAP
Sbjct: 112 HSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLAP 164

Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           E +  N+     D +  GV++ E++ GR P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 24/106 (22%), Positives = 57/106 (53%), Gaps = 6/106 (5%)

Query: 364 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423
           R L     + +   + +G+ +LH +    ++HRD++  N+ +++     +  +G ++F  
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-- 206

Query: 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             V+    +   GT    APE + R++  +K+D++S G++L E+++
Sbjct: 207 -PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 19/163 (11%)

Query: 318 RFARLHHPNLVAVKGCCYD-HGDRYIVYEFV---VNGPLDRWLHHIPRGGRSLDWAMRMK 373
           R     HPN+V +   C     DR      V   V+  L  +L  +P  G   +      
Sbjct: 55  RLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAE-----T 109

Query: 374 VATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430
           +   + Q   G+ FLH      +VHRD++  N+L+       L   GL++    ++    
Sbjct: 110 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP 166

Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
            V+   T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 167 VVV---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 23/96 (23%), Positives = 46/96 (47%), Gaps = 11/96 (11%)

Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWL---HHIPRGGRSLDWA 369
           EI     L H N+V++     +H D+  Y+++++  +   D W     H      S+  +
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPS 108

Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
           M   +   +  G+ +LH      V+HRD++ +N+L+
Sbjct: 109 MVKSLLWQILNGVHYLHSN---WVLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 22/206 (10%)

Query: 284 GTYSGILP-----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYD- 336
           GTY  +       +GS+ AVK L        +E  +E      L  HPN+V   G  Y  
Sbjct: 29  GTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87

Query: 337 ---HGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
              +GD+ ++V E    G +   +    + G  ++  +   +      G+  LH      
Sbjct: 88  DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---K 144

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNEL 451
            +HRD++ +N+LL  E G  L+  G+S  +    ++  T +  GT  ++APE +    +L
Sbjct: 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEVIACEQQL 202

Query: 452 TT----KSDVYSFGVLLLEIVSGRRP 473
            +    + DV+S G+  +E+  G  P
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDPP 228

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 22/208 (10%)

Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVK 331
           GN   G    G   SG  P  ++V VK L+ S S Q + +F  E   +  L H NL+   
Sbjct: 4   GNGWFGKVILGEVNSGYTP--AQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKV 389
           G C +     +V EF   G L  +L    R    +  D     ++A  +A G+  LH   
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSC-RKAELMTPDPTTLQRMACEIALGLLHLH--- 117

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY---GYLAPEF- 445
           K + +H D+   N LL  +    +   GLS     +  ++  V     +    ++APE  
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN---KYKEDYYVTPDQLWVPLRWIAPELV 174

Query: 446 --VYRNEL----TTKSDVYSFGVLLLEI 467
             V+ N L    T +S+V+S GV + E+
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 28/234 (11%)

Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIV 343
           G  VAVK+L R  FQ +   K  Y E+     ++H N++++      +    +  D Y+V
Sbjct: 46  GINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104

Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
            E +++  L + +H        LD      +   +  GI  LH      ++HRD++ SN+
Sbjct: 105 ME-LMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI 154

Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
           ++  +    ++  GL++      M    V+   T  Y APE +         D++S G +
Sbjct: 155 VVKSDCTLKILDFGLARTACTNFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCI 211

Query: 464 LLEIVSGRRPAQAVDSV-CWQSIFE-WATPLVQSHRYLELLDPLISSLSSDIPE 515
           + E+V G    Q  D +  W  + E   TP   S  ++  L P + +   + P+
Sbjct: 212 MGELVKGSVIFQGTDHIDQWNKVIEQLGTP---SAEFMNRLQPTVRNYVENRPQ 262

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 36/128 (28%), Positives = 60/128 (46%), Gaps = 8/128 (6%)

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
           ++HRD++++N+ L       L   G SK     V  +      GT  YLAPE   R   +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 453 TKSDVYSFGVLLLEIVSGRRPAQA------VDSVCWQSIFEWATPLVQSHRYLELLDPLI 506
            K+D++S GV+L E+++  RP +       +  V +     +  P+    +   LLDPL+
Sbjct: 250 KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK--ALLDPLL 307

Query: 507 SSLSSDIP 514
           S   +  P
Sbjct: 308 SKNPALRP 315

Length = 478

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 25/206 (12%)

Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVA 329
           G  +L   K  G Y          A+K LK+     K E     +E        HP L A
Sbjct: 9   GKVILVREKATGKY---------YAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           +K     H     V E+   G L     H+ R     +   R   A  ++  + +LH   
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVS-ALGYLHSC- 114

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVY 447
              VV+RD++  N++LD++    +   GL K    E + +   M    GT  YLAPE + 
Sbjct: 115 --DVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLE 168

Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRP 473
            N+     D +  GV++ E++ GR P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 10/178 (5%)

Query: 296 VAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VA+K+ K S  + + K+    E+     L   N+V +K      G  Y+V+E+V    L+
Sbjct: 29  VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88

Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
             L  +P G          KV + + Q I  +H   K  +VHRDI+  N+L+       L
Sbjct: 89  -LLEEMPNG------VPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKL 141

Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
              G ++ +  E           T  Y +PE +         D++S G +L E+  G+
Sbjct: 142 CDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 44.9 bits (107), Expect = 6e-05
 Identities = 47/201 (23%), Positives = 83/201 (41%), Gaps = 42/201 (20%)

Query: 292 DGSRVAVKRLKRSSFQRKKE-----FYSEIGRFARLHHPN---LVAVKGCCYDHGDR-YI 342
            G  VA+K++K    +  K+        EI     L HPN   L+ V    + H     +
Sbjct: 24  TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDV----FGHKSNINL 79

Query: 343 VYEFVVNGPLDRWLHHIPRGGRSLDWA-------MRMKVATTLAQGIAFLHDKVKPHVVH 395
           V+EF     ++  L  + +  +S+          M M       +G+ +LH      ++H
Sbjct: 80  VFEF-----METDLEKVIKD-KSIVLTPADIKSYMLM-----TLRGLEYLHSN---WILH 125

Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPEFVY-RNELT 452
           RD++ +N+L+  +    L   GL++    P   M  + V    T  Y APE ++      
Sbjct: 126 RDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV----TRWYRAPELLFGARHYG 181

Query: 453 TKSDVYSFGVLLLEIVSGRRP 473
              D++S G +  E++  R P
Sbjct: 182 VGVDMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 44.4 bits (105), Expect = 9e-05
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 20/164 (12%)

Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     + H N+V ++   +     Y+V+E++ +  L + +   P   ++     R+ +
Sbjct: 51  EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNP----RL-I 104

Query: 375 ATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKF--VPWEVMQ 428
            T L Q   GIA+ H      V+HRD++  N+L+D    A  L   GL++   +P     
Sbjct: 105 KTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161

Query: 429 ERTVMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSGR 471
              V    T  Y APE +      +T  D++S G +  E+V+ +
Sbjct: 162 HEVV----TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 44.6 bits (105), Expect = 9e-05
 Identities = 52/231 (22%), Positives = 98/231 (42%), Gaps = 28/231 (12%)

Query: 296 VAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIVYEF 346
           VA+K+L R  FQ +   K  Y E+     ++H N++ +      +    +  D YIV E 
Sbjct: 52  VAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110

Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
                +D  L  + +    LD      +   +  GI  LH      ++HRD++ SN+++ 
Sbjct: 111 -----MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK 160

Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
            +    ++  GL++      M    V+   T  Y APE +         D++S G ++ E
Sbjct: 161 SDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

Query: 467 IVSGRRPAQAVDSV-CWQSIFE-WATPLVQSHRYLELLDPLISSLSSDIPE 515
           ++ G       D +  W  + E   TP  +   +++ L P + +   + P+
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPE---FMKKLQPTVRTYVENRPK 265

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 44.4 bits (106), Expect = 9e-05
 Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 38/200 (19%)

Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK-----GCCYDHGDRYIVY 344
           G +VA+K++    F      K    EI     L H N++ +          D  D YIV 
Sbjct: 25  GRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83

Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRAS 401
           E      ++  LH + +  + L       +   L Q   G+ +LH     +V+HRD++ S
Sbjct: 84  EL-----METDLHKVIKSPQPLTDD---HIQYFLYQILRGLKYLH---SANVIHRDLKPS 132

Query: 402 NVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           N+L++         FG  L             + E  V    T  Y APE +  +   TK
Sbjct: 133 NILVNSNCDLKICDFG--LARGVDPDEDEKGFLTEYVV----TRWYRAPELLLSSSRYTK 186

Query: 455 S-DVYSFGVLLLEIVSGRRP 473
           + D++S G +  E++  R+P
Sbjct: 187 AIDIWSVGCIFAELL-TRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 49/214 (22%)

Query: 284 GTYSGILP-----DGSRVAVKRLK--------RSSFQRKKEFYSEIGRFARLHHPNLVAV 330
           GTY  +           VA+KR++         SS  R      EI     L H N+V +
Sbjct: 11  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR------EICLLKELKHKNIVRL 64

Query: 331 KGCCYD--HGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT----LAQGI 382
               YD  H D+   +V+E+  +  L ++         S +  +  ++  +    L +G+
Sbjct: 65  ----YDVLHSDKKLTLVFEYC-DQDLKKYFD-------SCNGDIDPEIVKSFMFQLLKGL 112

Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGY 440
           AF H     +V+HRD++  N+L+++     L   GL++   +P        V    T  Y
Sbjct: 113 AFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV----TLWY 165

Query: 441 LAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRP 473
             P+ ++  +L +T  D++S G +  E+ +  RP
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|153059 cd03589, CLECT_CEL-1_like, C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 28/152 (18%), Positives = 48/152 (31%), Gaps = 33/152 (21%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-----GHLAALTSYEEEHSAQKLCG 107
           CP  W        C+ + G+  +W+E+E  C+         HL ++ S EE      L  
Sbjct: 1   CPTFW--TAFGGYCYRFFGDRLTWEEAELRCRSFSIPGLIAHLVSIHSQEENDFVYDL-- 56

Query: 108 KNVNGCWVGGRSINTTVGL-------SWKWSD----NMSKWNESIHAVGSFNSSCTSLPC 156
                           +GL        ++W+D    + +KW          N  C  +  
Sbjct: 57  --FESSRGPDTPYGLWIGLHDRTSEGPFEWTDGSPVDFTKWAGGQPDNYGGNEDCVQMWR 114

Query: 157 HVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
                        +  +S     C+   P+IC
Sbjct: 115 R-----------GDAGQSWNDMPCDAVFPYIC 135

CLECT_CEL-1_like: C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. The CEL-1 CTLD binds three calcium ions and has a high specificity for N-acteylgalactosamine (GalNAc). CEL-1 exhibits strong cytotoxicity which is inhibited by GalNAc. This protein may play a role as a toxin defending against predation. Echinoidin is found in the coelomic fluid of the sea urchin and is specific for GalBeta1-3GalNAc. Echinoidin has a cell adhesive activity towards human cancer cells which is not mediated through the CTLD. Both CEL-1 and Echinoidin are multimeric proteins comprised of multiple dimers linked by disulfide bonds. Length = 137

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 17/198 (8%)

Query: 284 GTYSGI-----LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338
           GTY  +     L  G   AVK +K            EI       H N+VA  G      
Sbjct: 20  GTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE 79

Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
             +I  E+   G L   ++H+      L  A    V     QG+A+LH K K   +HRDI
Sbjct: 80  KLWICMEYCGGGSLQD-IYHVTGPLSELQIAY---VCRETLQGLAYLHSKGK---MHRDI 132

Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF--VYRN-ELTTKS 455
           + +N+LL +     L   G++  +   + + ++ +  GT  ++APE   V +N       
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVEKNGGYNQLC 190

Query: 456 DVYSFGVLLLEIVSGRRP 473
           D+++ G+  +E+   + P
Sbjct: 191 DIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 35/149 (23%), Positives = 66/149 (44%), Gaps = 6/149 (4%)

Query: 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
            ++L HP +V       +     I+ E+     LD  L  +   G++L      +    L
Sbjct: 56  LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115

Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
             G+ ++H +    ++HRD++A N+ L       +   G+S+ +        T    GT 
Sbjct: 116 LLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT--GTP 169

Query: 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
            Y++PE +      +KSD++S G +L E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 35/219 (15%)

Query: 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
           R LG    G  +S +  D   RVAVK++  +  Q  K    EI    RL H N+V V   
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 334 CYDHGDR--------------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
               G                YIV E+ +   L   L      G   +   R+     L 
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEY-METDLANVLEQ----GPLSEEHARL-FMYQLL 124

Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG-VGLSKFVPWEV-----MQERTVM 433
           +G+ ++H     +V+HRD++ +NV ++ E     +G  GL++ V         + E  V 
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180

Query: 434 AGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
              T  Y +P  +   N  T   D+++ G +  E+++G+
Sbjct: 181 ---TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 23/162 (14%)

Query: 321 RLHHPNLVAVKGCCYD-HGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLD---WAMRM 372
              HPN+V +   C+    DR     +V+E V +  L  +L   P+ G   +     MR 
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ 115

Query: 373 KVATTLAQGIAFLHDKVKPH-VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431
                L +G+ FLH     H +VHRD++  N+L+  +    +   GL++   +E M   +
Sbjct: 116 -----LLRGVDFLHS----HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-MALTS 165

Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           V+   T  Y APE + ++   T  D++S G +  E+   RRP
Sbjct: 166 VVV--TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 24/100 (24%), Positives = 49/100 (49%), Gaps = 4/100 (4%)

Query: 372 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431
           + +  ++ + I +LH+     ++HRDI+A N+ ++      L   G + F P ++   + 
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKY 240

Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
               GT    APE + R+      D++S G++L E+ +  
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 46/196 (23%), Positives = 81/196 (41%), Gaps = 39/196 (19%)

Query: 293 GSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVN 349
           G  VA+K+  L+R       +   EI       HP +V +    + HG    +V E++ +
Sbjct: 25  GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV-FPHGSGFVLVMEYMPS 83

Query: 350 GPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             L   L    R       +S    MRM     L +G+A++H      ++HRD++ +N+L
Sbjct: 84  D-LSEVLRDEERPLPEAQVKSY---MRM-----LLKGVAYMHAN---GIMHRDLKPANLL 131

Query: 405 LDE-------EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNELTTKS 455
           +         +FG A L      +    +V          T  Y APE +Y   +     
Sbjct: 132 ISADGVLKIADFGLARLFSEEEPRLYSHQV---------ATRWYRAPELLYGARKYDPGV 182

Query: 456 DVYSFGVLLLEIVSGR 471
           D+++ G +  E+++G 
Sbjct: 183 DLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 44/197 (22%), Positives = 88/197 (44%), Gaps = 41/197 (20%)

Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
           G++VA+K+L R  FQ +   K  Y E+     + H N++             ++  F  +
Sbjct: 40  GAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMKHENVIG------------LLDVFTPD 86

Query: 350 GPLDRWLHH---IPRGGRSLDWAMRMK---------VATTLAQGIAFLHDKVKPHVVHRD 397
             LDR+      +P  G  L   M+ +         +   + +G+ ++H      ++HRD
Sbjct: 87  LSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRD 143

Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG--TYGYLAPEFVYR-NELTTK 454
           ++  N+ ++E+    ++  GL++       Q  + M G   T  Y APE +      T  
Sbjct: 144 LKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRWYRAPEVILNWMHYTQT 196

Query: 455 SDVYSFGVLLLEIVSGR 471
            D++S G ++ E+++G+
Sbjct: 197 VDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|153058 cd03588, CLECT_CSPGs, C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins

 Score = 40.3 bits (94), Expect = 4e-04
 Identities = 20/81 (24%), Positives = 41/81 (50%), Gaps = 9/81 (11%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           C   W  ++ +  C+ +  +  +W+++E  C+E  GHL+++ + EE    Q+    N   
Sbjct: 1   CEEGW--DKFQGHCYRHFPDRETWEDAERRCREQQGHLSSIVTPEE----QEFVNNNAQD 54

Query: 113 C-WVGGRSINTTVGLSWKWSD 132
             W+G    + T+   ++WSD
Sbjct: 55  YQWIGLN--DRTIEGDFRWSD 73

CLECT_CSPGs: C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins (CSPGs) in human and chicken aggrecan, frog brevican, and zebra fish dermacan. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Xenopus brevican is expressed in the notochord and the brain during early embryogenesis. Zebra fish dermacan is expressed in dermal bones and may play a role in dermal bone development. CSPGs do contain LINK domain(s) which bind HA. These LINK domains are considered by one classification system to be a variety of CTLD, but are omitted from this hierarchical classification based on insignificant sequence similarity. Length = 124

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 42.1 bits (100), Expect = 4e-04
 Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 38/195 (19%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYS--------EIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343
           G  VA+K++K       K+FYS        E+    +L  HPN+V +K    ++ + Y V
Sbjct: 24  GELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76

Query: 344 YEFVVNGPLDRWLHHI--PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           +E+     ++  L+ +   R G+    ++   +   + QG+A +H   K    HRD++  
Sbjct: 77  FEY-----MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPE 128

Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERT----VMAGGTYGYLAPEFVYRNEL-TTKSD 456
           N+L+       +   GL++    E+         V    T  Y APE + R+   ++  D
Sbjct: 129 NLLVSGPEVVKIADFGLAR----EIRSRPPYTDYV---STRWYRAPEILLRSTSYSSPVD 181

Query: 457 VYSFGVLLLEIVSGR 471
           +++ G ++ E+ + R
Sbjct: 182 IWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 42.1 bits (99), Expect = 5e-04
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 15/156 (9%)

Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL-DWAMRMKVATTLAQGI 382
           HP +V +       G  Y++ E++  G L     H+ R G  + D A       +LA  +
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMHLEREGIFMEDTACFYLSEISLA--L 113

Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGY 440
             LH   +  +++RD++  N+LLD +    L   GL K    E + E TV     GT  Y
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEY 166

Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           +APE + R+      D +S G L+ ++++G  P  A
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 37/226 (16%)

Query: 262 ELRSITKNFSEGNRLLGDSKTGGTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYS- 314
             RS+T  F + NR+ G+    GTY GI         G  VA+K+++      +++    
Sbjct: 2   RCRSVT-EFEKLNRI-GE----GTY-GIVYRARDTTSGEIVALKKVR---MDNERDGIPI 51

Query: 315 ----EIGRFARLHHPNLVAVKGCCY-DHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
               EI     L HPN+V +K      H D  ++V E+     L   L ++P        
Sbjct: 52  SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPT---PFSE 107

Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEV 426
           +    +   L +G+ +LH+     ++HRD++ SN+LL ++    +   GL++   +P + 
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164

Query: 427 MQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGR 471
           M  + V    T  Y APE +      T + D+++ G +L E+++ +
Sbjct: 165 MTPKVV----TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 41.9 bits (99), Expect = 6e-04
 Identities = 44/191 (23%), Positives = 85/191 (44%), Gaps = 29/191 (15%)

Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIV 343
           G +VA+K+L R  FQ     K  Y E+     + H N++ +           D  D Y+V
Sbjct: 40  GRKVAIKKLSRP-FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98

Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
              +        L++I +  +  D  ++  V   L +G+ ++H      ++HRD++ SN+
Sbjct: 99  THLM-----GADLNNIVKCQKLSDDHIQFLVYQIL-RGLKYIH---SAGIIHRDLKPSNI 149

Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVY-RNELTTKSDVYSF 460
            ++E+    ++  GL++            M G   T  Y APE +          D++S 
Sbjct: 150 AVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202

Query: 461 GVLLLEIVSGR 471
           G ++ E+++G+
Sbjct: 203 GCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|165024 PHA02642, PHA02642, C-type lectin-like protein; Provisional

 Score = 40.9 bits (95), Expect = 6e-04
 Identities = 26/94 (27%), Positives = 44/94 (46%), Gaps = 7/94 (7%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP  WI      KCF +  + ++W    T+C  +G  L  + + EE +  ++   K+ + 
Sbjct: 88  CPKGWI--GFGYKCFYFSEDSKNWTFGNTFCTSLGATLVKVETEEELNFLKRY--KDSSD 143

Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGS 146
            W+G      +    WKW+DN S +N S    G+
Sbjct: 144 HWIGLN--RESSNHPWKWADN-SNYNASFVITGT 174

Length = 216

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)

Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 42  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101

Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
                  +   L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 102 HL-----MGADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLA 152

Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 153 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 205

Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 206 CIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 39/202 (19%)

Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCC 334
           L+ D++T  T+           +K L++SS       YS        H  PN+V +    
Sbjct: 11  LVMDTRTQQTF----------ILKGLRKSSE------YSRERLTIIPHCVPNMVCLHKYI 54

Query: 335 YDHGDRYIVYEFVVNGPLDRWLH-----HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
                 ++V +    G L  W H     +IP       WA  M VA      +  LH + 
Sbjct: 55  VSEDSVFLVLQHAEGGKL--WSHISKFLNIPEE-CVKRWAAEMVVA------LDALHRE- 104

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
              +V RD+  +N+LLD+    H   + L+ F  W  +++          Y APE    +
Sbjct: 105 --GIVCRDLNPNNILLDDR--GH---IQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGIS 157

Query: 450 ELTTKSDVYSFGVLLLEIVSGR 471
           E T   D +S G +L E+++G+
Sbjct: 158 EETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 39/161 (24%), Positives = 73/161 (45%), Gaps = 16/161 (9%)

Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           E+     L H N+V +    +      +V+E+     LD+ L        ++     +K+
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKI 108

Query: 375 -ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL--SKFVPWEVMQERT 431
               + +G+A+ H   +  V+HRD++  N+L++E     L   GL  +K VP +      
Sbjct: 109 FLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV 165

Query: 432 VMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSGR 471
           V    T  Y  P+ +   +E +T+ D++  G +  E+ SGR
Sbjct: 166 V----TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 34/114 (29%), Positives = 54/114 (47%), Gaps = 26/114 (22%)

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLD-------EEFGAHLMGVGLSKFVPWEVMQER 430
           +A+ +  +H   + H VHRDI+  NVLLD        +FG+ L           ++ Q+ 
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCL-----------KMNQDG 156

Query: 431 TV---MAGGTYGYLAPEFVYRNE-----LTTKSDVYSFGVLLLEIVSGRRPAQA 476
           TV   +A GT  Y++PE +   E        + D +S GV + E++ G  P  A
Sbjct: 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 39/203 (19%)

Query: 295 RVAVKRLKRSSF----QRKKEFYS-EIGRFARLHHPNLVAVKGCCYDHGDRYI--VYEFV 347
           R A+K++ + +     Q ++ F   +I  FA   +P +V++  C ++   R++  V E+V
Sbjct: 28  RFAMKKINKQNLILRNQIQQVFVERDILTFA--ENPFVVSMF-CSFE-TKRHLCMVMEYV 83

Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
             G     L +I  G   +D A RM  A T LA  + +LH+     +VHRD++  N+L+ 
Sbjct: 84  EGGDCATLLKNI--GALPVDMA-RMYFAETVLA--LEYLHNY---GIVHRDLKPDNLLIT 135

Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAG----------------GTYGYLAPEFVYRNE 450
                 L   GLSK     +M   T +                  GT  Y+APE + R  
Sbjct: 136 SMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG 192

Query: 451 LTTKSDVYSFGVLLLEIVSGRRP 473
                D ++ G++L E + G  P
Sbjct: 193 YGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 40/171 (23%), Positives = 79/171 (46%), Gaps = 23/171 (13%)

Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRW----LHHIPRGGRSLDW 368
           EI     L HPN++A++     H DR  ++++++  +   D W     H   +  +    
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQ 104

Query: 369 AMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKF 421
             R  V + L Q   GI +LH      V+HRD++ +N+L+     E     +  +G ++ 
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Query: 422 V--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVS 469
              P + + +   +   T+ Y APE +      TK+ D+++ G +  E+++
Sbjct: 162 FNSPLKPLADLDPVV-VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 41.3 bits (96), Expect = 0.002
 Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 28/192 (14%)

Query: 307 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGR 364
           + K +   E+     L H N+V       +  ++  YI+ EF   G L R +    +   
Sbjct: 54  REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG 113

Query: 365 SLDWAMRMKVATTLAQGIAFLHD-KVKPH---VVHRDIRASNVLLD---EEFG------- 410
            ++    + +   L   +A+ H+ K  P+   V+HRD++  N+ L       G       
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173

Query: 411 -------AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT--TKSDVYSFG 461
                  A +   GLSK +  E M    V   GT  Y +PE +     +   KSD+++ G
Sbjct: 174 NLNGRPIAKIGDFGLSKNIGIESMAHSCV---GTPYYWSPELLLHETKSYDDKSDMWALG 230

Query: 462 VLLLEIVSGRRP 473
            ++ E+ SG+ P
Sbjct: 231 CIIYELCSGKTP 242

Length = 1021

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 37/161 (22%), Positives = 72/161 (44%), Gaps = 16/161 (9%)

Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMRMK 373
           E+     L H N+V +    +      +V+E+     LD+ L  ++   G S++      
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKL 108

Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL--SKFVPWEVMQERT 431
               L +G+ + H   +  V+HRD++  N+L++E     L   GL  +K +P +      
Sbjct: 109 FLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV 165

Query: 432 VMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSGR 471
           V    T  Y  P+ +    + +T+ D++  G +  E+ +GR
Sbjct: 166 V----TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 51/196 (26%), Positives = 86/196 (43%), Gaps = 27/196 (13%)

Query: 292 DGSRVAVKRLKRSSFQRK---KEFYSEIG--RFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
           +   VA+K++    F +K   K    E+   R  R  H N+     C YD     IV+  
Sbjct: 26  EEETVAIKKITNV-FSKKILAKRALRELKLLRHFR-GHKNIT----CLYDMD---IVFPG 76

Query: 347 VVNG------PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
             N        ++  LH I R G+ L  A        +  G+ ++H     +V+HRD++ 
Sbjct: 77  NFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKP 133

Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKS-DV 457
            N+L++ +    +   GL++       +    M     T  Y APE +   +  TK+ DV
Sbjct: 134 GNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDV 193

Query: 458 YSFGVLLLEIVSGRRP 473
           +S G +L E++ GR+P
Sbjct: 194 WSVGCILAELL-GRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 45/185 (24%), Positives = 81/185 (43%), Gaps = 22/185 (11%)

Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFVVN 349
           G  VA+K++ +  S+    K  Y E+     L H N++++         D Y V E    
Sbjct: 35  GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL--- 91

Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
             L   LH +      L+          + +G+ ++H      VVHRD++ SN+L++E  
Sbjct: 92  --LGTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENC 145

Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFGVLLLE 466
              +   GL++      +Q+   M G   T  Y APE +    +   + D++S G +  E
Sbjct: 146 DLKICDFGLAR------IQDPQ-MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAE 198

Query: 467 IVSGR 471
           ++ G+
Sbjct: 199 MLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 39.3 bits (92), Expect = 0.003
 Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 14/182 (7%)

Query: 293 GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           G  VA+K+   S      KK    EI    +L HPNLV +          ++V+E+  + 
Sbjct: 26  GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85

Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L+    + PRG   +   +  K+     Q + F H   K + +HRD++  N+L+ ++  
Sbjct: 86  VLNELEKN-PRG---VPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQ 138

Query: 411 AHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEF-VYRNELTTKSDVYSFGVLLLEIV 468
             L   G ++ +          V    T  Y APE  V   +     DV++ G +  E++
Sbjct: 139 IKLCDFGFARILTGPGDDYTDYV---ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL 195

Query: 469 SG 470
           +G
Sbjct: 196 TG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 39.3 bits (91), Expect = 0.003
 Identities = 39/171 (22%), Positives = 79/171 (46%), Gaps = 23/171 (13%)

Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRW----LHHIPRGGRSLDW 368
           EI     L HPN+++++     H DR  ++++++  +   D W     H   +  +    
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQ 104

Query: 369 AMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKF 421
             R  V + L Q   GI +LH      V+HRD++ +N+L+     E     +  +G ++ 
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Query: 422 V--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVS 469
              P + + +   +   T+ Y APE +      TK+ D+++ G +  E+++
Sbjct: 162 FNSPLKPLADLDPVV-VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 39/161 (24%), Positives = 72/161 (44%), Gaps = 16/161 (9%)

Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           E+     L H N+V +    +      +V+E+     LD  L        +L     +K+
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKI 107

Query: 375 AT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL--SKFVPWEVMQERT 431
               L +G+++ H +    ++HRD++  N+L++E+    L   GL  +K VP +      
Sbjct: 108 FMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEV 164

Query: 432 VMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSGR 471
           V    T  Y  P+ +    E +T  D++  G +L E+ +GR
Sbjct: 165 V----TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	557
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.98
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
cd03599	153	CLECT_DGCR2_like C-type lectin-like domain (CTLD)	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
PHA02642	216	C-type lectin-like protein; Provisional	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
cd03588	124	CLECT_CSPGs C-type lectin-like domain (CTLD) of th	99.93
cd03597	129	CLECT_attractin_like C-type lectin-like domain (CT	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
cd03596	129	CLECT_tetranectin_like C-type lectin-like domain (	99.92
cd03589	137	CLECT_CEL-1_like C-type lectin-like domain (CTLD)	99.92
cd03590	126	CLECT_DC-SIGN_like C-type lectin-like domain (CTLD	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
cd03593	116	CLECT_NK_receptors_like C-type lectin-like domain	99.92
PHA02953	170	IEV and EEV membrane glycoprotein; Provisional	99.91
cd03594	129	CLECT_REG-1_like C-type lectin-like domain (CTLD)	99.91
PHA03097	157	C-type lectin-like protein; Provisional	99.9
cd03591	114	CLECT_collectin_like C-type lectin-like domain (CT	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
cd03603	118	CLECT_VCBS A bacterial subgroup of the C-type lect	99.88
cd03598	117	CLECT_EMBP_like C-type lectin-like domain (CTLD) o	99.88
cd03601	119	CLECT_TC14_like C-type lectin-like domain (CTLD) o	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
PHA02867	167	C-type lectin protein; Provisional	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.86
TIGR00864	2740	PCC polycystin cation channel protein. Note: this	99.86
smart00034	126	CLECT C-type lectin (CTL) or carbohydrate-recognit	99.86
cd03592	115	CLECT_selectins_like C-type lectin-like domain (CT	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
cd03602	108	CLECT_1 C-type lectin (CTL)/C-type lectin-like (CT	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
cd03600	141	CLECT_thrombomodulin_like C-type lectin-like domai	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
cd03595	149	CLECT_chondrolectin_like C-type lectin-like domain	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
PRK10345	210	hypothetical protein; Provisional	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
smart00090	237	RIO RIO-like kinase.	99.72
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.69
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.66
PHA02911	213	C-type lectin-like protein; Provisional	99.63
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
cd00037	116	CLECT C-type lectin (CTL)/C-type lectin-like (CTLD	99.6
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.6
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.57
PF00059	105	Lectin_C: Lectin C-type domain; InterPro: IPR00130	99.54
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.49
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.34
KOG1243	690	consensus Protein kinase [General function predict	99.32
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.28
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.28
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.17
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.13
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.07
KOG3087	229	consensus Serine/threonine protein kinase [General	99.07
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.05
PF05473	200	Herpes_UL45: UL45 protein; InterPro: IPR008646 Thi	99.02
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.92
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.89
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.86
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.84
COG4248	637	Uncharacterized protein with protein kinase and he	98.7
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.63
PRK09902	216	hypothetical protein; Provisional	98.59
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.56
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.55
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.46
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.29
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.13
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.12
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.07
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.05
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.02
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.01
PF01636	239	APH: Phosphotransferase enzyme family This family	98.0
PLN02876	822	acyl-CoA dehydrogenase	97.91
PRK10593	297	hypothetical protein; Provisional	97.88
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.86
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.72
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.62
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.61
PHA02673	161	ORF109 EEV glycoprotein; Provisional	97.52
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.43
PHA03093	185	EEV glycoprotein; Provisional	97.42
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.39
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.39

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-57  Score=463.30  Aligned_cols=291  Identities=42%  Similarity=0.736  Sum_probs=254.5

Q ss_pred             CccccCHHHHHHhhcCCCCCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeee
Q 008698          254 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC  333 (557)
Q Consensus       254 ~~~~~~~~el~~~~~~~~~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~  333 (557)
                      ....|+++|+..+|++|+..+. ||+|+||.||+|.+++|+.||||++.....+...+|.+|+.++.+++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~-ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNL-IGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcc-eecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            5678999999999999998774 599999999999999999999998876643315569999999999999999999999


Q ss_pred             eeeCC-ceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcE
Q 008698          334 CYDHG-DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH  412 (557)
Q Consensus       334 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k  412 (557)
                      |.+.+ +.+||||||++|+|.++|+.....  .++|.+|++||.++|+||+|||+.+.+.||||||||+|||||+++++|
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            99999 599999999999999999874332  899999999999999999999999999999999999999999999999


Q ss_pred             EeeccCCccCCc-cccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhh
Q 008698          413 LMGVGLSKFVPW-EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP  491 (557)
Q Consensus       413 l~Dfgl~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~  491 (557)
                      |+|||+|+..+. ....... . .||.+|+|||++..+..|.|+|||||||+|+||+||+.|.+...+.....+.+|+.+
T Consensus       218 lsDFGLa~~~~~~~~~~~~~-~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTT-V-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             ccCccCcccCCccccceeee-c-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            999999976654 2211111 1 499999999999999999999999999999999999998886654555668999999


Q ss_pred             hhhccccccccCcccccCCCCCCc-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          492 LVQSHRYLELLDPLISSLSSDIPE-AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       492 ~~~~~~~~~~~d~~l~~~~~~~~~-~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      .+...++.+++|+.+..   ...+ ..+...+..++.+|++.+|++||+|.||+++|+.+..
T Consensus       296 ~~~~~~~~eiiD~~l~~---~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKE---GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHCcchhheeCCCccC---CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            99999999999999853   2222 2577889999999999999999999999999976654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-51  Score=412.50  Aligned_cols=252  Identities=28%  Similarity=0.454  Sum_probs=215.9

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHHH
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW  355 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  355 (557)
                      .||+|-||+||.|.++....||+|.++... ...+.|.+|+++|++|+|+|||+++|+|..+++.+||||||+.|+|.+|
T Consensus       213 ~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~y  291 (468)
T KOG0197|consen  213 ELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDY  291 (468)
T ss_pred             HhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHH
Confidence            379999999999999777799999998763 4457899999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeecC
Q 008698          356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG  435 (557)
Q Consensus       356 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~  435 (557)
                      |+.  ..+..+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+...++.+..... ..
T Consensus       292 Lr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~-~k  365 (468)
T KOG0197|consen  292 LRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG-GK  365 (468)
T ss_pred             hhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC-CC
Confidence            986  4456799999999999999999999999   99999999999999999999999999999655444433332 22


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCC
Q 008698          436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP  514 (557)
Q Consensus       436 gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  514 (557)
                      -++.|.|||++..+.+|.|||||||||+||||+| |+.||...+..+....++                    ...+-..
T Consensus       366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le--------------------~GyRlp~  425 (468)
T KOG0197|consen  366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE--------------------RGYRLPR  425 (468)
T ss_pred             CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh--------------------ccCcCCC
Confidence            5789999999999999999999999999999999 999988765432211111                    1112334


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       515 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                      |..|++.++++|..||+.+|++|||++.+...|+.+...-
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            5568899999999999999999999999999999877643

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-49  Score=403.37  Aligned_cols=249  Identities=31%  Similarity=0.530  Sum_probs=206.5

Q ss_pred             ecccCceEEEEEEeCCCCE-EEEEEecccchhh--HHHHHHHHHHHhhcCCCcEEeeeeeeeeCC-ceEEEEecCCCCCh
Q 008698          277 LGDSKTGGTYSGILPDGSR-VAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHG-DRYIVYEFVVNGPL  352 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~~g~~-vavK~~~~~~~~~--~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~gsL  352 (557)
                      +|+|+||+||+|.+ .|+. ||||++.......  .++|.+|+.+|.+++|||||+++|+|.+.. ...+||||+++|+|
T Consensus        49 iG~G~~g~V~~~~~-~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL  127 (362)
T KOG0192|consen   49 LGSGSFGTVYKGKW-RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSL  127 (362)
T ss_pred             cccCCceeEEEEEe-CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcH
Confidence            79999999999999 5555 9999998653222  569999999999999999999999999887 79999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCCCeeeCCCC-CcEEeeccCCccCCccccccc
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH-VVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      .++++..  ....+++..++.++.|||+||.|||++   + ||||||||+|||++.++ ++||+|||+++......  ..
T Consensus       128 ~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~  200 (362)
T KOG0192|consen  128 SVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS  200 (362)
T ss_pred             HHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence            9999863  356799999999999999999999999   7 99999999999999997 99999999998765432  11


Q ss_pred             eeecCcccccccccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          431 TVMAGGTYGYLAPEFVY--RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~--~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      .....||+.|||||++.  ...|+.|+|||||||++|||+||+.||.+....      +.+.......     .      
T Consensus       201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~v~~~~-----~------  263 (362)
T KOG0192|consen  201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVASAVVVGG-----L------  263 (362)
T ss_pred             ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcC-----C------
Confidence            12245999999999999  568999999999999999999999999887542      1111111111     0      


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                        ....+..++..+..++.+||+.||+.||++.+++..|+.+..
T Consensus       264 --Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  264 --RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             --CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence              111123366789999999999999999999999999986644

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.6e-49  Score=418.37  Aligned_cols=256  Identities=27%  Similarity=0.422  Sum_probs=215.0

Q ss_pred             eeecccCceEEEEEEeC------CCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +-||+|+||.||+|...      +...||||.+++.... ...+|++|+++++.++|||||+|+|+|.++++.++|+|||
T Consensus       492 ~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm  571 (774)
T KOG1026|consen  492 EELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYM  571 (774)
T ss_pred             hhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEec
Confidence            34799999999999843      3467999999877544 7889999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCC------CC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeecc
Q 008698          348 VNGPLDRWLHHIPR------GG----RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  417 (557)
Q Consensus       348 ~~gsL~~~l~~~~~------~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  417 (557)
                      ..|+|.+||+....      .+    .+|+..+.+.||.|||.||.||-++   .+|||||.++|+||.++..+||+|||
T Consensus       572 ~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDfG  648 (774)
T KOG1026|consen  572 DHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDFG  648 (774)
T ss_pred             ccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEecccc
Confidence            99999999975321      12    3389999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhcc
Q 008698          418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH  496 (557)
Q Consensus       418 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (557)
                      +++..-..++.......--+++|||||.++.++||++||||||||+|||++| |+.||.+....+       +...++++
T Consensus       649 LsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe~i~~g  721 (774)
T KOG1026|consen  649 LSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIECIRAG  721 (774)
T ss_pred             cchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHHHHHcC
Confidence            9997655554433322225789999999999999999999999999999999 999998765432       22222222


Q ss_pred             ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       497 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ++             ...+.+|+.+++.||..||+.+|++||++.||-..|+...+.
T Consensus       722 ~l-------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  722 QL-------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             Cc-------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            21             223456888999999999999999999999999999877653

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=412.05  Aligned_cols=257  Identities=25%  Similarity=0.418  Sum_probs=218.6

Q ss_pred             CCeeecccCceEEEEEEeCC----CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          273 GNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      ..++||.|.||+||+|.++-    ...||||.++... ...+.+|+.|+.+|.++.||||++|.|+.....+.++|.|||
T Consensus       633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM  712 (996)
T KOG0196|consen  633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM  712 (996)
T ss_pred             EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence            35789999999999999743    4579999998763 455678999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|+.||+...   ..+++.++..|+++||.||+||.++   ++|||||.++|||++.|..+|++|||+++.+.++..
T Consensus       713 ENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  713 ENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             hCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            9999999998633   5599999999999999999999999   999999999999999999999999999998765542


Q ss_pred             cc-ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          428 QE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       428 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      .. .+....-+++|.|||.+...++|.+||||||||++||.++ |.+||.+++..+   .+.             .++  
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd---VIk-------------aIe--  848 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIK-------------AIE--  848 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH---HHH-------------HHH--
Confidence            21 1111113579999999999999999999999999999998 999998775421   111             111  


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCC
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV  555 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  555 (557)
                        ......+|++|+..|.+||+.||++|..+||++.+|+..|+++...|-
T Consensus       849 --~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  849 --QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             --hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence              112456788999999999999999999999999999999999887663

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-47  Score=367.04  Aligned_cols=245  Identities=25%  Similarity=0.440  Sum_probs=204.7

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc-eEEEEecCCCCCh
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-RYIVYEFVVNGPL  352 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~-~~lV~E~~~~gsL  352 (557)
                      .||+|..|+||++.+. +++.+|+|++... .....+++.+|++++...+||+||.++|.|...+. ..++||||++|||
T Consensus        86 ~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSL  165 (364)
T KOG0581|consen   86 VLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSL  165 (364)
T ss_pred             hcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCH
Confidence            5799999999999974 5889999999543 34556899999999999999999999999999984 9999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      ++++..    .+.+++...-+|+.+|++||.|||+ .   +||||||||+|||++..+.+||+|||.+..+..+    ..
T Consensus       166 d~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a  234 (364)
T KOG0581|consen  166 DDILKR----VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA  234 (364)
T ss_pred             HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence            999864    2569999999999999999999996 6   9999999999999999999999999999877654    22


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ....||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....+. ....             .++++....+..+
T Consensus       235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~-------------~~Ll~~Iv~~ppP  300 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDI-------------FELLCAIVDEPPP  300 (364)
T ss_pred             ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCH-------------HHHHHHHhcCCCC
Confidence            3345999999999999999999999999999999999999999764111 1111             1222222222223


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..+...+++++..++..|+++||++|||+.|+++
T Consensus       301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            3333347788999999999999999999999987

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=408.51  Aligned_cols=259  Identities=32%  Similarity=0.447  Sum_probs=215.9

Q ss_pred             CCCeeecccCceEEEEEEeCC--CC----EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILPD--GS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~--g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      ...+.||+|.||.||.|...+  |.    .||||.+++. +.+...+|++|..+|++++|||||+++|+|.+....++++
T Consensus       695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l  774 (1025)
T KOG1095|consen  695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL  774 (1025)
T ss_pred             EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence            345678999999999999644  33    4999999765 5677789999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          345 EFVVNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      |||++|+|..||++.+.   ....++....+.++.|||+|+.||+++   ++|||||.++|+||+....+||+|||+|+.
T Consensus       775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArD  851 (1025)
T KOG1095|consen  775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARD  851 (1025)
T ss_pred             hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHh
Confidence            99999999999987422   146799999999999999999999999   999999999999999999999999999995


Q ss_pred             CCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      .-...+........-+.+|||||++..+.+|.|+|||||||+|||++| |..||...+..+.                  
T Consensus       852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------------------  913 (1025)
T KOG1095|consen  852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------------------  913 (1025)
T ss_pred             hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------------------
Confidence            544433322222235689999999999999999999999999999999 9999987654321                  


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                       +...+.+. +..++..|++.+++||..||+.+|++||++..|++++..+...
T Consensus       914 -~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  914 -LLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             -HHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence             11111111 2334567889999999999999999999999999998876653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-45  Score=372.61  Aligned_cols=247  Identities=23%  Similarity=0.387  Sum_probs=209.5

Q ss_pred             CCCCCCeeecccCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEE
Q 008698          269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      ..++..++||+|+|+.+|.++. ..|..||+|++.+.   .....+.+.+|+++.+.|+|||||+++++|++.+..|+|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            3456677899999999999997 78999999999764   2344677899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      |+|++++|..++..    .+++++.+++.+..||+.||.|||++   +|+|||||..|+||++++++||+|||||..+..
T Consensus        98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            99999999998863    46799999999999999999999999   999999999999999999999999999988765


Q ss_pred             cccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      +.  +...+.+||+.|+|||++....++..+||||+||++|-|+.|++||+..+-.+   ...   .+...         
T Consensus       171 ~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke---ty~---~Ik~~---------  233 (592)
T KOG0575|consen  171 DG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE---TYN---KIKLN---------  233 (592)
T ss_pred             cc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH---HHH---HHHhc---------
Confidence            43  33345679999999999998889999999999999999999999998754221   111   11000         


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                            .-..|.....+..+||.++|+.+|.+|||+++|+.
T Consensus       234 ------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  234 ------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  11112344566889999999999999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=356.70  Aligned_cols=202  Identities=25%  Similarity=0.453  Sum_probs=178.2

Q ss_pred             CCCCCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEe
Q 008698          269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      +|....+ ||+|+|++||+|++. ++..||||.+...  ..+..+.+..|+.+|+.++|||||++++++..++..+||||
T Consensus        11 ~y~~~~~-iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   11 DYELSRE-IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             cceehhh-ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            3434444 699999999999974 5899999999776  45566778999999999999999999999999999999999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC------CCcEEeeccCC
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE------FGAHLMGVGLS  419 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~------~~~kl~Dfgl~  419 (557)
                      ||.+|+|.+|++..    ..+++...+.++.|+|.||++||++   +||||||||+||||+.+      -.+||+|||+|
T Consensus        90 yC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999762    4699999999999999999999999   99999999999999865      45799999999


Q ss_pred             ccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccc
Q 008698          420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC  481 (557)
Q Consensus       420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~  481 (557)
                      +.+......   .+.+|++-|||||++...+|+.|+|+||.|+|||++++|+.||+..+..+
T Consensus       163 R~L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  163 RFLQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             hhCCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            998754433   24469999999999999999999999999999999999999998766543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-45  Score=368.27  Aligned_cols=260  Identities=25%  Similarity=0.371  Sum_probs=214.7

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|-||+|-......+..||||.++.... ....+|.+|+++|.+++||||++++|+|..+++.++++|||++|+|
T Consensus       543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDL  622 (807)
T KOG1094|consen  543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDL  622 (807)
T ss_pred             hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcH
Confidence            455899999999999997789999999988754 3458999999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      ..|+......  .+....-.+|+.|||+||+||.+-   ++|||||.++|+|+|.++++||+|||.++.+-...+.....
T Consensus       623 nqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg  697 (807)
T KOG1094|consen  623 NQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG  697 (807)
T ss_pred             HHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence            9999864322  245566678999999999999998   99999999999999999999999999999776665555554


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      ...-+++|||||.+..+++|++||||+|||++||+++  ...||+...+.   +.++.+...........++        
T Consensus       698 r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~l--------  766 (807)
T KOG1094|consen  698 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVVL--------  766 (807)
T ss_pred             ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcceec--------
Confidence            4557899999999999999999999999999999988  77888766442   2333332222222111111        


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                        ..+.-|+..++++|++||+.|-++||+++++...|++.+
T Consensus       767 --~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  767 --SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             --cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence              123347788999999999999999999999999988654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-45  Score=355.36  Aligned_cols=254  Identities=23%  Similarity=0.332  Sum_probs=203.4

Q ss_pred             hhcCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccchh-------hHHHHHHHHHHHhhcCCCcEEeeeeeeeeC
Q 008698          266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ-------RKKEFYSEIGRFARLHHPNLVAVKGCCYDH  337 (557)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~  337 (557)
                      ..++++...+.||+|+||.|-+|.- .+|+.||||++++....       ......+|+++|++|+|||||++.++++..
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            3566777788899999999999984 57999999999764211       223457999999999999999999999999


Q ss_pred             CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCcEEe
Q 008698          338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLM  414 (557)
Q Consensus       338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~  414 (557)
                      +..|+||||+.+|.|.+++-.    ++.+.+..-..++.|++.|+.|||++   ||+||||||+|||+..+   ..+||+
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             CceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence            999999999999999999864    34577777788999999999999999   99999999999999766   779999


Q ss_pred             eccCCccCCccccccceeecCccccccccccccCCCC---CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhh
Q 008698          415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL---TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP  491 (557)
Q Consensus       415 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~  491 (557)
                      |||+|+....   .....+.+||+.|.|||++.+..+   ..+.|+||+|||||-++||.+||++.....  .+.+..  
T Consensus       322 DFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI--  394 (475)
T KOG0615|consen  322 DFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQI--  394 (475)
T ss_pred             ccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHH--
Confidence            9999998753   234455679999999999987543   348899999999999999999998764421  111100  


Q ss_pred             hhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       492 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        ..+++.  +.        ........++..+++.++|..||++|||++|+++
T Consensus       395 --~~G~y~--f~--------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  395 --LKGRYA--FG--------PLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             --hcCccc--cc--------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence              011100  00        0112456788999999999999999999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-45  Score=341.34  Aligned_cols=252  Identities=24%  Similarity=0.382  Sum_probs=207.1

Q ss_pred             eecccCceEEEEEE-eCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeee-eeeeCCc-eEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKG-CCYDHGD-RYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g-~~~~~~~-~~lV~E~~~~g  350 (557)
                      .||.|+||+||++. ..+|..||.|.++..  +.+..+....|+.+|++|+|||||++++ -+.+++. ++|||||+..|
T Consensus        26 ~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~G  105 (375)
T KOG0591|consen   26 KIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAG  105 (375)
T ss_pred             HHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhccc
Confidence            47999999999998 568999999998754  4455678999999999999999999999 4444544 89999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK-PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      +|...+...++..+.+++..+++++.|++.||..+|++.. ..|+||||||.||||+.++.+||+||||++++.......
T Consensus       106 DLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA  185 (375)
T KOG0591|consen  106 DLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFA  185 (375)
T ss_pred             CHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHH
Confidence            9999998888888899999999999999999999998422 139999999999999999999999999999987654433


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      ..  ..||+.||+||.+.+..|+.||||||+||++|||..-.+||.+.+-      .+..... .+.+            
T Consensus       186 ~S--~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L~~KI-~qgd------------  244 (375)
T KOG0591|consen  186 HS--LVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSLCKKI-EQGD------------  244 (375)
T ss_pred             Hh--hcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHHHHHH-HcCC------------
Confidence            22  3499999999999999999999999999999999999999987532      2211111 1110            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                      .+..+..-.+..+..|+..|+..||+.||+...+++.+.
T Consensus       245 ~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  245 YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            022333556788999999999999999998666665554

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-44  Score=371.68  Aligned_cols=254  Identities=24%  Similarity=0.382  Sum_probs=216.8

Q ss_pred             CeeecccCceEEEEEEe-CCCC----EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .++||+|+||+||+|.+ ++|.    +||+|++... ..+...++++|+..|.+++|||+++++|+|.... ..||.+||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            45789999999999995 4443    7999998654 4556789999999999999999999999998776 78999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      +.|+|.+|++..+   ..+.....+.+..|||+||.|||.+   +++||||.++||||.....+||+|||+++.+..+..
T Consensus       780 P~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  780 PLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             ccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            9999999998643   4588889999999999999999999   999999999999999999999999999999877655


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ........-.+.|||-|.+....||.+||||||||++||++| |..|+++....+..++++....              +
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR--------------L  919 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER--------------L  919 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc--------------C
Confidence            554444445789999999999999999999999999999999 9999998877665555442221              1


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                            .-+.-+...++.++.+||..|+..||+++++...+.+++..|
T Consensus       920 ------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  920 ------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             ------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence                  113346778999999999999999999999999998887654

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=359.25  Aligned_cols=259  Identities=24%  Similarity=0.402  Sum_probs=207.4

Q ss_pred             CCCCCCeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          269 NFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      ++......||+|+||+||+|.+.  ..||||++.-.  .....++|.+|+..+++-+|.||+-+.|+|.+.+. .+|.-+
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw  468 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW  468 (678)
T ss_pred             HHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence            33344556899999999999983  46999999754  34456899999999999999999999999998877 999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      |++-+|..+|+-.   ...|+..+.+.||.|||+||.|||.+   +|||||||..|||+.+++++||+||||+.....-.
T Consensus       469 CeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~  542 (678)
T KOG0193|consen  469 CEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS  542 (678)
T ss_pred             ccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence            9999999999853   25699999999999999999999999   99999999999999999999999999987544332


Q ss_pred             cccceeecCccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccC
Q 008698          427 MQERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  503 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  503 (557)
                      -........|...|||||++..   .+|+..|||||||+++|||+||..||.....+  +-++.       -++  ..+-
T Consensus       543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIifm-------VGr--G~l~  611 (678)
T KOG0193|consen  543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QIIFM-------VGR--GYLM  611 (678)
T ss_pred             cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heEEE-------ecc--cccC
Confidence            2223333448899999999975   47899999999999999999999999843321  11110       010  0011


Q ss_pred             cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       504 ~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      +.+     ......++.++.+|+..||..+|++||.+.+|+..|+.+..
T Consensus       612 pd~-----s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  612 PDL-----SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccc-----hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            111     11224567789999999999999999999999998887766

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=363.78  Aligned_cols=254  Identities=29%  Similarity=0.407  Sum_probs=207.5

Q ss_pred             eeecccCceEEEEEEeCC--C---CEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          275 RLLGDSKTGGTYSGILPD--G---SRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~--g---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      +.||+|+||.||+|.+..  +   ..||||..+..   ......+|++|+++|.+++|||||+++|++....+.++|||+
T Consensus       163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl  242 (474)
T KOG0194|consen  163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL  242 (474)
T ss_pred             ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence            568999999999999643  2   23899999853   355678999999999999999999999999999999999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      |.||+|.++|....   ..++..+++.++.+.|.||+|||++   ++|||||.++|+|++.++.+||+|||+++......
T Consensus       243 ~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~  316 (474)
T KOG0194|consen  243 CNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV  316 (474)
T ss_pred             cCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence            99999999998632   3699999999999999999999999   99999999999999999999999999998764222


Q ss_pred             cccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      ....  ...-+.+|+|||.+..+.||.++|||||||++||+++ |..||.+.....   +..++   ...+.        
T Consensus       317 ~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI---~~~~~--------  380 (474)
T KOG0194|consen  317 MKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKI---VKNGY--------  380 (474)
T ss_pred             eccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHH---HhcCc--------
Confidence            2111  1125789999999999999999999999999999999 899998765431   11111   01000        


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCC
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV  555 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  555 (557)
                           +...+...+..+..++.+||..+|++||||.++.+.|+.+.....
T Consensus       381 -----r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  381 -----RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             -----cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                 111122445678899999999999999999999999988776543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=356.46  Aligned_cols=238  Identities=26%  Similarity=0.460  Sum_probs=202.1

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHHH
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW  355 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  355 (557)
                      -||+|+.|.||+|.+ .++.||||+++.-.       ..+++.|++|+||||+.+.|+|....-.+||||||+.|.|...
T Consensus       131 WlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  131 WLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence            579999999999999 78899999885321       3468899999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeecC
Q 008698          356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG  435 (557)
Q Consensus       356 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~  435 (557)
                      |+.    ++.++......+..+||.||+|||.+   .|||||||.-||||+.+..+||+|||-++.....  . ....+.
T Consensus       203 Lka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--S-TkMSFa  272 (904)
T KOG4721|consen  203 LKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--S-TKMSFA  272 (904)
T ss_pred             Hhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--h-hhhhhh
Confidence            964    56789999999999999999999999   9999999999999999999999999999876543  1 222345


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCc
Q 008698          436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE  515 (557)
Q Consensus       436 gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  515 (557)
                      ||..|||||++...+.+.|+||||||||||||+||..||.+.+....    -|  .         +-...+    ....+
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----Iw--G---------VGsNsL----~LpvP  333 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IW--G---------VGSNSL----HLPVP  333 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EE--e---------ccCCcc----cccCc
Confidence            99999999999999999999999999999999999999988765321    01  0         001111    22335


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          516 AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       516 ~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ..|++.+.-|+++||+..|..||++.+|+..|+-.
T Consensus       334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            56788899999999999999999999999999743

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-44  Score=360.56  Aligned_cols=251  Identities=29%  Similarity=0.469  Sum_probs=214.3

Q ss_pred             eeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      ..||-|.||.||.|+|+. .-.||||.++.+. ...++|+.|+.+|+.++|||+|+|+|+|....++|||.|||.+|+|.
T Consensus       273 hKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLL  351 (1157)
T KOG4278|consen  273 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLL  351 (1157)
T ss_pred             eccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHH
Confidence            457999999999999865 5689999998764 45789999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +||+...+  ..++....+.++.||++||.||..+   ++|||||.++|+|+.++..+|++||||++++..+.+......
T Consensus       352 dYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGA  426 (1157)
T KOG4278|consen  352 DYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGA  426 (1157)
T ss_pred             HHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCc
Confidence            99987543  4588888999999999999999999   999999999999999999999999999999876655443332


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                       .-++.|.|||.+....++.|+|||+|||+||||.| |..||.+.+-..       +..++..+            ...+
T Consensus       427 -KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLEkg------------yRM~  486 (1157)
T KOG4278|consen  427 -KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLEKG------------YRMD  486 (1157)
T ss_pred             -cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHhcc------------cccc
Confidence             25789999999999999999999999999999999 999998765321       11111111            1112


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                       .+.+|++.+++||..||+.+|++||++.|+-+.|+.+-.
T Consensus       487 -~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  487 -GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             -CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence             245688899999999999999999999999999987654

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-42  Score=356.05  Aligned_cols=259  Identities=27%  Similarity=0.385  Sum_probs=201.2

Q ss_pred             CCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeC-CceEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-GDRYI  342 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~-~~~~l  342 (557)
                      ...+.||+|+||.||++..      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... +..++
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l   89 (338)
T cd05102          10 RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMV   89 (338)
T ss_pred             eeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEE
Confidence            3456789999999999974      235689999997543 23456789999999999 899999999988764 45789


Q ss_pred             EEecCCCCChHHHhccCCC----------------------------------------------------------CCC
Q 008698          343 VYEFVVNGPLDRWLHHIPR----------------------------------------------------------GGR  364 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~----------------------------------------------------------~~~  364 (557)
                      ||||+++|+|.+++.....                                                          ...
T Consensus        90 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (338)
T cd05102          90 IVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKS  169 (338)
T ss_pred             EEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccC
Confidence            9999999999999864211                                                          013


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeecCccccccccc
Q 008698          365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE  444 (557)
Q Consensus       365 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE  444 (557)
                      .+++..+..++.||++||.|||+.   +|+||||||+|||++.++.+||+|||+++...............++..|+|||
T Consensus       170 ~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  246 (338)
T cd05102         170 PLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE  246 (338)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence            588889999999999999999999   99999999999999999999999999998654332222222233678899999


Q ss_pred             cccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHH
Q 008698          445 FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVV  523 (557)
Q Consensus       445 ~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~  523 (557)
                      ++.+..++.++|||||||++|||++ |..||.......  .+..    ......     .        ...+...+..+.
T Consensus       247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~----~~~~~~-----~--------~~~~~~~~~~l~  307 (338)
T cd05102         247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQ----RLKDGT-----R--------MRAPENATPEIY  307 (338)
T ss_pred             HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHH----HHhcCC-----C--------CCCCCCCCHHHH
Confidence            9998899999999999999999997 999987643211  1110    011100     0        001122345689


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          524 DLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       524 ~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      +++.+||+.||++|||+.+|++.|+++.+
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.8e-41  Score=390.04  Aligned_cols=263  Identities=27%  Similarity=0.482  Sum_probs=210.4

Q ss_pred             cCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      ..+.+. .+||+|+||.||+|.. .+|..||||+++.....    ..+|++.+++++||||++++|++.+.+..++||||
T Consensus       690 ~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        690 SSLKEE-NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hhCCcc-cEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            344443 4679999999999996 57899999998654321    23457889999999999999999999999999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++|+|.++++.       ++|..+.+++.|||+||+|||+.+.++|+||||||+||+++.++..++. ||.........
T Consensus       765 ~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~  836 (968)
T PLN00113        765 IEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT  836 (968)
T ss_pred             CCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC
Confidence            999999999952       8999999999999999999997767799999999999999999888876 66554332111


Q ss_pred             cccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                            ...+++.|+|||++.+..++.++|||||||++|||+||+.||..... ....+.+|+............+|+.+
T Consensus       837 ------~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (968)
T PLN00113        837 ------KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSI  909 (968)
T ss_pred             ------CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccc
Confidence                  11378999999999999999999999999999999999999854322 23345566655444444555666655


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      ...  ...+.++..++.+++.+||+.+|++||||+||++.|+++.+
T Consensus       910 ~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        910 RGD--VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             cCC--CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            331  12234566788999999999999999999999999998866

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=340.93  Aligned_cols=249  Identities=24%  Similarity=0.409  Sum_probs=197.3

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC--ceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~~~~g  350 (557)
                      .+.||+|+||+||++...+ |...|||.+...+....+.+.+|+.+|.+++|||||+.+|......  ..+++|||+++|
T Consensus        22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G  101 (313)
T KOG0198|consen   22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG  101 (313)
T ss_pred             hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence            4578999999999999755 8999999987654333677899999999999999999999855444  589999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCcEEeeccCCccCCc-cccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPW-EVMQ  428 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~-~~~~  428 (557)
                      +|.+++....  + .|++..+..+..||++||.|||++   +|||+||||+|||++. ++.+||+|||+++.... ....
T Consensus       102 sL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen  102 SLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             cHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence            9999997532  2 699999999999999999999999   9999999999999999 79999999999987653 1111


Q ss_pred             cceeecCccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC-CcccchhHHHhhhhhhhccccccccCccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAV-DSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvil~el~tG~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      .......||+.|||||++..+. ...++|||||||++.||+||++|+... ..      .++........     .-   
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~------~~~~~~ig~~~-----~~---  241 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE------AEALLLIGRED-----SL---  241 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch------HHHHHHHhccC-----CC---
Confidence            2222345999999999998643 345999999999999999999998763 11      11111111110     00   


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  547 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L  547 (557)
                          + ..+...+....+++..|+..+|+.|||++++++.-
T Consensus       242 ----P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  242 ----P-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ----C-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence                1 11233556788999999999999999999999843

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-42  Score=338.48  Aligned_cols=266  Identities=26%  Similarity=0.375  Sum_probs=200.2

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHh--hcCCCcEEeeeeeeeeCC----ceEEEEecCCC
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFA--RLHHPNLVAVKGCCYDHG----DRYIVYEFVVN  349 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~H~niv~l~g~~~~~~----~~~lV~E~~~~  349 (557)
                      ++|+|.||.||+|.+ +++.||||++..   +..+.|.+|-++.+  .++|+||+++++.-....    +.+||+||.+.
T Consensus       217 li~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k  292 (534)
T KOG3653|consen  217 LIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK  292 (534)
T ss_pred             HhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence            689999999999999 679999999974   35567877766655  468999999999865544    78999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK------VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      |+|.+||..     ..++|....+|+..+++||+|||+.      .+|+|+|||||++||||.+|+++.|+|||+|..+.
T Consensus       293 GsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~  367 (534)
T KOG3653|consen  293 GSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE  367 (534)
T ss_pred             CcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence            999999975     5799999999999999999999954      47789999999999999999999999999998887


Q ss_pred             ccccccceeecCccccccccccccCC-CCC-----chhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHH-hhhhh----
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVYRN-ELT-----TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE-WATPL----  492 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s-----~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~-~~~~~----  492 (557)
                      ............||.+|||||++.+. .+.     .+.||||+|.|||||+++...++.....+.+--++ .+...    
T Consensus       368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e  447 (534)
T KOG3653|consen  368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE  447 (534)
T ss_pred             CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence            66554444446699999999999763 222     46899999999999999876654221112221111 00000    


Q ss_pred             -hhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          493 -VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       493 -~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                       ++.--+++...|.+.+....   ..-+..+.+.+..||+.||+.|.|+.-|-+++.++...
T Consensus       448 ~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  448 EMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             HHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence             00000111122222111111   13456788999999999999999999999988777653

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.2e-42  Score=341.63  Aligned_cols=247  Identities=19%  Similarity=0.332  Sum_probs=199.4

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhh---HHHHHHHHHHHhhcCCCcEEeeeeeeee----CCceEEEEecC
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYEFV  347 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~  347 (557)
                      ..||+|++|.||+|.+ +|+.||||+++......   .+.|.+|+.+|.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            3679999999999998 79999999997653322   4678899999999999999999999876    34678999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++..    ...+++.....++.|++.||.|||+..  +++||||||+|||+++++.+||+|||+++.......
T Consensus       105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~  178 (283)
T PHA02988        105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF  178 (283)
T ss_pred             CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccccc
Confidence            99999999964    346889999999999999999999732  788999999999999999999999999986543221


Q ss_pred             ccceeecCccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          428 QERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                           ...++..|+|||.+.+  ..++.++|||||||++|||+||+.||...+..+   +....   ....     ... 
T Consensus       179 -----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i---~~~~-----~~~-  241 (283)
T PHA02988        179 -----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLI---INKN-----NSL-  241 (283)
T ss_pred             -----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHH---HhcC-----CCC-
Confidence                 2237889999999976  678999999999999999999999998654321   11111   0000     000 


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                             ..+..++..+.+++.+||+.||++|||+++|++.|+.+..
T Consensus       242 -------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        242 -------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             -------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                   0112345679999999999999999999999999987643

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=332.72  Aligned_cols=236  Identities=22%  Similarity=0.330  Sum_probs=196.0

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      -++||+|+||.||.++.. +++.+|+|++++...   ...+...+|..+|.+++||.||.+...+.+.+.+|||+||+.|
T Consensus        30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G  109 (357)
T KOG0598|consen   30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG  109 (357)
T ss_pred             eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence            457899999999999854 589999999987632   3456788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |.|..+|++    ...+++..+.-++.+|+.||.|||++   +||||||||+|||||.+|+++|+||||++..-...  .
T Consensus       110 GeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~  180 (357)
T KOG0598|consen  110 GELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--D  180 (357)
T ss_pred             ccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC--C
Confidence            999999964    46699999999999999999999999   99999999999999999999999999998543332  2


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      .+.+.+||+.|||||++.+..|+..+|-||+|+++|||++|.+||...+....      .....+..         +   
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~------~~~I~~~k---------~---  242 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM------YDKILKGK---------L---  242 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH------HHHHhcCc---------C---
Confidence            23346799999999999999999999999999999999999999987654211      11111111         0   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCC
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRP  538 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP  538 (557)
                        ..++.-...+..+++...+..||++|.
T Consensus       243 --~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 --PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             --CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence              111112345688999999999999996

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.6e-40  Score=335.75  Aligned_cols=261  Identities=23%  Similarity=0.338  Sum_probs=199.9

Q ss_pred             CCeeecccCceEEEEEEeCC-----------------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeee
Q 008698          273 GNRLLGDSKTGGTYSGILPD-----------------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCC  334 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~  334 (557)
                      ..+.||+|+||.||++...+                 +..||+|.+.... .....+|.+|+.++.+++||||+++++++
T Consensus         9 ~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   88 (304)
T cd05096           9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC   88 (304)
T ss_pred             eeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence            34568999999999997532                 3369999987643 33456799999999999999999999999


Q ss_pred             eeCCceEEEEecCCCCChHHHhccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 008698          335 YDHGDRYIVYEFVVNGPLDRWLHHIPR---------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR  399 (557)
Q Consensus       335 ~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk  399 (557)
                      .+.+..++||||+++|+|.+++.....               ....+++..+..++.||+.||.|||+.   +|+|||||
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlk  165 (304)
T cd05096          89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLA  165 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCcc
Confidence            999999999999999999999864211               123578889999999999999999999   99999999


Q ss_pred             CCCeeeCCCCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCC
Q 008698          400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQAV  477 (557)
Q Consensus       400 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t--G~~p~~~~  477 (557)
                      |+|||++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++  +..||...
T Consensus       166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  245 (304)
T cd05096         166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL  245 (304)
T ss_pred             hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence            9999999999999999999976543322222222335789999999988899999999999999999997  55677654


Q ss_pred             CcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          478 DSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                      +..   ............... ...         ...+..++..+.+++.+||+.+|++|||+++|.+.|++
T Consensus       246 ~~~---~~~~~~~~~~~~~~~-~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         246 TDE---QVIENAGEFFRDQGR-QVY---------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CHH---HHHHHHHHHhhhccc-ccc---------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            322   122222111111000 000         00011244678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.9e-42  Score=336.59  Aligned_cols=248  Identities=30%  Similarity=0.499  Sum_probs=193.6

Q ss_pred             eeecccCceEEEEEEeC-----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          275 RLLGDSKTGGTYSGILP-----DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      +.||.|.||.||+|.+.     .+..|+||.++... ....+.|.+|++.+.+++||||++++|++...+..++|+||++
T Consensus         5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~   84 (259)
T PF07714_consen    5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP   84 (259)
T ss_dssp             EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred             eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence            46899999999999986     25689999996543 3447899999999999999999999999998888999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.++|...  ....+++.++..|+.|||.||.|||++   +++|+||+++|||++.++.+||+|||++.........
T Consensus        85 ~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   85 GGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             TEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            99999999873  235699999999999999999999999   9999999999999999999999999999876322222


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      ...........|+|||.+....++.++||||||+++|||+| |+.|+...+...   +.+..    .....         
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~----~~~~~---------  223 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKL----KQGQR---------  223 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHH----HTTEE---------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccc----ccccc---------
Confidence            11222236789999999998889999999999999999999 788887653321   11111    11100         


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  547 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L  547 (557)
                          ...+..++..+.+++.+||+.+|++||||++|++.|
T Consensus       224 ----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 ----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                001122445688999999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=327.62  Aligned_cols=259  Identities=20%  Similarity=0.300  Sum_probs=205.6

Q ss_pred             CCCCeeecccCceEEEEEE-eCCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          271 SEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      ++....||.|..++||+|. .+.+..||||++.-+. ....+.+++|+..|+.++||||++++..|..+..+|+||.||.
T Consensus        28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa  107 (516)
T KOG0582|consen   28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA  107 (516)
T ss_pred             eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence            3445578999999999998 4678999999997553 2336889999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +||+.+.+...-.  ..+++..+..|++++++||.|||.+   |.||||||+.||||+.+|.+||+|||.+..+......
T Consensus       108 ~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R  182 (516)
T KOG0582|consen  108 GGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR  182 (516)
T ss_pred             CCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence            9999999976443  3499999999999999999999999   9999999999999999999999999998766544321


Q ss_pred             cc-e-eecCccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          429 ER-T-VMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       429 ~~-~-~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      .. . ....||+.|||||++..  ..|+.|+||||||++..||.+|..||....+..  .+..    .++.. ..- .+ 
T Consensus       183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~----tLqn~-pp~-~~-  253 (516)
T KOG0582|consen  183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLL----TLQND-PPT-LL-  253 (516)
T ss_pred             eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHH----HhcCC-CCC-cc-
Confidence            11 1 33459999999999654  468999999999999999999999999876532  1111    01110 000 00 


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       . +.......+.....+.+++..|++.||++|||++++++
T Consensus       254 -t-~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 -T-SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             -c-ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence             0 00011112234558899999999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-41  Score=335.48  Aligned_cols=261  Identities=23%  Similarity=0.311  Sum_probs=200.6

Q ss_pred             eecccCceEEEEEE-eCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~g  350 (557)
                      .||+|.||.||+++ ..+|+.||+|+++.+.  .....-..+|+.+|++|.||||++|.+...+.  ..+|||+|||++ 
T Consensus       124 kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-  202 (560)
T KOG0600|consen  124 KIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-  202 (560)
T ss_pred             HhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-
Confidence            57999999999999 4679999999997664  33345678999999999999999999998876  689999999976 


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|..++..   ..-.|++.++..++.|++.||+|+|++   +|+|||||.+|||||+++.+||+|||||++.........
T Consensus       203 DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~  276 (560)
T KOG0600|consen  203 DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPY  276 (560)
T ss_pred             hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCccc
Confidence            78888763   345799999999999999999999999   999999999999999999999999999998765543332


Q ss_pred             eeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhhhhccc----c--cccc
Q 008698          431 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHR----Y--LELL  502 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~----~--~~~~  502 (557)
                      +. ..-|..|.|||.+.+. .|+.+.|+||.||||.||++|++.|.+.++.+.. .++..........+    +  ...+
T Consensus       277 T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~  355 (560)
T KOG0600|consen  277 TS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIF  355 (560)
T ss_pred             cc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccccc
Confidence            22 2268999999999885 7999999999999999999999999987654321 12221111000000    0  0111


Q ss_pred             CcccccCCCC--CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          503 DPLISSLSSD--IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       503 d~~l~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+... ....  ..-...+...++|+..+|..||.+|.|+.++++
T Consensus       356 kp~~~-y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  356 KPQQP-YKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCCCc-ccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            11100 0000  001223456889999999999999999999985

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.1e-40  Score=346.60  Aligned_cols=255  Identities=25%  Similarity=0.387  Sum_probs=199.3

Q ss_pred             CeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      .+.||+|+||.||++..      .++..||||+++... ....+.+.+|+.++..+ +||||+++++++...+..++|||
T Consensus        40 ~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E  119 (375)
T cd05104          40 GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITE  119 (375)
T ss_pred             hheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeeh
Confidence            45789999999999873      235689999997542 33456789999999999 89999999999999999999999


Q ss_pred             cCCCCChHHHhccCCC----------------------------------------------------------------
Q 008698          346 FVVNGPLDRWLHHIPR----------------------------------------------------------------  361 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~----------------------------------------------------------------  361 (557)
                      |+++|+|.+++.....                                                                
T Consensus       120 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (375)
T cd05104         120 YCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDV  199 (375)
T ss_pred             hccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccccc
Confidence            9999999999864211                                                                


Q ss_pred             -------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          362 -------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       362 -------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                             ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.+..+||+|||+++..............
T Consensus       200 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  276 (375)
T cd05104         200 TSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA  276 (375)
T ss_pred             HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCC
Confidence                   112578899999999999999999999   9999999999999999999999999999765433221111122


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      .++..|+|||.+.+..++.++|||||||++|||+| |..||......  ..+...    ...+.     ...        
T Consensus       277 ~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~----~~~~~-----~~~--------  337 (375)
T cd05104         277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKM----IKEGY-----RML--------  337 (375)
T ss_pred             CCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHH----HHhCc-----cCC--------
Confidence            35678999999999999999999999999999998 88888654321  111111    11110     000        


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      .+...+.++.+++.+||+.||++|||+.+|++.|++.
T Consensus       338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            0111235688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.6e-40  Score=329.17  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=200.8

Q ss_pred             CCeeecccCceEEEEEEeC----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          273 GNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      ..++||+|+||.||+|.+.    .+..||+|.++... ......|.+|+..+.+++||||+++++++...+..++||||+
T Consensus         9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   88 (266)
T cd05064           9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYM   88 (266)
T ss_pred             EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeC
Confidence            3457899999999999853    35689999997653 334567899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++...   ...+++.+++.++.|++.||+|||+.   +++||||||+|||++.++.+|++|||.+........
T Consensus        89 ~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          89 SNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             CCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence            999999998642   24689999999999999999999999   999999999999999999999999998765432211


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      . ......++..|+|||.+.+..++.++||||||+++||+++ |..||...+...   +....    ...     ..   
T Consensus       163 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~-----~~---  226 (266)
T cd05064         163 Y-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAV----EDG-----FR---  226 (266)
T ss_pred             h-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCC-----CC---
Confidence            1 1112225678999999999999999999999999999876 999997654321   11110    000     00   


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                           ...+..++..+.+++.+||+.+|++||++++|++.|+++
T Consensus       227 -----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 -----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                 011223456789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=341.78  Aligned_cols=252  Identities=28%  Similarity=0.430  Sum_probs=212.4

Q ss_pred             CCeeecccCceEEEEEEeCC---CC--EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          273 GNRLLGDSKTGGTYSGILPD---GS--RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~~---g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      .+++||.|-||.||+|++.+   |.  .||||+-+.+ .....+.|++|..+|++++||||++++|+|.+. +.++|||.
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL  471 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMEL  471 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEec
Confidence            35678999999999999643   33  5899998874 455678899999999999999999999998764 68999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      ++.|-|..||..   +...|+......++.||..||+|||+.   ++|||||.++|||+..+.-+|++|||+++.+....
T Consensus       472 ~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  472 APLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             ccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            999999999985   345699999999999999999999999   99999999999999999999999999999988776


Q ss_pred             cccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      +..... ..-++.|||||.+....+|.+||||-|||.+||+++ |..||++....+.-                -    .
T Consensus       546 yYkaS~-~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI----------------~----~  604 (974)
T KOG4257|consen  546 YYKASR-GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI----------------G----H  604 (974)
T ss_pred             hhhccc-cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE----------------E----E
Confidence            655443 336889999999999999999999999999999998 99999876432210                0    1


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      +....+...+..|+..++.|+.+||..+|.+||++.++...|+.+.+
T Consensus       605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            11122334456788899999999999999999999999998876543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-41  Score=336.65  Aligned_cols=244  Identities=23%  Similarity=0.343  Sum_probs=201.5

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .++||+|+|++|++++. ..++.+|||++.+.-   ....+-+..|-..|.+| .||.|++|+..|.+...+|.|+||++
T Consensus        78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~  157 (604)
T KOG0592|consen   78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP  157 (604)
T ss_pred             hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence            34689999999999995 458999999997652   22234567788889999 89999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.++|.+.    ..|++...+.++.||+.||+|||++   |||||||||+|||||.|+++||+|||-|+.+......
T Consensus       158 nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  158 NGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             CCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            99999999763    5699999999999999999999999   9999999999999999999999999999987644222


Q ss_pred             -----------cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          429 -----------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       429 -----------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                                 .......||..|.+||++.....+..+|+|+||||||.|+.|++||.+.++.-   +++.+.       
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---iFqkI~-------  300 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---IFQKIQ-------  300 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---HHHHHH-------
Confidence                       11133569999999999999999999999999999999999999998765421   111111       


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        + ++-        ..+.+.++.+.+|+.+.|..||++|+|.++|-+
T Consensus       301 --~-l~y--------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  301 --A-LDY--------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             --H-hcc--------cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence              0 111        112234467889999999999999999998876

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=342.13  Aligned_cols=244  Identities=24%  Similarity=0.409  Sum_probs=206.6

Q ss_pred             CeeecccCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ...||+|+.|.||.+. ..+++.||||++.......++-+++|+.+|+..+|+|||.++.-+...+.+++|||||++|+|
T Consensus       278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL  357 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL  357 (550)
T ss_pred             hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence            3457999999999998 456889999999888777778899999999999999999999999888999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+.+..     ..+++.++..|..++++||+|||.+   +|+|||||.+|||++.++.+||+|||++........  ...
T Consensus       358 TDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~  427 (550)
T KOG0578|consen  358 TDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRS  427 (550)
T ss_pred             hhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccc
Confidence            999865     4499999999999999999999999   999999999999999999999999999987765543  223


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...||+.|||||++....|.+|.||||||++++||+-|.+||-..++.  +.+...+.    .      -.+.+      
T Consensus       428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--rAlyLIa~----n------g~P~l------  489 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIAT----N------GTPKL------  489 (550)
T ss_pred             cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH--HHHHHHhh----c------CCCCc------
Confidence            344999999999999999999999999999999999999999875442  11111111    0      11111      


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..+...+..+.+++.+||+.|+++||++.|+|+
T Consensus       490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            122345677999999999999999999999997

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-40  Score=344.23  Aligned_cols=256  Identities=26%  Similarity=0.398  Sum_probs=199.4

Q ss_pred             CeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      .+.||+|+||.||++..      .++..||||.++... ......+.+|+.+++.+ +|+||+++++++...+..++|||
T Consensus        43 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~e  122 (374)
T cd05106          43 GKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITE  122 (374)
T ss_pred             hheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHh
Confidence            45679999999999873      234589999997543 33456788999999999 89999999999999999999999


Q ss_pred             cCCCCChHHHhccCCC----------------------------------------------------------------
Q 008698          346 FVVNGPLDRWLHHIPR----------------------------------------------------------------  361 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~----------------------------------------------------------------  361 (557)
                      |+++|+|.++++....                                                                
T Consensus       123 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (374)
T cd05106         123 YCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEED  202 (374)
T ss_pred             hccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhc
Confidence            9999999999854210                                                                


Q ss_pred             --CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeecCcccc
Q 008698          362 --GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG  439 (557)
Q Consensus       362 --~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~  439 (557)
                        ....+++.++++++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++...............++..
T Consensus       203 ~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~  279 (374)
T cd05106         203 TEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK  279 (374)
T ss_pred             cCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccc
Confidence              113578899999999999999999999   999999999999999999999999999976543322111122235678


Q ss_pred             ccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHH
Q 008698          440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGV  518 (557)
Q Consensus       440 y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~  518 (557)
                      |+|||++.+..++.++|||||||++|||++ |+.||.......  .+...    ....     .....        +...
T Consensus       280 y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~----~~~~-----~~~~~--------~~~~  340 (374)
T cd05106         280 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKM----VKRG-----YQMSR--------PDFA  340 (374)
T ss_pred             eeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHH----HHcc-----cCccC--------CCCC
Confidence            999999998899999999999999999997 999987643211  11110    0000     00000        0112


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          519 VQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       519 ~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      +..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus       341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            356889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=335.94  Aligned_cols=247  Identities=24%  Similarity=0.336  Sum_probs=201.1

Q ss_pred             CCCCCCeeecccCceEEEEEEe-CCCCEEEEEEeccc----ch-hhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceE
Q 008698          269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS----SF-QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRY  341 (557)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~  341 (557)
                      +.+...+.||+|+||.|+.|.. .+|..||+|++...    .. ...+.+.+|+.++++++ ||||++++.++......+
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~   96 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY   96 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence            3455566789999999999975 46899999977653    12 23456678999999998 999999999999999999


Q ss_pred             EEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCcEEeeccCCc
Q 008698          342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSK  420 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~~  420 (557)
                      +||||+.+|+|.+++..    ...+.+.....++.|+++|++|+|++   +|+||||||+|||+|.+ +++||+|||++.
T Consensus        97 ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   97 IVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999975    35688899999999999999999999   99999999999999999 999999999999


Q ss_pred             cCCccccccceeecCccccccccccccCCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccc
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNE-LT-TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  498 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (557)
                      ...  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||++.+..   .+...    ...+  
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l~~k----i~~~--  238 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NLYRK----IRKG--  238 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HHHHH----HhcC--
Confidence            774  1122334456999999999999877 75 7899999999999999999999874432   11111    0000  


Q ss_pred             ccccCcccccCCCCCCcHHH-HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          499 LELLDPLISSLSSDIPEAGV-VQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       499 ~~~~d~~l~~~~~~~~~~~~-~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       +          .. .+... ..++..|+.+|+..+|.+|+|+.+|++
T Consensus       239 -~----------~~-~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  239 -E----------FK-IPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             -C----------cc-CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence             0          00 11122 567899999999999999999999993

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-41  Score=331.88  Aligned_cols=260  Identities=21%  Similarity=0.279  Sum_probs=197.7

Q ss_pred             eecccCceEEEEEEe-CCCCEEEEEEecccchhhHHH--HHHHHHHHhhcC-CCcEEeeeeeeeeCC-ceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKE--FYSEIGRFARLH-HPNLVAVKGCCYDHG-DRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-H~niv~l~g~~~~~~-~~~lV~E~~~~g  350 (557)
                      .||.|.||+||+|+. .+|..||||+++..-. ..++  =++|++.|.+|+ ||||+++..++.+.+ .+++|||||+ -
T Consensus        17 klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~   94 (538)
T KOG0661|consen   17 KLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-C   94 (538)
T ss_pred             HhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-h
Confidence            369999999999995 4689999999976522 2333  368999999998 999999999999887 9999999995 5


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|..++.++   ++.|++..++.|+.||++||+|+|.+   |+.||||||+|||+..+..+||+|||+||..........
T Consensus        95 NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTe  168 (538)
T KOG0661|consen   95 NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTE  168 (538)
T ss_pred             hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCCCcch
Confidence            899998763   57899999999999999999999999   999999999999999999999999999997754433221


Q ss_pred             eeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhhhhc-----cccccccC
Q 008698          431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQS-----HRYLELLD  503 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~d  503 (557)
                         ...|..|+|||++.. +.|+.+.|+||+|||++|+.+-++.|.+.++.+.. .+.+....-.+.     ..+...+.
T Consensus       169 ---YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  169 ---YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             ---hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence               227889999998875 67899999999999999999999998876543211 111111100000     00111111


Q ss_pred             ccc---ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          504 PLI---SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       504 ~~l---~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      -.+   .+......-.....+..+++.+|++.||.+|||+++.++.
T Consensus       246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            111   0000000011256788999999999999999999999973

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.9e-41  Score=313.11  Aligned_cols=259  Identities=19%  Similarity=0.250  Sum_probs=197.2

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+|+|+||.||+.+.+ +|+.||||++..+.  ..-.+-.++|+++|++++|+|+|.++.+|......+||+||++..-|
T Consensus         9 kvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL   88 (396)
T KOG0593|consen    9 KVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVL   88 (396)
T ss_pred             ccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHH
Confidence            4599999999999965 49999999997653  33346678999999999999999999999999999999999987555


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .++ ..   ....++...+.+++.|++.|+.|+|++   ++|||||||+||||+.++.+||+|||+|+.+......... 
T Consensus        89 ~eL-e~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD-  160 (396)
T KOG0593|consen   89 HEL-ER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD-  160 (396)
T ss_pred             HHH-Hh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh-
Confidence            443 32   335589999999999999999999999   9999999999999999999999999999987643222211 


Q ss_pred             ecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHH--------hhhhhhhc-ccccccc
Q 008698          433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE--------WATPLVQS-HRYLELL  502 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~--------~~~~~~~~-~~~~~~~  502 (557)
                       ...|..|.|||.+.+ -+|...+||||.||++.||++|.+-|.+.++.+..-++.        ....+... ..+..+.
T Consensus       161 -YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~  239 (396)
T KOG0593|consen  161 -YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR  239 (396)
T ss_pred             -hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence             227899999999988 589999999999999999999998887766543221111        11111111 1111111


Q ss_pred             Cccccc---CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          503 DPLISS---LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       503 d~~l~~---~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      -|....   .+...  .....-+++++..|++.||.+|++-+|++.
T Consensus       240 lP~~~~~epLe~k~--p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  240 LPEPEHPEPLERKY--PKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCCCCccchhhhc--ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111110   00111  123456889999999999999999999885

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.1e-39  Score=325.89  Aligned_cols=253  Identities=28%  Similarity=0.466  Sum_probs=202.0

Q ss_pred             eeecccCceEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          275 RLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +.||+|+||.||+|....      ...||+|.++... .....+|.+|+..+.+++||||+++++++...+..+++|||+
T Consensus        11 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~   90 (283)
T cd05048          11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYL   90 (283)
T ss_pred             hcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecC
Confidence            357999999999998633      2579999987543 334567899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEee
Q 008698          348 VNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG  415 (557)
Q Consensus       348 ~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  415 (557)
                      ++|+|.+++.....            ....+++..++.++.|++.||+|||+.   +++|+||||+|||+++++.+||+|
T Consensus        91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~d  167 (283)
T cd05048          91 AHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISD  167 (283)
T ss_pred             CCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEECC
Confidence            99999999865321            114588999999999999999999999   999999999999999999999999


Q ss_pred             ccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhh
Q 008698          416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ  494 (557)
Q Consensus       416 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~  494 (557)
                      ||+++...............+++.|+|||.+.+..++.++|||||||++|||+| |..||.+....+   +...    +.
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~----i~  240 (283)
T cd05048         168 FGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEM----IR  240 (283)
T ss_pred             CcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HH
Confidence            999976543322222222336788999999988899999999999999999998 999987654321   1111    11


Q ss_pred             ccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       495 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ...        .     ...+..++.++.+|+.+||+.+|.+||++++|++.|+.+
T Consensus       241 ~~~--------~-----~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         241 SRQ--------L-----LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             cCC--------c-----CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            110        0     011233557799999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-39  Score=326.55  Aligned_cols=247  Identities=19%  Similarity=0.273  Sum_probs=196.9

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++.. .+|+.||||.+.....   .....+.+|+.++.+++|+||+++++++.+.+..++||||+++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence            35689999999999986 4689999999865422   2335678999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++......... 
T Consensus        85 g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  158 (285)
T cd05631          85 GDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV-  158 (285)
T ss_pred             CcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee-
Confidence            9999887542  234689999999999999999999999   9999999999999999999999999999765332211 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....||..|+|||++.+..++.++|||||||++|||++|+.||...........   ......        ..     
T Consensus       159 --~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~--------~~-----  220 (285)
T cd05631         159 --RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVK--------ED-----  220 (285)
T ss_pred             --cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhh--------cc-----
Confidence              123489999999999999999999999999999999999999986543211110   000000        00     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~  545 (557)
                       ....+...+..+.+|+.+||+.||++||+     ++++++
T Consensus       221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence             00111223456889999999999999997     788886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.1e-40  Score=332.96  Aligned_cols=254  Identities=21%  Similarity=0.374  Sum_probs=200.1

Q ss_pred             CeeecccCceEEEEEEeC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .+.||+|+||.||+|.+. +|.    .||+|.++... .....++.+|+.+++.++||||++++|++... ..++|+||+
T Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~   90 (316)
T cd05108          12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM   90 (316)
T ss_pred             eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecC
Confidence            446799999999999853 333    48999987543 34457899999999999999999999998765 567999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++...   ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        91 ~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  164 (316)
T cd05108          91 PFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK  164 (316)
T ss_pred             CCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence            999999998742   24588999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      .........+..|+|||++.+..++.++|||||||++|||+| |..||.+.........       .....       ..
T Consensus       165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~-------~~~~~-------~~  230 (316)
T cd05108         165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGE-------RL  230 (316)
T ss_pred             ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HhCCC-------CC
Confidence            221122224678999999999999999999999999999998 9999876433211111       11000       00


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                            ..+..+...+.+++.+||+.+|.+||++.+++..|..+...+
T Consensus       231 ------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         231 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence                  001123456889999999999999999999999998776644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.2e-39  Score=340.59  Aligned_cols=259  Identities=29%  Similarity=0.408  Sum_probs=201.8

Q ss_pred             CCCeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV  343 (557)
                      ...++||+|+||.||+|+..      .+..||||+++... ....+.+.+|+.++.++. ||||+++++++.+.+..++|
T Consensus        40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv  119 (400)
T cd05105          40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYII  119 (400)
T ss_pred             ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEE
Confidence            33457899999999999852      13479999997543 334567999999999995 99999999999999999999


Q ss_pred             EecCCCCChHHHhccCCC--------------------------------------------------------------
Q 008698          344 YEFVVNGPLDRWLHHIPR--------------------------------------------------------------  361 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~--------------------------------------------------------------  361 (557)
                      |||+++|+|.++|.....                                                              
T Consensus       120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (400)
T cd05105         120 TEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASK  199 (400)
T ss_pred             EEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhh
Confidence            999999999998864210                                                              


Q ss_pred             ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCc
Q 008698          362 ------------------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA  411 (557)
Q Consensus       362 ------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~  411 (557)
                                                    ....+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~  276 (400)
T cd05105         200 YSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIV  276 (400)
T ss_pred             hhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEE
Confidence                                          113478888999999999999999999   99999999999999999999


Q ss_pred             EEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhh
Q 008698          412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWAT  490 (557)
Q Consensus       412 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~  490 (557)
                      ||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......  .+..   
T Consensus       277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~~---  351 (400)
T cd05105         277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFYN---  351 (400)
T ss_pred             EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHHH---
Confidence            9999999976543222212222236788999999998889999999999999999997 889987543211  0110   


Q ss_pred             hhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       491 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                       .....     ..        ...+...+..+.+++.+||+.+|++|||+.+|++.|+++.+
T Consensus       352 -~~~~~-----~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         352 -KIKSG-----YR--------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             -HHhcC-----CC--------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence             00000     00        00112345678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.9e-39  Score=331.99  Aligned_cols=261  Identities=23%  Similarity=0.382  Sum_probs=199.4

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||++... +|..||+|.+... .......+.+|+.++.+++||||+++++++...+..++||||+++|+
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   89 (331)
T cd06649          10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   89 (331)
T ss_pred             EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence            346799999999999975 5889999998754 23345679999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++..    ...+++..+..++.|++.||.|||+..  +|+||||||+|||++.++.+||+|||++........    
T Consensus        90 L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----  159 (331)
T cd06649          90 LDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----  159 (331)
T ss_pred             HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccccc----
Confidence            9999864    245889999999999999999999851  699999999999999999999999999876543221    


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhc--cc------------
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS--HR------------  497 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~--~~------------  497 (557)
                      ....|+..|+|||++.+..++.++|||||||++|||+||+.||...+..+.......  +....  ..            
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  237 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSISPRPRPPG  237 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccCccccccc
Confidence            123489999999999988999999999999999999999999976543221111100  00000  00            


Q ss_pred             ---------------cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          498 ---------------YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       498 ---------------~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                                     ..+.++..........+......++.+++.+||+.||++|||+++|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                           0000000000000111111245678999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.3e-39  Score=321.50  Aligned_cols=249  Identities=26%  Similarity=0.415  Sum_probs=201.5

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      +.||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..++||||+++|+|.+
T Consensus        12 ~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   90 (261)
T cd05072          12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLD   90 (261)
T ss_pred             eecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHH
Confidence            4579999999999998888999999986543 345789999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++...  ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........... ...
T Consensus        91 ~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~-~~~  164 (261)
T cd05072          91 FLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR-EGA  164 (261)
T ss_pred             HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc-CCC
Confidence            98652  234688899999999999999999998   999999999999999999999999999986643322111 112


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      .++..|+|||++.+..++.++||||||+++|||+| |..||.......   ....    ....     ...        .
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~----~~~~-----~~~--------~  224 (261)
T cd05072         165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSA----LQRG-----YRM--------P  224 (261)
T ss_pred             ccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHH----HHcC-----CCC--------C
Confidence            25678999999988889999999999999999999 999986543221   1111    1100     000        0


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      .....+..+.+++.+|++.+|++||+++++.+.|+++
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            0112345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.3e-39  Score=318.77  Aligned_cols=246  Identities=25%  Similarity=0.432  Sum_probs=198.3

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      +.||+|+||.||++...++..+|+|.+.... ....++.+|+.++++++||||+++++++.+.+..++||||+++|+|.+
T Consensus        10 ~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~   88 (256)
T cd05114          10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN   88 (256)
T ss_pred             eEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence            4579999999999999888899999986543 335678999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++....   ..+++..+..++.|++.||.|||++   +++||||||+||++++++.+||+|||+++.......... ...
T Consensus        89 ~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~-~~~  161 (256)
T cd05114          89 YLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS-SGA  161 (256)
T ss_pred             HHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc-CCC
Confidence            986422   3589999999999999999999999   999999999999999999999999999976543222111 112


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      .++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..   ......   .....   ...          
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i---~~~~~---~~~----------  222 (256)
T cd05114         162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMI---SRGFR---LYR----------  222 (256)
T ss_pred             CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---HCCCC---CCC----------
Confidence            25678999999988889999999999999999999 89998765432   111111   11000   000          


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                       +...+..+.+++.+||+.+|++||+++++++.|.
T Consensus       223 -~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         223 -PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             1112346899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-39  Score=320.00  Aligned_cols=250  Identities=29%  Similarity=0.481  Sum_probs=202.3

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus        11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   89 (261)
T cd05068          11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL   89 (261)
T ss_pred             EEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence            35679999999999998788899999997653 34567899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++....  ...+++.++..++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++.......... ..
T Consensus        90 ~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~  163 (261)
T cd05068          90 EYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR-EG  163 (261)
T ss_pred             HHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc-CC
Confidence            9996532  35689999999999999999999999   999999999999999999999999999987653222111 11


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...+..|+|||++.+..++.++||||||+++|||+| |+.||.......   +..    .....     ..        .
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~-----~~--------~  223 (261)
T cd05068         164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ----QVDQG-----YR--------M  223 (261)
T ss_pred             CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcC-----CC--------C
Confidence            113468999999998899999999999999999999 999987543211   111    00000     00        0


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ..+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            01122346789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.9e-39  Score=323.60  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=201.8

Q ss_pred             eeecccCceEEEEEEeCC------CCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          275 RLLGDSKTGGTYSGILPD------GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~------g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +.||+|+||.||+|...+      ++.||||.++..... ..+.+.+|++++.+++||||+++++++...+..++||||+
T Consensus        11 ~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   90 (280)
T cd05049          11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYM   90 (280)
T ss_pred             hhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecC
Confidence            357999999999998633      478999999765433 4578999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeecc
Q 008698          348 VNGPLDRWLHHIP----------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  417 (557)
Q Consensus       348 ~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  417 (557)
                      ++++|.+++....          .....+++.++..++.|++.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus        91 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g  167 (280)
T cd05049          91 EHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFG  167 (280)
T ss_pred             CCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCcc
Confidence            9999999997532          1234588999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhcc
Q 008698          418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH  496 (557)
Q Consensus       418 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (557)
                      +++...............+++.|+|||++.+..++.++||||||+++|||++ |..||...+...   .....    ...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~----~~~  240 (280)
T cd05049         168 MSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI----TQG  240 (280)
T ss_pred             cceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcC
Confidence            9975433222111112225788999999999999999999999999999999 999987654321   11111    010


Q ss_pred             ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       497 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                      .             ...++...+..+.+++.+||+.+|++||++.||++.|++
T Consensus       241 ~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         241 R-------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             C-------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            0             001112244678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.7e-40  Score=333.35  Aligned_cols=240  Identities=23%  Similarity=0.259  Sum_probs=195.0

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +||+|+||.||++... +|+.||||+++...   ......+.+|+.++.+++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            5799999999999864 68999999997542   2334567889999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++..    ...+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        82 L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~  152 (323)
T cd05571          82 LFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM  152 (323)
T ss_pred             HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence            9998864    35689999999999999999999999   999999999999999999999999999875322211  12


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ....||+.|+|||.+.+..++.++|||||||++|||+||+.||...+...   +....    ....      .       
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~----~~~~------~-------  212 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI----LMEE------I-------  212 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHH----HcCC------C-------
Confidence            22348999999999998899999999999999999999999997643221   11110    0000      0       


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                       ..+......+.+++.+||+.||++||     ++.++++
T Consensus       213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence             01122345688999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.7e-39  Score=346.37  Aligned_cols=251  Identities=20%  Similarity=0.240  Sum_probs=201.4

Q ss_pred             CCCeeecccCceEEEEEEeC-C-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          272 EGNRLLGDSKTGGTYSGILP-D-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ...++||+|++|.||++... + +..||+|.+..........+.+|+.+|+.++||||+++++++...+..++||||+++
T Consensus        70 ~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~g  149 (478)
T PTZ00267         70 VLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG  149 (478)
T ss_pred             EEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCC
Confidence            34567899999999999853 3 578999987655555556788899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++.........+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       150 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~  226 (478)
T PTZ00267        150 GDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD  226 (478)
T ss_pred             CCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence            999998865333345689999999999999999999999   99999999999999999999999999998664332222


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+...   +..   .... ..    .+      
T Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~---~~~~-~~----~~------  289 (478)
T PTZ00267        227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQ---QVLY-GK----YD------  289 (478)
T ss_pred             cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh-CC----CC------
Confidence            2223448999999999999899999999999999999999999997543211   111   0000 00    00      


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ..+...+..+.+++.+||+.+|++||+++++++
T Consensus       290 ---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 ---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               011223456899999999999999999999875

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.6e-39  Score=319.88  Aligned_cols=249  Identities=29%  Similarity=0.476  Sum_probs=201.4

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      +.||+|++|.||++... .++.||+|.+... .....++.+|+..+.+++||||+++++++...+..++||||+++++|.
T Consensus        12 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   90 (263)
T cd05052          12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL   90 (263)
T ss_pred             eecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHH
Confidence            45799999999999965 4889999998754 334567999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++...  ....+++..++.++.|+++||+|||++   +++||||||+|||+++++.+||+|||++........... ..
T Consensus        91 ~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~-~~  164 (263)
T cd05052          91 DYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AG  164 (263)
T ss_pred             HHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeecc-CC
Confidence            998652  234689999999999999999999999   999999999999999999999999999987654322211 11


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ..++..|+|||.+.+..++.++||||||+++|||+| |..|+...+...   ....    ....     ..+        
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~-----~~~--------  224 (263)
T cd05052         165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----LEKG-----YRM--------  224 (263)
T ss_pred             CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCC-----CCC--------
Confidence            224668999999998899999999999999999998 999987543321   1111    0000     000        


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            01122346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.6e-39  Score=324.90  Aligned_cols=256  Identities=27%  Similarity=0.427  Sum_probs=205.7

Q ss_pred             eeecccCceEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      +.||+|+||.||++...      ++..+++|.+........+.+.+|+..+++++||||+++++++...+..++||||++
T Consensus        11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   90 (291)
T cd05094          11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMK   90 (291)
T ss_pred             eeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCC
Confidence            46799999999999742      355799999987766666789999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeec
Q 008698          349 NGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  416 (557)
Q Consensus       349 ~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  416 (557)
                      +++|.+++.....            ....+++..++.++.||+.||+|||++   +++||||||+|||++.++.+||+||
T Consensus        91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df  167 (291)
T cd05094          91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDF  167 (291)
T ss_pred             CCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECCC
Confidence            9999999965321            123589999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhc
Q 008698          417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS  495 (557)
Q Consensus       417 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~  495 (557)
                      |++................++..|+|||.+.+..++.++||||||+++|||+| |..||...+...   ..+.    ...
T Consensus       168 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~  240 (291)
T cd05094         168 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC----ITQ  240 (291)
T ss_pred             CcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhC
Confidence            99976543322222222336788999999998899999999999999999999 999987654321   1110    111


Q ss_pred             cccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       496 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      .....             .+...+..+.+++.+||+.+|++|||+++|++.|+++..+
T Consensus       241 ~~~~~-------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         241 GRVLE-------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             CCCCC-------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            10000             0112345688999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=339.40  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=208.1

Q ss_pred             eeecccCceEEEEEEeCC--CC--EEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGILPD--GS--RVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~--g~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ++||+|.||.|++|.|..  |+  .||||.++..... ....|++|+.+|.+|+|+|+++|||+..+ ....+|+|+++.
T Consensus       116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELapl  194 (1039)
T KOG0199|consen  116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPL  194 (1039)
T ss_pred             HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhccc
Confidence            368999999999999853  44  6999999877544 67899999999999999999999999887 678999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+.|++  .....|.......++.|||.||.||.++   ++|||||.++|+||-....+||+||||.+.+.......
T Consensus       195 GSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  195 GSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             chHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            999999987  3345688888999999999999999999   99999999999999999999999999999887554332


Q ss_pred             -ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          430 -RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       430 -~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                       ......-++.|+|||.+....++.+||||+|||++|||+| |..|+-+......                .+.+|.   
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI----------------L~~iD~---  330 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI----------------LKNIDA---  330 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH----------------HHhccc---
Confidence             2222224678999999999999999999999999999999 8888876654211                112221   


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HhcccCC
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ-LQQLAQP  553 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~-L~~~~~~  553 (557)
                       .+....++.|++.++++|+.||..+|.+||||..|.+. +...+++
T Consensus       331 -~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp  376 (1039)
T KOG0199|consen  331 -GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQP  376 (1039)
T ss_pred             -cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCC
Confidence             11233456789999999999999999999999999853 4444443

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.8e-39  Score=317.28  Aligned_cols=248  Identities=28%  Similarity=0.398  Sum_probs=197.4

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .||+|+||.||++... +++.||+|.+... .......+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            4799999999999864 6899999987654 2344567999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++..   ....+++.++..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++..............
T Consensus        82 ~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          82 TFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99864   234589999999999999999999999   999999999999999999999999999876543221111111


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..||..........       .....         .    ..
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-------~~~~~---------~----~~  215 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-------AIEQG---------V----RL  215 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-------HHHcC---------C----CC
Confidence            123567999999998889999999999999999998 888886543211100       00000         0    00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                      ..+...+..+.+++.+|++.+|++|||+++|++.|+.
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            1112234578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2e-39  Score=325.23  Aligned_cols=257  Identities=28%  Similarity=0.424  Sum_probs=204.3

Q ss_pred             CeeecccCceEEEEEEe------CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~------~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .+.||+|+||.||++..      .++..+|+|.+..........+.+|+.++.+++||||+++++++...+..++||||+
T Consensus        10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (288)
T cd05093          10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM   89 (288)
T ss_pred             ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence            34579999999999984      234569999998766556678999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccC
Q 008698          348 VNGPLDRWLHHIP---------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL  418 (557)
Q Consensus       348 ~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  418 (557)
                      ++++|.+++....         .....+++.+++.++.|++.||+|||++   +++||||||+|||+++++.+||+|||+
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~  166 (288)
T cd05093          90 KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGM  166 (288)
T ss_pred             CCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCCc
Confidence            9999999986432         1123589999999999999999999999   999999999999999999999999999


Q ss_pred             CccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                      ++...............++..|+|||.+.+..++.++||||||+++|||+| |..||.......   ....    .....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~----i~~~~  239 (288)
T cd05093         167 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC----ITQGR  239 (288)
T ss_pred             cccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCC
Confidence            976543322111122235778999999988889999999999999999999 899986554321   1110    11110


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ...     .        +...+..+.+++.+||+.+|.+|||+.+|++.|+++...
T Consensus       240 ~~~-----~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         240 VLQ-----R--------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             cCC-----C--------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            000     0        111335689999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.7e-39  Score=318.39  Aligned_cols=256  Identities=23%  Similarity=0.336  Sum_probs=205.1

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||+|... +++.||||.++..   .......+.+|+.++++++||||+++++++.+.+..++|+||+++
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   86 (267)
T cd08228           7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA   86 (267)
T ss_pred             eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence            446799999999999964 6899999987642   234456789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++.........++...+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++..........
T Consensus        87 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~  163 (267)
T cd08228          87 GDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA  163 (267)
T ss_pred             CcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHH
Confidence            999998865444445689999999999999999999999   99999999999999999999999999988664332211


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+....    .     ....      
T Consensus       164 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~----~-----~~~~------  225 (267)
T cd08228         164 --HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKI----E-----QCDY------  225 (267)
T ss_pred             --hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHH----h-----cCCC------
Confidence              1223788999999998888899999999999999999999998653221 11111110    0     0000      


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                       ...+....+..+.+++.+||+.+|++||++++|++.|++++
T Consensus       226 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         226 -PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence             11122334567899999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-39  Score=315.49  Aligned_cols=261  Identities=21%  Similarity=0.375  Sum_probs=196.9

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc--CCCcEEeeeeeeeeC----CceEEEEecCC
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL--HHPNLVAVKGCCYDH----GDRYIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~H~niv~l~g~~~~~----~~~~lV~E~~~  348 (557)
                      +.||+|.||+||+|.+ .|..||||++...   ++..+.+|.++...+  +|+||+.+++.=..+    ..++||.+|.+
T Consensus       217 e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe  292 (513)
T KOG2052|consen  217 EIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE  292 (513)
T ss_pred             EEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence            5689999999999999 8999999999754   356677888887764  999999998865433    25799999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-----DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-----~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      +|||.|||..     .+++....++++..+|+||++||     .+.+|.|.|||||+.|||+.+|+.+-|+|+|||-...
T Consensus       293 ~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~  367 (513)
T KOG2052|consen  293 HGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  367 (513)
T ss_pred             CCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence            9999999974     57999999999999999999999     3457899999999999999999999999999996554


Q ss_pred             ccc--cccceeecCccccccccccccCC----CC--CchhhHHHHHHHHHHHHcC----------CCCCCCCCcccchhH
Q 008698          424 WEV--MQERTVMAGGTYGYLAPEFVYRN----EL--TTKSDVYSFGVLLLEIVSG----------RRPAQAVDSVCWQSI  485 (557)
Q Consensus       424 ~~~--~~~~~~~~~gt~~y~aPE~~~~~----~~--s~~sDVwS~Gvil~el~tG----------~~p~~~~~~~~~~~~  485 (557)
                      ...  .........||.+|||||++...    .+  -..+||||||+|+||+.-.          +.||.+.-+.+ .+ 
T Consensus       368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D-Ps-  445 (513)
T KOG2052|consen  368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD-PS-  445 (513)
T ss_pred             ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC-CC-
Confidence            332  22223345599999999998642    11  2468999999999999863          34554432211 00 


Q ss_pred             HHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          486 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       486 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ++.-...+-..++...       ..+.....++...+.++|..||..+|..|.|+-.|-+.|.++.+.
T Consensus       446 ~eeMrkVVCv~~~RP~-------ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  446 FEEMRKVVCVQKLRPN-------IPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             HHHHhcceeecccCCC-------CCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            1111111111111111       112233456788899999999999999999999999999887653

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-39  Score=318.69  Aligned_cols=251  Identities=24%  Similarity=0.406  Sum_probs=201.2

Q ss_pred             CeeecccCceEEEEEEeCC----CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|+||.||+|.+..    ...||||.++... .....+|.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   88 (266)
T cd05033           9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME   88 (266)
T ss_pred             eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence            4567999999999999743    4579999987543 3445679999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +++|.+++...   ...+++.+++.++.|++.||+|||++   +|+|+||||+|||+++++.+||+|||+++........
T Consensus        89 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd05033          89 NGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT  162 (266)
T ss_pred             CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence            99999998642   23689999999999999999999998   9999999999999999999999999999876522211


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......   +....    ....          
T Consensus       163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~----------  225 (266)
T cd05033         163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV----EDGY----------  225 (266)
T ss_pred             eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCC----------
Confidence            11112225678999999998889999999999999999998 999986543221   11111    0000          


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                         ....+..++..+.+++.+||+.+|++||++++|++.|+++
T Consensus       226 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 ---RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               0001122346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.9e-39  Score=321.41  Aligned_cols=269  Identities=28%  Similarity=0.396  Sum_probs=202.7

Q ss_pred             CCCCCeeecccCceEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceE
Q 008698          270 FSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRY  341 (557)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~g~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~  341 (557)
                      +....+.||+|+||.||.+..     .+++.||+|.++... ......+.+|+.++++++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            334456789999999988653     357899999997653 23457788999999999999999999988654  3578


Q ss_pred             EEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      +||||+++|+|.+++..     ..+++.++..++.|++.||.|||++   +++||||||+|||+++++.+||+|||+++.
T Consensus        85 lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          85 LIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence            99999999999999864     3489999999999999999999999   999999999999999999999999999986


Q ss_pred             CCccccccc-eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          422 VPWEVMQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       422 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      ......... .....++..|+|||.+....++.++||||||+++|||+||..|+...... ..................+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhh
Confidence            643322111 11122566799999998888999999999999999999999998654321 1111111110011111111


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      .++...    ....+...+..+.+++.+||+.+|++|||+++|++.|+.+.
T Consensus       236 ~~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         236 LLERGM----RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhcCC----CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111111    11112234567999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=329.90  Aligned_cols=239  Identities=23%  Similarity=0.290  Sum_probs=192.3

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          277 LGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ||+|+||.||++... +++.||+|.++..   .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            599999999999975 5889999999753   223446788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~  151 (312)
T cd05585          81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN  151 (312)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence            999864    24589999999999999999999999   999999999999999999999999999975432221  112


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...||+.|+|||.+.+..++.++|||||||++|||+||+.||...+..   ....   ....         ...      
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---~~~~---~~~~---------~~~------  210 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---EMYR---KILQ---------EPL------  210 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---HHHH---HHHc---------CCC------
Confidence            234899999999999989999999999999999999999999764321   1111   1110         000      


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHH
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRM---SHVVH  545 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~---~evl~  545 (557)
                      ..+......+.+++.+||+.||++||++   .+++.
T Consensus       211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            0112234568899999999999999864   55543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.3e-39  Score=321.60  Aligned_cols=253  Identities=23%  Similarity=0.400  Sum_probs=198.2

Q ss_pred             CeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      .+.||+|+||.||+|...      .+..||||++.... .....++.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~   90 (277)
T cd05062          11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL   90 (277)
T ss_pred             eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEec
Confidence            346799999999998753      25679999986542 33456789999999999999999999999999999999999


Q ss_pred             CCCCChHHHhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          347 VVNGPLDRWLHHIPRG------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      +++|+|.+++......      ...+++..++.++.|++.||.|||+.   +++|+||||+|||+++++.+||+|||+++
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~~  167 (277)
T cd05062          91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR  167 (277)
T ss_pred             CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCcc
Confidence            9999999998653211      23468889999999999999999998   99999999999999999999999999987


Q ss_pred             cCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .....    ......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~~----~~~~~~  240 (277)
T cd05062         168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFV----MEGGLL  240 (277)
T ss_pred             ccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----HcCCcC
Confidence            6543322211112235778999999998889999999999999999999 788887543321   11110    000000


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                                   ..+..++..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       241 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         241 -------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                         0111234568999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.3e-40  Score=328.79  Aligned_cols=240  Identities=23%  Similarity=0.358  Sum_probs=202.1

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|+||.||+|+.+ +.+.||+|.+.+..  .+..+.+.+|+++++.++||||+.+++.++...+.++|.||+.+ +
T Consensus         8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~   86 (808)
T KOG0597|consen    8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-D   86 (808)
T ss_pred             HHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-h
Confidence            35799999999999964 47889999997653  34567899999999999999999999999999999999999966 9


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |..+|..    ...+++.++..++.++..||.|||++   +|+|||+||+|||++.++++|++|||+|+.+..... ..+
T Consensus        87 L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~-vlt  158 (808)
T KOG0597|consen   87 LFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS-VLT  158 (808)
T ss_pred             HHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCce-eee
Confidence            9999964    45699999999999999999999999   999999999999999999999999999998765332 222


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                       ...||+-|||||.+.+.+|+..+|.||+|||+||+++|++||....      +.+.+..+..+               .
T Consensus       159 -sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d---------------~  216 (808)
T KOG0597|consen  159 -SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKD---------------P  216 (808)
T ss_pred             -eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcC---------------C
Confidence             2339999999999999999999999999999999999999997532      22222222211               1


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      -.++......+.+++...+.+||..|.|..+++.
T Consensus       217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            1123356678999999999999999999999875

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.8e-39  Score=332.81  Aligned_cols=258  Identities=26%  Similarity=0.374  Sum_probs=200.4

Q ss_pred             CeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeC-CceEEEE
Q 008698          274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-GDRYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~-~~~~lV~  344 (557)
                      .+.||+|+||.||+|...      +++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++... ...+++|
T Consensus        12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~   91 (337)
T cd05054          12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV   91 (337)
T ss_pred             hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEE
Confidence            457899999999998632      35789999987543 23346788899999999 899999999988644 5678999


Q ss_pred             ecCCCCChHHHhccCCCC---------------------------------------------------------CCCCC
Q 008698          345 EFVVNGPLDRWLHHIPRG---------------------------------------------------------GRSLD  367 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~l~  367 (557)
                      ||+++|+|.+++......                                                         ...++
T Consensus        92 ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  171 (337)
T cd05054          92 EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLT  171 (337)
T ss_pred             ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCC
Confidence            999999999988542110                                                         13689


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeecCcccccccccccc
Q 008698          368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY  447 (557)
Q Consensus       368 ~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  447 (557)
                      +..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...............++..|+|||++.
T Consensus       172 ~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  248 (337)
T cd05054         172 LEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF  248 (337)
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhc
Confidence            999999999999999999999   99999999999999999999999999998764332222222333677899999999


Q ss_pred             CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHH
Q 008698          448 RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV  526 (557)
Q Consensus       448 ~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~  526 (557)
                      +..++.++|||||||++|||++ |..||......+  .+..    ......             ....+......+.+++
T Consensus       249 ~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~~-------------~~~~~~~~~~~~~~l~  309 (337)
T cd05054         249 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCR----RLKEGT-------------RMRAPEYATPEIYSIM  309 (337)
T ss_pred             CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHH----HHhccC-------------CCCCCccCCHHHHHHH
Confidence            9999999999999999999998 999987543211  1110    001000             0001122345689999


Q ss_pred             HHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          527 YACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       527 ~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      .+||+.+|++||++.||++.|+++.+.
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.5e-39  Score=321.90  Aligned_cols=253  Identities=22%  Similarity=0.327  Sum_probs=198.3

Q ss_pred             eeecccCceEEEEEEeC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGS----RVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      +.||+|+||.||+|.+. +|.    .|++|.+.... .....++..|+..++++.||||+++++++.. ...++++||++
T Consensus        13 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~   91 (279)
T cd05111          13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSP   91 (279)
T ss_pred             cccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCC
Confidence            46799999999999863 344    47888875442 2334678888889999999999999998754 45789999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++...   ...+++..+..++.||+.||+|||++   +++||||||+|||+++++.+||+|||+++........
T Consensus        92 ~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T cd05111          92 LGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK  165 (279)
T ss_pred             CCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence            99999999642   24689999999999999999999999   9999999999999999999999999999865433222


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .......++..|+|||.+.++.++.++||||||+++|||+| |..||.+.......++.       ....  ...     
T Consensus       166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~--~~~-----  231 (279)
T cd05111         166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-------EKGE--RLA-----  231 (279)
T ss_pred             cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCC--cCC-----
Confidence            22222336788999999998899999999999999999998 99998765432211111       1110  000     


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                            .+..+...+.+++.+||..+|++|||+.|+++.|..+...|
T Consensus       232 ------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         232 ------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence                  01113345788999999999999999999999999877655

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.5e-39  Score=316.31  Aligned_cols=246  Identities=27%  Similarity=0.447  Sum_probs=198.2

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      +.||+|++|.||.+...++..+|||.+.... ....++.+|+.++.+++||||+++++++.+.+..++||||+.+|+|.+
T Consensus        10 ~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   88 (256)
T cd05113          10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN   88 (256)
T ss_pred             eEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHH
Confidence            3579999999999998777789999987543 335679999999999999999999999998889999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++...   ...+++.+++.++.||+.||+|||+.   +++|+||||+|||++.++.+||+|||.++.......... ...
T Consensus        89 ~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~-~~~  161 (256)
T cd05113          89 YLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS-VGS  161 (256)
T ss_pred             HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec-CCC
Confidence            98642   23689999999999999999999999   999999999999999999999999999876543322111 112


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      .++..|+|||.+.+..++.++||||||+++|||+| |..||.......   ...   .......      .        .
T Consensus       162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~---~~~~~~~------~--------~  221 (256)
T cd05113         162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE---KVSQGLR------L--------Y  221 (256)
T ss_pred             ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH---HHhcCCC------C--------C
Confidence            25678999999988889999999999999999999 999987544311   111   0001000      0        0


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                      .+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            01112457899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.4e-39  Score=330.09  Aligned_cols=240  Identities=24%  Similarity=0.277  Sum_probs=194.2

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +||+|+||.||++... +|+.||+|+++...   ......+.+|+.++..++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            5799999999999864 68999999997542   2334567889999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |..++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        82 L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~  152 (323)
T cd05595          82 LFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM  152 (323)
T ss_pred             HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence            9988854    34689999999999999999999999   999999999999999999999999999875322211  11


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+...   .....   .. .        ..     
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~~~---~~-~--------~~-----  212 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELI---LM-E--------EI-----  212 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH---hc-C--------CC-----
Confidence            22348999999999998899999999999999999999999997654321   11100   00 0        00     


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                       ..+...+..+.+++.+||+.||++||     ++.++++
T Consensus       213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence             01122345688999999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.9e-39  Score=317.17  Aligned_cols=249  Identities=27%  Similarity=0.482  Sum_probs=205.5

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      +.||.|+||.||+|...+++.+|+|.+..........+.+|+.++..++||||+++++++.+.+..++||||+++++|.+
T Consensus        12 ~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   91 (261)
T cd05148          12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLA   91 (261)
T ss_pred             hhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHH
Confidence            35799999999999988899999999987765566789999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++...  .+..+++.++..++.|++.||+|||+.   +++|+||||+|||+++++.+||+|||++...........  ..
T Consensus        92 ~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~--~~  164 (261)
T cd05148          92 FLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS--DK  164 (261)
T ss_pred             HHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccccc--CC
Confidence            99753  235689999999999999999999999   999999999999999999999999999976643322211  22


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      .++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..   .......   . .     ..        ..
T Consensus       165 ~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~---~-~-----~~--------~~  224 (261)
T cd05148         165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQIT---A-G-----YR--------MP  224 (261)
T ss_pred             CCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHH---h-C-----Cc--------CC
Confidence            36778999999988889999999999999999998 89998764421   1111111   0 0     00        00


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      .+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            1123446788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.9e-39  Score=319.51  Aligned_cols=252  Identities=27%  Similarity=0.430  Sum_probs=199.5

Q ss_pred             eeecccCceEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          275 RLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      +.||+|+||.||+|..     .++..||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||++
T Consensus        11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   90 (283)
T cd05090          11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN   90 (283)
T ss_pred             eeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCC
Confidence            4679999999999984     346789999997543 3344678999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEee
Q 008698          349 NGPLDRWLHHIPR-------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG  415 (557)
Q Consensus       349 ~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  415 (557)
                      +++|.+++.....             ....+++.+++.++.|++.||+|||++   +++||||||+|||+++++.+||+|
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~d  167 (283)
T cd05090          91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISD  167 (283)
T ss_pred             CCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEecc
Confidence            9999999853211             123588999999999999999999999   999999999999999999999999


Q ss_pred             ccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhh
Q 008698          416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ  494 (557)
Q Consensus       416 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~  494 (557)
                      ||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......   +.+..    .
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~~~----~  240 (283)
T cd05090         168 LGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIEMV----R  240 (283)
T ss_pred             ccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----H
Confidence            999976543322222222335678999999988889999999999999999999 988986543211   11111    1


Q ss_pred             ccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       495 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                      ....       +      ..+..++..+.+++.+||+.+|.+||++.+|++.|..
T Consensus       241 ~~~~-------~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         241 KRQL-------L------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             cCCc-------C------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            0000       0      0111234568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=9.5e-39  Score=313.06  Aligned_cols=246  Identities=28%  Similarity=0.397  Sum_probs=198.6

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      +||+|+||.||+|...+++.||+|.++.... .....+.+|+.++.+++||||+++++++...+..++||||+++++|.+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            5799999999999988899999999876532 334578999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++...   ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......... ....
T Consensus        82 ~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~  154 (250)
T cd05085          82 FLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK  154 (250)
T ss_pred             HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence            88642   24588999999999999999999999   99999999999999999999999999987543322211 1112


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      .++..|+|||++.+..++.++||||||+++|||++ |..||.......   ...    .....     ...        .
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~----~~~~~-----~~~--------~  214 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---ARE----QVEKG-----YRM--------S  214 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH----HHHcC-----CCC--------C
Confidence            24678999999988889999999999999999999 999987543221   111    01100     000        0


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                      .+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            01123457899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=9.8e-39  Score=314.77  Aligned_cols=247  Identities=23%  Similarity=0.359  Sum_probs=196.0

Q ss_pred             ecccCceEEEEEEeC---CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          277 LGDSKTGGTYSGILP---DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ||+|+||.||+|.+.   ++..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++|+|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            699999999999863   35679999997653 233467999999999999999999999875 4578999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc-e
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER-T  431 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~  431 (557)
                      .+++...   ...+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||++........... .
T Consensus        82 ~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          82 NKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9998642   34689999999999999999999999   999999999999999999999999999986543322111 1


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |..||..........       ......             
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~-------------  215 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-------FIEQGK-------------  215 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-------HHHCCC-------------
Confidence            11224578999999988889999999999999999997 999997654321111       111110             


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ....+..++.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            0011123456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.5e-38  Score=312.98  Aligned_cols=256  Identities=24%  Similarity=0.387  Sum_probs=206.1

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|++|.||+|... +|+.||+|.++..   .....+.+.+|++++.+++|+||+++++++...+..++||||+++
T Consensus         7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   86 (267)
T cd08224           7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA   86 (267)
T ss_pred             eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence            446799999999999976 7899999988642   233456889999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++.........+++.++..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++..........
T Consensus        87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~  163 (267)
T cd08224          87 GDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA  163 (267)
T ss_pred             CCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCccc
Confidence            999999875444456689999999999999999999999   99999999999999999999999999987654332211


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....++..|+|||.+.+..++.++|||||||++|||++|+.||......    ..+....... .    ..       
T Consensus       164 --~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~-~----~~-------  225 (267)
T cd08224         164 --HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEK-C----DY-------  225 (267)
T ss_pred             --ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhhhc-C----CC-------
Confidence              1223788999999998888999999999999999999999998643311    1111110000 0    00       


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                       ...+....+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus       226 -~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         226 -PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence             11112234567899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.5e-39  Score=329.50  Aligned_cols=240  Identities=23%  Similarity=0.268  Sum_probs=194.7

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +||+|+||.||++... +|+.||||++....   ......+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            5799999999999864 58999999997542   2334678899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++..    ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        82 L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~  152 (328)
T cd05593          82 LFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM  152 (328)
T ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence            9988854    34689999999999999999999999   999999999999999999999999999875322211  11


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+...   .....   .. .      +.       
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~~~---~~-~------~~-------  212 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI---LM-E------DI-------  212 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHHHh---cc-C------Cc-------
Confidence            22348999999999998889999999999999999999999997644321   11100   00 0      00       


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                       ..+......+.+++.+||+.||++||     ++.++++
T Consensus       213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         213 -KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             -cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence             01122345688999999999999997     8898875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.2e-39  Score=321.22  Aligned_cols=264  Identities=19%  Similarity=0.218  Sum_probs=196.0

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||.||++... +++.||||+++...  ....+.+.+|+.++.+++||||+++++++...+..++||||++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (287)
T cd07848           6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN   85 (287)
T ss_pred             EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence            456799999999999975 57899999987542  233467889999999999999999999999999999999999988


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      ++..+...    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......... 
T Consensus        86 ~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  157 (287)
T cd07848          86 MLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN-  157 (287)
T ss_pred             HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc-
Confidence            77655432    24589999999999999999999999   99999999999999999999999999998654322111 


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhhh--------hhccccccc
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPL--------VQSHRYLEL  501 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~~--------~~~~~~~~~  501 (557)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.||...+...... +.....+.        .........
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            112238899999999998889999999999999999999999997654321110 00000000        000000000


Q ss_pred             cCcccccCC--CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          502 LDPLISSLS--SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       502 ~d~~l~~~~--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..+......  ........+..+.+++.+|++.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000  00001123457899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-38  Score=320.09  Aligned_cols=256  Identities=25%  Similarity=0.413  Sum_probs=202.5

Q ss_pred             eeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      ..||+|+||.||+|...      ....+|+|.+.... .....++.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus         6 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   85 (290)
T cd05045           6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYA   85 (290)
T ss_pred             ccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEec
Confidence            46799999999999852      23579999887543 334567999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 008698          348 VNGPLDRWLHHIPR--------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE  407 (557)
Q Consensus       348 ~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~  407 (557)
                      .+|+|.+++.....                    ....+++..++.++.|++.||.|||+.   +++||||||+|||+++
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~~  162 (290)
T cd05045          86 KYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAE  162 (290)
T ss_pred             CCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEcC
Confidence            99999999864221                    124588999999999999999999999   9999999999999999


Q ss_pred             CCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHH
Q 008698          408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF  486 (557)
Q Consensus       408 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~  486 (557)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||+| |..||....+..   +.
T Consensus       163 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~  239 (290)
T cd05045         163 GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER---LF  239 (290)
T ss_pred             CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH---HH
Confidence            99999999999976543322212222335678999999988889999999999999999999 999987654321   11


Q ss_pred             HhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       487 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      +....    .     ...        ..+...+..+.+++.+|++.+|++||++.++++.|+++..+
T Consensus       240 ~~~~~----~-----~~~--------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         240 NLLKT----G-----YRM--------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             HHHhC----C-----CCC--------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            11110    0     000        01122345788999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-39  Score=323.55  Aligned_cols=240  Identities=20%  Similarity=0.258  Sum_probs=195.6

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +|+.||+|++....   ......+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   85 (291)
T cd05612           6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG   85 (291)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence            346799999999999975 58999999986542   23346688999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        86 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~---  155 (291)
T cd05612          86 GELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT---  155 (291)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc---
Confidence            999999864    24689999999999999999999999   99999999999999999999999999997654221   


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+...   +.+.   ... ..        .   
T Consensus       156 --~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~~---i~~-~~--------~---  215 (291)
T cd05612         156 --WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYEK---ILA-GK--------L---  215 (291)
T ss_pred             --ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHh-CC--------c---
Confidence              12348999999999998889999999999999999999999997654321   1110   000 00        0   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVHQ  546 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~~  546 (557)
                         ..+......+.+++.+||+.||.+||+     ++++++.
T Consensus       216 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 ---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence               011122456889999999999999995     8888763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1e-38  Score=318.77  Aligned_cols=246  Identities=19%  Similarity=0.267  Sum_probs=196.2

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ||+|+||+||++... +|+.||+|.+.....   ...+.+..|+.+++.++|+||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            599999999999864 688999999875422   2235678899999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++.........+++..+..++.||+.||.|||+.   +|+||||||+||++++++.+||+|||++.........  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence            988865434456799999999999999999999999   9999999999999999999999999999765433221  11


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhhhhhhccccccccCcccccCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ...|++.|+|||++.+..++.++||||||+++|||++|+.||........ ..+..            ..+....     
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~------------~~~~~~~-----  218 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------RILNDSV-----  218 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH------------hhcccCC-----
Confidence            23488999999999999999999999999999999999999976432110 00000            0111100     


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                       ..+...+..+.+++.+||+.||++||     +++++++
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         219 -TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             -CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence             11122456688999999999999999     7788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-38  Score=316.47  Aligned_cols=253  Identities=26%  Similarity=0.426  Sum_probs=196.9

Q ss_pred             eeecccCceEEEEEEeCCC-C--EEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC------CceEEE
Q 008698          275 RLLGDSKTGGTYSGILPDG-S--RVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYIV  343 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g-~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lV  343 (557)
                      +.||+|+||.||+|...++ .  .||+|.++..  .....+.+.+|+.++.+++||||+++++++...      ...+++
T Consensus         5 ~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v   84 (272)
T cd05075           5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVI   84 (272)
T ss_pred             cccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEE
Confidence            4679999999999997543 2  6999988654  234457789999999999999999999987532      346899


Q ss_pred             EecCCCCChHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          344 YEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      |||+++|+|.+++....  .....+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++.
T Consensus        85 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  161 (272)
T cd05075          85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKK  161 (272)
T ss_pred             EEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccc
Confidence            99999999999874321  2234589999999999999999999999   999999999999999999999999999987


Q ss_pred             CCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      ..............+++.|+|||++.+..++.++||||||+++|||++ |..||.......   +...    ......  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~----~~~~~~--  232 (272)
T cd05075         162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDY----LRQGNR--  232 (272)
T ss_pred             cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHcCCC--
Confidence            643322111122236778999999998889999999999999999999 788887543321   1111    111100  


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                           .      ..+...+..+.+++.+||+.+|++|||+++|++.|+++
T Consensus       233 -----~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 -----L------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -----C------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 0      01112345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1e-38  Score=326.75  Aligned_cols=263  Identities=22%  Similarity=0.344  Sum_probs=196.9

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      ..+.||+|+||.||++... ++..+|+|.++.. .......+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus         9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   88 (333)
T cd06650           9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   88 (333)
T ss_pred             eeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCC
Confidence            3446799999999999975 5888999988754 2334567899999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++..    ...+++.....++.|++.||.|||+..  +++||||||+|||++.++.+||+|||++........   
T Consensus        89 ~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---  159 (333)
T cd06650          89 SLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---  159 (333)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc---
Confidence            99999864    245889999999999999999999741  699999999999999999999999999875532211   


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhh-hhcc-------------
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL-VQSH-------------  496 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~-~~~~-------------  496 (557)
                       ....|+..|+|||++.+..++.++|||||||++|||++|+.||.................. ....             
T Consensus       160 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         160 -NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             -ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence             1224889999999999888999999999999999999999999764332111111000000 0000             


Q ss_pred             -----------ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          497 -----------RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       497 -----------~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                                 ......+.................++.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                       0000000000000001111113456889999999999999999999976

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.1e-39  Score=319.22  Aligned_cols=256  Identities=24%  Similarity=0.380  Sum_probs=203.9

Q ss_pred             CeeecccCceEEEEEEeCC-----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeee-CCceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGILPD-----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~  346 (557)
                      .++||+|+||.||+|...+     +..|++|++... .......+.+|+.++.+++||||+++++++.. ....++++||
T Consensus        11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~   90 (280)
T cd05043          11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY   90 (280)
T ss_pred             eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence            4578999999999999765     688999998754 33445778999999999999999999998776 4678999999


Q ss_pred             CCCCChHHHhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          347 VVNGPLDRWLHHIPRG----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      +++|+|.+++......    ...+++.++..++.|++.||+|||++   +++||||||+||++++++.+||+|||+++.+
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~  167 (280)
T cd05043          91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDL  167 (280)
T ss_pred             CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence            9999999998654322    15689999999999999999999999   9999999999999999999999999999865


Q ss_pred             CccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccc
Q 008698          423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  501 (557)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (557)
                      .............++..|+|||++.+..++.++||||||+++||+++ |+.||...+...   +.....   ...     
T Consensus       168 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~---~~~-----  236 (280)
T cd05043         168 FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK---DGY-----  236 (280)
T ss_pred             cCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH---cCC-----
Confidence            43332211112236778999999988889999999999999999999 999997654321   111100   000     


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                       .  +      .....++..+.+++.+||+.+|++|||+.+|++.|+.+.+
T Consensus       237 -~--~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         237 -R--L------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             -C--C------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             0  0      0011234578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.4e-39  Score=297.30  Aligned_cols=262  Identities=20%  Similarity=0.270  Sum_probs=200.4

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccchh--hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.+|+|.||.||+|.. .+|+.||||+++.....  -....++|++.|+.++|+||+.+++++...+...||+|||+ .+
T Consensus         8 ~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-td   86 (318)
T KOG0659|consen    8 EKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TD   86 (318)
T ss_pred             hhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-cc
Confidence            3579999999999994 56999999999765332  23567899999999999999999999999999999999995 58


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |+..+++   ....++..++..++.++++|++|+|++   .|+||||||.|+|+++++.+||+|||+++...........
T Consensus        87 Le~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~  160 (318)
T KOG0659|consen   87 LEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH  160 (318)
T ss_pred             HHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence            9988874   346799999999999999999999999   9999999999999999999999999999988755443322


Q ss_pred             eecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhH-HHhh-hhhhhc----cccccccCc
Q 008698          432 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI-FEWA-TPLVQS----HRYLELLDP  504 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~-~~~~-~~~~~~----~~~~~~~d~  504 (557)
                      .  .-|..|.|||.+.+ ..|+...|+||.|||+.||+-|.+-|.+.++.+.... +... .+...+    ..+.+.++-
T Consensus       161 ~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~  238 (318)
T KOG0659|consen  161 Q--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI  238 (318)
T ss_pred             c--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence            2  36889999999987 5699999999999999999999887776654322111 1100 000000    000011100


Q ss_pred             c--cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          505 L--ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       505 ~--l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      .  ......... ..+...+++|+..++..||.+|+|+.|++++
T Consensus       239 ~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  239 QQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             hcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            0  000001112 2245567999999999999999999999863

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.4e-38  Score=318.07  Aligned_cols=251  Identities=25%  Similarity=0.380  Sum_probs=198.9

Q ss_pred             eecccCceEEEEEEeC------CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          276 LLGDSKTGGTYSGILP------DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .||+|+||.||+|...      +++.||||+++.... .....+.+|+.++..++||||+++++++...+..++++||++
T Consensus        12 ~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~   91 (283)
T cd05091          12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCS   91 (283)
T ss_pred             HhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCC
Confidence            4699999999999863      257899999975532 234678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeec
Q 008698          349 NGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  416 (557)
Q Consensus       349 ~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  416 (557)
                      +++|.+++....            .....+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+||
T Consensus        92 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Df  168 (283)
T cd05091          92 HSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDL  168 (283)
T ss_pred             CCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEeccc
Confidence            999999985321            1123588899999999999999999999   9999999999999999999999999


Q ss_pred             cCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhc
Q 008698          417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS  495 (557)
Q Consensus       417 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~  495 (557)
                      |+++...............+++.|+|||.+.++.++.++||||||+++|||+| |..||.......   ..+..    . 
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~i----~-  240 (283)
T cd05091         169 GLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VIEMI----R-  240 (283)
T ss_pred             ccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----H-
Confidence            99886543322222222335788999999988889999999999999999998 888887643321   11111    0 


Q ss_pred             cccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       496 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                             +...     ...+.+++..+.+++..||+.+|++||++++|++.|+.
T Consensus       241 -------~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         241 -------NRQV-----LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -------cCCc-----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                   0000     01122345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=315.50  Aligned_cols=254  Identities=25%  Similarity=0.458  Sum_probs=199.7

Q ss_pred             CeeecccCceEEEEEEeCC----CCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc------eE
Q 008698          274 NRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------RY  341 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~----g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~------~~  341 (557)
                      .+.||+|+||.||+|....    +..||||.++...  ......+.+|+..++.++||||+++++++...+.      .+
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05035           4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM   83 (273)
T ss_pred             ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence            3467999999999998642    3679999987542  3345688999999999999999999998876554      79


Q ss_pred             EEEecCCCCChHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCC
Q 008698          342 IVYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS  419 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~  419 (557)
                      +|+||+++|+|..++....  .....+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||++
T Consensus        84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccce
Confidence            9999999999999885432  2234689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhcccc
Q 008698          420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY  498 (557)
Q Consensus       420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (557)
                      +...............++..|+|||.+.+..++.++||||||+++|||++ |..||......   .+.....   . .. 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~---~-~~-  232 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLR---H-GN-  232 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---c-CC-
Confidence            86654332222222235678999999988889999999999999999999 88888654321   1111110   0 00 


Q ss_pred             ccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       499 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                                  ....+..++..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       233 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 ------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                        0001123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-38  Score=318.04  Aligned_cols=267  Identities=25%  Similarity=0.380  Sum_probs=198.6

Q ss_pred             eeecccCceEEEEEEeC-----CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeee--CCceEEEEecC
Q 008698          275 RLLGDSKTGGTYSGILP-----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFV  347 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-----~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~  347 (557)
                      +.||+|+||.||++...     ++..||+|.+........+.+.+|+.++.+++||||+++++++..  ....++||||+
T Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   89 (284)
T cd05081          10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL   89 (284)
T ss_pred             eeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEec
Confidence            46899999999999742     578999999987666666789999999999999999999998754  34678999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||+++.......
T Consensus        90 ~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  163 (284)
T cd05081          90 PYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE  163 (284)
T ss_pred             CCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence            999999998642   24589999999999999999999999   999999999999999999999999999987643322


Q ss_pred             ccc-eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 QER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ... .....++..|+|||.+.+..++.++|||||||++|||++|..|+.......................+.+.+..  
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  241 (284)
T cd05081         164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN--  241 (284)
T ss_pred             ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc--
Confidence            111 11112345699999998888999999999999999999988765432211000000000000000000001110  


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                        ......+...+..+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus       242 --~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         242 --NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             --CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence              0011112234567999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-40  Score=323.39  Aligned_cols=242  Identities=23%  Similarity=0.368  Sum_probs=202.6

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+||+|+||.||+|... .++.||+|++.-.. ....+++.+|+.+|..++++||.+++|.+..+..++++|||+.+|++
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV   98 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence            46899999999999964 58899999997653 34457889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+.|..    +..+++..+.-++.+++.||.|||++   +.+|||||+.|||+..++.+|++|||++..+.......  .
T Consensus        99 ~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~  169 (467)
T KOG0201|consen   99 LDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--K  169 (467)
T ss_pred             hhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc--c
Confidence            999853    34557888888999999999999999   99999999999999999999999999998776554433  3


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...||+.|||||++....|+.|+||||||++++||.+|.+|+....+....                -++-+.-    +.
T Consensus       170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----------------flIpk~~----PP  229 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----------------FLIPKSA----PP  229 (467)
T ss_pred             cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----------------EeccCCC----CC
Confidence            455999999999999889999999999999999999999999877653111                1111100    11


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..+......+.+++..|++.+|+.||++.++++
T Consensus       230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            111245667999999999999999999999987

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=314.05  Aligned_cols=246  Identities=24%  Similarity=0.404  Sum_probs=197.5

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      +.||+|++|.||++...++..+|+|.+.... .....+.+|+.++.+++||||+++++++...+..++||||+++++|.+
T Consensus        10 ~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   88 (256)
T cd05059          10 KELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLN   88 (256)
T ss_pred             hhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHH
Confidence            3579999999999998777889999986543 234678899999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++...   ...+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++......... ....
T Consensus        89 ~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-~~~~  161 (256)
T cd05059          89 YLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-SQGT  161 (256)
T ss_pred             HHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc-cCCC
Confidence            98642   23689999999999999999999999   99999999999999999999999999987654322111 1111


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      .++..|+|||.+.+..++.++||||||+++|||+| |..||...+..+   .....    .     .....        .
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~-----~~~~~--------~  221 (256)
T cd05059         162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESV----S-----AGYRL--------Y  221 (256)
T ss_pred             CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHH----H-----cCCcC--------C
Confidence            24568999999998899999999999999999999 889987543321   11100    0     00000        0


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                      .+...+..+.+++.+||+.+|++|||++++++.|.
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            01124567999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.2e-38  Score=319.63  Aligned_cols=263  Identities=17%  Similarity=0.209  Sum_probs=193.6

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||++... +++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||++ |+
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~   88 (288)
T cd07871          10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SD   88 (288)
T ss_pred             eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cC
Confidence            346799999999999864 58899999987542 2234567899999999999999999999999999999999996 58


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........  .
T Consensus        89 l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~--~  160 (288)
T cd07871          89 LKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--Y  160 (288)
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc--c
Confidence            98888642   34578999999999999999999999   9999999999999999999999999998754322211  1


Q ss_pred             eecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhh-----hhh----ccccccc
Q 008698          432 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP-----LVQ----SHRYLEL  501 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~-----~~~----~~~~~~~  501 (557)
                      ....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||...+..+..........     .+.    .......
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            12237899999998875 5689999999999999999999999976543221111100000     000    0000011


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..+................+..+++.+|++.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            11100000000000112356789999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.8e-39  Score=343.75  Aligned_cols=251  Identities=23%  Similarity=0.296  Sum_probs=199.7

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC--------ce
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--------DR  340 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--------~~  340 (557)
                      ...+.||+|+||+||++.. .+|+.||||++...  .......+.+|+..+..++|+||+++...+...+        ..
T Consensus        35 ~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i  114 (496)
T PTZ00283         35 WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMI  114 (496)
T ss_pred             EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEE
Confidence            3345789999999999985 46899999998654  2344567889999999999999999887765332        36


Q ss_pred             EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      ++||||+++|+|.+++.........+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       115 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~  191 (496)
T PTZ00283        115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSK  191 (496)
T ss_pred             EEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence            899999999999999976544556799999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      ...............||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +..   .... .    
T Consensus       192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~~---~~~~-~----  260 (496)
T PTZ00283        192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VMH---KTLA-G----  260 (496)
T ss_pred             eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHhc-C----
Confidence            6543322222233458999999999999899999999999999999999999997643211   111   1000 0    


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..++         .+...+..+.+++.+||+.+|.+||++.++++
T Consensus       261 ~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        261 RYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             CCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            0011         11223457899999999999999999999986

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-38  Score=317.38  Aligned_cols=255  Identities=23%  Similarity=0.376  Sum_probs=201.0

Q ss_pred             CeeecccCceEEEEEEe-CCCC----EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .+.||+|+||+||+|.+ .+|.    .||+|+++.. ......++.+|+.++..++||||+++++++... ..++++||+
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~   90 (279)
T cd05109          12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLM   90 (279)
T ss_pred             eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcC
Confidence            34689999999999985 3444    4899998754 334456789999999999999999999998754 568999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++...   ...+++..++.++.||+.||+|||++   +++||||||+|||+++++.+||+|||+++.......
T Consensus        91 ~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~  164 (279)
T cd05109          91 PYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET  164 (279)
T ss_pred             CCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence            999999998642   24689999999999999999999999   999999999999999999999999999987653322


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ........++..|+|||.+.+..++.++||||||+++|||+| |..||.......   +...    .....         
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~---------  228 (279)
T cd05109         165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDL----LEKGE---------  228 (279)
T ss_pred             eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCC---------
Confidence            211111224678999999988889999999999999999999 899986543211   1111    11000         


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCC
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV  555 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  555 (557)
                          ....+...+..+.+++.+||+.||+.||++.++++.|+.++..|-
T Consensus       229 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05109         229 ----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS  273 (279)
T ss_pred             ----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence                000112234568899999999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-39  Score=328.36  Aligned_cols=248  Identities=21%  Similarity=0.238  Sum_probs=198.7

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +++.||||+++...   ......+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g   85 (333)
T cd05600           6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG   85 (333)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence            346799999999999975 48899999997542   23346788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..    ...+++.++..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....     
T Consensus        86 ~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----  153 (333)
T cd05600          86 GDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----  153 (333)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence            999999964    24688999999999999999999999   999999999999999999999999999976543     


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+.   ......   .   ...+....   
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~i~~---~---~~~~~~~~---  221 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET---WENLKY---W---KETLQRPV---  221 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH---HHHHHh---c---cccccCCC---
Confidence            11223489999999999988999999999999999999999999976543221   110000   0   00010000   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                       ...+....+..+.+++.+|+..+|++||+++++++.
T Consensus       222 -~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 -YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence             000012245678899999999999999999999963

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.2e-39  Score=321.33  Aligned_cols=255  Identities=27%  Similarity=0.444  Sum_probs=202.3

Q ss_pred             CeeecccCceEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      .+.||+|+||.||++...      ....+|+|.+... ......++.+|+.++.++ +|+||+++++++...+..+++||
T Consensus        17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e   96 (293)
T cd05053          17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE   96 (293)
T ss_pred             eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence            456899999999999863      2367999998754 233446788999999999 89999999999999999999999


Q ss_pred             cCCCCChHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEE
Q 008698          346 FVVNGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL  413 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl  413 (557)
                      |+++|+|.+++....            .....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL  173 (293)
T cd05053          97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKI  173 (293)
T ss_pred             eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEEe
Confidence            999999999986421            2345689999999999999999999999   9999999999999999999999


Q ss_pred             eeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhh
Q 008698          414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPL  492 (557)
Q Consensus       414 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~  492 (557)
                      +|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   +..    .
T Consensus       174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~----~  246 (293)
T cd05053         174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---LFK----L  246 (293)
T ss_pred             CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---HHH----H
Confidence            99999987654332222222235678999999988889999999999999999998 989987543321   111    0


Q ss_pred             hhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          493 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       493 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      .....   .         .. .+..++..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       247 ~~~~~---~---------~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         247 LKEGY---R---------ME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHcCC---c---------CC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            00000   0         00 11123456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.1e-38  Score=312.20  Aligned_cols=246  Identities=26%  Similarity=0.367  Sum_probs=195.9

Q ss_pred             ecccCceEEEEEEe---CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          277 LGDSKTGGTYSGIL---PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       277 lg~G~~g~Vy~g~~---~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      ||+|+||.||+|.+   .++..+|+|+++...  ....+++.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus         3 lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~   81 (257)
T cd05116           3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGP   81 (257)
T ss_pred             CCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCc
Confidence            69999999999975   357889999986543  234578899999999999999999999875 456789999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc-
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER-  430 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-  430 (557)
                      |.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++.......... 
T Consensus        82 L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          82 LNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999864    24589999999999999999999999   999999999999999999999999999987644322111 


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      .....++..|+|||.+....++.++||||||+++|||+| |..||........   ....    ....            
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~i----~~~~------------  215 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQMI----ESGE------------  215 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HCCC------------
Confidence            111224578999999988888999999999999999998 9999976543211   1111    1100            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                       ....+..++..+.+++.+||+.+|++||++++|++.|++.
T Consensus       216 -~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 -RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence             0001122446788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.7e-38  Score=314.45  Aligned_cols=255  Identities=23%  Similarity=0.355  Sum_probs=204.8

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +.||+|++|.||++.. .+++.+|||.+...   ......++.+|+.++..++||||+++++++.+.+..+++|||++++
T Consensus         8 ~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~   87 (267)
T cd08229           8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG   87 (267)
T ss_pred             hhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCC
Confidence            4579999999999995 47899999988643   2234467899999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++.........+++.++..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.......... 
T Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-  163 (267)
T cd08229          88 DLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-  163 (267)
T ss_pred             CHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCccc-
Confidence            99999875444446789999999999999999999999   99999999999999999999999999987654332211 


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                       ....++..|+|||++.+..++.++||||||+++|||++|..||...... ...+..   .      ......       
T Consensus       164 -~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~---~------~~~~~~-------  225 (267)
T cd08229         164 -HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK---K------IEQCDY-------  225 (267)
T ss_pred             -ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhh---h------hhcCCC-------
Confidence             1223788999999998888999999999999999999999998654321 111111   0      001001       


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      ...+....+..+.+++.+||+.+|++||||.+|++.++++.
T Consensus       226 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         226 PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            11112235567999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=312.94  Aligned_cols=255  Identities=24%  Similarity=0.351  Sum_probs=212.3

Q ss_pred             CeeecccCceEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-CceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E  345 (557)
                      ..++.+|.||.||+|.+.      +.+.|-||.++.. +.-....++.|...+..+.|||+.++.+++.+. ..++..|.
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            346799999999999653      3456888888765 333456789999999999999999999998755 56799999


Q ss_pred             cCCCCChHHHhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          346 FVVNGPLDRWLHHI----PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       346 ~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      ++.-|+|..||...    ....+.++..+...++.|++.||+|||++   ++||.||.++|++||+..++||+|-.+++.
T Consensus       369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRD  445 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRD  445 (563)
T ss_pred             ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccc
Confidence            99999999999832    23457788999999999999999999999   999999999999999999999999999999


Q ss_pred             CCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      +.+.+++.-......+.+||+||.+....|+.++|||||||+||||+| |+.||...++.+......      +..    
T Consensus       446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk------dGy----  515 (563)
T KOG1024|consen  446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK------DGY----  515 (563)
T ss_pred             cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh------ccc----
Confidence            887777655444447889999999999999999999999999999999 999999888754322211      111    


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                                +..-|-+|+++++.+|..||...|++||+++|++.-|.+..
T Consensus       516 ----------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  516 ----------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             ----------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                      11123457889999999999999999999999999887653

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.1e-39  Score=327.47  Aligned_cols=239  Identities=25%  Similarity=0.325  Sum_probs=194.7

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +|+.||||+++...   ....+.+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  102 (329)
T PTZ00263         23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG  102 (329)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence            456899999999999975 58899999997542   23346788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......   
T Consensus       103 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---  172 (329)
T PTZ00263        103 GELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---  172 (329)
T ss_pred             ChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---
Confidence            999999864    24588899999999999999999999   99999999999999999999999999998654322   


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....||+.|+|||.+.+..++.++|||||||++|||+||..||...+...   ..+   .. ...        .+   
T Consensus       173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~---~i-~~~--------~~---  232 (329)
T PTZ00263        173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYE---KI-LAG--------RL---  232 (329)
T ss_pred             --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HHH---HH-hcC--------Cc---
Confidence              12348999999999999889999999999999999999999997643311   111   00 000        00   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~  545 (557)
                        . .+......+.+++.+||+.||++||+     ++++++
T Consensus       233 --~-~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        233 --K-FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             --C-CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence              0 01112346789999999999999997     677764

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.6e-38  Score=315.37  Aligned_cols=245  Identities=21%  Similarity=0.302  Sum_probs=192.4

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ||+|+||.||++... +|+.||+|.+.....   .....+..|++++.+++||||+++.+++.+....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            599999999999864 589999999864321   2234566799999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++...  ....+++..+..++.||+.||+|||+.   +++||||||+|||+++++.++|+|||++........   ..
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~  152 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---IT  152 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---ee
Confidence            9888642  234589999999999999999999999   999999999999999999999999999876543221   11


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||.........  .+....         .+...+.     
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~---------~~~~~~~-----  216 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRR---------TLEDEVK-----  216 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHH---------hhccccc-----
Confidence            234889999999999888999999999999999999999998754321100  000000         0100010     


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ......+.++.+++..||+.||++||++.|+++
T Consensus       217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             cccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            001123456889999999999999999977664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-38  Score=315.07  Aligned_cols=239  Identities=27%  Similarity=0.399  Sum_probs=188.3

Q ss_pred             eecccCceEEEEEEeCC-------------------------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEee
Q 008698          276 LLGDSKTGGTYSGILPD-------------------------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV  330 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l  330 (557)
                      .||+|+||.||+|.+..                         ...||+|++.........+|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            47999999999997421                         23589999976554555678899999999999999999


Q ss_pred             eeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-
Q 008698          331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-  409 (557)
Q Consensus       331 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~-  409 (557)
                      ++++.+.+..++||||+++|+|..++..   ....+++..++.++.||+.||+|||++   +|+||||||+|||++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            9999999999999999999999998864   234688999999999999999999999   999999999999997643 


Q ss_pred             ------CcEEeeccCCccCCccccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHH-cCCCCCCCCCccc
Q 008698          410 ------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIV-SGRRPAQAVDSVC  481 (557)
Q Consensus       410 ------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~-tG~~p~~~~~~~~  481 (557)
                            .+|++|||++.......      ...++..|+|||.+.+ ..++.++||||||+++|||+ +|..||.......
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                  37999999886432211      1226788999998875 56899999999999999995 6999987654322


Q ss_pred             chhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          482 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                      .....       ...       ...        +......+.+++.+||+.+|++||||.+|++.|.
T Consensus       230 ~~~~~-------~~~-------~~~--------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 KERFY-------EKK-------HRL--------PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHH-------Hhc-------cCC--------CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11110       000       000        0011235889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2e-38  Score=327.45  Aligned_cols=241  Identities=24%  Similarity=0.379  Sum_probs=189.2

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .||+|+||.||++... +|+.||||++.... ......+.+|+.++..++|+||+++++++...+..++||||+++|+|.
T Consensus        81 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  160 (353)
T PLN00034         81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE  160 (353)
T ss_pred             hccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccc
Confidence            5799999999999964 58999999986542 234567899999999999999999999999999999999999999985


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +.        ...++..+..++.||+.||.|||++   +|+||||||+|||+++++.+||+|||+++.......  ....
T Consensus       161 ~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~  227 (353)
T PLN00034        161 GT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNS  227 (353)
T ss_pred             cc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccc
Confidence            43        2356778889999999999999999   999999999999999999999999999986543211  1112


Q ss_pred             cCccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          434 AGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      ..||..|+|||.+..     ...+.++|||||||++|||++|+.||......++..+.....   ..    .        
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~---~~----~--------  292 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC---MS----Q--------  292 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---cc----C--------
Confidence            348999999998743     223568999999999999999999997443322222111100   00    0        


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                        ....+......+.+++.+||+.||++|||+.||++.
T Consensus       293 --~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 --PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              001112344678999999999999999999999974

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.5e-38  Score=311.78  Aligned_cols=239  Identities=26%  Similarity=0.396  Sum_probs=188.9

Q ss_pred             eecccCceEEEEEEeCC-------------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEE
Q 008698          276 LLGDSKTGGTYSGILPD-------------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~-------------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l  342 (557)
                      .||+|+||.||+|.+.+             ...|++|.+..........|.+|+.++..++||||+++++++......++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            47999999999998532             23589999876655556688999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-------cEEee
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-------AHLMG  415 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~-------~kl~D  415 (557)
                      ||||+++|+|..++..   ....+++..+..++.||++||+|||++   +|+||||||+|||++.++.       +|++|
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          82 VEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999988863   234589999999999999999999999   9999999999999987654       89999


Q ss_pred             ccCCccCCccccccceeecCcccccccccccc-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCcccchhHHHhhhhhh
Q 008698          416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIV-SGRRPAQAVDSVCWQSIFEWATPLV  493 (557)
Q Consensus       416 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwS~Gvil~el~-tG~~p~~~~~~~~~~~~~~~~~~~~  493 (557)
                      ||++.......      ...++..|+|||.+. +..++.++|||||||++|||+ +|..|+......+...+       .
T Consensus       156 ~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-------~  222 (262)
T cd05077         156 PGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-------Y  222 (262)
T ss_pred             CCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-------H
Confidence            99987543211      123778899999887 466899999999999999998 58888765432111100       0


Q ss_pred             hccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       494 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                      . ..    . . .    .    ......+.+++.+||+.||++||++.+|++.|+
T Consensus       223 ~-~~----~-~-~----~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 E-GQ----C-M-L----V----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             h-cC----c-c-C----C----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            0 00    0 0 0    0    012346889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.9e-38  Score=313.40  Aligned_cols=254  Identities=24%  Similarity=0.350  Sum_probs=192.8

Q ss_pred             eecccCceEEEEEEeCC---CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          276 LLGDSKTGGTYSGILPD---GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~---g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .||+|+||.||+|...+   +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            47999999999998643   4579999987543 3344678999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          352 LDRWLHHIPR-GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       352 L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      |.+++..... ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            9999975322 223567788889999999999999999   999999999999999999999999999975443322222


Q ss_pred             eeecCccccccccccccCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhcccccccc
Q 008698          431 TVMAGGTYGYLAPEFVYRN-------ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  502 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~-------~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (557)
                      .....++..|+|||++.+.       .++.++||||||+++|||++ |..||........   ....   .. .......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~---~~-~~~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYT---VR-EQQLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH---hh-cccCCCC
Confidence            2223367889999988642       35789999999999999997 9999976433211   1100   00 0001111


Q ss_pred             CcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       503 d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                      ++.+        .......+.+++..|| .+|++|||+++|+..|+
T Consensus       232 ~~~~--------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRL--------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCcc--------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111        1112345788999999 58999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-38  Score=315.81  Aligned_cols=253  Identities=25%  Similarity=0.387  Sum_probs=200.7

Q ss_pred             CeeecccCceEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      .+.||+|+||.||+|...+      +..||+|.+.... ......+.+|+.++..++||||+++++++...+..++||||
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   90 (277)
T cd05032          11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL   90 (277)
T ss_pred             EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence            3567999999999998642      4689999987543 34456789999999999999999999999999999999999


Q ss_pred             CCCCChHHHhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          347 VVNGPLDRWLHHIPR------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      +++|+|.+++.....      ....+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~  167 (277)
T cd05032          91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR  167 (277)
T ss_pred             CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccch
Confidence            999999999865322      123478899999999999999999999   99999999999999999999999999997


Q ss_pred             cCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ...............++..|+|||.+.+..++.++||||||+++|||+| |..||...+...   .....    ....  
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~----~~~~--  238 (277)
T cd05032         168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFV----IDGG--  238 (277)
T ss_pred             hhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHH----hcCC--
Confidence            6543322222222336789999999988889999999999999999998 999987544321   11111    0000  


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                            .     ...+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       239 ------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         239 ------H-----LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             ------C-----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                  0     00111235678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.9e-38  Score=311.68  Aligned_cols=247  Identities=26%  Similarity=0.431  Sum_probs=198.1

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      +.||+|++|.||++..+++..||+|.++.... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+++++|.+
T Consensus        12 ~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~   89 (260)
T cd05070          12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLD   89 (260)
T ss_pred             heeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHH
Confidence            45799999999999988888999999976533 3467999999999999999999999875 456899999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++...  ....+++.+++.++.|++.||+|||++   +++||||||+||++++++.++|+|||++........... ...
T Consensus        90 ~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~-~~~  163 (260)
T cd05070          90 FLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR-QGA  163 (260)
T ss_pred             HHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc-cCC
Confidence            98652  234589999999999999999999999   999999999999999999999999999976543322111 111


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      .++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+   .....   ...      ..        ..
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~---~~~------~~--------~~  223 (260)
T cd05070         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQV---ERG------YR--------MP  223 (260)
T ss_pred             CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH---HcC------CC--------CC
Confidence            25678999999988889999999999999999999 888987543221   11110   000      00        00


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                      .+.+.+..+.+++.+|++.+|++|||++++++.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            112344579999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.9e-38  Score=316.71  Aligned_cols=252  Identities=25%  Similarity=0.369  Sum_probs=200.1

Q ss_pred             eeecccCceEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      +.||+|+||.||++...      ++..+|+|.+..........+.+|+.++.+++|+||+++++++...+..++||||++
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   90 (280)
T cd05092          11 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMR   90 (280)
T ss_pred             cccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCC
Confidence            35799999999999632      356899999887766667789999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeecc
Q 008698          349 NGPLDRWLHHIPR-----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  417 (557)
Q Consensus       349 ~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  417 (557)
                      +|+|.+++.....           ....+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|||
T Consensus        91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~dfg  167 (280)
T cd05092          91 HGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFG  167 (280)
T ss_pred             CCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCCC
Confidence            9999999865321           113588999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhcc
Q 008698          418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH  496 (557)
Q Consensus       418 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (557)
                      ++................+++.|+|||.+.+..++.++|||||||++|||++ |.+||........   ..   .. ...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~---~~-~~~  240 (280)
T cd05092         168 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---IE---CI-TQG  240 (280)
T ss_pred             ceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---HH---HH-HcC
Confidence            9875543222111112225678999999998899999999999999999999 8999865433211   10   00 000


Q ss_pred             ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       497 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                      .             ....+..++..+.+++.+||+.||++||++++|++.|++
T Consensus       241 ~-------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         241 R-------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             c-------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            0             000011234568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2e-38  Score=320.16  Aligned_cols=253  Identities=25%  Similarity=0.374  Sum_probs=199.7

Q ss_pred             CeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      .+.||+|+||.||++...      .+..||||.++... ....+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus        40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e  119 (302)
T cd05055          40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE  119 (302)
T ss_pred             cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEE
Confidence            456799999999999741      34579999987543 33456789999999999 79999999999999999999999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      |+++|+|.+++....  ...+++.++..++.|++.||.|||++   +++|+||||+|||++.+..+|++|||+++.....
T Consensus       120 ~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  194 (302)
T cd05055         120 YCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMND  194 (302)
T ss_pred             cCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence            999999999986422  23489999999999999999999999   9999999999999999999999999999865433


Q ss_pred             ccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      ..........++..|+|||.+.+..++.++|||||||++|||+| |..||.......  .+..    .....     .. 
T Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~----~~~~~-----~~-  262 (302)
T cd05055         195 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYK----LIKEG-----YR-  262 (302)
T ss_pred             CceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHH----HHHcC-----Cc-
Confidence            22111112235678999999998889999999999999999998 999987643321  1111    00100     00 


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                            . ..+...+..+.+++.+|++.+|++|||+.+|++.|+++
T Consensus       263 ------~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 ------M-AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------C-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                  0 00112235689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.7e-38  Score=311.96  Aligned_cols=249  Identities=28%  Similarity=0.450  Sum_probs=199.8

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|+||.||++...+++.||+|.+.... .....+.+|+.++++++|+||+++++++ ..+..++||||+++++|.
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~L~   88 (260)
T cd05067          11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLV   88 (260)
T ss_pred             eeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCCHH
Confidence            45689999999999998889999999997653 3356789999999999999999999986 456789999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++...  .+..+++.++..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++........... ..
T Consensus        89 ~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~-~~  162 (260)
T cd05067          89 DFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR-EG  162 (260)
T ss_pred             HHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc-cC
Confidence            998652  235689999999999999999999998   999999999999999999999999999976543222111 11


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ..++..|+|||++.+..++.++||||||+++|||++ |+.||...+....   ...    ....     ...        
T Consensus       163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~-----~~~--------  222 (260)
T cd05067         163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQN----LERG-----YRM--------  222 (260)
T ss_pred             CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHH----HHcC-----CCC--------
Confidence            225678999999988889999999999999999999 9999976543211   110    0000     000        


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ..+...+.++.+++.+|++.+|++|||++++++.|+.+
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            00112345699999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.4e-38  Score=315.45  Aligned_cols=253  Identities=28%  Similarity=0.418  Sum_probs=198.1

Q ss_pred             CeeecccCceEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      .+.||+|++|.||+|...+      +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+..++||||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   90 (277)
T cd05036          11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL   90 (277)
T ss_pred             eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence            3467999999999999753      5679999886543 33456799999999999999999999999999999999999


Q ss_pred             CCCCChHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CcEEeeccCCc
Q 008698          347 VVNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSK  420 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgl~~  420 (557)
                      +++++|.+++.....   ....+++..++.++.||+.||+|||++   +++||||||+|||++.++   .+||+|||+++
T Consensus        91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~  167 (277)
T cd05036          91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR  167 (277)
T ss_pred             CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCcccc
Confidence            999999999865321   123589999999999999999999999   999999999999998754   58999999998


Q ss_pred             cCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ................+..|+|||++.+..++.++|||||||++|||++ |..||...+...   +....   ....   
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~~---~~~~---  238 (277)
T cd05036         168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEFV---TGGG---  238 (277)
T ss_pred             ccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---HcCC---
Confidence            6633222111111123568999999998899999999999999999997 999987654321   11100   0000   


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                                 ....+...+..+.+++.+|++.+|++|||+.+|++.|++
T Consensus       239 -----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         239 -----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             -----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                       001112234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-38  Score=324.73  Aligned_cols=240  Identities=22%  Similarity=0.295  Sum_probs=192.4

Q ss_pred             eecccCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          276 LLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .||+|+||.||++..    .+++.||||+++...    ......+.+|+.++..++||||+++++++...+..++||||+
T Consensus         3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~   82 (323)
T cd05584           3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYL   82 (323)
T ss_pred             eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCC
Confidence            579999999999985    357899999997542    223356788999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++..    ...+.+..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          83 SGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999864    24578888999999999999999999   999999999999999999999999999874322221


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .  .....|++.|+|||++.+..++.++|||||||++|||++|+.||...+...   ...   ..         ..... 
T Consensus       156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~~~---~~---------~~~~~-  217 (323)
T cd05584         156 V--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---TID---KI---------LKGKL-  217 (323)
T ss_pred             c--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---HHH---HH---------HcCCC-
Confidence            1  112348999999999998889999999999999999999999997654311   111   00         00000 


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                           ..+......+.+++.+|++.+|++||     +++++++
T Consensus       218 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 -----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                 00112345688999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.2e-38  Score=311.83  Aligned_cols=248  Identities=24%  Similarity=0.341  Sum_probs=199.3

Q ss_pred             eecccCceEEEEEEeCC--C--CEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILPD--G--SRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~--g--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .||+|++|.||+|.+.+  +  ..||||.++.... ...+.+.+|+..+++++||||+++++.+.+ ...++||||+++|
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG   80 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence            47999999999998643  3  3699999987755 566789999999999999999999999888 8899999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc-c
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-E  429 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~  429 (557)
                      +|.+++.....  ..+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||+++........ .
T Consensus        81 ~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          81 SLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             cHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            99999975322  4689999999999999999999999   9999999999999999999999999999876442211 1


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      ......++..|+|||++.+..++.++||||||+++|||+| |..||...+...   ......   ...       ...  
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~---~~~-------~~~--  220 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKID---KEG-------ERL--  220 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH---hcC-------CcC--
Confidence            1112336789999999988889999999999999999999 999986543321   111100   000       000  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                          ..+...+..+.+++.+|++.+|++|||+.+|++.|.
T Consensus       221 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ----ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                001123457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.4e-38  Score=330.49  Aligned_cols=256  Identities=27%  Similarity=0.403  Sum_probs=199.2

Q ss_pred             CeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      .+.||+|+||.||++.+.      .++.||||+++... ....+.+.+|+.+|.++. ||||+++++++...+..++|||
T Consensus        42 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E  121 (401)
T cd05107          42 GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITE  121 (401)
T ss_pred             hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEe
Confidence            356899999999999853      24689999997543 233457889999999997 9999999999999999999999


Q ss_pred             cCCCCChHHHhccCCC----------------------------------------------------------------
Q 008698          346 FVVNGPLDRWLHHIPR----------------------------------------------------------------  361 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~----------------------------------------------------------------  361 (557)
                      |+++|+|.++++....                                                                
T Consensus       122 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (401)
T cd05107         122 YCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKY  201 (401)
T ss_pred             ccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhh
Confidence            9999999999964321                                                                


Q ss_pred             ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCc
Q 008698          362 ------------------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA  411 (557)
Q Consensus       362 ------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~  411 (557)
                                                    ....+++..++.++.||+.||.|||+.   +++||||||+|||+++++.+
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~  278 (401)
T cd05107         202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLV  278 (401)
T ss_pred             hhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEE
Confidence                                          113477888999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhh
Q 008698          412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWAT  490 (557)
Q Consensus       412 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~  490 (557)
                      ||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+  .+..   
T Consensus       279 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--~~~~---  353 (401)
T cd05107         279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--QFYN---  353 (401)
T ss_pred             EEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--HHHH---
Confidence            9999999976432221111112236788999999988889999999999999999998 888986543211  0100   


Q ss_pred             hhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       491 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                       ....+.     ..        ..+...+..+.+++.+||+.+|++||++++|++.|+++.
T Consensus       354 -~~~~~~-----~~--------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         354 -AIKRGY-----RM--------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -HHHcCC-----CC--------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence             000000     00        011123467899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6e-39  Score=327.50  Aligned_cols=240  Identities=23%  Similarity=0.267  Sum_probs=193.4

Q ss_pred             eecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +||+|+||.||++.. .+|+.||+|+++...   ......+.+|+.++..++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            579999999999985 468999999997542   2334567889999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      |..++..    ...+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++.+||+|||+++........  
T Consensus        82 L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--  152 (325)
T cd05594          82 LFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--  152 (325)
T ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--
Confidence            9988854    3468999999999999999999997 6   9999999999999999999999999998753222111  


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....||+.|+|||++.+..++.++|||||||++|||+||..||...+....   ....    ...      ...     
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~---~~~i----~~~------~~~-----  214 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI----LME------EIR-----  214 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH---HHHH----hcC------CCC-----
Confidence            1223489999999999988999999999999999999999999976543211   1100    000      000     


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                         .+......+.+++.+|++.||++||     ++.++++
T Consensus       215 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         215 ---FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence               0112335688999999999999997     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.8e-38  Score=319.42  Aligned_cols=256  Identities=24%  Similarity=0.407  Sum_probs=202.2

Q ss_pred             CeeecccCceEEEEEEe--------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEE
Q 008698          274 NRLLGDSKTGGTYSGIL--------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~--------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV  343 (557)
                      .+.||+|+||.||++..        .++..||+|.+.... ......+.+|+.++..+ +||||+++++++...+..++|
T Consensus        20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   99 (304)
T cd05101          20 GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI   99 (304)
T ss_pred             cceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEE
Confidence            35679999999999973        124579999987542 34457789999999999 899999999999999999999


Q ss_pred             EecCCCCChHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCc
Q 008698          344 YEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA  411 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~  411 (557)
                      |||+++|+|.+++.....            ....+++.+++.++.||+.||.|||++   +++||||||+|||++.++.+
T Consensus       100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~~  176 (304)
T cd05101         100 VEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVM  176 (304)
T ss_pred             EecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCCCcE
Confidence            999999999999975321            124588899999999999999999999   99999999999999999999


Q ss_pred             EEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhh
Q 008698          412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWAT  490 (557)
Q Consensus       412 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~  490 (557)
                      ||+|||+++...............+++.|+|||++.+..++.++||||||+++|||+| |..||...+...   +...  
T Consensus       177 kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~--  251 (304)
T cd05101         177 KIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFKL--  251 (304)
T ss_pred             EECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHH--
Confidence            9999999986644332222222335678999999988889999999999999999999 788876543221   1111  


Q ss_pred             hhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       491 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                        .....             ....+..++..+.+++.+||+.+|++|||+.+|++.|+++..
T Consensus       252 --~~~~~-------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         252 --LKEGH-------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             --HHcCC-------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence              11110             000112345678899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.4e-38  Score=315.25  Aligned_cols=260  Identities=24%  Similarity=0.359  Sum_probs=201.0

Q ss_pred             CeeecccCceEEEEEEeCC-----------------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeee
Q 008698          274 NRLLGDSKTGGTYSGILPD-----------------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCY  335 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~  335 (557)
                      .+.||+|+||.||++...+                 +..||+|.+.... ....+.+.+|+.++.+++||||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05051          10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT   89 (296)
T ss_pred             cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            3467999999999988542                 2468999987653 344678899999999999999999999999


Q ss_pred             eCCceEEEEecCCCCChHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 008698          336 DHGDRYIVYEFVVNGPLDRWLHHIPR-------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE  408 (557)
Q Consensus       336 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~  408 (557)
                      ..+..++||||+++++|.+++.....       ....+++..++.++.|++.||+|||+.   +++||||||+||+++++
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~~  166 (296)
T cd05051          90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKN  166 (296)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecCC
Confidence            99999999999999999999865331       123689999999999999999999999   99999999999999999


Q ss_pred             CCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCcccchhHH
Q 008698          409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQAVDSVCWQSIF  486 (557)
Q Consensus       409 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t--G~~p~~~~~~~~~~~~~  486 (557)
                      +.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++  |..|+...+..   ...
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~~  243 (296)
T cd05051         167 YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ---QVI  243 (296)
T ss_pred             CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH---HHH
Confidence            9999999999976543332222223336788999999988889999999999999999998  67777654321   111


Q ss_pred             HhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       487 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                      ................          ..+...+.++.+++.+|++.+|++|||+.+|++.|++
T Consensus       244 ~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         244 ENAGHFFRDDGRQIYL----------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHHhccccccccccC----------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            1111111100000000          0111234579999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-38  Score=310.09  Aligned_cols=250  Identities=30%  Similarity=0.459  Sum_probs=203.7

Q ss_pred             eecccCceEEEEEEeCC----CCEEEEEEecccchhh-HHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILPD----GSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~----g~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .||+|+||.||++...+    +..|++|.++...... .+.+.+|+..+..++|+||+++++++.+....++||||++++
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG   81 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence            57999999999999754    7899999998664333 678999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          351 PLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       351 sL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      +|.+++......     ...+++.++..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||.+......
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999764221     36799999999999999999999999   9999999999999999999999999999876544


Q ss_pred             ccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      ..........++..|+|||.+....++.++||||||++++||++ |..||.......   +.+..    ....       
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~~~-------  224 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYL----RKGY-------  224 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcCC-------
Confidence            32222223337889999999988889999999999999999999 699987653321   11111    0000       


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                            ....+...+..+.+++.+||+.+|++|||++++++.|+
T Consensus       225 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  00111223567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.9e-38  Score=315.94  Aligned_cols=263  Identities=21%  Similarity=0.295  Sum_probs=189.4

Q ss_pred             CeeecccCceEEEEEEeC--CCCEEEEEEecccc--hhhHHHHHHHHHHHhhc---CCCcEEeeeeeee-----eCCceE
Q 008698          274 NRLLGDSKTGGTYSGILP--DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARL---HHPNLVAVKGCCY-----DHGDRY  341 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~--~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~l~g~~~-----~~~~~~  341 (557)
                      .+.||+|+||.||++...  +|+.||||.++...  ......+.+|+.++..+   +||||+++++++.     .....+
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~   85 (290)
T cd07862           6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   85 (290)
T ss_pred             eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence            346799999999999863  46889999986432  12234566677766665   6999999999885     235689


Q ss_pred             EEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      +||||+. ++|.+++....  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        86 lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          86 LVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             EEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            9999995 68999886532  34589999999999999999999999   999999999999999999999999999976


Q ss_pred             CCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhhhhhhcccccc
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  500 (557)
                      .....   ......|++.|+|||.+.+..++.++|||||||++|||++|++||......+. ..+.+............+
T Consensus       160 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         160 YSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             ccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            54321   12223489999999999888899999999999999999999999987644221 111111100000000000


Q ss_pred             c-c-CcccccCCCCCC---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 L-L-DPLISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~-~-d~~l~~~~~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      . + ............   ..+.+..+.+++.+|++.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0 0 000000000000   0123456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.9e-38  Score=311.39  Aligned_cols=249  Identities=27%  Similarity=0.404  Sum_probs=198.1

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|+||.||+|...++..||+|.++... ...+.+.+|+.++.+++||||+++++.+. .+..++||||+++|+|.
T Consensus        11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~   88 (262)
T cd05071          11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL   88 (262)
T ss_pred             eeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHH
Confidence            34579999999999998777789999997543 23467899999999999999999999874 45679999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++...  ....+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||.++.......... ..
T Consensus        89 ~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~-~~  162 (262)
T cd05071          89 DFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QG  162 (262)
T ss_pred             HHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccc-cC
Confidence            999642  234588999999999999999999999   999999999999999999999999999976543322111 11


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ..++..|+|||+..+..++.++||||||+++|||+| |..||.......   ....   . ...     .        ..
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~~---~-~~~-----~--------~~  222 (262)
T cd05071         163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQ---V-ERG-----Y--------RM  222 (262)
T ss_pred             CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHHH---H-hcC-----C--------CC
Confidence            225678999999988889999999999999999999 888886543221   1110   0 000     0        00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ....+.+..+.+++.+|++.+|++||+++++++.|+..
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            01123456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-38  Score=308.70  Aligned_cols=245  Identities=30%  Similarity=0.457  Sum_probs=201.0

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|++|.||++.. .|+.||||.++.... ..+++.+|+.++.+++|+||+++++++.+.+..++||||+++++|.
T Consensus        11 ~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   88 (256)
T cd05039          11 GATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV   88 (256)
T ss_pred             eeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence            44679999999999987 589999999976644 5678999999999999999999999999899999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++.......     .
T Consensus        89 ~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~  158 (256)
T cd05039          89 DYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----S  158 (256)
T ss_pred             HHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-----c
Confidence            999752  223689999999999999999999999   999999999999999999999999999986632211     1


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...+..|+|||++....++.++||||||+++|||++ |..||......   .+....    ....     .       . 
T Consensus       159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~----~~~~-----~-------~-  218 (256)
T cd05039         159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPHV----EKGY-----R-------M-  218 (256)
T ss_pred             CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----hcCC-----C-------C-
Confidence            225678999999988889999999999999999997 99998654322   111111    0000     0       0 


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ..+...+..+.+++.+||+.+|++|||+++++++|+++
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            00112346788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-38  Score=315.91  Aligned_cols=260  Identities=23%  Similarity=0.330  Sum_probs=197.4

Q ss_pred             CeeecccCceEEEEEEeCC---------------CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC
Q 008698          274 NRLLGDSKTGGTYSGILPD---------------GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH  337 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~---------------g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~  337 (557)
                      .+.||+|+||.||++...+               ...||+|.++.. .......|.+|++++.+++||||+++++++...
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   89 (295)
T cd05097          10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD   89 (295)
T ss_pred             hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence            3467999999999987532               235899998764 233456799999999999999999999999999


Q ss_pred             CceEEEEecCCCCChHHHhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008698          338 GDRYIVYEFVVNGPLDRWLHHIPR--------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  409 (557)
Q Consensus       338 ~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~  409 (557)
                      +..++||||+++++|.+++.....        ....+++..++.++.|++.||+|||+.   +++||||||+|||+++++
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~~~  166 (295)
T cd05097          90 DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHY  166 (295)
T ss_pred             CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcCCC
Confidence            999999999999999999864211        112478899999999999999999999   999999999999999999


Q ss_pred             CcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCcccchhHHH
Q 008698          410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQAVDSVCWQSIFE  487 (557)
Q Consensus       410 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t--G~~p~~~~~~~~~~~~~~  487 (557)
                      .+||+|||++................++..|+|||.+.+..++.++||||||+++|||++  |..||......   ....
T Consensus       167 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~---~~~~  243 (295)
T cd05097         167 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE---QVIE  243 (295)
T ss_pred             cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH---HHHH
Confidence            999999999976543322222222235778999999988889999999999999999998  56677654332   1111


Q ss_pred             hhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       488 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                      ...............          ..+...+..+.+++.+||+.+|++|||+++|++.|++
T Consensus       244 ~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         244 NTGEFFRNQGRQIYL----------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHhhhhccccccC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            111111100000000          0011134579999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.2e-38  Score=318.62  Aligned_cols=257  Identities=25%  Similarity=0.407  Sum_probs=201.1

Q ss_pred             CCeeecccCceEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEE
Q 008698          273 GNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l  342 (557)
                      ..+.||+|+||.||++...        ++..+|+|.++... .....++.+|+.++.++ +||||+++++++...+..++
T Consensus        22 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  101 (307)
T cd05098          22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV  101 (307)
T ss_pred             EeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            3456799999999998742        23579999997542 33456788999999999 79999999999999999999


Q ss_pred             EEecCCCCChHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 008698          343 VYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG  410 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~  410 (557)
                      ||||+++|+|.+++.....            ....+++.+++.++.|++.||+|||++   +++||||||+|||++.++.
T Consensus       102 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~  178 (307)
T cd05098         102 IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNV  178 (307)
T ss_pred             EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCCc
Confidence            9999999999999975321            123589999999999999999999998   9999999999999999999


Q ss_pred             cEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhh
Q 008698          411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA  489 (557)
Q Consensus       411 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~  489 (557)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......   +... 
T Consensus       179 ~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---~~~~-  254 (307)
T cd05098         179 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKL-  254 (307)
T ss_pred             EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH-
Confidence            99999999876543222111122224578999999988889999999999999999998 888886543211   1110 


Q ss_pred             hhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       490 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                         ......            . ..+...+..+.+++.+||+.+|++|||+.+|++.|+++.+
T Consensus       255 ---~~~~~~------------~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         255 ---LKEGHR------------M-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             ---HHcCCC------------C-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence               111100            0 0112234578899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-38  Score=325.84  Aligned_cols=240  Identities=23%  Similarity=0.326  Sum_probs=194.4

Q ss_pred             CeeecccCceEEEEEEeCC--CCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILPD--GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~--g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|+||.||+|...+  +..||+|++....   ......+.+|+.++..++||||+++++++.+.+..++||||++
T Consensus        35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~  114 (340)
T PTZ00426         35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI  114 (340)
T ss_pred             EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence            3467999999999998543  3689999986542   2334578899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.......  
T Consensus       115 ~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~--  185 (340)
T PTZ00426        115 GGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT--  185 (340)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc--
Confidence            9999999864    34689999999999999999999999   99999999999999999999999999998654221  


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                         ....||+.|+|||++.+..++.++|||||||++|||++|..||...+....   ..   ..         .+...  
T Consensus       186 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~---~i---------~~~~~--  245 (340)
T PTZ00426        186 ---YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---YQ---KI---------LEGII--  245 (340)
T ss_pred             ---ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---HH---HH---------hcCCC--
Confidence               223489999999999988899999999999999999999999986543211   10   00         00000  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVHQ  546 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~~  546 (557)
                          ..+......+.+++.+|++.+|++|+     +++++++.
T Consensus       246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                00112234578999999999999995     88888763

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-38  Score=307.61  Aligned_cols=248  Identities=26%  Similarity=0.393  Sum_probs=200.0

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      +||+|++|.||++...+++.||+|.++..... ....+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~   81 (251)
T cd05041           2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT   81 (251)
T ss_pred             ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence            57999999999999877999999998765433 55789999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++...   ...+++..++.++.+++.||+|||++   +++||||||+|||++.++.+||+|||++...............
T Consensus        82 ~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          82 FLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            98642   23588999999999999999999999   9999999999999999999999999999765422221111122


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      ..+..|+|||.+.+..++.++||||||+++|||+| |..||...........   .    ...     .        ...
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---~----~~~-----~--------~~~  215 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---I----ESG-----Y--------RMP  215 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---H----hcC-----C--------CCC
Confidence            24567999999988889999999999999999999 8888866543211110   0    000     0        000


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                      .+...+..+.+++.+|++.+|++|||++||++.|+.
T Consensus       216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            112344578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.5e-38  Score=321.59  Aligned_cols=239  Identities=23%  Similarity=0.294  Sum_probs=188.9

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .||+|+||.||++... +++.||||+++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5799999999999964 47899999997542   22334556677777654 8999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|..++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        82 ~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~  152 (316)
T cd05592          82 DLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--K  152 (316)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--c
Confidence            99998864    24589999999999999999999999   999999999999999999999999999975432221  1


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+...   +....   .. .      .+      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~i---~~-~------~~------  213 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDSI---LN-D------RP------  213 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHHH---Hc-C------CC------
Confidence            122348999999999998889999999999999999999999998654321   11110   00 0      00      


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVV  544 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~-evl  544 (557)
                        ..+......+.+++.+||+.+|++||++. +++
T Consensus       214 --~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         214 --HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             --CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence              01112345678999999999999999875 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.9e-38  Score=309.56  Aligned_cols=247  Identities=27%  Similarity=0.418  Sum_probs=197.4

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      ..||+|++|.||++...++..+|+|.+.... ...+.+.+|+.++++++|||++++++++. .+..++||||+++|+|.+
T Consensus        12 ~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~   89 (260)
T cd05069          12 VKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLD   89 (260)
T ss_pred             eeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHH
Confidence            4679999999999998777789999986543 33567899999999999999999999875 456899999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++........... ...
T Consensus        90 ~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~-~~~  163 (260)
T cd05069          90 FLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR-QGA  163 (260)
T ss_pred             HHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc-CCC
Confidence            99752  234589999999999999999999999   999999999999999999999999999976543221111 112


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      .++..|+|||...+..++.++||||||+++|||+| |..||.......   .....    ...     ...        .
T Consensus       164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~-----~~~--------~  223 (260)
T cd05069         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQV----ERG-----YRM--------P  223 (260)
T ss_pred             ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC-----CCC--------C
Confidence            25678999999988889999999999999999999 899987643321   11110    000     000        0


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                      .+.+.+..+.+++.+||+.+|++||++++|++.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            112345678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-38  Score=312.10  Aligned_cols=250  Identities=28%  Similarity=0.469  Sum_probs=196.4

Q ss_pred             eecccCceEEEEEEeCC-CC--EEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILPD-GS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~-g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +||+|+||.||+|...+ +.  .+|+|.++.. .......+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            57999999999999754 43  5788988753 234456789999999999 8999999999999999999999999999


Q ss_pred             ChHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccC
Q 008698          351 PLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL  418 (557)
Q Consensus       351 sL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  418 (557)
                      +|.+++.....            ....+++.++..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence            99999865321            123588999999999999999999998   999999999999999999999999999


Q ss_pred             CccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                      +......   ........+..|+|||++....++.++||||||+++|||+| |..||...+..   ......    ....
T Consensus       159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~----~~~~  228 (270)
T cd05047         159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKL----PQGY  228 (270)
T ss_pred             ccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHHH----hCCC
Confidence            8633211   11111224567999999988889999999999999999997 99998654321   111110    0000


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                         ..+          .+...+..+.+++.+||+.+|.+|||++++++.|+++.
T Consensus       229 ---~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 ---RLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ---CCC----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence               000          01123456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5e-38  Score=311.34  Aligned_cols=251  Identities=25%  Similarity=0.436  Sum_probs=199.7

Q ss_pred             CeeecccCceEEEEEEeCC-C---CEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILPD-G---SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|++|.||+|.... +   ..+|+|.++.. .....+.+.+|+.++.+++||||+++.+++...+..++||||++
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (268)
T cd05063          10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME   89 (268)
T ss_pred             eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence            4568999999999999743 3   37999998754 23445678999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +++|.+++...   ...+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.........
T Consensus        90 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  163 (268)
T cd05063          90 NGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG  163 (268)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence            99999998642   24689999999999999999999999   9999999999999999999999999999765433221


Q ss_pred             cce-eecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          429 ERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       429 ~~~-~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ... .....+..|+|||++.+..++.++||||||+++|||+| |..||...+...   +....    ...         .
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i----~~~---------~  227 (268)
T cd05063         164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAI----NDG---------F  227 (268)
T ss_pred             ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHH----hcC---------C
Confidence            111 11113467999999988889999999999999999998 999987544321   11110    000         0


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                          ......+.+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                0001122346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=328.56  Aligned_cols=235  Identities=24%  Similarity=0.344  Sum_probs=196.6

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ++||+|+||.|+.+..+ +++.+|||++++...   ...+....|-+++... +||.++.++.++...++.|.||||+.|
T Consensus       374 ~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~G  453 (694)
T KOG0694|consen  374 AVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAG  453 (694)
T ss_pred             EEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCC
Confidence            56899999999999975 478999999998743   3456677888887777 699999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |++..+.+     ...+++..+..++..|+.||+|||++   +||+||||.+|||||.+|.+||+|||+++..-.  ...
T Consensus       454 gdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g~  523 (694)
T KOG0694|consen  454 GDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QGD  523 (694)
T ss_pred             CcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC--CCC
Confidence            99543332     36699999999999999999999999   999999999999999999999999999985432  234


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      .+.+.+||+.|||||++.+..||..+|-|||||+||||+.|..||.+.+.++                   ++|..+.. 
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------------------~FdsI~~d-  583 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------------------VFDSIVND-  583 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------------------HHHHHhcC-
Confidence            5667789999999999999999999999999999999999999999876542                   22222211 


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  540 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~  540 (557)
                       .-.+|..++.+...++.+.+..+|++|.-+
T Consensus       584 -~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 -EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence             112344566788999999999999999976

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-38  Score=314.83  Aligned_cols=247  Identities=19%  Similarity=0.259  Sum_probs=196.6

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .++||+|+||.||++... +++.||||.+.....   .....+.+|+.++.+++||||+++++.+...+..++||||+++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05605           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG   84 (285)
T ss_pred             EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence            356899999999999864 689999999975422   2235678899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++......... 
T Consensus        85 ~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  158 (285)
T cd05605          85 GDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI-  158 (285)
T ss_pred             CcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc-
Confidence            9999888642  234689999999999999999999999   9999999999999999999999999999765422211 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....|+..|+|||++.+..++.++||||||+++|||++|..||..........   .....         +...    
T Consensus       159 --~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~---------~~~~----  220 (285)
T cd05605         159 --RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERR---------VKED----  220 (285)
T ss_pred             --ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHH---------hhhc----
Confidence              12348899999999998889999999999999999999999998654321110   00000         0000    


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                       ....+...+..+.+++.+||+.||++||     +++++++
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         221 -QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             -ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence             0011123455688999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.1e-38  Score=322.75  Aligned_cols=235  Identities=29%  Similarity=0.368  Sum_probs=189.2

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +||+|+||.||++... +++.||||+++...   ......+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            5799999999999964 58899999997542   23345677888888877 7999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        82 ~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~  152 (320)
T cd05590          82 DLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T  152 (320)
T ss_pred             hHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence            99998864    24589999999999999999999999   999999999999999999999999999875322211  1


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+...   +.+..   . ..   .     .    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i---~-~~---~-----~----  213 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAI---L-ND---E-----V----  213 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHH---h-cC---C-----C----
Confidence            122348999999999998889999999999999999999999997654321   11111   0 00   0     0    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRM  540 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~  540 (557)
                        ..+...+..+.+++.+|++.||++||++
T Consensus       214 --~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         214 --VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence              0111234568899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.2e-38  Score=322.67  Aligned_cols=247  Identities=23%  Similarity=0.300  Sum_probs=193.0

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +||+|+||.||++... +++.||||+++...   ......+.+|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            5799999999999864 58899999997542   23345678899999988 7999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++..    ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~  152 (329)
T cd05588          82 DLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT  152 (329)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence            99988854    24699999999999999999999999   99999999999999999999999999987432111  11


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccc--chhHHHhhhhhhhccccccccCccccc
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC--WQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......  .....++.....        .....  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~--  222 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--------LEKQI--  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--------HcCCC--
Confidence            222348999999999999899999999999999999999999996432211  011111111111        11100  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPR------MSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt------~~evl~  545 (557)
                         . .+...+..+.+++.+|++.||++||+      ++++++
T Consensus       223 ---~-~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         223 ---R-IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ---C-CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence               0 11123456889999999999999997      567764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-38  Score=323.23  Aligned_cols=240  Identities=25%  Similarity=0.331  Sum_probs=192.3

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +||+|+||.||+|... +++.||||+++...   ......+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            5799999999999975 47899999997542   23345677888888876 8999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|..++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.........  
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--  152 (321)
T cd05591          82 DLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--  152 (321)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcc--
Confidence            99988864    24588999999999999999999999   9999999999999999999999999998754322111  


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+...   +....   .. .   +..        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~i---~~-~---~~~--------  214 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFESI---LH-D---DVL--------  214 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHHH---Hc-C---CCC--------
Confidence            122348999999999998899999999999999999999999998654321   11110   00 0   000        


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRP-------RMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-------t~~evl~  545 (557)
                         .+......+.+++.+|++.||++||       +++++++
T Consensus       215 ---~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         215 ---YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             ---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence               0111235688999999999999999       7777774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-38  Score=309.18  Aligned_cols=250  Identities=28%  Similarity=0.455  Sum_probs=202.0

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|++|.||++..++++.||||.+.... ...+++.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   89 (261)
T cd05034          11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL   89 (261)
T ss_pred             eeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence            45679999999999998888899999997653 34567999999999999999999999999889999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++...  .+..+++..+..++.|++.||.|||++   +++|+||||+||++++++.+||+|||++............ .
T Consensus        90 ~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~-~  163 (261)
T cd05034          90 DFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE-G  163 (261)
T ss_pred             HHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhh-c
Confidence            999752  235689999999999999999999999   9999999999999999999999999998766432211111 1


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...+..|+|||.+.+..++.++||||||+++|||+| |+.||......   ........         ...        .
T Consensus       164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~---------~~~--------~  223 (261)
T cd05034         164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVER---------GYR--------M  223 (261)
T ss_pred             cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc---------CCC--------C
Confidence            124578999999998889999999999999999999 99998654321   11111100         000        0


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ..+.+.+..+.+++.+|++.+|++||+++++++.|+..
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence            01112345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.4e-38  Score=322.43  Aligned_cols=247  Identities=22%  Similarity=0.288  Sum_probs=191.7

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +||+|+||.||++... +++.||+|+++..   .......+.+|..++.++ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            5799999999999964 5789999999754   223345677888888877 8999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|..++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        82 ~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~  152 (329)
T cd05618          82 DLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T  152 (329)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence            99988854    24689999999999999999999999   999999999999999999999999999875322211  1


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc--hhHHHhhhhhhhccccccccCccccc
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW--QSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      .....||+.|+|||++.+..++.++|||||||++|||+||+.||........  .....+........        ..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------~~--  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------QI--  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--------CC--
Confidence            1223489999999999999999999999999999999999999964321110  01111111111100        00  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPR------MSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt------~~evl~  545 (557)
                          ..+......+.+++.+||+.||++||+      +.++++
T Consensus       223 ----~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         223 ----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             ----CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence                011223456889999999999999998      456654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.7e-38  Score=311.20  Aligned_cols=251  Identities=25%  Similarity=0.452  Sum_probs=199.6

Q ss_pred             CeeecccCceEEEEEEeCC-C---CEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILPD-G---SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|+||.||+|.... +   ..||||.+... ......+|..|+.++++++||||+++++++.+.+..++||||++
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   88 (269)
T cd05065           9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME   88 (269)
T ss_pred             EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence            4568999999999999643 3   36999998754 34446789999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++...   ...+++.+++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.........
T Consensus        89 ~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~  162 (269)
T cd05065          89 NGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  162 (269)
T ss_pred             CCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence            99999998642   34689999999999999999999999   9999999999999999999999999998765432211


Q ss_pred             cc-eeecC--ccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          429 ER-TVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       429 ~~-~~~~~--gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      .. .....  .+..|+|||.+.+..++.++||||||+++|||++ |..||...+..   .......    ..     .  
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~----~~-----~--  228 (269)
T cd05065         163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE----QD-----Y--  228 (269)
T ss_pred             cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH----cC-----C--
Confidence            11 11111  2457999999998899999999999999999997 99998765432   1111110    00     0  


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                            ....+.+++..+.+++.+||+.+|++||++++|++.|+++
T Consensus       229 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 ------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  0001123455688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.7e-38  Score=320.24  Aligned_cols=240  Identities=23%  Similarity=0.326  Sum_probs=190.4

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .||+|+||.||+|... +++.||||+++...   ......+..|..++... +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            5799999999999975 47899999997642   12345566777777764 9999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++..    ...+++.++..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  152 (316)
T cd05619          82 DLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K  152 (316)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence            99999864    24588999999999999999999999   999999999999999999999999999874322111  1


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..   .+.....    .      ..+..    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~----~------~~~~~----  215 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIR----M------DNPCY----  215 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----h------CCCCC----
Confidence            12234899999999999889999999999999999999999999765432   1111110    0      00100    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~-evl~  545 (557)
                          +......+.+++.+||+.+|++||++. ++.+
T Consensus       216 ----~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         216 ----PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ----CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence                111334678999999999999999997 6643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.4e-38  Score=315.29  Aligned_cols=252  Identities=26%  Similarity=0.428  Sum_probs=198.5

Q ss_pred             eeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      ..||+|+||.||++...      ++..||+|.+.... .....++.+|+..+++++||||+++++++.+.+..++||||+
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   90 (288)
T cd05050          11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYM   90 (288)
T ss_pred             ccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecC
Confidence            35699999999999853      46789999987543 344567999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008698          348 VNGPLDRWLHHIP------------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  409 (557)
Q Consensus       348 ~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~  409 (557)
                      ++|+|.+++....                  .....+++.+++.++.|++.||+|||+.   +++||||||+|||++.++
T Consensus        91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~~  167 (288)
T cd05050          91 AYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENM  167 (288)
T ss_pred             CCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecCCC
Confidence            9999999996421                  1123578899999999999999999999   999999999999999999


Q ss_pred             CcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHh
Q 008698          410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEW  488 (557)
Q Consensus       410 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~  488 (557)
                      .+||+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||......+   ... 
T Consensus       168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~---~~~-  243 (288)
T cd05050         168 VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE---VIY-  243 (288)
T ss_pred             ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-
Confidence            999999999875433221111111224678999999988899999999999999999998 888886543321   111 


Q ss_pred             hhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       489 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                         ......        ..     ..+...+.++.+++.+|++.+|++|||+.||++.|++
T Consensus       244 ---~~~~~~--------~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         244 ---YVRDGN--------VL-----SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---HHhcCC--------CC-----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence               011110        00     0011234678999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.4e-38  Score=320.92  Aligned_cols=240  Identities=23%  Similarity=0.309  Sum_probs=193.2

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +||+|+||.||++... +++.||||+++...   ......+.+|..++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5799999999999875 47899999997542   23345677888888888 7999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|..++..    ...+++.++..++.|++.||.|||+.   +++||||||+|||+++++.+||+|||+++........  
T Consensus        82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  152 (318)
T cd05570          82 DLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--  152 (318)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--
Confidence            99988864    24689999999999999999999999   9999999999999999999999999998653222111  


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||...+...   +....   . ...        .    
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~~i---~-~~~--------~----  213 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQSI---L-EDE--------V----  213 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHHHH---H-cCC--------C----
Confidence            122348999999999999999999999999999999999999997654321   11110   0 000        0    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRM-----SHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~-----~evl~  545 (557)
                        ..+...+..+.+++.+||+.||++||++     .++++
T Consensus       214 --~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         214 --RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             --CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence              0111234568899999999999999999     88765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1e-37  Score=314.09  Aligned_cols=260  Identities=21%  Similarity=0.322  Sum_probs=198.8

Q ss_pred             CeeecccCceEEEEEEeC-----------------CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeee
Q 008698          274 NRLLGDSKTGGTYSGILP-----------------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCY  335 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-----------------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~  335 (557)
                      .+.||+|+||.||++...                 ++..||+|+++.. ......++.+|+.++.+++|+||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05095          10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI   89 (296)
T ss_pred             eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            446799999999997532                 2446999999754 2334578999999999999999999999999


Q ss_pred             eCCceEEEEecCCCCChHHHhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 008698          336 DHGDRYIVYEFVVNGPLDRWLHHIPRG-------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE  408 (557)
Q Consensus       336 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~  408 (557)
                      ..+..++||||+++|+|.+++......       ...+++.++..++.|++.||+|||+.   +++|+||||+|||++.+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~~~  166 (296)
T cd05095          90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKN  166 (296)
T ss_pred             cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEcCC
Confidence            999999999999999999998753211       23578889999999999999999999   99999999999999999


Q ss_pred             CCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCcccchhHH
Q 008698          409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQAVDSVCWQSIF  486 (557)
Q Consensus       409 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t--G~~p~~~~~~~~~~~~~  486 (557)
                      +.++|+|||+++...............++..|+|||...++.++.++|||||||++|||+|  |..||.......   ..
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~---~~  243 (296)
T cd05095         167 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ---VI  243 (296)
T ss_pred             CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH---HH
Confidence            9999999999976543322221222224678999999888889999999999999999998  778886543321   11


Q ss_pred             HhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       487 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                      .............. ..         ..+..++..+.+++.+||+.||++||++.+|++.|++
T Consensus       244 ~~~~~~~~~~~~~~-~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         244 ENTGEFFRDQGRQV-YL---------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHhhccccc-cC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11111111000000 00         0112244678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-38  Score=325.17  Aligned_cols=263  Identities=19%  Similarity=0.263  Sum_probs=191.4

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-----CceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E  345 (557)
                      .+.||+|+||.||+|... +|+.||||+++..  ......++.+|+.++++++||||+++++++...     ...++|||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e   84 (338)
T cd07859           5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE   84 (338)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence            356899999999999964 6899999998643  223345788999999999999999999988643     24799999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      |+. ++|.+++..    ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          85 LME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             cCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            995 689888853    34589999999999999999999999   9999999999999999999999999999754322


Q ss_pred             ccc-cceeecCccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhh--------hhhh
Q 008698          426 VMQ-ERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT--------PLVQ  494 (557)
Q Consensus       426 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~--------~~~~  494 (557)
                      ... .......||..|+|||++.+  ..++.++|||||||++|||+||+.||...+............        ....
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            111 11122348999999999865  578999999999999999999999997654321111100000        0000


Q ss_pred             ccccccccCcccccCCCCCC---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          495 SHRYLELLDPLISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       495 ~~~~~~~~d~~l~~~~~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .....+.++..... .....   .......+.+++.+||+.+|++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         237 NEKARRYLSSMRKK-QPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hhhHHHHHHhhccc-CCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000000000000 00000   0012356789999999999999999999996

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.6e-38  Score=312.42  Aligned_cols=251  Identities=29%  Similarity=0.460  Sum_probs=198.4

Q ss_pred             eecccCceEEEEEEeCC-------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          276 LLGDSKTGGTYSGILPD-------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~-------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +||+|+||.||+|...+       +..+|||.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            47999999999998643       2579999886542 244678899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-----CcEEeeccCC
Q 008698          348 VNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-----GAHLMGVGLS  419 (557)
Q Consensus       348 ~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~Dfgl~  419 (557)
                      ++++|.+++.....   ....+++.+++.++.|++.||.|||+.   +++|+||||+||+++.+.     .++++|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            99999999965321   224588999999999999999999998   999999999999999877     8999999999


Q ss_pred             ccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhcccc
Q 008698          420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY  498 (557)
Q Consensus       420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (557)
                      +...............++..|+|||++.+..++.++||||||+++|||+| |..||...+...   .....    ...  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~--  229 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV----TAG--  229 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH----hcC--
Confidence            76543322222222235688999999998899999999999999999998 999986543211   11100    000  


Q ss_pred             ccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       499 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                           ...      ..+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus       230 -----~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         230 -----GRL------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -----Ccc------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                 000      1112245678999999999999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-38  Score=308.04  Aligned_cols=248  Identities=29%  Similarity=0.422  Sum_probs=197.6

Q ss_pred             eecccCceEEEEEEeCC----CCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILPD----GSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~----g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .||+|+||.||+|++..    +..+|+|.+..... ...+++.+|+.+++++.||||+++++++. .+..++||||+++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~   80 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG   80 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence            47999999999998532    26899999976543 34568999999999999999999999875 45689999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||+++..........
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          81 PLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999642    3689999999999999999999999   999999999999999999999999999986643322111


Q ss_pred             -eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          431 -TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       431 -~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..   .+.....    ....          
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~----~~~~----------  216 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLE----SGER----------  216 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----cCCc----------
Confidence             111124568999999988889999999999999999998 99998765432   1111111    1100          


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                         ...+..++..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus       217 ---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         217 ---LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence               0011223457889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=297.50  Aligned_cols=230  Identities=24%  Similarity=0.351  Sum_probs=194.2

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +.||.|+||.|-.++.+ +|..+|+|++++...   ...+...+|-.+|+.+.||+++++.+.+.+.+..++||||+++|
T Consensus        50 ~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GG  129 (355)
T KOG0616|consen   50 KTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGG  129 (355)
T ss_pred             eeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCc
Confidence            35799999999999864 588999999987643   33456788999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      -|.++|+.    .+.+++...+.+|.||+.||.|||+.   +|++|||||+|||||.+|.+||+|||+|+...     ..
T Consensus       130 ElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-----~r  197 (355)
T KOG0616|consen  130 ELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS-----GR  197 (355)
T ss_pred             cHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec-----Cc
Confidence            99999975    35699999999999999999999999   99999999999999999999999999998764     23


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      +.+.+||+.|+|||.+++..+..++|-|||||++|||+.|.+||....+.   .+.+            .++...+    
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~---~iY~------------KI~~~~v----  258 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI---QIYE------------KILEGKV----  258 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH---HHHH------------HHHhCcc----
Confidence            55677999999999999999999999999999999999999999876552   1111            1111111    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCC
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMR  537 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~R  537 (557)
                        ..|.-....+.+|+...++.|-.+|
T Consensus       259 --~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 --KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence              1222344568889999999998888

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.2e-37  Score=312.31  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=199.8

Q ss_pred             CeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      .+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+..+++++||||+++++++.+.+..++||||
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   90 (288)
T cd05061          11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL   90 (288)
T ss_pred             eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence            346799999999999753      24589999986543 23445788999999999999999999999999999999999


Q ss_pred             CCCCChHHHhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          347 VVNGPLDRWLHHIPR------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      +++|+|.+++.....      ....+++..+..++.|++.||.|||++   +|+||||||+|||+++++.+||+|||+++
T Consensus        91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~  167 (288)
T cd05061          91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR  167 (288)
T ss_pred             CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCccc
Confidence            999999999965321      123457788899999999999999999   99999999999999999999999999988


Q ss_pred             cCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ...............++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+   ....   .....   
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~---~~~~~---  238 (288)
T cd05061         168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKF---VMDGG---  238 (288)
T ss_pred             cccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---HHcCC---
Confidence            6543222111112225678999999998889999999999999999999 788886543321   1110   00000   


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                            .    . ..+..++..+.+++.+|++.+|++|||+.++++.|++..-+
T Consensus       239 ------~----~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  281 (288)
T cd05061         239 ------Y----L-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP  281 (288)
T ss_pred             ------C----C-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence                  0    0 00112345799999999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.2e-38  Score=320.24  Aligned_cols=242  Identities=21%  Similarity=0.266  Sum_probs=190.2

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +||+|+||.||++... +++.||+|+++...   ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            5799999999999964 57899999997642   23345678899999888 6999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|..++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  152 (327)
T cd05617          82 DLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT  152 (327)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence            99988853    24699999999999999999999999   99999999999999999999999999987532211  11


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||............+........        ...    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~----  220 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--------KPI----  220 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--------CCC----
Confidence            22334899999999999999999999999999999999999999754322111111111111110        000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRM  540 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~  540 (557)
                        ..+...+..+.+++.+|++.||++||++
T Consensus       221 --~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         221 --RIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             --CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence              0111234567899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3e-38  Score=317.83  Aligned_cols=244  Identities=21%  Similarity=0.280  Sum_probs=199.1

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccchhh---HHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      ..||+|+||+||.++- ++|..+|+|++++.....   .+.++.|-.+|....+|+||+|+..|.+.+.+||||||++||
T Consensus       147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG  226 (550)
T KOG0605|consen  147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG  226 (550)
T ss_pred             eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence            4679999999999985 459999999999875443   456788999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc-----
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE-----  425 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-----  425 (557)
                      ++..+|..    ...|++.....++.+++.|+.-||..   |+|||||||+|+|||..|++||+||||+.-+...     
T Consensus       227 D~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~  299 (550)
T KOG0605|consen  227 DMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES  299 (550)
T ss_pred             cHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence            99999964    46799999999999999999999999   9999999999999999999999999998533210     


Q ss_pred             --------------ccccce--------------------------eecCccccccccccccCCCCCchhhHHHHHHHHH
Q 008698          426 --------------VMQERT--------------------------VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL  465 (557)
Q Consensus       426 --------------~~~~~~--------------------------~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~  465 (557)
                                    ......                          ....|||.|||||++.+..|+..+|.||+|||+|
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Imy  379 (550)
T KOG0605|consen  300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMY  379 (550)
T ss_pred             hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHH
Confidence                          000000                          0112899999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCCcc-cchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC---HH
Q 008698          466 EIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---MS  541 (557)
Q Consensus       466 el~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt---~~  541 (557)
                      ||+.|-+||...++. .+..+..|...+..                  ........+..+||.+|+. ||..|.-   ++
T Consensus       380 EmLvGyPPF~s~tp~~T~rkI~nwr~~l~f------------------P~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~  440 (550)
T KOG0605|consen  380 EMLVGYPPFCSETPQETYRKIVNWRETLKF------------------PEEVDLSDEAKDLITRLLC-DPENRLGSKGAE  440 (550)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhhhccC------------------CCcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence            999999999887664 34555555433211                  1112233678899999999 9999985   55


Q ss_pred             HHH
Q 008698          542 HVV  544 (557)
Q Consensus       542 evl  544 (557)
                      ||-
T Consensus       441 EIK  443 (550)
T KOG0605|consen  441 EIK  443 (550)
T ss_pred             HHh
Confidence            554

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.4e-38  Score=315.73  Aligned_cols=253  Identities=28%  Similarity=0.464  Sum_probs=198.4

Q ss_pred             CeeecccCceEEEEEEeCC-C--CEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILPD-G--SRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .++||+|+||.||+|...+ +  ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++|+||++
T Consensus         7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~   86 (297)
T cd05089           7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP   86 (297)
T ss_pred             eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence            3468999999999998754 3  35789988743 334456789999999999 79999999999999999999999999


Q ss_pred             CCChHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeec
Q 008698          349 NGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  416 (557)
Q Consensus       349 ~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  416 (557)
                      +|+|.+++.....            ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+||
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~df  163 (297)
T cd05089          87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADF  163 (297)
T ss_pred             CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCc
Confidence            9999999965321            123588999999999999999999998   9999999999999999999999999


Q ss_pred             cCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhc
Q 008698          417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS  495 (557)
Q Consensus       417 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~  495 (557)
                      |++.......   .......+..|+|||++.+..++.++|||||||++|||+| |..||.......   +...    ...
T Consensus       164 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~~----~~~  233 (297)
T cd05089         164 GLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYEK----LPQ  233 (297)
T ss_pred             CCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----Hhc
Confidence            9986432111   1111123567999999988889999999999999999998 999997654321   1110    000


Q ss_pred             cccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       496 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      .     ...        ..+..++..+.+++.+||+.+|.+|||++++++.|+++..
T Consensus       234 ~-----~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         234 G-----YRM--------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             C-----CCC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0     000        0112234568899999999999999999999999987665

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1e-37  Score=306.60  Aligned_cols=245  Identities=24%  Similarity=0.346  Sum_probs=199.3

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|++|.||++... +++.|++|.+...  ......++.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd08529           6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD   85 (256)
T ss_pred             EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCc
Confidence            46799999999999964 5899999998643  33456789999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...  ....+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++.........  
T Consensus        86 L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~--  158 (256)
T cd08529          86 LHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA--  158 (256)
T ss_pred             HHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccchh--
Confidence            99999753  235689999999999999999999998   99999999999999999999999999988654332211  


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ....+++.|+|||++.+..++.++||||||+++|||+||+.||...+...   .....   . .    ....        
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~---~-~----~~~~--------  219 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKI---I-R----GVFP--------  219 (256)
T ss_pred             hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---H-c----CCCC--------
Confidence            12237889999999998889999999999999999999999997654211   11100   0 0    0000        


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                       ..+...+..+.+++.+||+.+|++||++.++++.
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 -PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence             0111344678999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.4e-39  Score=325.39  Aligned_cols=237  Identities=25%  Similarity=0.314  Sum_probs=191.0

Q ss_pred             eecccCceEEEEEEe----CCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          276 LLGDSKTGGTYSGIL----PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~----~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .||+|+||.||++..    .+|+.||+|++.....  .....+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus         3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (318)
T cd05582           3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG   82 (318)
T ss_pred             eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCC
Confidence            579999999999874    3588999999976432  2345677899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        83 ~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--  153 (318)
T cd05582          83 GDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--  153 (318)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence            999999854    24589999999999999999999999   999999999999999999999999999876533211  


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      ......|++.|+|||.+.+..++.++|||||||++|||+||+.||...+...   ....   ...         ...   
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~---i~~---------~~~---  215 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TMTM---ILK---------AKL---  215 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HHHH---HHc---------CCC---
Confidence            1222348999999999988888999999999999999999999997654321   1110   000         000   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH  542 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~e  542 (557)
                         ..+...+..+.+++.+||+.||++||++.+
T Consensus       216 ---~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 ---GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence               001123456889999999999999999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-37  Score=306.84  Aligned_cols=244  Identities=29%  Similarity=0.433  Sum_probs=195.7

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeee-eCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||.||++.. .|..||+|.++...  ..+.+.+|+.++++++|+|++++++++. +.+..++||||+++++|
T Consensus        11 ~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L   87 (256)
T cd05082          11 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL   87 (256)
T ss_pred             eeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence            35679999999999987 58889999986543  3467899999999999999999999764 45678999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++...  ....+++..++.++.|++.||+|||++   +++||||||+||++++++.+||+|||+++.......     
T Consensus        88 ~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-----  157 (256)
T cd05082          88 VDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----  157 (256)
T ss_pred             HHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC-----
Confidence            9998752  234588999999999999999999999   999999999999999999999999999875432211     


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ....+..|+|||++.+..++.++||||||+++|||++ |+.||...+..   .+...    .....     .+       
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~----~~~~~-----~~-------  218 (256)
T cd05082         158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR----VEKGY-----KM-------  218 (256)
T ss_pred             CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HhcCC-----CC-------
Confidence            1124568999999988889999999999999999998 99998654321   11111    11110     00       


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                       ..+..++..+.+++.+|++.+|++|||++++++.|+++
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence             01122345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.6e-38  Score=320.18  Aligned_cols=240  Identities=24%  Similarity=0.334  Sum_probs=189.0

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHH---hhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRF---ARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +.||+|+||.||++... +|+.||||+++...   ....+.+.+|..++   ..++||||+++++++...+..++||||+
T Consensus         5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~   84 (324)
T cd05589           5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYA   84 (324)
T ss_pred             EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCC
Confidence            46899999999999864 58999999997542   22234566665554   5678999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|..++..     ..+++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++...... 
T Consensus        85 ~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05589          85 AGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-  155 (324)
T ss_pred             CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence            99999888753     4589999999999999999999999   99999999999999999999999999987532211 


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                       .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+...   ...   .... ..        . 
T Consensus       156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~~---~i~~-~~--------~-  218 (324)
T cd05589         156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VFD---SIVN-DE--------V-  218 (324)
T ss_pred             -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh-CC--------C-
Confidence             11223348999999999998899999999999999999999999997654321   111   0000 00        0 


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                           ..+...+..+.+++.+||+.||++||     ++.++++
T Consensus       219 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 -----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                 01112345688999999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.2e-38  Score=319.92  Aligned_cols=239  Identities=25%  Similarity=0.319  Sum_probs=189.9

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +||+|+||.||++... +|+.||+|.++...   ......+..|..++... +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            5799999999999975 58899999997542   12345567788787765 8999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|..++..    ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        82 ~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  152 (316)
T cd05620          82 DLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R  152 (316)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence            99998864    24588999999999999999999999   999999999999999999999999999874321111  1


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..   .+.+...    ..      .+..    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~----~~------~~~~----  215 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIR----VD------TPHY----  215 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH----hC------CCCC----
Confidence            22334899999999999999999999999999999999999999765432   1111110    00      0000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVV  544 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~-evl  544 (557)
                          +......+.+++.+||+.||++||++. +++
T Consensus       216 ----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 ----PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                111334688999999999999999984 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.5e-38  Score=309.17  Aligned_cols=249  Identities=21%  Similarity=0.284  Sum_probs=195.8

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++.+++||||+++++.+...+..++||||+++++|
T Consensus        14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L   93 (267)
T cd06646          14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL   93 (267)
T ss_pred             hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcH
Confidence            44679999999999996 46889999999765444556788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++..    ...+++.++..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++.........  ..
T Consensus        94 ~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~  164 (267)
T cd06646          94 QDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--RK  164 (267)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccccc--cC
Confidence            998863    24589999999999999999999999   9999999999999999999999999999765322111  11


Q ss_pred             ecCcccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          433 MAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      ...++..|+|||.+.   ...++.++|||||||++|||++|+.|+........  ...     ....   ....+..   
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~-----~~~~---~~~~~~~---  231 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFL-----MSKS---NFQPPKL---  231 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--hee-----eecC---CCCCCCC---
Confidence            223788999999885   34578899999999999999999999865432110  000     0000   0000000   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  547 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L  547 (557)
                         ......+..+.+++.+||+.+|++|||+++|++.|
T Consensus       232 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 ---KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ---ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence               00112345788999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.5e-38  Score=309.97  Aligned_cols=253  Identities=23%  Similarity=0.348  Sum_probs=189.6

Q ss_pred             ecccCceEEEEEEeCC---CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          277 LGDSKTGGTYSGILPD---GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~~---g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ||+|+||.||+|...+   ...+|+|.+.... ......+.+|+..++.++||||+++++.+...+..++||||+++|+|
T Consensus         3 lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L   82 (269)
T cd05042           3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDL   82 (269)
T ss_pred             CCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcH
Confidence            6999999999997543   3478888876443 33456788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          353 DRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       353 ~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      .+++...... ....++.....++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||++............
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          83 KNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             HHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            9999753321 23456788899999999999999999   9999999999999999999999999998754332211111


Q ss_pred             eecCccccccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccC
Q 008698          432 VMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  503 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  503 (557)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||......+   ...   ...... .....+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~---~~~~~~-~~~~~~  232 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLK---QVVREQ-DIKLPK  232 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHH---HHhhcc-CccCCC
Confidence            22235678999998743       356789999999999999999 778886543211   100   000100 001111


Q ss_pred             cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       504 ~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                      +.+        +...+..+.+++..|| .||++|||+++|++.|.
T Consensus       233 ~~~--------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         233 PQL--------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             Ccc--------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111        1223455778888998 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.8e-38  Score=323.18  Aligned_cols=258  Identities=27%  Similarity=0.371  Sum_probs=197.8

Q ss_pred             CCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeC-CceEEE
Q 008698          273 GNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-GDRYIV  343 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~-~~~~lV  343 (557)
                      ..+.||+|+||.||++..      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... ...++|
T Consensus        11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv   90 (343)
T cd05103          11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI   90 (343)
T ss_pred             ccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEE
Confidence            345689999999999973      347899999997543 23346788999999999 789999999988654 467899


Q ss_pred             EecCCCCChHHHhccCCC--------------------------------------------------------------
Q 008698          344 YEFVVNGPLDRWLHHIPR--------------------------------------------------------------  361 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~--------------------------------------------------------------  361 (557)
                      |||+++|+|.++++....                                                              
T Consensus        91 ~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (343)
T cd05103          91 VEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQED  170 (343)
T ss_pred             EeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhh
Confidence            999999999999864211                                                              


Q ss_pred             -CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeecCccccc
Q 008698          362 -GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY  440 (557)
Q Consensus       362 -~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y  440 (557)
                       ....+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||++................++..|
T Consensus       171 ~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y  247 (343)
T cd05103         171 LYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  247 (343)
T ss_pred             hhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcce
Confidence             012478889999999999999999999   9999999999999999999999999999765332221112222356789


Q ss_pred             cccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHH
Q 008698          441 LAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVV  519 (557)
Q Consensus       441 ~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~  519 (557)
                      +|||.+.+..++.++||||||+++|||++ |..||......  ..+..    .......     ...        +....
T Consensus       248 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~----~~~~~~~-----~~~--------~~~~~  308 (343)
T cd05103         248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCR----RLKEGTR-----MRA--------PDYTT  308 (343)
T ss_pred             ECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHH----HHhccCC-----CCC--------CCCCC
Confidence            99999988889999999999999999997 89998654321  11110    0111000     000        11123


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          520 QKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       520 ~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      ..+.+++.+||+.+|++|||+.+|++.|+.+.+
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            468899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.4e-37  Score=308.53  Aligned_cols=254  Identities=21%  Similarity=0.350  Sum_probs=190.6

Q ss_pred             eecccCceEEEEEEeCCC---CEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          276 LLGDSKTGGTYSGILPDG---SRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .||+|+||.||+|...++   ..+++|.++... ....+.+.+|+..+..++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            379999999999985443   356677766443 3456789999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++.........++...+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999976433334577778889999999999999999   9999999999999999999999999998643222111111


Q ss_pred             eecCccccccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccC
Q 008698          432 VMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  503 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  503 (557)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||...+..   .....   ... .......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~---~~~-~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNH---VIK-DQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---HHh-hcccccCC
Confidence            22347889999998753       245789999999999999997 56787654321   11111   111 11122233


Q ss_pred             cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       504 ~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                      +.+.        ......+.+++..|| .+|++||++++|++.|.
T Consensus       232 ~~~~--------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLE--------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccC--------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            3221        113356788999999 57999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.3e-37  Score=307.30  Aligned_cols=250  Identities=28%  Similarity=0.441  Sum_probs=192.4

Q ss_pred             eecccCceEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeee-eCCceEEEEecCCC
Q 008698          276 LLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFVVN  349 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~~  349 (557)
                      +||+|+||.||+|...+    +..||+|.+... .....+.+.+|+.+++.++||||+++++++. ..+..++||||+.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence            57999999999998532    457999998643 3344678889999999999999999999876 45567999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc-
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-  428 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  428 (557)
                      |+|.+++...   ...+++..++.++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++........ 
T Consensus        82 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          82 GDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999642   23467888899999999999999999   9999999999999999999999999999755332111 


Q ss_pred             -cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          429 -ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       429 -~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                       .......++..|+|||.+.+..++.++||||||+++|||++| .+||...+..   .+..   ......          
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~---~~~~~~----------  219 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITV---YLLQGR----------  219 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---HHhcCC----------
Confidence             111122256789999999888899999999999999999995 5566543321   1111   110000          


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                          ....+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus       220 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 ----RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ----CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                00001123456889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-37  Score=316.14  Aligned_cols=256  Identities=25%  Similarity=0.418  Sum_probs=200.6

Q ss_pred             CeeecccCceEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEE
Q 008698          274 NRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV  343 (557)
                      .+.||+|+||.||++...        ....||+|.++... ......+.+|+.++.++ +||||+++++++...+..++|
T Consensus        17 ~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv   96 (314)
T cd05099          17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVI   96 (314)
T ss_pred             eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEE
Confidence            346799999999998742        24579999987542 33456788999999999 699999999999999999999


Q ss_pred             EecCCCCChHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCc
Q 008698          344 YEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA  411 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~  411 (557)
                      |||+++|+|.+++.....            ....+++.+++.++.|++.||.|||++   +++||||||+|||++.++.+
T Consensus        97 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~  173 (314)
T cd05099          97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVM  173 (314)
T ss_pred             EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCcE
Confidence            999999999999965321            124589999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhh
Q 008698          412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWAT  490 (557)
Q Consensus       412 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~  490 (557)
                      ||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......   +...  
T Consensus       174 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~--  248 (314)
T cd05099         174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---LFKL--  248 (314)
T ss_pred             EEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---HHHH--
Confidence            9999999986643322221222224568999999988889999999999999999999 888886544321   1111  


Q ss_pred             hhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       491 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                        ......   .         . .+..++.++.+++.+||+.+|++|||+.++++.|+++..
T Consensus       249 --~~~~~~---~---------~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         249 --LREGHR---M---------D-KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             --HHcCCC---C---------C-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence              111100   0         0 012234568899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=289.61  Aligned_cols=266  Identities=22%  Similarity=0.318  Sum_probs=212.3

Q ss_pred             hcCCCCCCeeecccCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC-----ce
Q 008698          267 TKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DR  340 (557)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~g~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~  340 (557)
                      .++.+...+.||+|||+-||.++ ..++..+|+|++...+.+..+..++|++..++++|||+++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            33444556678999999999998 5678999999998887778889999999999999999999999876443     48


Q ss_pred             EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      ||++.|...|+|.+.+......+..+++.+.+.|+.+|.+||.+||+. .+++.||||||.|||+++.+.+++.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            999999999999999988777778899999999999999999999998 4469999999999999999999999999987


Q ss_pred             cCCccccccc-------eeecCcccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhh
Q 008698          421 FVPWEVMQER-------TVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT  490 (557)
Q Consensus       421 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~  490 (557)
                      ..........       .....-|..|.|||.+.   +...+.++|||||||+||+|+.|..||+..-.           
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----------  246 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----------  246 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence            6543221111       11112578999999885   34578999999999999999999999975322           


Q ss_pred             hhhhccccc-cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          491 PLVQSHRYL-ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       491 ~~~~~~~~~-~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                         +.+.+. .+..+.+.-.....    .++.+.+++.+|++.||..||++.+++..++.+-
T Consensus       247 ---~GgSlaLAv~n~q~s~P~~~~----yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 ---QGGSLALAVQNAQISIPNSSR----YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ---cCCeEEEeeeccccccCCCCC----ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence               111111 22233332111111    4567999999999999999999999999998753

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.3e-37  Score=307.12  Aligned_cols=251  Identities=24%  Similarity=0.414  Sum_probs=200.3

Q ss_pred             CCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      ...+.||+|+||.||++...++..+|+|.+.... .....+.+|+.++++++|+||+++.+++.+ ...+++|||+++++
T Consensus         9 ~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~   86 (260)
T cd05073           9 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGS   86 (260)
T ss_pred             eEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCc
Confidence            3345689999999999998788899999987543 345678999999999999999999999877 77899999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.......... .
T Consensus        87 L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~-~  160 (260)
T cd05073          87 LLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-R  160 (260)
T ss_pred             HHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc-c
Confidence            99999752  234688899999999999999999998   99999999999999999999999999987654322211 1


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      ....++..|+|||++....++.++||||||+++|||+| |..||...+...   +...    ......       .    
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~----~~~~~~-------~----  222 (260)
T cd05073         161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRA----LERGYR-------M----  222 (260)
T ss_pred             cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HhCCCC-------C----
Confidence            11225678999999988889999999999999999999 899987643321   1111    010000       0    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                        ......+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus       223 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         223 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             --CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence              00112345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-37  Score=314.86  Aligned_cols=261  Identities=19%  Similarity=0.265  Sum_probs=192.0

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||++... +++.||||+++.... .....+.+|+.++++++||||+++++++.+.+..++||||++ ++
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~   88 (303)
T cd07869          10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD   88 (303)
T ss_pred             eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence            456799999999999975 688999999875432 223567889999999999999999999999999999999995 68


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        89 l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~  160 (303)
T cd07869          89 LCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TY  160 (303)
T ss_pred             HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cC
Confidence            88877642   24588899999999999999999999   999999999999999999999999999875432211  11


Q ss_pred             eecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc---c-----cccc
Q 008698          432 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR---Y-----LELL  502 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~-----~~~~  502 (557)
                      ....+++.|+|||.+.+ ..++.++|||||||++|||+||..||....+.  ...............   .     ...+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhcccc
Confidence            12337899999998865 45788999999999999999999999865331  111111110000000   0     0000


Q ss_pred             Ccc-cccCCCCC-----CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          503 DPL-ISSLSSDI-----PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       503 d~~-l~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ++. ........     ........+.+++.+|++.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000 00000000     00011245789999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-37  Score=311.92  Aligned_cols=267  Identities=24%  Similarity=0.355  Sum_probs=199.6

Q ss_pred             CCCCCeeecccCceEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceE
Q 008698          270 FSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRY  341 (557)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~g~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~  341 (557)
                      +....+.||+|+||.||.+..     .++..||+|.++... ......+.+|+.++++++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            334455689999999999974     357889999987553 33456799999999999999999999998775  5679


Q ss_pred             EEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      +||||+++++|.+++...   ...+++.++..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++.
T Consensus        85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence            999999999999998642   23589999999999999999999999   999999999999999999999999999986


Q ss_pred             CCccccc-cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc---
Q 008698          422 VPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR---  497 (557)
Q Consensus       422 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~---  497 (557)
                      ....... .......++..|+|||++.+..++.++||||||+++|||+|++.|.......    +.....+......   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~----~~~~~~~~~~~~~~~~  234 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL----FLKMIGPTHGQMTVTR  234 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch----hhhhcccccccccHHH
Confidence            5433211 1111233677899999998888999999999999999999987764322110    0000000000000   


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ..+.+....    ....+..++..+.+++.+|++.+|++|||++++++.|+++
T Consensus       235 ~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         235 LVRVLEEGK----RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHcCc----cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000000000    0011123456799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.1e-38  Score=316.38  Aligned_cols=253  Identities=27%  Similarity=0.464  Sum_probs=197.4

Q ss_pred             CeeecccCceEEEEEEeC-CCC--EEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|+||.||++... ++.  .+|+|.++.. .......+.+|+.++.++ +||||+++++++...+..++||||++
T Consensus        12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   91 (303)
T cd05088          12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   91 (303)
T ss_pred             eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence            356899999999999964 354  4688877643 234456788999999999 89999999999999999999999999


Q ss_pred             CCChHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeec
Q 008698          349 NGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  416 (557)
Q Consensus       349 ~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  416 (557)
                      +|+|.+++....            .....+++.+++.++.|++.||+|||++   +++||||||+|||++.++.+||+||
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~df  168 (303)
T cd05088          92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF  168 (303)
T ss_pred             CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCcc
Confidence            999999996432            1124689999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhc
Q 008698          417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS  495 (557)
Q Consensus       417 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~  495 (557)
                      |++......   ........+..|+|||++.+..++.++|||||||++|||+| |..||...+..+   .....    ..
T Consensus       169 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~  238 (303)
T cd05088         169 GLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL----PQ  238 (303)
T ss_pred             ccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHHHH----hc
Confidence            998643211   11111224678999999988888999999999999999998 999986543321   11110    00


Q ss_pred             cccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       496 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      .     .  ..      ..+...+..+.+++.+||+.+|++||+++++++.|+++.+
T Consensus       239 ~-----~--~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         239 G-----Y--RL------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             C-----C--cC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0     0  00      0011234568899999999999999999999999887544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.2e-38  Score=310.38  Aligned_cols=239  Identities=27%  Similarity=0.400  Sum_probs=189.3

Q ss_pred             eecccCceEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          276 LLGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .||+|+||.||+|....        ...||+|.+........+++.+|+.+++.++||||+++++++...+..++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            47999999999998632        2358899887655555678899999999999999999999999989999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC--------cEEeeccCC
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--------AHLMGVGLS  419 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~--------~kl~Dfgl~  419 (557)
                      ++|+|.+++...   ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.        ++++|||++
T Consensus        82 ~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          82 KFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999742   23689999999999999999999999   9999999999999987765        599999998


Q ss_pred             ccCCccccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCC-CCCCCCCcccchhHHHhhhhhhhccc
Q 008698          420 KFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR-RPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~-~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                      .......      ...++..|+|||++.+ ..++.++||||||+++|||++|. .|+...+.......       ...  
T Consensus       156 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~~~--  220 (258)
T cd05078         156 ITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------YED--  220 (258)
T ss_pred             cccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------HHc--
Confidence            6543211      1237889999999986 45799999999999999999985 55544332111000       000  


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                             ..     . .+.....++.+++.+||+.+|++|||+++|++.|+
T Consensus       221 -------~~-----~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 -------RH-----Q-LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -------cc-----c-CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   00     0 01112346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.3e-37  Score=306.57  Aligned_cols=251  Identities=25%  Similarity=0.404  Sum_probs=199.4

Q ss_pred             CeeecccCceEEEEEEeC----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|+||.||+|...    ++..+|+|.++... ....+.+.+|+.++.+++||||+++++++...+..++||||++
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (267)
T cd05066           9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME   88 (267)
T ss_pred             eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence            456799999999999863    23479999987542 3345688999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +++|.+++...   ...+++.+++.++.|++.||.|||+.   +++||||||+|||++.++.++++|||++.........
T Consensus        89 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          89 NGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence            99999999642   24589999999999999999999999   9999999999999999999999999999876433221


Q ss_pred             cce-eecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          429 ERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       429 ~~~-~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ... ....++..|+|||++.+..++.++||||||+++||+++ |..||...+..+   ......    ..     ...  
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~----~~-----~~~--  228 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIE----EG-----YRL--  228 (267)
T ss_pred             eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHh----CC-----CcC--
Confidence            111 11113568999999998889999999999999999987 999987654321   111110    00     000  


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                            ......+..+.+++.+|++.+|++||+|.++++.|+++
T Consensus       229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 ------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                  00112345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.2e-37  Score=318.87  Aligned_cols=247  Identities=22%  Similarity=0.273  Sum_probs=192.4

Q ss_pred             CeeecccCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEE
Q 008698          274 NRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      .+.||+|+||.||++..    .+++.||+|++.+..    ....+.+.+|+.++..+ +||||+++++++...+..++||
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (332)
T cd05614           5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL   84 (332)
T ss_pred             EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence            35689999999999875    358899999997532    22345678899999999 5999999999999999999999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+++|+|.+++..    ...+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        85 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          85 DYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            99999999999864    24589999999999999999999999   999999999999999999999999999976432


Q ss_pred             cccccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccC
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  503 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  503 (557)
                      .... ......||..|+|||.+.+. .++.++|||||||++|||+||+.||...........+  ......       .+
T Consensus       158 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~-------~~  227 (332)
T cd05614         158 EEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILK-------CD  227 (332)
T ss_pred             cCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhc-------CC
Confidence            2211 11223489999999998765 4788999999999999999999999754322111110  000000       11


Q ss_pred             cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       504 ~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                      +.+        +......+.+++.+||+.||++||     +++++++
T Consensus       228 ~~~--------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         228 PPF--------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCC--------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            111        112345688999999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-37  Score=311.31  Aligned_cols=243  Identities=21%  Similarity=0.368  Sum_probs=197.5

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      +.||+|++|.||+|.. .+++.||+|.+..........+.+|+.++..++||||+++++.+...+..++||||+++++|.
T Consensus        26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~  105 (296)
T cd06654          26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT  105 (296)
T ss_pred             EEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHH
Confidence            4579999999999985 468899999997665555678899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++..     ..+++.++..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.........  ...
T Consensus       106 ~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~  175 (296)
T cd06654         106 DVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RST  175 (296)
T ss_pred             HHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc--cCc
Confidence            99853     3488999999999999999999999   9999999999999999999999999998765332211  112


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      ..+++.|+|||.+.+..++.++|||||||++|||++|+.||.......  .+....    ...      .+.+      .
T Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~~----~~~------~~~~------~  237 (296)
T cd06654         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIA----TNG------TPEL------Q  237 (296)
T ss_pred             ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHHh----cCC------CCCC------C
Confidence            237889999999988888999999999999999999999997644311  111000    000      0000      0


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+......+.+++.+||..+|++|||+.+|++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            11234456889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.1e-37  Score=313.63  Aligned_cols=263  Identities=22%  Similarity=0.363  Sum_probs=198.2

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||++... ++..+|+|.++.. ......++.+|++++.+++||||+++++++.+.+..++||||+++++
T Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~   85 (308)
T cd06615           6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   85 (308)
T ss_pred             EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence            345799999999999864 5788999998654 23345678899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++..    ...+++..+..++.|+++||.|||+..  +++|+||||+|||+++++.+||+|||++........    
T Consensus        86 L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----  155 (308)
T cd06615          86 LDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----  155 (308)
T ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccccc----
Confidence            9999964    245899999999999999999999731  899999999999999999999999999875532211    


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcc---------------
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH---------------  496 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~---------------  496 (557)
                      ....++..|+|||++.+..++.++||||||+++|||++|+.||...+..................               
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            12347889999999988889999999999999999999999986544322111111000000000               


Q ss_pred             --ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          497 --RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       497 --~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                        ...+..+..........+.......+.+++.+||+.+|++|||+++|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00000000010101111112245568999999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.1e-37  Score=304.65  Aligned_cols=246  Identities=26%  Similarity=0.463  Sum_probs=197.5

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      +.||+|+||.||++...+++.+|+|.+.... ....+|.+|++++.+++||||+++++++......++||||+++++|.+
T Consensus        10 ~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   88 (256)
T cd05112          10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD   88 (256)
T ss_pred             eeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHH
Confidence            4679999999999998778899999987543 234678999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++........... ...
T Consensus        89 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~-~~~  161 (256)
T cd05112          89 YLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS-TGT  161 (256)
T ss_pred             HHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc-CCC
Confidence            98642   23588999999999999999999999   999999999999999999999999999876543222111 112


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      .++.+|+|||.+.+..++.++||||||+++|||++ |..||.......   +.+.   ....   .....+         
T Consensus       162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~~---~~~~~~---------  223 (256)
T cd05112         162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVET---INAG---FRLYKP---------  223 (256)
T ss_pred             ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH---HhCC---CCCCCC---------
Confidence            25678999999988889999999999999999998 999987544221   1110   0000   000111         


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                        ...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       224 --~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         224 --RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             --CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence              112356899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-37  Score=323.45  Aligned_cols=265  Identities=16%  Similarity=0.181  Sum_probs=194.3

Q ss_pred             CCCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      +...+.||+|+||.||++... +++.||+|...      ...+.+|+.++++++||||+++++++...+..++|+|++. 
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-  166 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-  166 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence            444567899999999999864 58899999753      2356789999999999999999999999999999999984 


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++|..++..    ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       167 ~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-  238 (391)
T PHA03212        167 TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-  238 (391)
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc-
Confidence            788888754    24588999999999999999999999   9999999999999999999999999999754322111 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc----hhHHHhhhhhhhc----------
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW----QSIFEWATPLVQS----------  495 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~----~~~~~~~~~~~~~----------  495 (557)
                      ......||+.|+|||++.+..++.++|||||||++|||+||+.|+...+....    .............          
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            11223489999999999998999999999999999999999988754322110    0000000000000          


Q ss_pred             ccccccc----CcccccCCCCC---CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcc
Q 008698          496 HRYLELL----DPLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQL  550 (557)
Q Consensus       496 ~~~~~~~----d~~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~  550 (557)
                      ....+..    ...........   .....+..+.+|+.+||+.||++|||++|+++  .++.+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence            0000000    00000000000   01134567889999999999999999999996  44443

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-37  Score=304.61  Aligned_cols=237  Identities=27%  Similarity=0.429  Sum_probs=189.4

Q ss_pred             eecccCceEEEEEEeCCCC-----------EEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEE
Q 008698          276 LLGDSKTGGTYSGILPDGS-----------RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      .||+|+||.||+|...+..           .|++|.+...... ...|.+|+.++++++||||+++++++.. +..++||
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            4799999999999975433           5888887655333 6789999999999999999999999988 7789999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-------CcEEeecc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-------GAHLMGVG  417 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~-------~~kl~Dfg  417 (557)
                      ||+++|+|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++       .+||+|||
T Consensus        80 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          80 EYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999997522   2689999999999999999999998   999999999999999887       79999999


Q ss_pred             CCccCCccccccceeecCccccccccccccCC--CCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhh
Q 008698          418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ  494 (557)
Q Consensus       418 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~  494 (557)
                      ++......      ....++..|+|||++...  .++.++||||||+++|||++ |..|+...+.........       
T Consensus       154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-------  220 (259)
T cd05037         154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-------  220 (259)
T ss_pred             cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-------
Confidence            99865431      112267789999999876  78999999999999999999 577776543221111100       


Q ss_pred             ccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       495 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                      .        ...    ...+   ....+.+++.+||..+|++|||+.+|++.|+
T Consensus       221 ~--------~~~----~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 D--------QHR----LPMP---DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             c--------CCC----CCCC---CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0        000    0000   1156889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.6e-37  Score=310.23  Aligned_cols=245  Identities=23%  Similarity=0.371  Sum_probs=195.4

Q ss_pred             eeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      +.||+|+||.||++.... +..+++|.+..........+.+|+.++..++||||+++++++...+..++||||+++++|.
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~   90 (282)
T cd06643          11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD   90 (282)
T ss_pred             hhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHH
Confidence            357999999999999754 7789999987666566778999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      .++..   ....+++..+..++.|+++||.|||+.   +++||||||+|||++.++.+||+|||++........  ....
T Consensus        91 ~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~  162 (282)
T cd06643          91 AVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDS  162 (282)
T ss_pred             HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc--cccc
Confidence            88764   234689999999999999999999999   999999999999999999999999999875432211  1112


Q ss_pred             cCcccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          434 AGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       434 ~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      ..++..|+|||++.     +..++.++|||||||++|||++|++||...+...  ....    .....      .+.+  
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~----~~~~~------~~~~--  228 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLK----IAKSE------PPTL--  228 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHH----HhhcC------CCCC--
Confidence            33789999999884     3457789999999999999999999987644211  1111    00000      0000  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ..+...+..+.+++.+||+.+|++||+++++++
T Consensus       229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         229 ----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ----CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                011223457899999999999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-37  Score=310.64  Aligned_cols=266  Identities=24%  Similarity=0.376  Sum_probs=201.1

Q ss_pred             eeecccCceEEEEEEeC-----CCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEEeeeeeeee--CCceEEEEec
Q 008698          275 RLLGDSKTGGTYSGILP-----DGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEF  346 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-----~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~  346 (557)
                      +.||+|+||.||++.+.     +++.||||.++..... ....|.+|++.++.++||||+++++++..  ....++||||
T Consensus        10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   89 (284)
T cd05038          10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY   89 (284)
T ss_pred             eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence            46799999999999863     3678999999765433 46789999999999999999999999877  5578999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+|||++.++.++|+|||++.......
T Consensus        90 ~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05038          90 LPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK  163 (284)
T ss_pred             CCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence            9999999999742   23589999999999999999999999   99999999999999999999999999998765322


Q ss_pred             cc-cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          427 MQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       427 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      .. .......++..|+|||.+.+..++.++||||||+++|||+||..|+......... ...............+.+...
T Consensus       164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05038         164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLELLKEG  242 (284)
T ss_pred             cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHHHHHHHHHcC
Confidence            11 1111122556799999998888999999999999999999999997653221100 000000000000000111100


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      .    ....+..++.++.+++.+||+.+|++||||.||+++|++++
T Consensus       243 ~----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         243 E----RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             C----cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            0    11112234467999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.7e-37  Score=316.70  Aligned_cols=236  Identities=23%  Similarity=0.293  Sum_probs=188.0

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCC-CcEEeeeeeeeeCCceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      +.||+|+||.||+|... +++.||||+++...   ....+.+..|..++..++| ++|+++++++.+.+..++||||+++
T Consensus         6 ~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   85 (324)
T cd05587           6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG   85 (324)
T ss_pred             EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCC
Confidence            46799999999999965 47899999997542   2344677889999999965 5688899999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..    ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        86 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--  156 (324)
T cd05587          86 GDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--  156 (324)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--
Confidence            999998864    24588999999999999999999999   999999999999999999999999999864322111  


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+...   +.....   .         ...   
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~---~---------~~~---  218 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSIM---E---------HNV---  218 (324)
T ss_pred             ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH---c---------CCC---
Confidence            1223348999999999999899999999999999999999999997654321   111110   0         000   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  540 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~  540 (557)
                         ..+......+.+++.+|++.+|++||+.
T Consensus       219 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 ---SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence               0011234568899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=305.94  Aligned_cols=263  Identities=21%  Similarity=0.290  Sum_probs=198.9

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEec--ccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeee-----CCceEEEEec
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLK--RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-----HGDRYIVYEF  346 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-----~~~~~lV~E~  346 (557)
                      +.||+|+||.|+.+.. .+|+.||||++.  .......++-++|+++|+.++|+||+.+++++..     -+..|+|+|+
T Consensus        28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el  107 (359)
T KOG0660|consen   28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL  107 (359)
T ss_pred             ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence            3579999999999985 468999999997  3344556788999999999999999999998764     3568999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      | ..+|...++.    ++.|+......+..|+++||+|+|+.   +|+||||||+|+|++.+...||+|||+|+......
T Consensus       108 M-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  108 M-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             H-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccC
Confidence            9 6688888854    45599999999999999999999999   99999999999999999999999999999876431


Q ss_pred             cccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccccc---
Q 008698          427 MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL---  502 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  502 (557)
                      ..........|..|.|||.+.. ..||.+.||||.|||+.||++|++-|.+.+.....+++....+......+..+-   
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence            1222222337899999998865 679999999999999999999999998876543333222221111111111110   


Q ss_pred             -CcccccCCCC--CC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          503 -DPLISSLSSD--IP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       503 -d~~l~~~~~~--~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       .+.+++....  .+    -.......++|+.+++..||.+|+|++|.++
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence             0011111000  00    0123456789999999999999999999986

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-37  Score=308.51  Aligned_cols=253  Identities=22%  Similarity=0.384  Sum_probs=200.5

Q ss_pred             eeecccCceEEEEEEeCC-CC----EEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          275 RLLGDSKTGGTYSGILPD-GS----RVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~-g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      +.||+|+||.||+|...+ |.    .||+|.+.... .....++.+|+..+.+++||||+++++++.. ...++||||++
T Consensus        13 ~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   91 (279)
T cd05057          13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMP   91 (279)
T ss_pred             ceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCC
Confidence            468999999999998643 33    68999887654 3345788999999999999999999999887 78899999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++...   ...+++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++........
T Consensus        92 ~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  165 (279)
T cd05057          92 LGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE  165 (279)
T ss_pred             CCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence            99999998642   23589999999999999999999998   9999999999999999999999999999876533222


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .......++..|+|||.+....++.++||||||+++||++| |+.||......+....   .    ....          
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~----~~~~----------  228 (279)
T cd05057         166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL---L----EKGE----------  228 (279)
T ss_pred             eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH---H----hCCC----------
Confidence            11111224578999999988889999999999999999999 9999876543221111   1    0000          


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                         ....+..+...+.+++.+||..+|++||++.++++.|+++...|
T Consensus       229 ---~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         229 ---RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence               00011123346889999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3e-37  Score=298.88  Aligned_cols=268  Identities=21%  Similarity=0.281  Sum_probs=197.9

Q ss_pred             ecccCceEEEEEEe-CCCCEEEEEEecccchh--hHHHHHHHHHHHhhcCCCc-EEeeeeeeeeCC------ceEEEEec
Q 008698          277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPN-LVAVKGCCYDHG------DRYIVYEF  346 (557)
Q Consensus       277 lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~n-iv~l~g~~~~~~------~~~lV~E~  346 (557)
                      ||+|+||+||+|+. .+|+.||+|+++-....  ......+|+.+|++++|+| |+++++++...+      ..++|+||
T Consensus        19 lGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~   98 (323)
T KOG0594|consen   19 LGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEF   98 (323)
T ss_pred             hCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEe
Confidence            69999999999995 46899999999765332  2345689999999999999 999999998877      78999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      + .-+|..++.........++...+..++.||+.||+|||++   +|+||||||+||||++++.+||+|||+|+...-..
T Consensus        99 ~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~  174 (323)
T KOG0594|consen   99 L-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM  174 (323)
T ss_pred             e-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCc
Confidence            9 5589999987554334577789999999999999999999   99999999999999999999999999999665332


Q ss_pred             cccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhhhhccccccccCc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      ....  ...+|..|.|||++.+. .|+...||||+|||+.||+++++-|.+..+.+.. .+++.......+.+.....-+
T Consensus       175 ~~yt--~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~  252 (323)
T KOG0594|consen  175 RTYT--PEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLP  252 (323)
T ss_pred             cccc--ccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccc
Confidence            2211  12378899999999986 7999999999999999999999888876552211 111111100001110000000


Q ss_pred             ccc-cCCCCCCcH-------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhcc
Q 008698          505 LIS-SLSSDIPEA-------GVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQL  550 (557)
Q Consensus       505 ~l~-~~~~~~~~~-------~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~--L~~~  550 (557)
                      ... .......+.       .......+++.+|++.+|.+|.|++.+++.  +..+
T Consensus       253 ~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  253 DYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             cccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            000 000000000       011367899999999999999999999985  5444

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3e-37  Score=305.92  Aligned_cols=252  Identities=22%  Similarity=0.316  Sum_probs=196.6

Q ss_pred             hcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEe
Q 008698          267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      ++++... .+||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++...+..++|+|
T Consensus         7 ~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           7 YDENGER-VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             cccCCce-EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            3444443 46799999999999954 578899999887666667789999999999999999999999999999999999


Q ss_pred             cCCCCChHHHhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCcEEeeccCCccC
Q 008698          346 FVVNGPLDRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFV  422 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~  422 (557)
                      |+++++|.+++....   ..+  ++..+..++.||+.||+|||+.   +|+||||||+||+++. ++.+||+|||++...
T Consensus        86 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          86 QVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             cCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            999999999987421   234  7888899999999999999999   9999999999999986 678999999998765


Q ss_pred             CccccccceeecCccccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          423 PWEVMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      ......  .....++..|+|||++....  ++.++||||||+++|||++|..||........   ..+.....      .
T Consensus       160 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~------~  228 (268)
T cd06624         160 AGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF------K  228 (268)
T ss_pred             ccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh------c
Confidence            322211  11223788999999987643  78899999999999999999999865432110   00000000      0


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       ..+        ..+......+.+++.+||+.+|++|||+.++++
T Consensus       229 -~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         229 -IHP--------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -cCC--------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence             000        012234466889999999999999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.1e-38  Score=319.78  Aligned_cols=236  Identities=23%  Similarity=0.321  Sum_probs=186.9

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHH-HHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +||+|+||+||++... +|+.||||++.....   .....+.+|.. +++.++||||+++++.+.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            5799999999999974 689999999975421   22344555554 567889999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|..++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (323)
T cd05575          82 ELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT  152 (323)
T ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence            99998864    34688999999999999999999999   99999999999999999999999999987532211  11


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +..   ...         ....    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~---~i~---------~~~~----  213 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYD---NIL---------NKPL----  213 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HHH---HHH---------cCCC----
Confidence            222348999999999999899999999999999999999999997654321   111   000         0000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS  541 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~  541 (557)
                       . .+...+..+.+++.+|++.||++||++.
T Consensus       214 -~-~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 -R-LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -C-CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             0 0111245688999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-38  Score=320.24  Aligned_cols=246  Identities=21%  Similarity=0.305  Sum_probs=205.6

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc-eEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-RYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~-~~lV~E~~~~  349 (557)
                      .+.+|+|+||.++....+ +++.+++|.+.-..  ....+...+|+.++++++|||||.+.+.+++++. .+|||+|++|
T Consensus         9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG   88 (426)
T KOG0589|consen    9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG   88 (426)
T ss_pred             hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence            346799999999988753 57899999987543  2334577899999999999999999999999988 9999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+.+...+  +..+++..+..++.|++.|+.|||++   .|+|||||+.|||++.+..+||+|||+|+.+...... 
T Consensus        89 g~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~-  162 (426)
T KOG0589|consen   89 GDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL-  162 (426)
T ss_pred             CCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchhh-
Confidence            99999997633  56799999999999999999999998   9999999999999999999999999999998766522 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                       .....||+.||.||.+.+.+|..|+|||||||++|||.+-+++|...+..   .++.....        ..++      
T Consensus       163 -a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~~--------~~~~------  224 (426)
T KOG0589|consen  163 -ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKINR--------GLYS------  224 (426)
T ss_pred             -hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHhh--------ccCC------
Confidence             22344999999999999999999999999999999999999999876543   22211111        1111      


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                         ..+.....++..++..|++.+|+.||++.+++.+
T Consensus       225 ---Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  225 ---PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ---CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence               1233456779999999999999999999999975

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.8e-37  Score=305.36  Aligned_cols=245  Identities=22%  Similarity=0.370  Sum_probs=193.2

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .++||+|+||.||++.. .+++.||+|.+... ......++.+|+.++.+++||||+++++.+...+..++||||+++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   85 (279)
T cd06619           6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS   85 (279)
T ss_pred             eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence            34689999999999985 46889999998654 33445679999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |..+.        .+++..+..++.|++.||+|||+.   +|+|+||||+|||++.++.+||+|||++.......    .
T Consensus        86 l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~  150 (279)
T cd06619          86 LDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----A  150 (279)
T ss_pred             hHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----c
Confidence            96542        367888999999999999999999   99999999999999999999999999997653221    1


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhhhhhccccccccCcccccCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      ....++..|+|||++.+..++.++||||||+++|||++|+.||.......... ..+.....         .+...    
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------~~~~~----  217 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI---------VDEDP----  217 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH---------hccCC----
Confidence            12348899999999998889999999999999999999999997543221100 00000000         00000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      ...+.......+.+++.+|++.+|++||+++++++.
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            001111233568899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.5e-37  Score=324.07  Aligned_cols=248  Identities=21%  Similarity=0.261  Sum_probs=191.2

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||+||++.. .+++.||||++....   ......+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g   85 (381)
T cd05626           6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG   85 (381)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence            34679999999999986 458899999997542   23346788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc-
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-  428 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  428 (557)
                      |+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++......... 
T Consensus        86 g~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          86 GDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            999999864    24588999999999999999999999   9999999999999999999999999997643110000 


Q ss_pred             --------------------------------------------cceeecCccccccccccccCCCCCchhhHHHHHHHH
Q 008698          429 --------------------------------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL  464 (557)
Q Consensus       429 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil  464 (557)
                                                                  .......||+.|+|||.+.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                        000123489999999999988899999999999999


Q ss_pred             HHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHH--hcCCCCCCCCCHHH
Q 008698          465 LEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYA--CTQHVPSMRPRMSH  542 (557)
Q Consensus       465 ~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~--Cl~~~P~~RPt~~e  542 (557)
                      |||+||..||...+......      ......       ..+    ..........++.+++.+  |+..+|..||++++
T Consensus       239 ~elltG~~Pf~~~~~~~~~~------~i~~~~-------~~~----~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQL------KVINWE-------NTL----HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHH------HHHccc-------ccc----CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            99999999997654321100      000000       000    000011123456778876  56667777999999


Q ss_pred             HHH
Q 008698          543 VVH  545 (557)
Q Consensus       543 vl~  545 (557)
                      +++
T Consensus       302 ~l~  304 (381)
T cd05626         302 IKA  304 (381)
T ss_pred             Hhc
Confidence            987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-37  Score=317.63  Aligned_cols=256  Identities=26%  Similarity=0.402  Sum_probs=200.8

Q ss_pred             CCeeecccCceEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEE
Q 008698          273 GNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l  342 (557)
                      ..+.||+|+||.||++...        ++..||+|.++... .....++.+|+.++.++ +||||+++++++...+..++
T Consensus        16 i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   95 (334)
T cd05100          16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV   95 (334)
T ss_pred             ecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEE
Confidence            3456899999999999742        12369999887542 33457899999999999 89999999999999999999


Q ss_pred             EEecCCCCChHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 008698          343 VYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG  410 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~  410 (557)
                      +|||+++|+|.+++.....            ....+++.+++.++.|++.||+|||++   +++||||||+|||++.++.
T Consensus        96 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~~  172 (334)
T cd05100          96 LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNV  172 (334)
T ss_pred             EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCc
Confidence            9999999999999865321            234588999999999999999999999   9999999999999999999


Q ss_pred             cEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhh
Q 008698          411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA  489 (557)
Q Consensus       411 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~  489 (557)
                      +||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...+....   ..  
T Consensus       173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~--  247 (334)
T cd05100         173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---FK--  247 (334)
T ss_pred             EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HH--
Confidence            99999999976543222211222224578999999998899999999999999999998 8888876543211   11  


Q ss_pred             hhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       490 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                       . ......            .. .+..++..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       248 -~-~~~~~~------------~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         248 -L-LKEGHR------------MD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             -H-HHcCCC------------CC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence             0 110000            00 11123456889999999999999999999999998776

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.5e-37  Score=316.97  Aligned_cols=237  Identities=24%  Similarity=0.316  Sum_probs=188.7

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|+||.||++... +++.||||+++...   ......+..|..++..+ +|++|+++++++...+..++||||++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   84 (323)
T cd05616           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN   84 (323)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence            346799999999999865 47899999997542   22334567788888777 68999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++..    ...+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        85 ~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-  156 (323)
T cd05616          85 GGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-  156 (323)
T ss_pred             CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence            9999988864    24588999999999999999999999   999999999999999999999999999875432211 


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                       ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+...   +....   .         +...  
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i---~---------~~~~--  218 (323)
T cd05616         157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSI---M---------EHNV--  218 (323)
T ss_pred             -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHH---H---------hCCC--
Confidence             1122348999999999999999999999999999999999999997654321   11110   0         0000  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  540 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~  540 (557)
                          ..+...+..+.+++.+|++.+|++|++.
T Consensus       219 ----~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 ----AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                0112234568899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.4e-37  Score=329.63  Aligned_cols=263  Identities=21%  Similarity=0.297  Sum_probs=188.4

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--------CceEE
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--------GDRYI  342 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--------~~~~l  342 (557)
                      ...+.||+|+||.||+|... +++.||||++....    ....+|+.+++.++||||+++++++...        ...++
T Consensus        69 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            34567899999999999964 58899999886432    2345799999999999999998876432        23578


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CcEEeeccCCcc
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKF  421 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~  421 (557)
                      ||||++ ++|.+++.........+++..+..++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||+++.
T Consensus       145 vmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~  220 (440)
T PTZ00036        145 VMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKN  220 (440)
T ss_pred             EEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence            999997 477777754444456799999999999999999999999   999999999999999665 699999999986


Q ss_pred             CCccccccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhh-hhhhh----
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWA-TPLVQ----  494 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~-~~~~~----  494 (557)
                      .......   ....+|+.|+|||++.+. .++.++|||||||++|||+||.+||.+...... ..+.... .+...    
T Consensus       221 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~  297 (440)
T PTZ00036        221 LLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE  297 (440)
T ss_pred             ccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            5432211   123478999999998764 689999999999999999999999986543211 1111100 00000    


Q ss_pred             -ccccccccCccccc-CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          495 -SHRYLELLDPLISS-LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       495 -~~~~~~~~d~~l~~-~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       .....++--+.... ......+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence             00000000000000 0000011123457889999999999999999999985

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.4e-37  Score=306.97  Aligned_cols=251  Identities=28%  Similarity=0.407  Sum_probs=199.3

Q ss_pred             CeeecccCceEEEEEEeCC----CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|+||.||+|...+    ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++||||++
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~   89 (270)
T cd05056          11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAP   89 (270)
T ss_pred             eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence            4568999999999998643    2479999987654 4456789999999999999999999998865 56789999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++...   ...+++.+++.++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||+++........
T Consensus        90 ~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  163 (270)
T cd05056          90 LGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY  163 (270)
T ss_pred             CCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence            99999999642   23589999999999999999999998   9999999999999999999999999999766443222


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      ... ...++..|+|||.+....++.++||||||+++|||++ |..||...+..+.   ..   .......        + 
T Consensus       164 ~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~---~~~~~~~--------~-  227 (270)
T cd05056         164 KAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IG---RIENGER--------L-  227 (270)
T ss_pred             ecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HH---HHHcCCc--------C-
Confidence            111 2224568999999988889999999999999999996 9999976543211   11   0000000        0 


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                           ..+..++..+.+++.+|+..+|++|||+.++++.|+++..
T Consensus       228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 0112234578999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.3e-38  Score=320.51  Aligned_cols=239  Identities=23%  Similarity=0.303  Sum_probs=188.0

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHH-HHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +||+|+||.||++... +|+.||+|++....   ......+..|.. +++.++||||+++++.+...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            5799999999999864 68999999997542   223345556654 467789999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|..++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  152 (325)
T cd05604          82 ELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T  152 (325)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence            99988854    34689999999999999999999999   999999999999999999999999999875322111  1


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...+...   +..   ....         ..+    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~---~~~~---------~~~----  213 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MYD---NILH---------KPL----  213 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HHH---HHHc---------CCc----
Confidence            122348999999999999899999999999999999999999997654321   111   0000         000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV  544 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl  544 (557)
                       .. .......+.+++.+|++.+|++||++.+.+
T Consensus       214 -~~-~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         214 -VL-RPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             -cC-CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence             00 011334678999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-38  Score=324.77  Aligned_cols=248  Identities=21%  Similarity=0.264  Sum_probs=197.8

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||+||++... +|+.||||+++...   ......+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (350)
T cd05573           6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG   85 (350)
T ss_pred             EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence            356899999999999975 58999999997542   13346788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc---
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV---  426 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---  426 (557)
                      |+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.......   
T Consensus        86 ~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          86 GDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            9999999752    4689999999999999999999998   99999999999999999999999999997654332   


Q ss_pred             ------------------------cccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 008698          427 ------------------------MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW  482 (557)
Q Consensus       427 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~  482 (557)
                                              .........||+.|+|||.+.+..++.++|||||||++|||++|+.||...+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                    00111223489999999999999999999999999999999999999986543211


Q ss_pred             hhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 008698          483 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVHQ  546 (557)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-~~evl~~  546 (557)
                         .   .......   +.+.  +    ..  ....+..+.+++.+|++ +|.+||+ ++++++.
T Consensus       239 ---~---~~i~~~~---~~~~--~----p~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         239 ---Y---NKIINWK---ESLR--F----PP--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ---H---HHHhccC---Cccc--C----CC--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence               0   0000000   0000  0    00  01134568899999997 9999999 9999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-38  Score=288.37  Aligned_cols=244  Identities=26%  Similarity=0.344  Sum_probs=202.8

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +..+.||+|.||.||.|..+ ++-.||+|++.++.   .+...++.+|+++-+.|+||||+++++++.+....||++||.
T Consensus        25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya  104 (281)
T KOG0580|consen   25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA  104 (281)
T ss_pred             cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence            34557899999999999964 47789999997653   234578999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      +.|.|...|+.  .....+++.....+..|+|.||.|+|.+   +||||||||+|+|++.++..||+|||-+...+    
T Consensus       105 ~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----  175 (281)
T KOG0580|consen  105 PRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----  175 (281)
T ss_pred             CCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC----
Confidence            99999999975  2345688888889999999999999999   99999999999999999999999999886544    


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .....+.+||..|.+||...+..++.+.|+|++|++.||++.|.+||......+   ...       .-.-.++.+    
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tYk-------rI~k~~~~~----  241 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TYK-------RIRKVDLKF----  241 (281)
T ss_pred             CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HHH-------HHHHccccC----
Confidence            223345569999999999999999999999999999999999999998654221   111       111112222    


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                             +......+.+++.+|+..+|.+|.+..|++.
T Consensus       242 -------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  242 -------PSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             -------CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                   2334556889999999999999999999986

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-38  Score=323.07  Aligned_cols=242  Identities=21%  Similarity=0.302  Sum_probs=202.6

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+-||.|+.|.|-.|++ .+|+.+|||++.+..   ......+.+|+.+|+.+.|||++++++++++..++|+|.||+++
T Consensus        17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g   96 (786)
T KOG0588|consen   17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG   96 (786)
T ss_pred             cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence            44579999999999995 579999999997652   23346688999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |-|.++|..    ..++++.+..+++.||+.|+.|.|..   +|+||||||+|+|||..+++||+|||+|..-.....- 
T Consensus        97 GELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL-  168 (786)
T KOG0588|consen   97 GELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL-  168 (786)
T ss_pred             chhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCccc-
Confidence            999999964    35699999999999999999999999   9999999999999999999999999999875544332 


Q ss_pred             ceeecCccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          430 RTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                        .+.+|++-|.|||++.+.+| ..++||||.|||||-|+||+.||++.+   ...+...+..    +.           
T Consensus       169 --eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV~~----G~-----------  228 (786)
T KOG0588|consen  169 --ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKVQR----GV-----------  228 (786)
T ss_pred             --cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHHHc----Cc-----------
Confidence              23469999999999999988 579999999999999999999998543   2333332221    11           


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                         -..+...+.++.+|+.+++..||++|.|++||++.
T Consensus       229 ---f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  229 ---FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             ---ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence               01123455678899999999999999999999983

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-38  Score=341.84  Aligned_cols=254  Identities=27%  Similarity=0.432  Sum_probs=205.7

Q ss_pred             eeecccCceEEEEEEeC----C----CCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEE
Q 008698          275 RLLGDSKTGGTYSGILP----D----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~----~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      +.+|+|.||.|++|...    .    ...||||.++... ....+.+..|+++|..+ +|+||+.++|+|...+..++|+
T Consensus       302 ~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~  381 (609)
T KOG0200|consen  302 KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIV  381 (609)
T ss_pred             ceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEE
Confidence            37899999999999842    1    4579999998653 34568899999999999 7999999999999999999999


Q ss_pred             ecCCCCChHHHhccCC---C---C----C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcE
Q 008698          345 EFVVNGPLDRWLHHIP---R---G----G--RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH  412 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~---~---~----~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k  412 (557)
                      ||+..|+|.+||+..+   .   .    .  ..++....+.++.|||.||+||++.   ++|||||.++|||++++..+|
T Consensus       382 Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~k  458 (609)
T KOG0200|consen  382 EYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIK  458 (609)
T ss_pred             EeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEE
Confidence            9999999999998755   0   0    1  2389999999999999999999999   999999999999999999999


Q ss_pred             EeeccCCccCCccccccceeec-CccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhh
Q 008698          413 LMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWAT  490 (557)
Q Consensus       413 l~Dfgl~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~  490 (557)
                      |+|||+++.............. .-+.+|||||.+....|+.|||||||||+||||+| |..||.+....  ..+.+   
T Consensus       459 IaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--~~l~~---  533 (609)
T KOG0200|consen  459 IADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--EELLE---  533 (609)
T ss_pred             EccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--HHHHH---
Confidence            9999999965544333222111 13567999999999999999999999999999999 89999763311  11111   


Q ss_pred             hhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       491 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                       ....+             .....|..|..+++++|+.||+.+|++||++.++++.|+..
T Consensus       534 -~l~~G-------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  534 -FLKEG-------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             -HHhcC-------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence             11111             12223445678899999999999999999999999999873

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-37  Score=303.22  Aligned_cols=247  Identities=22%  Similarity=0.333  Sum_probs=196.1

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .+.||+|++|.||.+... +++.||+|.+....     ......+.+|+.++.+++||||+++++++.+.+..++|+||+
T Consensus         7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   86 (263)
T cd06625           7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM   86 (263)
T ss_pred             cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence            456799999999999864 58999999986432     122357889999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||+++.......
T Consensus        87 ~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          87 PGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             CCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence            99999998864    24588899999999999999999999   999999999999999999999999999876543211


Q ss_pred             ccc-eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 QER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...+...  ...    ......     .    
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~----~~~~~~-----~----  224 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--AIF----KIATQP-----T----  224 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--HHH----HHhccC-----C----
Confidence            111 012337789999999999889999999999999999999999987543211  000    000000     0    


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                          ....+......+.+++.+||+.+|++|||+.++++.
T Consensus       225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         225 ----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                001112244568899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-37  Score=323.59  Aligned_cols=246  Identities=19%  Similarity=0.233  Sum_probs=193.2

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g  127 (370)
T cd05596          48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG  127 (370)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence            356799999999999864 58899999996532   22345578899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..     ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......... 
T Consensus       128 g~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-  198 (370)
T cd05596         128 GDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-  198 (370)
T ss_pred             CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-
Confidence            999999864     3478888999999999999999999   9999999999999999999999999999765432211 


Q ss_pred             ceeecCccccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          430 RTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      ......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||...+...   ...   .......       .
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~---~i~~~~~-------~  265 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYS---KIMDHKN-------S  265 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---HHH---HHHcCCC-------c
Confidence            11223489999999998653    47889999999999999999999997654321   111   0000000       0


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVH  545 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~evl~  545 (557)
                      +    ........+..+.+++.+|++.+|.+  |||++++++
T Consensus       266 ~----~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         266 L----TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             C----CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            0    00001123456889999999999988  999999976

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.8e-37  Score=313.39  Aligned_cols=254  Identities=22%  Similarity=0.399  Sum_probs=197.5

Q ss_pred             CeeecccCceEEEEEEeC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .+.||+|+||.||+|... +|.    .||+|.+.... .....++.+|+.+++.++||||+++++++... ..++++||+
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~   90 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM   90 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence            346899999999999863 343    57999887543 23345788999999999999999999998754 467999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++.......
T Consensus        91 ~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  164 (303)
T cd05110          91 PHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK  164 (303)
T ss_pred             CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccc
Confidence            999999998642   24588999999999999999999999   999999999999999999999999999986543322


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |..||..........+       .....       ..
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~-------~~~~~-------~~  230 (303)
T cd05110         165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-------LEKGE-------RL  230 (303)
T ss_pred             ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHCCC-------CC
Confidence            211222235678999999988889999999999999999998 8899875432211111       11100       00


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                            ..+..++..+.+++..||..+|++||+++++++.|+.+...+
T Consensus       231 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         231 ------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence                  001113356889999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3e-37  Score=319.80  Aligned_cols=198  Identities=21%  Similarity=0.250  Sum_probs=169.5

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||+||++... +++.||||+++...   ......+.+|+.++.+++||||+++++.+.+.+..++||||+++
T Consensus         6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g   85 (363)
T cd05628           6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG   85 (363)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence            456799999999999864 58899999997542   22345678899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc-
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-  428 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  428 (557)
                      |+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        86 g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          86 GDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            999999864    34689999999999999999999999   9999999999999999999999999998754321100 


Q ss_pred             --------------------------------cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008698          429 --------------------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA  476 (557)
Q Consensus       429 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~  476 (557)
                                                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                            001123589999999999998999999999999999999999999976


Q ss_pred             CC
Q 008698          477 VD  478 (557)
Q Consensus       477 ~~  478 (557)
                      .+
T Consensus       239 ~~  240 (363)
T cd05628         239 ET  240 (363)
T ss_pred             CC
Confidence            54

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.5e-37  Score=300.87  Aligned_cols=243  Identities=24%  Similarity=0.379  Sum_probs=197.5

Q ss_pred             eeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      +.||+|++|.||++...+ ++.+++|.++....  .+++.+|+..+++++||||+++++.+.+....++++||+++++|.
T Consensus         9 ~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~   86 (256)
T cd06612           9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVS   86 (256)
T ss_pred             hhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHH
Confidence            357999999999999765 78999999875532  678999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.........  ...
T Consensus        87 ~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~~~  158 (256)
T cd06612          87 DIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNT  158 (256)
T ss_pred             HHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccc--ccc
Confidence            99864   235689999999999999999999999   9999999999999999999999999998866433211  112


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.||.........  ..     ..     ....+      ...
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~~-----~~-----~~~~~------~~~  220 (256)
T cd06612         159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--FM-----IP-----NKPPP------TLS  220 (256)
T ss_pred             ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--hh-----hc-----cCCCC------CCC
Confidence            23788999999998888999999999999999999999998764332100  00     00     00000      001


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+......+.+++.+||+.+|++|||+.+|++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            11223456899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5e-37  Score=307.37  Aligned_cols=246  Identities=20%  Similarity=0.274  Sum_probs=194.3

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      ++||+|+||+||++... +++.||+|.+.....   .....+.+|+.++.+++|+||+++.+.+...+..++||||++++
T Consensus         6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (285)
T cd05632           6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG   85 (285)
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence            46899999999999864 588999999865422   22345788999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++.........  
T Consensus        86 ~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--  158 (285)
T cd05632          86 DLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI--  158 (285)
T ss_pred             cHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc--
Confidence            999888642  234699999999999999999999999   9999999999999999999999999998765322111  


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                       ....|+..|+|||++.+..++.++||||||+++|||++|..||...........   ......     ...        
T Consensus       159 -~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~-----~~~--------  221 (285)
T cd05632         159 -RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVL-----ETE--------  221 (285)
T ss_pred             -cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhh-----ccc--------
Confidence             122489999999999988899999999999999999999999976533211100   000000     000        


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~  545 (557)
                       .......+..+.+++..|++.+|++||+     ++++++
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 -EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence             0011123446789999999999999999     667765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.6e-37  Score=307.69  Aligned_cols=247  Identities=21%  Similarity=0.281  Sum_probs=195.4

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .++||+|+||.||++... +++.||||.+.....   .....+.+|+.++.+++|+||+++++.+.+.+..++||||+++
T Consensus         5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g   84 (285)
T cd05630           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG   84 (285)
T ss_pred             eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence            356899999999999864 588999999865422   2235678899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++......... 
T Consensus        85 ~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  158 (285)
T cd05630          85 GDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI-  158 (285)
T ss_pred             CcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc-
Confidence            9999988642  234589999999999999999999998   9999999999999999999999999998765422211 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....|+..|+|||++.+..++.++||||||+++|||++|..||...........   ....         ++....  
T Consensus       159 --~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~---------~~~~~~--  222 (285)
T cd05630         159 --KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERL---------VKEVQE--  222 (285)
T ss_pred             --cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhh---------hhhhhh--
Confidence              122489999999999988999999999999999999999999976432110000   0000         000000  


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~  545 (557)
                         ..+......+.+++.+||+.||++|||     ++|+++
T Consensus       223 ---~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 ---EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ---hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence               001123356889999999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.9e-37  Score=308.24  Aligned_cols=249  Identities=22%  Similarity=0.356  Sum_probs=200.4

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      +.||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  104 (297)
T cd06656          25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT  104 (297)
T ss_pred             eeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHH
Confidence            4579999999999995 469999999997665555677899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++..     ..+++.++..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++..........  ..
T Consensus       105 ~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~--~~  174 (297)
T cd06656         105 DVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--ST  174 (297)
T ss_pred             HHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc--Cc
Confidence            99864     3588999999999999999999999   99999999999999999999999999987654332211  12


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      ..+++.|+|||.+.+..++.++|||||||++|+|++|..||...+....  +..    .....      .+      ...
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~----~~~~~------~~------~~~  236 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL----IATNG------TP------ELQ  236 (297)
T ss_pred             ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eee----eccCC------CC------CCC
Confidence            2378899999999988899999999999999999999999976443210  000    00000      00      001


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhccc
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLA  551 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~  551 (557)
                      .+...+..+.+++.+||+.+|++||++++|++  .++..+
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            12233456889999999999999999999998  444333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-37  Score=317.76  Aligned_cols=239  Identities=21%  Similarity=0.274  Sum_probs=187.2

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHH-HHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .||+|+||.||++... +++.||+|++.....   .....+..|.. ++..++||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            5799999999999965 578899999975421   22234444544 567889999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++..    ...+++.....++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        82 ~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~  152 (325)
T cd05602          82 ELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T  152 (325)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence            99998864    34578888889999999999999999   999999999999999999999999999875322211  1


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...+...   .....   ..         ...    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i---~~---------~~~----  213 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNI---LN---------KPL----  213 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHH---Hh---------CCc----
Confidence            223348999999999999999999999999999999999999997654321   11110   00         000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV  544 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl  544 (557)
                        ......+..+.+++.+|++.+|.+||++.+.+
T Consensus       214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         214 --QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence              00112345688999999999999999987544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.1e-37  Score=306.20  Aligned_cols=244  Identities=23%  Similarity=0.383  Sum_probs=191.0

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeC------CceEEEEec
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH------GDRYIVYEF  346 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~------~~~~lV~E~  346 (557)
                      +.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +||||+++++++...      ...++||||
T Consensus        12 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~   90 (272)
T cd06637          12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF   90 (272)
T ss_pred             HheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence            35799999999999864 58899999986543 3456788999999998 799999999998753      357899999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++|+|.+++...  ....+++..+..++.|++.||+|||++   +|+|+||||+||++++++.+||+|||++.......
T Consensus        91 ~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~  165 (272)
T cd06637          91 CGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  165 (272)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence            9999999998752  234689999999999999999999999   99999999999999999999999999997654322


Q ss_pred             cccceeecCccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  501 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (557)
                      .  ......|+..|+|||++..     ..++.++|||||||++|||++|..||...+.....     . . ....     
T Consensus       166 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~-~-~~~~-----  231 (272)
T cd06637         166 G--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----F-L-IPRN-----  231 (272)
T ss_pred             c--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----H-H-HhcC-----
Confidence            1  1122348889999999863     35788999999999999999999998654321100     0 0 0000     


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..       ........+..+.+++.+||..+|.+|||+.++++
T Consensus       232 ~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         232 PA-------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CC-------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            00       00111123456889999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=308.28  Aligned_cols=244  Identities=21%  Similarity=0.331  Sum_probs=189.6

Q ss_pred             eecccCceEEEEEEe-CCCCEEEEEEecccch--------------hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--C
Q 008698          276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--------------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--G  338 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~  338 (557)
                      -||+|.||.|-++.. .+++.||||++.+...              ...+...+|+.+|++++|||||+|+.+..+.  +
T Consensus       104 eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~  183 (576)
T KOG0585|consen  104 EIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESD  183 (576)
T ss_pred             hhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccC
Confidence            469999999999985 4689999999965321              1235789999999999999999999998764  6


Q ss_pred             ceEEEEecCCCCChHHHhccCCCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeecc
Q 008698          339 DRYIVYEFVVNGPLDRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  417 (557)
Q Consensus       339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  417 (557)
                      .+|||+|||..|.+...     ..... ++..+.++++.++..||.|||.+   +||||||||+|+||++++++||+|||
T Consensus       184 ~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsDFG  255 (576)
T KOG0585|consen  184 KLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISDFG  255 (576)
T ss_pred             ceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeeccc
Confidence            78999999999887432     12234 99999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCcc---ccccceeecCccccccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhh
Q 008698          418 LSKFVPWE---VMQERTVMAGGTYGYLAPEFVYRNE----LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT  490 (557)
Q Consensus       418 l~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~  490 (557)
                      .+......   ..........||+.|+|||...++.    .+.+.||||+||+||-|+.|+.||.+....   .++.   
T Consensus       256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---~l~~---  329 (576)
T KOG0585|consen  256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---ELFD---  329 (576)
T ss_pred             eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH---HHHH---
Confidence            99865322   1122222245999999999988743    246789999999999999999999764321   1111   


Q ss_pred             hhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       491 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                               .++...+.    -....+..+.+.+|++++|++||+.|.+..+|...
T Consensus       330 ---------KIvn~pL~----fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  330 ---------KIVNDPLE----FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             ---------HHhcCccc----CCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence                     22222221    11112355678999999999999999999998754

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.9e-37  Score=304.39  Aligned_cols=249  Identities=22%  Similarity=0.377  Sum_probs=197.2

Q ss_pred             eeecccCceEEEEEEeCC--CCEEEEEEeccc----------chhhHHHHHHHHHHHhh-cCCCcEEeeeeeeeeCCceE
Q 008698          275 RLLGDSKTGGTYSGILPD--GSRVAVKRLKRS----------SFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYDHGDRY  341 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~--g~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~H~niv~l~g~~~~~~~~~  341 (557)
                      +.||+|+||.||+|....  ++.+|+|.+...          ......++.+|+.++.+ ++||||+++++++...+..+
T Consensus         6 ~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   85 (269)
T cd08528           6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLY   85 (269)
T ss_pred             hhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEE
Confidence            357999999999999765  688999987532          12234567888888875 69999999999999999999


Q ss_pred             EEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      +||||+++++|.+++.........+++..++.++.|++.||.|||+ .   +++|+||+|+|||++.++.+||+|||++.
T Consensus        86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~  162 (269)
T cd08528          86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDFGLAK  162 (269)
T ss_pred             EEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEeccccee
Confidence            9999999999999886543444569999999999999999999996 5   89999999999999999999999999998


Q ss_pred             cCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      ......   ......++..|+|||.+.+..++.++||||||+++|||++|+.||...+...   ..   ....       
T Consensus       163 ~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~---~~~~-------  226 (269)
T cd08528         163 QKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LA---TKIV-------  226 (269)
T ss_pred             eccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HH---HHHh-------
Confidence            654332   1122347889999999998889999999999999999999999986543211   11   1100       


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                        +....    .......+..+.+++.+||+.||++||++.||.++++
T Consensus       227 --~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 --EAVYE----PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --hccCC----cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence              00000    0011123456889999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.6e-37  Score=339.92  Aligned_cols=258  Identities=22%  Similarity=0.298  Sum_probs=199.4

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||+|... +|+.||||+++...   ....++|.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus         7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG   86 (932)
T PRK13184          7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG   86 (932)
T ss_pred             EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence            456799999999999964 58999999997542   23356799999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          350 GPLDRWLHHIPR-------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       350 gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      |+|.+++.....       ....+++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i  163 (932)
T PRK13184         87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFK  163 (932)
T ss_pred             CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcceec
Confidence            999998864211       123466778899999999999999999   9999999999999999999999999999865


Q ss_pred             Ccccc--------------c--cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHH
Q 008698          423 PWEVM--------------Q--ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF  486 (557)
Q Consensus       423 ~~~~~--------------~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~  486 (557)
                      .....              .  .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...+....   .
T Consensus       164 ~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki---~  240 (932)
T PRK13184        164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI---S  240 (932)
T ss_pred             ccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh---h
Confidence            21100              0  001112489999999999999999999999999999999999999976432110   0


Q ss_pred             HhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcccC
Q 008698          487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-RMSHVVHQLQQLAQ  552 (557)
Q Consensus       487 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-t~~evl~~L~~~~~  552 (557)
                             ...   ...++..     ..+..+.+..+.+++.+|++.||++|| +++++++.|+...+
T Consensus       241 -------~~~---~i~~P~~-----~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        241 -------YRD---VILSPIE-----VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             -------hhh---hccChhh-----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                   000   0011100     001123445688999999999999996 67778887776543

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.4e-37  Score=316.82  Aligned_cols=236  Identities=24%  Similarity=0.307  Sum_probs=186.1

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHH-HHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +||+|+||.||++... +|+.||+|++.....   .....+.+|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5799999999999974 588999999975422   22344555554 578889999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|..++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  152 (321)
T cd05603          82 ELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T  152 (321)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence            99888854    34588889999999999999999999   999999999999999999999999999875322211  1


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|..||...+..   .+.+..            ....+    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i------------~~~~~----  213 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNI------------LHKPL----  213 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHHHH------------hcCCC----
Confidence            12234899999999999888999999999999999999999999765421   111110            00000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS  541 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~  541 (557)
                        ..+......+.+++.+|++.+|.+||++.
T Consensus       214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 --QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             --CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence              01112345688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.2e-37  Score=318.55  Aligned_cols=247  Identities=23%  Similarity=0.283  Sum_probs=194.9

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||+||++... +|+.||+|+++....   .....+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (330)
T cd05601           6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG   85 (330)
T ss_pred             EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence            346799999999999864 588999999976422   2345688899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++...   ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++......... 
T Consensus        86 ~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-  158 (330)
T cd05601          86 GDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-  158 (330)
T ss_pred             CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-
Confidence            9999999752   24689999999999999999999999   9999999999999999999999999999866433222 


Q ss_pred             ceeecCcccccccccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccC
Q 008698          430 RTVMAGGTYGYLAPEFVY------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  503 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~------~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  503 (557)
                      ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........      .........   .+.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~---~~~  229 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQR---FLK  229 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCC---ccC
Confidence            112234899999999986      45678899999999999999999999976543210      011111000   000


Q ss_pred             cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       504 ~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                           . .  .....+..+.+++..|++ +|++|||++++++
T Consensus       230 -----~-~--~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         230 -----F-P--EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             -----C-C--CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                 0 0  011234568899999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.2e-38  Score=306.26  Aligned_cols=267  Identities=24%  Similarity=0.313  Sum_probs=199.2

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC-----ceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E~~  347 (557)
                      .+++|.|+||.||+|+.. ++..||||+.-.+..    ---+|+.+|+++.|||||+++.++....     ...+|||||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            457899999999999964 478999999854421    1236899999999999999999886442     235899999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCcEEeeccCCccCCccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~  426 (557)
                      +. +|.++++.....+..++...+.-+..||.+||+|||+.   +|+||||||.|+|+|.+ +.+||+|||.|+.+....
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            76 89998886555667788888999999999999999998   99999999999999987 889999999999876554


Q ss_pred             cccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhh-------h--cc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV-------Q--SH  496 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~-------~--~~  496 (557)
                      ...+-.   -|.-|+|||.+.+ ..||.+.||||.|||+.||+-|++-|.+.+..+  ++.+...-+.       .  ..
T Consensus       181 pniSYi---cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  181 PNISYI---CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             CceeEE---EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHHHhCCCCHHHHhhcCc
Confidence            432222   4678999999987 479999999999999999999999998865432  2222221110       0  01


Q ss_pred             ccccccCcccccCC-CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcccCC
Q 008698          497 RYLELLDPLISSLS-SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLAQP  553 (557)
Q Consensus       497 ~~~~~~d~~l~~~~-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~~~  553 (557)
                      ...+.-.+.+.... ........+.+..+++.++++.+|.+|.++.|++.  .++.+..+
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            11122222222111 11122335567899999999999999999999986  44444443

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.7e-37  Score=302.08  Aligned_cols=246  Identities=22%  Similarity=0.321  Sum_probs=197.7

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+...+..++||||+++|+
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   84 (255)
T cd08219           5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD   84 (255)
T ss_pred             EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence            356899999999999864 5889999998643 23445678899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...  ....+++..+..++.|++.||.|||++   +++|+||||+||++++++.++++|||++..........  
T Consensus        85 l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~--  157 (255)
T cd08219          85 LMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA--  157 (255)
T ss_pred             HHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccccc--
Confidence            99988642  234588999999999999999999999   99999999999999999999999999987654322111  


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ....++..|+|||++.+..++.++||||||+++|+|++|..||...+..   ...   .... ....    .        
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~---~~~~-~~~~----~--------  218 (255)
T cd08219         158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NLI---LKVC-QGSY----K--------  218 (255)
T ss_pred             ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HHH---HHHh-cCCC----C--------
Confidence            1223788999999998888999999999999999999999999754321   111   1100 0100    0        


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                       ..+...+..+.+++.+||+.+|++|||+.+|+..
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 -PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             0112234568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-37  Score=300.46  Aligned_cols=239  Identities=22%  Similarity=0.341  Sum_probs=200.5

Q ss_pred             eecccCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .||+|.||.|-++.. ..|+.||||.++++..   ++.-.+.+|+++|+.|+||||+.++.+|++.+...|||||..+|.
T Consensus        60 tLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~Ge  139 (668)
T KOG0611|consen   60 TLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGE  139 (668)
T ss_pred             HhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCcc
Confidence            479999999999884 6799999999987643   444567899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+|+..    .+.|++.+...+++||.+|+.|.|.+   +++|||||.+|||||.|+++||+|||++..+.....   .
T Consensus       140 LYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf---L  209 (668)
T KOG0611|consen  140 LYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF---L  209 (668)
T ss_pred             HHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccccH---H
Confidence            9999975    35699999999999999999999999   999999999999999999999999999987754433   2


Q ss_pred             eecCccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          432 VMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .+.+|++-|.+||.+.+.+| .+..|-||+||+||.|+.|..||++.+..   .++.   . +..+   +...|      
T Consensus       210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvr---Q-Is~G---aYrEP------  273 (668)
T KOG0611|consen  210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVR---Q-ISRG---AYREP------  273 (668)
T ss_pred             HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHH---H-hhcc---cccCC------
Confidence            34669999999999999887 57899999999999999999999986532   2211   1 1111   11111      


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                            +.+....-||.+++..+|++|.|+++|...
T Consensus       274 ------~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  274 ------ETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                  122346679999999999999999999764

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.6e-37  Score=308.77  Aligned_cols=243  Identities=23%  Similarity=0.383  Sum_probs=198.1

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      +.||.|++|.||+|.. .+|+.||+|.+........+.+.+|+..++.++||||+++++++...+..++|+||+++++|.
T Consensus        25 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  104 (296)
T cd06655          25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT  104 (296)
T ss_pred             EEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHH
Confidence            4579999999999985 468999999997665555678899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++..     ..+++.++..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.........  ...
T Consensus       105 ~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~  174 (296)
T cd06655         105 DVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RST  174 (296)
T ss_pred             HHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCC
Confidence            98853     3589999999999999999999999   9999999999999999999999999998765433221  112


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      ..++..|+|||.+.+..++.++|||||||++|||++|+.||...+....  +..     .....     .+.+      .
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~-----~~~~~-----~~~~------~  236 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL-----IATNG-----TPEL------Q  236 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-----HHhcC-----Cccc------C
Confidence            2378899999999888899999999999999999999999976543211  100     00000     0000      0


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+...+..+.+++.+||..+|++|||+.+|++
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            11223456889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=322.14  Aligned_cols=247  Identities=19%  Similarity=0.240  Sum_probs=193.5

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||+||++... +|+.||||++....   ......+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~   85 (364)
T cd05599           6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG   85 (364)
T ss_pred             EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence            356899999999999964 58999999997542   23345678899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..........
T Consensus        86 g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          86 GDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             cHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            999999864    24589999999999999999999999   99999999999999999999999999987543211000


Q ss_pred             ------------------------------------ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 008698          430 ------------------------------------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP  473 (557)
Q Consensus       430 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p  473 (557)
                                                          ......||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                                00112489999999999988999999999999999999999999


Q ss_pred             CCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q 008698          474 AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---MSHVVH  545 (557)
Q Consensus       474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt---~~evl~  545 (557)
                      |...+...   ...   ......   .    .+.    ..........+.+++.+|+. +|.+|++   ++++++
T Consensus       239 f~~~~~~~---~~~---~i~~~~---~----~~~----~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         239 FCSDNPQE---TYR---KIINWK---E----TLQ----FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCHHH---HHH---HHHcCC---C----ccC----CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            97654321   110   000000   0    000    00001123567889999996 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=295.56  Aligned_cols=258  Identities=21%  Similarity=0.262  Sum_probs=193.3

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccchh--hHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEEEEecCCCCC
Q 008698          277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVNGP  351 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~gs  351 (557)
                      |++|.||.||+|+.. +++.||+|+++.....  -.-.-++|+.+|.+++|||||.+-.+....  +..|+||||+++ +
T Consensus        84 I~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-D  162 (419)
T KOG0663|consen   84 IEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-D  162 (419)
T ss_pred             cccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-h
Confidence            599999999999964 5889999999755311  123458999999999999999998887643  568999999966 8


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+.+....   +++...+..-+..|+++|++|||.+   .|+|||||++|+|++..|.+||+|||+|+..+........
T Consensus       163 Lksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~  236 (419)
T KOG0663|consen  163 LKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTP  236 (419)
T ss_pred             HHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcccCcc
Confidence            999887643   6799999999999999999999999   9999999999999999999999999999988765332222


Q ss_pred             eecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhhhhccccccccCc-----
Q 008698          432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDP-----  504 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~-----  504 (557)
                      .  .-|..|.|||.+.+. .|+++.|+||+|||+.||+++++.|.+....+.. .++.....  ..+.+..-++.     
T Consensus       237 l--VVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGt--Pte~iwpg~~~lp~~k  312 (419)
T KOG0663|consen  237 L--VVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGT--PSEAIWPGYSELPAVK  312 (419)
T ss_pred             e--EEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCC--CccccCCCccccchhh
Confidence            2  258999999999875 6899999999999999999999999876543211 11111000  00000000000     


Q ss_pred             --ccc-----cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 --LIS-----SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 --~l~-----~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        ...     .+..........+.-++|+...+..||.+|.|++|.++
T Consensus       313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence              000     00001111113456788999999999999999999885

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.8e-37  Score=304.93  Aligned_cols=240  Identities=22%  Similarity=0.356  Sum_probs=195.3

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus        11 ~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   90 (277)
T cd06642          11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSAL   90 (277)
T ss_pred             HhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHH
Confidence            4799999999999864 57899999987543 334567899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++..     ..+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++++|||++..........  ..
T Consensus        91 ~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~--~~  160 (277)
T cd06642          91 DLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NT  160 (277)
T ss_pred             HHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchhh--hc
Confidence            98853     4588999999999999999999999   99999999999999999999999999997654332111  12


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      ..++..|+|||++.+..++.++||||||+++|||+||..|+..........      . ..     ....+        .
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~-~~-----~~~~~--------~  220 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------L-IP-----KNSPP--------T  220 (277)
T ss_pred             ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------h-hh-----cCCCC--------C
Confidence            237889999999998889999999999999999999999986543321100      0 00     00001        1


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .....+..+.+++.+||+.+|++||+|.+|++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            11223456889999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.8e-37  Score=303.60  Aligned_cols=252  Identities=27%  Similarity=0.390  Sum_probs=197.5

Q ss_pred             eeecccCceEEEEEEeC------CCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      ..||+|+||.||++...      +.+.|++|.+...... ...++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   90 (275)
T cd05046          11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYT   90 (275)
T ss_pred             eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEec
Confidence            35799999999999853      3467999998655433 4578999999999999999999999999989999999999


Q ss_pred             CCCChHHHhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          348 VNGPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      ++|+|.+++......     ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++++|||++...
T Consensus        91 ~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~  167 (275)
T cd05046          91 DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDV  167 (275)
T ss_pred             CCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccccc
Confidence            999999999753311     12689999999999999999999999   9999999999999999999999999998754


Q ss_pred             CccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccc
Q 008698          423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  501 (557)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (557)
                      ....... .....++..|+|||.+.+...+.++||||||+++|||++ |..||.......   ....    ........ 
T Consensus       168 ~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~----~~~~~~~~-  238 (275)
T cd05046         168 YNSEYYK-LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNR----LQAGKLEL-  238 (275)
T ss_pred             Ccccccc-cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHH----HHcCCcCC-
Confidence            3222111 111225678999999988888999999999999999999 788886543211   1111    01000000 


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                                 ..+...+..+.+++.+||+.+|++|||+.++++.|.+
T Consensus       239 -----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         239 -----------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                       0011234578999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2e-37  Score=322.31  Aligned_cols=260  Identities=19%  Similarity=0.252  Sum_probs=193.0

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC-----ceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E  345 (557)
                      .+.||+|+||.||++.. .+|+.||||.+...  .....+++.+|+.++..++||||+++++++...+     ..++|+|
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e   84 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE   84 (372)
T ss_pred             cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence            34679999999999996 46899999998653  2334567889999999999999999999998776     7899999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      |+. ++|.+++..    ...+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          85 LMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             ccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            996 578777743    35689999999999999999999999   9999999999999999999999999999765432


Q ss_pred             ccccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccc------
Q 008698          426 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY------  498 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  498 (557)
                      .... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||...+........   .........      
T Consensus       157 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~g~~~~~~~~~~  232 (372)
T cd07853         157 ESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI---TDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHHcCCCCHHHHHHh
Confidence            2211 1122378899999998774 4789999999999999999999999876543211111   000000000      


Q ss_pred             ----ccccCcccccCC----CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          499 ----LELLDPLISSLS----SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       499 ----~~~~d~~l~~~~----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ...+........    ...........+.+++.+|++.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                000000000000    00001112456889999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.2e-37  Score=310.90  Aligned_cols=269  Identities=16%  Similarity=0.224  Sum_probs=195.7

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||+++ +
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~   89 (309)
T cd07872          11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D   89 (309)
T ss_pred             EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence            346799999999999864 57889999987543 22335678899999999999999999999999999999999964 8


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........  .
T Consensus        90 l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~  161 (309)
T cd07872          90 LKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--Y  161 (309)
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccc--c
Confidence            88887542   34588999999999999999999999   9999999999999999999999999998754322211  1


Q ss_pred             eecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccc------ccccCc
Q 008698          432 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY------LELLDP  504 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~d~  504 (557)
                      ....+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...+..+.................      .+..+.
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            12237889999998865 46789999999999999999999999765543221111100000000000      000000


Q ss_pred             ccccCCCC---CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhccc
Q 008698          505 LISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLA  551 (557)
Q Consensus       505 ~l~~~~~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~  551 (557)
                      ........   ......+..+.+++.+|++.||.+|||++|+++  .++.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            00000000   000123456789999999999999999999997  444433

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-38  Score=321.31  Aligned_cols=246  Identities=24%  Similarity=0.344  Sum_probs=201.0

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ..+||+|.||+||.|...+ ...+|||-+........+-+.+|+.+.++|+|.|||+++|.+.+++.+-+.||.++||+|
T Consensus       580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            3568999999999999644 567999999877666677788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCcEEeeccCCccCCcccccc
Q 008698          353 DRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       353 ~~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      .++|+.  + -.++  ++.++-.+.+||++||.|||++   .|||||||-+|||++ -.|.+||+|||-++.+..-  ..
T Consensus       660 SsLLrs--k-WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP  731 (1226)
T KOG4279|consen  660 SSLLRS--K-WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NP  731 (1226)
T ss_pred             HHHHHh--c-cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC--Cc
Confidence            999974  2 2345  7778888999999999999999   999999999999996 5778999999999876432  22


Q ss_pred             ceeecCccccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          430 RTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .+.+..||..|||||++..+  .|..++|||||||++.||.||++||-.....      +.+...+.--    .+     
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp------qAAMFkVGmy----Kv-----  796 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP------QAAMFKVGMY----KV-----  796 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh------hHhhhhhcce----ec-----
Confidence            33344599999999999875  4889999999999999999999999754332      1111111100    00     


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ....|.+...+...++++|+.+||.+||++.++++
T Consensus       797 ---HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  797 ---HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ---CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence               12234667888999999999999999999999987

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=327.37  Aligned_cols=257  Identities=21%  Similarity=0.302  Sum_probs=207.3

Q ss_pred             CeeecccCceEEEEEEeCCC-CEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEEeeeeeee-e------CCceEEEE
Q 008698          274 NRLLGDSKTGGTYSGILPDG-SRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCY-D------HGDRYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~-~------~~~~~lV~  344 (557)
                      .+.|.+|||+.||.+....+ ..||+|++-..+....+.+.+|+.+|++|+ |+|||.+++... .      .-+.+|.|
T Consensus        42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm  121 (738)
T KOG1989|consen   42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM  121 (738)
T ss_pred             EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence            46789999999999998666 999999987777788899999999999996 999999999322 1      13568999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      |||.+|.|-+++..+..  ..|++.++++|+.|+++|+++||.. +++|||||||.+||||+.++..||+|||-+.....
T Consensus       122 EyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~  198 (738)
T KOG1989|consen  122 EYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL  198 (738)
T ss_pred             hhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence            99999999999986433  3499999999999999999999986 77899999999999999999999999999864322


Q ss_pred             cc-cc------cceeecCcccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhh
Q 008698          425 EV-MQ------ERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ  494 (557)
Q Consensus       425 ~~-~~------~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~  494 (557)
                      .. ..      +......-|+-|+|||.+.   +...++|+|||+|||+||-|+....||+.....              
T Consensus       199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--------------  264 (738)
T KOG1989|consen  199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--------------  264 (738)
T ss_pred             CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------------
Confidence            21 11      1111122589999999774   567899999999999999999999999865332              


Q ss_pred             ccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCCC
Q 008698          495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT  556 (557)
Q Consensus       495 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~  556 (557)
                           .+++...    .-.+.......+.+||..||+.+|.+||++-+|+..+.+++..+.+
T Consensus       265 -----aIlng~Y----~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~  317 (738)
T KOG1989|consen  265 -----AILNGNY----SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP  317 (738)
T ss_pred             -----eEEeccc----cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence                 2222221    1111134677899999999999999999999999999888775543

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.7e-37  Score=307.39  Aligned_cols=261  Identities=21%  Similarity=0.369  Sum_probs=198.0

Q ss_pred             HHHHHhhcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeee---
Q 008698          261 EELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCY---  335 (557)
Q Consensus       261 ~el~~~~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~---  335 (557)
                      +.+..+.++|... +.||+|+||.||++... +++.+|+|.++... ....++.+|+.++.++ +||||+++++++.   
T Consensus        11 ~~~~~~~~~~~~~-~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          11 DSFPDPSDTWEII-ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             ecCCCcccceeee-eeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3444455566444 46799999999999864 58899999986532 2346788899999999 6999999999874   


Q ss_pred             --eCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEE
Q 008698          336 --DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL  413 (557)
Q Consensus       336 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl  413 (557)
                        ..+..++||||+++++|.+++.........+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence              34568999999999999998864333345689999999999999999999999   9999999999999999999999


Q ss_pred             eeccCCccCCccccccceeecCccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHh
Q 008698          414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW  488 (557)
Q Consensus       414 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~  488 (557)
                      +|||++.........  .....|+..|+|||++..     ..++.++|||||||++|||++|+.|+.......  .+.. 
T Consensus       166 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~-  240 (286)
T cd06638         166 VDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK-  240 (286)
T ss_pred             ccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh-
Confidence            999998765432211  112348899999998853     447889999999999999999999987543211  1100 


Q ss_pred             hhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       489 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                          ..     ....+.+      ..+......+.+++.+||+.+|++|||+.||++.
T Consensus       241 ----~~-----~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         241 ----IP-----RNPPPTL------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ----cc-----ccCCCcc------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence                00     0000000      0011123468899999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1e-36  Score=315.33  Aligned_cols=263  Identities=22%  Similarity=0.300  Sum_probs=191.9

Q ss_pred             cCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC------
Q 008698          268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------  338 (557)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------  338 (557)
                      ++|.. .+.||+|+||.||++... +|+.||||++...  .......+.+|+.++..++||||+++++++...+      
T Consensus        21 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          21 KRYQQ-LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hceEE-EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            34433 457899999999999864 5899999998653  2334567889999999999999999999886443      


Q ss_pred             ceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccC
Q 008698          339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL  418 (557)
Q Consensus       339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  418 (557)
                      ..++||||+++ +|.+.+.      ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       100 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence            46999999965 5666653      2478889999999999999999999   999999999999999999999999999


Q ss_pred             CccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHh---------
Q 008698          419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEW---------  488 (557)
Q Consensus       419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~---------  488 (557)
                      ++.......   .....+|..|+|||.+.+..++.++|||||||++|||+||+.||...+.... ..+.+.         
T Consensus       170 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         170 ARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             ccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            975432211   1122378999999999998999999999999999999999999986543210 000000         


Q ss_pred             ------hhhhhhcc------ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          489 ------ATPLVQSH------RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       489 ------~~~~~~~~------~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                            ........      ...+.+....... ...........+.+++.+|++.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPS-ESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhcccccccc-ccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                  00000000      0000000000000 00001112456889999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-36  Score=304.51  Aligned_cols=245  Identities=23%  Similarity=0.376  Sum_probs=195.1

Q ss_pred             eeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      +.||+|+||.||+|.... ++.|++|.+..........+.+|+.+++.++||||+++++.+...+..++||||+++++|.
T Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~   97 (292)
T cd06644          18 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVD   97 (292)
T ss_pred             heecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHH
Confidence            357999999999999754 8899999998776666788999999999999999999999999999999999999999998


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      .++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.........  ...
T Consensus        98 ~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~  169 (292)
T cd06644          98 AIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR--RDS  169 (292)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc--cce
Confidence            887532   24589999999999999999999999   9999999999999999999999999998654322111  112


Q ss_pred             cCccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          434 AGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      ..++..|+|||++.+     ..++.++|||||||++|||++|..||...+...  ..    ......      ..+..  
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~----~~~~~~------~~~~~--  235 (292)
T cd06644         170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VL----LKIAKS------EPPTL--  235 (292)
T ss_pred             ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HH----HHHhcC------CCccC--
Confidence            237889999999853     446789999999999999999999987643211  00    000000      00000  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ..+...+..+.+++.+||+.+|++||+++++++
T Consensus       236 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 ----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                011223456889999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-36  Score=310.90  Aligned_cols=270  Identities=17%  Similarity=0.245  Sum_probs=194.5

Q ss_pred             eeeccc--CceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          275 RLLGDS--KTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G--~~g~Vy~g~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+||+|  +|++||++.. .+|+.||+|+++...  ......+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus         4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~   83 (327)
T cd08227           4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY   83 (327)
T ss_pred             hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence            357999  7899999986 468999999997542  23345677899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc--
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--  427 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--  427 (557)
                      |+|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++++||+..........  
T Consensus        84 ~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          84 GSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            99999986422  23589999999999999999999999   999999999999999999999999986543321110  


Q ss_pred             ---ccceeecCccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhh--------
Q 008698          428 ---QERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ--------  494 (557)
Q Consensus       428 ---~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~--------  494 (557)
                         ........++..|+|||++.+  ..++.++|||||||++|||++|+.||........  ..........        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccccccch
Confidence               001112236778999999976  4588999999999999999999999975432110  0000000000        


Q ss_pred             -cccc-----ccccCccc-------------ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhccc
Q 008698          495 -SHRY-----LELLDPLI-------------SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLA  551 (557)
Q Consensus       495 -~~~~-----~~~~d~~l-------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~  551 (557)
                       ....     ....+...             ...............+.+++.+||+.||++|||+++|++  .++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence             0000     00000000             000000111234567889999999999999999999987  344443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2e-36  Score=301.65  Aligned_cols=242  Identities=20%  Similarity=0.339  Sum_probs=198.1

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      +.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus        10 ~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   89 (277)
T cd06640          10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA   89 (277)
T ss_pred             hhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcH
Confidence            35799999999999964 58899999987543 34457789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++..     ..+++.+...++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.........  ..
T Consensus        90 ~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~~  159 (277)
T cd06640          90 LDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RN  159 (277)
T ss_pred             HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc--cc
Confidence            998863     3588899999999999999999999   9999999999999999999999999999765433211  11


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...++..|+|||++.+..++.++||||||+++|||+||..|+...++.....      .          +..    ....
T Consensus       160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~----------~~~----~~~~  219 (277)
T cd06640         160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------L----------IPK----NNPP  219 (277)
T ss_pred             cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------h----------hhc----CCCC
Confidence            2337889999999988889999999999999999999999987654321100      0          000    0011


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      ......+..+.+++.+||+.+|++||+++++++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            1223456778999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.8e-37  Score=303.15  Aligned_cols=253  Identities=26%  Similarity=0.428  Sum_probs=196.2

Q ss_pred             eeecccCceEEEEEEeC----CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC------ceEE
Q 008698          275 RLLGDSKTGGTYSGILP----DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYI  342 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~----~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~l  342 (557)
                      +.||+|+||.||+|...    +++.||||++...  .....+++.+|+.++++++||||+++++++...+      ..++
T Consensus         5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   84 (273)
T cd05074           5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV   84 (273)
T ss_pred             hcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence            46799999999999853    3678999998754  2344567899999999999999999999886532      2478


Q ss_pred             EEecCCCCChHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          343 VYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      ++||+.+|+|.+++....  .....+++.....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~  161 (273)
T cd05074          85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK  161 (273)
T ss_pred             EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccc
Confidence            999999999998875322  1223588999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ...............++..|++||.+....++.++||||||+++|||++ |++||...+..   .+.....   ....  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---~~~~--  233 (273)
T cd05074         162 KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI---KGNR--  233 (273)
T ss_pred             cccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH---cCCc--
Confidence            6543322211112235678999999988889999999999999999999 88888654331   1111110   0000  


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                            .      ..+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       234 ------~------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 ------L------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ------C------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  0      00112345799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3e-37  Score=320.10  Aligned_cols=247  Identities=19%  Similarity=0.238  Sum_probs=191.7

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +++.||+|++.+..   ......+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g  127 (370)
T cd05621          48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG  127 (370)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence            456899999999999975 47899999986532   22345678899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..     ..+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||++......... 
T Consensus       128 g~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~-  198 (370)
T cd05621         128 GDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV-  198 (370)
T ss_pred             CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCce-
Confidence            999999864     3488899999999999999999999   9999999999999999999999999999865432211 


Q ss_pred             ceeecCccccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          430 RTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+...   ..   ........       .
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---~~---~~i~~~~~-------~  265 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---TY---SKIMDHKN-------S  265 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH---HH---HHHHhCCc-------c
Confidence            11233489999999998754    37889999999999999999999997654321   11   11110000       0


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVHQ  546 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~evl~~  546 (557)
                      +    ........+..+.+++..|+..+|.+  ||+++|+++.
T Consensus       266 ~----~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 L----NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             c----CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            0    00001123456778899999865544  8999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-36  Score=299.53  Aligned_cols=242  Identities=29%  Similarity=0.461  Sum_probs=194.4

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|+||.||++.. +++.||+|.++...  ....+.+|+.++.+++||||+++++++... ..++||||+++++|.
T Consensus        11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~   86 (254)
T cd05083          11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLV   86 (254)
T ss_pred             eeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHH
Confidence            45679999999999985 78889999986542  346789999999999999999999998654 579999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......     ..
T Consensus        87 ~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~  156 (254)
T cd05083          87 NFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DN  156 (254)
T ss_pred             HHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-----CC
Confidence            999753  234589999999999999999999998   99999999999999999999999999987543211     11


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |+.||...+....   ...    .....             ..
T Consensus       157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~~-------------~~  216 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---KEC----VEKGY-------------RM  216 (254)
T ss_pred             CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---HHH----HhCCC-------------CC
Confidence            124568999999988899999999999999999998 9999876543211   110    00000             00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                      .++...+..+.+++.+||+.+|++||++++|++.|++
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            0112244678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.5e-37  Score=312.14  Aligned_cols=236  Identities=22%  Similarity=0.295  Sum_probs=188.0

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ++||+|+||.||++... +|+.||+|+++...   ....+.+..|..++..+. |++|+++.+++.+.+..++||||+++
T Consensus         6 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~   85 (323)
T cd05615           6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNG   85 (323)
T ss_pred             EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCC
Confidence            57899999999999864 58899999997542   223456778888888885 67788899999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..    ...+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        86 g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--  156 (323)
T cd05615          86 GDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--  156 (323)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc--
Confidence            999998854    24589999999999999999999999   999999999999999999999999999875432211  


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+...   +....   ..         ...   
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i---~~---------~~~---  218 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSI---ME---------HNV---  218 (323)
T ss_pred             cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH---Hh---------CCC---
Confidence            1122348999999999998889999999999999999999999997654321   11111   00         000   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  540 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~  540 (557)
                         ..+...+..+.+++.+|++.+|.+|++.
T Consensus       219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence               0111234567899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.3e-37  Score=310.09  Aligned_cols=198  Identities=18%  Similarity=0.328  Sum_probs=159.4

Q ss_pred             CeeecccCceEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeee--CCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~  348 (557)
                      ...||+|+||.||++...   +++.||+|.+....  ....+.+|+.++++++||||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            346799999999999864   46789999987543  23457889999999999999999998854  456789999985


Q ss_pred             CCChHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCcEEeeccCC
Q 008698          349 NGPLDRWLHHIP-----RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLS  419 (557)
Q Consensus       349 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Dfgl~  419 (557)
                       ++|.+++....     .....+++..+..++.||+.||+|||++   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             57877765321     1123589999999999999999999999   99999999999999    45678999999999


Q ss_pred             ccCCccccc-cceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008698          420 KFVPWEVMQ-ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAV  477 (557)
Q Consensus       420 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~  477 (557)
                      +........ .......+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            865433211 11122347899999999877 45899999999999999999999999654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.6e-36  Score=300.11  Aligned_cols=247  Identities=26%  Similarity=0.449  Sum_probs=195.9

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccc------hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .+.||+|+||+||+|...+|+.+|||.++...      ......+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (265)
T cd06631           5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV   84 (265)
T ss_pred             cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence            34679999999999998889999999986432      122356889999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        85 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          85 PGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence            99999999864    23588999999999999999999999   999999999999999999999999999875432111


Q ss_pred             ----ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccC
Q 008698          428 ----QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  503 (557)
Q Consensus       428 ----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  503 (557)
                          ........++..|+|||++.+..++.++||||||+++|||++|..||...+...  ....    .....   . ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~----~~~~~---~-~~  227 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFY----IGAHR---G-LM  227 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHH----hhhcc---C-CC
Confidence                111122347889999999998889999999999999999999999997543211  1000    00000   0 00


Q ss_pred             cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       504 ~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +.+        +......+.+++.+||+.+|++||++.++++
T Consensus       228 ~~~--------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         228 PRL--------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCC--------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            101        1123456889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.6e-37  Score=321.45  Aligned_cols=247  Identities=21%  Similarity=0.253  Sum_probs=189.4

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++.. .+++.||+|++....   ......+.+|+.++++++||||+++++.+.+.+..++||||+++
T Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g   85 (382)
T cd05625           6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG   85 (382)
T ss_pred             EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence            34679999999999986 458899999997542   23345788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc--
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--  427 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--  427 (557)
                      |+|.+++..    ...+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........  
T Consensus        86 g~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          86 GDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            999999864    24588899999999999999999999   999999999999999999999999999753211000  


Q ss_pred             -------------------------------------------ccceeecCccccccccccccCCCCCchhhHHHHHHHH
Q 008698          428 -------------------------------------------QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL  464 (557)
Q Consensus       428 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil  464 (557)
                                                                 ........||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                       0000122489999999999998999999999999999


Q ss_pred             HHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC---HH
Q 008698          465 LEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---MS  541 (557)
Q Consensus       465 ~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt---~~  541 (557)
                      |||++|+.||...++....      ......       ...+    ...........+.+++.+++ .+|++|++   ++
T Consensus       239 ~elltG~~Pf~~~~~~~~~------~~i~~~-------~~~~----~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQ------MKVINW-------QTSL----HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHH------HHHHcc-------CCCc----CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            9999999999865432110      000000       0000    00001112345667777765 49999997   77


Q ss_pred             HHHH
Q 008698          542 HVVH  545 (557)
Q Consensus       542 evl~  545 (557)
                      ++++
T Consensus       301 ei~~  304 (382)
T cd05625         301 EIKA  304 (382)
T ss_pred             HHhc
Confidence            7765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=297.70  Aligned_cols=248  Identities=22%  Similarity=0.332  Sum_probs=199.0

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|++|.||++... +++.+++|.+........+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|
T Consensus         8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l   87 (262)
T cd06613           8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL   87 (262)
T ss_pred             EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence            356799999999999964 5789999999876555668899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++...   ...+++.++..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++.........  ..
T Consensus        88 ~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--~~  159 (262)
T cd06613          88 QDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK--RK  159 (262)
T ss_pred             HHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhc--cc
Confidence            9988642   24689999999999999999999999   9999999999999999999999999998765432211  11


Q ss_pred             ecCccccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          433 MAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~---~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      ...++..|+|||.+...   .++.++||||||+++|||+||+.|+...+...  ....     ....   + +.+.    
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~-----~~~~---~-~~~~----  224 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFL-----ISKS---N-FPPP----  224 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HHhc---c-CCCc----
Confidence            23378899999998776   78999999999999999999999997654321  1100     0000   0 0000    


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       ........+..+.+++.+||+.+|.+|||+++|+.
T Consensus       225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 -KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             00112234567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-37  Score=321.36  Aligned_cols=248  Identities=20%  Similarity=0.236  Sum_probs=190.8

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++.. .+|+.||||++....   ......+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g   85 (377)
T cd05629           6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG   85 (377)
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence            34679999999999985 468999999986542   22346788899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc--
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--  427 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--  427 (557)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        86 g~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          86 GDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            999999864    24688999999999999999999999   999999999999999999999999999863211000  


Q ss_pred             -----------cc--------------------------------ceeecCccccccccccccCCCCCchhhHHHHHHHH
Q 008698          428 -----------QE--------------------------------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL  464 (557)
Q Consensus       428 -----------~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil  464 (557)
                                 ..                                ......||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                       00                                00012489999999999988999999999999999


Q ss_pred             HHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCC---CCHH
Q 008698          465 LEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR---PRMS  541 (557)
Q Consensus       465 ~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Pt~~  541 (557)
                      |||+||..||...+...   ...   ......   ..+.  .    ..  .......+.+++.+|+. +|.+|   |++.
T Consensus       239 ~elltG~~Pf~~~~~~~---~~~---~i~~~~---~~~~--~----p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         239 FECLIGWPPFCSENSHE---TYR---KIINWR---ETLY--F----PD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             hhhhcCCCCCCCCCHHH---HHH---HHHccC---CccC--C----CC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            99999999997654321   111   000000   0000  0    00  01123467889999997 66665   5999


Q ss_pred             HHHHH
Q 008698          542 HVVHQ  546 (557)
Q Consensus       542 evl~~  546 (557)
                      ++++.
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            98874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.6e-36  Score=303.90  Aligned_cols=261  Identities=20%  Similarity=0.260  Sum_probs=187.8

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhc---CCCcEEeeeeeeeeC-----CceEEE
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDH-----GDRYIV  343 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~-----~~~~lV  343 (557)
                      +.||+|+||.||++... +|+.||+|.++....  .....+.+|+.++.++   +||||+++++++...     ...++|
T Consensus         6 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv   85 (288)
T cd07863           6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV   85 (288)
T ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence            46799999999999865 588999999875321  1223456677666655   799999999987642     457999


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      |||+. ++|.+++...  ....+++.++..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus        86 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          86 FEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             Ecccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            99997 5898888652  234589999999999999999999999   99999999999999999999999999998654


Q ss_pred             ccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhhhhhhccccc---
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSHRYL---  499 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~---  499 (557)
                      .....   ....++..|+|||++.+..++.++|||||||++|||++|++||........ ..+..............   
T Consensus       160 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         160 CQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             CcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            32211   122378899999999988899999999999999999999999876543211 11111100000000000   


Q ss_pred             ---cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          500 ---ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       500 ---~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ..+.+..... ......+....+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         237 LPRGAFSPRGPRP-VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccCCCCCCc-hHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               0000000000 00000123456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-36  Score=318.59  Aligned_cols=262  Identities=17%  Similarity=0.189  Sum_probs=194.7

Q ss_pred             CCCeeecccCceEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          272 EGNRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      +..+.||+|+||.||++...   .++.||||.+...     ..+.+|+.+|++++||||+++++++...+..++|||++.
T Consensus        95 ~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  169 (392)
T PHA03207         95 NILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK  169 (392)
T ss_pred             EEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence            33456799999999998753   3578999988643     245689999999999999999999999999999999985


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                       ++|.+++..    ...+++.+++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.........
T Consensus       170 -~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        170 -CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             -CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence             688888842    35699999999999999999999999   9999999999999999999999999999765543332


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc---------
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL---------  499 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------  499 (557)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.................+.....         
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~  321 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL  321 (392)
T ss_pred             ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence            22223448999999999999899999999999999999999999997654322111111111111000000         


Q ss_pred             -cc---cCccccc-C--CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          500 -EL---LDPLISS-L--SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       500 -~~---~d~~l~~-~--~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                       ..   ....... .  ............+.+++.+|+..||++|||+.|++..
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence             00   0000000 0  0000001123467889999999999999999999873

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=301.68  Aligned_cols=241  Identities=22%  Similarity=0.346  Sum_probs=196.4

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .||.|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.+....++|+||+++++|.
T Consensus         8 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   87 (274)
T cd06609           8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL   87 (274)
T ss_pred             hhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHH
Confidence            5699999999999965 58899999987543 344567889999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++........  ...
T Consensus        88 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--~~~  157 (274)
T cd06609          88 DLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK--RNT  157 (274)
T ss_pred             HHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccccc--ccc
Confidence            99864     2689999999999999999999999   9999999999999999999999999999876543211  112


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      ..++..|+|||++.+..++.++||||||+++|||+||..||...++.....       ...     ....+.+       
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~-------~~~-----~~~~~~~-------  218 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF-------LIP-----KNNPPSL-------  218 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH-------Hhh-----hcCCCCC-------
Confidence            237888999999998889999999999999999999999997644321100       000     0011111       


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .....+..+.+++.+||..+|++|||++++++
T Consensus       219 ~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11113456889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-36  Score=300.31  Aligned_cols=245  Identities=22%  Similarity=0.309  Sum_probs=193.8

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      .||+|+||.||++... +++.||+|.++.........+.+|+.++..++||||+++++.+...+..++||||+++++|.+
T Consensus        16 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (267)
T cd06645          16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD   95 (267)
T ss_pred             HhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHH
Confidence            5799999999999864 588999999876654555678899999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++..    ...+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........  .....
T Consensus        96 ~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~  166 (267)
T cd06645          96 IYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKSF  166 (267)
T ss_pred             HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--ccccc
Confidence            8854    24689999999999999999999999   999999999999999999999999999875532211  11223


Q ss_pred             Ccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          435 GGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       435 ~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      .|+..|+|||++.   ...++.++|||||||++|||++|..|+....+..  .+...     ...   ....+...    
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~~-----~~~---~~~~~~~~----  232 (267)
T cd06645         167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFLM-----TKS---NFQPPKLK----  232 (267)
T ss_pred             cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHhh-----hcc---CCCCCccc----
Confidence            4889999999874   4568899999999999999999999986543211  00000     000   00001010    


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .  ....+..+.+++.+|++.+|++|||+++|++
T Consensus       233 ~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         233 D--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             c--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0  0112345889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.8e-36  Score=306.49  Aligned_cols=198  Identities=19%  Similarity=0.332  Sum_probs=159.1

Q ss_pred             CeeecccCceEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeee--CCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~  348 (557)
                      ...||+|+||.||++...   ++..||+|.+....  ....+.+|+.++++++||||+++++++..  ....++||||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            346799999999999964   35789999987543  23467889999999999999999998854  456799999986


Q ss_pred             CCChHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCcEEeeccCC
Q 008698          349 NGPLDRWLHHIP-----RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLS  419 (557)
Q Consensus       349 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Dfgl~  419 (557)
                       ++|.+++....     .....+++..+..++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             57777764221     1224588999999999999999999999   99999999999999    56678999999999


Q ss_pred             ccCCccccc-cceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008698          420 KFVPWEVMQ-ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAV  477 (557)
Q Consensus       420 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~  477 (557)
                      +........ .......+|+.|+|||.+.+ ..++.++|||||||++|||+||++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            865433221 11122347899999999876 45799999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-36  Score=304.42  Aligned_cols=248  Identities=23%  Similarity=0.354  Sum_probs=197.3

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .||+|+||+||++... +|+.||+|++.... ....+.+.+|++++..++||||+++++++...+..++||||+++++|.
T Consensus        12 ~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   91 (284)
T cd06620          12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD   91 (284)
T ss_pred             HcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHH
Confidence            5799999999999964 58899999886542 334578999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++..    ...+++.....++.+++.||.|||+..  +++||||||+||++++++.++|+|||++........    ..
T Consensus        92 ~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~----~~  161 (284)
T cd06620          92 RIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA----DT  161 (284)
T ss_pred             HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc----Cc
Confidence            98864    246899999999999999999999631  899999999999999999999999999865432211    12


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-----hhHHHhhhhhhhccccccccCccccc
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-----QSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      ..++..|+|||++.+..++.++|||||||++|||+||..||........     ..+.+.......         .    
T Consensus       162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------~----  228 (284)
T cd06620         162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ---------E----  228 (284)
T ss_pred             cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh---------c----
Confidence            3488999999999888899999999999999999999999986543210     111111111110         0    


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      .....+....+..+.+++.+|++.||++|||++||++.
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00111112245678899999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-36  Score=299.86  Aligned_cols=244  Identities=24%  Similarity=0.439  Sum_probs=195.1

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccchh---------hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEE
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      ..||+|++|.||+|... +++.||+|.+......         ..+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         6 ~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (267)
T cd06628           6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFL   85 (267)
T ss_pred             ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEE
Confidence            46799999999999864 5889999988643221         2256889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.+||+|||+++....
T Consensus        86 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06628          86 EYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEA  158 (267)
T ss_pred             EecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence            99999999999964    24588999999999999999999999   999999999999999999999999999886642


Q ss_pred             cccc----cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          425 EVMQ----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       425 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      ....    .......++..|+|||.+.+..++.++||||||+++|||++|+.||...+..  ....    ..      ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~----~~------~~  226 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIF----KI------GE  226 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHHH----HH------hc
Confidence            2111    1111223788999999998888999999999999999999999999764321  1110    00      00


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...+        ..+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       227 ~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 NASP--------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             cCCC--------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            0111        111234567889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=301.85  Aligned_cols=245  Identities=24%  Similarity=0.380  Sum_probs=196.3

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      .||+|++|.||++... ++..||+|.++.........+.+|+.++++++||||+++++.+...+..++||||+++++|.+
T Consensus        12 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   91 (280)
T cd06611          12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDS   91 (280)
T ss_pred             HhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHH
Confidence            4699999999999974 588999999977665666789999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++...   ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++.........  ....
T Consensus        92 ~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~  163 (280)
T cd06611          92 IMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTF  163 (280)
T ss_pred             HHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccc--ccee
Confidence            98642   24689999999999999999999999   9999999999999999999999999998765332221  1123


Q ss_pred             Ccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          435 GGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       435 ~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      .++..|+|||.+.     ...++.++||||||+++|||++|+.||...+...  .+..     ....     ..+.+   
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~-----~~~~-----~~~~~---  228 (280)
T cd06611         164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLK-----ILKS-----EPPTL---  228 (280)
T ss_pred             ecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHH-----HhcC-----CCCCc---
Confidence            3788999999875     3446789999999999999999999997654321  1100     0000     00000   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                         ..+...+..+.+++.+||+.+|++||++++|++.
T Consensus       229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         229 ---DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ---CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence               0112234568899999999999999999999873

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.5e-36  Score=297.96  Aligned_cols=245  Identities=23%  Similarity=0.376  Sum_probs=189.2

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E  345 (557)
                      .+.||+|+||.||++... +++.||+|.+....     ......+.+|+.++++++||||+++++++.+.  +..++++|
T Consensus         7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e   86 (266)
T cd06651           7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME   86 (266)
T ss_pred             cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence            346799999999999864 58999999986432     22345688999999999999999999988653  56789999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus        87 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          87 YMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence            9999999999864    23588999999999999999999998   9999999999999999999999999999765432


Q ss_pred             cc-ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          426 VM-QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       426 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      .. ........++..|+|||.+.+..++.++||||||+++|||++|+.||...+..  ....    ....     ....+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--~~~~----~~~~-----~~~~~  228 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--AAIF----KIAT-----QPTNP  228 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--HHHH----HHhc-----CCCCC
Confidence            11 11111233788999999998888999999999999999999999999754321  1110    0000     00011


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .        .+......+..++ +||..+|++||+++||++
T Consensus       229 ~--------~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         229 Q--------LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             C--------CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1        1122334456666 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.2e-37  Score=321.17  Aligned_cols=248  Identities=20%  Similarity=0.236  Sum_probs=190.9

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +++.||||++.....   .....+.+|+.+|.+++||||+++++.+.+.+..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~   85 (376)
T cd05598           6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG   85 (376)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence            346799999999999864 588999999965422   2345688999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc--
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--  427 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--  427 (557)
                      |+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++........  
T Consensus        86 g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          86 GDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            999999864    24588889999999999999999999   999999999999999999999999999753210000  


Q ss_pred             ---------------------------------------ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHH
Q 008698          428 ---------------------------------------QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV  468 (557)
Q Consensus       428 ---------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~  468 (557)
                                                             ........||+.|+|||++.+..++.++|||||||++|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                   00001234899999999999989999999999999999999


Q ss_pred             cCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC---CHHHHHH
Q 008698          469 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP---RMSHVVH  545 (557)
Q Consensus       469 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP---t~~evl~  545 (557)
                      +|+.||...+.......      ....       ...+    ...........+.+++.+|+ .+|.+|+   ++.++++
T Consensus       239 ~G~~Pf~~~~~~~~~~~------i~~~-------~~~~----~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         239 VGQPPFLADTPAETQLK------VINW-------ETTL----HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             hCCCCCCCCCHHHHHHH------Hhcc-------Cccc----cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            99999986543221110      0000       0000    00001112345677888866 4999999   8888886


Q ss_pred             H
Q 008698          546 Q  546 (557)
Q Consensus       546 ~  546 (557)
                      .
T Consensus       301 h  301 (376)
T cd05598         301 H  301 (376)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.9e-36  Score=302.75  Aligned_cols=263  Identities=22%  Similarity=0.322  Sum_probs=192.9

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|++|.||+|... ++..||||.++...  ......+.+|+.++.+++||||+++++++.+++..++||||++ ++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~   84 (285)
T cd07861           6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD   84 (285)
T ss_pred             eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence            45799999999999974 58999999986542  2234678899999999999999999999999999999999996 68


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++..... +..+++..+..++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||++.........  .
T Consensus        85 l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~  158 (285)
T cd07861          85 LKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV--Y  158 (285)
T ss_pred             HHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc--c
Confidence            9888865332 35689999999999999999999999   9999999999999999999999999998755322111  1


Q ss_pred             eecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhh----hhc----cccccc
Q 008698          432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPL----VQS----HRYLEL  501 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~----~~~----~~~~~~  501 (557)
                      ....+++.|+|||.+.+. .++.++||||||+++|||+||+.||......... .........    +..    ......
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            112367899999988654 5789999999999999999999999765332100 000000000    000    000000


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +....... ........+.++.+++.+||+.||++|||+++|++
T Consensus       239 ~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         239 FPKWKKGS-LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             ccccCcch-hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000000 00001113456789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-36  Score=310.07  Aligned_cols=188  Identities=19%  Similarity=0.324  Sum_probs=158.9

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      ...+.||+|+||.||++... +++.||+|.....      ....|+.++.+++||||+++++++...+..++|||++ .+
T Consensus        69 ~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~  141 (357)
T PHA03209         69 TVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SS  141 (357)
T ss_pred             EEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CC
Confidence            44456799999999999975 4678999985433      2356899999999999999999999999999999999 56


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++..   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......   
T Consensus       142 ~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---  212 (357)
T PHA03209        142 DLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---  212 (357)
T ss_pred             cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc---
Confidence            88888864   235689999999999999999999999   999999999999999999999999999975432211   


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQ  475 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~  475 (557)
                      .....||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence            112348999999999999899999999999999999999655543

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-36  Score=304.42  Aligned_cols=260  Identities=25%  Similarity=0.404  Sum_probs=198.7

Q ss_pred             HHHHHhhcCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeC-
Q 008698          261 EELRSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-  337 (557)
Q Consensus       261 ~el~~~~~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~-  337 (557)
                      .++..++++|.... .||+|+||.||++.. .+++.+|+|.+.... ....++.+|+.++.++ +|||++++++++... 
T Consensus        15 ~~~~~~~~~y~~~~-~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          15 ESLGDPTDTWEIIE-TIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             ccCCCCCCCeEEEE-EeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            44445555665544 569999999999996 458899999986542 2345678899999999 899999999998754 


Q ss_pred             ----CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEE
Q 008698          338 ----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL  413 (557)
Q Consensus       338 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl  413 (557)
                          +..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEE
Confidence                357999999999999998865333445689999999999999999999999   9999999999999999999999


Q ss_pred             eeccCCccCCccccccceeecCccccccccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHh
Q 008698          414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW  488 (557)
Q Consensus       414 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~  488 (557)
                      +|||++..........  ....++..|+|||.+...     .++.++|||||||++|||++|+.||...+..  ..+...
T Consensus       170 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~~  245 (291)
T cd06639         170 VDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFKI  245 (291)
T ss_pred             eecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHHH
Confidence            9999987654322211  122378899999988643     3688999999999999999999999765431  111110


Q ss_pred             hhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       489 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                           .....     +.+      ..+......+.+++.+||+.+|++||++.++++
T Consensus       246 -----~~~~~-----~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         246 -----PRNPP-----PTL------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -----hcCCC-----CCC------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                 00000     000      001123346889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.6e-36  Score=306.09  Aligned_cols=263  Identities=17%  Similarity=0.226  Sum_probs=193.0

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||++... +++.||+|.++... ......+.+|+.++.+++||||+++++++...+..++||||++ ++
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~   89 (301)
T cd07873          11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD   89 (301)
T ss_pred             eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cC
Confidence            346799999999999864 58899999986542 2234567889999999999999999999999999999999996 68


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   ...+++..+..++.||++||.|||+.   +++|+||||+|||+++++.+||+|||++.........  .
T Consensus        90 l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~  161 (301)
T cd07873          90 LKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--Y  161 (301)
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--c
Confidence            98888642   34588999999999999999999999   9999999999999999999999999998754322211  1


Q ss_pred             eecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc------
Q 008698          432 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP------  504 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~------  504 (557)
                      ....++..|+|||.+.+ ..++.++|||||||++|||+||+.||...+.......................++.      
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY  241 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence            11236889999998865 35788999999999999999999999765432111100000000000000000000      


Q ss_pred             ccccCCCC---CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 LISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 ~l~~~~~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ........   ......+..+.+++.+|++.||.+|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000000   000123456789999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.5e-36  Score=305.07  Aligned_cols=243  Identities=23%  Similarity=0.378  Sum_probs=196.5

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      .||+|+||.||++... ++..||||.+........+.+.+|+..+..++|+||+++++.+...+..++||||+++++|.+
T Consensus        29 ~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~  108 (292)
T cd06658          29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD  108 (292)
T ss_pred             cccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHH
Confidence            4799999999999864 588999999876655566789999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++..     ..+++..+..++.||+.||.|||++   +++||||||+||++++++.+||+|||++.........  ....
T Consensus       109 ~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~  178 (292)
T cd06658         109 IVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSL  178 (292)
T ss_pred             HHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Ccee
Confidence            8853     3488999999999999999999999   9999999999999999999999999998754322211  1122


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP  514 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  514 (557)
                      .++..|+|||.+.+..++.++||||||+++|||++|+.||...+...   .....         ...+.+.+.    .  
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~---------~~~~~~~~~----~--  240 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRRI---------RDNLPPRVK----D--  240 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---------HhcCCCccc----c--
Confidence            37889999999988889999999999999999999999987543311   11000         011111110    0  


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       515 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      .......+.+++.+|+..+|++|||++++++.
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11233467889999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.5e-36  Score=305.88  Aligned_cols=242  Identities=21%  Similarity=0.351  Sum_probs=196.0

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      .||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++...+..++||||+++++|.+
T Consensus        28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~  107 (297)
T cd06659          28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD  107 (297)
T ss_pred             hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence            4699999999999864 689999999976555556778999999999999999999999999999999999999999998


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++..     ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.........  ....
T Consensus       108 ~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~  177 (297)
T cd06659         108 IVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSL  177 (297)
T ss_pred             HHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccce
Confidence            8753     4589999999999999999999999   9999999999999999999999999998754432211  1223


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP  514 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  514 (557)
                      .++..|+|||++.+..++.++||||||+++|||++|+.||...+....  + .   . ....     ..+..      ..
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~-~---~-~~~~-----~~~~~------~~  239 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--M-K---R-LRDS-----PPPKL------KN  239 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-H---H-Hhcc-----CCCCc------cc
Confidence            388999999999888899999999999999999999999975443211  0 0   0 0000     00000      00


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       515 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .......+.+++.+|++.+|++||+++++++
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            1112345889999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-37  Score=315.65  Aligned_cols=240  Identities=23%  Similarity=0.287  Sum_probs=185.5

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhc---CCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ||+|+||+||++... +|+.||||++.....   .....+..|..++.+.   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            599999999999864 589999999965422   2223455666666655   699999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..    ...+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--  151 (330)
T cd05586          81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--  151 (330)
T ss_pred             ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence            999988864    34689999999999999999999999   999999999999999999999999999875432211  


Q ss_pred             ceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          430 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      ......||..|+|||.+.+. .++.++|||||||++|||+||+.||...+...   +..   . .....      .    
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---~~~---~-i~~~~------~----  214 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---MYR---N-IAFGK------V----  214 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---HHH---H-HHcCC------C----
Confidence            11223489999999998764 47899999999999999999999997644321   111   0 00000      0    


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP----RMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP----t~~evl~  545 (557)
                         ..+.......+.+++.+||+.+|.+||    ++.++++
T Consensus       215 ---~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         215 ---RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ---CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence               001111345678999999999999998    4566654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-36  Score=298.98  Aligned_cols=249  Identities=29%  Similarity=0.441  Sum_probs=195.5

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEecccchhhH--HHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||+||++.... ++.||+|.+........  ....+|+..+.+++||||+++++++...+..++||||++++
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~   83 (260)
T PF00069_consen    4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG   83 (260)
T ss_dssp             EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred             eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence            3568999999999999765 56899999987654333  23456999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++..    ...+++.++..++.|+++||.|||+.   +++|+||||+||++++++.++|+|||.+......  ...
T Consensus        84 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~  154 (260)
T PF00069_consen   84 SLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NEN  154 (260)
T ss_dssp             BHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSE
T ss_pred             cccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccc
Confidence            99999972    35689999999999999999999999   9999999999999999999999999999754111  112


Q ss_pred             eeecCcccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          431 TVMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~-~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      .....++..|+|||.+. +...+.++||||+|+++|+|++|..|+.................    .   . +....   
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~----~---~-~~~~~---  223 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK----R---P-LPSSS---  223 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH----T---H-HHHHT---
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc----c---c-ccccc---
Confidence            22334789999999998 78899999999999999999999999986522111111110000    0   0 00000   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       .  ........+.+++..||+.||++|||+.++++
T Consensus       224 -~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 -Q--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -T--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -c--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0  00001267999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.6e-36  Score=295.79  Aligned_cols=243  Identities=27%  Similarity=0.441  Sum_probs=195.8

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .+.||+|++|.||+|... +++.|++|.+....     ....+.+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus         5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   84 (258)
T cd06632           5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV   84 (258)
T ss_pred             cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence            346899999999999976 78999999986542     234567899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++....... 
T Consensus        85 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-  156 (258)
T cd06632          85 PGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-  156 (258)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence            99999999864    24588999999999999999999999   99999999999999999999999999987654332 


Q ss_pred             ccceeecCccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                        ......++..|+|||.+.... ++.++|+||||+++|+|++|..||......  ......    .....         
T Consensus       157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~~----~~~~~---------  219 (258)
T cd06632         157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKI----GRSKE---------  219 (258)
T ss_pred             --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHHH----Hhccc---------
Confidence              112233788999999987766 899999999999999999999998765421  111110    00000         


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ....+......+.+++.+||+.+|++||+++++++
T Consensus       220 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         220 ----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                00011123456889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.1e-36  Score=333.73  Aligned_cols=256  Identities=20%  Similarity=0.323  Sum_probs=195.1

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~  348 (557)
                      .+.||+|+||+||++... .+..||+|.+...  .......|..|+.++.+++||||+++++++...  ...++||||++
T Consensus        18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~   97 (1021)
T PTZ00266         18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD   97 (1021)
T ss_pred             EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence            456799999999999964 4778999998654  233456789999999999999999999988543  56899999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCeeecCCCCCCeeeCCC----------------
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK----PHVVHRDIRASNVLLDEE----------------  408 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~Dlk~~Nill~~~----------------  408 (557)
                      +|+|.++|.........+++..++.|+.||+.||+|||+...    .+||||||||+||||+.+                
T Consensus        98 gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng  177 (1021)
T PTZ00266         98 AGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG  177 (1021)
T ss_pred             CCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCC
Confidence            999999997543334569999999999999999999998521    259999999999999643                


Q ss_pred             -CCcEEeeccCCccCCccccccceeecCccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhH
Q 008698          409 -FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI  485 (557)
Q Consensus       409 -~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~  485 (557)
                       ..+||+|||++.........   ....||+.|+|||++.+  ..++.++||||||||||||+||..||...+..  ..+
T Consensus       178 ~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~--~ql  252 (1021)
T PTZ00266        178 RPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF--SQL  252 (1021)
T ss_pred             CCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH--HHH
Confidence             34899999999865432221   12348999999999864  45889999999999999999999999754321  111


Q ss_pred             HHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcccC
Q 008698          486 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLAQ  552 (557)
Q Consensus       486 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~~  552 (557)
                      ...    ....       +       ..+....+..+.+|+..||+.+|.+||++.|+++  .+..+.+
T Consensus       253 i~~----lk~~-------p-------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        253 ISE----LKRG-------P-------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             HHH----HhcC-------C-------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            110    0000       0       0111123456889999999999999999999994  5554443

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-36  Score=317.28  Aligned_cols=260  Identities=20%  Similarity=0.190  Sum_probs=190.0

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||.||++.... ++.||||....      ..+.+|+.+|++++|+||+++++++...+..++|||++ .++|
T Consensus       174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L  246 (461)
T PHA03211        174 HRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDL  246 (461)
T ss_pred             EEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCH
Confidence            4567999999999999754 78899996432      24578999999999999999999999999999999999 5788


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++...   ...+++.+++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++............
T Consensus       247 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  320 (461)
T PHA03211        247 YTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY  320 (461)
T ss_pred             HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence            8888542   24699999999999999999999999   99999999999999999999999999998654332221222


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-----hhHHHhhhhhhh-ccccccccC---
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-----QSIFEWATPLVQ-SHRYLELLD---  503 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~d---  503 (557)
                      ...||..|+|||++.+..++.++|||||||++|||++|..|+........     ..+......... .........   
T Consensus       321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l  400 (461)
T PHA03211        321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL  400 (461)
T ss_pred             ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence            23489999999999999999999999999999999998876543321110     111111110000 000000000   


Q ss_pred             ---------c-ccccCCCCCCc--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          504 ---------P-LISSLSSDIPE--AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       504 ---------~-~l~~~~~~~~~--~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                               . ...........  ......+.+|+.+||+.||++|||+.|+++.
T Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                     0 00000000000  0122467899999999999999999999963

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.4e-36  Score=315.28  Aligned_cols=252  Identities=19%  Similarity=0.243  Sum_probs=192.8

Q ss_pred             cCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEE
Q 008698          268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV  343 (557)
                      ++|.. .+.||+|+||.||++... +++.||+|++....   ......+.+|..++..++||||+++++.+.+.+..++|
T Consensus        43 ~~y~i-~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          43 EDYEV-VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhcEE-EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            34433 456799999999999975 57899999986432   22345678899999999999999999999999999999


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      |||+++|+|.+++..     ..++...+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       122 ~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         122 MEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            999999999999864     3488889999999999999999999   99999999999999999999999999998654


Q ss_pred             ccccccceeecCccccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ...... .....||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+...   ..   ..........
T Consensus       194 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~---~~i~~~~~~~  266 (371)
T cd05622         194 KEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TY---SKIMNHKNSL  266 (371)
T ss_pred             cCCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH---HH---HHHHcCCCcc
Confidence            322211 1233489999999998753    37889999999999999999999997654311   11   1111100000


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVHQ  546 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~evl~~  546 (557)
                      ..           ......+..+.+++..|+...+.+  ||+++++++.
T Consensus       267 ~~-----------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         267 TF-----------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             cC-----------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            00           001123456889999999844443  7899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.1e-36  Score=299.15  Aligned_cols=250  Identities=24%  Similarity=0.399  Sum_probs=194.1

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch----------hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEE
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF----------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l  342 (557)
                      .+.||+|++|.||+|... +|+.||+|.++....          ...+.+.+|+..+..++||||+++++++...+..++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI   85 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence            346899999999999854 689999998853211          112467889999999999999999999999999999


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      ||||+++++|.+++...    ..+++..+..++.||+.||.|||++   +++||||+|+||+++.++.++++|||+++..
T Consensus        86 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          86 FLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             EEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            99999999999998642    4689999999999999999999999   9999999999999999999999999999765


Q ss_pred             CccccccceeecCccccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          423 PWEVMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      .............++..|+|||.+....  ++.++||||||+++||+++|..|+...+..  ..+.+    ... .....
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~----~~~-~~~~~  231 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFK----LGN-KRSAP  231 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHH----hhc-cccCC
Confidence            4322222222234788999999987654  789999999999999999999998643221  01110    000 00001


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+..        ....+.+..+.+++.+||+.+|++|||+++|++
T Consensus       232 ~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         232 PIPP--------DVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCc--------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1111        011224567899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.1e-36  Score=295.46  Aligned_cols=247  Identities=23%  Similarity=0.316  Sum_probs=198.8

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||.|+||.||.+.. .+++.+++|.+...  +.....++.+|+.++++++|+||+++++++.+.+..++||||+++|
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (256)
T cd08221           5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG   84 (256)
T ss_pred             eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence            34689999999998884 45889999998654  2344567899999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++....  ...+++.++..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.........  
T Consensus        85 ~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~--  157 (256)
T cd08221          85 TLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--  157 (256)
T ss_pred             cHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccccc--
Confidence            9999987532  35689999999999999999999999   9999999999999999999999999998765443321  


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....+++.|+|||.+.+..++.++||||||+++|||++|..||.......   ..   .... ...        .    
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~---~~~~-~~~--------~----  218 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---LV---VKIV-QGN--------Y----  218 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH---HH---HHHH-cCC--------C----
Confidence            122337899999999988888999999999999999999999987543221   11   1100 000        0    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  547 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L  547 (557)
                       ...+...+..+.+++.+||+.+|++||++.++++.+
T Consensus       219 -~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         219 -TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence             001122345688999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.4e-36  Score=295.81  Aligned_cols=247  Identities=29%  Similarity=0.469  Sum_probs=198.1

Q ss_pred             eeecccCceEEEEEEeCC-----CCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          275 RLLGDSKTGGTYSGILPD-----GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~-----g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      +.||.|+||.||++...+     +..||+|.++..... ..+.+.+|+..+..++|+||+++++++.+.+..+++|||++
T Consensus         5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~   84 (258)
T smart00219        5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYME   84 (258)
T ss_pred             ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccC
Confidence            357999999999999754     478999999765433 56789999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +++|.+++....  ...+++.++..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.........
T Consensus        85 ~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       85 GGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             CCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            999999986522  12289999999999999999999999   9999999999999999999999999999866544222


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      ... ...++..|+|||.+.+..++.++||||||++++||++ |..||...+..   .+.+..    .....       . 
T Consensus       160 ~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~-------~-  223 (258)
T smart00219      160 KKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYL----KKGYR-------L-  223 (258)
T ss_pred             ccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----hcCCC-------C-
Confidence            211 1226789999999988889999999999999999999 78887654321   111111    10000       0 


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  547 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L  547 (557)
                           ..+...+..+.+++.+|++.+|++|||+.++++.|
T Consensus       224 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 -----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                 00112455789999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=309.84  Aligned_cols=250  Identities=20%  Similarity=0.234  Sum_probs=189.8

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +++.||||++.+..   ......+.+|..++..++|+||+++++++.+.+..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g   85 (331)
T cd05597           6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG   85 (331)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence            356799999999999964 58999999997532   22345688899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..........
T Consensus        86 ~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          86 GDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             CcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            9999998642   34589999999999999999999999   99999999999999999999999999987654322211


Q ss_pred             ceeecCccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          430 RTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                       .....||+.|+|||++..     ..++.++|||||||++|||++|+.||...+...      ..........   .+. 
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~---~~~-  228 (331)
T cd05597         160 -SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKE---HFQ-  228 (331)
T ss_pred             -ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCC---ccc-
Confidence             112348999999999863     457889999999999999999999997643211      1111111000   000 


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHH
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQH--VPSMRPRMSHVVHQ  546 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~--~P~~RPt~~evl~~  546 (557)
                       +.   ..  ....+..+.+++.+|+..  ++..||+++++++.
T Consensus       229 -~~---~~--~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 -FP---PD--VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -CC---Cc--cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence             00   00  011345677888887654  33448899998874

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.4e-36  Score=295.99  Aligned_cols=244  Identities=20%  Similarity=0.334  Sum_probs=196.8

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|+||.+|.+... +|+.||+|.+...  .....+++.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus         6 ~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd08218           6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGD   85 (256)
T ss_pred             EEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCc
Confidence            46799999999999854 5889999998643  23345688999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...  ....+++.+++.++.|++.||.|||+.   +++|+||+|+|||++.++.++|+|||++..........  
T Consensus        86 l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--  158 (256)
T cd08218          86 LYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA--  158 (256)
T ss_pred             HHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh--
Confidence            99988642  224578999999999999999999999   99999999999999999999999999997654332211  


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ....+++.|+|||++.+...+.++||||||++++||+||+.||...+..+   .   ...... +        ..     
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~---~~~~~~-~--------~~-----  218 (256)
T cd08218         159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---L---VLKIIR-G--------SY-----  218 (256)
T ss_pred             hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH---H---HHHHhc-C--------CC-----
Confidence            12237888999999988889999999999999999999999987543211   1   111100 0        00     


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...+......+.+++.+||+.+|++||++.+|++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            0011233456899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.4e-36  Score=311.07  Aligned_cols=265  Identities=20%  Similarity=0.269  Sum_probs=192.6

Q ss_pred             hcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC------
Q 008698          267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------  337 (557)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------  337 (557)
                      .++|.. .+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        16 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          16 LKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhceeE-EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            344433 356799999999999854 5889999999754  233456788999999999999999999987643      


Q ss_pred             CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeecc
Q 008698          338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  417 (557)
Q Consensus       338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  417 (557)
                      ...++||||+++ +|.+.+.      ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence            346999999964 6766664      2488899999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHh--------
Q 008698          418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEW--------  488 (557)
Q Consensus       418 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~--------  488 (557)
                      +++........   ....+|..|+|||++.+..++.++|||||||++|||++|+.||...+.... ....+.        
T Consensus       165 ~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         165 LARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             ccccCCCcccc---CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99865432211   123488999999999988899999999999999999999999976542211 000000        


Q ss_pred             -------hhhhhhc-cccccccCc-----ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          489 -------ATPLVQS-HRYLELLDP-----LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       489 -------~~~~~~~-~~~~~~~d~-----~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                             ....... ........+     .+..... .........+.+++.+|++.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS-EHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhcccccccccc-ccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   0000000 000000000     0000000 0011124568899999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.8e-36  Score=299.24  Aligned_cols=263  Identities=19%  Similarity=0.265  Sum_probs=194.6

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      ...||+|++|.||++... +|+.||+|++....  ....+.+.+|+.++.+++||||+++++++...+..++||||++++
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~   85 (286)
T cd07847           6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT   85 (286)
T ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence            346799999999999975 58999999986442  223456889999999999999999999999999999999999998


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|..++..    ...+++.++..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.........  
T Consensus        86 ~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--  156 (286)
T cd07847          86 VLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--  156 (286)
T ss_pred             HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCccc--
Confidence            88877643    24589999999999999999999998   9999999999999999999999999999866433211  


Q ss_pred             eeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHh-hhhhhh-------ccccc-c
Q 008698          431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW-ATPLVQ-------SHRYL-E  500 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~-~~~~~~-------~~~~~-~  500 (557)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|..||.+.+..+....... ......       ..... .
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            111236788999999876 4578999999999999999999999986544221110000 000000       00000 0


Q ss_pred             ccCcccccCCC-CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 LLDPLISSLSS-DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~~d~~l~~~~~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...+....... .......+..+.+++.+||+.+|++|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00000000000 0000123467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2e-36  Score=299.15  Aligned_cols=246  Identities=26%  Similarity=0.447  Sum_probs=197.8

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .||+|++|.||++... +++.||+|.+.... .....++.+|++.+++++||||+++++.+...+..++|+||+++++|.
T Consensus         8 ~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (265)
T cd06605           8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLD   87 (265)
T ss_pred             HhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHH
Confidence            5799999999999975 58899999987653 344577899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      +++....   ..+++..+..++.|++.||+|||+ .   +++|+||||+||++++++.++|+|||.+..........   
T Consensus        88 ~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~---  158 (265)
T cd06605          88 KILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT---  158 (265)
T ss_pred             HHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc---
Confidence            9987532   568999999999999999999999 7   99999999999999999999999999987553222111   


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                       ..++..|+|||.+.+..++.++||||||+++|+|++|+.||...+... ....+........             ....
T Consensus       159 -~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~-------------~~~~  223 (265)
T cd06605         159 -FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNE-------------PPPR  223 (265)
T ss_pred             -ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcC-------------CCCC
Confidence             347889999999998899999999999999999999999987543210 1111111111110             0011


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+....+..+.+++.+||..+|++|||+.+++.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            111124567899999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.1e-36  Score=293.39  Aligned_cols=245  Identities=22%  Similarity=0.342  Sum_probs=194.6

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeee-CCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~~  349 (557)
                      .+.||+|++|.||++... +++.||+|.+....  ....+.+.+|+.++++++|+|++++++.+.. .+..++||||+++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (257)
T cd08223           5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG   84 (257)
T ss_pred             EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence            356899999999999864 47899999986542  2345678899999999999999999988764 4457899999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++|.+++...  ....+++.++..++.|++.|++|||++   +++||||||+||+++.++.++|+|||++........  
T Consensus        85 ~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--  157 (257)
T cd08223          85 GDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--  157 (257)
T ss_pred             CcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC--
Confidence            9999998752  235689999999999999999999999   999999999999999999999999999876543221  


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      ......+++.|+|||.+.+..++.++||||||++++||++|+.||...+...   .   ...... ..    +       
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~---~~~~~~-~~----~-------  219 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS---L---VYRIIE-GK----L-------  219 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---H---HHHHHh-cC----C-------
Confidence            1122337889999999998889999999999999999999999987543211   1   111100 00    0       


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        ...+...+..+.+++.+|++.+|++|||+.++++
T Consensus       220 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 --PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             --CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              0011234467899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.2e-36  Score=311.40  Aligned_cols=265  Identities=19%  Similarity=0.267  Sum_probs=192.8

Q ss_pred             hcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC------
Q 008698          267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------  337 (557)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------  337 (557)
                      .++|.. .+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        23 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          23 LKRYQN-LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hcceeE-EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            344443 346799999999999864 5889999999753  233456788999999999999999999987543      


Q ss_pred             CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeecc
Q 008698          338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  417 (557)
Q Consensus       338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  417 (557)
                      ...++||||+++ +|.+++.      ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence            357999999964 6777664      2478899999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhh------
Q 008698          418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWAT------  490 (557)
Q Consensus       418 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~------  490 (557)
                      +++.......   .....+|..|+|||++.+..++.++|||||||++|||++|+.||...+..... .+.....      
T Consensus       172 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         172 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             CccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9986543221   11234889999999999999999999999999999999999999765432111 1100000      


Q ss_pred             ---------hhhhcc-c-----cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          491 ---------PLVQSH-R-----YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       491 ---------~~~~~~-~-----~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                               ...... .     ..+.....+... ...........+.+++.+|++.||++|||++++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA-DSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccc-cccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                     000000 0     000000000000 000011123568899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=307.79  Aligned_cols=249  Identities=24%  Similarity=0.342  Sum_probs=205.5

Q ss_pred             CCCCCeeecccCceEEEEEEeCC-CCEEEEEEecccchh---hHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEE
Q 008698          270 FSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~  344 (557)
                      +++..+.||+|.||.||+++.+. |+.+|+|.+.+....   ....+.+|+.+|.++. |||||.+.+.+++....++||
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm  115 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM  115 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence            34444678999999999999765 999999999776432   3468999999999998 999999999999999999999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC----CCcEEeeccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----FGAHLMGVGLSK  420 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgl~~  420 (557)
                      |++.+|.|.+.+...     .+++.....++.||+.++.|||+.   +|+||||||+|+|+...    +.+|++|||++.
T Consensus       116 EL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  116 ELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999763     299999999999999999999998   99999999999999643    479999999999


Q ss_pred             cCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      ....   ........||+.|+|||++....|+..+||||+||++|.|++|.+||..........       .+...++ +
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~-~  256 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF-D  256 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-C
Confidence            8765   233344569999999999999999999999999999999999999998765432111       0111111 0


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                              + ...+-......+.+++..++..||.+|+|+.++++.
T Consensus       257 --------f-~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  257 --------F-TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             --------C-CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                    1 111223456778999999999999999999999984

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.5e-36  Score=299.75  Aligned_cols=247  Identities=22%  Similarity=0.385  Sum_probs=194.6

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      +.||+|+||.||++... +|+.||+|.++.. .......+.+|+.++.+++||||+++++.+...+..++||||+++++|
T Consensus         7 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l   86 (286)
T cd06622           7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL   86 (286)
T ss_pred             hhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCH
Confidence            35799999999999975 6899999988654 333456889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      ..++.... ....+++..+..++.|++.||.|||+..  +++|+||||+||+++.++.+||+|||++........    .
T Consensus        87 ~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----~  159 (286)
T cd06622          87 DKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA----K  159 (286)
T ss_pred             HHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc----c
Confidence            99886421 1346899999999999999999999631  899999999999999999999999999876532221    1


Q ss_pred             ecCccccccccccccCCC------CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          433 MAGGTYGYLAPEFVYRNE------LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~------~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ...++..|+|||.+.+..      ++.++|||||||++|||++|+.||........   .....         .+.+...
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~---------~~~~~~~  227 (286)
T cd06622         160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLS---------AIVDGDP  227 (286)
T ss_pred             cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHH---------HHhhcCC
Confidence            223788999999986543      47899999999999999999999965432111   11000         0111000


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          . ..+......+.+++.+||+.+|++||+++++++
T Consensus       228 ----~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         228 ----P-TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ----C-CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                1 112235567889999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.5e-36  Score=295.33  Aligned_cols=246  Identities=21%  Similarity=0.319  Sum_probs=197.1

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeee--CCceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~  349 (557)
                      ..||.|++|.||++.. .+|+.||+|.+...  .....+++.+|+.++++++||||+++++++..  ....+++|||+++
T Consensus         6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~   85 (265)
T cd08217           6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG   85 (265)
T ss_pred             eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence            3579999999999985 46789999998654  23345678899999999999999999997754  3567999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-----DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-----~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ++|.+++.........+++..++.++.|++.||.|||     +.   +++|+||+|+||++++++.+||+|||++.....
T Consensus        86 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217          86 GDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             CCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            9999999764444567999999999999999999999     66   999999999999999999999999999987654


Q ss_pred             cccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      .....  ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..   .+.+.    ....        
T Consensus       163 ~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~----~~~~--------  225 (265)
T cd08217         163 DSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASK----IKEG--------  225 (265)
T ss_pred             Ccccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHH----HhcC--------
Confidence            33211  1223789999999999888999999999999999999999999765421   11111    0100        


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..     ...+...+..+.+++.+|++.+|++||++.+|++
T Consensus       226 ~~-----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         226 KF-----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             CC-----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            00     0112234467899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.6e-36  Score=300.06  Aligned_cols=244  Identities=22%  Similarity=0.361  Sum_probs=197.6

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      +.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+++++|.
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~  104 (293)
T cd06647          25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT  104 (293)
T ss_pred             eEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHH
Confidence            4679999999999985 468899999987655555678899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++..     ..+++.++..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++..........  ..
T Consensus       105 ~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~--~~  174 (293)
T cd06647         105 DVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--ST  174 (293)
T ss_pred             HHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc--cc
Confidence            99864     3478999999999999999999999   99999999999999999999999999987554332211  12


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      ..+++.|+|||.+.+..++.++||||||+++||+++|+.||...+....  +..    ...        ...    ....
T Consensus       175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~----~~~--------~~~----~~~~  236 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL----IAT--------NGT----PELQ  236 (293)
T ss_pred             ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eee----hhc--------CCC----CCCC
Confidence            2378899999999888899999999999999999999999976543210  000    000        000    0011


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      .+...+..+.+++.+||+.+|++||++++++..
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122244568899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-35  Score=300.60  Aligned_cols=240  Identities=24%  Similarity=0.406  Sum_probs=191.5

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +.||+|+||.||+|... +|+.||+|.+....   .....++.+|+.++..++||||+++.+++.+.+..++||||+. |
T Consensus        21 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g   99 (307)
T cd06607          21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-G   99 (307)
T ss_pred             eeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-C
Confidence            45799999999999864 58999999986432   2334678899999999999999999999999999999999996 6


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++...   ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.+||+|||++.......    
T Consensus       100 ~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~----  169 (307)
T cd06607         100 SASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN----  169 (307)
T ss_pred             CHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCC----
Confidence            777776532   24589999999999999999999999   99999999999999999999999999987654221    


Q ss_pred             eeecCcccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          431 TVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                        ...++..|+|||++.   ...++.++||||||+++|||+||..||...+....      .......       ++   
T Consensus       170 --~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~~-------~~---  231 (307)
T cd06607         170 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN-------DS---  231 (307)
T ss_pred             --CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhcC-------CC---
Confidence              123788999999885   35688899999999999999999999876543210      0000000       00   


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                         ........+..+.+++.+||+.+|++||++.+|+..
T Consensus       232 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 ---PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ---CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               111122345678999999999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-35  Score=297.46  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=196.7

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~g  350 (557)
                      +.||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++.+.  +..++||||++++
T Consensus         7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~   86 (287)
T cd06621           7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG   86 (287)
T ss_pred             EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence            35799999999999974 58899999987543 24457799999999999999999999988654  4689999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++.........++...+..++.||+.||+|||+.   +++|+||+|+||+++.++.++|+|||++.........  
T Consensus        87 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--  161 (287)
T cd06621          87 SLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG--  161 (287)
T ss_pred             CHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccccc--
Confidence            99998765433445689999999999999999999999   9999999999999999999999999998754322211  


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcc--cchhHHHhhhhhhhccccccccCccccc
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV--CWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                        ...++..|+|||.+.+..++.++||||||+++|||++|+.||......  ...++..+...    ..     .+.+..
T Consensus       162 --~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~-----~~~~~~  230 (287)
T cd06621         162 --TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MP-----NPELKD  230 (287)
T ss_pred             --cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CC-----chhhcc
Confidence              223778999999999889999999999999999999999999765321  11111111110    00     000100


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        ........+..+.+++.+||+.+|++|||+.||++
T Consensus       231 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 --EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             --CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence              00000123567899999999999999999999997

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9.9e-36  Score=294.19  Aligned_cols=253  Identities=22%  Similarity=0.338  Sum_probs=199.3

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||.|++|+||+|... ++..+|+|++.... ......+.+|+..++.++|+||+++++.+...+..++|+|++++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~   85 (267)
T cd06610           6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS   85 (267)
T ss_pred             eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence            345799999999999954 57899999987542 2356788999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc--
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE--  429 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~--  429 (557)
                      |.+++..... ...+++.....++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++..........  
T Consensus        86 l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~  161 (267)
T cd06610          86 LLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK  161 (267)
T ss_pred             HHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence            9999865221 24589999999999999999999999   99999999999999999999999999987655432221  


Q ss_pred             ceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          430 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      ......++..|+|||.+... .++.++|||||||++|||++|+.||...+...  .+...    ...      ..+.+  
T Consensus       162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~----~~~------~~~~~--  227 (267)
T cd06610         162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLT----LQN------DPPSL--  227 (267)
T ss_pred             ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHH----hcC------CCCCc--
Confidence            11223478899999998876 78999999999999999999999997654321  11110    000      00001  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       .........+..+.+++.+||+.+|++|||+++|++
T Consensus       228 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         228 -ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             -CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             011111234567889999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.1e-36  Score=294.49  Aligned_cols=244  Identities=20%  Similarity=0.291  Sum_probs=195.6

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|++|.||++... +++.+|||.+....  ......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd08220           5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG   84 (256)
T ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence            346799999999998864 58899999986542  334578899999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CcEEeeccCCccCCcccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      +|.+++...  ....+++..+..++.|++.||+|||++   +++|+||+|+||+++++. .+||+|||++......... 
T Consensus        85 ~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~-  158 (256)
T cd08220          85 TLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA-  158 (256)
T ss_pred             CHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc-
Confidence            999999752  234589999999999999999999999   999999999999998654 5799999999866433211 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+...   .....   ..         ...   
T Consensus       159 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~---~~---------~~~---  218 (256)
T cd08220         159 --YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKI---MS---------GTF---  218 (256)
T ss_pred             --cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHH---Hh---------cCC---
Confidence              12237889999999998888999999999999999999999987654321   11110   00         000   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        ...+...+..+.+++.+||+.+|++|||++|+++
T Consensus       219 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         219 --APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             --CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence              0011123456889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.6e-36  Score=298.98  Aligned_cols=247  Identities=24%  Similarity=0.433  Sum_probs=189.8

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHH-HhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGR-FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|+||.||++... +|+.||+|+++... ......+..|+.. ++.++||||+++++++...+..++||||++ |+
T Consensus         7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~   85 (283)
T cd06617           7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TS   85 (283)
T ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-cc
Confidence            45799999999999975 58999999987642 2334556667665 556689999999999999999999999995 78


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++.........+++..+..++.||+.||+|||+++  +++||||||+|||++.++.+||+|||++.........   
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~---  160 (283)
T cd06617          86 LDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---  160 (283)
T ss_pred             HHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccccc---
Confidence            88888654334467999999999999999999999752  7999999999999999999999999998765322111   


Q ss_pred             eecCccccccccccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          432 VMAGGTYGYLAPEFVYR----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~----~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      ....++..|+|||.+.+    ..++.++|+||||+++|||++|+.||...... ...+.    .....      ..    
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~----~~~~~------~~----  225 (283)
T cd06617         161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLK----QVVEE------PS----  225 (283)
T ss_pred             ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHH----HHHhc------CC----
Confidence            11237889999998865    44688999999999999999999998643221 11110    00000      00    


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ...+....+..+.+++.+||..+|++||++++|++
T Consensus       226 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 ---PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               11111223456889999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.7e-35  Score=292.09  Aligned_cols=247  Identities=23%  Similarity=0.415  Sum_probs=201.3

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|++|.||++...+ ++.|+||.+..... .....+.+|+..+.+++|+||+++++++...+..++||||+++++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (264)
T cd06623           6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS   85 (264)
T ss_pred             eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence            3568999999999999764 89999999876643 456789999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      |.+++...    ..+++..+..++.|+++||+|||+ .   +++|+||+|+||+++.++.++|+|||++.......... 
T Consensus        86 L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-  157 (264)
T cd06623          86 LADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-  157 (264)
T ss_pred             HHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-
Confidence            99999642    568999999999999999999999 8   99999999999999999999999999988664333221 


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                       ....++..|+|||.+.+..++.++||||||+++|||+||..||..........+.....            ....    
T Consensus       158 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------~~~~----  220 (264)
T cd06623         158 -NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC------------DGPP----  220 (264)
T ss_pred             -cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh------------cCCC----
Confidence             12237889999999988889999999999999999999999997654322222221111            0000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ........+..+.+++.+|++.+|++||+++++++
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            01111114467999999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.4e-36  Score=298.16  Aligned_cols=245  Identities=23%  Similarity=0.391  Sum_probs=190.4

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeee------CCceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD------HGDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~------~~~~~lV~E  345 (557)
                      .+.||.|+||.||+|.. .+++.||+|.+.... ....++..|+.++.++ +||||+++++++..      .+..+++||
T Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e   99 (282)
T cd06636          21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME   99 (282)
T ss_pred             heeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence            34679999999999996 458899999986543 3346788899999998 79999999999853      456799999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      |+++|+|.+++....  ...+++..+..++.||+.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus       100 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~  174 (282)
T cd06636         100 FCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  174 (282)
T ss_pred             eCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence            999999999986532  34588888999999999999999999   9999999999999999999999999998755322


Q ss_pred             ccccceeecCcccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          426 VMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      ...  .....++..|+|||.+.     ...++.++|||||||++|||++|..||....+..  ....     .     ..
T Consensus       175 ~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--~~~~-----~-----~~  240 (282)
T cd06636         175 VGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--ALFL-----I-----PR  240 (282)
T ss_pred             ccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh--hhhh-----H-----hh
Confidence            111  12233788999999886     3457889999999999999999999986543211  0000     0     00


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...       ........+..+.+++.+||+.+|.+|||+.||++
T Consensus       241 ~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         241 NPP-------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CCC-------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            000       11111234567899999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-36  Score=297.11  Aligned_cols=242  Identities=21%  Similarity=0.383  Sum_probs=193.9

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhcC---CCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      +.||+|+||.||+|.. .+++.||+|.++.. ......++.+|+.++++++   |||++++++++.+....++||||+++
T Consensus         7 ~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~   86 (277)
T cd06917           7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEG   86 (277)
T ss_pred             hheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCC
Confidence            3579999999999996 46899999998654 2334567889999999996   99999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++|.+++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......... 
T Consensus        87 ~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-  157 (277)
T cd06917          87 GSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-  157 (277)
T ss_pred             CcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-
Confidence            999999864     3689999999999999999999999   9999999999999999999999999999766543321 


Q ss_pred             ceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          430 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                       .....|+..|+|||.+.++ .++.++||||||+++|+|++|..||.........   .    ...     ....+.+  
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~----~~~-----~~~~~~~--  222 (277)
T cd06917         158 -RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---M----LIP-----KSKPPRL--  222 (277)
T ss_pred             -cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh---h----ccc-----cCCCCCC--
Confidence             1222488899999988754 4688999999999999999999999764321100   0    000     0000111  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                           .....+..+.+++.+||+.+|++||++.++++
T Consensus       223 -----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         223 -----EDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             -----CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                 11113456889999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-35  Score=297.92  Aligned_cols=243  Identities=23%  Similarity=0.374  Sum_probs=196.9

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      ..||+|++|.||++.. .+++.+++|++........+.+.+|+.++..++||||+++++++...+..++|+||+++++|.
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~  104 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT  104 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence            4689999999999985 468899999987655555677899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++..     ..+++..+..++.|++.||+|||++   +++||||+|+||+++.++.++|+|||++.........  ...
T Consensus       105 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~  174 (285)
T cd06648         105 DIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKS  174 (285)
T ss_pred             HHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--ccc
Confidence            99864     3588999999999999999999999   9999999999999999999999999988754332211  122


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      ..|+..|+|||.+.+..++.++||||||+++|||++|+.||...+....      ...... .     ..+.+    .  
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~~~-~-----~~~~~----~--  236 (285)
T cd06648         175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRIRD-N-----LPPKL----K--  236 (285)
T ss_pred             ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHh-c-----CCCCC----c--
Confidence            3378899999999888899999999999999999999999875433211      100000 0     00101    0  


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+...+..+.+++.+||+.+|++|||+.++++
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            01113457899999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.7e-36  Score=313.91  Aligned_cols=247  Identities=19%  Similarity=0.236  Sum_probs=190.4

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +++.||||+++...   ......+.+|+.++..++||||+++++.+.+.+..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g   85 (360)
T cd05627           6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG   85 (360)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence            356899999999999864 58899999997532   22345678899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc-
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-  428 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  428 (557)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......... 
T Consensus        86 g~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          86 GDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            999999864    24589999999999999999999999   9999999999999999999999999998754321100 


Q ss_pred             --------------------------------cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008698          429 --------------------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA  476 (557)
Q Consensus       429 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~  476 (557)
                                                      .......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                            001123489999999999999999999999999999999999999976


Q ss_pred             CCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q 008698          477 VDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---MSHVVH  545 (557)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt---~~evl~  545 (557)
                      .+....   ..   ......   ..+.  .   ...   ......+.+++.+++ .+|.+|++   ++++++
T Consensus       239 ~~~~~~---~~---~i~~~~---~~~~--~---p~~---~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         239 ETPQET---YR---KVMNWK---ETLV--F---PPE---VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCHHHH---HH---HHHcCC---Ccee--c---CCC---CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            543211   10   000000   0000  0   000   112345777888766 49999985   566664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.2e-35  Score=293.77  Aligned_cols=245  Identities=22%  Similarity=0.349  Sum_probs=190.5

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E  345 (557)
                      .++||+|+||.||.+... +|+.||||.+....     ....+.+.+|+.++.+++||||+++++++.+.  ...++|||
T Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (265)
T cd06652           7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME   86 (265)
T ss_pred             eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence            457899999999999864 58999999885321     22346788999999999999999999988663  45789999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      |+++++|.+++..    ...+++...+.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          87 HMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             ecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            9999999999864    23478889999999999999999999   9999999999999999999999999999765322


Q ss_pred             ccc-cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          426 VMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       426 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      ... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...+..  .....    ...     ...  
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~----~~~-----~~~--  226 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--AAIFK----IAT-----QPT--  226 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--HHHHH----Hhc-----CCC--
Confidence            111 1111233788999999998888999999999999999999999998754321  11100    000     000  


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                            ....+......+.+++.+|+. +|++||++++|++
T Consensus       227 ------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 ------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                  111123345567889999985 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.2e-36  Score=308.27  Aligned_cols=250  Identities=19%  Similarity=0.222  Sum_probs=189.8

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++.... ++.+|+|++.+..   ......+.+|..++..++|+||+++++++.+.+..++||||+++
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~   85 (332)
T cd05623           6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG   85 (332)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence            3467999999999999754 7789999986432   22234578899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++...   ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++......... 
T Consensus        86 g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-  158 (332)
T cd05623          86 GDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-  158 (332)
T ss_pred             CcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc-
Confidence            9999999642   24589999999999999999999999   9999999999999999999999999998754322211 


Q ss_pred             ceeecCcccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          430 RTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      ......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+...      ..........     ..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~-----~~  227 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKE-----RF  227 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCc-----cc
Confidence            112234899999999986     3457899999999999999999999997654321      1111111000     00


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCC--CCCCHHHHHHH
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPS--MRPRMSHVVHQ  546 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~--~RPt~~evl~~  546 (557)
                      ..    . ......+..+.+++.+|+..+|+  .||+++++++.
T Consensus       228 ~~----p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 QF----P-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cC----C-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            00    0 00112345678888887755444  47899998764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.2e-37  Score=313.61  Aligned_cols=249  Identities=20%  Similarity=0.367  Sum_probs=197.0

Q ss_pred             cCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEeccc----chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc--e
Q 008698          268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS----SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD--R  340 (557)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~--~  340 (557)
                      ..|.....+||+|+|-+||+|... +|..||--.++..    +....++|..|+.+|+.|+||||++++..+.+...  .
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i  118 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI  118 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence            334444567899999999999964 4778886555432    23445889999999999999999999999886654  7


Q ss_pred             EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCcEEeeccCC
Q 008698          341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLS  419 (557)
Q Consensus       341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~  419 (557)
                      -+|.|.+..|+|+.|+.+.    +.++.+.+.++++||++||.|||++ .|+|||||||.+||||+.+ |.+||+|+|||
T Consensus       119 n~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA  193 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA  193 (632)
T ss_pred             eeeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHH
Confidence            7899999999999999764    4588899999999999999999998 7799999999999999764 77999999999


Q ss_pred             ccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      .....+...    ...|||.|||||.+. ..|....||||||+.++||+|+..||......  .+++..+..-.+...+.
T Consensus       194 tl~r~s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~--AQIYKKV~SGiKP~sl~  266 (632)
T KOG0584|consen  194 TLLRKSHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP--AQIYKKVTSGIKPAALS  266 (632)
T ss_pred             HHhhccccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH--HHHHHHHHcCCCHHHhh
Confidence            887543222    234999999999876 88999999999999999999999999865432  22222222211111111


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+-                .+++.++|.+|+.. .++|||+.|+|+
T Consensus       267 kV~----------------dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  267 KVK----------------DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ccC----------------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            111                24688999999998 999999999997

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.4e-35  Score=295.43  Aligned_cols=242  Identities=21%  Similarity=0.374  Sum_probs=195.6

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      +.||+|+||.||+|... +++.||||.+.... ......+.+|+..+.+++||||+++++++...+..++||||+++++|
T Consensus        10 ~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l   89 (277)
T cd06641          10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA   89 (277)
T ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcH
Confidence            35799999999999864 68899999986543 23446788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..........  .
T Consensus        90 ~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~--~  159 (277)
T cd06641          90 LDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--N  159 (277)
T ss_pred             HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhhh--c
Confidence            998853     3588999999999999999999999   99999999999999999999999999987654322111  1


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...++..|+|||.+.+..++.++|||||||++|||++|..|+.......   ...   . .....             ..
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~---~-~~~~~-------------~~  219 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLF---L-IPKNN-------------PP  219 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHH---H-HhcCC-------------CC
Confidence            2237889999999988888999999999999999999999987543211   000   0 00000             00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      ..+...+..+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0112234568899999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.1e-35  Score=299.41  Aligned_cols=268  Identities=18%  Similarity=0.214  Sum_probs=197.1

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccchh-----hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ-----RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      +.||+|++|.||+|... +|+.||||.++.....     ....+.+|+.++.+++|+||+++++++.+.+..++||||+ 
T Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   84 (298)
T cd07841           6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-   84 (298)
T ss_pred             eeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-
Confidence            45799999999999964 5899999999765332     2356778999999999999999999999999999999999 


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++...   ...+++..+..++.||++||+|||++   +++|+||||+|||++.++.+||+|||++.........
T Consensus        85 ~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  158 (298)
T cd07841          85 ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK  158 (298)
T ss_pred             CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence            99999998642   13699999999999999999999999   9999999999999999999999999999765433211


Q ss_pred             cceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhhhhhh-----ccccccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQ-----SHRYLEL  501 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~  501 (557)
                      .  ....++..|+|||.+.+ ..++.++|||||||++|||++|.+||...++... ............     .......
T Consensus       159 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (298)
T cd07841         159 M--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY  236 (298)
T ss_pred             c--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence            1  11226778999998865 4578999999999999999999887765443211 111110000000     0000000


Q ss_pred             cCcccc-cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhccc
Q 008698          502 LDPLIS-SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLA  551 (557)
Q Consensus       502 ~d~~l~-~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~  551 (557)
                      ...... ..............+.+++.+||+.+|++|||+.||++.  +++-.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence            000000 000000012235678899999999999999999999984  44433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5e-36  Score=299.58  Aligned_cols=260  Identities=19%  Similarity=0.234  Sum_probs=190.7

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|++|.||++... +|+.||+|.++....  .....+.+|+.++.+++||||+++++++.+.+..++|+||++ ++
T Consensus         6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~   84 (284)
T cd07839           6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QD   84 (284)
T ss_pred             EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CC
Confidence            46799999999999974 589999999865422  223567889999999999999999999999999999999996 57


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   ...+++..+..++.||++||.|||+.   +++||||||+||+++.++.+||+|||+++........  .
T Consensus        85 l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~  156 (284)
T cd07839          85 LKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--Y  156 (284)
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--c
Confidence            88777532   24589999999999999999999999   9999999999999999999999999999765432211  1


Q ss_pred             eecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcc------ccccccCc
Q 008698          432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH------RYLELLDP  504 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~d~  504 (557)
                      ....++..|+|||.+.+. .++.++|||||||++|||+||..|+....+..  .............      ......+.
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            122368899999998764 46899999999999999999998865433211  1111000000000      00000000


Q ss_pred             c-cccCCC----CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 L-ISSLSS----DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 ~-l~~~~~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      . ......    ..........+.+++.+||+.||.+|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0 000000    0001123467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-35  Score=292.40  Aligned_cols=248  Identities=19%  Similarity=0.340  Sum_probs=195.8

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccc------hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      ++||+|++|.||++.. .+++.||+|++....      ....+.+.+|+..+++++|+||+++++++.+.+..++||||+
T Consensus         6 ~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~   85 (268)
T cd06630           6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWM   85 (268)
T ss_pred             ceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEecc
Confidence            4679999999999985 568999999986432      123467899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CcEEeeccCCccCCccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~  426 (557)
                      ++++|.+++..    ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++ .+||+|||++.......
T Consensus        86 ~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          86 AGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG  158 (268)
T ss_pred             CCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence            99999999864    24688999999999999999999999   999999999999998775 58999999987665432


Q ss_pred             ccc--ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          427 MQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       427 ~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      ...  ......++..|+|||.+.+..++.++||||+|++++||++|..||...........   ......          
T Consensus       159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~----------  225 (268)
T cd06630         159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIAS----------  225 (268)
T ss_pred             ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhc----------
Confidence            111  11122378899999999888889999999999999999999999865432211110   000000          


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         .......+......+.+++.+|++.+|++||++.++++
T Consensus       226 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 ---ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ---cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence               00011122334567889999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.5e-36  Score=307.81  Aligned_cols=249  Identities=20%  Similarity=0.227  Sum_probs=190.4

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +++.||+|.+....   ......+.+|..++..++|+||+++++++.+.+..++||||+++
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g   85 (331)
T cd05624           6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG   85 (331)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence            346799999999999965 57899999987532   22345578899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++......... 
T Consensus        86 g~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-  158 (331)
T cd05624          86 GDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-  158 (331)
T ss_pred             CcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-
Confidence            9999999642   24688999999999999999999999   9999999999999999999999999999765433221 


Q ss_pred             ceeecCccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          430 RTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      ......||+.|+|||++.+     +.++.++|||||||++|||++|+.||...+...   ...   ......... .+..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~---~i~~~~~~~-~~p~  231 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYG---KIMNHEERF-QFPS  231 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH---HHH---HHHcCCCcc-cCCC
Confidence            1122348999999999875     467889999999999999999999997643311   110   110000000 0000


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVH  545 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~evl~  545 (557)
                      .         ..+.+..+.+++.+|+..++++  |++++++++
T Consensus       232 ~---------~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         232 H---------ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             c---------cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            0         0123456888999988865544  568888875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.4e-35  Score=299.91  Aligned_cols=250  Identities=20%  Similarity=0.268  Sum_probs=194.9

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +.||+|+||.||++... .++.||+|.+.....   .....+.+|+.++..++||||+++++.+...+..++||||++++
T Consensus         7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~   86 (305)
T cd05609           7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGG   86 (305)
T ss_pred             eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence            46799999999999964 478999999876532   33457889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc--
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--  428 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~--  428 (557)
                      +|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++........  
T Consensus        87 ~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          87 DCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            99999964    24589999999999999999999999   9999999999999999999999999998742111000  


Q ss_pred             -----------cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          429 -----------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       429 -----------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                                 .......++..|+|||.+....++.++||||||+++|||++|..||.+.....   +....   .. . 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~~~~---~~-~-  231 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQV---IS-D-  231 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---Hh-c-
Confidence                       00011236789999999988889999999999999999999999997543221   11100   00 0 


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                        ....+..        ....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       232 --~~~~~~~--------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         232 --DIEWPEG--------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             --ccCCCCc--------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence              0000100        11234568899999999999999997767666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-36  Score=305.59  Aligned_cols=255  Identities=20%  Similarity=0.285  Sum_probs=202.8

Q ss_pred             hhcCCCCCCeeecccCceEEEEEEeCCCCEEEEEEecc--cchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEE
Q 008698          266 ITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKR--SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l  342 (557)
                      +.+..++.-+.||+||.+.||++...+.+.+|+|++..  .+.+...-|.+|+..|.+| .|.+|+++++|-..++.+|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            33344445567899999999999988889999998753  3556678899999999999 59999999999999999999


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      ||||= ..+|..+|....   ..++...++.+..|++.++.++|.+   ||||.||||.|+|+-.+ .+||+|||+|...
T Consensus       438 vmE~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANAI  509 (677)
T ss_pred             Eeecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhccc
Confidence            99975 668999997522   2233237889999999999999999   99999999999999764 7999999999998


Q ss_pred             CccccccceeecCccccccccccccCC-----------CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhh
Q 008698          423 PWEVMQERTVMAGGTYGYLAPEFVYRN-----------ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP  491 (557)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~  491 (557)
                      ..+.+........||+.||+||.+...           ..+.+|||||+|||||+|+.|+.||.....     .      
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~------  578 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----Q------  578 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----H------
Confidence            877777666677799999999998532           256789999999999999999999975321     1      


Q ss_pred             hhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       492 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ..++..+.||.-.-.-+..++.   .++.++|+.||..||.+|||..++|+
T Consensus       579 ---~aKl~aI~~P~~~Iefp~~~~~---~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  579 ---IAKLHAITDPNHEIEFPDIPEN---DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ---HHHHHhhcCCCccccccCCCCc---hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence               1123344554321111222222   23889999999999999999999997

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.8e-36  Score=299.98  Aligned_cols=263  Identities=24%  Similarity=0.287  Sum_probs=194.0

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|++|.||++... +++.||+|++.....  ...+.+.+|++++..++||||+++++++...+..++||||++++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (286)
T cd07846           6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT   85 (286)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence            346799999999999975 489999999865422  23467889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|..+...    ...+++.++..++.||+.||+|||+.   +++|+||+|+||++++++.++|+|||++.........  
T Consensus        86 ~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--  156 (286)
T cd07846          86 VLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--  156 (286)
T ss_pred             HHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc--
Confidence            98887643    23489999999999999999999999   9999999999999999999999999998765433211  


Q ss_pred             eeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhhhhhhcc-c---cccccCc
Q 008698          431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSH-R---YLELLDP  504 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~~~~~~~-~---~~~~~d~  504 (557)
                      .....++..|+|||++.+ ..++.++||||||+++|||++|.+||......+. ..+........... .   ...+.+.
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            111237889999999875 3468899999999999999999999875432111 01111000000000 0   0000000


Q ss_pred             ccccCCCC-----CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 LISSLSSD-----IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 ~l~~~~~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ........     ......+..+.+++.+||+.+|++||++.+|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00000000     001123567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.8e-35  Score=292.04  Aligned_cols=247  Identities=28%  Similarity=0.438  Sum_probs=196.6

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|++|.||+|... +++.|++|.++....  ...+.+.+|+.++++++|+||+++++.+.+.+..++|+||+++++
T Consensus         6 ~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (264)
T cd06626           6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT   85 (264)
T ss_pred             eEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCc
Confidence            46799999999999864 688999999876543  356789999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++............
T Consensus        86 L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          86 LEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             HHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence            9999864    24578899999999999999999999   9999999999999999999999999999876543322111


Q ss_pred             --eecCccccccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          432 --VMAGGTYGYLAPEFVYRNE---LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       432 --~~~~gt~~y~aPE~~~~~~---~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                        ....++..|+|||++.+..   .+.++||||||+++|||++|..||...+.. ......    ...      ...+.+
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~----~~~------~~~~~~  227 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFH----VGA------GHKPPI  227 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHH----Hhc------CCCCCC
Confidence              1233788999999998766   889999999999999999999999754321 111000    000      000101


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                            .........+.+++.+||+.+|++|||+++++.
T Consensus       228 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 ------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                  001123456789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-36  Score=308.14  Aligned_cols=264  Identities=19%  Similarity=0.288  Sum_probs=190.9

Q ss_pred             hhcCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-----
Q 008698          266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----  337 (557)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----  337 (557)
                      +.+.|.. .+.||+|+||.||++.. .+++.||||.+....  ......+.+|+.++++++||||+++++++...     
T Consensus        13 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          13 VPERYQN-LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhh-heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3344443 34679999999999985 468899999987542  22345678999999999999999999987533     


Q ss_pred             -CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeec
Q 008698          338 -GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  416 (557)
Q Consensus       338 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  416 (557)
                       ...++++|++ +++|.+++..     ..+++..+..++.||+.||.|||++   +|+||||||+|||+++++.+||+||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence             4568999988 7899887753     4599999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccCCccccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhhh---
Q 008698          417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATP---  491 (557)
Q Consensus       417 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~~---  491 (557)
                      |+++......     ....||..|+|||++.+ ..++.++|||||||++|||++|+.||...+.... ..+......   
T Consensus       163 g~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07878         163 GLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP  237 (343)
T ss_pred             ccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9998654321     12238899999999876 5689999999999999999999999976433211 001000000   


Q ss_pred             ----hhhccccccccCcccccCCCCC---CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          492 ----LVQSHRYLELLDPLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       492 ----~~~~~~~~~~~d~~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ..........+.. +.......   ........+.+++.+|++.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         238 EVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                0000000000000 00000000   00012235789999999999999999999996

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=294.76  Aligned_cols=248  Identities=22%  Similarity=0.398  Sum_probs=194.2

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCc------eEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD------RYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~------~~lV~E  345 (557)
                      .+.||+|++|.||++... +++.+++|++..... ..+++.+|+.++.++ +|+||+++++++.....      .++|||
T Consensus        11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e   89 (275)
T cd06608          11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME   89 (275)
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence            456799999999999974 578999999876543 446789999999999 79999999999976553      799999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      |+++++|.+++.........+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++......
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  166 (275)
T cd06608          90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST  166 (275)
T ss_pred             cCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence            9999999999875433346789999999999999999999999   9999999999999999999999999998765432


Q ss_pred             ccccceeecCccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          426 VMQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      ..  ......++..|+|||.+..     ..++.++||||||++++||+||..||......  ..+..    .. ..    
T Consensus       167 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~-~~----  233 (275)
T cd06608         167 LG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK----IP-RN----  233 (275)
T ss_pred             hh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH----hh-cc----
Confidence            21  1122337889999998754     24678899999999999999999999754321  11111    00 00    


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       ..+.+      ..+......+.+++.+||..||++|||+++|++
T Consensus       234 -~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         234 -PPPTL------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -CCCCC------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             00001      111224567889999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2e-35  Score=295.74  Aligned_cols=244  Identities=22%  Similarity=0.373  Sum_probs=198.0

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      ..||+|++|.||++... +++.|++|++..... ....+.+|+..+.+++|+||+++++.+...+..++|+||+++++|.
T Consensus        25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  103 (286)
T cd06614          25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT  103 (286)
T ss_pred             HhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence            45799999999999986 588999999976543 5677899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++....   ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.........  ...
T Consensus       104 ~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~  175 (286)
T cd06614         104 DIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RNS  175 (286)
T ss_pred             HHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh--hcc
Confidence            9997532   3699999999999999999999998   9999999999999999999999999998655432211  112


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      ..++..|+|||.+.+..++.++|||||||++|+|++|+.||...++...  ..    .... ..    ..       ...
T Consensus       176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~----~~~~-~~----~~-------~~~  237 (286)
T cd06614         176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LF----LITT-KG----IP-------PLK  237 (286)
T ss_pred             ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHh-cC----CC-------CCc
Confidence            2377899999999888899999999999999999999999876543211  00    0000 00    00       001


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .....+..+.+++.+|++.+|.+|||+.+|++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            11124467899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.1e-35  Score=299.05  Aligned_cols=245  Identities=23%  Similarity=0.400  Sum_probs=193.1

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .||+|+||.||++... ++..||+|.+....   ......+.+|+.++++++|||++++++++.+.+..++||||++ |+
T Consensus        32 ~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~  110 (317)
T cd06635          32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GS  110 (317)
T ss_pred             eeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CC
Confidence            5799999999999964 58899999986432   2334578899999999999999999999999999999999996 57


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   ...+++.++..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++.......     
T Consensus       111 l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~-----  179 (317)
T cd06635         111 ASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-----  179 (317)
T ss_pred             HHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCcc-----
Confidence            87776532   34589999999999999999999999   99999999999999999999999999987543221     


Q ss_pred             eecCcccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          432 VMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                       ...++..|+|||.+.   .+.++.++|||||||++|||++|+.||...+....  +...    ....         .  
T Consensus       180 -~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~----~~~~---------~--  241 (317)
T cd06635         180 -SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHI----AQNE---------S--  241 (317)
T ss_pred             -cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHH----Hhcc---------C--
Confidence             223788999999874   45688999999999999999999999875432110  1100    0000         0  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                        ........+..+.+++.+||+.+|++||++.+|++.+-....
T Consensus       242 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         242 --PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             --CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence              011112244568899999999999999999999986544443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-35  Score=289.33  Aligned_cols=246  Identities=22%  Similarity=0.274  Sum_probs=199.9

Q ss_pred             eecccCceEEEEEEeCC-CCEEEEEEecccchh---hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .||.|.-|+||.+.+.+ +..+|+|++.+....   ...+.+.|-++|+.+.||.++.||+.++.++..+||||||+||+
T Consensus        84 ~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGd  163 (459)
T KOG0610|consen   84 RLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGD  163 (459)
T ss_pred             HcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCcc
Confidence            57999999999999754 589999999876433   34567789999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc-----
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV-----  426 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-----  426 (557)
                      |...++.  +.++.+++..++.++.+|+-||.|||-.   |||+|||||+||||.++|++-|+||.|+.......     
T Consensus       164 L~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s  238 (459)
T KOG0610|consen  164 LHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS  238 (459)
T ss_pred             HHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence            9998876  5567899999999999999999999999   99999999999999999999999999976432100     


Q ss_pred             --------------------------c-c----------------------cceeecCccccccccccccCCCCCchhhH
Q 008698          427 --------------------------M-Q----------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDV  457 (557)
Q Consensus       427 --------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV  457 (557)
                                                . .                      .......||-.|+|||++.+...+.++|-
T Consensus       239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW  318 (459)
T KOG0610|consen  239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW  318 (459)
T ss_pred             CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH
Confidence                                      0 0                      00111237889999999999999999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCC
Q 008698          458 YSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR  537 (557)
Q Consensus       458 wS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R  537 (557)
                      |+|||++|||+.|..||.+.+..+               .+.+++-..+    .-......+..+.+||.+.|.+||++|
T Consensus       319 WtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l----~Fp~~~~vs~~akDLIr~LLvKdP~kR  379 (459)
T KOG0610|consen  319 WTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPL----KFPEEPEVSSAAKDLIRKLLVKDPSKR  379 (459)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCC----cCCCCCcchhHHHHHHHHHhccChhhh
Confidence            999999999999999998875431               1122222222    111112456779999999999999999


Q ss_pred             CC----HHHHHH
Q 008698          538 PR----MSHVVH  545 (557)
Q Consensus       538 Pt----~~evl~  545 (557)
                      ..    +.||-+
T Consensus       380 lg~~rGA~eIK~  391 (459)
T KOG0610|consen  380 LGSKRGAAEIKR  391 (459)
T ss_pred             hccccchHHhhc
Confidence            98    777765

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.7e-35  Score=292.26  Aligned_cols=242  Identities=21%  Similarity=0.286  Sum_probs=194.6

Q ss_pred             ecccCceEEEEEEeCC-CCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ||.|++|.||++.... ++.||+|++.....   ...+.+.+|+.++++++||||+++++.+.+.+..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            5999999999999754 89999999875422   3446789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++..    ...+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++.......   ...
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~  150 (262)
T cd05572          81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW  150 (262)
T ss_pred             HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence            999964    24589999999999999999999998   99999999999999999999999999998765432   111


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...++..|+|||.+.+..++.++|+||||+++|||++|..||....... .....   .         +.+...    ..
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~---------~~~~~~----~~  213 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYN---D---------ILKGNG----KL  213 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHH---H---------HhccCC----CC
Confidence            2237889999999988889999999999999999999999997654211 01110   0         010000    01


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  545 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~  545 (557)
                      ..+...+..+.+++.+||+.+|++||+     ++|+++
T Consensus       214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            111122567899999999999999999     677765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.8e-35  Score=295.67  Aligned_cols=260  Identities=18%  Similarity=0.248  Sum_probs=195.2

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|++|.||++... +|+.||||++....  ......+.+|+.++++++||||+++++++...+..++||||+ +++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~   84 (286)
T cd07832           6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSD   84 (286)
T ss_pred             eecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCC
Confidence            45799999999999964 68999999987653  233567899999999999999999999999999999999999 999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   ...+++.++..++.||++||+|||+.   +++|+||||+||+++.++.++|+|||++......... ..
T Consensus        85 L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~  157 (286)
T cd07832          85 LSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR-LY  157 (286)
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC-cc
Confidence            99998642   25699999999999999999999999   9999999999999999999999999999866433211 11


Q ss_pred             eecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcc------------cc
Q 008698          432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH------------RY  498 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~------------~~  498 (557)
                      ....++..|+|||.+.+. .++.++||||||++++||+||.+||....+..   ............            ..
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcchh
Confidence            123378899999988754 46899999999999999999988776543321   111111000000            00


Q ss_pred             ccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       499 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..+..+............+....+.+++.+|++.+|++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00000000000000000123467899999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-36  Score=281.57  Aligned_cols=245  Identities=20%  Similarity=0.341  Sum_probs=195.8

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc-----h---hhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEE
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-----F---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~-----~---~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV  343 (557)
                      .+++|.|..+.|-+... ++|+..|+|++....     .   .-.++-++|+.+|+++ .||+|+.+.+++..+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            44679999998888775 458899999985321     1   1134567899999998 799999999999999999999


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      +|.|+.|-|.++|..    .-.++++...+|+.|+.+|+.|||..   .||||||||+|||+|+|.++||+|||++..+.
T Consensus       102 Fdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen  102 FDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             hhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccC
Confidence            999999999999964    46799999999999999999999999   99999999999999999999999999998876


Q ss_pred             ccccccceeecCcccccccccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVY------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                      ...   .....+||++|+|||.+.      ...|+...|+||.|||+|.|+.|.+||......-.       ...+.+++
T Consensus       175 ~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM-------LR~ImeGk  244 (411)
T KOG0599|consen  175 PGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM-------LRMIMEGK  244 (411)
T ss_pred             Cch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH-------HHHHHhcc
Confidence            543   223346999999999885      23588899999999999999999999975322100       01111111


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +. .-         ...-.+....+.+|+.+|++.||++|.|++|+++
T Consensus       245 yq-F~---------speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  245 YQ-FR---------SPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             cc-cC---------CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            10 00         1112345677899999999999999999999986

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=295.67  Aligned_cols=261  Identities=20%  Similarity=0.287  Sum_probs=190.5

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|++|.||++... +++.||||.+..... .....+.+|+.++++++||||+++++++.+.+..++||||++ ++
T Consensus        10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~   88 (291)
T cd07844          10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TD   88 (291)
T ss_pred             EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CC
Confidence            356799999999999975 589999999865422 223457789999999999999999999999999999999997 58


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   ...+++.....++.|+++||.|||+.   +++||||||+|||++.++.+||+|||+++.........  
T Consensus        89 L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--  160 (291)
T cd07844          89 LKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY--  160 (291)
T ss_pred             HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCccc--
Confidence            99888642   24688999999999999999999999   99999999999999999999999999987543221111  


Q ss_pred             eecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhc---ccc------ccc
Q 008698          432 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS---HRY------LEL  501 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~  501 (557)
                      ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......  .............   ...      .+.
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            11126788999998875 45789999999999999999999999755421  1111100000000   000      000


Q ss_pred             cC---ccc--ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          502 LD---PLI--SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       502 ~d---~~l--~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..   +..  ...............+.+++.+|++.+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00   000  000000000111256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=300.03  Aligned_cols=247  Identities=24%  Similarity=0.300  Sum_probs=196.0

Q ss_pred             eeecccCceEEEEEEeCC-CCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +.||+|++|.||++...+ ++.||+|.+.....   ...+.+.+|+..+..++||||+++++.+.+.+..++||||+.++
T Consensus         7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   86 (316)
T cd05574           7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGG   86 (316)
T ss_pred             eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCC
Confidence            467999999999999754 89999999976532   24567889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc-
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE-  429 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-  429 (557)
                      +|.+++...  .+..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......... 
T Consensus        87 ~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (316)
T cd05574          87 ELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS  161 (316)
T ss_pred             CHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence            999998642  235689999999999999999999999   99999999999999999999999999987543221100 


Q ss_pred             --------------------------ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch
Q 008698          430 --------------------------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ  483 (557)
Q Consensus       430 --------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~  483 (557)
                                                ......|+..|+|||++.+..++.++||||||+++|+|++|..||...+...  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--  239 (316)
T cd05574         162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE--  239 (316)
T ss_pred             cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH--
Confidence                                      0011237889999999998889999999999999999999999997654321  


Q ss_pred             hHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHH
Q 008698          484 SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR----MSHVVH  545 (557)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt----~~evl~  545 (557)
                      .+.             ++.+....    .......+..+.+++.+||+.+|++|||    ++++++
T Consensus       240 ~~~-------------~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         240 TFS-------------NILKKEVT----FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHH-------------HHhcCCcc----CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            010             01111110    0001114567999999999999999999    777765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-37  Score=307.62  Aligned_cols=245  Identities=23%  Similarity=0.410  Sum_probs=198.9

Q ss_pred             ecccCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       277 lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ||.|+||.||-+.. .+...||||++..+..   ....+++.|+..|.+++|||++.+-|++......+|||||| -|+-
T Consensus        34 IGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSA  112 (948)
T KOG0577|consen   34 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSA  112 (948)
T ss_pred             hcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccH
Confidence            69999999999985 4577899999876543   34568899999999999999999999999999999999999 5677


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .|++.-.   .+++.+..+-.|..+.+.||+|||+.   +.||||||+.|||+++++.+||+|||.+....+..      
T Consensus       113 sDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn------  180 (948)
T KOG0577|consen  113 SDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN------  180 (948)
T ss_pred             HHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh------
Confidence            7766432   36788999999999999999999999   99999999999999999999999999987765432      


Q ss_pred             ecCcccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          433 MAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      .+.||+.|||||++.   .+.|+-|+||||+|++..||.-.++|+..++...  .++.    +.+++      .|.+   
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--ALYH----IAQNe------sPtL---  245 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYH----IAQNE------SPTL---  245 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--HHHH----HHhcC------CCCC---
Confidence            244999999999986   3689999999999999999999999988765321  1111    11111      1111   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                          ...+-...+.+++..|++.-|.+|||.++++..---..+.
T Consensus       246 ----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  246 ----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             ----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence                2345678899999999999999999999998754333333

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.4e-35  Score=293.19  Aligned_cols=240  Identities=20%  Similarity=0.244  Sum_probs=185.9

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHH---hhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRF---ARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l---~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ||+|+||.||++... +++.+|+|.+.....   .....+.+|...+   ...+||||+.+++.+...+..++||||+++
T Consensus         2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (279)
T cd05633           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG   81 (279)
T ss_pred             cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence            799999999999864 589999999865421   1223344454433   334799999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||+++++.++|+|||++........  
T Consensus        82 ~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--  152 (279)
T cd05633          82 GDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (279)
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence            999998864    24599999999999999999999999   999999999999999999999999999875432211  


Q ss_pred             ceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                        ....|+..|+|||.+.. ..++.++|||||||++|||++|..||..........+....          .....    
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~~----  216 (279)
T cd05633         153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------LTVNV----  216 (279)
T ss_pred             --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh----------hcCCc----
Confidence              12248999999998864 55789999999999999999999999765432211111000          00000    


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                          ..+...+..+.+++.+|++.||++||     |+.++++
T Consensus       217 ----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         217 ----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             ----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence                11223456788999999999999999     5999987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-35  Score=295.40  Aligned_cols=264  Identities=23%  Similarity=0.287  Sum_probs=195.6

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|++|.||++... +++.||||.++...  ....+.+.+|+.++++++|+||+++++++...+..++||||++++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~   85 (288)
T cd07833           6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT   85 (288)
T ss_pred             EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence            346799999999999975 48899999986542  233567899999999999999999999999999999999999987


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      .+..++..    ...+++.++..++.||+.||+|||+.   +++|+||+|+||++++++.+||+|||++...........
T Consensus        86 ~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          86 LLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence            77665542    24589999999999999999999999   999999999999999999999999999887654332111


Q ss_pred             eeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhhhhccccccccCccccc
Q 008698          431 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                       ....++..|+|||++.+. .++.++||||||+++|||++|..||......+.. .+.................++....
T Consensus       159 -~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         159 -TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             -cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence             122377889999999887 7899999999999999999999998754332110 0000000000000000000000000


Q ss_pred             -----CC-----CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 -----LS-----SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 -----~~-----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                           ..     ....+...+..+.+++.+||+.+|++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                 00     00011123577999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.4e-35  Score=315.52  Aligned_cols=258  Identities=16%  Similarity=0.216  Sum_probs=183.5

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCC------CcEEeeeeeeeeC-CceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH------PNLVAVKGCCYDH-GDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H------~niv~l~g~~~~~-~~~~lV~E  345 (557)
                      .+.||+|+||+||++... .++.||||+++... .....+..|+.++..++|      .+++++++++... +..++|||
T Consensus       134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~  212 (467)
T PTZ00284        134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMP  212 (467)
T ss_pred             EEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEe
Confidence            456799999999999864 57889999996532 223345566666666654      5588998888754 56889999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCC---------------
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEF---------------  409 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~~~~---------------  409 (557)
                      ++ +++|.+++..    ...+++..+..++.||+.||+|||+ .   +||||||||+|||++.++               
T Consensus       213 ~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        213 KY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             cc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            88 7788888864    2468999999999999999999997 5   999999999999998765               


Q ss_pred             -CcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHh
Q 008698          410 -GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW  488 (557)
Q Consensus       410 -~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~  488 (557)
                       .+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+...+...
T Consensus       285 ~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  359 (467)
T PTZ00284        285 CRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK  359 (467)
T ss_pred             ceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence             4899999987643221     1223489999999999999999999999999999999999999987654322221111


Q ss_pred             hhhhhhc--------cccccccC------ccc-----ccCCCC--CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          489 ATPLVQS--------HRYLELLD------PLI-----SSLSSD--IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       489 ~~~~~~~--------~~~~~~~d------~~l-----~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .......        ....++++      +..     ......  .........+.+|+.+||+.||++|||++|+++
T Consensus       360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            1000000        00000000      000     000000  000012345789999999999999999999997

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.5e-35  Score=296.22  Aligned_cols=258  Identities=22%  Similarity=0.284  Sum_probs=191.7

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||.|++|.||++... +|+.||||.++...  ......+.+|++++++++||||+++++++.+.+..++||||+. ++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~   84 (284)
T cd07860           6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QD   84 (284)
T ss_pred             eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cC
Confidence            35699999999999864 58999999986542  2233578899999999999999999999999999999999995 68


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...  ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++..........  
T Consensus        85 l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~--  157 (284)
T cd07860          85 LKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--  157 (284)
T ss_pred             HHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc--
Confidence            98888652  235689999999999999999999999   99999999999999999999999999987654322111  


Q ss_pred             eecCccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhhhhh-------hc-----cc
Q 008698          432 VMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLV-------QS-----HR  497 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~~~~-------~~-----~~  497 (557)
                      ....++..|+|||.+.+.. ++.++||||||+++|||+||+.||...+.... ....+......       ..     ..
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            1122678899999887644 58899999999999999999999975432210 01111000000       00     00


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ............     .......+.+++.+|++.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         238 FPKWARQDFSKV-----VPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cccccccCHHHH-----cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000000000000     0112356789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.6e-35  Score=284.59  Aligned_cols=244  Identities=25%  Similarity=0.401  Sum_probs=199.0

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      +.||+|++|.||++... +++.+++|++..........+.+|+..+++++|+|++++++++...+..++++||+++++|.
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~   85 (253)
T cd05122           6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLK   85 (253)
T ss_pred             eeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHH
Confidence            45799999999999975 68899999998765556678999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++....   ..+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||.+........   ...
T Consensus        86 ~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~  156 (253)
T cd05122          86 DLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNT  156 (253)
T ss_pred             HHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccc
Confidence            9986522   4689999999999999999999998   999999999999999999999999999876654322   122


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      ..++..|+|||.+.+..++.++||||||+++++|++|+.|+...+.......       ..........           
T Consensus       157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~-----------  218 (253)
T cd05122         157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-------IATNGPPGLR-----------  218 (253)
T ss_pred             eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-------HHhcCCCCcC-----------
Confidence            3378899999999888889999999999999999999999876532111000       0000000000           


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .....+..+.+++.+||+.+|++|||+.++++
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            01112456899999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.9e-35  Score=294.73  Aligned_cols=242  Identities=22%  Similarity=0.361  Sum_probs=195.7

Q ss_pred             eecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      .||+|+||.||++.. .+|+.||||++..........+.+|+.+++.++|+||+++++.+...+..++||||+++++|.+
T Consensus        27 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  106 (292)
T cd06657          27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD  106 (292)
T ss_pred             HcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHH
Confidence            479999999999987 4689999999876555566789999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      ++..     ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........  .....
T Consensus       107 ~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~  176 (292)
T cd06657         107 IVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL  176 (292)
T ss_pred             HHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence            8753     3488999999999999999999999   999999999999999999999999999875543221  11223


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP  514 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  514 (557)
                      .++..|+|||.+.+..++.++||||||+++|||++|..||...+.......   .    .     ..+.+.+..      
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~---~----~-----~~~~~~~~~------  238 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---I----R-----DNLPPKLKN------  238 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H----H-----hhCCcccCC------
Confidence            378899999999888889999999999999999999999875433211110   0    0     001111100      


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       515 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ....+..+.+++.+||+.+|.+||+++++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            0112345789999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.6e-35  Score=291.77  Aligned_cols=244  Identities=20%  Similarity=0.261  Sum_probs=191.9

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ||+|+||+||++... +|+.||+|.+....   ......+.+|+.++.+++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            599999999999854 58899999986532   22345667899999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++....  ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.+||+|||++........   ..
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~  152 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IK  152 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cc
Confidence            99987532  24689999999999999999999999   999999999999999999999999999876543211   11


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...++..|+|||++.+..++.++||||||+++++|++|+.||.............       ..    .... .    . 
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~----~~~~-~----~-  215 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK-------RR----TLEM-A----V-  215 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH-------hc----cccc-c----c-
Confidence            2237789999999988889999999999999999999999997654311110000       00    0000 0    0 


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                      ..+......+.+++.+||+.+|++||     ++.++++
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            01112345688999999999999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.4e-35  Score=292.35  Aligned_cols=244  Identities=20%  Similarity=0.321  Sum_probs=195.0

Q ss_pred             ecccCceEEEEEEeCC-CCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ||+|+||.||++...+ |+.+++|.+.....   ...+.+.+|+.++.+++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            5899999999999864 89999999976533   3456788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc-----
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM-----  427 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-----  427 (557)
                      .+++...    ..+++..+..++.||++||+|||+.   +++|+||+|+||++++++.++|+|||++........     
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9998642    3689999999999999999999999   999999999999999999999999999875433211     


Q ss_pred             -ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 -QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 -~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                       ........++..|+|||.......+.++||||||+++|||++|..||.......   .....    ....    ..   
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~----~~~~----~~---  219 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IFQNI----LNGK----IE---  219 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----hcCC----cC---
Confidence             011122337789999999988888999999999999999999999997554321   11100    0000    00   


Q ss_pred             ccCCCCCCcHH--HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          507 SSLSSDIPEAG--VVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       507 ~~~~~~~~~~~--~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                             .+..  .+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       220 -------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         220 -------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                   0111  2467899999999999999999966655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.6e-35  Score=292.31  Aligned_cols=261  Identities=18%  Similarity=0.217  Sum_probs=189.7

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|+.++..++|+||+++.+++...+..++||||+. ++
T Consensus        10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~   88 (291)
T cd07870          10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD   88 (291)
T ss_pred             EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence            34679999999999986 4688999999865432 223467889999999999999999999999999999999995 67


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.+||+|||+++........  .
T Consensus        89 l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~  160 (291)
T cd07870          89 LAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--Y  160 (291)
T ss_pred             HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--C
Confidence            77776532   24578888999999999999999999   9999999999999999999999999998754322211  1


Q ss_pred             eecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhh------------cccc
Q 008698          432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ------------SHRY  498 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~  498 (557)
                      ....++..|+|||.+.+. .++.++|||||||++|||+||..||...++.. ..+.. ......            ....
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEK-IWTVLGVPTEDTWPGVSKLPNY  238 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHH-HHHHcCCCChhhhhhhhhcccc
Confidence            122368899999998764 57889999999999999999999997654321 11111 000000            0000


Q ss_pred             ccccCccc-c-cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          499 LELLDPLI-S-SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       499 ~~~~d~~l-~-~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .....+.. . ..............+.+++.+|++.||++|||+.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000000 0 00000000012356789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.6e-35  Score=294.20  Aligned_cols=259  Identities=22%  Similarity=0.281  Sum_probs=192.0

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~  349 (557)
                      +.||+|++|.||+|... +++.+|+|.++....  .....+.+|+.++.+++||||+++++++...  +..++||||+. 
T Consensus        11 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-   89 (293)
T cd07843          11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-   89 (293)
T ss_pred             hhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-
Confidence            35799999999999975 588999999975432  2234577899999999999999999998877  88999999996 


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++|.+++...   ...+++..+..++.||+.||+|||+.   +++|+||||+|||++.++.+||+|||++..........
T Consensus        90 ~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  163 (293)
T cd07843          90 HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY  163 (293)
T ss_pred             cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence            5898888642   23689999999999999999999999   99999999999999999999999999998665432111


Q ss_pred             ceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhh-------hhhh------h
Q 008698          430 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWA-------TPLV------Q  494 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~-------~~~~------~  494 (557)
                        ....++..|+|||.+.+. .++.++|+||||+++|||++|..||......... .+....       ++..      .
T Consensus       164 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         164 --TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             --ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence              112367889999988764 4689999999999999999999999765432111 111000       0000      0


Q ss_pred             ccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       495 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...........+   ....+.......+.+++.+||+.+|++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         242 KKTFTKYPYNQL---RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccccccccchhh---hccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            000000000000   011111113556889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.8e-35  Score=288.46  Aligned_cols=244  Identities=20%  Similarity=0.380  Sum_probs=194.7

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|+||.||++... +|..||+|.+....  ....+.+.+|+.+++.++|+||+++++.+...+..++|+||+++++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (257)
T cd08225           6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGD   85 (257)
T ss_pred             EEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCc
Confidence            46799999999999975 48899999986542  2345678899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-cEEeeccCCccCCccccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      |.+++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++. +||+|||.+.........  
T Consensus        86 L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--  158 (257)
T cd08225          86 LMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL--  158 (257)
T ss_pred             HHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCccc--
Confidence            99998652  234589999999999999999999999   9999999999999998854 699999998766433211  


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....|++.|+|||++.+..++.++||||||+++|||++|..||...+..      +.......     ..+.+.     
T Consensus       159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-----~~~~~~-----  222 (257)
T cd08225         159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQ-----GYFAPI-----  222 (257)
T ss_pred             ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-----ccCCCC-----
Confidence            12234788999999998888999999999999999999999998754321      11111111     011110     


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ....+..+.+++.+|++.+|++|||+.+|++
T Consensus       223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                0112346889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=294.48  Aligned_cols=255  Identities=22%  Similarity=0.313  Sum_probs=209.3

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      ...+-||+|.|..|-.+++ =.|..||||++.+...  .....+.+|++.|+.++|||||++|.+......+|||+|.-.
T Consensus        21 DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD  100 (864)
T KOG4717|consen   21 DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGD  100 (864)
T ss_pred             hhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecC
Confidence            3344579999999988873 3699999999987643  345678999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-CCCCCcEEeeccCCccCCcccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      +|+|.+|+-+..   ..+.+....+++.||+.|+.|.|+.   .+|||||||+||.+ ..-+-+||+|||++..+.+.. 
T Consensus       101 ~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-  173 (864)
T KOG4717|consen  101 GGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-  173 (864)
T ss_pred             CchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc-
Confidence            999999997543   5599999999999999999999998   99999999999876 556778999999997665432 


Q ss_pred             ccceeecCccccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                        ...+.+|+..|-|||.+.+..|. ++.||||+|||||.|++|++||+..++.+-               +--++|-. 
T Consensus       174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCK-  235 (864)
T KOG4717|consen  174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCK-  235 (864)
T ss_pred             --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhccc-
Confidence              33345699999999999999885 678999999999999999999987765421               11222221 


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcccCCCCC
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLAQPPVT  556 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~~~~~~  556 (557)
                           -..+.....++.+||..|+..||++|.+.++|+.  .|+...+++.|
T Consensus       236 -----YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT  282 (864)
T KOG4717|consen  236 -----YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST  282 (864)
T ss_pred             -----ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence                 1234557788999999999999999999999986  56666665544

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-37  Score=287.35  Aligned_cols=243  Identities=22%  Similarity=0.335  Sum_probs=203.8

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      .||+|+||.||++.+. .|..||||.+.-.  .+.+++..|+.++.+...|++|++||.+.....+++|||||.-|+..+
T Consensus        40 KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSD  117 (502)
T KOG0574|consen   40 KLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISD  117 (502)
T ss_pred             HhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHH
Confidence            3599999999999864 5999999998644  456789999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      .++.   .+++|++.++-.++...++||+|||..   .-||||||+.|||++.++.+||+|||.+..+......  ..+.
T Consensus       118 I~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK--RNTV  189 (502)
T KOG0574|consen  118 IMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK--RNTV  189 (502)
T ss_pred             HHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh--hCcc
Confidence            9975   347899999999999999999999998   8899999999999999999999999999876543222  2334


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP  514 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  514 (557)
                      .||+-|||||++..-.|..++||||+|++..||.-|++||.+..+..                  .++=..-.+...-..
T Consensus       190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR------------------AIFMIPT~PPPTF~K  251 (502)
T KOG0574|consen  190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR------------------AIFMIPTKPPPTFKK  251 (502)
T ss_pred             ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc------------------eeEeccCCCCCCCCC
Confidence            59999999999999899999999999999999999999998865521                  111000011111222


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       515 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      +..-+..+-+++.+|+-..|++|-|+-++++.
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            45567789999999999999999999998873

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.6e-35  Score=293.22  Aligned_cols=239  Identities=23%  Similarity=0.315  Sum_probs=194.3

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|++|.||++... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   85 (290)
T cd05580           6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG   85 (290)
T ss_pred             EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence            356899999999999965 58999999986542   23346788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++|.+++..    ...++...+..++.|++.||.|||+.   +++|+||+|+|||++.++.+||+|||++......    
T Consensus        86 ~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----  154 (290)
T cd05580          86 GELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----  154 (290)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence            999999864    25689999999999999999999998   9999999999999999999999999999865433    


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                       .....+++.|+|||.+.+...+.++||||||+++|||++|..||...+..   ......   . ..        ..   
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~---~-~~--------~~---  215 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEKI---L-EG--------KV---  215 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---h-cC--------Cc---
Confidence             12223788999999998888899999999999999999999998764421   111100   0 00        00   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                         ..+......+.+++.+||+.+|.+||     +++|+++
T Consensus       216 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 ---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence               00112245688999999999999999     6777663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.6e-35  Score=293.70  Aligned_cols=265  Identities=19%  Similarity=0.232  Sum_probs=190.4

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCc-----eEEEE
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD-----RYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~-----~~lV~  344 (557)
                      .+.||+|+||.||++... +|+.||||.++....  .....+.+|+.++..+ +||||+++++++...+.     .++||
T Consensus         6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~   85 (295)
T cd07837           6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF   85 (295)
T ss_pred             eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence            346799999999999964 589999999865422  2345788899999999 56999999999887665     79999


Q ss_pred             ecCCCCChHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCcEEeeccCCccC
Q 008698          345 EFVVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFV  422 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~  422 (557)
                      ||+++ +|.+++...... ...+++..+..++.||++||.|||++   +++||||||+||+++. ++.+||+|||+++..
T Consensus        86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~  161 (295)
T cd07837          86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF  161 (295)
T ss_pred             eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceec
Confidence            99975 888888653322 35689999999999999999999999   9999999999999998 889999999998754


Q ss_pred             CccccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhhhhhhcccccc
Q 008698          423 PWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  500 (557)
                      .......  ....+++.|+|||.+.+ ..++.++||||||+++|||++|..||...+.... ..+...... ........
T Consensus       162 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  238 (295)
T cd07837         162 SIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT-PTEQVWPG  238 (295)
T ss_pred             CCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC-CChhhCcc
Confidence            3221111  11126788999998865 4578999999999999999999999976543211 111110000 00000000


Q ss_pred             ccCcc----cccCCCC---CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 LLDPL----ISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~~d~~----l~~~~~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..+..    .......   .........+.+++.+||+.+|++||+++|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000    0000000   000124567889999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=9.3e-35  Score=285.14  Aligned_cols=246  Identities=25%  Similarity=0.375  Sum_probs=199.8

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~  349 (557)
                      +.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+..+++++||||+++++.+...  +..++|+||+++
T Consensus         6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~   85 (260)
T cd06606           6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG   85 (260)
T ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence            46799999999999976 689999999876542  4567889999999999999999999999988  889999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+..........
T Consensus        86 ~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          86 GSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            9999998652    2799999999999999999999998   99999999999999999999999999988765443211


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      ......++..|+|||.+.....+.++||||||+++++|++|..||...+..     ...........    .        
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~----~--------  221 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGSSG----E--------  221 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhccccC----C--------
Confidence            122234788999999998888999999999999999999999999765411     01011100000    0        


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       ....+...+..+.+++.+|++.+|++||++.++++
T Consensus       222 -~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 -PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence             01112223567999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.9e-35  Score=291.17  Aligned_cols=243  Identities=22%  Similarity=0.310  Sum_probs=196.5

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||.|+||.||++... +++.||+|.+....   ....+.+.+|+..+++++||||+++++++.+.+..++|+||+.+
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   84 (258)
T cd05578           5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG   84 (258)
T ss_pred             EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence            346799999999999975 48999999997542   23457889999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++|.+++..    ...+++.++..++.|+++||.|||++   +++|+||+|+||++++++.++|+|||++........  
T Consensus        85 ~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--  155 (258)
T cd05578          85 GDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--  155 (258)
T ss_pred             CCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc--
Confidence            999999864    24689999999999999999999999   999999999999999999999999999876543321  


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+......+..    ....        .     
T Consensus       156 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~--------~-----  217 (258)
T cd05578         156 -TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----KQET--------A-----  217 (258)
T ss_pred             -ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH----Hhcc--------c-----
Confidence             112337889999999988889999999999999999999999998665321111110    0000        0     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH--HHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRM--SHVV  544 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~--~evl  544 (557)
                       ....+...+..+.+++.+||+.+|.+||++  .|++
T Consensus       218 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 -DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence             011112234678899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-35  Score=290.55  Aligned_cols=263  Identities=21%  Similarity=0.287  Sum_probs=193.9

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~  349 (557)
                      +.||+|++|.||+|... +|+.+|+|++....  ......+.+|+.++.+++|||++++++++...  +..++||||++ 
T Consensus         5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-   83 (287)
T cd07840           5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-   83 (287)
T ss_pred             EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-
Confidence            46799999999999975 48899999997653  23346788999999999999999999999888  88999999997 


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++|.+++...   ...+++..++.++.||++||+|||+.   +++|+||+|+||++++++.+||+|||++..........
T Consensus        84 ~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          84 HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            4888888642   24689999999999999999999999   99999999999999999999999999998665432111


Q ss_pred             ceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhhhhcc--ccccc----
Q 008698          430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSH--RYLEL----  501 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~----  501 (557)
                      . ....++..|+|||.+.+ ..++.++||||||+++|||+||+.||...+..... .+...........  .....    
T Consensus       158 ~-~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         158 Y-TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             c-cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence            1 11236788999998765 45789999999999999999999999765532111 1111000000000  00000    


Q ss_pred             -cCccc--ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          502 -LDPLI--SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       502 -~d~~l--~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       ..+..  ...........++..+.+++.+||+.+|++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             00000  000000001112567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-36  Score=282.44  Aligned_cols=269  Identities=20%  Similarity=0.321  Sum_probs=208.4

Q ss_pred             CHHHHHHhhcCCCCCCeeecccCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeee
Q 008698          259 TTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD  336 (557)
Q Consensus       259 ~~~el~~~~~~~~~~~~~lg~G~~g~Vy~g~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~  336 (557)
                      +++++..++..      +||+|+++.|-..+ +.+|.++|||++.+.....+.++.+|++++... .|+||++++.++++
T Consensus        74 ~F~d~YkLt~e------~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   74 KFEDMYKLTSE------LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             hHHHHHHhHHH------HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            35677776643      68999999999877 568999999999988888889999999999999 59999999999999


Q ss_pred             CCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---cEE
Q 008698          337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHL  413 (557)
Q Consensus       337 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~kl  413 (557)
                      +..+|||||-|.+|+|..++++    .+.+++.+..++..+||.||+|||.+   +|.||||||+|||-.....   +||
T Consensus       148 d~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             cceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence            9999999999999999999875    35699999999999999999999999   9999999999999976655   699


Q ss_pred             eeccCCccCCc-----cccccceeecCcccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch
Q 008698          414 MGVGLSKFVPW-----EVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ  483 (557)
Q Consensus       414 ~Dfgl~~~~~~-----~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~  483 (557)
                      +||.+..-...     ........++.|+..|||||+..     ...|..++|.||+|||||-|++|.+||.+.-..+  
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d--  298 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD--  298 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc--
Confidence            99988753221     12223334556899999999774     2357889999999999999999999998764321  


Q ss_pred             hHHHhhhhhhhccccccccCcccccCCCCCCcH---HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          484 SIFEWATPLVQSHRYLELLDPLISSLSSDIPEA---GVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~---~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        ..|-....-.. =++.+-..++....+.|+.   ..+.+..+++...+..+|..|.++.++++
T Consensus       299 --CGWdrGe~Cr~-CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  299 --CGWDRGEVCRV-CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             --CCccCCCccHH-HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence              01110000000 0011112222222333333   35677888999999999999999999987

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.5e-35  Score=296.08  Aligned_cols=260  Identities=20%  Similarity=0.235  Sum_probs=191.4

Q ss_pred             cccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHHH
Q 008698          278 GDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW  355 (557)
Q Consensus       278 g~G~~g~Vy~g~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  355 (557)
                      |.|+++.||++.. +++.||||+++..  .....+.+.+|+..++.++||||+++++++.+.+..+++|||+++|+|.++
T Consensus        11 ~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~   89 (314)
T cd08216          11 EDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL   89 (314)
T ss_pred             cCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence            4555556666555 7999999998754  344557899999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc-----ccc
Q 008698          356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM-----QER  430 (557)
Q Consensus       356 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-----~~~  430 (557)
                      +....  ...+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||.+........     ...
T Consensus        90 l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~  164 (314)
T cd08216          90 LKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF  164 (314)
T ss_pred             HHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence            97532  24588999999999999999999999   999999999999999999999999998865432211     111


Q ss_pred             eeecCccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhh----hhccc-------
Q 008698          431 TVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL----VQSHR-------  497 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~----~~~~~-------  497 (557)
                      .....++..|+|||.+..  ..++.++|||||||++|||++|+.||......  ..+.+.....    .....       
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhhcCC
Confidence            122236778999999876  35789999999999999999999999765332  1111111000    00000       


Q ss_pred             ccc----ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          498 YLE----LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       498 ~~~----~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...    ..++.................+.+++.+||+.+|++|||++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            000    011111111111122334567889999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-35  Score=292.13  Aligned_cols=262  Identities=23%  Similarity=0.296  Sum_probs=192.8

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||.|++|.||+|... +|+.||+|++....  ......+.+|+..+++++||||+++++++.+.+..+++|||+ .++
T Consensus         5 ~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~   83 (283)
T cd07835           5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLD   83 (283)
T ss_pred             eEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-CcC
Confidence            46799999999999864 69999999987543  223357889999999999999999999999999999999999 468


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++....  ...+++..+..++.|+++||+|||++   +++||||+|+||+++.++.++|+|||++..........  
T Consensus        84 l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--  156 (283)
T cd07835          84 LKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--  156 (283)
T ss_pred             HHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc--
Confidence            999886522  24689999999999999999999998   99999999999999999999999999997654322111  


Q ss_pred             eecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhhhhhh--------ccccccc
Q 008698          432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQ--------SHRYLEL  501 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~~~~~--------~~~~~~~  501 (557)
                      ....++..|+|||++.+. .++.++||||||+++|||+||+.||...+.... ....+.......        .......
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            112367899999988664 578999999999999999999999976543210 111110000000        0000000


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +.... ...........+..+.+++.+|++.+|++|||++|+++
T Consensus       237 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         237 FPKWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             ccccc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00000 00000001123356889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.7e-35  Score=292.15  Aligned_cols=249  Identities=23%  Similarity=0.401  Sum_probs=189.2

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||+. ++|
T Consensus        11 ~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l   89 (288)
T cd06616          11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISL   89 (288)
T ss_pred             HhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCH
Confidence            5799999999999864 58999999987542 344567899999999996 9999999999999999999999985 455


Q ss_pred             HHHhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          353 DRWLHHI-PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       353 ~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      .++.... ......+++..+..++.|++.||+|||+..  +++||||||+||+++.++.+||+|||++.........   
T Consensus        90 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---  164 (288)
T cd06616          90 DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---  164 (288)
T ss_pred             HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc---
Confidence            5543211 112356899999999999999999999632  8999999999999999999999999998755332211   


Q ss_pred             eecCccccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          432 VMAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~---~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      ....++..|+|||.+.+.   .++.++|||||||++|||++|+.||.....     ..+.......      ...+.+. 
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~------~~~~~~~-  232 (288)
T cd06616         165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK------GDPPILS-  232 (288)
T ss_pred             ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC------CCCCcCC-
Confidence            112378899999998776   689999999999999999999999875431     1111111000      0001110 


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        . ......+..+.+++.+||+.+|++|||+++|++
T Consensus       233 --~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         233 --N-SEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             --C-cCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0 111234567899999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.9e-35  Score=300.57  Aligned_cols=265  Identities=20%  Similarity=0.297  Sum_probs=194.4

Q ss_pred             hcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC------
Q 008698          267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------  337 (557)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------  337 (557)
                      .+.|.. .+.||+|+||.||++... +|+.||||.+...  .......+.+|+.++.+++||||+++++++...      
T Consensus        15 ~~~y~~-~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          15 LKRYQN-LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hcceEE-EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            344444 356799999999999964 6899999998643  233446778899999999999999999987643      


Q ss_pred             CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeecc
Q 008698          338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  417 (557)
Q Consensus       338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  417 (557)
                      ...++||||+. ++|.+.+..      .++...+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            35799999995 588887752      288899999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHh--------
Q 008698          418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEW--------  488 (557)
Q Consensus       418 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~--------  488 (557)
                      +++.......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... ..+...        
T Consensus       164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9986543221   1122378899999999998999999999999999999999999976542110 011000        


Q ss_pred             ---h----hhhhhc------cccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          489 ---A----TPLVQS------HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       489 ---~----~~~~~~------~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         .    ......      ..+.+.+...+............+..+.+++.+|++.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               0    000000      00001111111000011112234567889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.3e-35  Score=290.25  Aligned_cols=257  Identities=18%  Similarity=0.184  Sum_probs=188.9

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeC--CceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDH--GDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E~~~~  349 (557)
                      +.||+|+||.||++... +++.||+|.++... ........+|+..+.++. |+||+++++++.+.  +..++||||++ 
T Consensus         5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-   83 (282)
T cd07831           5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-   83 (282)
T ss_pred             eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-
Confidence            35799999999999864 58899999987542 222334567888899885 99999999999887  88999999996 


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++...   ...+++.++..++.|++.||.|||+.   +++||||+|+||+++. +.+||+|||+++.........
T Consensus        84 ~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          84 MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence            5888877542   24689999999999999999999999   9999999999999999 999999999998654332211


Q ss_pred             ceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhh-----------ccc
Q 008698          430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ-----------SHR  497 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~  497 (557)
                         ...++..|+|||.+.. ..++.++|||||||++|||++|..||...+..+.   +........           ...
T Consensus       157 ---~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         157 ---EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             ---CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhcccc
Confidence               1237889999997654 4578899999999999999999999976543221   111111000           000


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ......+..............+..+.+++.+||+.+|++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000000000000000001134578999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=293.77  Aligned_cols=267  Identities=18%  Similarity=0.263  Sum_probs=192.2

Q ss_pred             eeecccCceEEEEEEeC---CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEEEEec
Q 008698          275 RLLGDSKTGGTYSGILP---DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEF  346 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~---~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~  346 (557)
                      ..||+|++|.||+|...   +++.||+|.+....   ......+.+|+.++.+++||||+++++++.+.  +..++||||
T Consensus         6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   85 (316)
T cd07842           6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY   85 (316)
T ss_pred             EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence            45799999999999974   47899999997632   23346778899999999999999999999888  789999999


Q ss_pred             CCCCChHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC----CCCcEEeeccCCcc
Q 008698          347 VVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE----EFGAHLMGVGLSKF  421 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~Dfgl~~~  421 (557)
                      +++ +|.+++...... ...+++..+..++.||+.||+|||+.   +++||||||+|||++.    ++.+||+|||++..
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~  161 (316)
T cd07842          86 AEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARL  161 (316)
T ss_pred             CCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence            964 676666543322 23789999999999999999999999   9999999999999999    89999999999986


Q ss_pred             CCcccc-ccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch------hHHHhhhhhh
Q 008698          422 VPWEVM-QERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ------SIFEWATPLV  493 (557)
Q Consensus       422 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~------~~~~~~~~~~  493 (557)
                      ...... ........++..|+|||.+.+. .++.++||||||++++||++|.+||.........      ..........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (316)
T cd07842         162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL  241 (316)
T ss_pred             cCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHh
Confidence            543322 1111122368889999988764 5789999999999999999999999765433200      0000000000


Q ss_pred             hc------------cccccccCccc-ccCCCCCC----cH--HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          494 QS------------HRYLELLDPLI-SSLSSDIP----EA--GVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       494 ~~------------~~~~~~~d~~l-~~~~~~~~----~~--~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..            .......+... ........    +.  .....+.+++.+|++.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             CCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00            00000000000 00000000    00  23356889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-35  Score=287.24  Aligned_cols=242  Identities=21%  Similarity=0.249  Sum_probs=187.2

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHH-hhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRF-ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .||+|++|.||++... +|+.||||+++....   .....+..|..++ ...+|+|++++++++...+..++|+||++++
T Consensus         3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   82 (260)
T cd05611           3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG   82 (260)
T ss_pred             cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence            4799999999999864 588999999875432   2223345555443 4458999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++..    ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.+||+|||+++.....     
T Consensus        83 ~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----  150 (260)
T cd05611          83 DCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----  150 (260)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence            99999864    24588999999999999999999999   9999999999999999999999999998754321     


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                       ....++..|+|||.+.+..++.++||||||+++|||+||..||...+...   .....    .....    +  .    
T Consensus       151 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~~~----~--~----  212 (260)
T cd05611         151 -KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFDNI----LSRRI----N--W----  212 (260)
T ss_pred             -ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----Hhccc----C--C----
Confidence             12237889999999988888999999999999999999999997654321   11100    00000    0  0    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  547 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L  547 (557)
                      .......++..+.+++.+||+.+|++||++.++.+.|
T Consensus       213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            0001112346789999999999999999876555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.3e-35  Score=303.75  Aligned_cols=197  Identities=24%  Similarity=0.315  Sum_probs=167.4

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-C-----CcEEeeeeeeeeCCceEEEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-H-----PNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H-----~niv~l~g~~~~~~~~~lV~  344 (557)
                      +..++||+|+||.|.++.. .+++.||||+++... .-..+-..|+.+|..|+ |     -|+|++++++...++.+||+
T Consensus       189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVf  267 (586)
T KOG0667|consen  189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVF  267 (586)
T ss_pred             EEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeee
Confidence            4456799999999999985 459999999998652 33455677999999996 4     57999999999999999999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC--CcEEeeccCCccC
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF--GAHLMGVGLSKFV  422 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~Dfgl~~~~  422 (557)
                      |.+ .-+|.++|....  -..|+...++.|+.||+.||.+||+.   +|||+||||+||||.+..  .+||+|||.|...
T Consensus       268 ELL-~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  268 ELL-STNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             hhh-hhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            998 569999998643  35699999999999999999999999   999999999999996543  6899999999877


Q ss_pred             CccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcc
Q 008698          423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV  480 (557)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~  480 (557)
                      ......     ..-+..|+|||++.+.+|+.+.||||||||+.||+||.+.|.+.+..
T Consensus       342 ~q~vyt-----YiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~  394 (586)
T KOG0667|consen  342 SQRVYT-----YIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY  394 (586)
T ss_pred             CCccee-----eeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence            544332     22567899999999999999999999999999999998888776543

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.6e-34  Score=288.62  Aligned_cols=264  Identities=21%  Similarity=0.274  Sum_probs=193.6

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      +.||.|++|.||+|+.. +|+.||||.++.... .....+.+|+.++++++||||+++++++.+.+..++||||++ ++|
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l   84 (284)
T cd07836           6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDL   84 (284)
T ss_pred             eeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccH
Confidence            45799999999999975 588999999876532 234667889999999999999999999999999999999997 488


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++..... ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.++|+|||++..........  .
T Consensus        85 ~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~--~  158 (284)
T cd07836          85 KKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF--S  158 (284)
T ss_pred             HHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc--c
Confidence            888764322 34689999999999999999999999   99999999999999999999999999997553321111  1


Q ss_pred             ecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhhhhhh----ccccccccCccc
Q 008698          433 MAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQ----SHRYLELLDPLI  506 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~d~~l  506 (557)
                      ...++..|++||.+.+. .++.++||||||+++|||++|+.||...+..+. ..+.+.......    .......+....
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF  238 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence            12367889999988664 568899999999999999999999976543211 111111000000    000000000000


Q ss_pred             ccC---CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          507 SSL---SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       507 ~~~---~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...   .........+..+.+++.+|++.+|.+||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000   000001123456889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.7e-35  Score=286.38  Aligned_cols=244  Identities=23%  Similarity=0.321  Sum_probs=199.3

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|++|.||++... +++.+|+|.+....  ......+.+|+.++++++|+||+++.+++.+....++||||+++++
T Consensus         6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   85 (256)
T cd08530           6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGD   85 (256)
T ss_pred             eeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCC
Confidence            45799999999999854 67899999987542  3345678899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++.........+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+|++|||++.......    .
T Consensus        86 L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~  158 (256)
T cd08530          86 LSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----A  158 (256)
T ss_pred             HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC----c
Confidence            9999876444446789999999999999999999999   99999999999999999999999999998765431    1


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ....++..|+|||.+.+..++.++|+||||+++|||++|+.||...+....   ...    .....        .     
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~~----~~~~~--------~-----  218 (256)
T cd08530         159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RYK----VQRGK--------Y-----  218 (256)
T ss_pred             ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----HhcCC--------C-----
Confidence            123378899999999988899999999999999999999999976543211   110    00000        0     


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...+......+.+++.+|++.+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0111234567899999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.1e-34  Score=284.62  Aligned_cols=246  Identities=22%  Similarity=0.379  Sum_probs=200.3

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||.|++|.||++... ++..||+|++.....  .....+.+|++.++.++|||++++++.+...+..++|+||+++++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~   85 (258)
T cd08215           6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD   85 (258)
T ss_pred             eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCc
Confidence            46799999999999975 588999999976532  456778999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++.........+++..+..++.++++||.|||+.   +++|+||+|+||+++.++.++|+|||.+........  ..
T Consensus        86 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~  160 (258)
T cd08215          86 LSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LA  160 (258)
T ss_pred             HHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc--ee
Confidence            9999976433346799999999999999999999999   999999999999999999999999999976644331  11


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ....+++.|+|||.+.+..++.++||||||+++++|++|+.||...+..   .+..   .... .    ...+       
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~---~~~~-~----~~~~-------  222 (258)
T cd08215         161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELAL---KILK-G----QYPP-------  222 (258)
T ss_pred             cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHH---HHhc-C----CCCC-------
Confidence            2234788999999998888999999999999999999999998654321   1111   0000 0    0110       


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        .+...+..+.+++.+||..+|++|||+.++++
T Consensus       223 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 --IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              11123456889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2e-34  Score=294.45  Aligned_cols=262  Identities=19%  Similarity=0.265  Sum_probs=190.8

Q ss_pred             eccc--CceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          277 LGDS--KTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       277 lg~G--~~g~Vy~g~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      ||+|  +||+||++.. .+|+.||+|.+....  ....+.+.+|+.+++.++||||+++++++...+..++|+||+.+++
T Consensus         6 ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~   85 (328)
T cd08226           6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS   85 (328)
T ss_pred             hCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCC
Confidence            4555  8999999986 469999999986532  2334678899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc--
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE--  429 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~--  429 (557)
                      |.+++....  ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++++||+.+..........  
T Consensus        86 l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          86 ANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             HHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            999987532  24589999999999999999999998   99999999999999999999999998654322111100  


Q ss_pred             ---ceeecCccccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhh-------------
Q 008698          430 ---RTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP-------------  491 (557)
Q Consensus       430 ---~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~-------------  491 (557)
                         ......++..|+|||++.+.  .++.++||||||+++|||++|..||.......  ........             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccch
Confidence               00111246679999999764  47899999999999999999999997653211  00000000             


Q ss_pred             ---hhhcc--cc-----ccccCc----cc-ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          492 ---LVQSH--RY-----LELLDP----LI-SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       492 ---~~~~~--~~-----~~~~d~----~l-~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         .....  ..     ...+..    .+ ...........+...+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence               00000  00     000000    00 000011112346678999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=277.88  Aligned_cols=244  Identities=21%  Similarity=0.282  Sum_probs=193.2

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|.|+.||+... +.|+.+|+|.+.-.  +....+.+.+|+.+-..|+||||+++.....+....|+|+|+|.+++
T Consensus        17 e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~d   96 (355)
T KOG0033|consen   17 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE   96 (355)
T ss_pred             HHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchH
Confidence            3579999999998764 56888898887532  23356788999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCcEEeeccCCccCCccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      |..-+-.+    ...++...-....||+++|.|.|.+   +|||||+||.|+|+..   .--+||+|||++..+...   
T Consensus        97 l~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g---  166 (355)
T KOG0033|consen   97 LFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG---  166 (355)
T ss_pred             HHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCCc---
Confidence            87655431    4577888889999999999999999   9999999999999953   334799999999877622   


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      .......||++|||||++...+|+..+|||+-|||||-|+.|.+||.+.+..   .+++....    +.+  -+++    
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~~----g~y--d~~~----  233 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIKA----GAY--DYPS----  233 (355)
T ss_pred             cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHhc----ccc--CCCC----
Confidence            2222344999999999999999999999999999999999999999885542   22221111    000  0111    


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ..-....++..+|+.+|+..||.+|.|+.|.++
T Consensus       234 ----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  234 ----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ----cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                001224567889999999999999999999875

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=304.35  Aligned_cols=243  Identities=23%  Similarity=0.386  Sum_probs=199.4

Q ss_pred             ecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHHH
Q 008698          277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW  355 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  355 (557)
                      ||.|+||.||+++..+ +-..|-|++...+....+.|+-|+.+|+...||+||+|++.++-.+.++++.|||.||..+..
T Consensus        40 LGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDai  119 (1187)
T KOG0579|consen   40 LGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAI  119 (1187)
T ss_pred             hcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHH
Confidence            5999999999999765 345678888777777788999999999999999999999999999999999999999999888


Q ss_pred             hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeecC
Q 008698          356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG  435 (557)
Q Consensus       356 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~  435 (557)
                      +...   ++.|++.++.-+..|++.||.|||++   .|||||||+.|||++-+|.++|+|||.+.....  .........
T Consensus       120 mlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFI  191 (1187)
T KOG0579|consen  120 MLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFI  191 (1187)
T ss_pred             HHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh--HHhhhcccc
Confidence            7653   46799999999999999999999999   999999999999999999999999999865432  222334456


Q ss_pred             cccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          436 GTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       436 gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      ||+.|||||+..     ..+|..++||||||++|.||..+.+|....++.  .-++..+.     ...     |      
T Consensus       192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--RVllKiaK-----SeP-----P------  253 (1187)
T KOG0579|consen  192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAK-----SEP-----P------  253 (1187)
T ss_pred             CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--HHHHHHhh-----cCC-----C------
Confidence            999999999875     467999999999999999999999998765542  11111110     000     1      


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...-+......+.+++..|+..+|..||+++++++
T Consensus       254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            11112345567889999999999999999999986

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4e-34  Score=283.58  Aligned_cols=247  Identities=20%  Similarity=0.248  Sum_probs=187.0

Q ss_pred             HHhhcCCCCCCee-ecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCce
Q 008698          264 RSITKNFSEGNRL-LGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR  340 (557)
Q Consensus       264 ~~~~~~~~~~~~~-lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~  340 (557)
                      ....+++.....+ +|+|+||.||++.. .++..+|+|.+........     |+.....+ +||||+++++.+...+..
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            3333444333333 69999999999986 4588899999865422211     22222222 799999999999999999


Q ss_pred             EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CcEEeeccCC
Q 008698          341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLS  419 (557)
Q Consensus       341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~  419 (557)
                      ++||||+++++|.+++..    ...+++.++..++.|+++||.|||+.   +++||||||+||+++.++ .++|+|||++
T Consensus        85 ~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            999999999999999864    23799999999999999999999999   999999999999999998 9999999998


Q ss_pred             ccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      .......      ...++..|+|||++.+..++.++||||||+++|||++|+.||........ ....+...        
T Consensus       158 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~--------  222 (267)
T PHA03390        158 KIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKR--------  222 (267)
T ss_pred             eecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHh--------
Confidence            7654321      12378899999999988899999999999999999999999975433211 11111000        


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVH  545 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-~~evl~  545 (557)
                        .....      ......+..+.+++.+||+.+|.+||+ ++++++
T Consensus       223 --~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        223 --QQKKL------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             --hcccC------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence              00000      011134567899999999999999996 688874

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.1e-34  Score=295.24  Aligned_cols=269  Identities=15%  Similarity=0.219  Sum_probs=195.0

Q ss_pred             cCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhh--------------HHHHHHHHHHHhhcCCCcEEeeee
Q 008698          268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR--------------KKEFYSEIGRFARLHHPNLVAVKG  332 (557)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~H~niv~l~g  332 (557)
                      +.+....++||+|+||.||++... +++.||||.++......              ...+.+|+.++..++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            344445567899999999999964 68999999986542211              125788999999999999999999


Q ss_pred             eeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcE
Q 008698          333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH  412 (557)
Q Consensus       333 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k  412 (557)
                      ++...+..++||||+. |+|.+++..    ...+++.....++.|++.||+|||+.   +++|+||+|+|||++.++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            9999999999999996 689888853    34589999999999999999999999   999999999999999999999


Q ss_pred             EeeccCCccCCcccc------------ccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q 008698          413 LMGVGLSKFVPWEVM------------QERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDS  479 (557)
Q Consensus       413 l~Dfgl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~  479 (557)
                      |+|||++........            ........++..|+|||.+.+. .++.++||||||+++|||+||..||...++
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999976541110            0111112357789999998764 468999999999999999999999976654


Q ss_pred             ccch-hHHHhhhhhhhcccccccc-----CcccccCCC--CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          480 VCWQ-SIFEWATPLVQSHRYLELL-----DPLISSLSS--DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       480 ~~~~-~~~~~~~~~~~~~~~~~~~-----d~~l~~~~~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+.. .+......... .......     .+.......  ..........+.+++.+|++.+|++|||++|++.
T Consensus       240 ~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        240 IDQLGRIFELLGTPNE-DNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHHHhCCCch-hhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            2211 11110000000 0000000     000000000  0000112456889999999999999999999996

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=290.72  Aligned_cols=258  Identities=14%  Similarity=0.184  Sum_probs=181.6

Q ss_pred             CCCCCCeeecccCceEEEEEEeCC----CCEEEEEEecccchhh--H---------HHHHHHHHHHhhcCCCcEEeeeee
Q 008698          269 NFSEGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSSFQR--K---------KEFYSEIGRFARLHHPNLVAVKGC  333 (557)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~g~~~~----g~~vavK~~~~~~~~~--~---------~~~~~e~~~l~~l~H~niv~l~g~  333 (557)
                      +.+...++||+|+||.||+|...+    +..+|+|.........  .         .....+...+..+.|+||++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            334455678999999999999654    3456777543221111  0         112334455667789999999997


Q ss_pred             eeeCC----ceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008698          334 CYDHG----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  409 (557)
Q Consensus       334 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~  409 (557)
                      +....    ..++++|++. .++.+.+..    ....++..+..++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            66543    3477888763 466666543    12357888899999999999999999   999999999999999999


Q ss_pred             CcEEeeccCCccCCcccc-----ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh
Q 008698          410 GAHLMGVGLSKFVPWEVM-----QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS  484 (557)
Q Consensus       410 ~~kl~Dfgl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~  484 (557)
                      .++|+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~  241 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--N  241 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--H
Confidence            999999999976532211     111122348999999999999999999999999999999999999998653221  1


Q ss_pred             HHHhhh-hhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          485 IFEWAT-PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       485 ~~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                      +..... ...     ..+....+       ....++..+.+++..|++.+|++||+++++++.|+
T Consensus       242 ~~~~~~~~~~-----~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 LIHAAKCDFI-----KRLHEGKI-------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHhHHHHH-----HHhhhhhh-------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            111000 000     00111100       01123466889999999999999999999998774

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=288.25  Aligned_cols=261  Identities=22%  Similarity=0.286  Sum_probs=195.5

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|++|.||++... +|+.+++|.++....  .....+.+|+.++++++|+||+++++++...+..++|+||+++ +
T Consensus         5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~   83 (283)
T cd05118           5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D   83 (283)
T ss_pred             eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence            45799999999999974 688999999875532  2456788999999999999999999999999999999999964 8


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||.+.........  .
T Consensus        84 l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~--~  155 (283)
T cd05118          84 LYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP--Y  155 (283)
T ss_pred             HHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc--c
Confidence            88887642   24689999999999999999999999   9999999999999999999999999999766543211  1


Q ss_pred             eecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhhhhhccccccccC---c--
Q 008698          432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRYLELLD---P--  504 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d---~--  504 (557)
                      ....++..|+|||.+.+. .++.++||||||+++|+|+||+.||...+..+... ..+.... ..........+   .  
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGT-PDPEVWPKFTSLARNYK  234 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-CchHhcccchhhhhhhh
Confidence            112367889999998876 78999999999999999999999987654321110 0000000 00000000000   0  


Q ss_pred             -ccc---cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 -LIS---SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 -~l~---~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       ...   ...........+..+.+++.+||+.||.+||++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence             000   00000011235678999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.4e-34  Score=291.23  Aligned_cols=244  Identities=23%  Similarity=0.393  Sum_probs=191.7

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .||+|++|.||+|... ++..+|+|.+...   ......++.+|+.+++.++|+|++++++++...+..++||||+. |+
T Consensus        22 ~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~  100 (308)
T cd06634          22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GS  100 (308)
T ss_pred             heeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CC
Confidence            4699999999999964 5788999998642   22334578899999999999999999999999999999999996 68


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   ...+++.++..++.|++.||.|||+.   +++||||+|+|||++.++.+||+|||++.......     
T Consensus       101 l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-----  169 (308)
T cd06634         101 ASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----  169 (308)
T ss_pred             HHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCcc-----
Confidence            87776532   24589999999999999999999999   99999999999999999999999999987654221     


Q ss_pred             eecCcccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          432 VMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                       ...++..|+|||.+.   ...++.++|||||||++|||++|..|+...+....  +....    . ..     .     
T Consensus       170 -~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~----~-~~-----~-----  231 (308)
T cd06634         170 -XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA----Q-NE-----S-----  231 (308)
T ss_pred             -cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HHHHh----h-cC-----C-----
Confidence             123788999999875   34678899999999999999999999865432111  00000    0 00     0     


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                        ...........+.+++.+||+.+|++||++++|++.---..
T Consensus       232 --~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         232 --PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             --CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence              01111234456889999999999999999999997644333

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-34  Score=285.86  Aligned_cols=261  Identities=21%  Similarity=0.288  Sum_probs=190.7

Q ss_pred             eeecccCceEEEEEEeCC-CCEEEEEEecccch--hhHHHHHHHHHHHhhc---CCCcEEeeeeeeeeCCc-----eEEE
Q 008698          275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDHGD-----RYIV  343 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~~~-----~~lV  343 (557)
                      +.||+|++|.||+|...+ ++.||+|.++....  .....+.+|+.++.++   +||||+++++++...+.     .+++
T Consensus         5 ~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~   84 (287)
T cd07838           5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV   84 (287)
T ss_pred             EEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEE
Confidence            467999999999999864 89999999974321  2234566777776665   69999999999988776     8999


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      |||+. ++|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++....
T Consensus        85 ~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          85 FEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             ehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            99996 58988886522  23589999999999999999999999   99999999999999999999999999987664


Q ss_pred             ccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhhhhcccc----
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRY----  498 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~----  498 (557)
                      ......   ...++..|+|||.+.+..++.++||||||+++|||++|.+||......+.. .+.+...........    
T Consensus       159 ~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         159 FEMALT---SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             CCcccc---cccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            332111   122678899999999888999999999999999999999998765432111 111100000000000    


Q ss_pred             --ccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          499 --LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       499 --~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        ...+...... .......+....+.+++.+||+.||++||+++++++
T Consensus       236 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         236 LPRSSFPSYTPR-SFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cchhhccccccc-chhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence              0000000000 000001234567889999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=288.15  Aligned_cols=262  Identities=20%  Similarity=0.324  Sum_probs=192.0

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|++|+||+|... +++.|+||++..... .......+|+..+.+++ ||||+++++++...+..++||||+ +|+
T Consensus         5 ~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~   83 (283)
T cd07830           5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGN   83 (283)
T ss_pred             eeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCC
Confidence            45799999999999975 478999999865422 22334567999999998 999999999999999999999999 889


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++....  ...+++.++..++.|++.+|.|||++   +++|+||+|+||++++++.++|+|||++..........  
T Consensus        84 l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~--  156 (283)
T cd07830          84 LYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT--  156 (283)
T ss_pred             HHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC--
Confidence            998886522  34689999999999999999999999   99999999999999999999999999997654322211  


Q ss_pred             eecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhhhhh-----hccccccccCc
Q 008698          432 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLV-----QSHRYLELLDP  504 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~d~  504 (557)
                       ...++..|+|||.+.+ ..++.++||||||+++|||++|++||......+. ...........     ........++.
T Consensus       157 -~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         157 -DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             -CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence             1237889999998854 4578999999999999999999999866543211 00000000000     00000001111


Q ss_pred             ccccCCCCC---CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 LISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 ~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+.......   ........+.+++.+||+.+|++|||++|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            110000000   00011356889999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.9e-34  Score=286.30  Aligned_cols=240  Identities=20%  Similarity=0.246  Sum_probs=186.0

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHH---HHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIG---RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ||+|+||.||++... +++.||+|.+.....   .....+..|..   .+....||||+++++++.+.+..++||||+++
T Consensus         2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g   81 (278)
T cd05606           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG   81 (278)
T ss_pred             cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence            699999999999864 588999999865422   12223444433   44445799999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|..++..    ...+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+|||++........  
T Consensus        82 ~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--  152 (278)
T cd05606          82 GDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (278)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence            999988853    34699999999999999999999999   999999999999999999999999999875532221  


Q ss_pred             ceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          430 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                        ....|+..|+|||.+.++ .++.++||||||+++|||++|+.||.............    ..      ......+  
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~----~~------~~~~~~~--  218 (278)
T cd05606         153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MT------LTMAVEL--  218 (278)
T ss_pred             --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH----Hh------hccCCCC--
Confidence              122488999999998754 58899999999999999999999997653321111100    00      0001111  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                            +...+..+.+++.+|+..+|++||     ++.++++
T Consensus       219 ------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 ------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                  112345788999999999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-35  Score=299.02  Aligned_cols=261  Identities=21%  Similarity=0.300  Sum_probs=190.1

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-----CceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~  346 (557)
                      .+.||+|++|.||+|.. .+|+.||||+++... ......+.+|+.++.+++||||+++++++...     ...++|+||
T Consensus        10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~   89 (336)
T cd07849          10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL   89 (336)
T ss_pred             EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence            45679999999999985 468999999986432 23346688899999999999999999987644     357999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +. ++|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        90 ~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          90 ME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             cc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            96 588777753     4689999999999999999999999   99999999999999999999999999987654322


Q ss_pred             ccc-ceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhc---cccccc
Q 008698          427 MQE-RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS---HRYLEL  501 (557)
Q Consensus       427 ~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  501 (557)
                      ... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+....   ..........   .....+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHHHh
Confidence            111 1112347889999998765 4688999999999999999999999976432111   0000000000   000000


Q ss_pred             cCcc----cccCC--CCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          502 LDPL----ISSLS--SDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       502 ~d~~----l~~~~--~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      .+..    +....  ....    .......+.+++.+||+.+|++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000    00000  0000    01124568899999999999999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.2e-34  Score=291.66  Aligned_cols=246  Identities=23%  Similarity=0.418  Sum_probs=188.2

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|++|.||++...+ ++.||||.++... .....++..|+..+.+.. ||||+++++++.+....++||||+. +
T Consensus        20 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~   98 (296)
T cd06618          20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-T   98 (296)
T ss_pred             eeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-c
Confidence            3467999999999999865 8999999997543 234456777887777774 9999999999999999999999984 5


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      +|.+++...   ...+++.++..++.|++.||+|||+ .   +|+||||+|+||++++++.+||+|||++..........
T Consensus        99 ~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~  172 (296)
T cd06618          99 CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT  172 (296)
T ss_pred             CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCccc
Confidence            777766542   2468999999999999999999997 5   89999999999999999999999999987654322211


Q ss_pred             ceeecCccccccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          430 RTVMAGGTYGYLAPEFVYRNE----LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~----~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                         ...++..|+|||.+.+..    ++.++||||||+++|||++|+.||......     .+.........      .+.
T Consensus       173 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~------~~~  238 (296)
T cd06618         173 ---RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE------PPS  238 (296)
T ss_pred             ---CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC------CCC
Confidence               123678999999987553    788999999999999999999998653221     11111111100      000


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      .   ..   ....+.++.+++.+||+.+|++||+++++++.
T Consensus       239 ~---~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 L---PP---NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             C---CC---CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0   00   01234568999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2e-34  Score=289.68  Aligned_cols=263  Identities=19%  Similarity=0.239  Sum_probs=188.9

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      ..||+|++|.||+|... +|+.||+|.+.....  .....+.+|+.++++++||||+++++++.+.+..++||||++ ++
T Consensus         8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~   86 (294)
T PLN00009          8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LD   86 (294)
T ss_pred             EEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-cc
Confidence            45799999999999975 688999999865422  234678899999999999999999999999999999999995 57


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCcEEeeccCCccCCccccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      |.+++..  .....+++..+..++.||+.||+|||++   +++|+||+|+||+++. +..+||+|||++.......... 
T Consensus        87 l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~-  160 (294)
T PLN00009         87 LKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF-  160 (294)
T ss_pred             HHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc-
Confidence            8877754  2233468888889999999999999999   9999999999999985 5568999999997653321111 


Q ss_pred             eeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhhhhhhcc-----ccccccC
Q 008698          431 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSH-----RYLELLD  503 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~~~~~~~-----~~~~~~d  503 (557)
                       ....+++.|+|||++.+. .++.++||||||+++|+|+||..||...+..+. ..............     .+.+...
T Consensus       161 -~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T PLN00009        161 -THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS  239 (294)
T ss_pred             -ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence             112367899999988764 578999999999999999999999976533211 01110000000000     0000000


Q ss_pred             --cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          504 --PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       504 --~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        +..............+..+.+++.+|++.+|++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000000000000123456889999999999999999999986

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.3e-34  Score=290.10  Aligned_cols=240  Identities=24%  Similarity=0.400  Sum_probs=189.0

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      ..||+|+||.||+|+.. +|+.|++|.+....   ......+.+|+.++.+++|||++++++++.+.+..++||||+. |
T Consensus        27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~  105 (313)
T cd06633          27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G  105 (313)
T ss_pred             eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence            34799999999999864 58899999986432   2334578899999999999999999999999999999999995 6


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++..   ....+++.++..++.||+.||.|||+.   +++|+||+|+||+++.++.+||+|||++......     
T Consensus       106 ~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-----  174 (313)
T cd06633         106 SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-----  174 (313)
T ss_pred             CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-----
Confidence            77777753   234689999999999999999999999   9999999999999999999999999998643221     


Q ss_pred             eeecCcccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          431 TVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                       ....++..|+|||++.   ...++.++||||||+++|||++|..|+...+.....      ...... ..     +   
T Consensus       175 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~-~~-----~---  238 (313)
T cd06633         175 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN-DS-----P---  238 (313)
T ss_pred             -CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhc-CC-----C---
Confidence             1223788999999984   356888999999999999999999998765432110      000000 00     0   


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                          .......+..+.+++.+||+.+|.+||++.+++..
T Consensus       239 ----~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         239 ----TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00111123458899999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=274.12  Aligned_cols=244  Identities=23%  Similarity=0.412  Sum_probs=194.8

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .||.|+.|.|++.... .|...|||..... +....++++..+.++...+ .|.||+.+|+|..+...++.||.| ...+
T Consensus        99 dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~  177 (391)
T KOG0983|consen   99 DLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCA  177 (391)
T ss_pred             hhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHH
Confidence            3699999999999864 5899999999765 4455678888888877765 899999999999999999999988 4456


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      +.+|..   ...++++..+-++...+.+||.||-+++  +|+|||+||+|||+|+.+++|++|||++-.+..+..+....
T Consensus       178 ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsA  252 (391)
T KOG0983|consen  178 EKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSA  252 (391)
T ss_pred             HHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccccccc
Confidence            666653   3456999999999999999999999875  99999999999999999999999999998776555444333


Q ss_pred             ecCccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          433 MAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                         |.+.|||||.+.-   ..|..++||||||+.|+||.||+.||...+.+     ++......++.      -|.+.  
T Consensus       253 ---GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe~ltkvln~e------PP~L~--  316 (391)
T KOG0983|consen  253 ---GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FEVLTKVLNEE------PPLLP--  316 (391)
T ss_pred             ---CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HHHHHHHHhcC------CCCCC--
Confidence               8999999999864   46888999999999999999999999886543     11111111110      12221  


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          .....+..+.+++..|+..|+.+||...++++
T Consensus       317 ----~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  317 ----GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             ----cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                11225667999999999999999999999986

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3e-34  Score=289.37  Aligned_cols=263  Identities=21%  Similarity=0.231  Sum_probs=189.5

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC----------ceE
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----------DRY  341 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----------~~~  341 (557)
                      +.||+|++|.||+|... +|+.||+|.++...  ......+.+|+.++.+++||||+++++++.+..          ..+
T Consensus        13 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   92 (302)
T cd07864          13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFY   92 (302)
T ss_pred             eeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEE
Confidence            46799999999999975 58899999997542  223456788999999999999999999987654          789


Q ss_pred             EEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      +|+||+++ +|.+++...   ...+++..+..++.||+.||+|||+.   +|+|+||||+||++++++.+||+|||++..
T Consensus        93 lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~  165 (302)
T cd07864          93 LVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARL  165 (302)
T ss_pred             EEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccccccc
Confidence            99999975 777766532   34689999999999999999999999   999999999999999999999999999986


Q ss_pred             CCccccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      ......... ....++..|+|||.+.+ ..++.++|||||||++|||++|++||...+.......+.............+
T Consensus       166 ~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (302)
T cd07864         166 YNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD  244 (302)
T ss_pred             ccCCccccc-ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence            643322111 11225778999998865 3578899999999999999999999975443211111100000000000000


Q ss_pred             c--------cCcccccC-CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 L--------LDPLISSL-SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~--------~d~~l~~~-~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +        .+...... .........+..+.+++.+||+.+|++|||+++|++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0        00000000 000000113467899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-34  Score=296.54  Aligned_cols=263  Identities=21%  Similarity=0.266  Sum_probs=190.8

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeC--CceEEEEecCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH--GDRYIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~--~~~~lV~E~~~  348 (557)
                      +.||+|+||.||+|... +|+.||||++...  .......+.+|+.++.++ +||||+++++++...  ...++||||++
T Consensus        13 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~   92 (337)
T cd07852          13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME   92 (337)
T ss_pred             HhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc
Confidence            35799999999999975 5889999988542  223445678899999999 999999999988643  36799999996


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                       ++|..++..     ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.........
T Consensus        93 -~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          93 -TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN  163 (337)
T ss_pred             -cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence             599888854     2688999999999999999999999   9999999999999999999999999999865433221


Q ss_pred             ---cceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhh--------hhcc
Q 008698          429 ---ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL--------VQSH  496 (557)
Q Consensus       429 ---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~--------~~~~  496 (557)
                         .......++..|+|||.+.+ ..++.++||||||+++|||+||+.||..................        ....
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
T cd07852         164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP  243 (337)
T ss_pred             ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence               11112237889999998765 45788999999999999999999999765432111000000000        0000


Q ss_pred             ccccccCcccccCC--CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          497 RYLELLDPLISSLS--SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       497 ~~~~~~d~~l~~~~--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      ....+++.......  ........+..+.+++.+||+.+|++|||+.++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00011110000000  000001135678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.4e-34  Score=289.92  Aligned_cols=265  Identities=18%  Similarity=0.236  Sum_probs=188.1

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC--------ceEE
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--------DRYI  342 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--------~~~l  342 (557)
                      ...||+|+||.||++... +++.||||.+....  ......+.+|+.++++++||||+++++++...+        ..++
T Consensus        17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l   96 (310)
T cd07865          17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL   96 (310)
T ss_pred             EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence            345799999999999964 58899999986432  222345678999999999999999999987654        3499


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      ||||+. ++|.+++..   ....+++.++..++.||+.||.|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus        97 v~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          97 VFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             EEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence            999995 588887754   224689999999999999999999999   9999999999999999999999999999765


Q ss_pred             Cccccc--cceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcc---
Q 008698          423 PWEVMQ--ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH---  496 (557)
Q Consensus       423 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~---  496 (557)
                      ......  .......++..|+|||.+.+. .++.++||||||+++|||+||..||...+..................   
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            432211  111122367889999988664 46889999999999999999999987654322111111110000000   


Q ss_pred             --ccccccCccc-cc-----CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          497 --RYLELLDPLI-SS-----LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       497 --~~~~~~d~~l-~~-----~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        ...+..+... ..     ........-....+.+++.+||+.+|.+|||++++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence              0000000000 00     0000000011245679999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=281.04  Aligned_cols=243  Identities=26%  Similarity=0.446  Sum_probs=197.8

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|++|.||++... +++.|++|.+.....  .....+.+|++++.+++|||++++++++.+.+..++||||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (254)
T cd06627           5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG   84 (254)
T ss_pred             eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence            346799999999999865 578999999976643  45578999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.........  
T Consensus        85 ~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  155 (254)
T cd06627          85 SLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--  155 (254)
T ss_pred             cHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence            999998642    4689999999999999999999999   9999999999999999999999999999866543321  


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|..|+...+..  ......    .. . .            
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~~~~~----~~-~-~------------  215 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AALFRI----VQ-D-D------------  215 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HHHHHH----hc-c-C------------
Confidence            11223788999999998877899999999999999999999998754321  111100    00 0 0            


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ....+...+..+.+++.+|+..+|++|||+.+++.
T Consensus       216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            00111223456889999999999999999999984

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.6e-34  Score=291.09  Aligned_cols=261  Identities=18%  Similarity=0.230  Sum_probs=189.6

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~  349 (557)
                      +.||+|+||.||++... +|+.||+|+++....  .....+.+|+.++.+++|+||+++++++.+.  +..++||||+. 
T Consensus        13 ~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-   91 (309)
T cd07845          13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-   91 (309)
T ss_pred             eeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-
Confidence            45799999999999974 589999999864422  1234567899999999999999999998755  46899999996 


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++|.+++...   ...+++.++..++.||+.||+|||+.   +++||||||+||++++++.+||+|||++..........
T Consensus        92 ~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~  165 (309)
T cd07845          92 QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM  165 (309)
T ss_pred             CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccCCC
Confidence            5888887642   25689999999999999999999999   99999999999999999999999999998664332111


Q ss_pred             ceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccC-----
Q 008698          430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD-----  503 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-----  503 (557)
                        ....++..|+|||.+.+ ..++.++||||||+++|||++|..||...++............. ........++     
T Consensus       166 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  242 (309)
T cd07845         166 --TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT-PNESIWPGFSDLPLV  242 (309)
T ss_pred             --CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC-CChhhchhhhccccc
Confidence              11125778999999875 45789999999999999999999999765443211111000000 0000000000     


Q ss_pred             -c-ccccCCCCCC---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          504 -P-LISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       504 -~-~l~~~~~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       . .+........   .......+.+++.+|++.||++|||++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             0 0000000000   0112456789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-34  Score=297.09  Aligned_cols=263  Identities=22%  Similarity=0.274  Sum_probs=191.6

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-----CceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E  345 (557)
                      .+.||+|+||.||++... +++.||||.++..  .......+.+|+.++..++|+||+++++++...     ...++|+|
T Consensus        10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e   89 (337)
T cd07858          10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE   89 (337)
T ss_pred             EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence            346799999999999864 5899999998753  223345678899999999999999999987644     35799999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      |+. ++|.+++..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++......
T Consensus        90 ~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          90 LMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             CCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            995 788888753    34699999999999999999999999   9999999999999999999999999999865432


Q ss_pred             ccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHH-Hhhhh-------hhhcc
Q 008698          426 VMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF-EWATP-------LVQSH  496 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~-~~~~~-------~~~~~  496 (557)
                      ..  ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...+........ +....       .....
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         162 GD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             cc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            21  1112237889999998865 46889999999999999999999999765322111111 00000       00000


Q ss_pred             ccccccCccccc--CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          497 RYLELLDPLISS--LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       497 ~~~~~~d~~l~~--~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      .....+......  ..........+..+.+++.+||+.+|++|||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000000000000  00000011245678999999999999999999999975

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-34  Score=282.36  Aligned_cols=245  Identities=23%  Similarity=0.344  Sum_probs=191.2

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-----SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E  345 (557)
                      .++||+|++|.||++... +++.||+|.+...     .......+.+|+.++++++|+||+++++++.+.  +..++|+|
T Consensus         7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (264)
T cd06653           7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE   86 (264)
T ss_pred             eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence            457899999999999864 5899999987532     123346788999999999999999999998764  45789999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      |+++++|.+++..    ...+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++.....
T Consensus        87 ~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          87 YMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             eCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            9999999999864    23488999999999999999999999   9999999999999999999999999999765322


Q ss_pred             ccc-cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          426 VMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       426 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      ... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......  ......    ...     ..  
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~----~~~-----~~--  226 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIFKI----ATQ-----PT--  226 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHHHH----HcC-----CC--
Confidence            111 1111233788999999998888899999999999999999999999754321  111100    000     00  


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                            ....+......+.+++.+|++ +|.+||+..+++.
T Consensus       227 ------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 ------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                  111123345678999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=290.97  Aligned_cols=255  Identities=22%  Similarity=0.283  Sum_probs=206.7

Q ss_pred             HHHHhhcCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC
Q 008698          262 ELRSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH  337 (557)
Q Consensus       262 el~~~~~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~  337 (557)
                      |.+.++.+.....++||+|+||.||.... .+|+.+|.|.+.+...   +.....++|-.+|.+++.+.||.+-..+...
T Consensus       178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk  257 (591)
T KOG0986|consen  178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK  257 (591)
T ss_pred             HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence            44566666666678899999999998875 4699999999865422   3345568899999999999999999999999


Q ss_pred             CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeecc
Q 008698          338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  417 (557)
Q Consensus       338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  417 (557)
                      +.+++|+..|.||+|.-+|.+.  ++..+++..++.++.+|+.||.+||+.   +||.|||||+|||||+.|+++|+|.|
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             CceEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccc
Confidence            9999999999999999888764  346799999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       418 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                      ||............   .||.+|||||++..+.|+...|-||+||+||||+.|+.||.......-               
T Consensus       333 LAvei~~g~~~~~r---vGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---------------  394 (591)
T KOG0986|consen  333 LAVEIPEGKPIRGR---VGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---------------  394 (591)
T ss_pred             eEEecCCCCccccc---cCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---------------
Confidence            99877655444332   499999999999999999999999999999999999999976533211               


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS  541 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~  541 (557)
                       .+-+|.+.... ....+...+++...+....+..||++|....
T Consensus       395 -~eEvdrr~~~~-~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  395 -REEVDRRTLED-PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             -HHHHHHHHhcc-hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence             01122222111 1122344667788888999999999997543

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-34  Score=310.85  Aligned_cols=272  Identities=17%  Similarity=0.197  Sum_probs=183.2

Q ss_pred             hcCCCCCCeeecccCceEEEEEEeCC--CCEEEEE------------------EecccchhhHHHHHHHHHHHhhcCCCc
Q 008698          267 TKNFSEGNRLLGDSKTGGTYSGILPD--GSRVAVK------------------RLKRSSFQRKKEFYSEIGRFARLHHPN  326 (557)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~g~~~~--g~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~H~n  326 (557)
                      ...|... +.||+|+||+||++....  +...++|                  .+. ........+.+|+.+|.+++|||
T Consensus       147 ~~~Y~ii-~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        147 LAHFRVI-DDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhccEEE-eEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            3344443 457999999999987532  2222222                  111 11223456889999999999999


Q ss_pred             EEeeeeeeeeCCceEEEEecCCCCChHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 008698          327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPR-GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL  405 (557)
Q Consensus       327 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill  405 (557)
                      |+++++++...+..++|+|++ .++|.+++..... ........+...++.||+.||+|||++   +|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            999999999999999999998 4577777653211 112234566778999999999999999   99999999999999


Q ss_pred             CCCCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCCcccchh
Q 008698          406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR-PAQAVDSVCWQS  484 (557)
Q Consensus       406 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~-p~~~~~~~~~~~  484 (557)
                      +.++.+||+|||+++......... .....||..|+|||++.+..++.++|||||||++|||++|.. |+..........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            999999999999998664332211 112348999999999999999999999999999999999875 444332222222


Q ss_pred             HHHhhhhhh--hcc------ccccccCcc-cccCCCC----CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          485 IFEWATPLV--QSH------RYLELLDPL-ISSLSSD----IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       485 ~~~~~~~~~--~~~------~~~~~~d~~-l~~~~~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +.+......  ...      ++.+.++.. +......    .........+.+++.+|++.||++|||+.|+++
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            222111100  000      000000000 0000000    000112345778899999999999999999986

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5e-34  Score=285.93  Aligned_cols=251  Identities=21%  Similarity=0.230  Sum_probs=194.4

Q ss_pred             CeeecccCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEE
Q 008698          274 NRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      .+.||+|++|.||++..    .+++.||||+++...    ....+.+.+|+.++.++ +||||+++++.+...+..++||
T Consensus         5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   84 (288)
T cd05583           5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL   84 (288)
T ss_pred             EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence            34689999999999874    357899999987542    22345688999999999 6999999999999999999999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+++|+|.+++..    ...+++..+..++.|+++||.|||+.   +++||||+|+||+++.++.++|+|||+++....
T Consensus        85 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          85 DYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             ecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            99999999999864    24588999999999999999999998   999999999999999999999999999876543


Q ss_pred             cccccceeecCccccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccccc
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  502 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (557)
                      ..... .....++..|+|||.+.+..  .+.++||||||+++|||+||..||........  ..+.......       .
T Consensus       158 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~-------~  227 (288)
T cd05583         158 EEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILK-------S  227 (288)
T ss_pred             ccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHc-------c
Confidence            32211 11233788999999987654  78899999999999999999999864322110  0010110000       0


Q ss_pred             CcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       503 d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                      .+        ..+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       228 ~~--------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 KP--------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             CC--------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            00        0111233568899999999999999999888877654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.8e-34  Score=283.11  Aligned_cols=246  Identities=19%  Similarity=0.294  Sum_probs=191.2

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRS-----SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .+.||+|+||.||++.... +..+++|.++..     ......++.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (260)
T cd08222           5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC   84 (260)
T ss_pred             eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence            3467999999999998643 445666666532     1223346778899999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++++|.+++.........+++.+++.++.|++.||.|||+.   +++|+||+|+||++++ +.+||+|||++........
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~  160 (260)
T cd08222          85 EGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD  160 (260)
T ss_pred             CCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCCcc
Confidence            99999998875444456799999999999999999999999   9999999999999986 4699999999876543221


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .  .....++..|+|||.+.+..++.++||||||+++|+|++|..||......      .......         ...  
T Consensus       161 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~---------~~~--  221 (260)
T cd08222         161 L--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLRIV---------EGP--  221 (260)
T ss_pred             c--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHH---------cCC--
Confidence            1  11233788999999998888899999999999999999999998643221      1111100         000  


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ....+...+..+.+++.+||+.+|++||++.++++
T Consensus       222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 ---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence               00112345567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.4e-34  Score=294.73  Aligned_cols=262  Identities=21%  Similarity=0.299  Sum_probs=191.9

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeee----CCceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~  346 (557)
                      .+.||+|++|.||++... +|+.||+|++....  ......+.+|+.++.+++||||+++++++..    ....++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~   89 (334)
T cd07855          10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL   89 (334)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence            346799999999999964 58999999987542  2345677889999999999999999998753    3467999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +. |+|.+++..    ...+++..+..++.||+.||.|||++   +++||||||+|||+++++.+||+|||++.......
T Consensus        90 ~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          90 ME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             hh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            95 689888853    34589999999999999999999999   99999999999999999999999999987654322


Q ss_pred             ccc--ceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhh--------hhc
Q 008698          427 MQE--RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL--------VQS  495 (557)
Q Consensus       427 ~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~--------~~~  495 (557)
                      ...  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..............        ...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence            111  1112247889999998865 45889999999999999999999999765432111100000000        000


Q ss_pred             cccccccCcccccCCCCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          496 HRYLELLDPLISSLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       496 ~~~~~~~d~~l~~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..+.+.++.....  ...+    ....+..+.+++.+||+.+|++|||++++++
T Consensus       242 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         242 DRVRKYIQNLPRK--QPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhHHHHHhhcccC--CCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0001111100000  0000    0123567999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.1e-33  Score=283.83  Aligned_cols=247  Identities=20%  Similarity=0.258  Sum_probs=191.0

Q ss_pred             CeeecccCceEEEEEEe----CCCCEEEEEEecccch----hhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEE
Q 008698          274 NRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSSF----QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~----~~g~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      .+.||+|+||.||.+..    .+|+.||+|+++....    ...+.+.+|+.++.++ +|+||+++++++...+..++||
T Consensus         5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (290)
T cd05613           5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL   84 (290)
T ss_pred             eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence            34679999999999885    4689999999975422    2346678899999999 6999999999999888999999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||+|+|||++.++.+||+|||++.....
T Consensus        85 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          85 DYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            99999999999864    24588999999999999999999999   999999999999999999999999999976543


Q ss_pred             cccccceeecCccccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccccc
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  502 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (557)
                      ..... .....|+..|+|||.+.+.  .++.++||||||+++|||++|..||.......  ...+........       
T Consensus       158 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~-------  227 (290)
T cd05613         158 DEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS-------  227 (290)
T ss_pred             ccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhcc-------
Confidence            22211 1123378899999998753  46789999999999999999999986432211  111111111000       


Q ss_pred             CcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       503 d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                      .        ...+......+.+++.+|++.+|++||     ++++++.
T Consensus       228 ~--------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 E--------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             C--------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            0        001122345688999999999999997     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.6e-34  Score=292.92  Aligned_cols=267  Identities=17%  Similarity=0.271  Sum_probs=190.5

Q ss_pred             cCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC------
Q 008698          268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------  338 (557)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------  338 (557)
                      .+|.. ...||+|+||.||+|.. .+|+.||||++....  ......+.+|+.++.+++||||+++++++....      
T Consensus        15 ~~y~~-~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTS-LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEE-EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            44433 45679999999999996 468999999986532  223456889999999999999999999986543      


Q ss_pred             ceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccC
Q 008698          339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL  418 (557)
Q Consensus       339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  418 (557)
                      ..++|+||+. .+|..++.      ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+
T Consensus        94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            4589999985 47766552      3588999999999999999999999   999999999999999999999999999


Q ss_pred             CccCCccccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhh------
Q 008698          419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP------  491 (557)
Q Consensus       419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~------  491 (557)
                      ++......     ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+............+      
T Consensus       164 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07879         164 ARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF  238 (342)
T ss_pred             CcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            87643221     11236788999999876 4688999999999999999999999986542111000000000      


Q ss_pred             --hhhccccccccCcccccCCCCCC---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhccc
Q 008698          492 --LVQSHRYLELLDPLISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLA  551 (557)
Q Consensus       492 --~~~~~~~~~~~d~~l~~~~~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~  551 (557)
                        ............. .........   .......+.+++.+||+.||++||++++++..  ++...
T Consensus       239 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         239 VQKLEDKAAKSYIKS-LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHhcccchHHHHhh-cCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence              0000000000000 000000000   00123468899999999999999999999953  55444

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.9e-34  Score=289.29  Aligned_cols=264  Identities=22%  Similarity=0.330  Sum_probs=192.9

Q ss_pred             hhcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeee-CCceE
Q 008698          266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRY  341 (557)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~  341 (557)
                      ++++|.. .+.||.|+||.||++... +|+.||||.+...  .....+.+.+|+.++..++||||+++++++.. .+..+
T Consensus         8 ~~~~y~~-~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVD-LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEE-EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            4444443 456799999999999854 6899999988643  22334678899999999999999999998865 56789


Q ss_pred             EEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      +|+||+ +++|.+++..     ..+++.....++.|+++||+|||+.   +++||||+|+|||+++++.+||+|||++..
T Consensus        87 lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          87 FVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            999998 5689888753     3578888889999999999999999   999999999999999999999999999875


Q ss_pred             CCccccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhh-------hh
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWAT-------PL  492 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~-------~~  492 (557)
                      .....     ....++..|+|||.+.+ ..++.++||||||+++|||+||+.||.......... +.+...       ..
T Consensus       158 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            43221     11236788999998866 568999999999999999999999997654311110 000000       00


Q ss_pred             hhccccccccCcccccCCCCCCc----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          493 VQSHRYLELLDPLISSLSSDIPE----AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       493 ~~~~~~~~~~d~~l~~~~~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      .......+.+.. +... ...+.    ......+.+++.+|++.+|++|||+++++..
T Consensus       233 ~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQS-LPKR-EPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhh-cccc-CCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000001000 0000 00000    1134678999999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-34  Score=293.52  Aligned_cols=245  Identities=22%  Similarity=0.344  Sum_probs=199.8

Q ss_pred             CCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          270 FSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      ++...+.||+|.|+.|..+.. ..+..||||.+.+...  .....+.+|+++|..++|||||+++.+......+|+||||
T Consensus        57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey  136 (596)
T KOG0586|consen   57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY  136 (596)
T ss_pred             ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence            344456789999999999995 4599999999987633  3335589999999999999999999999999999999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +.+|.+.++|.+.    ....+.....++.|+.+|++|+|++   .|+|||||++||||+.+.++||+|||++..+....
T Consensus       137 a~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  137 ASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             ccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccc
Confidence            9999999999753    3355588889999999999999999   99999999999999999999999999998876433


Q ss_pred             cccceeecCccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      .   ....+|++.|.|||++.+..+ .+++|+||+|++||-|+.|..||++..-.+...               .++...
T Consensus       210 ~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------------rvl~gk  271 (596)
T KOG0586|consen  210 M---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------------RVLRGK  271 (596)
T ss_pred             c---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------------hheeee
Confidence            2   334569999999999998766 689999999999999999999998754322111               001000


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .     .. +--...++.+++.+.+-.+|.+|++++++.+
T Consensus       272 ~-----rI-p~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  272 Y-----RI-PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             e-----cc-cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            0     00 1112345778999999999999999999876

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.2e-34  Score=282.51  Aligned_cols=244  Identities=20%  Similarity=0.315  Sum_probs=196.0

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|++|.||++... +|+.||+|++...   .......+.+|..++.+++ ||||+++++++...+..++||||++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd05581           6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP   85 (280)
T ss_pred             eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence            346799999999999965 6899999998753   2233467889999999998 9999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........
T Consensus        86 ~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          86 NGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            9999999964    23699999999999999999999999   9999999999999999999999999998765433221


Q ss_pred             ------------------cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhh
Q 008698          429 ------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT  490 (557)
Q Consensus       429 ------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~  490 (557)
                                        .......++..|+|||.+....++.++||||||++++++++|..||...+..   .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~  235 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LTFQKIL  235 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHH
Confidence                              1112223678999999998888999999999999999999999999865421   1111100


Q ss_pred             hhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHH
Q 008698          491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM----SHVVH  545 (557)
Q Consensus       491 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~----~evl~  545 (557)
                                  +.      ....+...+..+.+++.+||+.+|++||++    +++++
T Consensus       236 ------------~~------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         236 ------------KL------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ------------hc------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                        00      001112234568899999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-33  Score=290.81  Aligned_cols=271  Identities=19%  Similarity=0.312  Sum_probs=195.8

Q ss_pred             CHHHHHHhhcCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeee
Q 008698          259 TTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCY  335 (557)
Q Consensus       259 ~~~el~~~~~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~  335 (557)
                      ...++..++++|... +.||+|+||.||++.. .+|+.||+|++....  ....+.+.+|+.++.+++||||+++++++.
T Consensus         8 ~~~~~~~~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           8 LNKTIWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             HHHHHhhccCceEEE-EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            345666677776554 4679999999999985 468899999987542  233467889999999999999999999876


Q ss_pred             eC------CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008698          336 DH------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  409 (557)
Q Consensus       336 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~  409 (557)
                      ..      +..+++++++ +++|.+++..     ..+++..+..++.|+++||+|||+.   +++||||||+||++++++
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence            43      3467888876 7899887753     3589999999999999999999999   999999999999999999


Q ss_pred             CcEEeeccCCccCCccccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHH
Q 008698          410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFE  487 (557)
Q Consensus       410 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~  487 (557)
                      .+||+|||+++......     ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+...... +..
T Consensus       158 ~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         158 ELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             CEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999987643221     12237889999998866 467889999999999999999999996543321110 000


Q ss_pred             hhh-------hhhhccc---cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          488 WAT-------PLVQSHR---YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       488 ~~~-------~~~~~~~---~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...       .......   ....+..... .............+.+++.+|++.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPK-MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCC-cchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            000       0000000   0000000000 0000000012456889999999999999999999986

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-34  Score=282.52  Aligned_cols=261  Identities=21%  Similarity=0.312  Sum_probs=194.5

Q ss_pred             eeecccCceEEEEEEeCC-CCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      ..||+|++|.||+|+..+ ++.||+|.+....  ....+.+.+|+.++++++|+||+++++++.+.+..++||||++ ++
T Consensus         5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~   83 (282)
T cd07829           5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD   83 (282)
T ss_pred             hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence            357999999999999754 8999999997653  2334678889999999999999999999999999999999997 58


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++....   ..+++..+..++.|++.||+|||+.   +++||||+|+||++++++.+||+|||+++.........  
T Consensus        84 l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~--  155 (282)
T cd07829          84 LKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--  155 (282)
T ss_pred             HHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc--
Confidence            999997521   4699999999999999999999999   99999999999999999999999999998664332211  


Q ss_pred             eecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhh-------hhhhhccc-cccc
Q 008698          432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWA-------TPLVQSHR-YLEL  501 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~-------~~~~~~~~-~~~~  501 (557)
                      ....++..|+|||.+.+. .++.++||||||+++|||++|..||...+..... .+....       +....... ....
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            112256789999998776 7899999999999999999999998765422110 010000       00000000 0000


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +........... .......+.+++.+||+.+|++||++++|+.
T Consensus       236 ~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         236 FPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000000000 0112457899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.9e-34  Score=291.18  Aligned_cols=272  Identities=21%  Similarity=0.281  Sum_probs=199.9

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC-----ceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E  345 (557)
                      .+.||+|++|.||++...+ |+.||||.+....  ....+.+.+|+..++.++||||+++++++...+     ..++|||
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e   84 (330)
T cd07834           5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE   84 (330)
T ss_pred             eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence            4568999999999999754 8999999987643  344567899999999999999999999988765     7899999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      |++ ++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++......
T Consensus        85 ~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          85 LME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             chh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            997 588888853    23799999999999999999999999   9999999999999999999999999999866543


Q ss_pred             ccc-cceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhhh-------hhc
Q 008698          426 VMQ-ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPL-------VQS  495 (557)
Q Consensus       426 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~~-------~~~  495 (557)
                      ... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+...... +.......       ...
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence            210 111122368889999999887 78999999999999999999999997665322111 00000000       000


Q ss_pred             cccccccCccccc--CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcccCC
Q 008698          496 HRYLELLDPLISS--LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLAQP  553 (557)
Q Consensus       496 ~~~~~~~d~~l~~--~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~~~  553 (557)
                      ....+.+......  ..........+..+.+++.+||+.+|++|||++++++.  +++...+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            0000000000000  00000011135678999999999999999999999983  5555543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=275.79  Aligned_cols=236  Identities=25%  Similarity=0.315  Sum_probs=191.3

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ||+|++|.||++... +++.+|+|.++....   .....+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            599999999999975 489999999876532   2456788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~  151 (250)
T cd05123          81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN  151 (250)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence            999964    23589999999999999999999998   999999999999999999999999999876543321  122


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...++..|+|||...+...+.++|+||||+++|||++|..||...+..   ......   ..         ..      .
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~---~~---------~~------~  210 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYEKI---LK---------DP------L  210 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---hc---------CC------C
Confidence            233788999999998888899999999999999999999999755431   111111   00         00      0


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSH  542 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~e  542 (557)
                      ..+...+..+.+++.+||..||++||++.+
T Consensus       211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         211 RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            011112456889999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.5e-34  Score=293.00  Aligned_cols=268  Identities=22%  Similarity=0.288  Sum_probs=191.1

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--------------C
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--------------G  338 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--------------~  338 (557)
                      .+.||.|+||.||+|... +|+.||+|.+........+.+.+|+.++++++||||+++++++...              .
T Consensus        10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~   89 (342)
T cd07854          10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN   89 (342)
T ss_pred             EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence            456799999999999864 5889999998766556667889999999999999999999876543              3


Q ss_pred             ceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCcEEeecc
Q 008698          339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVG  417 (557)
Q Consensus       339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg  417 (557)
                      ..++||||++ ++|.+++..     ..+++..+..++.||++||.|||+.   +++||||||+||+++. +..+|++|||
T Consensus        90 ~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          90 SVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             eEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcc
Confidence            5789999996 589888753     3588999999999999999999999   9999999999999974 5578999999


Q ss_pred             CCccCCcccccc-ceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhc
Q 008698          418 LSKFVPWEVMQE-RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS  495 (557)
Q Consensus       418 l~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  495 (557)
                      ++.......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+...........+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            997653321111 1111236788999998754 45788999999999999999999999765432111110000000000


Q ss_pred             cccccc---cCcccc-cCC-CCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcc
Q 008698          496 HRYLEL---LDPLIS-SLS-SDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQL  550 (557)
Q Consensus       496 ~~~~~~---~d~~l~-~~~-~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~  550 (557)
                      ....+.   +..... ... ...+    .......+.+++.+|++.||++|||++++++  .++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            000000   000000 000 0000    0123456889999999999999999999985  44433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=322.24  Aligned_cols=254  Identities=27%  Similarity=0.418  Sum_probs=198.8

Q ss_pred             hhcCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEE
Q 008698          266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l  342 (557)
                      ++-+...++ .||.|.||.||.++. ++|...|+|-++...  ....+.+.+|+.+|..++|||+|+++|+-...+..+|
T Consensus      1233 V~~rWqrg~-~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGN-FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             ceeeecccc-ccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            344444444 469999999999994 568889999876542  2334677899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      .||||++|+|.+.+..    ++..++.....+..|++.|++|||++   |||||||||.||||+.++.+|++|||.|...
T Consensus      1312 FMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence            9999999999999965    34577777778899999999999999   9999999999999999999999999999866


Q ss_pred             Ccccc--ccceeecCccccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          423 PWEVM--QERTVMAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       423 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                      .....  ........||+.|||||++.+.   ...-+.||||+|||+.||+||++|+...+.. |+-++..+..      
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~V~~g------ 1457 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYHVAAG------ 1457 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhHHhcc------
Confidence            54421  1111122399999999999763   2456889999999999999999999876542 2222211110      


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                          -        ..+.|.....+-.+++.+|++.||++|.++.|+++.
T Consensus      1458 ----h--------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 ----H--------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ----C--------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                0        111223366677899999999999999999888863

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-34  Score=295.89  Aligned_cols=197  Identities=26%  Similarity=0.405  Sum_probs=168.8

Q ss_pred             CeeecccCceEEEEEE-eCCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC------ceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~lV~E  345 (557)
                      .+.||+|+||.||+|+ -..|+.||||.++... ....+...+|+++|++++|||||++.++-.+..      ...+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            4468999999999999 4569999999998753 344677889999999999999999999765443      5689999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCC--cEEeeccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--EEFG--AHLMGVGLSKF  421 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~--~~~~--~kl~Dfgl~~~  421 (557)
                      ||.+|||+..|+.. .+...|++.+.+.++.+++.||.|||++   +|+||||||.||++-  .+++  -||+|||.|+.
T Consensus        98 yC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             ecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            99999999999864 4567899999999999999999999999   999999999999983  3333  59999999998


Q ss_pred             CCccccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAV  477 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~  477 (557)
                      ++....   .....||..|.+||.+.. ..|+..+|.|||||++||.+||..||...
T Consensus       174 l~d~s~---~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  174 LDDNSL---FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             CCCCCe---eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            875542   223349999999999985 78899999999999999999999999754

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.2e-33  Score=282.89  Aligned_cols=265  Identities=20%  Similarity=0.243  Sum_probs=187.1

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchh--hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC--------ceEE
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--------DRYI  342 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--------~~~l  342 (557)
                      .+.||+|++|.||++... +++.||||.+......  ....+.+|+.++.+++||||+++++++.+..        ..++
T Consensus        13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l   92 (311)
T cd07866          13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM   92 (311)
T ss_pred             EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence            345799999999999964 5889999998654221  2346788999999999999999999875443        4599


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      |+||+.. +|...+..   ....+++.++..++.|+++||+|||+.   +++|+||||+|||+++++.+||+|||+++..
T Consensus        93 v~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          93 VTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             EEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence            9999864 67766653   234699999999999999999999999   9999999999999999999999999999765


Q ss_pred             Cccccccc---------eeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhh
Q 008698          423 PWEVMQER---------TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATP  491 (557)
Q Consensus       423 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~  491 (557)
                      ........         .....++..|+|||.+.+. .++.++||||||+++|||++|++||.+.+...... +......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT  245 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            43221111         0112357889999987654 57899999999999999999999997654422111 1110000


Q ss_pred             hhh-----ccccccccCccc-ccCCCCC--CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          492 LVQ-----SHRYLELLDPLI-SSLSSDI--PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       492 ~~~-----~~~~~~~~d~~l-~~~~~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...     ........+... .......  ........+.+++.+|++.+|++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            000     000000000000 0000000  00112256889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-33  Score=288.48  Aligned_cols=264  Identities=18%  Similarity=0.288  Sum_probs=191.3

Q ss_pred             hhcCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC----
Q 008698          266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----  338 (557)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----  338 (557)
                      +.++|.. .+.||+|++|.||++.. .+|+.||||++....  ......+.+|+.++++++||||+++++++...+    
T Consensus        13 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          13 VPDRYRD-LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             cccceEE-EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            4444443 45679999999999985 468999999986432  223456889999999999999999999887553    


Q ss_pred             --ceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeec
Q 008698          339 --DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  416 (557)
Q Consensus       339 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  416 (557)
                        ..++||||+ +++|.+++..     ..+++..+..++.||+.||+|||+.   +|+||||||+||++++++.+||+||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence              358999998 7799888753     4589999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccCCccccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhh----
Q 008698          417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWAT----  490 (557)
Q Consensus       417 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~----  490 (557)
                      |++.......     ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.... ..+.....    
T Consensus       163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07880         163 GLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK  237 (343)
T ss_pred             ccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            9997653221     12236889999998876 4578999999999999999999999976543110 00000000    


Q ss_pred             ---hhhhccccccccCcccccCCCC---CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          491 ---PLVQSHRYLELLDPLISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       491 ---~~~~~~~~~~~~d~~l~~~~~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         .............. +......   .........+.+++.+|++.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         238 EFVQKLQSEDAKNYVKK-LPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHhhcchhHHHHHHh-ccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               00000000000000 0000000   000123446889999999999999999999994

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.1e-33  Score=286.22  Aligned_cols=263  Identities=18%  Similarity=0.221  Sum_probs=187.4

Q ss_pred             CeeecccCceEEEEEEeC-C--CCEEEEEEeccc--chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeC----CceEEE
Q 008698          274 NRLLGDSKTGGTYSGILP-D--GSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH----GDRYIV  343 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~--g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~----~~~~lV  343 (557)
                      .+.||+|+||.||++... .  +..||+|.+...  .....+.+.+|+.++.++ +||||+++++.+...    ...+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~   84 (332)
T cd07857           5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY   84 (332)
T ss_pred             EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence            346899999999999964 3  779999998643  222346788999999999 599999999875432    457889


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      +||+. ++|.+++..    ...+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus        85 ~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          85 EELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             Eeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            99885 689888853    35689999999999999999999999   99999999999999999999999999997654


Q ss_pred             ccccc--cceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhhhhhccccc
Q 008698          424 WEVMQ--ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRYL  499 (557)
Q Consensus       424 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~  499 (557)
                      .....  .......|+..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+...... ...... ........
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~  235 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG-TPDEETLS  235 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC-CCCHHHHH
Confidence            32211  11112347899999998766 468999999999999999999999987654321100 000000 00000000


Q ss_pred             cccCcc-------cccCCCCC---CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          500 ELLDPL-------ISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       500 ~~~d~~-------l~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+.++.       ........   ........+.+++.+|++.+|++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000       00000000   00012456889999999999999999999986

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-35  Score=270.31  Aligned_cols=263  Identities=23%  Similarity=0.410  Sum_probs=199.7

Q ss_pred             ccccCHHHHHHhhcCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccch-hhHHHHHHHHHHHhhc-CCCcEEeee
Q 008698          255 WKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARL-HHPNLVAVK  331 (557)
Q Consensus       255 ~~~~~~~el~~~~~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~  331 (557)
                      ...|+.+.++.+.        .||.|+||+|++-.+ +.|+..|||+++.... ...++++.|.+...+- +.||||+++
T Consensus        58 ~~~F~~~~Lqdlg--------~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy  129 (361)
T KOG1006|consen   58 LHTFTSDNLQDLG--------EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY  129 (361)
T ss_pred             ccccccchHHHHH--------HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence            3445555555443        479999999999876 4599999999987644 5667899999876665 789999999


Q ss_pred             eeeeeCCceEEEEecCCCCChHHHhcc-CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 008698          332 GCCYDHGDRYIVYEFVVNGPLDRWLHH-IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG  410 (557)
Q Consensus       332 g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~  410 (557)
                      |.+..++..++.||.| ..||+.+-.. .......+++..+-+|......||.||-...  .|||||+||+||||+..|.
T Consensus       130 Ga~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~  206 (361)
T KOG1006|consen  130 GALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGD  206 (361)
T ss_pred             hhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCC
Confidence            9999999999999999 5577654321 0122356888888899999999999998764  8999999999999999999


Q ss_pred             cEEeeccCCccCCccccccceeecCccccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHh
Q 008698          411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW  488 (557)
Q Consensus       411 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~  488 (557)
                      +||+|||++-.+..+....   .-.|...|||||.+...  .|..+|||||+|++|+|+.||+.||...++     +++.
T Consensus       207 vKLCDFGIcGqLv~SiAkT---~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeq  278 (361)
T KOG1006|consen  207 VKLCDFGICGQLVDSIAKT---VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQ  278 (361)
T ss_pred             EeeecccchHhHHHHHHhh---hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHH
Confidence            9999999997665432222   22388999999998643  488999999999999999999999986543     3333


Q ss_pred             hhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       489 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .......+       +.+..  ......+....+..++..|+..|.++||+..++.+
T Consensus       279 l~~Vv~gd-------pp~l~--~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  279 LCQVVIGD-------PPILL--FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHHHcCC-------CCeec--CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            33322221       11100  11111234567899999999999999999999875

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-34  Score=265.80  Aligned_cols=252  Identities=20%  Similarity=0.282  Sum_probs=199.0

Q ss_pred             HhhcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeC----C
Q 008698          265 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH----G  338 (557)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~----~  338 (557)
                      .++.+|....++||-|-.|.|-....+ +|..+|+|++...     ...++|++..-.. .|||||++++++.+.    .
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            466777777889999999999887753 5889999999654     3345777765555 699999999998643    5


Q ss_pred             ceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCcEEee
Q 008698          339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMG  415 (557)
Q Consensus       339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~D  415 (557)
                      .+++|||.|+||.|.+.++.  +....+++.+.-.|..||+.|+.|||+.   +|.||||||+|+|.+.   |...||+|
T Consensus       133 cLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             eeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence            57899999999999999876  4457799999999999999999999999   9999999999999964   55689999


Q ss_pred             ccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhc
Q 008698          416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS  495 (557)
Q Consensus       416 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  495 (557)
                      ||+|+....   .....+.+-|+.|.|||++....|....|+||+||++|-|+.|.+||.........            
T Consensus       208 fGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais------------  272 (400)
T KOG0604|consen  208 FGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------  272 (400)
T ss_pred             cccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC------------
Confidence            999986543   22333455789999999999999999999999999999999999999765432110            


Q ss_pred             cccccccCcccccCCCCCC---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          496 HRYLELLDPLISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       496 ~~~~~~~d~~l~~~~~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          .-+..++.....+.+   -...++...+++...++.+|++|.|+++++.
T Consensus       273 ----pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  273 ----PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             ----hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence                011111111112222   2346778889999999999999999999986

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-33  Score=288.65  Aligned_cols=265  Identities=19%  Similarity=0.314  Sum_probs=192.3

Q ss_pred             hhcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc---
Q 008698          266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD---  339 (557)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~---  339 (557)
                      +.++|.. ...||+|++|.||+|... +++.||||++...  .......+.+|+.++++++||||+++++++...+.   
T Consensus        13 ~~~~y~~-~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQN-LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEE-EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            3444433 456799999999999975 5789999998653  22334567889999999999999999998766554   


Q ss_pred             ---eEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeec
Q 008698          340 ---RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  416 (557)
Q Consensus       340 ---~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  416 (557)
                         .++|+||+ +++|.+++..     ..+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence               89999998 6799988863     4589999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccCCccccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhh---h
Q 008698          417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWAT---P  491 (557)
Q Consensus       417 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~---~  491 (557)
                      |++.......     ....++..|+|||.+.+ ..++.++||||||+++|||+||+.||...+.... ..+.+...   +
T Consensus       163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  237 (343)
T cd07851         163 GLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE  237 (343)
T ss_pred             cccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence            9997654321     11236788999998865 3678899999999999999999999975433211 00000000   0


Q ss_pred             h----hhccccccccCcccccCCCCC--CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          492 L----VQSHRYLELLDPLISSLSSDI--PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       492 ~----~~~~~~~~~~d~~l~~~~~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .    .........+...........  .....+..+.+++.+|++.+|++|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0    000000000000000000000  00112467889999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1e-32  Score=268.50  Aligned_cols=220  Identities=19%  Similarity=0.166  Sum_probs=175.1

Q ss_pred             cCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHHHhcc
Q 008698          280 SKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH  358 (557)
Q Consensus       280 G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  358 (557)
                      |.+|.||++... +++.||+|+++...     .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999864 58899999997653     233445555566799999999999999999999999999999998864


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeecCccc
Q 008698          359 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY  438 (557)
Q Consensus       359 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~  438 (557)
                      .    ..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++++|||.+.......     ....++.
T Consensus        79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~  146 (237)
T cd05576          79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVEN  146 (237)
T ss_pred             h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCc
Confidence            2    3589999999999999999999998   99999999999999999999999999876554321     1122567


Q ss_pred             cccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHH
Q 008698          439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGV  518 (557)
Q Consensus       439 ~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~  518 (557)
                      .|+|||.+.+..++.++||||+|+++|||++|..|+.......            .     ......        .+...
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~-----~~~~~~--------~~~~~  201 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N-----THTTLN--------IPEWV  201 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c-----cccccC--------CcccC
Confidence            8999999988888999999999999999999998865321100            0     000000        01123


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHH
Q 008698          519 VQKVVDLVYACTQHVPSMRPRMS  541 (557)
Q Consensus       519 ~~~l~~l~~~Cl~~~P~~RPt~~  541 (557)
                      ...+.+++.+|++.||++||++.
T Consensus       202 ~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         202 SEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             CHHHHHHHHHHccCCHHHhcCCC
Confidence            45688999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.8e-33  Score=302.16  Aligned_cols=254  Identities=24%  Similarity=0.330  Sum_probs=181.1

Q ss_pred             HhhcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-----
Q 008698          265 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----  337 (557)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----  337 (557)
                      +...+|.+. .+||+||||.||+++.+ ||+.||||++.... ......+.+|+..|++|+|||||+++..+.+.     
T Consensus       476 RY~~DFEEL-~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  476 RYLNDFEEL-ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hHhhhhHHH-HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            344455443 36799999999999943 89999999997553 33346788999999999999999987643210     


Q ss_pred             --------------------------------------------------------------------------------
Q 008698          338 --------------------------------------------------------------------------------  337 (557)
Q Consensus       338 --------------------------------------------------------------------------------  337 (557)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CceEEEEecCCCCChHHHhccCCCCCCCC-CHHHHHHHHHHHHHHH
Q 008698          338 ----------------------------------GDRYIVYEFVVNGPLDRWLHHIPRGGRSL-DWAMRMKVATTLAQGI  382 (557)
Q Consensus       338 ----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~~ia~gL  382 (557)
                                                        -.+||-||||+..+|.++++...    .. ......+++++|++||
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~----~~~~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH----FNSQRDEAWRLFREILEGL  710 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc----cchhhHHHHHHHHHHHHHH
Confidence                                              01267788887777777775421    11 3456778999999999


Q ss_pred             HHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC----c------------cccccceeecCccccccccccc
Q 008698          383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP----W------------EVMQERTVMAGGTYGYLAPEFV  446 (557)
Q Consensus       383 ~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~  446 (557)
                      .|+|++   +||||||||.|||+|++..+||+|||++....    .            ...........||.-|+|||.+
T Consensus       711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence            999999   99999999999999999999999999998721    0            0011122334599999999999


Q ss_pred             cCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHH
Q 008698          447 YRN---ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVV  523 (557)
Q Consensus       447 ~~~---~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~  523 (557)
                      .+.   .|+.|+|+||+|||++||+.   ||...-        +.+..+.      .+-++.+... .+. ..+....-.
T Consensus       788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--------ERa~iL~------~LR~g~iP~~-~~f-~~~~~~~e~  848 (1351)
T KOG1035|consen  788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--------ERASILT------NLRKGSIPEP-ADF-FDPEHPEEA  848 (1351)
T ss_pred             cccccccccchhhhHHHHHHHHHHhc---cCCchH--------HHHHHHH------hcccCCCCCC-ccc-ccccchHHH
Confidence            764   49999999999999999986   554321        1111111      1111112111 111 222334456


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHH
Q 008698          524 DLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       524 ~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .++.++++.||++|||+.|++.
T Consensus       849 slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  849 SLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHhcCCCccCCCHHHHhh
Confidence            7999999999999999999985

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.3e-33  Score=266.03  Aligned_cols=202  Identities=19%  Similarity=0.316  Sum_probs=163.9

Q ss_pred             CCCeeecccCceEEEEEEeCC-----CCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeee-CCceEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILPD-----GSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~-----g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lV  343 (557)
                      +....||+|.||.||+++..+     .+.+|||.++....  .-.....+|+.+++.++||||+.+..++.+ +...+++
T Consensus        27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~  106 (438)
T KOG0666|consen   27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL  106 (438)
T ss_pred             hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence            334457999999999997432     34799999976521  123456789999999999999999999887 7788999


Q ss_pred             EecCCCCChHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC----CCcEEeeccC
Q 008698          344 YEFVVNGPLDRWLHHIP-RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----FGAHLMGVGL  418 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgl  418 (557)
                      +||.++ +|-..++..+ ...+.++...+..|+.||+.|+.|||++   =|+||||||.|||+..+    +.+||+|+|+
T Consensus       107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999976 6766665432 3346899999999999999999999999   89999999999999887    8999999999


Q ss_pred             CccCCcccccc-ceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008698          419 SKFVPWEVMQE-RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAV  477 (557)
Q Consensus       419 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~  477 (557)
                      ++........- ......-|+.|.|||.+.+. .||++.||||.|||+.||+|-.+.|.+.
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            99876543211 12222368999999999884 6899999999999999999998888654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.6e-32  Score=262.34  Aligned_cols=238  Identities=25%  Similarity=0.374  Sum_probs=191.7

Q ss_pred             CceEEEEEEeCC-CCEEEEEEecccchhh-HHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHHHhcc
Q 008698          281 KTGGTYSGILPD-GSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH  358 (557)
Q Consensus       281 ~~g~Vy~g~~~~-g~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  358 (557)
                      +||.||+++..+ |+.+|+|++....... .+.+.+|+..+++++|+||+++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999864 8999999997664444 68899999999999999999999999999999999999999999999864


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeecCccc
Q 008698          359 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY  438 (557)
Q Consensus       359 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~  438 (557)
                      .    ..+++..+..++.+++.++.|||+.   +++|+||+|+||++++++.++|+|||.+.......   ......++.
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~  150 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP  150 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence            2    2288999999999999999999999   99999999999999999999999999998765432   112233788


Q ss_pred             cccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHH
Q 008698          439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGV  518 (557)
Q Consensus       439 ~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~  518 (557)
                      .|++||.+.+..++.++||||||+++++|++|..||......  ....+..    .....    .       ........
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~----~~~~~----~-------~~~~~~~~  213 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKI----GKPKP----P-------FPPPEWKI  213 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHH----hccCC----C-------CccccccC
Confidence            999999998888899999999999999999999998763221  1111110    00000    0       00000003


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          519 VQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       519 ~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +..+.+++.+|+..+|++||++.++++
T Consensus       214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      214 SPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CHHHHHHHHHHccCCchhccCHHHHhh
Confidence            457899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1e-31  Score=297.86  Aligned_cols=140  Identities=24%  Similarity=0.361  Sum_probs=125.1

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +++.||||+++...   ......+.+|+.++..++||||+++++++...+..++||||+.+
T Consensus         9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g   88 (669)
T cd05610           9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG   88 (669)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence            356799999999999975 58999999997542   23346788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      ++|.+++..    ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          89 GDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999864    23588899999999999999999998   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=9.6e-33  Score=275.52  Aligned_cols=243  Identities=22%  Similarity=0.339  Sum_probs=195.9

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      ++||+|.||+||.|+. ++|+.||||++.+..  .+...++++|+.+|.+++||.||.+...|+..+..++|||-+ +|+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence            4689999999999995 569999999997653  344578999999999999999999999999999999999999 666


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCcEEeeccCCccCCccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      ..+.+..  .....|++..-..++.||+.||.|||.+   +|+|+||||+|||+...   -++||+|||+|++.+.....
T Consensus       649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            6666644  2335689888889999999999999999   99999999999999654   35899999999998765443


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      .   ...||+.|+|||++....|...-|+||.|||+|--++|-.||....+  ..+.++-+          +.+-     
T Consensus       724 r---sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNA----------aFMy-----  783 (888)
T KOG4236|consen  724 R---SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNA----------AFMY-----  783 (888)
T ss_pred             h---hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhcc----------cccc-----
Confidence            3   34499999999999999999999999999999999999999975432  11111111          1111     


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        +..+-.+......+||...++..=++|-|.++-+.
T Consensus       784 --Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  784 --PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             --CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence              12233456667889999999999999998877654

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=9.7e-33  Score=261.23  Aligned_cols=234  Identities=23%  Similarity=0.293  Sum_probs=191.4

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccchhh---HHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      ++||+|.||.|...+- ..|+.+|+|++++...-.   ...-+.|-+.|...+||.+..+-..+...+.++.||||..+|
T Consensus       174 KvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGG  253 (516)
T KOG0690|consen  174 KVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGG  253 (516)
T ss_pred             HHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCc
Confidence            5789999999998874 368999999998764333   344577889999999999999988889999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      .|.-+|..    .+.+++...+.+..+|..||.|||++   +||.||||.+|.|+|.++++||+|||+.+..-  .....
T Consensus       254 eLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~t  324 (516)
T KOG0690|consen  254 ELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYGDT  324 (516)
T ss_pred             eEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc--cccce
Confidence            99877753    46788888889999999999999999   99999999999999999999999999997432  23345


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      +...+||+.|+|||++....|..+.|-|.+||++|||++|+.||...+..   .+++...-  .     ++         
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeLIl~--e-----d~---------  385 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFELILM--E-----DL---------  385 (516)
T ss_pred             eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHHHHh--h-----hc---------
Confidence            56678999999999999999999999999999999999999999876543   22222110  0     10         


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCC
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRP  538 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP  538 (557)
                        .++....++...|+...+..||.+|.
T Consensus       386 --kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  386 --KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             --cCCccCCHHHHHHHHHHhhcChHhhc
Confidence              11222334567788889999999996

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-32  Score=265.89  Aligned_cols=249  Identities=24%  Similarity=0.366  Sum_probs=191.5

Q ss_pred             eeecccCceEEEEEE-eCCCCEEEEEEecccc---hhh----HHHHHHHHHHHhhcCCCcEEeeeeeee-eCCceEEEEe
Q 008698          275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSS---FQR----KKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYE  345 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~-~~~g~~vavK~~~~~~---~~~----~~~~~~e~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E  345 (557)
                      .+||+|+|+.||++. +...+.||||+-.-..   ...    .+...+|..+.+.|.||.||++++++. +.+.++-|+|
T Consensus       469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE  548 (775)
T KOG1151|consen  469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE  548 (775)
T ss_pred             HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence            468999999999998 4567899999864321   111    234578999999999999999999986 4567899999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCcEEeeccCCccC
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGLSKFV  422 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~  422 (557)
                      |+++.+|+-||..    .+.+++++...|+.||+.||.||.+. +++|||-||||.||||-+   .+.+||+||||++++
T Consensus       549 YceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM  623 (775)
T KOG1151|consen  549 YCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM  623 (775)
T ss_pred             ecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence            9999999999964    46799999999999999999999987 789999999999999954   567899999999998


Q ss_pred             Cccccc-----cceeecCccccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhh
Q 008698          423 PWEVMQ-----ERTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV  493 (557)
Q Consensus       423 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~  493 (557)
                      ..+...     +.+....||+.|++||++.-+    ..+.|+||||.|||+|..+.|+.||...-.  .+++.+      
T Consensus       624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILq------  695 (775)
T KOG1151|consen  624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQ------  695 (775)
T ss_pred             cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHh------
Confidence            755433     223444599999999988643    468999999999999999999999986432  122221      


Q ss_pred             hccccccccCcccccCCCCCC-cHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 008698          494 QSHRYLELLDPLISSLSSDIP-EAGVVQKVVDLVYACTQHVPSMRPRMSHVV  544 (557)
Q Consensus       494 ~~~~~~~~~d~~l~~~~~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl  544 (557)
                       ...+...-.       ...+ ..-...+...+|.+|++..-++|....++.
T Consensus       696 -eNTIlkAtE-------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  696 -ENTILKATE-------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -hhchhccee-------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence             111111111       1111 122445678899999999999998877664

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.3e-32  Score=276.87  Aligned_cols=230  Identities=25%  Similarity=0.305  Sum_probs=183.7

Q ss_pred             ecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       277 lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      +|.|+|+.|-+... .+++..+||++.+..    .+-.+|+.++... +||||+++.+++.+..+.++|||.+.++-|.+
T Consensus       330 ~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~  405 (612)
T KOG0603|consen  330 LGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLR  405 (612)
T ss_pred             cCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHH
Confidence            69999999988874 568899999997652    2234566565555 79999999999999999999999999987766


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-CCCCCcEEeeccCCccCCccccccceee
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      .+..    .+.+. .++..|+.+|+.++.|||++   |+|||||||+|||+ ++.++++|+|||.++.....     ...
T Consensus       406 ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~t  472 (612)
T KOG0603|consen  406 RIRS----KPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDT  472 (612)
T ss_pred             HHHh----cchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcc
Confidence            6643    12233 77778999999999999999   99999999999999 58899999999999877654     122


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      .+-|..|.|||++....++.++|+||||++||||++|+.||......  .++...    +.                ...
T Consensus       473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~----i~----------------~~~  530 (612)
T KOG0603|consen  473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTR----IQ----------------MPK  530 (612)
T ss_pred             cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHh----hc----------------CCc
Confidence            33678999999999999999999999999999999999999865432  111110    00                111


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .....+....+|+.+||+.||.+||+|.++..
T Consensus       531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  531 FSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            11345667889999999999999999999975

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.5e-33  Score=255.23  Aligned_cols=264  Identities=19%  Similarity=0.260  Sum_probs=189.3

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--------CceEEEE
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--------GDRYIVY  344 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--------~~~~lV~  344 (557)
                      .||+|.||+||++... .|+.||+|++-...  ..-....++|+++|..++|+|++.++..|...        ..+|+||
T Consensus        24 kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf  103 (376)
T KOG0669|consen   24 KIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVF  103 (376)
T ss_pred             hcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeH
Confidence            5799999999999854 58889998764321  11124567899999999999999999988532        3479999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      .+++. +|...|.+.   ...++..++.+++.++.+||.|+|++   .|+|||+||.|+||+.++.+||+|||+++.+..
T Consensus       104 ~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~  176 (376)
T KOG0669|consen  104 DFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFST  176 (376)
T ss_pred             HHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence            99966 788888642   35689999999999999999999999   999999999999999999999999999986643


Q ss_pred             ccccc--ceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHH--------hhhhhh
Q 008698          425 EVMQE--RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE--------WATPLV  493 (557)
Q Consensus       425 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~--------~~~~~~  493 (557)
                      .....  ......-|..|.+||.+.+. .++++.|||.-|||+.||+||.+-+++........++.        .+++-.
T Consensus       177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~  256 (376)
T KOG0669|consen  177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV  256 (376)
T ss_pred             ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence            32211  11112248899999999874 68999999999999999999999888754321111111        122222


Q ss_pred             hcccccccc--CcccccCC----CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          494 QSHRYLELL--DPLISSLS----SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       494 ~~~~~~~~~--d~~l~~~~----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      .+-.+.+.+  .|..+...    ....+-.-.+..++|+...+..||.+||++++++..
T Consensus       257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            222222222  11110000    000000012357789999999999999999999864

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=5e-31  Score=230.32  Aligned_cols=261  Identities=20%  Similarity=0.255  Sum_probs=188.6

Q ss_pred             eecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .||+|.||+||+++. +.+..||+|.++.++  .......++|+-+|+.++|.|||+++++.-.++..-+|+||+ .-+|
T Consensus         9 kigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdl   87 (292)
T KOG0662|consen    9 KIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDL   87 (292)
T ss_pred             hhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHH
Confidence            469999999999995 458899999987542  223456789999999999999999999999999999999999 4578


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      ..|...   -+..++......++.|+++||.|.|++   .++||||||.|.||+.|+..|++|||+++..+........ 
T Consensus        88 kkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcysa-  160 (292)
T KOG0662|consen   88 KKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA-  160 (292)
T ss_pred             HHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec-
Confidence            887754   235689999999999999999999999   9999999999999999999999999999987654322222 


Q ss_pred             ecCccccccccccccCCC-CCchhhHHHHHHHHHHHHc-CCCCCCCCCcccc-hhHHHhhhhhhhcccc--ccccCcccc
Q 008698          433 MAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCW-QSIFEWATPLVQSHRY--LELLDPLIS  507 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~d~~l~  507 (557)
                       ..-|..|.+|+++.+.. |++..|+||-|||+.|+.. |++.|.+.+..+. ..++..........+.  ..+-|-..-
T Consensus       161 -evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  161 -EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             -eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence             12588999999998864 7889999999999999998 6655655443321 1111111110011110  011111100


Q ss_pred             cCCCCCC-----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIP-----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +......     .......=.++.+..+.-+|..|.++++.++
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            0000000     0011123346777778889999999998875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=4e-32  Score=285.37  Aligned_cols=248  Identities=25%  Similarity=0.332  Sum_probs=186.2

Q ss_pred             CCCCCeeecccCceE-EEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecC
Q 008698          270 FSEGNRLLGDSKTGG-TYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       270 ~~~~~~~lg~G~~g~-Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +....+++|.|+.|+ ||+|.+ +|+.||||++-..   ...-..+|+..|..- .|||||++++.-.+....|+..|.|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            344456789998764 799999 8999999998543   223457899999888 7999999999888889999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---C--CCcEEeeccCCccC
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---E--FGAHLMGVGLSKFV  422 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~---~--~~~kl~Dfgl~~~~  422 (557)
                       .-+|.+++...........-...+.+..|+++||++||+-   +||||||||.||||+.   +  ..++|+|||+++.+
T Consensus       586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence             5599999976311111111134467889999999999998   9999999999999976   2  46899999999988


Q ss_pred             Cccccccc-eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          423 PWEVMQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       423 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      ........ .....||.+|+|||.+....-+.++||||+|||+|..+|| .+||++.-.-       .+.-+..+..+ .
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-------~~NIl~~~~~L-~  733 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-------QANILTGNYTL-V  733 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-------hhhhhcCccce-e
Confidence            76544322 3445599999999999988888899999999999999995 8999864211       01111111100 0


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+          .+..++  ...+||.++++.+|..||++.+|+.
T Consensus       734 ~L----------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  734 HL----------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ee----------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            01          111122  6789999999999999999999985

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.2e-30  Score=275.96  Aligned_cols=259  Identities=18%  Similarity=0.246  Sum_probs=176.5

Q ss_pred             cCCCCCCeeecccCceEEEEEEe-----------------CCCCEEEEEEecccchhhHHHH--------------HHHH
Q 008698          268 KNFSEGNRLLGDSKTGGTYSGIL-----------------PDGSRVAVKRLKRSSFQRKKEF--------------YSEI  316 (557)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~g~~-----------------~~g~~vavK~~~~~~~~~~~~~--------------~~e~  316 (557)
                      ++|.. .+.||+|+||.||+|..                 .+++.||||++........++|              ..|+
T Consensus       145 d~F~i-~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        145 DDFQL-RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             cCceE-eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            34444 45679999999999964                 2356899999875433323333              3467


Q ss_pred             HHHhhcCCCcE-----Eeeeeeeee--------CCceEEEEecCCCCChHHHhccCCC--------------------CC
Q 008698          317 GRFARLHHPNL-----VAVKGCCYD--------HGDRYIVYEFVVNGPLDRWLHHIPR--------------------GG  363 (557)
Q Consensus       317 ~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~  363 (557)
                      ..+.+++|.++     ++++++|..        .+..+|||||+++|+|.++|+....                    ..
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77778876655     667777753        3568999999999999999864211                    01


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeecCcccccccc
Q 008698          364 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP  443 (557)
Q Consensus       364 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aP  443 (557)
                      ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++......... ......+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence            2356788899999999999999999   9999999999999999999999999999765432211 11122257899999


Q ss_pred             ccccCCCC----------------------CchhhHHHHHHHHHHHHcCCC-CCCCCCccc--ch----hHHHhhhhhhh
Q 008698          444 EFVYRNEL----------------------TTKSDVYSFGVLLLEIVSGRR-PAQAVDSVC--WQ----SIFEWATPLVQ  494 (557)
Q Consensus       444 E~~~~~~~----------------------s~~sDVwS~Gvil~el~tG~~-p~~~~~~~~--~~----~~~~~~~~~~~  494 (557)
                      |.+.....                      ..+.||||+||+++||++|.. |+.......  ..    .+..|.  ...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~  457 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYK  457 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhc
Confidence            98764321                      134699999999999999875 665321110  00    000010  000


Q ss_pred             ccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHH
Q 008698          495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVP---SMRPRMSHVVH  545 (557)
Q Consensus       495 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P---~~RPt~~evl~  545 (557)
                      ...    .+  .      ...........+++.+++..+|   .+|+|++|+++
T Consensus       458 ~~~----~~--~------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        458 GQK----YD--F------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ccC----CC--c------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            000    00  0      0011234568899999999766   68999999985

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.1e-32  Score=261.68  Aligned_cols=235  Identities=24%  Similarity=0.331  Sum_probs=188.2

Q ss_pred             eeecccCceEEEEEEeCC-CCEEEEEEecccch---hhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+||+|+||.|-.+..+. ...+|||+++++..   .+.+--+.|-++|+.. +-|.++++..++..-+.+|.||||+.+
T Consensus       355 ~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnG  434 (683)
T KOG0696|consen  355 MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNG  434 (683)
T ss_pred             EEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecC
Confidence            468999999999998643 56799999987632   1222234566666666 578899999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|--.+++.    ..+.+..+..+|.+||-||-|||++   +||.||||.+||+||.++++||+|||+++..-..  ..
T Consensus       435 GDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~--~~  505 (683)
T KOG0696|consen  435 GDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD--GV  505 (683)
T ss_pred             chhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccC--Cc
Confidence            9998877642    3478888999999999999999999   9999999999999999999999999999753222  23


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      .+.+.+||+.|+|||.+...+|+..+|-|||||+||||+.|++||++.+..+.   ++.            +.+.     
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---F~a------------I~eh-----  565 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQA------------IMEH-----  565 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH------------HHHc-----
Confidence            44567799999999999999999999999999999999999999998776432   211            1111     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCC
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPR  539 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt  539 (557)
                       .-.++...+.+...+...-+...|.+|..
T Consensus       566 -nvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  566 -NVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             -cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence             12234555667778888888999999863

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.4e-32  Score=260.64  Aligned_cols=261  Identities=20%  Similarity=0.238  Sum_probs=194.7

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-C-Cc----EEeeeeeeeeCCceEEEEe
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-H-PN----LVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H-~n----iv~l~g~~~~~~~~~lV~E  345 (557)
                      ...++|+|.||.|-..... .+..||||+++.-. .-.++-+-|++.|.++. + |+    +|.+.+++.-.++.++|+|
T Consensus        93 i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfe  171 (415)
T KOG0671|consen   93 IVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFE  171 (415)
T ss_pred             hhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEe
Confidence            3446799999999887743 37899999997653 23455667899999993 3 23    7888999999999999999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC------------------
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------------------  407 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~------------------  407 (557)
                      .+ |-|+.+||..  .+-.+++...++.|+.|++++++|||+.   +++|.||||+|||+.+                  
T Consensus       172 ll-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~  245 (415)
T KOG0671|consen  172 LL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP  245 (415)
T ss_pred             cc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceecc
Confidence            88 6699999975  3446799999999999999999999999   9999999999999842                  


Q ss_pred             --CCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhH
Q 008698          408 --EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI  485 (557)
Q Consensus       408 --~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~  485 (557)
                        +..+||+|||-|.......     .....|.-|.|||++.+-..+.++||||+||||.|+.||...|+..+..+...+
T Consensus       246 ~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM  320 (415)
T KOG0671|consen  246 LKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM  320 (415)
T ss_pred             CCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence              3458999999998654322     223378899999999999999999999999999999999999988775543333


Q ss_pred             HHhhhhhhhcccccc----------ccC-------cccccCC--------CCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 008698          486 FEWATPLVQSHRYLE----------LLD-------PLISSLS--------SDIPEAGVVQKVVDLVYACTQHVPSMRPRM  540 (557)
Q Consensus       486 ~~~~~~~~~~~~~~~----------~~d-------~~l~~~~--------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~  540 (557)
                      .+.+........+..          -+|       .......        .-.....+..++.+|+.+++..||.+|+|+
T Consensus       321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl  400 (415)
T KOG0671|consen  321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL  400 (415)
T ss_pred             HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence            222211110000000          000       0000000        001123456789999999999999999999


Q ss_pred             HHHHH
Q 008698          541 SHVVH  545 (557)
Q Consensus       541 ~evl~  545 (557)
                      .|+++
T Consensus       401 ~EAL~  405 (415)
T KOG0671|consen  401 REALS  405 (415)
T ss_pred             HHHhc
Confidence            99986

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.6e-31  Score=276.64  Aligned_cols=248  Identities=23%  Similarity=0.360  Sum_probs=200.2

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeee-----CCceEEEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD-----HGDRYIVY  344 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~-----~~~~~lV~  344 (557)
                      +....||.|.+|.||+++. ++|+.+|||+..... ...+++..|..+|+.. +|||++.++|++..     ++.++|||
T Consensus        22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM  100 (953)
T KOG0587|consen   22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM  100 (953)
T ss_pred             EEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence            3345789999999999984 568899999986553 3456777888898888 79999999999863     46789999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      |||.+||..+++.+..  +..+.|..+..|+.+++.||.+||.+   .++|||||-.|||++.++.+|+.|||++..+..
T Consensus       101 EfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen  101 EFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             eccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            9999999999998755  67799999999999999999999999   999999999999999999999999999987654


Q ss_pred             cccccceeecCccccccccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYRN-----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ...  ...+..||+.|||||++.-.     .|+..+|+||+|++..||--|.+|+.+..+.-  .+              
T Consensus       176 T~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--aL--------------  237 (953)
T KOG0587|consen  176 TVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--AL--------------  237 (953)
T ss_pred             ccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--hh--------------
Confidence            332  23344599999999999642     46778999999999999999999998765521  01              


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        +.....+......+..-.+++.++|..|+..|-..||++.++++
T Consensus       238 --F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 --FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             --ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence              10000000011123456788999999999999999999999885

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-31  Score=236.69  Aligned_cols=198  Identities=26%  Similarity=0.455  Sum_probs=167.8

Q ss_pred             eecccCceEEEEEEe-CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      -||+|++|.|-+-.+ .+|+..|+|.++.. ..+..++.++|+.+..+. ..|.+|.++|........++.||.| ..||
T Consensus        53 elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSl  131 (282)
T KOG0984|consen   53 ELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSL  131 (282)
T ss_pred             hhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhH
Confidence            369999999877664 57999999999765 445667889999886665 7999999999999999999999999 5688


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      +.|-.+.-..+..+++..+-+|+..|..||.|||++.  .+||||+||+|||++.++++|++|||++-.+.++....   
T Consensus       132 dkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt---  206 (282)
T KOG0984|consen  132 DKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT---  206 (282)
T ss_pred             HHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH---
Confidence            8877665556788999999999999999999999884  89999999999999999999999999998776543322   


Q ss_pred             ecCccccccccccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q 008698          433 MAGGTYGYLAPEFVYR----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDS  479 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~----~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~  479 (557)
                      ...|...|||||.+..    ..|+.||||||+|+.+.||.+++.||....+
T Consensus       207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            1238889999998864    3688999999999999999999999986543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.1e-30  Score=283.00  Aligned_cols=261  Identities=14%  Similarity=0.122  Sum_probs=160.5

Q ss_pred             CCeeecccCceEEEEEEeCC-----CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeee------eeeCCceE
Q 008698          273 GNRLLGDSKTGGTYSGILPD-----GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRY  341 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~~-----g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~------~~~~~~~~  341 (557)
                      ..+.||+|+||.||+|...+     +..||||++.....  .+.+..+  .+.+..+.+++.++..      +...+..+
T Consensus       136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (566)
T PLN03225        136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW  211 (566)
T ss_pred             EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence            34567999999999999744     68999999864321  1111111  1122222222222111      24566789


Q ss_pred             EEEecCCCCChHHHhccCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 008698          342 IVYEFVVNGPLDRWLHHIPRG----------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL  405 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill  405 (557)
                      +||||+++++|.+++......                ........+..++.||+.||.|||++   +|+||||||+|||+
T Consensus       212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NILl  288 (566)
T PLN03225        212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIF  288 (566)
T ss_pred             EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEEE
Confidence            999999999999988642100                01112344667999999999999999   99999999999999


Q ss_pred             CC-CCCcEEeeccCCccCCccccccceeecCccccccccccccCC----------------------CCCchhhHHHHHH
Q 008698          406 DE-EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN----------------------ELTTKSDVYSFGV  462 (557)
Q Consensus       406 ~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sDVwS~Gv  462 (557)
                      +. ++.+||+|||+++......... .....+++.|+|||.+...                      .++.++|||||||
T Consensus       289 ~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        289 SEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             eCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            86 5789999999998654332211 1223478999999965422                      2344679999999


Q ss_pred             HHHHHHcCCCCCCCCCcccchhHHHhhhhh-hhccccccccCcccccCCCCCC--cHHHHHHHHHHHHHhcCCCCCCCCC
Q 008698          463 LLLEIVSGRRPAQAVDSVCWQSIFEWATPL-VQSHRYLELLDPLISSLSSDIP--EAGVVQKVVDLVYACTQHVPSMRPR  539 (557)
Q Consensus       463 il~el~tG~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~--~~~~~~~l~~l~~~Cl~~~P~~RPt  539 (557)
                      +||||+++..|+...    ...+....... .........+.+..........  .........+|+.+|++.||++|||
T Consensus       368 iL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t  443 (566)
T PLN03225        368 IFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS  443 (566)
T ss_pred             HHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence            999999976654321    11110000000 0000000011110000000000  0001223568999999999999999


Q ss_pred             HHHHHH
Q 008698          540 MSHVVH  545 (557)
Q Consensus       540 ~~evl~  545 (557)
                      +.++++
T Consensus       444 a~e~L~  449 (566)
T PLN03225        444 AKAALA  449 (566)
T ss_pred             HHHHhC
Confidence            999997

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=287.42  Aligned_cols=246  Identities=22%  Similarity=0.248  Sum_probs=196.0

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      -++||+|+||.|..++.. .++.||.|++++...   ....-|..|-.+|..-..+-|+.+...|.+.+.+|+|||||+|
T Consensus        80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pG  159 (1317)
T KOG0612|consen   80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPG  159 (1317)
T ss_pred             HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccC
Confidence            347899999999999964 588999999987422   2345688888999998999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|-.+|.+.    ..+++...+.++.+|.-||+-||+.   |+|||||||+|||||..|++||+|||-+..+..+..- 
T Consensus       160 GDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V-  231 (1317)
T KOG0612|consen  160 GDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV-  231 (1317)
T ss_pred             chHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCcE-
Confidence            9999998652    2599999999999999999999999   9999999999999999999999999998777654433 


Q ss_pred             ceeecCccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          430 RTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      ....+.|||.|++||++..     +.|...+|-||+||++|||+.|..||...+      +++-...++...   +    
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~hk---~----  298 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMNHK---E----  298 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhchh---h----
Confidence            3334559999999999863     578999999999999999999999997532      222222222111   0    


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---MSHVVH  545 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt---~~evl~  545 (557)
                      .+ ++   +...+.++...+||.+.+. +|+.|..   .+++-.
T Consensus       299 ~l-~F---P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  299 SL-SF---PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hc-CC---CcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            11 01   1123366778899998775 8888888   777765

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=265.02  Aligned_cols=234  Identities=21%  Similarity=0.277  Sum_probs=194.4

Q ss_pred             ecccCceEEEEEEeCCCC-EEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          277 LGDSKTGGTYSGILPDGS-RVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~~g~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ||-|+||.|=....+... .+|+|.+++.   +....+.+..|-.+|...+.|.||++|-.+.+....|++||-|-+|.|
T Consensus       428 LGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGEl  507 (732)
T KOG0614|consen  428 LGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGEL  507 (732)
T ss_pred             cccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchh
Confidence            699999999998875433 3889988765   334456788899999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      -..|+.    ...++..+...++.-+.+|+.|||++   +||.|||||+|.+||.++-+||.|||+|+....   ...+.
T Consensus       508 WTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---g~KTw  577 (732)
T KOG0614|consen  508 WTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---GRKTW  577 (732)
T ss_pred             hhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc---CCcee
Confidence            999865    35688888999999999999999999   999999999999999999999999999987653   34566


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      +.+||+.|.|||.+.......++|.||+|++++||+||.+||++.++..--+++-      +      -+|       .-
T Consensus       578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL------k------Gid-------~i  638 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL------K------GID-------KI  638 (732)
T ss_pred             eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH------h------hhh-------hh
Confidence            7889999999999999889999999999999999999999999887642212111      0      111       11


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCC
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPR  539 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt  539 (557)
                      ..|........+|+++.+..+|.+|..
T Consensus       639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  639 EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hcccccchhHHHHHHHHHhcCcHhhhc
Confidence            122334456778999999999999986

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=2.6e-28  Score=230.67  Aligned_cols=210  Identities=29%  Similarity=0.494  Sum_probs=182.0

Q ss_pred             ecccCceEEEEEEeCC-CCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      ||+|.+|.||++...+ ++.+++|++...... ....+.+|+..+..++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            5899999999999854 899999999766432 35789999999999999999999999999899999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCcEEeeccCCccCCccccccceee
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      ++....   ..+++..+..++.+++++|+|||+.   +++|+||+|.||+++. ++.++|+|||.+........  ....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT  152 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence            986421   3589999999999999999999999   9999999999999999 89999999999976644321  1112


Q ss_pred             cCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ..+...|++||.+... ..+.++|+|++|+++++|                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            2367899999998877 788999999999999998                                             


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                             ..+.+++..|++.+|++||++.++++.
T Consensus       188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                   247789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.5e-29  Score=254.10  Aligned_cols=200  Identities=22%  Similarity=0.285  Sum_probs=167.6

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccchh---hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +-||-|+||+|.++.. ++...+|.|.+++.+.-   .......|-.||+....+-||+|+..|.+.+.+|+||+|++||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            4579999999999874 44668999999876432   2345678999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc---cc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE---VM  427 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~  427 (557)
                      ++-.+|-.    -..|++...+.++.++..|+.+.|..   |+|||||||+|||||.+|++||+||||+.-+...   .+
T Consensus       715 DmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  715 DMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             cHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            99988864    24688888999999999999999999   9999999999999999999999999997543211   00


Q ss_pred             c------cc-------------------------------eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcC
Q 008698          428 Q------ER-------------------------------TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG  470 (557)
Q Consensus       428 ~------~~-------------------------------~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG  470 (557)
                      .      ..                               .-...||..|+|||++....++..+|-||.|||||||+.|
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG  867 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence            0      00                               0011289999999999999999999999999999999999


Q ss_pred             CCCCCCCCccc
Q 008698          471 RRPAQAVDSVC  481 (557)
Q Consensus       471 ~~p~~~~~~~~  481 (557)
                      +.||-...+.+
T Consensus       868 ~~pf~~~tp~~  878 (1034)
T KOG0608|consen  868 QPPFLADTPGE  878 (1034)
T ss_pred             CCCccCCCCCc
Confidence            99998776643

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-30  Score=237.59  Aligned_cols=264  Identities=19%  Similarity=0.246  Sum_probs=190.0

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-----CceEEEEec
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVYEF  346 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~  346 (557)
                      +-||-|+||.||....+ +|+.||+|++...  +....+.+.+|+++|.-++|.|++..++...-.     .+.|++.|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            45799999999998864 6999999998643  344567899999999999999999998876533     345788888


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      | ..+|...+-    ..+.++...+.-+..||++||+|||+.   +|+||||||.|.|++.|...||+|||+++......
T Consensus       139 m-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  139 M-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             H-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh
Confidence            8 446766664    346788888889999999999999999   99999999999999999999999999999765443


Q ss_pred             cccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhh--------hhhhccc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT--------PLVQSHR  497 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  497 (557)
                      ....+ ...-|..|.|||.+++ ..|+.+.||||.|||+.||+..+..|+...+....+++....        ...-++.
T Consensus       211 ~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  211 RLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            32221 1225788999999987 468999999999999999999999988776643322222110        0000111


Q ss_pred             cccccCcccccC-----CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008698          498 YLELLDPLISSL-----SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  547 (557)
Q Consensus       498 ~~~~~d~~l~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L  547 (557)
                      ...++....+..     .....+..--.+...+....+..||++|.+.++.+..+
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            111111111100     00000111122345677788999999999999887654

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=233.38  Aligned_cols=242  Identities=23%  Similarity=0.287  Sum_probs=187.4

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ++||+|+|..|..+.+. +.+.+|+|++++.-   .....-.+.|-...... +||.+|.+..++.....++.|.||+++
T Consensus       256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~g  335 (593)
T KOG0695|consen  256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNG  335 (593)
T ss_pred             eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecC
Confidence            56899999999998864 57889999998752   23344556676666665 799999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|--+++.    .+.++++....+..+|..||.|||+.   |||.||||.+|||+|..+.+|++|+|..+..-.  ...
T Consensus       336 gdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~--~gd  406 (593)
T KOG0695|consen  336 GDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG--PGD  406 (593)
T ss_pred             cceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC--CCc
Confidence            999766643    45699999999999999999999999   999999999999999999999999999875432  234


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccc-chhHHHhhhhhhhccccccccCccccc
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC-WQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      .+.+.+||+.|+|||.+.+..|....|-|++||+++||+.|+.||+-..... .++--++..        .-++++.+.-
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf--------qvilekqiri  478 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF--------QVILEKQIRI  478 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH--------HHHhhhcccc
Confidence            4556779999999999999999999999999999999999999997432110 111111111        1122222211


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPR  539 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt  539 (557)
                            +...+.....+++.-++.||.+|..
T Consensus       479 ------prslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  479 ------PRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ------cceeehhhHHHHHHhhcCCcHHhcC
Confidence                  1223344567788889999999853

>cd03599 CLECT_DGCR2_like C-type lectin-like domain (CTLD) of the type found in DGCR2, an integral membrane protein deleted in DiGeorge Syndrome (DGS)

Probab=99.95  E-value=9e-28  Score=213.13  Aligned_cols=125  Identities=19%  Similarity=0.349  Sum_probs=102.3

Q ss_pred             CCccCcccCCCC--eeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC---------CCCeEEeee---
Q 008698           53 CPPDWIINEEKS--KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---------VNGCWVGGR---  118 (557)
Q Consensus        53 Cp~~w~~~~~~~--~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~---------~~~~WiGl~---  118 (557)
                      ||+||.  .|++  +||+++.+.+||.||+.+|+++|||||+|+|.+|++||.+++...         ...+||||+   
T Consensus         1 CP~gw~--~~~~~~~CYk~~~~~~tw~dA~~~C~~~Gg~Lasi~s~~e~~fl~~l~~~~~~~~~~~~~~~~~WIGL~~~~   78 (153)
T cd03599           1 CPSGWH--HYEGTASCYKVYLSGENYWDAVQTCQKVNGSLATFTTDQELQFILAQEWDFDERVFGRKDQCKFWVGYQYVI   78 (153)
T ss_pred             CCCchh--ccCCCCeEEEEeCCcCCHHHHHHHHHHcCCEEcCCCCHHHHHHHHHHHHhhcccccccccCCCEEEeecccc
Confidence            999999  8888  899999999999999999999999999999999999999999421         246999995   


Q ss_pred             -ecCCCCCCeeEEc-cCCCCCCcCcc---ccCCCCCCCCCCCCccccccCceeEee---------cCCCceeccccCCCC
Q 008698          119 -SINTTVGLSWKWS-DNMSKWNESIH---AVGSFNSSCTSLPCHVHATVDLCTLVS---------NGSRSLVTERCNTSH  184 (557)
Q Consensus       119 -~~~~~~~~~w~W~-Dg~~~~~~~~~---~~~~~~~~~~~~~c~~~~~~~~C~~~~---------~~~~~w~~~~C~~~~  184 (557)
                       +.+...+|.|+|+ ||+++.|.+|.   ..++|+          + ++|+|+.+.         .....|+|..|....
T Consensus        79 ~~~~~~~eg~w~WsddGs~~~y~~w~~~w~~gePn----------~-~~e~C~~~~~~~~~~~~~~~~~~W~d~~C~~~~  147 (153)
T cd03599          79 TNRNHSLEGRWEVAYKGSMEVFLPPEPIFATGMST----------N-DNVFCAQLQCFQIPSLRERGLHSWHAENCYEKS  147 (153)
T ss_pred             cccCcccCCeEEEecCCccceecCccccCCCCCCC----------C-CCCCCeEEEeeccccccccccCeeeCccCCCCC
Confidence             3355678999999 59998866543   333322          2 557888875         234579999999999


Q ss_pred             Cccccc
Q 008698          185 PFICMV  190 (557)
Q Consensus       185 ~~iC~~  190 (557)
                      +|||++
T Consensus       148 ~fiCq~  153 (153)
T cd03599         148 SFLCKR  153 (153)
T ss_pred             cceeCC
Confidence            999984

CLECT_DGCR2_like: C-type lectin-like domain (CTLD) of the type found in DGCR2, an integral membrane protein deleted in DiGeorge Syndrome (DGS). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. DGS is also known velo-cardio-facial syndrome (VCFS). DGS is a genetic abnormality that results in malformations of the heart, face, and limbs and is associated with schizophrenia and depressive disorders. DGCR2 is a candidate for involvement in the pathogenesis of DGS since the DGCR2 gene lies within the minimal DGS critical region (MDGRC) of 22q11, which when deleted gives rise to DGS, and the DGCR2 gene is in close proximity to the balanced translocation breakpoint in a DGS patient having a balanced translocation.

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=6.7e-27  Score=224.47  Aligned_cols=195  Identities=29%  Similarity=0.450  Sum_probs=168.1

Q ss_pred             eeecccCceEEEEEEeCC-CCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ..||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|+..+.+++|+|++++++++...+..++++||+++++|
T Consensus         5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   84 (225)
T smart00221        5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDL   84 (225)
T ss_pred             eEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCH
Confidence            467999999999999865 899999999876544 567899999999999999999999999998999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++....   ..+++..+..++.+++.++.|||+.   +++|+||+|+||+++.++.++|+|||.+......... ...
T Consensus        85 ~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~  157 (225)
T smart00221       85 FDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLK  157 (225)
T ss_pred             HHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-ccc
Confidence            99986422   1188999999999999999999999   9999999999999999999999999999876543211 111


Q ss_pred             ecCccccccccccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008698          433 MAGGTYGYLAPEFV-YRNELTTKSDVYSFGVLLLEIVSGRRPAQA  476 (557)
Q Consensus       433 ~~~gt~~y~aPE~~-~~~~~s~~sDVwS~Gvil~el~tG~~p~~~  476 (557)
                      ...++..|++||.+ ....++.++||||||++++||++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22367889999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=1.7e-27  Score=215.91  Aligned_cols=253  Identities=19%  Similarity=0.278  Sum_probs=190.2

Q ss_pred             eecccCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeC--CceEEEEecCCCCC
Q 008698          276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDH--GDRYIVYEFVVNGP  351 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E~~~~gs  351 (557)
                      .+|+|.+++||.|. ..++..++||+++..   ..+.+.+|+++|..|+ ||||++++++..+.  ..+.|++||+.+.+
T Consensus        45 k~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~D  121 (338)
T KOG0668|consen   45 KVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTD  121 (338)
T ss_pred             HHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcccc
Confidence            35999999999998 457889999999754   4567899999999996 99999999998765  56789999999988


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCcEEeeccCCccCCccccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +..+.       ..|+...+...+.+++.||.|.|+.   ||.|||+||.|+++|.. -..+|+|+|+|.+..+......
T Consensus       122 fk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV  191 (338)
T KOG0668|consen  122 FKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV  191 (338)
T ss_pred             HHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceeee
Confidence            87765       3588888999999999999999999   99999999999999864 5689999999988765543322


Q ss_pred             eeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhc------cccccccC
Q 008698          431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS------HRYLELLD  503 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~d  503 (557)
                      .   ..+..|..||.+-. ..|...-|+|||||+|..|+-.+.||....+.. .+++..+.-+.-.      .+..-.+|
T Consensus       192 R---VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~el~~Yl~KY~i~Ld  267 (338)
T KOG0668|consen  192 R---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDELYAYLNKYQIDLD  267 (338)
T ss_pred             e---eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHHHHHHHHHHccCCC
Confidence            2   25677889998875 457888999999999999999999997654321 2333322211100      00111122


Q ss_pred             ccccc------------CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          504 PLISS------------LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       504 ~~l~~------------~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +....            +.......-..++..+++...+..|-++|||+.|.+.
T Consensus       268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            22111            1111111123367889999999999999999999875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=3.2e-27  Score=224.26  Aligned_cols=254  Identities=20%  Similarity=0.282  Sum_probs=181.6

Q ss_pred             ecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC------CceEEEEecC
Q 008698          277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYIVYEFV  347 (557)
Q Consensus       277 lg~G~~g~Vy~g~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~~  347 (557)
                      +|.|.- .|..+.. -.+++||+|++...  .....++..+|+..+..+.|+||++++.++.-.      ...|+|||+|
T Consensus        25 ~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m  103 (369)
T KOG0665|consen   25 IGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM  103 (369)
T ss_pred             cCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh
Confidence            466666 4444432 24889999987543  334456778999999999999999999998643      3569999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                       .++|...+.      -.++-..+..|..|++.|++|||+.   +|+||||||+||++..+...||.|||+++.....  
T Consensus       104 -~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--  171 (369)
T KOG0665|consen  104 -DANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--  171 (369)
T ss_pred             -hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--
Confidence             668888776      2377788899999999999999999   9999999999999999999999999999865433  


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccc-chhHHH---------------hhhh
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC-WQSIFE---------------WATP  491 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~-~~~~~~---------------~~~~  491 (557)
                       -.......|..|.|||++.+..+.+.+||||.||++.||++|..-|.+.+..+ |....+               -+..
T Consensus       172 -~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~  250 (369)
T KOG0665|consen  172 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN  250 (369)
T ss_pred             -cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence             11112236788999999999889999999999999999999998887543211 111111               1111


Q ss_pred             hhh------ccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          492 LVQ------SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       492 ~~~------~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...      .....+.+...+-....+..+ -....+.+++.++|-.+|++|.+++++++
T Consensus       251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~-~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  251 YVENRPQYQAISFSELFPDSLFPVVLEGSK-LDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhhcChHhhccchhhhCCcccccccccCCc-cchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            110      011111111111000011111 12345778999999999999999999986

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=4.6e-27  Score=237.79  Aligned_cols=191  Identities=24%  Similarity=0.326  Sum_probs=160.6

Q ss_pred             eeecccCceEEEEEEeCC-CCEEEEEEecccchhh--------HHHHHHHHHHHhhcC---CCcEEeeeeeeeeCCceEE
Q 008698          275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQR--------KKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~l  342 (557)
                      +.+|+|+||.|+.+.++. ...|+||.+.+...-.        ...+-.|+.+|+.++   |+||+++++++++++..||
T Consensus       567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl  646 (772)
T KOG1152|consen  567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL  646 (772)
T ss_pred             eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence            347999999999999754 6789999987653211        123446899999997   9999999999999999999


Q ss_pred             EEecC-CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          343 VYEFV-VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       343 V~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      +||-. ++.+|.+++..    ...+++.+...|++||+.|+++||+.   +|||||||-+||.++.++-+||+|||.+..
T Consensus       647 ~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  647 ETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             EecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhh
Confidence            99965 35588899864    35689999999999999999999999   999999999999999999999999999876


Q ss_pred             CCccccccceeecCccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCC
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQA  476 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~el~tG~~p~~~  476 (557)
                      .......    ...||..|.|||++.+.+| ...-|||++|++||.++....||..
T Consensus       720 ~ksgpfd----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  720 TKSGPFD----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hcCCCcc----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            5433222    3449999999999998887 5667999999999999999988753

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=8.4e-28  Score=246.89  Aligned_cols=246  Identities=22%  Similarity=0.321  Sum_probs=196.6

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      ..+|+|.+|.||+++. ..++..|||+++-.......-..+|+.+++..+||||+.++|-+...+..++.|||+.+|+|.
T Consensus        21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQ  100 (829)
T KOG0576|consen   21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQ  100 (829)
T ss_pred             eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccc
Confidence            3569999999999995 458899999998776666777889999999999999999999999999999999999999998


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +.-+-    ..++++-++-.+.++.++||+|||+.   +-+|||||-.|||+++.+.+|++|||.+.......  .....
T Consensus       101 diy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~Krks  171 (829)
T KOG0576|consen  101 DIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AKRKS  171 (829)
T ss_pred             ceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh--hhhhc
Confidence            86543    46799999999999999999999999   88999999999999999999999999987554322  22234


Q ss_pred             cCcccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          434 AGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       434 ~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      ..||+.|||||+..   .+.|..++|||+.|+...|+---++|..+..+.  +.++-......+..        .+    
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~l~LmTkS~~qpp--------~l----  237 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RALFLMTKSGFQPP--------TL----  237 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HHHHHhhccCCCCC--------cc----
Confidence            45999999999774   467899999999999999998888887654431  22221111111111        11    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        ..+..-.+.+-++++.|+-.+|++|||++.+++
T Consensus       238 --kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 --KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             --cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence              111223456889999999999999999998775

>PHA02642 C-type lectin-like protein; Provisional

Probab=99.94  E-value=2.8e-26  Score=210.91  Aligned_cols=122  Identities=21%  Similarity=0.501  Sum_probs=102.8

Q ss_pred             CCCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCC
Q 008698           47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL  126 (557)
Q Consensus        47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~  126 (557)
                      ...+.+||.||.  .|+++||+|+.+.++|.+|+.+|+++||+||+|+|++|++||+++..  ...+||||+  +...++
T Consensus        82 ~~k~~~CP~gW~--~~~~kCYyfs~~~ksW~eA~~~C~s~ga~La~I~seeE~~FL~~~~~--~~~yWIGLs--d~~~e~  155 (216)
T PHA02642         82 TIKYVTCPKGWI--GFGYKCFYFSEDSKNWTFGNTFCTSLGATLVKVETEEELNFLKRYKD--SSDHWIGLN--RESSNH  155 (216)
T ss_pred             CcccCCCCCcCE--EECCEEEEEeCcccCHHHHHHHHhhCCCeEeeECCHHHHHHHHHhhc--CCeEEEEeE--eCCCCC
Confidence            345689999999  89999999999999999999999999999999999999999999876  457999999  555679


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccccc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE  193 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~  193 (557)
                      .|+|+||+++.+. +|..+  +              ++|+.+..  ..+.+.+|.....|||++...
T Consensus       156 ~W~WvDGS~~n~~-~~i~G--~--------------g~CAyLs~--~~i~s~~C~~~~~wIC~K~l~  203 (216)
T PHA02642        156 PWKWADNSNYNAS-FVITG--T--------------GECAYLND--IRISSSRVYANRKWICSKTYT  203 (216)
T ss_pred             ceEECCCCccCcc-eeccC--C--------------CceEEEeC--CceEccCcCCCceEEeeeecc
Confidence            9999999987654 44333  2              35665543  589999999999999987643

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=6e-27  Score=234.19  Aligned_cols=272  Identities=17%  Similarity=0.161  Sum_probs=199.1

Q ss_pred             HHhhcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC------CCcEEeeeeeeee
Q 008698          264 RSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH------HPNLVAVKGCCYD  336 (557)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------H~niv~l~g~~~~  336 (557)
                      .++..+.++.....|+|-|++|.++... .|..||||+++... ...+.=+.|+++|.+|.      --+.++++..|..
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            3444455555556799999999999854 48899999997652 22344578999999994      3578899999999


Q ss_pred             CCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-cEEee
Q 008698          337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-AHLMG  415 (557)
Q Consensus       337 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~D  415 (557)
                      .++++||+|-+ .-+|.+.|....+ +..|....+..++.|+.-||..|-..   +|+|.||||+|||+++... +||+|
T Consensus       506 knHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCD  580 (752)
T KOG0670|consen  506 KNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCD  580 (752)
T ss_pred             cceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeecc
Confidence            99999999987 5689999976543 35688889999999999999999987   9999999999999987654 69999


Q ss_pred             ccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhh-
Q 008698          416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ-  494 (557)
Q Consensus       416 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~-  494 (557)
                      ||.|............    -+..|.|||.+.+.+|+..-|+||.||.||||.||+..|.+.....+..++-.....+. 
T Consensus       581 fGSA~~~~eneitPYL----VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~  656 (752)
T KOG0670|consen  581 FGSASFASENEITPYL----VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN  656 (752)
T ss_pred             CccccccccccccHHH----HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence            9999876544332211    34579999999999999999999999999999999999987654332222211111100 


Q ss_pred             ----ccc---------------------------cccccCc------cccc-CCCCCCcHHHHHHHHHHHHHhcCCCCCC
Q 008698          495 ----SHR---------------------------YLELLDP------LISS-LSSDIPEAGVVQKVVDLVYACTQHVPSM  536 (557)
Q Consensus       495 ----~~~---------------------------~~~~~d~------~l~~-~~~~~~~~~~~~~l~~l~~~Cl~~~P~~  536 (557)
                          .+.                           ++..+.|      .+.. ......+......+.+|+..|+..||++
T Consensus       657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K  736 (752)
T KOG0670|consen  657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK  736 (752)
T ss_pred             HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence                000                           0111111      0000 0011112345678889999999999999


Q ss_pred             CCCHHHHHH
Q 008698          537 RPRMSHVVH  545 (557)
Q Consensus       537 RPt~~evl~  545 (557)
                      |.|.++.|+
T Consensus       737 Rit~nqAL~  745 (752)
T KOG0670|consen  737 RITVNQALK  745 (752)
T ss_pred             cCCHHHHhc
Confidence            999999875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=5.2e-27  Score=266.44  Aligned_cols=196  Identities=21%  Similarity=0.257  Sum_probs=139.7

Q ss_pred             hcCC-CcEEeeeeee-------eeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 008698          321 RLHH-PNLVAVKGCC-------YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH  392 (557)
Q Consensus       321 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  392 (557)
                      .++| +||+++++++       ...+.+++++|++ +++|.++|..   ....+++.+++.++.||++||+|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            4455 5788888877       2334677889987 6699999964   235699999999999999999999999   9


Q ss_pred             eeecCCCCCCeeeCC-------------------CCCcEEeeccCCccCCcccc--------------ccceeecCcccc
Q 008698          393 VVHRDIRASNVLLDE-------------------EFGAHLMGVGLSKFVPWEVM--------------QERTVMAGGTYG  439 (557)
Q Consensus       393 ivH~Dlk~~Nill~~-------------------~~~~kl~Dfgl~~~~~~~~~--------------~~~~~~~~gt~~  439 (557)
                      |+||||||+||||+.                   ++.+|++|||+++.......              ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999954                   45567777777754221000              000111237888


Q ss_pred             ccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHH
Q 008698          440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVV  519 (557)
Q Consensus       440 y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~  519 (557)
                      |||||++.+..++.++|||||||+||||++|.+|+.....    .+...     ..    ..+.+..         ....
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~-----~~----~~~~~~~---------~~~~  238 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSL-----RH----RVLPPQI---------LLNW  238 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHH-----HH----hhcChhh---------hhcC
Confidence            9999999999999999999999999999999887643211    00000     00    0111100         0112


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          520 QKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       520 ~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .....++.+||+.+|.+||+|.||++
T Consensus       239 ~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        239 PKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHHHHhCCCChhhCcChHHHhh
Confidence            34568889999999999999999986

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-25  Score=222.17  Aligned_cols=127  Identities=19%  Similarity=0.273  Sum_probs=105.2

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-----C---CcEEeeeeeee----eCCce
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----H---PNLVAVKGCCY----DHGDR  340 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H---~niv~l~g~~~----~~~~~  340 (557)
                      .+.||=|.|++||++.. .+.+.||+|+.+.. ..-.+.-+.|+++|++++     |   ..||+|++.|.    ++.+.
T Consensus        83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HV  161 (590)
T KOG1290|consen   83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHV  161 (590)
T ss_pred             EEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEE
Confidence            35579999999999985 35678999999754 234566788999999983     3   35999999986    45678


Q ss_pred             EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 008698          341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD  406 (557)
Q Consensus       341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~  406 (557)
                      ++|+|++ |-+|..++..  ..-+.++...+.+|+.||+.||.|||..|  +|||.||||+|||+.
T Consensus       162 CMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  162 CMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             EEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence            9999998 6688888865  23456999999999999999999999998  999999999999983

>cd03588 CLECT_CSPGs C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins

Probab=99.93  E-value=4.4e-26  Score=198.37  Aligned_cols=122  Identities=22%  Similarity=0.474  Sum_probs=102.9

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEcc
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD  132 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~D  132 (557)
                      ||+||+  .|+++||+|+.++++|.+|+.+|+.+||+||+|+|++|++||.++..   ..+||||+  +...++.|.|+|
T Consensus         1 Cp~gw~--~~~~~Cy~~~~~~~sw~~A~~~C~~~gg~La~i~s~~e~~fl~~~~~---~~~WIGl~--~~~~~~~~~W~d   73 (124)
T cd03588           1 CEEGWD--KFQGHCYRHFPDRETWEDAERRCREQQGHLSSIVTPEEQEFVNNNAQ---DYQWIGLN--DRTIEGDFRWSD   73 (124)
T ss_pred             CCccce--ecCCEEEEEECCccCHHHHHHHHHhcCCEEeccCCHHHHHHHHHhcc---CcEEecce--ecCCCCceEeCC
Confidence            999999  89999999999999999999999999999999999999999998864   46899999  656678999999


Q ss_pred             CCCCCCcCccccCCCCCCCCCCCCccccccCceeEee-cCCCceeccccCCCCCccccc
Q 008698          133 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS-NGSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       133 g~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~-~~~~~w~~~~C~~~~~~iC~~  190 (557)
                      |+++.+.+ |..++|++.        ..+.++|+.+. ...+.|++..|....+|||+.
T Consensus        74 g~~~~~~~-W~~~~p~~~--------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~  123 (124)
T cd03588          74 GHPLQFEN-WRPNQPDNF--------FATGEDCVVMIWHEEGEWNDVPCNYHLPFTCKK  123 (124)
T ss_pred             CCcccccC-cCCCCCCCC--------CCCCCCeEEEecCCCCeEcCCCCCCCCeeeeeC
Confidence            99987765 555554431        13456787764 345689999999999999975

CLECT_CSPGs: C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins (CSPGs) in human and chicken aggrecan, frog brevican, and zebra fish dermacan. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Xenopus brevican is expressed in the notochord and the brain during early embryogenesis. Zebra fish dermacan is expressed in dermal bones and may play a role in dermal bone development. CSPGs do contain LINK domain(s) which bind HA. These LINK domains are considered by one classif

>cd03597 CLECT_attractin_like C-type lectin-like domain (CTLD) of the type found in human and mouse attractin (AtrN) and attractin-like protein (ALP)

Probab=99.93  E-value=4.9e-26  Score=198.99  Aligned_cols=121  Identities=21%  Similarity=0.383  Sum_probs=100.5

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC-----CCCeEEeeeecCCCCCCe
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-----VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~-----~~~~WiGl~~~~~~~~~~  127 (557)
                      ||+||.  .|+++||+++.+.++|.+|+.+|+++||+||+|+|.+|++||.+++++.     ...+||||+  +.. +|.
T Consensus         1 Cp~gw~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~~~~E~~fi~~~~~~~~~~~~~~~~WIGl~--d~~-~g~   75 (129)
T cd03597           1 CGEGWH--LVGNSCLKINTARESYDNAKLYCRNLNAVLASLTTQKKVEFVLKELQKHQMTKQKLTPWVGLR--KIN-VSY   75 (129)
T ss_pred             CCCcCE--EcCCEEEEEEcCCCCHHHHHHHHHHcCCEEcCCCCHHHHHHHHHHHHhhcccCCCCceEEeee--cCC-CCc
Confidence            999999  8999999999999999999999999999999999999999999877542     247999999  544 588


Q ss_pred             eEEccCCCCCC-cCccccCCCCCCCCCCCCccccccCceeEeecC-CCceeccccCCC-CCccccc
Q 008698          128 WKWSDNMSKWN-ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTS-HPFICMV  190 (557)
Q Consensus       128 w~W~Dg~~~~~-~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~~~~C~~~-~~~iC~~  190 (557)
                      |.|+||+++.+ ++.|.+++|++.            ++|+.+... ...|+|..|... .+|||++
T Consensus        76 w~W~Dgs~~~~~~~~W~~geP~~~------------~~C~~~~~~~~~~w~d~~C~~~~~~~iCe~  129 (129)
T cd03597          76 WCWEDMSPFTNTTLQWLPGEPSDA------------GFCGYLEEPAVSGLKANPCTNPVNGSVCER  129 (129)
T ss_pred             eEECCCCCCCCccccCCCCCCCCc------------ccEEEEcccccCccccCCcCCCCcceeecC
Confidence            99999999853 445666665531            478776433 456999999998 6999974

CLECT_attractin_like: C-type lectin-like domain (CTLD) of the type found in human and mouse attractin (AtrN) and attractin-like protein (ALP). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Mouse AtrN (the product of the mahogany gene) has been shown to bind Agouti protein and to function in agouti-induced pigmentation and obesity. Mutations in AtrN have also been shown to cause spongiform encephalopathy and hypomyelination in rats and hamsters. The cytoplasmic region of mouse ALP has been shown to binds to melanocortin receptor (MCR4). Signaling through MCR4 plays a role in appetite suppression. Attractin may have therapeutic potential in the treatment of obesity. Human attractin (hAtrN) has been shown to be expressed on activated T cells and released extracellularly. The

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=7.4e-26  Score=209.59  Aligned_cols=168  Identities=23%  Similarity=0.268  Sum_probs=126.1

Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++...   +..+++.++..++.||+.||+|||+.   +      ||+|||++.++.+|+  ||++.......   
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            7899999642   35699999999999999999999998   5      999999999999999  99987654321   


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                          ..|++.|||||++.+..++.++|||||||++|||+||+.||......  ............     . .++.    
T Consensus        64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~-----~-~~~~----  127 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMP-----A-DDPR----  127 (176)
T ss_pred             ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhc-----c-CCcc----
Confidence                13789999999999999999999999999999999999998654321  111111100000     0 0000    


Q ss_pred             CCCCCcHHHHH--HHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          510 SSDIPEAGVVQ--KVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       510 ~~~~~~~~~~~--~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                       ..........  .+.+++.+||+.+|.+||++.++++.+..+.
T Consensus       128 -~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      128 -DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             -ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence             0011122223  5899999999999999999999999886543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=4.7e-26  Score=224.09  Aligned_cols=266  Identities=24%  Similarity=0.331  Sum_probs=191.3

Q ss_pred             hhcCCCCCCeeecccCceEEEEEEeC----CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCce
Q 008698          266 ITKNFSEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR  340 (557)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~g~~~----~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~  340 (557)
                      +.+.+...+ .||+|.|++||++...    .++.||+|.+...+  ....+.+|++.|..+ -+.||+++.+++...+..
T Consensus        34 ~~~~~~~v~-kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   34 ISNAYKVVN-KIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhc-cccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            333444434 5699999999999853    46789999987653  345688999999999 699999999999999999


Q ss_pred             EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCcEEeeccCC
Q 008698          341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLS  419 (557)
Q Consensus       341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~  419 (557)
                      .+|+||+++....++...       ++..++..++..+..||.++|.+   |||||||||.|+|.+.. +.-.|.|||++
T Consensus       111 ~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             EEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence            999999999999999864       77889999999999999999999   99999999999999864 45689999998


Q ss_pred             ccCCccc------c------------------------------------ccceeecCccccccccccccCC-CCCchhh
Q 008698          420 KFVPWEV------M------------------------------------QERTVMAGGTYGYLAPEFVYRN-ELTTKSD  456 (557)
Q Consensus       420 ~~~~~~~------~------------------------------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sD  456 (557)
                      .......      .                                    ........||++|.|||++..- .-|++.|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7211000      0                                    0000111289999999999864 4688999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhh-----------------hhcccc---c------cccC-ccccc-
Q 008698          457 VYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL-----------------VQSHRY---L------ELLD-PLISS-  508 (557)
Q Consensus       457 VwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~-----------------~~~~~~---~------~~~d-~~l~~-  508 (557)
                      |||-|||++-+++++.||....++. ..+.+.+...                 ++..++   .      +-++ ..+.+ 
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             eeeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            9999999999999999997653321 1111111100                 000000   0      0010 00100 


Q ss_pred             ----CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 ----LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ----~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ..........+..+++++.+|++.||.+|.|+++.|+
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                0001111122347889999999999999999999986

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-26  Score=212.82  Aligned_cols=245  Identities=23%  Similarity=0.416  Sum_probs=187.6

Q ss_pred             ecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          277 LGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      |.+...|+.|+|++ .|..+++|++.-.  .....+.|..|.-.|+.+.||||++++|.|.....+.++..||+.|+|..
T Consensus       198 l~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslyn  276 (448)
T KOG0195|consen  198 LAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYN  276 (448)
T ss_pred             hccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHH
Confidence            57788899999999 5666777877533  22334678999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      .|+.  ..+..++..+..+++.+||+||+|||+. .+-|.---|.+..|++|++.+++|+- +-+++      +-+....
T Consensus       277 vlhe--~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf------sfqe~gr  346 (448)
T KOG0195|consen  277 VLHE--QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQEVGR  346 (448)
T ss_pred             HHhc--CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee------eeecccc
Confidence            9986  4456678889999999999999999987 33344446889999999999998852 11111      1111112


Q ss_pred             CccccccccccccCCCC---CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          435 GGTYGYLAPEFVYRNEL---TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~---s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      .-.+.||+||.++..+-   -.++|+|||.+++|||.|...||.+..+.+-..-                  ..+.++..
T Consensus       347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk------------------ialeglrv  408 (448)
T KOG0195|consen  347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK------------------IALEGLRV  408 (448)
T ss_pred             ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh------------------hhhccccc
Confidence            24688999999987543   2478999999999999999999988765432110                  01111112


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      .+ +.+....+.+||.-|++.||.+||.++.|+-.|+++.
T Consensus       409 ~i-ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  409 HI-PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cC-CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            22 2345667889999999999999999999999998764

>cd03596 CLECT_tetranectin_like C-type lectin-like domain (CTLD) of the type found in the tetranectin (TN), cartilage derived C-type lectin (CLECSF1), and stem cell growth factor (SCGF)

Probab=99.92  E-value=2.9e-25  Score=194.64  Aligned_cols=122  Identities=16%  Similarity=0.297  Sum_probs=103.3

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCeeE
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLSWK  129 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~w~  129 (557)
                      ||+||.   .+++||+|+.+++||.+|+.+|+++||+||+|+|.+|++||.++++..   ...+||||+  +...++.|.
T Consensus         1 c~~g~~---~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--~~~~~~~w~   75 (129)
T cd03596           1 CLKGTK---IHKKCYLVSEETKHYHEASEDCIARGGTLATPRDSDENDALRDYVKASVPGNWEVWLGIN--DMVAEGKWV   75 (129)
T ss_pred             CCCCcE---ECCEEEEEecccCCHHHHHHHHHhcCCeEecCCCHHHHHHHHHHHHhccCCCCcEEEecc--ccCccCeEE
Confidence            999997   788999999999999999999999999999999999999999877532   457999999  666779999


Q ss_pred             EccCCCCCCcCcccc--CCCCCCCCCCCCccccccCceeEeecC-CCceeccccCCCCCcccc
Q 008698          130 WSDNMSKWNESIHAV--GSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICM  189 (557)
Q Consensus       130 W~Dg~~~~~~~~~~~--~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~  189 (557)
                      |+||+++.+.+|-..  ++|++          ++.++|+.+... .+.|++..|....+|||+
T Consensus        76 w~dG~~~~~~~W~~~~~~~p~~----------~~~~~Cv~l~~~~~~~W~d~~C~~~~~fICe  128 (129)
T cd03596          76 DVNGSPISYFNWEREITAQPDG----------GKRENCVALSSSAQGKWFDEDCRREKPYVCE  128 (129)
T ss_pred             eCCCCCccccccCCCCCCCCCC----------CCCCCCEEEccCCCCcCcCccCCCCCceecc
Confidence            999999987776552  44432          245788887654 567999999999999997

CLECT_tetranectin_like: C-type lectin-like domain (CTLD) of the type found in the tetranectin (TN), cartilage derived C-type lectin (CLECSF1), and stem cell growth factor (SCGF). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. TN binds to plasminogen and stimulates activation of plasminogen, playing a key role in the regulation of proteolytic processes. The TN CTLD binds two calcium ions. Its calcium free form binds to various kringle-like protein ligands. Two residues involved in the coordination of calcium are critical for the binding of TN to the fourth kringle (K4) domain of plasminogen (Plg K4). TN binds the kringle 1-4 form of angiostatin (AST K1-4). AST K1-4 is a fragment of Plg, commonly found in cancer tissues. TN inhibits the bin

>cd03589 CLECT_CEL-1_like C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina

Probab=99.92  E-value=3.2e-25  Score=196.65  Aligned_cols=123  Identities=24%  Similarity=0.497  Sum_probs=103.2

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhhC-----CCeEeeeCCHHHHHHHHHHhCCC-----CCCeEEeeeecCC
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-----GGHLAALTSYEEEHSAQKLCGKN-----VNGCWVGGRSINT  122 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-----~~~L~~i~s~~e~~f~~~~~~~~-----~~~~WiGl~~~~~  122 (557)
                      ||+||+  .|+++||+|+.+.++|.+|+.+|+++     +|+||+|+|++|++||.+++...     ...+||||+  +.
T Consensus         1 Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~~g~~~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~WiGl~--~~   76 (137)
T cd03589           1 CPTFWT--AFGGYCYRFFGDRLTWEEAELRCRSFSIPGLIAHLVSIHSQEENDFVYDLFESSRGPDTPYGLWIGLH--DR   76 (137)
T ss_pred             CCcchh--hhCCEEEEEeCCCcCHHHHHHHHHhhcCCCCCceEcccCCHHHHHHHHHHHhhccccCCCCcEEEeee--cC
Confidence            999999  89999999999999999999999997     69999999999999999988642     467999999  65


Q ss_pred             CCCCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecC---CCceeccccCCCCCcccc
Q 008698          123 TVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG---SRSLVTERCNTSHPFICM  189 (557)
Q Consensus       123 ~~~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~---~~~w~~~~C~~~~~~iC~  189 (557)
                      ..++.|.|+||+++.|.+ |.+++|++         ..+.++|+.+...   ...|++..|....+|||+
T Consensus        77 ~~~~~~~W~dG~~~~~~~-W~~~~P~~---------~~~~~~C~~~~~~~~~~~~W~d~~C~~~~~fIC~  136 (137)
T cd03589          77 TSEGPFEWTDGSPVDFTK-WAGGQPDN---------YGGNEDCVQMWRRGDAGQSWNDMPCDAVFPYICK  136 (137)
T ss_pred             CccCceEeCCcCcCCcCC-cCCCCCCC---------CCCCCCceeeecCCCCCCeecCCCCCCCcceeee
Confidence            667999999999987766 44444443         2245788777643   356999999999999997

CLECT_CEL-1_like: C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. The CEL-1 CTLD binds three calcium ions and has a high specificity for N-acteylgalactosamine (GalNAc). CEL-1 exhibits strong cytotoxicity which is inhibited by GalNAc. This protein may play a role as a toxin defending against predation. Echinoidin is found in the coelomic fluid of the sea urchin and is specific for GalBeta1-3GalNAc. Echinoidin has a cell adhesive activity towards human cancer cells which is not mediated through the CTLD. Both CEL-1 and Echinoidin are multimeric proteins comprised of multiple dimers linked by disulfide bonds.

>cd03590 CLECT_DC-SIGN_like C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR)

Probab=99.92  E-value=1.2e-24  Score=189.96  Aligned_cols=125  Identities=25%  Similarity=0.538  Sum_probs=105.0

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEcc
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD  132 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~D  132 (557)
                      ||.||.  .|+++||+|+..+++|.+|+.+|+.+||+||+|+|++|++||.+++. ....+||||+  +...++.|+|+|
T Consensus         1 Cp~~w~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~-~~~~~WiGl~--~~~~~~~~~W~d   75 (126)
T cd03590           1 CPTNWK--SFQSSCYFFSTEKKSWEESRQFCEDMGAHLVIINSQEEQEFISKILS-GNRSYWIGLS--DEETEGEWKWVD   75 (126)
T ss_pred             CCCCce--EeCCEEEEEeCCCcCHHHHHHHHHhCCCEEEeeCCHHHHHHHHHHhC-CCCCEEEeee--cCCCcCCeEecC
Confidence            999999  89999999999999999999999999999999999999999999986 4568999999  555679999999


Q ss_pred             CCCCC-CcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccc
Q 008698          133 NMSKW-NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       133 g~~~~-~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~  190 (557)
                      |+++. .+..|..++|++.        +.+.++|+.+......|.+..|....+|||+.
T Consensus        76 g~~~~~~~~~W~~~~p~~~--------~~~~~~C~~~~~~~~~w~~~~C~~~~~fiCek  126 (126)
T cd03590          76 GTPLNSSKTFWHPGEPNNW--------GGGGEDCAELVYDSGGWNDVPCNLEYRWICEK  126 (126)
T ss_pred             CCCCCCccCCcCCCcCCCC--------CCCCCCCEEEECCCCcEeCcCCCCCEeeeeeC
Confidence            99982 3444555554431        11357888887655789999999999999973

CLECT_DC-SIGN_like: C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR). This group also contains proteins similar to hepatic asialoglycoprotein receptor (ASGP-R) and langerin in human. These proteins are type II membrane proteins with a CTLD ectodomain. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. DC-SIGN is thought to mediate the initial contact between dendritic cells and resting T cells, and may also mediate the rolling of DCs on epithelium. DC-SIGN and DC-SIGNR bind to oligosaccharides present on human tissues, as well as, on path

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5.2e-25  Score=204.48  Aligned_cols=240  Identities=22%  Similarity=0.315  Sum_probs=173.3

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeee-eeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGC-CYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E~~~~g  350 (557)
                      ++.+|+|.||.+-.+.+. ..+.+++|.+... ....++|.+|...--.| .|.||+.-+++ +...+....++||++.|
T Consensus        29 ~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~g  107 (378)
T KOG1345|consen   29 NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRG  107 (378)
T ss_pred             HHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccc
Confidence            446799999999999874 4678999998765 34567899998765555 69999987765 45566778899999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-CC-CCCcEEeeccCCccCCccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DE-EFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill-~~-~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|.+-+..     ..+-+..-.+++.|+++|+.|+|++   .+||||||.+|||| +. ..++|++|||+++..+.....
T Consensus       108 dL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~  179 (378)
T KOG1345|consen  108 DLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY  179 (378)
T ss_pred             hhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence            99887753     3477788889999999999999999   99999999999999 33 347999999999765422111


Q ss_pred             cceeecCccccccccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc---ccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRN-----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR---YLE  500 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~  500 (557)
                           ...+..|.+||.....     ...+.+|||.||++++..+||+.|++.... ..+...+|..  +..+.   +.+
T Consensus       180 -----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~--w~~rk~~~~P~  251 (378)
T KOG1345|consen  180 -----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQ--WLKRKNPALPK  251 (378)
T ss_pred             -----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHH--HhcccCccCch
Confidence                 1145679999977532     346789999999999999999999984322 2222222221  11111   111


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV  543 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev  543 (557)
                      .+.             ...+.+.++..+-+.++|++|=...++
T Consensus       252 ~F~-------------~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  252 KFN-------------PFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             hhc-------------ccCHHHHHHHHHhcCCcccccchhHHH
Confidence            111             123456778888888999988444333

>cd03593 CLECT_NK_receptors_like C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs)

Probab=99.92  E-value=1.4e-24  Score=186.69  Aligned_cols=116  Identities=25%  Similarity=0.551  Sum_probs=99.4

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEcc
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD  132 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~D  132 (557)
                      ||+||+  .|+++||+++.++++|.+|+.+|+.+||+||+|+|++|++||.+++.  ...+||||+  +...++.|.|+|
T Consensus         1 Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WiGl~--~~~~~~~~~W~d   74 (116)
T cd03593           1 CPKDWI--CYGNKCYYFSMEKKTWNESKEACSSKNSSLLKIDDEEELEFLQSQIG--SSSYWIGLS--REKSEKPWKWID   74 (116)
T ss_pred             CCCcCE--EeCCEEEEEEcCCCCHHHHHHHHHhCCCcEEEECCHHHHHHHHHhcC--CCceEEEEe--ecCCCCCeEccC
Confidence            999999  89999999999999999999999999999999999999999999884  568999999  555679999999


Q ss_pred             CCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccc
Q 008698          133 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       133 g~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~  190 (557)
                      |+++.  +|+...|++            +.++|+.+...  .|.+..|....+|||++
T Consensus        75 g~~~~--~~~~~~~~~------------~~~~C~~~~~~--~w~~~~C~~~~~~IC~k  116 (116)
T cd03593          75 GSPLN--NLFNIRGST------------KSGNCAYLSST--GIYSEDCSTKKRWICEK  116 (116)
T ss_pred             CCccc--ccccccCCC------------CCCCceEEcCC--cEEcccCCcCceeeeeC
Confidence            99977  555444321            34578776543  79999999999999974

CLECT_NK_receptors_like: C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs), including proteins similar to oxidized low density lipoprotein (OxLDL) receptor (LOX-1), CD94, CD69, NKG2-A and -D, osteoclast inhibitory lectin (OCIL), dendritic cell-associated C-type lectin-1 (dectin-1), human myeloid inhibitory C-type lectin-like receptor (MICL), mast cell-associated functional antigen (MAFA), killer cell lectin-like receptors: subfamily F, member 1 (KLRF1) and subfamily B, member 1 (KLRB1), and lys49 receptors. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. NKRs are variously associated with activation or inhibition of natural killer (NK) cells. Activating NKRs stimulate cytolysis by NK cells of virally infected or transformed cells; inhibitory NKRs block cytolysis up

>PHA02953 IEV and EEV membrane glycoprotein; Provisional

Probab=99.91  E-value=2e-24  Score=194.68  Aligned_cols=117  Identities=15%  Similarity=0.208  Sum_probs=94.6

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEE
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW  130 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W  130 (557)
                      .+||+||.  .|+++||+++.+.+||.||+.+|+.+||+|++++  +|+.|+..+..  ...+||||+  |  .+|.|.|
T Consensus        45 ~~CP~GW~--~~~~~CYk~f~~~~tW~~A~~~C~~~Gg~L~~~~--~e~~fv~~~~~--~~~~WIGL~--d--~eg~W~w  114 (170)
T PHA02953         45 SACAKGWI--PYDNYCYLDTNIQLSTYGAVYLCNKYRARLPKPN--FRHLKVLSLTY--GKDFWVSLK--K--KNNRWLD  114 (170)
T ss_pred             CcCcccCh--hhCCEEEEEECCcCCHHHHHHHHHhcCCCCCCCc--HHHHHHHHhcc--CCCEEEeEE--C--CCCceEe
Confidence            58999999  8999999999999999999999999999998877  77889988765  447999999  6  4689999


Q ss_pred             ccCCC-CCCcCc-----cccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          131 SDNMS-KWNESI-----HAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       131 ~Dg~~-~~~~~~-----~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      .||++ +.+.+|     |.++| +           ++.|+|+.+..  ..|+|..|....+|||+++
T Consensus       115 ~Dggs~~~y~~~~~~~~w~~~~-~-----------~~~e~C~~~~~--~~W~d~~C~~~~~fICqk~  167 (170)
T PHA02953        115 INTNKTVDMNKNTELKKIKSKT-K-----------NDNEACYIYKS--GELKETVCNSVNYIICVKR  167 (170)
T ss_pred             CCCCeeeccccccccccccCCC-C-----------CCCCCceEEeC--CeEEeccCCCCcEEEEEEe
Confidence            99754 444332     33222 1           24578887753  4799999999999999874

>cd03594 CLECT_REG-1_like C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2)

Probab=99.91  E-value=3.1e-24  Score=188.27  Aligned_cols=122  Identities=27%  Similarity=0.606  Sum_probs=101.5

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhhC--CCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCe
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~  127 (557)
                      ||+||+  .|+++||+++.+++||.||+.+|+++  ||+||+|+|.+|++||.++++..   ...+||||+  +...++.
T Consensus         1 Cp~gw~--~~~~~Cy~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--~~~~~~~   76 (129)
T cd03594           1 CPKGWL--PYKGNCYGYFRQPLSWSDAELFCQKYGPGAHLASIHSPAEAAAIASLISSYQKAYQPVWIGLH--DPQQSRG   76 (129)
T ss_pred             CCCCCE--ecCCEeeeEeccCcCHHHHHHHHHhcCCCceEcccCCHHHHHHHHHHHHhhccCCccEEEeec--cCCCCCc
Confidence            999999  89999999999999999999999998  59999999999999999988542   457999999  6666689


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMV  190 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~  190 (557)
                      |+|+||+++.+.+ |.+++|+           .+.++|+.+...+  ..|++..|....+|||+.
T Consensus        77 ~~W~dg~~~~~~~-W~~~~p~-----------~~~~~Cv~~~~~~~~~~W~~~~C~~~~~fICe~  129 (129)
T cd03594          77 WEWSDGSKLDYRS-WDRNPPY-----------ARGGYCAELSRSTGFLKWNDANCEERNPFICKY  129 (129)
T ss_pred             eEeCCCCcceecc-cCCCCCC-----------CCCCCceEEEecCCCCeEECCCCCCCceeeeeC
Confidence            9999999986655 5555432           1346787776443  369999999999999973

CLECT_REG-1_like: C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. REG-1 is a proliferating factor which participates in various kinds of tissue regeneration including pancreatic beta-cell regeneration, regeneration of intestinal mucosa, regeneration of motor neurons, and perhaps in tissue regeneration of damaged heart. REG-1 may play a role on the pathophysiology of Alzheimer's disease and in the development of gastric cancers. Its expression is correlated with reduced survival from early-stage colorectal cancer. REG-1 also binds and aggregates

>PHA03097 C-type lectin-like protein; Provisional

Probab=99.90  E-value=1.6e-23  Score=187.46  Aligned_cols=112  Identities=16%  Similarity=0.434  Sum_probs=93.7

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEE
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW  130 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W  130 (557)
                      ..||.||.  .|+++||+|+.+.++|.+|+.+|+++||+||+|+|++|++||.+++.  ...|||||+  +..  +   |
T Consensus        44 ~~CP~gW~--~~~~~CY~~s~~~~sW~~A~~~C~~~g~~La~I~~~~E~~fi~~~~~--~~~~WIGL~--d~~--~---W  112 (157)
T PHA03097         44 LNCRSGWV--GYNNKCYTFSENITNKHLAIERCADMDGILTLIDDQKEVLFVSRYKG--GQDLWIGIE--KKK--G---D  112 (157)
T ss_pred             CCCCCCce--eeCCEEEEEecCCCcHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhcC--CCCEEEeee--cCC--C---c
Confidence            58999999  89999999999999999999999999999999999999999999876  457999999  543  2   9


Q ss_pred             ccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       131 ~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      +||++... +++.               ..+.++|+.+..  ..|++..|.....|||+.+
T Consensus       113 ~dgs~~~~-~~~~---------------~~~~e~Cv~i~~--~~w~d~~C~~~~~~ICek~  155 (157)
T PHA03097        113 DDDREVLD-KVVK---------------PPKSGKCAYLKD--KTIISSNCNATKGWICFDR  155 (157)
T ss_pred             cCCCcccc-cccC---------------CCCCCCEEEEEC--CcEEeCCCCCCeeEEEeec
Confidence            99987543 2221               113467887755  3599999999999999875

>cd03591 CLECT_collectin_like C-type lectin-like domain (CTLD) of the type found in human collectins including lung surfactant proteins A and D, mannose- or mannan binding lectin (MBL), and CL-L1 (collectin liver 1)

Probab=99.89  E-value=7e-23  Score=175.41  Aligned_cols=113  Identities=19%  Similarity=0.274  Sum_probs=96.0

Q ss_pred             CeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCCCcCccc
Q 008698           64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHA  143 (557)
Q Consensus        64 ~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~~~~  143 (557)
                      .+||+++.++++|.+|+.+|+.+||+||+|+|.+|++||.+++......+||||+  +...++.|+|+||+++.|.+ |.
T Consensus         1 ~k~y~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~~~w~dg~~~~y~~-W~   77 (114)
T cd03591           1 EKIFVTNGEEKNFDDAQKLCSEAGGTLAMPRNAAENAAIASYVKKGNTYAFIGIT--DLETEGQFVYLDGGPLTYTN-WK   77 (114)
T ss_pred             CcEEEeCCceeCHHHHHHHHhhcCCEEecCCCHHHHHHHHHHHhcCCccEEEecc--cCCcCCcEEeCCCCCcccCC-cC
Confidence            3799999999999999999999999999999999999999999754568999999  66667999999999996666 55


Q ss_pred             cCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccc
Q 008698          144 VGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM  189 (557)
Q Consensus       144 ~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~  189 (557)
                      +++|++         .++.++|+.+. .++.|++..|....+|||+
T Consensus        78 ~~ep~~---------~~~~~~Cv~~~-~~~~W~~~~C~~~~~fICe  113 (114)
T cd03591          78 PGEPNN---------AGGGEDCVEMY-TSGKWNDVACNLTRLFVCE  113 (114)
T ss_pred             CCCCCC---------CCCCCCeEEEC-CCCcCcCccCCCCeeEEee
Confidence            554443         22356888887 4568999999999999997

CLECT_collectin_like: C-type lectin-like domain (CTLD) of the type found in human collectins including lung surfactant proteins A and D, mannose- or mannan binding lectin (MBL), and CL-L1 (collectin liver 1). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. The CTLDs of these collectins bind carbohydrates on surfaces (e.g. pathogens, allergens, necrotic, or apoptotic cells) and mediate functions associated with killing and phagocytosis. MBPs recognize high mannose oligosaccharides in a calcium dependent manner, bind to a broad range of pathogens, and trigger cell killing by activating the complement pathway. MBP also acts directly as an opsonin. SP-A and SP-D in addition to functioning as host defense components, a

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.9e-22  Score=205.09  Aligned_cols=164  Identities=16%  Similarity=0.118  Sum_probs=123.4

Q ss_pred             hcCCCCCCeeecccCceEEEEEEeC--CCCEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc
Q 008698          267 TKNFSEGNRLLGDSKTGGTYSGILP--DGSRVAVKRLKRS-----SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD  339 (557)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~g~~~--~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~  339 (557)
                      ..+|.. .+.||+|+||+||++...  +++.||||++...     .......|.+|+++|.+++|+|+++.+..   .+.
T Consensus        17 ~~~Y~~-~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         17 SARFVE-TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             cCCceE-ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            334444 456799999999999864  5778899987533     12235678999999999999999853322   246


Q ss_pred             eEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeeeCCCCCcEEeeccC
Q 008698          340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI-RASNVLLDEEFGAHLMGVGL  418 (557)
Q Consensus       340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~Dfgl  418 (557)
                      .++||||+++++|.. +..       ..   ...++.|+++||.|||++   +|+|||| ||+|||++.++.+||+|||+
T Consensus        93 ~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         93 DGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             cEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            799999999999963 210       11   146788999999999999   9999999 99999999999999999999


Q ss_pred             CccCCccccccc------eeecCccccccccccccC
Q 008698          419 SKFVPWEVMQER------TVMAGGTYGYLAPEFVYR  448 (557)
Q Consensus       419 ~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  448 (557)
                      ++..........      .....+++.|+|||.+.-
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            987654321111      112337788999998864

>cd03603 CLECT_VCBS A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins

Probab=99.88  E-value=2e-22  Score=173.37  Aligned_cols=112  Identities=18%  Similarity=0.364  Sum_probs=93.9

Q ss_pred             eeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCCCcCcccc
Q 008698           65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV  144 (557)
Q Consensus        65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~~~~~  144 (557)
                      +||+|+.++++|.||+..|+++||+||+|+|++|++||.+++. ....+||||+  +...++.|+|+||+++.+.+ |..
T Consensus         1 ~~Y~~~~~~~sw~~A~~~C~~~g~~La~I~s~~E~~fv~~~~~-~~~~~WiG~~--~~~~~~~w~W~dg~~~~~~~-W~~   76 (118)
T cd03603           1 HFYKFVDGGMTWEAAQTLAESLGGHLVTINSAEENDWLLSNFG-GYGASWIGAS--DAATEGTWKWSDGEESTYTN-WGS   76 (118)
T ss_pred             CeEEEeCCCcCHHHHHHHHHHcCCEEcccCCHHHHHHHHHHhc-cCCCEEEeee--cCCCCCceEeCCCCcCCCCC-cCC
Confidence            6999999999999999999999999999999999999999986 3558999999  55567999999999987766 444


Q ss_pred             CCC-CCCCCCCCCccccccCceeEeec---CCCceeccccC-CCCCcccc
Q 008698          145 GSF-NSSCTSLPCHVHATVDLCTLVSN---GSRSLVTERCN-TSHPFICM  189 (557)
Q Consensus       145 ~~~-~~~~~~~~c~~~~~~~~C~~~~~---~~~~w~~~~C~-~~~~~iC~  189 (557)
                      ++| ++         ..+.++|+.+..   .++.|+|..|. ....|||+
T Consensus        77 ~eP~~~---------~~~~~~Cv~~~~~~~~~~~W~d~~C~~~~~~~iCe  117 (118)
T cd03603          77 GEPHNN---------GGGNEDYAAINHFPGISGKWNDLANSYNTLGYVIE  117 (118)
T ss_pred             CCCCCC---------CCCCcCeEEeecCCCCCCcCccCCCCccccceEEe
Confidence            444 32         234578887754   35689999999 99999995

CLECT_VCBS: A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces including CaCO3 and ice. Bacterial CTLDs within this group are functionally uncharacterized. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. CTLDs associate with each other through several different surface

>cd03598 CLECT_EMBP_like C-type lectin-like domain (CTLD) of the type found in the human proteins, eosinophil major basic protein (EMBP) and prepro major basic protein homolog (MBPH)

Probab=99.88  E-value=1.8e-22  Score=173.63  Aligned_cols=115  Identities=19%  Similarity=0.430  Sum_probs=94.8

Q ss_pred             CeeeEEecCCCChHHHHHHHhh-CCCeEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCeeEEccCCCCCCcCc
Q 008698           64 SKCFGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESI  141 (557)
Q Consensus        64 ~~Cy~~~~~~~~w~~a~~~C~~-~~~~L~~i~s~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~~  141 (557)
                      ++||+|+.+++||.||+..|++ .||+||+|+|++|++||.+++... ...+||||++.+...++.|.|+||++..|.+ 
T Consensus         1 ~~Cy~~~~~~~t~~~A~~~C~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~WiGl~~~~~~~~~~~~W~dg~~~~y~~-   79 (117)
T cd03598           1 GRCYRFVKSPRTFRDAQVICRRCYRGNLASIHSFAFNYRVQRLVSTLNQAQVWIGGIITGKGRCRRFSWVDGSVWNYAY-   79 (117)
T ss_pred             CceEEEecCCCCHHHHHHHhhcCCCceEeeecChhHhHHHHHHHhCCCCCCEEEeeEcCCCCcCCeeEeCCCCccCcCC-
Confidence            4799999999999999999999 499999999999999999998643 5679999994422557999999999987766 


Q ss_pred             cccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccc
Q 008698          142 HAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       142 ~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~  190 (557)
                      |.+++|++           +.++|+.+....+.|++..|....+|||+.
T Consensus        80 W~~g~p~~-----------~~~~Cv~~~~~~g~W~~~~C~~~~~fiC~~  117 (117)
T cd03598          80 WAPGQPGN-----------RRGHCVELCTRGGHWRRAHCKLRRPFICSY  117 (117)
T ss_pred             CCCCCCCC-----------CCCCcEEEeCCCCeECCCcCCCCceeeecC
Confidence            55554432           346787776555789999999999999973

CLECT_EMBP_like: C-type lectin-like domain (CTLD) of the type found in the human proteins, eosinophil major basic protein (EMBP) and prepro major basic protein homolog (MBPH). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Eosinophils and basophils carry out various functions in allergic, parasitic, and inflammatory diseases. EMBP is stored in eosinophil crystalloid granules and is released upon degranulation. EMBP is also expressed in basophils. The proform of EMBP is expressed in placental X cells and breast tissue and increases significantly during human pregnancy. EMBP has cytotoxic properties and damages bacteria and mammalian cells, in vitro, as well as, helminth parasites. EMBP deposition has been observed in the inflamed tissue of all

>cd03601 CLECT_TC14_like C-type lectin-like domain (CTLD) of the type found in lectins TC14, TC14-2, TC14-3, and TC14-4 from the budding tunicate Polyandrocarpa misakiensis and PfG6 from the Acorn worm

Probab=99.88  E-value=1.9e-22  Score=173.94  Aligned_cols=113  Identities=19%  Similarity=0.328  Sum_probs=88.5

Q ss_pred             eEEecCCCChHHHHHHHhhCCCeEeeeCCHHH--HHHHHHHhCCCCCCeEEeeeecCC-CCCCeeEEccCCCCC-CcCcc
Q 008698           67 FGYIGNFRSWDESETYCKEIGGHLAALTSYEE--EHSAQKLCGKNVNGCWVGGRSINT-TVGLSWKWSDNMSKW-NESIH  142 (557)
Q Consensus        67 y~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e--~~f~~~~~~~~~~~~WiGl~~~~~-~~~~~w~W~Dg~~~~-~~~~~  142 (557)
                      |+|+.+++||.+|+.+|+.+||+||+|+|++|  +++|..........+||||+  |. ..+|.|+|+||+++. .++.|
T Consensus         3 ~~~~~~~~~w~~A~~~C~~~G~~La~i~s~~e~~~~~i~~~~~~~~~~~WIGl~--d~~~~~g~~~W~dG~~~~~~y~~W   80 (119)
T cd03601           3 ILCSDETMNYAKAGAFCRSRGMRLASLAMRDSEMRDAILAFTLVKGHGYWVGAD--NLQDGEYDFLWNDGVSLPTDSDLW   80 (119)
T ss_pred             EEEcCCcCCHHHHHHHHHhcCCEEeeecCHHHHHHHHHHhccccCCccEEEEec--cCCCCCCCeEeCCCCCcCCCCCcc
Confidence            89999999999999999999999999999988  33333322112347999999  66 667999999999984 34556


Q ss_pred             ccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccc
Q 008698          143 AVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       143 ~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~  190 (557)
                      .+++|++         .++.|+|+.+....+.|+|..|....+|||++
T Consensus        81 ~~geP~~---------~~~~e~Cv~~~~~~~~W~d~~C~~~~~fICek  119 (119)
T cd03601          81 APNEPSN---------PQSRQLCVQLWSKYNLLDDEYCGRAKRVICEK  119 (119)
T ss_pred             CCCcCcC---------cCCCcCCeEEeCCCCCEeCccCCCCceeeecC
Confidence            6666654         23457888776655789999999999999974

CLECT_TC14_like: C-type lectin-like domain (CTLD) of the type found in lectins TC14, TC14-2, TC14-3, and TC14-4 from the budding tunicate Polyandrocarpa misakiensis and PfG6 from the Acorn worm. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. TC14 is homodimeric. The CTLD of TC14 binds D-galactose and D-fucose. TC14 is expressed constitutively by multipotent epithelial and mesenchymal cells and plays in role during budding, in inducing the aggregation of undifferentiated mesenchymal cells to give rise to epithelial forming tissue. TC14-2 and TC14-3 shows calcium-dependent galactose binding activity. TC14-3 is a cytostatic factor which blocks cell growth and dedifferentiation of the atrial epithelium during asexual reproducti

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=1.7e-20  Score=189.12  Aligned_cols=257  Identities=27%  Similarity=0.389  Sum_probs=191.8

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchh---hHHHHHHHHHHHhhcCCC-cEEeeeeeeeeCCceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHP-NLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      ..||.|+||.||++...  ..+++|.+......   ....+.+|+..+..+.|+ +|+++++.+......+++++++.++
T Consensus         6 ~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~   83 (384)
T COG0515           6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGG   83 (384)
T ss_pred             EeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCC
Confidence            35799999999999986  88999999765332   367899999999999888 7999999997777789999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CcEEeeccCCccCCcccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++.+++...... ..++......+..|++.++.|+|+.   +++|||+||+||+++... .++++|||+++.........
T Consensus        84 ~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  159 (384)
T COG0515          84 SLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS  159 (384)
T ss_pred             cHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence            999777542211 2688999999999999999999999   999999999999999998 69999999998554433221


Q ss_pred             ----ceeecCccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcc-cchhHHHhhhhhhhccccccc
Q 008698          430 ----RTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYLEL  501 (557)
Q Consensus       430 ----~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  501 (557)
                          ......|+..|+|||.+.+   ..++...|+||+|++++++++|..|+...... ..............    . .
T Consensus       160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~-~  234 (384)
T COG0515         160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT----P-S  234 (384)
T ss_pred             cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC----c-c
Confidence                1233448999999999987   57889999999999999999999996654421 00111111100000    0 0


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      .....    ...........+.+++..|+..+|..|.++.+....
T Consensus       235 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         235 LASPL----SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccc----CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000    000001223467889999999999999998887653

>PHA02867 C-type lectin protein; Provisional

Probab=99.87  E-value=3.7e-22  Score=177.14  Aligned_cols=113  Identities=19%  Similarity=0.410  Sum_probs=90.9

Q ss_pred             CCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCe
Q 008698           48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~  127 (557)
                      ..+++||+||.  .|+++||+|+.+.++|.+|+.+|+++||+||+|+|++|++||.++.+   ..+||||+  +.+   .
T Consensus        44 ~~~~~CP~gWi--~~~~~CY~fs~~~~tW~~A~~~C~~~ga~La~I~s~eE~~Fl~~~~~---~~~WIGLs--~~~---~  113 (167)
T PHA02867         44 YFSKVCPDEWI--GYNSKCYYFTINETNWNDSKKLCDVMDSSLIRFDNIETLNFVSRYGK---GSYWIDIN--QNR---K  113 (167)
T ss_pred             CcCCCCCCCCE--EECCEEEEEeccccCHHHHHHHHhhCCCEECCcCCHHHHHHHHHcCC---CCEEEEEE--eCC---C
Confidence            34579999999  89999999999999999999999999999999999999999998754   47999999  432   3


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      |.|.+++..      ..              ..+.++|+.+..  +...+.+|.....+||+++.
T Consensus       114 ~~~~~~s~~------~~--------------~~~~~~Ca~i~~--~~i~s~~C~~~~~wIC~K~~  156 (167)
T PHA02867        114 IPGINFSLY------YE--------------QGVNDICLLFDT--SNIIEMSCIFHERTICVKED  156 (167)
T ss_pred             CCCccCcee------ee--------------cCCCCcEEEEeC--CeEEeecccCCcEEEEEccC
Confidence            556554332      11              113346776654  47899999999999998863

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=8.5e-21  Score=193.03  Aligned_cols=258  Identities=17%  Similarity=0.174  Sum_probs=187.1

Q ss_pred             CCCeeecccCceEEEEEEeCCC--CEEEEEEecccchhhHHHHHHHHHHHhhcCC----CcEEeeeeee-eeCCceEEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILPDG--SRVAVKRLKRSSFQRKKEFYSEIGRFARLHH----PNLVAVKGCC-YDHGDRYIVY  344 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~g--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H----~niv~l~g~~-~~~~~~~lV~  344 (557)
                      ...+.||+|+||.||.+.....  ..+|+|............+..|..++..+..    +++..+++.. ......++||
T Consensus        21 ~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM  100 (322)
T KOG1164|consen   21 KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVM  100 (322)
T ss_pred             EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEE
Confidence            3455689999999999996553  4789998765432222267778888888762    5777888777 4677889999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-----CCcEEeeccCC
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-----FGAHLMGVGLS  419 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~Dfgl~  419 (557)
                      +.+ +.+|.++.....  .+.++..+.+.|+.|++.+|.+||+.   |++||||||.|+.+...     ..+.+.|||++
T Consensus       101 ~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen  101 SLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             ecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            987 889999775533  56799999999999999999999999   99999999999999865     45899999999


Q ss_pred             ccCC--cccc----cc-c-eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhh
Q 008698          420 KFVP--WEVM----QE-R-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP  491 (557)
Q Consensus       420 ~~~~--~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~  491 (557)
                      +...  ....    .. . .....||.+|+++.+..+.+.+.+.|+||++-++.|+..|..|+...........+.... 
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~-  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP-  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh-
Confidence            8322  1111    11 1 123449999999999999999999999999999999999999986654321111111000 


Q ss_pred             hhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       492 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                            .......         .....+..+.++...+-..+..++|....+...|+...
T Consensus       254 ------~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  254 ------RKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             ------hhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence                  0001110         01112234556666666689999999999988876543

>TIGR00864 PCC polycystin cation channel protein

Probab=99.86  E-value=7.6e-22  Score=231.46  Aligned_cols=131  Identities=18%  Similarity=0.345  Sum_probs=106.1

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhC-CCeEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCe-
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLS-  127 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~s~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~-  127 (557)
                      ..||+||..+.++++||+|+.+.++|.||+.+|+++ |||||+|+|++|++||.++++.. ...+||||+  |...+|. 
T Consensus       316 ~~CP~GW~~f~~~g~CYk~~~e~~TW~dAe~~C~s~GGAhLAsI~S~eEn~FL~~lv~~s~~~~vWIGLs--D~~~EG~g  393 (2740)
T TIGR00864       316 PHCPKDGEIFEENGHCFQIVPEEAAWLDAQEQCLARAGAALAIVDNDALQNFLARKVTHSLDRGVWIGFS--DVNGAEKG  393 (2740)
T ss_pred             CCCCCCCeecCCCCEEEEEeCCccCHHHHHHHhhccCCeEEecCCCHHHHHHHHHHhhccCCccEEEeee--CCCCCCce
Confidence            589999984456899999999999999999999999 59999999999999999998643 346999999  6555554 


Q ss_pred             -eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccccC
Q 008698          128 -WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN  194 (557)
Q Consensus       128 -w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~s  194 (557)
                       |+|+||+++..+..|.+++|++          .+.|+|+.+.. .+.|+|..|....+|||+.+...
T Consensus       394 ~WvWsDGS~l~~YtnW~pGEPNn----------~~~EdCV~l~~-~g~WND~~Cs~~~~FICE~~~~~  450 (2740)
T TIGR00864       394 PAHQGEAFEAEECEEGLAGEPHP----------ARAEHCVRLDP-RGQCNSDLCNAPHAYVCELNPGG  450 (2740)
T ss_pred             eeEECCCCcccCccCcCCCCCCC----------CCCCCCEEEcC-CCCEEccCCCCCeeEEeEECCCC
Confidence             9999999984444466665553          23478877654 35699999999999999876544

Note: this model has been restricted to the amino half because for technical reasons.

>smart00034 CLECT C-type lectin (CTL) or carbohydrate-recognition domain (CRD)

Probab=99.86  E-value=2e-21  Score=168.95  Aligned_cols=122  Identities=26%  Similarity=0.624  Sum_probs=101.6

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCeeE
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLSWK  129 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~w~  129 (557)
                      ||+||.  .++++||+++....+|.+|+.+|+++||+||+|+|.+|++||.+++...   ...+||||+  +....+.|+
T Consensus         1 Cp~~w~--~~~~~Cy~~~~~~~~~~~A~~~C~~~~~~La~i~~~~e~~~i~~~~~~~~~~~~~~WiG~~--~~~~~~~~~   76 (126)
T smart00034        1 CPSGWI--SYGGKCYKFSTEKKTWADAQAFCQSLGAHLASIHSEAENDFVASLLKNSGSNSDYYWIGLS--DPDSNGSWQ   76 (126)
T ss_pred             CCcchh--hhCCEEEEEECCccCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHHHhhcCCCCCEEEecC--ccCcCCCeE
Confidence            999999  7899999999999999999999999999999999999999999998753   568999999  545568999


Q ss_pred             EccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC-CceeccccCCCCCcccc
Q 008698          130 WSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICM  189 (557)
Q Consensus       130 W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~-~~w~~~~C~~~~~~iC~  189 (557)
                      |+||++...+..|.+++ +          ..+.+.|+.+.... ..|.+..|....+|||+
T Consensus        77 W~dg~~~~~~~~w~~~~-~----------~~~~~~C~~~~~~~~~~w~~~~C~~~~~~ICe  126 (126)
T smart00034       77 WSDGSGPVNYSNWAPGE-P----------NGGSGDCVVLSTSGGGKWNDVSCTSKLPFVCE  126 (126)
T ss_pred             ECCCCCCCCccccCCCC-C----------CCCCCCCEEEecCCCCcccCCCCCCCcccccC
Confidence            99999944344455542 1          22456787776554 57999999999999995

Many of these domains function as calcium-dependent carbohydrate binding modules.

>cd03592 CLECT_selectins_like C-type lectin-like domain (CTLD) of the type found in the type 1 transmembrane proteins: P(platlet)-, E(endothelial)-, and L(leukocyte)- selectins (sels)

Probab=99.86  E-value=1.9e-21  Score=166.80  Aligned_cols=111  Identities=20%  Similarity=0.332  Sum_probs=91.7

Q ss_pred             eEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCeeEEccCCCCCCcCccccC
Q 008698           67 FGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVG  145 (557)
Q Consensus        67 y~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~~~~~~  145 (557)
                      |+|+.++++|.+|+.+|+.+||+||+|+|++|++||.+++... ...+||||+  +...++.|.|+||+++.|.+|. ++
T Consensus         3 Y~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~i~~~~~~~~~~~~WiG~~--~~~~~~~W~~~dg~~~~y~~W~-~g   79 (115)
T cd03592           3 YHYSTEKMTFNEAVKYCKSRGTDLVAIQNAEENALLNGFALKYNLGYYWIDGN--DINNEGTWVDTDKKELEYKNWA-PG   79 (115)
T ss_pred             EEEcCCccCHHHHHHHHHHcCCeEeecCCHHHHHHHHHHHHhcCCCCEEEeCc--cCCccCeEEeCCCCcccccccC-CC
Confidence            8999999999999999999999999999999999999976533 447999999  5556799999999987766654 45


Q ss_pred             CCCCCCCCCCCccccccCceeEeecC-CCceeccccCCCCCccccc
Q 008698          146 SFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       146 ~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~~  190 (557)
                      +|++          .+.++|+.+... .+.|++..|....+|||++
T Consensus        80 eP~~----------~~~~~Cv~~~~~~~g~W~d~~C~~~~~fICe~  115 (115)
T cd03592          80 EPNN----------GRNENCLEIYIKDNGKWNDEPCSKKKSAICYT  115 (115)
T ss_pred             CCCC----------CCCCCceEEccCCCCCCcCcCCCCCccceeCC
Confidence            4443          124678777653 5779999999999999974

CLECT_selectins_like: C-type lectin-like domain (CTLD) of the type found in the type 1 transmembrane proteins: P(platlet)-, E(endothelial)-, and L(leukocyte)- selectins (sels). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. P- E- and L-sels are cell adhesion receptors that mediate the initial attachment, tethering, and rolling of lymphocytes on inflamed vascular walls enabling subsequent lymphocyte adhesion and transmigration. L- sel is expressed constitutively on most leukocytes. P-sel is stored in the Weibel-Palade bodies of endothelial cells and in the alpha granules of platlets. E- sels are present on endothelial cells. Following platelet and/or endothelial cell activation P- sel is rapidly translocated to the cell surface and E-sel exp

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=2e-21  Score=200.98  Aligned_cols=217  Identities=24%  Similarity=0.393  Sum_probs=164.3

Q ss_pred             HhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-eecC
Q 008698          319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV-VHRD  397 (557)
Q Consensus       319 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vH~D  397 (557)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+..   ....+++.-...+.++|+.||.|||+.   +| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            3567899999999999999999999999999999999975   346699999999999999999999987   44 9999


Q ss_pred             CCCCCeeeCCCCCcEEeeccCCccCCccccccceeecCccccccccccccCC---C----CCchhhHHHHHHHHHHHHcC
Q 008698          398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN---E----LTTKSDVYSFGVLLLEIVSG  470 (557)
Q Consensus       398 lk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~s~~sDVwS~Gvil~el~tG  470 (557)
                      |+++|+++|..+.+||+|||+....................-|.|||.+...   .    .+.++||||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            9999999999999999999999876431111111111134579999988763   1    46789999999999999999


Q ss_pred             CCCCCCCCcccc-hhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          471 RRPAQAVDSVCW-QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       471 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                      +.||........ ..++..+.   +  .....+.|.+...      .+..+.+..++..||..+|.+||++++|-..++.
T Consensus       155 ~~~~~~~~~~~~~~eii~~~~---~--~~~~~~rP~i~~~------~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~  223 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRVK---K--GGSNPFRPSIELL------NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT  223 (484)
T ss_pred             cCccccccccCChHHHHHHHH---h--cCCCCcCcchhhh------hhcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence            999987433221 11221111   1  1122233333111      1334468999999999999999999999998876


Q ss_pred             ccC
Q 008698          550 LAQ  552 (557)
Q Consensus       550 ~~~  552 (557)
                      +..
T Consensus       224 ~~~  226 (484)
T KOG1023|consen  224 INK  226 (484)
T ss_pred             hcc
Confidence            654

>cd03602 CLECT_1 C-type lectin (CTL)/C-type lectin-like (CTLD) domain subgroup 1; a subgroup of protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins

Probab=99.85  E-value=4.1e-21  Score=162.80  Aligned_cols=108  Identities=21%  Similarity=0.420  Sum_probs=90.6

Q ss_pred             eeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCCCcCcccc
Q 008698           65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV  144 (557)
Q Consensus        65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~~~~~  144 (557)
                      +||+|+.++++|.+|+.+|+.+||+||+|+|++|++||.+++......+||||+  +.  ++.|.|+||++..+.+ |.+
T Consensus         1 ~~y~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~--~~~~~W~dg~~~~~~~-w~~   75 (108)
T cd03602           1 RTFYLVNESKTWSEAQQYCRENYTDLATVQNQEDNALLSNLSRVSNSAAWIGLY--RD--VDSWRWSDGSESSFRN-WNT   75 (108)
T ss_pred             CceEEeccccCHHHHHHHHHHHCCccCeecCHHHHHHHHHHHhccCCcEEEEEE--CC--CCceEEcCCCCCccCc-cCC
Confidence            489999999999999999999999999999999999999998644668999999  44  5899999999976665 444


Q ss_pred             CCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccc
Q 008698          145 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       145 ~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~  190 (557)
                      ++|+            +.++|+.+... +.|++..|....+|||+.
T Consensus        76 ~~~~------------~~~~C~~~~~~-~~w~~~~C~~~~~fIC~~  108 (108)
T cd03602          76 FQPF------------GQGDCATMYSS-GRWYAALCSALKPFICYD  108 (108)
T ss_pred             CCCC------------CCCCeeEECcC-CeECcccCCCCcCEeccC
Confidence            4322            23578877654 689999999999999973

CLECT_1: C-type lectin (CTL)/C-type lectin-like (CTLD) domain subgroup 1; a subgroup of protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces including CaCO3 and ice. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. CTLDs associate with each other through several different surfaces to form dimers, trimers, or tetramers from which ligand-binding sites project in differe

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=9e-22  Score=212.98  Aligned_cols=256  Identities=18%  Similarity=0.223  Sum_probs=184.1

Q ss_pred             CCCCCeeecccCceEEEEEEe-CCCCEEEEEEec----ccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEE
Q 008698          270 FSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLK----RSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~----~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l  342 (557)
                      +.....++|.|++|.|+.... ...+..+.|...    ...  ......+..|+.+-..++|||++..+..+.+....+-
T Consensus       319 y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~  398 (601)
T KOG0590|consen  319 YGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ  398 (601)
T ss_pred             cCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence            334456789999997777663 233434444332    111  1112236677888888999999988887777766666


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      +|||+++ +|..++..    ...++...+-.++.|+..|++|+|+.   ||.|||||++|++++.++.+||+|||.+...
T Consensus       399 ~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  399 SMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVF  470 (601)
T ss_pred             hhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceee
Confidence            7999999 99988864    23588888999999999999999999   9999999999999999999999999999765


Q ss_pred             Cccccc--cceeecCccccccccccccCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          423 PWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTT-KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       423 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~-~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ......  .......|+-+|+|||.+...+|.+ ..||||.|+++..|++|+.|+......+.+. ...    ...... 
T Consensus       471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~----~~~~~~-  544 (601)
T KOG0590|consen  471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTN----NYSDQR-  544 (601)
T ss_pred             ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhh----cccccc-
Confidence            443332  2333445899999999999988876 5799999999999999999986543321110 000    000000 


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+...      ........+.....++.++++.+|.+|.|+++|++
T Consensus       545 ~~~~~------~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  545 NIFEG------PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccC------hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00000      11112334566789999999999999999999986

>cd03600 CLECT_thrombomodulin_like C-type lectin-like domain (CTLD) of the type found in human thrombomodulin(TM), Endosialin, C14orf27, and C1qR

Probab=99.84  E-value=8.2e-21  Score=169.02  Aligned_cols=119  Identities=18%  Similarity=0.317  Sum_probs=93.0

Q ss_pred             CCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC-------CCCeEEeeeecCC------CCCCee
Q 008698           62 EKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-------VNGCWVGGRSINT------TVGLSW  128 (557)
Q Consensus        62 ~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~-------~~~~WiGl~~~~~------~~~~~w  128 (557)
                      .+++||+++.++++|.+|+.+|+++|||||+|+|.+|++||++++...       ...+||||++...      ..++.|
T Consensus         2 ~~~~Cy~~~~~~~sw~~A~~~C~~~gg~La~i~s~~E~~~v~~~l~~~~~~~~~~~~~~WIGl~~~~~~~~~~~~~~~~f   81 (141)
T cd03600           2 VSDACYTLHPQKLTFLEAQRSCIELGGNLATVRSGEEADVVSLLLAAGPGRHGRGSLRLWIGLQREPRQCSDPSLPLRGF   81 (141)
T ss_pred             CCCceEEEeCCccCHHHHHHHHHhhCCEeeecCCHHHHHHHHHHHhhccccccCCCccEEEeEecCcccCccccccCCcc
Confidence            467899999999999999999999999999999999999999988643       3579999994211      234789


Q ss_pred             EEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecC-----CCceeccccCCC-CCccccc
Q 008698          129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-----SRSLVTERCNTS-HPFICMV  190 (557)
Q Consensus       129 ~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-----~~~w~~~~C~~~-~~~iC~~  190 (557)
                      .|+||++...++.|.++| ++.+         +.++|+.+...     ...|++..|... .+|||+.
T Consensus        82 ~W~d~~~~~~y~~W~~~p-~n~~---------~~~~Cv~l~~~~~~~~~~~W~d~~C~~~~~~fIC~~  139 (141)
T cd03600          82 SWVTGDQDTDFSNWLQEP-AGTC---------TSPRCVALSAAGSTPDNLKWKDGPCSARADGYLCKF  139 (141)
T ss_pred             EECCCCCCCCccccccCC-CCCC---------CCCccEEEEccCCCCCCCccccCCcCCCCCCeEEee
Confidence            999987654455566664 4432         34677776543     247999999987 4799985

CLECT_thrombomodulin_like: C-type lectin-like domain (CTLD) of the type found in human thrombomodulin(TM), Endosialin, C14orf27, and C1qR. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. In these thrombomodulin-like proteins the residues involved in coordinating Ca2+ in the classical MBP-A CTLD are not conserved. TM exerts anti-fibrinolytic and anti-inflammatory activity. TM also regulates blood coagulation in the anticoagulant protein C pathway. In this pathway, the procoagulant properties of thrombin (T) are lost when it binds TM. TM also plays a key role in tumor biology. It is expressed on endothelial cells and on several type of tumor cell including squamous cell carcinoma. Loss of TM expression correlates with advanced stage and poor prognosis. Loss of function of TM func

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=9.7e-21  Score=177.06  Aligned_cols=138  Identities=17%  Similarity=0.164  Sum_probs=106.7

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchh--h-------HHH-----------------HHHHHHHHhhcCCCcEE
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ--R-------KKE-----------------FYSEIGRFARLHHPNLV  328 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~--~-------~~~-----------------~~~e~~~l~~l~H~niv  328 (557)
                      ..||+|++|.||+|...+|+.||||+++.....  .       ...                 ..+|+..+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            357999999999999888999999999754211  1       112                 23489999999877764


Q ss_pred             eeeeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCCCCCeeeCC
Q 008698          329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL-HDKVKPHVVHRDIRASNVLLDE  407 (557)
Q Consensus       329 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlk~~Nill~~  407 (557)
                      ....+..  ...++||||++++++......    ...++......++.|++.+|.|+ |+.   +|+||||||+|||++ 
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-  152 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence            3332211  233899999988877544321    24688999999999999999999 688   999999999999998 


Q ss_pred             CCCcEEeeccCCccC
Q 008698          408 EFGAHLMGVGLSKFV  422 (557)
Q Consensus       408 ~~~~kl~Dfgl~~~~  422 (557)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd03595 CLECT_chondrolectin_like C-type lectin-like domain (CTLD) of the type found in the human type-1A transmembrane proteins chondrolectin (CHODL) and layilin

Probab=99.84  E-value=1.4e-20  Score=168.89  Aligned_cols=117  Identities=17%  Similarity=0.343  Sum_probs=90.7

Q ss_pred             CCCCeeeEEe-----cCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCC------CC
Q 008698           61 EEKSKCFGYI-----GNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTV------GL  126 (557)
Q Consensus        61 ~~~~~Cy~~~-----~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~------~~  126 (557)
                      .|+++||+++     .+++||.+|+.+|+.+||+||+|+|++|++||.+++...   ...+||||++...+.      ++
T Consensus         7 ~~~~~Cy~~~~~~~~~~~~tw~~A~~~C~~~g~~LasI~s~~E~~~i~~~i~~~~~~~~~~WIGl~~~~~~~~~~~~~~~   86 (149)
T cd03595           7 GTEKPCYKIAYFQDSRRRLNFEEARQACREDGGELLSIESENEQKLIERFIQTLRASDGDFWIGLRRSSQYNVTSSACSS   86 (149)
T ss_pred             CCCCccEEEEEEeccccccCHHHHHHHHHHcCCEECccCCHHHHHHHHHHHHhhcCCCCcEEEEeECCCCccccccccCC
Confidence            5668999864     789999999999999999999999999999999987532   457999999432210      25


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecC-----------CCceeccccCCCCCcccc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-----------SRSLVTERCNTSHPFICM  189 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-----------~~~w~~~~C~~~~~~iC~  189 (557)
                      .|.|+||+++.|.+|.. ++|++           +.++|+.+...           ...|++..|....+|||+
T Consensus        87 ~~~W~dG~~~~y~~W~~-~eP~~-----------~~~~Cv~l~~~~~~~~~~~~~~~~~W~d~~C~~~~~fICe  148 (149)
T cd03595          87 LYYWLDGSISTFRNWYV-DEPSC-----------GSEVCVVMYHQPSAPAGQGGPYLFQWNDDNCNMKNNFICK  148 (149)
T ss_pred             ccEEcCCCccCccCCCC-CCCCC-----------cccCCEEEEecCCCCcCcCcccCCCccCCCCCCCcccccC
Confidence            69999999988776544 44432           23567665431           236999999999999997

CLECT_chondrolectin_like: C-type lectin-like domain (CTLD) of the type found in the human type-1A transmembrane proteins chondrolectin (CHODL) and layilin. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. CHODL is predominantly expressed in muscle cells and is associated with T-cell maturation. Various alternatively spliced isoforms have been of CHODL have been identified. The transmembrane form of CHODL is localized in the ER-Golgi apparatus. Layilin is widely expressed in different cell types. The extracellular CTLD of layilin binds hyaluronan (HA), a major constituent of the extracellular matrix (ECM). The cytoplasmic tail of layilin binds various members of the band 4.1/ERM superfamily (talin, radixin, and merlin). The ERM proteins are cytoskeleton-membrane l

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=6.8e-20  Score=175.17  Aligned_cols=201  Identities=18%  Similarity=0.272  Sum_probs=167.0

Q ss_pred             CeeecccCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||..+.|+ +-++.+||||.-...+  ...++..|....+.| .-++|..++.+-.++.+..||+|.+ +.|
T Consensus        33 GkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPS  109 (449)
T KOG1165|consen   33 GKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPS  109 (449)
T ss_pred             ccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcC
Confidence            4457999999999999 5589999999864432  345677788888887 5799999988888888999999988 889


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-----CcEEeeccCCccCCccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-----GAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~Dfgl~~~~~~~~  426 (557)
                      |+|++.-   .++.|+.+++..+|.|++.-++|+|++   .+|.|||||+|+||...+     .+.++|||+|+...+..
T Consensus       110 LEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~  183 (449)
T KOG1165|consen  110 LEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK  183 (449)
T ss_pred             HHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence            9988753   457799999999999999999999999   999999999999997543     47999999999876554


Q ss_pred             cccc-----eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch
Q 008698          427 MQER-----TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ  483 (557)
Q Consensus       427 ~~~~-----~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~  483 (557)
                      +...     .....||.+||+--...+.+-+.+-|+=|+|-++...+-|..|+++.......
T Consensus       184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK  245 (449)
T KOG1165|consen  184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK  245 (449)
T ss_pred             ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH
Confidence            4322     22334999999999999999999999999999999999999999987554433

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=1.9e-20  Score=177.30  Aligned_cols=174  Identities=10%  Similarity=0.106  Sum_probs=132.1

Q ss_pred             HHhhcCCCCCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHH---------HHHHHHHHHhhcCCCcEEeeeeee
Q 008698          264 RSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKK---------EFYSEIGRFARLHHPNLVAVKGCC  334 (557)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~---------~~~~e~~~l~~l~H~niv~l~g~~  334 (557)
                      ..+.++.....+++|.|+||.||.... ++..+|||+++........         .+.+|+..+.+++|++|..+..++
T Consensus        26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            344555566677899999999999655 6778999999754322222         268999999999999999998885


Q ss_pred             eeC--------CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 008698          335 YDH--------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD  406 (557)
Q Consensus       335 ~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~  406 (557)
                      ...        +..+|||||++|.+|.++..        ++.    ....+++.+|..+|+.   +++|||++|+||+++
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~  169 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS  169 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence            533        35789999999999987642        222    2456999999999999   999999999999999


Q ss_pred             CCCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHH
Q 008698          407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV  468 (557)
Q Consensus       407 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~  468 (557)
                      +++ ++|+|||............              .++....+..++|+||||+++.-+.
T Consensus       170 ~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        170 KNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence            988 9999999886543221111              1334445667899999999887654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=8.4e-20  Score=167.31  Aligned_cols=252  Identities=17%  Similarity=0.247  Sum_probs=185.2

Q ss_pred             CeeecccCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC-CcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      -+.||+|+||.+|.|. ..+|..||||+-+...  ...++..|..+...|+| ..|..+..+..+.....+||+.+ +.|
T Consensus        20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPs   96 (341)
T KOG1163|consen   20 VRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPS   96 (341)
T ss_pred             EEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Ccc
Confidence            3457999999999998 4679999999876542  33467788999999965 66777788888888999999988 889


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCcEEeeccCCccCCccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      |++++.-.   .+.++.++.+-++-|++.-+.|+|.+   ++|||||||+|.|..-+   ..+.++|||+|+...+..+.
T Consensus        97 LEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~  170 (341)
T KOG1163|consen   97 LEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR  170 (341)
T ss_pred             HHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence            99988653   35699999999999999999999999   99999999999999654   34789999999876443322


Q ss_pred             cc-----eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccC
Q 008698          429 ER-----TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  503 (557)
Q Consensus       429 ~~-----~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  503 (557)
                      ..     .....||.+|.+--...+-+-+.+-|+=|+|-+|..+--|..|+++......++-.+....    .+..-.+.
T Consensus       171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E----kK~s~~ie  246 (341)
T KOG1163|consen  171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE----KKMSTPIE  246 (341)
T ss_pred             ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH----hhcCCCHH
Confidence            11     1122389999998888777778899999999999999999999998765433332221111    11111111


Q ss_pred             cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008698          504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  547 (557)
Q Consensus       504 ~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L  547 (557)
                      ..         -.+.+.++.-.+.-|-..-=++-|...-+-+.+
T Consensus       247 ~L---------C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  247 VL---------CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             HH---------hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            11         122344566667777777777777765555443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=6.4e-21  Score=206.20  Aligned_cols=247  Identities=21%  Similarity=0.236  Sum_probs=177.0

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccc-hhhHHHHHHHHHH--HhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSS-FQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .||++.|=.|.+++.++|. |+||++-+.. .-..+.|.+++.-  ...++|||.+++.-+.......|||-+|..+ +|
T Consensus        30 ~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nL  107 (1431)
T KOG1240|consen   30 NLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NL  107 (1431)
T ss_pred             ccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hh
Confidence            4799999999999997777 9999986543 3334444444333  4455899999998887777788899999854 78


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc--CCccccccc
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQER  430 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~--~~~~~~~~~  430 (557)
                      .|.|..    ...+...+..-|+.|++.||.-.|..   +|+|||||.+||||+.-.-+.|+||.--+.  ++.+...+.
T Consensus       108 yDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  108 YDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             hhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence            887753    34577788889999999999999999   999999999999999999999999976542  232222222


Q ss_pred             ee---ecCccccccccccccC----------CC-CCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhc
Q 008698          431 TV---MAGGTYGYLAPEFVYR----------NE-LTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS  495 (557)
Q Consensus       431 ~~---~~~gt~~y~aPE~~~~----------~~-~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~  495 (557)
                      ..   +.+.-..|+|||.+..          .. .+++-||||+||++.||++ |++||.-      .+++.+-..-  .
T Consensus       181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr~~~--~  252 (1431)
T KOG1240|consen  181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYRSGN--A  252 (1431)
T ss_pred             eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHhccC--c
Confidence            21   1123357999997743          12 5788999999999999999 6777752      2333221110  0


Q ss_pred             cccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       496 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      ......+..        .    +...+.+++..|++.||+.|.+++++++.-.+..
T Consensus       253 ~~~e~~Le~--------I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  253 DDPEQLLEK--------I----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             cCHHHHHHh--------C----cCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence            111111111        1    1125889999999999999999999999865544

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=1.1e-19  Score=170.40  Aligned_cols=138  Identities=17%  Similarity=0.173  Sum_probs=109.3

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchh--h------------------------HHHHHHHHHHHhhcCCCcEE
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ--R------------------------KKEFYSEIGRFARLHHPNLV  328 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~H~niv  328 (557)
                      ..||+|++|.||+|...+|+.||||+++.....  .                        ...+.+|...+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            368999999999999878999999998754210  0                        12235789999999999875


Q ss_pred             eeeeeeeeCCceEEEEecCCCCChHHH-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeC
Q 008698          329 AVKGCCYDHGDRYIVYEFVVNGPLDRW-LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLD  406 (557)
Q Consensus       329 ~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~  406 (557)
                      ....+...  ..++||||++++++... +..     ..++......++.|++.+|.++|+ .   +|+||||||+|||++
T Consensus        83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            44333322  34899999988865433 321     347788899999999999999999 8   999999999999999


Q ss_pred             CCCCcEEeeccCCccCC
Q 008698          407 EEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       407 ~~~~~kl~Dfgl~~~~~  423 (557)
                       ++.++|+|||++....
T Consensus       153 -~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 -DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CCCEEEEEcccceecC
Confidence             7899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=8e-19  Score=171.25  Aligned_cols=230  Identities=18%  Similarity=0.193  Sum_probs=146.7

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEeccc---chhhHHHHHHHHHHHhhcCC----------CcEEeeeeeee----
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHH----------PNLVAVKGCCY----  335 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H----------~niv~l~g~~~----  335 (557)
                      ..+||.|+++.||.++..+ |+++|||++...   .....+++.+|.-....+.+          -.++..++...    
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            4578999999999999754 899999997533   22345667777655555332          11211112111    


Q ss_pred             -----eC---C-----ceEEEEecCCCCChHHHhc---cCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 008698          336 -----DH---G-----DRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR  399 (557)
Q Consensus       336 -----~~---~-----~~~lV~E~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk  399 (557)
                           ..   +     ..+++|+-+ .++|.+++.   ........+....++.+..|+++.+++||+.   |++|+||+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence                 11   0     236677766 668877753   2222223355566778889999999999999   99999999


Q ss_pred             CCCeeeCCCCCcEEeeccCCccCCccccccceeecCccccccccccccC--------CCCCchhhHHHHHHHHHHHHcCC
Q 008698          400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR--------NELTTKSDVYSFGVLLLEIVSGR  471 (557)
Q Consensus       400 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDVwS~Gvil~el~tG~  471 (557)
                      |+|+|++.+|.+.|+||+.....+.....     ...+..|.+||....        -.+|.+.|.|++|+++|.|++|.
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            99999999999999999877654432221     124578999996643        24788999999999999999999


Q ss_pred             CCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCC
Q 008698          472 RPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR  537 (557)
Q Consensus       472 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R  537 (557)
                      .||....+......                   ..    ... . +.++.+..|+...++.+|.+|
T Consensus       248 lPf~~~~~~~~~~~-------------------~f----~~C-~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEW-------------------DF----SRC-R-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGG-------------------GG----TTS-S----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccc-------------------cc----hhc-C-CcCHHHHHHHHHHccCCcccC
Confidence            99986543211100                   11    111 2 567789999999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=2e-18  Score=163.04  Aligned_cols=135  Identities=15%  Similarity=0.196  Sum_probs=105.4

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-----CCCcEEeeeeeeeeCC---ce-EEEE
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-----HHPNLVAVKGCCYDHG---DR-YIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~g~~~~~~---~~-~lV~  344 (557)
                      ..+||+|++|.||.  .++....+||++........+.+.+|+.++..+     .||||++++|++.++.   .. .+|+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            45789999999996  433333479998765445567899999999999     5799999999998763   32 3789


Q ss_pred             ec--CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeeecCCCCCCeeeCC----CCCcEEeecc
Q 008698          345 EF--VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI-AFLHDKVKPHVVHRDIRASNVLLDE----EFGAHLMGVG  417 (557)
Q Consensus       345 E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~Dfg  417 (557)
                      ||  +++|+|.+++.+     ..+++.  ..++.|++.++ +|||++   +|+||||||+|||++.    +..++|+||+
T Consensus        85 e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         85 DFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             cCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            99  557999999964     225554  35677888777 999999   9999999999999974    3479999955


Q ss_pred             CCc
Q 008698          418 LSK  420 (557)
Q Consensus       418 l~~  420 (557)
                      .+.
T Consensus       155 G~~  157 (210)
T PRK10345        155 GES  157 (210)
T ss_pred             CCc
Confidence            443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2.6e-18  Score=159.45  Aligned_cols=184  Identities=11%  Similarity=-0.006  Sum_probs=136.2

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhh----HHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR----KKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ..|++|+||+||.+.. ++.+++.+.+.....-.    ...+.+|+++|.+|+ |+++++++++    +..+++|||+.+
T Consensus         8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G   82 (218)
T PRK12274          8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG   82 (218)
T ss_pred             eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence            4679999999997665 78888888886653311    225789999999994 5889998886    456999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI-RASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      .+|...+..           ....++.|++.+|.++|+.   +|+|||| ||+|||++.++.++|+|||++.........
T Consensus        83 ~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         83 AAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            888654311           1135778999999999999   9999999 799999999999999999999855432210


Q ss_pred             ----c-------ceeecCccccccccccccCC-CCC-chhhHHHHHHHHHHHHcCCCCCCCC
Q 008698          429 ----E-------RTVMAGGTYGYLAPEFVYRN-ELT-TKSDVYSFGVLLLEIVSGRRPAQAV  477 (557)
Q Consensus       429 ----~-------~~~~~~gt~~y~aPE~~~~~-~~s-~~sDVwS~Gvil~el~tG~~p~~~~  477 (557)
                          .       .......++.|++|+-..-. ..+ ...+-++-|.-+|.++||..+....
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                0       00011146677777643321 233 4678899999999999998876543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=1.9e-19  Score=186.25  Aligned_cols=224  Identities=26%  Similarity=0.288  Sum_probs=172.6

Q ss_pred             ecccCceEEEEEE----eCCCCEEEEEEecccchhh--HHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          277 LGDSKTGGTYSGI----LPDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       277 lg~G~~g~Vy~g~----~~~g~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      +|+|+||.|+...    .+.|.-+|.|++++.....  ......|..++..++ ||.++++...+..+...+++++|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            5999999998744    3457789999887643211  124556777888886 99999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |.|...+.+    ...++......+...+|-+++++|+.   +++|||+|++||+++.+|.+++.|||+++..-..... 
T Consensus        82 g~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   82 GDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             chhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            999877753    34567777777888999999999999   9999999999999999999999999999865433222 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                           +||..|||||.+.  .....+|-||||++++||+||-.||....          ...+         +..     
T Consensus       154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~----------~~~I---------l~~-----  202 (612)
T KOG0603|consen  154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT----------MKRI---------LKA-----  202 (612)
T ss_pred             -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH----------HHHH---------hhh-----
Confidence                 5899999999987  45778999999999999999999998610          0000         000     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  540 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~  540 (557)
                       ....+.........++......+|..|.-.
T Consensus       203 -~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  203 -ELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             -ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence             111234445556677777778888888754

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=1.1e-17  Score=163.48  Aligned_cols=197  Identities=23%  Similarity=0.302  Sum_probs=138.3

Q ss_pred             CCCcEEeeeeeeeeC---------------------------CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHH
Q 008698          323 HHPNLVAVKGCCYDH---------------------------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVA  375 (557)
Q Consensus       323 ~H~niv~l~g~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  375 (557)
                      +|||||++.++|.+.                           ...|+||...+ -+|+.++..     +..+.....-|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence            699999999987532                           24589998774 489999864     446677788899


Q ss_pred             HHHHHHHHHHhcCCCCCeeecCCCCCCeee--CCCCC--cEEeeccCCccCCcc----ccccceeecCcccccccccccc
Q 008698          376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLL--DEEFG--AHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEFVY  447 (557)
Q Consensus       376 ~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill--~~~~~--~kl~Dfgl~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~  447 (557)
                      .|+++|+.|||.+   +|.|||||++|||+  |+|..  ..|+|||.+-.....    .+.......+|...-||||...
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999   99999999999998  44433  588999987543221    1112223344788899999886


Q ss_pred             CCC--C----CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHH
Q 008698          448 RNE--L----TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQK  521 (557)
Q Consensus       448 ~~~--~----s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~  521 (557)
                      ..+  .    -.|+|.|+.|.+.||+++...||....... .+.          ..+.+.--|.+        +..++..
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~----------r~Yqe~qLPal--------p~~vpp~  485 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDT----------RTYQESQLPAL--------PSRVPPV  485 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-ech----------hhhhhhhCCCC--------cccCChH
Confidence            422  1    248999999999999999999997632210 000          00111111111        2234556


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008698          522 VVDLVYACTQHVPSMRPRMSHVVHQL  547 (557)
Q Consensus       522 l~~l~~~Cl~~~P~~RPt~~evl~~L  547 (557)
                      +.+++...++.||++||+..-....|
T Consensus       486 ~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  486 ARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHHHHhcCCccccCCccHHHhHH
Confidence            88999999999999999976555444

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=2.9e-17  Score=156.74  Aligned_cols=133  Identities=19%  Similarity=0.300  Sum_probs=112.9

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .||+|++|.||+|.. +|..|+||+......        .....+.+|+.++..++|++|.....++...+..++||||+
T Consensus         3 ~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          3 LIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             ccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            579999999999988 788899998654321        11246788999999999999887777777778889999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      ++++|.+++...       .. .+..++.+++.+|.++|+.   +++|+|++|+|||++ ++.++|+|||.+..
T Consensus        82 ~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999988531       12 7889999999999999999   999999999999999 78899999998864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=2.5e-17  Score=155.68  Aligned_cols=131  Identities=20%  Similarity=0.299  Sum_probs=107.3

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +||+|++|.||+|.+ +|..|++|+......        ....++.+|+.++..++|+++.....+....+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999996 788999998653211        12356788999999999887665555556666779999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      ++++|.+++...    . .      .++.+++.+|.+||+.   +++|+|++|+||+++ ++.+++.|||++...
T Consensus        80 ~g~~l~~~~~~~----~-~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEG----N-D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhc----H-H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999887531    0 0      7899999999999999   999999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=6.8e-17  Score=156.32  Aligned_cols=141  Identities=16%  Similarity=0.146  Sum_probs=108.7

Q ss_pred             CCCCeeecccCceEEEEEE--eCCCCEEEEEEecccchh------------------------hHHHHHHHHHHHhhcCC
Q 008698          271 SEGNRLLGDSKTGGTYSGI--LPDGSRVAVKRLKRSSFQ------------------------RKKEFYSEIGRFARLHH  324 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~H  324 (557)
                      +.....||+|++|.||+|.  ..+|+.||||+++.....                        ....+.+|+..+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            4455678999999999998  568999999998753210                        11235689999999975


Q ss_pred             Cc--EEeeeeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCC
Q 008698          325 PN--LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH-VVHRDIRAS  401 (557)
Q Consensus       325 ~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~Dlk~~  401 (557)
                      ..  +.++++.    ...++||||+++++|...+..    ...+...+...++.||+.+|++||+.   + ++||||||+
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~  178 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY  178 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence            33  3444442    235899999999888665422    23456666789999999999999999   8 999999999


Q ss_pred             CeeeCCCCCcEEeeccCCccCC
Q 008698          402 NVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       402 Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      ||+++ ++.++|+|||.+....
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccC
Confidence            99999 8899999999987543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=9e-17  Score=177.69  Aligned_cols=189  Identities=19%  Similarity=0.230  Sum_probs=146.6

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC---CCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.+|+|+||+||+|...+|+.||+|+=+..+.-.   |.-=.+++.||+   -+-|..+...+.-.+.-+||+||.+.|
T Consensus       703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~G  779 (974)
T KOG1166|consen  703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYG  779 (974)
T ss_pred             EeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccc
Confidence            45689999999999998889999999987654221   222223333443   233444444445567778999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-------CCCcEEeeccCCccCC
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-------EFGAHLMGVGLSKFVP  423 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~-------~~~~kl~Dfgl~~~~~  423 (557)
                      +|.++++    ..+.+++...+.++.|++.-+..||..   +|||+||||+|.||..       +..++|+|||.+..+.
T Consensus       780 tlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~  852 (974)
T KOG1166|consen  780 TLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK  852 (974)
T ss_pred             cHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence            9999997    356799999999999999999999999   9999999999999943       4568999999997553


Q ss_pred             ccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR  472 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~  472 (557)
                      --.....-....+|-.+--+|...+.+.+...|.|.|.-+++-|+-|+.
T Consensus       853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            2211111222337888899999999999999999999999999999874

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.69  E-value=2.3e-16  Score=149.01  Aligned_cols=136  Identities=16%  Similarity=0.147  Sum_probs=106.3

Q ss_pred             CCCCeeecccCceEEEEEEeCCCCEEEEEEecccch----------------------hhHHHHHHHHHHHhhcCCCc--
Q 008698          271 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF----------------------QRKKEFYSEIGRFARLHHPN--  326 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~H~n--  326 (557)
                      +...+.||+|+||.||++...+|+.||||+++....                      .....+..|...+..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            333456899999999999988899999998764320                      01123677888999998874  


Q ss_pred             EEeeeeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 008698          327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD  406 (557)
Q Consensus       327 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~  406 (557)
                      ++..++    ....++||||+++++|......          .....++.+++.++.++|+.   +++||||||+||+++
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~  159 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD  159 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence            444443    3456899999999998765420          23457889999999999998   999999999999999


Q ss_pred             CCCCcEEeeccCCccCC
Q 008698          407 EEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       407 ~~~~~kl~Dfgl~~~~~  423 (557)
                      +++.++|+|||++....
T Consensus       160 ~~~~~~liDfg~~~~~~  176 (198)
T cd05144         160 DDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCCcEEEEECCccccCC
Confidence            99999999999996554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=3.9e-16  Score=169.57  Aligned_cols=132  Identities=18%  Similarity=0.244  Sum_probs=108.1

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEe-ccc-c------hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRL-KRS-S------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~-~~~-~------~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      .++||+|+||.||+|.+.+. .+++|+. .+. .      .....++.+|++++..++|++++....+....+..++|||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             cceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            45789999999999987444 4444443 211 1      1123568899999999999999888777777778899999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      |+++++|.+++.            ....++.+++.+|.|||+.   +++||||||+|||+ +++.++|+|||+++..
T Consensus       417 ~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        417 YIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             ecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            999999998874            3467899999999999999   99999999999999 6778999999998753

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.66  E-value=5e-17  Score=165.42  Aligned_cols=124  Identities=21%  Similarity=0.429  Sum_probs=105.9

Q ss_pred             ceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccC
Q 008698          339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL  418 (557)
Q Consensus       339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  418 (557)
                      .+|+.|+++...+|.++|...+ .....++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            4689999999999999997533 34567888899999999999999   5   899999999999999999999999999


Q ss_pred             CccCCccc----cccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc
Q 008698          419 SKFVPWEV----MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS  469 (557)
Q Consensus       419 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t  469 (557)
                      ........    .........||..||+||.+.+..|+.|+||||+|+||+|+++
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            87665443    1112223349999999999999999999999999999999998

>PHA02911 C-type lectin-like protein; Provisional

Probab=99.63  E-value=1.4e-15  Score=134.94  Aligned_cols=109  Identities=20%  Similarity=0.473  Sum_probs=79.6

Q ss_pred             CCCCCCCCccCcccCCCCeeeEEecCCCCh--HHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCC
Q 008698           47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSW--DESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV  124 (557)
Q Consensus        47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w--~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~  124 (557)
                      .+...+||.+|.  .|+++||+|+...++|  ..|+++|..+||+|+. ++.||++||+.        +|.|+.      
T Consensus        97 ~~~~~pC~~nW~--~H~nkCYlFS~~s~sWsW~~Srr~C~~kGATLLk-~sdEELeFIqn--------~wkGks------  159 (213)
T PHA02911         97 SPSEPICSRDWI--NHMGICLLSLGEEVGFRMEIAKRFCEKKDADLIG-KIDEEKKALEN--------IWTGND------  159 (213)
T ss_pred             CCCCCCCchhhH--hhCCEEEEEeccccccchhHHHHHHHhcCCEecc-CcHHHHHHHHH--------HHhccc------
Confidence            344458999999  8999999999995555  8899999999999999 88899999984        577764      


Q ss_pred             CCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecC----CCceeccccCCCCCccccccc
Q 008698          125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG----SRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       125 ~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~----~~~w~~~~C~~~~~~iC~~~~  192 (557)
                       +.|.|.||.. ....    ..+.+              .|+.+...    -+..-...|.....|||++..
T Consensus       160 -~~~fWID~r~-ngSt----~n~s~--------------sCA~Is~~~~~~~~~V~sesCs~~~~wICqK~~  211 (213)
T PHA02911        160 -HSRFWIDNRA-AAST----FDPVN--------------ECAIGTQNHIPEVPEVLKSPCDERHSFICIKKD  211 (213)
T ss_pred             -cceEEecCcc-ccce----ecCCC--------------CeEEEEcccccCCCceEccccCCCceEEEEecc
Confidence             5788888621 0000    01122              35544331    145778899999999998753

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.61  E-value=5.6e-15  Score=143.23  Aligned_cols=136  Identities=21%  Similarity=0.220  Sum_probs=106.1

Q ss_pred             Ceeec-ccCceEEEEEEeCCCCEEEEEEecccc-------------hhhHHHHHHHHHHHhhcCCCcE--EeeeeeeeeC
Q 008698          274 NRLLG-DSKTGGTYSGILPDGSRVAVKRLKRSS-------------FQRKKEFYSEIGRFARLHHPNL--VAVKGCCYDH  337 (557)
Q Consensus       274 ~~~lg-~G~~g~Vy~g~~~~g~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~H~ni--v~l~g~~~~~  337 (557)
                      ..+|| .|+.|+||.... ++..++||.+....             ......+.+|+.++.+++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            34678 899999999988 57889999885321             1223567889999999998875  6677664433


Q ss_pred             C----ceEEEEecCCC-CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcE
Q 008698          338 G----DRYIVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH  412 (557)
Q Consensus       338 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k  412 (557)
                      .    ..++|||++++ .+|.+++..     ..++..    .+.+|+.+|.+||+.   ||+||||||+|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            2    23599999997 689888753     234443    367899999999999   999999999999999988999


Q ss_pred             EeeccCCccC
Q 008698          413 LMGVGLSKFV  422 (557)
Q Consensus       413 l~Dfgl~~~~  422 (557)
                      |+|||.+...
T Consensus       183 LIDfg~~~~~  192 (239)
T PRK01723        183 LIDFDRGELR  192 (239)
T ss_pred             EEECCCcccC
Confidence            9999988753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=6.9e-15  Score=131.58  Aligned_cols=134  Identities=18%  Similarity=0.152  Sum_probs=113.0

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC--CcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH--PNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      +.+|+|.++.||++... +..+++|.......  ...+.+|+..+..++|  .++++++++....+..+++|||++++++
T Consensus         4 ~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           4 KLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             eecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            35799999999999984 48899999866533  5678899999999976  5889998888887889999999988776


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      ..+           +......++.+++++|++||.....+++|+|++|+||++++++.+++.|||.+...
T Consensus        81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            432           55667788999999999999864457999999999999999899999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd00037 CLECT C-type lectin (CTL)/C-type lectin-like (CTLD) domain

Probab=99.60  E-value=5e-15  Score=126.03  Aligned_cols=113  Identities=27%  Similarity=0.576  Sum_probs=90.1

Q ss_pred             eeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCC-CCCCeEEeeeecCCCCCCeeEEccCCC-CCCcCcc
Q 008698           65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGK-NVNGCWVGGRSINTTVGLSWKWSDNMS-KWNESIH  142 (557)
Q Consensus        65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~-~~~~~WiGl~~~~~~~~~~w~W~Dg~~-~~~~~~~  142 (557)
                      .||+++..+.+|.+|+..|+++||+|++|++.+|++||.+++.. ....+|||++  .....+.|.|+||++ ..+.+|.
T Consensus         1 ~Cy~~~~~~~~~~~A~~~C~~~~~~L~~~~~~~e~~~i~~~~~~~~~~~~wvg~~--~~~~~~~~~~~~~~~~~~~~~w~   78 (116)
T cd00037           1 SCYKFSTEKLTWEEAQEYCRSLGGHLASIHSEEENDFLASLLKKSSSSDVWIGLN--DLSSEGTWKWSDGSPLVDYTNWA   78 (116)
T ss_pred             CCEEEcCCccCHHHHHHHHHHcCCEEcccCCHHHHHHHHHHHhCCCCCCEEEccc--ccCcCCCeEecCCCccccccCCC
Confidence            49999999999999999999999999999999999999999862 3568999999  443458999999999 4455544


Q ss_pred             ccCCCCCCCCCCCCccccccCceeEeecC-CCceeccccCCCCCccccc
Q 008698          143 AVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       143 ~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~~  190 (557)
                      ..+| .          ....++|+.+... ...|++..|....+++|+.
T Consensus        79 ~~~~-~----------~~~~~~C~~~~~~~~~~~~~~~C~~~~~~iC~~  116 (116)
T cd00037          79 PGEP-N----------PGGSEDCVVLSSSSDGKWNDVSCSSKLPFICEK  116 (116)
T ss_pred             CCCc-C----------CCCCCCeeEEccCCCCCccCCCCCCCceeeecC
Confidence            4443 1          2234567776554 3679999999999999963

CLECT: C-type lectin (CTL)/C-type lectin-like (CTLD) domain; protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. This group is chiefly comprised of eukaryotic CTLDs, but contains some, as yet functionally uncharacterized, bacterial CTLDs. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces, including CaCO3 and ice. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. For example: mannose-binding lectin and lung surfactant proteins A and D bind carbohydrates on surfaces (e.g. pathogens, allergens, necrotic, and apoptotic cells) and mediate functions associated with killing and phagocytosis; P (platlet)-, E (endothelial)-, and L (leukocyte)- selectins (sels) mediate the initia

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.60  E-value=4.3e-15  Score=138.85  Aligned_cols=135  Identities=19%  Similarity=0.239  Sum_probs=96.9

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchh--hHHHH----------------------HHHHHHHhhcCCCc--EE
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ--RKKEF----------------------YSEIGRFARLHHPN--LV  328 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~--~~~~~----------------------~~e~~~l~~l~H~n--iv  328 (557)
                      +.||+|+||.||++...+|+.||||+++.....  ....+                      ..|...+.++.+..  +.
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            357999999999999888999999998754211  11111                      34566666664432  33


Q ss_pred             eeeeeeeeCCceEEEEecCCCCChHHH-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeC
Q 008698          329 AVKGCCYDHGDRYIVYEFVVNGPLDRW-LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLD  406 (557)
Q Consensus       329 ~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~  406 (557)
                      +.+++    ...++||||++++++... +...     ... .....++.+++.++.++|+ .   +|+|+||||+||+++
T Consensus        83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             ceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            44432    246899999998654211 1110     011 5677899999999999998 7   999999999999999


Q ss_pred             CCCCcEEeeccCCccCC
Q 008698          407 EEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       407 ~~~~~kl~Dfgl~~~~~  423 (557)
                       ++.++++|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             8899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.57  E-value=2.2e-15  Score=163.66  Aligned_cols=206  Identities=22%  Similarity=0.280  Sum_probs=137.1

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      -++|..|++|.||...+.. .+.+|.|.- +..     .++           +||..+.+      ..+.|      |+-
T Consensus        88 IklisngAygavylvrh~~trqrfa~kiN-kq~-----lil-----------Rnilt~a~------npfvv------gDc  138 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKIN-KQN-----LIL-----------RNILTFAG------NPFVV------GDC  138 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhccc-ccc-----hhh-----------hccccccC------Cccee------chh
Confidence            4578999999999998753 566777432 221     111           12222211      12223      444


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc------
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV------  426 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~------  426 (557)
                      ...+..    -..++.        +++.+++|||+.   +|+|||+||+|.+|+.=+.+|++|||+++......      
T Consensus       139 ~tllk~----~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e  203 (1205)
T KOG0606|consen  139 ATLLKN----IGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE  203 (1205)
T ss_pred             hhhccc----CCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence            444532    122332        227889999999   99999999999999999999999999987542111      


Q ss_pred             ------cccc-eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          427 ------MQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       427 ------~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                            .++. ....+||+.|+|||++....|...+|-|++|+|+||.+-|+.||++..++++-..+-.....+     .
T Consensus       204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w-----p  278 (1205)
T KOG0606|consen  204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW-----P  278 (1205)
T ss_pred             cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc-----c
Confidence                  1111 123359999999999999999999999999999999999999999886654321111000000     0


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS  541 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~  541 (557)
                      +- |            ...+.++.+++.+.++.+|.+|--..
T Consensus       279 E~-d------------ea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  279 EE-D------------EALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             cc-C------------cCCCHHHHHHHHHHHHhChHhhcccc
Confidence            10 1            11234578889999999999996433

>PF00059 Lectin_C: Lectin C-type domain; InterPro: IPR001304 Lectins occur in plants, animals, bacteria and viruses

Probab=99.54  E-value=1.2e-14  Score=121.85  Aligned_cols=101  Identities=26%  Similarity=0.546  Sum_probs=80.1

Q ss_pred             CCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCCCcCc---cccCCCC
Q 008698           72 NFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESI---HAVGSFN  148 (557)
Q Consensus        72 ~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~~---~~~~~~~  148 (557)
                      ++++|.+|+.+|+++||+||+|+|.+|++||.+++. ....+|||+. ..  ..+.|.|.||++.....+   |  .+  
T Consensus         1 e~~~~~~A~~~C~~~~~~L~~i~~~~e~~~i~~~~~-~~~~~Wig~~-~~--~~~~~~w~~~~~~~~~~~~~~w--~~--   72 (105)
T PF00059_consen    1 EPMTWEEAQQYCQSMGAHLASINSEEENDFIQSQLK-SNESYWIGLD-SD--NNGTWKWIDGSPNSPENFYTNW--NP--   72 (105)
T ss_dssp             EEEEHHHHHHHHHHTTSEEB-GSSHHHHHHHHHHHH-SSSEEEEEEE-SS--STSEEEETTSSBSSSTTBSGCB--SS--
T ss_pred             CCCCHHHHHHHHhcCCCEEeEeCCHHHhhhhhhccc-ccceeeeeee-cc--ccceeccccCCCcccccccccc--cc--
Confidence            468999999999999999999999999999999986 4678999992 23  348999999988775432   3  11  


Q ss_pred             CCCCCCCCccccccCceeEe-ecCCCceeccccCCCCCccccc
Q 008698          149 SSCTSLPCHVHATVDLCTLV-SNGSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       149 ~~~~~~~c~~~~~~~~C~~~-~~~~~~w~~~~C~~~~~~iC~~  190 (557)
                                ....+.|+.+ ....+.|.+..|....+|||++
T Consensus        73 ----------~~~~~~C~~~~~~~~~~w~~~~C~~~~~fiCek  105 (105)
T PF00059_consen   73 ----------PNDSENCAYIYYSSSGKWNDVPCSEKYPFICEK  105 (105)
T ss_dssp             ----------GGSSEEEEEEGCSTTTEEEEEETTSEEEEEEEE
T ss_pred             ----------CCCCCCeEEEEEcCCCeEEeeCCCCCeeEEeeC
Confidence                      2345678877 4455789999999999999974

Initially described for their carbohydrate-binding activity [], they are now recognised as a more diverse group of proteins, some of which are involved in protein-protein, protein-lipid or protein-nucleic acid interactions []. There are at least twelve structural families of lectins: C-type lectins, which are Ca+-dependent. S-type (galectins), a widespread family of glycan-binding proteins []. I-type, which have an immunoglobulin-like fold and can recognise sialic acids, other sugars and glycosaminoglycans []. P-type, which bind phosphomannosyl receptors []. Pentraxins []. (Trout) egg lectins. Calreticulin and calnexin, which act as molecular chaperones of the endoplasmic reticulum []. ERGIC-53 and VIP-36 []. Discoidins []. Eel aggutinins (fucolectins) []. Annexin lectins []. Fibrinogen-type lectins, which includes ficolins, tachylectins 5A and 5B, and Limax flavus (Spotted garden slug) agglutinin (these proteins have clear distinctions from one another, but they share a homologous fibrinogen-like domain used for carbohydrate binding). Also unclassified orphan lectins, including amphoterin, Cel-II, complement factor H, thrombospondin, sailic acid-binding lectins, adherence lectin, and cytokins (such as tumour necrosis factor and several interleukins). C-type lectins can be further divided into seven subgroups based on additional non-lectin domains and gene structure: (I) hyalectans, (II) asialoglycoprotein receptors, (III) collectins, (IV) selectins, (V) NK group transmembrane receptors, (VI) macrophage mannose receptors, and (VII) simple (single domain) lectins []. Therefore, lectins are a diverse group of proteins, both in terms of structure and activity. Carbohydrate binding ability may have evolved independently and sporadically in numerous unrelated families, where each evolved a structure that was conserved to fulfil some other activity and function. In general, animal lectins act as recognition molecules within the immune system, their functions involving defence against pathogens, cell trafficking, immune regulation and the prevention of autoimmunity [].; GO: 0005488 binding; PDB: 1T8D_A 2H2T_B 1T8C_A 2H2R_A 1TN3_A 1RJH_A 1HTN_A 3G8K_B 2E3X_B 1UMR_D ....

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=2e-14  Score=137.93  Aligned_cols=206  Identities=19%  Similarity=0.282  Sum_probs=145.0

Q ss_pred             HHHHhhcCCCcEEeeeeeeeeC-----CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 008698          316 IGRFARLHHPNLVAVKGCCYDH-----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK  390 (557)
Q Consensus       316 ~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  390 (557)
                      +..|-.+-|.|||++..|+.+.     ....++.|||..|+|..+|+........+....-.++..||++||.|||+. .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            3445566799999999887654     345789999999999999998877788899999999999999999999985 7


Q ss_pred             CCeeecCCCCCCeeeCCCCCcEEeeccCCccCC--ccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHH
Q 008698          391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP--WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV  468 (557)
Q Consensus       391 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~  468 (557)
                      |.|+|+++..+-|++..++-+|+.--.-...-.  ............+-++|.|||+-.....+.++|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            899999999999999998888875322211111  011111222333678999999887777888999999999999998


Q ss_pred             cCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          469 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       469 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      -|..--........           .+    +.+...+....++ .       =..++..|++.+|..||+|.+++-
T Consensus       277 ilEiq~tnseS~~~-----------~e----e~ia~~i~~len~-l-------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNSESKVE-----------VE----ENIANVIIGLENG-L-------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCCcceee-----------hh----hhhhhheeeccCc-c-------ccCcCcccccCCCCCCcchhhhhc
Confidence            87643221111100           00    0011111111111 1       125678899999999999999875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=3.9e-15  Score=161.55  Aligned_cols=248  Identities=19%  Similarity=0.244  Sum_probs=178.8

Q ss_pred             eecccCceEEEEEEeCC--CCEEEEEEecccc--hhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILPD--GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~--g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .||+|+++.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++...+.+..+++.+|..++
T Consensus        27 ~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~  106 (601)
T KOG0590|consen   27 SIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG  106 (601)
T ss_pred             cccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence            47999999998776533  4456666664432  222334445777766775 999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeecCCCCCCeeeCCCC-CcEEeeccCCccCCc-ccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-DKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPW-EVM  427 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~-~~~  427 (557)
                      ++.+.+..  ......+....-.++.|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||+|..... ...
T Consensus       107 ~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~  181 (601)
T KOG0590|consen  107 SLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGA  181 (601)
T ss_pred             cccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccCCc
Confidence            99877732  11113455566678999999999999 77   999999999999999999 999999999987766 444


Q ss_pred             ccceeecCc-cccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          428 QERTVMAGG-TYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       428 ~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      ........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|........ .....|...     .  ...   
T Consensus       182 ~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~-----~--~~~---  250 (601)
T KOG0590|consen  182 ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSN-----K--GRF---  250 (601)
T ss_pred             ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccc-----c--ccc---
Confidence            444444457 9999999999884 45678899999999999999999977654322 111111110     0  000   


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV  544 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl  544 (557)
                           ...+.........++...++..+|+.|.+.+++.
T Consensus       251 -----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  251 -----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -----ccCccccCChhhhhcccccccCCchhcccccccc
Confidence                 0111122334567788888889999999988765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=3.1e-13  Score=142.26  Aligned_cols=140  Identities=19%  Similarity=0.203  Sum_probs=100.2

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhh----------------------------------------HHHHHH
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR----------------------------------------KKEFYS  314 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~----------------------------------------~~~~~~  314 (557)
                      +.||+|++|.||+|++.+|+.||||+.+......                                        +-+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            3579999999999999999999999986542110                                        012455


Q ss_pred             HHHHHhhcC-----CCcEEeeeeee-eeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHhc
Q 008698          315 EIGRFARLH-----HPNLVAVKGCC-YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ-GIAFLHD  387 (557)
Q Consensus       315 e~~~l~~l~-----H~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~  387 (557)
                      |+..+.+++     ++++. +-.++ ......+|||||+++++|.++.....   ...   .+..++..++. .+..+|.
T Consensus       203 Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence            666666652     34433 22222 22345799999999999988764311   112   23456666665 4788898


Q ss_pred             CCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       388 ~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      .   +++|+|++|.||+++.++.+++.|||++..+..
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8   999999999999999999999999999977653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.34  E-value=1e-12  Score=136.75  Aligned_cols=242  Identities=19%  Similarity=0.237  Sum_probs=175.1

Q ss_pred             eecc--cCceEEEEEEe---CCCCEEEEEEecc--cchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecC
Q 008698          276 LLGD--SKTGGTYSGIL---PDGSRVAVKRLKR--SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       276 ~lg~--G~~g~Vy~g~~---~~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      -+|.  |.+|.+|.+..   .++..+|+|.-+.  ........=.+|+....++ .|+|.++....+...+..++-.|++
T Consensus       121 ~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~  200 (524)
T KOG0601|consen  121 RTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC  200 (524)
T ss_pred             ccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc
Confidence            3588  99999999885   4578899998432  2223333445677777777 5999999888889999999999988


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeeecCCCCCCeeeCCC-CCcEEeeccCCccC
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFV  422 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~  422 (557)
                       +.+|.++.+..   ...++.........+..+    ||.++|+.   .++|-|+||.||++..+ ..++++|||+....
T Consensus       201 -~~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i  273 (524)
T KOG0601|consen  201 -GESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI  273 (524)
T ss_pred             -cchhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeEEc
Confidence             57888887642   244777778888888888    99999999   99999999999999999 88999999998876


Q ss_pred             Cccccccc---eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          423 PWEVMQER---TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       423 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ........   .....|...|++||... +-++..+|+||+|.+..|-.+|..+........|.++-.+..       ..
T Consensus       274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i-------p~  345 (524)
T KOG0601|consen  274 SDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI-------PL  345 (524)
T ss_pred             cCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC-------ch
Confidence            65542211   11223778899999764 566889999999999999999877654432222222111110       00


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +..+             .-..++...+..+++.+|..|++.+.+..
T Consensus       346 e~~~-------------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  346 EFCE-------------GGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             hhhc-------------CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1111             11234555888999999999999777653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.32  E-value=2.5e-11  Score=127.52  Aligned_cols=166  Identities=23%  Similarity=0.267  Sum_probs=126.0

Q ss_pred             eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHH
Q 008698          290 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA  369 (557)
Q Consensus       290 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~  369 (557)
                      ..++.+|.|...+...........+-++.|+.++||||++++...+..+..|||.|-+  -.|..++..       +...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-------l~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-------LGKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------hHHH
Confidence            3468889998887665433455677889999999999999999999999999999987  357777754       4456


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeecCccccccccccccCC
Q 008698          370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN  449 (557)
Q Consensus       370 ~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  449 (557)
                      ...-.+.||+.||.|||+.+  +++|++|..+.|+|+..|.-||++|-+.........  .......-..|..|+.+...
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            66778899999999999765  899999999999999999999999988754322111  00000012345666644322


Q ss_pred             CCCchhhHHHHHHHHHHHHcC
Q 008698          450 ELTTKSDVYSFGVLLLEIVSG  470 (557)
Q Consensus       450 ~~s~~sDVwS~Gvil~el~tG  470 (557)
                      .  -..|.|-||+++||++.|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCc
Confidence            2  346999999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.28  E-value=4.2e-12  Score=135.37  Aligned_cols=147  Identities=16%  Similarity=0.174  Sum_probs=94.5

Q ss_pred             hcCCCCCCeeecccCceEEEEEEeCC-CCEEEEEEecccchhh----------------------------------H--
Q 008698          267 TKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQR----------------------------------K--  309 (557)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~----------------------------------~--  309 (557)
                      ...|+.  +.||+|++|.||++++.+ |+.||||+.++.-...                                  .  
T Consensus       119 F~~fd~--~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        119 FDDFDI--KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHhcCh--hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            334554  357999999999999987 9999999997541100                                  0  


Q ss_pred             ----HHHHHHHHHHhhcC----CCcEEeeeeeeee-CCceEEEEecCCCCChHHHh--ccCCCCCCCCCHHHHHHHHHHH
Q 008698          310 ----KEFYSEIGRFARLH----HPNLVAVKGCCYD-HGDRYIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATTL  378 (557)
Q Consensus       310 ----~~~~~e~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~i  378 (557)
                          -+|.+|+..+.+++    +.+.+.+=.++.+ ....+|||||++|+++.++-  .........+.......++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence                12445555555552    4333333333322 34678999999999997742  2110000123233333334444


Q ss_pred             HHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CcEEeeccCCccCCcc
Q 008698          379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLSKFVPWE  425 (557)
Q Consensus       379 a~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgl~~~~~~~  425 (557)
                             +..   |++|+|++|.||+++.++    .+++.|||+...++..
T Consensus       277 -------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 -------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                   345   999999999999999988    8999999999877543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.28  E-value=1.5e-11  Score=112.86  Aligned_cols=129  Identities=15%  Similarity=0.060  Sum_probs=94.8

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEE-eeeeeeeeCCceEEEEecCCCCChHH
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLV-AVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      .++.|..+.||+... .+..|++|....... ....+.+|+..+..+.+.+++ +++.+  .....++||||+++.++..
T Consensus         5 ~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           5 PLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT   80 (170)
T ss_pred             ecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence            468999999999987 478899999765431 233567889999888655544 44443  2334589999999988753


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      ..         .   ....++.+++++|+.||+..  ...++|+|++|.||+++ ++.+++.||+.+..
T Consensus        81 ~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 ED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            20         1   11245678999999999882  22369999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.17  E-value=4.2e-10  Score=104.62  Aligned_cols=134  Identities=15%  Similarity=0.124  Sum_probs=97.1

Q ss_pred             eecccCceEEEEEEeCC-------CCEEEEEEecccc----------------------hhhHHHHH----HHHHHHhhc
Q 008698          276 LLGDSKTGGTYSGILPD-------GSRVAVKRLKRSS----------------------FQRKKEFY----SEIGRFARL  322 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~-------g~~vavK~~~~~~----------------------~~~~~~~~----~e~~~l~~l  322 (557)
                      .||.|-=+.||.|...+       +..+|||+.+...                      ....+.+.    +|+..|.++
T Consensus         4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl   83 (197)
T cd05146           4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM   83 (197)
T ss_pred             ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            57999999999998653       4799999875210                      01122333    799999998


Q ss_pred             CC--CcEEeeeeeeeeCCceEEEEecCCCCChHH-HhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCC
Q 008698          323 HH--PNLVAVKGCCYDHGDRYIVYEFVVNGPLDR-WLHHIPRGGRSLDWAMRMKVATTLAQGIAFL-HDKVKPHVVHRDI  398 (557)
Q Consensus       323 ~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dl  398 (557)
                      ..  -++..++++    ...++||||+.++.+.. .+.+     ..++..+...+..+++.+|..| |..   +++|+||
T Consensus        84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL  151 (197)
T cd05146          84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL  151 (197)
T ss_pred             HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            53  456666654    45689999997654321 1221     2345556677889999999999 788   9999999


Q ss_pred             CCCCeeeCCCCCcEEeeccCCccC
Q 008698          399 RASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       399 k~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      ++.|||+++ +.+.|+|||-+...
T Consensus       152 s~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEEC-CcEEEEECCCceeC
Confidence            999999974 67999999987644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.13  E-value=4.8e-10  Score=107.42  Aligned_cols=141  Identities=24%  Similarity=0.269  Sum_probs=108.9

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCC--CcEEeeeeeeeeC---CceEEEEecCCC
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHH--PNLVAVKGCCYDH---GDRYIVYEFVVN  349 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~---~~~~lV~E~~~~  349 (557)
                      .|+.|..+.+|++...+|+.+++|....... .....+.+|+.++..+++  .++.+++.+....   +..++||||+++
T Consensus         5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G   84 (223)
T cd05154           5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG   84 (223)
T ss_pred             ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence            4699999999999987778999999765422 234578899999999965  3456677766553   256899999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV----------------------------------------  389 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------  389 (557)
                      .++.+.+..     ..++..++..++.+++++|..||+..                                        
T Consensus        85 ~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          85 RVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            888665421     24677788888889999999998531                                        


Q ss_pred             -------------CCCeeecCCCCCCeeeCC--CCCcEEeeccCCcc
Q 008698          390 -------------KPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKF  421 (557)
Q Consensus       390 -------------~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgl~~~  421 (557)
                                   ...++|+|+.+.||+++.  +..+.|.||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         246799999999999998  56689999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.07  E-value=1.3e-09  Score=98.03  Aligned_cols=130  Identities=20%  Similarity=0.229  Sum_probs=100.2

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccc--------hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSS--------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      ++++|+-+.+|.+.+ -|.++++|.-.+..        .-...+-.+|+.++.+++--.|...+-+..+.+...++|||+
T Consensus         3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            468999999999977 45557777542211        112345678999999987666655555566777888999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      ++..|.+++...           +..++..|-.-+.-||..   +|+|+||.++||++..+. +.++|||++..
T Consensus        82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999888642           245677777778889999   999999999999998875 89999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.07  E-value=1.6e-09  Score=96.97  Aligned_cols=142  Identities=19%  Similarity=0.229  Sum_probs=105.1

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEe-ccc-------chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRL-KRS-------SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~-~~~-------~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      -.++-+|+-+.|+++.+ .|+...||.- .+.       ..-...+..+|++.|.+++--.|....-++.+...-.|+||
T Consensus        12 l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             ceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            34789999999999998 6777777753 221       11224567889999999876566555556667777789999


Q ss_pred             cCCC-CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---cEEeeccCCcc
Q 008698          346 FVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSKF  421 (557)
Q Consensus       346 ~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgl~~~  421 (557)
                      |+++ .++.+++...-.  ..-.......++..|-+.+.-||.+   +++|+||..+||+|..++.   +.++|||++..
T Consensus        91 ~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9966 378888865322  1222333367888999999999999   9999999999999965543   48999999864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.05  E-value=1.8e-10  Score=120.03  Aligned_cols=246  Identities=17%  Similarity=0.176  Sum_probs=168.5

Q ss_pred             hhcCCCCCCeeecccCceEEEEEEe--CCCCEEEEEEecccchhhHHH--HHHHHHHHhhc-CCCcEEeeeeeeeeCCce
Q 008698          266 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSRVAVKRLKRSSFQRKKE--FYSEIGRFARL-HHPNLVAVKGCCYDHGDR  340 (557)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~g~~--~~g~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~H~niv~l~g~~~~~~~~  340 (557)
                      .+.+|.+.. .||.|.|+.|+....  .++..+++|.+.........+  -+.|+.+...+ .|.++++....+......
T Consensus       263 ~~~df~~v~-~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  263 KLTDFGLVS-KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             ecCCcceeE-EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            344555544 359999999998774  357889999886553322222  24566666666 588888877777777778


Q ss_pred             EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCcEEeeccCC
Q 008698          341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLS  419 (557)
Q Consensus       341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~  419 (557)
                      |+--||++++++.....    ....+++..++++..|++.++.++|+.   .++|+|+||+||++..+ +..++.|||..
T Consensus       342 ~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             cCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence            89999999998876552    234577888899999999999999988   99999999999999886 77899999998


Q ss_pred             ccCCccccccceeecCcccccc--ccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          420 KFVPWEVMQERTVMAGGTYGYL--APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       420 ~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                      ..+.....     .....-+++  +|+......+-.+.|++|||.-+.|.++|..--....        +|.        
T Consensus       415 t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~--------  473 (524)
T KOG0601|consen  415 TRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSL--------  473 (524)
T ss_pred             cccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cce--------
Confidence            64321111     111233444  5555555677889999999999999999864322111        000        


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                        .+.....    ...+  .....+..+.......++..||.+.++....+
T Consensus       474 --~i~~~~~----p~~~--~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  474 --TIRSGDT----PNLP--GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             --eeecccc----cCCC--chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence              0010000    1111  11245667777888999999999988776544

>PF05473 Herpes_UL45: UL45 protein; InterPro: IPR008646 This family consists several UL45 proteins and homologues found in the herpes simplex virus family

Probab=99.02  E-value=7.6e-10  Score=102.81  Aligned_cols=57  Identities=19%  Similarity=0.539  Sum_probs=51.0

Q ss_pred             CCCCCCccCcccCCCCeeeEEecCCC-ChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhC
Q 008698           49 WKAPCPPDWIINEEKSKCFGYIGNFR-SWDESETYCKEIGGHLAALTSYEEEHSAQKLCG  107 (557)
Q Consensus        49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~-~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~  107 (557)
                      .+..||+||+  +|+++||+|+...+ ||.||+.+|.+++++|+.+++.+....+.+...
T Consensus        81 ~~~~CP~~Wi--~~~~~Cy~~~~~~~~t~~eA~~~C~~~~s~L~~~~~~~~L~~ll~~~~  138 (200)
T PF05473_consen   81 GCGPCPKGWI--GYNNSCYRFSNSPKKTWEEARNICAAYNSTLANVNNAKSLLELLDVLN  138 (200)
T ss_pred             cCCCCCccce--eeCCEEEEEeCCCCcCHHHHHHHHHhcCCcCCCchhHHHHHHHHHHhc
Confidence            4579999999  99999999999998 999999999999999999998888777766554

The herpes simplex virus UL45 gene encodes an 18 kDa virion envelope protein whose function remains unknown. It has been suggested that the 18 kDa UL45 gene product is required for efficient growth in the central nervous system at low doses and may play an important role under the conditions of a naturally acquired infection []. The Equine herpesvirus 1 UL45 protein represents a type II membrane glycoprotein which has found to be non-essential for EHV-1 growth in vitro but deletion reduces the viruses' replication efficiency [].

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.92  E-value=1.8e-08  Score=98.97  Aligned_cols=141  Identities=13%  Similarity=0.135  Sum_probs=101.9

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchh-----------hHHHHHHHHHHHhhcCCCcE--Eeeeeeeee-----
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ-----------RKKEFYSEIGRFARLHHPNL--VAVKGCCYD-----  336 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~H~ni--v~l~g~~~~-----  336 (557)
                      +++-......|++..+ +|+.|.||........           ....+.+|...+.++...+|  ++++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3445555556778777 7889999977543311           11247789988888854343  334445433     


Q ss_pred             CCceEEEEecCCCC-ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-------C
Q 008698          337 HGDRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-------E  408 (557)
Q Consensus       337 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~-------~  408 (557)
                      ....+||+|++++. +|.+++....  ....+...+..++.+++..+.-||..   ||+|+|+++.|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence            23468999999876 7998885321  13455677789999999999999999   9999999999999975       4


Q ss_pred             CCcEEeeccCCcc
Q 008698          409 FGAHLMGVGLSKF  421 (557)
Q Consensus       409 ~~~kl~Dfgl~~~  421 (557)
                      ..+.++||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6789999998853

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.89  E-value=7.4e-09  Score=95.91  Aligned_cols=125  Identities=23%  Similarity=0.297  Sum_probs=81.7

Q ss_pred             EEEEEEeCCCCEEEEEEecccc--------------------------hhhHHHHHHHHHHHhhcCCC--cEEeeeeeee
Q 008698          284 GTYSGILPDGSRVAVKRLKRSS--------------------------FQRKKEFYSEIGRFARLHHP--NLVAVKGCCY  335 (557)
Q Consensus       284 ~Vy~g~~~~g~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~H~--niv~l~g~~~  335 (557)
                      .||.|...+|..+|||..+...                          ........+|.+.|.++...  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899999899999999875310                          01123457899999999765  456666442 


Q ss_pred             eCCceEEEEecCC--CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeeecCCCCCCeeeCCCCCcE
Q 008698          336 DHGDRYIVYEFVV--NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF-LHDKVKPHVVHRDIRASNVLLDEEFGAH  412 (557)
Q Consensus       336 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~Dlk~~Nill~~~~~~k  412 (557)
                         ...|||||++  +..+..+...      .++......++.+++..+.. +|..   +++|+||.+.|||++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               3479999998  5445433221      11133445677778776665 4677   99999999999999988 999


Q ss_pred             EeeccCCccC
Q 008698          413 LMGVGLSKFV  422 (557)
Q Consensus       413 l~Dfgl~~~~  422 (557)
                      |+|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.86  E-value=7.6e-08  Score=98.69  Aligned_cols=171  Identities=17%  Similarity=0.249  Sum_probs=128.7

Q ss_pred             CceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeee----eCCceEEEEecCCC-CChHH
Q 008698          281 KTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY----DHGDRYIVYEFVVN-GPLDR  354 (557)
Q Consensus       281 ~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~----~~~~~~lV~E~~~~-gsL~~  354 (557)
                      ...+.|++.. -||..|++|+++....+.......-++.++++.|+|+|++..++.    .+..+++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            4467888884 479999999995443333323334577899999999999998876    34567999999985 46665


Q ss_pred             HhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          355 WLHHIP-----------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       355 ~l~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      +-....           ..+...++..++.++.|+..||.++|+.   |+.-+-|.+++||++.+.+++|+..|+...+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            443221           1234578899999999999999999999   99999999999999999999999988877654


Q ss_pred             ccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP  473 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p  473 (557)
                      .+..                |-+.+   -.+-|.=.||.+++.|.||...
T Consensus       445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            3320                11111   2367999999999999999754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.84  E-value=3e-09  Score=116.75  Aligned_cols=241  Identities=19%  Similarity=0.177  Sum_probs=156.3

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      -+.+|+++.++...-. .|...+.|+.....   .++.+....+-.++-..+||-+++..--+......+||++|..+++
T Consensus       811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~  890 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD  890 (1205)
T ss_pred             cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence            4578888888765521 13223333332221   1112223333333333456777766555566778899999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC-c------
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP-W------  424 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~-~------  424 (557)
                      |...|+...    ..+..-.......+..+++|||+.   .+.|+|++|.|.|...++..+++|||...... .      
T Consensus       891 ~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~  963 (1205)
T KOG0606|consen  891 LPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL  963 (1205)
T ss_pred             chhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence            999887632    344444455666788899999998   79999999999999999999999998332111 0      


Q ss_pred             --------------cc----cc----cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 008698          425 --------------EV----MQ----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW  482 (557)
Q Consensus       425 --------------~~----~~----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~  482 (557)
                                    ..    ..    .......+|+.|.+||.+.+......+|.|++|++++|.++|.+||....+.  
T Consensus       964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq-- 1041 (1205)
T KOG0606|consen  964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ-- 1041 (1205)
T ss_pred             ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh--
Confidence                          00    00    0011223789999999999999999999999999999999999999875442  


Q ss_pred             hhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 008698          483 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS  541 (557)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~  541 (557)
                       +.+            ..++...+.-  . .-+........+++..-+..+|..|-.|.
T Consensus      1042 -~~f------------~ni~~~~~~~--p-~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 -QIF------------ENILNRDIPW--P-EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             -hhh------------hccccCCCCC--C-CCccccChhhhhhhhhhhccCchhccCcc
Confidence             111            1111111100  0 01122344566777888888998887765

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.70  E-value=1.7e-07  Score=93.83  Aligned_cols=265  Identities=18%  Similarity=0.190  Sum_probs=154.7

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeee------eeCC-ceEEEEec
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCC------YDHG-DRYIVYEF  346 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~------~~~~-~~~lV~E~  346 (557)
                      +-||+|+-+.+|..-- -+. -+-|+..........+.   +..|... .||-+..-+.+=      -+.+ ..-++|..
T Consensus        17 r~LgqGgea~ly~l~e-~~d-~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~   91 (637)
T COG4248          17 RPLGQGGEADLYTLGE-VRD-QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK   91 (637)
T ss_pred             ccccCCccceeeecch-hhc-hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence            4579999999996431 122 23466654432222222   2233333 455443311110      1111 23456666


Q ss_pred             CCCC-ChHHHhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          347 VVNG-PLDRWLHHI--PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       347 ~~~g-sL~~~l~~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      +.+- ....+++..  ++.-....|...++.++.+|.+.+-||..   |.+-+|+.++|+|++++..+.|.|-..-....
T Consensus        92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~  168 (637)
T COG4248          92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA  168 (637)
T ss_pred             CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeecc
Confidence            5443 233333221  12224578999999999999999999999   99999999999999999999988743222111


Q ss_pred             ccccccceeecCcccccccccccc-----CCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCcccc-hhHHHhhhhhhhcc
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCW-QSIFEWATPLVQSH  496 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~el~tG-~~p~~~~~~~~~-~~~~~~~~~~~~~~  496 (557)
                      .   ........|...|.+||.-.     +..-+...|.|.+||++++++.| ++||.+...... ..-.+   ..+..+
T Consensus       169 n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~g  242 (637)
T COG4248         169 N---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAHG  242 (637)
T ss_pred             C---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhcc
Confidence            1   11122334888999999554     33456789999999999999985 999987522100 00000   000111


Q ss_pred             ccccccCcc--cccCCCCCCcHHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHHHhcccCC
Q 008698          497 RYLELLDPL--ISSLSSDIPEAGVVQKVVDLVYACTQH--VPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       497 ~~~~~~d~~--l~~~~~~~~~~~~~~~l~~l~~~Cl~~--~P~~RPt~~evl~~L~~~~~~  553 (557)
                      .+...-+..  +.......+-.-.+..+..+..+|+..  .+.-|||++.-+..|..+++.
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            111111111  111112222233456777888899875  367899999999988776654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.63  E-value=9.3e-09  Score=108.91  Aligned_cols=152  Identities=21%  Similarity=0.290  Sum_probs=102.2

Q ss_pred             HHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc-cce------eecCcccccccccccc
Q 008698          375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-ERT------VMAGGTYGYLAPEFVY  447 (557)
Q Consensus       375 ~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~------~~~~gt~~y~aPE~~~  447 (557)
                      +.+++.||.|+|..  .++||++|.|++|.++.++..||+.|+.+......... ...      ........|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34456999999976  49999999999999999999999999987544321110 000      0111346799999999


Q ss_pred             CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHH
Q 008698          448 RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV  526 (557)
Q Consensus       448 ~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~  526 (557)
                      +...+.++|+||+||++|.+.. |+.-+..........+     .       ....+....     ......+.++.+-+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-----~-------~~~~~~~~~-----~~s~~~p~el~~~l  245 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-----S-------RNLLNAGAF-----GYSNNLPSELRESL  245 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-----h-------hcccccccc-----cccccCcHHHHHHH
Confidence            9888999999999999999995 5444433221110000     0       011111111     11133456788889


Q ss_pred             HHhcCCCCCCCCCHHHHHH
Q 008698          527 YACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       527 ~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+.+..++.-||++.++..
T Consensus       246 ~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  246 KKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHHhcCCcccCcchhhhhc
Confidence            9999999999998877654

>PRK09902 hypothetical protein; Provisional

Probab=98.59  E-value=9.7e-07  Score=82.41  Aligned_cols=138  Identities=13%  Similarity=0.099  Sum_probs=103.0

Q ss_pred             cccCceEEEEEEeCCCCEEEEEEeccc---c---hhhHHHHHHHHHHHhhcCCCc--EEeeeeeeeeC----CceEEEEe
Q 008698          278 GDSKTGGTYSGILPDGSRVAVKRLKRS---S---FQRKKEFYSEIGRFARLHHPN--LVAVKGCCYDH----GDRYIVYE  345 (557)
Q Consensus       278 g~G~~g~Vy~g~~~~g~~vavK~~~~~---~---~~~~~~~~~e~~~l~~l~H~n--iv~l~g~~~~~----~~~~lV~E  345 (557)
                      |.||.+.|++-.+ +|..+-+|+-...   +   ......|.+|+..|.++...+  +.+++..-...    -.-+||+|
T Consensus        27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            8899999999887 5557889976421   1   235688999999999995433  44444222221    23589999


Q ss_pred             cCCC-CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC--cEEeeccCCcc
Q 008698          346 FVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--AHLMGVGLSKF  421 (557)
Q Consensus       346 ~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgl~~~  421 (557)
                      -+++ -+|.+++.+.  .-.+.+...+..++.+++..+.-||+.   ++.|+|+-+.|||++.++.  ++++||--++.
T Consensus       106 ~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        106 DMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             eCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            7653 5888888542  123467788889999999999999999   9999999999999986667  89999976653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.56  E-value=4e-07  Score=86.94  Aligned_cols=130  Identities=19%  Similarity=0.231  Sum_probs=91.0

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccc----------------------hhhHHHHHHHHHHHhhcCCC--cEEe
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS----------------------FQRKKEFYSEIGRFARLHHP--NLVA  329 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~H~--niv~  329 (557)
                      ...||-|--+.||.|..++|.++|||.-+...                      ........+|.++|.+|.-.  .+.+
T Consensus        96 G~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~  175 (304)
T COG0478          96 GTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPK  175 (304)
T ss_pred             ccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCC
Confidence            34689999999999999999999999764221                      01123457899999999654  6666


Q ss_pred             eeeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008698          330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  409 (557)
Q Consensus       330 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~  409 (557)
                      .+++    +.-.+||||+++-.|...-         ++....-.++..|+.-+.-+-..   |+||+|+.+-|||+++++
T Consensus       176 P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         176 PIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             cccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence            6543    4557999999886553221         11222233344444444444355   999999999999999999


Q ss_pred             CcEEeeccCC
Q 008698          410 GAHLMGVGLS  419 (557)
Q Consensus       410 ~~kl~Dfgl~  419 (557)
                      .+.++||--+
T Consensus       240 ~~~vIDwPQ~  249 (304)
T COG0478         240 DIVVIDWPQA  249 (304)
T ss_pred             CEEEEeCccc
Confidence            9999999644

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.55  E-value=5.4e-07  Score=85.48  Aligned_cols=107  Identities=23%  Similarity=0.270  Sum_probs=83.3

Q ss_pred             HHHHHHHHHHHhhcCCC--cEEeeeeeeeeCC----ceEEEEecCCCC-ChHHHhccCCCCCCCCCHHHHHHHHHHHHHH
Q 008698          309 KKEFYSEIGRFARLHHP--NLVAVKGCCYDHG----DRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQG  381 (557)
Q Consensus       309 ~~~~~~e~~~l~~l~H~--niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g  381 (557)
                      .....+|...+.+++..  ..++.+++.....    ..++|+|++++. +|.+++....    .++......++.+++..
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL  130 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence            34677888888887533  3445566655432    348999999874 7999886421    26667788999999999


Q ss_pred             HHHHhcCCCCCeeecCCCCCCeeeCCCC---CcEEeeccCCccC
Q 008698          382 IAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSKFV  422 (557)
Q Consensus       382 L~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgl~~~~  422 (557)
                      ++-||..   +|+|+|+++.|||++.+.   .+.++||+.++..
T Consensus       131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999   999999999999999887   7899999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.46  E-value=9.1e-07  Score=94.15  Aligned_cols=142  Identities=15%  Similarity=0.158  Sum_probs=91.7

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhh------------------------------HH----------HHHH
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR------------------------------KK----------EFYS  314 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~------------------------------~~----------~~~~  314 (557)
                      .-|+.++-|.||+|++++|+.||||+.++.-...                              .+          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            3579999999999999999999999987431100                              01          1345


Q ss_pred             HHHHHhhcC-----CCcEEeeeeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 008698          315 EIGRFARLH-----HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV  389 (557)
Q Consensus       315 e~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~  389 (557)
                      |...+.+++     .+++.-.-=+..-.+...|+|||++|-.+.+......   ..++.+.+.....++-  +..+-.. 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f--~~q~~~d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF--LRQLLRD-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH--HHHHHhc-
Confidence            555555542     3443322212223456789999999988887743211   2344333222222221  1222223 


Q ss_pred             CCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       390 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                        |++|.|..|-||+++.++.+-+.|||+....+.
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence              999999999999999999999999999877653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.29  E-value=1.3e-05  Score=76.97  Aligned_cols=139  Identities=14%  Similarity=0.214  Sum_probs=84.7

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc--EEeeeeeeeeCCceEEEEecCCCCC-h
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAVKGCCYDHGDRYIVYEFVVNGP-L  352 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gs-L  352 (557)
                      .||+|..+.||+.   .|..+++|......  ......+|.+++..+..-.  +.+.+++....+...+|||+++|.+ +
T Consensus         8 ~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         8 QTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            5799999999983   35567889876532  3455788999998886433  3566777777777789999998863 2


Q ss_pred             HHHh---------------------ccCCCCCCCCCHHHHHHHHH----------HHH-HHHHHHhcC-CCCCeeecCCC
Q 008698          353 DRWL---------------------HHIPRGGRSLDWAMRMKVAT----------TLA-QGIAFLHDK-VKPHVVHRDIR  399 (557)
Q Consensus       353 ~~~l---------------------~~~~~~~~~l~~~~~~~i~~----------~ia-~gL~yLH~~-~~~~ivH~Dlk  399 (557)
                      ...+                     +........++.. ...+..          .+. ....+|... ..+.++|+|+.
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            1111                     1111111111100 000000          011 112222211 13467899999


Q ss_pred             CCCeeeCCCCCcEEeeccCCcc
Q 008698          400 ASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       400 ~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      |.||++++++ +.|.||+.+..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999887 99999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.13  E-value=3.3e-05  Score=73.35  Aligned_cols=154  Identities=18%  Similarity=0.143  Sum_probs=100.1

Q ss_pred             cCHHHHHHhhcCCC--CCCeeecccCceEEEEEEeCCCCEEEEEEecccchhh-------------------H-----HH
Q 008698          258 FTTEELRSITKNFS--EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR-------------------K-----KE  311 (557)
Q Consensus       258 ~~~~el~~~~~~~~--~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~-------------------~-----~~  311 (557)
                      .+.+.+..+.....  +....|+.|.-+.||+|...++..+|||+.+......                   .     .-
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            34455555543322  2233467777789999998889999999986431110                   0     11


Q ss_pred             HHHHHHHHhhcC--CCcEEeeeeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 008698          312 FYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV  389 (557)
Q Consensus       312 ~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~  389 (557)
                      ..+|+..|.++.  +-.+.+.+++.    ...|||||+....+    .......-+++..+...+..++++.|.-|-..+
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            256788888873  44444554442    34699999955311    111111223344466777888888888887622


Q ss_pred             CCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       390 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                        ++||+||..-|||+. ++.+.|+|+|-|...
T Consensus       187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             --CcccccchhhheEEE-CCeEEEEECcccccc
Confidence              999999999999999 789999999977544

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.12  E-value=5e-05  Score=71.33  Aligned_cols=133  Identities=13%  Similarity=0.197  Sum_probs=85.2

Q ss_pred             CCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHH---------HHHHHHHHhhcCC---CcEEeeeeeeee---
Q 008698          272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKE---------FYSEIGRFARLHH---PNLVAVKGCCYD---  336 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~H---~niv~l~g~~~~---  336 (557)
                      ...+++-......|.+-.. +|+.+++|..+....-..+.         ..+++..+.+++.   ...+.++.+...   
T Consensus        34 ~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~  112 (229)
T PF06176_consen   34 KIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIF  112 (229)
T ss_pred             eEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeec
Confidence            3334556666666666666 78999999987653222222         2334444444432   222222222221   


Q ss_pred             --CCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEe
Q 008698          337 --HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM  414 (557)
Q Consensus       337 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  414 (557)
                        ....+++|||++|..|.++..        ++.    .++..+++++.-||..   |++|+|..|.|++++++ .+++.
T Consensus       113 ~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iI  176 (229)
T PF06176_consen  113 RYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRII  176 (229)
T ss_pred             cceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEE
Confidence              234468999999988765532        222    2456678889999999   99999999999999865 49999


Q ss_pred             eccCCcc
Q 008698          415 GVGLSKF  421 (557)
Q Consensus       415 Dfgl~~~  421 (557)
                      ||+..+.
T Consensus       177 D~~~k~~  183 (229)
T PF06176_consen  177 DTQGKRM  183 (229)
T ss_pred             ECccccc
Confidence            9987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.07  E-value=2.2e-05  Score=83.46  Aligned_cols=140  Identities=16%  Similarity=0.092  Sum_probs=89.0

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhh-------------------------------------HHHHHHHHH
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR-------------------------------------KKEFYSEIG  317 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~-------------------------------------~~~~~~e~~  317 (557)
                      +-|+..+.|.||++++++|+.||||+-++.-...                                     +-+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            3579999999999999999999999876431100                                     012344544


Q ss_pred             HHhh----cCCCc------EEeeeeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 008698          318 RFAR----LHHPN------LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD  387 (557)
Q Consensus       318 ~l~~----l~H~n------iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~  387 (557)
                      -..+    ++|-+      |.+++-  .-.....|+||||+|..+.+.-.-.   ...++...+..-+.+...-+-    
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i~~~l~~~~~~qI----  317 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAID---KRGISPHDILNKLVEAYLEQI----  317 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHH---HcCCCHHHHHHHHHHHHHHHH----
Confidence            3333    34555      333322  2234678999999998776543211   123555444333333322222    


Q ss_pred             CCCCCeeecCCCCCCeeeCC----CCCcEEeeccCCccCCc
Q 008698          388 KVKPHVVHRDIRASNVLLDE----EFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       388 ~~~~~ivH~Dlk~~Nill~~----~~~~kl~Dfgl~~~~~~  424 (557)
                       ...|++|+|-.|-||+++.    ++.+.+-|||+......
T Consensus       318 -f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 -FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             -HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence             2238999999999999984    67799999999876643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.05  E-value=9.9e-07  Score=92.83  Aligned_cols=180  Identities=17%  Similarity=0.127  Sum_probs=129.0

Q ss_pred             ecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc-EEeeeeeeeeCCceEEEEecCCCC-ChHH
Q 008698          277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN-LVAVKGCCYDHGDRYIVYEFVVNG-PLDR  354 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~g-sL~~  354 (557)
                      +++++++.++|.+-...+...++.+...     ....-++++|.+++||| .++.++-+..+...+++++++..+ +-..
T Consensus       250 fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~  324 (829)
T KOG0576|consen  250 FVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL  324 (829)
T ss_pred             HHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence            4888999999876434444445555432     34455788899999999 666666666667788999998776 2111


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeec
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  434 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  434 (557)
                      -.   ......+...+...+...-+++++|||+.   .=+|+|    ||+..+ ...|..||+....+....   .....
T Consensus       325 ~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~  390 (829)
T KOG0576|consen  325 EM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTA  390 (829)
T ss_pred             cC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccccC
Confidence            11   11123345555666677778899999987   558888    777666 578999999987765443   22334


Q ss_pred             CccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008698          435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQ  475 (557)
Q Consensus       435 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~  475 (557)
                      .+++.|+|||+...+.+..+.|+||.|+-..++--|-+|-.
T Consensus       391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            48999999999999999999999999998777777777654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.02  E-value=0.00013  Score=68.33  Aligned_cols=134  Identities=17%  Similarity=0.281  Sum_probs=94.9

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccc----------------hhhHHHHHHHHHHHhhcC------CCcEEeee
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS----------------FQRKKEFYSEIGRFARLH------HPNLVAVK  331 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------H~niv~l~  331 (557)
                      ..+||+|+.-.||.  ++++....||+.....                .....+..+|+.....+.      +..|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            34689999999996  5667778899987654                122456677777666665      88899999


Q ss_pred             eeeeeCCceEEEEecCCC------CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 008698          332 GCCYDHGDRYIVYEFVVN------GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL  405 (557)
Q Consensus       332 g~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill  405 (557)
                      |+..++.-.-+|+|.+.+      -+|.+++.+     ..++. ...+.+.   +-..||-++   .|+.+||+|.||++
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIVV  151 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEEE
Confidence            999998888999998753      257888853     33555 3333333   345667777   89999999999999


Q ss_pred             CCCC----CcEEee-ccCCcc
Q 008698          406 DEEF----GAHLMG-VGLSKF  421 (557)
Q Consensus       406 ~~~~----~~kl~D-fgl~~~  421 (557)
                      ..+.    .+.|.| ||-...
T Consensus       152 ~~~~~~~~~lvlIDG~G~~~~  172 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGEKEL  172 (199)
T ss_pred             EecCCCceEEEEEeCCCCccc
Confidence            5432    456666 554443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.01  E-value=6.7e-05  Score=73.07  Aligned_cols=137  Identities=18%  Similarity=0.142  Sum_probs=82.9

Q ss_pred             CceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEecCCCCChHHHh---
Q 008698          281 KTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWL---  356 (557)
Q Consensus       281 ~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l---  356 (557)
                      ....||+...+ +..+.||......   ...+.+|+.++..+. +--+.+++++....+..++|||+++|.+|....   
T Consensus        11 ~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~   86 (244)
T cd05150          11 SGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEEL   86 (244)
T ss_pred             CcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhccc
Confidence            34889998764 4788889876543   335667888887773 444557777766666789999999988776432   


Q ss_pred             ----------------ccCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHhc----CCCCCee
Q 008698          357 ----------------HHIPRGGRSLDWA--MRMKVAT--------------------TLAQGIAFLHD----KVKPHVV  394 (557)
Q Consensus       357 ----------------~~~~~~~~~l~~~--~~~~i~~--------------------~ia~gL~yLH~----~~~~~iv  394 (557)
                                      +........+...  ..+....                    .+...+..|-.    ...+.++
T Consensus        87 ~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~  166 (244)
T cd05150          87 EPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVT  166 (244)
T ss_pred             CHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEE
Confidence                            1111111111100  0000000                    01112222211    1234699


Q ss_pred             ecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          395 HRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       395 H~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      |+|+.|.|||++++....|+||+.+..
T Consensus       167 HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         167 HGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CCCCCCccEEEeCCcEEEEEEcccccc
Confidence            999999999999987788999987653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.00  E-value=7.8e-05  Score=71.61  Aligned_cols=142  Identities=18%  Similarity=0.207  Sum_probs=82.4

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC--cEEeeeeeee---eCCceEEEEecCCCC
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP--NLVAVKGCCY---DHGDRYIVYEFVVNG  350 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~g~~~---~~~~~~lV~E~~~~g  350 (557)
                      .++.|..+.||+....+ ..+++|.....  .....+.+|..++..+...  .+.+++.+..   .....+++|+++++.
T Consensus         4 ~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    4 PLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             cCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            46899999999999866 69999997655  4556777888888887432  3456665432   233468999999988


Q ss_pred             ChHH----------------Hh---ccCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc--
Q 008698          351 PLDR----------------WL---HHIPRGGRSLDWAM---------RMKV------------ATTLAQ-GIAFLHD--  387 (557)
Q Consensus       351 sL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~--  387 (557)
                      ++..                .+   +........+....         ....            ...+.. .+..+++  
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            7776                11   11100111111110         0000            111222 3333332  


Q ss_pred             --CCCCCeeecCCCCCCeeeC-CCCCcEEeeccCCc
Q 008698          388 --KVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSK  420 (557)
Q Consensus       388 --~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgl~~  420 (557)
                        .....++|+|+.|.|||++ +++.+.|.||+.+.
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence              2345799999999999999 55555799998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=97.91  E-value=0.00015  Score=83.25  Aligned_cols=149  Identities=18%  Similarity=0.283  Sum_probs=92.5

Q ss_pred             eeecccCceEEEEEEeCCC---CEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCcE--EeeeeeeeeC---CceEEEE
Q 008698          275 RLLGDSKTGGTYSGILPDG---SRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNL--VAVKGCCYDH---GDRYIVY  344 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV~  344 (557)
                      ..++.|.++.+|+....++   ..+++|+..... ......+.+|+.+|..+. |.++  .+++++|.+.   +..|+||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            4468999999999877554   467888765432 223457889999999995 6665  7778877664   4679999


Q ss_pred             ecCCCCChHH--------------------H---hccCCCC-------CCCCCH--HHHHHHH---------------HH
Q 008698          345 EFVVNGPLDR--------------------W---LHHIPRG-------GRSLDW--AMRMKVA---------------TT  377 (557)
Q Consensus       345 E~~~~gsL~~--------------------~---l~~~~~~-------~~~l~~--~~~~~i~---------------~~  377 (557)
                      ||+++..+.+                    .   |+.....       +.+...  .++..+.               ..
T Consensus       124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~  203 (822)
T PLN02876        124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK  203 (822)
T ss_pred             EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence            9998764321                    1   1111100       011111  1111111               12


Q ss_pred             HHHHHHHHhcCCC--------CCeeecCCCCCCeeeCCC-CC-cEEeeccCCccCC
Q 008698          378 LAQGIAFLHDKVK--------PHVVHRDIRASNVLLDEE-FG-AHLMGVGLSKFVP  423 (557)
Q Consensus       378 ia~gL~yLH~~~~--------~~ivH~Dlk~~Nill~~~-~~-~kl~Dfgl~~~~~  423 (557)
                      +...+.+|..+..        +.++|+|+++.|||++.+ .. .-|.||.++....
T Consensus       204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence            3344667754322        359999999999999853 33 5789999887653

>PRK10593 hypothetical protein; Provisional

Probab=97.88  E-value=0.00028  Score=70.83  Aligned_cols=75  Identities=9%  Similarity=0.044  Sum_probs=55.2

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC---CcEEeeeeeeee---CCceEEEEecCC
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH---PNLVAVKGCCYD---HGDRYIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H---~niv~l~g~~~~---~~~~~lV~E~~~  348 (557)
                      .-||.|..+.||+....++ .+.+|..+..  .....+.+|...|+.+.-   -.+.++++++..   .+..+||||+++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~   96 (297)
T PRK10593         20 ECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR   96 (297)
T ss_pred             eecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence            3579999999999876556 4677775431  133578899999988843   357788887754   366899999999


Q ss_pred             CCCh
Q 008698          349 NGPL  352 (557)
Q Consensus       349 ~gsL  352 (557)
                      ++++
T Consensus        97 G~~~  100 (297)
T PRK10593         97 GVSV  100 (297)
T ss_pred             CEec
Confidence            8765

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.86  E-value=5.7e-05  Score=70.30  Aligned_cols=105  Identities=18%  Similarity=0.165  Sum_probs=80.9

Q ss_pred             HHHHHHHhhcCC-CcEEeeeeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 008698          313 YSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP  391 (557)
Q Consensus       313 ~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  391 (557)
                      .+|.-++..+++ +++++++|.|-    .++|.||...+++...-... ..-...+|..|.+||.++++.+.+|++....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            357778888865 69999999983    36899999877653210000 0112478999999999999999999986544


Q ss_pred             CeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       392 ~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      .+.-.|++++|+-+++++++|+.|.......
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            6888999999999999999999998876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.72  E-value=0.00035  Score=62.96  Aligned_cols=126  Identities=17%  Similarity=0.230  Sum_probs=85.1

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEe-eeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~-l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      +.|++|.+|.||+|.+ .|..+|+|+-+.+  .....+..|+++|..+.-.++.+ ++.+    +.-++.|||+.|-+|.
T Consensus        28 ~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~~L~  100 (201)
T COG2112          28 KELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGRPLG  100 (201)
T ss_pred             hhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCcchh
Confidence            3579999999999998 6779999987655  35678999999999998766653 3332    2234569999887886


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC-CCCeeeCCCCCcEEeeccCCcc
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR-ASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk-~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      +.-..       .+...++.    +++.---|...   ||-|+.|. |...+|.++..+-|+||.-|..
T Consensus       101 ~~~~~-------~~rk~l~~----vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         101 KLEIG-------GDRKHLLR----VLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhc-------ccHHHHHH----HHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            65431       13333333    33332223333   89998886 4444444444899999998864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.62  E-value=0.00044  Score=66.97  Aligned_cols=71  Identities=14%  Similarity=0.109  Sum_probs=43.1

Q ss_pred             ecccCce-EEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC---cEEeeeeeeeeC---CceEEEEecCCC
Q 008698          277 LGDSKTG-GTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP---NLVAVKGCCYDH---GDRYIVYEFVVN  349 (557)
Q Consensus       277 lg~G~~g-~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~E~~~~  349 (557)
                      ++.|+.. .||+.    +..+++|..+..  .....+.+|.+.+..+...   .+.++++.....   ...+++||+++|
T Consensus         5 ~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G   78 (235)
T cd05155           5 VDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG   78 (235)
T ss_pred             ccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence            4666655 58874    345777876542  2345788899888877421   233444433222   234889999988


Q ss_pred             CChH
Q 008698          350 GPLD  353 (557)
Q Consensus       350 gsL~  353 (557)
                      .++.
T Consensus        79 ~~l~   82 (235)
T cd05155          79 ETAT   82 (235)
T ss_pred             CCCC
Confidence            7663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.61  E-value=0.00028  Score=79.62  Aligned_cols=196  Identities=19%  Similarity=0.162  Sum_probs=133.0

Q ss_pred             HHHHHHHHhhcCCCcEEeeeeeeeeCCce----EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 008698          312 FYSEIGRFARLHHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD  387 (557)
Q Consensus       312 ~~~e~~~l~~l~H~niv~l~g~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~  387 (557)
                      ...|+..+.++.|+|++.++++..+....    .+..|++..-++...+..    -..++..+.+.+..+..+||.|+|+
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence            45577788889999999999887655332    344567777777777754    3457888888999999999999999


Q ss_pred             CCCCCeeecCCCCC---CeeeCCCCCcEEe--eccCCccCCccccccceeecCccccccccccccCCCCCc--hhhHHHH
Q 008698          388 KVKPHVVHRDIRAS---NVLLDEEFGAHLM--GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT--KSDVYSF  460 (557)
Q Consensus       388 ~~~~~ivH~Dlk~~---Nill~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~sDVwS~  460 (557)
                      .   ...|.-|..+   +.-.+..+...++  ||+.+..+..........   -+..|.+||......+..  ..|+|.+
T Consensus       305 ~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~---~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 L---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDL---LAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             h---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhc---CccccccccccccccchhhhhhHHHHH
Confidence            8   5555555554   4445566666666  888877665443322211   345678888777655544  4799999


Q ss_pred             HHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 008698          461 GVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  540 (557)
Q Consensus       461 Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~  540 (557)
                      |..+..+..|..+-.....                  ...+++.            .......+....|+..++++|++.
T Consensus       379 gll~~~~~~~~~i~~~~~~------------------~~~~l~~------------~~~~~~~d~~~~~~~~~~~~Rl~~  428 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSAV------------------PVSLLDV------------LSTSELLDALPKCLDEDSEERLSA  428 (1351)
T ss_pred             HHHHhhhhhcCcccccccc------------------hhhhhcc------------ccchhhhhhhhhhcchhhhhccch
Confidence            9999999988655221100                  0011110            011146677789999999999999


Q ss_pred             HHHHHHH
Q 008698          541 SHVVHQL  547 (557)
Q Consensus       541 ~evl~~L  547 (557)
                      .+++...
T Consensus       429 ~~ll~~~  435 (1351)
T KOG1035|consen  429 LELLTHP  435 (1351)
T ss_pred             hhhhhch
Confidence            9998754

>PHA02673 ORF109 EEV glycoprotein; Provisional

Probab=97.52  E-value=9.8e-05  Score=63.93  Aligned_cols=40  Identities=23%  Similarity=0.526  Sum_probs=33.5

Q ss_pred             CCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeC
Q 008698           50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALT   94 (557)
Q Consensus        50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~   94 (557)
                      ...|+-=    .++++||.+. ++++|+||...|...|+.|.+-.
T Consensus        74 ~~tC~GI----~~~~~Cltl~-~p~tf~eAn~~C~~~g~~LPs~~  113 (161)
T PHA02673         74 NRTCDGI----NAGNKCLTLK-YPDTWTNANERCKELGQRLPSPS  113 (161)
T ss_pred             cCcCCCc----ccCCeeEEeC-CCCcHHHHHHHHHhcCCcCCCCc
Confidence            4567432    4789999999 88999999999999999999853

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.43  E-value=0.0017  Score=62.64  Aligned_cols=72  Identities=14%  Similarity=0.055  Sum_probs=46.3

Q ss_pred             eecccCceEEEEEEeCC--CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcE-EeeeeeeeeCCceEEEEecCCCCCh
Q 008698          276 LLGDSKTGGTYSGILPD--GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~--g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .|..|-...+|+....+  ++.|++|....... ......+|+.++..+...++ +++++...    ..++|||+++.++
T Consensus         5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            45778888999988654  67899997754321 11233468888888843333 34444322    2479999988765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PHA03093 EEV glycoprotein; Provisional

Probab=97.42  E-value=0.00028  Score=62.72  Aligned_cols=41  Identities=12%  Similarity=0.334  Sum_probs=35.0

Q ss_pred             CCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeee
Q 008698           49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAAL   93 (557)
Q Consensus        49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i   93 (557)
                      ....|.-=    .|+++||.|..++++|+||...|...|+.|.+-
T Consensus        97 ~~~~C~GI----~~~~~C~~~~~epkTf~dA~~~C~~~g~~LPs~  137 (185)
T PHA03093         97 HKESCKGI----VYDGSCYIFHSEPKTFSDAKADCAKKSSTLPNS  137 (185)
T ss_pred             ccCcCCCe----ecCCEeEEecCCCcCHHHHHHHHHhcCCcCCCc
Confidence            34567532    378999999999999999999999999999983

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.39  E-value=0.0029  Score=65.65  Aligned_cols=74  Identities=16%  Similarity=0.003  Sum_probs=52.7

Q ss_pred             eecccCceEEEEEEeCCC-CEEEEEEeccc------c-hhhHHHHHHHHHHHhhcC---CCcEEeeeeeeeeCCceEEEE
Q 008698          276 LLGDSKTGGTYSGILPDG-SRVAVKRLKRS------S-FQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g-~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~lV~  344 (557)
                      .||.|.+..||+....+| +.|+||.-...      . ....+++..|.+.|..+.   -.++++++.+  +.+..++||
T Consensus        33 elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVM  110 (401)
T PRK09550         33 EIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVM  110 (401)
T ss_pred             EcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEE
Confidence            479999999999998777 48999985421      1 123456777888887762   2456677765  445678999


Q ss_pred             ecCCCCC
Q 008698          345 EFVVNGP  351 (557)
Q Consensus       345 E~~~~gs  351 (557)
                      |++++..
T Consensus       111 E~L~~~~  117 (401)
T PRK09550        111 EDLSDHK  117 (401)
T ss_pred             ecCCCcc
Confidence            9998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.39  E-value=0.002  Score=63.28  Aligned_cols=139  Identities=14%  Similarity=0.065  Sum_probs=78.6

Q ss_pred             ecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcE-EeeeeeeeeCCceEEEEecCCCCChHHH
Q 008698          277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEFVVNGPLDRW  355 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~~  355 (557)
                      +..|-.+.+|+... +++.+++|........-.....+|..++..+....+ .++++..    ...+||||++|.++..-
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence            35677789998874 677888987654322111235678888888753333 2333332    23689999988665321


Q ss_pred             -----------------hccCCCCCCCCCHHHH-HHHHHH---------HHHHHHHHhcC-----CCCCeeecCCCCCCe
Q 008698          356 -----------------LHHIPRGGRSLDWAMR-MKVATT---------LAQGIAFLHDK-----VKPHVVHRDIRASNV  403 (557)
Q Consensus       356 -----------------l~~~~~~~~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~ivH~Dlk~~Ni  403 (557)
                                       |+.......+++...+ .....+         +..-+..+-..     ..+.++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             1221111222222211 111111         11112222211     133689999999999


Q ss_pred             eeCCCCCcEEeeccCCcc
Q 008698          404 LLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       404 ll~~~~~~kl~Dfgl~~~  421 (557)
                      ++++++ +.+.||..+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999876 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	557
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-41
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-39
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-31
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-31
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-31
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-29
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-29
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-28
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		8e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-06
1jwi_A	131	Crystal Structure Of Bitiscetin, A Von Willeband Fa		5e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-05
2afp_A	129	The Solution Structure Of Type Ii Antifreeze Protei		4e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-05
3soa_A	444	Full-Length Human Camkii Length = 444		8e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-05
1fvu_B	125	Crystal Structure Of Botrocetin Length = 125		8e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-05
2zib_A	133	Crystal Structure Analysis Of Calcium-Independent T		8e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-04
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-04
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-04
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-04
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-04
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-04
1sl6_A	184	Crystal Structure Of A Fragment Of Dc-signr (contai		9e-04
2xr6_A	170	Crystal Structure Of The Complex Of The Carbohydrat		9e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  165 bits (418), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 97/299 (32%), Positives = 158/299 (52%), Gaps = 15/299 (5%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKK-EFYS 314
           K F+  EL+  + NFS  N +LG    G  Y G L DG+ VAVKRLK    Q  + +F +
Sbjct: 26  KRFSLRELQVASDNFSNKN-ILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQT 84
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           E+   +   H NL+ ++G C    +R +VY ++ NG +   L   P     LDW  R ++
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
           A   A+G+A+LHD   P ++HRD++A+N+LLDEEF A +   GL+K + ++       + 
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 204
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAV-----DSVCWQSIFEWA 489
            GT G++APE++   + + K+DV+ +GV+LLE+++G+R          D V    + +W 
Sbjct: 205 -GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM---LLDWV 260
Query: 490 TPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
             L++  +                     V++++ +   CTQ  P  RP+MS VV  L+
Sbjct: 261 KGLLKEKKLEALVDVDLQGNYKDEE----VEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 95/299 (31%), Positives = 155/299 (51%), Gaps = 15/299 (5%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKK-EFYS 314
           K F+  EL+  + NF   N +LG    G  Y G L DG  VAVKRLK    Q  + +F +
Sbjct: 18  KRFSLRELQVASDNFXNKN-ILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           E+   +   H NL+ ++G C    +R +VY ++ NG +   L   P     LDW  R ++
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
           A   A+G+A+LHD   P ++HRD++A+N+LLDEEF A +   GL+K + ++       + 
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 196
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAV-----DSVCWQSIFEWA 489
            G  G++APE++   + + K+DV+ +GV+LLE+++G+R          D V    + +W 
Sbjct: 197 -GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM---LLDWV 252
Query: 490 TPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
             L++  +                     V++++ +   CTQ  P  RP+MS VV  L+
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEE----VEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 89/225 (39%), Positives = 125/225 (55%), Gaps = 21/225 (9%)
Query: 258 FTTEELRSITKNFSE-----GNRLLGDSKTGGTYSGILPDGSRVAVKRLKR----SSFQR 308
           F+  EL+++T NF E     G   +G+   G  Y G + + + VAVK+L      ++ + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           K++F  EI   A+  H NLV + G   D  D  +VY ++ NG L   L  +  G   L W
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSW 132
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL---SKFVPWE 425
            MR K+A   A GI FLH+    H +HRDI+++N+LLDE F A +   GL   S+     
Sbjct: 133 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
           VM  R V   GT  Y+APE   R E+T KSD+YSFGV+LLEI++G
Sbjct: 190 VMXSRIV---GTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  132 bits (332), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 89/225 (39%), Positives = 125/225 (55%), Gaps = 21/225 (9%)
Query: 258 FTTEELRSITKNFSE-----GNRLLGDSKTGGTYSGILPDGSRVAVKRLKR----SSFQR 308
           F+  EL+++T NF E     G   +G+   G  Y G + + + VAVK+L      ++ + 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           K++F  EI   A+  H NLV + G   D  D  +VY ++ NG L   L  +  G   L W
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSW 126
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL---SKFVPWE 425
            MR K+A   A GI FLH+    H +HRDI+++N+LLDE F A +   GL   S+     
Sbjct: 127 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
           VM  R V   GT  Y+APE   R E+T KSD+YSFGV+LLEI++G
Sbjct: 184 VMXXRIV---GTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  132 bits (332), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 89/225 (39%), Positives = 125/225 (55%), Gaps = 21/225 (9%)
Query: 258 FTTEELRSITKNFSE-----GNRLLGDSKTGGTYSGILPDGSRVAVKRLKR----SSFQR 308
           F+  EL+++T NF E     G   +G+   G  Y G + + + VAVK+L      ++ + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           K++F  EI   A+  H NLV + G   D  D  +VY ++ NG L   L  +  G   L W
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSW 132
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL---SKFVPWE 425
            MR K+A   A GI FLH+    H +HRDI+++N+LLDE F A +   GL   S+     
Sbjct: 133 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
           VM  R V   GT  Y+APE   R E+T KSD+YSFGV+LLEI++G
Sbjct: 190 VMXXRIV---GTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/253 (33%), Positives = 137/253 (54%), Gaps = 11/253 (4%)
Query: 246 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS 305
           ++S LVP         +L   T NF +   L+G    G  Y G+L DG++VA+KR    S
Sbjct: 17  SSSYLVPFESYRVPLVDLEEATNNF-DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 306 FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS 365
            Q  +EF +EI   +   HP+LV++ G C +  +  ++Y+++ NG L R L+       S
Sbjct: 76  SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 366 LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
           + W  R+++    A+G+ +LH +    ++HRD+++ N+LLDE F   +   G+SK     
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-- 483
                  +  GT GY+ PE+  +  LT KSDVYSFGV+L E++  R  +  V S+  +  
Sbjct: 193 DQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR--SAIVQSLPREMV 250
Query: 484 SIFEWATPLVQSH 496
           ++ EWA   V+SH
Sbjct: 251 NLAEWA---VESH 260

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/253 (33%), Positives = 137/253 (54%), Gaps = 11/253 (4%)
Query: 246 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS 305
           ++S LVP         +L   T NF +   L+G    G  Y G+L DG++VA+KR    S
Sbjct: 17  SSSYLVPFESYRVPLVDLEEATNNF-DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 306 FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS 365
            Q  +EF +EI   +   HP+LV++ G C +  +  ++Y+++ NG L R L+       S
Sbjct: 76  SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 366 LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
           + W  R+++    A+G+ +LH +    ++HRD+++ N+LLDE F   +   G+SK     
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-- 483
                  +  GT GY+ PE+  +  LT KSDVYSFGV+L E++  R  +  V S+  +  
Sbjct: 193 GQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR--SAIVQSLPREMV 250
Query: 484 SIFEWATPLVQSH 496
           ++ EWA   V+SH
Sbjct: 251 NLAEWA---VESH 260

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/224 (38%), Positives = 121/224 (54%), Gaps = 19/224 (8%)
Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDG----SRVAVKRLKR----SSFQRK 309
           F+  EL+++T NF E    +G +K G    G++  G    + VAVK+L      ++ + K
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
           ++F  EI   A+  H NLV + G   D  D  +VY +  NG L   L  +  G   L W 
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLD-GTPPLSWH 124
Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL---SKFVPWEV 426
            R K+A   A GI FLH+    H +HRDI+++N+LLDE F A +   GL   S+     V
Sbjct: 125 XRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
              R V   GT  Y APE   R E+T KSD+YSFGV+LLEI++G
Sbjct: 182 XXSRIV---GTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 108/200 (54%), Gaps = 14/200 (7%)
Query: 293 GSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           GS VAVK L    F  +R  EF  E+    RL HPN+V   G      +  IV E++  G
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 351 PLDRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
            L R LH    G R  LD   R+ +A  +A+G+ +LH++  P +VHRD+++ N+L+D+++
Sbjct: 120 SLYRLLHK--SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKY 176
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              +   GLS+      +  +   A GT  ++APE +       KSDVYSFGV+L E+ +
Sbjct: 177 TVKVCDFGLSRLKASXFLXSKX--AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234
Query: 470 GRR------PAQAVDSVCWQ 483
            ++      PAQ V +V ++
Sbjct: 235 LQQPWGNLNPAQVVAAVGFK 254

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 293 GSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           GS VAVK L    F  +R  EF  E+    RL HPN+V   G      +  IV E++  G
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 351 PLDRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
            L R LH    G R  LD   R+ +A  +A+G+ +LH++  P +VHR++++ N+L+D+++
Sbjct: 120 SLYRLLHK--SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKY 176
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              +   GLS+      +  ++  A GT  ++APE +       KSDVYSFGV+L E+ +
Sbjct: 177 TVKVCDFGLSRLKASTFLSSKS--AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234
Query: 470 GRR------PAQAVDSVCWQ 483
            ++      PAQ V +V ++
Sbjct: 235 LQQPWGNLNPAQVVAAVGFK 254

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 13/197 (6%)
Query: 293 GSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
           G  VAVK  +        Q  +    E   FA L HPN++A++G C    +  +V EF  
Sbjct: 30  GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
            GPL+R L      G+ +   + +  A  +A+G+ +LHD+    ++HRD+++SN+L+ ++
Sbjct: 90  GGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQK 144
Query: 409 FGAHLMGVGLSKFVPWEVMQE--RT--VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
                +   + K   + + +E  RT  + A G Y ++APE +  +  +  SDV+S+GVLL
Sbjct: 145 VENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLL 204
Query: 465 LEIVSGRRPAQAVDSVC 481
            E+++G  P + +D + 
Sbjct: 205 WELLTGEVPFRGIDGLA 221

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 135
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTX---TAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 234
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 235 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 238
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 239 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 132
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTF---TAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDP---SQVYELLEKDYRMER--------------- 231
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 232 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTX---TAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 238
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 239 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 132
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTX---TAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDP---SQVYELLEKDYRMER--------------- 231
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 232 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 238
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 239 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 147
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 205 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 246
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 247 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 284

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 136
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 235
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 236 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 136
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 235
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 236 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 135
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 234
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 235 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 136
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 235
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 236 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 238
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 239 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 138
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 237
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 238 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 233
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 234 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 132
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTX---TAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDP---SQVYELLEKDYRMER--------------- 231
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 232 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 233
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 234 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 233
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 234 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 233
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 234 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 233
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 234 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 238
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 239 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 125/274 (45%), Gaps = 34/274 (12%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 233
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546
               G  +KV +L+ AC Q  PS RP  +  +HQ
Sbjct: 234 --PEGCPEKVYELMRACWQWNPSDRPSFAE-IHQ 264

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + +  +EF  E      + HPNLV + G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 341
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           R++ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E    L + +R               
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYEL---LEKDYR--------------M 438
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 33/280 (11%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + +  +EF  E      + HPNLV + G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 380
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           R++ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      ++E    L + +R               
Sbjct: 438 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYEL---LEKDYR--------------M 477
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 478 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 517

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 125/280 (44%), Gaps = 35/280 (12%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G    G       VAVK +K  S   + EF+ E     +L HP LV   G C  
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++ NG L   L+++   G+ L+ +  +++   + +G+AFL        +HR
Sbjct: 75  EYPIYIVTEYISNGCL---LNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHR 128
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 453
           D+ A N L+D +    +   G++++    V+ ++ V + GT     + APE  +  + ++
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRY----VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FG+L+ E+ S G+ P     +       E    + Q HR               
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGHRLYRPHLAS------- 231
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                    +  ++Y+C   +P  RP    ++  ++ L +
Sbjct: 232 -------DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 80  E-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIE---DAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL EIV+ GR P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 119/274 (43%), Gaps = 34/274 (12%)
Query: 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                YIV E++  G L  +L    R    +   + + +AT ++  + +L  K   + +H
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNR--EEVTAVVLLYMATQISSAMEYLEKK---NFIH 153
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N  + 
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNTFSI 210
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           KSDV++FGVLL EI + G  P   +D      + E    + Q                  
Sbjct: 211 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPE---------------- 254
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546
               G   KV +L+ AC +  P+ RP  +   HQ
Sbjct: 255 ----GCPPKVYELMRACWKWSPADRPSFAE-THQ 283

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 86  E-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 139
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL EIV+ GR P
Sbjct: 197 SDVWSFGILLTEIVTHGRIP 216

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YI+ E++ NG L  +L   P G + L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 80  E-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL EIV+ GR P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 88  E-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 141
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL EIV+ GR P
Sbjct: 199 SDVWSFGILLTEIVTHGRIP 218

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 82  E-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 135
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL EIV+ GR P
Sbjct: 193 SDVWSFGILLTEIVTHGRIP 212

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YI+ E++ NG L  +L   P G + L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 81  E-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 134
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL EIV+ GR P
Sbjct: 192 SDVWSFGILLTEIVTHGRIP 211

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 89  E-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 142
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL EIV+ GR P
Sbjct: 200 SDVWSFGILLTEIVTHGRIP 219

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 80  E-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL EIV+ GR P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YI+ E++ NG L  +L   P G + L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 86  E-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 139
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL EIV+ GR P
Sbjct: 197 SDVWSFGILLTEIVTHGRIP 216

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YI+ E++ NG L  +L   P G + L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 85  E-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 138
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTIK 195
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL EIV+ GR P
Sbjct: 196 SDVWSFGILLTEIVTHGRIP 215

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YI+ E++ NG L  +L   P G + L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 80  E-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL EIV+ GR P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YI+ E++ NG L  +L   P G + L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 90  E-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 143
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTIK 200
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL EIV+ GR P
Sbjct: 201 SDVWSFGILLTEIVTHGRIP 220

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YI+ E++ NG L  +L   P G + L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 75  E-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 128
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTIK 185
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL EIV+ GR P
Sbjct: 186 SDVWSFGILLTEIVTHGRIP 205

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 110/224 (49%), Gaps = 22/224 (9%)
Query: 253 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEF 312
           P W+V   E L+ + +        LG  + G  + G     ++VAVK LK+ S      F
Sbjct: 2   PEWEV-PRETLKLVER--------LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAF 51
Query: 313 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
            +E     +L H  LV +          YI+ E++ NG L  +L   P G + L     +
Sbjct: 52  LAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLL 108
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
            +A  +A+G+AF+ ++   + +HR++RA+N+L+ +     +   GL++ +      E T 
Sbjct: 109 DMAAQIAEGMAFIEER---NYIHRNLRAANILVSDTLSCKIADFGLARLIE---DNEYTA 162
Query: 433 MAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
             G  +   + APE +     T KSDV+SFG+LL EIV+ GR P
Sbjct: 163 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 93/181 (51%), Gaps = 12/181 (6%)
Query: 293 GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVN 349
           G  VAVK LK     Q +  +  EI     L+H +++  KGCC D G++   +V E+V  
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV-- 100
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
            PL     ++PR   S+  A  +  A  + +G+A+LH +   H +HR++ A NVLLD + 
Sbjct: 101 -PLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDR 154
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIV 468
              +   GL+K VP      R    G +  +  APE +   +    SDV+SFGV L E++
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 469 S 469
           +
Sbjct: 215 T 215

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ EF+  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYG 101
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 102 SLREYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 155
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 21/224 (9%)
Query: 253 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEF 312
           P+W++   E ++ + K        LG  + G  + G   + ++VAVK LK  +   +  F
Sbjct: 5   PAWEI-PRESIKLVKK--------LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-F 54
Query: 313 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
             E      L H  LV +          YI+ EF+  G L  +L     GG+ L     +
Sbjct: 55  LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKS-DEGGKVL-LPKLI 112
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
             +  +A+G+A++  K   + +HRD+RA+NVL+ E     +   GL++ +      E T 
Sbjct: 113 DFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIE---DNEYTA 166
Query: 433 MAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
             G  +   + APE +     T KS+V+SFG+LL EIV+ G+ P
Sbjct: 167 REGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 93/181 (51%), Gaps = 12/181 (6%)
Query: 293 GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVN 349
           G  VAVK LK     Q +  +  EI     L+H +++  KGCC D G++   +V E+V  
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV-- 100
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
            PL     ++PR   S+  A  +  A  + +G+A+LH +   H +HR++ A NVLLD + 
Sbjct: 101 -PLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDR 154
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIV 468
              +   GL+K VP      R    G +  +  APE +   +    SDV+SFGV L E++
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 469 S 469
           +
Sbjct: 215 T 215

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 92/181 (50%), Gaps = 12/181 (6%)
Query: 293 GSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEFVVN 349
           G  VAVK LK  +  Q +  +  EI     L+H +++  KGCC D G     +V E+V  
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV-- 117
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
            PL     ++PR   S+  A  +  A  + +G+A+LH +   H +HRD+ A NVLLD + 
Sbjct: 118 -PLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDR 171
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIV 468
              +   GL+K VP      R    G +  +  APE +   +    SDV+SFGV L E++
Sbjct: 172 LVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231
Query: 469 S 469
           +
Sbjct: 232 T 232

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           + LG  + G  + G   + ++VAVK LK  +   +  F  E      L H  LV +    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVV 77
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 YI+ E++  G L  +L     GG+ L     +  +  +A+G+A++  K   + +
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKS-DEGGKVL-LPKLIDFSAQIAEGMAYIERK---NYI 132
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELT 452
           HRD+RA+NVL+ E     +   GL++ +      E T   G  +   + APE +     T
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGCFT 189
Query: 453 TKSDVYSFGVLLLEIVS-GRRP 473
            KSDV+SFG+LL EIV+ G+ P
Sbjct: 190 IKSDVWSFGILLYEIVTYGKIP 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 37  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 96
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 97  SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 150
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 151 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 99  SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 152
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 38  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 97
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 98  SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 151
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 152 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 99  SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 152
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 102 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 155
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 70  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 130 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 183
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 184 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 113/233 (48%), Gaps = 30/233 (12%)
Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSG-ILPDGSRVAVKRL-------KRSSFQRK 309
           F    L ++  N  E  + +G    G  + G ++ D S VA+K L       +    ++ 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
           +EF  E+   + L+HPN+V + G    H    +V EFV  G L    H +      + W+
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDL---YHRLLDKAHPIKWS 122
Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFG--AHLMGVGLSKFVPW 424
           +++++   +A GI ++ ++  P +VHRD+R+ N+ L   DE     A +   GLS+    
Sbjct: 123 VKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---- 177
Query: 425 EVMQERTVMAG--GTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRP 473
              Q    ++G  G + ++APE +   E   T K+D YSF ++L  I++G  P
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 44  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 103
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 104 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 157
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 158 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 46  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 105
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 106 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 159
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 160 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 43  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 102
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 103 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 156
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 157 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 117 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 170
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 351 PLDRWLH-HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
            L  +L  H  R    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E 
Sbjct: 102 SLRDYLQAHAER----IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENEN 154
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIV 468
              +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ 
Sbjct: 155 RVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 214
Query: 469 S 469
           +
Sbjct: 215 T 215

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 117 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 170
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 45  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 104
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 105 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 158
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 159 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 118/271 (43%), Gaps = 39/271 (14%)
Query: 295 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           +VAVK LK ++   +KE   SE+   + L  H N+V + G C   G   ++ E+   G L
Sbjct: 70  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 129
Query: 353 DRWLHHIPRG------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
             +L            GR L+    +  ++ +AQG+AFL  K   + +HRD+ A NVLL 
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 186
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGV 462
               A +   GL++    ++M +   +  G       ++APE ++    T +SDV+S+G+
Sbjct: 187 NGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 242
Query: 463 LLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQK 521
           LL EI S G  P   +              LV S  Y                 A   + 
Sbjct: 243 LLWEIFSLGLNPYPGI--------------LVNSKFY-----KLVKDGYQMAQPAFAPKN 283
Query: 522 VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
           +  ++ AC    P+ RP    +   LQ+ AQ
Sbjct: 284 IYSIMQACWALEPTHRPTFQQICSFLQEQAQ 314

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 118/271 (43%), Gaps = 39/271 (14%)
Query: 295 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           +VAVK LK ++   +KE   SE+   + L  H N+V + G C   G   ++ E+   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 353 DRWLHHIPRG------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
             +L            GR L+    +  ++ +AQG+AFL  K   + +HRD+ A NVLL 
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 194
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGV 462
               A +   GL++    ++M +   +  G       ++APE ++    T +SDV+S+G+
Sbjct: 195 NGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 250
Query: 463 LLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQK 521
           LL EI S G  P   +              LV S  Y                 A   + 
Sbjct: 251 LLWEIFSLGLNPYPGI--------------LVNSKFY-----KLVKDGYQMAQPAFAPKN 291
Query: 522 VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
           +  ++ AC    P+ RP    +   LQ+ AQ
Sbjct: 292 IYSIMQACWALEPTHRPTFQQICSFLQEQAQ 322

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
           S P    L   +W++   E LR   K        LG    G  + G     +RVA+K LK
Sbjct: 167 SKPQTQGLAKDAWEI-PRESLRLEVK--------LGQGCFGEVWMGTWNGTTRVAIKTLK 217
Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
             +    + F  E     +L H  LV +     +    YIV E++  G L  +L      
Sbjct: 218 PGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--ET 273
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
           G+ L     + +A  +A G+A++    + + VHRD+RA+N+L+ E     +   GL++ +
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 423 PWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
                 E T   G  +   + APE       T KSDV+SFG+LL E+ + GR P
Sbjct: 331 E---DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
           S P    L   +W++   E LR   K        LG    G  + G     +RVA+K LK
Sbjct: 167 SKPQTQGLAKDAWEI-PRESLRLEVK--------LGQGCFGEVWMGTWNGTTRVAIKTLK 217
Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
             +    + F  E     +L H  LV +     +    YIV E++  G L  +L      
Sbjct: 218 PGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--ET 273
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
           G+ L     + +A  +A G+A++    + + VHRD+RA+N+L+ E     +   GL++ +
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 423 PWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
                 E T   G  +   + APE       T KSDV+SFG+LL E+ + GR P
Sbjct: 331 E---DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 93/187 (49%), Gaps = 24/187 (12%)
Query: 293 GSRVAVKRLK-------RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI--V 343
           G  VAVK LK       RS +QR      EI     L+H ++V  KGCC D G++ +  V
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQR------EIEILRTLYHEHIVKYKGCCEDQGEKSVQLV 90
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
            E+V   PL     ++PR    +  A  +  A  + +G+A+LH +   H +HR + A NV
Sbjct: 91  MEYV---PLGSLRDYLPR--HCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNV 142
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGV 462
           LLD +    +   GL+K VP      R    G +  +  APE +   +    SDV+SFGV
Sbjct: 143 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGV 202
Query: 463 LLLEIVS 469
            L E+++
Sbjct: 203 TLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 93/187 (49%), Gaps = 24/187 (12%)
Query: 293 GSRVAVKRLK-------RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI--V 343
           G  VAVK LK       RS +QR      EI     L+H ++V  KGCC D G++ +  V
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQR------EIEILRTLYHEHIVKYKGCCEDQGEKSVQLV 91
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
            E+V   PL     ++PR    +  A  +  A  + +G+A+LH +   H +HR + A NV
Sbjct: 92  MEYV---PLGSLRDYLPR--HCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNV 143
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGV 462
           LLD +    +   GL+K VP      R    G +  +  APE +   +    SDV+SFGV
Sbjct: 144 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGV 203
Query: 463 LLLEIVS 469
            L E+++
Sbjct: 204 TLYELLT 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
           S P    L   +W++   E LR   K        LG    G  + G     +RVA+K LK
Sbjct: 167 SKPQTQGLAKDAWEI-PRESLRLEVK--------LGQGCFGEVWMGTWNGTTRVAIKTLK 217
Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
             +    + F  E     +L H  LV +     +    YIV E++  G L  +L      
Sbjct: 218 PGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVGEYMSKGSLLDFLKG--ET 273
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
           G+ L     + +A  +A G+A++    + + VHRD+RA+N+L+ E     +   GL++ +
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 423 PWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
                 E T   G  +   + APE       T KSDV+SFG+LL E+ + GR P
Sbjct: 331 E---DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 130/289 (44%), Gaps = 51/289 (17%)
Query: 289 ILPDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 344
           I  DG R+  A+KR+K  +S    ++F  E+    +L HHPN++ + G C   G  Y+  
Sbjct: 46  IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105
Query: 345 EFVVNGPLDRWLHHIPRGGRSLD----WAMRMKVATTL------------AQGIAFLHDK 388
           E+  +G L  +L    R  R L+    +A+    A+TL            A+G+ +L  K
Sbjct: 106 EYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 161
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
                +HRD+ A N+L+ E + A +   GLS+    EV  ++T M      ++A E +  
Sbjct: 162 ---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT-MGRLPVRWMAIESLNY 215
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXX 507
           +  TT SDV+S+GVLL EIVS G  P       C  +  E    L Q +R          
Sbjct: 216 SVYTTNSDVWSYGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYR---------- 259
Query: 508 XXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556
                        +V DL+  C +  P  RP  + ++  L ++ +   T
Sbjct: 260 ----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 99  SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 152
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 129/285 (45%), Gaps = 51/285 (17%)
Query: 289 ILPDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 344
           I  DG R+  A+KR+K  +S    ++F  E+    +L HHPN++ + G C   G  Y+  
Sbjct: 36  IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 95
Query: 345 EFVVNGPLDRWLHHIPRGGRSLD----WAMRMKVATTL------------AQGIAFLHDK 388
           E+  +G L  +L    R  R L+    +A+    A+TL            A+G+ +L  K
Sbjct: 96  EYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 151
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
                +HRD+ A N+L+ E + A +   GLS+    EV  ++T M      ++A E +  
Sbjct: 152 ---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT-MGRLPVRWMAIESLNY 205
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXX 507
           +  TT SDV+S+GVLL EIVS G  P       C  +  E    L Q +R          
Sbjct: 206 SVYTTNSDVWSYGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYR---------- 249
Query: 508 XXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                        +V DL+  C +  P  RP  + ++  L ++ +
Sbjct: 250 ----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 290

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 112/233 (48%), Gaps = 30/233 (12%)
Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSG-ILPDGSRVAVKRL-------KRSSFQRK 309
           F    L ++  N  E  + +G    G  + G ++ D S VA+K L       +    ++ 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
           +EF  E+   + L+HPN+V + G    H    +V EFV  G L    H +      + W+
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDL---YHRLLDKAHPIKWS 122
Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFG--AHLMGVGLSKFVPW 424
           +++++   +A GI ++ ++  P +VHRD+R+ N+ L   DE     A +   G S+    
Sbjct: 123 VKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ---- 177
Query: 425 EVMQERTVMAG--GTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRP 473
              Q    ++G  G + ++APE +   E   T K+D YSF ++L  I++G  P
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 112/233 (48%), Gaps = 30/233 (12%)
Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSG-ILPDGSRVAVKRL-------KRSSFQRK 309
           F    L ++  N  E  + +G    G  + G ++ D S VA+K L       +    ++ 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
           +EF  E+   + L+HPN+V + G    H    +V EFV  G L    H +      + W+
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDL---YHRLLDKAHPIKWS 122
Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFG--AHLMGVGLSKFVPW 424
           +++++   +A GI ++ ++  P +VHRD+R+ N+ L   DE     A +    LS+    
Sbjct: 123 VKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ---- 177
Query: 425 EVMQERTVMAG--GTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRP 473
              Q    ++G  G + ++APE +   E   T K+D YSF ++L  I++G  P
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 128/288 (44%), Gaps = 51/288 (17%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G  + G  + G   +  +VA+K +K  S   + +F  E     +L HP LV + G C +
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS-EDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA-MRMKVATTLAQGIAFLHDKVKPHVVH 395
                +V+EF+ +G L  +L    R  R L  A   + +   + +G+A+L +     V+H
Sbjct: 94  QAPICLVFEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELT 452
           RD+ A N L+ E     +   G+++F    V+ ++   + GT     + +PE    +  +
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 453 TKSDVYSFGVLLLEIVS-------GRRPAQAVDSVCWQSIFEWATP-LVQSHRYXXXXXX 504
           +KSDV+SFGVL+ E+ S        R  ++ V+ +   + F    P L  +H Y      
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--STGFRLYKPRLASTHVY------ 254
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                               ++  C +  P  RP  S ++ QL ++A+
Sbjct: 255 -------------------QIMNHCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 104/234 (44%), Gaps = 22/234 (9%)
Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
           S P    L   +W++   E LR   K        LG    G  + G     +RVA+K LK
Sbjct: 168 SKPQTQGLAKDAWEI-PRESLRLEVK--------LGQGCFGEVWMGTWNGTTRVAIKTLK 218
Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
             +    + F  E     +L H  LV +     +    YIV E++  G L  +L      
Sbjct: 219 PGNMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--EM 274
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
           G+ L     + +A  +A G+A++    + + VHRD+RA+N+L+ E     +   GL + +
Sbjct: 275 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLI 331
Query: 423 PWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
                 E T   G  +   + APE       T KSDV+SFG+LL E+ + GR P
Sbjct: 332 E---DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 40  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 99
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    +    +D    ++  + + +G+ +L  K     +HR++   N+L++ E  
Sbjct: 100 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRNLATRNILVENENR 153
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 154 VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
           S P    L   +W++   E LR   K        LG    G  + G     +RVA+K LK
Sbjct: 250 SKPQTQGLAKDAWEI-PRESLRLEVK--------LGQGCFGEVWMGTWNGTTRVAIKTLK 300
Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
             +    + F  E     +L H  LV +     +    YIV E++  G L  +L      
Sbjct: 301 PGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--ET 356
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
           G+ L     + +A  +A G+A++    + + VHRD+RA+N+L+ E     +   GL++ +
Sbjct: 357 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 413
Query: 423 PWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
                 E T   G  +   + APE       T KSDV+SFG+LL E+ + GR P
Sbjct: 414 E---DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 119/266 (44%), Gaps = 45/266 (16%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           VA+K+++  S   +K F  E+ + +R++HPN+V + G C +     +V E+   G L   
Sbjct: 35  VAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNV 90
Query: 356 LHHIPRGGRSLDW---AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
           LH    G   L +   A  M      +QG+A+LH      ++HRD++  N+LL    G  
Sbjct: 91  LH----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA--GGT 144
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 472
           ++ +    F     +Q       G+  ++APE    +  + K DV+S+G++L E+++ R+
Sbjct: 145 VLKI--CDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 202
Query: 473 PAQAVDSVCWQSIFEWAT------PLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLV 526
           P   +    ++ +  WA       PL+++                      + + +  L+
Sbjct: 203 PFDEIGGPAFRIM--WAVHNGTRPPLIKN----------------------LPKPIESLM 238
Query: 527 YACTQHVPSMRPRMSHVVHQLQQLAQ 552
             C    PS RP M  +V  +  L +
Sbjct: 239 TRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 119/266 (44%), Gaps = 45/266 (16%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           VA+K+++  S   +K F  E+ + +R++HPN+V + G C +     +V E+   G L   
Sbjct: 34  VAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNV 89
Query: 356 LHHIPRGGRSLDW---AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
           LH    G   L +   A  M      +QG+A+LH      ++HRD++  N+LL    G  
Sbjct: 90  LH----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA--GGT 143
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 472
           ++ +    F     +Q       G+  ++APE    +  + K DV+S+G++L E+++ R+
Sbjct: 144 VLKI--CDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
Query: 473 PAQAVDSVCWQSIFEWAT------PLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLV 526
           P   +    ++ +  WA       PL+++                      + + +  L+
Sbjct: 202 PFDEIGGPAFRIM--WAVHNGTRPPLIKN----------------------LPKPIESLM 237
Query: 527 YACTQHVPSMRPRMSHVVHQLQQLAQ 552
             C    PS RP M  +V  +  L +
Sbjct: 238 TRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 27/246 (10%)
Query: 245 PAASALVPPSWKVFTTEELRSITKNFSEG--------NRLLGDSKTGGTYSGILP-DGSR 295
           P     + P    FT E+     + F++          +++G  + G   SG L   G R
Sbjct: 5   PGMKIFIDP----FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKR 60
Query: 296 ---VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
              VA+K LK   + +++++F SE     +  HPN++ ++G         I+ EF+ NG 
Sbjct: 61  EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS 120
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
           LD +L    +          + +   +A G+ +L D    + VHRD+ A N+L++     
Sbjct: 121 LDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVC 174
Query: 412 HLMGVGLSKFVPWEVMQERTVMAGG---TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
            +   GLS+F+  +        A G      + APE +   + T+ SDV+S+G+++ E++
Sbjct: 175 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 234
Query: 469 S-GRRP 473
           S G RP
Sbjct: 235 SYGERP 240

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 130/289 (44%), Gaps = 51/289 (17%)
Query: 289 ILPDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 344
           I  DG R+  A+KR+K  +S    ++F  E+    +L HHPN++ + G C   G  Y+  
Sbjct: 43  IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 102
Query: 345 EFVVNGPLDRWLHHIPRGGRSLD----WAMRMKVATTL------------AQGIAFLHDK 388
           E+  +G L  +L    R  R L+    +A+    A+TL            A+G+ +L  K
Sbjct: 103 EYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 158
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
                +HR++ A N+L+ E + A +   GLS+    EV  ++T M      ++A E +  
Sbjct: 159 ---QFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKT-MGRLPVRWMAIESLNY 212
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXX 507
           +  TT SDV+S+GVLL EIVS G  P       C  +  E    L Q +R          
Sbjct: 213 SVYTTNSDVWSYGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYR---------- 256
Query: 508 XXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556
                        +V DL+  C +  P  RP  + ++  L ++ +   T
Sbjct: 257 ----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 301

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 120/284 (42%), Gaps = 52/284 (18%)
Query: 295 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           +VAVK LK ++   +KE   SE+   + L  H N+V + G C   G   ++ E+   G L
Sbjct: 63  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 122
Query: 353 DRWLH--------------HIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
             +L                 P G     GR L+    +  ++ +AQG+AFL  K   + 
Sbjct: 123 LNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NC 179
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRN 449
           +HRD+ A NVLL     A +   GL++    ++M +   +  G       ++APE ++  
Sbjct: 180 IHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPVKWMAPESIFDC 235
Query: 450 ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXX 508
             T +SDV+S+G+LL EI S G  P   +              LV S  Y          
Sbjct: 236 VYTVQSDVWSYGILLWEIFSLGLNPYPGI--------------LVNSKFY-----KLVKD 276
Query: 509 XXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                  A   + +  ++ AC    P+ RP    +   LQ+ AQ
Sbjct: 277 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 320

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 290 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDR----- 340
           L D   VAVK L R+   R   FY    R A+    L+HP +VAV    YD G+      
Sbjct: 34  LRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV----YDTGEAETPAG 88
Query: 341 ---YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
              YIV E+V    L   +H    G  +   A+  +V     Q + F H      ++HRD
Sbjct: 89  PLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAI--EVIADACQALNFSHQN---GIIHRD 141
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           ++ +N+++       +M  G+++ +      V Q   V+  GT  YL+PE    + +  +
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDAR 199
Query: 455 SDVYSFGVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSH 496
           SDVYS G +L E+++G  P    + DSV +Q + E   P    H
Sbjct: 200 SDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARH 243

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G  + G  + G   +  +VA+K ++  +   +++F  E     +L HP LV + G C +
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                +V+EF+ +G L  +L    RG  + +  + M     + +G+A+L +     V+HR
Sbjct: 72  QAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGM--CLDVCEGMAYLEEAC---VIHR 125
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 453
           D+ A N L+ E     +   G+++F    V+ ++   + GT     + +PE    +  ++
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 454 KSDVYSFGVLLLEIVS-------GRRPAQAVDSVCWQSIFEWATP-LVQSHRYXXXXXXX 505
           KSDV+SFGVL+ E+ S        R  ++ V+ +   + F    P L  +H Y       
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--STGFRLYKPRLASTHVY------- 232
Query: 506 XXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                              ++  C +  P  RP  S ++ QL ++A+
Sbjct: 233 ------------------QIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G  + G  + G   +  +VA+K ++  +   +++F  E     +L HP LV + G C +
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                +V+EF+ +G L  +L    RG  + +  + M     + +G+A+L +     V+HR
Sbjct: 74  QAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGM--CLDVCEGMAYLEEAC---VIHR 127
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 453
           D+ A N L+ E     +   G+++F    V+ ++   + GT     + +PE    +  ++
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 454 KSDVYSFGVLLLEIVS-------GRRPAQAVDSVCWQSIFEWATP-LVQSHRYXXXXXXX 505
           KSDV+SFGVL+ E+ S        R  ++ V+ +   + F    P L  +H Y       
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--STGFRLYKPRLASTHVY------- 234
Query: 506 XXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                              ++  C +  P  RP  S ++ QL ++A+
Sbjct: 235 ------------------QIMNHCWKERPEDRPAFSRLLRQLAEIAE 263

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           + LG+ + G  + G     ++VA+K LK  +    + F  E     +L H  LV +    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMS-PESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
            +    YIV E++  G L  +L      GR+L     + +A  +A G+A++    + + +
Sbjct: 74  SEE-PIYIVTEYMNKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYI 127
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELT 452
           HRD+R++N+L+       +   GL++ +      E T   G  +   + APE       T
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIE---DNEXTARQGAKFPIKWTAPEAALYGRFT 184
Query: 453 TKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
            KSDV+SFG+LL E+V+ GR P   +++
Sbjct: 185 IKSDVWSFGILLTELVTKGRVPYPGMNN 212

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G  + G  + G   +  +VA+K ++  +   +++F  E     +L HP LV + G C +
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                +V+EF+ +G L  +L    RG  + +  + M     + +G+A+L +     V+HR
Sbjct: 77  QAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGM--CLDVCEGMAYLEEAC---VIHR 130
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 453
           D+ A N L+ E     +   G+++F    V+ ++   + GT     + +PE    +  ++
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 186
Query: 454 KSDVYSFGVLLLEIVS-------GRRPAQAVDSVCWQSIFEWATP-LVQSHRYXXXXXXX 505
           KSDV+SFGVL+ E+ S        R  ++ V+ +   + F    P L  +H Y       
Sbjct: 187 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--STGFRLYKPRLASTHVY------- 237
Query: 506 XXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                              ++  C +  P  RP  S ++ QL ++A+
Sbjct: 238 ------------------QIMNHCWRERPEDRPAFSRLLRQLAEIAE 266

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 121/277 (43%), Gaps = 45/277 (16%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           D   VAVK LK +S   +K+F+ E      L H ++V   G C +     +V+E++ +G 
Sbjct: 42  DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 101
Query: 352 LDRWLH-HIPRG--------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
           L+++L  H P             L  +  + +A  +A G+ +L  +   H VHRD+   N
Sbjct: 102 LNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRN 158
Query: 403 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVY 458
            L+ E     +   G+S+    +V        GG       ++ PE +   + TT+SDV+
Sbjct: 159 CLVGENLLVKIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 214
Query: 459 SFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP--LVQSHRYXXXXXXXXXXXXXXXXX 515
           S GV+L EI + G++P   + +     + E  T   ++Q  R                  
Sbjct: 215 SLGVVLWEIFTYGKQPWYQLSN---NEVIECITQGRVLQRPR------------------ 253
Query: 516 AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
               Q+V +L+  C Q  P MR  +  +   LQ LA+
Sbjct: 254 -TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
            + LG  + G  +       ++VAVK +K  S   +  F +E      L H  LV +   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 78
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
                  YI+ EF+  G L  +L      G        +  +  +A+G+AF+  +   + 
Sbjct: 79  VTKE-PIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 132
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNEL 451
           +HRD+RA+N+L+       +   GL++ +      E T   G  +   + APE +     
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF 189
Query: 452 TTKSDVYSFGVLLLEIVS-GRRP 473
           T KSDV+SFG+LL+EIV+ GR P
Sbjct: 190 TIKSDVWSFGILLMEIVTYGRIP 212

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVIEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE---DNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 78  E-PIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 131
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 189 SDVWSFGILLTELTTKGRVP 208

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 104/204 (50%), Gaps = 17/204 (8%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G  + G  + G   +  +VA+K ++  +   +++F  E     +L HP LV + G C +
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA-MRMKVATTLAQGIAFLHDKVKPHVVH 395
                +V+EF+ +G L  +L    R  R L  A   + +   + +G+A+L +     V+H
Sbjct: 74  QAPICLVFEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEE---ASVIH 126
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELT 452
           RD+ A N L+ E     +   G+++F    V+ ++   + GT     + +PE    +  +
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 453 TKSDVYSFGVLLLEIVS-GRRPAQ 475
           +KSDV+SFGVL+ E+ S G+ P +
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYE 206

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 91/183 (49%), Gaps = 14/183 (7%)
Query: 293 GSRVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI--VYEFVVN 349
           G +VAVK LK  S      +   EI     L+H N+V  KG C + G   I  + EF+ +
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
           G L  +L   P+    ++   ++K A  + +G+ +L  +     VHRD+ A NVL++ E 
Sbjct: 98  GSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 151
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYG---YLAPEFVYRNELTTKSDVYSFGVLLLE 466
              +   GL+K +  E  +E   +         + APE + +++    SDV+SFGV L E
Sbjct: 152 QVKIGDFGLTKAI--ETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHE 209
Query: 467 IVS 469
           +++
Sbjct: 210 LLT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 91/183 (49%), Gaps = 14/183 (7%)
Query: 293 GSRVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI--VYEFVVN 349
           G +VAVK LK  S      +   EI     L+H N+V  KG C + G   I  + EF+ +
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
           G L  +L   P+    ++   ++K A  + +G+ +L  +     VHRD+ A NVL++ E 
Sbjct: 110 GSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 163
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYG---YLAPEFVYRNELTTKSDVYSFGVLLLE 466
              +   GL+K +  E  +E   +         + APE + +++    SDV+SFGV L E
Sbjct: 164 QVKIGDFGLTKAI--ETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHE 221
Query: 467 IVS 469
           +++
Sbjct: 222 LLT 224

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 74  E-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 185 SDVWSFGILLTELTTKGRVP 204

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVIEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 122/278 (43%), Gaps = 49/278 (17%)
Query: 295 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           +VAVK LK ++   +KE   SE+   + L  H N+V + G C   G   ++ E+   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 353 DRWLHHIPRGGRSLD----WAMRMKVATT---------LAQGIAFLHDKVKPHVVHRDIR 399
              L+ + R  R L+    +A+    A+T         +AQG+AFL  K   + +HRD+ 
Sbjct: 138 ---LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVA 191
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKS 455
           A NVLL     A +   GL++    ++M +   +  G       ++APE ++    T +S
Sbjct: 192 ARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS 247
Query: 456 DVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXX 514
           DV+S+G+LL EI S G  P   +              LV S  Y                
Sbjct: 248 DVWSYGILLWEIFSLGLNPYPGI--------------LVNSKFY-----KLVKDGYQMAQ 288
Query: 515 XAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
            A   + +  ++ AC    P+ RP    +   LQ+ AQ
Sbjct: 289 PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 76  E-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 187 SDVWSFGILLTELTTKGRVP 206

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 126/289 (43%), Gaps = 34/289 (11%)
Query: 274 NRLLGDSKTGGTYSGILPDGS-----RVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNL 327
            +++G  + G  Y G+L   S      VA+K LK    ++++ +F  E G   +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + ++G    +    I+ E++ NG LD++L         L     ++    +A G+ +L +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMKYLAN 165
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFV 446
               + VHRD+ A N+L++      +   GLS+ +  +     T   G     + APE +
Sbjct: 166 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 447 YRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXX 505
              + T+ SDV+SFG+++ E+++ G RP        W+         + +H         
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP-------YWE---------LSNHEVMKAINDG 266
Query: 506 XXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
                     + + Q    L+  C Q   + RP+ + +V  L +L + P
Sbjct: 267 FRLPTPMDCPSAIYQ----LMMQCWQQERARRPKFADIVSILDKLIRAP 311

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 24/199 (12%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           D   VAVK LK  +   +K+F  E      L H ++V   G C D     +V+E++ +G 
Sbjct: 44  DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 103
Query: 352 LDRWLHH-----------IPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
           L+++L              PR  +  L  +  + +A+ +A G+ +L  +   H VHRD+ 
Sbjct: 104 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLA 160
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG----TYGYLAPEFVYRNELTTKS 455
             N L+       +   G+S+    +V        GG       ++ PE +   + TT+S
Sbjct: 161 TRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 216
Query: 456 DVYSFGVLLLEIVS-GRRP 473
           DV+SFGV+L EI + G++P
Sbjct: 217 DVWSFGVILWEIFTYGKQP 235

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVCEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LGD   G  Y     + G+  A K ++  S +  +++  EI   A   HP +V + G  Y
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
             G  +I+ EF   G +D  +  + RG   L       V   + + + FLH K    ++H
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSK---RIIH 132
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT-- 453
           RD++A NVL+  E    L   G+S     + +Q+R    G  Y ++APE V    +    
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPY-WMAPEVVMCETMKDTP 190
Query: 454 ---KSDVYSFGVLLLEIVSGRRP 473
              K+D++S G+ L+E+     P
Sbjct: 191 YDYKADIWSLGITLIEMAQIEPP 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVMEYMSKGCLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
           G+ +LGD +           G++VAVK +K  +    + F +E     +L H NLV + G
Sbjct: 207 GDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 333 CCYDH-GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
              +  G  YIV E++  G L  +L    RG   L     +K +  + + + +L      
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 308
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRN 449
           + VHRD+ A NVL+ E+  A +   GL+K       +  +    G     + APE +   
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREK 361
Query: 450 ELTTKSDVYSFGVLLLEIVS-GRRP 473
           + +TKSDV+SFG+LL EI S GR P
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 117/275 (42%), Gaps = 43/275 (15%)
Query: 295 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           +VAVK LK ++   +KE   SE+   + L  H N+V + G C   G   ++ E+   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 353 DRWLHHIPR----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
             +L    R             +L     +  ++ +AQG+AFL  K   + +HRD+ A N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARN 194
Query: 403 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVY 458
           VLL     A +   GL++    ++M +   +  G       ++APE ++    T +SDV+
Sbjct: 195 VLLTNGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 459 SFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAG 517
           S+G+LL EI S G  P   +              LV S  Y                 A 
Sbjct: 251 SYGILLWEIFSLGLNPYPGI--------------LVNSKFY-----KLVKDGYQMAQPAF 291
Query: 518 VVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
             + +  ++ AC    P+ RP    +   LQ+ AQ
Sbjct: 292 APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
           G+ +LGD +           G++VAVK +K  +    + F +E     +L H NLV + G
Sbjct: 20  GDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 333 CCYDH-GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
              +  G  YIV E++  G L  +L    RG   L     +K +  + + + +L      
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 121
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRN 449
           + VHRD+ A NVL+ E+  A +   GL+K       +  +    G     + APE +   
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREK 174
Query: 450 ELTTKSDVYSFGVLLLEIVS-GRRP 473
           + +TKSDV+SFG+LL EI S GR P
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
            + LG  + G  +       ++VAVK +K  S   +  F +E      L H  LV +   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 251
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
                  YI+ EF+  G L  +L      G        +  +  +A+G+AF+  +   + 
Sbjct: 252 VTKE-PIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNEL 451
           +HRD+RA+N+L+       +   GL++ +      E T   G  +   + APE +     
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 452 TTKSDVYSFGVLLLEIVS-GRRP 473
           T KSDV+SFG+LL+EIV+ GR P
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIP 385

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVTEYMSKGCLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LGD   G  Y     + G+  A K ++  S +  +++  EI   A   HP +V + G  Y
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
             G  +I+ EF   G +D  +  + RG   L       V   + + + FLH K    ++H
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT-- 453
           RD++A NVL+  E    L   G+S     + +Q+R    G  Y ++APE V    +    
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPY-WMAPEVVMCETMKDTP 198
Query: 454 ---KSDVYSFGVLLLEIVSGRRP 473
              K+D++S G+ L+E+     P
Sbjct: 199 YDYKADIWSLGITLIEMAQIEPP 221

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 128/287 (44%), Gaps = 49/287 (17%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G  + G  + G   +  +VA+K ++  +   +++F  E     +L HP LV + G C +
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                +V EF+ +G L  +L    RG  + +  + M     + +G+A+L +     V+HR
Sbjct: 75  QAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGM--CLDVCEGMAYLEEAC---VIHR 128
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 453
           D+ A N L+ E     +   G+++F    V+ ++   + GT     + +PE    +  ++
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 454 KSDVYSFGVLLLEIVS-------GRRPAQAVDSVCWQSIFEWATP-LVQSHRYXXXXXXX 505
           KSDV+SFGVL+ E+ S        R  ++ V+ +   + F    P L  +H Y       
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--STGFRLYKPRLASTHVY------- 235
Query: 506 XXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                              ++  C +  P  RP  S ++ QL ++A+
Sbjct: 236 ------------------QIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     ++ H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
           G+ +LGD +           G++VAVK +K  +    + F +E     +L H NLV + G
Sbjct: 35  GDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 333 CCYDH-GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
              +  G  YIV E++  G L  +L    RG   L     +K +  + + + +L      
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 136
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRN 449
           + VHRD+ A NVL+ E+  A +   GL+K       +  +    G     + APE +   
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREK 189
Query: 450 ELTTKSDVYSFGVLLLEIVS-GRRP 473
           + +TKSDV+SFG+LL EI S GR P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++  G L  +L      G+ L     + ++  +A G+A++    + + VHR
Sbjct: 82  E-PIYIVTEYMNKGSLLDFLKG--ETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 193 SDVWSFGILLTELTTKGRVP 212

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++  G L  +L      G+ L     + ++  +A G+A++    + + VHR
Sbjct: 82  E-PIYIVTEYMNKGSLLDFLKG--ETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIE---DNEWTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 193 SDVWSFGILLTELTTKGRVP 212

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 93/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEFVVNG 350
           G+ VAVK+L+ S   ++++F  EI     LH   +V  +G  Y  G  +  +V E++ +G
Sbjct: 36  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSG 95
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    R    LD +  +  ++ + +G+ +L  +     VHRD+ A N+L++ E  
Sbjct: 96  CLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAH 149
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +         G +  +  APE +  N  + +SDV+SFGV+L E+ +
Sbjct: 150 VKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 128/291 (43%), Gaps = 56/291 (19%)
Query: 289 ILPDGSR--VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
           +LP+  +  VAVK LK +S   +++F  E      L H ++V   G C +     +V+E+
Sbjct: 65  LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124
Query: 347 VVNGPLDRWLH-HIPR-----GGRS-----LDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
           + +G L+R+L  H P      GG       L     + VA+ +A G+ +L      H VH
Sbjct: 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVH 181
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
           RD+   N L+ +     +   G+S+ +    +  +  RT++      ++ PE +   + T
Sbjct: 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML---PIRWMPPESILYRKFT 238
Query: 453 TKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYXXXXXXX 505
           T+SDV+SFGV+L EI + G++P       +A+D  C     E   P              
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID--CITQGRELERP-------------- 282
Query: 506 XXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ-PPV 555
                          +V  ++  C Q  P  R  +  V  +LQ LAQ PPV
Sbjct: 283 ----------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                IV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 75  E-PIXIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 128
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIE---DNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 186 SDVWSFGILLTELTTKGRVP 205

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 29/205 (14%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
           G+ +LGD +           G++VAVK +K  +    + F +E     +L H NLV + G
Sbjct: 26  GDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 72
Query: 333 CCYDH-GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
              +  G  YIV E++  G L  +L    RG   L     +K +  + + + +L      
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 127
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRN 449
           + VHRD+ A NVL+ E+  A +   GL+K       +  +    G     + APE +   
Sbjct: 128 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREA 180
Query: 450 ELTTKSDVYSFGVLLLEIVS-GRRP 473
             +TKSDV+SFG+LL EI S GR P
Sbjct: 181 AFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 91/183 (49%), Gaps = 11/183 (6%)
Query: 296 VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           VA+K LK   + +++++F SE     +  HPN++ ++G         I+ EF+ NG LD 
Sbjct: 38  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 97
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414
           +L    +          + +   +A G+ +L D    + VHR + A N+L++      + 
Sbjct: 98  FLR---QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRALAARNILVNSNLVCKVS 151
Query: 415 GVGLSKFVPWEVMQERTVMAGG---TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 470
             GLS+F+  +        A G      + APE +   + T+ SDV+S+G+++ E++S G
Sbjct: 152 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 211
Query: 471 RRP 473
            RP
Sbjct: 212 ERP 214

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 17/243 (6%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 295
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 296 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E++ NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK 187
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 470
           +   GLS+ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 471 RRP 473
            RP
Sbjct: 248 ERP 250

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 277 LGDSKTGGTY----SGILPDGSR--VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV 330
           LG+   G  +      +LP+  +  VAVK LK +S   +++F  E      L H ++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPR-----GGRS-----LDWAMRMKVATTLA 379
            G C +     +V+E++ +G L+R+L  H P      GG       L     + VA+ +A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGG 436
            G+ +L      H VHRD+   N L+ +     +   G+S+ +    +  +  RT++   
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--- 199
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWA 489
              ++ PE +   + TT+SDV+SFGV+L EI + G++P       +A+D  C     E  
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID--CITQGRELE 257
Query: 490 TPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
            P                             +V  ++  C Q  P  R  +  V  +LQ 
Sbjct: 258 RP------------------------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 293
Query: 550 LAQ-PPV 555
           LAQ PPV
Sbjct: 294 LAQAPPV 300

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 17/243 (6%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 295
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 296 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E++ NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GFVHRDLAARNILINSNLVCK 187
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 470
           +   GLS+ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 471 RRP 473
            RP
Sbjct: 248 ERP 250

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 274 NRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 328
           ++++G  + G   SG L   S+    VA+K LK   + +++++F  E     +  HPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            ++G         IV E++ NG LD +L    +          + +   +A G+ +L D 
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 447
                VHRD+ A N+L++      +   GLS+ +  +     T   G     + +PE + 
Sbjct: 138 ---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRP 473
             + T+ SDV+S+G++L E++S G RP
Sbjct: 195 YRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 277 LGDSKTGGTY----SGILPDGSR--VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV 330
           LG+   G  +      +LP+  +  VAVK LK +S   +++F  E      L H ++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPR-----GGRS-----LDWAMRMKVATTLA 379
            G C +     +V+E++ +G L+R+L  H P      GG       L     + VA+ +A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGG 436
            G+ +L      H VHRD+   N L+ +     +   G+S+ +    +  +  RT++   
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--- 193
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWA 489
              ++ PE +   + TT+SDV+SFGV+L EI + G++P       +A+D  C     E  
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID--CITQGRELE 251
Query: 490 TPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
            P                             +V  ++  C Q  P  R  +  V  +LQ 
Sbjct: 252 RP------------------------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 287
Query: 550 LAQ-PPV 555
           LAQ PPV
Sbjct: 288 LAQAPPV 294

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/313 (23%), Positives = 143/313 (45%), Gaps = 43/313 (13%)
Query: 260 TEELRS------ITKNFSEGNRLLGDSKTGGTYSGILP--DGS--RVAVK--RLKRSSFQ 307
           +EEL++      I +N     ++LG+ + G    G L   DG+  +VAVK  +L  SS +
Sbjct: 19  SEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR 78
Query: 308 RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-----YIVYEFVVNGPLDRWLHH--IP 360
             +EF SE        HPN++ + G C +   +      ++  F+  G L  +L +  + 
Sbjct: 79  EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE 138
Query: 361 RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420
            G + +     +K    +A G+ +L ++   + +HRD+ A N +L ++    +   GLSK
Sbjct: 139 TGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK 195
Query: 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
            +       +  +A     ++A E +     T+KSDV++FGV + EI + G  P   V +
Sbjct: 196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255
Query: 480 VCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPR 539
                ++++   L+  HR                     + ++ +++Y+C +  P  RP 
Sbjct: 256 ---HEMYDY---LLHGHR--------------LKQPEDCLDELYEIMYSCWRTDPLDRPT 295
Query: 540 MSHVVHQLQQLAQ 552
            S +  QL++L +
Sbjct: 296 FSVLRLQLEKLLE 308

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 93/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G+ VAVK+L+ S   ++++F  EI     LH   +V  +G  Y  G +   +V E++ +G
Sbjct: 40  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 99
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    R    LD +  +  ++ + +G+ +L  +     VHRD+ A N+L++ E  
Sbjct: 100 CLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAH 153
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +         G +  +  APE +  N  + +SDV+SFGV+L E+ +
Sbjct: 154 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 274 NRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 328
           ++++G  + G   SG L   S+    VA+K LK   + +++++F  E     +  HPN++
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            ++G         IV E++ NG LD +L    +          + +   +A G+ +L D 
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM 154
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 447
                VHRD+ A N+L++      +   GLS+ +  +     T   G     + +PE + 
Sbjct: 155 ---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 211
Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRP 473
             + T+ SDV+S+G++L E++S G RP
Sbjct: 212 YRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 93/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G+ VAVK+L+ S   ++++F  EI     LH   +V  +G  Y  G +   +V E++ +G
Sbjct: 52  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    R    LD +  +  ++ + +G+ +L  +     VHRD+ A N+L++ E  
Sbjct: 112 CLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAH 165
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +         G +  +  APE +  N  + +SDV+SFGV+L E+ +
Sbjct: 166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 17/243 (6%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 295
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 296 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E++ NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK 187
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 470
           +   GLS+ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 471 RRP 473
            RP
Sbjct: 248 ERP 250

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 93/180 (51%), Gaps = 9/180 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
           G+ VAVK+L+ S   ++++F  EI     LH   +V  +G  Y  G +   +V E++ +G
Sbjct: 39  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 98
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +L    R    LD +  +  ++ + +G+ +L  +     VHRD+ A N+L++ E  
Sbjct: 99  CLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAH 152
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GL+K +P +         G +  +  APE +  N  + +SDV+SFGV+L E+ +
Sbjct: 153 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 8/190 (4%)
Query: 287 SGILPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343
           +  L DG  VA+K+++       K   +   EI    +L+HPN++       +  +  IV
Sbjct: 51  AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
            E    G L R + H  +  R +      K    L   +  +H +    V+HRDI+ +NV
Sbjct: 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANV 167
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
            +       L  +GL +F   +     +++  GT  Y++PE ++ N    KSD++S G L
Sbjct: 168 FITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCL 225
Query: 464 LLEIVSGRRP 473
           L E+ + + P
Sbjct: 226 LYEMAALQSP 235

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 275 RLLGDSKTGGTYSGILP-DGSR---VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVA 329
           R++G  + G   SG L   G R   VA+K LK   + +++++F  E     +  HPN++ 
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           ++G         IV E++ NG LD +L    +          + +   ++ G+ +L D  
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGISAGMKYLSDM- 143
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYR 448
               VHRD+ A N+L++      +   GLS+ +  +     T   G     + APE +  
Sbjct: 144 --GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRP 473
            + T+ SDV+S+G+++ E+VS G RP
Sbjct: 202 RKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 17/243 (6%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 295
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 12  LKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 71
Query: 296 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E++ NG L
Sbjct: 72  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 131
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 132 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK 185
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 470
           +   GLS+ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 186 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 245
Query: 471 RRP 473
            RP
Sbjct: 246 ERP 248

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+ A+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 93/181 (51%), Gaps = 10/181 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           G +VAVK++     QR++  ++E+      HH N+V +        + ++V EF+  G L
Sbjct: 70  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGAL 129
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
              + H       ++      V  ++ + +++LH++    V+HRDI++ ++LL  +    
Sbjct: 130 TDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIK 181
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 472
           L   G    V  EV + + ++  GT  ++APE + R    T+ D++S G++++E++ G  
Sbjct: 182 LSDFGFCAQVSKEVPKRKXLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 239
Query: 473 P 473
           P
Sbjct: 240 P 240

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 17/243 (6%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 295
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 296 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E++ NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK 187
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 470
           +   GLS+ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 471 RRP 473
            RP
Sbjct: 248 ERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 274 NRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 328
           ++++G  + G   SG L   S+    VA+K LK   + +++++F  E     +  HPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            ++G         IV E++ NG LD +L    +          + +   +A G+ +L D 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 447
                VHRD+ A N+L++      +   GLS+ +  +     T   G     + +PE + 
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRP 473
             + T+ SDV+S+G++L E++S G RP
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
           E+LRSI       K ++   ++ G   +G  Y+ + +  G  VA++++      +K+   
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
           +EI       +PN+V          + ++V E++  G L   +         +D      
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 120
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTV 432
           V     Q + FLH      V+HRDI++ N+LL  +    L   G  ++  P +   +R+ 
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRST 175
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           M G  Y ++APE V R     K D++S G++ +E++ G  P
Sbjct: 176 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 290 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDR----- 340
           L D   VAVK L R+   R   FY    R A+    L+HP +VAV    YD G+      
Sbjct: 34  LRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV----YDTGEAETPAG 88
Query: 341 ---YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
              YIV E+V    L   +H    G  +   A+  +V     Q + F H      ++HRD
Sbjct: 89  PLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAI--EVIADACQALNFSHQN---GIIHRD 141
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           ++ +N+++       +M  G+++ +      V Q   V+  GT  YL+PE    + +  +
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDAR 199
Query: 455 SDVYSFGVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSH 496
           SDVYS G +L E+++G  P    +  SV +Q + E   P    H
Sbjct: 200 SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
           E+LRSI       K ++   ++ G   +G  Y+ + +  G  VA++++      +K+   
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
           +EI       +PN+V          + ++V E++  G L   +         +D      
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 120
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTV 432
           V     Q + FLH      V+HRDI++ N+LL  +    L   G  ++  P +   +R+ 
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSX 175
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           M G  Y ++APE V R     K D++S G++ +E++ G  P
Sbjct: 176 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
           E+LRSI       K ++   ++ G   +G  Y+ + +  G  VA++++      +K+   
Sbjct: 8   EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 66
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
           +EI       +PN+V          + ++V E++  G L   +         +D      
Sbjct: 67  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 121
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTV 432
           V     Q + FLH      V+HRDI++ N+LL  +    L   G  ++  P +   +R+ 
Sbjct: 122 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSX 176
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           M G  Y ++APE V R     K D++S G++ +E++ G  P
Sbjct: 177 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 109/243 (44%), Gaps = 17/243 (6%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 295
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 296 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E++ NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK 187
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 470
           +   GL++ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 471 RRP 473
            RP
Sbjct: 248 ERP 250

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
            + LG  + G  +       ++VAVK +K  S   +  F +E      L H  LV +   
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 245
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
                  YI+ EF+  G L  +L       + L     +  +  +A+G+AF+  +   + 
Sbjct: 246 VTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NY 299
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 453
           +HRD+RA+N+L+       +   GL++           V A     + APE +     T 
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLAR-----------VGAKFPIKWTAPEAINFGSFTI 348
Query: 454 KSDVYSFGVLLLEIVS-GRRP 473
           KSDV+SFG+LL+EIV+ GR P
Sbjct: 349 KSDVWSFGILLMEIVTYGRIP 369

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 108/243 (44%), Gaps = 17/243 (6%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 295
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 296 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E + NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL 133
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GAVHRDLAARNILINSNLVCK 187
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 470
           +   GLS+ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 471 RRP 473
            RP
Sbjct: 248 ERP 250

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDR--------YIV 343
           VAVK L R+   R   FY    R A+    L+HP +VAV    YD G+         YIV
Sbjct: 40  VAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIV 94
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
            E+V    L   +H    G  +   A+  +V     Q + F H      ++HRD++ +N+
Sbjct: 95  MEYVDGVTLRDIVHT--EGPMTPKRAI--EVIADACQALNFSHQN---GIIHRDVKPANI 147
Query: 404 LLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
           ++       +M  G+++ +      V Q   V+  GT  YL+PE    + +  +SDVYS 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDARSDVYSL 205
Query: 461 GVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSH 496
           G +L E+++G  P    +  SV +Q + E   P    H
Sbjct: 206 GCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 290 LPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFV 347
           +P G  +AVKR++ + + Q +K    ++    R +  P  V   G  +  GD +I  E +
Sbjct: 29  VPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME-L 87
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
           ++  LD++   +   G+++   +  K+A ++ + +  LH K+   V+HRD++ SNVL++ 
Sbjct: 88  MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINA 145
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVL 463
                +   G+S ++  +V ++   +  G   Y+APE +     +   + KSD++S G+ 
Sbjct: 146 LGQVKMCDFGISGYLVDDVAKD---IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT 202
Query: 464 LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 494
           ++E+   R P  +           W TP  Q
Sbjct: 203 MIELAILRFPYDS-----------WGTPFQQ 222

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ F
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 207
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    ++ +  +T  A     ++
Sbjct: 208 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-GAKLPVKWM 263
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 314

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 134/325 (41%), Gaps = 54/325 (16%)
Query: 247 ASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKR 300
           +S  VP  W+V + E++  +        R LG    G  Y G   D       +RVAVK 
Sbjct: 1   SSVFVPDEWEV-SREKITLL--------RELGQGSFGMVYEGNARDIIKGEAETRVAVKT 51
Query: 301 LKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI 359
           +  S+  R++ EF +E          ++V + G         +V E + +G L  +L  +
Sbjct: 52  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 111
Query: 360 -PRG----GRSLDWAMRM-KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
            P      GR       M ++A  +A G+A+L+ K     VHRD+ A N ++  +F   +
Sbjct: 112 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 168
Query: 414 MGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              G+++    ++ +      GG       ++APE +     TT SD++SFGV+L EI S
Sbjct: 169 GDFGMTR----DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224
Query: 470 -GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 528
              +P Q + +       E     V    Y                     ++V DL+  
Sbjct: 225 LAEQPYQGLSN-------EQVLKFVMDGGYLDQPD-------------NCPERVTDLMRM 264
Query: 529 CTQHVPSMRPRMSHVVHQLQQLAQP 553
           C Q  P MRP    +V+ L+    P
Sbjct: 265 CWQFNPKMRPTFLEIVNLLKDDLHP 289

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 134/325 (41%), Gaps = 54/325 (16%)
Query: 247 ASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKR 300
           +S  VP  W+V + E++  +        R LG    G  Y G   D       +RVAVK 
Sbjct: 4   SSVFVPDEWEV-SREKITLL--------RELGQGSFGMVYEGNARDIIKGEAETRVAVKT 54
Query: 301 LKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI 359
           +  S+  R++ EF +E          ++V + G         +V E + +G L  +L  +
Sbjct: 55  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
Query: 360 -PRG----GRSLDWAMRM-KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
            P      GR       M ++A  +A G+A+L+ K     VHRD+ A N ++  +F   +
Sbjct: 115 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 171
Query: 414 MGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              G+++    ++ +      GG       ++APE +     TT SD++SFGV+L EI S
Sbjct: 172 GDFGMTR----DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
Query: 470 -GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 528
              +P Q + +       E     V    Y                     ++V DL+  
Sbjct: 228 LAEQPYQGLSN-------EQVLKFVMDGGYLDQPD-------------NCPERVTDLMRM 267
Query: 529 CTQHVPSMRPRMSHVVHQLQQLAQP 553
           C Q  P MRP    +V+ L+    P
Sbjct: 268 CWQFNPKMRPTFLEIVNLLKDDLHP 292

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 274 NRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 328
           ++++G  + G   SG L   S+    VA+K LK   + +++++F  E     +  HPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            ++G         IV E + NG LD +L    +          + +   +A G+ +L D 
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 447
                VHRD+ A N+L++      +   GLS+ +  +     T   G     + +PE + 
Sbjct: 138 ---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRP 473
             + T+ SDV+S+G++L E++S G RP
Sbjct: 195 YRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ F
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 146
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    ++ +  +T  A     ++
Sbjct: 147 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-GAKLPVKWM 202
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 253

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ F
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 149
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    ++ +  +T  A     ++
Sbjct: 150 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKT-GAKLPVKWM 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 256

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 11/183 (6%)
Query: 296 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           VA+K LK    +R ++EF SE     +  HPN++ ++G   +     I+ EF+ NG LD 
Sbjct: 47  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 106
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414
           +L  +  G  ++   + M     +A G+ +L +      VHRD+ A N+L++      + 
Sbjct: 107 FL-RLNDGQFTVIQLVGM--LRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVS 160
Query: 415 GVGLSKFVPWEVMQE-RTVMAGGTYG--YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 470
             GLS+F+         T   GG     + APE +   + T+ SD +S+G+++ E++S G
Sbjct: 161 DFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFG 220
Query: 471 RRP 473
            RP
Sbjct: 221 ERP 223

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ F
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 148
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    ++ +  +T  A     ++
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-GAKLPVKWM 204
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 255

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
           E+LRSI       K ++   ++ G   +G  Y+ + +  G  VA++++      +K+   
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
           +EI       +PN+V          + ++V E++  G L   +         +D      
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 120
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTV 432
           V     Q + FLH      V+HRDI++ N+LL  +    L   G  ++  P +   +R+ 
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSE 175
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           M G  Y ++APE V R     K D++S G++ +E++ G  P
Sbjct: 176 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ F
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 153
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    ++ +  +T  A     ++
Sbjct: 154 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-GAKLPVKWM 209
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 260

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ F
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 149
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    ++ +  +T  A     ++
Sbjct: 150 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-GAKLPVKWM 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 256

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           G  + +K L R   + ++ F  E+     L HPN++   G  Y       + E++  G L
Sbjct: 35  GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94
Query: 353 DRWLHHIPRGGRSLD----WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
              +       +S+D    W+ R+  A  +A G+A+LH     +++HRD+ + N L+ E 
Sbjct: 95  RGII-------KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVREN 144
Query: 409 FGAHLMGVGLSKFVPWEVMQ-------------ERTVMAGGTYGYLAPEFVYRNELTTKS 455
               +   GL++ +  E  Q             +R  + G  Y ++APE +       K 
Sbjct: 145 KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY-WMAPEMINGRSYDEKV 203
Query: 456 DVYSFGVLLLEIV 468
           DV+SFG++L EI+
Sbjct: 204 DVFSFGIVLCEII 216

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 108/243 (44%), Gaps = 17/243 (6%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 295
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 296 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E++ NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK 187
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 470
           +   GL + +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 471 RRP 473
            RP
Sbjct: 248 ERP 250

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 11/183 (6%)
Query: 296 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           VA+K LK    +R ++EF SE     +  HPN++ ++G   +     I+ EF+ NG LD 
Sbjct: 45  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 104
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414
           +L  +  G  ++   + M     +A G+ +L +      VHRD+ A N+L++      + 
Sbjct: 105 FL-RLNDGQFTVIQLVGM--LRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVS 158
Query: 415 GVGLSKFVPWEVMQER-TVMAGGTYG--YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 470
             GLS+F+         T   GG     + APE +   + T+ SD +S+G+++ E++S G
Sbjct: 159 DFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFG 218
Query: 471 RRP 473
            RP
Sbjct: 219 ERP 221

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 117/279 (41%), Gaps = 49/279 (17%)
Query: 295 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           +VAVK LK ++   +KE   SE+   + L  H N+V + G C   G   ++ E+   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 353 DRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
             +L               H P     L     +  ++ +AQG+AFL  K   + +HRD+
Sbjct: 138 LNFLRRKRPPGLEYSYNPSHNPE--EQLSSRDLLHFSSQVAQGMAFLASK---NCIHRDV 192
Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTK 454
            A NVLL     A +   GL++    ++M +   +  G       ++APE ++    T +
Sbjct: 193 AARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ 248
Query: 455 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXX 513
           SDV+S+G+LL EI S G  P   +              LV S  Y               
Sbjct: 249 SDVWSYGILLWEIFSLGLNPYPGI--------------LVNSKFY-----KLVKDGYQMA 289
Query: 514 XXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
             A   + +  ++ AC    P+ RP    +   LQ+ AQ
Sbjct: 290 QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 328

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 135/325 (41%), Gaps = 54/325 (16%)
Query: 247 ASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKR 300
           +S  VP  W+V + E++  +        R LG    G  Y G   D       +RVAVK 
Sbjct: 4   SSVYVPDEWEV-SREKITLL--------RELGQGSFGMVYEGNARDIIKGEAETRVAVKT 54
Query: 301 LKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI 359
           +  S+  R++ EF +E          ++V + G         +V E + +G L  +L  +
Sbjct: 55  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
Query: 360 -PRG----GRSLDWAMRM-KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
            P      GR       M ++A  +A G+A+L+ K     VHRD+ A N ++  +F   +
Sbjct: 115 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 171
Query: 414 MGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              G+++    ++ +      GG       ++APE +     TT SD++SFGV+L EI S
Sbjct: 172 GDFGMTR----DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
Query: 470 -GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 528
              +P Q + +       E     V    Y                     ++V DL+  
Sbjct: 228 LAEQPYQGLSN-------EQVLKFVMDGGYLDQPD-------------NCPERVTDLMRM 267
Query: 529 CTQHVPSMRPRMSHVVHQLQQLAQP 553
           C Q  P+MRP    +V+ L+    P
Sbjct: 268 CWQFNPNMRPTFLEIVNLLKDDLHP 292

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ F
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 148
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    ++ +  +T  A     ++
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-GAKLPVKWM 204
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 255

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 274 NRLLGDSKTGGTYSGILP-DGSR---VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 328
            R++G  + G   SG L   G R   VA+K LK   + +++++F  E     +  HPN+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            ++G         IV EF+ NG LD +L    +          + +   +A G+ +L D 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLR---KHDGQFTVIQLVGMLRGIAAGMRYLADM 164
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 447
                VHRD+ A N+L++      +   GLS+ +  +     T   G     + APE + 
Sbjct: 165 ---GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRP 473
             + T+ SDV+S+G+++ E++S G RP
Sbjct: 222 YRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 109/231 (47%), Gaps = 21/231 (9%)
Query: 258 FTTEELRSITKNFSEG--------NRLLGDSKTGGTYSGILP-DGSR---VAVKRLKRS- 304
           FT E+     + F++          +++G  + G   SG L   G R   VA+K LK   
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 305 SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR 364
           + +++++F SE     +  HPN++ ++G         I+ E++ NG LD +L      GR
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGR 127
Query: 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
                  + +   +  G+ +L D      VHRD+ A N+L++      +   G+S+ +  
Sbjct: 128 -FTVIQLVGMLRGIGSGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLED 183
Query: 425 EVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
           +     T   G     + APE +   + T+ SDV+S+G+++ E++S G RP
Sbjct: 184 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 290 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDR----- 340
           L D   VAVK L R+   R   FY    R A+    L+HP +VAV    YD G+      
Sbjct: 34  LRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV----YDTGEAETPAG 88
Query: 341 ---YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
              YIV E+V    L   +H    G  +   A+  +V     Q + F H      ++HRD
Sbjct: 89  PLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAI--EVIADACQALNFSHQN---GIIHRD 141
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           ++ +N+L+       ++  G+++ +      V Q   V+  GT  YL+PE    + +  +
Sbjct: 142 VKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVI--GTAQYLSPEQARGDSVDAR 199
Query: 455 SDVYSFGVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSH 496
           SDVYS G +L E+++G  P    +  SV +Q + E   P    H
Sbjct: 200 SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 108/243 (44%), Gaps = 17/243 (6%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 295
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 296 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E + NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL 133
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK 187
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 470
           +   GLS+ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 471 RRP 473
            RP
Sbjct: 248 ERP 250

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDR--------YIV 343
           VAVK L R+   R   FY    R A+    L+HP +VAV    YD G+         YIV
Sbjct: 57  VAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIV 111
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
            E+V    L   +H    G  +   A+  +V     Q + F H      ++HRD++ +N+
Sbjct: 112 MEYVDGVTLRDIVHT--EGPMTPKRAI--EVIADACQALNFSHQN---GIIHRDVKPANI 164
Query: 404 LLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
           ++       +M  G+++ +      V Q   V+  GT  YL+PE    + +  +SDVYS 
Sbjct: 165 MISATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDARSDVYSL 222
Query: 461 GVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSH 496
           G +L E+++G  P    +  SV +Q + E   P    H
Sbjct: 223 GCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 260

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 13/219 (5%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK-KEFYSEIGRFARL 322
           SI ++  E   ++G   T    +    P   +VA+KR+     Q    E   EI   ++ 
Sbjct: 6   SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 65
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS----LDWAMRMKVATTL 378
           HHPN+V+         + ++V + +  G +   + HI   G      LD +    +   +
Sbjct: 66  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--- 435
            +G+ +LH   K   +HRD++A N+LL E+    +   G+S F+       R  +     
Sbjct: 126 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 436 GTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRP 473
           GT  ++APE + +      K+D++SFG+  +E+ +G  P
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 38/233 (16%)
Query: 268 KNFSEGNRLLGDSKTGGTYS----GILP--DGSRVAVKRLKR-SSFQRKKEFYSEIGRFA 320
           +N  E  R +G+   G  +     G+LP    + VAVK LK  +S   + +F  E    A
Sbjct: 46  RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 105
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPR------------------- 361
              +PN+V + G C       +++E++  G L+ +L  +                     
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 362 -GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420
            G   L  A ++ +A  +A G+A+L ++     VHRD+   N L+ E     +   GLS+
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 421 FVPWEVMQERTVMAGGTYG----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
                +       A G       ++ PE ++ N  TT+SDV+++GV+L EI S
Sbjct: 223 ----NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 13/219 (5%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK-KEFYSEIGRFARL 322
           SI ++  E   ++G   T    +    P   +VA+KR+     Q    E   EI   ++ 
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS----LDWAMRMKVATTL 378
           HHPN+V+         + ++V + +  G +   + HI   G      LD +    +   +
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--- 435
            +G+ +LH   K   +HRD++A N+LL E+    +   G+S F+       R  +     
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 436 GTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRP 473
           GT  ++APE + +      K+D++SFG+  +E+ +G  P
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 112/231 (48%), Gaps = 28/231 (12%)
Query: 257 VFTTEELRSITKNF-SEGN-RLLGDS--KTGGTYSGIL------PDGSRVAVKRLKRSSF 306
           V T E+ ++  +    +G+ RLL DS  K G   +GI+        G +VAVK +     
Sbjct: 24  VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ 83
Query: 307 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 366
           QR++  ++E+       H N+V +        + +++ EF+  G L   +  +      L
Sbjct: 84  QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RL 138
Query: 367 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG----LSKFV 422
           +      V   + Q +A+LH +    V+HRDI++ ++LL  +    L   G    +SK V
Sbjct: 139 NEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195
Query: 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           P     +R  + G  Y ++APE + R+   T+ D++S G++++E+V G  P
Sbjct: 196 P-----KRKXLVGTPY-WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 134/325 (41%), Gaps = 54/325 (16%)
Query: 247 ASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKR 300
           +S  VP  W+V + E++  +        R LG    G  Y G   D       +RVAVK 
Sbjct: 4   SSVFVPDEWEV-SREKITLL--------RELGQGSFGMVYEGNARDIIKGEAETRVAVKT 54
Query: 301 LKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI 359
           +  S+  R++ EF +E          ++V + G         +V E + +G L  +L  +
Sbjct: 55  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
Query: 360 -PRG----GRSLDWAMRM-KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
            P      GR       M ++A  +A G+A+L+ K     VHRD+ A N ++  +F   +
Sbjct: 115 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 171
Query: 414 MGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              G+++    ++ +      GG       ++APE +     TT SD++SFGV+L EI S
Sbjct: 172 GDFGMTR----DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
Query: 470 -GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 528
              +P Q + +       E     V    Y                     ++V DL+  
Sbjct: 228 LAEQPYQGLSN-------EQVLKFVMDGGYLDQPD-------------NCPERVTDLMRM 267
Query: 529 CTQHVPSMRPRMSHVVHQLQQLAQP 553
           C Q  P MRP    +V+ L+    P
Sbjct: 268 CWQFNPKMRPTFLEIVNLLKDDLHP 292

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 134/325 (41%), Gaps = 54/325 (16%)
Query: 247 ASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKR 300
           +S  VP  W+V + E++  +        R LG    G  Y G   D       +RVAVK 
Sbjct: 4   SSVFVPDEWEV-SREKITLL--------RELGQGSFGMVYEGNARDIIKGEAETRVAVKT 54
Query: 301 LKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI 359
           +  S+  R++ EF +E          ++V + G         +V E + +G L  +L  +
Sbjct: 55  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
Query: 360 -PRG----GRSLDWAMRM-KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
            P      GR       M ++A  +A G+A+L+ K     VHRD+ A N ++  +F   +
Sbjct: 115 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 171
Query: 414 MGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              G+++    ++ +      GG       ++APE +     TT SD++SFGV+L EI S
Sbjct: 172 GDFGMTR----DIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
Query: 470 -GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 528
              +P Q + +       E     V    Y                     ++V DL+  
Sbjct: 228 LAEQPYQGLSN-------EQVLKFVMDGGYLDQPD-------------NCPERVTDLMRM 267
Query: 529 CTQHVPSMRPRMSHVVHQLQQLAQP 553
           C Q  P MRP    +V+ L+    P
Sbjct: 268 CWQFNPKMRPTFLEIVNLLKDDLHP 292

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 7/157 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +  C  D    Y    +  NG L +++  I     S D          + 
Sbjct: 92  SRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 147
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 148 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           Y++PE +        SD+++ G ++ ++V+G  P +A
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 125/314 (39%), Gaps = 39/314 (12%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 308
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 91
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 367
           + +F  E    ++L+H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 92  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 368 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 152 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 207
Query: 426 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 480
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 208 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 266
Query: 481 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 540
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 267 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 307
Query: 541 SHVVHQLQQLAQPP 554
           + ++ +++   Q P
Sbjct: 308 AIILERIEYCTQDP 321

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 275 RLLGDSKTGGTYSGILP-DGSR---VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVA 329
           +++G  + G   SG L   G R   VA+K LK   + +++++F SE     +  HPN++ 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           ++G         I+ E++ NG LD +L      GR       + +   +  G+ +L D  
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGR-FTVIQLVGMLRGIGSGMKYLSDM- 135
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYR 448
               VHRD+ A N+L++      +   G+S+ +  +     T   G     + APE +  
Sbjct: 136 --SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRP 473
            + T+ SDV+S+G+++ E++S G RP
Sbjct: 194 RKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 290 LPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFV 347
           +P G  +AVKR++ + + Q +K    ++    R +  P  V   G  +  GD +I  E +
Sbjct: 73  VPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME-L 131
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
           ++  LD++   +   G+++   +  K+A ++ + +  LH K+   V+HRD++ SNVL++ 
Sbjct: 132 MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINA 189
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVL 463
                +   G+S ++   V +    +  G   Y+APE +     +   + KSD++S G+ 
Sbjct: 190 LGQVKMCDFGISGYLVDSVAK---TIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT 246
Query: 464 LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 494
           ++E+   R P  +           W TP  Q
Sbjct: 247 MIELAILRFPYDS-----------WGTPFQQ 266

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 275 RLLGDSKTGGTYSGILP-DGSR---VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVA 329
           +++G  + G   SG L   G R   VA+K LK   + +++++F SE     +  HPN++ 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           ++G         I+ E++ NG LD +L      GR       + +   +  G+ +L D  
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGR-FTVIQLVGMLRGIGSGMKYLSDM- 129
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYR 448
               VHRD+ A N+L++      +   G+S+ +  +     T   G     + APE +  
Sbjct: 130 --SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRP 473
            + T+ SDV+S+G+++ E++S G RP
Sbjct: 188 RKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 110/280 (39%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y     +   + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---KVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLPPEMIE 179
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    D+    S  E+  P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDF----------- 228
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 229 -------------VTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 291 PDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVV 348
           P G  +AVKR++ +  ++ +K+   ++    R    P +V   G  +  GD +I  E + 
Sbjct: 45  PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKV--ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
               D++  ++      LD  +  ++    TLA   A  H K    ++HRDI+ SN+LLD
Sbjct: 105 TS-FDKFYKYV---YSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD 160
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGV 462
                 L   G+S  +   + + R     G   Y+APE +     R     +SDV+S G+
Sbjct: 161 RSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGI 217
Query: 463 LLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 494
            L E+ +GR P        W S+F+  T +V+
Sbjct: 218 TLYELATGRFPYPK-----WNSVFDQLTQVVK 244

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 125/314 (39%), Gaps = 39/314 (12%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 308
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 367
           + +F  E    ++L+H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 78  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 368 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 138 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 193
Query: 426 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 480
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 194 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 252
Query: 481 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 540
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 253 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 293
Query: 541 SHVVHQLQQLAQPP 554
           + ++ +++   Q P
Sbjct: 294 AIILERIEYCTQDP 307

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G    G       VA+K +K  S   + EF  E      L H  LV + G C  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               +I+ E++ NG L  +L  +    ++      +++   + + + +L  K     +HR
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+ A N L++++    +   GLS++V   +  E T   G  +   +  PE +  ++ ++K
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEETSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 455 SDVYSFGVLLLEIVS-GRRPAQ 475
           SD+++FGVL+ EI S G+ P +
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/320 (24%), Positives = 124/320 (38%), Gaps = 51/320 (15%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 308
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 35  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 94
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 367
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 95  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 154
Query: 368 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 155 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG-------D 204
Query: 426 VMQERTVMAGGTY----------GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPA 474
               R +   G Y           ++ PE       T+K+D +SFGVLL EI S G  P 
Sbjct: 205 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 264
Query: 475 QAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVP 534
            +  +   Q + E+ T                          G V +++     C QH P
Sbjct: 265 PSKSN---QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQP 304
Query: 535 SMRPRMSHVVHQLQQLAQPP 554
             RP  + ++ +++   Q P
Sbjct: 305 EDRPNFAIILERIEYCTQDP 324

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/320 (24%), Positives = 124/320 (38%), Gaps = 51/320 (15%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 308
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 58  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 117
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 367
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 368 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG-------D 227
Query: 426 VMQERTVMAGGTY----------GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPA 474
               R +   G Y           ++ PE       T+K+D +SFGVLL EI S G  P 
Sbjct: 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287
Query: 475 QAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVP 534
            +  +   Q + E+ T                          G V +++     C QH P
Sbjct: 288 PSKSN---QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQP 327
Query: 535 SMRPRMSHVVHQLQQLAQPP 554
             RP  + ++ +++   Q P
Sbjct: 328 EDRPNFAIILERIEYCTQDP 347

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 89/185 (48%), Gaps = 17/185 (9%)
Query: 296 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           VA+K LK    +R +++F SE     +  HPN++ ++G         IV E++ NG LD 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIA----FLHDKVKPHVVHRDIRASNVLLDEEFG 410
           +L       R+ D    +     + +G+     +L D      VHRD+ A NVL+D    
Sbjct: 140 FL-------RTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLV 189
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             +   GLS+ +  +     T   G     + APE +     ++ SDV+SFGV++ E+++
Sbjct: 190 CKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
Query: 470 -GRRP 473
            G RP
Sbjct: 250 YGERP 254

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 274 NRLLGDSKTGGTYSGILPD--GSR--VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 328
           NR+LG+   G  Y G+  +  G +  VAVK  K+  +   K++F SE      L HP++V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            + G   +    +I+ E    G L    H++ R   SL     +  +  + + +A+L   
Sbjct: 73  KLIGII-EEEPTWIIMELYPYGELG---HYLERNKNSLKVLTLVLYSLQICKAMAYLESI 128
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
              + VHRDI   N+L+       L   GLS+++  E   + +V       +++PE +  
Sbjct: 129 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TRLPIKWMSPESINF 184
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRP 473
              TT SDV+ F V + EI+S G++P
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 352 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 121 LREYLQARRPPGLEFSFNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 175
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDV 235
Query: 458 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 516
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 236 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHRM--------------DKPS 275
Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 276 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 95/191 (49%), Gaps = 17/191 (8%)
Query: 292 DGSRVAVKRLK--RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
           DG +  +K +   R S + ++E   E+   A + HPN+V  +    ++G  YIV ++   
Sbjct: 48  DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 350 GPLDRWLHH----IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
           G L + ++     + +  + LDW +++ +A      +  +HD+    ++HRDI++ N+ L
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLA------LKHVHDR---KILHRDIKSQNIFL 158
Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
            ++    L   G+++ +   V   R  +  GT  YL+PE         KSD+++ G +L 
Sbjct: 159 TKDGTVQLGDFGIARVLNSTVELARACI--GTPYYLSPEICENKPYNNKSDIWALGCVLY 216
Query: 466 EIVSGRRPAQA 476
           E+ + +   +A
Sbjct: 217 ELCTLKHAFEA 227

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           +G   +G  Y+ + +  G  VA++++      +K+   +EI       +PN+V       
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
              + ++V E++  G L   +         +D      V     Q + FLH      V+H
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 396 RDIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           R+I++ N+LL  +    L   G  ++  P +   +R+ M G  Y ++APE V R     K
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPY-WMAPEVVTRKAYGPK 197
Query: 455 SDVYSFGVLLLEIVSGRRP 473
            D++S G++ +E++ G  P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 274 NRLLGDSKTGGTYSGILPD--GSR--VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 328
           NR+LG+   G  Y G+  +  G +  VAVK  K+  +   K++F SE      L HP++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            + G   +    +I+ E    G L    H++ R   SL     +  +  + + +A+L   
Sbjct: 77  KLIGII-EEEPTWIIMELYPYGELG---HYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
              + VHRDI   N+L+       L   GLS+++  E   + +V       +++PE +  
Sbjct: 133 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TRLPIKWMSPESINF 188
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRP 473
              TT SDV+ F V + EI+S G++P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 29/197 (14%)
Query: 294 SRVAVKRLKRSSFQRKK-------------EFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
           S  A+K +K+S F + +             E Y+EI     L HPN++ +     D    
Sbjct: 62  SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
           Y+V EF   G L  +   I R     D      +   +  GI +LH   K ++VHRDI+ 
Sbjct: 122 YLVTEFYEGGEL--FEQIINR--HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKP 174
Query: 401 SNVLLDEE---FGAHLMGVGLSKFVPWEV-MQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
            N+LL+ +       ++  GLS F   +  +++R     GT  Y+APE V + +   K D
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL----GTAYYIAPE-VLKKKYNEKCD 229
Query: 457 VYSFGVLLLEIVSGRRP 473
           V+S GV++  ++ G  P
Sbjct: 230 VWSCGVIMYILLCGYPP 246

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 274 NRLLGDSKTGGTYSGILPD--GSR--VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 328
           NR+LG+   G  Y G+  +  G +  VAVK  K+  +   K++F SE      L HP++V
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            + G   +    +I+ E    G L    H++ R   SL     +  +  + + +A+L   
Sbjct: 89  KLIGII-EEEPTWIIMELYPYGELG---HYLERNKNSLKVLTLVLYSLQICKAMAYLESI 144
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
              + VHRDI   N+L+       L   GLS+++  E   + +V       +++PE +  
Sbjct: 145 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TRLPIKWMSPESINF 200
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRP 473
              TT SDV+ F V + EI+S G++P
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 102 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161
Query: 352 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 216
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 217 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 276
Query: 458 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 516
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 277 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 316
Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 317 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G    G       VA+K +K  S   + EF  E      L H  LV + G C  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               +I+ E++ NG L  +L  +    ++      +++   + + + +L  K     +HR
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+ A N L++++    +   GLS++V   +  E T   G  +   +  PE +  ++ ++K
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 186
Query: 455 SDVYSFGVLLLEIVS-GRRPAQ 475
           SD+++FGVL+ EI S G+ P +
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G    G       VA+K +K  S   + EF  E      L H  LV + G C  
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               +I+ E++ NG L  +L  +    ++      +++   + + + +L  K     +HR
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QFLHR 128
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+ A N L++++    +   GLS++V   +  E T   G  +   +  PE +  ++ ++K
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 185
Query: 455 SDVYSFGVLLLEIVS-GRRPAQ 475
           SD+++FGVL+ EI S G+ P +
Sbjct: 186 SDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 264 RSITKNFSEG----NRLLGDSKTGGT-YSGILPDGSR---VAVKRLKRSSFQR-KKEFYS 314
           RS T+          +++G   +G   Y  +   G R   VA+K LK    +R +++F S
Sbjct: 40  RSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS 99
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           E     +  HPN++ ++G         IV E++ NG LD +L       R+ D    +  
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-------RTHDGQFTIMQ 152
Query: 375 ATTLAQGIA----FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430
              + +G+     +L D      VHRD+ A NVL+D      +   GLS+ +  +     
Sbjct: 153 LVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 431 TVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
           T   G     + APE +     ++ SDV+SFGV++ E+++ G RP
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 308
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 76
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 367
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 368 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 137 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 192
Query: 426 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 480
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 251
Query: 481 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 540
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 252 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 292
Query: 541 SHVVHQLQQLAQPP 554
           + ++ +++   Q P
Sbjct: 293 AIILERIEYCTQDP 306

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 352 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 121 LREYLQARRPPGLEYCYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 175
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 235
Query: 458 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 516
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 236 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 275
Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 276 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 46  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 105
Query: 352 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 106 LREYLQARRPPGLEYCYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 160
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 220
Query: 458 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 516
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 221 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 260
Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 261 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 167
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 168 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 223
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 274

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 308
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 76
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 367
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 136
Query: 368 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 137 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 192
Query: 426 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 480
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 251
Query: 481 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 540
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 252 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 292
Query: 541 SHVVHQLQQLAQPP 554
           + ++ +++   Q P
Sbjct: 293 AIILERIEYCTQDP 306

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 352 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 121 LREYLQAREPPGLEYSYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 175
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 235
Query: 458 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 516
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 236 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 275
Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 276 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 264 RSITKNFSEGNRLLGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
           RS   NF +    +G+  TG    + +   G  VAVK++     QR++  ++E+      
Sbjct: 19  RSYLDNFIK----IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 74
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
            H N+V +        + ++V EF+  G L   + H       ++      V   + Q +
Sbjct: 75  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQAL 129
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
           + LH +    V+HRDI++ ++LL  +    L   G    V  EV + + ++  GT  ++A
Sbjct: 130 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMA 184
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           PE + R     + D++S G++++E+V G  P
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 308
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 91
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 367
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 151
Query: 368 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 152 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 207
Query: 426 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 480
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 208 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 266
Query: 481 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 540
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 267 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 307
Query: 541 SHVVHQLQQLAQPP 554
           + ++ +++   Q P
Sbjct: 308 AIILERIEYCTQDP 321

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 148
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 204
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 255

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G    G       VA+K +K  S   + EF  E      L H  LV + G C  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               +I+ E++ NG L  +L  +    ++      +++   + + + +L  K     +HR
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+ A N L++++    +   GLS++V   +  E T   G  +   +  PE +  ++ ++K
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 455 SDVYSFGVLLLEIVS-GRRPAQ 475
           SD+++FGVL+ EI S G+ P +
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 264 RSITKNFSEGNRLLGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
           RS   NF +    +G+  TG    + +   G  VAVK++     QR++  ++E+      
Sbjct: 23  RSYLDNFIK----IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 78
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
            H N+V +        + ++V EF+  G L   + H       ++      V   + Q +
Sbjct: 79  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQAL 133
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
           + LH +    V+HRDI++ ++LL  +    L   G    V  EV + + ++  GT  ++A
Sbjct: 134 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMA 188
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           PE + R     + D++S G++++E+V G  P
Sbjct: 189 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 148
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 204
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 255

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 147
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 148 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 203
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 254

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 53  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 112
Query: 352 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 113 LREYLQARRPPGLEYSYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 167
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 168 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 227
Query: 458 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 516
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 228 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 267
Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 268 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 50  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 109
Query: 352 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 110 LREYLQARRPPGLEYSYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 164
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 165 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 224
Query: 458 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 516
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 225 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 264
Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 265 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 298

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 352 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 121 LREYLQARRPPGLEYSYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 175
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 235
Query: 458 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 516
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 236 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 275
Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 276 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 12  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 127
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSCHAP----SSRRTTLSGTLDYLPPEMIE 180
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 229
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 230 -------------VTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 264 RSITKNFSEGNRLLGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
           RS   NF +    +G+  TG    + +   G  VAVK++     QR++  ++E+      
Sbjct: 30  RSYLDNFIK----IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 85
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
            H N+V +        + ++V EF+  G L   + H       ++      V   + Q +
Sbjct: 86  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQAL 140
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
           + LH +    V+HRDI++ ++LL  +    L   G    V  EV + + ++  GT  ++A
Sbjct: 141 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMA 195
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           PE + R     + D++S G++++E+V G  P
Sbjct: 196 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 166
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 167 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 222
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 273

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G    G       VA+K +K  S   + EF  E      L H  LV + G C  
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               +I+ E++ NG L  +L  +    ++      +++   + + + +L  K     +HR
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QFLHR 124
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+ A N L++++    +   GLS++V   +  E T   G  +   +  PE +  ++ ++K
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 455 SDVYSFGVLLLEIVS-GRRPAQ 475
           SD+++FGVL+ EI S G+ P +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYE 203

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 145
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 146 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 201
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 252

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 13  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 73  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 128
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 129 K---RVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 181
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 230
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 231 -------------VTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 140
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 141 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 196
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 197 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 247

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 308
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 367
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 368 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 138 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-QD 193
Query: 426 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 480
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 194 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 252
Query: 481 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 540
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 253 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 293
Query: 541 SHVVHQLQQLAQPP 554
           + ++ +++   Q P
Sbjct: 294 AIILERIEYCTQDP 307

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 264 RSITKNFSEGNRLLGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
           RS   NF +    +G+  TG    + +   G  VAVK++     QR++  ++E+      
Sbjct: 28  RSYLDNFIK----IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 83
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
            H N+V +        + ++V EF+  G L   + H       ++      V   + Q +
Sbjct: 84  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQAL 138
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
           + LH +    V+HRDI++ ++LL  +    L   G    V  EV + + ++  GT  ++A
Sbjct: 139 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMA 193
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           PE + R     + D++S G++++E+V G  P
Sbjct: 194 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G    G       VA+K +K  S   + EF  E      L H  LV + G C  
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               +I+ E++ NG L  +L  +    ++      +++   + + + +L  K     +HR
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QFLHR 135
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+ A N L++++    +   GLS++V   +  E T   G  +   +  PE +  ++ ++K
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 192
Query: 455 SDVYSFGVLLLEIVS-GRRPAQ 475
           SD+++FGVL+ EI S G+ P +
Sbjct: 193 SDIWAFGVLMWEIYSLGKMPYE 214

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 109/236 (46%), Gaps = 27/236 (11%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 147
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK--FVPWEVMQERTVMAGGTYGYLA 442
           L  K     VHRD+ A N +LDE+F   +   GL++  +            A     ++A
Sbjct: 148 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
            E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 254

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 37  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 97  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 152
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 153 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 205
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 254
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 255 -------------VTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 308
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 9   KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 68
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 367
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 69  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 128
Query: 368 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 129 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 184
Query: 426 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 480
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 185 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 243
Query: 481 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 540
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 244 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 284
Query: 541 SHVVHQLQQLAQPP 554
           + ++ +++   Q P
Sbjct: 285 AIILERIEYCTQDP 298

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           LG  + G    G       VA+K +K  S   + EF  E      L H  LV + G C  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               +I+ E++ NG L  +L  +    ++      +++   + + + +L  K     +HR
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
           D+ A N L++++    +   GLS++V   +  E T   G  +   +  PE +  ++ ++K
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSRGSKFPVRWSPPEVLMYSKFSSK 186
Query: 455 SDVYSFGVLLLEIVS-GRRPAQ 475
           SD+++FGVL+ EI S G+ P +
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 54  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 113
Query: 352 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 114 LREYLQARRPPGLEYSYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 168
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 169 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 228
Query: 458 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 516
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 229 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 268
Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 269 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 81/325 (24%), Positives = 135/325 (41%), Gaps = 54/325 (16%)
Query: 247 ASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKR 300
           +S  VP  W+V + E++  +        R LG    G  Y G   D       +RVAVK 
Sbjct: 4   SSVYVPDEWEV-SREKITLL--------RELGQGSFGMVYEGNARDIIKGEAETRVAVKT 54
Query: 301 LKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI 359
           +  S+  R++ EF +E          ++V + G         +V E + +G L  +L  +
Sbjct: 55  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
Query: 360 -PRG----GRSLDWAMRM-KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
            P      GR       M ++A  +A G+A+L+ K     VHR++ A N ++  +F   +
Sbjct: 115 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKI 171
Query: 414 MGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              G+++    ++ +      GG       ++APE +     TT SD++SFGV+L EI S
Sbjct: 172 GDFGMTR----DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
Query: 470 -GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 528
              +P Q + +       E     V    Y                     ++V DL+  
Sbjct: 228 LAEQPYQGLSN-------EQVLKFVMDGGYLDQPD-------------NCPERVTDLMRM 267
Query: 529 CTQHVPSMRPRMSHVVHQLQQLAQP 553
           C Q  P+MRP    +V+ L+    P
Sbjct: 268 CWQFNPNMRPTFLEIVNLLKDDLHP 292

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 308
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 34  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 93
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 367
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 94  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 153
Query: 368 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 154 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 209
Query: 426 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 480
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 210 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 268
Query: 481 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 540
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 269 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 309
Query: 541 SHVVHQLQQLAQPP 554
           + ++ +++   Q P
Sbjct: 310 AIILERIEYCTQDP 323

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDR--------YIV 343
           VAVK L R+   R   FY    R A+    L+HP +VAV    Y  G+         YIV
Sbjct: 40  VAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV----YATGEAETPAGPLPYIV 94
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
            E+V    L   +H    G  +   A+  +V     Q + F H      ++HRD++ +N+
Sbjct: 95  MEYVDGVTLRDIVHT--EGPMTPKRAI--EVIADACQALNFSHQN---GIIHRDVKPANI 147
Query: 404 LLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
           ++       +M  G+++ +      V Q   V+  GT  YL+PE    + +  +SDVYS 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDARSDVYSL 205
Query: 461 GVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSH 496
           G +L E+++G  P    +  SV +Q + E   P    H
Sbjct: 206 GCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 28  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 87
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 88  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 143
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 144 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 196
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 197 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 245
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 246 -------------VTEGARDLISRLLKHNPSQRPMLREVL 272

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 308
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 24  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 83
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 367
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 84  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 143
Query: 368 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 144 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 199
Query: 426 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 480
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 200 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 258
Query: 481 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 540
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 259 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 299
Query: 541 SHVVHQLQQLAQPP 554
           + ++ +++   Q P
Sbjct: 300 AIILERIEYCTQDP 313

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 111/280 (39%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 16  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 131
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      RT + G T  YL PE + 
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCG-TLDYLPPEXIE 184
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 185 GRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 233
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 234 -------------VTEGARDLISRLLKHNPSQRPXLREVL 260

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 19/219 (8%)
Query: 271 SEGNRLLGDSKTGGTYSGILPDGSR----VAVKRLKRSSFQRKKEFYSEIGRFAR-LHHP 325
           +  +R++G    G  Y G   D ++     A+K L R +  ++ E +   G   R L+HP
Sbjct: 23  THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 326 NLVAVKGCCYD-HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
           N++A+ G      G  +++  ++ +G L +++    R     D    +     +A+G+ +
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEY 139
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP----WEVMQERTVMAGGTYGY 440
           L ++     VHRD+ A N +LDE F   +   GL++ +     + V Q R       +  
Sbjct: 140 LAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVD 478
           L     YR   TTKSDV+SFGVLL E+++ G  P + +D
Sbjct: 197 LESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHID 233

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 146
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 147 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 202
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 253

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    R    +  
Sbjct: 58  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPE 113
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
            +  KV+  + +G+A+L +K +  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 114 EILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 167
Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 486
                  GT  Y+APE +     + +SD++S G+ L+E+  GR P    D+   ++IF
Sbjct: 168 SMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIF 225

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 274 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 329 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 384
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 143
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 441
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 144 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 199
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 250

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 308
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 367
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 368 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 138 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 193
Query: 426 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 480
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 194 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 252
Query: 481 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 540
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 253 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 293
Query: 541 SHVVHQLQQLAQPP 554
           + ++ +++   Q P
Sbjct: 294 AIILERIEYCTQDP 307

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 16  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 131
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 184
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 233
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 234 -------------VTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 81/325 (24%), Positives = 135/325 (41%), Gaps = 54/325 (16%)
Query: 247 ASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKR 300
           +S  VP  W+V + E++  +        R LG    G  Y G   D       +RVAVK 
Sbjct: 5   SSVYVPDEWEV-SREKITLL--------RELGQGSFGMVYEGNARDIIKGEAETRVAVKT 55
Query: 301 LKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI 359
           +  S+  R++ EF +E          ++V + G         +V E + +G L  +L  +
Sbjct: 56  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 115
Query: 360 -PRG----GRSLDWAMRM-KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
            P      GR       M ++A  +A G+A+L+ K     VHR++ A N ++  +F   +
Sbjct: 116 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKI 172
Query: 414 MGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              G+++    ++ +      GG       ++APE +     TT SD++SFGV+L EI S
Sbjct: 173 GDFGMTR----DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228
Query: 470 -GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 528
              +P Q + +       E     V    Y                     ++V DL+  
Sbjct: 229 LAEQPYQGLSN-------EQVLKFVMDGGYLDQPD-------------NCPERVTDLMRM 268
Query: 529 CTQHVPSMRPRMSHVVHQLQQLAQP 553
           C Q  P+MRP    +V+ L+    P
Sbjct: 269 CWQFNPNMRPTFLEIVNLLKDDLHP 293

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 14  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 129
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 182
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
                 K D++S GVL  E + G+ P +A
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 179
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 228
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 229 -------------VTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 16  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + + L  + +     D        T LA  +++ H 
Sbjct: 76  LRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYITELANALSYCHS 131
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 184
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 233
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 234 -------------VTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRS-SFQR 308
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQD 91
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 367
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 368 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 152 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 207
Query: 426 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 480
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 208 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 266
Query: 481 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 540
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 267 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 307
Query: 541 SHVVHQLQQLAQPP 554
           + ++ +++   Q P
Sbjct: 308 AIILERIEYCTQDP 321

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 16  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + + L  + +     D        T LA  +++ H 
Sbjct: 76  LRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYITELANALSYCHS 131
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLXGTLDYLPPEMIE 184
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 233
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 234 -------------VTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 11/156 (7%)
Query: 334 CYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
           C+   DR Y V E+V  G L   ++HI + GR       +  A  +A G+ FL  K    
Sbjct: 410 CFQTMDRLYFVMEYVNGGDL---MYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSK---G 462
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
           +++RD++  NV+LD E    +   G+ K   W+ +  +     GT  Y+APE +      
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC--GTPDYIAPEIIAYQPYG 520
Query: 453 TKSDVYSFGVLLLEIVSGRRPAQAVD-SVCWQSIFE 487
              D ++FGVLL E+++G+ P +  D    +QSI E
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 14  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 129
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 182
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------------- 229
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 230 -----------DFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 14  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 129
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLPPEMIE 182
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 231
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 232 -------------VTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 264 RSITKNFSEGNRLLGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
           RS   NF +    +G+  TG    + +   G  VAVK++     QR++  ++E+      
Sbjct: 73  RSYLDNFIK----IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 128
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
            H N+V +        + ++V EF+  G L   + H       ++      V   + Q +
Sbjct: 129 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQAL 183
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
           + LH +    V+HRDI++ ++LL  +    L   G    V  EV + + ++  GT  ++A
Sbjct: 184 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMA 238
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           PE + R     + D++S G++++E+V G  P
Sbjct: 239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 97/192 (50%), Gaps = 14/192 (7%)
Query: 291 PD-GSRVAVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           PD G   A+K LK+++ + +    +++ R   A ++HP +V +       G  Y++ +F+
Sbjct: 53  PDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFL 112
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
             G L      + +     +  ++  +A  LA G+  LH      +++RD++  N+LLDE
Sbjct: 113 RGGDL---FTRLSKEVMFTEEDVKFYLAE-LALGLDHLHSL---GIIYRDLKPENILLDE 165
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
           E    L   GLSK     +  E+   +  GT  Y+APE V R   +  +D +S+GVL+ E
Sbjct: 166 EGHIKLTDFGLSK---EAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFE 222
Query: 467 IVSGRRPAQAVD 478
           +++G  P Q  D
Sbjct: 223 MLTGSLPFQGKD 234

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 45/297 (15%)
Query: 275 RLLGDSKTGGTYSGILPD------GSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNL 327
           R LG    G  Y G   D       +RVAVK +  S+  R++ EF +E          ++
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRG----GRSLDWAMRM-KVATTLAQG 381
           V + G         +V E + +G L  +L  + P      GR       M ++A  +A G
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---- 437
           +A+L+ K     VHRD+ A N ++  +F   +   G+++    ++ +      GG     
Sbjct: 142 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 194
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH 496
             ++APE +     TT SD++SFGV+L EI S   +P Q + +       E     V   
Sbjct: 195 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVLKFVMDG 247
Query: 497 RYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            Y                     ++V DL+  C Q  P MRP    +V+ L+    P
Sbjct: 248 GYLDQPD-------------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 291

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 13  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 73  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 128
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 129 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLCGTLDYLPPEMIE 181
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 230
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 231 -------------VTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 264 RSITKNFSEGNRLLGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
           RS   NF +    +G+  TG    + +   G  VAVK++     QR++  ++E+      
Sbjct: 150 RSYLDNFIK----IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 205
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
            H N+V +        + ++V EF+  G L   + H       ++      V   + Q +
Sbjct: 206 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQAL 260
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
           + LH +    V+HRDI++ ++LL  +    L   G    V  EV + + ++  GT  ++A
Sbjct: 261 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMA 315
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           PE + R     + D++S G++++E+V G  P
Sbjct: 316 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTELCGTLDYLPPEMIE 179
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 228
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 229 -------------VTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 85/168 (50%), Gaps = 12/168 (7%)
Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
           ++  +EI     L HPN++ +     D+ + YIV E    G L   +      G++L   
Sbjct: 65  EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH----LMGVGLSKFVPWE 425
              ++   +   +A+ H +   HVVH+D++  N+L  ++   H    ++  GL++    +
Sbjct: 125 YVAELMKQMMNALAYFHSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSD 180
Query: 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
              E +  A GT  Y+APE V++ ++T K D++S GV++  +++G  P
Sbjct: 181 ---EHSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 296 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 354 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 401
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 462 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 520
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 521 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 10  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 69
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 70  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 125
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 126 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 178
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
                 K D++S GVL  E + G+ P +A
Sbjct: 179 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA 207

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 308
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 44  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 103
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 367
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 104 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 163
Query: 368 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 164 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 219
Query: 426 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 480
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 220 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 278
Query: 481 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 540
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 279 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 319
Query: 541 SHVVHQLQQLAQPP 554
           + ++ +++   Q P
Sbjct: 320 AIILERIEYCTQDP 333

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 296 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 59  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 118
Query: 354 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 401
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 119 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 175
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 176 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 235
Query: 462 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 520
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 236 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 275
Query: 521 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 276 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 305

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 296 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 354 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 401
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 462 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 520
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 521 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 296 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 62  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 121
Query: 354 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 401
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 122 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 178
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 179 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 238
Query: 462 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 520
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 239 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 278
Query: 521 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 279 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 308

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLPPEMIE 179
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
                 K D++S GVL  E + G+ P +A
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 15  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 130
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 131 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 183
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
                 K D++S GVL  E + G+ P +A
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA 212

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 14  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 129
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 182
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
                 K D++S GVL  E + G+ P +A
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 12  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 127
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPPEMIE 180
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 229
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 230 -------------VTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTXLCGTLDYLPPEMIE 179
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
                 K D++S GVL  E + G+ P +A
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 16  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 131
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPPEMIE 184
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 233
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 234 -------------VTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPPEMIE 179
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 228
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 229 -------------VTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPPEMIE 179
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
                 K D++S GVL  E + G+ P +A
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 296 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 57  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 116
Query: 354 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 401
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 117 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTAR 173
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 174 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 233
Query: 462 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 520
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 234 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 273
Query: 521 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 274 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 303

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 296 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLR 129
Query: 354 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 401
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 462 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 520
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 521 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 12  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 127
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDTLCGTLDYLPPEMIE 180
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 229
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 230 -------------VTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSR---VAVKRLKRSSFQR---KKEFYSEIGRFARLHHP 325
           E  R LG  K G  Y  +  +  R   +A+K L ++  ++   + +   E+   + L HP
Sbjct: 8   EIGRPLGKGKFGNVY--LAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 65
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
           N++ + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ 
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYC 121
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
           H K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE 
Sbjct: 122 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEM 174
Query: 446 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           +       K D++S GVL  E + G+ P +A
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 205

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLCGTLDYLPPEMIE 179
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
                 K D++S GVL  E + G+ P +A
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 14  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 129
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLCGTLDYLPPEMIE 182
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
                 K D++S GVL  E + G+ P +A
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 11/156 (7%)
Query: 334 CYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
           C+   DR Y V E+V  G L   ++HI + GR       +  A  +A G+ FL  K    
Sbjct: 89  CFQTMDRLYFVMEYVNGGDL---MYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSK---G 141
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
           +++RD++  NV+LD E    +   G+ K   W+ +  +     GT  Y+APE +      
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC--GTPDYIAPEIIAYQPYG 199
Query: 453 TKSDVYSFGVLLLEIVSGRRPAQAVD-SVCWQSIFE 487
              D ++FGVLL E+++G+ P +  D    +QSI E
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 296 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 354 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 401
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 462 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 520
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 521 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 297 AVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           A+K LK+++ + +    +++ R     ++HP +V +       G  Y++ +F+  G L  
Sbjct: 56  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-- 113
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414
               + +     +  ++  +A  LA  +  LH      +++RD++  N+LLDEE    L 
Sbjct: 114 -FTRLSKEVMFTEEDVKFYLAE-LALALDHLHSL---GIIYRDLKPENILLDEEGHIKLT 168
Query: 415 GVGLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
             GLSK     +  E+   +  GT  Y+APE V R   T  +D +SFGVL+ E+++G  P
Sbjct: 169 DFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
Query: 474 AQAVD 478
            Q  D
Sbjct: 226 FQGKD 230

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 290 LPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFV 347
           +P G   AVKR++ + + Q +K    ++    R +  P  V   G  +  GD +I  E +
Sbjct: 56  VPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXE-L 114
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
            +  LD++   +   G+++   +  K+A ++ + +  LH K+   V+HRD++ SNVL++ 
Sbjct: 115 XDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINA 172
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVL 463
                    G+S ++  +V ++   +  G   Y APE +     +   + KSD++S G+ 
Sbjct: 173 LGQVKXCDFGISGYLVDDVAKD---IDAGCKPYXAPERINPELNQKGYSVKSDIWSLGIT 229
Query: 464 LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 494
            +E+   R P  +           W TP  Q
Sbjct: 230 XIELAILRFPYDS-----------WGTPFQQ 249

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 65  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 120
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 121 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 224

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 297 AVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           A+K LK+++ + +    +++ R     ++HP +V +       G  Y++ +F+  G L  
Sbjct: 57  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-- 114
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414
               + +     +  ++  +A  LA  +  LH      +++RD++  N+LLDEE    L 
Sbjct: 115 -FTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLT 169
Query: 415 GVGLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
             GLSK     +  E+   +  GT  Y+APE V R   T  +D +SFGVL+ E+++G  P
Sbjct: 170 DFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226
Query: 474 AQAVD 478
            Q  D
Sbjct: 227 FQGKD 231

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 297 AVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           A+K LK+++ + +    +++ R     ++HP +V +       G  Y++ +F+  G L  
Sbjct: 56  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-- 113
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414
               + +     +  ++  +A  LA  +  LH      +++RD++  N+LLDEE    L 
Sbjct: 114 -FTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLT 168
Query: 415 GVGLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
             GLSK     +  E+   +  GT  Y+APE V R   T  +D +SFGVL+ E+++G  P
Sbjct: 169 DFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
Query: 474 AQAVD 478
            Q  D
Sbjct: 226 FQGKD 230

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 296 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 175
Query: 354 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 401
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 232
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 292
Query: 462 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 520
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 293 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 332
Query: 521 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 333 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 117
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 118 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 221

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 140
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 141 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 64  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 119
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 120 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 223

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 142
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 143 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           Y++PE +        SD+++ G ++ ++V+G  P +A
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 88  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 143
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 144 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 247

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 142
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 143 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 140
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 141 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 118
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 119 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 222

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 142
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 143 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 90  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 145
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 146 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 249

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 142
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 143 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           Y++PE +        SD+++ G ++ ++V+G  P +A
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 140
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 141 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 142
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 143 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 140
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 141 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 31/235 (13%)
Query: 249 ALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS 304
           A+  P WK    E++R I  +F +   +LG   TG     IL +  R    VA+K + + 
Sbjct: 4   AVEGPRWK--QAEDIRDIY-DFRD---VLG---TGAFSEVILAEDKRTQKLVAIKCIAKE 54
Query: 305 SFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRG 362
           + + K+    +EI    ++ HPN+VA+       G  Y++ + V  G L DR    + +G
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKG 111
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL---LDEEFGAHLMGVGLS 419
             +   A R+     +   + +LHD     +VHRD++  N+L   LDE+    +   GLS
Sbjct: 112 FYTERDASRL--IFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166
Query: 420 KFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           K   P  V+      A GT GY+APE + +   +   D +S GV+   ++ G  P
Sbjct: 167 KMEDPGSVLS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 69  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIV 124
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 125 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           Y++PE +        SD+++ G ++ ++V+G  P +A
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 31/235 (13%)
Query: 249 ALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS 304
           A+  P WK    E++R I  +F +   +LG   TG     IL +  R    VA+K + + 
Sbjct: 4   AVEGPRWK--QAEDIRDIY-DFRD---VLG---TGAFSEVILAEDKRTQKLVAIKCIAKE 54
Query: 305 SFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRG 362
           + + K+    +EI    ++ HPN+VA+       G  Y++ + V  G L DR    + +G
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKG 111
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL---LDEEFGAHLMGVGLS 419
             +   A R+     +   + +LHD     +VHRD++  N+L   LDE+    +   GLS
Sbjct: 112 FYTERDASRL--IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166
Query: 420 KFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           K   P  V+      A GT GY+APE + +   +   D +S GV+   ++ G  P
Sbjct: 167 KMEDPGSVLS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKI----GSFDETCTRFYTAEIV 142
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 143 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +     +  SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 37  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 97  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 152
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 153 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDDLCGTLDYLPPEMIE 205
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 504
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 254
Query: 505 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        V +   DL+    +H PS RP +  V+
Sbjct: 255 -------------VTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 16/213 (7%)
Query: 268 KNFSEGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLH 323
           ++F  G R LG  K G  Y         + A+K L ++  ++   + +   E+   + L 
Sbjct: 12  EDFDIG-RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HPN++ + G  +D    Y++ E+   G + R L  + R     D        T LA  ++
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR----FDEQRTATYITELANALS 126
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 443
           + H K    V+HRDI+  N+LL       +   G S   P      R     GT  YL P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 179
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           E +       K D++S GVL  E + G  P +A
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEA 212

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIV 139
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 140 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 243

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 88  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 143
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 144 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 485
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 247

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 93/193 (48%), Gaps = 28/193 (14%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC--CYDHGDR--------- 340
           DG    +KR+K ++ + ++E    +   A+L H N+V   GC   +D+            
Sbjct: 35  DGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90
Query: 341 -----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                +I  EF   G L++W+    R G  LD  + +++   + +G+ ++H K    +++
Sbjct: 91  KTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELFEQITKGVDYIHSK---KLIN 145
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
           RD++ SN+ L +     +   GL   +  +  + R   + GT  Y++PE +   +   + 
Sbjct: 146 RDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXR---SKGTLRYMSPEQISSQDYGKEV 202
Query: 456 DVYSFGVLLLEIV 468
           D+Y+ G++L E++
Sbjct: 203 DLYALGLILAELL 215

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 296 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLR 129
Query: 354 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 401
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 462 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 520
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 521 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 31/235 (13%)
Query: 249 ALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS 304
           A+  P WK    E++R I  +F +   +LG   TG     IL +  R    VA+K + + 
Sbjct: 4   AVEGPRWK--QAEDIRDIY-DFRD---VLG---TGAFSEVILAEDKRTQKLVAIKCIAKE 54
Query: 305 SFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRG 362
           + + K+    +EI    ++ HPN+VA+       G  Y++ + V  G L DR    + +G
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKG 111
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL---LDEEFGAHLMGVGLS 419
             +   A R+     +   + +LHD     +VHRD++  N+L   LDE+    +   GLS
Sbjct: 112 FYTERDASRL--IFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166
Query: 420 KFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           K   P  V+      A GT GY+APE + +   +   D +S GV+   ++ G  P
Sbjct: 167 KMEDPGSVLS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 320
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 67  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 122
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKL 174
Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           VAVK LK  +S    ++  SE     +++HP+++ + G C   G   ++ E+   G L  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 355 WLHHIPRGG--------------------RSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
           +L    + G                    R+L     +  A  ++QG+ +L +     +V
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV 172
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD+ A N+L+ E     +   GLS+ V  E    +         ++A E ++ +  TT+
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 455 SDVYSFGVLLLEIVS 469
           SDV+SFGVLL EIV+
Sbjct: 233 SDVWSFGVLLWEIVT 247

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 320
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 67  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLST 122
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTXXKASKGKL 174
Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 31/235 (13%)
Query: 249 ALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS 304
           A+  P WK    E++R I  +F +   +LG   TG     IL +  R    VA+K + + 
Sbjct: 4   AVEGPRWK--QAEDIRDIY-DFRD---VLG---TGAFSEVILAEDKRTQKLVAIKCIAKK 54
Query: 305 SFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRG 362
           + + K+    +EI    ++ HPN+VA+       G  Y++ + V  G L DR    + +G
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKG 111
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL---LDEEFGAHLMGVGLS 419
             +   A R+     +   + +LHD     +VHRD++  N+L   LDE+    +   GLS
Sbjct: 112 FYTERDASRL--IFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166
Query: 420 KFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           K   P  V+      A GT GY+APE + +   +   D +S GV+   ++ G  P
Sbjct: 167 KMEDPGSVLS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 320
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 64  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 119
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 120 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKL 171
Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 320
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 67  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 122
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKL 174
Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           VAVK LK  +S    ++  SE     +++HP+++ + G C   G   ++ E+   G L  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 355 WLHHIPRGG--------------------RSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
           +L    + G                    R+L     +  A  ++QG+ +L +     +V
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---SLV 172
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD+ A N+L+ E     +   GLS+ V  E    +         ++A E ++ +  TT+
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 455 SDVYSFGVLLLEIVS 469
           SDV+SFGVLL EIV+
Sbjct: 233 SDVWSFGVLLWEIVT 247

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIV 139
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 140 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           Y++PE +        SD+++ G ++ ++V+G  P +A
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 297 AVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-D 353
           A+K ++++S       +   E+     L HPN++ +     D  + Y+V E    G L D
Sbjct: 66  AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
             +H +      +D A+ +K   +   G+ +LH   K ++VHRD++  N+LL+ +    L
Sbjct: 126 EIIHRMKFN--EVDAAVIIKQVLS---GVTYLH---KHNIVHRDLKPENLLLESKEKDAL 177
Query: 414 MGV---GLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
           + +   GLS  F   + M+ER     GT  Y+APE V R +   K DV+S GV+L  +++
Sbjct: 178 IKIVDFGLSAVFENQKKMKERL----GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLA 232
Query: 470 GRRP----------------AQAVDSVCWQSIFEWATPLVQ 494
           G  P                    DS  W+++ E A  L++
Sbjct: 233 GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 87/183 (47%), Gaps = 13/183 (7%)
Query: 295 RVAVKRL---KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           +VA+K +    R   +  K F  E+   ++L H N+V++     +    Y+V E++    
Sbjct: 38  KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
           L  ++     G  S+D A+       +  GI   HD     +VHRDI+  N+L+D     
Sbjct: 98  LSEYIE--SHGPLSVDTAINF--TNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTL 150
Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSG 470
            +   G++K +  E    +T    GT  Y +PE   + E T + +D+YS G++L E++ G
Sbjct: 151 KIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQA-KGEATDECTDIYSIGIVLYEMLVG 208
Query: 471 RRP 473
             P
Sbjct: 209 EPP 211

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 113/271 (41%), Gaps = 46/271 (16%)
Query: 294 SRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           + V +K L ++     + F+      ++L H +LV   G C+   +  +V EFV  G LD
Sbjct: 41  TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLD 100
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEF 409
            +L    +    ++   +++VA  LA  + FL +     ++H ++ A N+LL    D + 
Sbjct: 101 TYLK---KNKNCINILWKLEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKT 154
Query: 410 G----AHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVL 463
           G      L   G+S   +P +++QER         ++ PE +     L   +D +SFG  
Sbjct: 155 GNPPFIKLSDPGISITVLPKDILQERI-------PWVPPECIENPKNLNLATDKWSFGTT 207
Query: 464 LLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKV 522
           L EI S G +P  A+DS      +E        H+                  A    ++
Sbjct: 208 LWEICSGGDKPLSALDSQRKLQFYE------DRHQL----------------PAPKAAEL 245
Query: 523 VDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            +L+  C  + P  RP    ++  L  L  P
Sbjct: 246 ANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 38/270 (14%)
Query: 296 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK  + +    +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 70  VAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 354 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 401
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 462 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 520
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 521 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 38/270 (14%)
Query: 296 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 354 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 401
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
           NVL+ E     +   GL++ +      + T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 462 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 520
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 521 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 320
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 10  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 69
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 70  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 125
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 126 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKL 177
Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 178 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 221

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 118/252 (46%), Gaps = 20/252 (7%)
Query: 253 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKRSSFQ 307
           PS       +LR + +   +  ++LG    G  Y GI +P+G  V    A+K L  ++  
Sbjct: 22  PSGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP 81
Query: 308 RKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRS 365
           +   EF  E    A + HP+LV + G C     + +V + + +G L  ++H H    G  
Sbjct: 82  KANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQ 140
Query: 366 L--DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423
           L  +W ++      +A+G+ +L ++    +VHRD+ A NVL+       +   GL++ + 
Sbjct: 141 LLLNWCVQ------IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 191
Query: 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCW 482
            +  +           ++A E ++  + T +SDV+S+GV + E+++ G +P   + +   
Sbjct: 192 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 251
Query: 483 QSIFEWATPLVQ 494
             + E    L Q
Sbjct: 252 PDLLEKGERLPQ 263

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 320
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 9   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 68
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 69  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 124
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 125 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKL 176
Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 177 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 220

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           VAVK LK  +S    ++  SE     +++HP+++ + G C   G   ++ E+   G L  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 355 WLHHIPRGG--------------------RSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
           +L    + G                    R+L     +  A  ++QG+ +L +     +V
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV 172
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD+ A N+L+ E     +   GLS+ V  E    +         ++A E ++ +  TT+
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 455 SDVYSFGVLLLEIVS 469
           SDV+SFGVLL EIV+
Sbjct: 233 SDVWSFGVLLWEIVT 247

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 320
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 35  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 94
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 95  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 150
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 151 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKL 202
Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 203 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 246

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 85/171 (49%), Gaps = 12/171 (7%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 51  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 107
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S  +  E+  
Sbjct: 108 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN 164
Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR--RPAQAV 477
           E      GT  Y++PE +     + +SD++S G+ L+E+  GR  RP  A+
Sbjct: 165 EFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAI 211

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 320
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 12  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 71
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 72  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 127
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 128 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKL 179
Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 275 RLLGDSKTGGTY-SGILPDGSRVAVKRLKRSSFQRKKEFY-----SEIGRFARLHHPNLV 328
           R+LG    G    + +   G   AVK LK+    +  +         I   AR +HP L 
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLT 87
Query: 329 AVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
            +  CC+   DR + V EFV  G L   + HI +  R  D A     A  +   + FLHD
Sbjct: 88  QL-FCCFQTPDRLFFVMEFVNGGDL---MFHIQKS-RRFDEARARFYAAEIISALMFLHD 142
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    +++RD++  NVLLD E    L   G+ K      +   T    GT  Y+APE + 
Sbjct: 143 K---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC--GTPDYIAPEILQ 197
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
                   D ++ GVLL E++ G  P +A
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 327
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 14  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 129
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDDLCGTLDYLPPEMIE 182
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
                 K D++S GVL  E + G+ P +A
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 320
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 67  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLST 122
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRY-----MEDSTYYKASKGKL 174
Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 16/213 (7%)
Query: 268 KNFSEGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLH 323
           ++F  G R LG  K G  Y         + A+K L ++  ++   + +   E+   + L 
Sbjct: 12  EDFDIG-RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HPN++ + G  +D    Y++ E+   G + R L  + R     D        T LA  ++
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR----FDEQRTATYITELANALS 126
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 443
           + H K    V+HRDI+  N+LL       +   G S   P      R     GT  YL P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRDTLCGTLDYLPP 179
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           E +       K D++S GVL  E + G  P +A
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEA 212

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 14/203 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAV-KRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LGD   G  Y     + S +A  K +   S +  +++  EI   A   HPN+V +    Y
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
              + +I+ EF   G +D  +  +    R L  +    V       + +LHD     ++H
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNE 450
           RD++A N+L   +    L   G+S       +Q R    G  Y ++APE V         
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDXFIGTPY-WMAPEVVMCETSKDRP 216
Query: 451 LTTKSDVYSFGVLLLEIVSGRRP 473
              K+DV+S G+ L+E+     P
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPP 239

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 14/203 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAV-KRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LGD   G  Y     + S +A  K +   S +  +++  EI   A   HPN+V +    Y
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
              + +I+ EF   G +D  +  +    R L  +    V       + +LHD     ++H
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNE 450
           RD++A N+L   +    L   G+S       +Q R    G  Y ++APE V         
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRP 216
Query: 451 LTTKSDVYSFGVLLLEIVSGRRP 473
              K+DV+S G+ L+E+     P
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPP 239

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 110 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 166
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 167 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 219
Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 486
                  GT  Y++PE +     + +SD++S G+ L+E+  GR P    D+   + +F
Sbjct: 220 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 277

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 13/210 (6%)
Query: 268 KNFSEGNRLLGDSKTGGTYSG-ILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLH 323
           ++F  GN LLG     G Y    +  G  VA+K + + +  +    +   +E+    +L 
Sbjct: 11  EDFKVGN-LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HP+++ +     D    Y+V E   NG ++R+L +  +     +    M    T   G+ 
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT---GML 126
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 443
           +LH      ++HRD+  SN+LL       +   GL+     ++  E+     GT  Y++P
Sbjct: 127 YLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLCGTPNYISP 181
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           E   R+    +SDV+S G +   ++ GR P
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 138/341 (40%), Gaps = 84/341 (24%)
Query: 246 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 298
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 5   AADVYVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 54
Query: 299 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 357
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 55  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 113
Query: 358 HIPRGGRSLDWAMR-------------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
                 RSL   M              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 114 ------RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 164
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 460
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 165 VAEDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 220
Query: 461 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 519
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 221 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 253
Query: 520 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 254 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 14/203 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAV-KRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LGD   G  Y     + S +A  K +   S +  +++  EI   A   HPN+V +    Y
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
              + +I+ EF   G +D  +  +    R L  +    V       + +LHD     ++H
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNE 450
           RD++A N+L   +    L   G+S       +Q R    G  Y ++APE V         
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDSFIGTPY-WMAPEVVMCETSKDRP 216
Query: 451 LTTKSDVYSFGVLLLEIVSGRRP 473
              K+DV+S G+ L+E+     P
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPP 239

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 273 GNRLLGDSKTGGTYSGILP-----DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHH 324
           G+ +LGD+   GT+  +        G +VAVK L R    S     +   EI       H
Sbjct: 16  GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
           P+++ +        D ++V E+V  G L     +I + GR LD     ++   +  G+ +
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGEL---FDYICKNGR-LDEKESRRLFQQILSGVDY 131
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
            H  +   VVHRD++  NVLLD    A +   GLS  +      E    + G+  Y APE
Sbjct: 132 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRXSCGSPNYAAPE 185
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGRRP 473
            +  R     + D++S GV+L  ++ G  P
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/341 (22%), Positives = 140/341 (41%), Gaps = 84/341 (24%)
Query: 246 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 298
           AA   VP  W+V   +    IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 1   AADVYVPDEWEVAREK----ITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 50
Query: 299 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 357
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 51  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 109
Query: 358 HIPRGGRSLDWAM-------------RMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
                 RSL  AM              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 110 ------RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 160
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 460
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 161 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 216
Query: 461 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 519
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 217 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 249
Query: 520 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 250 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 290

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/341 (22%), Positives = 139/341 (40%), Gaps = 84/341 (24%)
Query: 246 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 298
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 11  AADVYVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 60
Query: 299 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 357
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 61  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 119
Query: 358 HIPRGGRSLDWAM-------------RMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
                 RSL  AM              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 120 ------RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 460
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 171 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226
Query: 461 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 519
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 227 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 259
Query: 520 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 112/251 (44%), Gaps = 18/251 (7%)
Query: 253 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSF 306
           PS +      LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S 
Sbjct: 3   PSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 62
Query: 307 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS- 365
           +  KE   E    A + +P++  + G C     + I+        LD    H    G   
Sbjct: 63  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQY 122
Query: 366 -LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
            L+W ++      +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  
Sbjct: 123 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 173
Query: 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQ 483
           E  +           ++A E +     T +SDV+S+GV + E+++ G +P   + +    
Sbjct: 174 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233
Query: 484 SIFEWATPLVQ 494
           SI E    L Q
Sbjct: 234 SILEKGERLPQ 244

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 104
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 105 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 486
                  GT  Y++PE +     + +SD++S G+ L+E+  GR P    D+   + +F
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 104
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 105 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 486
                  GT  Y++PE +     + +SD++S G+ L+E+  GR P    D+   + +F
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 112/271 (41%), Gaps = 46/271 (16%)
Query: 294 SRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           + V +K L ++     + F+      ++L H +LV   G C    +  +V EFV  G LD
Sbjct: 41  TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD 100
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEF 409
            +L    +    ++   +++VA  LA  + FL +     ++H ++ A N+LL    D + 
Sbjct: 101 TYLK---KNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKT 154
Query: 410 G----AHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVL 463
           G      L   G+S   +P +++QER         ++ PE +     L   +D +SFG  
Sbjct: 155 GNPPFIKLSDPGISITVLPKDILQERI-------PWVPPECIENPKNLNLATDKWSFGTT 207
Query: 464 LLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKV 522
           L EI S G +P  A+DS      +E        H+                  A    ++
Sbjct: 208 LWEICSGGDKPLSALDSQRKLQFYE------DRHQL----------------PAPKAAEL 245
Query: 523 VDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            +L+  C  + P  RP    ++  L  L  P
Sbjct: 246 ANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 85/191 (44%), Gaps = 8/191 (4%)
Query: 292 DGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFV 347
           DG  +  K L   S     K+   SE+     L HPN+V       D  +   YIV E+ 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP--HVVHRDIRASNVLL 405
             G L   +    +  + LD    ++V T L   +   H +      V+HRD++ +NV L
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
           D +    L   GL++ +  +    +T +  GT  Y++PE + R     KSD++S G LL 
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207
Query: 466 EIVSGRRPAQA 476
           E+ +   P  A
Sbjct: 208 ELCALMPPFTA 218

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 138/341 (40%), Gaps = 84/341 (24%)
Query: 246 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 298
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 2   AADVFVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 51
Query: 299 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 357
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 52  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 110
Query: 358 HIPRGGRSLDWAMR-------------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
                 RSL   M              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 111 ------RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 161
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 460
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 162 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 217
Query: 461 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 519
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 218 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 250
Query: 520 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 251 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 291

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 112/270 (41%), Gaps = 38/270 (14%)
Query: 296 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++  +   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLR 129
Query: 354 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 401
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 462 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 520
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 521 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 8/195 (4%)
Query: 277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           +G    G  +SG L  D + VAVK  + +     K +F  E     +  HPN+V + G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 YIV E V  G    +L  +   G  L     +++    A G+ +L  K     +
Sbjct: 182 TQKQPIYIVMELVQGG---DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD+ A N L+ E+    +   G+S+     V      +      + APE +     +++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 455 SDVYSFGVLLLEIVS 469
           SDV+SFG+LL E  S
Sbjct: 296 SDVWSFGILLWETFS 310

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 10  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 69
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 70  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ--- 126
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 127 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 240
Query: 494 Q 494
           Q
Sbjct: 241 Q 241

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 15/217 (6%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGILPDGSR-VAVKRLKRSSFQRK---KEFYSEIGRF 319
           R  T +  E  R LG  K G  Y          VA+K L +S  +++    +   EI   
Sbjct: 18  RHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQ 77
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           A LHHPN++ +    YD    Y++ E+   G L + L    +   + D      +   LA
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL----QKSCTFDEQRTATIMEELA 133
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + + H K    V+HRDI+  N+LL  +    +   G S   P   ++ +T+   GT  
Sbjct: 134 DALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAP--SLRRKTMC--GTLD 186
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           YL PE +       K D++  GVL  E++ G  P ++
Sbjct: 187 YLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFES 223

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 284 GTYSGILPDGSRV-----AVKRLKRSSFQRKKE--FYSEIGRFARLHHPNLVAVKGCCYD 336
           G++  +L    R+     AVK + ++S + K       E+    +L HPN++ +     D
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E    G L  +   I R   S   A R  +   +  GI ++H   K ++VHR
Sbjct: 93  SSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAAR--IIKQVFSGITYMH---KHNIVHR 145
Query: 397 DIRASNVLL---DEEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
           D++  N+LL   +++    ++  GLS  F     M++R     GT  Y+APE V R    
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI----GTAYYIAPE-VLRGTYD 200
Query: 453 TKSDVYSFGVLLLEIVSGRRP 473
            K DV+S GV+L  ++SG  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 104
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 105 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 486
                  GT  Y++PE +     + +SD++S G+ L+E+  GR P    D+   + +F
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 104
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 105 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 486
                  GT  Y++PE +     + +SD++S G+ L+E+  GR P    D+   + +F
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 11/210 (5%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
           G R+ G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G
Sbjct: 15  GQRI-GSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
                    IV ++     L   LH I       +    + +A   AQG+ +LH K    
Sbjct: 74  YS-TKPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---S 126
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RN 449
           ++HRD++++N+ L E+    +   GL+          +     G+  ++APE +    +N
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 450 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
             + +SDVY+FG++L E+++G+ P   +++
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 216

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 8/195 (4%)
Query: 277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           +G    G  +SG L  D + VAVK  + +     K +F  E     +  HPN+V + G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 YIV E V  G    +L  +   G  L     +++    A G+ +L  K     +
Sbjct: 182 TQKQPIYIVMELVQGG---DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD+ A N L+ E+    +   G+S+     V      +      + APE +     +++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 455 SDVYSFGVLLLEIVS 469
           SDV+SFG+LL E  S
Sbjct: 296 SDVWSFGILLWETFS 310

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 11/210 (5%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
           G R+ G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G
Sbjct: 13  GQRI-GSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
                    IV ++     L   LH I       +    + +A   AQG+ +LH K    
Sbjct: 72  YS-TKPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---S 124
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RN 449
           ++HRD++++N+ L E+    +   GL+          +     G+  ++APE +    +N
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 450 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
             + +SDVY+FG++L E+++G+ P   +++
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 116/243 (47%), Gaps = 20/243 (8%)
Query: 262 ELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKRSSFQRKK-EFYSE 315
           +LR + +   +  ++LG    G  Y GI +P+G  V    A+K L  ++  +   EF  E
Sbjct: 8   QLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDE 67
Query: 316 IGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRSL--DWAMRM 372
               A + HP+LV + G C     + +V + + +G L  ++H H    G  L  +W ++ 
Sbjct: 68  ALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ- 125
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
                +A+G+ +L ++    +VHRD+ A NVL+       +   GL++ +  +  +    
Sbjct: 126 -----IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 177
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP 491
                  ++A E ++  + T +SDV+S+GV + E+++ G +P   + +     + E    
Sbjct: 178 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER 237
Query: 492 LVQ 494
           L Q
Sbjct: 238 LPQ 240

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
           G R+ G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G
Sbjct: 13  GQRI-GSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 333 CCYDHGDRY-IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
             Y    +  IV ++     L   LH I       +    + +A   AQG+ +LH K   
Sbjct: 72  --YSTAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK--- 123
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---R 448
            ++HRD++++N+ L E+    +   GL+          +     G+  ++APE +    +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 449 NELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
           N  + +SDVY+FG++L E+++G+ P   +++
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 94/206 (45%), Gaps = 10/206 (4%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G    
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 79
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                IV ++     L   LH I       +    + +A   AQG+ +LH K    ++HR
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHR 133
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTT 453
           D++++N+ L E+    +   GL+          +     G+  ++APE +    +N  + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 454 KSDVYSFGVLLLEIVSGRRPAQAVDS 479
           +SDVY+FG++L E+++G+ P   +++
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 104
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 105 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
                  GT  Y++PE +     + +SD++S G+ L+E+  GR P    D+
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
           P +V   G  Y  G+  I  E +  G LD+ L    + GR  +  +  KV+  + +G+ +
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILG-KVSIAVIKGLTY 146
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           L +K K  ++HRD++ SN+L++      L   G+S     +++        GT  Y++PE
Sbjct: 147 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE 200
Query: 445 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 486
            +     + +SD++S G+ L+E+  GR P    D+   + +F
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 125
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 126 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 494 Q 494
           Q
Sbjct: 240 Q 240

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 71
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 128
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 129 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 242
Query: 494 Q 494
           Q
Sbjct: 243 Q 243

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 94/206 (45%), Gaps = 10/206 (4%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G    
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 79
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                IV ++     L   LH I       +    + +A   AQG+ +LH K    ++HR
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHR 133
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTT 453
           D++++N+ L E+    +   GL+          +     G+  ++APE +    +N  + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 454 KSDVYSFGVLLLEIVSGRRPAQAVDS 479
           +SDVY+FG++L E+++G+ P   +++
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 284 GTYSGILPDGSRV-----AVKRLKRSSFQRKKE--FYSEIGRFARLHHPNLVAVKGCCYD 336
           G++  +L    R+     AVK + ++S + K       E+    +L HPN++ +     D
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E    G L  +   I R   S   A R  +   +  GI ++H   K ++VHR
Sbjct: 93  SSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAAR--IIKQVFSGITYMH---KHNIVHR 145
Query: 397 DIRASNVLL---DEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNEL 451
           D++  N+LL   +++    ++  GLS        Q+ T M    GT  Y+APE V R   
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLST-----CFQQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 452 TTKSDVYSFGVLLLEIVSGRRP 473
             K DV+S GV+L  ++SG  P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 70
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 127
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 128 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 494 Q 494
           Q
Sbjct: 242 Q 242

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 10  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 69
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 70  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 126
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 127 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 240
Query: 494 Q 494
           Q
Sbjct: 241 Q 241

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRF 319
            I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E    
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
            +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLS 501
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-- 437
             +A+L  K     VHRDI A NVL+       L   GLS++     M++ T        
Sbjct: 502 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGK 553
Query: 438 --YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 477
               ++APE +     T+ SDV+ FGV + EI+  G +P Q V
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ--- 125
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 126 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 494 Q 494
           Q
Sbjct: 240 Q 240

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 125
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 126 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 494 Q 494
           Q
Sbjct: 240 Q 240

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 112/270 (41%), Gaps = 38/270 (14%)
Query: 296 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++  +   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLR 129
Query: 354 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 401
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 462 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 520
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 521 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 138/341 (40%), Gaps = 84/341 (24%)
Query: 246 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 298
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 4   AADVYVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 53
Query: 299 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 357
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 54  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 112
Query: 358 HIPRGGRSLDWAMR-------------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
                 RSL   M              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 113 ------RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 163
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 460
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 164 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 219
Query: 461 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 519
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 220 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 252
Query: 520 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 253 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 6   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 65
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 66  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 122
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 123 ---IAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 176
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 177 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 236
Query: 494 Q 494
           Q
Sbjct: 237 Q 237

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 15  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 74
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 75  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 131
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 132 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 185
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 186 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 245
Query: 494 Q 494
           Q
Sbjct: 246 Q 246

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 284 GTYSGILPDGSRV-----AVKRLKRSSFQRKKE--FYSEIGRFARLHHPNLVAVKGCCYD 336
           G++  +L    R+     AVK + ++S + K       E+    +L HPN++ +     D
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
               YIV E    G L  +   I R   S   A R  +   +  GI ++H   K ++VHR
Sbjct: 93  SSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAAR--IIKQVFSGITYMH---KHNIVHR 145
Query: 397 DIRASNVLL---DEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNEL 451
           D++  N+LL   +++    ++  GLS        Q+ T M    GT  Y+APE V R   
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLST-----CFQQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 452 TTKSDVYSFGVLLLEIVSGRRP 473
             K DV+S GV+L  ++SG  P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 19  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 78
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 79  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 135
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 136 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 190 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 249
Query: 494 Q 494
           Q
Sbjct: 250 Q 250

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 3   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 119
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 120 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 233
Query: 494 Q 494
           Q
Sbjct: 234 Q 234

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 71
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 128
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 129 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 242
Query: 494 Q 494
           Q
Sbjct: 243 Q 243

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 138/341 (40%), Gaps = 84/341 (24%)
Query: 246 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 298
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 5   AADVYVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 54
Query: 299 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 357
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 55  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 113
Query: 358 HIPRGGRSLDWAMR-------------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
                 RSL   M              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 114 ------RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 164
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 460
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 165 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 220
Query: 461 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 519
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 221 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 253
Query: 520 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 254 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 71
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 128
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 129 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 242
Query: 494 Q 494
           Q
Sbjct: 243 Q 243

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 70
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 127
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 128 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 494 Q 494
           Q
Sbjct: 242 Q 242

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 138/341 (40%), Gaps = 84/341 (24%)
Query: 246 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 298
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 4   AADVYVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 53
Query: 299 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 357
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 54  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 112
Query: 358 HIPRGGRSLDWAMR-------------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
                 RSL   M              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 113 ------RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 163
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 460
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 164 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 219
Query: 461 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 519
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 220 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 252
Query: 520 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 253 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 125
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 126 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 494 Q 494
           Q
Sbjct: 240 Q 240

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 71
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 128
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 129 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 242
Query: 494 Q 494
           Q
Sbjct: 243 Q 243

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 138/341 (40%), Gaps = 84/341 (24%)
Query: 246 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 298
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 11  AADVYVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 60
Query: 299 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 357
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 61  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 119
Query: 358 HIPRGGRSLDWAMR-------------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
                 RSL   M              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 120 ------RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 460
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 171 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226
Query: 461 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 519
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 227 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 259
Query: 520 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
           G R+ G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G
Sbjct: 13  GQRI-GSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
                    IV ++     L   LH I       +    + +A   AQG+ +LH K    
Sbjct: 72  YS-TKPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---S 124
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVY---R 448
           ++HRD++++N+ L E+    +   GL ++   W    +   ++G    ++APE +    +
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDK 183
Query: 449 NELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
           N  + +SDVY+FG++L E+++G+ P   +++
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRF 319
            I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E    
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
            +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLS 501
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-- 437
             +A+L  K     VHRDI A NVL+       L   GLS++     M++ T        
Sbjct: 502 TALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRY-----MEDSTYYKASKGK 553
Query: 438 --YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 477
               ++APE +     T+ SDV+ FGV + EI+  G +P Q V
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 34  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 93
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 94  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 150
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 151 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 204
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 205 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 264
Query: 494 Q 494
           Q
Sbjct: 265 Q 265

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 16  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 75
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 132
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 133 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 494 Q 494
           Q
Sbjct: 247 Q 247

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 139/341 (40%), Gaps = 84/341 (24%)
Query: 246 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 298
           AA   VP  W+V   +    IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 33  AADVYVPDEWEVAREK----ITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 82
Query: 299 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 357
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 83  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 141
Query: 358 HIPRGGRSLDWAMR-------------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
                 RSL   M              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 142 ------RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 192
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 460
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 193 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 248
Query: 461 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 519
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 249 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 281
Query: 520 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 282 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 322

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/313 (22%), Positives = 130/313 (41%), Gaps = 75/313 (23%)
Query: 274 NRLLGDSKTGGTYSGIL-------PDGSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHP 325
           +R LG    G  Y G+        P+ +RVA+K +  ++  R++ EF +E       +  
Sbjct: 15  SRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR-------------M 372
           ++V + G         ++ E +  G L  +L       RSL   M              +
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-------RSLRPEMENNPVLAPPSLSKMI 126
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
           ++A  +A G+A+L+       VHRD+ A N ++ E+F   +   G+++    ++ +    
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXX 179
Query: 433 MAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE 487
             GG       +++PE +     TT SDV+SFGV+L EI +   +P Q + +        
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------- 231
Query: 488 WATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQK-------VVDLVYACTQHVPSMRPRM 540
                 Q  R+                  G++ K       +++L+  C Q+ P MRP  
Sbjct: 232 -----EQVLRF--------------VMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSF 272
Query: 541 SHVVHQLQQLAQP 553
             ++  +++  +P
Sbjct: 273 LEIISSIKEEMEP 285

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 93/206 (45%), Gaps = 41/206 (19%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC------------------ 333
           DG    ++R+K ++ + ++E    +   A+L H N+V   GC                  
Sbjct: 36  DGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESS 91
Query: 334 CYDHGDR-----------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
            YD  +            +I  EF   G L++W+    R G  LD  + +++   + +G+
Sbjct: 92  DYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELFEQITKGV 149
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
            ++H K    ++HRD++ SN+ L +     +   GL   +  +  + R   + GT  Y++
Sbjct: 150 DYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR---SKGTLRYMS 203
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIV 468
           PE +   +   + D+Y+ G++L E++
Sbjct: 204 PEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 94/206 (45%), Gaps = 10/206 (4%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G    
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 101
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                IV ++     L   LH I       +    + +A   AQG+ +LH K    ++HR
Sbjct: 102 KPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHR 155
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTT 453
           D++++N+ L E+    +   GL+          +     G+  ++APE +    +N  + 
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 454 KSDVYSFGVLLLEIVSGRRPAQAVDS 479
           +SDVY+FG++L E+++G+ P   +++
Sbjct: 216 QSDVYAFGIVLYELMTGQLPYSNINN 241

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 21/236 (8%)
Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR-VAVKRL 301
           + P  ++LVP  W   +    R    +F E    LG   T   Y        +  A+K L
Sbjct: 30  AAPGTASLVPDYWIDGSN---RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL 86
Query: 302 KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIP 360
           K++    KK   +EIG   RL HPN++ +K       +  +V E V  G L DR +    
Sbjct: 87  KKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY 144
Query: 361 RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVG 417
              R    A++      + + +A+LH+     +VHRD++  N+L      +    +   G
Sbjct: 145 YSERDAADAVKQ-----ILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFG 196
Query: 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           LSK V  +V+  +TV   GT GY APE +       + D++S G++   ++ G  P
Sbjct: 197 LSKIVEHQVLM-KTVC--GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 11/171 (6%)
Query: 319 FARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
            A L  P  +     C+   DR Y V E+V  G L   ++HI + G+       +  A  
Sbjct: 73  LALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGK-FKEPQAVFYAAE 128
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           ++ G+ FLH   K  +++RD++  NV+LD E    +   G+ K    + +  R     GT
Sbjct: 129 ISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFC--GT 183
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD-SVCWQSIFE 487
             Y+APE +         D +++GVLL E+++G+ P    D    +QSI E
Sbjct: 184 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 234

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 92/189 (48%), Gaps = 12/189 (6%)
Query: 296 VAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK L  +  + Q+ + F +E+G   +  H N++   G         IV ++     L 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 119
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
             LH I       +    + +A   AQG+ +LH K    ++HRD++++N+ L E+    +
Sbjct: 120 HHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKI 173
Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSG 470
              GL+          +     G+  ++APE +    +N  + +SDVY+FG++L E+++G
Sbjct: 174 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 233
Query: 471 RRPAQAVDS 479
           + P   +++
Sbjct: 234 QLPYSNINN 242

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 84/183 (45%), Gaps = 16/183 (8%)
Query: 293 GSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           G  VA+K+   S   +  KK    EI    +L H NLV +   C      Y+V+EFV + 
Sbjct: 50  GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            LD  L   P G   LD+ +  K    +  GI F H     +++HRDI+  N+L+ +   
Sbjct: 110 ILDD-LELFPNG---LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGV 162
Query: 411 AHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEI 467
             L   G ++ +  P EV  +       T  Y APE +  +    K+ DV++ G L+ E+
Sbjct: 163 VKLCDFGFARTLAAPGEVYDDEV----ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218
Query: 468 VSG 470
             G
Sbjct: 219 FMG 221

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 97/207 (46%), Gaps = 12/207 (5%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G    
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 94
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                IV ++     L   LH I       +    + +A   AQG+ +LH K    ++HR
Sbjct: 95  KPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHR 148
Query: 397 DIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELT 452
           D++++N+ L E+    +   GL ++   W    +   ++G    ++APE +    +N  +
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYS 207
Query: 453 TKSDVYSFGVLLLEIVSGRRPAQAVDS 479
            +SDVY+FG++L E+++G+ P   +++
Sbjct: 208 FQSDVYAFGIVLYELMTGQLPYSNINN 234

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 8/191 (4%)
Query: 292 DGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFV 347
           DG  +  K L   S     K+   SE+     L HPN+V       D  +   YIV E+ 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP--HVVHRDIRASNVLL 405
             G L   +    +  + LD    ++V T L   +   H +      V+HRD++ +NV L
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
           D +    L   GL++ +  +    +  +  GT  Y++PE + R     KSD++S G LL 
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKAFV--GTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207
Query: 466 EIVSGRRPAQA 476
           E+ +   P  A
Sbjct: 208 ELCALMPPFTA 218

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 91/185 (49%), Gaps = 28/185 (15%)
Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLV----AVKGCCYDHGDRYIVYEFVVNGPLDRWLHH 358
           + S+Q ++E +S  G    + H NL+    A K       + +++  F   G L  +L  
Sbjct: 51  KQSWQSEREIFSTPG----MKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLK- 105
Query: 359 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--------KPHVVHRDIRASNVLLDEEFG 410
               G  + W     VA T+++G+++LH+ V        KP + HRD ++ NVLL  +  
Sbjct: 106 ----GNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLT 161
Query: 411 AHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFV-----YRNELTTKSDVYSFGVLL 464
           A L   GL+ +F P +   + T    GT  Y+APE +     ++ +   + D+Y+ G++L
Sbjct: 162 AVLADFGLAVRFEPGKPPGD-THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 220
Query: 465 LEIVS 469
            E+VS
Sbjct: 221 WELVS 225

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 273 GNRL-LGDSKTGGTYSG-ILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV 330
           G+R+ LG    G  Y+G  L +  R+A+K +     +  +  + EI     L H N+V  
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT-LAQGIAFLHDKV 389
            G   ++G   I  E V  G L   L    + G   D    +   T  + +G+ +LHD  
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRS--KWGPLKDNEQTIGFYTKQILEGLKYLHDN- 141
Query: 390 KPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
              +VHRDI+  NVL++   G   +   G SK +    +   T    GT  Y+APE + +
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDK 197
Query: 449 NE--LTTKSDVYSFGVLLLEIVSGRRP 473
                   +D++S G  ++E+ +G+ P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 97/207 (46%), Gaps = 12/207 (5%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G    
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 102
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                IV ++     L   LH I       +    + +A   AQG+ +LH K    ++HR
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHR 156
Query: 397 DIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELT 452
           D++++N+ L E+    +   GL ++   W    +   ++G    ++APE +    +N  +
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYS 215
Query: 453 TKSDVYSFGVLLLEIVSGRRPAQAVDS 479
            +SDVY+FG++L E+++G+ P   +++
Sbjct: 216 FQSDVYAFGIVLYELMTGQLPYSNINN 242

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 76/149 (51%), Gaps = 10/149 (6%)
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
           P +V   G  Y  G+  I  E +  G LD+ L    + GR  +  +  KV+  + +G+ +
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILG-KVSIAVIKGLTY 138
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           L +K K  ++HRD++ SN+L++      L   G+S     +++        GT  Y++PE
Sbjct: 139 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE 192
Query: 445 FVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
            +     + +SD++S G+ L+E+  GR P
Sbjct: 193 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 273 GNRL-LGDSKTGGTYSG-ILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV 330
           G+R+ LG    G  Y+G  L +  R+A+K +     +  +  + EI     L H N+V  
Sbjct: 11  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT-LAQGIAFLHDKV 389
            G   ++G   I  E V  G L   L    + G   D    +   T  + +G+ +LHD  
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRS--KWGPLKDNEQTIGFYTKQILEGLKYLHDN- 127
Query: 390 KPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
              +VHRDI+  NVL++   G   +   G SK +    +   T    GT  Y+APE + +
Sbjct: 128 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDK 183
Query: 449 NE--LTTKSDVYSFGVLLLEIVSGRRP 473
                   +D++S G  ++E+ +G+ P
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG+   G  Y  I  + G  VA+K++   S    +E   EI    +   P++V   G  +
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
            + D +IV E+   G +   +       ++L       +  +  +G+ +LH   K   +H
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFMRK---IH 148
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
           RDI+A N+LL+ E  A L   G++  +  + M +R  + G  + ++APE +        +
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPF-WMAPEVIQEIGYNCVA 206
Query: 456 DVYSFGVLLLEIVSGRRP 473
           D++S G+  +E+  G+ P
Sbjct: 207 DIWSLGITAIEMAEGKPP 224

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 43/227 (18%)
Query: 277 LGDSKTGGTYSGIL------PDGSRVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVA 329
           LG+ + G  Y G L           VA+K LK ++    ++EF  E    ARL HPN+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWL----HHIPRGGRSLDWAMR--------MKVATT 377
           + G         +++ +  +G L  +L     H   G    D  ++        + +   
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           +A G+ +L      HVVH+D+   NVL+ ++    +  +GL           R V A   
Sbjct: 154 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF----------REVYAADY 200
Query: 438 YG----------YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
           Y           ++APE +   + +  SD++S+GV+L E+ S G +P
Sbjct: 201 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
           +  + E+     L HP LV +     D  D ++V + ++ G L    +H+ +     +  
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL---RYHLQQNVHFKEET 116
Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429
           +++ +   L   + +L ++    ++HRD++  N+LLDE    H+    ++  +P E   +
Sbjct: 117 VKLFICE-LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--Q 170
Query: 430 RTVMAGGTYGYLAPEFVYRNELTTKS---DVYSFGVLLLEIVSGRRPAQAVDSVCWQSI 485
            T MA GT  Y+APE     +    S   D +S GV   E++ GRRP     S   + I
Sbjct: 171 ITTMA-GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 101/229 (44%), Gaps = 38/229 (16%)
Query: 272 EGNRLLGDSKTG----GTYSGILPDGS--RVAVKRLKRSSFQRKKE-FYSEIGRFARL-H 323
           E  ++LG    G     T  GI   G   +VAVK LK  +   ++E   SE+    +L  
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPR----------GGRSLDWAMRMK 373
           H N+V + G C   G  Y+++E+   G L  +L                 + L+    + 
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 374 VAT---------TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
           V T          +A+G+ FL  K     VHRD+ A NVL+       +   GL++    
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLAR---- 220
Query: 425 EVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
           ++M +   +  G       ++APE ++    T KSDV+S+G+LL EI S
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++L     G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 16  LRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 75
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 132
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 133 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 494 Q 494
           Q
Sbjct: 247 Q 247

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 70
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 127
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   G +K +  E  +      
Sbjct: 128 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 494 Q 494
           Q
Sbjct: 242 Q 242

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 13  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 72
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 73  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 129
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   G +K +  E  +      
Sbjct: 130 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 243
Query: 494 Q 494
           Q
Sbjct: 244 Q 244

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 110/251 (43%), Gaps = 18/251 (7%)
Query: 253 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSF 306
           PS +      LR + +   +  ++LG    G  Y G+ +P+G +V    A+  L+  +S 
Sbjct: 33  PSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSP 92
Query: 307 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS- 365
           +  KE   E    A + +P++  + G C     + I         LD    H    G   
Sbjct: 93  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY 152
Query: 366 -LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
            L+W ++      +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  
Sbjct: 153 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 203
Query: 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQ 483
           E  +           ++A E +     T +SDV+S+GV + E+++ G +P   + +    
Sbjct: 204 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263
Query: 484 SIFEWATPLVQ 494
           SI E    L Q
Sbjct: 264 SILEKGERLPQ 274

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 110
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 111 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 163
Query: 429 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 477
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 164 DENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 218

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 126
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 127 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 179
Query: 429 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 477
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 180 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 234

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 126
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 127 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 179
Query: 429 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 477
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 180 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 234

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++L     G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 9   LRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 125
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 126 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 494 Q 494
           Q
Sbjct: 240 Q 240

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 110
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 111 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 163
Query: 429 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 477
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 164 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 218

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 104/242 (42%), Gaps = 43/242 (17%)
Query: 262 ELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLK-RSSFQRKKEFYS 314
           +L+ I+ +       LG+ + G  Y G L           VA+K LK ++    ++EF  
Sbjct: 2   KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 61
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWL----HHIPRGGRSLDWAM 370
           E    ARL HPN+V + G         +++ +  +G L  +L     H   G    D  +
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 371 R--------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
           +        + +   +A G+ +L      HVVH+D+   NVL+ ++    +  +GL    
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF--- 175
Query: 423 PWEVMQERTVMAGGTYG----------YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GR 471
                  R V A   Y           ++APE +   + +  SD++S+GV+L E+ S G 
Sbjct: 176 -------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 228
Query: 472 RP 473
           +P
Sbjct: 229 QP 230

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/313 (22%), Positives = 129/313 (41%), Gaps = 75/313 (23%)
Query: 274 NRLLGDSKTGGTYSGIL-------PDGSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHP 325
           +R LG    G  Y G+        P+ +RVA+K +  ++  R++ EF +E       +  
Sbjct: 17  SRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR-------------M 372
           ++V + G         ++ E +  G L  +L       RSL   M              +
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-------RSLRPEMENNPVLAPPSLSKMI 128
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
           ++A  +A G+A+L+       VHRD+ A N ++ E+F   +   G+++    ++ +    
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 181
Query: 433 MAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE 487
             GG       +++PE +     TT SDV+SFGV+L EI +   +P Q + +        
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------- 233
Query: 488 WATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQK-------VVDLVYACTQHVPSMRPRM 540
                 Q  R+                  G++ K       + +L+  C Q+ P MRP  
Sbjct: 234 -----EQVLRF--------------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 274
Query: 541 SHVVHQLQQLAQP 553
             ++  +++  +P
Sbjct: 275 LEIISSIKEEMEP 287

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 70
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 127
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   G +K +  E  +      
Sbjct: 128 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 494 Q 494
           Q
Sbjct: 242 Q 242

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 52  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 106
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 107 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 159
Query: 429 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 477
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 70  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 124
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 125 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 177
Query: 429 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 477
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 178 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 232

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++L     G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 16  LRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 75
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 132
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 133 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 494 Q 494
           Q
Sbjct: 247 Q 247

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 50  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 104
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 105 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 157
Query: 429 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 477
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 158 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 212

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 116
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 117 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 169
Query: 429 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 477
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 125
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   G +K +  E  +      
Sbjct: 126 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 494 Q 494
           Q
Sbjct: 240 Q 240

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 414 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 468
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 469 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 521
Query: 429 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 477
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 70
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 127
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   G +K +  E  +      
Sbjct: 128 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 494 Q 494
           Q
Sbjct: 242 Q 242

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 415 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 469
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 470 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 522
Query: 429 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 477
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 523 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 577

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 8/191 (4%)
Query: 292 DGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFV 347
           DG  +  K L   S     K+   SE+     L HPN+V       D  +   YIV E+ 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP--HVVHRDIRASNVLL 405
             G L   +    +  + LD    ++V T L   +   H +      V+HRD++ +NV L
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
           D +    L   GL++ +  +  ++      GT  Y++PE + R     KSD++S G LL 
Sbjct: 150 DGKQNVKLGDFGLARILNHD--EDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207
Query: 466 EIVSGRRPAQA 476
           E+ +   P  A
Sbjct: 208 ELCALMPPFTA 218

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 18/241 (7%)
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 316
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 16  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 75
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 374
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 132
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              +A+G+ +L D+    +VHRD+ A NVL+       +   G +K +  E  +      
Sbjct: 133 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 494 Q 494
           Q
Sbjct: 247 Q 247

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 26/248 (10%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRK 309
           ++    ELR +        ++LG    G  Y GI +PDG  V    A+K L+  +S +  
Sbjct: 12  RILKETELRKV--------KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN 63
Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LD 367
           KE   E    A +  P +  + G C     + +         LD    +  R G    L+
Sbjct: 64  KEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLN 123
Query: 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427
           W M+      +A+G+++L D     +VHRD+ A NVL+       +   GL++ +  +  
Sbjct: 124 WCMQ------IAKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 174
Query: 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 486
           +           ++A E + R   T +SDV+S+GV + E+++ G +P   + +     + 
Sbjct: 175 EYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 234
Query: 487 EWATPLVQ 494
           E    L Q
Sbjct: 235 EKGERLPQ 242

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 93/206 (45%), Gaps = 10/206 (4%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G    
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 78
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                IV ++     L    HH+       +    + +A   A+G+ +LH K    ++HR
Sbjct: 79  KPQLAIVTQWCEGSSL---YHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHR 132
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTT 453
           D++++N+ L E+    +   GL+          +     G+  ++APE +     N  + 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 454 KSDVYSFGVLLLEIVSGRRPAQAVDS 479
           +SDVY+FG++L E+++G+ P   +++
Sbjct: 193 QSDVYAFGIVLYELMTGQLPYSNINN 218

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/313 (22%), Positives = 129/313 (41%), Gaps = 75/313 (23%)
Query: 274 NRLLGDSKTGGTYSGIL-------PDGSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHP 325
           +R LG    G  Y G+        P+ +RVA+K +  ++  R++ EF +E       +  
Sbjct: 17  SRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR-------------M 372
           ++V + G         ++ E +  G L  +L       RSL   M              +
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-------RSLRPEMENNPVLAPPSLSKMI 128
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
           ++A  +A G+A+L+       VHRD+ A N  + E+F   +   G+++    ++ +    
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR----DIYETDYY 181
Query: 433 MAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE 487
             GG       +++PE +     TT SDV+SFGV+L EI +   +P Q + +        
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------- 233
Query: 488 WATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQK-------VVDLVYACTQHVPSMRPRM 540
                 Q  R+                  G++ K       +++L+  C Q+ P MRP  
Sbjct: 234 -----EQVLRF--------------VMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSF 274
Query: 541 SHVVHQLQQLAQP 553
             ++  +++  +P
Sbjct: 275 LEIISSIKEEMEP 287

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 84/185 (45%), Gaps = 15/185 (8%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFY---SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
           +G   A+K LK+    R K+      E    + + HP ++ + G   D    +++ +++ 
Sbjct: 30  NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 89
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
            G L   L    R  +     +    A  +   + +LH K    +++RD++  N+LLD+ 
Sbjct: 90  GGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN 142
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
               +   G +K+VP     + T    GT  Y+APE V         D +SFG+L+ E++
Sbjct: 143 GHIKITDFGFAKYVP-----DVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 197
Query: 469 SGRRP 473
           +G  P
Sbjct: 198 AGYTP 202

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 293 GSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
           G+  A+K +K+SS            E+    +L HPN++ +     D  + Y+V E    
Sbjct: 29  GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRG 88
Query: 350 GPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
           G L D  +  + +    +D A+ MK   +   G  +LH   K ++VHRD++  N+LL+ +
Sbjct: 89  GELFDEII--LRQKFSEVDAAVIMKQVLS---GTTYLH---KHNIVHRDLKPENLLLESK 140
Query: 409 FGAHLMGV---GLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
               L+ +   GLS  F     M+ER     GT  Y+APE V R +   K DV+S GV+L
Sbjct: 141 SRDALIKIVDFGLSAHFEVGGKMKERL----GTAYYIAPE-VLRKKYDEKCDVWSCGVIL 195
Query: 465 LEIVSGRRP 473
             ++ G  P
Sbjct: 196 YILLCGYPP 204

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 44/201 (21%)
Query: 296 VAVKRL---KRSSFQRKKEFYSEIGRFARLHHPNLVAV-----KGCCYDHGDRYIVYEFV 347
           VAVK      + S+Q + E YS  G    + H N++       +G   D  D +++  F 
Sbjct: 50  VAVKIFPIQDKQSWQNEYEVYSLPG----MKHENILQFIGAEKRGTSVD-VDLWLITAFH 104
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-------KPHVVHRDIRA 400
             G L  +L         + W     +A T+A+G+A+LH+ +       KP + HRDI++
Sbjct: 105 EKGSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159
Query: 401 SNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYG------YLAPEFV-----YR 448
            NVLL     A +   GL+ KF       E    AG T+G      Y+APE +     ++
Sbjct: 160 KNVLLKNNLTACIADFGLALKF-------EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQ 212
Query: 449 NELTTKSDVYSFGVLLLEIVS 469
            +   + D+Y+ G++L E+ S
Sbjct: 213 RDAFLRIDMYAMGLVLWELAS 233

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           G   A+K +K+S   R     +EI    ++ H N+V ++         Y+V + V  G L
Sbjct: 34  GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93
Query: 353 -DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL-LDEEFG 410
            DR L    RG  +   A    V   +   + +LH+     +VHRD++  N+L L  E  
Sbjct: 94  FDRILE---RGVYTEKDASL--VIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEEN 145
Query: 411 AHLM--GVGLSKFVPWEVMQERTVM--AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
           + +M    GLSK      M++  +M  A GT GY+APE + +   +   D +S GV+   
Sbjct: 146 SKIMITDFGLSK------MEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYI 199
Query: 467 IVSGRRP-AQAVDSVCWQSI----FEWATPL 492
           ++ G  P  +  +S  ++ I    +E+ +P 
Sbjct: 200 LLCGYPPFYEETESKLFEKIKEGYYEFESPF 230

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 293 GSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
           G+  A+K +K+SS            E+    +L HPN++ +     D  + Y+V E    
Sbjct: 46  GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRG 105
Query: 350 GPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
           G L D  +  + +    +D A+ MK    +  G  +LH   K ++VHRD++  N+LL+ +
Sbjct: 106 GELFDEII--LRQKFSEVDAAVIMK---QVLSGTTYLH---KHNIVHRDLKPENLLLESK 157
Query: 409 FGAHLMGV---GLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
               L+ +   GLS  F     M+ER     GT  Y+APE V R +   K DV+S GV+L
Sbjct: 158 SRDALIKIVDFGLSAHFEVGGKMKERL----GTAYYIAPE-VLRKKYDEKCDVWSCGVIL 212
Query: 465 LEIVSGRRP 473
             ++ G  P
Sbjct: 213 YILLCGYPP 221

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
           +HP LV +  C       + V E+V  G L   + H+ R  +  +   R   A  ++  +
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 166
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK--FVPWEVMQERTVMAGGTYGY 440
            +LH++    +++RD++  NVLLD E    L   G+ K    P +     T    GT  Y
Sbjct: 167 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNY 219
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
           +APE +   +     D ++ GVL+ E+++GR P   V S
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
           +HP LV +  C       + V E+V  G L   + H+ R  +  +   R   A  ++  +
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 134
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK--FVPWEVMQERTVMAGGTYGY 440
            +LH++    +++RD++  NVLLD E    L   G+ K    P +     T    GT  Y
Sbjct: 135 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSXFCGTPNY 187
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
           +APE +   +     D ++ GVL+ E+++GR P   V S
Sbjct: 188 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 226

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G  Y 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YS 89
Query: 337 HGDRY-IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
              +  IV ++     L    HH+       +    + +A   A+G+ +LH K    ++H
Sbjct: 90  TAPQLAIVTQWCEGSSL---YHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIH 143
Query: 396 RDIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNEL 451
           RD++++N+ L E+    +   GL ++   W    +   ++G    ++APE +     N  
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDSNPY 202
Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
           + +SDVY+FG++L E+++G+ P   +++
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINN 230

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 94/190 (49%), Gaps = 14/190 (7%)
Query: 296 VAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK L  +  + Q+ + F +E+G   +  H N++   G         IV ++     L 
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSL- 106
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
              HH+       +    + +A   A+G+ +LH K    ++HRD++++N+ L E+    +
Sbjct: 107 --YHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKI 161
Query: 414 MGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVS 469
              GL ++   W    +   ++G    ++APE +     N  + +SDVY+FG++L E+++
Sbjct: 162 GDFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220
Query: 470 GRRPAQAVDS 479
           G+ P   +++
Sbjct: 221 GQLPYSNINN 230

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 14/185 (7%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 352
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 353 DRWL-----HHIPRGGRSLDWAMR---MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +L       +P      D+      +  +  +A+G+ FL  +     +HRD+ A N+L
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARNIL 176
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
           L E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SFGVLL
Sbjct: 177 LSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 465 LEIVS 469
            EI S
Sbjct: 237 WEIFS 241

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/206 (21%), Positives = 93/206 (45%), Gaps = 10/206 (4%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           +G    G  Y G       V + ++   + ++ + F +E+    +  H N++   G    
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM-T 102
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
             +  IV ++     L + LH              + +A   AQG+ +LH K   +++HR
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLH---VQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHR 156
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTT 453
           D++++N+ L E     +   GL+         ++     G+  ++APE +     N  + 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 454 KSDVYSFGVLLLEIVSGRRPAQAVDS 479
           +SDVYS+G++L E+++G  P   +++
Sbjct: 217 QSDVYSYGIVLYELMTGELPYSHINN 242

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 16/187 (8%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 352
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 353 DRWL-----HHIPRGGRSL--DWAMR---MKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
             +L       +P     L  D+      +  +  +A+G+ FL  +     +HRD+ A N
Sbjct: 122 STYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARN 178
Query: 403 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
           +LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SFGV
Sbjct: 179 ILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 463 LLLEIVS 469
           LL EI S
Sbjct: 239 LLWEIFS 245

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
           +HP LV +  C       + V E+V  G L   + H+ R  +  +   R   A  ++  +
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 119
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK--FVPWEVMQERTVMAGGTYGY 440
            +LH++    +++RD++  NVLLD E    L   G+ K    P +     T    GT  Y
Sbjct: 120 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSXFCGTPNY 172
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
           +APE +   +     D ++ GVL+ E+++GR P   V S
Sbjct: 173 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 211

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 110/272 (40%), Gaps = 41/272 (15%)
Query: 275 RLLGDSKTGGTY-SGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
           R +G    G  Y +  + +   VA+K++  S  Q     ++   E+    +L HPN +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
           +GC       ++V E+ +    D    H     + L       V     QG+A+LH    
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH-- 173
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY--- 447
            +++HRD++A N+LL E  G     V L  F    +M       G  Y ++APE +    
Sbjct: 174 -NMIHRDVKAGNILLSEP-GL----VKLGDFGSASIMAPANXFVGTPY-WMAPEVILAMD 226
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYXXXXXXXX 506
             +   K DV+S G+  +E+   + P   ++++     I +  +P +QS  +        
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS------- 279
Query: 507 XXXXXXXXXAGVVQKVVDLVYACTQHVPSMRP 538
                        +   + V +C Q +P  RP
Sbjct: 280 -------------EYFRNFVDSCLQKIPQDRP 298

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 13/159 (8%)
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
           +HP LV +  C       + V E+V  G L   + H+ R  R L        +  ++  +
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQ-RKLPEEHARFYSAEISLAL 123
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGY 440
            +LH++    +++RD++  NVLLD E    L   G+ K    E ++  + T    GT  Y
Sbjct: 124 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTSXFCGTPNY 176
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
           +APE +   +     D ++ GVL+ E+++GR P   V S
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 15/194 (7%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY-IVYEFVVNGPL 352
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 353 DRWL-----HHIPRGGRSLDWAMRMKV---ATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +L       +P      D+     +   +  +A+G+ FL  +     +HRD+ A N+L
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASR---KXIHRDLAARNIL 176
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
           L E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SFGVLL
Sbjct: 177 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 465 LEIVS-GRRPAQAV 477
            EI S G  P   V
Sbjct: 237 WEIFSLGASPYPGV 250

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 12/136 (8%)
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           +V   +  G L   ++H+ + G     A  +  A  +  G+  LH   +  +V+RD++  
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEICCGLEDLH---RERIVYRDLKPE 315
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYS 459
           N+LLD+     +  +GL+  VP     E   + G  GT GY+APE V     T   D ++
Sbjct: 316 NILLDDHGHIRISDLGLAVHVP-----EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 370
Query: 460 FGVLLLEIVSGRRPAQ 475
            G LL E+++G+ P Q
Sbjct: 371 LGCLLYEMIAGQSPFQ 386

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/291 (21%), Positives = 119/291 (40%), Gaps = 42/291 (14%)
Query: 275 RLLGDSKTGGTY-SGILPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAV 330
           R +G    G  Y +  + +   VA+K++    + S ++ ++   E+    +L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
           +GC       ++V E+ +    D    H     + L       V     QG+A+LH    
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH-- 134
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY--- 447
            +++HRD++A N+LL E  G     V L  F    +M       G  Y ++APE +    
Sbjct: 135 -NMIHRDVKAGNILLSEP-GL----VKLGDFGSASIMAPANXFVGTPY-WMAPEVILAMD 187
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYXXXXXXXX 506
             +   K DV+S G+  +E+   + P   ++++     I +  +P +QS  +        
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS------- 240
Query: 507 XXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQLQQLAQPPVT 556
                        +   + V +C Q +P  RP    ++ H+     +PP  
Sbjct: 241 -------------EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 13/120 (10%)
Query: 362 GGRSLDWAM-----RMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
           GG +LD          ++AT L +   G+ +LH + K   +HRDI+A+NVLL E+    L
Sbjct: 105 GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKL 161
Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
              G++  +    ++  T +  GT  ++APE + ++   +K+D++S G+  +E+  G  P
Sbjct: 162 ADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 273 GNRLLGDSKTGGTYSGI-----LPDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHH 324
           G+ +LGD+   GT+  +        G +VAVK L R    S     +   EI       H
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
           P+++ +        D ++V E+V  G L     +I + GR  +   R ++   +   + +
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGEL---FDYICKHGRVEEMEAR-RLFQQILSAVDY 126
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAP 443
            H  +   VVHRD++  NVLLD    A +   GLS  +   E +++    + G+  Y AP
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRD----SCGSPNYAAP 179
Query: 444 EFVY-RNELTTKSDVYSFGVLLLEIVSGRRP 473
           E +  R     + D++S GV+L  ++ G  P
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSE--IGRFARLHHPNL----VA 329
           L+G  + G  Y G L D   VAVK     SF  ++ F +E  I R   + H N+    V 
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 330 VKGCCYDHGDRYI-VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-- 386
            +    D    Y+ V E+  NG L ++L        + DW    ++A ++ +G+A+LH  
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 387 ----DKVKPHVVHRDIRASNVLLDE-------EFGAHLMGVGLSKFVPWEVMQERTVMAG 435
               D  KP + HRD+ + NVL+         +FG  +   G     P E      +   
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE-EDNAAISEV 189
Query: 436 GTYGYLAPEFV-----YRNELTT--KSDVYSFGVLLLEI 467
           GT  Y+APE +      R+  +   + D+Y+ G++  EI
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 74/158 (46%), Gaps = 5/158 (3%)
Query: 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
            A++H   +V++        D  +V   +  G +   ++++            +     +
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
             G+  LH +   ++++RD++  NVLLD++    +  +GL+  V  +  Q +T    GT 
Sbjct: 299 VSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTP 353
Query: 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           G++APE +   E     D ++ GV L E+++ R P +A
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 74/158 (46%), Gaps = 5/158 (3%)
Query: 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
            A++H   +V++        D  +V   +  G +   ++++            +     +
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
             G+  LH +   ++++RD++  NVLLD++    +  +GL+  V  +  Q +T    GT 
Sbjct: 299 VSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTP 353
Query: 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           G++APE +   E     D ++ GV L E+++ R P +A
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 12/136 (8%)
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           +V   +  G L   ++H+ + G     A  +  A  +  G+  LH   +  +V+RD++  
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEICCGLEDLH---RERIVYRDLKPE 315
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYS 459
           N+LLD+     +  +GL+  VP     E   + G  GT GY+APE V     T   D ++
Sbjct: 316 NILLDDHGHIRISDLGLAVHVP-----EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 370
Query: 460 FGVLLLEIVSGRRPAQ 475
            G LL E+++G+ P Q
Sbjct: 371 LGCLLYEMIAGQSPFQ 386

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           +++G+   G  +   L +   VA+K++ +    + +E   +I R  +  HPN+V +K   
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNREL--QIMRIVK--HPNVVDLKAFF 101
Query: 335 YDHGDRY------IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
           Y +GD+       +V E+V    + R   H  +  +++   +       L + +A++H  
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 389 VKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
               + HRDI+  N+LLD   G   L+  G +K +   +  E  V    +  Y APE ++
Sbjct: 161 ---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL---IAGEPNVSXICSRYYRAPELIF 214
Query: 448 -RNELTTKSDVYSFGVLLLEIVSGR 471
                TT  D++S G ++ E++ G+
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 92/192 (47%), Gaps = 19/192 (9%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYS-EIGRFARLHHPNLVAVKGC------CYDHGDRYIVYE 345
           G +VA+K+ ++    + +E +  EI    +L+HPN+V+ +           +    +  E
Sbjct: 40  GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 99
Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
           +   G L ++L+         +  +R  + + ++  + +LH+     ++HRD++  N++L
Sbjct: 100 YCEGGDLRKYLNQFENCCGLKEGPIRT-LLSDISSALRYLHEN---RIIHRDLKPENIVL 155
Query: 406 D---EEFGAHLMGVGLSKFVPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
               +     ++ +G +K    E+ Q E      GT  YLAPE + + + T   D +SFG
Sbjct: 156 QPGPQRLIHKIIDLGYAK----ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 211
Query: 462 VLLLEIVSGRRP 473
            L  E ++G RP
Sbjct: 212 TLAFECITGFRP 223

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 74/158 (46%), Gaps = 5/158 (3%)
Query: 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
            A++H   +V++        D  +V   +  G +   ++++            +     +
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
             G+  LH +   ++++RD++  NVLLD++    +  +GL+  V  +  Q +T    GT 
Sbjct: 299 VSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTP 353
Query: 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           G++APE +   E     D ++ GV L E+++ R P +A
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 74/158 (46%), Gaps = 5/158 (3%)
Query: 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
            A++H   +V++        D  +V   +  G +   ++++            +     +
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
             G+  LH +   ++++RD++  NVLLD++    +  +GL+  V  +  Q +T    GT 
Sbjct: 299 VSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTP 353
Query: 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
           G++APE +   E     D ++ GV L E+++ R P +A
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 92/192 (47%), Gaps = 19/192 (9%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYS-EIGRFARLHHPNLVAVKGC------CYDHGDRYIVYE 345
           G +VA+K+ ++    + +E +  EI    +L+HPN+V+ +           +    +  E
Sbjct: 39  GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98
Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
           +   G L ++L+         +  +R  + + ++  + +LH+     ++HRD++  N++L
Sbjct: 99  YCEGGDLRKYLNQFENCCGLKEGPIRT-LLSDISSALRYLHEN---RIIHRDLKPENIVL 154
Query: 406 D---EEFGAHLMGVGLSKFVPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
               +     ++ +G +K    E+ Q E      GT  YLAPE + + + T   D +SFG
Sbjct: 155 QPGPQRLIHKIIDLGYAK----ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 210
Query: 462 VLLLEIVSGRRP 473
            L  E ++G RP
Sbjct: 211 TLAFECITGFRP 222

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 293 GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVVNG 350
           G  +AVK+++RS + +  K    ++    + H  P +V   G    + D +I  E +  G
Sbjct: 50  GHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--G 107
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
                L    +G        +M VA  + + + +L  K K  V+HRD++ SN+LLDE   
Sbjct: 108 TCAEKLKKRMQGPIPERILGKMTVA--IVKALYYL--KEKHGVIHRDVKPSNILLDERGQ 163
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV-----YRNELTTKSDVYSFGVLLL 465
             L   G+S  +  +  ++R+    G   Y+APE +      + +   ++DV+S G+ L+
Sbjct: 164 IKLCDFGISGRLVDDKAKDRSA---GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLV 220
Query: 466 EIVSGRRPAQ--AVDSVCWQSIFEWATPLVQSH 496
           E+ +G+ P +    D      + +   PL+  H
Sbjct: 221 ELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH 253

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 273 GNRLLGDSKTGGTYSGI-----LPDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHH 324
           G+ +LGD+   GT+  +        G +VAVK L R    S     +   EI       H
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
           P+++ +        D ++V E+V  G L     +I + GR  +   R ++   +   + +
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGEL---FDYICKHGRVEEMEAR-RLFQQILSAVDY 126
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
            H  +   VVHRD++  NVLLD    A +   GLS  +      E    + G+  Y APE
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRTSCGSPNYAAPE 180
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGRRP 473
            +  R     + D++S GV+L  ++ G  P
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 272 EGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYS---EIGRFARLH 323
           +G R+LG     G++  ++       G   AVK + +   ++K +  S   E+    +L 
Sbjct: 29  KGQRVLG----KGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HPN++ +     D G  Y+V E    G L  +   I R   S   A R  +   +  GI 
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAAR--IIRQVLSGIT 140
Query: 384 FLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYG 439
           ++H   K  +VHRD++  N+LL+   ++    ++  GLS  F   + M+++     GT  
Sbjct: 141 YMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI----GTAY 193
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
           Y+APE V       K DV+S GV+L  ++SG
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLAGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 352
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 353 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 400
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 461 GVLLLEIVS 469
           GVLL EI S
Sbjct: 237 GVLLWEIFS 245

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 15/185 (8%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           G ++A K +K    + K+E  +EI    +L H NL+ +        D  +V E+V  G L
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
Query: 353 -DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
            DR +         LD  + MK    + +GI  +H   + +++H D++  N+L       
Sbjct: 174 FDRIIDE-SYNLTELDTILFMK---QICEGIRHMH---QMYILHLDLKPENILCVNRDAK 226
Query: 412 H--LMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
              ++  GL+ ++ P    +E+  +  GT  +LAPE V  + ++  +D++S GV+   ++
Sbjct: 227 QIKIIDFGLARRYKP----REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
Query: 469 SGRRP 473
           SG  P
Sbjct: 283 SGLSP 287

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLD 367
           ++ Y EI    +L HPN+V +     D  +   Y+V+E V  GP+       P       
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEV 426
           +  +      L +GI +LH +    ++HRDI+ SN+L+ E+    +   G+S +F   + 
Sbjct: 141 FYFQ-----DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 427 MQERTVMAGGTYGYLAPEFV--YRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQ 483
           +   TV   GT  ++APE +   R   + K+ DV++ GV L   V G+ P      +C  
Sbjct: 193 LLSNTV---GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249
Query: 484 S 484
           S
Sbjct: 250 S 250

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 140
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+DE+    +   G +K V     + RT    GT  YL
Sbjct: 141 FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 192
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 25/192 (13%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY-IVYEFVVNGPL 352
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 61  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 120
Query: 353 DRWLHHIPRGGRS---------------LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
             +L    R  R+               L     +  +  +A+G+ FL  +     +HRD
Sbjct: 121 STYL----RSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
           + A N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 458 YSFGVLLLEIVS 469
           +SFGVLL EI S
Sbjct: 234 WSFGVLLWEIFS 245

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 40/193 (20%)
Query: 297 AVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           AVK + +S    K++   EI    R   HPN++ +K    D    Y+V E +        
Sbjct: 56  AVKVIDKS----KRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELM-------- 103
Query: 356 LHHIPRGGRSLDWAMRMK---------VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
                RGG  LD  +R K         V  T+ + + +LH +    VVHRD++ SN+L  
Sbjct: 104 -----RGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ---GVVHRDLKPSNILYV 155
Query: 407 EEFG----AHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSF 460
           +E G      +   G +K    ++  E  ++    Y   ++APE + R       D++S 
Sbjct: 156 DESGNPECLRICDFGFAK----QLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSL 211
Query: 461 GVLLLEIVSGRRP 473
           G+LL  +++G  P
Sbjct: 212 GILLYTMLAGYTP 224

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 40/193 (20%)
Query: 297 AVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           AVK + +S    K++   EI    R   HPN++ +K    D    Y+V E +        
Sbjct: 56  AVKVIDKS----KRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELM-------- 103
Query: 356 LHHIPRGGRSLDWAMRMK---------VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
                RGG  LD  +R K         V  T+ + + +LH +    VVHRD++ SN+L  
Sbjct: 104 -----RGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ---GVVHRDLKPSNILYV 155
Query: 407 EEFG----AHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSF 460
           +E G      +   G +K    ++  E  ++    Y   ++APE + R       D++S 
Sbjct: 156 DESGNPECLRICDFGFAK----QLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSL 211
Query: 461 GVLLLEIVSGRRP 473
           G+LL  +++G  P
Sbjct: 212 GILLYTMLAGYTP 224

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 272 EGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYS---EIGRFARLH 323
           +G R+LG     G++  ++       G   AVK + +   ++K +  S   E+    +L 
Sbjct: 35  KGQRVLGK----GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HPN++ +     D G  Y+V E    G L  +   I R   S   A R  +   +  GI 
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAAR--IIRQVLSGIT 146
Query: 384 FLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYG 439
           ++H   K  +VHRD++  N+LL+   ++    ++  GLS  F   + M+++     GT  
Sbjct: 147 YMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI----GTAY 199
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           Y+APE V       K DV+S GV+L  ++SG  P
Sbjct: 200 YIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 232

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 114/277 (41%), Gaps = 51/277 (18%)
Query: 296 VAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK S+   ++E   SE+   + L +H N+V + G C   G   ++ E+   G L 
Sbjct: 56  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115
Query: 354 RWLHH--------------IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
            +L                +     +LD    +  +  +A+G+AFL  K   + +HRD+ 
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 172
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKS 455
           A N+LL       +   GL++    ++  +   +  G       ++APE ++    T +S
Sbjct: 173 ARNILLTHGRITKICDFGLAR----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 228
Query: 456 DVYSFGVLLLEIV---SGRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           DV+S+G+ L E+    S   P   VDS  ++ I E    L   H                
Sbjct: 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH---------------- 272
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
                   ++ D++  C    P  RP    +V  +++
Sbjct: 273 -----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 114/277 (41%), Gaps = 51/277 (18%)
Query: 296 VAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK S+   ++E   SE+   + L +H N+V + G C   G   ++ E+   G L 
Sbjct: 72  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 131
Query: 354 RWLHH--------------IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
            +L                +     +LD    +  +  +A+G+AFL  K   + +HRD+ 
Sbjct: 132 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 188
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKS 455
           A N+LL       +   GL++    ++  +   +  G       ++APE ++    T +S
Sbjct: 189 ARNILLTHGRITKICDFGLAR----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 244
Query: 456 DVYSFGVLLLEIV---SGRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           DV+S+G+ L E+    S   P   VDS  ++ I E    L   H                
Sbjct: 245 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH---------------- 288
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
                   ++ D++  C    P  RP    +V  +++
Sbjct: 289 -----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 320

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 15/214 (7%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQRK---KEFYSEIGRF 319
           R  T +  +  R LG  K G  Y         + A+K L +S  +++    +   EI   
Sbjct: 10  RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQ 69
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           + L HPN++ +    +D    Y++ EF   G L + L    + GR  D          LA
Sbjct: 70  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ---KHGR-FDEQRSATFMEELA 125
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
             + + H++    V+HRDI+  N+L+  +    +   G S   P      R     GT  
Sbjct: 126 DALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRXMCGTLD 178
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           YL PE +       K D++  GVL  E + G  P
Sbjct: 179 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 212

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 21/188 (11%)
Query: 293 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           G  VAVK     +L  SS Q+    + E+     L+HPN+V +          Y+V E+ 
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQK---LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYA 95
Query: 348 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
             G + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD
Sbjct: 96  SGGEVFDYLVAH----GRMKEKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLD 147
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLL 465
            +    +   G S    +     +     G+  Y APE F  +     + DV+S GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTF---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 466 EIVSGRRP 473
            +VSG  P
Sbjct: 205 TLVSGSLP 212

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY-EFVVNGPL 352
           VAVK LK  ++    +   SE+     + HH N+V + G C   G   +V  EF   G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 353 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 400
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 461 GVLLLEIVS 469
           GVLL EI S
Sbjct: 228 GVLLWEIFS 236

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 52/301 (17%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSR-VAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVA 329
           G    G       Y  I  D +  VAVK LK S+   ++E   SE+   + L +H N+V 
Sbjct: 50  GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 109
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHH--------------IPRGGRSLDWAMRMKVA 375
           + G C   G   ++ E+   G L  +L                +     +LD    +  +
Sbjct: 110 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 169
Query: 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435
             +A+G+AFL  K   + +HRD+ A N+LL       +   GL++    ++  +   +  
Sbjct: 170 YQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSNYVVK 222
Query: 436 GT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIV---SGRRPAQAVDSVCWQSIFEW 488
           G       ++APE ++    T +SDV+S+G+ L E+    S   P   VDS  ++ I E 
Sbjct: 223 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 282
Query: 489 ATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
              L   H                        ++ D++  C    P  RP    +V  ++
Sbjct: 283 FRMLSPEH---------------------APAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321
Query: 549 Q 549
           +
Sbjct: 322 K 322

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 19/185 (10%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYS---EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
           G   AVK + +   ++K +  S   E+    +L HPN++ +     D G  Y+V E    
Sbjct: 74  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 133
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--- 406
           G L  +   I R   S   A R  +   +  GI ++H   K  +VHRD++  N+LL+   
Sbjct: 134 GEL--FDEIISRKRFSEVDAAR--IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKS 186
Query: 407 EEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
           ++    ++  GLS  F   + M+++     GT  Y+APE V       K DV+S GV+L 
Sbjct: 187 KDANIRIIDFGLSTHFEASKKMKDKI----GTAYYIAPE-VLHGTYDEKCDVWSTGVILY 241
Query: 466 EIVSG 470
            ++SG
Sbjct: 242 ILLSG 246

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY-IVYEFVVNGPL 352
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 110
Query: 353 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 400
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 461 GVLLLEIVS 469
           GVLL EI S
Sbjct: 228 GVLLWEIFS 236

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 21/188 (11%)
Query: 293 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           G  VAVK     +L  SS Q+    + E+     L+HPN+V +          Y+V E+ 
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQK---LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYA 95
Query: 348 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
             G + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD
Sbjct: 96  SGGEVFDYLVAH----GRMKEKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLD 147
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLL 465
            +    +   G S    +     +     G+  Y APE F  +     + DV+S GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTF---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 466 EIVSGRRP 473
            +VSG  P
Sbjct: 205 TLVSGSLP 212

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLXGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/169 (22%), Positives = 82/169 (48%), Gaps = 9/169 (5%)
Query: 307 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 366
            +K++  +EI     L +P++V   G   D    Y+V E        R L  + +  +++
Sbjct: 84  HQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRR----RSLLELHKRRKAV 139
Query: 367 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426
                        QG+ +LH+     V+HRD++  N+ L+++    +   GL+  + ++ 
Sbjct: 140 TEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG 196
Query: 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQ 475
            +++T+   GT  Y+APE + +   + + D++S G +L  ++ G+ P +
Sbjct: 197 ERKKTLC--GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 114/277 (41%), Gaps = 51/277 (18%)
Query: 296 VAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK S+   ++E   SE+   + L +H N+V + G C   G   ++ E+   G L 
Sbjct: 79  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 354 RWLHH--------------IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
            +L                +     +LD    +  +  +A+G+AFL  K   + +HRD+ 
Sbjct: 139 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 195
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKS 455
           A N+LL       +   GL++    ++  +   +  G       ++APE ++    T +S
Sbjct: 196 ARNILLTHGRITKICDFGLAR----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 251
Query: 456 DVYSFGVLLLEIV---SGRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 512
           DV+S+G+ L E+    S   P   VDS  ++ I E    L   H                
Sbjct: 252 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH---------------- 295
Query: 513 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
                   ++ D++  C    P  RP    +V  +++
Sbjct: 296 -----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 148
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 149 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 200
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 19/185 (10%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYS---EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
           G   AVK + +   ++K +  S   E+    +L HPN++ +     D G  Y+V E    
Sbjct: 75  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 134
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--- 406
           G L  +   I R   S   A R  +   +  GI ++H   K  +VHRD++  N+LL+   
Sbjct: 135 GEL--FDEIISRKRFSEVDAAR--IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKS 187
Query: 407 EEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
           ++    ++  GLS  F   + M+++     GT  Y+APE V       K DV+S GV+L 
Sbjct: 188 KDANIRIIDFGLSTHFEASKKMKDKI----GTAYYIAPE-VLHGTYDEKCDVWSTGVILY 242
Query: 466 EIVSG 470
            ++SG
Sbjct: 243 ILLSG 247

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 23/189 (12%)
Query: 293 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           G  VAV+     +L  SS Q+    + E+     L+HPN+V +          Y+V E+ 
Sbjct: 39  GKEVAVRIIDKTQLNSSSLQK---LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYA 95
Query: 348 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
             G + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD
Sbjct: 96  SGGEVFDYLVAH----GRMKEKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLD 147
Query: 407 EEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLL 464
            +    +   G S +F     + E      G+  Y APE F  +     + DV+S GV+L
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDEFC----GSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 465 LEIVSGRRP 473
             +VSG  P
Sbjct: 204 YTLVSGSLP 212

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HP L  +        + + V E++  G L   ++HI +     D +     A  +  G+ 
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHI-QSCHKFDLSRATFYAAEIILGLQ 132
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--QERTVMAGGTYGYL 441
           FLH K    +V+RD++  N+LLD++    +   G+ K    E M    +T    GT  Y+
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK----ENMLGDAKTNXFCGTPDYI 185
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
           APE +   +     D +SFGVLL E++ G+ P    D 
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 352
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 353 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 400
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 122 STYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 178
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 179 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 238
Query: 461 GVLLLEIVS 469
           GVLL EI S
Sbjct: 239 GVLLWEIFS 247

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY-IVYEFVVNGPL 352
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 353 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 400
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 461 GVLLLEIVS 469
           GVLL EI S
Sbjct: 237 GVLLWEIFS 245

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 112/273 (41%), Gaps = 43/273 (15%)
Query: 296 VAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           VAVK LK S+   ++E   SE+   + L +H N+V + G C   G   ++ E+   G L 
Sbjct: 79  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 354 RWLHH--------------IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
            +L                +     +LD    +  +  +A+G+AFL  K   + +HRD+ 
Sbjct: 139 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 195
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
           A N+LL       +   GL++ +  +        A     ++APE ++    T +SDV+S
Sbjct: 196 ARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 255
Query: 460 FGVLLLEIV---SGRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 516
           +G+ L E+    S   P   VDS  ++ I E    L   H                    
Sbjct: 256 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH-------------------- 295
Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
               ++ D++  C    P  RP    +V  +++
Sbjct: 296 -APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 10/160 (6%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
            EI   ++   P +    G        +I+ E++  G     L   P     LD      
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIAT 108
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
           +   + +G+ +LH + K   +HRDI+A+NVLL E     L   G++  +    ++  T +
Sbjct: 109 ILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 165
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
             GT  ++APE + ++   +K+D++S G+  +E+  G  P
Sbjct: 166 --GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 174
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 226
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFAEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 79/169 (46%), Gaps = 9/169 (5%)
Query: 307 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 366
            +K++  +EI     L +P++V   G   D    Y+V E        R L  + +  +++
Sbjct: 84  HQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRR----RSLLELHKRRKAV 139
Query: 367 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426
                        QG+ +LH+     V+HRD++  N+ L+++    +   GL+  + ++ 
Sbjct: 140 TEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD- 195
Query: 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQ 475
             ER     GT  Y+APE + +   + + D++S G +L  ++ G+ P +
Sbjct: 196 -GERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 21/188 (11%)
Query: 293 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           G  VAVK     +L  SS Q+    + E+     L+HPN+V +          Y+V E+ 
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQK---LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYA 95
Query: 348 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
             G + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD
Sbjct: 96  SGGEVFDYLVAH----GRMKEKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLD 147
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLL 465
            +    +   G S    +     +     G   Y APE F  +     + DV+S GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTF---GNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 466 EIVSGRRP 473
            +VSG  P
Sbjct: 205 TLVSGSLP 212

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 15/185 (8%)
Query: 293 GSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           G  VAVK + ++       ++ + E+     L+HPN+V +          Y+V E+   G
Sbjct: 40  GREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGG 99
Query: 351 PL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
            + D  + H    GR  +   R K    ++  + + H K   ++VHRD++A N+LLD + 
Sbjct: 100 EVFDYLVAH----GRMKEKEARAKFRQIVS-AVQYCHQK---YIVHRDLKAENLLLDGDM 151
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLLEIV 468
              +   G S    + V  +     G    Y APE F  +     + DV+S GV+L  +V
Sbjct: 152 NIKIADFGFSN--EFTVGNKLDTFCGSP-PYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208
Query: 469 SGRRP 473
           SG  P
Sbjct: 209 SGSLP 213

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI   ++   P +    G        +I+ E++  G     L   P     LD      +
Sbjct: 75  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATI 129
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              + +G+ +LH + K   +HRDI+A+NVLL E     L   G++  +    ++  T + 
Sbjct: 130 LREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV- 185
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
            GT  ++APE + ++   +K+D++S G+  +E+  G  P
Sbjct: 186 -GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY-IVYEFVVNGPL 352
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 353 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 400
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 461 GVLLLEIVS 469
           GVLL EI S
Sbjct: 237 GVLLWEIFS 245

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HP L  +        + + V E++  G L   ++HI +     D +     A  +  G+ 
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHI-QSCHKFDLSRATFYAAEIILGLQ 133
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--QERTVMAGGTYGYL 441
           FLH K    +V+RD++  N+LLD++    +   G+ K    E M    +T    GT  Y+
Sbjct: 134 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK----ENMLGDAKTNEFCGTPDYI 186
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
           APE +   +     D +SFGVLL E++ G+ P    D 
Sbjct: 187 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 224

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 12/159 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV 480
           APE +         D ++ GVL+ E+ +G  P  A + +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPI 244

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY-EFVVNGPL 352
           VAVK LK  ++    +   SE+     + HH N+V + G C   G   +V  EF   G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 353 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 400
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 461 GVLLLEIVS 469
           GVLL EI S
Sbjct: 228 GVLLWEIFS 236

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 84/203 (41%), Gaps = 15/203 (7%)
Query: 275 RLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
           R LG  K G  Y         + A+K L +S  +++    +   EI   + L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
               +D    Y++ EF   G L + L    + GR  D          LA  + + H++  
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQ---KHGR-FDEQRSATFMEELADALHYCHER-- 133
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
             V+HRDI+  N+L+  +    +   G S   P      R     GT  YL PE +    
Sbjct: 134 -KVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRXMCGTLDYLPPEMIEGKT 188
Query: 451 LTTKSDVYSFGVLLLEIVSGRRP 473
              K D++  GVL  E + G  P
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPP 211

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 52  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 104
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
           D+ + Y+V E+V  G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 105 DNSNLYMVMEYVPGGEM---FSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS---LDLIY 157
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
           RD++  N+L+D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 158 RDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAV 212
Query: 456 DVYSFGVLLLEIVSGRRP 473
           D ++ GVL+ E+ +G  P
Sbjct: 213 DWWALGVLIYEMAAGYPP 230

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 26/161 (16%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HPN++ +K     +   ++V++ +  G L  +L        +L      K+   L + I 
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVIC 125
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLA 442
            LH   K ++VHRD++  N+LLD++    L   G S +  P E ++E      GT  YLA
Sbjct: 126 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE----VCGTPSYLA 178
Query: 443 PEFV----------YRNELTTKSDVYSFGVLLLEIVSGRRP 473
           PE +          Y  E+    D++S GV++  +++G  P
Sbjct: 179 PEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 215

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 75/176 (42%), Gaps = 9/176 (5%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
            EI   A L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R  
Sbjct: 54  KEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF- 110
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
               L  G+ +LH      + HRDI+  N+LLDE     +   GL+    +   +     
Sbjct: 111 -FHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 434 AGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
             GT  Y+APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/297 (22%), Positives = 125/297 (42%), Gaps = 51/297 (17%)
Query: 269 NFSEGNRL--LGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHH 324
           +F + N L  L ++ +G  + G    G+ + VK LK    S ++ ++F  E  R     H
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 325 PNLVAVKGCCYDHGDRY--IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
           PN++ V G C      +  ++  ++  G L   LH        +D +  +K A  +A+G+
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGM 124
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAH--LMGVGLSKFVPWEVMQERTVMAGGTY-- 438
           AFLH  ++P +    + + +V++DE+  A   +  V  S   P           G  Y  
Sbjct: 125 AFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----------GRMYAP 172
Query: 439 GYLAPEFVYRNELTTK---SDVYSFGVLLLEIVSGRRPAQAVDS--VCWQSIFEWATPLV 493
            ++APE + +    T    +D++SF VLL E+V+   P   + +  +  +   E   P +
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232
Query: 494 QSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
                                  G+   V  L+  C    P+ RP+   +V  L+++
Sbjct: 233 P---------------------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY-IVYEFVVNGPL 352
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156
Query: 353 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 400
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 213
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273
Query: 461 GVLLLEIVS 469
           GVLL EI S
Sbjct: 274 GVLLWEIFS 282

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 154
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 206
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 21/188 (11%)
Query: 293 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           G  VAV+     +L  SS Q+    + E+     L+HPN+V +          Y+V E+ 
Sbjct: 39  GKEVAVRIIDKTQLNSSSLQK---LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYA 95
Query: 348 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
             G + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD
Sbjct: 96  SGGEVFDYLVAH----GRMKEKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLD 147
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLL 465
            +    +   G S    +     +     G+  Y APE F  +     + DV+S GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTF---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 466 EIVSGRRP 473
            +VSG  P
Sbjct: 205 TLVSGSLP 212

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 296 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY-EFVVNGPL 352
           VAVK LK  ++    +   SE+     + HH N+V + G C   G   +V  EF   G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 353 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 400
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 461 GVLLLEIVS 469
           GVLL EI S
Sbjct: 228 GVLLWEIFS 236

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 26/161 (16%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HPN++ +K     +   ++V++ +  G L  +L        +L      K+   L + I 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVIC 138
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLA 442
            LH   K ++VHRD++  N+LLD++    L   G S +  P E ++E      GT  YLA
Sbjct: 139 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE----VCGTPSYLA 191
Query: 443 PEFV----------YRNELTTKSDVYSFGVLLLEIVSGRRP 473
           PE +          Y  E+    D++S GV++  +++G  P
Sbjct: 192 PEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 79/169 (46%), Gaps = 9/169 (5%)
Query: 307 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 366
            +K++  +EI     L +P++V   G   D    Y+V E        R L  + +  +++
Sbjct: 84  HQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRR----RSLLELHKRRKAV 139
Query: 367 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426
                        QG+ +LH+     V+HRD++  N+ L+++    +   GL+  + ++ 
Sbjct: 140 TEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD- 195
Query: 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQ 475
             ER     GT  Y+APE + +   + + D++S G +L  ++ G+ P +
Sbjct: 196 -GERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 102/223 (45%), Gaps = 27/223 (12%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAV--------KRLKRSSF 306
           ++F   ELR +        ++LG    G  + G+ +P+G  + +         +  R SF
Sbjct: 26  RIFKETELRKL--------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 77
Query: 307 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 366
           Q   +    IG    L H ++V + G C       +V +++   PL   L H+ +   +L
Sbjct: 78  QAVTDHMLAIGS---LDHAHIVRLLGLC-PGSSLQLVTQYL---PLGSLLDHVRQHRGAL 130
Query: 367 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426
              + +     +A+G+ +L +     +VHR++ A NVLL       +   G++  +P + 
Sbjct: 131 GPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 187
Query: 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
            Q     A     ++A E ++  + T +SDV+S+GV + E+++
Sbjct: 188 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 21/188 (11%)
Query: 293 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           G  VAVK     +L  SS Q+    + E+     L+HPN+V +          Y+V E+ 
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQK---LFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYA 95
Query: 348 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
             G + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD
Sbjct: 96  SGGEVFDYLVAH----GRXKEKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLD 147
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLL 465
            +    +   G S    +     +     G   Y APE F  +     + DV+S GV+L 
Sbjct: 148 ADXNIKIADFGFSNEFTF---GNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 466 EIVSGRRP 473
            +VSG  P
Sbjct: 205 TLVSGSLP 212

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 102/223 (45%), Gaps = 27/223 (12%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAV--------KRLKRSSF 306
           ++F   ELR +        ++LG    G  + G+ +P+G  + +         +  R SF
Sbjct: 8   RIFKETELRKL--------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 59
Query: 307 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 366
           Q   +    IG    L H ++V + G C       +V +++   PL   L H+ +   +L
Sbjct: 60  QAVTDHMLAIGS---LDHAHIVRLLGLC-PGSSLQLVTQYL---PLGSLLDHVRQHRGAL 112
Query: 367 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426
              + +     +A+G+ +L +     +VHR++ A NVLL       +   G++  +P + 
Sbjct: 113 GPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
Query: 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
            Q     A     ++A E ++  + T +SDV+S+GV + E+++
Sbjct: 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 40/193 (20%)
Query: 297 AVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           AVK + +S    K++   EI    R   HPN++ +K    D    Y+V E +        
Sbjct: 51  AVKIIDKS----KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM-------- 98
Query: 356 LHHIPRGGRSLDWAMRMK---------VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
                +GG  LD  +R K         V  T+ + + +LH +    VVHRD++ SN+L  
Sbjct: 99  -----KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYV 150
Query: 407 EEFG----AHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSF 460
           +E G      +   G +K    ++  E  ++    Y   ++APE + R       D++S 
Sbjct: 151 DESGNPESIRICDFGFAK----QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSL 206
Query: 461 GVLLLEIVSGRRP 473
           GVLL  +++G  P
Sbjct: 207 GVLLYTMLTGYTP 219

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 154
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 206
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 52  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 104
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
           D+ + Y+V E+V  G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 105 DNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIY 157
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
           RD++  N+L+D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 158 RDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAV 212
Query: 456 DVYSFGVLLLEIVSGRRP 473
           D ++ GVL+ E+ +G  P
Sbjct: 213 DWWALGVLIYEMAAGYPP 230

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 79/170 (46%), Gaps = 9/170 (5%)
Query: 307 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 366
            +K++  +EI     L +P++V   G   D    Y+V E        R L  + +  +++
Sbjct: 68  HQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRR----RSLLELHKRRKAV 123
Query: 367 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426
                        QG+ +LH+     V+HRD++  N+ L+++    +   GL+  + ++ 
Sbjct: 124 TEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD- 179
Query: 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
             ER     GT  Y+APE + +   + + D++S G +L  ++ G+ P + 
Sbjct: 180 -GERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 228

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 71/158 (44%), Gaps = 12/158 (7%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HPN+V +    +D    ++V E +  G L   +    +  +         +   L   ++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERI----KKKKHFSETEASYIMRKLVSAVS 120
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
            +HD     VVHRD++  N+L  +E       ++  G ++  P +    +T     T  Y
Sbjct: 121 HMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHY 175
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD 478
            APE + +N      D++S GV+L  ++SG+ P Q+ D
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 112
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
           D+ + Y+V E+V  G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 113 DNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIY 165
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
           RD++  N+L+D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 456 DVYSFGVLLLEIVSGRRP 473
           D ++ GVL+ E+ +G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 117
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 118 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 112
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
           D+ + Y+V E+V  G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 113 DNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIY 165
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
           RD++  N+L+D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 456 DVYSFGVLLLEIVSGRRP 473
           D ++ GVL+ E+ +G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 112
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
           D+ + Y+V E+V  G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 113 DNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIY 165
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
           RD++  N+L+D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 456 DVYSFGVLLLEIVSGRRP 473
           D ++ GVL+ E+ +G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 154
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEYL 206
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+++D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 9/176 (5%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
            EI     L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R  
Sbjct: 53  KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF- 109
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
               L  G+ +LH      + HRDI+  N+LLDE     +   GL+    +   +     
Sbjct: 110 -FHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 434 AGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
             GT  Y+APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 28/197 (14%)
Query: 295 RVAVK---RLKRSSFQRKKEFYSEIGRFAR-------LHHPNLVAVKGCCYDHGDRYIVY 344
           ++AV+   R++R++ +  K F  ++ RF +       L HPN++ +     D+ D Y+V 
Sbjct: 26  KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85
Query: 345 EFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
           E    G L +R +H   R  R  D A  MK    +   +A+ H   K +V HRD++  N 
Sbjct: 86  ELCTGGELFERVVHK--RVFRESDAARIMK---DVLSAVAYCH---KLNVAHRDLKPENF 137
Query: 404 LL---DEEFGAHLMGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
           L      +    L+  GL ++F P ++M+ +     GT  Y++P+ V       + D +S
Sbjct: 138 LFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----GTPYYVSPQ-VLEGLYGPECDEWS 192
Query: 460 FGVLLLEIVSGRRPAQA 476
            GV++  ++ G  P  A
Sbjct: 193 AGVMMYVLLCGYPPFSA 209

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 87/193 (45%), Gaps = 40/193 (20%)
Query: 297 AVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           AVK + +S    K++   EI    R   HPN++ +K   YD G     Y +VV       
Sbjct: 51  AVKIIDKS----KRDPTEEIEILLRYGQHPNIITLKDV-YDDGK----YVYVVT------ 95
Query: 356 LHHIPRGGRSLDWAMRMK---------VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
              + +GG  LD  +R K         V  T+ + + +LH +    VVHRD++ SN+L  
Sbjct: 96  --ELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYV 150
Query: 407 EEFG----AHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSF 460
           +E G      +   G +K    ++  E  ++    Y   ++APE + R       D++S 
Sbjct: 151 DESGNPESIRICDFGFAK----QLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSL 206
Query: 461 GVLLLEIVSGRRP 473
           GVLL   ++G  P
Sbjct: 207 GVLLYTXLTGYTP 219

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 154
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 206
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI   ++   P +    G        +I+ E++  G     L   P     LD      +
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATI 124
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVM 433
              + +G+ +LH + K   +HRDI+A+NVLL E     L   G++ +    ++ +   V 
Sbjct: 125 LREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV- 180
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
             GT  ++APE + ++   +K+D++S G+  +E+  G  P
Sbjct: 181 --GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 84  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 139
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 140 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEYL 191
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 192 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 28/197 (14%)
Query: 295 RVAVK---RLKRSSFQRKKEFYSEIGRFAR-------LHHPNLVAVKGCCYDHGDRYIVY 344
           ++AV+   R++R++ +  K F  ++ RF +       L HPN++ +     D+ D Y+V 
Sbjct: 43  KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 102
Query: 345 EFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
           E    G L +R +H   R  R  D A  MK    +   +A+ H   K +V HRD++  N 
Sbjct: 103 ELCTGGELFERVVHK--RVFRESDAARIMK---DVLSAVAYCH---KLNVAHRDLKPENF 154
Query: 404 LL---DEEFGAHLMGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
           L      +    L+  GL ++F P ++M+ +     GT  Y++P+ V       + D +S
Sbjct: 155 LFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----GTPYYVSPQ-VLEGLYGPECDEWS 209
Query: 460 FGVLLLEIVSGRRPAQA 476
            GV++  ++ G  P  A
Sbjct: 210 AGVMMYVLLCGYPPFSA 226

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 117
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 118 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 117
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 118 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 117
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 118 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 115
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 116 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 219

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 74/161 (45%), Gaps = 12/161 (7%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
            EI   ++   P +    G        +I+ E++  G     L   P     LD      
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIAT 108
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTV 432
           +   + +G+ +LH + K   +HRDI+A+NVLL E     L   G++ +    ++ +   V
Sbjct: 109 ILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV 165
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
              GT  ++APE + ++   +K+D++S G+  +E+  G  P
Sbjct: 166 ---GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ ++ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 9/176 (5%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
            EI     L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R  
Sbjct: 54  KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF- 110
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
               L  G+ +LH      + HRDI+  N+LLDE     +   GL+    +   +     
Sbjct: 111 -FHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 434 AGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
             GT  Y+APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 167 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 80  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 132
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
           D+ + Y+V E+V  G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 133 DNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIY 185
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
           RD++  N+L+D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 186 RDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAV 240
Query: 456 DVYSFGVLLLEIVSGRRP 473
           D ++ GVL+ E+ +G  P
Sbjct: 241 DWWALGVLIYEMAAGYPP 258

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 112/252 (44%), Gaps = 31/252 (12%)
Query: 242 LSNPAASALVPPSWKVFTT-----EELRSITKNFSEGNRLLGDSKTG-GTYSGILPDGSR 295
           +++P     +P    VF +     EEL+         N L+ D + G G +  +     R
Sbjct: 299 ITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYR 358
Query: 296 -------VAVKRLKRSSFQRK-KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
                  VA+K LK+ + +   +E   E     +L +P +V + G C       +V E  
Sbjct: 359 MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMA 417
Query: 348 VNGPLDRWL----HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
             GPL ++L      IP    +       ++   ++ G+ +L +K   + VHR++ A NV
Sbjct: 418 GGGPLHKFLVGKREEIPVSNVA-------ELLHQVSMGMKYLEEK---NFVHRNLAARNV 467
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG-TYGYLAPEFVYRNELTTKSDVYSFGV 462
           LL     A +   GLSK +  +        AG     + APE +   + +++SDV+S+GV
Sbjct: 468 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 527
Query: 463 LLLEIVS-GRRP 473
            + E +S G++P
Sbjct: 528 TMWEALSYGQKP 539

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 25/190 (13%)
Query: 293 GSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           G  VA+K + ++       ++ + E+     L+HPN+V +          Y++ E+   G
Sbjct: 37  GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 96
Query: 351 PL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
            + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD + 
Sbjct: 97  EVFDYLVAH----GRMKEKEARSKFRQIVS-AVQYCHQK---RIVHRDLKAENLLLDADM 148
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAG-----GTYGYLAPE-FVYRNELTTKSDVYSFGVL 463
              +   G S         E TV        G+  Y APE F  +     + DV+S GV+
Sbjct: 149 NIKIADFGFS--------NEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVI 200
Query: 464 LLEIVSGRRP 473
           L  +VSG  P
Sbjct: 201 LYTLVSGSLP 210

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           + D+ T   ++G      ++  K L     QR+K    EI     L H ++V   G   D
Sbjct: 58  ISDADTKEVFAG------KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFED 110
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
           +   ++V E        R L  + +  ++L           +  G  +LH   +  V+HR
Sbjct: 111 NDFVFVVLELCRR----RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 163
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
           D++  N+ L+E+    +   GL+  V ++   ER  +  GT  Y+APE + +   + + D
Sbjct: 164 DLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVD 221
Query: 457 VYSFGVLLLEIVSGRRPAQA 476
           V+S G ++  ++ G+ P + 
Sbjct: 222 VWSIGCIMYTLLVGKPPFET 241

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 117
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 118 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 117
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 118 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           + D+ T   ++G      ++  K L     QR+K    EI     L H ++V   G   D
Sbjct: 34  ISDADTKEVFAG------KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFED 86
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
           +   ++V E        R L  + +  ++L           +  G  +LH   +  V+HR
Sbjct: 87  NDFVFVVLELCRR----RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 139
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
           D++  N+ L+E+    +   GL+  V ++   ER  +  GT  Y+APE + +   + + D
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVD 197
Query: 457 VYSFGVLLLEIVSGRRPAQA 476
           V+S G ++  ++ G+ P + 
Sbjct: 198 VWSIGCIMYTLLVGKPPFET 217

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 433 MAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +   +  +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 15/184 (8%)
Query: 293 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
           G+  A+K L +    + KE     +E      ++ P LV ++    D+ + Y+V E+   
Sbjct: 66  GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
           G +     H+ R GR  +   R   A  +     +LH      +++RD++  N+++D++ 
Sbjct: 126 GEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQG 178
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              +   GL+K V     + RT    GT  YLAPE +         D ++ GVL+ E+ +
Sbjct: 179 YIQVTDFGLAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 470 GRRP 473
           G  P
Sbjct: 234 GYPP 237

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 9/176 (5%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
            EI     L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R  
Sbjct: 53  KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF- 109
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
               L  G+ +LH      + HRDI+  N+LLDE     +   GL+    +   +     
Sbjct: 110 -FHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 434 AGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
             GT  Y+APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           + D+ T   ++G      ++  K L     QR+K    EI     L H ++V   G   D
Sbjct: 36  ISDADTKEVFAG------KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFED 88
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
           +   ++V E        R L  + +  ++L           +  G  +LH   +  V+HR
Sbjct: 89  NDFVFVVLELCRR----RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 141
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
           D++  N+ L+E+    +   GL+  V ++  +++T+   GT  Y+APE + +   + + D
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAPEVLSKKGHSFEVD 199
Query: 457 VYSFGVLLLEIVSGRRPAQA 476
           V+S G ++  ++ G+ P + 
Sbjct: 200 VWSIGCIMYTLLVGKPPFET 219

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           + D+ T   ++G      ++  K L     QR+K    EI     L H ++V   G   D
Sbjct: 60  ISDADTKEVFAG------KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFED 112
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
           +   ++V E        R L  + +  ++L           +  G  +LH   +  V+HR
Sbjct: 113 NDFVFVVLELCRR----RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 165
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
           D++  N+ L+E+    +   GL+  V ++   ER  +  GT  Y+APE + +   + + D
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVD 223
Query: 457 VYSFGVLLLEIVSGRRPAQA 476
           V+S G ++  ++ G+ P + 
Sbjct: 224 VWSIGCIMYTLLVGKPPFET 243

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           + D+ T   ++G      ++  K L     QR+K    EI     L H ++V   G   D
Sbjct: 40  ISDADTKEVFAG------KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFED 92
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
           +   ++V E        R L  + +  ++L           +  G  +LH   +  V+HR
Sbjct: 93  NDFVFVVLELCRR----RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 145
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
           D++  N+ L+E+    +   GL+  V ++  +++T+   GT  Y+APE + +   + + D
Sbjct: 146 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAPEVLSKKGHSFEVD 203
Query: 457 VYSFGVLLLEIVSGRRPAQA 476
           V+S G ++  ++ G+ P + 
Sbjct: 204 VWSIGCIMYTLLVGKPPFET 223

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 115
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 116 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 172
Query: 433 MAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +   +  +T  D++S G +  E+V+ R
Sbjct: 173 ----TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           + D+ T   ++G      ++  K L     QR+K    EI     L H ++V   G   D
Sbjct: 36  ISDADTKEVFAG------KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFED 88
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
           +   ++V E        R L  + +  ++L           +  G  +LH   +  V+HR
Sbjct: 89  NDFVFVVLELCRR----RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 141
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
           D++  N+ L+E+    +   GL+  V ++  +++T+   GT  Y+APE + +   + + D
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAPEVLSKKGHSFEVD 199
Query: 457 VYSFGVLLLEIVSGRRPAQA 476
           V+S G ++  ++ G+ P + 
Sbjct: 200 VWSIGCIMYTLLVGKPPFET 219

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 107
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 164
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 165 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 293 GSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           G  VA+K + ++       ++ + E+     L+HPN+V +          Y++ E+   G
Sbjct: 40  GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99
Query: 351 PL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
            + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD + 
Sbjct: 100 EVFDYLVAH----GRMKEKEARSKFRQIVS-AVQYCHQK---RIVHRDLKAENLLLDADM 151
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLLEIV 468
              +   G S    + V  +     G    Y APE F  +     + DV+S GV+L  +V
Sbjct: 152 NIKIADFGFSN--EFTVGGKLDAFCGAP-PYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208
Query: 469 SGRRP 473
           SG  P
Sbjct: 209 SGSLP 213

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 9/160 (5%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRP-AQAVDS 479
           APE + R E   +  DV+S G++L  +++G  P  Q  DS
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/298 (22%), Positives = 124/298 (41%), Gaps = 39/298 (13%)
Query: 268 KNFSEGNRLLGDSKTGGTYSGILP--DGS--RVAVKRLKRSSFQRK--KEFYSEIGRFAR 321
           + F+ G R+LG  + G      L   DGS  +VAVK LK         +EF  E      
Sbjct: 23  QQFTLG-RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKE 81
Query: 322 LHHPNLVAVKGCCYDHGDR------YIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMK 373
             HP++  + G       +       ++  F+ +G L  +L    I     +L     ++
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
               +A G+ +L  +   + +HRD+ A N +L E+    +   GLS+ +       +   
Sbjct: 142 FMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPL 492
           +     +LA E +  N  T  SDV++FGV + EI++ G+ P   +++     I+ +   L
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNY---L 252
Query: 493 VQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           +  +R                     +++V DL+Y C    P  RP  + +  +L+ +
Sbjct: 253 IGGNRLKQPPE--------------CMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 109
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 166
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 167 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 111
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 110
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 168 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 111
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 107
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 165 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 107
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 164
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 165 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 15/184 (8%)
Query: 293 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
           G+  A+K L +    + KE     +E      ++ P LV ++    D+ + Y+V E+   
Sbjct: 66  GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
           G +     H+ R GR  +   R   A  +     +LH      +++RD++  N+++D++ 
Sbjct: 126 GEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQG 178
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              +   GL+K V     + RT    GT  YLAPE +         D ++ GVL+ E+ +
Sbjct: 179 YIKVTDFGLAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 470 GRRP 473
           G  P
Sbjct: 234 GYPP 237

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 109
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 167 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCC 334
           LG+      Y G+    G  VA+K +K  S +        EI     L H N+V +    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGG--RSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
           +      +V+EF+ N  L +++     G   R L+  +       L QG+AF H+     
Sbjct: 73  HTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---K 128
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
           ++HRD++  N+L+++     L   GL++   +P        V    T  Y AP+ +  + 
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV----TLWYRAPDVLMGSR 184
Query: 451 -LTTKSDVYSFGVLLLEIVSGR 471
             +T  D++S G +L E+++G+
Sbjct: 185 TYSTSIDIWSCGCILAEMITGK 206

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 107
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 165 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 110
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 168 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 110
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 168 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 109
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 167 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/232 (19%), Positives = 108/232 (46%), Gaps = 41/232 (17%)
Query: 266 ITKNFSEGNRLLGDSK-----TGGTYSGIL---PDGSRVAVKRLKRSSFQRKKEF----- 312
           + K   E ++ + D +       G ++ I+    D    A+K+ ++S  ++K++F     
Sbjct: 19  LNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNN 78
Query: 313 ------------YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIP 360
                        +E+     + +   +  +G   ++ + YI+YE++ N  + ++  +  
Sbjct: 79  DKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF 138
Query: 361 RGGRSLDWAMRMKVATTLAQGI----AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416
              ++    + ++V   + + +    +++H++   ++ HRD++ SN+L+D+        V
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKN-----GRV 191
Query: 417 GLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRNELT---TKSDVYSFGVLL 464
            LS F   E M ++ +    GTY ++ PEF + NE +    K D++S G+ L
Sbjct: 192 KLSDFGESEYMVDKKIKGSRGTYEFMPPEF-FSNESSYNGAKVDIWSLGICL 242

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 109
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 167 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 296 VAVKRLKRSSFQRK-KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           VA+K LK+ + +   +E   E     +L +P +V + G C       +V E    GPL +
Sbjct: 40  VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHK 98
Query: 355 WL----HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
           +L      IP    +       ++   ++ G+ +L +K   + VHRD+ A NVLL     
Sbjct: 99  FLVGKREEIPVSNVA-------ELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHY 148
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGG-TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
           A +   GLSK +  +        AG     + APE +   + +++SDV+S+GV + E +S
Sbjct: 149 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
Query: 470 -GRRP 473
            G++P
Sbjct: 209 YGQKP 213

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 112
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 113 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 170 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LSMDLKKFMDASALTGIPL--PLIKSY 109
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 167 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 107
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 165 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 115
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 116 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 172
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 173 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LSMDLKKFMDASALTGIPL--PLIKSY 111
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 272 EGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYS---EIGRFARLH 323
           +G R+LG     G++  ++       G   AVK + +   ++K +  S   E+    +L 
Sbjct: 29  KGQRVLG----KGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HPN+  +     D G  Y+V E    G L  +   I R   S   A R  +   +  GI 
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAAR--IIRQVLSGIT 140
Query: 384 FLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
           + H   K  +VHRD++  N+LL+   ++    ++  GLS    +E  ++     G  Y Y
Sbjct: 141 YXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKXKDKIGTAY-Y 194
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
           +APE V       K DV+S GV+L  ++SG
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 26/161 (16%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HPN++ +K     +   ++V++ +  G L  +L        +L      K+   L + I 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVIC 138
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLA 442
            LH   K ++VHRD++  N+LLD++    L   G S +  P E +  R+V   GT  YLA
Sbjct: 139 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--RSVC--GTPSYLA 191
Query: 443 PEFV----------YRNELTTKSDVYSFGVLLLEIVSGRRP 473
           PE +          Y  E+    D++S GV++  +++G  P
Sbjct: 192 PEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 112
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 113 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 169
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 170 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           AP  +         D ++ GVL+ E+ +G  P
Sbjct: 206 APAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 93/239 (38%), Gaps = 30/239 (12%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSRVA 297
           +  PA S   P    +    +   + K+   GN    RL+ D ++             VA
Sbjct: 1   MDRPAVSG--PMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSN----------ELVA 48
Query: 298 VKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 357
           VK ++R   +  +    EI     L HPN+V  K          IV E+   G L     
Sbjct: 49  VKYIERGE-KIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---FE 104
Query: 358 HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM--G 415
            I   GR  +   R      L  G+++ H      V HRD++  N LLD      L    
Sbjct: 105 RICNAGRFSEDEARF-FFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICA 160
Query: 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRRP 473
            G SK     V+  +     GT  Y+APE + + E   K +DV+S GV L  ++ G  P
Sbjct: 161 FGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 81/187 (43%), Gaps = 19/187 (10%)
Query: 293 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           G  VAVK     +L  SS Q+    + E+     L+HPN+V +          Y+V E+ 
Sbjct: 32  GKEVAVKIIDKTQLNSSSLQK---LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYA 88
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
             G +  +L  +  G     W    +      Q ++ +    +  +VHRD++A N+LLD 
Sbjct: 89  SGGEVFDYL--VAHG-----WMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDA 141
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLLE 466
           +    +   G S    +     +     G+  Y APE F  +     + DV+S GV+L  
Sbjct: 142 DMNIKIADFGFSNEFTF---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYT 198
Query: 467 IVSGRRP 473
           +VSG  P
Sbjct: 199 LVSGSLP 205

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 297 AVKRLKRSSFQRKKE---FYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           AVK L++ +  +KKE     SE     + + HP LV +          Y V +++  G L
Sbjct: 67  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
               +H+ R    L+   R   A  +A  + +LH     ++V+RD++  N+LLD +    
Sbjct: 127 ---FYHLQRERCFLEPRARF-YAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIV 179
Query: 413 LMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
           L   GL K    E ++  +  +   GT  YLAPE +++       D +  G +L E++ G
Sbjct: 180 LTDFGLCK----ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235
Query: 471 RRP 473
             P
Sbjct: 236 LPP 238

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 93/239 (38%), Gaps = 30/239 (12%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSRVA 297
           +  PA S   P    +    +   + K+   GN    RL+ D ++             VA
Sbjct: 1   MDRPAVSG--PMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSN----------ELVA 48
Query: 298 VKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 357
           VK ++R   +  +    EI     L HPN+V  K          IV E+   G L     
Sbjct: 49  VKYIERGE-KIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---FE 104
Query: 358 HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM--G 415
            I   GR  +   R      L  G+++ H      V HRD++  N LLD      L    
Sbjct: 105 RICNAGRFSEDEARF-FFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICA 160
Query: 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRRP 473
            G SK        + TV   GT  Y+APE + + E   K +DV+S GV L  ++ G  P
Sbjct: 161 FGYSKSSVLHSQPKDTV---GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E++  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E++  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 19/210 (9%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCC 334
           L+G+   G  Y G      ++A  ++   +   ++E   EI    +  HH N+    G  
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 335 YDHG------DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
                       ++V EF   G +   + +    G +L       +   + +G++ LH  
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLH-- 146
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
            +  V+HRDI+  NVLL E     L+  G+S  +   V +  T +  GT  ++APE +  
Sbjct: 147 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIAC 203
Query: 449 NE-----LTTKSDVYSFGVLLLEIVSGRRP 473
           +E        KSD++S G+  +E+  G  P
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 174
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     +  T    GT  YL
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGATWTLCGTPEYL 226
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 293 GSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           G   AVK + + + + K+    +EI    ++ H N+VA++         Y+V + V  G 
Sbjct: 47  GKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGE 106
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLL-- 405
           L      I   G   +     K A+TL +     + +LH   +  +VHRD++  N+L   
Sbjct: 107 L---FDRIVEKGFYTE-----KDASTLIRQVLDAVYYLH---RMGIVHRDLKPENLLYYS 155
Query: 406 -DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
            DEE    +   GLSK    E   +    A GT GY+APE + +   +   D +S GV+ 
Sbjct: 156 QDEESKIMISDFGLSKM---EGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 212
Query: 465 LEIVSGRRP-AQAVDSVCWQSI----FEWATP 491
             ++ G  P     DS  ++ I    +E+ +P
Sbjct: 213 YILLCGYPPFYDENDSKLFEQILKAEYEFDSP 244

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG++F H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 93/239 (38%), Gaps = 30/239 (12%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSRVA 297
           +  PA +   P    +    +   + K+   GN    RL+ D +              VA
Sbjct: 1   MDRPAVAG--PMDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQAN----------ELVA 48
Query: 298 VKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 357
           VK ++R   +  +    EI     L HPN+V  K          IV E+   G L     
Sbjct: 49  VKYIERGE-KIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---FE 104
Query: 358 HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL--MG 415
            I   GR  +   R      L  G+++ H      V HRD++  N LLD      L    
Sbjct: 105 RICNAGRFSEDEARF-FFQQLISGVSYAHAM---QVAHRDLKLENTLLDGSPAPRLKIAD 160
Query: 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRRP 473
            G SK     V+  +   A GT  Y+APE + + E   K +DV+S GV L  ++ G  P
Sbjct: 161 FGYSK---ASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+   G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+++D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+   G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 154
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYL 206
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+   G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+++D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L  ++      G  L   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKTFMDASALTGIPL--PLIKSY 111
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 15/121 (12%)
Query: 362 GGRSLDWAM-----RMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
           GG +LD           +AT L +   G+ +LH + K   +HRDI+A+NVLL E+    L
Sbjct: 101 GGSALDLLKPGPLEETYIATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKL 157
Query: 414 MGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 472
              G++ +    ++ +   V   GT  ++APE + ++    K+D++S G+  +E+  G  
Sbjct: 158 ADFGVAGQLTDTQIKRNXFV---GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP 214
Query: 473 P 473
           P
Sbjct: 215 P 215

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L  ++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKDFMDASALTGIPL--PLIKSY 108
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT   L
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEAL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L  ++      G  L   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LSMDLKDFMDASALTGIPL--PLIKSY 111
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEIG 317
           +T N  E  +LLG     GT+  ++       G   A+K LK+     K E     +E  
Sbjct: 145 VTMNEFEYLKLLGK----GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 318 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
                 HP L A+K     H     V E+   G L     H+ R  R             
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-RVFSEDRARFYGAE 256
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-- 435
           +   + +LH +   +VV+RD++  N++LD++    +   GL K    E +++   M    
Sbjct: 257 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFC 310
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+E  V+  L +++      G  L   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEH-VDQDLKKFMDASALTGIPL--PLIKSY 111
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+EF ++  L  ++      G  L   +    
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LSMDLKDFMDASALTGIPL--PLIKSY 110
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 168 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 87/198 (43%), Gaps = 19/198 (9%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 112
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
           D+ + Y+V E+   G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 113 DNSNLYMVMEYAPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIY 165
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
           RD++  N+++D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 166 RDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 456 DVYSFGVLLLEIVSGRRP 473
           D ++ GVL+ E+ +G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEIG 317
           +T N  E  +LLG     GT+  ++       G   A+K LK+     K E     +E  
Sbjct: 148 VTMNEFEYLKLLGK----GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 203
Query: 318 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
                 HP L A+K     H     V E+   G L     H+ R  R             
Sbjct: 204 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-RVFSEDRARFYGAE 259
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-- 435
           +   + +LH +   +VV+RD++  N++LD++    +   GL K    E +++   M    
Sbjct: 260 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFC 313
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 314 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P LV ++    D+ + Y+V E+   G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+++D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 18/157 (11%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HP+++ +          ++V++ +  G L  +L        +L       +  +L + ++
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVS 214
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLA 442
           FLH     ++VHRD++  N+LLD+     L   G S    P E ++E      GT GYLA
Sbjct: 215 FLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE----LCGTPGYLA 267
Query: 443 PEFVYRNELTT------KSDVYSFGVLLLEIVSGRRP 473
           PE +  +   T      + D+++ GV+L  +++G  P
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           +A+G+ FL  +     +HRD+ A N+LL E+    +   GL++ +  +    R   A   
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             ++APE ++    T +SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           +A+G+ FL  +     +HRD+ A N+LL E+    +   GL++ +  +    R   A   
Sbjct: 207 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             ++APE ++    T +SDV+SFGVLL EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           +A+G+ FL  +     +HRD+ A N+LL E+    +   GL++ +  +    R   A   
Sbjct: 200 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             ++APE ++    T +SDV+SFGVLL EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 92/239 (38%), Gaps = 30/239 (12%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSRVA 297
           +  PA S   P    +    +   + K+   GN    RL+ D ++             VA
Sbjct: 1   MDRPAVSG--PMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSN----------ELVA 48
Query: 298 VKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 357
           VK ++R   +       EI     L HPN+V  K          IV E+   G L     
Sbjct: 49  VKYIERGE-KIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---FE 104
Query: 358 HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM--G 415
            I   GR  +   R      L  G+++ H      V HRD++  N LLD      L    
Sbjct: 105 RICNAGRFSEDEARF-FFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICD 160
Query: 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRRP 473
            G SK     V+  +     GT  Y+APE + + E   K +DV+S GV L  ++ G  P
Sbjct: 161 FGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           +A+G+ FL  +     +HRD+ A N+LL E+    +   GL++ +  +    R   A   
Sbjct: 209 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
             ++APE ++    T +SDV+SFGVLL EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 8/169 (4%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L HP++V +       G  Y+V+EF+    L   +      G     A+       + + 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG-- 439
           + + HD    +++HRD++  NVLL  +  +    V L  F     + E  ++AGG  G  
Sbjct: 143 LRYCHDN---NIIHRDVKPENVLLASKENS--APVKLGDFGVAIQLGESGLVAGGRVGTP 197
Query: 440 -YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 487
            ++APE V R       DV+  GV+L  ++SG  P        ++ I +
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK 246

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM 372
           +EI    +L+HP ++ +K   +D  D YIV E +  G L D+ +     G + L  A   
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCK 117
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
                +   + +LH+     ++HRD++  NVLL  +    L  + ++ F   +++ E ++
Sbjct: 118 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSL 172
Query: 433 MAG--GTYGYLAPEF---VYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           M    GT  YLAPE    V         D +S GV+L   +SG  P
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 29/177 (16%)
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMA 434
           +A+G+ FL  +     +HRD+ A N+LL E     +   GL++ +   P  V +  T + 
Sbjct: 208 VARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
                ++APE ++    +TKSDV+S+GVLL EI S G  P   V     Q   ++ + L 
Sbjct: 265 ---LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGV-----QMDEDFCSRLR 316
Query: 494 QSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           +  R                       ++  ++  C    P  RPR + +V +L  L
Sbjct: 317 EGMRMRAPEYS--------------TPEIYQIMLDCWHRDPKERPRFAELVEKLGDL 359

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM 372
           +EI    +L+HP ++ +K   +D  D YIV E +  G L D+ +     G + L  A   
Sbjct: 63  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCK 116
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
                +   + +LH+     ++HRD++  NVLL  +    L  + ++ F   +++ E ++
Sbjct: 117 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSL 171
Query: 433 MAG--GTYGYLAPEF---VYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           M    GT  YLAPE    V         D +S GV+L   +SG  P
Sbjct: 172 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM 372
           +EI    +L+HP ++ +K   +D  D YIV E +  G L D+ +     G + L  A   
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCK 117
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
                +   + +LH+     ++HRD++  NVLL  +    L  + ++ F   +++ E ++
Sbjct: 118 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSL 172
Query: 433 MAG--GTYGYLAPEF---VYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           M    GT  YLAPE    V         D +S GV+L   +SG  P
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM 372
           +EI    +L+HP ++ +K   +D  D YIV E +  G L D+ +     G + L  A   
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCK 117
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
                +   + +LH+     ++HRD++  NVLL  +    L  + ++ F   +++ E ++
Sbjct: 118 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSL 172
Query: 433 MAG--GTYGYLAPEF---VYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           M    GT  YLAPE    V         D +S GV+L   +SG  P
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 76/181 (41%), Gaps = 14/181 (7%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           VAVK ++R +    +    EI     L HPN+V  K          I+ E+   G L   
Sbjct: 48  VAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL--- 103
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM- 414
              I   GR  +   R      L+ G+++ H      + HRD++  N LLD      L  
Sbjct: 104 YERICNAGRFSEDEARFFFQQLLS-GVSYCHSM---QICHRDLKLENTLLDGSPAPRLKI 159
Query: 415 -GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRR 472
              G SK     V+  +     GT  Y+APE + R E   K +DV+S GV L  ++ G  
Sbjct: 160 CDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAY 216
Query: 473 P 473
           P
Sbjct: 217 P 217

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEIG 317
           +T N  E  +LLG     GT+  ++       G   A+K LK+     K E     +E  
Sbjct: 6   VTMNEFEYLKLLGK----GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 61
Query: 318 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
                 HP L A+K     H     V E+   G L     H+ R  R             
Sbjct: 62  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-RVFSEDRARFYGAE 117
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-- 435
           +   + +LH +   +VV+RD++  N++LD++    +   GL K    E +++   M    
Sbjct: 118 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKXFC 171
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM 372
           +EI    +L+HP ++ +K   +D  D YIV E +  G L D+ +     G + L  A   
Sbjct: 70  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCK 123
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
                +   + +LH+     ++HRD++  NVLL  +    L  + ++ F   +++ E ++
Sbjct: 124 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSL 178
Query: 433 MAG--GTYGYLAPEF---VYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           M    GT  YLAPE    V         D +S GV+L   +SG  P
Sbjct: 179 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEIG 317
           +T N  E  +LLG     GT+  ++       G   A+K LK+     K E     +E  
Sbjct: 5   VTMNEFEYLKLLGK----GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 60
Query: 318 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
                 HP L A+K     H     V E+   G L     H+ R  R             
Sbjct: 61  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-RVFSEDRARFYGAE 116
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-- 435
           +   + +LH +   +VV+RD++  N++LD++    +   GL K    E +++   M    
Sbjct: 117 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKXFC 170
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 171 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEIG 317
           +T N  E  +LLG     GT+  ++       G   A+K LK+     K E     +E  
Sbjct: 7   VTMNEFEYLKLLGK----GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 62
Query: 318 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
                 HP L A+K     H     V E+   G L     H+ R  R             
Sbjct: 63  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-RVFSEDRARFYGAE 118
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-- 435
           +   + +LH +   +VV+RD++  N++LD++    +   GL K    E +++   M    
Sbjct: 119 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKXFC 172
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 173 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM 372
           +EI    +L+HP ++ +K   +D  D YIV E +  G L D+ +     G + L  A   
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCK 256
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
                +   + +LH+     ++HRD++  NVLL  +    L  + ++ F   +++ E ++
Sbjct: 257 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSL 311
Query: 433 MAG--GTYGYLAPEF---VYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           M    GT  YLAPE    V         D +S GV+L   +SG  P
Sbjct: 312 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM 372
           +EI    +L+HP ++ +K   +D  D YIV E +  G L D+ +     G + L  A   
Sbjct: 189 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCK 242
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
                +   + +LH+     ++HRD++  NVLL  +    L  + ++ F   +++ E ++
Sbjct: 243 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSL 297
Query: 433 MAG--GTYGYLAPEF---VYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           M    GT  YLAPE    V         D +S GV+L   +SG  P
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P L  ++    D+ + Y+V E+   G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 154
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+++D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYL 206
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
           +EI    +LHHP L+ +     D  +  ++ EF+  G L      I      +  A  + 
Sbjct: 97  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVIN 153
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA--HLMGVGL-SKFVPWEVMQER 430
                 +G+  +H+     +VH DI+  N++ + +  +   ++  GL +K  P E+++  
Sbjct: 154 YMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 210
Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV 480
           T  A     + APE V R  +   +D+++ GVL   ++SG  P    D +
Sbjct: 211 TATA----EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEI 316
            +T N  +  +LLG     GT+  ++       G   A+K L++     K E     +E 
Sbjct: 6   KVTMNDFDYLKLLG----KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 61
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
                  HP L A+K     H     V E+   G L     H+ R     +   R     
Sbjct: 62  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF-YGA 117
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG- 435
            +   + +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M   
Sbjct: 118 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXF 170
Query: 436 -GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
            GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 265 SITKNFSEGN----RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFA 320
            + K+   GN    RL+ D ++             VAVK ++R   +  +    EI    
Sbjct: 21  ELVKDIGSGNFGVARLMRDKQSN----------ELVAVKYIERGE-KIDENVKREIINHR 69
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
            L HPN+V  K          IV E+   G L      I   GR  +   R      L  
Sbjct: 70  SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---FERICNAGRFSEDEARF-FFQQLIS 125
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM--GVGLSKFVPWEVMQERTVMAGGTY 438
           G+++ H      V HRD++  N LLD      L     G SK     V+  +     GT 
Sbjct: 126 GVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 179
Query: 439 GYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRRP 473
            Y+APE + + E   K +DV+S GV L  ++ G  P
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEI 316
            +T N  +  +LLG     GT+  ++       G   A+K L++     K E     +E 
Sbjct: 1   KVTMNDFDYLKLLG----KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
                  HP L A+K     H     V E+   G L     H+ R     +   R     
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF-YGA 112
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG- 435
            +   + +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M   
Sbjct: 113 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXF 165
Query: 436 -GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
            GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HP L A+K     H     V E+   G L     H+ R     +   R      +   + 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIVSALE 119
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 441
           +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M    GT  YL
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYL 172
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +  N+     D +  GV++ E++ GR P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HP L A+K     H     V E+   G L     H+ R     +   R      +   + 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIVSALE 119
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 441
           +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M    GT  YL
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXFCGTPEYL 172
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +  N+     D +  GV++ E++ GR P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HP L A+K     H     V E+   G L     H+ R     +   R      +   + 
Sbjct: 67  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIVSALE 122
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 441
           +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M    GT  YL
Sbjct: 123 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYL 175
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +  N+     D +  GV++ E++ GR P
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEI 316
            +T N  +  +LLG     GT+  ++       G   A+K L++     K E     +E 
Sbjct: 1   KVTMNDFDYLKLLGK----GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
                  HP L A+K     H     V E+   G L     H+ R     +   R     
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF-YGA 112
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG- 435
            +   + +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M   
Sbjct: 113 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTF 165
Query: 436 -GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
            GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P L  ++    D+ + Y+V E+   G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 154
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+++D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYL 206
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/201 (22%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCC 334
           +G+   G  Y      G  VA+KR++  +           EI     LHHPN+V++    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHV 393
           +      +V+EF     +++ L  +    ++     ++K+    L +G+A  H   +  +
Sbjct: 89  HSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRI 140
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVY-RNE 450
           +HRD++  N+L++ +    L   GL++   +P        V    T  Y AP+ +    +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVLMGSKK 196
Query: 451 LTTKSDVYSFGVLLLEIVSGR 471
            +T  D++S G +  E+++G+
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>pdb|1JWI|A Chain A, Crystal Structure Of Bitiscetin, A Von Willeband Factor- Dependent Platelet Aggregation Inducer. Length = 131

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 57/140 (40%), Gaps = 22/140 (15%)
Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCG----K 108
           C PDW  +  K  C+       +W+++E +C E  GHLA++ S EE     KL      K
Sbjct: 4   CLPDW--SSYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTK 61
Query: 109 NVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
            V   W+G R  + T   S +W+D  S   E++       + C  L  H           
Sbjct: 62  FVYDAWIGLRDESKTQQCSPQWTDGSSVVYENVDEP----TKCFGLDVHTEY-------- 109
Query: 169 SNGSRSLVTERCNTSHPFIC 188
               R+     C   +PFIC
Sbjct: 110 ----RTWTDLPCGEKNPFIC 125

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/201 (22%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCC 334
           +G+   G  Y      G  VA+KR++  +           EI     LHHPN+V++    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHV 393
           +      +V+EF     +++ L  +    ++     ++K+    L +G+A  H   +  +
Sbjct: 89  HSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRI 140
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVY-RNE 450
           +HRD++  N+L++ +    L   GL++   +P        V    T  Y AP+ +    +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVLMGSKK 196
Query: 451 LTTKSDVYSFGVLLLEIVSGR 471
            +T  D++S G +  E+++G+
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 12/152 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           ++ P L  ++    D+ + Y+V E+   G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 154
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +LH      +++RD++  N+++D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYL 206
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HP L A+K     H     V E+   G L     H+ R     +   R      +   + 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIVSALE 119
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 441
           +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M    GT  YL
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXFCGTPEYL 172
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           APE +  N+     D +  GV++ E++ GR P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/118 (26%), Positives = 64/118 (54%), Gaps = 9/118 (7%)
Query: 357 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416
           +H+ + G   +  MR   A  +  G+  +H++    VV+RD++ +N+LLDE     +  +
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIIL-GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 336
Query: 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRP 473
           GL+     +  +++   + GT+GY+APE + +     + +D +S G +L +++ G  P
Sbjct: 337 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/118 (26%), Positives = 64/118 (54%), Gaps = 9/118 (7%)
Query: 357 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416
           +H+ + G   +  MR   A  +  G+  +H++    VV+RD++ +N+LLDE     +  +
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIIL-GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 336
Query: 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRP 473
           GL+     +  +++   + GT+GY+APE + +     + +D +S G +L +++ G  P
Sbjct: 337 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 96/230 (41%), Gaps = 29/230 (12%)
Query: 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVK 331
           E   L+G  + G  Y G       + +  ++R +  + K F  E+  + +  H N+V   
Sbjct: 36  EIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVK 390
           G C       I+          R L+ + R  +  LD     ++A  + +G+ +LH K  
Sbjct: 96  GACMSPPHLAIITSLCKG----RTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK-- 149
Query: 391 PHVVHRDIRASNVLLDE------EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
             ++H+D+++ NV  D       +FG       +S  +     +++  +  G   +LAPE
Sbjct: 150 -GILHKDLKSKNVFYDNGKVVITDFGL----FSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 445 FVYRNELTTK---------SDVYSFGVLLLEIVSGRRP--AQAVDSVCWQ 483
            + +    T+         SDV++ G +  E+ +   P   Q  +++ WQ
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI     L+HPN+V +    +     Y+V+E  V+  L  ++      G  L   +    
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEH-VHQDLKTFMDASALTGIPL--PLIKSY 107
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 165 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/118 (26%), Positives = 64/118 (54%), Gaps = 9/118 (7%)
Query: 357 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416
           +H+ + G   +  MR   A  +  G+  +H++    VV+RD++ +N+LLDE     +  +
Sbjct: 280 YHLSQHGVFSEADMRFYAAEIIL-GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 335
Query: 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRP 473
           GL+     +  +++   + GT+GY+APE + +     + +D +S G +L +++ G  P
Sbjct: 336 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 322 LHHPNLVAV-KGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
             HPN+V +   C     DR     +V+E V +  L  +L  +P  G   +    M    
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ- 128
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG 436
            L +G+ FLH      VVHRD++  N+L+       L   GL++   +++     V+   
Sbjct: 129 -LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--- 181
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/118 (26%), Positives = 64/118 (54%), Gaps = 9/118 (7%)
Query: 357 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416
           +H+ + G   +  MR   A  +  G+  +H++    VV+RD++ +N+LLDE     +  +
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIIL-GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 336
Query: 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRP 473
           GL+     +  +++   + GT+GY+APE + +     + +D +S G +L +++ G  P
Sbjct: 337 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 14/180 (7%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           +  K+L    FQ K E  + I R  +L HPN+V +     +    Y+V++ V  G L  +
Sbjct: 39  INTKKLSARDFQ-KLEREARICR--KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL--F 93
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415
              + R   S   A        + + IA+ H      +VHR+++  N+LL  +  A    
Sbjct: 94  EDIVAREFYS--EADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASK--AKGAA 146
Query: 416 VGLSKF-VPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           V L+ F +  EV          GT GYL+PE + ++  +   D+++ GV+L  ++ G  P
Sbjct: 147 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 14/180 (7%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           +  K+L    FQ K E  + I R  +L HPN+V +     +    Y+V++ V  G L  +
Sbjct: 39  INTKKLSARDFQ-KLEREARICR--KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL--F 93
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415
              + R   S   A        + + IA+ H      +VHR+++  N+LL  +  A    
Sbjct: 94  EDIVAREFYS--EADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASK--AKGAA 146
Query: 416 VGLSKF-VPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           V L+ F +  EV          GT GYL+PE + ++  +   D+++ GV+L  ++ G  P
Sbjct: 147 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 40/191 (20%)
Query: 299 KRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD------HGDRYIVY--EFVVNG 350
           ++L +S  QR KE   E      L HPN+V      YD       G + IV   E   +G
Sbjct: 62  RKLTKSERQRFKE---EAEXLKGLQHPNIVRF----YDSWESTVKGKKCIVLVTELXTSG 114
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
            L  +L              ++KV  +    + +G+ FLH +  P ++HRD++  N+ + 
Sbjct: 115 TLKTYLKRFK--------VXKIKVLRSWCRQILKGLQFLHTRTPP-IIHRDLKCDNIFIT 165
Query: 407 EEFGAHLMG-VGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKSDVYSFGV 462
              G+  +G +GL+         +R   A    GT  + APE  Y  +     DVY+FG 
Sbjct: 166 GPTGSVKIGDLGLATL-------KRASFAKAVIGTPEFXAPE-XYEEKYDESVDVYAFGX 217
Query: 463 LLLEIVSGRRP 473
             LE  +   P
Sbjct: 218 CXLEXATSEYP 228

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 14/180 (7%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           +  K+L    FQ K E  + I R  +L HPN+V +     +    Y+V++ V  G L  +
Sbjct: 38  INTKKLSARDFQ-KLEREARICR--KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL--F 92
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415
              + R   S   A        + + IA+ H      +VHR+++  N+LL  +  A    
Sbjct: 93  EDIVAREFYS--EADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASK--AKGAA 145
Query: 416 VGLSKF-VPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           V L+ F +  EV          GT GYL+PE + ++  +   D+++ GV+L  ++ G  P
Sbjct: 146 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 322 LHHPNLVAV-KGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
             HPN+V +   C     DR     +V+E V +  L  +L  +P  G   +    M    
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ- 128
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG 436
            L +G+ FLH      VVHRD++  N+L+       L   GL++   +++     V+   
Sbjct: 129 -LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--- 181
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 14/180 (7%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           +  K+L    FQ K E  + I R  +L HPN+V +     +    Y+V++ V  G L  +
Sbjct: 62  INTKKLSARDFQ-KLEREARICR--KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL--F 116
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415
              + R   S   A        + + IA+ H      +VHR+++  N+LL  +  A    
Sbjct: 117 EDIVAREFYS--EADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASK--AKGAA 169
Query: 416 VGLSKF-VPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           V L+ F +  EV          GT GYL+PE + ++  +   D+++ GV+L  ++ G  P
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 322 LHHPNLVAV-KGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
             HPN+V +   C     DR     +V+E V +  L  +L  +P  G   +    M    
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ- 128
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG 436
            L +G+ FLH      VVHRD++  N+L+       L   GL++   +++     V+   
Sbjct: 129 -LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--- 181
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 333 CCYDHGDRY-IVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
             Y  G++  +VY   +N  LD       R   H  R  ++L           L + +A+
Sbjct: 81  FFYSSGEKKDVVY---LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 443
           +H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y AP
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAP 191
Query: 444 EFVY-RNELTTKSDVYSFGVLLLEIVSGR 471
           E ++   + T+  DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 81  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 192
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 26  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 81
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 82  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 139
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 140 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 193
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 194 LIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 81  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 192
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 44  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 99
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 100 FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 157
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 158 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 211
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 212 LIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 33  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 88
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 89  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 147 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 200
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 201 LIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 86/186 (46%), Gaps = 13/186 (6%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEFVVNG 350
           G  VA+K++ +    R +E    +   A LHHPN+V ++   Y  G  DR  +Y  VV  
Sbjct: 48  GMSVAIKKVIQDPRFRNREL-QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106
Query: 351 PLDRWLHHIPRGGRSLDWA---MRMKVAT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
            +   LH   R       A   + +KV    L + I  LH     +V HRDI+  NVL++
Sbjct: 107 YVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVN 165
Query: 407 EEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLL 464
           E  G   L   G +K +      E  V    +  Y APE ++ N+  TT  D++S G + 
Sbjct: 166 EADGTLKLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIF 222
Query: 465 LEIVSG 470
            E++ G
Sbjct: 223 AEMMLG 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 92
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 93  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 151 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 204
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 35/198 (17%)
Query: 293 GSRVAVKRL---KRSSFQRKKEFYSEIGRFARLHHPNLVA-----VKGCCYDHGDRYIVY 344
           G +VAVK     + +S+ R+ E Y  +     + H N++      +KG        Y++ 
Sbjct: 60  GEKVAVKVFFTTEEASWFRETEIYQTV----LMRHENILGFIAADIKGTG-SWTQLYLIT 114
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIR 399
           ++  NG L  +L        +LD    +K+A +   G+  LH ++     KP + HRD++
Sbjct: 115 DYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169
Query: 400 ASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAG---GTYGYLAPEF----VYRNEL 451
           + N+L+ +     +  +GL+ KF+      E  +      GT  Y+ PE     + RN  
Sbjct: 170 SKNILVKKNGTCCIADLGLAVKFI--SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 452 TT--KSDVYSFGVLLLEI 467
            +   +D+YSFG++L E+
Sbjct: 228 QSYIMADMYSFGLILWEV 245

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 29  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 84
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 85  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 143 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 196
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 197 LIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 114
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 115 FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 173 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 226
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 277 LGDSKTGGTYSG--ILPDGS--RVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVA 329
           LGD   G    G    P G    VAVK LK     + +   +F  E+     L H NL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           + G       + +     +   LDR   H    G  L   +  + A  +A+G+ +L  K 
Sbjct: 80  LYGVVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLS-RYAVQVAEGMGYLESK- 134
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEF 445
               +HRD+ A N+LL       +   GL + +P      VMQE   +    + + APE 
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP---FAWCAPES 189
Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
           +     +  SD + FGV L E+ + G+ P
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 15/181 (8%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           +  K+L     Q K E  + I R   L HPN+V +     + G  Y+V++ V  G L   
Sbjct: 64  INTKKLSARDHQ-KLEREARICRL--LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFED 120
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415
           +  + R     ++      +  + Q +  ++   +  +VHRD++  N+LL  +       
Sbjct: 121 I--VAR-----EYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKG--AA 171
Query: 416 VGLSKF-VPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 472
           V L+ F +  EV  E+    G  GT GYL+PE + ++      D+++ GV+L  ++ G  
Sbjct: 172 VKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYP 231
Query: 473 P 473
           P
Sbjct: 232 P 232

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 277 LGDSKTGGTYSG--ILPDGS--RVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVA 329
           LGD   G    G    P G    VAVK LK     + +   +F  E+     L H NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           + G       + +     +   LDR   H    G  L   +  + A  +A+G+ +L  K 
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLS-RYAVQVAEGMGYLESK- 130
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEF 445
               +HRD+ A N+LL       +   GL + +P      VMQE   +    + + APE 
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVP---FAWCAPES 185
Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
           +     +  SD + FGV L E+ + G+ P
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 92
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 93  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 151 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 204
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 81  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 192
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIV 343
           G  VAVK+L R  FQ +   K  Y E+     ++H N++++      +    +  D Y+V
Sbjct: 47  GINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 105
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
            E +++  L + +H        LD      +   +  GI  LH      ++HRD++ SN+
Sbjct: 106 ME-LMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI 155
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
           ++  +    ++  GL++      M    V+   T  Y APE +         D++S G +
Sbjct: 156 VVKSDCTLKILDFGLARTASTNFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCI 212
Query: 464 LLEIVSGRRPAQAVDSV-CWQSIFE 487
           + E+V G    Q  D +  W  + E
Sbjct: 213 MGELVKGSVIFQGTDHIDQWNKVIE 237

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 53  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 108
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 109 FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 166
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 167 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 220
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 277 LGDSKTGGTYSG--ILPDGS--RVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVA 329
           LGD   G    G    P G    VAVK LK     + +   +F  E+     L H NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           + G       + +     +   LDR   H    G  L   +  + A  +A+G+ +L  K 
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLS-RYAVQVAEGMGYLESK- 130
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEF 445
               +HRD+ A N+LL       +   GL + +P      VMQE   +    + + APE 
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP---FAWCAPES 185
Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
           +     +  SD + FGV L E+ + G+ P
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 38  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 93
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 94  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 151
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 152 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 205
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 206 LIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 86/190 (45%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++G GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILGFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
           +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++  
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYF 86
Query: 334 CYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
            Y  G++    E  +N  LD       R   H  R  ++L           L + +A++H
Sbjct: 87  FYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
                 + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE 
Sbjct: 145 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPEL 198
Query: 446 VY-RNELTTKSDVYSFGVLLLEIVSGR 471
           ++   + T+  DV+S G +L E++ G+
Sbjct: 199 IFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 88/191 (46%), Gaps = 29/191 (15%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIV 343
           G++VA+K+L R  FQ +   K  Y E+     + H N++ +           D  D Y+V
Sbjct: 50  GAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
             F+    L + + H   G   + +     +   + +G+ ++H      ++HRD++  N+
Sbjct: 109 MPFM-GTDLGKLMKHEKLGEDRIQF-----LVYQMLKGLRYIH---AAGIIHRDLKPGNL 159
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG--TYGYLAPEFVYR-NELTTKSDVYSF 460
            ++E+    ++  GL++       Q  + M G   T  Y APE +      T   D++S 
Sbjct: 160 AVNEDCELKILDFGLAR-------QADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSV 212
Query: 461 GVLLLEIVSGR 471
           G ++ E+++G+
Sbjct: 213 GCIMAEMITGK 223

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 277 LGDSKTGGTYSG--ILPDGS--RVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVA 329
           LGD   G    G    P G    VAVK LK     + +   +F  E+     L H NL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           + G       + +     +   LDR   H    G  L   +  + A  +A+G+ +L  K 
Sbjct: 80  LYGVVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLS-RYAVQVAEGMGYLESK- 134
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEF 445
               +HRD+ A N+LL       +   GL + +P      VMQE   +    + + APE 
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP---FAWCAPES 189
Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
           +     +  SD + FGV L E+ + G+ P
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 67/294 (22%), Positives = 118/294 (40%), Gaps = 47/294 (15%)
Query: 269 NFSEGNRL--LGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHH 324
           +F + N L  L ++ +G  + G    G+ + VK LK    S ++ ++F  E  R     H
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 325 PNLVAVKGCCYDHGDRY--IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
           PN++ V G C      +  ++  +   G L   LH        +D +  +K A   A+G 
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHE--GTNFVVDQSQAVKFALDXARGX 124
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GY 440
           AFLH  ++P +    + + +V +DE+  A +    + KF             G  Y   +
Sbjct: 125 AFLH-TLEPLIPRHALNSRSVXIDEDXTARISXADV-KF--------SFQSPGRXYAPAW 174
Query: 441 LAPEFVYRNELTTK---SDVYSFGVLLLEIVSGRRPAQAVDS--VCWQSIFEWATPLVQS 495
           +APE + +    T    +D +SF VLL E+V+   P   + +  +  +   E   P +  
Sbjct: 175 VAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIP- 233
Query: 496 HRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
                                G+   V  L   C    P+ RP+   +V  L++
Sbjct: 234 --------------------PGISPHVSKLXKICXNEDPAKRPKFDXIVPILEK 267

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 277 LGDSKTGGTYSG--ILPDGS--RVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVA 329
           LGD   G    G    P G    VAVK LK     + +   +F  E+     L H NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           + G       + +     +   LDR   H    G  L   +  + A  +A+G+ +L  K 
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLS-RYAVQVAEGMGYLESK- 130
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEF 445
               +HRD+ A N+LL       +   GL + +P      VMQE   +    + + APE 
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP---FAWCAPES 185
Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
           +     +  SD + FGV L E+ + G+ P
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 277 LGDSKTGGTYSG--ILPDGS--RVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVA 329
           LGD   G    G    P G    VAVK LK     + +   +F  E+     L H NL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           + G       + +     +   LDR   H    G  L   +  + A  +A+G+ +L  K 
Sbjct: 86  LYGVVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLS-RYAVQVAEGMGYLESK- 140
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEF 445
               +HRD+ A N+LL       +   GL + +P      VMQE   +    + + APE 
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVP---FAWCAPES 195
Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
           +     +  SD + FGV L E+ + G+ P
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++ +    + +E   +I R  +L H N+V ++ 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL--QIMR--KLDHCNIVRLRY 80
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 81  FFYSSGEKKD--EVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 192
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 277 LGDSKTGGTYSG--ILPDGS--RVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVA 329
           LGD   G    G    P G    VAVK LK     + +   +F  E+     L H NL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           + G       + +     +   LDR   H    G  L   +  + A  +A+G+ +L  K 
Sbjct: 86  LYGVVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLS-RYAVQVAEGMGYLESK- 140
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEF 445
               +HRD+ A N+LL       +   GL + +P      VMQE   +    + + APE 
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP---FAWCAPES 195
Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
           +     +  SD + FGV L E+ + G+ P
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 86/190 (45%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       MAG   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 86/190 (45%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       MAG   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 114
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 115 FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 173 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 226
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 61  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 116
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 117 FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 174
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 175 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 228
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++ +    + +E   +I R  +L H N+V ++ 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL--QIMR--KLDHCNIVRLRY 80
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 81  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 192
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 63  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 118
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 119 FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 176
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 177 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 230
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 86/190 (45%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 103 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 153
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       MAG   T  Y APE +          D++S G
Sbjct: 154 VNEDCELKILDFGLARHTDDE-------MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVG 206
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 207 CIMAELLTGR 216

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L HPN+V +     + G  Y++++ V  G L   +  + R     ++      +  + Q 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI--VAR-----EYYSEADASHCIQQI 130
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF-VPWEVMQERTVMAG--GTY 438
           +  +    +  VVHRD++  N+LL  +       V L+ F +  EV  E+    G  GT 
Sbjct: 131 LEAVLHCHQMGVVHRDLKPENLLLASKLKG--AAVKLADFGLAIEVEGEQQAWFGFAGTP 188
Query: 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           GYL+PE + ++      D+++ GV+L  ++ G  P
Sbjct: 189 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 104 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 159
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 160 FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 217
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 218 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 271
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 13/160 (8%)
Query: 318 RFARLHHPNLVAVKG-CCYDHGDRYIVYEFV---VNGPLDRWLHHIPRGGRSLDWAMRMK 373
           R     HPN+V +   C     DR I    V   V+  L  +L   P  G  L       
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKD 116
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
           +     +G+ FLH      +VHRD++  N+L+       L   GL++   +++  +  V+
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV 173
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
              T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 174 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 209

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
            +++G+   G  Y   L D G  VA+K++ +    + +E   +I R  +L H N+V ++ 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL--QIMR--KLDHCNIVRLRY 80
Query: 333 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 81  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 192
Query: 445 FVY-RNELTTKSDVYSFGVLLLEIVSGR 471
            ++   + T+  DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 86/187 (45%), Gaps = 17/187 (9%)
Query: 293 GSRVAVKRLKRSSFQR--KKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
           G   A+K LK++   R  K   +++  R     + HP +V +       G  Y++ E++ 
Sbjct: 45  GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLS 104
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
            G L      + R G  ++      +A  ++  +  LH K    +++RD++  N++L+ +
Sbjct: 105 GGEL---FMQLEREGIFMEDTACFYLAE-ISMALGHLHQK---GIIYRDLKPENIMLNHQ 157
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
               L   GL K    E + + TV     GT  Y+APE + R+      D +S G L+ +
Sbjct: 158 GHVKLTDFGLCK----ESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYD 213
Query: 467 IVSGRRP 473
           +++G  P
Sbjct: 214 MLTGAPP 220

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 8/169 (4%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L HP++V +       G  Y+V+EF+    L   +      G     A+       + + 
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG-- 439
           + + HD    +++HRD++   VLL  +  +    V L  F     + E  ++AGG  G  
Sbjct: 145 LRYCHDN---NIIHRDVKPHCVLLASKENS--APVKLGGFGVAIQLGESGLVAGGRVGTP 199
Query: 440 -YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 487
            ++APE V R       DV+  GV+L  ++SG  P        ++ I +
Sbjct: 200 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK 248

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 47/109 (43%), Gaps = 28/109 (25%)
Query: 393 VVHRDIRASNVLLDEEF------------GAHLMGVGLSKFVPWEVMQER---------- 430
           +VHRD++ SN L +               G H   + L KFV  E  QER          
Sbjct: 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197
Query: 431 -----TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRP 473
                     GT G+ APE + +    TT  D++S GV+ L ++SGR P
Sbjct: 198 SRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 86/187 (45%), Gaps = 17/187 (9%)
Query: 293 GSRVAVKRLKRSSFQR--KKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
           G   A+K LK++   R  K   +++  R     + HP +V +       G  Y++ E++ 
Sbjct: 45  GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLS 104
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
            G L      + R G  ++      +A  ++  +  LH K    +++RD++  N++L+ +
Sbjct: 105 GGEL---FMQLEREGIFMEDTACFYLAE-ISMALGHLHQK---GIIYRDLKPENIMLNHQ 157
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
               L   GL K    E + + TV     GT  Y+APE + R+      D +S G L+ +
Sbjct: 158 GHVKLTDFGLCK----ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYD 213
Query: 467 IVSGRRP 473
           +++G  P
Sbjct: 214 MLTGAPP 220

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 8/169 (4%)
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
           L HP++V +       G  Y+V+EF+    L   +      G     A+       + + 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG-- 439
           + + HD    +++HRD++   VLL  +  +    V L  F     + E  ++AGG  G  
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENS--APVKLGGFGVAIQLGESGLVAGGRVGTP 197
Query: 440 -YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 487
            ++APE V R       DV+  GV+L  ++SG  P        ++ I +
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK 246

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 20/192 (10%)
Query: 290 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDRYIVYE 345
           +P G   A K +       +   + ++ R AR    L HPN+V +     + G  Y+V++
Sbjct: 26  IPTGQEYAAKIINTKKLSARD--HQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFD 83
Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
            V  G L  +   + R     ++      +  + Q +  ++      +VHRD++  N+LL
Sbjct: 84  LVTGGEL--FEDIVAR-----EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLL 136
Query: 406 -DEEFGAHLMGVGLSKF-VPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFG 461
             +  GA    V L+ F +  EV  ++    G  GT GYL+PE + ++      D+++ G
Sbjct: 137 ASKSKGA---AVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACG 193
Query: 462 VLLLEIVSGRRP 473
           V+L  ++ G  P
Sbjct: 194 VILYILLVGYPP 205

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKXQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDXELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIV 343
           G  VAVK+L R  FQ +   K  Y E+     ++H N++++      +    +  D Y+V
Sbjct: 49  GINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 107
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
            E +++  L + +H        LD      +   +  GI  LH      ++HRD++ SN+
Sbjct: 108 ME-LMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI 157
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
           ++  +    ++  GL++      M    V+   T  Y APE +         D++S G +
Sbjct: 158 VVKSDCTLKILDFGLARTACTNFMMTPYVV---TRYYRAPEVILGMGYAANVDIWSVGCI 214
Query: 464 LLEIVSGRRPAQAVDSV-CWQSIFE 487
           + E+V G    Q  D +  W  + E
Sbjct: 215 MGELVKGCVIFQGTDHIDQWNKVIE 239

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 81/192 (42%), Gaps = 35/192 (18%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ + SS +R   ++E   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 45  IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD 104
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414
           +L        SL      +    +  G+ +LH K    + H D++  N++L         
Sbjct: 105 FLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIML--------- 148
Query: 415 GVGLSKFVPWEVMQ------ERTVMAG-------GTYGYLAPEFVYRNELTTKSDVYSFG 461
              L K VP   ++         + AG       GT  ++APE V    L  ++D++S G
Sbjct: 149 ---LDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG 205
Query: 462 VLLLEIVSGRRP 473
           V+   ++SG  P
Sbjct: 206 VITYILLSGASP 217

>pdb|2AFP|A Chain A, The Solution Structure Of Type Ii Antifreeze Protein Reveals A New Member Of The Lectin Family Length = 129

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 39/136 (28%), Positives = 56/136 (41%), Gaps = 17/136 (12%)
Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP  W       +C  Y     +W  +ET C ++GGHLA++ S EE    Q L   N   
Sbjct: 7   CPAGW--QPLGDRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTL---NAGV 61
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
            W+GG S     G +W WSD             +F S C++ P  V A   +  + +   
Sbjct: 62  VWIGG-SACLQAG-AWTWSDGTPM---------NFRSWCSTKPDDVLAACCM-QMTAAAD 109
Query: 173 RSLVTERCNTSHPFIC 188
           +      C  SH  +C
Sbjct: 110 QCWDDLPCPASHKSVC 125

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 20/192 (10%)
Query: 290 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDRYIVYE 345
           +P G   A K +       +   + ++ R AR    L HPN+V +     + G  Y+V++
Sbjct: 26  IPTGQEYAAKIINTKKLSARD--HQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFD 83
Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
            V  G L  +   + R     ++      +  + Q +  ++      +VHRD++  N+LL
Sbjct: 84  LVTGGEL--FEDIVAR-----EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLL 136
Query: 406 -DEEFGAHLMGVGLSKF-VPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFG 461
             +  GA    V L+ F +  EV  ++    G  GT GYL+PE + ++      D+++ G
Sbjct: 137 ASKSKGA---AVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACG 193
Query: 462 VLLLEIVSGRRP 473
           V+L  ++ G  P
Sbjct: 194 VILYILLVGYPP 205

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 81/192 (42%), Gaps = 35/192 (18%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ + SS +R   ++E   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 38  IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD 97
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414
           +L        SL      +    +  G+ +LH K    + H D++  N++L         
Sbjct: 98  FLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIML--------- 141
Query: 415 GVGLSKFVPWEVMQ------ERTVMAG-------GTYGYLAPEFVYRNELTTKSDVYSFG 461
              L K VP   ++         + AG       GT  ++APE V    L  ++D++S G
Sbjct: 142 ---LDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG 198
Query: 462 VLLLEIVSGRRP 473
           V+   ++SG  P
Sbjct: 199 VITYILLSGASP 210

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 103 HLMGAD-----LNNIVKCAKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 153
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 154 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 206
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 207 CIMAELLTGR 216

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
           ++E   E+    ++ HPN++ +     +  D  ++ E V  G L  +L        SL  
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSE 114
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV-LLDEEFGA---HLMGVGLSKFVPW 424
                    +  G+ +LH K    + H D++  N+ LLD+        L+  GL+  +  
Sbjct: 115 EEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170
Query: 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           + ++ + +   GT  ++APE V    L  ++D++S GV+   ++SG  P
Sbjct: 171 DGVEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKXQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 13/160 (8%)
Query: 318 RFARLHHPNLVAVKG-CCYDHGDRYIVYEFV---VNGPLDRWLHHIPRGGRSLDWAMRMK 373
           R     HPN+V +   C     DR I    V   V+  L  +L   P  G  L       
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKD 124
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
           +     +G+ FLH      +VHRD++  N+L+       L   GL++   +++     V+
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV 181
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
              T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 182 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 217

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 112 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 162
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 163 VNEDXELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 215
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 216 CIMAELLTGR 225

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 13/160 (8%)
Query: 318 RFARLHHPNLVAVKG-CCYDHGDRYIVYEFV---VNGPLDRWLHHIPRGGRSLDWAMRMK 373
           R     HPN+V +   C     DR I    V   V+  L  +L   P  G  L       
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKD 116
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
           +     +G+ FLH      +VHRD++  N+L+       L   GL++   +++     V+
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV 173
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
              T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 174 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 209

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 112 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 162
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 163 VNEDXELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 215
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 216 CIMAELLTGR 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 57  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 116
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 117 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 167
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 168 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 220
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 221 CIMAELLTGR 230

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 117
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 118 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 168
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 169 VNEDXELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 221
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 222 CIMAELLTGR 231

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDAGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/204 (21%), Positives = 88/204 (43%), Gaps = 35/204 (17%)
Query: 292 DGSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDR---------- 340
           D    A+KR++  + +  +E    E+   A+L HP +V       +              
Sbjct: 29  DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88
Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR---MKVATTLAQGIAFLHDKVKPHVVH 395
             YI  +      L  W++    G  +++   R   + +   +A+ + FLH K    ++H
Sbjct: 89  YLYIQMQLCRKENLKDWMN----GRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMH 141
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-----------GTYGYLAPE 444
           RD++ SN+    +    +   GL   +  +  +E+TV+             GT  Y++PE
Sbjct: 142 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQD-EEEQTVLTPMPAYARHTGQVGTKLYMSPE 200
Query: 445 FVYRNELTTKSDVYSFGVLLLEIV 468
            ++ N  + K D++S G++L E++
Sbjct: 201 QIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 114 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 164
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 165 VNEDCELKILDFGLARHTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 217
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 218 CIMAELLTGR 227

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 87/190 (45%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKS-DVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +       ++ D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNAMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 114 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 164
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 165 VNEDCELKILDFGLARHTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 217
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 218 CIMAELLTGR 227

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 114 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 164
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 165 VNEDCELKILDFGLARHTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 217
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 218 CIMAELLTGR 227

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 103 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 153
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 154 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 206
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 207 CIMAELLTGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 53  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 113 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 163
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 164 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 216
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 217 CIMAELLTGR 226

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 84/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKSQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL +    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDSELKILDFGLCRHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 112 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 162
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 163 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 215
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 216 CIMAELLTGR 225

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 109 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 159
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 160 VNEDSELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 212
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 213 CIMAELLTGR 222

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGXVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 46  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 105
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 106 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 156
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 157 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 209
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 210 CIMAELLTGR 219

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 89/195 (45%), Gaps = 20/195 (10%)
Query: 282 TGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
            G  Y+ ++ +  +++ +        +K E  + I R   L HPN+V +     + G  Y
Sbjct: 35  AGQEYAAMIINTKKLSARD------HQKLEREARICRL--LKHPNIVRLHDSISEEGHHY 86
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           ++++ V  G L   +  + R     ++      +  + Q +  +    +  VVHR+++  
Sbjct: 87  LIFDLVTGGELFEDI--VAR-----EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPE 139
Query: 402 NVLLDEEFGAHLMGVGLSKF-VPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVY 458
           N+LL  +       V L+ F +  EV  E+    G  GT GYL+PE + ++      D++
Sbjct: 140 NLLLASKLKG--AAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLW 197
Query: 459 SFGVLLLEIVSGRRP 473
           + GV+L  ++ G  P
Sbjct: 198 ACGVILYILLVGYPP 212

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 114 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 164
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 165 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 217
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 218 CIMAELLTGR 227

>pdb|1FVU|B Chain B, Crystal Structure Of Botrocetin Length = 125

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 24/86 (27%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CPPDW  +  +  C+ +   +  WD++E +C E   G HL +  S EE    + L  + +
Sbjct: 2   CPPDW--SSYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEML 59
Query: 111 NG--CWVGGRSINTTVGLSWKWSDNM 134
            G   W+G   +       ++W+D M
Sbjct: 60  KGDVVWIGLSDVWNKC--RFEWTDGM 83

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|2ZIB|A Chain A, Crystal Structure Analysis Of Calcium-Independent Type Ii Antifreeze Protein Length = 133

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 25/80 (31%), Positives = 40/80 (50%), Gaps = 7/80 (8%)
Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP  W ++ ++  CF       +WD +E  C   GGHLA++ S EE+   + +    V  
Sbjct: 10  CPAGWTLHGQR--CFYSEATAMTWDLAEANCVNKGGHLASIHSLEEQLYIKDIVAGIV-- 65
Query: 113 CWVGGRSINTTVGLSWKWSD 132
            W+GG +    V  +W W+D
Sbjct: 66  -WIGGSACK--VAGAWSWTD 82

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 113 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 163
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 164 VNEDSELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 216
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 217 CIMAELLTGR 226

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 25/196 (12%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 334
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSA---GII 148
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKEN 205
Query: 455 SDVYSFGVLLLEIVSG 470
            D++S GV++ E++ G
Sbjct: 206 VDIWSVGVIMGEMIKG 221

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 112 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 162
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 163 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 215
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 216 CIMAELLTGR 225

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 109 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 159
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 160 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 212
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 213 CIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 109 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 159
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 160 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 212
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 213 CIMAELLTGR 222

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 109 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 159
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 160 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 212
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 213 CIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 113 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 163
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 164 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 216
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 217 CIMAELLTGR 226

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDYGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 127 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 177
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 178 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 230
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 231 CIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 66  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 125
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 126 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 176
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 177 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 229
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 230 CIMAELLTGR 239

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 44  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 103
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 104 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 154
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 155 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 207
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 208 CIMAELLTGR 217

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 117
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 118 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 168
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 169 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 221
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 222 CIMAELLTGR 231

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 43  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 103 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 153
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 154 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 206
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 207 CIMAELLTGR 216

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 25/196 (12%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 334
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSA---GII 148
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKEN 205
Query: 455 SDVYSFGVLLLEIVSG 470
            D++S GV++ E++ G
Sbjct: 206 VDIWSVGVIMGEMIKG 221

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 129
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 130 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 180
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 181 VNEDCELKILDFGLARHTDDE-------MXGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 233
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 234 CIMAELLTGR 243

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 129
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 130 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 180
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 181 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 233
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 234 CIMAELLTGR 243

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 113 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 163
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 164 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 216
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 217 CIMAELLTGR 226

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 44  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 103
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 104 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 154
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 155 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 207
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 208 CIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 45  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 104
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 105 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 155
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 156 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 208
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 209 CIMAELLTGR 218

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 59  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 119 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 169
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 170 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 222
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 223 CIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 59  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 119 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 169
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 170 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 222
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 223 CIMAELLTGR 232

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 127 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 177
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 178 VNEDCELKILDFGLARHTDDE-------MXGXVATRWYRAPEIMLNWMHYNQTVDIWSVG 230
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 231 CIMAELLTGR 240

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 13/160 (8%)
Query: 318 RFARLHHPNLVAVKG-CCYDHGDRYIVYEFV---VNGPLDRWLHHIPRGGRSLDWAMRMK 373
           R     HPN+V +   C     DR I    V   V+  L  +L   P  G  L       
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKD 116
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
           +     +G+ FLH      +VHRD++  N+L+       L   GL++   +++     V+
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV 173
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
              T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 174 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 209

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 66  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 125
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 126 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 176
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 177 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 229
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 230 CIMAELLTGR 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 67  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 127 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 177
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 178 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 230
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 231 CIMAELLTGR 240

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDRGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 372 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431
           + +   +A+ + FLH K    ++HRD++ SN+    +    +   GL   +  +  +E+T
Sbjct: 167 LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE-EEQT 222
Query: 432 VMAG-----------GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
           V+             GT  Y++PE ++ N  + K D++S G++L E++
Sbjct: 223 VLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 81/205 (39%), Gaps = 36/205 (17%)
Query: 282 TGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
           TG  Y+       R+   R   S    ++E   E+     + HPN++ +     +  D  
Sbjct: 50  TGKEYAAKFIKKRRLXSSRRGVS----REEIEREVNILREIRHPNIITLHDIFENKTDVV 105
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           ++ E V  G L  +L        SL      +    +  G+ +LH K    + H D++  
Sbjct: 106 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPE 158
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQ------ERTVMAG-------GTYGYLAPEFVYR 448
           N++L            L K VP   ++         + AG       GT  ++APE V  
Sbjct: 159 NIML------------LDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 206
Query: 449 NELTTKSDVYSFGVLLLEIVSGRRP 473
             L  ++D++S GV+   ++SG  P
Sbjct: 207 EPLGLEADMWSIGVITYILLSGASP 231

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 88/190 (46%), Gaps = 19/190 (10%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHH----PNLVAVKGCCYDHGDRYIVYEF 346
           G   A+K LK+++  +K +  +E  R  R  L H    P LV +          +++ ++
Sbjct: 82  GKLYAMKVLKKATIVQKAK-TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 140
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
           +  G L     H+ +  R  +  +++ V   +   +  LH   K  +++RDI+  N+LLD
Sbjct: 141 INGGEL---FTHLSQRERFTEHEVQIYVGE-IVLALEHLH---KLGIIYRDIKLENILLD 193
Query: 407 EEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV--YSFGVL 463
                 L   GLSK FV  E   ER     GT  Y+AP+ V   +      V  +S GVL
Sbjct: 194 SNGHVVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251
Query: 464 LLEIVSGRRP 473
           + E+++G  P
Sbjct: 252 MYELLTGASP 261

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDGGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 23/189 (12%)
Query: 293 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           G +VA+K      L +S  Q + E   EI     L HP+++ +        +  +V E+ 
Sbjct: 29  GQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA 86
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
            N   D   + + R   S   A R      +   + + H   +  +VHRD++  N+LLDE
Sbjct: 87  GNELFD---YIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVHRDLKPENLLLDE 138
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVY-RNELTTKSDVYSFGVLL 464
                +   GLS      +M +   +    G+  Y APE +  +     + DV+S GV+L
Sbjct: 139 HLNVKIADFGLS-----NIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 193
Query: 465 LEIVSGRRP 473
             ++  R P
Sbjct: 194 YVMLCRRLP 202

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 34/189 (17%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
           ++ + LK+S    + E   EI     L HP+++ +        D  +V E+         
Sbjct: 42  ISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-------- 91
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-------KPHVVHRDIRASNVLLDEE 408
                 GG   D+ +  K  T   +G  F    +       +  +VHRD++  N+LLD+ 
Sbjct: 92  ------GGELFDYIVEKKRMTE-DEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN 144
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTT--KSDVYSFGVLL 464
               +   GLS      +M +   +    G+  Y APE V   +L    + DV+S G++L
Sbjct: 145 LNVKIADFGLSN-----IMTDGNFLKTSCGSPNYAAPE-VINGKLYAGPEVDVWSCGIVL 198
Query: 465 LEIVSGRRP 473
             ++ GR P
Sbjct: 199 YVMLVGRLP 207

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 23/189 (12%)
Query: 293 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           G +VA+K      L +S  Q + E   EI     L HP+++ +        +  +V E+ 
Sbjct: 39  GQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA 96
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
            N   D   + + R   S   A R      +   + + H   +  +VHRD++  N+LLDE
Sbjct: 97  GNELFD---YIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVHRDLKPENLLLDE 148
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVY-RNELTTKSDVYSFGVLL 464
                +   GLS      +M +   +    G+  Y APE +  +     + DV+S GV+L
Sbjct: 149 HLNVKIADFGLS-----NIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 203
Query: 465 LEIVSGRRP 473
             ++  R P
Sbjct: 204 YVMLCRRLP 212

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 23/189 (12%)
Query: 293 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           G +VA+K      L +S  Q + E   EI     L HP+++ +        +  +V E+ 
Sbjct: 38  GQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA 95
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
            N   D   + + R   S   A R      +   + + H   +  +VHRD++  N+LLDE
Sbjct: 96  GNELFD---YIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVHRDLKPENLLLDE 147
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVY-RNELTTKSDVYSFGVLL 464
                +   GLS      +M +   +    G+  Y APE +  +     + DV+S GV+L
Sbjct: 148 HLNVKIADFGLS-----NIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 202
Query: 465 LEIVSGRRP 473
             ++  R P
Sbjct: 203 YVMLCRRLP 211

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 23/189 (12%)
Query: 293 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           G +VA+K      L +S  Q + E   EI     L HP+++ +        +  +V E+ 
Sbjct: 33  GQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA 90
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
            N   D   + + R   S   A R      +   + + H   +  +VHRD++  N+LLDE
Sbjct: 91  GNELFD---YIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVHRDLKPENLLLDE 142
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVY-RNELTTKSDVYSFGVLL 464
                +   GLS      +M +   +    G+  Y APE +  +     + DV+S GV+L
Sbjct: 143 HLNVKIADFGLSN-----IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 197
Query: 465 LEIVSGRRP 473
             ++  R P
Sbjct: 198 YVMLCRRLP 206

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 17/202 (8%)
Query: 290 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHGDRY---IVYE 345
           L DG   A+KR+     Q ++E   E       +HPN++  V  C  + G ++   ++  
Sbjct: 51  LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
           F   G L   +  +   G  L     + +   + +G+  +H K      HRD++ +N+LL
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILL 167
Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGG-------TYGYLAPEFVYRNE---LTTKS 455
            +E    LM +G        V   R  +          T  Y APE         +  ++
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227
Query: 456 DVYSFGVLLLEIVSGRRPAQAV 477
           DV+S G +L  ++ G  P   V
Sbjct: 228 DVWSLGCVLYAMMFGEGPYDMV 249

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L +   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 59  GLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 119 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 169
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 170 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 222
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 223 CIMAELLTGR 232

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVK----RLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VK 331
           +G  + G  + G    G  VAVK    R +RS F R+ E Y  +     L H N++  + 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTV----MLRHENILGFIA 65
Query: 332 GCCYDHG---DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
               D+G     ++V ++  +G L  +L+        +     +K+A + A G+A LH +
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHME 120
Query: 389 V-----KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG----GTYG 439
           +     KP + HRD+++ N+L+ +     +  +GL+  V  +   +   +A     GT  
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKR 178
Query: 440 YLAPEFVYRN------ELTTKSDVYSFGVLLLEI 467
           Y+APE +  +      E   ++D+Y+ G++  EI
Sbjct: 179 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVK----RLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VK 331
           +G  + G  + G    G  VAVK    R +RS F R+ E Y  +     L H N++  + 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTV----MLRHENILGFIA 64
Query: 332 GCCYDHG---DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
               D+G     ++V ++  +G L  +L+        +     +K+A + A G+A LH +
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHME 119
Query: 389 V-----KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG----GTYG 439
           +     KP + HRD+++ N+L+ +     +  +GL+  V  +   +   +A     GT  
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKR 177
Query: 440 YLAPEFVYRN------ELTTKSDVYSFGVLLLEI 467
           Y+APE +  +      E   ++D+Y+ G++  EI
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 84/188 (44%), Gaps = 13/188 (6%)
Query: 293 GSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGC---CYDHGDRYIVYEFV 347
           G +VA+K++  +       K    E+       H N++A+K        +G+   VY  V
Sbjct: 80  GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY--V 137
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
           V   ++  LH I    + L           L +G+ ++H      V+HRD++ SN+L++E
Sbjct: 138 VLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNE 194
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFGVLL 464
                +   G+++ +     + +  M     T  Y APE +   +E T   D++S G + 
Sbjct: 195 NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIF 254
Query: 465 LEIVSGRR 472
            E+++ R+
Sbjct: 255 GEMLARRQ 262

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 35/198 (17%)
Query: 293 GSRVAVK----RLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHG---DRYIVY 344
           G  VAVK    R +RS F R+ E Y  +     L H N++  +     D+G     ++V 
Sbjct: 32  GEEVAVKIFSSREERSWF-REAEIYQTV----MLRHENILGFIAADNKDNGTWTQLWLVS 86
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIR 399
           ++  +G L  +L+        +     +K+A + A G+A LH ++     KP + HRD++
Sbjct: 87  DYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 141
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG----GTYGYLAPEFVYRN------ 449
           + N+L+ +     +  +GL+  V  +   +   +A     GT  Y+APE +  +      
Sbjct: 142 SKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 199
Query: 450 ELTTKSDVYSFGVLLLEI 467
           E   ++D+Y+ G++  EI
Sbjct: 200 ESFKRADIYAMGLVFWEI 217

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 35/198 (17%)
Query: 293 GSRVAVK----RLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHG---DRYIVY 344
           G  VAVK    R +RS F R+ E Y  +     L H N++  +     D+G     ++V 
Sbjct: 65  GEEVAVKIFSSREERSWF-REAEIYQTV----MLRHENILGFIAADNKDNGTWTQLWLVS 119
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIR 399
           ++  +G L  +L+        +     +K+A + A G+A LH ++     KP + HRD++
Sbjct: 120 DYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG----GTYGYLAPEFVYRN------ 449
           + N+L+ +     +  +GL+  V  +   +   +A     GT  Y+APE +  +      
Sbjct: 175 SKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 232
Query: 450 ELTTKSDVYSFGVLLLEI 467
           E   ++D+Y+ G++  EI
Sbjct: 233 ESFKRADIYAMGLVFWEI 250

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 35/198 (17%)
Query: 293 GSRVAVK----RLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHG---DRYIVY 344
           G  VAVK    R +RS F R+ E Y  +     L H N++  +     D+G     ++V 
Sbjct: 52  GEEVAVKIFSSREERSWF-REAEIYQTV----MLRHENILGFIAADNKDNGTWTQLWLVS 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIR 399
           ++  +G L  +L+        +     +K+A + A G+A LH ++     KP + HRD++
Sbjct: 107 DYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 161
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG----GTYGYLAPEFVYRN------ 449
           + N+L+ +     +  +GL+  V  +   +   +A     GT  Y+APE +  +      
Sbjct: 162 SKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 219
Query: 450 ELTTKSDVYSFGVLLLEI 467
           E   ++D+Y+ G++  EI
Sbjct: 220 ESFKRADIYAMGLVFWEI 237

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIVY 344
           G ++AVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 76  GLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVT 135
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 136 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLA 186
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 187 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNMTVDIWSVG 239
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 240 CIMAELLTGR 249

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 83/200 (41%), Gaps = 21/200 (10%)
Query: 284 GTYSGILPDGSR-----VAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           GTY  +    +R     VA+KR++              EI     L H N+V +    + 
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                +V+EF  +  L ++          LD  +       L +G+ F H +   +V+HR
Sbjct: 73  DKKLTLVFEFC-DQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHR 125
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TT 453
           D++  N+L++      L   GL++   +P        V    T  Y  P+ ++  +L +T
Sbjct: 126 DLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV----TLWYRPPDVLFGAKLYST 181
Query: 454 KSDVYSFGVLLLEIVSGRRP 473
             D++S G +  E+ +  RP
Sbjct: 182 SIDMWSAGCIFAELANAARP 201

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 35/198 (17%)
Query: 293 GSRVAVK----RLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHG---DRYIVY 344
           G  VAVK    R +RS F R+ E Y  +     L H N++  +     D+G     ++V 
Sbjct: 29  GEEVAVKIFSSREERSWF-REAEIYQTV----MLRHENILGFIAADNKDNGTWTQLWLVS 83
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIR 399
           ++  +G L  +L+        +     +K+A + A G+A LH ++     KP + HRD++
Sbjct: 84  DYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 138
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG----GTYGYLAPEFVYRN------ 449
           + N+L+ +     +  +GL+  V  +   +   +A     GT  Y+APE +  +      
Sbjct: 139 SKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 196
Query: 450 ELTTKSDVYSFGVLLLEI 467
           E   ++D+Y+ G++  EI
Sbjct: 197 ESFKRADIYAMGLVFWEI 214

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 407
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 408 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPAFVAPEIVNYEPLGLEADMWSIGV 205
Query: 463 LLLEIVSGRRP 473
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 14/168 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
           EI    RL H N++ +    Y+   +  Y+V E+ V G +   L  +P   +        
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPE--KRFPVCQAH 112
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
                L  G+ +LH +    +VH+DI+  N+LL       +  +G+++ +      +   
Sbjct: 113 GYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 433 MAGGTYGYLAPEFVYRNELTT----KSDVYSFGVLLLEIVSGRRPAQA 476
            + G+  +  PE    N L T    K D++S GV L  I +G  P + 
Sbjct: 170 TSQGSPAFQPPEIA--NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 16/199 (8%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           +G+   G  Y      G   A+K  RL++           EI     L H N+V +    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
           +      +V+E + +  L + L  +  GG  L+          L  GIA+ HD+    V+
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLD-VCEGG--LESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVY-RNEL 451
           HRD++  N+L++ E    +   GL++   +P        V    T  Y AP+ +    + 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVLMGSKKY 178
Query: 452 TTKSDVYSFGVLLLEIVSG 470
           +T  D++S G +  E+V+G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 16/199 (8%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           +G+   G  Y      G   A+K  RL++           EI     L H N+V +    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
           +      +V+E + +  L + L  +  GG  L+          L  GIA+ HD+    V+
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLD-VCEGG--LESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVY-RNEL 451
           HRD++  N+L++ E    +   GL++   +P        V    T  Y AP+ +    + 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVLMGSKKY 178
Query: 452 TTKSDVYSFGVLLLEIVSG 470
           +T  D++S G +  E+V+G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 18/164 (10%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMK 373
           EI   +R+ H N++ V     + G   +V E   +G  L  ++   PR    LD  +   
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASY 134
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
           +   L   + +L  K    ++HRDI+  N+++ E+F   L+  G + ++      ER  +
Sbjct: 135 IFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL------ERGKL 185
Query: 434 AG---GTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIVSGRRP 473
                GT  Y APE +  N     + +++S GV L  +V    P
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 16/199 (8%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           +G+   G  Y      G   A+K  RL++           EI     L H N+V +    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
           +      +V+E + +  L + L  +  GG  L+          L  GIA+ HD+    V+
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLD-VCEGG--LESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVY-RNEL 451
           HRD++  N+L++ E    +   GL++   +P        V    T  Y AP+ +    + 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLMGSKKY 178
Query: 452 TTKSDVYSFGVLLLEIVSG 470
           +T  D++S G +  E+V+G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 83/200 (41%), Gaps = 21/200 (10%)
Query: 284 GTYSGILPDGSR-----VAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYD 336
           GTY  +    +R     VA+KR++              EI     L H N+V +    + 
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
                +V+EF  +  L ++          LD  +       L +G+ F H +   +V+HR
Sbjct: 73  DKKLTLVFEFC-DQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHR 125
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TT 453
           D++  N+L++      L   GL++   +P        V    T  Y  P+ ++  +L +T
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYRPPDVLFGAKLYST 181
Query: 454 KSDVYSFGVLLLEIVSGRRP 473
             D++S G +  E+ +  RP
Sbjct: 182 SIDMWSAGCIFAELANAGRP 201

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/181 (21%), Positives = 72/181 (39%), Gaps = 7/181 (3%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           G+  A K +       K+    EI   + L HP LV +     D  +  ++YEF+  G L
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
                 +      +     ++    + +G+  +H+    + VH D++  N++   +    
Sbjct: 242 ---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNE 295
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 472
           L  +        +  Q   V   GT  + APE      +   +D++S GVL   ++SG  
Sbjct: 296 LKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354
Query: 473 P 473
           P
Sbjct: 355 P 355

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 16/183 (8%)
Query: 293 GSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           G  VA+K+   S      KK    EI    +L HPNLV +          ++V+E+  + 
Sbjct: 28  GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
                LH + R  R +   +   +     Q + F H   K + +HRD++  N+L+ +   
Sbjct: 88  ----VLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSV 140
Query: 411 AHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLLEI 467
             L   G ++ +  P +   +       T  Y +PE  V   +     DV++ G +  E+
Sbjct: 141 IKLCDFGFARLLTGPSDYYDDEV----ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAEL 196
Query: 468 VSG 470
           +SG
Sbjct: 197 LSG 199

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 334
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSA---GII 148
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKEN 205
Query: 455 SDVYSFGVLLLEIVSG 470
            D++S G ++ E++ G
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 43  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 407
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 103 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 155
Query: 408 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 156 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 204
Query: 463 LLLEIVSGRRP 473
           +   ++SG  P
Sbjct: 205 ITYILLSGASP 215

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 407
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 408 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 463 LLLEIVSGRRP 473
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 84/188 (44%), Gaps = 13/188 (6%)
Query: 293 GSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGC---CYDHGDRYIVYEFV 347
           G +VA+K++  +       K    E+       H N++A+K        +G+   VY  V
Sbjct: 79  GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY--V 136
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
           V   ++  LH I    + L           L +G+ ++H      V+HRD++ SN+L++E
Sbjct: 137 VLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNE 193
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFGVLL 464
                +   G+++ +     + +  M     T  Y APE +   +E T   D++S G + 
Sbjct: 194 NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIF 253
Query: 465 LEIVSGRR 472
            E+++ R+
Sbjct: 254 GEMLARRQ 261

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 407
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 408 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 463 LLLEIVSGRRP 473
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 43  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 407
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 103 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 155
Query: 408 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 156 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 204
Query: 463 LLLEIVSGRRP 473
           +   ++SG  P
Sbjct: 205 ITYILLSGASP 215

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 407
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 408 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 463 LLLEIVSGRRP 473
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 407
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 408 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 463 LLLEIVSGRRP 473
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 407
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 408 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 463 LLLEIVSGRRP 473
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 407
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 408 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 463 LLLEIVSGRRP 473
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 407
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 408 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 463 LLLEIVSGRRP 473
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 334
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKEN 205
Query: 455 SDVYSFGVLLLEIVSG 470
            D++S G ++ E++ G
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/181 (21%), Positives = 72/181 (39%), Gaps = 7/181 (3%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           G+  A K +       K+    EI   + L HP LV +     D  +  ++YEF+  G L
Sbjct: 76  GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 135
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
                 +      +     ++    + +G+  +H+    + VH D++  N++   +    
Sbjct: 136 ---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNE 189
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 472
           L  +        +  Q   V   GT  + APE      +   +D++S GVL   ++SG  
Sbjct: 190 LKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 248
Query: 473 P 473
           P
Sbjct: 249 P 249

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 87/195 (44%), Gaps = 20/195 (10%)
Query: 282 TGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
           TG  Y+  + +  +++ +        +K E  + I R   L H N+V +     + G  Y
Sbjct: 28  TGHEYAAKIINTKKLSARD------HQKLEREARICRL--LKHSNIVRLHDSISEEGFHY 79
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           +V++ V  G L   +  + R     ++      +  + Q +  +    +  VVHRD++  
Sbjct: 80  LVFDLVTGGELFEDI--VAR-----EYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPE 132
Query: 402 NVLLDEEFGAHLMGVGLSKF-VPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVY 458
           N+LL  +       V L+ F +  EV  ++    G  GT GYL+PE + +       D++
Sbjct: 133 NLLLASKCKG--AAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIW 190
Query: 459 SFGVLLLEIVSGRRP 473
           + GV+L  ++ G  P
Sbjct: 191 ACGVILYILLVGYPP 205

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 407
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 408 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 463 LLLEIVSGRRP 473
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 407
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 408 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 463 LLLEIVSGRRP 473
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 25/194 (12%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 334
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD++ SN+++  +    ++  GL++      M E  V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV---TRYYRAPEVILGMGYKEN 205
Query: 455 SDVYSFGVLLLEIV 468
            D++S G ++ E+V
Sbjct: 206 VDIWSVGCIMGEMV 219

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 84/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 344
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
           ++E+    ++   L++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFYLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 462 VLLLEIVSGR 471
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/111 (23%), Positives = 60/111 (54%), Gaps = 9/111 (8%)
Query: 372 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSKFVPWEVMQ 428
           +++   + +G+ +LH   + ++VH D++  N+LL   +      ++  G+S+ +     +
Sbjct: 134 IRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACE 189
Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
            R +M  GT  YLAPE +  + +TT +D+++ G++   +++   P    D+
Sbjct: 190 LREIM--GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 334
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKEN 205
Query: 455 SDVYSFGVLLLEIVSG 470
            D++S G ++ E++ G
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|1SL6|A Chain A, Crystal Structure Of A Fragment Of Dc-signr (containg The Carbohydrate Recognition Domain And Two Repeats Of The Neck) Complexed With Lewis-x. Length = 184

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 21/80 (26%), Positives = 38/80 (47%), Gaps = 4/80 (5%)
Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP DW   +    C+    + R+W +S T C+E+   L  + + EE++  Q    ++   
Sbjct: 53  CPKDWTFFQ--GNCYFMSNSQRNWHDSVTACQEVRAQLVVIKTAEEQNFLQLQTSRSNRF 110
Query: 113 CWVGGRSINTTVGLSWKWSD 132
            W+G   +N     +W+W D
Sbjct: 111 SWMGLSDLNQEG--TWQWVD 128

>pdb|2XR6|A Chain A, Crystal Structure Of The Complex Of The Carbohydrate Recognition Domain Of Human Dc-Sign With Pseudo Trimannoside Mimic Length = 170

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 4/81 (4%)
Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
           PCP +W   +    C+    + R+W +S T CKE+G  L  + S EE++  Q    ++  
Sbjct: 21  PCPWEWTFFQ--GNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNR 78
Query: 112 GCWVGGRSINTTVGLSWKWSD 132
             W+G   +N     +W+W D
Sbjct: 79  FTWMGLSDLNQEG--TWQWVD 97

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 407
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPR 156
Query: 408 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 463 LLLEIVSGRRP 473
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 298 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFD 103
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 407
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 408 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 463 LLLEIVSGRRP 473
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 334
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKEN 205
Query: 455 SDVYSFGVLLLEIVSG 470
            D++S G ++ E++ G
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 334
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV---TRYYRAPEVILGMGYKEN 205
Query: 455 SDVYSFGVLLLEIVSG 470
            D++S G ++ E++ G
Sbjct: 206 VDIWSVGCIMGEMIKG 221

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	557
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-107
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-104
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-97
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-57
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-50
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-50
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-49
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-47
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-47
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-45
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-44
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-42
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-42
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-39
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-38
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-38
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-38
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-37
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-33
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-32
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-31
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-31
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-31
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-30
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-30
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-29
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-29
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-29
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-29
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-29
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-28
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-28
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-28
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-28
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-28
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-28
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-27
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-27
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-27
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-27
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-26
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-26
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-26
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-26
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-26
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-26
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-25
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-24
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-24
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-24
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-24
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-23
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-22
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-22
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-22
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-22
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-21
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-21
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-20
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-20
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-20
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-20
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-20
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-19
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-19
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-18
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-18
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-18
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-18
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-18
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-17
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-17
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-17
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-17
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-17
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-16
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-16
1fm5_A	199	Early activation antigen CD69; C-type lectin-like	1e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-16
1mpu_A	138	NKG2-D type II integral membrane protein; C-type l	2e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-16
3rs1_A	122	C-type lectin domain family 2 member I; C-type lec	3e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-16
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-16
1ypq_A	135	Oxidised low density lipoprotein (lectin-like) rec	4e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-16
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-16
1jwi_A	131	Bitiscetin; domain swapping, C-type lectin, toxin;	2e-15
1hq8_A	123	NKG2-D; homodimer, CIS-proline, apoptosis; 1.95A {	3e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-15
2yhf_A	118	C-type lectin domain family 5 member A; immune sys	3e-15
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-15
3hup_A	130	Early activation antigen CD69; C-type lectin-like	4e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-15
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-15
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-15
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-14
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-14
3vpp_A	132	C-type lectin domain family 9 member A; dendritic	1e-14
3m9z_A	139	Killer cell lectin-like receptor subfamily B MEMB;	2e-14
1egg_A	147	Macrophage mannose receptor; C-type lectin, sugar	4e-14
2bpd_A	142	Dectin-1; receptor, beta-glucan, fungal recognitio	4e-14
3c8j_A	203	Natural killer cell receptor LY49C; MHC, virus, im	4e-14
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-14
1sb2_A	133	Rhodocetin alpha subunit; C-type lectin, domain sw	4e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-14
3ff9_A	115	Killer cell lectin-like receptor subfamily G membe	5e-14
1oz7_A	131	Echicetin A-chain; platelet aggregation, dimer, to	5e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-14
3bdw_B	120	NKG2-A/NKG2-B type II integral membrane protein; N	6e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-14
3bdw_A	123	Natural killer cells antigen CD94; NK cells, recep	7e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-14
2c6u_A	122	CLEC1B protein; lectin, rhodocytin, aggretin, C-ty	1e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-13
1c3a_A	135	Flavocetin-A: alpha subunit; C-type lectin-like do	1e-13
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-13
3ff7_C	112	Killer cell lectin-like receptor subfamily G membe	1e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-13
1umr_C	125	Convulxin beta, CVX beta; lectin, C-type lectin, p	2e-13
1ukm_B	128	EMS16 B chain, EMS16 subunit B; domain swapping, C	2e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-13
1sb2_B	129	Rhodocetin beta subunit; C-type lectin, domain swa	3e-13
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-13
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-13
2e3x_C	122	Coagulation factor X-activating enzyme light CHAI;	4e-13
2py2_A	136	Antifreeze protein type II; type II antifreeze pro	4e-13
3ubu_A	131	Agglucetin subunit alpha-1; platelet inhibiting, a	4e-13
3g8k_A	130	Lectin-related NK cell receptor LY49L1; natural ki	4e-13
3gpr_D	124	Rhodocetin subunit delta; disulfide bond, lectin,	4e-13
1tdq_B	130	Aggrecan core protein; extracellular matrix, lecti	5e-13
1umr_A	135	Convulxin alpha, CVX alpha; lectin, C-type lectin,	5e-13
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-13
1jwi_B	125	Platelet aggregation inducer; domain swapping, C-t	6e-13
1oz7_B	123	Echicetin B-chain; platelet aggregation, dimer, to	7e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-13
3bx4_B	146	Aggretin beta chain; toxin; 1.70A {Agkistrodon rho	8e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-13
1fvu_A	133	Botrocetin alpha chain; VON WILLBRAND factor modul	1e-12
3g8l_A	190	Lectin-related NK cell receptor LY49L1; natural ki	1e-12
2kv3_A	131	Regenerating islet-derived protein 4; GISP, C-type	1e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-12
1j34_A	129	Coagulation factor IX-binding protein A chain; mag	2e-12
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-12
3gpr_C	134	Rhodocetin subunit gamma; disulfide bond, lectin,	3e-12
1sl6_A	184	C-type lectin DC-signr; sugar binding protein; HET	3e-12
1fvu_B	125	Botrocetin beta chain; VON WILLBRAND factor modula	3e-12
1c3a_B	125	Flavocetin-A: beta subunit; C-type lectin-like dom	3e-12
1j34_B	123	Coagulation factor IX-binding protein B chain; mag	3e-12
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-12
1pwb_A	177	SP-D, PSP-D, pulmonary surfactant-associated prote	4e-12
2afp_A	129	Protein (SEA raven type II antifreeze protein); re	4e-12
3bx4_A	136	Aggretin alpha chain; toxin; 1.70A {Agkistrodon rh	4e-12
3c22_A	156	C-type lectin domain family 4 member K; coiled coi	4e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-06
2xr6_A	170	CD209 antigen; sugar binding protein, carbohydrate	5e-12
2b6b_D	175	CD209 antigen; cryo EM dengue CRD DC-SIGN, icosahe	5e-12
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-12
3ubu_B	126	Agglucetin subunit beta-2; platelet inhibiting, ag	6e-12
1qdd_A	144	Lithostathine; pancreatic stone inhibitor, metal b	8e-12
1jzn_A	135	Galactose-specific lectin; C-type lectin, protein-	8e-12
2e3x_B	134	Coagulation factor X-activating enzyme light CHAI;	9e-12
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-11
3kqg_A	182	Langerin, C-type lectin domain family 4 member K;	1e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-11
2ox9_A	140	Collectin placenta 1; C-type lectin, sugar binding	1e-11
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-11
1ukm_A	134	EMS16 A chain, EMS16 subunit A; domain swapping, C	1e-11
1dv8_A	128	Asialoglycoprotein receptor 1; C-type lectin CRD,	1e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-11
2h2t_B	175	Low affinity immunoglobulin epsilon FC receptor (	2e-11
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-11
2ls8_A	156	C-type lectin domain family 4 member D; structural	2e-11
1uv0_A	149	Pancreatitis-associated protein 1; lectin, C-type,	2e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-11
2zib_A	133	Type II antifreeze protein; thermal hysteresis, le	3e-11
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-11
1gz2_A	142	Ovocleidin-17, OC-17 ovocleidin; structural protei	6e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-10
2vuv_A	129	Codakine; sugar-binding protein, C-type, lectin, m	1e-10
3pbf_A	148	Pulmonary surfactant-associated protein A; collect	2e-10
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-10
1tn3_A	137	Tetranectin; plasminogen binding, kringle 4, C-typ	2e-10
1rtm_1	149	Mannose-binding protein-A; lectin; 1.80A {Rattus n	3e-10
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-10
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-10
1htn_A	182	Tetranectin; plasminogen binding, kringle 4, alpha	6e-10
1buu_A	168	Protein (mannose-binding protein A); lectin, HOST	6e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-10
1hup_A	141	Mannose-binding protein; alpha-helical coiled-coil	8e-10
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-10
1h8u_A	117	MBP, eosinophil granule major basic protein 1; lec	1e-09
3cfw_A	164	L-selectin; EGF, cell adhesion, EGF-like domain, g	1e-09
1byf_A	125	TC14, protein (polyandrocarpa lectin); C-type lect	1e-09
3alu_A	157	Lectin CEL-IV, C-type; C-type lectin, raffinose, s	1e-09
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-09
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-09
1g1t_A	157	E-selectin; EGF, adhesion molecule, SLEX, immune s	3e-09
1g1s_A	162	P-selectin; selectin, lectin, EGF, sulphated, SLEX	4e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-09
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-09
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-09
1wmz_A	140	Lectin CEL-I, N-acetyl-D-galactosamine-specific C-	1e-08
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-08
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-08
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-08
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-08
2msb_A	115	Mannose-binding protein-A; lectin; HET: BMA MAN; 1	3e-08
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-08
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-08
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-08
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-08
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-08
1rdl_1	113	SUB-MBP-C, mannose-binding protein-C; C-type lecti	9e-08
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-08
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-07
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-07
1wk1_A	150	Hypothetical protein YK1067A12; lectin C-type doma	5e-07
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-07
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-06
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-06
3fd4_A	191	Glycoprotein GP42; C type lectin, virus entry, mem	6e-06
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-06
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-05
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-05
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-05
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-05
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-05
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-05
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  324 bits (832), Expect = e-107
 Identities = 101/299 (33%), Positives = 165/299 (55%), Gaps = 13/299 (4%)

Query: 254 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ-RKKEF 312
             K F+  EL+  + NFS  N +LG    G  Y G L DG+ VAVKRLK    Q  + +F
Sbjct: 16  QLKRFSLRELQVASDNFSNKN-ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74

Query: 313 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
            +E+   +   H NL+ ++G C    +R +VY ++ NG +   L   P     LDW  R 
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134

Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT- 431
           ++A   A+G+A+LHD   P ++HRD++A+N+LLDEEF A +   GL+K + ++     T 
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194

Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP---AQAVDSVCWQSIFEW 488
           V   GT G++APE++   + + K+DV+ +GV+LLE+++G+R    A+  +      + +W
Sbjct: 195 VR--GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD-VMLLDW 251

Query: 489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
              L++  +   L+D     L  +  +   V++++ +   CTQ  P  RP+MS VV  L
Sbjct: 252 VKGLLKEKKLEALVDV---DLQGNYKDEE-VEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  314 bits (807), Expect = e-104
 Identities = 94/326 (28%), Positives = 160/326 (49%), Gaps = 19/326 (5%)

Query: 233 SKRRRKSRKLSNPAASALVPPSW-KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILP 291
           SK  + +  +++  +S+ + P         +L   T NF     L+G    G  Y G+L 
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKF-LIGHGVFGKVYKGVLR 61

Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           DG++VA+KR    S Q  +EF +EI   +   HP+LV++ G C +  +  ++Y+++ NG 
Sbjct: 62  DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121

Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
           L R L+       S+ W  R+++    A+G+ +LH      ++HRD+++ N+LLDE F  
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVP 178

Query: 412 HLMGVGLSKFVPWEVMQERT-----VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
            +   G+SK        ++T     V   GT GY+ PE+  +  LT KSDVYSFGV+L E
Sbjct: 179 KITDFGISKKGTEL---DQTHLSTVVK--GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233

Query: 467 IVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV 526
           ++  R            ++ EWA     + +  +++DP   +L+  I     ++K  D  
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP---NLADKIRPES-LRKFGDTA 289

Query: 527 YACTQHVPSMRPRMSHVVHQLQQLAQ 552
             C       RP M  V+ +L+   +
Sbjct: 290 VKCLALSSEDRPSMGDVLWKLEYALR 315

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  296 bits (759), Expect = 8e-97
 Identities = 99/309 (32%), Positives = 153/309 (49%), Gaps = 29/309 (9%)

Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTG----GT-YSGILPDGSRVAVKRLK----RSSF 306
             F+  EL+++T NF E    +G +K G    G  Y G + + + VAVK+L      ++ 
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 307 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 366
           + K++F  EI   A+  H NLV + G   D  D  +VY ++ NG L   L     G   L
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPL 130

Query: 367 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426
            W MR K+A   A GI FLH+    H +HRDI+++N+LLDE F A +   GL++      
Sbjct: 131 SWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 427 MQERT--VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD-SVCWQ 483
               T  ++  GT  Y+APE + R E+T KSD+YSFGV+LLEI++G      VD     Q
Sbjct: 188 QTVMTSRIV--GTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPA---VDEHREPQ 241

Query: 484 SIFEWATPLVQSHRYLE-LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH 542
            + +    +    + +E  +D  ++   S       V+ +  +   C     + RP +  
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADST-----SVEAMYSVASQCLHEKKNKRPDIKK 296

Query: 543 VVHQLQQLA 551
           V   LQ++ 
Sbjct: 297 VQQLLQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  194 bits (494), Expect = 2e-57
 Identities = 66/320 (20%), Positives = 113/320 (35%), Gaps = 40/320 (12%)

Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK---RSSFQRKKEFYS 314
             TE L   +             + G  +         VAVK      + S+Q + E YS
Sbjct: 14  LGTENLYFQSMPLQLLEVK-ARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYS 71

Query: 315 EIGRFARLHHPNLVAVKGCC----YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAM 370
                  + H N++   G          D +++  F   G L  +L         + W  
Sbjct: 72  ----LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNE 122

Query: 371 RMKVATTLAQGIAFLH-------DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423
              +A T+A+G+A+LH       D  KP + HRDI++ NVLL     A +   GL+    
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 424 WEVMQERTVMAGGTYGYLAPE-----FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD 478
                  T    GT  Y+APE       ++ +   + D+Y+ G++L E+ S    A    
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 479 SVCWQSIFEWATPL------VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 532
                  FE           +Q     +   P++        +   +  + + +  C  H
Sbjct: 243 DEY-MLPFEEEIGQHPSLEDMQEVVVHKKKRPVL---RDYWQKHAGMAMLCETIEECWDH 298

Query: 533 VPSMRPRMSHVVHQLQQLAQ 552
               R     V  ++ Q+ +
Sbjct: 299 DAEARLSAGCVGERITQMQR 318

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  175 bits (445), Expect = 1e-50
 Identities = 79/275 (28%), Positives = 130/275 (47%), Gaps = 41/275 (14%)

Query: 293 GSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           GS VAVK L    F  +R  EF  E+    RL HPN+V   G      +  IV E++  G
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119

Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L R LH        LD   R+ +A  +A+G+ +LH++  P +VHR++++ N+L+D+++ 
Sbjct: 120 SLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYT 177

Query: 411 AHLMGVGLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIV 468
             +   GLS+    +     +  +  GT  ++APE V R+E    KSDVYSFGV+L E+ 
Sbjct: 178 VKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWELA 233

Query: 469 SGRRP------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 522
           + ++P      AQ V +V ++                            +IP   +  +V
Sbjct: 234 TLQQPWGNLNPAQVVAAVGFK------------------------CKRLEIPR-NLNPQV 268

Query: 523 VDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 557
             ++  C  + P  RP  + ++  L+ L +  V  
Sbjct: 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  173 bits (440), Expect = 2e-50
 Identities = 73/282 (25%), Positives = 125/282 (44%), Gaps = 45/282 (15%)

Query: 283 GGTYSGILPDGSRVAVKRLKRSSFQ----RKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338
           G  Y      G  VAVK  +    +      +    E   FA L HPN++A++G C    
Sbjct: 21  GKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79

Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
           +  +V EF   GPL+R L      G+ +   + +  A  +A+G+ +LHD+    ++HRD+
Sbjct: 80  NLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134

Query: 399 RASNVLLDEEFGAHLMGV--------GLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRN 449
           ++SN+L+ ++     +          GL++          T M+  G Y ++APE V R 
Sbjct: 135 KSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMAPE-VIRA 188

Query: 450 EL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508
            + +  SDV+S+GVLL E+++G  P + +D          A  +  +   L         
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNKLALP-------- 234

Query: 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           + S  PE         L+  C    P  RP  ++++ QL  +
Sbjct: 235 IPSTCPEP-----FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  171 bits (435), Expect = 2e-49
 Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 51/290 (17%)

Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           L ++ +G  + G    G+ + VK LK   +  ++ ++F  E  R     HPN++ V G C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 335 YD--HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
                    ++  ++  G L   LH        +D +  +K A  +A+G+AFLH   +P 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL-EPL 133

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-- 450
           +    + + +V++DE+  A +    +         Q    M      ++APE   + +  
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFS-----FQSPGRM--YAPAWVAPE-ALQKKPE 185

Query: 451 --LTTKSDVYSFGVLLLEIVSGRRP------AQAVDSVCWQSIFEWATPLVQSHRYLELL 502
                 +D++SF VLL E+V+   P       +    V  +                   
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE------------------- 226

Query: 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                 L   IP  G+   V  L+  C    P+ RP+   +V  L+++  
Sbjct: 227 -----GLRPTIPP-GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  165 bits (421), Expect = 3e-47
 Identities = 65/281 (23%), Positives = 119/281 (42%), Gaps = 45/281 (16%)

Query: 286 YSGI-LPDGSRVAVKRLKRSSFQ-------RKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
           + G  + D S VA+K L     +       + +EF  E+   + L+HPN+V + G  ++ 
Sbjct: 36  HKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN- 94

Query: 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
               +V EFV  G L   L         + W++++++   +A GI ++ ++  P +VHRD
Sbjct: 95  -PPRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRD 149

Query: 398 IRASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAG-GTYGYLAPE-FVYRNE 450
           +R+ N+ L        +       GLS+          +V    G + ++APE      E
Sbjct: 150 LRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLLGNFQWMAPETIGAEEE 203

Query: 451 L-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509
             T K+D YSF ++L  I++G  P         +  F     + +              +
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYG--KIKFINM--IREEGLRPT--------I 251

Query: 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
             D P      ++ +++  C    P  RP  S++V +L +L
Sbjct: 252 PEDCPP-----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  165 bits (421), Expect = 4e-47
 Identities = 64/276 (23%), Positives = 114/276 (41%), Gaps = 46/276 (16%)

Query: 286 YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345
                     VA+K+++  S   +K F  E+ + +R++HPN+V + G C +     +V E
Sbjct: 25  CKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVME 79

Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
           +   G L   LH           A  M      +QG+A+LH      ++HRD++  N+LL
Sbjct: 80  YAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 138

Query: 406 DEE--------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSD 456
                      FG        +       +Q       G+  ++APE V+     + K D
Sbjct: 139 VAGGTVLKICDFG-------TACD-----IQTHMTNNKGSAAWMAPE-VFEGSNYSEKCD 185

Query: 457 VYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEA 516
           V+S+G++L E+++ R+P   +    ++    WA   V +             L  ++P+ 
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFR--IMWA---VHNGTRPP--------LIKNLPKP 232

Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                +  L+  C    PS RP M  +V  +  L +
Sbjct: 233 -----IESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  159 bits (404), Expect = 8e-45
 Identities = 62/282 (21%), Positives = 120/282 (42%), Gaps = 49/282 (17%)

Query: 284 GTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
           G + G       VAVK L  ++   Q+ + F +E+G   +  H N++   G         
Sbjct: 43  GKWHG------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLA 95

Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           IV ++     L   LH         +    + +A   A+G+ +LH K    ++HRD++++
Sbjct: 96  IVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSN 149

Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL----TTKSDV 457
           N+ L E+    +   GL+          +     G+  ++APE V R +     + +SDV
Sbjct: 150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSNPYSFQSDV 208

Query: 458 YSFGVLLLEIVSGRRP-------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
           Y+FG++L E+++G+ P        Q ++ V                     L P +S + 
Sbjct: 209 YAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG-----------------SLSPDLSKVR 251

Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
           S+ P+      +  L+  C +     RP    ++ ++++LA+
Sbjct: 252 SNCPKR-----MKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  154 bits (390), Expect = 1e-42
 Identities = 51/292 (17%), Positives = 105/292 (35%), Gaps = 64/292 (21%)

Query: 284 GTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
           G + G       VA++ +        + K F  E+  + +  H N+V   G C       
Sbjct: 52  GRWHG------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105

Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           I+        L   +         LD     ++A  + +G+ +LH K    ++H+D+++ 
Sbjct: 106 IITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSK 159

Query: 402 NVLLDEE------FGAHLMGVGLSKFV-PWEVMQERTVMAG--GTYGYLAPEFVYRNEL- 451
           NV  D        F       GL       +  +    +    G   +LAPE + R    
Sbjct: 160 NVFYDNGKVVITDF-------GLFSISGVLQAGRREDKLRIQNGWLCHLAPE-IIRQLSP 211

Query: 452 ---------TTKSDVYSFGVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSHRYLE 500
                    +  SDV++ G +  E+ +   P   Q  +++ WQ        +    +   
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ--------MGTGMK--- 260

Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                      ++ + G+ +++ D++  C       RP  + ++  L++L +
Sbjct: 261 ----------PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  152 bits (385), Expect = 5e-42
 Identities = 58/283 (20%), Positives = 103/283 (36%), Gaps = 39/283 (13%)

Query: 284 GTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343
            T+      G  + +K L R   + ++ F  E+     L HPN++   G  Y       +
Sbjct: 29  VTHRE---TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85

Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
            E++  G L   +           W+ R+  A  +A G+A+LH     +++HRD+ + N 
Sbjct: 86  TEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNC 139

Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG------------GTYGYLAPEFVYRNEL 451
           L+ E     +   GL++ +  E  Q   + +             G   ++APE +     
Sbjct: 140 LVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY 199

Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511
             K DV+SFG++L EI+                 F      +    +L+   P       
Sbjct: 200 DEKVDVFSFGIVLCEIIGRVNADPDYLPR--TMDF-----GLNVRGFLDRYCP------P 246

Query: 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
           + P +        +   C    P  RP    + H L+ L    
Sbjct: 247 NCPPS-----FFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  146 bits (370), Expect = 1e-39
 Identities = 71/330 (21%), Positives = 117/330 (35%), Gaps = 49/330 (14%)

Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK---RSSFQRKKEFYS 314
               E      N      + G  + G  Y G L D   VAVK      R +F  +K  Y 
Sbjct: 3   AAASEPSLDLDNLKLLELI-GRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIY- 59

Query: 315 EIGRFARLHHPNLVAVKGCCY-----DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
              R   + H N+                +  +V E+  NG L ++L        + DW 
Sbjct: 60  ---RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWV 111

Query: 370 MRMKVATTLAQGIAFLH------DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423
              ++A ++ +G+A+LH      D  KP + HRD+ + NVL+  +    +   GLS  + 
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

Query: 424 WEVMQERTVMAG------GTYGYLAPE-------FVYRNELTTKSDVYSFGVLLLEIVSG 470
              +              GT  Y+APE                + D+Y+ G++  EI   
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

Query: 471 RRPAQAVDSVC-WQSIFEWATPLVQSHRYLELLDPLISS--LSSDIPEA-----GVVQKV 522
                  +SV  +Q  F+     V +H   E +  L+S        PEA       V+ +
Sbjct: 232 CTDLFPGESVPEYQMAFQT---EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288

Query: 523 VDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
            + +  C       R        ++ +L  
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAELMM 318

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  143 bits (362), Expect = 2e-38
 Identities = 57/289 (19%), Positives = 115/289 (39%), Gaps = 33/289 (11%)

Query: 286 YSGILPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
           + G    G +VAVK       +S+ R+ E Y        + H N++              
Sbjct: 54  WMGKW-RGEKVAVKVFFTTEEASWFRETEIYQ----TVLMRHENILGFIAADIKGTGSWT 108

Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHV 393
             Y++ ++  NG L  +L        +LD    +K+A +   G+  LH ++     KP +
Sbjct: 109 QLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163

Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPE------F 445
            HRD+++ N+L+ +     +  +GL+     +  +         GT  Y+ PE       
Sbjct: 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN 223

Query: 446 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS--VCWQSIFEWATPLVQSHRYLELLD 503
               +    +D+YSFG++L E+         V+   + +  +   + P  +  R +  + 
Sbjct: 224 RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV-PSDPSYEDMREIVCIK 282

Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
            L  S  +       ++++  L+  C  H P+ R     V   L ++++
Sbjct: 283 KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  142 bits (360), Expect = 3e-38
 Identities = 57/296 (19%), Positives = 108/296 (36%), Gaps = 47/296 (15%)

Query: 286 YSGILPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
           + G    G  VAVK        S+ R+ E Y        L H N++              
Sbjct: 59  WRGKW-RGEEVAVKIFSSREERSWFREAEIYQT----VMLRHENILGFIAADNKDNGTWT 113

Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHV 393
             ++V ++  +G L  +L+       ++     +K+A + A G+A LH ++     KP +
Sbjct: 114 QLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 168

Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNEL 451
            HRD+++ N+L+ +     +  +GL+                  GT  Y+APE V  + +
Sbjct: 169 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSI 227

Query: 452 -------TTKSDVYSFGVLLLEIVSGRRPAQAVDS--------VCWQSIFEWATPLVQSH 496
                    ++D+Y+ G++  EI          +         V      E    +V   
Sbjct: 228 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 287

Query: 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
           +    L P I +          ++ +  ++  C     + R     +   L QL+Q
Sbjct: 288 K----LRPNIPNRWQSCE---ALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  139 bits (352), Expect = 2e-37
 Identities = 63/318 (19%), Positives = 118/318 (37%), Gaps = 52/318 (16%)

Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFA 320
           R++ ++ +    + G  + G  + G    G  VAVK        S+ R+ E Y+      
Sbjct: 4   RTVARDITLLECV-GKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNT----V 57

Query: 321 RLHHPNLV----AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
            L H N++    +     +     +++  +   G L  +L        +LD    +++  
Sbjct: 58  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVL 112

Query: 377 TLAQGIAFLH-----DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431
           ++A G+A LH      + KP + HRD+++ N+L+ +     +  +GL+        Q   
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172

Query: 432 VMAG--GTYGYLAPEFVYRNEL-------TTKSDVYSFGVLLLEIVSGRRPAQAV----- 477
                 GT  Y+APE V    +         + D+++FG++L E+         V     
Sbjct: 173 GNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

Query: 478 ---DSVCWQSIFEWATPLV--QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 532
              D V     FE    +V     R      P I    +       +  +  L+  C   
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQR------PNI---PNRWFSDPTLTSLAKLMKECWYQ 282

Query: 533 VPSMRPRMSHVVHQLQQL 550
            PS R     +   L ++
Sbjct: 283 NPSARLTALRIKKTLTKI 300

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  128 bits (324), Expect = 7e-33
 Identities = 73/294 (24%), Positives = 110/294 (37%), Gaps = 51/294 (17%)

Query: 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
             +G    G  +SG L  D + VAVK  +       K +F  E     +  HPN+V + G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
            C      YIV E V  G    +L      G  L     +++    A G+ +L  K    
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK---C 233

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVY 447
            +HRD+ A N L+ E+    +   G+S+        +    A G    +     APE + 
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEADGVYAASGGLRQVPVKWTAPEALN 288

Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYLE 500
               +++SDV+SFG+LL E  S G  P       Q  + V             +  R   
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE------------KGGR--- 333

Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
            L           PE      V  L+  C  + P  RP  S +  +LQ + +  
Sbjct: 334 -LPC---------PE-LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  125 bits (315), Expect = 5e-32
 Identities = 76/286 (26%), Positives = 118/286 (41%), Gaps = 43/286 (15%)

Query: 284 GTYSGILPDGS--RVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
           G  SG+  D S  +VAVK L    S Q + +F  E    ++ +H N+V   G       R
Sbjct: 49  GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108

Query: 341 YIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMR--MKVATTLAQGIAFLHDKVKPHVVHRD 397
           +I+ E +  G L  +L    PR  +    AM   + VA  +A G  +L +    H +HRD
Sbjct: 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRD 165

Query: 398 IRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRN 449
           I A N LL       +  +   G+++ +        +    G    L      PE     
Sbjct: 166 IAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPVKWMPPEAFMEG 220

Query: 450 ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508
             T+K+D +SFGVLL EI S G  P  +      Q + E+   +    R    +DP    
Sbjct: 221 IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEF---VTSGGR----MDP---- 266

Query: 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
                P+      V  ++  C QH P  RP  + ++ +++   Q P
Sbjct: 267 -----PK-NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  127 bits (320), Expect = 1e-31
 Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 29/280 (10%)

Query: 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
             LG  + G  Y G+       VAVK LK  + + + EF  E      + HPNLV + G 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284

Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
           C      YI+ EF+  G L  +L       + +   + + +AT ++  + +L  K   + 
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NF 339

Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 453
           +HR++ A N L+ E     +   GLS+ +  +        A     + APE +  N+ + 
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNKFSI 398

Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512
           KSDV++FGVLL EI + G  P   +D                     ++ + L      +
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRME 439

Query: 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
            PE G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 440 RPE-GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  124 bits (314), Expect = 1e-31
 Identities = 76/286 (26%), Positives = 117/286 (40%), Gaps = 43/286 (15%)

Query: 284 GTYSGILPDGS--RVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
           G  SG+  D S  +VAVK L    S Q + +F  E    ++ +H N+V   G       R
Sbjct: 90  GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149

Query: 341 YIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMR--MKVATTLAQGIAFLHDKVKPHVVHRD 397
           +I+ E +  G L  +L    PR  +    AM   + VA  +A G  +L +    H +HRD
Sbjct: 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRD 206

Query: 398 IRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRN 449
           I A N LL       +  +   G+++ +             G    L      PE     
Sbjct: 207 IAARNCLLTCPGPGRVAKIGDFGMARDI-----YRAGYYRKGGCAMLPVKWMPPEAFMEG 261

Query: 450 ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508
             T+K+D +SFGVLL EI S G  P  +      Q + E+   +    R    +DP    
Sbjct: 262 IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEF---VTSGGR----MDP---- 307

Query: 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
                P+      V  ++  C QH P  RP  + ++ +++   Q P
Sbjct: 308 -----PK-NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  121 bits (306), Expect = 4e-31
 Identities = 68/296 (22%), Positives = 114/296 (38%), Gaps = 58/296 (19%)

Query: 284 GTYSGILPDGS--RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
                + P      VAVK LK  +   +K+F  E      L H ++V   G C D     
Sbjct: 34  AECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 93

Query: 342 IVYEFVVNGPLDRWL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           +V+E++ +G L+++L                +    L  +  + +A+ +A G+ +L  + 
Sbjct: 94  MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ- 152

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL--- 441
             H VHRD+   N L+       +   G+S          R V +   Y       L   
Sbjct: 153 --HFVHRDLATRNCLVGANLLVKIGDFGMS----------RDVYSTDYYRVGGHTMLPIR 200

Query: 442 --APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY 498
              PE +   + TT+SDV+SFGV+L EI + G++P   +       + E     +   R 
Sbjct: 201 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS---NTEVIE----CITQGRV 253

Query: 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
           LE             P     ++V D++  C Q  P  R  +  +   L  L +  
Sbjct: 254 LE------------RPR-VCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  121 bits (305), Expect = 6e-31
 Identities = 63/290 (21%), Positives = 124/290 (42%), Gaps = 44/290 (15%)

Query: 284 GTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
             Y  +  + G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R  
Sbjct: 29  CRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88

Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
            ++ E++  G L  +L    +    +D    ++  + + +G+ +L  K     +HRD+  
Sbjct: 89  KLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLAT 142

Query: 401 SNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNEL 451
            N+L++ E   + + +   GL+K +P +  +E   +          Y   APE +  ++ 
Sbjct: 143 RNILVENE---NRVKIGDFGLTKVLPQD--KEFFKVKEPGESPIFWY---APESLTESKF 194

Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD-------P 504
           +  SDV+SFGV+L E+ +    +++  +   + I       +     +ELL        P
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 254

Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
                    P+      +  ++  C  +  + RP    +  ++ Q+    
Sbjct: 255 ------DGCPDE-----IYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  121 bits (305), Expect = 1e-30
 Identities = 72/295 (24%), Positives = 116/295 (39%), Gaps = 57/295 (19%)

Query: 284 GTYSGILPDGS--RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
                +LP+     VAVK LK +S   +++F  E      L H ++V   G C +     
Sbjct: 60  AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119

Query: 342 IVYEFVVNGPLDRWL-----------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
           +V+E++ +G L+R+L                    L     + VA+ +A G+ +L     
Sbjct: 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-- 177

Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL---- 441
            H VHRD+   N L+ +     +   G+S          R + +   Y       L    
Sbjct: 178 -HFVHRDLATRNCLVGQGLVVKIGDFGMS----------RDIYSTDYYRVGGRTMLPIRW 226

Query: 442 -APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499
             PE +   + TT+SDV+SFGV+L EI + G++P   +         +     +   R L
Sbjct: 227 MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---NTEAID----CITQGREL 279

Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
           E             P      +V  ++  C Q  P  R  +  V  +LQ LAQ P
Sbjct: 280 E------------RPR-ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  119 bits (301), Expect = 2e-30
 Identities = 63/298 (21%), Positives = 104/298 (34%), Gaps = 68/298 (22%)

Query: 284 GTYSGILPDGS----RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339
           G    +   G      V +K L ++     + F+      ++L H +LV   G C    +
Sbjct: 27  GVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86

Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
             +V EFV  G LD +L    +    ++   +++VA  LA  + FL +     ++H ++ 
Sbjct: 87  NILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVC 140

Query: 400 ASNVLLDEEFGAHLMGV--------GLSKF----------VPWEVMQERTVMAGGTYGYL 441
           A N+LL  E                G+S            +PW                +
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW----------------V 184

Query: 442 APE-FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499
            PE       L   +D +SFG  L EI S G +P  A+DS   Q   +      +    L
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---QRKLQ----FYEDRHQL 237

Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 557
                          E      + +L+  C  + P  RP    ++  L  L  P +  
Sbjct: 238 PAPKA---------AE------LANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  120 bits (302), Expect = 2e-30
 Identities = 72/291 (24%), Positives = 125/291 (42%), Gaps = 47/291 (16%)

Query: 284 GTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
             Y  +  + G+ VAVK+L+ S   ++++F  EI     LH   +V  +G  Y  G +  
Sbjct: 42  CRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101

Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
            +V E++ +G L  +L    R    LD +  +  ++ + +G+ +L  +     VHRD+ A
Sbjct: 102 RLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAA 155

Query: 401 SNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNEL 451
            N+L++ E     + +   GL+K +P +  ++  V+          Y   APE +  N  
Sbjct: 156 RNILVESE---AHVKIADFGLAKLLPLD--KDYYVVREPGQSPIFWY---APESLSDNIF 207

Query: 452 TTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD------- 503
           + +SDV+SFGV+L E+ +   +      S  +  +      +    R LELL+       
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKSCS--PSAEFLRMMGCERDVPALSRLLELLEEGQRLPA 265

Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
           P         P       V +L+  C    P  RP  S +  QL  L    
Sbjct: 266 P------PACPAE-----VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  120 bits (302), Expect = 3e-30
 Identities = 63/286 (22%), Positives = 124/286 (43%), Gaps = 44/286 (15%)

Query: 284 GTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
             Y  +  + G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R  
Sbjct: 60  CRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119

Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
            ++ E++  G L  +L    +    +D    ++  + + +G+ +L  K     +HRD+  
Sbjct: 120 KLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLAT 173

Query: 401 SNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNEL 451
            N+L++ E   + + +   GL+K +P +  +E   +          Y   APE +  ++ 
Sbjct: 174 RNILVENE---NRVKIGDFGLTKVLPQD--KEYYKVKEPGESPIFWY---APESLTESKF 225

Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD-------P 504
           +  SDV+SFGV+L E+ +    +++  +   + I       +     +ELL        P
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 285

Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
                    P+      +  ++  C  +  + RP    +  ++ Q+
Sbjct: 286 ------DGCPDE-----IYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  119 bits (300), Expect = 4e-30
 Identities = 62/291 (21%), Positives = 115/291 (39%), Gaps = 53/291 (18%)

Query: 284 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
           G   G++ D    RVA+K +   +S + + EF +E       +  ++V + G        
Sbjct: 44  GVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103

Query: 341 YIVYEFVVNGPLDRWL------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
            ++ E +  G L  +L                  +  +++A  +A G+A+L+       V
Sbjct: 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFV 160

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL-----APE 444
           HRD+ A N ++ E+F   +   G++          R +     Y     G L     +PE
Sbjct: 161 HRDLAARNCMVAEDFTVKIGDFGMT----------RDIYETDYYRKGGKGLLPVRWMSPE 210

Query: 445 FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503
            +     TT SDV+SFGV+L EI +   +P Q +     + +       V     L+   
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQVLR----FVMEGGLLD--- 260

Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
                     P+      + +L+  C Q+ P MRP    ++  +++  +P 
Sbjct: 261 ---------KPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  118 bits (298), Expect = 5e-30
 Identities = 54/258 (20%), Positives = 106/258 (41%), Gaps = 47/258 (18%)

Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRF-------ARLHHPNLVAVKGCCYDHGD----RYIV 343
           +VA+K +     + K+E    + RF       ++L H N+V++     D  +     Y+V
Sbjct: 38  KVAIKAI-FIPPREKEET---LKRFEREVHNSSQLSHQNIVSM----IDVDEEDDCYYLV 89

Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
            E++    L  ++      G  L     +     +  GI   HD     +VHRDI+  N+
Sbjct: 90  MEYIEGPTLSEYIE---SHGP-LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNI 142

Query: 404 LLDEEFGAHLMGVGLSKFVPWEVM-QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
           L+D      +   G++K +    + Q   V+  GT  Y +PE          +D+YS G+
Sbjct: 143 LIDSNKTLKIFDFGIAKALSETSLTQTNHVL--GTVQYFSPEQAKGEATDECTDIYSIGI 200

Query: 463 LLLEIVSGRRPAQAVDSVCWQSIFEWATPL-VQSHRYLELLDPLISSLSSDIPEAGVVQK 521
           +L E++ G  P            F   T + +      + +  + + +  DIP++     
Sbjct: 201 VLYEMLVGEPP------------FNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS----- 243

Query: 522 VVDLVYACTQHVPSMRPR 539
           + +++   T+   + R +
Sbjct: 244 LSNVILRATEKDKANRYK 261

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  119 bits (299), Expect = 1e-29
 Identities = 42/357 (11%), Positives = 85/357 (23%), Gaps = 65/357 (18%)

Query: 227 LLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTY 286
           L+ Y R +  ++   +     + + P + +      L    +        L        +
Sbjct: 21  LIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLV-EPLRVGDRSVVF 79

Query: 287 SGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCC-------- 334
               +      A+K     +   + E    +      ARL   +    +           
Sbjct: 80  LVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139

Query: 335 ------------------YDHGDRYIVYEFVV--NGPLDRWLHHIPRGGRSLDWAMRMKV 374
                             Y   +  ++          L   L  +              +
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199

Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
              L +  A L  K    +VH      N+ +  +    L  V     V       R   +
Sbjct: 200 TAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPAS 251

Query: 435 GGTYGYLAPEFVYRNEL--TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 492
                Y   EF+  +    T   + +  G+ +  +     P            F   TP 
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP------------FGLVTPG 299

Query: 493 VQSHRYLELL-----DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
           ++       L     D L     + +P+      V  L+          R      +
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDF-----VKTLIGRFLNFDRRRRLLPLEAM 351

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  117 bits (295), Expect = 2e-29
 Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 44/288 (15%)

Query: 284 GTYSGILPD-GSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 340
             Y     + G +VAVK LK  S      +   EI     L+H N+V  KG C + G   
Sbjct: 40  CRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99

Query: 341 -YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
             ++ EF+ +G L  +L   P+    ++   ++K A  + +G+ +L  +     VHRD+ 
Sbjct: 100 IKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLA 153

Query: 400 ASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNE 450
           A NVL++ E   H + +   GL+K +  +  +E   +          Y   APE + +++
Sbjct: 154 ARNVLVESE---HQVKIGDFGLTKAIETD--KEYYTVKDDRDSPVFWY---APECLMQSK 205

Query: 451 LTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE-WATPLVQSHRYLE----LLDP 504
               SDV+SFGV L E+++     +  +               + +    L+    L  P
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP 265

Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                  + P+      V  L+  C +  PS R    +++   + L +
Sbjct: 266 ------PNCPDE-----VYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  116 bits (292), Expect = 2e-29
 Identities = 66/288 (22%), Positives = 121/288 (42%), Gaps = 41/288 (14%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           + +G  + G  + G   +  +VA+K ++  +   +++F  E     +L HP LV + G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
            +     +V EF+ +G L  +L               + +   + +G+A+L +     V+
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 126

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 448
           HRD+ A N L+ E     +   G+++FV  +   + T   G            +PE    
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKWA----SPEVFSF 179

Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507
           +  ++KSDV+SFGVL+ E+ S G+ P +        S  E    +    R    L     
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVEDISTGFR----LYK--- 226

Query: 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV 555
                 P       V  ++  C +  P  RP  S ++ QL ++A+  +
Sbjct: 227 ------PR-LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  117 bits (295), Expect = 2e-29
 Identities = 63/292 (21%), Positives = 113/292 (38%), Gaps = 54/292 (18%)

Query: 284 GTYSGILPDGSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 340
                      +VAVK LK    +    +EF  E        HP++  + G       + 
Sbjct: 42  AQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101

Query: 341 -----YIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
                 ++  F+ +G L  +L    I     +L     ++    +A G+ +L  +   + 
Sbjct: 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NF 158

Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL-----AP 443
           +HRD+ A N +L E+    +   GLS          R + +G  Y       L     A 
Sbjct: 159 IHRDLAARNCMLAEDMTVCVADFGLS----------RKIYSGDYYRQGCASKLPVKWLAL 208

Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502
           E +  N  T  SDV++FGV + EI++ G+ P   +++     I+ +   L+  +R    L
Sbjct: 209 ESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN---AEIYNY---LIGGNR----L 258

Query: 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
                      P    +++V DL+Y C    P  RP  + +  +L+ +    
Sbjct: 259 KQ---------PP-ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  119 bits (300), Expect = 3e-29
 Identities = 72/284 (25%), Positives = 120/284 (42%), Gaps = 39/284 (13%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           + +G  + G    G    G++VAVK +K  +    + F +E     +L H NLV + G  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 335 YDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
            +     YIV E++  G L  +L    RG   L     +K +  + + + +L      + 
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310

Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY--LAPEFVYRNEL 451
           VHRD+ A NVL+ E+  A +   GL+K       +  +    G       APE +   + 
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363

Query: 452 TTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
           +TKSDV+SFG+LL EI S GR P   +     + +      + + ++   +  P      
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPR---VEKGYK---MDAP------ 408

Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
              P A     V D++  C     + RP    +  QL+ +    
Sbjct: 409 DGCPPA-----VYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  116 bits (293), Expect = 4e-29
 Identities = 67/290 (23%), Positives = 124/290 (42%), Gaps = 53/290 (18%)

Query: 284 GTYSGILPDGSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 340
           G          +VAVK +K   SS +  +EF SE        HPN++ + G C +   + 
Sbjct: 53  GNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112

Query: 341 ----YIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                ++  F+  G L  +L    +  G + +     +K    +A G+ +L ++   + +
Sbjct: 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFL 169

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL-----APE 444
           HRD+ A N +L ++    +   GLS          + + +G  Y       +     A E
Sbjct: 170 HRDLAARNCMLRDDMTVCVADFGLS----------KKIYSGDYYRQGRIAKMPVKWIAIE 219

Query: 445 FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503
            +     T+KSDV++FGV + EI + G  P   V +     ++++   L+  HR    L 
Sbjct: 220 SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---HEMYDY---LLHGHR----LK 269

Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
                     PE   + ++ +++Y+C +  P  RP  S +  QL++L + 
Sbjct: 270 Q---------PE-DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  115 bits (291), Expect = 4e-29
 Identities = 82/288 (28%), Positives = 129/288 (44%), Gaps = 41/288 (14%)

Query: 275 RLLGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
             LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77

Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
           C      YI+ EF+  G L  +L       + +   + + +AT ++  + +L  K   + 
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132

Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVY 447
           +HRD+ A N L+ E     +   GLS+ +  +     T  AG       T    APE + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWT----APESLA 185

Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506
            N+ + KSDV++FGVLL EI + G  P   +D      ++E    L + +R    ++   
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYEL---LEKDYR----MER-- 233

Query: 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
                  PE G  +KV +L+ AC Q  PS RP  + +    + + Q  
Sbjct: 234 -------PE-GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  118 bits (297), Expect = 8e-29
 Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 29/281 (10%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
             LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
            +    YIV E++  G L  +L      G+ L     + +A  +A G+A++      + V
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD+RA+N+L+ E     +   GL++ +       R         + APE       T K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361

Query: 455 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513
           SDV+SFG+LL E+ + GR P   +     + + +    + + +R   +  P       + 
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMV---NREVLDQ---VERGYR---MPCP------PEC 406

Query: 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
           PE+     + DL+  C +  P  RP   ++   L+      
Sbjct: 407 PES-----LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  118 bits (297), Expect = 9e-29
 Identities = 67/250 (26%), Positives = 110/250 (44%), Gaps = 17/250 (6%)

Query: 227 LLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTY 286
           L+ + +       +KLS P  S+     W+    E    I +   +  + LG  + G  +
Sbjct: 150 LVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWE----IPRESLKLEKKLGAGQFGEVW 205

Query: 287 SGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
                  ++VAVK +K  S   +  F +E      L H  LV +          YI+ EF
Sbjct: 206 MATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEF 263

Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
           +  G L  +L      G        +  +  +A+G+AF+  +   + +HRD+RA+N+L+ 
Sbjct: 264 MAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVS 318

Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY--LAPEFVYRNELTTKSDVYSFGVLL 464
                 +   GL++ +      E T   G  +     APE +     T KSDV+SFG+LL
Sbjct: 319 ASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375

Query: 465 LEIVS-GRRP 473
           +EIV+ GR P
Sbjct: 376 MEIVTYGRIP 385

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  113 bits (286), Expect = 1e-28
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 41/285 (14%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           + LG  + G    G       VAVK +K  S   + EF+ E     +L HP LV   G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 YIV E++ NG L  +L      G+ L+ +  +++   + +G+AFL        +
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 448
           HRD+ A N L+D +    +   G++++V  +   +     G       +    APE  + 
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGTKFPVKWS----APEVFHY 179

Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507
            + ++KSDV++FG+L+ E+ S G+ P          +  E    + Q HR    L     
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLY------TNSEVVLKVSQGHR----LYR--- 226

Query: 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                 P       +  ++Y+C   +P  RP    ++  ++ L +
Sbjct: 227 ------PH-LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (286), Expect = 3e-28
 Identities = 63/263 (23%), Positives = 107/263 (40%), Gaps = 52/263 (19%)

Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRF-------ARLHHPNLVAVKGCCYDHGD-------- 339
            VAVK L R+   R   F     RF       A L+HP +VAV    YD G+        
Sbjct: 39  DVAVKVL-RADLARDPSF---YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPL 90

Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
            YIV E+V    L   +H     G  +     ++V     Q + F H      ++HRD++
Sbjct: 91  PYIVMEYVDGVTLRDIVH---TEGP-MTPKRAIEVIADACQALNFSHQN---GIIHRDVK 143

Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWE---VMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
            +N+++       +M  G+++ +      V Q   V+  GT  YL+PE    + +  +SD
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDARSD 201

Query: 457 VYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEA 516
           VYS G +L E+++G  P            F   +P+  +++++       S+    +   
Sbjct: 202 VYSLGCVLYEVLTGEPP------------FTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249

Query: 517 GVVQKVVDLVYACTQHVPSMRPR 539
                +  +V       P  R +
Sbjct: 250 -----LDAVVLKALAKNPENRYQ 267

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  113 bits (285), Expect = 3e-28
 Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 43/281 (15%)

Query: 284 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRY 341
           GT           AVK L R +      +F +E        HPN++++ G C    G   
Sbjct: 44  GTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103

Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           +V  ++ +G L  ++        +      +     +A+G+ +L  K     VHRD+ A 
Sbjct: 104 VVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAAR 157

Query: 402 NVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNELTT 453
           N +LDE+F    + V   GL++ +     +E   +   T   L     A E +   + TT
Sbjct: 158 NCMLDEKF---TVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 211

Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512
           KSDV+SFGVLL E+++ G  P   V++     I  +   L+Q  R   LL P        
Sbjct: 212 KSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVY---LLQGRR---LLQP------EY 256

Query: 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            P+      + +++  C      MRP  S +V ++  +   
Sbjct: 257 CPDP-----LYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  117 bits (294), Expect = 3e-28
 Identities = 69/277 (24%), Positives = 117/277 (42%), Gaps = 29/277 (10%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
             LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
            +    YIV E++  G L  +L      G+ L     + +A  +A G+A++      + V
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD+RA+N+L+ E     +   GL++ +       R         + APE       T K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444

Query: 455 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513
           SDV+SFG+LL E+ + GR P   +     + + +    + + +R   +  P       + 
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMV---NREVLDQ---VERGYR---MPCP------PEC 489

Query: 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           PE+     + DL+  C +  P  RP   ++   L+  
Sbjct: 490 PES-----LHDLMCQCWRKEPEERPTFEYLQAFLEDY 521

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  114 bits (288), Expect = 4e-28
 Identities = 83/376 (22%), Positives = 141/376 (37%), Gaps = 53/376 (14%)

Query: 200 HCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASAL------VPP 253
           H  R   +  G++          I           ++  S  L    A+ +      + P
Sbjct: 14  HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNP 73

Query: 254 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGS----RVAVKRLKR-SSFQR 308
                    +   +      N ++G    G  Y G L D        AVK L R +    
Sbjct: 74  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133

Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-RYIVYEFVVNGPLDRWLHHIPRGGRSLD 367
             +F +E        HPN++++ G C        +V  ++ +G L  ++        +  
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPT 190

Query: 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPW 424
               +     +A+G+ FL  K     VHRD+ A N +LDE+F    + V   GL++ +  
Sbjct: 191 VKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKF---TVKVADFGLARDM-- 242

Query: 425 EVMQERTVMAGGTYGYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVD 478
              +E   +   T   L     A E +   + TTKSDV+SFGVLL E+++ G  P   V+
Sbjct: 243 -YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301

Query: 479 SVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
           +     I  +   L+Q  R   LL P         P+      + +++  C      MRP
Sbjct: 302 T---FDITVY---LLQGRR---LLQP------EYCPDP-----LYEVMLKCWHPKAEMRP 341

Query: 539 RMSHVVHQLQQLAQPP 554
             S +V ++  +    
Sbjct: 342 SFSELVSRISAIFSTF 357

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  112 bits (283), Expect = 4e-28
 Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 47/288 (16%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           + +G  + G    G    G++VAVK +K  +    + F +E     +L H NLV + G  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 335 YDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
            +     YIV E++  G L  +L    RG   L     +K +  + + + +L      + 
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138

Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVY 447
           VHRD+ A NVL+ E+  A +   GL+K       +  +    G      T    APE + 
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWT----APEALR 187

Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506
             + +TKSDV+SFG+LL EI S GR P   +     + +      + + ++    +D   
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPR---VEKGYK----MDA-- 235

Query: 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
                  P+ G    V +++  C     +MRP    +  QL+ +    
Sbjct: 236 -------PD-GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  113 bits (285), Expect = 4e-28
 Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 34/282 (12%)

Query: 284 GTYSGILPD-GSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 340
             Y       G  VAVK LK  +  Q +  +  EI     L+H +++  KGCC D G   
Sbjct: 50  YCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109

Query: 341 -YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
             +V E+V  G L  +L        S+  A  +  A  + +G+A+LH +   H +HRD+ 
Sbjct: 110 LQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLA 161

Query: 400 ASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNEL 451
           A NVLLD +    L+ +   GL+K VP     E   +     G       APE +   + 
Sbjct: 162 ARNVLLDND---RLVKIGDFGLAKAVPEG--HEYYRVRED--GDSPVFWYAPECLKEYKF 214

Query: 452 TTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
              SDV+SFGV L E+++                        V       L + L     
Sbjct: 215 YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL-----RLTELLERGER 269

Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
              P+     +V  L+  C +   S RP   +++  L+ + +
Sbjct: 270 LPRPD-KCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  113 bits (285), Expect = 5e-28
 Identities = 71/295 (24%), Positives = 114/295 (38%), Gaps = 57/295 (19%)

Query: 284 GTYSGILPDGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
            T  G+  + +  +VAVK LK +     K+   SE+   + L  H N+V + G C   G 
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124

Query: 340 RYIVYEFVVNGPLDRWL----------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
             ++ E+   G L  +L                  +      +  ++ +AQG+AFL  K 
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK- 183

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL--- 441
             + +HRD+ A NVLL     A +   GL+          R +M    Y       L   
Sbjct: 184 --NCIHRDVAARNVLLTNGHVAKIGDFGLA----------RDIMNDSNYIVKGNARLPVK 231

Query: 442 --APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY 498
             APE ++    T +SDV+S+G+LL EI S G  P                 P +  +  
Sbjct: 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------------YPGILVNS- 274

Query: 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
            +    +        P     + +  ++ AC    P+ RP    +   LQ+ AQ 
Sbjct: 275 -KFYKLVKDGYQMAQPA-FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  113 bits (286), Expect = 5e-28
 Identities = 69/308 (22%), Positives = 121/308 (39%), Gaps = 73/308 (23%)

Query: 284 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
               G+LP      VAVK LK  +S   + +F  E    A   +PN+V + G C      
Sbjct: 66  ARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125

Query: 341 YIVYEFVVNGPLDRWL--------------------HHIPRGGRSLDWAMRMKVATTLAQ 380
            +++E++  G L+ +L                         G   L  A ++ +A  +A 
Sbjct: 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 185

Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT 437
           G+A+L ++     VHRD+   N L+ E     ++ +   GLS          R + +   
Sbjct: 186 GMAYLSER---KFVHRDLATRNCLVGEN---MVVKIADFGLS----------RNIYSADY 229

Query: 438 Y-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 486
           Y       +      PE ++ N  TT+SDV+++GV+L EI S G +P   +     + + 
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA---HEEVI 286

Query: 487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546
                 V+    L              PE     ++ +L+  C   +P+ RP    +   
Sbjct: 287 Y----YVRDGNILA------------CPE-NCPLELYNLMRLCWSKLPADRPSFCSIHRI 329

Query: 547 LQQLAQPP 554
           LQ++ +  
Sbjct: 330 LQRMCERA 337

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  111 bits (281), Expect = 7e-28
 Identities = 63/291 (21%), Positives = 113/291 (38%), Gaps = 53/291 (18%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           + LG  + G    G       VA+K +K  S     EF  E      L H  LV + G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 +I+ E++ NG L  +L               +++   + + + +L  K     +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 142

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 448
           HRD+ A N L++++    +   GLS++V  +   E T   G       +     PE +  
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWS----PPEVLMY 195

Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYLEL 501
           ++ ++KSD+++FGVL+ EI S G+ P      ++  + +             Q  R    
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI------------AQGLR---- 239

Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
           L           P     +KV  ++Y+C       RP    ++  +  +  
Sbjct: 240 LYR---------PH-LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  111 bits (281), Expect = 9e-28
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 21/206 (10%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
             LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +
Sbjct: 78  TQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 448
           HRD+RA+N+L+ +     +   GL++ +      E T   G       T    APE +  
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWT----APEAINY 184

Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRP 473
              T KSDV+SFG+LL EIV+ GR P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIP 210

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  111 bits (279), Expect = 2e-27
 Identities = 67/294 (22%), Positives = 113/294 (38%), Gaps = 65/294 (22%)

Query: 284 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
           G   G  P      VA+K LK  +    ++EF  E    ARL HPN+V + G        
Sbjct: 28  GHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 87

Query: 341 YIVYEFVVNGPLDRWL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            +++ +  +G L  +L                    +L+    + +   +A G+ +L   
Sbjct: 88  SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH 147

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY-----GY 440
              HVVH+D+   NVL+ ++     + +   GL           R V A   Y       
Sbjct: 148 ---HVVHKDLATRNVLVYDK---LNVKISDLGLF----------REVYAADYYKLLGNSL 191

Query: 441 L-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ 494
           L     APE +   + +  SD++S+GV+L E+ S G +P         Q + E    +++
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVVE----MIR 244

Query: 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
           + + L              P+      V  L+  C    PS RPR   +  +L+
Sbjct: 245 NRQVLP------------CPD-DCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  111 bits (279), Expect = 2e-27
 Identities = 66/278 (23%), Positives = 125/278 (44%), Gaps = 37/278 (13%)

Query: 284 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRY 341
           G Y     +  + A+K L R +  Q+ + F  E      L+HPN++A+ G      G  +
Sbjct: 40  GEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99

Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           ++  ++ +G L +++       R+      +     +A+G+ +L ++     VHRD+ A 
Sbjct: 100 VLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAAR 153

Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNELTTKSD 456
           N +LDE F   +   GL++ +   + +E   +    +  L     A E +     TTKSD
Sbjct: 154 NCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSD 210

Query: 457 VYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 515
           V+SFGVLL E+++ G  P + +D      +  +   L Q  R   L  P         P+
Sbjct: 211 VWSFGVLLWELLTRGAPPYRHIDP---FDLTHF---LAQGRR---LPQP------EYCPD 255

Query: 516 AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
           +     +  ++  C +  P++RP    +V +++Q+   
Sbjct: 256 S-----LYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  111 bits (280), Expect = 2e-27
 Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 49/284 (17%)

Query: 284 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342
           G           VA+K LK   + +++++F SE     +  HPN++ ++G         I
Sbjct: 68  GRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127

Query: 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
           V E++ NG LD +L               + +   +  G+ +L D      VHRD+ A N
Sbjct: 128 VTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARN 181

Query: 403 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG-----TYGYLAPEFVYRNELTTKSDV 457
           VL+D      +   GLS+ +  +     T   G      T    APE +     ++ SDV
Sbjct: 182 VLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAIAFRTFSSASDV 237

Query: 458 YSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
           +SFGV++ E+++ G RP         + SV             + +R    L        
Sbjct: 238 WSFGVVMWEVLAYGERPYWNMTNRDVISSV------------EEGYR----LPA------ 275

Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
              P  G    +  L+  C     + RPR S +V  L  L + P
Sbjct: 276 ---PM-GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  110 bits (278), Expect = 3e-27
 Identities = 53/282 (18%), Positives = 102/282 (36%), Gaps = 36/282 (12%)

Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFAR 321
           S    F + +  +G       Y G+       VA   L+     +   + F  E      
Sbjct: 22  SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 81

Query: 322 LHHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
           L HPN+V                 +V E + +G L        +  + +   +       
Sbjct: 82  LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQ 137

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG-VGLSKFVPWEVMQERTVMAGG 436
           + +G+ FLH +  P ++HRD++  N+ +    G+  +G +GL+          + V+  G
Sbjct: 138 ILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVI--G 192

Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH 496
           T  ++APE +Y  +     DVY+FG+ +LE+ +   P     +     I+   T      
Sbjct: 193 TPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTS----- 244

Query: 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
               +       ++   PE        +++  C +     R 
Sbjct: 245 ---GVKPASFDKVAI--PEV------KEIIEGCIRQNKDERY 275

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  111 bits (280), Expect = 6e-27
 Identities = 71/295 (24%), Positives = 126/295 (42%), Gaps = 49/295 (16%)

Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 329
           +++G  + G   SG L   S+    VA+K LK   + +++++F  E     +  HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           ++G         IV E++ NG LD +L    +          + +   +A G+ +L D  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM- 166

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFV 446
               VHRD+ A N+L++      +   GL + +  E   E      G      + +PE +
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIRWTSPEAI 222

Query: 447 YRNELTTKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYL 499
              + T+ SDV+S+G++L E++S G RP         + +V             + +R  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------------DEGYR-- 268

Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
             L P       D P A     +  L+  C Q   + RP+   +V  L +L + P
Sbjct: 269 --LPP-----PMDCPAA-----LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  109 bits (275), Expect = 6e-27
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 19/210 (9%)

Query: 273 GNRLLGDSKTGGTYSGILPDGSR---VAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNL 327
            ++ LG    G    G          VAVK LK   +    K E  +E     +L +P +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
           V + G C       +V E    GPL+++L    +  R +     +++   ++ G+ +L +
Sbjct: 81  VRMIGICEAES-WMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEE 135

Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPE 444
               + VHRD+ A NVLL  +  A +   GLSK +  +  +              + APE
Sbjct: 136 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--ENYYKAQTHGKWPVKWYAPE 190

Query: 445 FVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
            +   + ++KSDV+SFGVL+ E  S G++P
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  109 bits (275), Expect = 8e-27
 Identities = 56/250 (22%), Positives = 99/250 (39%), Gaps = 25/250 (10%)

Query: 292 DGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
           DG  VA+K+++       + + +   EI    +L+HPN++       +  +  IV E   
Sbjct: 56  DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115

Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
            G L R + H  +  R +      K    L   +  +H +    V+HRDI+ +NV +   
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT 172

Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
               L  +GL +F   +     +++  GT  Y++PE ++ N    KSD++S G LL E+ 
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230

Query: 469 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYA 528
           + + P                           L   +       +P     +++  LV  
Sbjct: 231 ALQSPFYG-----------------DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 273

Query: 529 CTQHVPSMRP 538
           C    P  RP
Sbjct: 274 CINPDPEKRP 283

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  110 bits (278), Expect = 1e-26
 Identities = 68/299 (22%), Positives = 110/299 (36%), Gaps = 68/299 (22%)

Query: 284 GTYSGILPDGS----RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH 337
               GI  D       VAVK LK  ++ +   +  SE+     +  H N++ + G C   
Sbjct: 100 AEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159

Query: 338 GDRYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
           G  Y++ E+   G L            +            + +   +     LA+G+ +L
Sbjct: 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219

Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY---- 438
             +     +HRD+ A NVL+ E    ++M +   GL+          R +     Y    
Sbjct: 220 ASQ---KCIHRDLAARNVLVTEN---NVMKIADFGLA----------RDINNIDYYKKTT 263

Query: 439 -GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP 491
            G L     APE ++    T +SDV+SFGVL+ EI + G  P   +              
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----------- 312

Query: 492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
                   EL   L      D P      ++  ++  C   VPS RP    +V  L ++
Sbjct: 313 --------ELFKLLKEGHRMDKPA-NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  109 bits (275), Expect = 1e-26
 Identities = 67/298 (22%), Positives = 108/298 (36%), Gaps = 56/298 (18%)

Query: 284 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
               GI    +   VAVK LK  ++    +   SE+     + HH N+V + G C   G 
Sbjct: 46  ADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105

Query: 340 -RYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
              ++ EF   G L               +         L     +  +  +A+G+ FL 
Sbjct: 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 165

Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-- 441
            +     +HRD+ A N+LL E+    ++ +   GL++      + +           L  
Sbjct: 166 SR---KCIHRDLAARNILLSEKN---VVKICDFGLAR-----DIYKDPDYVRKGDARLPL 214

Query: 442 ---APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
              APE ++    T +SDV+SFGVLL EI S G  P   V     +         ++   
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEFCR----RLKEGT 268

Query: 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV 555
            +              P+     ++   +  C    PS RP  S +V  L  L Q   
Sbjct: 269 RMR------------APD-YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  110 bits (276), Expect = 1e-26
 Identities = 67/297 (22%), Positives = 110/297 (37%), Gaps = 58/297 (19%)

Query: 284 GTYSGILPDGS----RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH 337
               GI  D       VAVK LK  ++ +   +  SE+     +  H N++ + G C   
Sbjct: 54  AEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113

Query: 338 GDRYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
           G  Y++ E+   G L            +            + +   +     LA+G+ +L
Sbjct: 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173

Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL- 441
             +     +HRD+ A NVL+ E    ++M +   GL++      +         T G L 
Sbjct: 174 ASQ---KCIHRDLAARNVLVTEN---NVMKIADFGLAR-----DINNIDYYKKTTNGRLP 222

Query: 442 ----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH 496
               APE ++    T +SDV+SFGVL+ EI + G  P   +                   
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------------- 266

Query: 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
              EL   L      D P      ++  ++  C   VPS RP    +V  L ++   
Sbjct: 267 ---ELFKLLKEGHRMDKPA-NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  109 bits (275), Expect = 1e-26
 Identities = 62/293 (21%), Positives = 122/293 (41%), Gaps = 46/293 (15%)

Query: 275 RLLGDSKTGGTYSGIL-PDGSR----VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLV 328
           ++LG    G  Y G+  P+G +    VA+K L+ ++  +  KE   E    A + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            + G C       ++ + +  G L  ++        ++     +     +A+G+ +L D+
Sbjct: 81  RLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT---YGYLA 442
               +VHRD+ A NVL+        + +   GL+K +  E   E+   A G      ++A
Sbjct: 137 ---RLVHRDLAARNVLVKTP---QHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWMA 187

Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501
            E +     T +SDV+S+GV + E+++ G +P   + +     I      L +  R   L
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSI---LEKGER---L 238

Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
             P                 V  ++  C       RP+   ++ +  ++A+ P
Sbjct: 239 PQP------PICTID-----VYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  108 bits (271), Expect = 2e-26
 Identities = 55/270 (20%), Positives = 101/270 (37%), Gaps = 34/270 (12%)

Query: 292 DGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFV 347
           DG  +  K       +   K+   SE+     L HPN+V       D  +   YIV E+ 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89

Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK--VKPHVVHRDIRASNVLL 405
             G L   +    +  + LD    ++V T L   +   H +      V+HRD++ +NV L
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149

Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
           D +    L   GL++ +  +    +T +  GT  Y++PE + R     KSD++S G LL 
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207

Query: 466 EIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDL 525
           E+ +   P  A      + +       ++  ++      +    S ++          ++
Sbjct: 208 ELCALMPPFTAFS---QKELAG----KIREGKF----RRIPYRYSDEL---------NEI 247

Query: 526 VYACTQHVPSMRP------RMSHVVHQLQQ 549
           +          RP          ++     
Sbjct: 248 ITRMLNLKDYHRPSVEEILENPLILEHHHH 277

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  109 bits (274), Expect = 2e-26
 Identities = 64/287 (22%), Positives = 120/287 (41%), Gaps = 54/287 (18%)

Query: 286 YSGIL--PDGSR---VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339
           Y G+L    G +   VA+K LK   + +++ +F  E G   +  H N++ ++G    +  
Sbjct: 61  YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120

Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
             I+ E++ NG LD++L               + +   +A G+ +L +    + VHRD+ 
Sbjct: 121 MMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLA 174

Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG-----TYGYLAPEFVYRNELTTK 454
           A N+L++      +   GLS+ +  +     T   G      T    APE +   + T+ 
Sbjct: 175 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAISYRKFTSA 230

Query: 455 SDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507
           SDV+SFG+++ E+++ G RP       + + ++                R    L     
Sbjct: 231 SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------------NDGFR----LPT--- 271

Query: 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
                 P       +  L+  C Q   + RP+ + +V  L +L + P
Sbjct: 272 ------PM-DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  108 bits (271), Expect = 3e-26
 Identities = 50/257 (19%), Positives = 95/257 (36%), Gaps = 47/257 (18%)

Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRF-------ARLHHPNLVAVKGCCYDHGD----RYIV 343
            VA+K +   +      F     R         RL  P++V +    +D G+     Y+ 
Sbjct: 61  IVALKLM-SETLSSDPVF---RTRMQREARTAGRLQEPHVVPI----HDFGEIDGQLYVD 112

Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
              +    L   L    +G  +   A+   +   +   +   H        HRD++  N+
Sbjct: 113 MRLINGVDLAAMLRR--QGPLAPPRAVA--IVRQIGSALDAAHAA---GATHRDVKPENI 165

Query: 404 LLDEEFGAHLMGVGLSKFVPWEVM-QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
           L+  +  A+L+  G++     E + Q    +  GT  Y+APE    +  T ++D+Y+   
Sbjct: 166 LVSADDFAYLVDFGIASATTDEKLTQLGNTV--GTLYYMAPERFSESHATYRADIYALTC 223

Query: 463 LLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 522
           +L E ++G  P Q  D +           ++ +H    +  P  S++   IP A      
Sbjct: 224 VLYECLTGSPPYQG-DQL----------SVMGAHINQAI--PRPSTVRPGIPVA-----F 265

Query: 523 VDLVYACTQHVPSMRPR 539
             ++       P  R  
Sbjct: 266 DAVIARGMAKNPEDRYV 282

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  109 bits (273), Expect = 3e-26
 Identities = 54/274 (19%), Positives = 112/274 (40%), Gaps = 35/274 (12%)

Query: 292 DGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
           DG +  +K   + R S + ++E   E+   A + HPN+V  +    ++G  YIV ++   
Sbjct: 48  DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107

Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
           G L + ++   + G        +     +   +  +HD+    ++HRDI++ N+ L ++ 
Sbjct: 108 GDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDG 162

Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              L   G+++ +   V   R  +  GT  YL+PE         KSD+++ G +L E+ +
Sbjct: 163 TVQLGDFGIARVLNSTVELARACI--GTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220

Query: 470 GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYAC 529
            +   +A      +++       + S  +     P+    S D+           LV   
Sbjct: 221 LKHAFEAGS---MKNLVL----KIISGSF----PPVSLHYSYDL---------RSLVSQL 260

Query: 530 TQHVPSMRP------RMSHVVHQLQQLAQPPVTK 557
            +  P  RP          +  ++++   P +  
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIA 294

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  108 bits (271), Expect = 3e-26
 Identities = 68/304 (22%), Positives = 118/304 (38%), Gaps = 73/304 (24%)

Query: 284 GTYSGILPDGS--RVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
            T   +        VAVK LK  +S    ++  SE     +++HP+++ + G C   G  
Sbjct: 42  ATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101

Query: 341 YIVYEFVVNGPLDRWL--------------------HHIPRGGRSLDWAMRMKVATTLAQ 380
            ++ E+   G L  +L                           R+L     +  A  ++Q
Sbjct: 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQ 161

Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT 437
           G+ +L +     +VHRD+ A N+L+ E      M +   GLS          R V    +
Sbjct: 162 GMQYLAEM---KLVHRDLAARNILVAEG---RKMKISDFGLS----------RDVYEEDS 205

Query: 438 Y-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 486
           Y     G +     A E ++ +  TT+SDV+SFGVLL EIV+ G  P   +         
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--------- 256

Query: 487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546
                         L + L +    + P+    +++  L+  C +  P  RP  + +   
Sbjct: 257 --------PPE--RLFNLLKTGHRMERPD-NCSEEMYRLMLQCWKQEPDKRPVFADISKD 305

Query: 547 LQQL 550
           L+++
Sbjct: 306 LEKM 309

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  108 bits (271), Expect = 3e-26
 Identities = 63/302 (20%), Positives = 110/302 (36%), Gaps = 67/302 (22%)

Query: 284 GTYSGILPDGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
            T  G++   +   VAVK LK S     ++   SE+   + L +H N+V + G C   G 
Sbjct: 42  ATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101

Query: 340 RYIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMR-------------MKVATTLAQGIAFL 385
             ++ E+   G L  +L         S                   +  +  +A+G+AFL
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161

Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY---- 438
             K   + +HRD+ A N+LL       +  +   GL+          R +     Y    
Sbjct: 162 ASK---NCIHRDLAARNILLTHG---RITKICDFGLA----------RDIKNDSNYVVKG 205

Query: 439 -GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP 491
              L     APE ++    T +SDV+S+G+ L E+ S G  P        +  +   +  
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP--------YPGMPVDS-- 255

Query: 492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551
                   +    +        PE     ++ D++  C    P  RP    +V  +++  
Sbjct: 256 --------KFYKMIKEGFRMLSPE-HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306

Query: 552 QP 553
             
Sbjct: 307 SE 308

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  108 bits (273), Expect = 5e-26
 Identities = 71/303 (23%), Positives = 113/303 (37%), Gaps = 68/303 (22%)

Query: 284 GTYSGILPDGS----RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH 337
               G+  D      +VAVK LK  ++ +   +  SE+     +  H N++ + G C   
Sbjct: 88  AEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147

Query: 338 GDRYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
           G  Y++ E+   G L            +   +        L     +  A  +A+G+ +L
Sbjct: 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207

Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY---- 438
             K     +HRD+ A NVL+ E+   ++M +   GL+          R +     Y    
Sbjct: 208 ASK---KCIHRDLAARNVLVTED---NVMKIADFGLA----------RDIHHIDYYKKTT 251

Query: 439 -GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP 491
            G L     APE ++    T +SDV+SFGVLL EI + G  P   V              
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----------- 300

Query: 492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551
                   EL   L      D P      ++  ++  C   VPS RP    +V  L ++ 
Sbjct: 301 --------ELFKLLKEGHRMDKPS-NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351

Query: 552 QPP 554
              
Sbjct: 352 ALT 354

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  105 bits (264), Expect = 2e-25
 Identities = 49/197 (24%), Positives = 77/197 (39%), Gaps = 16/197 (8%)

Query: 284 GTYSGILPDGSRVAVKRLKR---SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
           G +         VAVK LK    S  +   +F  E+     L H NL+ + G        
Sbjct: 37  GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95

Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
            +V E    G L   L    +           + A  +A+G+ +L  K     +HRD+ A
Sbjct: 96  KMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAA 149

Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDV 457
            N+LL       +   GL + +P     +  VM       + + APE +     +  SD 
Sbjct: 150 RNLLLATRDLVKIGDFGLMRALPQN--DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 207

Query: 458 YSFGVLLLEIVS-GRRP 473
           + FGV L E+ + G+ P
Sbjct: 208 WMFGVTLWEMFTYGQEP 224

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  105 bits (263), Expect = 2e-25
 Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 17/196 (8%)

Query: 286 YSGILPDGSR---VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
             G+     +   VA+K LK+ +     +E   E     +L +P +V + G C       
Sbjct: 27  RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LM 85

Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           +V E    GPL ++L         +  +   ++   ++ G+ +L +K   + VHRD+ A 
Sbjct: 86  LVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAAR 139

Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVY 458
           NVLL     A +   GLSK +  +                 + APE +   + +++SDV+
Sbjct: 140 NVLLVNRHYAKISDFGLSKALGAD--DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 197

Query: 459 SFGVLLLEIVS-GRRP 473
           S+GV + E +S G++P
Sbjct: 198 SYGVTMWEALSYGQKP 213

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  105 bits (263), Expect = 6e-25
 Identities = 69/304 (22%), Positives = 115/304 (37%), Gaps = 72/304 (23%)

Query: 284 GTYSGILPDGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
            T  GI   G   +VAVK LK       ++   SE+    +L  H N+V + G C   G 
Sbjct: 64  ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123

Query: 340 RYIVYEFVVNGPLDRWL-------------------HHIPRGGRSLDWAMRMKVATTLAQ 380
            Y+++E+   G L  +L                            L +   +  A  +A+
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183

Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT 437
           G+ FL  K     VHRD+ A NVL+       ++ +   GL+          R +M+   
Sbjct: 184 GMEFLEFK---SCVHRDLAARNVLVTHG---KVVKICDFGLA----------RDIMSDSN 227

Query: 438 Y-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 486
           Y       L     APE ++    T KSDV+S+G+LL EI S G  P   +      + +
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV--DANFY 285

Query: 487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546
           +    L+Q+   ++             P     +++  ++ +C       RP   ++   
Sbjct: 286 K----LIQNGFKMD------------QPF-YATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

Query: 547 LQQL 550
           L   
Sbjct: 329 LGCQ 332

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  103 bits (260), Expect = 1e-24
 Identities = 53/290 (18%), Positives = 118/290 (40%), Gaps = 40/290 (13%)

Query: 275 RLLGDSKTGGTYSGILPDGSR-----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           ++LG    G  + G+           V +K ++  S  Q  +     +     L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            + G C       +V +++  G L   +    +   +L   + +     +A+G+ +L + 
Sbjct: 79  RLLGLCPGSS-LQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEF 445
               +VHR++ A NVLL       +   G++  +P +   ++ ++         ++A E 
Sbjct: 135 ---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD---DKQLLYSEAKTPIKWMALES 188

Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504
           ++  + T +SDV+S+GV + E+++ G  P   +       + +    L +  R   L  P
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL---AEVPDL---LEKGER---LAQP 239

Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
            I +             V  ++  C     ++RP    + ++  ++A+ P
Sbjct: 240 QICT-----------IDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  107 bits (268), Expect = 1e-24
 Identities = 44/204 (21%), Positives = 80/204 (39%), Gaps = 39/204 (19%)

Query: 292 DGSRVAVKRLKRS---SFQRKKEFYSEIGRF-ARLHHPNLVAVKGCCYDHGDR------- 340
           +G  V +K L  S     Q      +E  +F A + HP++V +    ++  +        
Sbjct: 105 NGRPVVLKGLVHSGDAEAQAM--AMAE-RQFLAEVVHPSIVQI----FNFVEHTDRHGDP 157

Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
             YIV E+V    L R           +  A+       +   +++LH      +V+ D+
Sbjct: 158 VGYIVMEYVGGQSLKRSK----GQKLPVAEAIA--YLLEILPALSYLHSI---GLVYNDL 208

Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVY 458
           +  N++L EE    L+ +G        +     +   GT G+ APE + R   T  +D+Y
Sbjct: 209 KPENIMLTEE-QLKLIDLGAVS----RINSFGYLY--GTPGFQAPE-IVRTGPTVATDIY 260

Query: 459 SFGVLLLEIVSGRRP--AQAVDSV 480
           + G  L  +         + VD +
Sbjct: 261 TVGRTLAALTLDLPTRNGRYVDGL 284

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  103 bits (259), Expect = 1e-24
 Identities = 64/290 (22%), Positives = 123/290 (42%), Gaps = 40/290 (13%)

Query: 275 RLLGDSKTGGTYSGIL-PDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
           ++LG    G  Y G+  P+G +    VA+K L+  +S +  KE   E    A + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            + G C       ++ + +  G L  ++        ++     +     +A+G+ +L D+
Sbjct: 81  RLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEF 445
               +VHRD+ A NVL+       +   GL+K +  E   E+   A G      ++A E 
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWMALES 190

Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504
           +     T +SDV+S+GV + E+++ G +P   + +     I      L +  R   L  P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSI---LEKGER---LPQP 241

Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
            I +             V  ++  C       RP+   ++ +  ++A+ P
Sbjct: 242 PICT-----------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  103 bits (258), Expect = 2e-24
 Identities = 72/295 (24%), Positives = 120/295 (40%), Gaps = 60/295 (20%)

Query: 286 YSGILPDGS---RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR 340
               +         A+KR+K  +S    ++F  E+    +L HHPN++ + G C   G  
Sbjct: 42  LKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101

Query: 341 YIVYEFVVNGPLDRWL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
           Y+  E+  +G L  +L                    +L     +  A  +A+G+ +L  K
Sbjct: 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 161

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL---- 441
                +HRD+ A N+L+ E    ++  +   GLS+         + V    T G L    
Sbjct: 162 ---QFIHRDLAARNILVGEN---YVAKIADFGLSR--------GQEVYVKKTMGRLPVRW 207

Query: 442 -APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499
            A E +  +  TT SDV+S+GVLL EIVS G  P   +       ++E    L Q +R  
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEK---LPQGYR-- 259

Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
             L+          P      +V DL+  C +  P  RP  + ++  L ++ +  
Sbjct: 260 --LEK---------PL-NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  101 bits (255), Expect = 2e-24
 Identities = 74/291 (25%), Positives = 116/291 (39%), Gaps = 44/291 (15%)

Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 329
           R +G+ + G  + GI          VA+K  K  +S   +++F  E     +  HP++V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           + G   ++   +I+ E    G L  +L        SLD A  +  A  L+  +A+L  K 
Sbjct: 81  LIGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK- 135

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APE 444
               VHRDI A NVL+       L   GLS+++           A    G L     APE
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----EDSTYYKASK--GKLPIKWMAPE 187

Query: 445 FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503
            +     T+ SDV+ FGV + EI+  G +P Q V +     +      +    R    L 
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGR---IENGER----LP 237

Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
                     P       +  L+  C  + PS RPR + +  QL  + +  
Sbjct: 238 M---------PP-NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  101 bits (255), Expect = 2e-24
 Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 20/197 (10%)

Query: 284 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342
           G Y+    +   VAVK  K+  +   K++F SE      L HP++V + G   +    +I
Sbjct: 31  GVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89

Query: 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
           + E    G L  +L    R   SL     +  +  + + +A+L      + VHRDI   N
Sbjct: 90  IMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRN 143

Query: 403 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNELTTKSDV 457
           +L+       L   GLS+++      E    A      L     +PE +     TT SDV
Sbjct: 144 ILVASPECVKLGDFGLSRYI----EDEDYYKASV--TRLPIKWMSPESINFRRFTTASDV 197

Query: 458 YSFGVLLLEIVS-GRRP 473
           + F V + EI+S G++P
Sbjct: 198 WMFAVCMWEILSFGKQP 214

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  105 bits (263), Expect = 5e-24
 Identities = 67/309 (21%), Positives = 118/309 (38%), Gaps = 36/309 (11%)

Query: 192 HENKCYYLHCHREYL--ITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASA 249
                  ++C +E     +    SG    T  A    L   +R      S   +   A  
Sbjct: 240 KLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARI 299

Query: 250 LVPPSWKVFTT------------EELRSITKNFSEGNRLLGDSKTG----GT-YSGILPD 292
             P   +                EEL+         N L+ D + G    G+   G+   
Sbjct: 300 TSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRM 359

Query: 293 GSR---VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
             +   VA+K LK+ +     +E   E     +L +P +V + G C       +V E   
Sbjct: 360 RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAG 418

Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
            GPL ++L         +  +   ++   ++ G+ +L +K   + VHR++ A NVLL   
Sbjct: 419 GGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNR 472

Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVYSFGVLLL 465
             A +   GLSK +  +                 + APE +   + +++SDV+S+GV + 
Sbjct: 473 HYAKISDFGLSKALGAD--DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530

Query: 466 EIVS-GRRP 473
           E +S G++P
Sbjct: 531 EALSYGQKP 539

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  104 bits (262), Expect = 6e-24
 Identities = 75/291 (25%), Positives = 117/291 (40%), Gaps = 44/291 (15%)

Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 329
           R +G+ + G  + GI          VA+K  K  +S   +++F  E     +  HP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           + G   ++   +I+ E    G L  +L        SLD A  +  A  L+  +A+L  K 
Sbjct: 456 LIGVITEN-PVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESK- 510

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APE 444
               VHRDI A NVL+       L   GLS+      M++ T       G L     APE
Sbjct: 511 --RFVHRDIAARNVLVSSNDCVKLGDFGLSR-----YMEDSTYYKASK-GKLPIKWMAPE 562

Query: 445 FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503
            +     T+ SDV+ FGV + EI+  G +P Q V +     +      +    R    L 
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGR---IENGER----LP 612

Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
                     P       +  L+  C  + PS RPR + +  QL  + +  
Sbjct: 613 M---------PP-NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  101 bits (253), Expect = 8e-24
 Identities = 55/278 (19%), Positives = 100/278 (35%), Gaps = 37/278 (13%)

Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----YIVYEFV 347
           DG   A+KR+     Q ++E   E       +HPN++ +   C          +++  F 
Sbjct: 53  DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112

Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
             G L   +  +   G  L     + +   + +G+  +H        HRD++ +N+LL +
Sbjct: 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGD 169

Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAG-------GTYGYLAPEFV--YRNE-LTTKSDV 457
           E    LM +G        V   R  +          T  Y APE      +  +  ++DV
Sbjct: 170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDV 229

Query: 458 YSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG 517
           +S G +L  ++ G  P            ++       S         L       IP++ 
Sbjct: 230 WSLGCVLYAMMFGEGP------------YDMVFQKGDSVA-------LAVQNQLSIPQSP 270

Query: 518 VV-QKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
                +  L+ +     P  RP +  ++ QL+ L  P 
Sbjct: 271 RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  100 bits (252), Expect = 1e-23
 Identities = 63/323 (19%), Positives = 108/323 (33%), Gaps = 58/323 (17%)

Query: 230 YRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI 289
           Y +S  + + R++S    ++    S     +       ++F      LG     G+Y  +
Sbjct: 19  YFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRL-SRLGH----GSYGEV 73

Query: 290 L-----PDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY 341
                  DG   AVKR        K      +E+G   ++  HP  V ++    + G  Y
Sbjct: 74  FKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133

Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           +  E      L     H    G SL  A            +A LH +    +VH D++ +
Sbjct: 134 LQTELC-GPSL---QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPA 186

Query: 402 NVLLDEEFGAHLMGV------GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
           N+ L         G       GL             V  G    Y+APE + +    T +
Sbjct: 187 NIFLGPR------GRCKLGDFGLLVE--LGTAGAGEVQEGDPR-YMAPE-LLQGSYGTAA 236

Query: 456 DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 515
           DV+S G+ +LE+          +   WQ + +             L     + LSS++  
Sbjct: 237 DVFSLGLTILEVACNMELPHGGEG--WQQLRQ-----------GYLPPEFTAGLSSEL-- 281

Query: 516 AGVVQKVVDLVYACTQHVPSMRP 538
                    ++    +  P +R 
Sbjct: 282 -------RSVLVMMLEPDPKLRA 297

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 98.7 bits (246), Expect = 7e-23
 Identities = 53/263 (20%), Positives = 96/263 (36%), Gaps = 38/263 (14%)

Query: 231 RRSKRRRKSRKLSNPAASALVPPSW---KVFTTEELRSITKNFSEGNR------LLGDSK 281
                  K+    +     L P +     V  TE+L+ +   + E          +G   
Sbjct: 11  HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGS 70

Query: 282 TGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
            G  +       G + AVK+++   F+ +     E+   A L  P +V + G   +    
Sbjct: 71  FGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWV 125

Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
            I  E +  G L      + +    L     +       +G+ +LH +    ++H D++A
Sbjct: 126 NIFMELLEGGSL----GQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKA 178

Query: 401 SNVLLDEE--------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
            NVLL  +        FG    L   GL K      +     + G    ++APE V    
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGK-----SLLTGDYIPGTET-HMAPEVVMGKP 232

Query: 451 LTTKSDVYSFGVLLLEIVSGRRP 473
              K D++S   ++L +++G  P
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHP 255

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 43/266 (16%), Positives = 86/266 (32%), Gaps = 47/266 (17%)

Query: 292 DGSRVAVKRLKR--SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348
           DG   A+KR K+  +    ++    E+   A L  H ++V       +     I  E+  
Sbjct: 35  DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94

Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
            G L   +    R       A    +   + +G+ ++H      +VH DI+ SN+ +   
Sbjct: 95  GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRT 151

Query: 409 --------------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL--T 452
                         + ++ +   +        +    V  G +  +LA E V +      
Sbjct: 152 SIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSR-FLANE-VLQENYTHL 209

Query: 453 TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512
            K+D+++  + ++         +  D   W  I +   P             +   LS +
Sbjct: 210 PKADIFALALTVVCAAGAEPLPRNGDQ--WHEIRQGRLP------------RIPQVLSQE 255

Query: 513 IPEAGVVQKVVDLVYACTQHVPSMRP 538
                      +L+       P  RP
Sbjct: 256 F---------TELLKVMIHPDPERRP 272

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 59/287 (20%), Positives = 109/287 (37%), Gaps = 69/287 (24%)

Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----------- 340
           DG    +KR+K +     ++   E+   A+L H N+V   GC                  
Sbjct: 35  DGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90

Query: 341 -----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
                +I  EF   G L++W+    R G  LD  + +++   + +G+ ++H K    +++
Sbjct: 91  KTKCLFIQMEFCDKGTLEQWIEK--RRGEKLDKVLALELFEQITKGVDYIHSK---KLIN 145

Query: 396 RDIRASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
           RD++ SN+ L +        V     GL   +  +  + R+    GT  Y++PE +   +
Sbjct: 146 RDLKPSNIFLVDT-----KQVKIGDFGLVTSLKNDGKRTRSK---GTLRYMSPEQISSQD 197

Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
              + D+Y+ G++L E++     A                       + +L D +IS + 
Sbjct: 198 YGKEVDLYALGLILAELLHVCDTAFETSKF-----------------FTDLRDGIISDIF 240

Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 557
                    +K   L+       P  RP  S +      L    V K
Sbjct: 241 D--------KKEKTLLQKLLSKKPEDRPNTSEI------LRTLTVWK 273

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 46/277 (16%), Positives = 96/277 (34%), Gaps = 63/277 (22%)

Query: 292 DGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR---------- 340
           D    A+KR++  + +  +++   E+   A+L HP +V       +              
Sbjct: 29  DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88

Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
             YI  +      L  W++         + ++ + +   +A+ + FLH K    ++HRD+
Sbjct: 89  YLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDL 144

Query: 399 RASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAG----------GTYGYLAP 443
           + SN+    +       V     GL   +  +  ++  +             GT  Y++P
Sbjct: 145 KPSNIFFTMD-----DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP 199

Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD--SVCWQSIFEWATPLVQSHRYLEL 501
           E ++ N  + K D++S G++L E++    P             +     P + + +Y   
Sbjct: 200 EQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCE 256

Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
                                  +V       P  RP
Sbjct: 257 ---------------------YVMVQDMLSPSPMERP 272

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 95.1 bits (237), Expect = 7e-22
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 38/273 (13%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
            +LG    G  Y+G  L +  R+A+K +     +  +  + EI     L H N+V   G 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT-LAQGIAFLHDKVKPH 392
             ++G   I  E V  G L   L    + G   D    +   T  + +G+ +LHD     
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRS--KWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142

Query: 393 VVHRDIRASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
           +VHRDI+  NVL++   G     +     G SK +        T    GT  Y+APE + 
Sbjct: 143 IVHRDIKGDNVLINTYSGV----LKISDFGTSKRLAGINPCTETFT--GTLQYMAPEIID 196

Query: 448 RNEL--TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505
           +        +D++S G  ++E+ +G+ P   +      ++F+            ++   +
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-PQAAMFKVGM--------FKVHPEI 247

Query: 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
             S+S++             +  C +  P  R 
Sbjct: 248 PESMSAE---------AKAFILKCFEPDPDKRA 271

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 94.6 bits (236), Expect = 8e-22
 Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 14/184 (7%)

Query: 293 GSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
              +A+K L +S  +++    +   EI   + L HPN++ +    +D    Y++ EF   
Sbjct: 39  KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98

Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
           G L      + + GR  +      +   LA  + + H++    V+HRDI+  N+L+  + 
Sbjct: 99  GEL---YKELQKHGRFDEQRSATFMEE-LADALHYCHER---KVIHRDIKPENLLMGYKG 151

Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              +   G S   P      R     GT  YL PE +       K D++  GVL  E + 
Sbjct: 152 ELKIADFGWSVHAP----SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207

Query: 470 GRRP 473
           G  P
Sbjct: 208 GMPP 211

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 44/184 (23%), Positives = 78/184 (42%), Gaps = 14/184 (7%)

Query: 293 GSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
              +A+K L ++  ++     +   E+   + L HPN++ + G  +D    Y++ E+   
Sbjct: 34  KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93

Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
           G +      + +  +  +      +   LA  +++ H K    V+HRDI+  N+LL    
Sbjct: 94  GTV---YRELQKLSKFDEQRTATYITE-LANALSYCHSK---RVIHRDIKPENLLLGSAG 146

Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
              +   G S   P      R     GT  YL PE +       K D++S GVL  E + 
Sbjct: 147 ELKIADFGWSVHAP----SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202

Query: 470 GRRP 473
           G+ P
Sbjct: 203 GKPP 206

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 53/249 (21%), Positives = 97/249 (38%), Gaps = 19/249 (7%)

Query: 233 SKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEG---NRLLGDSKTGGTYSGI 289
           SK R K                WK +  + +     +  +       LG    G  +  +
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71

Query: 290 -LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
               G     K +       K    +EI    +LHHP L+ +     D  +  ++ EF+ 
Sbjct: 72  EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131

Query: 349 NGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
            G L DR    I      +  A  +       +G+  +H+     +VH DI+  N++ + 
Sbjct: 132 GGELFDR----IAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCET 184

Query: 408 EFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
           +  + +  +  GL+  + P E+++  T     T  + APE V R  +   +D+++ GVL 
Sbjct: 185 KKASSVKIIDFGLATKLNPDEIVKVTT----ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

Query: 465 LEIVSGRRP 473
             ++SG  P
Sbjct: 241 YVLLSGLSP 249

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 94.4 bits (235), Expect = 3e-21
 Identities = 37/212 (17%), Positives = 91/212 (42%), Gaps = 43/212 (20%)

Query: 292 DGSRVAVKRLKRSSFQRKKEFYS-----------------EIGRFARLHHPNLVAVKGCC 334
           D    A+K+ ++S  ++K++F                   E+     + +   +  +G  
Sbjct: 53  DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVK 390
            ++ + YI+YE++ N  + ++  +     ++    + ++V   + +      +++H++  
Sbjct: 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK- 171

Query: 391 PHVVHRDIRASNVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 443
            ++ HRD++ SN+L+D+        F       G S+++  + +  +     GTY ++ P
Sbjct: 172 -NICHRDVKPSNILMDKNGRVKLSDF-------GESEYMVDKKI--KGSR--GTYEFMPP 219

Query: 444 EFVYRNELT--TKSDVYSFGVLLLEIVSGRRP 473
           EF          K D++S G+ L  +     P
Sbjct: 220 EFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 95.5 bits (238), Expect = 4e-21
 Identities = 58/250 (23%), Positives = 98/250 (39%), Gaps = 22/250 (8%)

Query: 231 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI- 289
                    R+           P    F T +   +++ +    + LG    G       
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGM--FITSKKGHLSEMYQRV-KKLGSGAYGEVLLCRD 58

Query: 290 LPDGSRVAVKRLKRSSFQRKKE--FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
                  A+K ++++S           E+     L HPN++ +     D  + Y+V E  
Sbjct: 59  KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118

Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-D 406
             G L      I    +  +      +   +  G+ +LH     ++VHRD++  N+LL  
Sbjct: 119 KGGEL---FDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLES 171

Query: 407 EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
           +E  A +  V  GLS      + M+ER     GT  Y+APE V R +   K DV+S GV+
Sbjct: 172 KEKDALIKIVDFGLSAVFENQKKMKERL----GTAYYIAPE-VLRKKYDEKCDVWSIGVI 226

Query: 464 LLEIVSGRRP 473
           L  +++G  P
Sbjct: 227 LFILLAGYPP 236

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 95.1 bits (237), Expect = 5e-21
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 21/226 (9%)

Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--- 311
            +F        +  +    R+LG    G          G   AVK + +   ++K +   
Sbjct: 14  GMFVQHSTAIFSDRYKGQ-RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72

Query: 312 FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR 371
              E+    +L HPN++ +     D G  Y+V E    G L      I    R       
Sbjct: 73  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKR-FSEVDA 128

Query: 372 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVM 427
            ++   +  GI ++H      +VHRD++  N+LL  +   A++  +  GLS      + M
Sbjct: 129 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185

Query: 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           +++     GT  Y+APE V       K DV+S GV+L  ++SG  P
Sbjct: 186 KDKI----GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 94.0 bits (233), Expect = 8e-21
 Identities = 47/354 (13%), Positives = 88/354 (24%), Gaps = 74/354 (20%)

Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-L 290
           R+          +  +++L           EL    +    G  +LG             
Sbjct: 42  RTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG-TVLGQEDPYAYLEATDQ 100

Query: 291 PDGSRVAVKRL---KRSSFQRKKEFYSEIGRFARL----------------------HHP 325
             G    V      +R      K+   E+ R   L                        P
Sbjct: 101 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160

Query: 326 NLVAVKGCCYDHGDRYIVYEFVV-------NGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
               +     D  D +++  F +              L       +SL    R+++   +
Sbjct: 161 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 220

Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
            + +A LH      +VH  +R  +++LD+  G  L G                   G  +
Sbjct: 221 IRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV----RDGASAVSPIGRGF 273

Query: 439 G---YLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 490
                 A   +         +T   D ++ G+ +  I     P                 
Sbjct: 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP------------NTDDA 321

Query: 491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
            L             I     +IP+      V  L+    ++    R      +
Sbjct: 322 AL--------GGSEWIFRSCKNIPQP-----VRALLEGFLRYPKEDRLLPLQAM 362

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 94.4 bits (235), Expect = 1e-20
 Identities = 63/258 (24%), Positives = 106/258 (41%), Gaps = 33/258 (12%)

Query: 234 KRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPD 292
                S + +       + P    +  ++   I +++ +  R LG    G          
Sbjct: 4   HHHHSSGRENLYFQGIAINPGM--YVRKKEGKIGESYFKV-RKLGSGAYGEVLLCKEKNG 60

Query: 293 GSRVAVKRLKRSSF-------------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339
            S  A+K +K+S F             +  +E Y+EI     L HPN++ +     D   
Sbjct: 61  HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120

Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
            Y+V EF   G L      I    +  D      +   +  GI +LH     ++VHRDI+
Sbjct: 121 FYLVTEFYEGGEL---FEQIINRHK-FDECDAANIMKQILSGICYLHKH---NIVHRDIK 173

Query: 400 ASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
             N+LL ++    ++  V  GLS F      +++R     GT  Y+APE V + +   K 
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL----GTAYYIAPE-VLKKKYNEKC 228

Query: 456 DVYSFGVLLLEIVSGRRP 473
           DV+S GV++  ++ G  P
Sbjct: 229 DVWSCGVIMYILLCGYPP 246

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 43/274 (15%), Positives = 93/274 (33%), Gaps = 54/274 (19%)

Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----------- 340
           D    A+K+++ +  ++     SE+   A L+H  +V       +  +            
Sbjct: 30  DSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88

Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
             +I  E+  NG L      I     +       ++   + + ++++H +    ++HRD+
Sbjct: 89  TLFIQMEYCENGTL---YDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDL 142

Query: 399 RASNVLLDEE-------FG---AHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFV 446
           +  N+ +DE        FG        + + K     +      +    GT  Y+A E V
Sbjct: 143 KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE-V 201

Query: 447 YRNELT--TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504
                    K D+YS G++  E++          ++  + +             +E    
Sbjct: 202 LDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI-LKKLRS---------VSIEFPPD 251

Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
              +           +K   ++     H P+ RP
Sbjct: 252 FDDNKMKV-------EK--KIIRLLIDHDPNKRP 276

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 51/252 (20%), Positives = 92/252 (36%), Gaps = 27/252 (10%)

Query: 235 RRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGI- 289
                 K   P  +A   P+      E    +    S       R LG       +    
Sbjct: 3   APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISD 62

Query: 290 LPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
                  A K + +S   +     +   EI     L H ++V   G   D+   ++V E 
Sbjct: 63  ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122

Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
                L   L    R     +   R      +  G  +LH      V+HRD++  N+ L+
Sbjct: 123 CRRRSL---LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLN 175

Query: 407 EEFGAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
           E+     + V     GL+  V ++  +++ +   GT  Y+APE + +   + + DV+S G
Sbjct: 176 ED-----LEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIG 228

Query: 462 VLLLEIVSGRRP 473
            ++  ++ G+ P
Sbjct: 229 CIMYTLLVGKPP 240

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 92.9 bits (231), Expect = 2e-20
 Identities = 51/259 (19%), Positives = 83/259 (32%), Gaps = 41/259 (15%)

Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           D   VAVKR+    F        E+        HPN++       D   +YI  E     
Sbjct: 47  DNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AA 102

Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L  +   + +   +      + +      G+A LH     ++VHRD++  N+L+     
Sbjct: 103 TLQEY---VEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNA 156

Query: 411 AHLMGV-----GLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNE---LTTKSDVYSFG 461
              +       GL K          R     GT G++APE +  +     T   D++S G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216

Query: 462 VLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS--SLSSDIPEAGVV 519
            +   ++S                F                + L+   SL    PE    
Sbjct: 217 CVFYYVISEGSH-----------PF--------GKSLQRQANILLGACSLDCLHPEKHED 257

Query: 520 QKVVDLVYACTQHVPSMRP 538
               +L+       P  RP
Sbjct: 258 VIARELIEKMIAMDPQKRP 276

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 92.0 bits (228), Expect = 3e-20
 Identities = 46/351 (13%), Positives = 87/351 (24%), Gaps = 79/351 (22%)

Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-L 290
           R+          +  +++L           EL    +    G  +LG             
Sbjct: 37  RTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG-TVLGQEDPYAYLEATDQ 95

Query: 291 PDGSRVAVKRLKRSSFQRKKE----------------------------FYSEIGRFARL 322
             G    V     +                                   F          
Sbjct: 96  ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155

Query: 323 HHPNLVAVKGCCYDHG--DRYIVYEFVV--NGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
               ++ V+    D     R+ +Y  +          L       +SL    R+++   +
Sbjct: 156 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 215

Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
            + +A LH      +VH  +R  +++LD+  G  L G          V     V++  + 
Sbjct: 216 IRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL------VRDGARVVSSVSR 266

Query: 439 GYLAPEFVYRNEL-----------TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 487
           G+  PE   R              T   D ++ G+++  I     P              
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP------------IT 314

Query: 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
                             I     +IP+      V  L+    ++    R 
Sbjct: 315 --------KDAALGGSEWIFRSCKNIPQP-----VRALLEGFLRYPKEDRL 352

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 89.9 bits (224), Expect = 3e-20
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 30/212 (14%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAV 330
            LLG     G Y    +  G  VA+K + + +  +    +   +E+    +L HP+++ +
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76

Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
                D    Y+V E   NG ++R+L +  R     +   R  +   +  G+ +LH    
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQ-IITGMLYLHSH-- 131

Query: 391 PHVVHRDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             ++HRD+  SN+LL          FG    L                 T+   GT  Y+
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---------YTLC--GTPNYI 179

Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           +PE   R+    +SDV+S G +   ++ GR P
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 25/206 (12%), Positives = 59/206 (28%), Gaps = 19/206 (9%)

Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
           +  +  +K  K ++          + R         +             +V E    G 
Sbjct: 94  NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153

Query: 352 L-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
           L +    +     + +   + +  A  +   I  +HD     ++H DI+  N +L   F 
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL 210

Query: 411 AHLMGV-----------GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDV 457
                            G S  +  ++  + T+      T G+   E +       + D 
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDM--KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268

Query: 458 YSFGVLLLEIVSGRRPAQAVDSVCWQ 483
           +     +  ++ G       +    +
Sbjct: 269 FGVAATVYCMLFGTYMKVKNEGGECK 294

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 89.6 bits (223), Expect = 5e-20
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 21/218 (9%)

Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFARL 322
           +I   F    R LG    G  +       G    +K + +   Q   E   +EI     L
Sbjct: 19  TIDDLFIFK-RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77

Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVATTLA 379
            HPN++ +     D+ + YIV E    G L +R +    RG        A  MK    + 
Sbjct: 78  DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK---QMM 134

Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAG 435
             +A+ H +   HVVH+D++  N+L  D    + +  +  GL++     E          
Sbjct: 135 NALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---- 187

Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           GT  Y+APE V++ ++T K D++S GV++  +++G  P
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.0 bits (221), Expect = 6e-20
 Identities = 37/266 (13%), Positives = 68/266 (25%), Gaps = 64/266 (24%)

Query: 296 VAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----YIVYEFVV 348
           VA+  +           +E  S   R +R+  P +  V     D         +V E++ 
Sbjct: 59  VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV----LDVVHTRAGGLVVAEWIR 114

Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
            G L            S   A+R     +LA      H      V       S V +  +
Sbjct: 115 GGSLQEVA----DTSPSPVGAIR--AMQSLAAAADAAHRA---GVALSIDHPSRVRVSID 165

Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
               L                           +            + D+   G  L  ++
Sbjct: 166 GDVVL----------------------AYPATMPDA-------NPQDDIRGIGASLYALL 196

Query: 469 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYA 528
             R P                    +     + ++P  + +  DIP       +  +   
Sbjct: 197 VNRWPLPEAGV-------RSGLAPAERDTAGQPIEP--ADIDRDIPFQ-----ISAVAAR 242

Query: 529 CTQHVPSMRPRMSHVVHQLQQLAQPP 554
             Q    +R   S +++ +QQ     
Sbjct: 243 SVQGDGGIRSA-STLLNLMQQATAVA 267

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 92.2 bits (229), Expect = 8e-20
 Identities = 47/250 (18%), Positives = 97/250 (38%), Gaps = 19/250 (7%)

Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEG---NRLLGDSKTGGTYSG 288
              +  + +   +      V   WK +  + +     +  +    +  LG    G  +  
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176

Query: 289 I-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
                G+  A K +       K+    EI   + L HP LV +     D  +  ++YEF+
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236

Query: 348 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
             G L ++    +      +     ++    + +G+  +H+    + VH D++  N++  
Sbjct: 237 SGGELFEK----VADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFT 289

Query: 407 EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
            +    L  +  GL+  + P + ++  T    GT  + APE      +   +D++S GVL
Sbjct: 290 TKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

Query: 464 LLEIVSGRRP 473
              ++SG  P
Sbjct: 346 SYILLSGLSP 355

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 51/243 (20%), Positives = 96/243 (39%), Gaps = 21/243 (8%)

Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSE-----GNRLLGDSKTGGTY 286
               R   +     A +  +P     F    + +     +         +LG  + G  +
Sbjct: 47  DLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVH 106

Query: 287 SGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345
                  G ++A K +K    + K+E  +EI    +L H NL+ +        D  +V E
Sbjct: 107 KCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166

Query: 346 FVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
           +V  G L DR    I     +L     +     + +GI  +H     +++H D++  N+L
Sbjct: 167 YVDGGELFDR----IIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENIL 219

Query: 405 LDEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
                   +  +  GL++   P E ++       GT  +LAPE V  + ++  +D++S G
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPREKLKVNF----GTPEFLAPEVVNYDFVSFPTDMWSVG 275

Query: 462 VLL 464
           V+ 
Sbjct: 276 VIA 278

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 90.1 bits (224), Expect = 3e-19
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 20/217 (9%)

Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFA 320
            +  + ++    +LG    G              AVK + ++S + K       E+    
Sbjct: 18  GTFAERYNIV-CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
           +L HPN++ +     D    YIV E    G L      I +  R        ++   +  
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKR-FSEHDAARIIKQVFS 132

Query: 381 GIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGG 436
           GI ++H     ++VHRD++  N+LL  +E    +  +  GLS        M++R     G
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI----G 185

Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           T  Y+APE V R     K DV+S GV+L  ++SG  P
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 33/188 (17%), Positives = 71/188 (37%), Gaps = 22/188 (11%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
                 K +K      +     EI       H N++ +        +  +++EF+    +
Sbjct: 30  KKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88

Query: 353 -DRWLHHIPRGGRSL---DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
            +R    I      L   +    +     + + + FLH     ++ H DIR  N++    
Sbjct: 89  FER----INTSAFELNEREIVSYVH---QVCEALQFLHSH---NIGHFDIRPENIIYQTR 138

Query: 409 FGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
             + +  +  G ++ + P +  +           Y APE    + ++T +D++S G L+ 
Sbjct: 139 RSSTIKIIEFGQARQLKPGDNFRLLF----TAPEYYAPEVHQHDVVSTATDMWSLGTLVY 194

Query: 466 EIVSGRRP 473
            ++SG  P
Sbjct: 195 VLLSGINP 202

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 87.6 bits (218), Expect = 3e-19
 Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 22/212 (10%)

Query: 260 TEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGR 318
           + +  +I K F     +LG       +       G   A+K +K+S   R     +EI  
Sbjct: 1   SMQTTNIRKTFIFM-EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAV 59

Query: 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVA 375
             ++ H N+V ++         Y+V + V  G L DR    I   G     D ++ ++  
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDR----ILERGVYTEKDASLVIQ-- 113

Query: 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERTV 432
             +   + +LH+     +VHRD++  N+L    E  + +M    GLSK     +M     
Sbjct: 114 -QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC- 168

Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
              GT GY+APE + +   +   D +S GV+ 
Sbjct: 169 ---GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 24/217 (11%)

Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH 323
            I + ++     +G    G     +      R A K++ +   +    F  EI     L 
Sbjct: 6   DINQYYTLE-NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64

Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVATTLAQ 380
           HPN++ +     D+ D Y+V E    G L +R    +         D A  MK    +  
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGELFER----VVHKRVFRESDAARIMK---DVLS 117

Query: 381 GIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGG 436
            +A+ H     +V HRD++  N L   +   + L  +  GL+    P ++M+ +     G
Sbjct: 118 AVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----G 170

Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           T  Y++P+ V       + D +S GV++  ++ G  P
Sbjct: 171 TPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 86.1 bits (214), Expect = 8e-19
 Identities = 42/189 (22%), Positives = 79/189 (41%), Gaps = 22/189 (11%)

Query: 293 GSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
               A K + +S   +     +   EI     L H ++V   G   D+   ++V E    
Sbjct: 40  KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99

Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
             L   L    R     +   R      +  G  +LH      V+HRD++  N+ L+E+ 
Sbjct: 100 RSL---LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNED- 151

Query: 410 GAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
               + V     GL+  V ++  +++ +   GT  Y+APE + +   + + DV+S G ++
Sbjct: 152 ----LEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205

Query: 465 LEIVSGRRP 473
             ++ G+ P
Sbjct: 206 YTLLVGKPP 214

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 60/264 (22%), Positives = 107/264 (40%), Gaps = 50/264 (18%)

Query: 291 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348
           P G  +AVKR++   + Q +K    ++    R    P  V   G  +  GD +I  E + 
Sbjct: 30  PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM- 88

Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
           +  LD++   +   G+++   +  K+A ++ + +  LH K+   V+HRD++ SNVL++  
Sbjct: 89  DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINAL 146

Query: 409 -------FG--AHLMG-VGLSKFVPWEVMQERTVMAGGTYGYLAPE----FVYRNELTTK 454
                  FG   +L+  V                   G   Y+APE     + +   + K
Sbjct: 147 GQVKMCDFGISGYLVDDVAKDIDA-------------GCKPYMAPERINPELNQKGYSVK 193

Query: 455 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514
           SD++S G+ ++E+   R P              W TP        + L  ++   S  +P
Sbjct: 194 SDIWSLGITMIELAILRFP-----------YDSWGTP-------FQQLKQVVEEPSPQLP 235

Query: 515 EAGVVQKVVDLVYACTQHVPSMRP 538
                 + VD    C +     RP
Sbjct: 236 ADKFSAEFVDFTSQCLKKNSKERP 259

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 58/289 (20%), Positives = 104/289 (35%), Gaps = 56/289 (19%)

Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-----------GD 339
            G   A+KRL  +  ++ +    E+    +L  HPN+V                      
Sbjct: 52  SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ----FCSAASIGKEESDTGQA 107

Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
            +++   +  G L  +L  +   G  L     +K+     + +  +H + KP ++HRD++
Sbjct: 108 EFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLK 165

Query: 400 ASNVLLDEE-------FG---AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV--Y 447
             N+LL  +       FG           S       + E  +    T  Y  PE +  Y
Sbjct: 166 VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY 225

Query: 448 RNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL-VQSHRYLELLDPL 505
            N  +  K D+++ G +L  +   + P            FE    L + + +Y     P 
Sbjct: 226 SNFPIGEKQDIWALGCILYLLCFRQHP------------FEDGAKLRIVNGKYSI---PP 270

Query: 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
             +  +             L+ A  Q  P  R  ++ VVHQLQ++A   
Sbjct: 271 HDTQYTVF---------HSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 48/209 (22%), Positives = 70/209 (33%), Gaps = 34/209 (16%)

Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
            G  VAVKR+             EI        HPN++            YI  E   N 
Sbjct: 38  QGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL-CNL 93

Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDE 407
            L   +        +L         + L Q   G+A LH      ++HRD++  N+L+  
Sbjct: 94  NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVST 150

Query: 408 EFGAHLMGV-------------GLSKFVPWEVMQERTVM--AGGTYGYLAPE-------F 445
                                 GL K +       RT +    GT G+ APE        
Sbjct: 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL 210

Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
             +  LT   D++S G +   I+S G+ P
Sbjct: 211 QTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 87.8 bits (217), Expect = 2e-18
 Identities = 43/193 (22%), Positives = 86/193 (44%), Gaps = 21/193 (10%)

Query: 293 GSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIVYE 345
           G +VA+K+ ++    + +E +  EI    +L+HPN+V+             +    +  E
Sbjct: 39  GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98

Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
           +   G L ++L+        L       + + ++  + +LH+     ++HRD++  N++L
Sbjct: 99  YCEGGDLRKYLNQFENCCG-LKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVL 154

Query: 406 DEEFGAHLMGV---GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSF 460
                  +  +   G +K      + +  +     GT  YLAPE + + + T   D +SF
Sbjct: 155 QPGPQRLIHKIIDLGYAKE-----LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSF 209

Query: 461 GVLLLEIVSGRRP 473
           G L  E ++G RP
Sbjct: 210 GTLAFECITGFRP 222

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 26/219 (11%)

Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--FYSEIGRFAR 321
           +  + ++    +LG    G              AVK + ++S + K       E+    +
Sbjct: 19  TFAERYNIV-CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77

Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVATTL 378
           L HPN++ +     D    YIV E    G L D     I +  R    D A  +K    +
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDE----IIKRKRFSEHDAARIIK---QV 130

Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMA 434
             GI ++H     ++VHRD++  N+LL  +E    +  +  GLS        M++R    
Sbjct: 131 FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--- 184

Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
            GT  Y+APE V R     K DV+S GV+L  ++SG  P
Sbjct: 185 -GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 85.0 bits (210), Expect = 5e-18
 Identities = 43/209 (20%), Positives = 81/209 (38%), Gaps = 21/209 (10%)

Query: 278 GDSKTGGTYSGI-LPDGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           G             P G  V V+R  L+  S +       E+      +HPN+V  +   
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA---QGIAFLHDKVKP 391
               + ++V  F+  G     +      G +        +A  L    + + ++H     
Sbjct: 96  IADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVLKALDYIHHM--- 147

Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-----GTYGYLAPEFV 446
             VHR ++AS++L+  +   +L G+  +  +     ++R V            +L+PE +
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207

Query: 447 YRNEL--TTKSDVYSFGVLLLEIVSGRRP 473
            +N      KSD+YS G+   E+ +G  P
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGHVP 236

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 84.3 bits (209), Expect = 7e-18
 Identities = 50/247 (20%), Positives = 90/247 (36%), Gaps = 35/247 (14%)

Query: 245 PAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVK---- 299
           P  S        +   ++       +     ++G          I    G + AVK    
Sbjct: 3   PGISGGGGGILDM--ADDDVLFEDVYELC-EVIGKGPFSVVRRCINRETGQQFAVKIVDV 59

Query: 300 -RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLH 357
            +   S     ++   E      L HP++V +       G  Y+V+EF+    L      
Sbjct: 60  AKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE--- 116

Query: 358 HIPRGGRSLDW------AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFG 410
            I +   +         +  M+    + + + + HD    +++HRD++   VLL  +E  
Sbjct: 117 -IVKRADAGFVYSEAVASHYMR---QILEALRYCHDN---NIIHRDVKPHCVLLASKENS 169

Query: 411 AHLMGV--GLSKFV--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
           A +     G++  +     V   R     GT  ++APE V R       DV+  GV+L  
Sbjct: 170 APVKLGGFGVAIQLGESGLVAGGRV----GTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225

Query: 467 IVSGRRP 473
           ++SG  P
Sbjct: 226 LLSGCLP 232

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 29/207 (14%)

Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           +G   +G  Y+ + +  G  VA++++      +K+   +EI       +PN+V       
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
              + ++V E++  G L   +         +D      V     Q + FLH      V+H
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 396 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
           RDI++ N+LL  +       FG  A +               +R+ M G  Y ++APE V
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQIT----------PEQSKRSTMVGTPY-WMAPEVV 188

Query: 447 YRNELTTKSDVYSFGVLLLEIVSGRRP 473
            R     K D++S G++ +E++ G  P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 66/250 (26%), Positives = 106/250 (42%), Gaps = 25/250 (10%)

Query: 231 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI- 289
              +        + P  ++LVP  W   +  +  +++  F      LG   T   Y    
Sbjct: 18  LYFQSMSSVTASAAPGTASLVPDYWIDGSNRD--ALSDFFEVE-SELGRGATSIVYRCKQ 74

Query: 290 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
                  A+K LK++    KK   +EIG   RL HPN++ +K       +  +V E V  
Sbjct: 75  KGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132

Query: 350 GPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-D 406
           G L DR    + +G  S  D A  +K    + + +A+LH+     +VHRD++  N+L   
Sbjct: 133 GELFDRI---VEKGYYSERDAADAVK---QILEAVAYLHEN---GIVHRDLKPENLLYAT 183

Query: 407 EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
               A L     GLSK V    +M+       GT GY APE +       + D++S G++
Sbjct: 184 PAPDAPLKIADFGLSKIVEHQVLMKTVC----GTPGYCAPEILRGCAYGPEVDMWSVGII 239

Query: 464 LLEIVSGRRP 473
              ++ G  P
Sbjct: 240 TYILLCGFEP 249

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 29/207 (14%)

Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           +G+  TG          G +VAVK +     QR++  ++E+       H N+V +     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
              + +++ EF+  G L   +  +      L+      V   + Q +A+LH +    V+H
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLHAQ---GVIH 164

Query: 396 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
           RDI++ ++LL  +       FG  A +           + + +R  + G  Y ++APE +
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQIS----------KDVPKRKSLVGTPY-WMAPEVI 213

Query: 447 YRNELTTKSDVYSFGVLLLEIVSGRRP 473
            R+   T+ D++S G++++E+V G  P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPP 240

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 49/294 (16%), Positives = 106/294 (36%), Gaps = 55/294 (18%)

Query: 286 YSGILPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK--GCCYDHGDRY 341
           +  +       A+K +       +    + +EI    +L   +   ++           Y
Sbjct: 45  FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104

Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           +V E   N  L+ WL       +S+D   R      + + +  +H      +VH D++ +
Sbjct: 105 MVMECG-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPA 156

Query: 402 NVLLDEEFGAHLMGV------GLSKFVPWEVMQERTVMAGGTYGYLAPE----------- 444
           N L+ +       G+      G++  +  +          GT  Y+ PE           
Sbjct: 157 NFLIVD-------GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209

Query: 445 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504
              +++++ KSDV+S G +L  +  G+ P              +   + Q  +   ++DP
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQIINQISKLHAIIDP 255

Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV-VHQLQQLAQPPVTK 557
              +   + P+    + + D++  C +  P  R  +  +  H   Q+   PV +
Sbjct: 256 ---NHEIEFPD-IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 305

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 40/264 (15%), Positives = 91/264 (34%), Gaps = 37/264 (14%)

Query: 231 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL 290
             +  + + + + +P               E +    + +S   + +G   +   +  + 
Sbjct: 19  ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL-KQIGSGGSSKVFQVLN 77

Query: 291 PDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK--GCCYDHGDRYIVYEF 346
                 A+K +       +    + +EI    +L   +   ++           Y+V E 
Sbjct: 78  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137

Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
             N  L+ WL       +S+D   R      + + +  +H      +VH D++ +N L+ 
Sbjct: 138 G-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV 189

Query: 407 EE------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-----------FVYRN 449
           +       FG       ++  +  +          G   Y+ PE              ++
Sbjct: 190 DGMLKLIDFG-------IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242

Query: 450 ELTTKSDVYSFGVLLLEIVSGRRP 473
           +++ KSDV+S G +L  +  G+ P
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTP 266

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 56/281 (19%), Positives = 103/281 (36%), Gaps = 52/281 (18%)

Query: 291 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
           P G  +A K +        + +   E+      + P +V   G  Y  G+  I  E +  
Sbjct: 56  PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115

Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE- 408
           G LD+ L    +    +   +  KV+  + +G+ +L +K K  ++HRD++ SN+L++   
Sbjct: 116 GSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRG 169

Query: 409 ------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
                 FG    L+    + FV             GT  Y++PE +     + +SD++S 
Sbjct: 170 EIKLCDFGVSGQLIDSMANSFV-------------GTRSYMSPERLQGTHYSVQSDIWSM 216

Query: 461 GVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG--- 517
           G+ L+E+  GR P    D+   + +F        +        P        +       
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276

Query: 518 ---VVQKVV-----------------DLVYACTQHVPSMRP 538
              ++  +V                 D V  C    P+ R 
Sbjct: 277 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 16/183 (8%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           A+K L++    ++ +      E    +RL HP  V +     D    Y    +  NG L 
Sbjct: 59  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL- 117

Query: 354 RWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
             L +I + G   +   R   A    A  + +LH K    ++HRD++  N+LL+E+   H
Sbjct: 118 --LKYIRKIGSFDETCTRFYTAEIVSA--LEYLHGK---GIIHRDLKPENILLNED--MH 168

Query: 413 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
           +     G +K +  E  Q R     GT  Y++PE +        SD+++ G ++ ++V+G
Sbjct: 169 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

Query: 471 RRP 473
             P
Sbjct: 229 LPP 231

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 47/228 (20%), Positives = 81/228 (35%), Gaps = 27/228 (11%)

Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFAR 321
           +S + +    + +LG   T   + G     G   A+K     SF R  +    E     +
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 322 LHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
           L+H N+V +     +   R   ++ EF   G L   L   P     L  +  + V   + 
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVV 122

Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH----LMGVGLSKFVPWEVMQERTVMAG 435
            G+  L +     +VHR+I+  N++            L   G ++      +++      
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-----LEDDEQFVS 174

Query: 436 --GTYGYLAPEFVYRNELTT--------KSDVYSFGVLLLEIVSGRRP 473
             GT  YL P+   R  L            D++S GV      +G  P
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 81.1 bits (201), Expect = 5e-17
 Identities = 42/221 (19%), Positives = 87/221 (39%), Gaps = 25/221 (11%)

Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEF 312
           +    + + +    +   ++ LG  K       I    G   A K LK+    +    E 
Sbjct: 16  ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI 75

Query: 313 YSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSL---D 367
             EI         P ++ +     +  +  ++ E+   G +       +P     +   D
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC---LPELAEMVSEND 132

Query: 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-P 423
               +K    + +G+ +LH     ++VH D++  N+LL        +  V  G+S+ +  
Sbjct: 133 VIRLIK---QILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186

Query: 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
              ++E      GT  YLAPE +  + +TT +D+++ G++ 
Sbjct: 187 ACELREIM----GTPEYLAPEILNYDPITTATDMWNIGIIA 223

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 80.7 bits (200), Expect = 5e-17
 Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 23/218 (10%)

Query: 267 TKNFSEG---NRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFA 320
           +  FS+       LG          +    G   A K +       +  ++   E     
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLA 379
           +L HPN+V +     +    Y+V++ V  G L +     + R   S   A        + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADAS--HCIQQIL 115

Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAG 435
           + IA+ H      +VHR+++  N+LL  +  GA +     GL+  V   E          
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---- 168

Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           GT GYL+PE + ++  +   D+++ GV+L  ++ G  P
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 80.9 bits (200), Expect = 8e-17
 Identities = 50/295 (16%), Positives = 108/295 (36%), Gaps = 57/295 (19%)

Query: 286 YSGILPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK--GCCYDHGDRY 341
           +  +       A+K +       +    + +EI    +L   +   ++           Y
Sbjct: 26  FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85

Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           +V E   N  L+ WL       +S+D   R      + + +  +H      +VH D++ +
Sbjct: 86  MVMECG-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPA 137

Query: 402 NVLLDEEFGAHLMGV------GLSKFV-PWEVMQERTVMAGGTYGYLAPE---------- 444
           N L+ +       G+      G++  + P      +    G T  Y+ PE          
Sbjct: 138 NFLIVD-------GMLKLIDFGIANQMQPDTTSVVKDSQVG-TVNYMPPEAIKDMSSSRE 189

Query: 445 -FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503
               +++++ KSDV+S G +L  +  G+ P              +   + Q  +   ++D
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQIINQISKLHAIID 235

Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQLQQLAQPPVTK 557
           P   +   + P+    + + D++  C +  P  R  +  ++ H   Q+   PV +
Sbjct: 236 P---NHEIEFPD-IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 286

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 43/183 (23%), Positives = 84/183 (45%), Gaps = 16/183 (8%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           A+K + +     + E    + E+     L HP LV +     D  D ++V + ++ G L 
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL- 102

Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
              +H+ +     +  +++ +   L   + +L ++    ++HRD++  N+LLDE    H+
Sbjct: 103 --RYHLQQNVHFKEETVKLFICE-LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHI 156

Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT--TKS-DVYSFGVLLLEIVSG 470
               ++  +P E    +     GT  Y+APE     +    + + D +S GV   E++ G
Sbjct: 157 TDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

Query: 471 RRP 473
           RRP
Sbjct: 214 RRP 216

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 81.4 bits (201), Expect = 1e-16
 Identities = 43/232 (18%), Positives = 79/232 (34%), Gaps = 35/232 (15%)

Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFAR 321
           +S + +    + +LG   T   + G     G   A+K     SF R  +    E     +
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 322 LHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT-- 377
           L+H N+V +     +   R   ++ EF   G L      +     +  + +         
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL---YTVLEEPSNA--YGLPESEFLIVL 118

Query: 378 --LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH----LMGVGLSKFVPWEVMQERT 431
             +  G+  L +     +VHR+I+  N++            L   G ++      +++  
Sbjct: 119 RDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-----LEDDE 170

Query: 432 VMAG--GTYGYLAPEFVYRNELTT--------KSDVYSFGVLLLEIVSGRRP 473
                 GT  YL P+   R  L            D++S GV      +G  P
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1fm5_A Early activation antigen CD69; C-type lectin-like domain, natural killer cell receptor, lectin, C-type lectin, immune system; 2.27A {Homo sapiens} SCOP: d.169.1.1 Length = 199

 Score = 77.7 bits (191), Expect = 1e-16
 Identities = 37/182 (20%), Positives = 69/182 (37%), Gaps = 29/182 (15%)

Query: 10  VPLQCFLLLVAYY---VLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKC 66
           VP+ C ++ V +    ++ L+A              +  +    + C  DW+  +   KC
Sbjct: 39  VPVLCAVMNVVFITILIIALIALSVGQYNCPGQYTFSMPSDSHVSSCSEDWVGYQ--RKC 96

Query: 67  FGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL 126
           +      RSW  ++  C E G  LA + S ++ +  ++  G+     WVG   +    G 
Sbjct: 97  YFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGR--EEHWVG---LKKEPGH 151

Query: 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPF 186
            WKWS+   ++N   +  GS                  C  + N    + +  C  +  +
Sbjct: 152 PWKWSNG-KEFNNWFNVTGSDK----------------CVFLKNT--EVSSMECEKNLYW 192

Query: 187 IC 188
           IC
Sbjct: 193 IC 194

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 46/219 (21%), Positives = 85/219 (38%), Gaps = 25/219 (11%)

Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL- 322
           ++T ++    ++LG    G          G + A+K L  S   R+     E+    +  
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQAS 79

Query: 323 HHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHI-PRGGRSLDWAMRMKVATT 377
             P++V +     +         I+ E +  G L      I  RG ++       ++   
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQAFTEREAAEIMRD 136

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERTVMA 434
           +   I FLH     ++ HRD++  N+L   +E  A L     G +K      +Q      
Sbjct: 137 IGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC--- 190

Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
             T  Y+APE +   +     D++S GV++  ++ G  P
Sbjct: 191 -YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 47/247 (19%), Positives = 80/247 (32%), Gaps = 51/247 (20%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLV 328
             +G    G     I     +  A+K     ++++ + +  +   +E+    +LHHPN+ 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 329 AVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM--------------- 372
            +     D     +V E    G L D+    I          +                 
Sbjct: 92  RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 373 --------------------KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
                                +   +   + +LH++    + HRDI+  N L        
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFE 208

Query: 413 LMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNEL--TTKSDVYSFGVLLLE 466
           +  V  GLSK        E   M    GT  ++APE +         K D +S GVLL  
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 467 IVSGRRP 473
           ++ G  P
Sbjct: 269 LLMGAVP 275

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 48/223 (21%), Positives = 87/223 (39%), Gaps = 20/223 (8%)

Query: 259 TTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--FYSE 315
            T      T+ +      LG          + +  G   A   +       +       E
Sbjct: 2   ATITCTRFTEEYQLF-EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60

Query: 316 IGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRS-LDWAMRMK 373
                 L HPN+V +     + G  Y++++ V  G L +     + R   S  D +  ++
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQ 117

Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQER 430
               + + +   H      VVHR+++  N+LL  +  GA +     GL+  V  E  Q+ 
Sbjct: 118 ---QILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQA 169

Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
                GT GYL+PE + ++      D+++ GV+L  ++ G  P
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>1mpu_A NKG2-D type II integral membrane protein; C-type lectin-like domain, immune system; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 1hyr_B Length = 138

 Score = 74.8 bits (184), Expect = 2e-16
 Identities = 31/155 (20%), Positives = 58/155 (37%), Gaps = 23/155 (14%)

Query: 34  NQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAAL 93
           N   N ++   + + +  PCP +WI  +  + C+ +    ++W ES+  C      L  +
Sbjct: 2   NSLFNQEVQIPLTESYCGPCPKNWICYK--NNCYQFFDESKNWYESQASCMSQNASLLKV 59

Query: 94  TSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTS 153
            S E+    Q L     +  W+G    +     SW+W D  S  + ++  +         
Sbjct: 60  YSKED----QDLLKLVKSYHWMGLV--HIPTNGSWQWEDG-SILSPNLLTIIEMQKG--- 109

Query: 154 LPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
                    D     S+       E C+T + +IC
Sbjct: 110 ---------DCALYASSF--KGYIENCSTPNTYIC 133

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 23/225 (10%)

Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYS 314
           F        + N+      LG          +    G   A K +       +  ++   
Sbjct: 19  FMMNASTKFSDNYDVK-EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77

Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRS-LDWAMRM 372
           E     +L HPN+V +     +    Y+V++ V  G L +     + R   S  D +  +
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCI 134

Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQ 428
           +    + + IA+ H      +VHR+++  N+LL  +  GA +     GL+  V   E   
Sbjct: 135 Q---QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188

Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
                  GT GYL+PE + ++  +   D+++ GV+L  ++ G  P
Sbjct: 189 GFA----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 38/185 (20%), Positives = 75/185 (40%), Gaps = 26/185 (14%)

Query: 293 GSRVAVKRLKRSSFQR------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
           G   A K +K+   +       ++E   E+    ++ H N++ +     +  D  ++ E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96

Query: 347 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
           V  G L D       +   S  +    +K    +  G+ +LH K    + H D++  N++
Sbjct: 97  VSGGELFDFL---AQKESLSEEEATSFIK---QILDGVNYLHTK---KIAHFDLKPENIM 147

Query: 405 LD--EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
           L        H+  +  GL+  +      +       GT  ++APE V    L  ++D++S
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 203

Query: 460 FGVLL 464
            GV+ 
Sbjct: 204 IGVIT 208

>3rs1_A C-type lectin domain family 2 member I; C-type lectin-like, ligand of NK receptor, natural killer CE receptors, surface of activated T lymphocytes; 1.94A {Mus musculus} Length = 122

 Score = 74.0 bits (182), Expect = 3e-16
 Identities = 30/144 (20%), Positives = 56/144 (38%), Gaps = 26/144 (18%)

Query: 45  MNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQK 104
           MNK + A C  +W      +KCF + G  R+W  ++ +C      LA   + EE    ++
Sbjct: 1   MNKTY-AACSKNWTGVG--NKCFYFSGYPRNWTFAQAFCMAQEAQLARFDNEEELIFLKR 57

Query: 105 LCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
             G      W+G    ++     WKW++N +++N     +G                   
Sbjct: 58  FKGD--FDSWIGLHRESS--EHPWKWTNN-TEYNNMNPILGVGR---------------- 96

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
              +S+    + + R   +  +IC
Sbjct: 97  YAYLSSD--RISSSRSYINRMWIC 118

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 79.7 bits (197), Expect = 4e-16
 Identities = 62/255 (24%), Positives = 99/255 (38%), Gaps = 40/255 (15%)

Query: 236 RRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGN--------RLLGDSKTGGTYS 287
           + K R L+N +  AL     KVF   +L    ++             + LG    G    
Sbjct: 94  KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153

Query: 288 GI-LPDGSRVAVKRLKRSSFQRKKE--------FYSEIGRFARLHHPNLVAVKGCCYDHG 338
                   +VA++ + +  F               +EI    +L+HP ++ +K   +D  
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAE 212

Query: 339 DRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
           D YIV E +  G L D+    +    R L  A        +   + +LH+     ++HRD
Sbjct: 213 DYYIVLELMEGGELFDK----VVGNKR-LKEATCKLYFYQMLLAVQYLHEN---GIIHRD 264

Query: 398 IRASNVLLD-EEFGAHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPE---FVYRN 449
           ++  NVLL  +E    +     G SK      + E ++M    GT  YLAPE    V   
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKI-----LGETSLMRTLCGTPTYLAPEVLVSVGTA 319

Query: 450 ELTTKSDVYSFGVLL 464
                 D +S GV+L
Sbjct: 320 GYNRAVDCWSLGVIL 334

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 15/208 (7%)

Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCC 334
           +G   T    +    P   +VA+KR+     Q    E   EI   ++ HHPN+V+     
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR-MKVATTLAQ---GIAFLHDKVK 390
               + ++V + +  G +   + HI   G      +    +AT L +   G+ +LH    
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 140

Query: 391 PHVVHRDIRASNVLLDEEFGAHLM--GVG--LSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
              +HRD++A N+LL E+    +   GV   L+        + R    G    ++APE +
Sbjct: 141 -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC-WMAPEVM 198

Query: 447 YRNEL-TTKSDVYSFGVLLLEIVSGRRP 473
            +      K+D++SFG+  +E+ +G  P
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAP 226

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 38/185 (20%), Positives = 72/185 (38%), Gaps = 26/185 (14%)

Query: 293 GSRVAVK-----RLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
           G   A K     RL  S     +E    E+     + HPN++ +     +  D  ++ E 
Sbjct: 30  GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89

Query: 347 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
           V  G L D       +   +  +    +K    +  G+ +LH K    + H D++  N++
Sbjct: 90  VSGGELFDFL---AEKESLTEDEATQFLK---QILDGVHYLHSK---RIAHFDLKPENIM 140

Query: 405 LD--EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
           L         +  +  G++  +      +       GT  ++APE V    L  ++D++S
Sbjct: 141 LLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 196

Query: 460 FGVLL 464
            GV+ 
Sbjct: 197 IGVIT 201

>1ypq_A Oxidised low density lipoprotein (lectin-like) receptor 1; oxidized low density lipoprotein receptor, LOX-1, CTLD, C- type lectin like domain; 1.40A {Homo sapiens} SCOP: d.169.1.1 PDB: 1ypu_A 1yxk_A 3vlg_A 1ypo_A 1yxj_A Length = 135

 Score = 74.4 bits (183), Expect = 4e-16
 Identities = 28/139 (20%), Positives = 48/139 (34%), Gaps = 17/139 (12%)

Query: 51  APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
           APCP DWI +     C+ +     +W++S+  C  +   L  + S  +    Q+    + 
Sbjct: 7   APCPQDWIWHG--ENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSS 64

Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESI-HAVGSFNSSCTSLPCHVHATVDLCTLVS 169
              W+G    N      W W D  S     +    G+ + +  S  C             
Sbjct: 65  FPFWMGLSRRNP--SYPWLWEDG-SPLMPHLFRVRGAVSQTYPSGTC-----------AY 110

Query: 170 NGSRSLVTERCNTSHPFIC 188
               ++  E C  +   IC
Sbjct: 111 IQRGAVYAENCILAAFSIC 129

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 39/185 (21%), Positives = 75/185 (40%), Gaps = 26/185 (14%)

Query: 293 GSRVAVKRLKRSS------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
           G   A K +K+           ++E   E+    ++ HPN++ +     +  D  ++ E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96

Query: 347 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
           V  G L D       +   S  +    +K    +  G+ +LH K    + H D++  N++
Sbjct: 97  VSGGELFDFL---AQKESLSEEEATSFIK---QILDGVNYLHTK---KIAHFDLKPENIM 147

Query: 405 LD--EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
           L        H+  +  GL+  +      +       GT  ++APE V    L  ++D++S
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 203

Query: 460 FGVLL 464
            GV+ 
Sbjct: 204 IGVIT 208

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 33/210 (15%)

Query: 291 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348
           P G  +AVKR++     + +K+   ++    R    P +V   G  +  GD +I  E + 
Sbjct: 45  PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM- 103

Query: 349 NGPLDRWLHHI-PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
           +   D++  ++       +   +  K+     + +  L + +K  ++HRDI+ SN+LLD 
Sbjct: 104 STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDR 161

Query: 408 E-------FG--AHLMG-VGLSKFVPWEVMQERTVMAGGTYGYLAPE----FVYRNELTT 453
                   FG    L+  +  ++               G   Y+APE       R     
Sbjct: 162 SGNIKLCDFGISGQLVDSIAKTRDA-------------GCRPYMAPERIDPSASRQGYDV 208

Query: 454 KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ 483
           +SDV+S G+ L E+ +GR P    +SV  Q
Sbjct: 209 RSDVWSLGITLYELATGRFPYPKWNSVFDQ 238

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 77.7 bits (192), Expect = 7e-16
 Identities = 38/194 (19%), Positives = 78/194 (40%), Gaps = 26/194 (13%)

Query: 293 GSRVAVKRLKRS------SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
           G + A K +K+           +++   E+     + HPN++ +     +  D  ++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95

Query: 347 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
           V  G L D       +   +  +    +K    +  G+ +LH      + H D++  N++
Sbjct: 96  VAGGELFDFL---AEKESLTEEEATEFLK---QILNGVYYLHSL---QIAHFDLKPENIM 146

Query: 405 L--DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
           L         +  +  GL+  +      +       GT  ++APE V    L  ++D++S
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 202

Query: 460 FGVLLLEIVSGRRP 473
            GV+   ++SG  P
Sbjct: 203 IGVITYILLSGASP 216

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 78.6 bits (194), Expect = 8e-16
 Identities = 47/256 (18%), Positives = 90/256 (35%), Gaps = 32/256 (12%)

Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-L 290
                    +   P          K     +  +I  ++   +++LG    G        
Sbjct: 25  TPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNK 84

Query: 291 PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR----YIVYE 345
               + A+K L+     R+     E+    R    P++V +     +         IV E
Sbjct: 85  RTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139

Query: 346 FVVNGPLDRWLHHI-PRGGRSL---DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
            +  G L      I  RG ++    + +  MK   ++ + I +LH     ++ HRD++  
Sbjct: 140 CLDGGEL---FSRIQDRGDQAFTEREASEIMK---SIGEAIQYLHSI---NIAHRDVKPE 190

Query: 402 NVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
           N+L   +   A L     G +K       +         T  Y+APE +   +     D+
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC----YTPYYVAPEVLGPEKYDKSCDM 246

Query: 458 YSFGVLLLEIVSGRRP 473
           +S GV++  ++ G  P
Sbjct: 247 WSLGVIMYILLCGYPP 262

>1jwi_A Bitiscetin; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_A Length = 131

 Score = 72.4 bits (178), Expect = 2e-15
 Identities = 36/144 (25%), Positives = 55/144 (38%), Gaps = 30/144 (20%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           C PDW   +    C+       +W+++E +C E  GHLA++ S EE     KL  + +  
Sbjct: 4   CLPDWSSYK--GHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTK 61

Query: 113 ----CWVGGRSINTTVGLSWKWSDNMS----KWNESIHAVGSFNSSCTSLPCHVHATVDL 164
                W+G R  + T   S +W+D  S      +E         + C  L  H       
Sbjct: 62  FVYDAWIGLRDESKTQQCSPQWTDGSSVVYENVDE--------PTKCFGLDVHT------ 107

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
                   R+     C   +PFIC
Sbjct: 108 ------EYRTWTDLPCGEKNPFIC 125

>1hq8_A NKG2-D; homodimer, CIS-proline, apoptosis; 1.95A {Mus musculus} SCOP: d.169.1.1 PDB: 1jsk_A 1kcg_A* Length = 123

 Score = 71.3 bits (175), Expect = 3e-15
 Identities = 27/137 (19%), Positives = 47/137 (34%), Gaps = 23/137 (16%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
           PCP +WI +   + C+ +    ++W++S+  C      L  + S EE    Q       +
Sbjct: 5   PCPNNWICHR--NNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEE----QDFLKLVKS 58

Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
             W+G          SW+W D  S  + +   +                        S+ 
Sbjct: 59  YHWMGLV--QIPANGSWQWEDG-SSLSYNQLTLVEIPKG------------SCAVYGSSF 103

Query: 172 SRSLVTERCNTSHPFIC 188
                TE C   + +IC
Sbjct: 104 --KAYTEDCANLNTYIC 118

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 78.0 bits (192), Expect = 3e-15
 Identities = 40/184 (21%), Positives = 83/184 (45%), Gaps = 18/184 (9%)

Query: 297 AVKRLKRSSFQRKKEFYSEIG------RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           A+K L +   + K+     +         +    P +V +    +       + + +  G
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277

Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
            L    +H+ + G   +  MR   A  +  G+  +H++    VV+RD++ +N+LLDE   
Sbjct: 278 DL---HYHLSQHGVFSEADMRFYAAE-IILGLEHMHNR---FVVYRDLKPANILLDEHGH 330

Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVS 469
             +  +GL+     +  +++   + GT+GY+APE + +      S D +S G +L +++ 
Sbjct: 331 VRISDLGLAC----DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386

Query: 470 GRRP 473
           G  P
Sbjct: 387 GHSP 390

>2yhf_A C-type lectin domain family 5 member A; immune system; 1.90A {Homo sapiens} Length = 118

 Score = 71.3 bits (175), Expect = 3e-15
 Identities = 29/136 (21%), Positives = 55/136 (40%), Gaps = 23/136 (16%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP DW   +  ++CF    +  SW+ES  +CK  G  LA + + E+    Q +   +   
Sbjct: 2   CPKDWEFYQ--ARCFFLSTSESSWNESRDFCKGKGSTLAIVNTPEKLKFLQDI--TDAEK 57

Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
            ++G           W+W +N S +N ++      N +C ++                 +
Sbjct: 58  YFIGLIYHRE--EKRWRWINN-SVFNGNVTNQNQ-NFNCATI---------------GLT 98

Query: 173 RSLVTERCNTSHPFIC 188
           ++     C+ S+  IC
Sbjct: 99  KTFDAASCDISYRRIC 114

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 32/212 (15%)

Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LGD   G  Y       G+  A K ++  S +  +++  EI   A   HP +V + G  Y
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86

Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
             G  +I+ EF   G +D  +  + RG   L       V   + + + FLH K    ++H
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSK---RIIH 140

Query: 396 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
           RD++A NVL+  E       FG  A  +          + +Q+R    G  Y ++APE V
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNL----------KTLQKRDSFIGTPY-WMAPEVV 189

Query: 447 YRNELT-----TKSDVYSFGVLLLEIVSGRRP 473
               +       K+D++S G+ L+E+     P
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 42/252 (16%), Positives = 83/252 (32%), Gaps = 50/252 (19%)

Query: 304 SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGG 363
           SS         +I R       N V            YI  +      L  W++      
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSL 158

Query: 364 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------FGAHLMGV 416
              +  + + +   +A+ + FLH K    ++HRD++ SN+    +       FG      
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG------ 209

Query: 417 GLSKFVPWEVMQERTVMAG----------GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
            L   +  +  ++  +             GT  Y++PE ++ N  + K D++S G++L E
Sbjct: 210 -LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

Query: 467 IVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV 526
           ++           +    +     PL+ + +Y +                        +V
Sbjct: 269 LLYSFSTQMERVRI-ITDVRNLKFPLLFTQKYPQE---------------------HMMV 306

Query: 527 YACTQHVPSMRP 538
                  P+ RP
Sbjct: 307 QDMLSPSPTERP 318

>3hup_A Early activation antigen CD69; C-type lectin-like domain, disulfide bond, glycoprotein, LEC membrane, phosphoprotein, signal-anchor, transmembrane; 1.37A {Homo sapiens} PDB: 1e87_A 1e8i_A 3cck_A Length = 130

 Score = 71.3 bits (175), Expect = 4e-15
 Identities = 31/138 (22%), Positives = 54/138 (39%), Gaps = 26/138 (18%)

Query: 51  APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
           + C  DW+  +   KC+      RSW  ++  C E G  LA + S ++ +  ++  G+  
Sbjct: 14  SSCSEDWVGYQ--RKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGR-- 69

Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
              WVG   +    G  WKWS+   ++N   +  GS                  C  + N
Sbjct: 70  EEHWVG---LKKEPGHPWKWSNG-KEFNNWFNVTGSDK----------------CVFLKN 109

Query: 171 GSRSLVTERCNTSHPFIC 188
               + +  C  +  +IC
Sbjct: 110 T--EVSSMECEKNLYWIC 125

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 49/264 (18%), Positives = 102/264 (38%), Gaps = 37/264 (14%)

Query: 231 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI- 289
              K      K +       + P  ++      +   + +     ++G   +      + 
Sbjct: 57  EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPK-DVIGRGVSSVVRRCVH 115

Query: 290 LPDGSRVAVKRLKRSSFQRKKE--------FYSEIGRFARLH-HPNLVAVKGCCYDHGDR 340
              G   AVK ++ ++ +   E           E     ++  HP+++ +          
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175

Query: 341 YIVYEFVVNGPL-DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
           ++V++ +  G L D     +      S        +  +L + ++FLH     ++VHRD+
Sbjct: 176 FLVFDLMRKGELFDY----LTEKVALSEKET--RSIMRSLLEAVSFLHAN---NIVHRDL 226

Query: 399 RASNVLLDEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTT-- 453
           +  N+LLD+     +     G S  + P E ++E      GT GYLAPE +  +   T  
Sbjct: 227 KPENILLDDN--MQIRLSDFGFSCHLEPGEKLRELC----GTPGYLAPEILKCSMDETHP 280

Query: 454 ----KSDVYSFGVLLLEIVSGRRP 473
               + D+++ GV+L  +++G  P
Sbjct: 281 GYGKEVDLWACGVILFTLLAGSPP 304

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 74.3 bits (183), Expect = 8e-15
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 12/199 (6%)

Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYS-EIGRFARLHHPNLVAVKGCC 334
           +G    G  + GI       VA+K +     + + E    EI   ++   P +    G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 +I+ E++  G     L   P     LD      +   + +G+ +LH +     +
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE---KKI 141

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRDI+A+NVLL E     L   G++  +  +   +R    G  + ++APE + ++   +K
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPF-WMAPEVIKQSAYDSK 199

Query: 455 SDVYSFGVLLLEIVSGRRP 473
           +D++S G+  +E+  G  P
Sbjct: 200 ADIWSLGITAIELARGEPP 218

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 74.7 bits (184), Expect = 8e-15
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 29/207 (14%)

Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
           LG+   G  Y  I    G  VA+K++        +E   EI    +   P++V   G  +
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYF 94

Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
            + D +IV E+   G +   +    +   +L       +  +  +G+ +LH       +H
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLHFM---RKIH 148

Query: 396 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
           RDI+A N+LL+ E       FG    L           + M +R  + G  + ++APE +
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLT----------DTMAKRNTVIGTPF-WMAPEVI 197

Query: 447 YRNELTTKSDVYSFGVLLLEIVSGRRP 473
                   +D++S G+  +E+  G+ P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 48/230 (20%), Positives = 91/230 (39%), Gaps = 25/230 (10%)

Query: 269 NFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPN 326
           +    ++ LG+         +        AVK + +      ++   EI        HPN
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPN 67

Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR--SLDWAMRMKVATTLAQGIAF 384
           +V +    +D    ++V E +  G L      I +       + +  M+    L   ++ 
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEASYIMR---KLVSAVSH 121

Query: 385 LHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYL 441
           +HD     VVHRD++  N+L  DE     +  +  G ++  P +    +T     T  Y 
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC--FTLHYA 176

Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP----AQAVDSVCWQSIFE 487
           APE + +N      D++S GV+L  ++SG+ P     +++       I +
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 226

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 17/183 (9%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 352
           A K+L++   +++K      +E     +++   +V++    Y+  D   +V   +  G L
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDL 271

Query: 353 DRWLHHIPRGGRSLDWAMRMKV-ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
                HI   G++     R    A  +  G+  LH +    +V+RD++  N+LLD+    
Sbjct: 272 ---KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHI 325

Query: 412 HLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
            +  +GL+      V + +T+    GT GY+APE V     T   D ++ G LL E+++G
Sbjct: 326 RISDLGLAV----HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

Query: 471 RRP 473
           + P
Sbjct: 382 QSP 384

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 15/182 (8%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           A+K LK+     K E     +E        HP L A+K     H     V E+   G L 
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL- 235

Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
               H+ R     +   R   A  +   + +LH +   +VV+RD++  N++LD++    +
Sbjct: 236 --FFHLSRERVFSEDRARFYGAE-IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKI 290

Query: 414 MGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
              GL K    E +++   M    GT  YLAPE +  N+     D +  GV++ E++ GR
Sbjct: 291 TDFGLCK----EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

Query: 472 RP 473
            P
Sbjct: 347 LP 348

>3vpp_A C-type lectin domain family 9 member A; dendritic cell, C-type lectin-like domain, membrane, immune; 1.64A {Homo sapiens} Length = 132

 Score = 69.7 bits (171), Expect = 1e-14
 Identities = 34/142 (23%), Positives = 44/142 (30%), Gaps = 24/142 (16%)

Query: 51  APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
           +PCP +WI N     C+     +  W  S+  C + G  L  + S EE         K  
Sbjct: 2   SPCPNNWIQNR--ESCYYVSEIWSIWHTSQENCLKEGSTLLQIESKEEMDFITGSLRKIK 59

Query: 111 NG--CWVGGRSINTTVGLSWKWSDN--MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
                WVG           W W D    S          S N  C               
Sbjct: 60  GSYDYWVGLSQDGH--SGRWLWQDGSSPSPGLLPAERSQSANQVC--------------- 102

Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
                S SL++  C+T   FIC
Sbjct: 103 -GYVKSNSLLSSNCDTWKYFIC 123

>3m9z_A Killer cell lectin-like receptor subfamily B MEMB; C-type lectin-like domain, domain swapping, disulfide bond, transmembrane protein; 1.70A {Mus musculus} PDB: 3t3a_A Length = 139

 Score = 69.4 bits (170), Expect = 2e-14
 Identities = 30/136 (22%), Positives = 49/136 (36%), Gaps = 19/136 (13%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP DW+ +    KCF       +W+E    C   G  L  +   EE         +  N 
Sbjct: 6   CPQDWLSHR--DKCFHVSQVSNTWEEGLVDCDGKGATLMLIQDQEELRFLLDSIKEKYNS 63

Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
            W+G R       ++WKW +  S  N  +  +     + +            C  +S   
Sbjct: 64  FWIGLRYTLP--DMNWKWING-STLNSDVLKITGDTENDS------------CAAISGD- 107

Query: 173 RSLVTERCNTSHPFIC 188
             +  E CN+ + +IC
Sbjct: 108 -KVTFESCNSDNRWIC 122

>1egg_A Macrophage mannose receptor; C-type lectin, sugar binding protein; 2.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1egi_A Length = 147

 Score = 69.0 bits (169), Expect = 4e-14
 Identities = 32/148 (21%), Positives = 56/148 (37%), Gaps = 26/148 (17%)

Query: 52  PCPPDWIINEEKSKCFGYIGNF----RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCG 107
            CP DW  +   S CF          ++W ES  +C+ +GG LA++ + EE+ +  +L  
Sbjct: 4   KCPEDWGASSRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLIT 63

Query: 108 KNVNG---CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHA 160
            + +     W+G    + +    + WSD    +   W       G  N+      C    
Sbjct: 64  ASGSYHKLFWLGLTYGSPS-E-GFTWSDGSPVSYENWAY-----GEPNNYQNVEYC-GE- 114

Query: 161 TVDLCTLVSNGSRSLVTERCNTSHPFIC 188
                 L  + + S     C   + +IC
Sbjct: 115 ------LKGDPTMSWNDINCEHLNNWIC 136

>2bpd_A Dectin-1; receptor, beta-glucan, fungal recognition, C-type lectin-like domain, CTLD, carbohydrate; 1.5A {Mus musculus} PDB: 2bph_A 2bpe_A 2cl8_A* Length = 142

 Score = 68.7 bits (168), Expect = 4e-14
 Identities = 28/139 (20%), Positives = 50/139 (35%), Gaps = 18/139 (12%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHS--AQKLCGKN 109
            C P+WI++     C+ +  +  SW  S+ +C ++G HL  + +  +E      +     
Sbjct: 16  SCLPNWIMHG--KSCYLFSFSGNSWYGSKRHCSQLGAHLLKIDN-SKEFEFIESQTSSHR 72

Query: 110 VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS 169
           +N  W+G     +     W W D  + +  S     +         C           V 
Sbjct: 73  INAFWIGLSRNQS--EGPWFWEDGSAFFPNSFQVRNAVPQESLLHNC-----------VW 119

Query: 170 NGSRSLVTERCNTSHPFIC 188
                +  + CNTS   IC
Sbjct: 120 IHGSEVYNQICNTSSYSIC 138

>3c8j_A Natural killer cell receptor LY49C; MHC, virus, immune system; 2.60A {Mus musculus} SCOP: d.169.1.1 PDB: 3c8k_D 1p4l_D 1ja3_A 1p1z_D Length = 203

 Score = 70.3 bits (172), Expect = 4e-14
 Identities = 25/152 (16%), Positives = 43/152 (28%), Gaps = 25/152 (16%)

Query: 47  KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLC 106
                     W      +KC+ +I N  +W   +  C+  G  +  +   +E    Q+  
Sbjct: 74  SRDTGRGVKYWFCYS--TKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHV 131

Query: 107 GKNVNGCWVGGRSINTTVGLSWKWSDN-MSKWNESIHAVGSFNSSCTSLPCHVHATVDLC 165
                  W+G           W W DN  SK +  I  +   +  C              
Sbjct: 132 IP--GNYWIGLSYDKK--KKEWAWIDNGPSKLDMKIKKMNFKSRGC-------------- 173

Query: 166 TLVSNGSRSLVTERCNTSHPFICMVEHENKCY 197
             V      +    CN  +  IC    +   +
Sbjct: 174 --VFLSKARIEDIDCNIPYYCIC--GKKLDKF 201

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 45/230 (19%), Positives = 89/230 (38%), Gaps = 30/230 (13%)

Query: 265 SITKNFSE----GNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRF 319
           S +  F +       +LG+       + I L      AVK +++     +   + E+   
Sbjct: 5   SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64

Query: 320 ARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR--SLDWAMRMKVAT 376
            +   H N++ +     +    Y+V+E +  G +   L HI +      L+ ++ ++   
Sbjct: 65  YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQ--- 118

Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWE---VMQER 430
            +A  + FLH+K    + HRD++  N+L       + +      L   +           
Sbjct: 119 DVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175

Query: 431 TVMAG--GTYGYLAPEFVYRNELTTKS-----DVYSFGVLLLEIVSGRRP 473
             +    G+  Y+APE V              D++S GV+L  ++SG  P
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>1sb2_A Rhodocetin alpha subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_A Length = 133

 Score = 68.2 bits (167), Expect = 4e-14
 Identities = 27/146 (18%), Positives = 48/146 (32%), Gaps = 30/146 (20%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W   +  S C+      ++W+E+E +C E     HL ++ +  E      +   N 
Sbjct: 2   CPDGWSSTK--SYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNF 59

Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
                  W+G +  N     + +WSD    +     E       +   C  +        
Sbjct: 60  ENKIYRSWIGLKIENKGQRSNLEWSDGSSISYENLYE------PYMEKCFLM-------- 105

Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
                  +G     T  C   + F+C
Sbjct: 106 ----DHQSGLPKWHTADCEEKNVFMC 127

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 21/211 (9%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEF----YSEIGRFARLHHPNLVA 329
            LLG+   G     +      R AVK LK+   +R          EI    RL H N++ 
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 330 VKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAF 384
           +    Y+   +  Y+V E+ V G  +  L  +P     +  A          Q   G+ +
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEM-LDSVPEKRFPVCQAHGY-----FCQLIDGLEY 124

Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           LH +    +VH+DI+  N+LL       +  +G+++ +      +    + G+  +  PE
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 445 FVYRNEL--TTKSDVYSFGVLLLEIVSGRRP 473
                +     K D++S GV L  I +G  P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>3ff9_A Killer cell lectin-like receptor subfamily G member 1; natural killer cell receptor KLTG1, glycoprotein, membrane, phosphoprotein, signal-anchor; 1.80A {Mus musculus} PDB: 3ff8_C Length = 115

 Score = 67.8 bits (166), Expect = 5e-14
 Identities = 25/136 (18%), Positives = 44/136 (32%), Gaps = 27/136 (19%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP  W  N   S C+ +    + W+ S  +C + G HL      +      +  G+  + 
Sbjct: 2   CPILWTRNG--SHCYYFSMEKKDWNSSLKFCADKGSHLLTFPDNQGVKLFGEYLGQ--DF 57

Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
            W+G R+I+      W+W       +  I         C ++                  
Sbjct: 58  YWIGLRNID-----GWRWEGG-PALSLRILTNSL-IQRCGAI----------------HR 94

Query: 173 RSLVTERCNTSHPFIC 188
             L    C  +  +IC
Sbjct: 95  NGLQASSCEVALQWIC 110

>1oz7_A Echicetin A-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1 Length = 131

 Score = 68.3 bits (167), Expect = 5e-14
 Identities = 34/145 (23%), Positives = 53/145 (36%), Gaps = 30/145 (20%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG--GHLAALTSYEEEHSAQKLCGKNV 110
           CPP W  N     C+      ++WDE+E +C + G  GHL ++ S +EE     +  +N+
Sbjct: 2   CPPGWSSNG--VYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENI 59

Query: 111 NG---CWVGGRSINTTVGLSWKWSDNMS----KWNESIHAVGSFNSSCTSLPCHVHATVD 163
                 W G    +     S +WSD       +            S C  L         
Sbjct: 60  GKMYKIWTGLSERSKEQHCSSRWSDGSFFRSYEIAIR-------YSECFVL--------- 103

Query: 164 LCTLVSNGSRSLVTERCNTSHPFIC 188
                 +  R+ V   C  + PF+C
Sbjct: 104 ---EKQSVFRTWVATPCENTFPFMC 125

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 45/192 (23%), Positives = 74/192 (38%), Gaps = 27/192 (14%)

Query: 297 AVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           A+K + +    ++ E   F  E           +  +     D    Y+V E+ V G L 
Sbjct: 90  AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL- 148

Query: 354 RWLHHIPRGGR--SLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
             L  + + G     + A R  +A   +A  I  +H       VHRDI+  N+LLD    
Sbjct: 149 --LTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVHRL---GYVHRDIKPDNILLDRC-- 198

Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVY-------SFG 461
            H+     G    +  +    R+++A GT  YL+PE +        +  Y       + G
Sbjct: 199 GHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257

Query: 462 VLLLEIVSGRRP 473
           V   E+  G+ P
Sbjct: 258 VFAYEMFYGQTP 269

>3bdw_B NKG2-A/NKG2-B type II integral membrane protein; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} PDB: 3cdg_K 3cii_H Length = 120

 Score = 67.4 bits (165), Expect = 6e-14
 Identities = 24/137 (17%), Positives = 43/137 (31%), Gaps = 25/137 (18%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
            CP +WI     + C+      R+W+ES   C      L ++ + EE     K       
Sbjct: 6   HCPEEWITYS--NSCYYIGKERRTWEESLLACTSKNSSLLSIDNEEE----MKFLSIISP 59

Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
             W+G    ++     W   +    +   I    +   +C  L                 
Sbjct: 60  SSWIGVFRNSS--HHPWVTMNG-LAFKHEIKDSDNAELNCAVL----------------Q 100

Query: 172 SRSLVTERCNTSHPFIC 188
              L + +C +S  + C
Sbjct: 101 VNRLKSAQCGSSIIYHC 117

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 71.9 bits (177), Expect = 6e-14
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 23/189 (12%)

Query: 293 GSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           G  VA+K + ++       ++ + E+     L+HPN+V +          Y++ E+   G
Sbjct: 40  GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99

Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLD 406
            +     ++   GR     M+ K A +  +     + + H K    +VHRD++A N+LLD
Sbjct: 100 EV---FDYLVAHGR-----MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLD 148

Query: 407 EEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLL 464
            +    +   G S +F     +        G   Y APE     +    + DV+S GV+L
Sbjct: 149 ADMNIKIADFGFSNEFTVGGKLDA----FCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204

Query: 465 LEIVSGRRP 473
             +VSG  P
Sbjct: 205 YTLVSGSLP 213

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 73.3 bits (180), Expect = 7e-14
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 352
           A K+L +   +++K +     E    A++H   +V++    ++      +V   +  G +
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDI 272

Query: 353 DRWLHHIPRGGRSLDWAMRMKV-ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
              ++++           R       +  G+  LH +   ++++RD++  NVLLD++   
Sbjct: 273 RYHIYNVDEDNPGFQEP-RAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNV 328

Query: 412 HLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
            +  +GL+     E+   +T   G  GT G++APE +   E     D ++ GV L E+++
Sbjct: 329 RISDLGLAV----ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

Query: 470 GRRP 473
            R P
Sbjct: 385 ARGP 388

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 71.5 bits (176), Expect = 7e-14
 Identities = 44/201 (21%), Positives = 83/201 (41%), Gaps = 34/201 (16%)

Query: 293 GSRVAVKRLKRSSFQ---------RKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI 342
               AVK +  +             ++    E+    ++  HPN++ +K     +   ++
Sbjct: 42  CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101

Query: 343 VYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
           V++ +  G L D       +   S       K+   L + I  LH     ++VHRD++  
Sbjct: 102 VFDLMKKGELFDYL---TEKVTLSEKET--RKIMRALLEVICALHKL---NIVHRDLKPE 153

Query: 402 NVLLDEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPE------FVYRNELT 452
           N+LLD++   ++     G S  + P E ++E      GT  YLAPE              
Sbjct: 154 NILLDDD--MNIKLTDFGFSCQLDPGEKLREVC----GTPSYLAPEIIECSMNDNHPGYG 207

Query: 453 TKSDVYSFGVLLLEIVSGRRP 473
            + D++S GV++  +++G  P
Sbjct: 208 KEVDMWSTGVIMYTLLAGSPP 228

>3bdw_A Natural killer cells antigen CD94; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 3cdg_J 1b6e_A 3cii_G Length = 123

 Score = 67.4 bits (165), Expect = 7e-14
 Identities = 22/139 (15%), Positives = 42/139 (30%), Gaps = 26/139 (18%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
            C   W+       C+      ++W+ES   C      L  L + +E          +  
Sbjct: 4   SCQEKWVGYR--CNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDE----LDFMSSSQQ 57

Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSS--CTSLPCHVHATVDLCTLVS 169
             W+G          +W W +  S  ++ +       ++  C                  
Sbjct: 58  FYWIGLSYSEE--HTAWLWENG-SALSQYLFPSFETFNTKNC-------------IAYNP 101

Query: 170 NGSRSLVTERCNTSHPFIC 188
           NG  + + E C   + +IC
Sbjct: 102 NG--NALDESCEDKNRYIC 118

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.5 bits (176), Expect = 9e-14
 Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 18/183 (9%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           A+K L++     K E     +E        HP L A+K     H     V E+   G L 
Sbjct: 34  AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL- 92

Query: 354 RWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
               H+ R    + + A R   A  +   + +LH +    VV+RDI+  N++LD++    
Sbjct: 93  --FFHLSRERVFTEERA-RFYGAE-IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK 145

Query: 413 LMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
           +   GL K    E + +   M    GT  YLAPE +  N+     D +  GV++ E++ G
Sbjct: 146 ITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

Query: 471 RRP 473
           R P
Sbjct: 202 RLP 204

>2c6u_A CLEC1B protein; lectin, rhodocytin, aggretin, C-type lectin-like, platelets, thrombosis; 1.6A {Homo sapiens} Length = 122

 Score = 66.7 bits (163), Expect = 1e-13
 Identities = 26/142 (18%), Positives = 45/142 (31%), Gaps = 29/142 (20%)

Query: 51  APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
           +PC  +W        C+G+  +  +W+ES+ YC ++   L  + +       +       
Sbjct: 1   SPCDTNWRYYG--DSCYGFFRHNLTWEESKQYCTDMNATLLKIDNRNIVEYIKARTHLIR 58

Query: 111 NGCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
              WVG           WKW D    + + +       G+ N                C 
Sbjct: 59  ---WVGLS--RQKSNEVWKWEDGSVISENMFEFLEDGKGNMN----------------CA 97

Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
              NG   +    C   H  +C
Sbjct: 98  YFHNG--KMHPTFCENKHYLMC 117

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 21/183 (11%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           A+K L +    + K+     +E      ++ P LV ++    D+ + Y+V E+V  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM- 128

Query: 354 RWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
               H+ R GR  +   R   A   L     +LH      +++RD++  N+L+D++   +
Sbjct: 129 --FSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL---DLIYRDLKPENLLIDQQ--GY 179

Query: 413 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
           +     G +K V       RT    GT   LAPE +         D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAKRVK-----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

Query: 471 RRP 473
             P
Sbjct: 235 YPP 237

>1c3a_A Flavocetin-A: alpha subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_A Length = 135

 Score = 67.1 bits (164), Expect = 1e-13
 Identities = 29/146 (19%), Positives = 52/146 (35%), Gaps = 30/146 (20%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
           C P W   +    C+      ++W+++E++C+E     HL ++ S  E     +L  + +
Sbjct: 4   CIPGWSAYD--RYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKI 61

Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
                  W+G R  N       +WSD    N     +       F+  C +L        
Sbjct: 62  KTSFQYVWIGLRIQNKEQQCRSEWSDASSVNYENLVK------QFSKKCYAL-------- 107

Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
                     R+     C T +P +C
Sbjct: 108 ----KKGTELRTWFNVYCGTENPEVC 129

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 50/189 (26%), Positives = 79/189 (41%), Gaps = 31/189 (16%)

Query: 293 GSRVAVKRLKRSSFQRKKE--------FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344
             +VA+K + +  F               +EI    +L+HP ++ +K   +D  D YIV 
Sbjct: 35  CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVL 93

Query: 345 EFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
           E +  G L D+    +    R L  A        +   + +LH+     ++HRD++  NV
Sbjct: 94  ELMEGGELFDK----VVGNKR-LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENV 145

Query: 404 LLD-EEFGAHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPE---FVYRNELTTKS 455
           LL  +E    +     G SK      + E ++M    GT  YLAPE    V         
Sbjct: 146 LLSSQEEDCLIKITDFGHSKI-----LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV 200

Query: 456 DVYSFGVLL 464
           D +S GV+L
Sbjct: 201 DCWSLGVIL 209

>3ff7_C Killer cell lectin-like receptor subfamily G member 1; KLRG1-cadherin complex, calcium, cell adhesion, cell junction, cell membrane; 1.80A {Homo sapiens} Length = 112

 Score = 66.2 bits (162), Expect = 1e-13
 Identities = 27/136 (19%), Positives = 47/136 (34%), Gaps = 26/136 (19%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP  W+     + C+ +    + W+ S  +C     HL  +T  +E    Q    +    
Sbjct: 1   CPDRWMKYG--NHCYYFSVEEKDWNSSLEFCLARDSHLLVITDNQEMSLLQVFLSE--AF 56

Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
            W+G R+ +      W+W D  S  N S  +  SF  +C ++                  
Sbjct: 57  SWIGLRNNS-----GWRWEDG-SPLNFSRISSNSFVQTCGAI----------------NK 94

Query: 173 RSLVTERCNTSHPFIC 188
             L    C     ++C
Sbjct: 95  NGLQASSCEVPLHWVC 110

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 53/188 (28%), Positives = 73/188 (38%), Gaps = 22/188 (11%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
              VAVK ++R +   +     EI     L HPN+V  K          I+ E+   G L
Sbjct: 45  KELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103

Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDEE 408
                 I   GR          A    Q    G+++ H      + HRD++  N LLD  
Sbjct: 104 ---YERICNAGR-----FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGS 152

Query: 409 FGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLL 465
               L     G SK        + TV   GT  Y+APE + R E     +DV+S GV L 
Sbjct: 153 PAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLRQEYDGKIADVWSCGVTLY 209

Query: 466 EIVSGRRP 473
            ++ G  P
Sbjct: 210 VMLVGAYP 217

>1umr_C Convulxin beta, CVX beta; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_B Length = 125

 Score = 65.9 bits (161), Expect = 2e-13
 Identities = 27/144 (18%), Positives = 51/144 (35%), Gaps = 34/144 (23%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W   +    C+       +W ++E +C +   G HL +  S EE     K+  +++
Sbjct: 4   CPSHWSSYD--RYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSL 61

Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
                W+G    N     +W+WSD       +W+E                         
Sbjct: 62  KSTFFWIGAN--NIWNKCNWQWSDGTKPEYKEWHEEFE---------------------- 97

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
           C +        ++  C+ ++ F+C
Sbjct: 98  CLISRTFDNQWLSAPCSDTYSFVC 121

>1ukm_B EMS16 B chain, EMS16 subunit B; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_B* Length = 128

 Score = 65.9 bits (161), Expect = 2e-13
 Identities = 34/144 (23%), Positives = 49/144 (34%), Gaps = 32/144 (22%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W   +    C+      ++W E+E  C +   G  LA++ S EEE    KL  K +
Sbjct: 1   CPLGWSSFD--QHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKAL 58

Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
                W+G    N      W+WSD    +   W             CT +          
Sbjct: 59  KFTSMWIGLN--NPWKDCKWEWSDNARFDYKAWKR--------RPYCTVM---------- 98

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
             +V        T  C  S  F+C
Sbjct: 99  --VVKPDRIFWFTRGCEKSVSFVC 120

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 43/199 (21%), Positives = 77/199 (38%), Gaps = 30/199 (15%)

Query: 290 LPDGSRVAVKRLKRS--------SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
                 V VK +K+            +  +   EI   +R+ H N++ V     + G   
Sbjct: 46  KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105

Query: 342 IVYEFVVNGP--LDRWLHHIPRGGRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVH 395
           +V E   +G          I R  R     +   +A+     L   + +L  K    ++H
Sbjct: 106 LVMEKHGSGLDLFA----FIDRHPR-----LDEPLASYIFRQLVSAVGYLRLK---DIIH 153

Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TK 454
           RDI+  N+++ E+F   L+  G + ++    +        GT  Y APE +  N     +
Sbjct: 154 RDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLMGNPYRGPE 210

Query: 455 SDVYSFGVLLLEIVSGRRP 473
            +++S GV L  +V    P
Sbjct: 211 LEMWSLGVTLYTLVFEENP 229

>1sb2_B Rhodocetin beta subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_B Length = 129

 Score = 65.5 bits (160), Expect = 3e-13
 Identities = 25/146 (17%), Positives = 43/146 (29%), Gaps = 36/146 (24%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W  ++    C+      ++W E+E +C +    GHL ++ S  E      +   N 
Sbjct: 4   CPTTWSASK--LYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNF 61

Query: 111 NGC----WVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
           +      W G    N       KW++    +     E       +   C           
Sbjct: 62  DKQRYRAWTGLTERN------LKWTNGASVSYENLYE------PYIRKC----------- 98

Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
                   G        C   + F+C
Sbjct: 99  -FVVQPWEGKSKWYKADCEEKNAFLC 123

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 20/204 (9%)

Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYS---EIGRFARLHHPNLVAVKG 332
           +G    G  Y    + +   VA+K++  S  Q  +++     E+    +L HPN +  +G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121

Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
           C       ++V E+ +    D    H     + L       V     QG+A+LH     +
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---N 174

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RN 449
           ++HRD++A N+LL E     L   G +      +M       G  Y ++APE +      
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPY-WMAPEVILAMDEG 228

Query: 450 ELTTKSDVYSFGVLLLEIVSGRRP 473
           +   K DV+S G+  +E+   + P
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPP 252

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 22/179 (12%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
               AVK + +     K++   EI    R   HPN++ +K    D    Y+V E +  G 
Sbjct: 47  NMEFAVKIIDK----SKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102

Query: 352 L-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL--DE 407
           L D+    + +   S  + +  +    T+ + + +LH +    VVHRD++ SN+L   + 
Sbjct: 103 LLDKI---LRQKFFSEREASAVLF---TITKTVEYLHAQ---GVVHRDLKPSNILYVDES 153

Query: 408 EFGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
                +     G +K +  E     T     T  ++APE + R       D++S GVLL
Sbjct: 154 GNPESIRICDFGFAKQLRAENGLLMTPC--YTANFVAPEVLERQGYDAACDIWSLGVLL 210

>2e3x_C Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis} Length = 122

 Score = 65.5 bits (160), Expect = 4e-13
 Identities = 32/144 (22%), Positives = 49/144 (34%), Gaps = 34/144 (23%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W+  E    C+    + ++W ++E +C E   G HL +L S EEE     L  +N+
Sbjct: 3   CPSGWLSYE--QHCYKGFNDLKNWTDAEKFCTEQKKGSHLVSLHSREEEKFVVNLISENL 60

Query: 111 N--GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
                W+G    N       +WSD          E         S C  +          
Sbjct: 61  EYPATWIGLG--NMWKDCRMEWSDRGNVKYKALAE--------ESYCLIM---------- 100

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
                   +   +  CN   P +C
Sbjct: 101 ----ITHEKVWKSMTCNFIAPVVC 120

>2py2_A Antifreeze protein type II; type II antifreeze protein; 1.70A {Clupea harengus} Length = 136

 Score = 65.8 bits (161), Expect = 4e-13
 Identities = 27/144 (18%), Positives = 49/144 (34%), Gaps = 30/144 (20%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP DW +     +CF +      W +++  C + G +LA++ S EE    ++L   ++  
Sbjct: 4   CPTDWKMFN--GRCFLFNPLQLHWADAQESCMKEGANLASIHSLEESTFVKELTSADLIP 61

Query: 113 CWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVG----SFNSSCTSLPCHVHATVDL 164
            W+GG     +    W W D+     + W            +    C      +      
Sbjct: 62  SWIGGTDCQVS-T-RWFWMDSTSMDYADWCA-----AQPDTTLTECC------IQ----- 103

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
             +     +      C   H  IC
Sbjct: 104 --MNVGIGKCWNDTPCTHLHSSIC 125

>3ubu_A Agglucetin subunit alpha-1; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus} Length = 131

 Score = 65.5 bits (160), Expect = 4e-13
 Identities = 30/145 (20%), Positives = 56/145 (38%), Gaps = 28/145 (19%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN 109
            C P W   +    C+      ++WD++E +C E   GGHL ++ S  E     +L  +N
Sbjct: 3   DCLPGWSAYD--QSCYRVFKLLKTWDDAEKFCTERPKGGHLVSIESAGERDFVAQLVSEN 60

Query: 110 VNG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVD 163
                 W+G +  +     S +W+D    +   ++E        +  C  L         
Sbjct: 61  KQTDNVWLGLKIQSKGQQCSTEWTDGSSVSYENFSE------YQSKKCFVL--------- 105

Query: 164 LCTLVSNGSRSLVTERCNTSHPFIC 188
                + G R+ +   C + + F+C
Sbjct: 106 ---EKNTGFRTWLNLNCGSEYSFVC 127

>3gpr_D Rhodocetin subunit delta; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma} Length = 124

 Score = 65.2 bits (159), Expect = 4e-13
 Identities = 29/144 (20%), Positives = 49/144 (34%), Gaps = 32/144 (22%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W        C+      ++W+++E++C     G  LA++ S EEE    KL  + +
Sbjct: 1   CPLHWSSYN--GYCYRVFSELKTWEDAESFCYAQHKGSRLASIHSREEEAFVGKLASQTL 58

Query: 111 N--GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
                W+G    N      W+WSD    +   W           + C  +          
Sbjct: 59  KYTSMWLGLN--NAWAACKWEWSDDAKLDYKVWLR--------RAYCAVM---------- 98

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
             +V           C  +  F+C
Sbjct: 99  --VVKTDRIFWYNRGCEKTVSFLC 120

>1tdq_B Aggrecan core protein; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: d.169.1.1 Length = 130

 Score = 65.0 bits (159), Expect = 5e-13
 Identities = 29/142 (20%), Positives = 50/142 (35%), Gaps = 25/142 (17%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
            C   W   +    C+ +  +  +W ++E  C+E   HL+++ + EE+    K       
Sbjct: 6   QCEEGWTKFQ--GHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQEFVNKNAQDYQ- 62

Query: 112 GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTL 167
             W+G           ++WSD       KW               + P +  AT + C +
Sbjct: 63  --WIGLNDRTIEG--DFRWSDGHSLQFEKWRP-------------NQPDNFFATGEDCVV 105

Query: 168 VSNGSRSL-VTERCNTSHPFIC 188
           +    R       CN   PF C
Sbjct: 106 MIWHERGEWNDVPCNYQLPFTC 127

>1umr_A Convulxin alpha, CVX alpha; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_A Length = 135

 Score = 65.2 bits (159), Expect = 5e-13
 Identities = 30/146 (20%), Positives = 51/146 (34%), Gaps = 30/146 (20%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CP DW   +    C+       +W+++E +C +   G HL ++ S +E      +  +N+
Sbjct: 4   CPSDWYYYD--QHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNI 61

Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
                   +G R  N     S KWSD    +     +       + + C+ L        
Sbjct: 62  EESFSHVSIGLRVQNKEKQCSTKWSDGSSVSYDNLLD------LYITKCSLL-------- 107

Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
                   G R      C    PF+C
Sbjct: 108 ----KKETGFRKWFVASCIGKIPFVC 129

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 41/214 (19%)

Query: 291 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVV 348
             G  +AVK+++R  + +  K    ++    + H  P +V   G    + D +I  E + 
Sbjct: 48  KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106

Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
               ++    +      +   +  K+   + + + +L +K    V+HRD++ SN+LLDE 
Sbjct: 107 GTCAEKLKKRMQGP---IPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER 161

Query: 409 -------FG--AHLMG-VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-----TT 453
                  FG    L+      +               G   Y+APE +   +        
Sbjct: 162 GQIKLCDFGISGRLVDDKAKDRSA-------------GCAAYMAPERIDPPDPTKPDYDI 208

Query: 454 KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 487
           ++DV+S G+ L+E+ +G+ P +       ++ FE
Sbjct: 209 RADVWSLGISLVELATGQFPYKN-----CKTDFE 237

>1jwi_B Platelet aggregation inducer; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_B Length = 125

 Score = 64.7 bits (158), Expect = 6e-13
 Identities = 29/144 (20%), Positives = 52/144 (36%), Gaps = 34/144 (23%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
           C PDW   +    C+      ++W ++E +CKE+  GGHL ++ S EE     KL  + +
Sbjct: 4   CLPDWSSYK--GHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKM 61

Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
                W+G    +       +W+D    +    ++               P         
Sbjct: 62  RIVLVWIGLS--HFWRICPLRWTDGARLDYRALSDE--------------PI-------- 97

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
           C +  +     +   CN    F+C
Sbjct: 98  CFVAESFHNKWIQWTCNRKKSFVC 121

>1oz7_B Echicetin B-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1 Length = 123

 Score = 64.3 bits (157), Expect = 7e-13
 Identities = 27/144 (18%), Positives = 47/144 (32%), Gaps = 34/144 (23%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           C PDW + E    C+       +W ++E +C +    GHL +  + +E      L    +
Sbjct: 2   CLPDWSVYE--GYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPML 59

Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
                W+G    +     +W+WSD    +   W+   H                      
Sbjct: 60  KNDLVWIGLT--DYWRDCNWEWSDGAQLDYKAWDNERH---------------------- 95

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
           C +  N         C  +  F+C
Sbjct: 96  CFIYKNTDNQWTRRDCTWTFSFVC 119

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 68.7 bits (169), Expect = 8e-13
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 31/189 (16%)

Query: 297 AVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
           A+K LK+++ + +    +++ R     ++HP +V +       G  Y++ +F+  G L  
Sbjct: 56  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-- 113

Query: 355 WLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----- 408
               + +    + +   +  +A  LA  +  LH      +++RD++  N+LLDEE     
Sbjct: 114 -FTRLSKEVMFTEEDV-KFYLAE-LALALDHLHSL---GIIYRDLKPENILLDEEGHIKL 167

Query: 409 --FGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
             FG       LSK    E +    +     GT  Y+APE V R   T  +D +SFGVL+
Sbjct: 168 TDFG-------LSK----ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLM 216

Query: 465 LEIVSGRRP 473
            E+++G  P
Sbjct: 217 FEMLTGTLP 225

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 68.3 bits (168), Expect = 8e-13
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 21/183 (11%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           A+K LK+    R K+      E    + + HP ++ + G   D    +++ +++  G L 
Sbjct: 35  AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL- 93

Query: 354 RWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
                + +  R  +   +   A   LA  + +LH K    +++RD++  N+LLD+  G H
Sbjct: 94  --FSLLRKSQRFPNPVAKFYAAEVCLA--LEYLHSK---DIIYRDLKPENILLDKN-G-H 144

Query: 413 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
           +     G +K+VP     + T    GT  Y+APE V         D +SFG+L+ E+++G
Sbjct: 145 IKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

Query: 471 RRP 473
             P
Sbjct: 200 YTP 202

>3bx4_B Aggretin beta chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_B Length = 146

 Score = 65.1 bits (159), Expect = 8e-13
 Identities = 33/146 (22%), Positives = 50/146 (34%), Gaps = 34/146 (23%)

Query: 51  APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK 108
           A CP  W   E    C+      ++W ++E +CK      HL +  S EE     KL   
Sbjct: 23  ADCPSGWSSYE--GHCYKPFNEPKNWADAERFCKLQPKHSHLVSFQSAEEADFVVKLTRP 80

Query: 109 NVNG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
            +     W+G    N   G +W+WSD    N   W E         S C +         
Sbjct: 81  RLKANLVWMGLS--NIWHGCNWQWSDGARLNYKDWQE--------QSECLAF-------- 122

Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
                        +   C+++  F+C
Sbjct: 123 ------RGVHTEWLNMDCSSTCSFVC 142

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 69.3 bits (170), Expect = 9e-13
 Identities = 46/187 (24%), Positives = 77/187 (41%), Gaps = 22/187 (11%)

Query: 297 AVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           A+K L +    ++ +   F+ E    A  + P +V +     D    Y+V E++  G L 
Sbjct: 98  AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL- 156

Query: 354 RWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
             ++ +        WA R   A   LA  +  +H       +HRD++  N+LLD+    H
Sbjct: 157 --VNLMSNYDVPEKWA-RFYTAEVVLA--LDAIHSM---GFIHRDVKPDNMLLDKS--GH 206

Query: 413 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT---TKS-DVYSFGVLLLE 466
           L     G    +  +    R   A GT  Y++PE +          +  D +S GV L E
Sbjct: 207 LKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265

Query: 467 IVSGRRP 473
           ++ G  P
Sbjct: 266 MLVGDTP 272

>1fvu_A Botrocetin alpha chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_B 1u0n_B 1u0o_A Length = 133

 Score = 64.4 bits (157), Expect = 1e-12
 Identities = 34/147 (23%), Positives = 50/147 (34%), Gaps = 31/147 (21%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHS-AQKLCGKN 109
           CP  W   E    C+ +     +W ++E +C E   GGHL ++  Y +E      L  KN
Sbjct: 2   CPSGWSSYE--GNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKN 59

Query: 110 VNG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHAT 161
           +       W+G R  N     S +WSD    +     E           C          
Sbjct: 60  IQSSDLYAWIGLRVENKEKQCSSEWSDGSSVSYENVVE------RTVKKC------FALE 107

Query: 162 VDLCTLVSNGSRSLVTERCNTSHPFIC 188
            D       G    +   C   +PF+C
Sbjct: 108 KD------LGFVLWINLYCAQKNPFVC 128

>3g8l_A Lectin-related NK cell receptor LY49L1; natural killer cell receptor, immune system; 2.50A {Mus musculus} Length = 190

 Score = 66.1 bits (161), Expect = 1e-12
 Identities = 23/140 (16%), Positives = 43/140 (30%), Gaps = 27/140 (19%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
                W       KC+ ++ + ++W   +  C+     L  + + +E    + L     +
Sbjct: 66  GFEKYWFCYG--IKCYYFVMDRKTWSGCKQTCQISSLSLLKIDNEDELKFLKLLVPS--D 121

Query: 112 GCWVGGRSINTTVGLSWKWSDN---MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
             W+G    N      W W +N       N   + +                    C L+
Sbjct: 122 SYWIGLSYDNK--KKDWAWINNGPSKLALNTMKYNIRDGG----------------CMLL 163

Query: 169 SNGSRSLVTERCNTSHPFIC 188
           S     L  + C+ S   IC
Sbjct: 164 SKT--RLDNDNCDKSFICIC 181

>2kv3_A Regenerating islet-derived protein 4; GISP, C-type lectin, REG IV, disulfide bond, glycoPro lectin, secreted, sugar binding protein; NMR {Homo sapiens} Length = 131

 Score = 64.0 bits (156), Expect = 1e-12
 Identities = 30/147 (20%), Positives = 52/147 (35%), Gaps = 31/147 (21%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN 109
            C P W  ++  S C+GY    R+W ++E  C+    G HLA++ S +E  +  +     
Sbjct: 2   SCAPGWFYHK--SNCYGYFRKLRNWSDAELECQSYGNGAHLASILSLKEASTIAEYISGY 59

Query: 110 VNG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSS--CTSLPCHVHAT 161
                 W+G    +      W+W D        W+       S   +  C  +       
Sbjct: 60  QRSQSIWIGLH--DPQKRQQWQWIDGAMYLYRSWSG-----KSMGGNKHCAEM------- 105

Query: 162 VDLCTLVSNGSRSLVTERCNTSHPFIC 188
                  +N   +  +  CN    F+C
Sbjct: 106 -----SSNNNFLTWSSNECNKRQHFLC 127

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 47/193 (24%), Positives = 79/193 (40%), Gaps = 31/193 (16%)

Query: 297 AVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
           A+K L +    ++ E   F  E           +  +     D  + Y+V ++ V G L 
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL- 161

Query: 354 RWLHHIPRGGRSL--DWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
             L  + +    L  + A R  +A   +A  I  +H     H VHRDI+  N+L+D    
Sbjct: 162 --LTLLSKFEDRLPEEMA-RFYLAEMVIA--IDSVHQL---HYVHRDIKPDNILMDMN-- 211

Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKS-----DVYSF 460
            H+     G       ++M++ TV +    GT  Y++PE +   E          D +S 
Sbjct: 212 GHIRLADFGSCL----KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267

Query: 461 GVLLLEIVSGRRP 473
           GV + E++ G  P
Sbjct: 268 GVCMYEMLYGETP 280

>1j34_A Coagulation factor IX-binding protein A chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_A* 1j35_A* 1x2t_A* 1x2w_A 1ixx_A 1y17_A 1wt9_A 1iod_A* Length = 129

 Score = 63.6 bits (155), Expect = 2e-12
 Identities = 37/148 (25%), Positives = 55/148 (37%), Gaps = 34/148 (22%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W   E    C+     +++WD++E +C E   GGHL ++ S  E     +L  +N+
Sbjct: 2   CPSGWSSYE--GHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENI 59

Query: 111 NGC----WVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHA 160
                  W+G R        S +WSD    +   W   ES   +G      T        
Sbjct: 60  QNTKSYVWIGLRVQGKEKQCSSEWSDGSSVSYENWIEAESKTCLG--LEKET-------- 109

Query: 161 TVDLCTLVSNGSRSLVTERCNTSHPFIC 188
                     G R  V   C   +PF+C
Sbjct: 110 ----------GFRKWVNIYCGQQNPFVC 127

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 48/187 (25%), Positives = 72/187 (38%), Gaps = 17/187 (9%)

Query: 293 GSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
              VAVK +         E    EI     L+H N+V   G   +   +Y+  E+   G 
Sbjct: 32  EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91

Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDE 407
           L      I          M    A         G+ +LH      + HRDI+  N+LLDE
Sbjct: 92  L---FDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDE 140

Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLE 466
                +   GL+    +   +       GT  Y+APE + R E      DV+S G++L  
Sbjct: 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTA 200

Query: 467 IVSGRRP 473
           +++G  P
Sbjct: 201 MLAGELP 207

>3gpr_C Rhodocetin subunit gamma; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma} Length = 134

 Score = 63.2 bits (154), Expect = 3e-12
 Identities = 33/148 (22%), Positives = 48/148 (32%), Gaps = 34/148 (22%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           C P W   +    C+      ++WDE+E +C E    GHL ++ S  E     +L   N+
Sbjct: 3   CLPGWSAYD--QHCYQAFNEPKTWDEAERFCTEQAKRGHLVSIGSDGEADFVAQLVTNNI 60

Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHA 160
                  W+G R        S +WS         W   ES    G    +          
Sbjct: 61  KRPELYVWIGLRDRRKEQQCSSEWSMSASIIYVNWNTGESQMCQGLARWT---------- 110

Query: 161 TVDLCTLVSNGSRSLVTERCNTSHPFIC 188
                     G R      C   +PF+C
Sbjct: 111 ----------GFRKWDYSDCQAKNPFVC 128

>1sl6_A C-type lectin DC-signr; sugar binding protein; HET: GAL NDG FUC; 2.25A {Homo sapiens} SCOP: d.169.1.1 PDB: 1xar_A Length = 184

 Score = 64.5 bits (157), Expect = 3e-12
 Identities = 33/166 (19%), Positives = 59/166 (35%), Gaps = 27/166 (16%)

Query: 29  SDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGG 88
           S           L  +  +  +  CP DW   +    C+    + R+W +S T C+E+  
Sbjct: 30  SKQQQIYQELTDLKTAFERLCR-HCPKDWTFFQGN--CYFMSNSQRNWHDSVTACQEVRA 86

Query: 89  HLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN--MSKWNESIHAVGS 146
            L  + + EE++  Q    ++    W+G   +N   G +W+W D   +S   +     G 
Sbjct: 87  QLVVIKTAEEQNFLQLQTSRSNRFSWMGLSDLNQE-G-TWQWVDGSPLSPSFQRYWNSGE 144

Query: 147 FNSS----CTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
            N+S    C                           RC+  + +IC
Sbjct: 145 PNNSGNEDC----------------AEFSGSGWNDNRCDVDNYWIC 174

>1fvu_B Botrocetin beta chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_C 1u0n_C 1u0o_B Length = 125

 Score = 62.8 bits (153), Expect = 3e-12
 Identities = 28/144 (19%), Positives = 48/144 (33%), Gaps = 32/144 (22%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CPPDW   E    C+ +   +  WD++E +C E   G HL +  S EE    + L  + +
Sbjct: 2   CPPDWSSYE--GHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEML 59

Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
            G   W+G    +      ++W+D    +   +         +                 
Sbjct: 60  KGDVVWIGLS--DVWNKCRFEWTDGMEFDYDDYYLI----AEYE---------------- 97

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
           C      +       C     F+C
Sbjct: 98  CVASKPTNNKWWIIPCTRFKNFVC 121

>1c3a_B Flavocetin-A: beta subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_B Length = 125

 Score = 62.8 bits (153), Expect = 3e-12
 Identities = 23/144 (15%), Positives = 45/144 (31%), Gaps = 34/144 (23%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W   +    C+       +W+++E +C +   G HL +  S EE           +
Sbjct: 4   CPLGWSSYD--EHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPIL 61

Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
                W+G    N     + +WSD    +   W+                          
Sbjct: 62  KYDFVWIGLS--NVWNECTKEWSDGTKLDYKAWSGGSD---------------------- 97

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
           C +        ++  C++ +  +C
Sbjct: 98  CIVSKTTDNQWLSMDCSSKYYVVC 121

>1j34_B Coagulation factor IX-binding protein B chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_B 1ixx_B* 1j35_B* 1x2t_B* 1x2w_B 1wt9_B 1iod_B 1y17_B Length = 123

 Score = 62.8 bits (153), Expect = 3e-12
 Identities = 30/144 (20%), Positives = 48/144 (33%), Gaps = 34/144 (23%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CP DW   E    C+      ++W ++E +C +   GGHL +  S EE     KL  +  
Sbjct: 2   CPSDWSSYE--GHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTF 59

Query: 111 NGC--WVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
                W+G    N     +W+WS+        W E  +                      
Sbjct: 60  GHSIFWMGLS--NVWNQCNWQWSNAAMLRYKAWAEESY---------------------- 95

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
           C    + +    +  C     F+C
Sbjct: 96  CVYFKSTNNKWRSRACRMMAQFVC 119

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 53/249 (21%), Positives = 85/249 (34%), Gaps = 47/249 (18%)

Query: 252 PPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF 306
           PP+     T       +   E       LLG    G  ++G  L D  +VA+K + R+  
Sbjct: 10  PPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRV 69

Query: 307 QRKKEF------YSEIGRFARLH----HPNLVAVKGCCYDHGDRYIVYEFVVNGP-LDRW 355
                         E+    ++     HP ++ +           +V E  +    L   
Sbjct: 70  LGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL--- 126

Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE------- 408
             +I   G  L           +   I   H +    VVHRDI+  N+L+D         
Sbjct: 127 FDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182

Query: 409 ---FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLL 464
               GA L     + F              GT  Y  PE++ R++     + V+S G+LL
Sbjct: 183 DFGSGALLHDEPYTDFD-------------GTRVYSPPEWISRHQYHALPATVWSLGILL 229

Query: 465 LEIVSGRRP 473
            ++V G  P
Sbjct: 230 YDMVCGDIP 238

>1pwb_A SP-D, PSP-D, pulmonary surfactant-associated protein D; collectin, C-type lectin, alpha-helical coiled coil, carbohydrate recognition domain; HET: GLC; 1.40A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 PDB: 1pw9_A* 3ikn_A* 3ikp_A* 3ikq_A* 3ikr_A* 2rie_A* 2ggx_A* 2ggu_A* 2ork_A* 2orj_A* 2ria_A* 2rib_A* 2ric_A* 2rid_A* 2os9_A* 3dbz_A 3g81_A* 3g83_A* 1b08_A 3g84_A* ... Length = 177

 Score = 64.0 bits (156), Expect = 4e-12
 Identities = 22/104 (21%), Positives = 38/104 (36%), Gaps = 8/104 (7%)

Query: 40  QLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE 99
            L A+ ++  K    P+     EK   F   G  + + E++  C + GG LA+  S  E 
Sbjct: 42  HLQAAFSQYKKVELFPNGQSVGEK--IFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAEN 99

Query: 100 HSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD----NMSKWNE 139
            + Q+L        ++      T  G  + +        S W  
Sbjct: 100 AALQQLVVAKNEAAFLSMTDSKTE-G-KFTYPTGESLVYSNWAP 141

>2afp_A Protein (SEA raven type II antifreeze protein); recombinant SEA raven protein, solution backbone fold, C- type lectin; NMR {Hemitripterus americanus} SCOP: d.169.1.1 Length = 129

 Score = 62.3 bits (152), Expect = 4e-12
 Identities = 35/145 (24%), Positives = 51/145 (35%), Gaps = 33/145 (22%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
            CP  W       +C  Y     +W  +ET C ++GGHLA++ S EE    Q L    V 
Sbjct: 6   NCPAGWQPLG--DRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTLNAGVV- 62

Query: 112 GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVG----SFNSSCTSLPCHVHATVD 163
             W+GG +     G +W WSD    N   W               + C      +     
Sbjct: 63  --WIGGSACLQA-G-AWTWSDGTPMNFRSWCS-----TKPDDVLAACC------MQ---- 103

Query: 164 LCTLVSNGSRSLVTERCNTSHPFIC 188
              + +   +      C  SH  +C
Sbjct: 104 ---MTAAADQCWDDLPCPASHKSVC 125

>3bx4_A Aggretin alpha chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_A Length = 136

 Score = 62.9 bits (153), Expect = 4e-12
 Identities = 33/150 (22%), Positives = 51/150 (34%), Gaps = 35/150 (23%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCK--EIGGHLAALTSYEE-----EHSAQK 104
            C   W   +    C+      ++WDE+E +C+  E G HLA++ S  E        +QK
Sbjct: 4   DCDFGWSPYD--QHCYQAFNEQKTWDEAEKFCRAQENGAHLASIESNGEADFVSWLISQK 61

Query: 105 LCGKNVNGCWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHV 158
               + +  W+G R+ N     S +WSD    +        +           T      
Sbjct: 62  DELADEDYVWIGLRAQNKEQQCSSEWSDGSSVSYENLIDLHTKKCGA--LEKLT------ 113

Query: 159 HATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
                       G R  V   C   H F+C
Sbjct: 114 ------------GFRKWVNYYCEQMHAFVC 131

>3c22_A C-type lectin domain family 4 member K; coiled coil, glycoprotein, membrane, signal-anchor, transmembrane, immune system, sugar binding protein; 1.50A {Homo sapiens} PDB: 3p5g_A* 3p5d_A* 3p5f_A* 3p5e_A* 3p5h_A* 3p5i_A* 3p7g_A* 3p7f_A* 3p7h_A* 3bc7_A* 3bbs_A* 3bc6_A* Length = 156

 Score = 63.2 bits (154), Expect = 4e-12
 Identities = 19/94 (20%), Positives = 33/94 (35%), Gaps = 6/94 (6%)

Query: 40  QLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE 99
           ++   M  D        W   +     + +    ++W  +E +C     HL ++TS  E+
Sbjct: 10  KIEGRMQNDILQVVSQGWKYFK--GNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQ 67

Query: 100 HSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133
               K  G      W+G        G  W W D+
Sbjct: 68  EFLYKTAGG--LIYWIGLTKAGME-G-DWSWVDD 97

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 49/190 (25%), Positives = 74/190 (38%), Gaps = 43/190 (22%)

Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
           +  +A+G+ FL  +     +HRD+ A N+LL E+    +   GL+          R +  
Sbjct: 199 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA----------RDIYK 245

Query: 435 GGTY-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQ 483
              Y       L     APE ++    T +SDV+SFGVLL EI S G  P   V     +
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DE 303

Query: 484 SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
                   L +  R   +  P  ++            ++   +  C    PS RP  S +
Sbjct: 304 EFCRR---LKEGTR---MRAPDYTT-----------PEMYQTMLDCWHGEPSQRPTFSEL 346

Query: 544 VHQLQQLAQP 553
           V  L  L Q 
Sbjct: 347 VEHLGNLLQA 356

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 30/155 (19%), Positives = 49/155 (31%), Gaps = 16/155 (10%)

Query: 284 GTYSGILPDGS--RVAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
               GI    +   VAVK LK  +     +   SE+     + HH N+V + G C   G 
Sbjct: 41  ADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100

Query: 340 R-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
              ++ EF   G L  +L              R +      +G  F   K     +  D+
Sbjct: 101 PLMVIVEFCKFGNLSTYLRS-----------KRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
           +     +     +   G    K +     +E    
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184

>2xr6_A CD209 antigen; sugar binding protein, carbohydrate binding, mannose; HET: MAN 07B; 1.35A {Homo sapiens} PDB: 1sl4_A* 2it6_A* 1k9i_A* 2xr5_A* 1sl5_A* 2it5_A* 1xph_A 1k9j_A* Length = 170

 Score = 63.7 bits (155), Expect = 5e-12
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 4/81 (4%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
           PCP +W   +    C+    + R+W +S T CKE+G  L  + S EE++  Q    ++  
Sbjct: 21  PCPWEWTFFQ--GNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNR 78

Query: 112 GCWVGGRSINTTVGLSWKWSD 132
             W+G   +N     +W+W D
Sbjct: 79  FTWMGLSDLNQE--GTWQWVD 97

>2b6b_D CD209 antigen; cryo EM dengue CRD DC-SIGN, icosahedral virus, virus-recepto; 25.00A {Homo sapiens} SCOP: d.169.1.1 Length = 175

 Score = 63.7 bits (155), Expect = 5e-12
 Identities = 26/101 (25%), Positives = 46/101 (45%), Gaps = 4/101 (3%)

Query: 33  SNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAA 92
            +  S+G +    +     PCP +W   +    C+    + R+W +S T CKE+G  L  
Sbjct: 7   HHHHSSGLVPRGSHMRLCHPCPWEWTFFQ--GNCYFMSNSQRNWHDSITACKEVGAQLVV 64

Query: 93  LTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133
           + S EE++  Q    ++    W+G   +N     +W+W D 
Sbjct: 65  IKSAEEQNFLQLQSSRSNRFTWMGLSDLNQE--GTWQWVDG 103

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 48/187 (25%), Positives = 72/187 (38%), Gaps = 17/187 (9%)

Query: 293 GSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
              VAVK +         E    EI     L+H N+V   G   +   +Y+  E+   G 
Sbjct: 32  EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91

Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDE 407
           L      I          M    A         G+ +LH      + HRDI+  N+LLDE
Sbjct: 92  L---FDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDE 140

Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLE 466
                +   GL+    +   +       GT  Y+APE + R E      DV+S G++L  
Sbjct: 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTA 200

Query: 467 IVSGRRP 473
           +++G  P
Sbjct: 201 MLAGELP 207

>3ubu_B Agglucetin subunit beta-2; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus} Length = 126

 Score = 62.0 bits (151), Expect = 6e-12
 Identities = 32/144 (22%), Positives = 52/144 (36%), Gaps = 33/144 (22%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W   E    C+  +   ++WD++E +C E   GGHL ++ S EE      L    +
Sbjct: 4   CPLRWSAYE--GHCYLVVKEKKTWDDAEKFCTEQRKGGHLVSVHSREEADFLVHLAYPIL 61

Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
           +    W+G    N       +WSD    +   W +         S C             
Sbjct: 62  DLSLIWMGLS--NMWNDCKREWSDGTKLDFKSWAK--------TSDC------------- 98

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
               ++G    +   C+  H F+C
Sbjct: 99  LIGKTDGDNQWLNMDCSKKHYFVC 122

>1qdd_A Lithostathine; pancreatic stone inhibitor, metal binding protein; HET: SIA NDG GAL; 1.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1lit_A Length = 144

 Score = 62.1 bits (151), Expect = 8e-12
 Identities = 25/146 (17%), Positives = 46/146 (31%), Gaps = 29/146 (19%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKNVN 111
           CP         S C+ +  +  +W +++ YC+ +  G+L ++ +  E      L  ++  
Sbjct: 14  CPEGTNAYR--SYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKESGT 71

Query: 112 G---CWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHATV 162
                W+G    +     +W WS     +   W               C SL        
Sbjct: 72  DDFNVWIGLH--DPKKNRAWHWSSGSLVSYKSWGIGAPSSV---NPGYCVSL-------- 118

Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
                 S G +      C     F+C
Sbjct: 119 ----TSSTGFQKWKDVPCEDKFSFVC 140

>1jzn_A Galactose-specific lectin; C-type lectin, protein-disaccharide complex, sugar binding P; HET: BGC GAL; 2.20A {Crotalus atrox} SCOP: d.169.1.1 PDB: 1muq_A* Length = 135

 Score = 61.6 bits (150), Expect = 8e-12
 Identities = 32/147 (21%), Positives = 54/147 (36%), Gaps = 29/147 (19%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
           CP DW+       C+      ++W+++E +C++   G HLA+   Y E     +      
Sbjct: 3   CPLDWLPMN--GLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAEYISDYH 60

Query: 111 NG---CWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHAT 161
            G    W+G R  +     SW+W+D    +   W  N+  H        C  L       
Sbjct: 61  KGQENVWIGLR--DKKKDFSWEWTDRSCTDYLTWDKNQPDHYQN--KEFCVEL------- 109

Query: 162 VDLCTLVSNGSRSLVTERCNTSHPFIC 188
                +   G R    + C +   F+C
Sbjct: 110 -----VSLTGYRLWNDQVCESKDAFLC 131

>2e3x_B Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis} Length = 134

 Score = 61.7 bits (150), Expect = 9e-12
 Identities = 32/146 (21%), Positives = 49/146 (33%), Gaps = 30/146 (20%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CPPD  +      C+      ++W+ +E +C E    GHL ++ S EE     KL     
Sbjct: 3   CPPDSSLYR--YFCYRVFKEHKTWEAAERFCMEHPNNGHLVSIESMEEAEFVAKLLSNTT 60

Query: 111 NGC----WVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
                  W+G    +     S +WSD    +  K  +       F   C  L        
Sbjct: 61  GKFITHFWIGLMIKDKEQECSSEWSDGSSVSYDKLGK-----QEFR-KCFVL-------- 106

Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
                  +G R      C   + F+C
Sbjct: 107 ----EKESGYRMWFNRNCEERYLFVC 128

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 50/266 (18%), Positives = 85/266 (31%), Gaps = 45/266 (16%)

Query: 233 SKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSG 288
           S               + + P   +  T+      K   E       LLG    G  YSG
Sbjct: 3   SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62

Query: 289 I-LPDGSRVAVKRLKRSSFQRKKEF------YSEIGRFARLHH--PNLVAVKGCCYDHGD 339
           I + D   VA+K +++       E         E+    ++      ++ +         
Sbjct: 63  IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122

Query: 340 RYIVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
             ++ E       L      I   G  L   +       + + +   H+     V+HRDI
Sbjct: 123 FVLILERPEPVQDL---FDFITERGA-LQEELARSFFWQVLEAVRHCHNC---GVLHRDI 175

Query: 399 RASNVLLDEE----------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
           +  N+L+D             GA L     + F              GT  Y  PE++  
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-------------GTRVYSPPEWIRY 222

Query: 449 NELT-TKSDVYSFGVLLLEIVSGRRP 473
           +      + V+S G+LL ++V G  P
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIP 248

>3kqg_A Langerin, C-type lectin domain family 4 member K; trimer, NECK and CRD, coiled coil, immune system; 2.30A {Homo sapiens} Length = 182

 Score = 62.5 bits (152), Expect = 1e-11
 Identities = 26/156 (16%), Positives = 52/156 (33%), Gaps = 12/156 (7%)

Query: 33  SNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAA 92
            +  +  +L    N   +      W   +     + +    ++W  +E +C     HL +
Sbjct: 30  GSLENMSKLLKRQNDILQ-VVSQGWKYFK--GNFYYFSLIPKTWYSAEQFCVSRNSHLTS 86

Query: 93  LTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCT 152
           +TS  E+    K  G      W+G        G  W W D+ + +N+      S      
Sbjct: 87  VTSESEQEFLYKTAGG--LIYWIGLTKAGME-G-DWSWVDD-TPFNKV----QSARFWIP 137

Query: 153 SLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
             P +         + +   ++     C+ +  FIC
Sbjct: 138 GEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFIC 173

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 65.3 bits (160), Expect = 1e-11
 Identities = 49/187 (26%), Positives = 90/187 (48%), Gaps = 25/187 (13%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
           A+K +K+      ++     +E   F +  +HP LV +   C+    R + V E+V  G 
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGD 96

Query: 352 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
           L   + H+ R  +   + A R   A  ++  + +LH++    +++RD++  NVLLD E  
Sbjct: 97  L---MFHMQRQRKLPEEHA-RFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSE-- 146

Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
            H+     G+ K    E ++     +   GT  Y+APE +   +     D ++ GVL+ E
Sbjct: 147 GHIKLTDYGMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202

Query: 467 IVSGRRP 473
           +++GR P
Sbjct: 203 MMAGRSP 209

>2ox9_A Collectin placenta 1; C-type lectin, sugar binding protein; HET: GAL NAG FUC; 1.95A {Mus musculus} PDB: 2ox8_A Length = 140

 Score = 61.2 bits (149), Expect = 1e-11
 Identities = 26/140 (18%), Positives = 49/140 (35%), Gaps = 20/140 (14%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CPP W       KC+ +      +++++ +C++   HL  + S EE+   +K        
Sbjct: 5   CPPHWKNFT--DKCYYFSLEKEIFEDAKLFCEDKSSHLVFINSREEQQWIKKHTVGR-ES 61

Query: 113 CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
            W+G           WKW D    +   W       G  ++  +            C  +
Sbjct: 62  HWIGLTDSEQE-S-EWKWLDGSPVDYKNWKA-----GQPDNWGSGHGPGED-----CAGL 109

Query: 169 SNGSRSLVTERCNTSHPFIC 188
               +     +C+  + FIC
Sbjct: 110 IYAGQ-WNDFQCDEINNFIC 128

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 37/203 (18%)

Query: 286 YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----- 340
           +   L +   VA+K++     Q K+    E+     + HPN+V +K   Y +GD+     
Sbjct: 57  FQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112

Query: 341 -YIVYEFVVNGPLD--RWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHR 396
             +V E+V   P    R   H  +  +++   + +K+    L + +A++H      + HR
Sbjct: 113 LNLVLEYV---PETVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIHSI---GICHR 165

Query: 397 DIRASNVLLDEEFGAHLMGV------GLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYR- 448
           DI+  N+LLD        GV      G +K  +  E           +  Y APE ++  
Sbjct: 166 DIKPQNLLLDPP-----SGVLKLIDFGSAKILIAGEPNVSYIC----SRYYRAPELIFGA 216

Query: 449 NELTTKSDVYSFGVLLLEIVSGR 471
              TT  D++S G ++ E++ G+
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239

>1ukm_A EMS16 A chain, EMS16 subunit A; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_A* Length = 134

 Score = 61.3 bits (149), Expect = 1e-11
 Identities = 33/148 (22%), Positives = 52/148 (35%), Gaps = 34/148 (22%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CP DW   +    C+  IG  ++W E+E +C E    GHL ++ S EE +   +L    +
Sbjct: 4   CPSDWTAYD--QHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFM 61

Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHA 160
           +      W+G R        + +W+D        W   ES    G   +  T        
Sbjct: 62  HRSEIYVWIGLRDRREEQQCNPEWNDGSKIIYVNWKEGESKMCQG--LTKWT-------- 111

Query: 161 TVDLCTLVSNGSRSLVTERCNTSHPFIC 188
                              C   +PF+C
Sbjct: 112 ----------NFHDWNNINCEDLYPFVC 129

>1dv8_A Asialoglycoprotein receptor 1; C-type lectin CRD, signaling protein; 2.30A {Homo sapiens} SCOP: d.169.1.1 Length = 128

 Score = 60.9 bits (148), Expect = 1e-11
 Identities = 27/147 (18%), Positives = 49/147 (33%), Gaps = 34/147 (23%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP +W+ +E    C+ +  + ++W +++ YC+    HL  +TS+EE+   Q   G     
Sbjct: 1   CPVNWVEHE--RSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIGP--VN 56

Query: 113 CWVGGRSINTTVGLSWKWSD------NMSKW-----NESIHAVGSFNSSCTSLPCHVHAT 161
            W+G    N      WKW D          W     ++           C          
Sbjct: 57  TWMGLHDQNGP----WKWVDGTDYETGFKNWRPEQPDDWYGHGLGGGEDCAHF------- 105

Query: 162 VDLCTLVSNGSRSLVTERCNTSHPFIC 188
                           + C   + ++C
Sbjct: 106 --------TDDGRWNDDVCQRPYRWVC 124

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 48/187 (25%), Positives = 90/187 (48%), Gaps = 25/187 (13%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
           A++ +K+      ++     +E   F +  +HP LV +   C+    R + V E+V  G 
Sbjct: 81  AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGD 139

Query: 352 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
           L   + H+ R  +   + A R   A  ++  + +LH++    +++RD++  NVLLD E  
Sbjct: 140 L---MFHMQRQRKLPEEHA-RFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSE-- 189

Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
            H+     G+ K    E ++     +   GT  Y+APE +   +     D ++ GVL+ E
Sbjct: 190 GHIKLTDYGMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 245

Query: 467 IVSGRRP 473
           +++GR P
Sbjct: 246 MMAGRSP 252

>2h2t_B Low affinity immunoglobulin epsilon FC receptor ( IGE receptor) (FC-epsilon-RII)...; C-type lectin, calcium-bound, lectin domain; 1.30A {Homo sapiens} PDB: 2h2r_A 1t8c_A 1t8d_A Length = 175

 Score = 61.7 bits (150), Expect = 2e-11
 Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 10/92 (10%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
            CP  WI  +   KC+ +    + W  +   C ++ G L ++ S EE+    K       
Sbjct: 16  TCPEKWINFQ--RKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKRASH--T 71

Query: 112 GCWVGGRSINTTVGLSWKWSD----NMSKWNE 139
           G W+G R+++      + W D    + S W  
Sbjct: 72  GSWIGLRNLDLK--GEFIWVDGSHVDYSNWAP 101

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 60/253 (23%), Positives = 97/253 (38%), Gaps = 41/253 (16%)

Query: 237 RKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSR 295
             +R L     SAL  P+  +F   EL             +G+   G  Y G  +  G  
Sbjct: 6   SPARSLDEIDLSALRDPA-GIFELVEL-------------VGNGTYGQVYKGRHVKTGQL 51

Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY------IVYEFVV 348
            A+K +  +    ++E   EI    +  HH N+    G               +V EF  
Sbjct: 52  AAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 110

Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLL 405
            G +   + +        +W     +A    +   G++ LH      V+HRDI+  NVLL
Sbjct: 111 AGSVTDLIKNTKGNTLKEEW-----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLL 162

Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-----TKSDVYSF 460
            E     L+  G+S  +    +  R    G  Y ++APE +  +E        KSD++S 
Sbjct: 163 TENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPY-WMAPEVIACDENPDATYDFKSDLWSL 220

Query: 461 GVLLLEIVSGRRP 473
           G+  +E+  G  P
Sbjct: 221 GITAIEMAEGAPP 233

>2ls8_A C-type lectin domain family 4 member D; structural genomics, NEW YORK structural genomics research consortium, nysgrc, PSI-biology, immune system; NMR {Homo sapiens} Length = 156

 Score = 61.3 bits (149), Expect = 2e-11
 Identities = 22/81 (27%), Positives = 41/81 (50%), Gaps = 5/81 (6%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP DW   +  S C+  + + ++W ESE  C  +G HL  +++  E++   +   + ++ 
Sbjct: 3   CPIDWRAFQ--SNCYFPLTDNKTWAESERNCSGMGAHLMTISTEAEQNFIIQFLDRRLS- 59

Query: 113 CWVGGRSINTTVGLSWKWSDN 133
            ++G R  N   G  W+W D 
Sbjct: 60  YFLGLRDENAK-G-QWRWVDQ 78

>1uv0_A Pancreatitis-associated protein 1; lectin, C-type, secreted, inflammatory response, acute phase; 1.78A {Homo sapiens} SCOP: d.169.1.1 PDB: 2go0_A Length = 149

 Score = 61.0 bits (148), Expect = 2e-11
 Identities = 29/149 (19%), Positives = 49/149 (32%), Gaps = 30/149 (20%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKNVN 111
           CP         S C+    + +SW +++  C++   G+L ++ S  E      L     N
Sbjct: 14  CPKGSKAYG--SHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGN 71

Query: 112 G---CWVGGRSIN---TTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHAT 161
                W+G           G  W+WS     N   W  +              P  + + 
Sbjct: 72  SYSYVWIGLHDPTQGTEPNGEGWEWSSSDVMNYFAWERN--------------PSTISSP 117

Query: 162 VDLCTLVSNGSRSL--VTERCNTSHPFIC 188
              C  +S  +  L      CN   P++C
Sbjct: 118 GH-CASLSRSTAFLRWKDYNCNVRLPYVC 145

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 25/187 (13%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
           AVK LK+    +  +      E    A     P L  +   C+   DR Y V E+V  G 
Sbjct: 49  AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGD 107

Query: 352 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
           L   ++HI + GR     A     A  +A G+ FL  K    +++RD++  NV+LD E G
Sbjct: 108 L---MYHIQQVGRFKEPHA-VFYAAE-IAIGLFFLQSK---GIIYRDLKLDNVMLDSE-G 158

Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
            H+     G+ K    E + +        GT  Y+APE +         D ++FGVLL E
Sbjct: 159 -HIKIADFGMCK----ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213

Query: 467 IVSGRRP 473
           +++G+ P
Sbjct: 214 MLAGQAP 220

>2zib_A Type II antifreeze protein; thermal hysteresis, lectin; 1.34A {Brachyopsis rostratus} Length = 133

 Score = 60.1 bits (146), Expect = 3e-11
 Identities = 32/144 (22%), Positives = 51/144 (35%), Gaps = 33/144 (22%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP  W ++    +CF       +WD +E  C   GGHLA++ S EE+   + +    V  
Sbjct: 10  CPAGWTLHG--QRCFYSEATAMTWDLAEANCVNKGGHLASIHSLEEQLYIKDIVAGIV-- 65

Query: 113 CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVG----SFNSSCTSLPCHVHATVDL 164
            W+GG +     G +W W+D    +   W              +  C             
Sbjct: 66  -WIGGSACKVA-G-AWSWTDGTPVDYRTWCP-----TKPNDILSDCC------------- 104

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
             + +   +      C  SH  IC
Sbjct: 105 MQMTAAVDKCWDDLPCPASHASIC 128

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 52/195 (26%), Positives = 80/195 (41%), Gaps = 34/195 (17%)

Query: 293 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYE 345
           G +VAVK L R   +          EI       HP+++ +    Y       D ++V E
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL----YQVISTPTDFFMVME 91

Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRAS 401
           +V  G L     +I + GR     +    A  L Q     + + H      VVHRD++  
Sbjct: 92  YVSGGEL---FDYICKHGR-----VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPE 140

Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM--AGGTYGYLAPEFVYRNELT-TKSDVY 458
           NVLLD    A +   GLS       M +   +  + G+  Y APE +        + D++
Sbjct: 141 NVLLDAHMNAKIADFGLSNM-----MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 195

Query: 459 SFGVLLLEIVSGRRP 473
           S GV+L  ++ G  P
Sbjct: 196 SCGVILYALLCGTLP 210

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 54/186 (29%), Positives = 79/186 (42%), Gaps = 23/186 (12%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           AVK LK+    +  +     +E    +   +HP L  +  C       + V EFV  G L
Sbjct: 52  AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111

Query: 353 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
              + HI +  R     A R   A  +   + FLHDK    +++RD++  NVLLD E   
Sbjct: 112 ---MFHIQKSRRFDEARA-RFYAAE-IISALMFLHDK---GIIYRDLKLDNVLLDHE--G 161

Query: 412 HLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
           H      G+ K    E +      A   GT  Y+APE +         D ++ GVLL E+
Sbjct: 162 HCKLADFGMCK----EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEM 217

Query: 468 VSGRRP 473
           + G  P
Sbjct: 218 LCGHAP 223

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 24/160 (15%)

Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR-SLDWAMRMKVA-TTLAQ 380
             P LV +          +++ +++  G L     H+ +  R +     ++ V    LA 
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGEL---FTHLSQRERFTEHEV-QIYVGEIVLA- 171

Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV--GLSKFVPWEVMQERTVMAG--- 435
            +  LH      +++RDI+  N+LLD   G H++    GLSK    E + + T  A    
Sbjct: 172 -LEHLHKL---GIIYRDIKLENILLDSN-G-HVVLTDFGLSK----EFVADETERAYDFC 221

Query: 436 GTYGYLAPEFVYRNEL-TTKS-DVYSFGVLLLEIVSGRRP 473
           GT  Y+AP+ V   +    K+ D +S GVL+ E+++G  P
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 62.9 bits (154), Expect = 6e-11
 Identities = 45/191 (23%), Positives = 83/191 (43%), Gaps = 33/191 (17%)

Query: 297 AVKRLKRSS-FQRKKEFY---SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           A+K LK++   +  K+     +E      + HP +V +       G  Y++ E++  G L
Sbjct: 49  AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108

Query: 353 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--- 408
                 + R G    D A    +A  ++  +  LH K    +++RD++  N++L+ +   
Sbjct: 109 ---FMQLEREGIFMEDTA-CFYLAE-ISMALGHLHQK---GIIYRDLKPENIMLNHQGHV 160

Query: 409 ----FGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
               FG       L K    E + +   T    GT  Y+APE + R+      D +S G 
Sbjct: 161 KLTDFG-------LCK----ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGA 209

Query: 463 LLLEIVSGRRP 473
           L+ ++++G  P
Sbjct: 210 LMYDMLTGAPP 220

>1gz2_A Ovocleidin-17, OC-17 ovocleidin; structural protein, CTLD, eggshell structural protein, phosphoprotein, sugar-binding protein, glycoprotein; HET: SEP; 1.5A {Gallus gallus} SCOP: d.169.1.1 Length = 142

 Score = 59.4 bits (144), Expect = 6e-11
 Identities = 32/153 (20%), Positives = 50/153 (32%), Gaps = 36/153 (23%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
           C P W+       C G+     SW  +E++C+    G HLAA+ S  E     +L   + 
Sbjct: 5   CGPGWVPTP--GGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASR 62

Query: 111 NGCWVGGRSINTT-VGLS-------WKWSD----NMSKWNESIHAVGSFNSS---CTSLP 155
            G   G  +     +GL        W+WSD      + W+       +       C +L 
Sbjct: 63  GGDGSGEGADGRVWIGLHRPAGSRSWRWSDGTAPRFASWHR-----TAKARRGGRCAAL- 116

Query: 156 CHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
                             S     C   + F+C
Sbjct: 117 -----------RDEEAFTSWAARPCTERNAFVC 138

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 52/183 (28%), Positives = 81/183 (44%), Gaps = 17/183 (9%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           AVK LK+    +  +      E    A     P L  +  C       Y V E+V  G L
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429

Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
              ++HI + GR  +       A  +A G+ FL  K    +++RD++  NV+LD E    
Sbjct: 430 ---MYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK 482

Query: 413 LMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
           +   G+ K    E + +   T    GT  Y+APE +         D ++FGVLL E+++G
Sbjct: 483 IADFGMCK----ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538

Query: 471 RRP 473
           + P
Sbjct: 539 QAP 541

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 62.6 bits (153), Expect = 9e-11
 Identities = 50/191 (26%), Positives = 79/191 (41%), Gaps = 33/191 (17%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
           A+K LK+       +      E    +    HP L  +        + + V E++  G L
Sbjct: 46  AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105

Query: 353 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--- 408
              ++HI    +  L  A     A  +  G+ FLH K    +V+RD++  N+LLD++   
Sbjct: 106 ---MYHIQSCHKFDLSRA-TFYAAE-IILGLQFLHSK---GIVYRDLKLDNILLDKDGHI 157

Query: 409 ----FGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGV 462
               FG       + K    E M          GT  Y+APE +   +     D +SFGV
Sbjct: 158 KIADFG-------MCK----ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV 206

Query: 463 LLLEIVSGRRP 473
           LL E++ G+ P
Sbjct: 207 LLYEMLIGQSP 217

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 35/192 (18%)

Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
           AVK L++ +  +KKE     SE     + + HP LV +    +   D+ Y V +++  G 
Sbjct: 67  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGE 125

Query: 352 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-- 408
           L    +H+ R        A R   A  +A  + +LH     ++V+RD++  N+LLD +  
Sbjct: 126 L---FYHLQRERCFLEPRA-RFYAAE-IASALGYLHSL---NIVYRDLKPENILLDSQGH 177

Query: 409 -----FGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
                FG       L K    E ++    T    GT  YLAPE +++       D +  G
Sbjct: 178 IVLTDFG-------LCK----ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG 226

Query: 462 VLLLEIVSGRRP 473
            +L E++ G  P
Sbjct: 227 AVLYEMLYGLPP 238

>2vuv_A Codakine; sugar-binding protein, C-type, lectin, mannose, invertebrate; HET: CIT; 1.3A {Codakia orbicularis} PDB: 2vuz_A* Length = 129

 Score = 58.1 bits (141), Expect = 1e-10
 Identities = 28/140 (20%), Positives = 52/140 (37%), Gaps = 21/140 (15%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP  W        C+ Y     SW  +++ C+ +GG LA   +  E      +C +N + 
Sbjct: 2   CPDGWTQFL--DLCYIYQSAKASWASAQSSCQALGGILAEPDTACENEVLIHMCKENGDA 59

Query: 113 ----CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
                W+GG+ +      +W+WS + +           +     + P +     D C  +
Sbjct: 60  GSFGPWLGGQKVGG----AWQWSSSGAA--------FDYLRWGPNEPNNSGGNED-C--L 104

Query: 169 SNGSRSLVTERCNTSHPFIC 188
                S    RC+    ++C
Sbjct: 105 HYNWLSWNDLRCHYQASYLC 124

>3pbf_A Pulmonary surfactant-associated protein A; collectin, carbohydrate binding, lectin, mannose, sugar BIND protein; 1.80A {Rattus norvegicus} PDB: 1r14_A* 1r13_A* 3paq_A* 3par_A 3pak_A Length = 148

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 8/91 (8%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
                +   +K   F   G   ++D  +  C   GG++A   + EE  +   +  K  N 
Sbjct: 27  LQGSMLSVGDK--VFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNY 84

Query: 113 CWVGGRSINTTVGLSWKWSDNM----SKWNE 139
            ++G     T  G  + + D      + W  
Sbjct: 85  VYLGMIEDQTP-G-DFHYLDGASVSYTNWYP 113

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 44/211 (20%)

Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
           G++ G+         G  VA+K++     Q K+    E+    +L H N+V ++   Y  
Sbjct: 65  GSF-GVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSS 119

Query: 338 GDR------YIVYEFVVNGPLD--RWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDK 388
           G++       +V ++V   P    R   H  R  ++L   + +K+    L + +A++H  
Sbjct: 120 GEKKDEVYLNLVLDYV---PETVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYIHSF 175

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGV------GLSK-FVPWEVMQERTVMAGGTYGYL 441
               + HRDI+  N+LLD +       V      G +K  V  E           +  Y 
Sbjct: 176 ---GICHRDIKPQNLLLDPD-----TAVLKLCDFGSAKQLVRGEPNVSYIC----SRYYR 223

Query: 442 APEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
           APE ++   + T+  DV+S G +L E++ G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>1tn3_A Tetranectin; plasminogen binding, kringle 4, C-type lectin, carbohydrate recognition domain; 2.00A {Homo sapiens} SCOP: d.169.1.1 PDB: 1rjh_A 3l9j_C Length = 137

 Score = 58.2 bits (141), Expect = 2e-10
 Identities = 15/85 (17%), Positives = 30/85 (35%), Gaps = 8/85 (9%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
            C     ++    KCF      +++ E+   C   GG L+   +  E  +  +   ++V 
Sbjct: 5   VCLKGTKVHM---KCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVG 61

Query: 112 G---CWVGGRSINTTVGLSWKWSDN 133
                W+G   +    G +W     
Sbjct: 62  NEAEIWLGLNDMAAE-G-TWVDMTG 84

>1rtm_1 Mannose-binding protein-A; lectin; 1.80A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1 PDB: 1kwu_A* 1kwv_A* 1kwt_A* 1kwx_A* 1kwy_A* 1kx1_A* 1kww_A 1kwz_A* 1kx0_A* 3kmb_1* 1kmb_1* 2kmb_1* 4kmb_1* 1afb_1* 1afa_1* 1afd_1 1bch_1* 1bcj_1* 1fif_A 1fih_A* Length = 149

 Score = 57.7 bits (140), Expect = 3e-10
 Identities = 16/104 (15%), Positives = 34/104 (32%), Gaps = 11/104 (10%)

Query: 40  QLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE 99
            L + +    K          +   K F        + + +  C E+ G +A   + EE 
Sbjct: 15  TLKSKLELTNKLHAFSMG--KKSGKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEEN 72

Query: 100 HSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD----NMSKWNE 139
            + Q++   +    ++G     T  G  + +        S W +
Sbjct: 73  KAIQEVAKTSA---FLGITDEVTE-G-QFMYVTGGRLTYSNWKK 111

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 54/225 (24%), Positives = 85/225 (37%), Gaps = 65/225 (28%)

Query: 292 DGSRVAVKRLKRSSFQRKKEFYS--------------------------EIGRFARLHHP 325
           D +  A+K L +    R+  F                            EI    +L HP
Sbjct: 37  DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP 96

Query: 326 NLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ--- 380
           N+V +     D  +   Y+V+E V  GP+      +P         +    A    Q   
Sbjct: 97  NVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKP-----LSEDQARFYFQDLI 147

Query: 381 -GIAFLHDKVKPHVVHRDIRASNVLLDEE-------FGAHLMGVGLS-KFVPWEVMQERT 431
            GI +LH +    ++HRDI+ SN+L+ E+       F       G+S +F   + +   T
Sbjct: 148 KGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF-------GVSNEFKGSDALLSNT 197

Query: 432 VMAGGTYGYLAPEFVYRNELT---TKSDVYSFGVLLLEIVSGRRP 473
           V   GT  ++APE +            DV++ GV L   V G+ P
Sbjct: 198 V---GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 60.0 bits (146), Expect = 6e-10
 Identities = 55/219 (25%), Positives = 82/219 (37%), Gaps = 54/219 (24%)

Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
           GT+ G          G  VA+K++     + +      +   A LHHPN+V ++   Y  
Sbjct: 34  GTF-GTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTL 91

Query: 338 GDR-------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT----LAQGIAFLH 386
           G+R        +V E+V   P    LH   R       A    +       L + I  LH
Sbjct: 92  GERDRRDIYLNVVMEYV---PDT--LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146

Query: 387 DKVKPHVVHRDIRASNVLLDEE--------FGAHLMGVGLSK-FVPWEVMQERTVMAGGT 437
                +V HRDI+  NVL++E         F       G +K   P E           +
Sbjct: 147 LPSV-NVCHRDIKPHNVLVNEADGTLKLCDF-------GSAKKLSPSEPNVAYIC----S 194

Query: 438 YGYLAPEFV-----YRNELTTKSDVYSFGVLLLEIVSGR 471
             Y APE +     Y    TT  D++S G +  E++ G 
Sbjct: 195 RYYRAPELIFGNQHY----TTAVDIWSVGCIFAEMMLGE 229

>1htn_A Tetranectin; plasminogen binding, kringle 4, alpha-helical coiled coil, C-type lectin, carbohydrate recognition domain; 2.80A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 Length = 182

 Score = 57.9 bits (140), Expect = 6e-10
 Identities = 15/86 (17%), Positives = 30/86 (34%), Gaps = 8/86 (9%)

Query: 51  APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
             C     ++    KCF      +++ E+   C   GG L+   +  E  +  +   ++V
Sbjct: 49  TVCLKGTKVHM---KCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSV 105

Query: 111 NG---CWVGGRSINTTVGLSWKWSDN 133
                 W+G   +    G +W     
Sbjct: 106 GNEAEIWLGLNDMAAE-G-TWVDMTG 129

>1buu_A Protein (mannose-binding protein A); lectin, HOST defense, metalloprotein, sugar binding protein; 1.90A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1 Length = 168

 Score = 57.4 bits (139), Expect = 6e-10
 Identities = 17/110 (15%), Positives = 37/110 (33%), Gaps = 13/110 (11%)

Query: 35  QSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALT 94
           ++    L + +    K          +   K F        + + +  C E+ G +A   
Sbjct: 29  EAEINTLKSKLELTNKLHAFSMG--KKSGKKFFVTNHERMPFSKVKALCSELRGTVAIPR 86

Query: 95  SYEEEHSA-QKLCGKNVNGCWVGGRSINTTVGLSWKWSD----NMSKWNE 139
           +  EE+ A Q++   +    ++G     T  G  + +        S W +
Sbjct: 87  N-AEENKAIQEVAKTSA---FLGITDEVTE-G-QFMYVTGGRLTYSNWKK 130

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 24/206 (11%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKG 332
           R LG  K    +  I + +  +V VK LK     +KK+   EI     L   PN++ +  
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLAD 98

Query: 333 CCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
              D   R   +V+E V N    +    +       D+ +R  +   L + + + H    
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFKQLYQTLT------DYDIRFYMYEIL-KALDYCHSM-- 149

Query: 391 PHVVHRDIRASNVLLDEEFGA-HLMGVGLSKF-VPWEVMQERTVMAGGTYGYLAPE-FVY 447
             ++HRD++  NV++D E     L+  GL++F  P +    R      +  +  PE  V 
Sbjct: 150 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA----SRYFKGPELLVD 204

Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRP 473
                   D++S G +L  ++  + P
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEP 230

>1hup_A Mannose-binding protein; alpha-helical coiled-coil, C-type lectin; 2.50A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 Length = 141

 Score = 56.2 bits (136), Expect = 8e-10
 Identities = 17/104 (16%), Positives = 34/104 (32%), Gaps = 11/104 (10%)

Query: 40  QLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE 99
            L   M +  K          +  +K F   G   ++++ +  C +    +A   +  E 
Sbjct: 7   ALQTEMARIKKWLTFSLG--KQVGNKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAEN 64

Query: 100 HSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNM----SKWNE 139
            + Q L  +     ++G      T G  +          + WNE
Sbjct: 65  GAIQNLIKEEA---FLGITDEK-TEG-QFVDLTGNRLTYTNWNE 103

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 55/197 (27%), Positives = 83/197 (42%), Gaps = 38/197 (19%)

Query: 293 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYE 345
           G +VAVK L R   +          EI       HP+++ +    Y       D ++V E
Sbjct: 41  GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL----YQVISTPSDIFMVME 96

Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRAS 401
           +V  G L     +I + GR     +  K +  L Q    G+ + H      VVHRD++  
Sbjct: 97  YVSGGEL---FDYICKNGR-----LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPE 145

Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQE----RTVMAGGTYGYLAPEFVYRNELT-TKSD 456
           NVLLD    A +   GLS       M +    RT  + G+  Y APE +        + D
Sbjct: 146 NVLLDAHMNAKIADFGLSNM-----MSDGEFLRT--SCGSPNYAAPEVISGRLYAGPEVD 198

Query: 457 VYSFGVLLLEIVSGRRP 473
           ++S GV+L  ++ G  P
Sbjct: 199 IWSSGVILYALLCGTLP 215

>1h8u_A MBP, eosinophil granule major basic protein 1; lectin, eosinophil granule protein, EMBP; 1.8A {Homo sapiens} SCOP: d.169.1.1 PDB: 2brs_A* Length = 117

 Score = 55.1 bits (133), Expect = 1e-09
 Identities = 22/125 (17%), Positives = 43/125 (34%), Gaps = 14/125 (11%)

Query: 66  CFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGK-NVNGCWVGGRSINTT 123
            +  + + +++ ++   C+    G+L ++ ++   +  Q      N    W+GGR   + 
Sbjct: 3   RYLLVRSLQTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSG 62

Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
               ++W D  S+WN        F       P         C  +           C   
Sbjct: 63  RCRRFQWVDG-SRWN--------FAYWAAHQPWSRGGH---CVALCTRGGYWRRAHCLRR 110

Query: 184 HPFIC 188
            PFIC
Sbjct: 111 LPFIC 115

>3cfw_A L-selectin; EGF, cell adhesion, EGF-like domain, glycoprotein, membrane, sushi, transmembrane; HET: NAG MAN BMA; 2.20A {Homo sapiens} Length = 164

 Score = 56.4 bits (136), Expect = 1e-09
 Identities = 18/123 (14%), Positives = 41/123 (33%), Gaps = 7/123 (5%)

Query: 66  CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125
            + Y     +W  +  +C++    L A+ +  E    +K    + +  W+G R I     
Sbjct: 2   TYHYSEKPMNWQRARRFCRDNYTDLVAIQNKAEIEYLEKTLPFSRSYYWIGIRKIGGI-- 59

Query: 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHP 185
            +W  ++            G  N+      C     V++    +  +     + C+    
Sbjct: 60  WTWVGTNKSLTEEAENWGDGEPNNKKNKEDC-----VEIYIKRNKDAGKWNDDACHKLKA 114

Query: 186 FIC 188
            +C
Sbjct: 115 ALC 117

>1byf_A TC14, protein (polyandrocarpa lectin); C-type lectin, galactose-specific, sugar binding protein; 2.00A {Polyandrocarpa misakiensis} SCOP: d.169.1.1 PDB: 1tlg_A* Length = 125

 Score = 55.5 bits (134), Expect = 1e-09
 Identities = 10/71 (14%), Positives = 25/71 (35%), Gaps = 3/71 (4%)

Query: 65  KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE--HSAQKLCGKNVNGCWVGGRSINT 122
               +     ++ ++ TYC+  G  L +    +     +         +  WVG  ++  
Sbjct: 3   YEILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGADNLQD 62

Query: 123 TVGLSWKWSDN 133
               ++ W+D 
Sbjct: 63  G-AYNFLWNDG 72

>3alu_A Lectin CEL-IV, C-type; C-type lectin, raffinose, sugar binding protein; HET: RAF; 1.65A {Cucumaria echinata} PDB: 3als_A* 3alt_A* Length = 157

 Score = 56.0 bits (135), Expect = 1e-09
 Identities = 29/155 (18%), Positives = 52/155 (33%), Gaps = 29/155 (18%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-----------GHLAALTSYEEEH 100
            CPP W       KCF    N  ++D +E  C++ G           GHLA++ S E + 
Sbjct: 4   SCPPLWTGFN--GKCFRLFHNHLNFDNAENACRQFGLASCSGDELATGHLASIHSAESQA 61

Query: 101 SAQKLCGKNVNGCWVGGRSINTTVGLS-------WKWSDNMSKWNESIHAVGSFNSSCTS 153
              +L   ++     GG +    +G+          W+D  S  +        ++   + 
Sbjct: 62  FLTELVKTSLPDLITGGWAPQVYIGMKVGSTNSDQTWTDG-SSVD--------YDGWVSG 112

Query: 154 LPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
            P +   +                   N +  +IC
Sbjct: 113 EPNNGPNSRGAIAAGDYSRGFWADVYSNNNFKYIC 147

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 35/195 (17%)

Query: 293 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYE 345
             +VA+K + R   ++         EI     L HP+++ +    YD      D  +V E
Sbjct: 34  QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL----YDVITTPTDIVMVIE 89

Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRAS 401
           +   G L     +I    R     M         Q     I + H      +VHRD++  
Sbjct: 90  YA-GGEL---FDYIVEKKR-----MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPE 137

Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM--AGGTYGYLAPEFVYRNELT-TKSDVY 458
           N+LLD+     +   GLS       M +   +  + G+  Y APE +        + DV+
Sbjct: 138 NLLLDDNLNVKIADFGLSNI-----MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVW 192

Query: 459 SFGVLLLEIVSGRRP 473
           S G++L  ++ GR P
Sbjct: 193 SCGIVLYVMLVGRLP 207

>1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A Length = 157

 Score = 55.2 bits (133), Expect = 3e-09
 Identities = 24/130 (18%), Positives = 42/130 (32%), Gaps = 21/130 (16%)

Query: 66  CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125
            +       ++DE+  YC++   HL A+ + EE      +   + +  W+G R +N    
Sbjct: 2   SYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNV-- 59

Query: 126 LSWKWSD-------NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTE 178
             W W             W       G  N+      C     V++             E
Sbjct: 60  --WVWVGTQKPLTEEAKNWAP-----GEPNNRQKDEDC-----VEIYIKREKDVGMWNDE 107

Query: 179 RCNTSHPFIC 188
           RC+     +C
Sbjct: 108 RCSKKKLALC 117

>1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A Length = 162

 Score = 55.2 bits (133), Expect = 4e-09
 Identities = 16/67 (23%), Positives = 25/67 (37%), Gaps = 4/67 (5%)

Query: 66  CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125
            + Y     SW+ S  YC+     L A+ +  E     K+     +  W+G R  N    
Sbjct: 2   TYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIRKNNK--- 58

Query: 126 LSWKWSD 132
            +W W  
Sbjct: 59  -TWTWVG 64

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 43/222 (19%), Positives = 81/222 (36%), Gaps = 51/222 (22%)

Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL- 322
           +I  ++   +++LG    G            + A+K L+     R+     E+    R  
Sbjct: 14  AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRAS 68

Query: 323 HHPNLVAVKGCCYDHGDR----YIVYEFVVNGPL-DRWLHHIPRGGRSL---DWAMRMKV 374
             P++V +     +         IV E +  G L  R      RG ++    + +  MK 
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMK- 124

Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERT 431
             ++ + I +LH     ++ HRD++  N+L   +   A L     G +K    E   E+ 
Sbjct: 125 --SIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTGEK- 174

Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
                 Y                 D++S GV++  ++ G  P
Sbjct: 175 ------YD-------------KSCDMWSLGVIMYILLCGYPP 197

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 56.8 bits (138), Expect = 5e-09
 Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 47/213 (22%)

Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQ--------RKKEFYSEIGRFARLHHPNLVA 329
           GTY G             VA+KR++             R      EI     L H N+V 
Sbjct: 13  GTY-GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR------EICLLKELKHKNIVR 65

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           +    +      +V+EF  +  L ++          LD  +       L +G+ F H + 
Sbjct: 66  LHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 390 KPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
             +V+HRD++  N+L++         FG A   G+ +  +   EV+         T  Y 
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-EVV---------TLWYR 168

Query: 442 APEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRP 473
            P+ ++  +L +T  D++S G +  E+ +  RP
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 29/145 (20%), Positives = 60/145 (41%), Gaps = 32/145 (22%)

Query: 284 GTYSGI-------LPDGSRVAVKRLKRSSF----QRKKEFYSEIGRFARLHHPNLVAVKG 332
           GTY  +         D    A+K+++ +       R      EI     L HPN+++++ 
Sbjct: 32  GTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVISLQK 85

Query: 333 CCYDHGDR--YIVYEFVVNGPLD-RWLHHIPRGGRSLDWAMRMKVATT------LAQGIA 383
               H DR  ++++++      D   +    R  ++    +++           +  GI 
Sbjct: 86  VFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 384 FLHDKVKPHVVHRDIRASNVLLDEE 408
           +LH      V+HRD++ +N+L+  E
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGE 164

>1wmz_A Lectin CEL-I, N-acetyl-D-galactosamine-specific C-type; C-type lectin, N-acetylgalactosamine, invertebrate, sugar binding protein; HET: NGA A2G; 1.70A {Cucumaria echinata} SCOP: d.169.1.1 PDB: 1wmy_A* Length = 140

 Score = 53.2 bits (128), Expect = 1e-08
 Identities = 19/155 (12%), Positives = 40/155 (25%), Gaps = 31/155 (20%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-------GHLAALTSYEEEHSAQKL 105
           CP DW        C+ +     +W+ +   C             L ++ S  E+      
Sbjct: 3   CPTDWEAEG--DHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNY 60

Query: 106 CGKNVNG---CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHV 158
                +     W+G    +      + W+D      +KW       G  ++   +     
Sbjct: 61  WRGIDSQAGQLWIGLY--DKYNEGDFIWTDGSKVGYTKWAG-----GQPDNWNNAEDY-- 111

Query: 159 HATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE 193
                          +           ++C +  E
Sbjct: 112 ------GQFRHTEGGAWNDNSAAAQAKYMCKLTFE 140

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 55.7 bits (135), Expect = 2e-08
 Identities = 35/120 (29%), Positives = 53/120 (44%), Gaps = 13/120 (10%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
           G  VA+K+   S     K        EI    +L H NLV +   C      Y+V+EF V
Sbjct: 50  GRIVAIKKFLESDD--DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF-V 106

Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
           +  +   L   P G   LD+ +  K    +  GI F H     +++HRDI+  N+L+ + 
Sbjct: 107 DHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQS 160

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 31/146 (21%), Positives = 55/146 (37%), Gaps = 39/146 (26%)

Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKG 332
           G +               VA+K++K       K+        EI     L HPN++ +  
Sbjct: 21  GQF-ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 79

Query: 333 CCYDHGDRYIVYEFV----------VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
                 +  +V++F+           +  L     HI    ++    M M       QG+
Sbjct: 80  AFGHKSNISLVFDFMETDLEVIIKDNSLVLT--PSHI----KAY---MLM-----TLQGL 125

Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEE 408
            +LH      ++HRD++ +N+LLDE 
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDEN 148

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 42/193 (21%), Positives = 81/193 (41%), Gaps = 33/193 (17%)

Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK------GCCYDHGDRYIV 343
              VA+K+L R  FQ +   K  Y E+     ++H N++++           +  D Y+V
Sbjct: 87  DRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145

Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRA 400
            E      +D  L  + +     +     +++  L Q   GI  LH      ++HRD++ 
Sbjct: 146 MEL-----MDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLHSA---GIIHRDLKP 192

Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVY 458
           SN+++  +    ++  GL++           +M     T  Y APE +         D++
Sbjct: 193 SNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 247

Query: 459 SFGVLLLEIVSGR 471
           S G ++ E+V  +
Sbjct: 248 SVGCIMGEMVRHK 260

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 54.5 bits (132), Expect = 3e-08
 Identities = 27/119 (22%), Positives = 50/119 (42%), Gaps = 11/119 (9%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYS--EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
           G  VA+K+   S      +  +  EI    +L HPNLV +          ++V+E+    
Sbjct: 28  GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY---- 83

Query: 351 PLDRWL-HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
             D  + H + R  R +   +   +     Q + F H     + +HRD++  N+L+ + 
Sbjct: 84  -CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKH 138

>2msb_A Mannose-binding protein-A; lectin; HET: BMA MAN; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1msb_A 1ytt_A* Length = 115

 Score = 51.1 bits (123), Expect = 3e-08
 Identities = 14/80 (17%), Positives = 29/80 (36%), Gaps = 9/80 (11%)

Query: 64  SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
            K F        + + +  C E+ G +A   + EE  + Q++   +    ++G     T 
Sbjct: 3   KKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAKTSA---FLGITDEVTE 59

Query: 124 VGLSWKWSD----NMSKWNE 139
            G  + +        S W +
Sbjct: 60  -G-QFMYVTGGRLTYSNWKK 77

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 54.1 bits (131), Expect = 4e-08
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 49/214 (22%)

Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYS----EIGRFARLHHPNLVAVKGC 333
           GTY            G  VA+K +K      ++   S    EI     L H N+V +   
Sbjct: 16  GTY-ATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIVRLYDV 71

Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVK 390
            +      +V+EF ++  L +++     G       + + V     Q   G+AF H+   
Sbjct: 72  IHTENKLTLVFEF-MDNDLKKYMDSRTVGNTPRGLELNL-VKYFQWQLLQGLAFCHEN-- 127

Query: 391 PHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
             ++HRD++  N+L+++        FG A   G+ ++ F   EV+         T  Y A
Sbjct: 128 -KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS-EVV---------TLWYRA 176

Query: 443 PEF-----VYRNELTTKSDVYSFGVLLLEIVSGR 471
           P+       Y    +T  D++S G +L E+++G+
Sbjct: 177 PDVLMGSRTY----STSIDIWSCGCILAEMITGK 206

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 43/193 (22%), Positives = 80/193 (41%), Gaps = 33/193 (17%)

Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK------GCCYDHGDRYIV 343
              VA+K+L R  FQ +   K  Y E+     ++H N++ +           +  D YIV
Sbjct: 50  ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108

Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRA 400
            E      +D  L  + +     +     +++  L Q   GI  LH      ++HRD++ 
Sbjct: 109 MEL-----MDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLHSA---GIIHRDLKP 155

Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVY 458
           SN+++  +    ++  GL++           +M     T  Y APE +         D++
Sbjct: 156 SNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 210

Query: 459 SFGVLLLEIVSGR 471
           S G ++ E++ G 
Sbjct: 211 SVGCIMGEMIKGG 223

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 53.4 bits (129), Expect = 6e-08
 Identities = 40/220 (18%), Positives = 79/220 (35%), Gaps = 61/220 (27%)

Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKG 332
           GTY G             VA+KR++    + ++E        E+     L H N++ +K 
Sbjct: 45  GTY-GEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100

Query: 333 CCYDHGDRYIVYEFV---------VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
             + +   ++++E+           N  +   +  I    +S    +       L  G+ 
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVS--MRVI----KSF---LYQ-----LINGVN 146

Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV-----GLSKF--VPWEVMQERTVMAGG 436
           F H +     +HRD++  N+LL     +    +     GL++   +P        +    
Sbjct: 147 FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII---- 199

Query: 437 TYGYLAPEF-----VYRNELTTKSDVYSFGVLLLEIVSGR 471
           T  Y  PE       Y    +T  D++S   +  E++   
Sbjct: 200 TLWYRPPEILLGSRHY----STSVDIWSIACIWAEMLMKT 235

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 52.9 bits (128), Expect = 9e-08
 Identities = 46/196 (23%), Positives = 85/196 (43%), Gaps = 40/196 (20%)

Query: 293 GSRVAVKRLKRSSFQ--------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344
           G  VA+KR++  +          R      EI     LHHPN+V++    +      +V+
Sbjct: 45  GRIVALKRIRLDAEDEGIPSTAIR------EISLLKELHHPNIVSLIDVIHSERCLTLVF 98

Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
           EF +   L + L     G   L  +        L +G+A  H      ++HRD++  N+L
Sbjct: 99  EF-MEKDLKKVLDENKTG---LQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLL 151

Query: 405 LDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKS 455
           ++ +       FG A   G+ +  +   EV+         T  Y AP+ +  ++  +T  
Sbjct: 152 INSDGALKLADFGLARAFGIPVRSYTH-EVV---------TLWYRAPDVLMGSKKYSTSV 201

Query: 456 DVYSFGVLLLEIVSGR 471
           D++S G +  E+++G+
Sbjct: 202 DIWSIGCIFAEMITGK 217

>1rdl_1 SUB-MBP-C, mannose-binding protein-C; C-type lectin, calcium-binding protein; HET: MMA; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1rdj_1* 1rdk_1* 1rdi_1* 1rdm_1* 1rdn_1* 1rdo_1 1bv4_A 1kza_1* 1kzb_1* 1kzc_1* 1kzd_1* 1kze_1* Length = 113

 Score = 49.6 bits (119), Expect = 9e-08
 Identities = 15/80 (18%), Positives = 28/80 (35%), Gaps = 11/80 (13%)

Query: 65  KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSA-QKLCGKNVNGCWVGGRSINTT 123
           K F         + ++  C E+ G +A   +  EE+ A Q +        ++G     T 
Sbjct: 2   KYFMSSVRRMPLNRAKALCSELQGTVATPRN-AEENRAIQNVAKDVA---FLGITDQRTE 57

Query: 124 VGLSWKWSD----NMSKWNE 139
               ++         + WNE
Sbjct: 58  -N-VFEDLTGNRVRYTNWNE 75

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 52.9 bits (128), Expect = 9e-08
 Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 54/203 (26%)

Query: 293 GSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
           G   A+K+++    +++ E   S    EI     L H N+V +    +      +V+E +
Sbjct: 26  GETFALKKIR---LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82

Query: 348 ----------VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
                       G L+          +S    +       L  GIA+ HD+    V+HRD
Sbjct: 83  DQDLKKLLDVCEGGLE--SVTA----KSF---LLQ-----LLNGIAYCHDR---RVLHRD 125

Query: 398 IRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
           ++  N+L++ E       FG A   G+ + K+   E++         T  Y AP+ +  +
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIV---------TLWYRAPDVLMGS 175

Query: 450 EL-TTKSDVYSFGVLLLEIVSGR 471
           +  +T  D++S G +  E+V+G 
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 51.8 bits (125), Expect = 2e-07
 Identities = 37/192 (19%), Positives = 80/192 (41%), Gaps = 33/192 (17%)

Query: 293 GSRVAVKRLKRSSFQRKKEFYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
            + VA+K ++    + ++        E+     L H N+V +    +      +V+E++ 
Sbjct: 27  DNLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL- 82

Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
           +  L ++L         ++          L +G+A+ H +    V+HRD++  N+L++E 
Sbjct: 83  DKDLKQYLDDCGNI---INMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINER 136

Query: 409 -------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNELTTKSDVYS 459
                  FG A    +    +   EV+         T  Y  P+ +    + +T+ D++ 
Sbjct: 137 GELKLADFGLARAKSIPTKTYDN-EVV---------TLWYRPPDILLGSTDYSTQIDMWG 186

Query: 460 FGVLLLEIVSGR 471
            G +  E+ +GR
Sbjct: 187 VGCIFYEMATGR 198

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 50/247 (20%), Positives = 101/247 (40%), Gaps = 49/247 (19%)

Query: 249 ALVPPSWKVFTTEELRSITKNFSEGNR-----LLGDSKTGGTYSGI-LPDGSRVAVKRLK 302
           +  PP+   F  +E+      +           +G    G   S +    G++VA+K+L 
Sbjct: 2   SSPPPARSGFYRQEVTKTA--WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY 59

Query: 303 RSSFQRK---KEFYSEIGRFARLHHPNLVAVK------GCCYDHGDRYIVYEFVVNGPLD 353
           R  FQ +   K  Y E+     + H N++ +           D  D Y+V  F     + 
Sbjct: 60  RP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MG 113

Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----- 408
             L  + +  +  +  ++  V   L +G+ ++H      ++HRD++  N+ ++E+     
Sbjct: 114 TDLGKLMKHEKLGEDRIQFLVYQML-KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKI 169

Query: 409 --FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLL 464
             FG A      ++ +V              T  Y APE +      T++ D++S G ++
Sbjct: 170 LDFGLARQADSEMTGYV-------------VTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216

Query: 465 LEIVSGR 471
            E+++G+
Sbjct: 217 AEMITGK 223

>1wk1_A Hypothetical protein YK1067A12; lectin C-type domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Caenorhabditis elegans} SCOP: d.169.1.1 Length = 150

 Score = 48.7 bits (116), Expect = 5e-07
 Identities = 11/70 (15%), Positives = 23/70 (32%), Gaps = 5/70 (7%)

Query: 64  SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
            K      +  S  ++  +C   GG+LA     ++ +    +        W+G      +
Sbjct: 8   VKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAAN--TQFWIGLF--KNS 63

Query: 124 VGLSWKWSDN 133
            G  + W   
Sbjct: 64  DG-QFYWDRG 72

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 50.3 bits (121), Expect = 8e-07
 Identities = 34/153 (22%), Positives = 60/153 (39%), Gaps = 48/153 (31%)

Query: 284 GTYSGI-----LPDGSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKGC 333
           GT+  +        G +VA+K++     + +KE F      EI     L H N+V +   
Sbjct: 28  GTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 334 CYDHGDR--------YIVYEFV----------VNGPLDRWLHHIPRGGRSLDWAMRMKVA 375
           C              Y+V++F           V       L  I    + +   M+M   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT--LSEI----KRV---MQM--- 132

Query: 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
             L  G+ ++H      ++HRD++A+NVL+  +
Sbjct: 133 --LLNGLYYIHRN---KILHRDMKAANVLITRD 160

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 49.1 bits (118), Expect = 2e-06
 Identities = 39/165 (23%), Positives = 64/165 (38%), Gaps = 36/165 (21%)

Query: 323 HHPNLVAVKGCCYDHGDR-----YIVYEFVVNGPLDRWLHHIPRGGRSLDWA---MRMKV 374
            HPN+V +   C            +V+E V +  L  +L  +P  G   +     M    
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-- 128

Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEV 426
              L +G+ FLH      VVHRD++  N+L+          FG A +    +       V
Sbjct: 129 ---LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTS-VV 180

Query: 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
           +         T  Y APE + ++   T  D++S G +  E+   +
Sbjct: 181 V---------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 47.6 bits (114), Expect = 6e-06
 Identities = 49/221 (22%), Positives = 78/221 (35%), Gaps = 57/221 (25%)

Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYS--------EIGRFARLH---HPN 326
           G Y G          G  VA+K ++                    E+    RL    HPN
Sbjct: 20  GAY-GTVYKARDPHSGHFVALKSVR---VPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 327 LVAVKGCCYDHGDR-----YIVYEFVVNGPLDRWLHHIPRGGRSLDWA---MRMKVATTL 378
           +V +   C            +V+E V +  L  +L   P  G   +     MR       
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ-----F 129

Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQER 430
            +G+ FLH      +VHRD++  N+L+          FG A +    +    P  V+   
Sbjct: 130 LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTP-VVV--- 181

Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
                 T  Y APE + ++   T  D++S G +  E+   +
Sbjct: 182 ------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3fd4_A Glycoprotein GP42; C type lectin, virus entry, membrane fusion, HOST-virus interaction, lectin, membrane, transmembrane, viral protein; 2.40A {Human herpesvirus 4} PDB: 1kg0_C Length = 191

 Score = 46.0 bits (108), Expect = 6e-06
 Identities = 21/146 (14%), Positives = 36/146 (24%), Gaps = 25/146 (17%)

Query: 50  KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 109
                      +    CF +     +W+     C E+           +           
Sbjct: 69  YCNTREYTFSYK--GCCFYFTKKKHTWNGCFQACAELYPCTYFYGPTPDILPVVTRNLNA 126

Query: 110 VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS 169
           +   WVG   +      +W   D  +     I                       CT VS
Sbjct: 127 IESLWVG---VYRVGEGNWTSLDGGTFKVYQIFGSH-------------------CTYVS 164

Query: 170 NGSRSLVTE-RCNTSHPFICMVEHEN 194
             S   V+   C+   P +C+ +  N
Sbjct: 165 KFSTVPVSHHECSFLKPCLCVSQRSN 190

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 47.3 bits (113), Expect = 8e-06
 Identities = 49/219 (22%), Positives = 88/219 (40%), Gaps = 49/219 (22%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
             +G    G   S I    G +VA+K+L R  FQ +   K  Y E+     + H N++ +
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQHENVIGL 88

Query: 331 K------GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---G 381
                      +  D Y+V  F     +   L  I     S +     K+   + Q   G
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEE-----KIQYLVYQMLKG 138

Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVM 433
           + ++H      VVHRD++  N+ ++E+       FG A      ++ +V           
Sbjct: 139 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV----------- 184

Query: 434 AGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGR 471
              T  Y APE +       ++ D++S G ++ E+++G+
Sbjct: 185 --VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 30/203 (14%)

Query: 284 GTYSGIL-----PDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK---- 331
           G Y  +        G RVAVK+L R  FQ     K  Y E+     + H N++ +     
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98

Query: 332 --GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
                 +  D Y+V        +   L++I +  +  D  ++  +   L +G+ ++H   
Sbjct: 99  PARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA- 151

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
              ++HRD++ SN+ ++E+    ++  GL++    + M         T  Y APE +   
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVA----TRWYRAPEIMLNW 204

Query: 450 ELTTKS-DVYSFGVLLLEIVSGR 471
               ++ D++S G ++ E+++GR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 45/205 (21%), Positives = 83/205 (40%), Gaps = 44/205 (21%)

Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK--------------GCCY 335
             RVA+K++           K    EI    RL H N+V V               G   
Sbjct: 36  DKRVAIKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92

Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
           +    YIV E+     ++  L ++   G  L+   R+ +   L +G+ ++H     +V+H
Sbjct: 93  ELNSVYIVQEY-----METDLANVLEQGPLLEEHARLFMYQLL-RGLKYIHSA---NVLH 143

Query: 396 RDIRASNVLLDEE--------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FV 446
           RD++ +N+ ++ E        FG  L  +    +     + E  V    T  Y +P   +
Sbjct: 144 RDLKPANLFINTEDLVLKIGDFG--LARIMDPHYSHKGHLSEGLV----TKWYRSPRLLL 197

Query: 447 YRNELTTKSDVYSFGVLLLEIVSGR 471
             N  T   D+++ G +  E+++G+
Sbjct: 198 SPNNYTKAIDMWAAGCIFAEMLTGK 222

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 31/142 (21%), Positives = 57/142 (40%), Gaps = 30/142 (21%)

Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCC 334
           G+Y G         +   VA+K++ R  F+     K    EI    RL+H ++V V    
Sbjct: 64  GSY-GHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIV 121

Query: 335 YDHG-----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLH 386
                    + Y+V E       D     + R    L     + + T L     G+ ++H
Sbjct: 122 IPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLT---ELHIKTLLYNLLVGVKYVH 173

Query: 387 DKVKPHVVHRDIRASNVLLDEE 408
                 ++HRD++ +N L++++
Sbjct: 174 SA---GILHRDLKPANCLVNQD 192

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 48/245 (19%), Positives = 85/245 (34%), Gaps = 80/245 (32%)

Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
           G++ GI      +  G R A+K++     Q  +    E+     L H N++ +    Y  
Sbjct: 18  GSF-GIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVNIIKLVDYFYTT 72

Query: 338 GDR--------------------------------------YIVYEFVVNGPLD--RWLH 357
           GD                                        ++ E+V   P    + L 
Sbjct: 73  GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV---PDTLHKVLK 129

Query: 358 HIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------- 408
              R GRS+     + +    L + + F+H      + HRDI+  N+L++ +        
Sbjct: 130 SFIRSGRSIP-MNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCD 185

Query: 409 FGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLE 466
           F       G +K  +P E           +  Y APE +    E T   D++S G +  E
Sbjct: 186 F-------GSAKKLIPSEPSVAYIC----SRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234

Query: 467 IVSGR 471
           ++ G+
Sbjct: 235 LILGK 239

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 43/216 (19%), Positives = 77/216 (35%), Gaps = 44/216 (20%)

Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCY-----DHGDRYIVY 344
              VA+K++ R  F+     K    EI    RL    ++ +             + YIV 
Sbjct: 51  EKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109

Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRAS 401
           E       D  L  + +    L       + T L     G  F+H+     ++HRD++ +
Sbjct: 110 EI-----ADSDLKKLFKTPIFLT---EEHIKTILYNLLLGENFIHES---GIIHRDLKPA 158

Query: 402 NVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYG------------YL 441
           N LL+++       FG A  +       +  ++ +                       Y 
Sbjct: 159 NCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR 218

Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQA 476
           APE +   E  TKS D++S G +  E+++  +    
Sbjct: 219 APELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 34/214 (15%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
             +G+   G   S     +  RVA+K  K S F+ +   +    EI    R  H N++ +
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFEHQTYCQRTLREIKILLRFRHENIIGI 90

Query: 331 K-----GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
                        D YIV +      ++  L+ + +     +  +   +   L +G+ ++
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYFLYQIL-RGLKYI 144

Query: 386 HDKVKPHVVHRDIRASNVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
           H     +V+HRD++ SN+LL+         FG  L  V          + E       T 
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFG--LARVADPDHDHTGFLTEYVA----TR 195

Query: 439 GYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGR 471
            Y APE +  ++  TKS D++S G +L E++S R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 44/213 (20%), Positives = 79/213 (37%), Gaps = 39/213 (18%)

Query: 284 GTY----SGILPDGSRVAVKRLKRSS--------FQRK---KEFYSEIGRFARLHHPNLV 328
           G+Y    +G+  +G  VA+KR+  +                K    EI      HHPN++
Sbjct: 33  GSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92

Query: 329 AVK-----GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVATTLAQG 381
            ++              Y+V E      +   L  +    R +     ++  +   L  G
Sbjct: 93  GLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVISPQHIQYFMYHIL-LG 146

Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYG 439
           +  LH+     VVHRD+   N+LL +     +    L++                     
Sbjct: 147 LHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR-----EDTADANKTHYVTHRW 198

Query: 440 YLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGR 471
           Y APE V + +  TK  D++S G ++ E+ + +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 41.8 bits (99), Expect = 4e-04
 Identities = 45/200 (22%), Positives = 81/200 (40%), Gaps = 32/200 (16%)

Query: 291 PDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK-----GCCYDHGDRYI 342
           P G  VA+K++    F +         EI       H N++ +          +  + YI
Sbjct: 34  PTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91

Query: 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
           + E      +   LH +       D  ++  +  TL + +  LH     +V+HRD++ SN
Sbjct: 92  IQEL-----MQTDLHRVISTQMLSDDHIQYFIYQTL-RAVKVLHGS---NVIHRDLKPSN 142

Query: 403 VLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELT 452
           +L++         FG A    +  S     E   +++ M     T  Y APE +  +   
Sbjct: 143 LLINSNCDLKVCDFGLAR--IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY 200

Query: 453 TKS-DVYSFGVLLLEIVSGR 471
           +++ DV+S G +L E+   R
Sbjct: 201 SRAMDVWSCGCILAELFLRR 220

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	557
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
1ypq_A	135	Oxidised low density lipoprotein (lectin-like) rec	99.95
3vpp_A	132	C-type lectin domain family 9 member A; dendritic	99.95
2py2_A	136	Antifreeze protein type II; type II antifreeze pro	99.94
3rs1_A	122	C-type lectin domain family 2 member I; C-type lec	99.94
2b6b_D	175	CD209 antigen; cryo EM dengue CRD DC-SIGN, icosahe	99.94
2bpd_A	142	Dectin-1; receptor, beta-glucan, fungal recognitio	99.94
1sl6_A	184	C-type lectin DC-signr; sugar binding protein; HET	99.94
3kqg_A	182	Langerin, C-type lectin domain family 4 member K;	99.94
3bdw_A	123	Natural killer cells antigen CD94; NK cells, recep	99.94
3m9z_A	139	Killer cell lectin-like receptor subfamily B MEMB;	99.94
3c22_A	156	C-type lectin domain family 4 member K; coiled coi	99.94
3bx4_B	146	Aggretin beta chain; toxin; 1.70A {Agkistrodon rho	99.94
3bdw_B	120	NKG2-A/NKG2-B type II integral membrane protein; N	99.93
3g8k_A	130	Lectin-related NK cell receptor LY49L1; natural ki	99.93
2c6u_A	122	CLEC1B protein; lectin, rhodocytin, aggretin, C-ty	99.93
1gz2_A	142	Ovocleidin-17, OC-17 ovocleidin; structural protei	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1dv8_A	128	Asialoglycoprotein receptor 1; C-type lectin CRD,	99.93
1tdq_B	130	Aggrecan core protein; extracellular matrix, lecti	99.93
2afp_A	129	Protein (SEA raven type II antifreeze protein); re	99.93
2kv3_A	131	Regenerating islet-derived protein 4; GISP, C-type	99.93
1wmz_A	140	Lectin CEL-I, N-acetyl-D-galactosamine-specific C-	99.93
1hq8_A	123	NKG2-D; homodimer, CIS-proline, apoptosis; 1.95A {	99.93
2ox9_A	140	Collectin placenta 1; C-type lectin, sugar binding	99.93
1egg_A	147	Macrophage mannose receptor; C-type lectin, sugar	99.93
2yhf_A	118	C-type lectin domain family 5 member A; immune sys	99.93
2xr6_A	170	CD209 antigen; sugar binding protein, carbohydrate	99.93
1qdd_A	144	Lithostathine; pancreatic stone inhibitor, metal b	99.93
1jzn_A	135	Galactose-specific lectin; C-type lectin, protein-	99.93
1oz7_B	123	Echicetin B-chain; platelet aggregation, dimer, to	99.93
1jwi_B	125	Platelet aggregation inducer; domain swapping, C-t	99.93
2e3x_C	122	Coagulation factor X-activating enzyme light CHAI;	99.93
1fvu_B	125	Botrocetin beta chain; VON WILLBRAND factor modula	99.92
1umr_C	125	Convulxin beta, CVX beta; lectin, C-type lectin, p	99.92
1mpu_A	138	NKG2-D type II integral membrane protein; C-type l	99.92
1fm5_A	199	Early activation antigen CD69; C-type lectin-like	99.92
1j34_B	123	Coagulation factor IX-binding protein B chain; mag	99.92
2h2t_B	175	Low affinity immunoglobulin epsilon FC receptor (	99.92
3ff7_C	112	Killer cell lectin-like receptor subfamily G membe	99.92
1uv0_A	149	Pancreatitis-associated protein 1; lectin, C-type,	99.92
1tn3_A	137	Tetranectin; plasminogen binding, kringle 4, C-typ	99.92
3gpr_C	134	Rhodocetin subunit gamma; disulfide bond, lectin,	99.92
1c3a_B	125	Flavocetin-A: beta subunit; C-type lectin-like dom	99.92
3ff9_A	115	Killer cell lectin-like receptor subfamily G membe	99.92
3hup_A	130	Early activation antigen CD69; C-type lectin-like	99.92
3ubu_B	126	Agglucetin subunit beta-2; platelet inhibiting, ag	99.92
3alu_A	157	Lectin CEL-IV, C-type; C-type lectin, raffinose, s	99.92
2zib_A	133	Type II antifreeze protein; thermal hysteresis, le	99.92
3ubu_A	131	Agglucetin subunit alpha-1; platelet inhibiting, a	99.92
1c3a_A	135	Flavocetin-A: alpha subunit; C-type lectin-like do	99.92
1sb2_A	133	Rhodocetin alpha subunit; C-type lectin, domain sw	99.92
1ukm_B	128	EMS16 B chain, EMS16 subunit B; domain swapping, C	99.92
1hup_A	141	Mannose-binding protein; alpha-helical coiled-coil	99.92
1fvu_A	133	Botrocetin alpha chain; VON WILLBRAND factor modul	99.92
1jwi_A	131	Bitiscetin; domain swapping, C-type lectin, toxin;	99.92
3bx4_A	136	Aggretin alpha chain; toxin; 1.70A {Agkistrodon rh	99.92
3gpr_D	124	Rhodocetin subunit delta; disulfide bond, lectin,	99.92
1ukm_A	134	EMS16 A chain, EMS16 subunit A; domain swapping, C	99.91
3c8j_A	203	Natural killer cell receptor LY49C; MHC, virus, im	99.91
1rtm_1	149	Mannose-binding protein-A; lectin; 1.80A {Rattus n	99.91
1umr_A	135	Convulxin alpha, CVX alpha; lectin, C-type lectin,	99.91
2vuv_A	129	Codakine; sugar-binding protein, C-type, lectin, m	99.91
1oz7_A	131	Echicetin A-chain; platelet aggregation, dimer, to	99.91
2ls8_A	156	C-type lectin domain family 4 member D; structural	99.85
1j34_A	129	Coagulation factor IX-binding protein A chain; mag	99.91
1buu_A	168	Protein (mannose-binding protein A); lectin, HOST	99.91
3g8l_A	190	Lectin-related NK cell receptor LY49L1; natural ki	99.91
2e3x_B	134	Coagulation factor X-activating enzyme light CHAI;	99.91
1sb2_B	129	Rhodocetin beta subunit; C-type lectin, domain swa	99.91
1htn_A	182	Tetranectin; plasminogen binding, kringle 4, alpha	99.91
2msb_A	115	Mannose-binding protein-A; lectin; HET: BMA MAN; 1	99.9
1wk1_A	150	Hypothetical protein YK1067A12; lectin C-type doma	99.9
1h8u_A	117	MBP, eosinophil granule major basic protein 1; lec	99.9
1rdl_1	113	SUB-MBP-C, mannose-binding protein-C; C-type lecti	99.89
1pwb_A	177	SP-D, PSP-D, pulmonary surfactant-associated prote	99.89
1byf_A	125	TC14, protein (polyandrocarpa lectin); C-type lect	99.88
3pbf_A	148	Pulmonary surfactant-associated protein A; collect	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
1g1t_A	157	E-selectin; EGF, adhesion molecule, SLEX, immune s	99.84
3cfw_A	164	L-selectin; EGF, cell adhesion, EGF-like domain, g	99.84
1g1s_A	162	P-selectin; selectin, lectin, EGF, sulphated, SLEX	99.84
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.62
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.25
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.02
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.89
3k7b_A	96	Protein A33; C-type lectin-like domain, homodimer,	98.77
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.56
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.39
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.31
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.2
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.15
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.88
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.78
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.74
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.74
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.63
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.18
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.16
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.96
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.93
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.84
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.58
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.49
3fd4_A	191	Glycoprotein GP42; C type lectin, virus entry, mem	96.43
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	96.36
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.21
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.06
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.03
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	95.87
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.75
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	95.72
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.13
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.16
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.42
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.1

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-56  Score=453.56  Aligned_cols=257  Identities=26%  Similarity=0.387  Sum_probs=206.4

Q ss_pred             eeecccCceEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      +.||+|+||+||+|.+.      +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+|||||++
T Consensus        47 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~  126 (329)
T 4aoj_A           47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMR  126 (329)
T ss_dssp             EEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             EEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            45799999999999864      478899999988777778899999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeecc
Q 008698          349 NGPLDRWLHHIPR-----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  417 (557)
Q Consensus       349 ~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  417 (557)
                      +|+|.++|+....           ...++++.+++.|+.|||+||+|||++   +||||||||+||||++++.+||+|||
T Consensus       127 ~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DFG  203 (329)
T 4aoj_A          127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFG  203 (329)
T ss_dssp             TCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             CCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcccc
Confidence            9999999975432           124699999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhcc
Q 008698          418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH  496 (557)
Q Consensus       418 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (557)
                      +++...............||+.|||||++.+..++.++|||||||+||||+| |+.||...+...   +...+    ..+
T Consensus       204 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i----~~g  276 (329)
T 4aoj_A          204 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AIDCI----TQG  276 (329)
T ss_dssp             ----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHHHH----HHT
T ss_pred             cceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHHHH----HcC
Confidence            9987654443333334459999999999999999999999999999999999 899998764321   11111    111


Q ss_pred             ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       497 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                      .             ....+..+++++.+|+.+||+.||++||||+||++.|+.+.+.|
T Consensus       277 ~-------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          277 R-------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             C-------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             C-------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence            0             00112335567999999999999999999999999999987643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.2e-57  Score=450.11  Aligned_cols=256  Identities=27%  Similarity=0.402  Sum_probs=211.2

Q ss_pred             CeeecccCceEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .+.||+|+||+||+|.+.      +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+|||||+
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~   97 (299)
T 4asz_A           18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM   97 (299)
T ss_dssp             EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence            456899999999999863      47789999998877777889999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccC
Q 008698          348 VNGPLDRWLHHIP---------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL  418 (557)
Q Consensus       348 ~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  418 (557)
                      ++|+|.++|+...         .....+++.+++.|+.|||+||+|||++   +||||||||+||||++++.+||+|||+
T Consensus        98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFGl  174 (299)
T 4asz_A           98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGM  174 (299)
T ss_dssp             TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSC
T ss_pred             CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCccc
Confidence            9999999997532         2335799999999999999999999999   999999999999999999999999999


Q ss_pred             CccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                      |+...............||+.|||||++.+..++.++|||||||+||||+| |+.||...+..+   +....    ..+.
T Consensus       175 a~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i----~~~~  247 (299)
T 4asz_A          175 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI----TQGR  247 (299)
T ss_dssp             HHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHH----HHTC
T ss_pred             ceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----HcCC
Confidence            986654433222222348999999999999999999999999999999999 899998765421   11111    1111


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                                   ....+..++.++.+|+.+||+.||++||||++|++.|+++.+
T Consensus       248 -------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          248 -------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                         011123355679999999999999999999999999998765

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.2e-56  Score=448.47  Aligned_cols=253  Identities=25%  Similarity=0.371  Sum_probs=208.7

Q ss_pred             eeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +.||+|+||+||+|.+.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+|||||+
T Consensus        32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~  111 (308)
T 4gt4_A           32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC  111 (308)
T ss_dssp             EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcC
Confidence            35899999999999862      46789999997543 344678999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEee
Q 008698          348 VNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG  415 (557)
Q Consensus       348 ~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  415 (557)
                      ++|+|.++|.....            ....+++.+++.|+.|||+||+|||++   +||||||||+||||++++.+||+|
T Consensus       112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~D  188 (308)
T 4gt4_A          112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISD  188 (308)
T ss_dssp             SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred             CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEECC
Confidence            99999999965321            124699999999999999999999999   999999999999999999999999


Q ss_pred             ccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhh
Q 008698          416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ  494 (557)
Q Consensus       416 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~  494 (557)
                      ||+++...............||++|||||++.++.++.++|||||||+||||+| |..||.+.+..+   +...+    .
T Consensus       189 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~i----~  261 (308)
T 4gt4_A          189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEMI----R  261 (308)
T ss_dssp             SCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHHH----H
T ss_pred             cccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----H
Confidence            999987654443333334458999999999999999999999999999999999 899998765421   22111    1


Q ss_pred             ccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       495 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      .+.             ....+.+++..+.+|+.+||+.||++||||+||++.|+..
T Consensus       262 ~~~-------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          262 NRQ-------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             TTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             cCC-------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            110             0111234567799999999999999999999999999865

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-55  Score=440.13  Aligned_cols=255  Identities=24%  Similarity=0.398  Sum_probs=200.2

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||+||+|++.  ..||||+++..  +....++|.+|+.+|++++|||||+++|++.+ +..+|||||+++|+
T Consensus        41 ~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGs  117 (307)
T 3omv_A           41 STRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSS  117 (307)
T ss_dssp             EEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCB
T ss_pred             eeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCC
Confidence            456899999999999874  36999998754  34456789999999999999999999998865 56899999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.++|+..   ...+++.+++.|+.|||+||+|||++   +||||||||+||||++++.+||+|||+|+...........
T Consensus       118 L~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~  191 (307)
T 3omv_A          118 LYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV  191 (307)
T ss_dssp             HHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred             HHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence            99999742   34699999999999999999999999   9999999999999999999999999999876544333333


Q ss_pred             eecCccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          432 VMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      ....||+.|||||++.+   +.|+.++|||||||+||||+||+.||.+.+...  .+.    ......    ...+.+. 
T Consensus       192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~~----~~~~~~----~~~p~~~-  260 (307)
T 3omv_A          192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QII----FMVGRG----YASPDLS-  260 (307)
T ss_dssp             --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHH----HHHHTT----CCCCCST-
T ss_pred             cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HHH----HHHhcC----CCCCCcc-
Confidence            44569999999999864   468999999999999999999999998654321  111    111111    1111111 


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                          ..+.+++..+.+|+.+||+.||++||||.||++.|+.+..
T Consensus       261 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          261 ----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             ----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             ----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                1123355679999999999999999999999999987754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1e-53  Score=436.69  Aligned_cols=260  Identities=26%  Similarity=0.346  Sum_probs=208.9

Q ss_pred             CCCCeeecccCceEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeC-CceE
Q 008698          271 SEGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDH-GDRY  341 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~-~~~~  341 (557)
                      .+..+.||+|+||+||+|.+..      ++.||||+++... ....++|.+|+.+|.+++ |||||+++|+|.+. +..+
T Consensus        66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~  145 (353)
T 4ase_A           66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  145 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEE
Confidence            3445678999999999998532      3689999997653 344578999999999995 59999999999764 5689


Q ss_pred             EEEecCCCCChHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008698          342 IVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  409 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~  409 (557)
                      +|||||++|+|.++|+....            ....+++.+++.++.|||+||+|||++   +||||||||+|||+++++
T Consensus       146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~  222 (353)
T 4ase_A          146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN  222 (353)
T ss_dssp             EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCC
Confidence            99999999999999975321            134589999999999999999999999   999999999999999999


Q ss_pred             CcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHh
Q 008698          410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEW  488 (557)
Q Consensus       410 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~  488 (557)
                      .+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.....  .+.. 
T Consensus       223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~--~~~~-  299 (353)
T 4ase_A          223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR-  299 (353)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH-
T ss_pred             CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--HHHH-
Confidence            999999999997655443333333458999999999999999999999999999999998 999998754321  1111 


Q ss_pred             hhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       489 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                         .+..+.             ....+..++.++.+++.+||+.||++||||+||++.|+++.+
T Consensus       300 ---~i~~g~-------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          300 ---RLKEGT-------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             ---HHHHTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHcCC-------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence               111110             011122345679999999999999999999999999987654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.3e-53  Score=425.86  Aligned_cols=266  Identities=21%  Similarity=0.288  Sum_probs=200.3

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC----ceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----DRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~~~~  349 (557)
                      .+.||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|++.+.+    ..+|||||+++
T Consensus         8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~   85 (303)
T 3hmm_A            8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence            35689999999999998 789999999975432 2233445677778899999999999998664    57999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK-----VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      |+|.++|+.     ..+++..+.+++.|+|.||+|||++     ..++||||||||+||||+.++.+||+|||+|+....
T Consensus        86 gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  160 (303)
T 3hmm_A           86 GSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             CBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             CcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence            999999975     4599999999999999999999976     255899999999999999999999999999986543


Q ss_pred             cccc--cceeecCccccccccccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch--hH------HHh
Q 008698          425 EVMQ--ERTVMAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ--SI------FEW  488 (557)
Q Consensus       425 ~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~--~~------~~~  488 (557)
                      ....  .......||+.|||||++.+.      .++.++|||||||+||||+||.+|+.........  ..      .+.
T Consensus       161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~  240 (303)
T 3hmm_A          161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE  240 (303)
T ss_dssp             TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred             CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence            3221  122234599999999998754      4678999999999999999998887654321110  00      000


Q ss_pred             hhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       489 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ......    .+.+++.+.   ......+++..+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus       241 ~~~~~~----~~~~rp~~p---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          241 MRKVVC----EQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHT----TSCCCCCCC---GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHh----cccCCCCCC---ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            000000    111222211   1112235677899999999999999999999999999988754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.5e-52  Score=412.02  Aligned_cols=245  Identities=20%  Similarity=0.352  Sum_probs=194.3

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeee----CCceEEEEe
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYE  345 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E  345 (557)
                      ..+.||+|+||+||+|... ++..||||++...  .....+.|.+|+.+|++++|||||++++++.+    .+..+||||
T Consensus        30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE  109 (290)
T 3fpq_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence            3445899999999999964 5889999999654  33445789999999999999999999999865    345799999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCcEEeeccCCccCCc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~  424 (557)
                      |+++|+|.+++..    ...+++..+..++.||+.||+|||++ +++|+||||||+||||+. ++.+||+|||+|+....
T Consensus       110 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          110 LMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999975    35699999999999999999999998 123999999999999984 78999999999986543


Q ss_pred             cccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      ..    .....||+.|||||++.+ .|+.++|||||||++|||+||+.||.+....  ..+....    ....     .+
T Consensus       185 ~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~i----~~~~-----~~  248 (290)
T 3fpq_A          185 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRV----TSGV-----KP  248 (290)
T ss_dssp             TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHH----TTTC-----CC
T ss_pred             Cc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHHH----HcCC-----CC
Confidence            22    223459999999998864 6999999999999999999999999764332  1111111    1100     00


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                             ...+...++++.+|+.+||+.||++|||++|+++
T Consensus       249 -------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   0011112346889999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.8e-52  Score=420.14  Aligned_cols=249  Identities=22%  Similarity=0.337  Sum_probs=206.2

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||.||++... +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..||||||+++|+|
T Consensus        79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L  158 (346)
T 4fih_A           79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  158 (346)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred             eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence            345799999999999974 6999999999766555567789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++..     ..+++.++..++.||+.||+|||++   +||||||||+||||+.++.+||+|||+|+........  ..
T Consensus       159 ~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~  228 (346)
T 4fih_A          159 TDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RK  228 (346)
T ss_dssp             HHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BC
T ss_pred             HHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--cc
Confidence            999975     3599999999999999999999999   9999999999999999999999999999876543222  22


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+...   .....    ..     ...+.+      
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i----~~-----~~~~~~------  290 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMI----RD-----NLPPRL------  290 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH----HH-----SSCCCC------
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHH----Hc-----CCCCCC------
Confidence            3459999999999999999999999999999999999999998754321   11111    00     011111      


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcc
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQL  550 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~  550 (557)
                      ......+..+.+|+.+||+.||++|||++|+++  .|.+.
T Consensus       291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence            111234567899999999999999999999987  35443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.6e-52  Score=419.96  Aligned_cols=245  Identities=20%  Similarity=0.338  Sum_probs=197.2

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||+||++.. .+|+.||||+++..  .....+.+.+|+.+|++++|||||++++++.+.+..||||||+++|
T Consensus        29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg  108 (350)
T 4b9d_A           29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG  108 (350)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence            45689999999999996 46999999999754  3344678999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.++|..  .....+++.++..++.||+.||+|||++   +||||||||+||||+.++.+||+|||+|+.......  .
T Consensus       109 ~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  181 (350)
T 4b9d_A          109 DLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--L  181 (350)
T ss_dssp             BHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH--H
T ss_pred             cHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc--c
Confidence            99999975  2345689999999999999999999999   999999999999999999999999999987654321  1


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....||+.|||||++.+..|+.++|||||||+||||+||+.||...+...   +..   .... ...    .       
T Consensus       182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~---~i~~-~~~----~-------  243 (350)
T 4b9d_A          182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVL---KIIS-GSF----P-------  243 (350)
T ss_dssp             HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHH-TCC----C-------
T ss_pred             ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH---HHHc-CCC----C-------
Confidence            122349999999999999999999999999999999999999998754321   111   1111 100    0       


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        ..+...+.++.+|+.+||+.||++|||++|+++
T Consensus       244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              011223456899999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.3e-52  Score=413.80  Aligned_cols=244  Identities=21%  Similarity=0.295  Sum_probs=203.5

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +..+.||+|+||+||++.. .+|+.||||++++..   ....+.+.+|+++|++++|||||++++++.+.+..|+||||+
T Consensus        35 ~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~  114 (311)
T 4aw0_A           35 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA  114 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence            3456789999999999996 468999999997542   234578999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++..    ...+++.++..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus       115 ~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          115 KNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             TTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            99999999965    24699999999999999999999999   999999999999999999999999999987754443


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      ........||+.|||||++.+..|+.++||||+||++|||+||+.||...+...   +....   .. ..      ..  
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i---~~-~~------~~--  252 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAKI---IK-LE------YD--  252 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH-TC------CC--
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---Hc-CC------CC--
Confidence            333444569999999999999999999999999999999999999998654321   11111   11 10      00  


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV  543 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev  543 (557)
                            .+...+.++.+|+.+||+.||++|||++|+
T Consensus       253 ------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          253 ------FPEKFFPKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             ------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             ------CCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence                  111234568899999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.5e-51  Score=414.27  Aligned_cols=246  Identities=19%  Similarity=0.228  Sum_probs=198.7

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||.||++... +|+.||||+++....     ..+|+.+|++++|||||++++++.+.+..||||||+++|+|
T Consensus        63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L  137 (336)
T 4g3f_A           63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL  137 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred             CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence            345799999999999964 589999999976532     24799999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CcEEeeccCCccCCcccccc--
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQE--  429 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~~--  429 (557)
                      .++|..    ...+++.++..++.||+.||+|||++   +||||||||+||||+.++ .+||+|||+|+.........  
T Consensus       138 ~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~  210 (336)
T 4g3f_A          138 GQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL  210 (336)
T ss_dssp             HHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred             HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence            999975    24699999999999999999999999   999999999999999987 59999999998765433221  


Q ss_pred             -ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          430 -RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       430 -~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                       ......||+.|||||++.+..++.++|||||||++|||+||+.||...+.......+      ....       +....
T Consensus       211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~-------~~~~~  277 (336)
T 4g3f_A          211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEP-------PPIRE  277 (336)
T ss_dssp             ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HHSC-------CGGGG
T ss_pred             ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HcCC-------CCchh
Confidence             122345999999999999999999999999999999999999999876543221111      0100       00000


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  549 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~  549 (557)
                           .+..++..+.+++.+||+.||++|||+.|+++.|..
T Consensus       278 -----~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          278 -----IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             -----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                 112344678899999999999999999999988754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-50  Score=421.07  Aligned_cols=252  Identities=22%  Similarity=0.333  Sum_probs=207.3

Q ss_pred             CCCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ++..+.||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||++
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g  232 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  232 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence            334456899999999999964 5999999999876555667799999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..     ..+++.++..++.||+.||+|||++   +||||||||+||||+.++.+||+|||+|+........ 
T Consensus       233 G~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-  303 (423)
T 4fie_A          233 GALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-  303 (423)
T ss_dssp             EEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-
T ss_pred             CcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-
Confidence            999999975     3599999999999999999999999   9999999999999999999999999999876543222 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                       .....||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+....   ....    ..     ...+.+.  
T Consensus       304 -~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i----~~-----~~~~~~~--  368 (423)
T 4fie_A          304 -RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMI----RD-----NLPPRLK--  368 (423)
T ss_dssp             -BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH----HH-----SCCCCCS--
T ss_pred             -ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHH----Hc-----CCCCCCc--
Confidence             2233499999999999999999999999999999999999999986543211   1111    00     0111110  


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcc
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQL  550 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~  550 (557)
                          .....+..+.+|+.+||+.||++|||++|+++  .|.+.
T Consensus       369 ----~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          369 ----NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             ----CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence                01123456889999999999999999999987  35443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.6e-50  Score=395.57  Aligned_cols=242  Identities=19%  Similarity=0.287  Sum_probs=187.8

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +..+.||+|+||+||++.. .+|+.||||++++..   ......+.+|+.+|++++|||||++++++.+.+..|+||||+
T Consensus        16 ~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   95 (275)
T 3hyh_A           16 QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA   95 (275)
T ss_dssp             EEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            3446789999999999996 469999999997542   233567999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                       +|+|.+++..    ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        96 -~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           96 -GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             -CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             -CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence             6899999865    24699999999999999999999999   999999999999999999999999999986543322


Q ss_pred             ccceeecCccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                         .....||+.|||||++.+..+ +.++||||+||++|||+||+.||.+.+..   .+.....    ...        .
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~~i~----~~~--------~  229 (275)
T 3hyh_A          168 ---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFKNIS----NGV--------Y  229 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HTC--------C
T ss_pred             ---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH----cCC--------C
Confidence               223459999999999998776 57999999999999999999999765432   1111111    110        0


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                            ..+...+..+.+|+.+||+.||++|||++|+++
T Consensus       230 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 ------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                  011123456889999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2e-50  Score=402.83  Aligned_cols=244  Identities=24%  Similarity=0.289  Sum_probs=192.1

Q ss_pred             CCCeeecccCceEEEEEEeC----CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEe
Q 008698          272 EGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~----~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      +..+.||+|+||+||++...    .++.||||++++..  ......+.+|+.+|++++|||||++++++.+.+..|+|||
T Consensus        27 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE  106 (304)
T 3ubd_A           27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILD  106 (304)
T ss_dssp             EEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEEC
T ss_pred             EEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEE
Confidence            33457899999999999852    47899999997542  2233568899999999999999999999999999999999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      |+++|+|.+++..    ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus       107 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          107 FLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             CCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            9999999999975    24699999999999999999999999   9999999999999999999999999999865432


Q ss_pred             ccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      ..  ......||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..+   +....   .. ..        
T Consensus       180 ~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i---~~-~~--------  242 (304)
T 3ubd_A          180 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMTMI---LK-AK--------  242 (304)
T ss_dssp             -C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH-CC--------
T ss_pred             Cc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHHHH---Hc-CC--------
Confidence            22  1223459999999999999999999999999999999999999998754422   11111   11 00        


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  545 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~  545 (557)
                      .      ..+...+.++.+|+.+||+.||++|||     ++|+++
T Consensus       243 ~------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 L------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             C------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             C------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            0      011224456889999999999999998     467774

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.5e-48  Score=387.78  Aligned_cols=251  Identities=20%  Similarity=0.308  Sum_probs=185.8

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc------------e
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------------R  340 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~------------~  340 (557)
                      +.||+|+||+||++.. .+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+.            .
T Consensus        11 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l   90 (299)
T 4g31_A           11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL   90 (299)
T ss_dssp             EEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEE
T ss_pred             eEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEE
Confidence            4689999999999996 468999999997543 3345789999999999999999999999876543            6


Q ss_pred             EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      |+||||+++|+|.+++.... .....++..++.++.||++||+|||++   +|+||||||+||||+.++.+||+|||+|+
T Consensus        91 ~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla~  166 (299)
T 4g31_A           91 YIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVT  166 (299)
T ss_dssp             EEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC-
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccce
Confidence            89999999999999997532 123456777889999999999999999   99999999999999999999999999998


Q ss_pred             cCCcccccc----------ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhh
Q 008698          421 FVPWEVMQE----------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT  490 (557)
Q Consensus       421 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~  490 (557)
                      .........          ......||+.|||||++.+..|+.++|||||||++|||++   ||.....     ......
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-----~~~~~~  238 (299)
T 4g31_A          167 AMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-----RVRTLT  238 (299)
T ss_dssp             -------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----HHHHHH
T ss_pred             ecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----HHHHHH
Confidence            765432211          1122359999999999999999999999999999999997   7653211     000000


Q ss_pred             hhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhccc
Q 008698          491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLA  551 (557)
Q Consensus       491 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~  551 (557)
                      . .....             .........+.+.+|+.+||+.||++|||+.|+++  .++++.
T Consensus       239 ~-~~~~~-------------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          239 D-VRNLK-------------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             H-HHTTC-------------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             H-HhcCC-------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            0 00000             00011223455778999999999999999999997  455543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.7e-47  Score=385.70  Aligned_cols=284  Identities=31%  Similarity=0.526  Sum_probs=237.0

Q ss_pred             HHHHHhhcCCCCCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCce
Q 008698          261 EELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR  340 (557)
Q Consensus       261 ~el~~~~~~~~~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~  340 (557)
                      .++..++++|... +.||+|+||.||+|...+|+.||||++........+.+.+|+.++.+++||||+++++++.+.+..
T Consensus        32 ~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           32 VDLEEATNNFDHK-FLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             SCCCCCCCCCSCC-CCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHHhccCcc-ceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            3444556666554 467999999999999888999999999877666678899999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      ++||||+++|+|.+++.........+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999999976544445799999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      ...............||+.|+|||.+.+..++.++||||||+++|||+||+.||....+........+.........+..
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            65433222222223489999999999888999999999999999999999999987766555556666555555555555


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      .+++.+    ......+.+..+.+++.+||+.||++|||++||++.|+.+..
T Consensus       268 ~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          268 IVDPNL----ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSSSC----TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcChhh----ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            565544    233456788899999999999999999999999999987643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.3e-46  Score=379.31  Aligned_cols=294  Identities=33%  Similarity=0.589  Sum_probs=240.8

Q ss_pred             CCccccCHHHHHHhhcCCCCCCeeecccCceEEEEEEeCCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEEeee
Q 008698          253 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVK  331 (557)
Q Consensus       253 ~~~~~~~~~el~~~~~~~~~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~  331 (557)
                      .....++..++....++|.... .||+|+||.||++...+|+.||||++..... .....+.+|+.++.+++||||++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   93 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKN-ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR   93 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTT-EEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred             CccceecHHHHHHHhhccccce-eEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence            3456788899998888887755 5699999999999988899999999976532 2234689999999999999999999


Q ss_pred             eeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCc
Q 008698          332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA  411 (557)
Q Consensus       332 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~  411 (557)
                      +++.+.+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            99999999999999999999999998765556679999999999999999999999877799999999999999999999


Q ss_pred             EEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--cccchhHHHhh
Q 008698          412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD--SVCWQSIFEWA  489 (557)
Q Consensus       412 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~--~~~~~~~~~~~  489 (557)
                      ||+|||++.......... .....||+.|+|||.+.+..++.++||||||+++|||+||+.||....  ......+..+.
T Consensus       174 kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            999999998765433222 222348999999999988889999999999999999999999996321  11122344555


Q ss_pred             hhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       490 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      .............+..+    ......+.+..+.+++.+||+.||++|||++||++.|++...
T Consensus       253 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDL----QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TTTTSSCCSTTSSCTTC----TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             HHHhhchhhhhhcChhh----ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            55555555555555544    334456788899999999999999999999999999986543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=388.35  Aligned_cols=265  Identities=20%  Similarity=0.263  Sum_probs=196.5

Q ss_pred             CCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeee------CCceEEE
Q 008698          273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD------HGDRYIV  343 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~------~~~~~lV  343 (557)
                      ..+.||+|+||+||++.. .+|+.||||+++..  .....+.+.+|+.+|+.++|||||++++++..      .+..|||
T Consensus        58 ~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~iv  137 (398)
T 4b99_A           58 IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV  137 (398)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEE
Confidence            345789999999999996 46999999999754  23445678999999999999999999998764      3678999


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      |||++ |+|.+++..    ...+++.++..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.+.
T Consensus       138 mE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          138 LDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            99995 789999864    35799999999999999999999999   99999999999999999999999999998764


Q ss_pred             cccc--ccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          424 WEVM--QERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       424 ~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      ....  ........||+.|||||++.+. .++.++||||+||++|||+||++||.+.+..+....+..............
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            3321  1222344699999999998875 569999999999999999999999987654322111110000000000000


Q ss_pred             c----cCcccccCCCCC-Cc-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 L----LDPLISSLSSDI-PE-----AGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~----~d~~l~~~~~~~-~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .    ....+....... .+     ......+.+|+.+||+.||++|||++|+++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0    000000000000 00     112356889999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.2e-45  Score=376.02  Aligned_cols=196  Identities=22%  Similarity=0.325  Sum_probs=165.9

Q ss_pred             CCCCeeecccCceEEEEEEeC----CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEe
Q 008698          271 SEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~~~----~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      ++..+.||+|+||+||+++..    .++.||||.+....  ...++.+|+++|..+ +||||+++++++.+.+..++|||
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            444567899999999999852    46789999986553  345788999999998 69999999999999999999999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCcEEeeccCCccCCc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPW  424 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~~~  424 (557)
                      |+++|+|.+++.       .+++.++..++.||+.||+|||++   +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus       101 ~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A          101 YLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             CCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             CCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            999999999984       389999999999999999999999   99999999999999877 7899999999976543


Q ss_pred             cccc--------------------------cceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008698          425 EVMQ--------------------------ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAV  477 (557)
Q Consensus       425 ~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~  477 (557)
                      ....                          .......||+.|||||++.+. .++.++||||+||++|||+||+.||...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            2110                          111233599999999999875 5899999999999999999999999654


Q ss_pred             C
Q 008698          478 D  478 (557)
Q Consensus       478 ~  478 (557)
                      +
T Consensus       251 ~  251 (361)
T 4f9c_A          251 S  251 (361)
T ss_dssp             S
T ss_pred             C
Confidence            4

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.1e-45  Score=395.93  Aligned_cols=247  Identities=19%  Similarity=0.284  Sum_probs=203.8

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      ..+.||+|+||.||++... +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..++||||+++|+
T Consensus       161 i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~  240 (573)
T 3uto_A          161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE  240 (573)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred             EEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence            3456899999999999964 699999999987766667889999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC--CCcEEeeccCCccCCcccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--FGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |.++|..   ....+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+++.+.....  
T Consensus       241 L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~--  312 (573)
T 3uto_A          241 LFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--  312 (573)
T ss_dssp             HHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE--
T ss_pred             HHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc--
Confidence            9999864   234699999999999999999999999   99999999999999854  7899999999987754322  


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                       .....||+.|||||++.+..|+.++|||||||++|||++|..||.+.+....   ....   .. ... . +.      
T Consensus       313 -~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---~~~i---~~-~~~-~-~~------  376 (573)
T 3uto_A          313 -VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNV---KS-CDW-N-MD------  376 (573)
T ss_dssp             -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH---HT-TCC-C-CC------
T ss_pred             -eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHH---Hh-CCC-C-CC------
Confidence             2234599999999999999999999999999999999999999987654211   1111   00 000 0 00      


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        .......+..+.+|+.+||+.||++|||++|+++
T Consensus       377 --~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          377 --DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             --SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0001123456889999999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.4e-44  Score=389.61  Aligned_cols=245  Identities=19%  Similarity=0.227  Sum_probs=195.4

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHH---HHHHHHHhhcCCCcEEeeeeeeeeCCceEEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~---~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      +..++||+|+||.||++... +|+.||||++++...   .....+   .+++.+++.++|||||++++++.+.+..|+||
T Consensus       192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm  271 (689)
T 3v5w_A          192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL  271 (689)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence            33467899999999999964 599999999975421   122233   34466777889999999999999999999999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+++|+|.++|..    ...+++..+..++.||+.||+|||++   +||||||||+||||+.++.+||+|||+|+....
T Consensus       272 Ey~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          272 DLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             CCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999975    24699999999999999999999999   999999999999999999999999999987654


Q ss_pred             cccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccC
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  503 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  503 (557)
                      ...    ...+||+.|||||++.. ..|+.++|+|||||++|||++|.+||.+.+......+.....   .         
T Consensus       345 ~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~---~---------  408 (689)
T 3v5w_A          345 KKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---T---------  408 (689)
T ss_dssp             CCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH---H---------
T ss_pred             CCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---C---------
Confidence            322    23459999999999975 579999999999999999999999997654332222111110   0         


Q ss_pred             cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008698          504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  545 (557)
Q Consensus       504 ~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~  545 (557)
                      ..      ...+...+..+.+|+.+||+.||++|++     ++||++
T Consensus       409 ~~------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          409 MA------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CC------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CC------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            00      0111224456889999999999999998     678765

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.9e-43  Score=351.69  Aligned_cols=286  Identities=32%  Similarity=0.510  Sum_probs=228.2

Q ss_pred             CccccCHHHHHHhhcCCCCC-----CeeecccCceEEEEEEeCCCCEEEEEEeccc----chhhHHHHHHHHHHHhhcCC
Q 008698          254 SWKVFTTEELRSITKNFSEG-----NRLLGDSKTGGTYSGILPDGSRVAVKRLKRS----SFQRKKEFYSEIGRFARLHH  324 (557)
Q Consensus       254 ~~~~~~~~el~~~~~~~~~~-----~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~H  324 (557)
                      ....|+.+++..++++|...     .+.||+|+||.||+|.. +++.||||++...    .....+.+.+|+.++.+++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34668999999999998875     25679999999999987 7899999998653    22345789999999999999


Q ss_pred             CcEEeeeeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008698          325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL  404 (557)
Q Consensus       325 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nil  404 (557)
                      |||+++++++.+.+..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+.   +++||||||+|||
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil  165 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL  165 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence            999999999999999999999999999999986432 235699999999999999999999999   9999999999999


Q ss_pred             eCCCCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh
Q 008698          405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS  484 (557)
Q Consensus       405 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~  484 (557)
                      ++.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||+||..||..........
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  244 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL  244 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence            99999999999999986654332222223348999999998764 58999999999999999999999998754432211


Q ss_pred             HHHhhhhhhh-ccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          485 IFEWATPLVQ-SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       485 ~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                        ........ ...+.+.+++.+     ...+...+..+.+++.+||+.+|++|||+++|++.|+++..
T Consensus       245 --~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          245 --DIKEEIEDEEKTIEDYIDKKM-----NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             --HHHHHHHTTSCCHHHHSCSSC-----SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             --HHHHHhhhhhhhhhhhccccc-----cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence              11111111 111223333322     12345678889999999999999999999999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.8e-44  Score=358.72  Aligned_cols=254  Identities=28%  Similarity=0.444  Sum_probs=198.6

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||+||++.. +|+.||||++....  ....+++.+|+.++.+++||||+++++++.+.+..++||||+++|+
T Consensus        42 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  120 (309)
T 3p86_A           42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS  120 (309)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCB
T ss_pred             eeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCc
Confidence            45689999999999987 78999999997653  3445689999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |.+++.... ....+++..+..++.||+.||+|||+.   +  |+||||||+|||++.++.+||+|||+++........ 
T Consensus       121 L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-  195 (309)
T 3p86_A          121 LYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-  195 (309)
T ss_dssp             HHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------------
T ss_pred             HHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccc-
Confidence            999997521 112489999999999999999999999   8  999999999999999999999999999765433211 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                       .....||+.|+|||.+.+..++.++||||||+++|||+||+.||...+....   .....   ...       .     
T Consensus       196 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~---~~~~~---~~~-------~-----  256 (309)
T 3p86_A          196 -SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV---VAAVG---FKC-------K-----  256 (309)
T ss_dssp             -------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH---HHHHH---HSC-------C-----
T ss_pred             -cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH---hcC-------C-----
Confidence             1223489999999999999999999999999999999999999986543211   11100   000       0     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                       ....+...+..+.+++.+||+.||++|||+++|++.|+.+.+.
T Consensus       257 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          257 -RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             -CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence             0011122345689999999999999999999999999887664

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1e-43  Score=367.76  Aligned_cols=256  Identities=24%  Similarity=0.398  Sum_probs=207.5

Q ss_pred             CCeeecccCceEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEE
Q 008698          273 GNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l  342 (557)
                      ..+.||+|+||.||++...        ++..||||+++... ....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus        85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  164 (370)
T 2psq_A           85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV  164 (370)
T ss_dssp             EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred             eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence            3457899999999999852        35579999997653 34457899999999999 89999999999999999999


Q ss_pred             EEecCCCCChHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 008698          343 VYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG  410 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~  410 (557)
                      ||||+++|+|.+++.....            ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~  241 (370)
T 2psq_A          165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV  241 (370)
T ss_dssp             EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCC
T ss_pred             EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCCC
Confidence            9999999999999976432            124589999999999999999999999   9999999999999999999


Q ss_pred             cEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhh
Q 008698          411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA  489 (557)
Q Consensus       411 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~  489 (557)
                      +||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||.......   +....
T Consensus       242 ~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~~~~~  318 (370)
T 2psq_A          242 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFKLL  318 (370)
T ss_dssp             EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH
T ss_pred             EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence            99999999986654332222223347889999999999999999999999999999999 999997654322   11111


Q ss_pred             hhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       490 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                          ....             ....+..++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       319 ----~~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          319 ----KEGH-------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             ----HTTC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----hcCC-------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                1110             00112234467899999999999999999999999998764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.8e-44  Score=364.78  Aligned_cols=269  Identities=21%  Similarity=0.288  Sum_probs=204.4

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc----eEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD----RYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~----~~lV~E~~~~  349 (557)
                      .+.||+|+||.||+|.. .++.||||++.... .....+.+|+.++.+++||||+++++++.....    .++||||+++
T Consensus        29 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~  106 (322)
T 3soc_A           29 LEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK  106 (322)
T ss_dssp             EEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             hheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence            45689999999999987 58999999997553 334556679999999999999999999987543    6999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK-------VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      |+|.+++..     ..+++..+..++.|++.||+|||+.       ++++|+||||||+|||++.++.+||+|||+++..
T Consensus       107 g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~  181 (322)
T 3soc_A          107 GSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF  181 (322)
T ss_dssp             CBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred             CCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence            999999975     3499999999999999999999976       2348999999999999999999999999999765


Q ss_pred             CccccccceeecCccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          423 PWEVMQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                      .............||+.|+|||++.+     ..++.++|||||||++|||+||+.||.......................
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (322)
T 3soc_A          182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED  261 (322)
T ss_dssp             CTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHH
T ss_pred             ccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhh
Confidence            54333222223448999999999986     3456789999999999999999999986544322111111000000000


Q ss_pred             c-----ccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          498 Y-----LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       498 ~-----~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      .     .....+.+.   ........+..+.+++.+||+.||++|||++||++.|+++.+
T Consensus       262 ~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          262 MQEVVVHKKKRPVLR---DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HHHHHTTSCCCCCCC---GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhhhhcccCCCCcc---ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            0     001111110   111223466779999999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=358.43  Aligned_cols=255  Identities=23%  Similarity=0.384  Sum_probs=207.0

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||+||++... +++.||+|.+........+.+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus        15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L   94 (310)
T 3s95_A           15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL   94 (310)
T ss_dssp             EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence            457899999999999974 5899999999777677778999999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc--
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER--  430 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~--  430 (557)
                      .+++...   ...+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..........  
T Consensus        95 ~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  168 (310)
T 3s95_A           95 RGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL  168 (310)
T ss_dssp             HHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred             HHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence            9999752   35699999999999999999999999   999999999999999999999999999987643322111  


Q ss_pred             ----------eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          431 ----------TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       431 ----------~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                                .....||+.|+|||.+.+..++.++||||||+++|||++|..|+............          ....
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~----------~~~~  238 (310)
T 3s95_A          169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----------NVRG  238 (310)
T ss_dssp             -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------CHHH
T ss_pred             ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------hhhc
Confidence                      11334899999999999999999999999999999999999998764332111000          0000


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      ..+...        +..++..+.+++.+||+.||++|||++++++.|+.+..
T Consensus       239 ~~~~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          239 FLDRYC--------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             HHHHTC--------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccccC--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            011100        11223458899999999999999999999999987653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.2e-44  Score=362.33  Aligned_cols=255  Identities=25%  Similarity=0.414  Sum_probs=205.5

Q ss_pred             CeeecccCceEEEEEEeC----CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILP----DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|+||.||+|...    .+..||||+++.. .....+.+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus        54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  133 (325)
T 3kul_A           54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME  133 (325)
T ss_dssp             EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred             eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence            467899999999999974    3456999999765 34456789999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++...   ...+++.++..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       134 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  207 (325)
T 3kul_A          134 NGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA  207 (325)
T ss_dssp             TCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred             CCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence            99999999642   34699999999999999999999999   9999999999999999999999999999876543221


Q ss_pred             c-ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          429 E-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       429 ~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      . ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||........   ....    ...     .    
T Consensus       208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~~----~~~-----~----  271 (325)
T 3kul_A          208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV---ISSV----EEG-----Y----  271 (325)
T ss_dssp             CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HHHH----HTT-----C----
T ss_pred             eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHH----HcC-----C----
Confidence            1 1122236788999999998899999999999999999999 9999976543211   1111    000     0    


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                          ....+..++..+.+++.+||+.||++|||+++|++.|+.+...+
T Consensus       272 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          272 ----RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             ----CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                00112234467899999999999999999999999999876544

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.6e-43  Score=352.57  Aligned_cols=246  Identities=21%  Similarity=0.345  Sum_probs=203.9

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      ...+.||+|+||+||++.. .+|+.||||++........+.+.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus        23 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~  102 (297)
T 3fxz_A           23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG  102 (297)
T ss_dssp             CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCC
Confidence            3445789999999999985 568999999997665566778999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++..     ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.........  
T Consensus       103 ~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  172 (297)
T 3fxz_A          103 SLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--  172 (297)
T ss_dssp             BHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--
T ss_pred             CHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc--
Confidence            99999975     3589999999999999999999999   9999999999999999999999999999766543322  


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....||+.|+|||.+.+..++.++||||||+++|||+||..||...+.....  .    ......      .+      
T Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~----~~~~~~------~~------  234 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--Y----LIATNG------TP------  234 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--H----HHHHHC------SC------
T ss_pred             cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--H----HHHhCC------CC------
Confidence            22234899999999999999999999999999999999999999765432111  0    000000      00      


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ....+...+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            01112234566889999999999999999999987

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.8e-44  Score=374.44  Aligned_cols=253  Identities=27%  Similarity=0.383  Sum_probs=206.0

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||+|... +++.||||+++... .....+|.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus       119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~  198 (377)
T 3cbl_A          119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD  198 (377)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence            456899999999999985 68999999997542 3344678999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   +..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...........
T Consensus       199 L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~  272 (377)
T 3cbl_A          199 FLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG  272 (377)
T ss_dssp             HHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence            99999742   24589999999999999999999999   9999999999999999999999999999865433222211


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      ....+++.|+|||.+.+..++.++||||||+++|||+| |..||...+....   .+.    .....             
T Consensus       273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~---~~~----~~~~~-------------  332 (377)
T 3cbl_A          273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT---REF----VEKGG-------------  332 (377)
T ss_dssp             SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH---HHH----HHTTC-------------
T ss_pred             CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHcCC-------------
Confidence            12225778999999998899999999999999999999 9999976543211   111    11100             


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      ....+..++..+.+++.+||+.||++|||+++|++.|+++..
T Consensus       333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            001122244678999999999999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.4e-43  Score=355.91  Aligned_cols=262  Identities=22%  Similarity=0.329  Sum_probs=213.0

Q ss_pred             cccCHHHHHHhhcCCC---------CCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC
Q 008698          256 KVFTTEELRSITKNFS---------EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP  325 (557)
Q Consensus       256 ~~~~~~el~~~~~~~~---------~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~  325 (557)
                      ..++.+++..+++...         ...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++.+++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            4577888888776532         22346899999999999975 6999999999876666678899999999999999


Q ss_pred             cEEeeeeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 008698          326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL  405 (557)
Q Consensus       326 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill  405 (557)
                      ||+++++++...+..++||||+++|+|.+++..     ..+++..+..++.||+.||.|||+.   +|+||||||+|||+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll  174 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL  174 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence            999999999999999999999999999999863     4599999999999999999999999   99999999999999


Q ss_pred             CCCCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhH
Q 008698          406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI  485 (557)
Q Consensus       406 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~  485 (557)
                      +.++.+||+|||++.........  .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+...   .
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~  249 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---A  249 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H
T ss_pred             CCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence            99999999999999866543221  122348999999999999999999999999999999999999997654321   1


Q ss_pred             HHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          486 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       486 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ....    .     ....+.+      ......+..+.+++.+||+.||++|||++++++
T Consensus       250 ~~~~----~-----~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          250 MKRL----R-----DSPPPKL------KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHHH----H-----HSSCCCC------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHH----h-----cCCCCCc------CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1100    0     0001111      011223456889999999999999999999997

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.8e-43  Score=375.92  Aligned_cols=253  Identities=25%  Similarity=0.406  Sum_probs=207.4

Q ss_pred             CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ..+.||+|+||.||+|...++..||||+++... ...++|.+|+.+|++++||||+++++++. .+..++||||+++|+|
T Consensus       192 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L  269 (454)
T 1qcf_A          192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSL  269 (454)
T ss_dssp             EEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred             EEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcH
Confidence            345789999999999999889999999998653 35678999999999999999999999986 6678999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++...  ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......... .
T Consensus       270 ~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~-~  343 (454)
T 1qcf_A          270 LDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR-E  343 (454)
T ss_dssp             HHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT-C
T ss_pred             HHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc-C
Confidence            9999742  123588999999999999999999999   999999999999999999999999999987654322221 2


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ...+|+.|+|||++....++.++|||||||++|||+| |+.||...+..+   +....    ...     .        .
T Consensus       344 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i----~~~-----~--------~  403 (454)
T 1qcf_A          344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRAL----ERG-----Y--------R  403 (454)
T ss_dssp             SSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHH----HHT-----C--------C
T ss_pred             CCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC-----C--------C
Confidence            2236789999999998899999999999999999999 999998654321   11111    100     0        0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ...+..++..+.+++.+||+.||++|||+++|++.|+.+...
T Consensus       404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            011223456799999999999999999999999999988653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.6e-43  Score=366.52  Aligned_cols=255  Identities=24%  Similarity=0.408  Sum_probs=195.8

Q ss_pred             CCCeeecccCceEEEEEEeC----CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          272 EGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      ...+.||+|+||.||+|...    ++..||||+++.. .....++|.+|+.++.+++||||+++++++.+.+..++||||
T Consensus        48 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (373)
T 2qol_A           48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY  127 (373)
T ss_dssp             CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeC
Confidence            44567899999999999864    5778999999765 334567899999999999999999999999999999999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++|+|.+++..   ....+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       128 ~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          128 MENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             CTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             CCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            999999999974   234699999999999999999999999   99999999999999999999999999998765432


Q ss_pred             ccc-ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          427 MQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       427 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      ... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...+...   +....    ...        
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i----~~~--------  266 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAV----DEG--------  266 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHH----HTT--------
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC--------
Confidence            211 1122225778999999998999999999999999999998 999997654321   11111    000        


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                       .    ....+..++..+.+++.+||+.||++||++++|++.|+++..
T Consensus       267 -~----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          267 -Y----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             -E----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -C----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence             0    000112344678999999999999999999999999987754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-43  Score=348.64  Aligned_cols=252  Identities=24%  Similarity=0.404  Sum_probs=207.2

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|+||.||++...+++.||||++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||+++|+|.
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (269)
T 4hcu_A           15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS   93 (269)
T ss_dssp             EEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred             eheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence            35689999999999999889999999997653 33567999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++...   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++........... ..
T Consensus        94 ~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~  166 (269)
T 4hcu_A           94 DYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TG  166 (269)
T ss_dssp             HHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST-TS
T ss_pred             HHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc-cC
Confidence            999642   34689999999999999999999999   999999999999999999999999999986654322221 12


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ..+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......   .....   .. .     ..        .
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~~~~---~~-~-----~~--------~  226 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDI---ST-G-----FR--------L  226 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH---HT-T-----CC--------C
T ss_pred             cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHH---hc-C-----cc--------C
Confidence            236788999999998899999999999999999999 999997654321   11111   00 0     00        0


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ..+...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            01112345688999999999999999999999999987653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.7e-43  Score=346.58  Aligned_cols=252  Identities=26%  Similarity=0.445  Sum_probs=207.0

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|+||.||++...++..||||+++... ...+++.+|+.++.+++||||+++++++.+.+..++||||+++++|.
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   91 (268)
T 3sxs_A           13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL   91 (268)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred             eeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence            45689999999999999888899999997653 34567999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++...   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++........... ..
T Consensus        92 ~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~-~~  164 (268)
T 3sxs_A           92 NYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS-VG  164 (268)
T ss_dssp             HHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC-CS
T ss_pred             HHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc-cC
Confidence            999752   24599999999999999999999999   999999999999999999999999999986654432222 22


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ..+|+.|+|||.+.+..++.++||||||+++|||+| |..||..........      ......   .           .
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~~~~---~-----------~  224 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------KVSQGH---R-----------L  224 (268)
T ss_dssp             CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HHHTTC---C-----------C
T ss_pred             CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH------HHHcCC---C-----------C
Confidence            236778999999988889999999999999999999 999997654321110      000000   0           0


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|+.+.+.
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            01112235688999999999999999999999999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.1e-44  Score=358.68  Aligned_cols=271  Identities=21%  Similarity=0.358  Sum_probs=203.8

Q ss_pred             CCCeeecccCceEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEEEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVY  344 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~  344 (557)
                      +..+.||+|+||.||++.+     .+++.||||++........+.+.+|+.++.+++||||+++++++...  ...++||
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   92 (295)
T 3ugc_A           13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM   92 (295)
T ss_dssp             EEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEE
T ss_pred             hhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEE
Confidence            3445789999999999984     35889999999877666778899999999999999999999998653  5589999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        93 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           93 EYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             ECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred             EeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence            999999999999753   23599999999999999999999999   999999999999999999999999999987654


Q ss_pred             cccc-cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc-ccccc
Q 008698          425 EVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR-YLELL  502 (557)
Q Consensus       425 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  502 (557)
                      .... .......++..|+|||.+.+..++.++||||||+++|||+||..|+......    ............. .....
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHHHHHHH
T ss_pred             CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchhHHHHH
Confidence            3221 1222233778899999999999999999999999999999999998653211    0000000000000 00000


Q ss_pred             CcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       503 d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      +. +........+..++..+.+++.+||+.||++|||++||++.|+++...
T Consensus       243 ~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          243 EL-LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HH-HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HH-HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            00 000001112234556799999999999999999999999999987643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.3e-42  Score=353.24  Aligned_cols=241  Identities=20%  Similarity=0.298  Sum_probs=199.2

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||.||++.. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus        20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~   99 (328)
T 3fe3_A           20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG   99 (328)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence            45689999999999996 57999999999754  3344577899999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++........   
T Consensus       100 ~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---  169 (328)
T 3fe3_A          100 EVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---  169 (328)
T ss_dssp             BHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---
T ss_pred             cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---
Confidence            999998652    4599999999999999999999999   999999999999999999999999999976543322   


Q ss_pred             eeecCccccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s-~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      .....||+.|+|||.+.+..++ .++|||||||++|||+||+.||.+.+...   +....   . ....           
T Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i---~-~~~~-----------  231 (328)
T 3fe3_A          170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERV---L-RGKY-----------  231 (328)
T ss_dssp             GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---H-HCCC-----------
T ss_pred             cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH---H-hCCC-----------
Confidence            1223489999999999887765 79999999999999999999998754321   11111   0 0000           


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       232 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          232 ---RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ---CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ---CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               001123456889999999999999999999987

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.2e-43  Score=376.77  Aligned_cols=253  Identities=29%  Similarity=0.472  Sum_probs=208.8

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+.+|.+++||||+++++++.+.+..++||||+++|+|
T Consensus       225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L  303 (495)
T 1opk_A          225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL  303 (495)
T ss_dssp             EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCH
Confidence            4568999999999999865 8899999997653 3467899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++...  ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......... .
T Consensus       304 ~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~-~  377 (495)
T 1opk_A          304 LDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-A  377 (495)
T ss_dssp             HHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC-T
T ss_pred             HHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceeec-C
Confidence            9999763  235689999999999999999999999   999999999999999999999999999987654322211 1


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ...+++.|+|||++.+..++.++|||||||++|||+| |..||...+...   +.+..    ...         .    .
T Consensus       378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~---------~----~  437 (495)
T 1opk_A          378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL----EKD---------Y----R  437 (495)
T ss_dssp             TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH----HTT---------C----C
T ss_pred             CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC---------C----C
Confidence            2236789999999998899999999999999999999 999998755322   11111    100         0    0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ...+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            011223456789999999999999999999999999988654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4e-43  Score=358.96  Aligned_cols=260  Identities=25%  Similarity=0.402  Sum_probs=208.4

Q ss_pred             CCCeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      ...+.||+|+||.||++...      +++.||||+++... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        50 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  129 (343)
T 1luf_A           50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF  129 (343)
T ss_dssp             EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEE
Confidence            34456899999999999974      34789999997653 344578999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008698          345 EFVVNGPLDRWLHHIPRG--------------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL  404 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nil  404 (557)
                      ||+++|+|.+++......                    ...+++.+++.++.||++||.|||++   +|+||||||+|||
T Consensus       130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl  206 (343)
T 1luf_A          130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL  206 (343)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEE
Confidence            999999999999763211                    25699999999999999999999999   9999999999999


Q ss_pred             eCCCCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccch
Q 008698          405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQ  483 (557)
Q Consensus       405 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~  483 (557)
                      ++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |..||...+...  
T Consensus       207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--  284 (343)
T 1luf_A          207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE--  284 (343)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--
T ss_pred             ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH--
Confidence            99999999999999976544332222333447899999999998899999999999999999999 999997654321  


Q ss_pred             hHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          484 SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                       +..    .......             ...+..++..+.+++.+||+.||++|||+.+|++.|+++.+..
T Consensus       285 -~~~----~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          285 -VIY----YVRDGNI-------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             -HHH----HHHTTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             -HHH----HHhCCCc-------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence             111    1111100             0011223457899999999999999999999999999987754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.7e-43  Score=371.69  Aligned_cols=253  Identities=26%  Similarity=0.393  Sum_probs=202.0

Q ss_pred             CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ..+.||+|+||.||+|...++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++||||+++|+|
T Consensus       188 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL  265 (452)
T 1fmk_A          188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL  265 (452)
T ss_dssp             EEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred             eeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCH
Confidence            345689999999999999888889999998653 345789999999999999999999999876 678999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++...  .+..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......... .
T Consensus       266 ~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-~  339 (452)
T 1fmk_A          266 LDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-Q  339 (452)
T ss_dssp             HHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred             HHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc-c
Confidence            9999642  224589999999999999999999999   999999999999999999999999999987653322211 2


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ...+++.|+|||.+.+..++.++||||||+++|||+| |+.||......+   +....    ...     .        .
T Consensus       340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i----~~~-----~--------~  399 (452)
T 1fmk_A          340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQV----ERG-----Y--------R  399 (452)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH----HTT-----C--------C
T ss_pred             CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC-----C--------C
Confidence            2236789999999998899999999999999999999 999997654321   11111    100     0        0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ...+..++..+.+++.+||+.||++|||+++|++.|+.+...
T Consensus       400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            011223456789999999999999999999999999988653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.8e-43  Score=369.69  Aligned_cols=248  Identities=28%  Similarity=0.399  Sum_probs=203.7

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC-ceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-DRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||.||+|.. .|+.||||+++...  ..+.|.+|+.+|.+++||||+++++++.+.+ ..++||||+++|+|
T Consensus       198 ~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L  274 (450)
T 1k9a_A          198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL  274 (450)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred             EeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence            45689999999999998 58899999997653  4578999999999999999999999987765 78999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++...  ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......     .
T Consensus       275 ~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~  344 (450)
T 1k9a_A          275 VDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D  344 (450)
T ss_dssp             HHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred             HHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----c
Confidence            9999753  224579999999999999999999999   99999999999999999999999999998543221     1


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ...+++.|+|||.+.+..++.++||||||+++|||+| |..||...+.....   ..    ...+.             .
T Consensus       345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~----i~~~~-------------~  404 (450)
T 1k9a_A          345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PR----VEKGY-------------K  404 (450)
T ss_dssp             --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---HH----HHTTC-------------C
T ss_pred             CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHcCC-------------C
Confidence            1237889999999999999999999999999999999 99999876443211   11    11110             0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                      ...+..++..+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus       405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence            0112234567999999999999999999999999999876543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=365.71  Aligned_cols=257  Identities=28%  Similarity=0.375  Sum_probs=205.2

Q ss_pred             CCeeecccCceEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEe
Q 008698          273 GNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      ..+.||+|+||.||+|.+.      +++.||||+++.. .......+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  154 (367)
T 3l9p_A           75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE  154 (367)
T ss_dssp             EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEE
Confidence            3456899999999999853      4668999999754 34455679999999999999999999999999999999999


Q ss_pred             cCCCCChHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CcEEeeccCC
Q 008698          346 FVVNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLS  419 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgl~  419 (557)
                      |+++|+|.+++.....   ....+++.+++.++.||+.||+|||++   +|+||||||+|||++.++   .+||+|||++
T Consensus       155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a  231 (367)
T 3l9p_A          155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA  231 (367)
T ss_dssp             CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred             eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCccc
Confidence            9999999999975332   224599999999999999999999999   999999999999999544   5999999999


Q ss_pred             ccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhcccc
Q 008698          420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY  498 (557)
Q Consensus       420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (557)
                      +...............+|+.|+|||.+.+..++.++|||||||++|||+| |..||...+...   +.....    ... 
T Consensus       232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~~i~----~~~-  303 (367)
T 3l9p_A          232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVT----SGG-  303 (367)
T ss_dssp             HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHH----TTC-
T ss_pred             cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCC-
Confidence            75433222222233347899999999998999999999999999999998 999997654321   111110    000 


Q ss_pred             ccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       499 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                                  ....+..++..+.+++.+||+.||++|||+++|++.|+.+.+
T Consensus       304 ------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          304 ------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             ------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence                        001122334568999999999999999999999999987654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=360.50  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=207.9

Q ss_pred             CCCeeecccCceEEEEEEeC--------CCCEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceE
Q 008698          272 EGNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY  341 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~--------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~  341 (557)
                      ...+.||+|+||.||++...        ++..||||+++.. ......++.+|+.++.++ +||||+++++++.+.+..+
T Consensus        72 ~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  151 (382)
T 3tt0_A           72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY  151 (382)
T ss_dssp             EEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             EeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceE
Confidence            33457899999999999852        2457999999765 334457899999999999 9999999999999999999


Q ss_pred             EEEecCCCCChHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008698          342 IVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  409 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~  409 (557)
                      +||||+++|+|.+++.....            ....+++.++..++.||+.||+|||+.   +|+||||||+|||++.++
T Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  228 (382)
T 3tt0_A          152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDN  228 (382)
T ss_dssp             EEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTC
T ss_pred             EEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCC
Confidence            99999999999999976432            124599999999999999999999999   999999999999999999


Q ss_pred             CcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHh
Q 008698          410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEW  488 (557)
Q Consensus       410 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~  488 (557)
                      .+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |..||...+...   +...
T Consensus       229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~---~~~~  305 (382)
T 3tt0_A          229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKL  305 (382)
T ss_dssp             CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHH
T ss_pred             cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999987654433222333347889999999999999999999999999999999 999997654321   1111


Q ss_pred             hhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       489 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      .    ....     .        ...+..++..+.+++.+||+.||++|||++||++.|+++.
T Consensus       306 ~----~~~~-----~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          306 L----KEGH-----R--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             H----HTTC-----C--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H----HcCC-----C--------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1    1110     0        0011223456899999999999999999999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.6e-43  Score=362.74  Aligned_cols=259  Identities=27%  Similarity=0.370  Sum_probs=204.9

Q ss_pred             CCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCc-eEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD-RYI  342 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~-~~l  342 (557)
                      ...+.||+|+||.||++.+      .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++.+.+. .++
T Consensus        25 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~i  104 (359)
T 3vhe_A           25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV  104 (359)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred             eeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEE
Confidence            3456789999999999973      246789999997653 34457899999999999 89999999999887654 899


Q ss_pred             EEecCCCCChHHHhccCCCC------------------------------------------------------------
Q 008698          343 VYEFVVNGPLDRWLHHIPRG------------------------------------------------------------  362 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~------------------------------------------------------------  362 (557)
                      ||||+++|+|.+++......                                                            
T Consensus       105 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (359)
T 3vhe_A          105 IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED  184 (359)
T ss_dssp             EEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------C
T ss_pred             EEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccc
Confidence            99999999999999764321                                                            


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeecCccccc
Q 008698          363 --GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY  440 (557)
Q Consensus       363 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y  440 (557)
                        ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...............||+.|
T Consensus       185 ~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y  261 (359)
T 3vhe_A          185 LYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  261 (359)
T ss_dssp             TTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred             hhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence              12289999999999999999999999   9999999999999999999999999999866443332223334488999


Q ss_pred             cccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHH
Q 008698          441 LAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVV  519 (557)
Q Consensus       441 ~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~  519 (557)
                      +|||++.+..++.++||||||+++|||+| |..||.......  .+..    ......             ....+...+
T Consensus       262 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~~-------------~~~~~~~~~  322 (359)
T 3vhe_A          262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGT-------------RMRAPDYTT  322 (359)
T ss_dssp             CCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHHHTC-------------CCCCCTTCC
T ss_pred             EChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHHcCC-------------CCCCCCCCC
Confidence            99999999999999999999999999999 999997654321  1111    011100             000111234


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          520 QKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       520 ~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      ..+.+++.+||+.||++|||++||++.|+++.+
T Consensus       323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            568999999999999999999999999987653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.2e-42  Score=348.68  Aligned_cols=258  Identities=21%  Similarity=0.340  Sum_probs=196.5

Q ss_pred             CCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhh--cCCCcEEeeeeeeeeC----CceEEEEe
Q 008698          272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHHPNLVAVKGCCYDH----GDRYIVYE  345 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~g~~~~~----~~~~lV~E  345 (557)
                      ...+.||+|+||+||+|.. +|+.||||++...   ....+.+|.+++..  ++||||+++++++...    +..++|||
T Consensus        11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e   86 (301)
T 3q4u_A           11 TLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH   86 (301)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             EEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence            3345789999999999998 7999999999654   34556666666666  7999999999987643    45799999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeecCCCCCCeeeCCCCCcEEeecc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH--------DKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  417 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  417 (557)
                      |+++|+|.+++..     ..+++..+..++.||+.||+|||        +.   +|+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           87 YHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             CCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             hccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCC
Confidence            9999999999953     46999999999999999999999        77   99999999999999999999999999


Q ss_pred             CCccCCcccccc--ceeecCccccccccccccCC------CCCchhhHHHHHHHHHHHHcC----------CCCCCCCCc
Q 008698          418 LSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIVSG----------RRPAQAVDS  479 (557)
Q Consensus       418 l~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwS~Gvil~el~tG----------~~p~~~~~~  479 (557)
                      +++.........  ......||+.|+|||.+.+.      .++.++||||||+++|||+||          ..||.....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            997654332211  11223489999999999876      456799999999999999999          777765433


Q ss_pred             ccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          480 VCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ....  ...........    ...+.+   .........+..+.+++.+||+.||++|||+++|++.|+++
T Consensus       239 ~~~~--~~~~~~~~~~~----~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          239 NDPS--FEDMRKVVCVD----QQRPNI---PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SSCC--HHHHHHHHTTS----CCCCCC---CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcc--hhhhhHHHhcc----CCCCCC---ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            2111  00001101000    001101   01112345778899999999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9.8e-43  Score=351.44  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=208.2

Q ss_pred             CCeeecccCceEEEEEEe------CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEe
Q 008698          273 GNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      ..+.||+|+||.||++..      .+++.||||+++.. .....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  106 (314)
T 2ivs_A           27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE  106 (314)
T ss_dssp             EEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEe
Confidence            345789999999999985      24578999999764 33445789999999999999999999999999999999999


Q ss_pred             cCCCCChHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 008698          346 FVVNGPLDRWLHHIPR--------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL  405 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill  405 (557)
                      |+++|+|.+++.....                    ....+++.++..++.||+.||+|||++   +|+||||||+|||+
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli  183 (314)
T 2ivs_A          107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILV  183 (314)
T ss_dssp             CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEE
Confidence            9999999999976432                    123489999999999999999999999   99999999999999


Q ss_pred             CCCCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchh
Q 008698          406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQS  484 (557)
Q Consensus       406 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~  484 (557)
                      +.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |..||..........
T Consensus       184 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  263 (314)
T 2ivs_A          184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN  263 (314)
T ss_dssp             ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999986654433222333347889999999998889999999999999999999 999997655432111


Q ss_pred             HHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          485 IFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      .   .    ....             ....+...+..+.+++.+||+.||++|||+++|++.|+++..
T Consensus       264 ~---~----~~~~-------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          264 L---L----KTGH-------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             H---H----HTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H---h----hcCC-------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1   1    1100             000112234578999999999999999999999999998754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.8e-43  Score=356.55  Aligned_cols=252  Identities=22%  Similarity=0.368  Sum_probs=197.2

Q ss_pred             CeeecccCceEEEEEEeC-CCC----EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .+.||+|+||+||+|... +++    +||+|.++.. .....+++.+|+.++.+++||||+++++++.+.+ .++|+||+
T Consensus        20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~   98 (327)
T 3poz_A           20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM   98 (327)
T ss_dssp             EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECC
T ss_pred             ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEec
Confidence            457899999999999953 344    4688887643 2345678999999999999999999999998754 78999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++...   ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        99 ~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  172 (327)
T 3poz_A           99 PFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             TTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence            999999999753   24699999999999999999999999   999999999999999999999999999987654433


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.............       ...         
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~---------  236 (327)
T 3poz_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE---------  236 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC---------
T ss_pred             cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-------cCC---------
Confidence            333333347889999999999999999999999999999999 999998765432211111       000         


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                          ....+..++..+.+++.+||+.+|++|||+.+|++.|+.+..
T Consensus       237 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          237 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                001112234568899999999999999999999999987654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-43  Score=359.22  Aligned_cols=260  Identities=25%  Similarity=0.347  Sum_probs=203.7

Q ss_pred             CCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV  343 (557)
                      ...+.||+|+||.||++..      .++..||||+++... ....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus        48 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  127 (344)
T 1rjb_A           48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI  127 (344)
T ss_dssp             EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEE
Confidence            3456789999999999995      245689999997542 23457899999999999 899999999999999999999


Q ss_pred             EecCCCCChHHHhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008698          344 YEFVVNGPLDRWLHHIPRG-------------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL  404 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nil  404 (557)
                      |||+++|+|.+++......                   ...+++..+..++.||+.||+|||++   +|+||||||+|||
T Consensus       128 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl  204 (344)
T 1rjb_A          128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVL  204 (344)
T ss_dssp             EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEE
T ss_pred             EecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEE
Confidence            9999999999999753221                   13489999999999999999999999   9999999999999


Q ss_pred             eCCCCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccch
Q 008698          405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQ  483 (557)
Q Consensus       405 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~  483 (557)
                      ++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......  
T Consensus       205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--  282 (344)
T 1rjb_A          205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA--  282 (344)
T ss_dssp             EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred             EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH--
Confidence            99999999999999986543332222222337889999999998899999999999999999998 999997654321  


Q ss_pred             hHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          484 SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      .+...    ....     ...        ..+...+..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       283 ~~~~~----~~~~-----~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          283 NFYKL----IQNG-----FKM--------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             HHHHH----HHTT-----CCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HHHHH----HhcC-----CCC--------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            11110    1100     000        01112345789999999999999999999999999877653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-42  Score=344.92  Aligned_cols=250  Identities=24%  Similarity=0.387  Sum_probs=202.8

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|+||.||++...++..||||+++... ...+++.+|+.++.+++||||+++++++.+.+..++||||+++|+|.
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  107 (283)
T 3gen_A           29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL  107 (283)
T ss_dssp             EEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHH
T ss_pred             HhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHH
Confidence            35689999999999999888899999997653 23567999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++...   ...+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++........... ..
T Consensus       108 ~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~-~~  180 (283)
T 3gen_A          108 NYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-VG  180 (283)
T ss_dssp             HHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST-TS
T ss_pred             HHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccc-cC
Confidence            999642   24599999999999999999999999   999999999999999999999999999986654322221 12


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ..+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...+......      ....      ....        
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~------~~~~------~~~~--------  240 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE------HIAQ------GLRL--------  240 (283)
T ss_dssp             TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HHHT------TCCC--------
T ss_pred             CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH------HHhc------ccCC--------
Confidence            236788999999998889999999999999999999 999998654321111      0000      0000        


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      ..+...+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            011122356889999999999999999999999998764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3e-42  Score=340.03  Aligned_cols=247  Identities=24%  Similarity=0.398  Sum_probs=200.5

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||+|.. +|+.||||+++..  .....+.+.+|+.++.+++||||+++++++.+.  +..++||||+++
T Consensus        15 ~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   93 (271)
T 3kmu_A           15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY   93 (271)
T ss_dssp             EEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred             HHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence            45689999999999998 5899999999764  334457899999999999999999999999877  778999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      |+|.+++..  .....+++.++..++.||+.||+|||+.   +  ++||||||+|||++.++.++|+|||++......  
T Consensus        94 ~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~--  166 (271)
T 3kmu_A           94 GSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP--  166 (271)
T ss_dssp             CBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT--
T ss_pred             CcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeeccc--
Confidence            999999975  2234699999999999999999999998   7  999999999999999999999999987653221  


Q ss_pred             ccceeecCccccccccccccCCCCCc---hhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTT---KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                           ...+|+.|+|||.+.+..++.   ++||||||+++|||+||+.||...+....      ........     ..+
T Consensus       167 -----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~-----~~~  230 (271)
T 3kmu_A          167 -----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALEG-----LRP  230 (271)
T ss_dssp             -----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHSC-----CCC
T ss_pred             -----CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhcC-----CCC
Confidence                 123789999999998765444   89999999999999999999976543211      00111100     011


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                              ..+...+..+.+++.+||+.||++|||++++++.|+++.+
T Consensus       231 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          231 --------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                    1112234568999999999999999999999999998765

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.4e-42  Score=340.14  Aligned_cols=248  Identities=27%  Similarity=0.481  Sum_probs=190.8

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccch----hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF----QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++.. .|+.||||+++....    ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        12 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   90 (271)
T 3dtc_A           12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG   90 (271)
T ss_dssp             EEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred             eeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence            45789999999999997 589999999875422    2346789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--------CCCcEEeeccCCcc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--------EFGAHLMGVGLSKF  421 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~--------~~~~kl~Dfgl~~~  421 (557)
                      ++|.+++..     ..+++..+..++.|++.||.|||++...+|+||||||+|||++.        ++.+||+|||++..
T Consensus        91 ~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~  165 (271)
T 3dtc_A           91 GPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE  165 (271)
T ss_dssp             EEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred             CCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence            999999853     46999999999999999999999992222999999999999986        67899999999976


Q ss_pred             CCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccc
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  501 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (557)
                      .......    ...||+.|+|||.+.+..++.++||||||+++|||+||+.||...+.....      ..... ..    
T Consensus       166 ~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~-~~----  230 (271)
T 3dtc_A          166 WHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------YGVAM-NK----  230 (271)
T ss_dssp             --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HHHHT-SC----
T ss_pred             ccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------Hhhhc-CC----
Confidence            5433221    234899999999999888999999999999999999999999865432110      00000 00    


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      .        ....+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       231 ~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          231 L--------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             C--------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            0        0011122345789999999999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.9e-42  Score=351.15  Aligned_cols=259  Identities=23%  Similarity=0.371  Sum_probs=193.6

Q ss_pred             CCCeeecccCceEEEEEEeCCC----CEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCce-----
Q 008698          272 EGNRLLGDSKTGGTYSGILPDG----SRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-----  340 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~g----~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~-----  340 (557)
                      ...+.||+|+||.||++.....    ..||||+++..  .....+.+.+|+.++++++||||+++++++...+..     
T Consensus        26 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (323)
T 3qup_A           26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPI  105 (323)
T ss_dssp             EEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------C
T ss_pred             EEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCc
Confidence            3456789999999999996543    27999999764  334567899999999999999999999999877655     


Q ss_pred             -EEEEecCCCCChHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeecc
Q 008698          341 -YIVYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  417 (557)
Q Consensus       341 -~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  417 (557)
                       ++||||+++|+|.+++....  .....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg  182 (323)
T 3qup_A          106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFG  182 (323)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeecc
Confidence             99999999999999986432  2223699999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhcc
Q 008698          418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH  496 (557)
Q Consensus       418 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (557)
                      +++...............+++.|+|||.+.+..++.++||||||+++|||+| |..||...+.......   .   ....
T Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---~---~~~~  256 (323)
T 3qup_A          183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY---L---IGGN  256 (323)
T ss_dssp             C-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---H---HTTC
T ss_pred             ccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH---H---hcCC
Confidence            9987654433222223347889999999999899999999999999999999 9999987554321111   0   0000


Q ss_pred             ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       497 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                                    ....+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       257 --------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          257 --------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             --------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                          0011122345789999999999999999999999999887653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.4e-42  Score=348.38  Aligned_cols=259  Identities=24%  Similarity=0.376  Sum_probs=207.9

Q ss_pred             CCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV  343 (557)
                      ...+.||+|+||.||++..      .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  105 (313)
T 1t46_A           26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI  105 (313)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEE
Confidence            3445789999999999984      346789999997653 34457899999999999 999999999999999999999


Q ss_pred             EecCCCCChHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008698          344 YEFVVNGPLDRWLHHIPR--------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  409 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~  409 (557)
                      |||+++|+|.+++.....              ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  182 (313)
T 1t46_A          106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGR  182 (313)
T ss_dssp             EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTT
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCC
Confidence            999999999999976432              123589999999999999999999999   999999999999999999


Q ss_pred             CcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHh
Q 008698          410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEW  488 (557)
Q Consensus       410 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~  488 (557)
                      .+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......  .+...
T Consensus       183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~  260 (313)
T 1t46_A          183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--KFYKM  260 (313)
T ss_dssp             EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--HHHHH
T ss_pred             CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--HHHHH
Confidence            999999999987654433222223337789999999998899999999999999999999 999997654321  11111


Q ss_pred             hhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       489 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                          ....     ...        ..+...+..+.+++.+||+.||.+|||++++++.|+++..
T Consensus       261 ----~~~~-----~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          261 ----IKEG-----FRM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             ----HHHT-----CCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----hccC-----CCC--------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence                0100     000        0112234568999999999999999999999999987654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.6e-41  Score=346.39  Aligned_cols=242  Identities=24%  Similarity=0.279  Sum_probs=199.0

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +|+.||||++++..   ......+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g   89 (337)
T 1o6l_A           10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   89 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            456899999999999975 58999999997542   23456789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        90 g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--  160 (337)
T 1o6l_A           90 GELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--  160 (337)
T ss_dssp             CBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--
Confidence            999999864    24689999999999999999999999   999999999999999999999999999986432221  


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +....   .. ..        +   
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i---~~-~~--------~---  222 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELI---LM-EE--------I---  222 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH-CC--------C---
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HHHHH---Hc-CC--------C---
Confidence            1223348999999999999999999999999999999999999997654321   11111   00 00        0   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                         ..+...+..+.+++.+||+.||++||     +++||++
T Consensus       223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence               01112345688999999999999999     8999976

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-41  Score=340.53  Aligned_cols=258  Identities=21%  Similarity=0.326  Sum_probs=202.8

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      ...+.||+|+||.||++... +++.||+|.+...   .....+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus        14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   93 (294)
T 4eqm_A           14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI   93 (294)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCC
Confidence            33457899999999999964 6899999998543   2344578999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++........
T Consensus        94 ~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           94 EGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             CSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            99999999965    24699999999999999999999999   999999999999999999999999999987653322


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .. .....||+.|+|||.+.+..++.++||||||+++|||+||+.||........      .......     .......
T Consensus       167 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~-----~~~~~~~  234 (294)
T 4eqm_A          167 TQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQD-----SVPNVTT  234 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSS-----CCCCHHH
T ss_pred             cc-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhc-----cCCCcch
Confidence            21 2223489999999999999999999999999999999999999986543211      0000100     0000000


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcccCC
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-RMSHVVHQLQQLAQP  553 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-t~~evl~~L~~~~~~  553 (557)
                      ..     ..+.+..+.+++.+|++.||++|| +++++.+.|+.+...
T Consensus       235 ~~-----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          235 DV-----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             HS-----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             hc-----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            00     112345688999999999999999 999999999887653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.9e-43  Score=357.07  Aligned_cols=258  Identities=27%  Similarity=0.384  Sum_probs=204.5

Q ss_pred             CCCeeecccCceEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV  343 (557)
                      ...+.||+|+||.||++....      ++.||||.+.... ....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        49 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv  128 (333)
T 2i1m_A           49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI  128 (333)
T ss_dssp             EEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEE
Confidence            345678999999999999642      3489999997653 34467899999999999 899999999999999999999


Q ss_pred             EecCCCCChHHHhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEE
Q 008698          344 YEFVVNGPLDRWLHHIPR----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL  413 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl  413 (557)
                      |||+++|+|.+++.....          ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||
T Consensus       129 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl  205 (333)
T 2i1m_A          129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKI  205 (333)
T ss_dssp             EECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEB
T ss_pred             EecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEEE
Confidence            999999999999864211          134689999999999999999999999   9999999999999999999999


Q ss_pred             eeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhh
Q 008698          414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPL  492 (557)
Q Consensus       414 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~  492 (557)
                      +|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......  .+...    
T Consensus       206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~----  279 (333)
T 2i1m_A          206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYKL----  279 (333)
T ss_dssp             CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHHH----
T ss_pred             CccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHHH----
Confidence            99999986543322222222336789999999998899999999999999999999 999997654321  11111    


Q ss_pred             hhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          493 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       493 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      ....     ...        ..+...+..+.+++.+||+.||.+|||+++|++.|+++.
T Consensus       280 ~~~~-----~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          280 VKDG-----YQM--------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHT-----CCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhcC-----CCC--------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            1100     000        001112456889999999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.8e-42  Score=341.69  Aligned_cols=262  Identities=24%  Similarity=0.409  Sum_probs=195.4

Q ss_pred             hcCCCCCCeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEE
Q 008698          267 TKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      .++.+...+.||+|+||.||++...  ..||||+++..  .....+.+.+|+.++.+++||||+++++++ ..+..++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3344455567899999999999863  36999999754  334457899999999999999999999965 556689999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        99 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           99 QWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             ECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence            99999999999964   235699999999999999999999999   999999999999999999999999999986543


Q ss_pred             cccccceeecCcccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccc
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  501 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (557)
                      ...........||+.|+|||.+.   +..++.++||||||+++|||++|+.||.......  .+.+.    .....    
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~----~~~~~----  242 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEM----VGRGS----  242 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHH----HHHTS----
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHH----hcccc----
Confidence            32222223344899999999986   5678899999999999999999999997654321  11111    11111    


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      ..+.+..     ....++..+.+++.+||+.+|++|||++++++.|+++++
T Consensus       243 ~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          243 LSPDLSK-----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCCCTTS-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCcchhh-----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            1111111     112244679999999999999999999999999998875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.1e-42  Score=348.36  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=197.8

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++..++||||+++++++.+.+..++||||+++|+
T Consensus        12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~   91 (323)
T 3tki_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   91 (323)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred             eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence            456899999999999975 68999999986543 2334678899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++..    ...+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++............
T Consensus        92 L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           92 LFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             GGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             HHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            9999864    34599999999999999999999999   9999999999999999999999999999865433322222


Q ss_pred             eecCccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          432 VMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      ....||+.|+|||++.+..+ +.++||||||+++|||+||+.||....... .....+...    .   .          
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~----~---~----------  226 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK----K---T----------  226 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHTT----C---T----------
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhcc----c---c----------
Confidence            33458999999999987765 779999999999999999999997654321 111111100    0   0          


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      ...+....+..+.+|+.+||+.||++|||++|+++.
T Consensus       227 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            001112234568899999999999999999999863

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-42  Score=353.41  Aligned_cols=252  Identities=21%  Similarity=0.325  Sum_probs=199.3

Q ss_pred             CeeecccCceEEEEEEeC-CCCE----EEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSR----VAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .+.||+|+||.||+|... +++.    ||+|.+.... ......+.+|+.++.+++||||+++++++. .+..++||||+
T Consensus        18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   96 (325)
T 3kex_A           18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL   96 (325)
T ss_dssp             EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred             eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence            457899999999999964 3443    8888875432 233456788999999999999999999886 56689999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++...   ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        97 ~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  170 (325)
T 3kex_A           97 PLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK  170 (325)
T ss_dssp             TTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred             CCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence            999999999742   24688999999999999999999999   999999999999999999999999999987755443


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ........+|..|+|||.+.+..++.++||||||+++|||+| |..||.............       ...  ..     
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~--~~-----  236 (325)
T 3kex_A          171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-------KGE--RL-----  236 (325)
T ss_dssp             CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-------TTC--BC-----
T ss_pred             cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-------cCC--CC-----
Confidence            333334447889999999998899999999999999999999 999998765432211111       000  00     


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                            ..+..++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       237 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          237 ------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                  0011123347789999999999999999999999988765

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.1e-42  Score=339.45  Aligned_cols=252  Identities=24%  Similarity=0.401  Sum_probs=206.5

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|+||.||++...+++.||+|++..... ..+++.+|+.++.+++||||+++++++.+.+..++||||+++++|.
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   91 (267)
T 3t9t_A           13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS   91 (267)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred             eeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence            456899999999999998889999999976532 3468999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++...   ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++........... ..
T Consensus        92 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~-~~  164 (267)
T 3t9t_A           92 DYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TG  164 (267)
T ss_dssp             HHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST-TS
T ss_pred             HHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc-cc
Confidence            999752   24689999999999999999999999   999999999999999999999999999986643322111 12


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..||...+...   .....   .. .     ...        
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~i---~~-~-----~~~--------  224 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDI---ST-G-----FRL--------  224 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH---HT-T-----CCC--------
T ss_pred             ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHHH---hc-C-----CcC--------
Confidence            236788999999988889999999999999999999 899987654321   11110   00 0     000        


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ..+...+..+.+++.+||+.||++|||++++++.|+++.+.
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            01112345688999999999999999999999999988654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.1e-42  Score=373.43  Aligned_cols=253  Identities=26%  Similarity=0.391  Sum_probs=206.8

Q ss_pred             CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ..+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++||||+++|+|
T Consensus       271 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL  348 (535)
T 2h8h_A          271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL  348 (535)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEH
T ss_pred             hheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcH
Confidence            345689999999999999888899999998654 345789999999999999999999999876 678999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .++|...  ....+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......... .
T Consensus       349 ~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~-~  422 (535)
T 2h8h_A          349 LDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-Q  422 (535)
T ss_dssp             HHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT-C
T ss_pred             HHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc-c
Confidence            9999642  224589999999999999999999999   999999999999999999999999999987654322211 1


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ...++..|+|||.+.+..++.++|||||||++|||+| |+.||......+   +....    ....             .
T Consensus       423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~~i----~~~~-------------~  482 (535)
T 2h8h_A          423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQV----ERGY-------------R  482 (535)
T ss_dssp             STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHHHH----HTTC-------------C
T ss_pred             CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCC-------------C
Confidence            2236789999999998899999999999999999999 999997654321   11111    1100             0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ...+..++..+.+|+.+||+.||++|||+++|++.|+.+...
T Consensus       483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            011123456789999999999999999999999999988654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.4e-41  Score=346.58  Aligned_cols=257  Identities=24%  Similarity=0.399  Sum_probs=205.8

Q ss_pred             CCCeeecccCceEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceE
Q 008698          272 EGNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY  341 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~  341 (557)
                      ...+.||+|+||.||++...        ++..||||+++... ......+.+|+.++.++ +||||+++++++.+.+..+
T Consensus        38 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  117 (334)
T 2pvf_A           38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY  117 (334)
T ss_dssp             EEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCE
T ss_pred             EEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceE
Confidence            34467899999999999863        46789999997653 34457899999999999 8999999999999999999


Q ss_pred             EEEecCCCCChHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008698          342 IVYEFVVNGPLDRWLHHIPRG------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  409 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~  409 (557)
                      +||||+++|+|.+++......            ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus       118 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  194 (334)
T 2pvf_A          118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENN  194 (334)
T ss_dssp             EEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred             EEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCC
Confidence            999999999999999754321            23589999999999999999999999   999999999999999999


Q ss_pred             CcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHh
Q 008698          410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEW  488 (557)
Q Consensus       410 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~  488 (557)
                      .+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......   +...
T Consensus       195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~  271 (334)
T 2pvf_A          195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFKL  271 (334)
T ss_dssp             CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHH
T ss_pred             CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---HHHH
Confidence            999999999987654433222233347889999999988889999999999999999999 999997654321   1111


Q ss_pred             hhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       489 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      .    ....     .        ...+..++..+.+++.+||+.+|.+|||+++|++.|+++.
T Consensus       272 ~----~~~~-----~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          272 L----KEGH-----R--------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             H----HHTC-----C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H----hcCC-----C--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1    1110     0        0011223456899999999999999999999999998764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.1e-41  Score=341.94  Aligned_cols=267  Identities=21%  Similarity=0.285  Sum_probs=198.5

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||+||++...+|+.||||++....  ......+.+|+.++.+++||||+++++++.+.+..++||||++ |+
T Consensus        26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~  104 (311)
T 3niz_A           26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KD  104 (311)
T ss_dssp             EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EE
T ss_pred             hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CC
Confidence            35679999999999999889999999997542  2234678999999999999999999999999999999999997 58


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++..   ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........  .
T Consensus       105 l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~  176 (311)
T 3niz_A          105 LKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--Y  176 (311)
T ss_dssp             HHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----
T ss_pred             HHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCccc--c
Confidence            8888764   234599999999999999999999999   9999999999999999999999999999866433221  1


Q ss_pred             eecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhhhhhccccccc------cC
Q 008698          432 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRYLEL------LD  503 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~d  503 (557)
                      ....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +......... ......      .+
T Consensus       177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~  255 (311)
T 3niz_A          177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP-REWPQVQELPLWKQ  255 (311)
T ss_dssp             -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCT-TTSGGGTTSHHHHS
T ss_pred             cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCCh-HHhhhhhccchhhh
Confidence            22348999999999876 568999999999999999999999998765433211 1110000000 000000      00


Q ss_pred             cccccCCCCC---CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcc
Q 008698          504 PLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQL  550 (557)
Q Consensus       504 ~~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~  550 (557)
                      ..........   .......++.+|+.+||+.||++|||++|+++  .++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence            0000000000   00112356889999999999999999999997  44443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=8.2e-42  Score=350.92  Aligned_cols=252  Identities=22%  Similarity=0.290  Sum_probs=200.3

Q ss_pred             CCCCeeecccCceEEEEEEeC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEE
Q 008698          271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      ++..+.||+|+||.||++... +|+.||||++....     ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus        26 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  105 (351)
T 3c0i_A           26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF  105 (351)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            344567899999999999864 68999999986432     124578999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---cEEeeccCCcc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSKF  421 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgl~~~  421 (557)
                      ||+++|+|.+++.........+++..+..++.||+.||+|||++   +|+||||||+|||++.++.   +||+|||++..
T Consensus       106 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             ECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            99999999988865433345689999999999999999999999   9999999999999987655   99999999987


Q ss_pred             CCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccc
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  501 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (557)
                      .......  .....||+.|+|||++.+..++.++|||||||++|||++|..||.....    .+....   .. ...  .
T Consensus       183 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i---~~-~~~--~  250 (351)
T 3c0i_A          183 LGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGI---IK-GKY--K  250 (351)
T ss_dssp             CCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHH---HH-TCC--C
T ss_pred             ecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHH---Hc-CCC--C
Confidence            6543221  1223489999999999998999999999999999999999999976421    111110   00 000  0


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..+..        ....+..+.+++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 MNPRQ--------WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CCHHH--------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCccc--------cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00000        0112456889999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-41  Score=340.30  Aligned_cols=273  Identities=17%  Similarity=0.187  Sum_probs=207.6

Q ss_pred             CCCeeecccCceEEEEEEeCC-CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC--ceEEEEecC
Q 008698          272 EGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEFV  347 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~~  347 (557)
                      ...+.||+|+||+||++.... |+.||||+++... ....+.+.+|+.++.+++||||+++++++...+  ..++||||+
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   91 (319)
T 4euu_A           12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC   91 (319)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCC
Confidence            345678999999999999754 8999999997543 334677889999999999999999999988765  779999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCcEEeeccCCccCC
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Dfgl~~~~~  423 (557)
                      ++|+|.+++..... ...+++.++..++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++...
T Consensus        92 ~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~  167 (319)
T 4euu_A           92 PCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (319)
T ss_dssp             TTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred             CCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence            99999999975322 23499999999999999999999999   99999999999999    778889999999998765


Q ss_pred             ccccccceeecCcccccccccccc--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccc-chhHHHhhhhhhh
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVY--------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC-WQSIFEWATPLVQ  494 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~-~~~~~~~~~~~~~  494 (557)
                      .....   ....||+.|+|||.+.        +..++.++|||||||++|||+||+.||....... .............
T Consensus       168 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          168 DDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             TTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             CCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            43322   1234899999999886        5678999999999999999999999997544321 1111111111000


Q ss_pred             cccccc---ccCccc----ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          495 SHRYLE---LLDPLI----SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       495 ~~~~~~---~~d~~l----~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      ......   ......    .-.............+.+++.+||+.||++|||++|+++...+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            000000   000000    000012234667888999999999999999999999999887544

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.2e-41  Score=348.56  Aligned_cols=247  Identities=20%  Similarity=0.255  Sum_probs=200.0

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEecccchh------hHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      ...+.||+|+||.||++... +|+.||||+++.....      ..+.+.+|+.+|.+++||||+++++++.+.+..++||
T Consensus        15 ~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   94 (361)
T 2yab_A           15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL   94 (361)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEE
Confidence            34457899999999999975 5899999999765321      3578999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CcEEeeccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLSK  420 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgl~~  420 (557)
                      ||+++|+|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++    .+||+|||++.
T Consensus        95 e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           95 ELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             ECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            99999999999964    35699999999999999999999999   999999999999998877    79999999998


Q ss_pred             cCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      .......   .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...   ......    ...  .
T Consensus       168 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~~~i~----~~~--~  235 (361)
T 2yab_A          168 EIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANIT----AVS--Y  235 (361)
T ss_dssp             ECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH----TTC--C
T ss_pred             EcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hcC--C
Confidence            7654321   122349999999999998899999999999999999999999997654321   111100    000  0


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+++..        ....+..+.+++.+||..||++|||++|+++
T Consensus       236 ~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 DFDEEF--------FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCCHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCchh--------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000000        0123456889999999999999999999985

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.1e-41  Score=339.02  Aligned_cols=259  Identities=18%  Similarity=0.232  Sum_probs=205.4

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ...+.||+|+||.||++.. .+|+.||||++....  ....+.+|+..+.++ +|+|++++++++.+....++||||+ +
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   89 (298)
T 1csn_A           13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G   89 (298)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence            3445789999999999995 568999999986543  234688899999999 8999999999999999999999999 9


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-----cEEeeccCCccCCc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-----AHLMGVGLSKFVPW  424 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~Dfgl~~~~~~  424 (557)
                      ++|.+++...   +..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.     +||+|||+++....
T Consensus        90 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A           90 PSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             CCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence            9999999753   34599999999999999999999999   9999999999999987766     99999999986654


Q ss_pred             cccc-----cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          425 EVMQ-----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       425 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ....     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.....................
T Consensus       164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (298)
T 1csn_A          164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  243 (298)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence            3221     11223448999999999999999999999999999999999999998765433222222111110000000


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      +.             ....+..+.+++.+||+.||++|||+++|++.|+++.+
T Consensus       244 ~~-------------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          244 EL-------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HH-------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HH-------------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            00             01234568999999999999999999999999987643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.1e-42  Score=341.76  Aligned_cols=253  Identities=27%  Similarity=0.370  Sum_probs=193.1

Q ss_pred             CCCeeecccCceEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          272 EGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      +..+.||+|+||.||+|....    +..||||+++.. .....+.+.+|+.++.+++||||+++++++. .+..++||||
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~   96 (281)
T 1mp8_A           18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL   96 (281)
T ss_dssp             EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             EEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEec
Confidence            345678999999999998643    457999998764 3344578999999999999999999999974 5678999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++|+|.+++...   ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        97 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (281)
T 1mp8_A           97 CTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  170 (281)
T ss_dssp             CTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccc
Confidence            9999999999752   24699999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      ... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||........   ....    ....        
T Consensus       171 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i----~~~~--------  234 (281)
T 1mp8_A          171 YYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRI----ENGE--------  234 (281)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHH----HTTC--------
T ss_pred             ccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHH----HcCC--------
Confidence            221 122236789999999988899999999999999999997 9999986544321   1111    0000        


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                           ....+..++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus       235 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          235 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                 000112234578899999999999999999999999987643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-41  Score=343.80  Aligned_cols=245  Identities=17%  Similarity=0.207  Sum_probs=199.4

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||.||++... +++.||+|.+.... .....+.+|+.++..++||||+++++++.+.+..++||||+++|+|
T Consensus        10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L   88 (321)
T 1tki_A           10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI   88 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred             eeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence            456899999999999975 58899999997543 4456789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--CCCcEEeeccCCccCCccccccc
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      .+++..   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.  ++.+||+|||++.........  
T Consensus        89 ~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~--  160 (321)
T 1tki_A           89 FERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--  160 (321)
T ss_dssp             HHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE--
T ss_pred             HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc--
Confidence            999964   234699999999999999999999999   9999999999999987  789999999999876543221  


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                       ....||+.|+|||++.+..++.++||||||+++|||++|..||...+...   .....   .... .  ..+..     
T Consensus       161 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i---~~~~-~--~~~~~-----  225 (321)
T 1tki_A          161 -RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENI---MNAE-Y--TFDEE-----  225 (321)
T ss_dssp             -EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---HHTC-C--CCCHH-----
T ss_pred             -ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHHHH---HcCC-C--CCChh-----
Confidence             22348999999999998889999999999999999999999997654321   11111   0000 0  00000     


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         .....+..+.+++.+||+.||++|||++|+++
T Consensus       226 ---~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          226 ---AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               00123456889999999999999999999997

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.3e-42  Score=344.62  Aligned_cols=249  Identities=25%  Similarity=0.409  Sum_probs=198.8

Q ss_pred             CCeeecccCceEEEEEEeCC-C-------CEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEE
Q 008698          273 GNRLLGDSKTGGTYSGILPD-G-------SRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~~-g-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      ..+.||+|+||.||++.... +       ..||+|++........+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   91 (289)
T 4fvq_A           12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQ   91 (289)
T ss_dssp             EEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEE
T ss_pred             eeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEE
Confidence            34578999999999998643 3       579999998776667788999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC--------cEEeec
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--------AHLMGV  416 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~--------~kl~Df  416 (557)
                      ||+++|+|.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.        +||+||
T Consensus        92 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df  165 (289)
T 4fvq_A           92 EFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP  165 (289)
T ss_dssp             ECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred             ECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccC
Confidence            999999999999752   24489999999999999999999999   9999999999999998887        999999


Q ss_pred             cCCccCCccccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCC-CCCCCcccchhHHHhhhhhhh
Q 008698          417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRP-AQAVDSVCWQSIFEWATPLVQ  494 (557)
Q Consensus       417 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p-~~~~~~~~~~~~~~~~~~~~~  494 (557)
                      |++.......      ...+++.|+|||.+.+ ..++.++||||||+++|||+||..| +...+.......       ..
T Consensus       166 g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-------~~  232 (289)
T 4fvq_A          166 GISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-------YE  232 (289)
T ss_dssp             CSCTTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------HH
T ss_pred             cccccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-------hh
Confidence            9997654321      1227889999999987 6789999999999999999996544 443322110000       00


Q ss_pred             ccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCC
Q 008698          495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV  555 (557)
Q Consensus       495 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  555 (557)
                      ..       ..+.   ..     .+..+.+++.+||+.||++|||++++++.|+++..|..
T Consensus       233 ~~-------~~~~---~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          233 DR-------HQLP---AP-----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             TT-------CCCC---CC-----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             cc-------CCCC---CC-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence            00       0000   01     12347899999999999999999999999999987654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.4e-41  Score=341.91  Aligned_cols=246  Identities=19%  Similarity=0.280  Sum_probs=199.2

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccch------hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEe
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      ..+.||+|+||.||++... +|+.||||+++....      ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        15 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   94 (326)
T 2y0a_A           15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE   94 (326)
T ss_dssp             EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEE
Confidence            3456899999999999975 589999999975432      135789999999999999999999999999999999999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CcEEeeccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLSKF  421 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgl~~~  421 (557)
                      |+++|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++    .+||+|||+++.
T Consensus        95 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           95 LVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             CCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             cCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            9999999999964    35699999999999999999999999   999999999999999887    799999999987


Q ss_pred             CCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccc
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  501 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (557)
                      .......   ....||+.|+|||++.+..++.++|||||||++|||++|..||.......   ......   . ... . 
T Consensus       168 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~---~-~~~-~-  235 (326)
T 2y0a_A          168 IDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVS---A-VNY-E-  235 (326)
T ss_dssp             CCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH---H-TCC-C-
T ss_pred             CCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHH---h-cCC-C-
Confidence            6433221   22348999999999998899999999999999999999999997654321   111000   0 000 0 


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +....        ....+..+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~--------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          236 FEDEY--------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CCHHH--------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCccc--------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000        0112356889999999999999999999987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3e-41  Score=336.31  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=197.4

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhh-------HHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR-------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV  343 (557)
                      ...+.||+|+||.||++.. .+++.||||++.......       .+.+.+|+.++.+++||||+++++++.+..  ++|
T Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv   99 (287)
T 4f0f_A           22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMV   99 (287)
T ss_dssp             EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEE
T ss_pred             eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEE
Confidence            3445789999999999997 468999999986542211       167899999999999999999999986554  799


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCC-----cEEeec
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFG-----AHLMGV  416 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlk~~Nill~~~~~-----~kl~Df  416 (557)
                      |||+++|+|.+++..   ....+++..+..++.|++.||+|||++   +  |+||||||+|||++.++.     +||+||
T Consensus       100 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A          100 MEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             EEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            999999999988864   235699999999999999999999999   8  999999999999988776     999999


Q ss_pred             cCCccCCccccccceeecCcccccccccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhh
Q 008698          417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVY--RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ  494 (557)
Q Consensus       417 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~  494 (557)
                      |+++.....     .....||+.|+|||.+.  ...++.++||||||+++|||++|+.||.......... ....   ..
T Consensus       174 g~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~---~~  244 (287)
T 4f0f_A          174 GLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-INMI---RE  244 (287)
T ss_dssp             TTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HHHH---HH
T ss_pred             Ccccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HHHH---hc
Confidence            999754322     22234899999999984  4567899999999999999999999997654432111 1100   00


Q ss_pred             ccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       495 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                       ..    ..+        ..+..++..+.+++.+||+.||++|||+++|++.|+++
T Consensus       245 -~~----~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          245 -EG----LRP--------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -SC----CCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -cC----CCC--------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence             00    011        11123446789999999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.6e-41  Score=344.09  Aligned_cols=255  Identities=15%  Similarity=0.180  Sum_probs=202.8

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||+|.. .+|+.||||++....  ....+.+|+.++.++ +||||+++++++.+.+..++||||+ +++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~   90 (330)
T 2izr_A           14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPS   90 (330)
T ss_dssp             EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             EEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCC
Confidence            45689999999999995 568999999987543  234688999999999 9999999999999999999999999 999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-----cEEeeccCCccCCccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-----AHLMGVGLSKFVPWEV  426 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~Dfgl~~~~~~~~  426 (557)
                      |.+++...   ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.     +||+|||+++......
T Consensus        91 L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           91 LEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             HHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             HHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            99999753   35699999999999999999999999   9999999999999998887     9999999998654332


Q ss_pred             ccc-----ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccc
Q 008698          427 MQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  501 (557)
Q Consensus       427 ~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (557)
                      ...     ......||+.|+|||++.+..++.++||||||+++|||++|..||...+................... .+.
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~  243 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-IEV  243 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-HHH
T ss_pred             CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-HHH
Confidence            211     11234589999999999999999999999999999999999999987654433222221111000000 000


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                          +    .    ...+ .+.+++..||+.||.+||++++|++.|+++.
T Consensus       244 ----~----~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          244 ----L----C----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             ----H----T----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             ----H----h----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence                0    0    0122 6899999999999999999999999997553

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.1e-42  Score=346.94  Aligned_cols=271  Identities=27%  Similarity=0.373  Sum_probs=207.0

Q ss_pred             CCCCCCeeecccCceEEEEEEeC-----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--Cce
Q 008698          269 NFSEGNRLLGDSKTGGTYSGILP-----DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDR  340 (557)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~g~~~-----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~  340 (557)
                      .+....+.||+|+||+||++.+.     +|+.||||+++... ......+.+|+.++.+++||||+++++++.+.  ...
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            34345567899999999998742     57899999997653 34467899999999999999999999999874  567


Q ss_pred             EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      ++||||+++|+|.+++..     ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence            999999999999999975     3499999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccccc-cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          421 FVPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       421 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ........ .......+|..|+|||.+.+..++.++||||||+++|||+||..||....... .................
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLT  261 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHH
Confidence            76543221 12223347888999999998889999999999999999999999986532110 00000000000000111


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      +.++...    ....+..++..+.+++.+||+.||++|||++++++.|+.+.+
T Consensus       262 ~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          262 ELLERGE----RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhccc----CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            1111111    111123345679999999999999999999999999987653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=339.79  Aligned_cols=244  Identities=23%  Similarity=0.338  Sum_probs=189.8

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccchh--------------------------hHHHHHHHHHHHhhcCCC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--------------------------RKKEFYSEIGRFARLHHP  325 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~H~  325 (557)
                      ..+.||+|+||.||++... +|+.||||++......                          ..+.+.+|+.++++++||
T Consensus        17 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   96 (298)
T 2zv2_A           17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP   96 (298)
T ss_dssp             EEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCT
T ss_pred             EEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCC
Confidence            3456899999999999864 5889999999654211                          135688999999999999


Q ss_pred             cEEeeeeeeee--CCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 008698          326 NLVAVKGCCYD--HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV  403 (557)
Q Consensus       326 niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Ni  403 (557)
                      ||+++++++.+  .+..++||||+++++|.+++.     ...+++..+..++.||+.||+|||++   +|+||||||+||
T Consensus        97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL  168 (298)
T ss_dssp             TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence            99999999986  567899999999999987653     24699999999999999999999999   999999999999


Q ss_pred             eeCCCCCcEEeeccCCccCCccccccceeecCccccccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCcc
Q 008698          404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE---LTTKSDVYSFGVLLLEIVSGRRPAQAVDSV  480 (557)
Q Consensus       404 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDVwS~Gvil~el~tG~~p~~~~~~~  480 (557)
                      |++.++.+||+|||+++........  .....||+.|+|||.+.+..   ++.++||||||+++|||++|+.||......
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  246 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM  246 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence            9999999999999999866433221  12234899999999998755   478899999999999999999999765322


Q ss_pred             cchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          481 CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .   +..   . .....    ..  .      ......+..+.+++.+||+.||++|||++|+++
T Consensus       247 ~---~~~---~-~~~~~----~~--~------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          247 C---LHS---K-IKSQA----LE--F------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             H---HHH---H-HHHCC----CC--C------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             H---HHH---H-Hhccc----CC--C------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            1   111   0 00000    00  0      001123356889999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.8e-42  Score=339.92  Aligned_cols=251  Identities=29%  Similarity=0.463  Sum_probs=206.4

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||.||++...+ +..||||.+.... ...+.+.+|+.++.+++||||+++++++.+.+..++||||+++++|
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   96 (288)
T 3kfa_A           18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL   96 (288)
T ss_dssp             EEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred             EeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcH
Confidence            4568999999999999754 8899999997653 4567899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........... .
T Consensus        97 ~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~-~  170 (288)
T 3kfa_A           97 LDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-A  170 (288)
T ss_dssp             HHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE-T
T ss_pred             HHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc-c
Confidence            9999763  335699999999999999999999999   999999999999999999999999999987654432221 1


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ...+|+.|+|||.+.+..++.++||||||+++|||++ |..||...+........   .    ..     .        .
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~---~----~~-----~--------~  230 (288)
T 3kfa_A          171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---E----KD-----Y--------R  230 (288)
T ss_dssp             TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---H----TT-----C--------C
T ss_pred             CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---h----cc-----C--------C
Confidence            2236789999999998899999999999999999999 99999765443211111   0    00     0        0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      ...+...+..+.+++.+|++.||++|||++++++.|+.+.
T Consensus       231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence            0111223457899999999999999999999999998654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-41  Score=338.84  Aligned_cols=251  Identities=23%  Similarity=0.334  Sum_probs=203.5

Q ss_pred             CeeecccCceEEEEEEeC---CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP---DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~---~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||+|...   ++..||||+++.. .....+.+.+|+.++.+++||||+++++++ ..+..++||||+++
T Consensus        15 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~   93 (287)
T 1u59_A           15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGG   93 (287)
T ss_dssp             EEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred             hccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence            447899999999999853   5778999999765 334567899999999999999999999998 55678999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc-
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-  428 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  428 (557)
                      ++|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++......... 
T Consensus        94 ~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  167 (287)
T 1u59_A           94 GPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  167 (287)
T ss_dssp             EEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             CCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence            999999964   235699999999999999999999999   9999999999999999999999999999876433221 


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||........   ....    ....          
T Consensus       168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~i----~~~~----------  230 (287)
T 1u59_A          168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFI----EQGK----------  230 (287)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HHHH----HTTC----------
T ss_pred             eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHH----hcCC----------
Confidence            11222336889999999988889999999999999999999 9999976544221   1111    1100          


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                         ....+..++..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       231 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          231 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               00111234467999999999999999999999999998653

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-41  Score=350.83  Aligned_cols=248  Identities=19%  Similarity=0.279  Sum_probs=202.0

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      ...+.||+|+||.||++... +|+.||+|++..........+.+|+.+|.+++||||+++++++.+.+..++||||+++|
T Consensus        54 ~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg  133 (387)
T 1kob_A           54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG  133 (387)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred             EEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCC
Confidence            33456899999999999974 58999999998766566678999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--CCCcEEeeccCCccCCccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|.+++..   ....+++..+..++.||+.||+|||++   +|+||||||+|||++.  ++.+||+|||+++....... 
T Consensus       134 ~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-  206 (387)
T 1kob_A          134 ELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-  206 (387)
T ss_dssp             BHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred             cHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc-
Confidence            99999864   234699999999999999999999999   9999999999999974  46799999999987654322 


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                        .....||+.|+|||++.+..++.++|||||||++|||+||..||...+...   .....   .. ...  .++.    
T Consensus       207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~i---~~-~~~--~~~~----  271 (387)
T 1kob_A          207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNV---KR-CDW--EFDE----  271 (387)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH---HH-CCC--CCCS----
T ss_pred             --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HHHHH---Hh-CCC--CCCc----
Confidence              222348999999999999999999999999999999999999998654321   11111   00 000  0000    


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ......+..+.+++.+||+.||++|||++|+++
T Consensus       272 ----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          272 ----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             ----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                001123456889999999999999999999987

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=372.62  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=199.1

Q ss_pred             eecccCceEEEEEEeC---CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          276 LLGDSKTGGTYSGILP---DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .||+|+||.||+|.+.   ++..||||+++... ....++|.+|+.+|.+++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            5799999999999864   46679999997653 3456889999999999999999999999876 56899999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc-cc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-ER  430 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~  430 (557)
                      |.+++..   ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus       422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            9999964   235699999999999999999999999   9999999999999999999999999999876533221 11


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                      .....+++.|+|||++.+..++.++|||||||++|||+| |+.||...+..+.   ...    +..+.            
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~----i~~~~------------  556 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAF----IEQGK------------  556 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---HHH----HHTTC------------
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHH----HHcCC------------
Confidence            222236789999999998999999999999999999998 9999987654321   111    11110            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                       ....+..++..+.+++.+||+.+|++||++++|++.|+.+
T Consensus       557 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          557 -RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             -CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence             0011223456799999999999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.5e-42  Score=347.74  Aligned_cols=254  Identities=22%  Similarity=0.362  Sum_probs=197.1

Q ss_pred             CCeeecccCceEEEEEEeC-CCC----EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      ..+.||+|+||.||++... +++    +||+|.+... .......+.+|+.++.+++||||+++++++...+ .++|+||
T Consensus        19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~   97 (327)
T 3lzb_A           19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQL   97 (327)
T ss_dssp             EEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECC
T ss_pred             EEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEe
Confidence            3457899999999999964 444    3577777543 3345678999999999999999999999988754 7899999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++|+|.+++...   ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        98 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           98 MPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             CSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred             cCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence            9999999999753   34699999999999999999999999   99999999999999999999999999998765443


Q ss_pred             cccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      .........+|+.|+|||.+.+..++.++||||||+++|||++ |..||.............       ...        
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~~--------  236 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE--------  236 (327)
T ss_dssp             --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC--------
T ss_pred             ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC--------
Confidence            3333333347889999999999999999999999999999999 999998765432211111       000        


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                           ....+...+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       237 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          237 -----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             -----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                 0011122345688999999999999999999999999988754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.5e-41  Score=346.11  Aligned_cols=245  Identities=20%  Similarity=0.282  Sum_probs=198.3

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||.||++... +|+.||||++....  ....+.+.+|+.++.+++||||+++++++.+.+..++||||+++|
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg  113 (362)
T 2bdw_A           34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG  113 (362)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence            456799999999999964 58999999997542  344567899999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CcEEeeccCCccCCcccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgl~~~~~~~~~  427 (557)
                      +|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++   .+||+|||++........
T Consensus       114 ~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          114 ELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             BHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence            99998864    35689999999999999999999999   999999999999998654   599999999987653322


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                         .....||+.|+|||++.+..++.++|||||||++|||++|..||...+...   +....    ..... ..      
T Consensus       187 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i----~~~~~-~~------  249 (362)
T 2bdw_A          187 ---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQI----KAGAY-DY------  249 (362)
T ss_dssp             ---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHTCC-CC------
T ss_pred             ---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----HhCCC-CC------
Confidence               122348999999999999899999999999999999999999997654321   11111    00100 00      


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ........+..+.+++.+||+.||++|||+.++++
T Consensus       250 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          250 ---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             ---CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               00001123456889999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=339.72  Aligned_cols=250  Identities=24%  Similarity=0.420  Sum_probs=194.1

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|+||.||++.. .++.||||++...  ...+.|.+|+.++++++||||+++++++.  +..++||||+++|+|.
T Consensus        13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~   87 (307)
T 2eva_A           13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLY   87 (307)
T ss_dssp             EEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred             eeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence            45789999999999998 5889999999654  34578999999999999999999999876  4579999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-cEEeeccCCccCCcccccccee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      +++.... ....+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++.......     .
T Consensus        88 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----~  161 (307)
T 2eva_A           88 NVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----T  161 (307)
T ss_dssp             HHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------
T ss_pred             HHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----c
Confidence            9997532 1235789999999999999999999932239999999999999998887 7999999997553221     1


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...||+.|+|||.+.+..++.++||||||+++|||+||+.||......... .   .... ....     .+        
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~---~~~~-~~~~-----~~--------  223 (307)
T 2eva_A          162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-I---MWAV-HNGT-----RP--------  223 (307)
T ss_dssp             ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-H---HHHH-HTTC-----CC--------
T ss_pred             cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-H---HHHH-hcCC-----CC--------
Confidence            223899999999999989999999999999999999999999765432111 0   0000 0000     00        


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      ......+..+.+++.+||+.||++|||++++++.|+.+.+
T Consensus       224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            0112234568899999999999999999999999987654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.7e-42  Score=352.91  Aligned_cols=263  Identities=14%  Similarity=0.126  Sum_probs=200.1

Q ss_pred             CCCeeecccCceEEEEEEeCC------CCEEEEEEecccchhhH-----------HHHHHHHHHHhhcCCCcEEeeeeee
Q 008698          272 EGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSSFQRK-----------KEFYSEIGRFARLHHPNLVAVKGCC  334 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~------g~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~H~niv~l~g~~  334 (557)
                      ...+.||+|+||.||+|...+      ++.||||++........           ..+.+|+..+..++||||+++++++
T Consensus        38 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~  117 (364)
T 3op5_A           38 KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSG  117 (364)
T ss_dssp             EEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEE
T ss_pred             EEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeee
Confidence            345678999999999998754      47899999876532111           2344566677888999999999998


Q ss_pred             eeC----CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CC
Q 008698          335 YDH----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--EE  408 (557)
Q Consensus       335 ~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~--~~  408 (557)
                      ...    ...++||||+ +++|.+++...   ...+++.+++.++.||+.||+|||++   +|+||||||+|||++  .+
T Consensus       118 ~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          118 LHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCT
T ss_pred             eeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCC
Confidence            765    4579999999 99999999752   35699999999999999999999999   999999999999999  88


Q ss_pred             CCcEEeeccCCccCCccccccc-----eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch
Q 008698          409 FGAHLMGVGLSKFVPWEVMQER-----TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ  483 (557)
Q Consensus       409 ~~~kl~Dfgl~~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~  483 (557)
                      +.+||+|||+++..........     .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......  
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~--  268 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP--  268 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH--
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH--
Confidence            9999999999987654322111     122348999999999999999999999999999999999999998643321  


Q ss_pred             hHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          484 SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      ......... ....+.+.+++.+.       ....+..+.+++..||+.+|++||++++|++.|+++.
T Consensus       269 ~~~~~~~~~-~~~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          269 KYVRDSKIR-YRENIASLMDKCFP-------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             HHHHHHHHH-HHHCHHHHHHHHSC-------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHH-hhhhHHHHHHHhcc-------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            111111111 11122233333221       0123456899999999999999999999999997654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=349.75  Aligned_cols=245  Identities=20%  Similarity=0.280  Sum_probs=196.2

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      ++||+|+||.||++.. .+|+.||||+++.......+.+.+|+.++.+++||||+++++++.+.+..++||||+++|+|.
T Consensus        95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~  174 (373)
T 2x4f_A           95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF  174 (373)
T ss_dssp             EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred             eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence            4689999999999986 468999999998776667788999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee--CCCCCcEEeeccCCccCCccccccce
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL--DEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill--~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      +++...   ...+++..+..++.||+.||+|||+.   +|+||||||+|||+  +.++.+||+|||+++........   
T Consensus       175 ~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~---  245 (373)
T 2x4f_A          175 DRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---  245 (373)
T ss_dssp             HHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---
Confidence            988642   24589999999999999999999999   99999999999999  56778999999999876543221   


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ....||+.|+|||++.+..++.++|||||||++|||+||..||...+....   ..   .......  ......      
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~---~i~~~~~--~~~~~~------  311 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET---LN---NILACRW--DLEDEE------  311 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH---HHHHTCC--CSCSGG------
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HHHhccC--CCChhh------
Confidence            223489999999999988999999999999999999999999987543211   11   1111000  000000      


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ....+..+.+++.+||+.||++|||++|+++
T Consensus       312 ---~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          312 ---FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             ---GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               0123456899999999999999999999997

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-41  Score=351.00  Aligned_cols=252  Identities=26%  Similarity=0.430  Sum_probs=192.2

Q ss_pred             eeecccCceEEEEEEeC--CC--CEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeee-CCceEEEEecCC
Q 008698          275 RLLGDSKTGGTYSGILP--DG--SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~--~g--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~  348 (557)
                      +.||+|+||.||+|...  ++  ..||||.++.. .....++|.+|+.++++++||||+++++++.+ .+..++||||++
T Consensus        95 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~  174 (373)
T 3c1x_A           95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK  174 (373)
T ss_dssp             EEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCT
T ss_pred             cEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCC
Confidence            57899999999999863  22  36899998754 33456789999999999999999999998754 467899999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++..   ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........
T Consensus       175 ~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          175 HGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             TCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            9999999974   234689999999999999999999999   9999999999999999999999999999865433211


Q ss_pred             c--ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          429 E--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       429 ~--~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      .  ......+|+.|+|||.+.+..++.++||||||+++|||+| |.+||...+........       ....        
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~-------~~~~--------  313 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------LQGR--------  313 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH-------HTTC--------
T ss_pred             cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH-------HcCC--------
Confidence            1  1122337789999999999999999999999999999999 67777665443211110       0000        


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                           ....+..++..+.+++.+||+.||++|||++++++.|+++..
T Consensus       314 -----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          314 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 001112234578999999999999999999999999987654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=343.72  Aligned_cols=262  Identities=22%  Similarity=0.267  Sum_probs=204.6

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeee----CCceEEEEec
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYEF  346 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~  346 (557)
                      ...+.||+|+||.||++.. .+|+.||||++........+.+.+|+.++.+++||||+++++++..    .+..++||||
T Consensus        32 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~  111 (317)
T 2buj_A           32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF  111 (317)
T ss_dssp             EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEEC
T ss_pred             EEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEe
Confidence            3345789999999999996 5789999999977666677889999999999999999999999873    3467999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++|+|.+++.........+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus       112 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  188 (317)
T 2buj_A          112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV  188 (317)
T ss_dssp             CTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred             CCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence            999999999976444456799999999999999999999999   99999999999999999999999999987654221


Q ss_pred             ccc-------ceeecCccccccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcc
Q 008698          427 MQE-------RTVMAGGTYGYLAPEFVYRNE---LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  496 (557)
Q Consensus       427 ~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (557)
                      ...       ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||........ .+...    ... 
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~----~~~-  262 (317)
T 2buj_A          189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA----VQN-  262 (317)
T ss_dssp             ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH----HHC-
T ss_pred             ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH----hhc-
Confidence            110       011223689999999987654   68999999999999999999999864211100 00000    000 


Q ss_pred             ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       497 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                              ..    ........+..+.+++.+||+.||.+|||+++|++.|+.+.+++
T Consensus       263 --------~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          263 --------QL----SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             --------C------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             --------cC----CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence                    00    00001123456899999999999999999999999999988764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2e-41  Score=342.10  Aligned_cols=256  Identities=25%  Similarity=0.436  Sum_probs=194.1

Q ss_pred             CeeecccCceEEEEEEeC----CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC-----ceEE
Q 008698          274 NRLLGDSKTGGTYSGILP----DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYI  342 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~----~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~l  342 (557)
                      .+.||+|+||.||++...    .+..||||.++..  .....+.+.+|+.++.+++||||+++++++.+.+     ..++
T Consensus        39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  118 (313)
T 3brb_A           39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV  118 (313)
T ss_dssp             EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEE
T ss_pred             ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEE
Confidence            456899999999999864    2458999998754  3344577999999999999999999999998755     3499


Q ss_pred             EEecCCCCChHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          343 VYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      ||||+++|+|.+++....  .....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus       119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~  195 (313)
T 3brb_A          119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK  195 (313)
T ss_dssp             EEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC-
T ss_pred             EEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcce
Confidence            999999999999985422  2345699999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ...............+++.|+|||.+.+..++.++||||||+++|||++ |..||........   ....   .. ..  
T Consensus       196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~---~~-~~--  266 (313)
T 3brb_A          196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YDYL---LH-GH--  266 (313)
T ss_dssp             ---------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHH---HT-TC--
T ss_pred             ecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHHH---Hc-CC--
Confidence            7654332222233347889999999999999999999999999999999 8889876543221   1110   00 00  


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                                 ....+...+..+.+++.+||+.||++|||++++++.|+++.+
T Consensus       267 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          267 -----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             -----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                       001112234578999999999999999999999999988754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.5e-41  Score=344.68  Aligned_cols=241  Identities=19%  Similarity=0.277  Sum_probs=196.7

Q ss_pred             CCeeecccCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      ..+.||+|+||.||++.. .+|+.||||++.....   .....+.+|+.+++.++||||+++++++.+.+..++||||+ 
T Consensus        13 i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-   91 (336)
T 3h4j_B           13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-   91 (336)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-
Confidence            345789999999999996 5689999999975421   22357899999999999999999999999999999999999 


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.........
T Consensus        92 ~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~  164 (336)
T 3h4j_B           92 GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL  164 (336)
T ss_dssp             CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence            7899988864    24599999999999999999999999   9999999999999999999999999999876543222


Q ss_pred             cceeecCccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                         ....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.........                ..+.... 
T Consensus       165 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~~~-  224 (336)
T 3h4j_B          165 ---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNSCV-  224 (336)
T ss_dssp             ---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCSSC-
T ss_pred             ---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHcCC-
Confidence               22348999999999988775 78999999999999999999999764332110                0000000 


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ...+...+..+.+++.+||+.||.+|||++|+++
T Consensus       225 ----~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          225 ----YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ----CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ----CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                0111223456889999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.2e-41  Score=343.04  Aligned_cols=259  Identities=22%  Similarity=0.385  Sum_probs=206.7

Q ss_pred             CCCeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      ...+.||+|+||.||+|...      +++.||||.+.... ......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  107 (322)
T 1p4o_A           28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM  107 (322)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEE
Confidence            33457899999999999854      36789999997543 344567999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccC
Q 008698          345 EFVVNGPLDRWLHHIP------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL  418 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  418 (557)
                      ||+++|+|.+++....      .....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       108 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~  184 (322)
T 1p4o_A          108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM  184 (322)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             EeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCcc
Confidence            9999999999986421      1124578999999999999999999999   999999999999999999999999999


Q ss_pred             CccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                      ++...............+|+.|+|||.+.+..++.++||||||+++|||+| |..||...+...   +...    .....
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~----~~~~~  257 (322)
T 1p4o_A          185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLRF----VMEGG  257 (322)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHHH----HHTTC
T ss_pred             ccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---HHHH----HHcCC
Confidence            986543332222222336889999999998889999999999999999999 889987654321   1111    01110


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                              .     ...+...+..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       258 --------~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          258 --------L-----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             --------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             --------c-----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence                    0     001122345688999999999999999999999999987654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.2e-41  Score=337.73  Aligned_cols=250  Identities=27%  Similarity=0.443  Sum_probs=202.2

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|+||.||++...+++.||||.++... ...+.+.+|+.++.+++||||+++++++. .+..++||||+++++|.
T Consensus        18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~   95 (279)
T 1qpc_A           18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV   95 (279)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred             eeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence            45689999999999998888899999997653 34578999999999999999999999876 45689999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++...  ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++........... ..
T Consensus        96 ~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~  169 (279)
T 1qpc_A           96 DFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EG  169 (279)
T ss_dssp             HHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC-TT
T ss_pred             HHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc-cC
Confidence            999641  123699999999999999999999999   999999999999999999999999999987654322211 12


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ..++..|+|||.+.+..++.++||||||+++|||+| |..||.......   +....    ...     ...        
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~----~~~-----~~~--------  229 (279)
T 1qpc_A          170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNL----ERG-----YRM--------  229 (279)
T ss_dssp             CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH----HTT-----CCC--------
T ss_pred             CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHHHH----hcc-----cCC--------
Confidence            236788999999988889999999999999999999 999987654321   11110    000     000        


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      ..+...+..+.+++.+||+.||++|||++++++.|+++.
T Consensus       230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            011223457899999999999999999999999998764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7e-42  Score=343.39  Aligned_cols=270  Identities=23%  Similarity=0.333  Sum_probs=203.1

Q ss_pred             CCCCeeecccCceEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC--CceEE
Q 008698          271 SEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYI  342 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~l  342 (557)
                      +...+.||+|+||.||++.+     .+++.||||+++... ......+.+|+.++.+++||||+++++++.+.  +..++
T Consensus        23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  102 (302)
T 4e5w_A           23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL  102 (302)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred             hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence            44456789999999999983     468899999997543 33457899999999999999999999999876  66899


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus       103 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          103 IMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence            99999999999999642   24599999999999999999999999   9999999999999999999999999999876


Q ss_pred             Cccccc-cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccc
Q 008698          423 PWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  501 (557)
Q Consensus       423 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (557)
                      ...... .......+|..|+|||.+.+..++.++||||||+++|||+||..|+.....    .......+..........
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCHHHH
Confidence            543321 222233478889999999988899999999999999999999988643211    000000000000000000


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                      ... +........+...+..+.+++.+||+.||++|||++++++.|+++.
T Consensus       253 ~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          253 VNT-LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHH-HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH-HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            000 0000011112234567999999999999999999999999998764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.3e-41  Score=335.71  Aligned_cols=263  Identities=21%  Similarity=0.274  Sum_probs=195.5

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||++...+|+.||||++.....  .....+.+|+.++++++||||+++++++.+.+..++||||+++ +
T Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~   85 (288)
T 1ob3_A            7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D   85 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred             hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence            346899999999999997899999999965432  2246788999999999999999999999999999999999975 8


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.........  .
T Consensus        86 l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~  157 (288)
T 1ob3_A           86 LKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--Y  157 (288)
T ss_dssp             HHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             HHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccc--c
Confidence            99888642   25689999999999999999999999   9999999999999999999999999999765322111  1


Q ss_pred             eecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhhh----hccccccccCcc
Q 008698          432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLV----QSHRYLELLDPL  505 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~d~~  505 (557)
                      ....+|+.|+|||.+.+. .++.++|||||||++|||+||+.||...+..... .+........    .........++.
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            123489999999998764 5899999999999999999999999875432211 1111000000    000000001111


Q ss_pred             cccCCC---CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          506 ISSLSS---DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       506 l~~~~~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ......   .......+..+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            100000   0001123456889999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.5e-41  Score=343.62  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=179.1

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||++... +|+.||||++...   ....+.+|+.++..+. ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            456899999999999975 5899999999654   3467789999999996 9999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CcEEeeccCCccCCccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgl~~~~~~~~~~  428 (557)
                      |.+++..    ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++   .+||+|||+++........
T Consensus        93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            9999975    35699999999999999999999999   999999999999997665   7999999999865433221


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                        .....||+.|+|||.+.+..++.++||||||+++|||++|..||...+..... ...+.... .......  +     
T Consensus       166 --~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~~--~-----  235 (325)
T 3kn6_A          166 --LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDFS--F-----  235 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCCC--C-----
T ss_pred             --ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCCC--C-----
Confidence              12234799999999999999999999999999999999999999865432110 11111110 1100000  0     


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ........+..+.+|+.+||+.||++|||++|+++
T Consensus       236 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          236 ---EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             ---CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ---CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence               00001124567899999999999999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-41  Score=335.63  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=199.8

Q ss_pred             eeecccCceEEEEEEeCC-C---CEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCce-EEEEecCC
Q 008698          275 RLLGDSKTGGTYSGILPD-G---SRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~-g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~-~lV~E~~~  348 (557)
                      +.||+|+||+||+|...+ +   ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++||||+.
T Consensus        27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~  106 (298)
T 3pls_A           27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMC  106 (298)
T ss_dssp             EEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCT
T ss_pred             ceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEeccc
Confidence            578999999999998533 2   379999997643 34567899999999999999999999999876655 99999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++........
T Consensus       107 ~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          107 HGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             TCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             CCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            9999999974   235689999999999999999999999   9999999999999999999999999999865443221


Q ss_pred             --cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC-CCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          429 --ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPA-QAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       429 --~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                        .......+++.|+|||.+.+..++.++||||||+++|||+||..|+ ...+........       ....        
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~-------~~~~--------  245 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-------AQGR--------  245 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH-------HTTC--------
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh-------hcCC--------
Confidence              1222334788999999999999999999999999999999965554 433322111110       0000        


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                           ....+...+..+.+++.+||+.||++|||++++++.|+++..
T Consensus       246 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          246 -----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                 000112234568999999999999999999999999987654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.6e-41  Score=353.18  Aligned_cols=246  Identities=21%  Similarity=0.293  Sum_probs=197.4

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||.||++.. .+|+.||+|++....  ....+.+.+|+.++.+++||||+++++++.+.+..++||||+++|
T Consensus        16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   95 (444)
T 3soa_A           16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG   95 (444)
T ss_dssp             EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCC
T ss_pred             EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCC
Confidence            45679999999999986 468999999997653  234567899999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCcEEeeccCCccCCcccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      +|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+||+|||++........
T Consensus        96 ~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           96 ELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             BHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            99999875    24599999999999999999999999   999999999999998   467899999999976654322


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .  .....||+.|+|||++.+..++.++|||||||++|||++|..||...+...   +....    ..... ....+   
T Consensus       169 ~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~~~i----~~~~~-~~~~~---  235 (444)
T 3soa_A          169 A--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LYQQI----KAGAY-DFPSP---  235 (444)
T ss_dssp             B--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH----HHTCC-CCCTT---
T ss_pred             e--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HHHHH----HhCCC-CCCcc---
Confidence            1  122349999999999999899999999999999999999999997654321   11111    11100 00000   


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                            .....+..+.+++.+||+.||++|||+.|+++
T Consensus       236 ------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          236 ------EWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             ------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                  00123456889999999999999999999987

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.7e-41  Score=339.67  Aligned_cols=257  Identities=24%  Similarity=0.387  Sum_probs=195.6

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++.. .+|+.||||+++..   .......+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus        37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  116 (310)
T 2wqm_A           37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA  116 (310)
T ss_dssp             EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCS
T ss_pred             EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCC
Confidence            45689999999999996 46899999999753   334567889999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++.........+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++......... 
T Consensus       117 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-  192 (310)
T 2wqm_A          117 GDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-  192 (310)
T ss_dssp             CBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------------
T ss_pred             CCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc-
Confidence            999999875433446799999999999999999999999   9999999999999999999999999999765433221 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                       .....+++.|+|||.+.+..++.++||||||+++|||++|..||....... ..+..   .. .....     +     
T Consensus       193 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~~-~~~~~-----~-----  256 (310)
T 2wqm_A          193 -AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK---KI-EQCDY-----P-----  256 (310)
T ss_dssp             -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHH---HH-HTTCS-----C-----
T ss_pred             -ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHH---Hh-hcccC-----C-----
Confidence             112348899999999999999999999999999999999999997543211 11111   11 11000     0     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                        .......+..+.+++.+||+.||++|||+++|++.|+++..
T Consensus       257 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          257 --PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             --CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence              00112234568899999999999999999999999987754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=347.11  Aligned_cols=244  Identities=26%  Similarity=0.329  Sum_probs=196.0

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEec
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      +..+.||+|+||.||++... +|+.||||++++..   ......+.+|..++..+ +||||+++++++.+.+..++||||
T Consensus        26 ~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~  105 (353)
T 3txo_A           26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEF  105 (353)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeC
Confidence            33457899999999999964 58999999997642   23456788999999988 799999999999999999999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++|+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       106 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          106 VNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            999999999965    24599999999999999999999999   99999999999999999999999999998543222


Q ss_pred             cccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +....   .. .        ..
T Consensus       179 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i---~~-~--------~~  241 (353)
T 3txo_A          179 V--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAI---LN-D--------EV  241 (353)
T ss_dssp             ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH-C--------CC
T ss_pred             c--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HHHHH---Hc-C--------CC
Confidence            1  2223459999999999998889999999999999999999999998754421   11111   11 0        00


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM------SHVVH  545 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~------~evl~  545 (557)
                            ..+...+..+.+++.+||+.||++||++      ++|++
T Consensus       242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                  0111234568899999999999999998      67765

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=345.73  Aligned_cols=245  Identities=22%  Similarity=0.317  Sum_probs=198.7

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      ..+.||+|+||.||++... +++.||+|++....   ......+.+|+.+|..++||||+++++++.+.+..++||||+.
T Consensus        19 i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~   98 (384)
T 4fr4_A           19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLL   98 (384)
T ss_dssp             EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence            3457899999999999965 48899999997542   2345678999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++........ 
T Consensus        99 gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-  170 (384)
T 4fr4_A           99 GGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-  170 (384)
T ss_dssp             TEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCCc-
Confidence            9999999964    34699999999999999999999999   999999999999999999999999999987643322 


Q ss_pred             cceeecCccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          429 ERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                        .....||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+......    .         
T Consensus       171 --~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~---------  235 (384)
T 4fr4_A          171 --ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----T---------  235 (384)
T ss_dssp             --BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----C---------
T ss_pred             --eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----c---------
Confidence              223449999999999874   4589999999999999999999999976544322222211110    0         


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVH  545 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-~~evl~  545 (557)
                           ....+...+..+.+|+.+||+.||++||+ +++|++
T Consensus       236 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 -----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                 00111223456899999999999999998 777764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.8e-41  Score=342.42  Aligned_cols=259  Identities=27%  Similarity=0.369  Sum_probs=204.7

Q ss_pred             CCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCC-ceEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG-DRYI  342 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~-~~~l  342 (557)
                      ...+.||+|+||.||++..      .+++.||||+++... ......+.+|+.++.++ +||||+++++++...+ ..++
T Consensus        30 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~l  109 (316)
T 2xir_A           30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV  109 (316)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred             eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEE
Confidence            4456789999999999984      346899999997653 33456899999999999 7999999999987654 4899


Q ss_pred             EEecCCCCChHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 008698          343 VYEFVVNGPLDRWLHHIPRG------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG  410 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~  410 (557)
                      ||||+++|+|.+++......            ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~  186 (316)
T 2xir_A          110 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNV  186 (316)
T ss_dssp             EEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCC
Confidence            99999999999999753321            12389999999999999999999999   9999999999999999999


Q ss_pred             cEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhh
Q 008698          411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA  489 (557)
Q Consensus       411 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~  489 (557)
                      +||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......  .+... 
T Consensus       187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~-  263 (316)
T 2xir_A          187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRR-  263 (316)
T ss_dssp             EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHHHH-
T ss_pred             EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--HHHHH-
Confidence            99999999987654332222222337889999999998899999999999999999999 999997654321  11110 


Q ss_pred             hhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       490 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                         ......     .        ..+...+..+.+++.+||+.||.+|||+++|++.|+++.+
T Consensus       264 ---~~~~~~-----~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          264 ---LKEGTR-----M--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             ---HHHTCC-----C--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---hccCcc-----C--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence               111000     0        0011234568899999999999999999999999987654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=346.78  Aligned_cols=249  Identities=18%  Similarity=0.287  Sum_probs=192.2

Q ss_pred             CCCCeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCC--CcEEeeeeeeeeCCceEEEEec
Q 008698          271 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHH--PNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      +...+.||+|+||.||++...+++.||||++...  .....+.+.+|+.+|.+++|  |||+++++++.+.+..++||| 
T Consensus        11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-   89 (343)
T 3dbq_A           11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-   89 (343)
T ss_dssp             EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred             EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence            3445678999999999999988999999998754  33445789999999999976  999999999999999999999 


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +.+|+|.+++..    ...+++.++..++.||+.||+|||++   +|+||||||+|||++ ++.+||+|||+++......
T Consensus        90 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           90 CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            468899999975    24689999999999999999999999   999999999999997 5679999999998765443


Q ss_pred             cccceeecCccccccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYR-----------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS  495 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  495 (557)
                      .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||...... ...+    .     
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~----~-----  231 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKL----H-----  231 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-HHHH----H-----
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-HHHH----H-----
Confidence            3322333459999999999864           67899999999999999999999999754321 0001    0     


Q ss_pred             cccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       496 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                          ..+++...    ...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       232 ----~~~~~~~~----~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          232 ----AIIDPNHE----IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ----HHHCTTSC----CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----HHhcCCcc----cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                11111110    00111123468899999999999999999999863

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-41  Score=343.88  Aligned_cols=253  Identities=23%  Similarity=0.415  Sum_probs=197.8

Q ss_pred             CeeecccCceEEEEEEeCC-----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILPD-----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .+.||+|+||.||+|....     +..||||.++.. .......+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus        49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  128 (333)
T 1mqb_A           49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM  128 (333)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence            3678999999999998643     236999999764 3344567999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++...   ...+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       129 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  202 (333)
T 1mqb_A          129 ENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  202 (333)
T ss_dssp             TTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             CCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence            999999999752   35699999999999999999999999   999999999999999999999999999987653322


Q ss_pred             cc-ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          428 QE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       428 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      .. ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||...+...   +....    ....     .  
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~~----~~~~-----~--  268 (333)
T 1mqb_A          203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAI----NDGF-----R--  268 (333)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH----HTTC-----C--
T ss_pred             cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH----HCCC-----c--
Confidence            11 1122236789999999998999999999999999999999 999997654321   11111    1000     0  


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                            ...+..++..+.+++.+||+.+|++||++.+|++.|+++..
T Consensus       269 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          269 ------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             ------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                  00112234568999999999999999999999999987643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.6e-41  Score=335.74  Aligned_cols=254  Identities=26%  Similarity=0.415  Sum_probs=199.2

Q ss_pred             CeeecccCceEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeee-eCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~  347 (557)
                      .+.||+|+||.||+|...+    ...||||.+... .....+.+.+|+.++++++||||+++++++. ..+..++||||+
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  109 (298)
T 3f66_A           30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  109 (298)
T ss_dssp             EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred             cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence            4578999999999998643    236899998764 3345578999999999999999999999865 456789999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       110 ~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          110 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             TTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred             CCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccch
Confidence            99999999964   235689999999999999999999999   999999999999999999999999999987654332


Q ss_pred             c--cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          428 Q--ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       428 ~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      .  .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...........   .   ....        
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~---~---~~~~--------  249 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---L---LQGR--------  249 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH---H---HTTC--------
T ss_pred             hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---H---hcCC--------
Confidence            1  11223347889999999998899999999999999999999 5566655433221110   0   0000        


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                            ....+...+..+.+++.+||+.||++|||++++++.|+++...
T Consensus       250 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          250 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                  0011122345689999999999999999999999999887553

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=339.54  Aligned_cols=239  Identities=22%  Similarity=0.318  Sum_probs=188.5

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||+||+|... +|+.||||++...  .......+..|+..+.++ +||||+++++++.+.+..++||||+ +
T Consensus        62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~  140 (311)
T 3p1a_A           62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G  140 (311)
T ss_dssp             EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred             eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence            346799999999999975 6999999998653  233445566677666666 9999999999999999999999999 7


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++|.+++...   ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........  
T Consensus       141 ~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~--  212 (311)
T 3p1a_A          141 PSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--  212 (311)
T ss_dssp             CBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCCC--
Confidence            7999888653   35699999999999999999999999   999999999999999999999999999876643322  


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                       .....||+.|+|||++.+ .++.++|||||||++|||++|..|+.....  +..        ....    ...+..   
T Consensus       213 -~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~~--------~~~~----~~~~~~---  273 (311)
T 3p1a_A          213 -GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--WQQ--------LRQG----YLPPEF---  273 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--HHH--------HTTT----CCCHHH---
T ss_pred             -CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHH--------Hhcc----CCCccc---
Confidence             222348999999998875 789999999999999999999777654211  000        0000    011111   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                           +...+..+.+++.+||+.||++|||++|+++
T Consensus       274 -----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          274 -----TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                 1123456899999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.9e-41  Score=333.88  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=198.1

Q ss_pred             CeeecccCceEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|+||.||+|...+    +..||||.+... .....+.+.+|+.++.+++||||+++++++.+ +..++||||++
T Consensus        17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   95 (281)
T 3cc6_A           17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYP   95 (281)
T ss_dssp             EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCC
Confidence            4578999999999998643    236999999765 34456789999999999999999999999765 45789999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +++|.+++...   ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.........
T Consensus        96 ~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  169 (281)
T 3cc6_A           96 YGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY  169 (281)
T ss_dssp             TCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred             CCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence            99999999752   24589999999999999999999999   9999999999999999999999999999876543222


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      . .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||............       ....          
T Consensus       170 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~-------~~~~----------  231 (281)
T 3cc6_A          170 K-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-------EKGD----------  231 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH-------HHTC----------
T ss_pred             c-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH-------hcCC----------
Confidence            1 122337889999999988899999999999999999999 99999765443211111       0000          


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                         ....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       232 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          232 ---RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence               00011123456889999999999999999999999998764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.4e-41  Score=341.10  Aligned_cols=246  Identities=19%  Similarity=0.306  Sum_probs=192.3

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc------------
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------------  339 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~------------  339 (557)
                      .+.||+|+||.||++... +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+.            
T Consensus        11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~   90 (332)
T 3qd2_B           11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL   90 (332)
T ss_dssp             EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred             eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence            346799999999999975 79999999997543 3356789999999999999999999999865442            


Q ss_pred             ---------------------------------------------eEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHH
Q 008698          340 ---------------------------------------------RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV  374 (557)
Q Consensus       340 ---------------------------------------------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i  374 (557)
                                                                   .++||||+++|+|.+++..... ....++..+..+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~i  169 (332)
T 3qd2_B           91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREHGVCLHI  169 (332)
T ss_dssp             -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCHHHHHHH
T ss_pred             ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhhHHHHHH
Confidence                                                         7999999999999999976332 244677789999


Q ss_pred             HHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc----------cceeecCccccccccc
Q 008698          375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ----------ERTVMAGGTYGYLAPE  444 (557)
Q Consensus       375 ~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~----------~~~~~~~gt~~y~aPE  444 (557)
                      +.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........          .......||+.|+|||
T Consensus       170 ~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  246 (332)
T 3qd2_B          170 FIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE  246 (332)
T ss_dssp             HHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred             HHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence            99999999999999   9999999999999999999999999999876543211          1112234899999999


Q ss_pred             cccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHH
Q 008698          445 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVD  524 (557)
Q Consensus       445 ~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~  524 (557)
                      .+.+..++.++||||||+++|||++|..|+...     .....   . ....        .     ...........+.+
T Consensus       247 ~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~---~-~~~~--------~-----~~~~~~~~~~~~~~  304 (332)
T 3qd2_B          247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIIT---D-VRNL--------K-----FPLLFTQKYPQEHM  304 (332)
T ss_dssp             HHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHH---H-HHTT--------C-----CCHHHHHHCHHHHH
T ss_pred             HhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHH---H-hhcc--------C-----CCcccccCChhHHH
Confidence            999999999999999999999999987664211     00000   0 0000        0     01112334566789


Q ss_pred             HHHHhcCCCCCCCCCHHHHHH
Q 008698          525 LVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       525 l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ++.+||+.||++|||++|+++
T Consensus       305 li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          305 MVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCCcCCCHHHHhh
Confidence            999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-41  Score=346.34  Aligned_cols=268  Identities=25%  Similarity=0.347  Sum_probs=205.7

Q ss_pred             CeeecccCceEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeee--eCCceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY--DHGDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~--~~~~~~lV~E~  346 (557)
                      .+.||+|+||.||++.+     .+++.||||++........+.+.+|+.++.+++||||+++++++.  +.+..++||||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~  107 (327)
T 3lxl_A           28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY  107 (327)
T ss_dssp             EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred             hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence            45689999999999984     358899999998777677788999999999999999999999887  45668999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus       108 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~  181 (327)
T 3lxl_A          108 LPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK  181 (327)
T ss_dssp             CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred             cCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence            9999999999642   23599999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cc-cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          427 MQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       427 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      .. .......+|..|+|||.+.+..++.++||||||+++|||++|+.||........... .............+.+...
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  260 (327)
T 3lxl_A          182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALSRLLELLEEG  260 (327)
T ss_dssp             SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHHHHHHHHHTT
T ss_pred             ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHHHHHHHhhcc
Confidence            21 112223478889999999988899999999999999999999999865322100000 0000000000000011100


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      .    ....+..++..+.+++.+||+.||++|||+++|++.|+.+..
T Consensus       261 ~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          261 Q----RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             c----CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0    111123345679999999999999999999999999987754

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2e-41  Score=373.43  Aligned_cols=249  Identities=27%  Similarity=0.386  Sum_probs=199.0

Q ss_pred             eeecccCceEEEEEEeC---CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGILP---DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~---~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      +.||+|+||.||+|.+.   .++.||||+++...  ....+++.+|+.+|.+++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            46899999999999753   46789999997643  2346789999999999999999999999864 568999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc-
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-  428 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  428 (557)
                      |+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++........ 
T Consensus       454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999964    34699999999999999999999999   9999999999999999999999999999876543221 


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...+.......       .....          
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-------i~~~~----------  589 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------LEKGE----------  589 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTC----------
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC----------
Confidence            12222336789999999998899999999999999999999 9999987654221111       11110          


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                         ....+..++..+.+++..||+.||++|||+++|++.|+++.
T Consensus       590 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          590 ---RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence               01112234567999999999999999999999999998753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.9e-41  Score=345.34  Aligned_cols=240  Identities=23%  Similarity=0.416  Sum_probs=194.6

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +.||+|+||.||++.. .+|+.||||++....   ....+++.+|+.++.+++||||+++++++.+.+..++||||+. |
T Consensus        60 ~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g  138 (348)
T 1u5q_A           60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G  138 (348)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred             eEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-C
Confidence            4679999999999996 568999999997542   2334678999999999999999999999999999999999996 6


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++...   ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.......    
T Consensus       139 ~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~----  208 (348)
T 1u5q_A          139 SASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----  208 (348)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC----
T ss_pred             CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC----
Confidence            888877532   25699999999999999999999999   99999999999999999999999999998654321    


Q ss_pred             eeecCcccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          431 TVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                        ...||+.|+|||++.   ...++.++|||||||++|||+||+.||...+...  .+    .......      .+.. 
T Consensus       209 --~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~----~~~~~~~------~~~~-  273 (348)
T 1u5q_A          209 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--AL----YHIAQNE------SPAL-  273 (348)
T ss_dssp             --CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH----HHHHHSC------CCCC-
T ss_pred             --cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HH----HHHHhcC------CCCC-
Confidence              234899999999985   5678999999999999999999999997654321  11    1111110      0101 


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                            .....+..+.+++.+||+.||++|||++++++.
T Consensus       274 ------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          274 ------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                  111234568899999999999999999999863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.6e-40  Score=346.15  Aligned_cols=268  Identities=17%  Similarity=0.233  Sum_probs=199.7

Q ss_pred             CCCeeeccc--CceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          272 EGNRLLGDS--KTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       272 ~~~~~lg~G--~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      +..+.||+|  +||.||++... +|+.||||+++...  ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        28 ~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  107 (389)
T 3gni_B           28 ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF  107 (389)
T ss_dssp             EEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEc
Confidence            334578999  99999999975 69999999997543  34457788999999999999999999999999999999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++|+|.+++....  ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||.+.......
T Consensus       108 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          108 MAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             CTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred             cCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence            99999999997632  34599999999999999999999999   99999999999999999999999999986542221


Q ss_pred             c-----ccceeecCccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhh----c
Q 008698          427 M-----QERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ----S  495 (557)
Q Consensus       427 ~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~----~  495 (557)
                      .     ........||+.|+|||.+.+  ..++.++|||||||++|||++|+.||.+.+....  +.........    .
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDT  260 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-----------
T ss_pred             ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCccccc
Confidence            1     111112248899999999987  5789999999999999999999999976544321  1110000000    0


Q ss_pred             ------------------cccccccCccc-----ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          496 ------------------HRYLELLDPLI-----SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       496 ------------------~~~~~~~d~~l-----~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                                        ....+.+....     ............+..+.+|+.+||+.||++|||++|+++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                              00000000000     0000001122345678999999999999999999999863

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.3e-41  Score=348.28  Aligned_cols=247  Identities=19%  Similarity=0.307  Sum_probs=192.1

Q ss_pred             CCCeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcC--CCcEEeeeeeeeeCCceEEEEecC
Q 008698          272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      ...+.||+|+||.||++...+++.||||++...  .....+.+.+|+.+|.+++  ||||+++++++...+..++||| +
T Consensus        59 ~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~  137 (390)
T 2zmd_A           59 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C  137 (390)
T ss_dssp             EEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-C
T ss_pred             EEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-c
Confidence            334578999999999999888999999998654  3345678999999999996  5999999999999999999999 5


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      .+++|.+++..    ...+++.++..++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||+++.......
T Consensus       138 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          138 GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             CSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            68899999975    24689999999999999999999999   999999999999996 57899999999987654433


Q ss_pred             ccceeecCccccccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcc
Q 008698          428 QERTVMAGGTYGYLAPEFVYR-----------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  496 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (557)
                      ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||...... ...+           
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~-----------  277 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKL-----------  277 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHH-----------
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-HHHH-----------
Confidence            222233459999999999865           36889999999999999999999999754321 0001           


Q ss_pred             ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       497 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        ..++++.........    .+..+.+++.+||+.||++|||+.||++
T Consensus       278 --~~~~~~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          278 --HAIIDPNHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             --HHHHCTTSCCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HHHhCccccCCCCcc----chHHHHHHHHHHcccChhhCCCHHHHhh
Confidence              011111110000111    1346889999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-40  Score=338.51  Aligned_cols=265  Identities=21%  Similarity=0.368  Sum_probs=197.1

Q ss_pred             CCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhh--cCCCcEEeeeeeeeeC----CceEEEEe
Q 008698          272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHHPNLVAVKGCCYDH----GDRYIVYE  345 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~g~~~~~----~~~~lV~E  345 (557)
                      ...+.||+|+||.||+|.. .|+.||||++...   ....+.+|.+++..  ++||||+++++++...    +..++|||
T Consensus        40 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e  115 (337)
T 3mdy_A           40 QMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD  115 (337)
T ss_dssp             EEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEEC
T ss_pred             EEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEe
Confidence            3455779999999999998 5999999999644   23444555555554  4999999999999877    67899999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      |+++|+|.+++..     ..+++..+..++.|++.||+|||+..     .++|+||||||+|||++.++.+||+|||+++
T Consensus       116 ~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~  190 (337)
T 3mdy_A          116 YHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  190 (337)
T ss_dssp             CCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence            9999999999965     35999999999999999999999762     3489999999999999999999999999997


Q ss_pred             cCCccccccc--eeecCccccccccccccCCCCCch------hhHHHHHHHHHHHHcC----------CCCCCCCCcccc
Q 008698          421 FVPWEVMQER--TVMAGGTYGYLAPEFVYRNELTTK------SDVYSFGVLLLEIVSG----------RRPAQAVDSVCW  482 (557)
Q Consensus       421 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~------sDVwS~Gvil~el~tG----------~~p~~~~~~~~~  482 (557)
                      ..........  .....||+.|+|||.+.+...+.+      +|||||||++|||+||          ..||........
T Consensus       191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  270 (337)
T 3mdy_A          191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP  270 (337)
T ss_dssp             ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence            6543322211  122348999999999987665554      9999999999999999          555544322110


Q ss_pred             hhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          483 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                      .  ...........    ...+..   .......+++..+.+++.+||+.||++|||+.+|++.|+++.+..
T Consensus       271 ~--~~~~~~~~~~~----~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          271 S--YEDMREIVCIK----KLRPSF---PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             C--HHHHHHHHTTS----CCCCCC---CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             c--hhhhHHHHhhh----ccCccc---cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            0  00001111100    011111   011112467888999999999999999999999999999887654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-40  Score=336.35  Aligned_cols=239  Identities=23%  Similarity=0.331  Sum_probs=198.2

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +|+.||+|+++...   ....+.+.+|..++..++||||+++++++.+.+..++||||+++
T Consensus        11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g   90 (318)
T 1fot_A           11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG   90 (318)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence            356899999999999974 68999999997542   23456788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.....    
T Consensus        91 g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----  159 (318)
T 1fot_A           91 GELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----  159 (318)
T ss_dssp             CBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence            999999975    24689999999999999999999999   9999999999999999999999999999865432    


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                       .....||+.|+|||.+.+..++.++|||||||++|||++|..||...+...   ...   ....         ..+   
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~---~i~~---------~~~---  220 (318)
T 1fot_A          160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYE---KILN---------AEL---  220 (318)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHH---------CCC---
T ss_pred             -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh---------CCC---
Confidence             123358999999999999999999999999999999999999997654321   111   1111         000   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                         ..+...+..+.+++.+|++.||++||     ++++|++
T Consensus       221 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence               00112345688999999999999999     8899885

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.1e-41  Score=345.25  Aligned_cols=243  Identities=23%  Similarity=0.310  Sum_probs=197.7

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEec
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      ...+.||+|+||.||++... +|+.||||+++...   ......+.+|..++..+ +||||+++++++.+.+..++||||
T Consensus        20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~   99 (345)
T 1xjd_A           20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY   99 (345)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence            33457899999999999975 58899999997642   23456788899999887 999999999999999999999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++|+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A          100 LNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            999999999965    24589999999999999999999999   99999999999999999999999999998543222


Q ss_pred             cccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|..||...+...   +....   .. .      .+. 
T Consensus       173 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i---~~-~------~~~-  236 (345)
T 1xjd_A          173 A--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSI---RM-D------NPF-  236 (345)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH-C------CCC-
T ss_pred             C--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH---Hh-C------CCC-
Confidence            1  1223459999999999999999999999999999999999999998654321   11111   00 0      000 


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVV  544 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~-evl  544 (557)
                             .+...+..+.+++.+||+.||++||++. +|+
T Consensus       237 -------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          237 -------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                   1112345688999999999999999997 665

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.8e-41  Score=339.61  Aligned_cols=260  Identities=19%  Similarity=0.271  Sum_probs=194.4

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .++||+|+||.||++.. .+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++||||+++|+
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   97 (316)
T 2ac3_A           18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS   97 (316)
T ss_dssp             CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence            35689999999999995 46899999999876556678899999999985 79999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---cEEeeccCCccCCcccc-
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSKFVPWEVM-  427 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgl~~~~~~~~~-  427 (557)
                      |.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.   +||+|||++........ 
T Consensus        98 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~  170 (316)
T 2ac3_A           98 ILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC  170 (316)
T ss_dssp             HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred             HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence            9999975    24689999999999999999999999   9999999999999998776   99999999976542211 


Q ss_pred             ----ccceeecCccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccc
Q 008698          428 ----QERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  498 (557)
Q Consensus       428 ----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (557)
                          ........||+.|+|||.+.+     ..++.++||||||+++|||+||+.||................+.......
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  250 (316)
T 2ac3_A          171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF  250 (316)
T ss_dssp             -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred             ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence                111122348999999999875     45789999999999999999999999875432210000000000000000


Q ss_pred             ccccCcccccCCCCCCc---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          499 LELLDPLISSLSSDIPE---AGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       499 ~~~~d~~l~~~~~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..+....     ...+.   ...+..+.+++.+||+.||++|||++|+++
T Consensus       251 ~~i~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          251 ESIQEGK-----YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHCC-----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhccC-----cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            0000000     00111   113456899999999999999999999997

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-40  Score=346.19  Aligned_cols=249  Identities=22%  Similarity=0.298  Sum_probs=195.2

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .++||+|+||.||++... +++.||||++++...   .....+.+|..++.++ +||||+++++++.+.+..++||||++
T Consensus        57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~  136 (396)
T 4dc2_A           57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN  136 (396)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence            457899999999999975 478999999976532   2234578899999887 89999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|..++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......  
T Consensus       137 gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--  207 (396)
T 4dc2_A          137 GGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--  207 (396)
T ss_dssp             TCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC--
Confidence            9999999865    24699999999999999999999999   99999999999999999999999999998533221  


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc--hhHHHhhhhhhhccccccccCccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW--QSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ............        ...+
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~--------~~~~  279 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--------EKQI  279 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH--------HCCC
T ss_pred             CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh--------cccc
Confidence            122334599999999999999999999999999999999999999975432111  000010111010        0000


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM------SHVVH  545 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~------~evl~  545 (557)
                            ..+...+..+.+|+.+||+.||++||++      +||++
T Consensus       280 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          280 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             ------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence                  1112234568899999999999999995      56655

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.8e-42  Score=347.89  Aligned_cols=263  Identities=27%  Similarity=0.376  Sum_probs=202.6

Q ss_pred             hcCCCCCCeeecccCceEEEEEEe------CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc
Q 008698          267 TKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD  339 (557)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~g~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~  339 (557)
                      ..+.+...+.||+|+||.||++..      .+++.||||++... ......++.+|+.++.+++||||+++++++.+.+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            333344456789999999999984      24778999999754 34456789999999999999999999999999999


Q ss_pred             eEEEEecCCCCChHHHhccCCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCcEE
Q 008698          340 RYIVYEFVVNGPLDRWLHHIPRG---GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHL  413 (557)
Q Consensus       340 ~~lV~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl  413 (557)
                      .++||||+++|+|.+++......   ...+++..+..++.||+.||.|||++   +|+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999764321   24589999999999999999999999   9999999999999984   456999


Q ss_pred             eeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhh
Q 008698          414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPL  492 (557)
Q Consensus       414 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~  492 (557)
                      +|||++................+++.|+|||.+.+..++.++||||||+++|||+| |..||.......   +....   
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~---  258 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFV---  258 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHH---
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHHHH---
Confidence            99999875432222222223347889999999988899999999999999999999 999987654321   11111   


Q ss_pred             hhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          493 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       493 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                       ....             ....+..++..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       259 -~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          259 -TSGG-------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             -HTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -hcCC-------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence             0000             001112234568999999999999999999999999986654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.8e-41  Score=343.78  Aligned_cols=246  Identities=25%  Similarity=0.322  Sum_probs=184.5

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +..+.||+|+||.||++... +++.||||+++...  ..+.+.+|+.++.+++||||+++++++.+.+..++||||+++|
T Consensus        56 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  133 (349)
T 2w4o_A           56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG  133 (349)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence            33457899999999999975 47899999997653  3467889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCcEEeeccCCccCCcccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      +|.+++..    ...+++.++..++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++.......
T Consensus       134 ~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  206 (349)
T 2w4o_A          134 ELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL  206 (349)
T ss_dssp             BHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence            99999864    34589999999999999999999999   9999999999999975   88999999999986543221


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                         .....||+.|+|||++.+..++.++|||||||++|||++|..||.......  .+....    ..... ....+   
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i----~~~~~-~~~~~---  273 (349)
T 2w4o_A          207 ---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRI----LNCEY-YFISP---  273 (349)
T ss_dssp             ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHH----HTTCC-CCCTT---
T ss_pred             ---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHH----HhCCC-ccCCc---
Confidence               122348999999999999899999999999999999999999997654321  111100    00000 00000   


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                            ...+.+..+.+++.+||+.||++|||+.|+++
T Consensus       274 ------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          274 ------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  01123456889999999999999999999997

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=347.75  Aligned_cols=268  Identities=22%  Similarity=0.360  Sum_probs=205.5

Q ss_pred             CCCCeeecccCceEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC--ceEEE
Q 008698          271 SEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIV  343 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--~~~lV  343 (557)
                      ....+.||+|+||.||++.+     .+|+.||||++........+.+.+|+.++.+++||||+++++++...+  ..++|
T Consensus        43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  122 (326)
T 2w1i_A           43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI  122 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred             ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence            34456789999999999984     368899999998776666788999999999999999999999987654  67999


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      |||+++++|.+++...   ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       123 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          123 MEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             ECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999753   24589999999999999999999999   99999999999999999999999999998765


Q ss_pred             cccccc-ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhh----hhcccc
Q 008698          424 WEVMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL----VQSHRY  498 (557)
Q Consensus       424 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~----~~~~~~  498 (557)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||+||..|+......    +.......    .....+
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchhhhHHHH
Confidence            432211 112233678899999998888999999999999999999999987642110    00000000    000000


Q ss_pred             ccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       499 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      .+.+....    ....+..++..+.+++.+||+.||++|||+.+|++.|+++..
T Consensus       273 ~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          273 IELLKNNG----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHTTC----CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhhcCC----CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            01111000    111122345679999999999999999999999999987753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.8e-41  Score=332.99  Aligned_cols=247  Identities=23%  Similarity=0.355  Sum_probs=193.8

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||++... ++..||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||||+++|+
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  106 (285)
T 3is5_A           27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE  106 (285)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCB
T ss_pred             cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCc
Confidence            456799999999999964 58899999987653 3346789999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCcEEeeccCCccCCccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      |.+++.........+++..+..++.|++.||+|||+.   +|+||||||+|||+   +.++.+||+|||++........ 
T Consensus       107 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~-  182 (285)
T 3is5_A          107 LLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-  182 (285)
T ss_dssp             HHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------
T ss_pred             HHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc-
Confidence            9998865333346799999999999999999999999   99999999999999   4567899999999986543322 


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                        .....||+.|+|||.+. ..++.++||||||+++|||++|+.||...+.........      . .      .+... 
T Consensus       183 --~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~------~-~------~~~~~-  245 (285)
T 3is5_A          183 --STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT------Y-K------EPNYA-  245 (285)
T ss_dssp             ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-C------CCCCC-
T ss_pred             --CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc------c-C------Ccccc-
Confidence              12234899999999875 568999999999999999999999998654322111000      0 0      00000 


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        ..  ....+..+.+++.+||+.||++|||++||++
T Consensus       246 --~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          246 --VE--CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             --C----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             --cc--cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00  0012346889999999999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.5e-41  Score=335.36  Aligned_cols=249  Identities=27%  Similarity=0.383  Sum_probs=198.8

Q ss_pred             eeecccCceEEEEEEe---CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGIL---PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~---~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      +.||+|+||.||++..   .+++.||||+++...  ....+++.+|+.++..++||||+++++++ ..+..++||||+++
T Consensus        23 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~  101 (291)
T 1xbb_A           23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAEL  101 (291)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred             CccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCC
Confidence            3789999999999964   246789999997543  23357899999999999999999999998 66778999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc-
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-  428 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  428 (557)
                      ++|.+++..    ...+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++......... 
T Consensus       102 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (291)
T 1xbb_A          102 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  174 (291)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence            999999975    24589999999999999999999999   9999999999999999999999999999876443221 


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .......+++.|+|||.+.+..++.++||||||+++|||+| |..||...+....   ...    .....          
T Consensus       175 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~----~~~~~----------  237 (291)
T 1xbb_A          175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAM----LEKGE----------  237 (291)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHH----HHTTC----------
T ss_pred             cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH----HHcCC----------
Confidence            11222336789999999988889999999999999999999 9999986543211   111    11110          


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                         ....+...+..+.+++.+||+.||++|||+.+|++.|+++-
T Consensus       238 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          238 ---RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               00011223467899999999999999999999999998753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.7e-41  Score=345.40  Aligned_cols=247  Identities=21%  Similarity=0.261  Sum_probs=188.4

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      ...+.||+|+||.||++... +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus        23 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~  101 (361)
T 3uc3_A           23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG  101 (361)
T ss_dssp             EEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             EEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence            33456899999999999975 68999999997653 23467889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC--cEEeeccCCccCCccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--AHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.  +||+|||+++....... 
T Consensus       102 ~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~-  173 (361)
T 3uc3_A          102 ELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  173 (361)
T ss_dssp             BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC-
Confidence            99999864    24599999999999999999999999   9999999999999987765  99999999974332211 


Q ss_pred             cceeecCccccccccccccCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhhhhhhccccccccCccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~-sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                        .....||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ .....   ....         ...
T Consensus       174 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---~~~~---------~~~  239 (361)
T 3uc3_A          174 --PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ---RILS---------VKY  239 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH---HHHT---------TCC
T ss_pred             --CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH---HHhc---------CCC
Confidence              122348999999999988877655 8999999999999999999986543211 11111   1100         000


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ........+..+.+|+.+||+.||++|||++|+++
T Consensus       240 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          240 ----SIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             ----CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ----CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence                00000112356889999999999999999999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=332.30  Aligned_cols=265  Identities=19%  Similarity=0.243  Sum_probs=194.6

Q ss_pred             CCCCeeecccCceEEEEEEe-CCCCEEEEEEecccch-----hhHHHHHHHHHHHhhc---CCCcEEeeeeeeeeCC---
Q 008698          271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF-----QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDHG---  338 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~~---  338 (557)
                      ++..+.||+|+||+||++.. .+|+.||||+++....     .....+.+|+.++.++   +||||+++++++....   
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~   90 (308)
T 3g33_A           11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR   90 (308)
T ss_dssp             CEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSS
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCC
Confidence            34455789999999999995 4689999999864321     1124566777766666   5999999999998765   


Q ss_pred             --ceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeec
Q 008698          339 --DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  416 (557)
Q Consensus       339 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  416 (557)
                        ..++||||+. |+|.+++...  ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           91 EIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             EEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             ceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeC
Confidence              4799999996 6999999753  234499999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhhhhhc
Q 008698          417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQS  495 (557)
Q Consensus       417 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~~~~~  495 (557)
                      |+++........   ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+...... +...... ...
T Consensus       165 g~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~  240 (308)
T 3g33_A          165 GLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL-PPE  240 (308)
T ss_dssp             SCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC-CCT
T ss_pred             ccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CCh
Confidence            999866433222   22348999999999999999999999999999999999999998765432111 1111000 000


Q ss_pred             cccccccC---cccccCCCCC---CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          496 HRYLELLD---PLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       496 ~~~~~~~d---~~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ........   ..........   ...+.+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            00000000   0000000000   00123457889999999999999999999986

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-40  Score=338.64  Aligned_cols=244  Identities=20%  Similarity=0.272  Sum_probs=189.3

Q ss_pred             CCCeeecccCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV  343 (557)
                      +..+.||+|+||.||++..    .+|+.||||+++...    ......+.+|+.++.+++||||+++++++...+..++|
T Consensus        20 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   99 (327)
T 3a62_A           20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLI   99 (327)
T ss_dssp             EEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEE
T ss_pred             EEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEE
Confidence            3345789999999999986    478999999997642    23345688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      |||+++|+|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       100 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A          100 LEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             EECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             EeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            999999999999964    24589999999999999999999999   99999999999999999999999999997543


Q ss_pred             ccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccC
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  503 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  503 (557)
                      ....  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+...   ...   .... .       
T Consensus       173 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~---~i~~-~-------  236 (327)
T 3a62_A          173 HDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TID---KILK-C-------  236 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHH-T-------
T ss_pred             cCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHh-C-------
Confidence            2211  1222348999999999999899999999999999999999999998654321   111   1110 0       


Q ss_pred             cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       504 ~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                       ..      ..+...+..+.+++.+||+.||++||     +++++++
T Consensus       237 -~~------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 -KL------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -CC------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -CC------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence             00      00112345688999999999999999     7778876

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.9e-41  Score=354.67  Aligned_cols=256  Identities=20%  Similarity=0.244  Sum_probs=200.3

Q ss_pred             hhcCCCCCCeeecccCceEEEEEEeCC-CCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceE
Q 008698          266 ITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY  341 (557)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~  341 (557)
                      ..++|.. .+.||+|+||+||++...+ ++.||||++++...   .....+.+|..++..++||||+++++++.+.+..+
T Consensus        72 ~~~~y~~-~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           72 HREDFEI-LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CGGGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             ChhheEE-EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            3444443 4567999999999999764 78999999975422   12234889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      +||||+++|+|.+++...   ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       151 lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             EEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence            999999999999999742   35699999999999999999999999   999999999999999999999999999976


Q ss_pred             CCccccccceeecCcccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcc
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  496 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (557)
                      ........ .....||+.|+|||++.     ...++.++|||||||++|||+||+.||...+..+.   ...........
T Consensus       225 ~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~~~  300 (437)
T 4aw2_A          225 LMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMNHKERF  300 (437)
T ss_dssp             CCTTSCEE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHHC
T ss_pred             cccCCCcc-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---HHhhhhccccc
Confidence            54433221 12235999999999987     46789999999999999999999999987543221   11110000000


Q ss_pred             ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 008698          497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVH  545 (557)
Q Consensus       497 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~evl~  545 (557)
                      .    + +      ..  ....+..+.+|+.+|+..+|++  ||+++|+++
T Consensus       301 ~----~-p------~~--~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          301 Q----F-P------TQ--VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             C----C-C------SS--CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             c----C-C------cc--cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            0    0 0      00  0113456889999999888888  999999987

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.2e-40  Score=338.02  Aligned_cols=249  Identities=22%  Similarity=0.279  Sum_probs=196.2

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|+||.||++... +|+.||||+++...   ......+.+|..++.++ +||||+++++++.+.+..++||||++
T Consensus        14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~   93 (345)
T 3a8x_A           14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   93 (345)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence            456899999999999975 58899999997642   33456788999999988 89999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        94 gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~-  165 (345)
T 3a8x_A           94 GGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-  165 (345)
T ss_dssp             SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC-
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCC-
Confidence            9999999864    24599999999999999999999999   999999999999999999999999999986432221 


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch--hHHHhhhhhhhccccccccCccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ--SIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                       ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........  .............        ..
T Consensus       166 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--------~~  236 (345)
T 3a8x_A          166 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------QI  236 (345)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--------CC
T ss_pred             -cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--------CC
Confidence             122345999999999999999999999999999999999999999753221100  0000000101100        00


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM------SHVVH  545 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~------~evl~  545 (557)
                            ..+...+..+.+++.+||+.||++||++      +|+++
T Consensus       237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          237 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             ------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence                  0112234568899999999999999995      56664

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.6e-40  Score=329.63  Aligned_cols=261  Identities=20%  Similarity=0.272  Sum_probs=194.7

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||+||++... +|+.||||+++...  ......+.+|+.++.+++||||+++++++.+.+..++||||+++ 
T Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-   85 (292)
T 3o0g_A            7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-   85 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred             eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence            346799999999999974 58999999997543  23357789999999999999999999999999999999999975 


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++........  
T Consensus        86 ~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  157 (292)
T 3o0g_A           86 DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--  157 (292)
T ss_dssp             EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC--
T ss_pred             CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc--
Confidence            56555543   235699999999999999999999999   9999999999999999999999999999866433221  


Q ss_pred             eeecCccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcc---cc---ccccC
Q 008698          431 TVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH---RY---LELLD  503 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~d  503 (557)
                      .....||+.|+|||.+.+.. ++.++|||||||++|||+||..|+.......  .............   ..   ....+
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhccccc
Confidence            12234899999999998765 7999999999999999999888865433211  1111111110000   00   00000


Q ss_pred             --cc---cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          504 --PL---ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       504 --~~---l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        +.   ................+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence              00   0000000011224467889999999999999999999987

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.7e-40  Score=345.51  Aligned_cols=250  Identities=18%  Similarity=0.259  Sum_probs=189.8

Q ss_pred             CCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeee----CCceEE
Q 008698          269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD----HGDRYI  342 (557)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~----~~~~~l  342 (557)
                      +|....++||+|+||.||++... +|+.||||+++..     ..+.+|+.++.++ +||||+++++++..    .+..++
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            44443457899999999999964 5889999999643     3567888887554 89999999999875    567899


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCcEEeeccCC
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGLS  419 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgl~  419 (557)
                      ||||+++|+|.+++...  ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||++
T Consensus       137 v~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999752  235699999999999999999999999   9999999999999998   788999999999


Q ss_pred             ccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhhhhcccc
Q 008698          420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRY  498 (557)
Q Consensus       420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~  498 (557)
                      +.......   .....||+.|+|||++.+..++.++|||||||++|||++|..||......... ......    .....
T Consensus       212 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~  284 (400)
T 1nxk_A          212 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQY  284 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCC
T ss_pred             cccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCcc
Confidence            86543221   22334899999999999999999999999999999999999999765443211 011100    00000


Q ss_pred             ccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       499 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          +  .    ........+..+.+|+.+||+.||++|||++||++
T Consensus       285 ----~--~----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          285 ----E--F----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             ----C--C----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----c--C----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                0  0    00001123456899999999999999999999997

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.4e-40  Score=326.97  Aligned_cols=241  Identities=21%  Similarity=0.292  Sum_probs=198.1

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||.||++.... +..||+|++........+.+.+|+.++.+++||||+++++++.+.+..++||||+++++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   93 (277)
T 3f3z_A           14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL   93 (277)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcH
Confidence            4567999999999999754 779999999876556678899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCcEEeeccCCccCCcccccc
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      .+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||+   +.++.+||+|||++......... 
T Consensus        94 ~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~-  165 (277)
T 3f3z_A           94 FERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-  165 (277)
T ss_dssp             HHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB-
T ss_pred             HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch-
Confidence            998865    24589999999999999999999999   99999999999999   78899999999999765533222 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....||+.|+|||.+.+ .++.++||||||+++|||+||+.||...+.....   .   . .....            
T Consensus       166 --~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~---~-~~~~~------------  223 (277)
T 3f3z_A          166 --RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM---L---K-IREGT------------  223 (277)
T ss_dssp             --CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---H-HHHCC------------
T ss_pred             --hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH---H---H-HHhCC------------
Confidence              22348999999998865 4899999999999999999999999765432111   0   0 00000            


Q ss_pred             CCCCCcH---HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEA---GVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~---~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       ...+..   ..+..+.+++.+||+.||++|||+.++++
T Consensus       224 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          224 -FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000000   23457889999999999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2e-40  Score=340.22  Aligned_cols=239  Identities=21%  Similarity=0.292  Sum_probs=198.3

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +|+.||||+++...   ....+.+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus        46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g  125 (350)
T 1rdq_E           46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG  125 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence            356899999999999975 58999999997542   23456789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++...    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......   
T Consensus       126 g~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~---  195 (350)
T 1rdq_E          126 GEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---  195 (350)
T ss_dssp             CBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCc---
Confidence            9999999752    4589999999999999999999999   99999999999999999999999999998654321   


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....||+.|+|||.+.+..++.++|||||||++|||++|..||...+...   +..   .... ..        +   
T Consensus       196 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~---~i~~-~~--------~---  255 (350)
T 1rdq_E          196 --WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYE---KIVS-GK--------V---  255 (350)
T ss_dssp             --CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHH-CC--------C---
T ss_pred             --ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HHH---HHHc-CC--------C---
Confidence              22348999999999999999999999999999999999999997654321   111   1111 10        0   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~  545 (557)
                         ..+...+..+.+++.+||+.||++||+     +++|++
T Consensus       256 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence               011123456889999999999999998     888875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=333.76  Aligned_cols=260  Identities=19%  Similarity=0.267  Sum_probs=194.9

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||.||++... +|+.||||++....  ....+.+.+|+.++.+++||||+++++++.+.+..++||||++++
T Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (311)
T 4agu_A            8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT   87 (311)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence            356799999999999975 48999999986543  233567889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.........  
T Consensus        88 ~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  158 (311)
T 4agu_A           88 VLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--  158 (311)
T ss_dssp             HHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             hHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--
Confidence            99988754    35599999999999999999999999   9999999999999999999999999999866433221  


Q ss_pred             eeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhh-h-------hhhhccccccc
Q 008698          431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA-T-------PLVQSHRYLEL  501 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~-~-------~~~~~~~~~~~  501 (557)
                      .....||..|+|||.+.+ ..++.++||||||+++|||+||..||...+........... .       ...........
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            122348999999999876 56899999999999999999999999876543221111100 0       00000000000


Q ss_pred             cCcccccCCCCCCc-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          502 LDPLISSLSSDIPE-----AGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       502 ~d~~l~~~~~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .  .+... ....+     ...+..+.+++.+||+.||++|||++|+++
T Consensus       239 ~--~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          239 V--KIPDP-EDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             C--CCCCC-SSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             C--cCCCc-cccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0  00000 00000     123456889999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=329.12  Aligned_cols=243  Identities=22%  Similarity=0.351  Sum_probs=178.8

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++.. .+|+.||||++.....   .....+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus        16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   95 (278)
T 3cok_A           16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN   95 (278)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence            45689999999999996 4689999999965422   2246789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++|.+++...   ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++......... 
T Consensus        96 ~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-  168 (278)
T 3cok_A           96 GEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-  168 (278)
T ss_dssp             EEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             CcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc-
Confidence            9999999742   35699999999999999999999999   9999999999999999999999999999865432221 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                       .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........   .            .......   
T Consensus       169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~------------~~~~~~~---  229 (278)
T 3cok_A          169 -HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---N------------KVVLADY---  229 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCC---
T ss_pred             -ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---H------------HHhhccc---
Confidence             11234899999999999888999999999999999999999999765432110   0            0000000   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ..+...+..+.+++.+||+.||++|||++++++
T Consensus       230 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 ---EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence               011123456889999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.4e-40  Score=336.85  Aligned_cols=265  Identities=23%  Similarity=0.314  Sum_probs=190.6

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      +.||+|+||.||++... +|+.||||+++.... .....+.+|+.++++++||||+++++++.+.+..++||||++ |+|
T Consensus        11 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L   89 (317)
T 2pmi_A           11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDL   89 (317)
T ss_dssp             --------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBH
T ss_pred             eEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCH
Confidence            45799999999999864 589999999975432 234678899999999999999999999999999999999997 699


Q ss_pred             HHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          353 DRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       353 ~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      .+++....  .....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++........  
T Consensus        90 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--  164 (317)
T 2pmi_A           90 KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--  164 (317)
T ss_dssp             HHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC--
T ss_pred             HHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCccc--
Confidence            99886432  2224589999999999999999999999   9999999999999999999999999999865432211  


Q ss_pred             eeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhhh----hhccccccccCc
Q 008698          431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPL----VQSHRYLELLDP  504 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~d~  504 (557)
                      .....+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...+...... +.......    +..........+
T Consensus       165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T 2pmi_A          165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNP  244 (317)
T ss_dssp             CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCT
T ss_pred             CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccc
Confidence            122348999999999976 468999999999999999999999998765432111 11100000    000000000000


Q ss_pred             ccccCCCCC--------CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 LISSLSSDI--------PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 ~l~~~~~~~--------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .+.......        .....+..+.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          245 NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            000000000        00112356899999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3e-40  Score=326.89  Aligned_cols=247  Identities=23%  Similarity=0.343  Sum_probs=199.1

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++..++||||+++++++.+.+..++||||+++++
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (276)
T 2yex_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   91 (276)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence            346799999999999975 68999999997543 3445788999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++............
T Consensus        92 L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           92 LFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             GGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             HHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            9999864    34689999999999999999999999   9999999999999999999999999999765433222222


Q ss_pred             eecCccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          432 VMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      ....|++.|+|||.+.+..+ +.++||||||+++|||++|..||....... .....+..    ..   ...        
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~----~~---~~~--------  228 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKE----KK---TYL--------  228 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHT----TC---TTS--------
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhh----cc---ccc--------
Confidence            23448999999999987665 779999999999999999999997654321 11111110    00   000        


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        ......+..+.+++.+||+.||++|||++|+++
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence              011223456889999999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.8e-41  Score=355.31  Aligned_cols=244  Identities=24%  Similarity=0.276  Sum_probs=190.2

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +..+.||+|+||.||++.. .+|+.||||+++..   .......+.+|+.++..++||||+++++++.+.+..++||||+
T Consensus       151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  230 (446)
T 4ejn_A          151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA  230 (446)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCC
T ss_pred             EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeC
Confidence            3345789999999999996 45899999999754   2233467789999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      ++|+|.+++..    ...+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++.+||+|||+++......
T Consensus       231 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          231 NGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             SSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            99999999864    2469999999999999999999998 8   99999999999999999999999999998643322


Q ss_pred             cccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +....   .. ..        .
T Consensus       304 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i---~~-~~--------~  366 (446)
T 4ejn_A          304 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI---LM-EE--------I  366 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH-CC--------C
T ss_pred             c--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHH---Hh-CC--------C
Confidence            2  1223459999999999999999999999999999999999999997654321   11111   00 00        0


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                            ..+...+..+.+++.+||+.||++||     |++|+++
T Consensus       367 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 ------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                  01112345688999999999999999     9999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-40  Score=352.78  Aligned_cols=243  Identities=24%  Similarity=0.353  Sum_probs=199.7

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      ...+.||+|+||.||+|... +|+.||||++.....   .....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~   98 (476)
T 2y94_A           19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV   98 (476)
T ss_dssp             EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            33457899999999999975 699999999975422   23567899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++........
T Consensus        99 ~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           99 SGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             SSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            99999999964    34699999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ccceeecCccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                         .....||+.|+|||.+.+..+ +.++|||||||++|||++|..||...+...   +....    .        +...
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~~i----~--------~~~~  233 (476)
T 2y94_A          172 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFKKI----C--------DGIF  233 (476)
T ss_dssp             ---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHHHH----H--------TTCC
T ss_pred             ---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHHHH----h--------cCCc
Confidence               223348999999999988765 689999999999999999999998654321   11111    0        0000


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                            ..+...+..+.+++.+||+.||++|||++||++
T Consensus       234 ------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          234 ------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                  001122356889999999999999999999997

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.4e-40  Score=338.14  Aligned_cols=267  Identities=21%  Similarity=0.328  Sum_probs=203.9

Q ss_pred             HhhcCCCCCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhh--cCCCcEEeeeeeeeeCC----
Q 008698          265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHHPNLVAVKGCCYDHG----  338 (557)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~g~~~~~~----  338 (557)
                      .+.++|. ..+.||+|+||.||++.. +|+.||||++...   ....+.+|.+++..  ++||||+++++++...+    
T Consensus        39 ~~~~~y~-~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           39 TIARTIV-LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHCE-EEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             cccccEE-EEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            3344443 345779999999999998 6999999999654   34677888888887  79999999999998776    


Q ss_pred             ceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeecCCCCCCeeeCCCCC
Q 008698          339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH--------DKVKPHVVHRDIRASNVLLDEEFG  410 (557)
Q Consensus       339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlk~~Nill~~~~~  410 (557)
                      ..++||||+++|+|.+++..     ..+++.++..++.|++.||.|||        +.   +|+||||||+|||++.++.
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~  185 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT  185 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred             eeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence            78999999999999999975     35899999999999999999999        77   9999999999999999999


Q ss_pred             cEEeeccCCccCCcccccc--ceeecCccccccccccccCC------CCCchhhHHHHHHHHHHHHcC----------CC
Q 008698          411 AHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIVSG----------RR  472 (557)
Q Consensus       411 ~kl~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwS~Gvil~el~tG----------~~  472 (557)
                      +||+|||++..........  ......||+.|+|||.+.+.      .++.++||||||+++|||+||          ..
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            9999999997654332111  12233489999999998765      234789999999999999999          66


Q ss_pred             CCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          473 PAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       473 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      ||........ ...... .....    ....+.+.   ......+++..+.+++.+||+.||++|||+++|++.|+++.+
T Consensus       266 p~~~~~~~~~-~~~~~~-~~~~~----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          266 PYYDLVPSDP-SVEEMR-KVVCE----QKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             TTTTTSCSSC-CHHHHH-HHHTT----SCCCCCCC---GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccccCcCcc-cHHHHH-HHHHH----HHhCCCCc---ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            7765432211 000101 10111    11111110   011123577889999999999999999999999999998866


Q ss_pred             C
Q 008698          553 P  553 (557)
Q Consensus       553 ~  553 (557)
                      .
T Consensus       337 ~  337 (342)
T 1b6c_B          337 Q  337 (342)
T ss_dssp             T
T ss_pred             H
Confidence            4

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.9e-41  Score=343.67  Aligned_cols=265  Identities=15%  Similarity=0.133  Sum_probs=196.3

Q ss_pred             CCCCeeecccCceEEEEEEeC----CCCEEEEEEecccchh-----------hHHHHHHHHHHHhhcCCCcEEeeeeeee
Q 008698          271 SEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSSFQ-----------RKKEFYSEIGRFARLHHPNLVAVKGCCY  335 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~~~----~g~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~H~niv~l~g~~~  335 (557)
                      +...+.||+|+||.||++...    ++..||||++......           ....+.+|+..+..++||||+++++++.
T Consensus        39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~  118 (345)
T 2v62_A           39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL  118 (345)
T ss_dssp             EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred             EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence            344567899999999999975    5788999998755321           1134677888999999999999999998


Q ss_pred             e----CCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC--
Q 008698          336 D----HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF--  409 (557)
Q Consensus       336 ~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~--  409 (557)
                      .    .+..++||||+ +++|.+++...    ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.++  
T Consensus       119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          119 TEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred             cccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence            7    67889999999 99999999752    3699999999999999999999999   999999999999999887  


Q ss_pred             CcEEeeccCCccCCccccc-----cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh
Q 008698          410 GAHLMGVGLSKFVPWEVMQ-----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS  484 (557)
Q Consensus       410 ~~kl~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~  484 (557)
                      .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||+||+.||........ .
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV-A  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH-H
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH-H
Confidence            9999999999876433211     111233489999999999999999999999999999999999999965322111 1


Q ss_pred             HHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          485 IFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       485 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ....... ... .....+....    .   ....+..+.+++.+||+.||++|||+++|++.|+++..+
T Consensus       270 ~~~~~~~-~~~-~~~~~~~~~~----~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          270 VQTAKTN-LLD-ELPQSVLKWA----P---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             HHHHHHH-HHH-TTTHHHHHHS----C---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             HHHHHHh-hcc-cccHHHHhhc----c---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence            1110000 000 0000000000    0   012345799999999999999999999999999987653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.9e-41  Score=350.10  Aligned_cols=246  Identities=20%  Similarity=0.245  Sum_probs=196.9

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +++.||+|++++...   .....+.+|..++..++||||+++++++.+.+..++||||+++
T Consensus        74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  153 (410)
T 3v8s_A           74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG  153 (410)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            456899999999999975 488999999975321   2234588999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..     ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       154 g~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~-  224 (410)
T 3v8s_A          154 GDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-  224 (410)
T ss_dssp             EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE-
T ss_pred             CcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc-
Confidence            999999975     3589999999999999999999999   9999999999999999999999999999876543221 


Q ss_pred             ceeecCccccccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          430 RTVMAGGTYGYLAPEFVYRNE----LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~----~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      ......||+.|+|||++.+..    ++.++|||||||++|||+||+.||...+....   ....   .....  ...-+ 
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i---~~~~~--~~~~p-  295 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSKI---MNHKN--SLTFP-  295 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH---HTHHH--HCCCC-
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH---HHHH---Hhccc--cccCC-
Confidence            122345999999999998655    78999999999999999999999986543211   1111   00000  00000 


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVH  545 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~evl~  545 (557)
                              .....+..+.+|+.+||+.+|.+  ||+++||++
T Consensus       296 --------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          296 --------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             --------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             --------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence                    00113356889999999999988  999999997

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.7e-40  Score=330.47  Aligned_cols=259  Identities=17%  Similarity=0.240  Sum_probs=199.8

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeee-eeCCceEEEEecCCC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC-YDHGDRYIVYEFVVN  349 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E~~~~  349 (557)
                      ...+.||+|+||.||++.. .+++.||||++....  ...++.+|+.++..++|+|++..++.+ .+.+..++||||+ +
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   88 (296)
T 4hgt_A           12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G   88 (296)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-C
Confidence            3455789999999999996 568899999876542  224588899999999888877766665 5667789999999 9


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCcEEeeccCCccCCccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      ++|.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||+   +.++.+||+|||+++......
T Consensus        89 ~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           89 PSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             CBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            9999998742   24699999999999999999999999   99999999999999   788999999999998664432


Q ss_pred             ccc-----ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccc
Q 008698          427 MQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  501 (557)
Q Consensus       427 ~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (557)
                      ...     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.................    ..
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~  238 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS----TP  238 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH----SC
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc----ch
Confidence            211     112334899999999999999999999999999999999999999876543322222211110000    00


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      ... +        ....+..+.+++.+||+.||++|||+++|++.|+++.+
T Consensus       239 ~~~-~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          239 IEV-L--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHH-H--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hhh-h--------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            000 0        01123568999999999999999999999999987643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.5e-41  Score=335.37  Aligned_cols=254  Identities=22%  Similarity=0.298  Sum_probs=200.9

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeee--CCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~  348 (557)
                      .+.||+|+||.||++... +|+.||+|.+...  .....+.+.+|+.++.+++||||+++++++.+  .+..++||||++
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   90 (279)
T 2w5a_A           11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE   90 (279)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred             ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence            356899999999999975 6899999999754  23445789999999999999999999998754  567899999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH-----VVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      +|+|.+++.........+++..+..++.|++.||.|||+.   +     ++||||||+|||++.++.+||+|||++....
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~  167 (279)
T 2w5a_A           91 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN  167 (279)
T ss_dssp             TEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHHC-
T ss_pred             CCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeec
Confidence            9999999976433445699999999999999999999998   7     9999999999999999999999999997654


Q ss_pred             ccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccC
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  503 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  503 (557)
                      ......  ....|++.|+|||.+.+..++.++||||||+++|||+||..||...+...   +...    .......    
T Consensus       168 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----i~~~~~~----  234 (279)
T 2w5a_A          168 HDTSFA--KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGK----IREGKFR----  234 (279)
T ss_dssp             --CHHH--HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----HHHTCCC----
T ss_pred             cccccc--cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHH----Hhhcccc----
Confidence            332111  12238899999999998899999999999999999999999998654321   1111    1111100    


Q ss_pred             cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       504 ~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                               ..+...+..+.+++.+||+.||++|||++||++.+...+.
T Consensus       235 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          235 ---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             ---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                     0111234568999999999999999999999988765443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.7e-40  Score=328.18  Aligned_cols=240  Identities=26%  Similarity=0.367  Sum_probs=194.8

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +++.||||++....   ......+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (279)
T 3fdn_A           14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL   93 (279)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence            456899999999999865 47799999986542   22356789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........  
T Consensus        94 ~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~--  164 (279)
T 3fdn_A           94 GTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--  164 (279)
T ss_dssp             EEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred             CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcccc--
Confidence            9999998652    4589999999999999999999999   999999999999999999999999999865443221  


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....|++.|+|||.+.+..++.++||||||+++|||++|..||...+....   ....    ..      ...     
T Consensus       165 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~----~~------~~~-----  224 (279)
T 3fdn_A          165 --TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRI----SR------VEF-----  224 (279)
T ss_dssp             -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH----HH------TCC-----
T ss_pred             --cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---HHHH----Hh------CCC-----
Confidence              223489999999999998899999999999999999999999976543211   1100    00      000     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ..+...+..+.+++.+||+.||++|||++||++
T Consensus       225 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          225 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ---CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence               011123456889999999999999999999997

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.2e-40  Score=328.26  Aligned_cols=245  Identities=21%  Similarity=0.289  Sum_probs=197.8

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||.||++... +|+.||+|++...  .....+.+.+|+.++.+++||||+++++++.+.+..++||||++++
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   90 (284)
T 3kk8_A           11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG   90 (284)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence            456799999999999964 5899999999654  2334577889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---cEEeeccCCccCCcccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgl~~~~~~~~~  427 (557)
                      +|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.   +||+|||++........
T Consensus        91 ~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           91 ELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            99888864    24589999999999999999999999   9999999999999987655   99999999976653322


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .   ....||+.|+|||.+.+..++.++||||||+++|||++|..||...+....   ....    ..... ....+   
T Consensus       164 ~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~----~~~~~-~~~~~---  229 (284)
T 3kk8_A          164 W---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YAQI----KAGAY-DYPSP---  229 (284)
T ss_dssp             C---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHTCC-CCCTT---
T ss_pred             c---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH---HHHH----Hhccc-cCCch---
Confidence            1   123489999999999999999999999999999999999999976543211   1110    00000 00000   


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                            .....+..+.+++.+||+.||++|||++|+++
T Consensus       230 ------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          230 ------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                  00123456889999999999999999999987

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=338.75  Aligned_cols=266  Identities=24%  Similarity=0.372  Sum_probs=193.2

Q ss_pred             CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHH--HHHHhhcCCCcEEeeeeeeee-----CCceEEEEe
Q 008698          273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSE--IGRFARLHHPNLVAVKGCCYD-----HGDRYIVYE  345 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e--~~~l~~l~H~niv~l~g~~~~-----~~~~~lV~E  345 (557)
                      ..+.||+|+||.||+|.. +++.||||++....   ...+..|  +..+..++||||+++++.+..     ....++|||
T Consensus        17 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e   92 (336)
T 3g2f_A           17 LLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME   92 (336)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred             eeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence            345789999999999987 78999999997543   3334444  444556899999999985542     235689999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeeecCCCCCCeeeCCCCCcEEeeccCC
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV------KPHVVHRDIRASNVLLDEEFGAHLMGVGLS  419 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~  419 (557)
                      |+++|+|.+++..     ...++..+..++.||+.||+|||+.+      .++|+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a  167 (336)
T 3g2f_A           93 YYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS  167 (336)
T ss_dssp             CCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence            9999999999965     34588999999999999999999873      338999999999999999999999999999


Q ss_pred             ccCCcccc------ccceeecCccccccccccccC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcc-cchhH
Q 008698          420 KFVPWEVM------QERTVMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQSI  485 (557)
Q Consensus       420 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~-~~~~~  485 (557)
                      +.......      ........||+.|+|||.+.+       ..++.++|||||||++|||+||..|+...... .....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  247 (336)
T 3g2f_A          168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA  247 (336)
T ss_dssp             EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred             eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence            86643221      111223348999999999976       45677999999999999999997776543221 11111


Q ss_pred             HHh----------hhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          486 FEW----------ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       486 ~~~----------~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ...          .......    ....+.+..  ........+..+.+++.+||+.||++|||++||++.|+++..+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          248 FQTEVGNHPTFEDMQVLVSR----EKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             THHHHCSSCCHHHHHHHHTT----SCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hhcccCCCchHHHHHhhhcc----cccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            100          0000000    001111100  1111234677899999999999999999999999999887653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.4e-41  Score=341.75  Aligned_cols=267  Identities=19%  Similarity=0.226  Sum_probs=200.6

Q ss_pred             HHhhcCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC
Q 008698          264 RSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-----SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH  337 (557)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~  337 (557)
                      ..+.++|.. .+.||+|+||.||++.. .+++.||||++...     .....+.+.+|+.++.+++||||+++++++.+.
T Consensus        22 ~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           22 LELQKKYHL-KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhheee-cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            344555544 44679999999999996 45889999998654     234457899999999999999999999999999


Q ss_pred             CceEEEEecCCCCChHHHhccCCCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 008698          338 GDRYIVYEFVVNGPLDRWLHHIPRG------------------------------------GRSLDWAMRMKVATTLAQG  381 (557)
Q Consensus       338 ~~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~g  381 (557)
                      +..++||||+++|+|.+++......                                    ...+++..+..++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999998521100                                    1224677788999999999


Q ss_pred             HHHHhcCCCCCeeecCCCCCCeeeCCCC--CcEEeeccCCccCCccccc--cceeecCccccccccccccC--CCCCchh
Q 008698          382 IAFLHDKVKPHVVHRDIRASNVLLDEEF--GAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYR--NELTTKS  455 (557)
Q Consensus       382 L~yLH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~Dfgl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~~s  455 (557)
                      |+|||+.   +|+||||||+|||++.++  .+||+|||+++........  .......||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999999   999999999999998776  8999999999765322111  11223448999999999875  6789999


Q ss_pred             hHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCC
Q 008698          456 DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPS  535 (557)
Q Consensus       456 DVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~  535 (557)
                      ||||||+++|||++|+.||.........      ........  ....+         .....+..+.+++.+||+.||.
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~------~~~~~~~~--~~~~~---------~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTI------SQVLNKKL--CFENP---------NYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCC--CTTSG---------GGGGSCHHHHHHHHHHSCSCTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHH------HHHHhccc--ccCCc---------ccccCCHHHHHHHHHHcCCChh
Confidence            9999999999999999999765432111      11111000  00000         0112345688999999999999


Q ss_pred             CCCCHHHHHH--HHhccc
Q 008698          536 MRPRMSHVVH--QLQQLA  551 (557)
Q Consensus       536 ~RPt~~evl~--~L~~~~  551 (557)
                      +|||+.++++  .+.++.
T Consensus       321 ~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          321 ERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             TSCCHHHHHHSHHHHTTS
T ss_pred             HCCCHHHHhcChhhccCh
Confidence            9999999987  455443

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.3e-41  Score=333.05  Aligned_cols=244  Identities=24%  Similarity=0.446  Sum_probs=197.9

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeee----------------
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----------------  336 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----------------  336 (557)
                      .+.||+|+||.||++... +|+.||||.++...    ..+.+|+.++.+++||||+++++++..                
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~   91 (284)
T 2a19_B           16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK   91 (284)
T ss_dssp             EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCE
T ss_pred             eeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccC
Confidence            456899999999999975 69999999997653    356789999999999999999998864                


Q ss_pred             CCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeec
Q 008698          337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  416 (557)
Q Consensus       337 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  416 (557)
                      ....++||||+++|+|.+++...  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  166 (284)
T 2a19_B           92 TKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDF  166 (284)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred             cceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcc
Confidence            34579999999999999999752  235699999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcc
Q 008698          417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  496 (557)
Q Consensus       417 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (557)
                      |++.........   ....+++.|+|||.+.+..++.++||||||+++|||++|..|+....     ....    ...  
T Consensus       167 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~----~~~--  232 (284)
T 2a19_B          167 GLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----KFFT----DLR--  232 (284)
T ss_dssp             TTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----HHHH----HHH--
T ss_pred             hhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----HHHH----Hhh--
Confidence            999866543221   12348999999999999899999999999999999999998864211     0000    000  


Q ss_pred             ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       497 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                            +..+    ..    ..+..+.+++.+||+.||++|||+.|+++.|+.+...+
T Consensus       233 ------~~~~----~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          233 ------DGII----SD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             ------TTCC----CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             ------cccc----cc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence                  0111    11    12345789999999999999999999999999887754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.1e-41  Score=339.56  Aligned_cols=254  Identities=28%  Similarity=0.457  Sum_probs=200.3

Q ss_pred             CCeeecccCceEEEEEEeC-CCCE--EEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSR--VAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      ..+.||+|+||.||++... +|..  ||||.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus        29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~  108 (327)
T 1fvr_A           29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA  108 (327)
T ss_dssp             EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecC
Confidence            3457899999999999964 4554  499998753 233456789999999999 9999999999999999999999999


Q ss_pred             CCCChHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEee
Q 008698          348 VNGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG  415 (557)
Q Consensus       348 ~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  415 (557)
                      ++|+|.+++....            .....+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~D  185 (327)
T 1fvr_A          109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD  185 (327)
T ss_dssp             TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred             CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEcc
Confidence            9999999997532            2234699999999999999999999999   999999999999999999999999


Q ss_pred             ccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhh
Q 008698          416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ  494 (557)
Q Consensus       416 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~  494 (557)
                      ||+++.......   .....+++.|+|||.+.+..++.++||||||+++|||+| |..||...+...   +....    .
T Consensus       186 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~~----~  255 (327)
T 1fvr_A          186 FGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL----P  255 (327)
T ss_dssp             TTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHG----G
T ss_pred             cCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---HHHHh----h
Confidence            999875432211   122237889999999988889999999999999999998 999997654321   11110    0


Q ss_pred             ccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       495 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      ..     ..        ...+...+..+.+++.+||+.||++|||++++++.|+++..
T Consensus       256 ~~-----~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          256 QG-----YR--------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             GT-----CC--------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cC-----CC--------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            00     00        00112234568999999999999999999999999987654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.3e-40  Score=339.95  Aligned_cols=243  Identities=23%  Similarity=0.316  Sum_probs=197.4

Q ss_pred             CCeeecccCceEEEEEEeCC-CCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecC
Q 008698          273 GNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      ..+.||+|+||.||++.... |+.||||+++...   ......+.+|..++..+ +||||+++++++.+.+..++||||+
T Consensus        24 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~  103 (353)
T 2i0e_A           24 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV  103 (353)
T ss_dssp             EEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCC
Confidence            34578999999999999754 7899999997642   23456788999999988 8999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++...    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       104 ~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A          104 NGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             CSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence            999999999742    4599999999999999999999999   999999999999999999999999999986432221


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +....   .. .        .+ 
T Consensus       177 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i---~~-~--------~~-  238 (353)
T 2i0e_A          177 --TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSI---ME-H--------NV-  238 (353)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH-C--------CC-
T ss_pred             --ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHHHH---Hh-C--------CC-
Confidence              1223459999999999999999999999999999999999999998654321   11111   11 0        00 


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~  545 (557)
                           ..+...+..+.+++.+||+.||++||+     +++|++
T Consensus       239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                 011223456889999999999999995     477764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.1e-41  Score=333.21  Aligned_cols=246  Identities=28%  Similarity=0.428  Sum_probs=194.1

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-CceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||.||++.. +|+.||||.++...  ..+.+.+|+.++.+++||||+++++++.+. +..++||||+++|+|
T Consensus        26 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L  102 (278)
T 1byg_A           26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL  102 (278)
T ss_dssp             EEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred             EeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence            45689999999999987 58999999997553  456799999999999999999999987654 578999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++...  ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.......     .
T Consensus       103 ~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~  172 (278)
T 1byg_A          103 VDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D  172 (278)
T ss_dssp             HHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred             HHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-----c
Confidence            9999642  112388999999999999999999999   99999999999999999999999999987554321     1


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ...+++.|+|||.+.+..++.++||||||+++|||+| |..||.......   +....    ...     ...       
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~----~~~-----~~~-------  233 (278)
T 1byg_A          173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKG-----YKM-------  233 (278)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHH----TTT-----CCC-------
T ss_pred             CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hcC-----CCC-------
Confidence            2237889999999988899999999999999999999 999997654321   11110    000     000       


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                       ..+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       234 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          234 -DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence             1112234578999999999999999999999999998764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=342.94  Aligned_cols=248  Identities=15%  Similarity=0.175  Sum_probs=197.3

Q ss_pred             CCeeecccCceEEEEEE------eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC---CCcEEeeeeeeeeCCceEEE
Q 008698          273 GNRLLGDSKTGGTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~------~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~lV  343 (557)
                      ..+.||+|+||.||+|.      ..+++.||||+++...   ..++.+|+.++.+++   |+||+++++++...+..++|
T Consensus        69 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv  145 (365)
T 3e7e_A           69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV  145 (365)
T ss_dssp             EEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEE
T ss_pred             EEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEE
Confidence            34578999999999994      4568899999997653   456777777777776   99999999999999999999


Q ss_pred             EecCCCCChHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-----------CCCc
Q 008698          344 YEFVVNGPLDRWLHHIPR-GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-----------EFGA  411 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~-----------~~~~  411 (557)
                      |||+++|+|.+++..... ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.           ++.+
T Consensus       146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~  222 (365)
T 3e7e_A          146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGL  222 (365)
T ss_dssp             ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred             EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCCE
Confidence            999999999999964222 245699999999999999999999999   9999999999999998           8999


Q ss_pred             EEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhh
Q 008698          412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP  491 (557)
Q Consensus       412 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~  491 (557)
                      ||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||+.||........         
T Consensus       223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---------  293 (365)
T 3e7e_A          223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---------  293 (365)
T ss_dssp             EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---------
T ss_pred             EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---------
Confidence            99999999755322222233344599999999999999999999999999999999999999864332110         


Q ss_pred             hhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhccc
Q 008698          492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR-PRMSHVVHQLQQLA  551 (557)
Q Consensus       492 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R-Pt~~evl~~L~~~~  551 (557)
                               .+....    ...+   ..+.+.+++..|++.+|.+| |+++++.+.|++..
T Consensus       294 ---------~~~~~~----~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          294 ---------KPEGLF----RRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             ---------EECSCC----TTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             ---------eechhc----cccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence                     011111    1111   13457789999999999999 57888888777543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-40  Score=334.37  Aligned_cols=255  Identities=18%  Similarity=0.243  Sum_probs=195.0

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      ..+.||+|+||.||++... +++.||||++.....   ...+.+.+|+.++.+++||||+++++++...+..++||||++
T Consensus        38 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  117 (309)
T 2h34_A           38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLIN  117 (309)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred             EEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecC
Confidence            3457899999999999964 688999999975432   234778999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.........
T Consensus       118 ~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          118 GVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence            9999999975    24589999999999999999999999   9999999999999999999999999999765443222


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                      . .....|++.|+|||.+.+..++.++||||||+++|||+||+.||...+...   +.    ......     . +....
T Consensus       191 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~----~~~~~~-----~-~~~~~  256 (309)
T 2h34_A          191 Q-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---MG----AHINQA-----I-PRPST  256 (309)
T ss_dssp             -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---HH----HHHHSC-----C-CCGGG
T ss_pred             c-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---HH----HHhccC-----C-CCccc
Confidence            1 122348999999999998899999999999999999999999997643211   10    000000     0 00000


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcccCC
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP-RMSHVVHQLQQLAQP  553 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-t~~evl~~L~~~~~~  553 (557)
                      .     +...+..+.+++.+||+.||++|| +++++++.|++....
T Consensus       257 ~-----~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          257 V-----RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             T-----STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             c-----CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            0     112234688999999999999999 999999999876553

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=8.5e-40  Score=336.85  Aligned_cols=267  Identities=17%  Similarity=0.227  Sum_probs=199.5

Q ss_pred             hhcCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-----CCcEEeeeeeeeeCCc
Q 008698          266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----HPNLVAVKGCCYDHGD  339 (557)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~g~~~~~~~  339 (557)
                      +.++|.. .+.||+|+||.||++.. .+++.||||+++.. ......+..|+.++..++     ||||+++++++...+.
T Consensus        33 ~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~  110 (360)
T 3llt_A           33 LNNAFLV-IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH  110 (360)
T ss_dssp             ETTTEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred             ecCEEEE-EEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence            3344433 45679999999999997 46889999999754 344567788999999986     9999999999999999


Q ss_pred             eEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC------------
Q 008698          340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------------  407 (557)
Q Consensus       340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~------------  407 (557)
                      .++||||+ +++|.+++....  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.            
T Consensus       111 ~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          111 MCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             EEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             eEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhc
Confidence            99999999 999999997632  34599999999999999999999999   9999999999999975            


Q ss_pred             -------------CCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008698          408 -------------EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPA  474 (557)
Q Consensus       408 -------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~  474 (557)
                                   ++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence                         7889999999998644321     1234899999999999999999999999999999999999999


Q ss_pred             CCCCcccchhHHHhhhhhhhc--------cccccccCcc-cc-cCCCCCCc---------------HHHHHHHHHHHHHh
Q 008698          475 QAVDSVCWQSIFEWATPLVQS--------HRYLELLDPL-IS-SLSSDIPE---------------AGVVQKVVDLVYAC  529 (557)
Q Consensus       475 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~d~~-l~-~~~~~~~~---------------~~~~~~l~~l~~~C  529 (557)
                      ...+.................        ......++.. .. ........               ......+.+|+.+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            876543221111111000000        0000000000 00 00000000               00125678999999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 008698          530 TQHVPSMRPRMSHVVH  545 (557)
Q Consensus       530 l~~~P~~RPt~~evl~  545 (557)
                      |+.||++|||++|+++
T Consensus       340 L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          340 LQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CCSSGGGSCCHHHHTT
T ss_pred             hcCChhhCCCHHHHhc
Confidence            9999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.3e-40  Score=334.62  Aligned_cols=246  Identities=20%  Similarity=0.235  Sum_probs=199.2

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccch------hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEe
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      ..+.||+|+||.||++... +|+.||||+++....      ...+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   95 (321)
T 2a2a_A           16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE   95 (321)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEE
Confidence            3456899999999999975 589999999975432      136789999999999999999999999999999999999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CcEEeeccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLSKF  421 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgl~~~  421 (557)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++    .+||+|||++..
T Consensus        96 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           96 LVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             CCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence            9999999999964    34689999999999999999999999   999999999999999888    799999999986


Q ss_pred             CCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccc
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  501 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (557)
                      .......   ....||+.|+|||.+.+..++.++||||||+++|||+||..||.......   .....    ....  ..
T Consensus       169 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i----~~~~--~~  236 (321)
T 2a2a_A          169 IEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANI----TSVS--YD  236 (321)
T ss_dssp             CCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH----HTTC--CC
T ss_pred             cCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----Hhcc--cc
Confidence            6543221   22348999999999998999999999999999999999999997654321   11100    0000  00


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .++..        ....+..+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          237 FDEEF--------FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CCHHH--------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cChhh--------hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00000        0112356889999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.8e-40  Score=326.62  Aligned_cols=258  Identities=17%  Similarity=0.237  Sum_probs=200.1

Q ss_pred             CCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeee-eeCCceEEEEecCCCC
Q 008698          273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC-YDHGDRYIVYEFVVNG  350 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E~~~~g  350 (557)
                      ..+.||+|+||.||++.. .+|+.||||++.....  ..++.+|+.++..++|++++..++.+ ...+..++||||+ ++
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~   89 (296)
T 3uzp_A           13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP   89 (296)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence            345689999999999996 5789999999875532  24688999999999988876666655 5667789999999 99


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCcEEeeccCCccCCcccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      +|.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||+   +.++.+||+|||++........
T Consensus        90 ~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           90 SLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             BHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             CHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence            999999742   24699999999999999999999999   99999999999999   4888999999999986654322


Q ss_pred             cc-----ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccccc
Q 008698          428 QE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  502 (557)
Q Consensus       428 ~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (557)
                      ..     ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.....................    ...
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~  239 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS----TPI  239 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH----SCH
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC----Cch
Confidence            11     112334899999999999999999999999999999999999999875443222222111110000    000


Q ss_pred             CcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       503 d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      . .+        ....+..+.+++.+||+.||++|||+++|++.|+++.+
T Consensus       240 ~-~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  280 (296)
T 3uzp_A          240 E-VL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             H-HH--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             H-HH--------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence            0 00        01123568999999999999999999999999987643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=8.5e-41  Score=337.41  Aligned_cols=254  Identities=24%  Similarity=0.321  Sum_probs=191.5

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCce----EEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----YIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~----~lV  343 (557)
                      ...+.||+|+||.||++.. .+++.||||+++...   ......+.+|+.++.+++||||+++++++...+..    ++|
T Consensus        15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv   94 (311)
T 3ork_A           15 ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV   94 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEE
Confidence            3345789999999999996 568999999997642   23346789999999999999999999998765543    999


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      |||+++|+|.+++..    ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        95 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           95 MEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA  167 (311)
T ss_dssp             EECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence            999999999999964    24589999999999999999999999   99999999999999999999999999998664


Q ss_pred             ccccc-cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccccc
Q 008698          424 WEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  502 (557)
Q Consensus       424 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (557)
                      ..... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||...+....      ........    ..
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~----~~  237 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVRED----PI  237 (311)
T ss_dssp             --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCC----CC
T ss_pred             ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCC----CC
Confidence            43221 122233489999999999999999999999999999999999999976543211      11111100    00


Q ss_pred             CcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhc
Q 008698          503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQLQQ  549 (557)
Q Consensus       503 d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl-~~L~~  549 (557)
                      .+..       .....+..+.+++.+||+.||++||++.+++ +.|.+
T Consensus       238 ~~~~-------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          238 PPSA-------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             CHHH-------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             Cccc-------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            0000       0011345688999999999999999666555 45543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-40  Score=343.71  Aligned_cols=261  Identities=22%  Similarity=0.347  Sum_probs=200.3

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||++... +|+.||+|++... .....+.+.+|+.++.+++||||+++++++.+.+..++||||+++|+
T Consensus        38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  117 (360)
T 3eqc_A           38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS  117 (360)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence            456899999999999975 5899999999765 33445789999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      |.+++...    ..+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++.+||+|||++......    .
T Consensus       118 L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~  186 (360)
T 3eqc_A          118 LDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M  186 (360)
T ss_dssp             HHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C
T ss_pred             HHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccccc----c
Confidence            99999752    458999999999999999999998 5   7999999999999999999999999998654221    1


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhh-------------------
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP-------------------  491 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~-------------------  491 (557)
                      .....||+.|+|||++.+..++.++||||||+++|||+||+.||...+.............                   
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3eqc_A          187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK  266 (360)
T ss_dssp             ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred             ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence            1223489999999999999999999999999999999999999986543321111100000                   


Q ss_pred             ----hhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          492 ----LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       492 ----~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ........+.++..........+....+..+.+++.+||+.||++|||++|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                000000001111111111111222224557899999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-40  Score=343.47  Aligned_cols=276  Identities=17%  Similarity=0.187  Sum_probs=208.2

Q ss_pred             CCCCeeecccCceEEEEEEeCC-CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC--ceEEEEec
Q 008698          271 SEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEF  346 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~  346 (557)
                      +...+.||+|+||.||+|.... |+.||||+++... ....+.+.+|+.++.+++||||+++++++.+.+  ..++||||
T Consensus        11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~   90 (396)
T 4eut_A           11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF   90 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred             eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence            3345678999999999999754 8999999997643 334577889999999999999999999988765  67999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCcEEeeccCCccC
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Dfgl~~~~  422 (557)
                      +++|+|.+++..... ...+++..+..++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++..
T Consensus        91 ~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~  166 (396)
T 4eut_A           91 CPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (396)
T ss_dssp             CTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred             CCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence            999999999975322 23499999999999999999999999   99999999999999    77788999999999876


Q ss_pred             CccccccceeecCccccccccccccC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccc-chhHHHhhhhhh
Q 008698          423 PWEVMQERTVMAGGTYGYLAPEFVYR--------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC-WQSIFEWATPLV  493 (557)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~-~~~~~~~~~~~~  493 (557)
                      ......   ....||+.|+|||.+.+        ..++.++|||||||++|||+||+.||....... ............
T Consensus       167 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          167 EDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             CCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             cCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            543222   12348999999998865        467889999999999999999999997543321 111111111100


Q ss_pred             hccccc---cccCccc----ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          494 QSHRYL---ELLDPLI----SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       494 ~~~~~~---~~~d~~l----~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ......   ...+..+    .-.............+.+++.+||+.||++|||++++++.|+.+...
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            000000   0000000    00001123366788899999999999999999999999999876553

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.3e-40  Score=330.33  Aligned_cols=244  Identities=22%  Similarity=0.329  Sum_probs=196.2

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||.||++... +|+.||||.++.........+.+|+.++.+++||||+++++++.+.+..++||||+++++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   93 (304)
T 2jam_A           14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL   93 (304)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccH
Confidence            456899999999999974 6899999999876555567789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCcEEeeccCCccCCcccccc
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      .+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+|||++........  
T Consensus        94 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~--  164 (304)
T 2jam_A           94 FDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--  164 (304)
T ss_dssp             HHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT--
T ss_pred             HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc--
Confidence            999864    24589999999999999999999999   99999999999999   7889999999999976543221  


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....|++.|+|||.+.+..++.++||||||+++|||++|..||.......   +.+..    ..... . ..      
T Consensus       165 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i----~~~~~-~-~~------  227 (304)
T 2jam_A          165 --STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFEKI----KEGYY-E-FE------  227 (304)
T ss_dssp             --HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH----HHCCC-C-CC------
T ss_pred             --ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----HcCCC-C-CC------
Confidence              12238999999999999999999999999999999999999997654321   11111    11100 0 00      


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        .......+..+.+++.+||+.||++|||++++++
T Consensus       228 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          228 --SPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             --TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             --ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              0011123456889999999999999999999987

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.7e-40  Score=329.07  Aligned_cols=243  Identities=19%  Similarity=0.328  Sum_probs=193.3

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeee----CCceEEEEe
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYE  345 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E  345 (557)
                      ..+.||+|+||.||+|... ++..||+|.+...  .....+.+.+|+.++.+++||||+++++++..    .+..++|||
T Consensus        30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e  109 (290)
T 1t4h_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEE
Confidence            3456899999999999864 5789999998754  33456789999999999999999999998865    355799999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeC-CCCCcEEeeccCCccC
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLD-EEFGAHLMGVGLSKFV  422 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~  422 (557)
                      |+++|+|.+++..    ...+++..+..++.||+.||.|||+.   +  |+||||||+|||++ .++.+||+|||++...
T Consensus       110 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          110 LMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             ecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            9999999999965    24589999999999999999999998   7  99999999999998 7889999999999755


Q ss_pred             CccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccccc
Q 008698          423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  502 (557)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (557)
                      .....    ....||+.|+|||.+. +.++.++||||||+++|||++|+.||.......  ......    ........ 
T Consensus       183 ~~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~----~~~~~~~~-  250 (290)
T 1t4h_A          183 RASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRV----TSGVKPAS-  250 (290)
T ss_dssp             CTTSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHH----TTTCCCGG-
T ss_pred             ccccc----ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHHHH----hccCCccc-
Confidence            43321    2234899999999876 458999999999999999999999997643321  111100    00000000 


Q ss_pred             CcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       503 d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                                 .+...+..+.+++.+||+.||++|||++++++
T Consensus       251 -----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          251 -----------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                       01112346889999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=339.18  Aligned_cols=236  Identities=23%  Similarity=0.361  Sum_probs=195.2

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEE
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      .+.||+|+||.||++.. .+|+.||||+++....        .....+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  108 (335)
T 3dls_A           29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM  108 (335)
T ss_dssp             EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence            45679999999999985 4688999999976421        12346788999999999999999999999999999999


Q ss_pred             ecCCCC-ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          345 EFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       345 E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      ||+..| +|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus       109 e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          109 EKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             ECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            999777 99999864    34599999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccccccceeecCccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccccc
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  502 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (557)
                      .....   ....||+.|+|||.+.+..+ +.++||||||+++|||++|..||......                     .
T Consensus       182 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------------~  237 (335)
T 3dls_A          182 RGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------------V  237 (335)
T ss_dssp             TTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------------T
T ss_pred             CCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------------H
Confidence            43322   12348999999999988776 88999999999999999999999653210                     0


Q ss_pred             CcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       503 d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      ....      ..+...+..+.+++.+||+.||++|||++++++.
T Consensus       238 ~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 EAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             TTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             hhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000      0011133568899999999999999999999973

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.7e-40  Score=336.22  Aligned_cols=255  Identities=19%  Similarity=0.270  Sum_probs=200.1

Q ss_pred             hhcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceE
Q 008698          266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY  341 (557)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~  341 (557)
                      +.+.+....+.||+|+||.||++... +|+.||||+++...  ......+.+|+.++.++ +||||+++++++.+.+..+
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~  105 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII  105 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence            33344444467899999999999975 58999999997542  23467899999999999 5799999999999999999


Q ss_pred             EEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCcEEeeccC
Q 008698          342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGL  418 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgl  418 (557)
                      +||||+++|+|.+++..  .....+++.++..++.||+.||+|||+.   +|+||||||+|||++.   ++.+||+|||+
T Consensus       106 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            99999999999999864  2335699999999999999999999999   9999999999999998   78999999999


Q ss_pred             CccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccc
Q 008698          419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  498 (557)
Q Consensus       419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (557)
                      ++........   ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+....   ....   .. .. 
T Consensus       181 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i---~~-~~-  249 (327)
T 3lm5_A          181 SRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---YLNI---SQ-VN-  249 (327)
T ss_dssp             CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH---HH-TC-
T ss_pred             ccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHH---Hh-cc-
Confidence            9876433221   223489999999999999999999999999999999999999976543211   1000   00 00 


Q ss_pred             ccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       499 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         .+.      ........+..+.+++.+||+.||++|||++++++
T Consensus       250 ---~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          250 ---VDY------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             ---CCC------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---ccc------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence               000      00011123456889999999999999999999987

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.5e-40  Score=329.01  Aligned_cols=240  Identities=19%  Similarity=0.274  Sum_probs=193.5

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++... +++.||||+++..  ......++.+|+..+..+ +||||+++++++.+.+..++||||+++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   95 (289)
T 1x8b_A           16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG   95 (289)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence            346799999999999975 6999999999754  234457888999999999 999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-------------------CCC
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-------------------EFG  410 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~-------------------~~~  410 (557)
                      |+|.+++.........+++..+..++.||+.||+|||++   +|+||||||+|||++.                   ...
T Consensus        96 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~  172 (289)
T 1x8b_A           96 GSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM  172 (289)
T ss_dssp             CBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------CCC
T ss_pred             CcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCceE
Confidence            999999975333335689999999999999999999999   9999999999999984                   447


Q ss_pred             cEEeeccCCccCCccccccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhh
Q 008698          411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA  489 (557)
Q Consensus       411 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~  489 (557)
                      +||+|||++........      ..||+.|+|||.+.+. .++.++||||||+++|||++|.+|+.....      ..  
T Consensus       173 ~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------~~--  238 (289)
T 1x8b_A          173 FKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ------WH--  238 (289)
T ss_dssp             EEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH------HH--
T ss_pred             EEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH------HH--
Confidence            89999999986643321      2389999999999875 567899999999999999999987643211      00  


Q ss_pred             hhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       490 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        .......     +.+        +...+..+.+++.+||+.||++|||+.++++
T Consensus       239 --~~~~~~~-----~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          239 --EIRQGRL-----PRI--------PQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             --HHHTTCC-----CCC--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHHcCCC-----CCC--------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence              0011100     000        1123456899999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.4e-40  Score=354.56  Aligned_cols=247  Identities=21%  Similarity=0.273  Sum_probs=201.1

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      ..++||+|+||.||++... +|+.||||++....   ......+.+|+.+|.+++||||+++++++.+.+..++||||++
T Consensus       188 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~  267 (576)
T 2acx_A          188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN  267 (576)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence            3467899999999999974 69999999997542   2335678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++...  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       268 gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~-  341 (576)
T 2acx_A          268 GGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  341 (576)
T ss_dssp             SCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred             CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCcc-
Confidence            99999999753  234599999999999999999999999   999999999999999999999999999987643322 


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                        .....||+.|+|||++.+..++.++|||||||++|||++|..||......... .+....    ...      .    
T Consensus       342 --~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i----~~~------~----  405 (576)
T 2acx_A          342 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV----KEV------P----  405 (576)
T ss_dssp             --EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH----HHC------C----
T ss_pred             --ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh----hcc------c----
Confidence              22235999999999999989999999999999999999999999875432111 111111    000      0    


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                          ...+...+..+.+|+.+||+.||++||     +++||++
T Consensus       406 ----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 ----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                001122345688999999999999999     7888875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.7e-40  Score=327.66  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=195.8

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+||+|+||.||+|.. .+++.||||.+........+.+.+|+.++..++||||+++++++.+.+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            3689999999999996 468899999998766566778999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCcEEeeccCCccCCcccccccee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      +++.... ....+++..+..++.||+.||.|||++   +++||||||+|||++. ++.+||+|||++.........  ..
T Consensus       108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--~~  181 (295)
T 2clq_A          108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TE  181 (295)
T ss_dssp             HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred             HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--cc
Confidence            9997632 234577899999999999999999999   9999999999999987 889999999999765432211  12


Q ss_pred             ecCccccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          433 MAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      ...|++.|+|||.+.+..  ++.++||||||+++|||++|+.||........ .....  .  .     ....+.     
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~--~--~-----~~~~~~-----  246 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKV--G--M-----FKVHPE-----  246 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHHHH--H--H-----HCCCCC-----
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHHhh--c--c-----cccccc-----
Confidence            234899999999987643  78999999999999999999999975433211 00000  0  0     000111     


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         .+...+..+.+++.+||+.||++|||++++++
T Consensus       247 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          247 ---IPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ---CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ---ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               11223456889999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=337.04  Aligned_cols=252  Identities=21%  Similarity=0.314  Sum_probs=184.1

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEEeeeeeee--------eCCceEE
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCY--------DHGDRYI  342 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~--------~~~~~~l  342 (557)
                      ..+.||+|+||.||++... +|+.||||++..........+.+|+.++.++. ||||+++++++.        .....++
T Consensus        32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~l  111 (337)
T 3ll6_A           32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL  111 (337)
T ss_dssp             EEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEE
T ss_pred             EEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEE
Confidence            3457899999999999964 68999999997776666788999999999996 999999999984        3345799


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      ||||+. |+|.+++..... ...+++..+..++.||+.||+|||+.   +  |+||||||+|||++.++.+||+|||++.
T Consensus       112 v~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  186 (337)
T 3ll6_A          112 LTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSAT  186 (337)
T ss_dssp             EEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred             EEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccce
Confidence            999995 799998864222 34699999999999999999999998   7  9999999999999999999999999998


Q ss_pred             cCCcccccc----------ceeecCccccccccccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHH
Q 008698          421 FVPWEVMQE----------RTVMAGGTYGYLAPEFV---YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE  487 (557)
Q Consensus       421 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~  487 (557)
                      .........          ......||+.|+|||.+   .+..++.++||||||+++|||+||+.||.......      
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------  260 (337)
T 3ll6_A          187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR------  260 (337)
T ss_dssp             CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred             eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH------
Confidence            765332211          11123489999999998   56678999999999999999999999997543211      


Q ss_pred             hhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       488 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                                   .++.....    .........+.+++.+||+.||++|||++|+++.|+.+..
T Consensus       261 -------------~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          261 -------------IVNGKYSI----PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ------------------CCC----CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------------hhcCcccC----CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                         00000000    0001112347899999999999999999999999987654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=348.27  Aligned_cols=254  Identities=21%  Similarity=0.252  Sum_probs=198.4

Q ss_pred             hcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEE
Q 008698          267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l  342 (557)
                      .++|.. .+.||+|+||.||++... +|+.||||++++...   .....+.+|..++..++||||+++++++.+.+..++
T Consensus        60 ~~~f~~-~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  138 (412)
T 2vd5_A           60 RDDFEI-LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL  138 (412)
T ss_dssp             GGGEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             hhhEEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            344433 456899999999999974 699999999975422   223457899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      ||||+++|+|.+++...   +..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       139 VmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~  212 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKL  212 (412)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheec
Confidence            99999999999999742   24699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CccccccceeecCcccccccccccc-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhc
Q 008698          423 PWEVMQERTVMAGGTYGYLAPEFVY-------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS  495 (557)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  495 (557)
                      ...... ......||+.|+|||++.       ...++.++|||||||++|||++|+.||...+....   ......... 
T Consensus       213 ~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i~~~~~-  287 (412)
T 2vd5_A          213 RADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET---YGKIVHYKE-  287 (412)
T ss_dssp             CTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHH-
T ss_pred             cCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH---HHHHHhccc-
Confidence            543221 112235999999999987       35689999999999999999999999987543211   111100000 


Q ss_pred             cccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHH
Q 008698          496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR---PRMSHVVH  545 (557)
Q Consensus       496 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Pt~~evl~  545 (557)
                          ..--+.        .+...+..+.+++.+||. +|.+|   |+++||++
T Consensus       288 ----~~~~p~--------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          288 ----HLSLPL--------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             ----HCCCC------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             ----CcCCCc--------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence                000000        011234568899999999 99998   58999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=341.37  Aligned_cols=260  Identities=17%  Similarity=0.188  Sum_probs=200.2

Q ss_pred             CCCeeecccCceEEEEEEeCC---------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEe-------------
Q 008698          272 EGNRLLGDSKTGGTYSGILPD---------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA-------------  329 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~---------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~-------------  329 (557)
                      ...+.||+|+||.||++....         ++.||||++...     ..+.+|+.++.+++||||++             
T Consensus        45 ~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i  119 (352)
T 2jii_A           45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI  119 (352)
T ss_dssp             EEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred             EEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence            344678999999999999753         789999999754     46889999999999999987             


Q ss_pred             --eeeeeee-CCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 008698          330 --VKGCCYD-HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD  406 (557)
Q Consensus       330 --l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~  406 (557)
                        +++++.. .+..++||||+ +++|.+++...  ....+++..+..++.||+.||+|||++   +|+||||||+|||++
T Consensus       120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVD  193 (352)
T ss_dssp             CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEE
T ss_pred             cchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEc
Confidence              5667665 67889999999 99999999753  135699999999999999999999999   999999999999999


Q ss_pred             CCC--CcEEeeccCCccCCcccccc-----ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q 008698          407 EEF--GAHLMGVGLSKFVPWEVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS  479 (557)
Q Consensus       407 ~~~--~~kl~Dfgl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~  479 (557)
                      .++  .+||+|||+++.........     ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            998  89999999998765432211     11223489999999999998999999999999999999999999987542


Q ss_pred             ccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          480 VCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      .. ..+.........  ......+...       .....+..+.+++.+||+.||++|||+++|++.|+++.+
T Consensus       274 ~~-~~~~~~~~~~~~--~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          274 NT-EDIMKQKQKFVD--KPGPFVGPCG-------HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             CH-HHHHHHHHHHHH--SCCCEECTTS-------CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CH-HHHHHHHHhccC--Chhhhhhhcc-------ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            21 111111111110  1111111100       001123568999999999999999999999999987653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1e-39  Score=351.40  Aligned_cols=249  Identities=19%  Similarity=0.295  Sum_probs=201.6

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .++||+|+||.||++... +|+.||||++.+...   .....+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus       190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g  269 (543)
T 3c4z_A          190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG  269 (543)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence            356899999999999975 599999999975422   3346789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++.........+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~-  345 (543)
T 3c4z_A          270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-  345 (543)
T ss_dssp             CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC-
T ss_pred             CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc-
Confidence            999999976544456799999999999999999999999   9999999999999999999999999999876433221 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-hhHHHhhhhhhhccccccccCccccc
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                       .....||+.|+|||++.+..++.++|||||||++|||+||+.||........ ..+....   ..         ...  
T Consensus       346 -~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i---~~---------~~~--  410 (543)
T 3c4z_A          346 -TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV---LE---------QAV--  410 (543)
T ss_dssp             -BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH---HH---------CCC--
T ss_pred             -cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH---hh---------ccc--
Confidence             1223599999999999999999999999999999999999999986543211 1111111   00         000  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM-----SHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~-----~evl~  545 (557)
                          ..+...+..+.+++.+||+.||++||++     ++|++
T Consensus       411 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          411 ----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                0112234568899999999999999975     66664

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.1e-39  Score=324.23  Aligned_cols=251  Identities=19%  Similarity=0.266  Sum_probs=198.9

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch------hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      .+.||+|+||.||++... +|+.||||.++....      ...+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   89 (283)
T 3bhy_A           10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL   89 (283)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEee
Confidence            456899999999999975 589999999875422      2367899999999999999999999999999999999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CcEEeeccCCccC
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLSKFV  422 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgl~~~~  422 (557)
                      +++++|.+++..    ...+++..+..++.||+.||.|||+.   +++||||||+||+++.++    .+||+|||++...
T Consensus        90 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           90 VSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            999999999964    24689999999999999999999999   999999999999998877    7999999999865


Q ss_pred             CccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccccc
Q 008698          423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  502 (557)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (557)
                      ......   ....+++.|+|||.+.+..++.++||||||+++|||++|..||...+....   ....    ....  ...
T Consensus       163 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~----~~~~--~~~  230 (283)
T 3bhy_A          163 EAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET---LTNI----SAVN--YDF  230 (283)
T ss_dssp             C-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH----HTTC--CCC
T ss_pred             cCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH---HHHh----Hhcc--cCC
Confidence            433221   123489999999999988999999999999999999999999976543211   1100    0000  000


Q ss_pred             CcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhccc
Q 008698          503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLA  551 (557)
Q Consensus       503 d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~  551 (557)
                      ....        ....+..+.+++.+||+.||++|||+.++++  .++.+.
T Consensus       231 ~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          231 DEEY--------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             CHHH--------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             cchh--------cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            0000        0112356889999999999999999999997  444443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.5e-40  Score=328.97  Aligned_cols=245  Identities=22%  Similarity=0.365  Sum_probs=200.4

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  104 (303)
T 3a7i_A           25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG  104 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCC
Confidence            3345689999999999986 468999999997543 34467899999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++......... 
T Consensus       105 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  175 (303)
T 3a7i_A          105 GSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-  175 (303)
T ss_dssp             EEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC-
T ss_pred             CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccc-
Confidence            999999863     4699999999999999999999999   9999999999999999999999999999765433221 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                       .....|++.|+|||.+.+..++.++||||||+++|||++|..||.........   .   . .....     .+.+   
T Consensus       176 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~-~~~~~-----~~~~---  239 (303)
T 3a7i_A          176 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---F---L-IPKNN-----PPTL---  239 (303)
T ss_dssp             -BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H---H-HHHSC-----CCCC---
T ss_pred             -cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---H---H-hhcCC-----CCCC---
Confidence             12234899999999999999999999999999999999999999765432111   0   0 00000     0001   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                           +...+..+.+++.+||+.||++|||++++++.
T Consensus       240 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          240 -----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             -----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             -----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                 11223568899999999999999999999873

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.8e-40  Score=326.68  Aligned_cols=243  Identities=19%  Similarity=0.310  Sum_probs=199.2

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      ..+.||+|+||.||++... +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   98 (294)
T 2rku_A           19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR   98 (294)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCC
Confidence            3457899999999999975 4789999998654   23445778999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +++|.+++..    ...+++.++..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.........
T Consensus        99 ~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           99 RRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             TCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            9999998864    24689999999999999999999999   9999999999999999999999999999865432221


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                        .....||+.|+|||.+.+..++.++||||||+++|||+||+.||.......   ...   . .....        .  
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~---~-~~~~~--------~--  232 (294)
T 2rku_A          172 --KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYL---R-IKKNE--------Y--  232 (294)
T ss_dssp             --BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---H-HHTTC--------C--
T ss_pred             --cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-Hhhcc--------C--
Confidence              122348999999999998889999999999999999999999997654321   110   0 00000        0  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ..+...+..+.+++.+||+.||++|||++++++
T Consensus       233 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          233 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ----CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                001123356889999999999999999999997

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-40  Score=345.45  Aligned_cols=261  Identities=23%  Similarity=0.314  Sum_probs=186.7

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCC--ceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHG--DRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~--~~~lV~E~~  347 (557)
                      .+.||+|+||.||++.. .+|+.||||++...  .......+.+|+.++.++. ||||+++++++...+  ..++||||+
T Consensus        14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~   93 (388)
T 3oz6_A           14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM   93 (388)
T ss_dssp             EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred             EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence            45679999999999986 46899999998643  3445567889999999997 999999999997544  689999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc-
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV-  426 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-  426 (557)
                      + |+|.+++..     ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus        94 ~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           94 E-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             S-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             C-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            6 689998875     4689999999999999999999999   99999999999999999999999999997653210 


Q ss_pred             ------------------cccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHH
Q 008698          427 ------------------MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE  487 (557)
Q Consensus       427 ------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~  487 (557)
                                        .........||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.......  
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~--  242 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER--  242 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--
Confidence                              0111122358999999999986 6789999999999999999999999987654321111  


Q ss_pred             hhhhhhhcccc---cc--------ccCcc---c---ccCCCCC------------CcHHHHHHHHHHHHHhcCCCCCCCC
Q 008698          488 WATPLVQSHRY---LE--------LLDPL---I---SSLSSDI------------PEAGVVQKVVDLVYACTQHVPSMRP  538 (557)
Q Consensus       488 ~~~~~~~~~~~---~~--------~~d~~---l---~~~~~~~------------~~~~~~~~l~~l~~~Cl~~~P~~RP  538 (557)
                       ..........   ..        .++..   .   .......            +....+..+.+|+.+||+.||++||
T Consensus       243 -i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~  321 (388)
T 3oz6_A          243 -IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI  321 (388)
T ss_dssp             -HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             -HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence             1000000000   00        00000   0   0000000            0012345688999999999999999


Q ss_pred             CHHHHHHH
Q 008698          539 RMSHVVHQ  546 (557)
Q Consensus       539 t~~evl~~  546 (557)
                      |++|+++.
T Consensus       322 t~~e~l~H  329 (388)
T 3oz6_A          322 SANDALKH  329 (388)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhCC
Confidence            99999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.4e-40  Score=341.02  Aligned_cols=240  Identities=21%  Similarity=0.282  Sum_probs=185.9

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHH-HhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGR-FARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      ..+.||+|+||.||++... +++.||||++++...   .....+.+|..+ ++.++||||+++++++.+.+..++||||+
T Consensus        42 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~  121 (373)
T 2r5t_A           42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI  121 (373)
T ss_dssp             EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCC
Confidence            3457899999999999975 488999999976532   233456677776 56789999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       122 ~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-  193 (373)
T 2r5t_A          122 NGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-  193 (373)
T ss_dssp             CSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence            99999999865    24589999999999999999999999   99999999999999999999999999997532221 


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                       .......||+.|+|||++.+..++.++|||||||++|||++|..||...+...   +..   ....         ..+ 
T Consensus       194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~---------~~~-  256 (373)
T 2r5t_A          194 -STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYD---NILN---------KPL-  256 (373)
T ss_dssp             -CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---HHH---HHHH---------SCC-
T ss_pred             -CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHH---HHHh---------ccc-
Confidence             12223459999999999999999999999999999999999999997654321   111   1111         000 


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH  542 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~e  542 (557)
                           ..+...+..+.+++.+||+.||++||++.+
T Consensus       257 -----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          257 -----QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             -----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                 001123356889999999999999999853

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.6e-41  Score=347.60  Aligned_cols=237  Identities=17%  Similarity=0.178  Sum_probs=183.5

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHH---HHHhhcCCCcEEeee-------eeeeeCC-
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEI---GRFARLHHPNLVAVK-------GCCYDHG-  338 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~H~niv~l~-------g~~~~~~-  338 (557)
                      .+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+   ..+++++||||++++       +++.+.+ 
T Consensus        78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  157 (377)
T 3byv_A           78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  157 (377)
T ss_dssp             EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred             cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence            45689999999999996 56999999999743   334567899999   555566899999998       5555443 


Q ss_pred             ----------------ceEEEEecCCCCChHHHhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 008698          339 ----------------DRYIVYEFVVNGPLDRWLHHIP---RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR  399 (557)
Q Consensus       339 ----------------~~~lV~E~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk  399 (557)
                                      ..++||||+ +|+|.+++....   .....+++..+..++.||+.||+|||++   +|+|||||
T Consensus       158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDik  233 (377)
T 3byv_A          158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR  233 (377)
T ss_dssp             CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred             ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence                            278999999 689999997421   1122345688889999999999999999   99999999


Q ss_pred             CCCeeeCCCCCcEEeeccCCccCCccccccceeecCccccccccccccCC-----------CCCchhhHHHHHHHHHHHH
Q 008698          400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-----------ELTTKSDVYSFGVLLLEIV  468 (557)
Q Consensus       400 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDVwS~Gvil~el~  468 (557)
                      |+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||++|||+
T Consensus       234 p~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell  307 (377)
T 3byv_A          234 PVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW  307 (377)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred             HHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence            9999999999999999999985432     1223347 999999999887           8999999999999999999


Q ss_pred             cCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          469 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       469 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ||+.||.........               ..+... .    .     ..+..+.+++.+||+.||++|||+.++++
T Consensus       308 tg~~Pf~~~~~~~~~---------------~~~~~~-~----~-----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          308 CADLPITKDAALGGS---------------EWIFRS-C----K-----NIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HSSCCC------CCS---------------GGGGSS-C----C-----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HCCCCCcccccccch---------------hhhhhh-c----c-----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999764432110               000100 0    1     12356889999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-39  Score=332.69  Aligned_cols=243  Identities=20%  Similarity=0.315  Sum_probs=199.3

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      ..+.||+|+||.||++... +++.||+|++...   .....+.+.+|+.++..++||||+++++++.+.+..++||||++
T Consensus        45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  124 (335)
T 2owb_A           45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR  124 (335)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence            3457899999999999975 4789999998754   23456778999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +++|.+++..    ...+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.........
T Consensus       125 ~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          125 RRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             TCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence            9999998864    24689999999999999999999999   9999999999999999999999999999865433221


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                        .....||..|+|||.+.+..++.++||||||+++|||++|+.||.......   ...   .. ....      ..+  
T Consensus       198 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~~-~~~~------~~~--  260 (335)
T 2owb_A          198 --KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYL---RI-KKNE------YSI--  260 (335)
T ss_dssp             --BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HH-HHTC------CCC--
T ss_pred             --ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HHH---HH-hcCC------CCC--
Confidence              122348999999999999889999999999999999999999997654321   111   00 0000      000  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                            +......+.+++.+||+.||++|||++|+++
T Consensus       261 ------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          261 ------PKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  1122346889999999999999999999997

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.2e-39  Score=322.64  Aligned_cols=242  Identities=22%  Similarity=0.322  Sum_probs=190.9

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      ..+.||+|+||.||++... +|+.||||++....   ......+.+|+..++.++||||+++++++.+.+..++||||++
T Consensus        15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   94 (276)
T 2h6d_A           15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS   94 (276)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccC
Confidence            3457899999999999975 69999999996542   2335678999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +++|.+++...    ..+++..+..++.||+.||.|||++   +++|+||||+|||++.++.+||+|||++.........
T Consensus        95 ~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  167 (276)
T 2h6d_A           95 GGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL  167 (276)
T ss_dssp             SCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             CCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcce
Confidence            99999999652    3589999999999999999999999   9999999999999999999999999999876543221


Q ss_pred             cceeecCccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                         ....+++.|+|||.+.+..+ +.++||||||+++|||++|..||.......   +....    ....      .   
T Consensus       168 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~----~~~~------~---  228 (276)
T 2h6d_A          168 ---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKKI----RGGV------F---  228 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCC------C---
T ss_pred             ---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHh----hcCc------c---
Confidence               12348899999999987765 689999999999999999999997643221   11111    0000      0   


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                           ..+...+..+.+++.+||+.||++|||++++++
T Consensus       229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                 001122356889999999999999999999997

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.3e-40  Score=335.45  Aligned_cols=245  Identities=24%  Similarity=0.276  Sum_probs=192.9

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||.||++... +|+.||||+++....    ...+|+.++.++ +||||+++++++.+.+..++||||+++|+
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~  102 (342)
T 2qr7_A           27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE  102 (342)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCc
Confidence            356799999999999975 588999999976532    245688888888 79999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-C---CcEEeeccCCccCCcccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-F---GAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~-~---~~kl~Dfgl~~~~~~~~~  427 (557)
                      |.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||+.++ +   .+||+|||+++.......
T Consensus       103 L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~  175 (342)
T 2qr7_A          103 LLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG  175 (342)
T ss_dssp             HHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred             HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence            9999864    34699999999999999999999999   99999999999998543 2   489999999986543221


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                        ......||+.|+|||++.+..++.++|||||||++|||++|..||..........+....    ......      . 
T Consensus       176 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~~~~~------~-  242 (342)
T 2qr7_A          176 --LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GSGKFS------L-  242 (342)
T ss_dssp             --CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----HHCCCC------C-
T ss_pred             --ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----ccCCcc------c-
Confidence              122345899999999998888899999999999999999999999864332222222211    111100      0 


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ........+..+.+++.+||+.||++|||++++++
T Consensus       243 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          243 ---SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ---CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               00011123456889999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.4e-39  Score=323.79  Aligned_cols=241  Identities=24%  Similarity=0.301  Sum_probs=197.8

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      ..+.||+|+||.||++... +++.||||++....   ......+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus        18 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   97 (284)
T 2vgo_A           18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAP   97 (284)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             eeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCC
Confidence            3456899999999999975 47789999996542   2234678999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++...    ..+++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||++........ 
T Consensus        98 ~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  169 (284)
T 2vgo_A           98 RGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR-  169 (284)
T ss_dssp             TEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB-
T ss_pred             CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccccc-
Confidence            99999998652    4589999999999999999999999   999999999999999999999999999875543221 


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                         ....|++.|+|||.+.+..++.++||||||+++|||++|..||...+.....      ..... .      +..   
T Consensus       170 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~-~------~~~---  230 (284)
T 2vgo_A          170 ---RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH------RRIVN-V------DLK---  230 (284)
T ss_dssp             ---CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHT-T------CCC---
T ss_pred             ---ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH------HHHhc-c------ccC---
Confidence               2234899999999999989999999999999999999999999765432110      00000 0      000   


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                           .+...+..+.+++.+|++.||++|||++++++
T Consensus       231 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          231 -----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                 01123456889999999999999999999987

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1e-39  Score=343.27  Aligned_cols=247  Identities=24%  Similarity=0.341  Sum_probs=186.1

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEE
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l  342 (557)
                      ...+.||+|+||.||++... +++.||||++.....        .....+.+|+.+|.+++||||+++++++. .+..++
T Consensus       138 ~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~l  216 (419)
T 3i6u_A          138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYI  216 (419)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEE
T ss_pred             EEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEE
Confidence            34557899999999999864 589999999875421        12235889999999999999999999975 456899


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCcEEeeccCC
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLS  419 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgl~  419 (557)
                      ||||+++|+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.+   ..+||+|||++
T Consensus       217 v~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          217 VLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             EEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             EEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccc
Confidence            9999999999998864    35699999999999999999999999   99999999999999754   45999999999


Q ss_pred             ccCCccccccceeecCccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcc
Q 008698          420 KFVPWEVMQERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  496 (557)
Q Consensus       420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (557)
                      +.......   .....||+.|+|||++.+   ..++.++|||||||++|||+||..||.......  .+....    ...
T Consensus       290 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i----~~~  360 (419)
T 3i6u_A          290 KILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----TSG  360 (419)
T ss_dssp             TSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHH----HTT
T ss_pred             eecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHH----hcC
Confidence            87653322   122348999999999864   567889999999999999999999997643321  111100    000


Q ss_pred             ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       497 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .. ... +..        ....+..+.+++.+||+.||++|||++|+++
T Consensus       361 ~~-~~~-~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          361 KY-NFI-PEV--------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CC-CCC-HHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CC-CCC-chh--------hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00 000 000        0123456889999999999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=337.61  Aligned_cols=269  Identities=17%  Similarity=0.225  Sum_probs=192.9

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhh-HHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||+||++... +++.||||+++...... ...+.+|+.++.+++||||+++++++.+.+..++||||++ |+
T Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~   85 (324)
T 3mtl_A            7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD   85 (324)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred             EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence            346799999999999975 68999999997543221 2245679999999999999999999999999999999996 68


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++........  .
T Consensus        86 l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~  157 (324)
T 3mtl_A           86 LKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--Y  157 (324)
T ss_dssp             HHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccc--c
Confidence            99888752   34699999999999999999999999   9999999999999999999999999999765432221  1


Q ss_pred             eecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc------
Q 008698          432 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP------  504 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~------  504 (557)
                      ....+|+.|+|||.+.+ ..++.++||||||+++|||+||+.||...+..+.......................      
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            12347999999999876 56899999999999999999999999876543211111100000000000000000      


Q ss_pred             ccccCCCCC---CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhccc
Q 008698          505 LISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLA  551 (557)
Q Consensus       505 ~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~  551 (557)
                      .........   ........+.+|+.+||+.||++|||++|+++  .+..+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence            000000000   00123456889999999999999999999987  444443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.9e-39  Score=345.31  Aligned_cols=259  Identities=19%  Similarity=0.252  Sum_probs=190.5

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC------CceEEE
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYIV  343 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lV  343 (557)
                      ..+.||+|+||.||++... +|+.||||++...  .....+++.+|+.+|+.++||||+++++++...      ...++|
T Consensus        66 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv  145 (464)
T 3ttj_A           66 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV  145 (464)
T ss_dssp             EEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred             EEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEE
Confidence            3456899999999999864 5889999999754  334467889999999999999999999998654      356999


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      |||+++ +|.+.+.      ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       146 ~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          146 MELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             EECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             EeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence            999965 4666664      2489999999999999999999999   99999999999999999999999999998664


Q ss_pred             ccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhh------------
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWAT------------  490 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~------------  490 (557)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.. .+.+...            
T Consensus       216 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          216 TSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             -CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             CCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence            3321   12234899999999999999999999999999999999999999876532211 1111000            


Q ss_pred             ---hhhhcc------ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          491 ---PLVQSH------RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       491 ---~~~~~~------~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ......      .....+...+.. ............+.+|+.+||+.||++|||++|+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFP-ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSC-CSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhHhhcccccCCCChHHhCcccccc-cccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               000000      000000000000 000011223567899999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.9e-40  Score=330.92  Aligned_cols=255  Identities=23%  Similarity=0.314  Sum_probs=192.7

Q ss_pred             CeeecccCceEEEEEEeC--CCC--EEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGILP--DGS--RVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~--~g~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      .+.||+|+||.||++.+.  +++  .||||+++..   .....+.+.+|+.++.+++||||+++++++.+.+ .++||||
T Consensus        23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~  101 (291)
T 1u46_A           23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTEL  101 (291)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEEC
T ss_pred             eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEec
Confidence            456899999999999853  233  6999998754   2344578999999999999999999999987765 8899999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++|+|.+++...   ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.......
T Consensus       102 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  175 (291)
T 1u46_A          102 APLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  175 (291)
T ss_dssp             CTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             ccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence            9999999999752   24589999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cc-cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          427 MQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       427 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      .. .......+|..|+|||.+.+..++.++||||||+++|||++ |..||...+...   +..   .......       
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~~~~~~~-------  242 (291)
T 1u46_A          176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILH---KIDKEGE-------  242 (291)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HHHTSCC-------
T ss_pred             cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HHH---HHHccCC-------
Confidence            21 11222347889999999988889999999999999999999 999997654321   111   1101000       


Q ss_pred             ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       505 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                            ....+...+..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus       243 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          243 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             ------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                  00011223467899999999999999999999999999876543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-40  Score=337.62  Aligned_cols=248  Identities=20%  Similarity=0.248  Sum_probs=195.9

Q ss_pred             CeeecccCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEE
Q 008698          274 NRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      .+.||+|+||.||++..    .+|+.||||+++...    ......+.+|+.++.++ +||||+++++++...+..++||
T Consensus        59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~  138 (355)
T 1vzo_A           59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL  138 (355)
T ss_dssp             EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence            45689999999999997    468999999987532    22345677899999999 7999999999999999999999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+++|+|.+++...    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       139 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          139 DYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  211 (355)
T ss_dssp             CCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence            999999999999752    4589999999999999999999999   999999999999999999999999999986543


Q ss_pred             cccccceeecCccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccccc
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  502 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (557)
                      ...... ....||+.|+|||++.+  ..++.++|||||||++|||+||+.||..........  .........       
T Consensus       212 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~-------  281 (355)
T 1vzo_A          212 DETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKS-------  281 (355)
T ss_dssp             GGGGGG-CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHC-------
T ss_pred             CCCCcc-cCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHhcc-------
Confidence            322222 22348999999999986  347899999999999999999999997644322111  111111100       


Q ss_pred             CcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 008698          503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVHQ  546 (557)
Q Consensus       503 d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~~  546 (557)
                      .        ...+...+..+.+++.+||+.||++||     |++|+++.
T Consensus       282 ~--------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          282 E--------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             C--------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             C--------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            0        011122345688999999999999999     99999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=325.01  Aligned_cols=254  Identities=22%  Similarity=0.332  Sum_probs=197.0

Q ss_pred             CCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccc----hhhHHHHHHHHHHHhhcCCCcEEeeeeeee--eCCceE
Q 008698          269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHPNLVAVKGCCY--DHGDRY  341 (557)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~--~~~~~~  341 (557)
                      +|.. .+.||+|+||.||++... +++.||||+++...    ......+.+|+.++.+++||||+++++++.  +.+..+
T Consensus         6 ~y~i-~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            6 KYLM-GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CBCC-CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             ceeE-eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            3433 456799999999999974 58899999997542    234578999999999999999999999984  456789


Q ss_pred             EEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      +||||++++ |.+++....  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus        85 lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            999999876 777776532  35699999999999999999999999   999999999999999999999999999987


Q ss_pred             CCccccccceeecCccccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ..............||+.|+|||.+.+..  ++.++||||||+++|||++|+.||...+...   +.+.    ...... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----i~~~~~-  230 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---LFEN----IGKGSY-  230 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH----HHHCCC-
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---HHHH----HhcCCC-
Confidence            65333223333445899999999987644  3789999999999999999999998654321   1111    011100 


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcc
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQL  550 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~  550 (557)
                                   ..+..++..+.+++.+||+.||++|||++|+++  .+.+.
T Consensus       231 -------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          231 -------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             -------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             -------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence                         001123456889999999999999999999997  34443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=328.87  Aligned_cols=249  Identities=22%  Similarity=0.347  Sum_probs=196.7

Q ss_pred             CCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +.++..+.||+|+||.||++... +|+.||||.+....  ....+.+|+.++.+++||||+++++++...+..++||||+
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            33444567899999999999975 48999999997643  3467899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++++|.+++...   ...+++..+..++.||+.||.|||+.   +++|+||||+|||++.++.+||+|||++........
T Consensus       107 ~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          107 GAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             TTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            999999998631   35699999999999999999999999   999999999999999999999999999976543221


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .  .....|++.|+|||.+.+..++.++||||||+++|||++|..||...+....  .    ... ....     .+.  
T Consensus       181 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~-~~~~-----~~~--  244 (314)
T 3com_A          181 K--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--I----FMI-PTNP-----PPT--  244 (314)
T ss_dssp             C--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H----HHH-HHSC-----CCC--
T ss_pred             c--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--H----HHH-hcCC-----Ccc--
Confidence            1  1223489999999999998999999999999999999999999976543210  0    000 0000     000  


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ...+...+..+.+++.+||+.||++|||++++++
T Consensus       245 ----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 ----FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ----CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                0011223456889999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7e-40  Score=333.67  Aligned_cols=260  Identities=25%  Similarity=0.330  Sum_probs=194.4

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||.||++... +|+.||||++....  ....+.+.+|+.++.+++||||+++++++.+.+..++||||++++
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  109 (331)
T 4aaa_A           30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT  109 (331)
T ss_dssp             EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence            357899999999999975 48999999986543  233567889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.........  
T Consensus       110 ~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  180 (331)
T 4aaa_A          110 ILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--  180 (331)
T ss_dssp             HHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             hHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc--
Confidence            99887653    24599999999999999999999999   9999999999999999999999999999765433221  


Q ss_pred             eeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhh-------hhhhcc-cccc
Q 008698          431 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWAT-------PLVQSH-RYLE  500 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~-------~~~~~~-~~~~  500 (557)
                      .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||...+..... .+.....       ...... ....
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence            1223489999999999875 6899999999999999999999999876542211 1110000       000000 0000


Q ss_pred             ccCcccccCCCCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 LLDPLISSLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~~d~~l~~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...+.+   ....+    ....+..+.+++.+||+.||++|||++|+++
T Consensus       261 ~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          261 VRLPEI---KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CCCCCC---SSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccCccc---cccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000000   00000    0123567899999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.3e-40  Score=331.20  Aligned_cols=247  Identities=24%  Similarity=0.361  Sum_probs=194.3

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      ..+.||+|+||.||++... +|+.||+|++........+.+.+|+.++.+++||||+++++++...+..++||||+++++
T Consensus        23 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  102 (302)
T 2j7t_A           23 IVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGA  102 (302)
T ss_dssp             EEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEE
T ss_pred             ecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCc
Confidence            3456899999999999975 489999999987666667889999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++...   ...+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++.......  ...
T Consensus       103 l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~  174 (302)
T 2j7t_A          103 VDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKR  174 (302)
T ss_dssp             HHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-
T ss_pred             HHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc--ccc
Confidence            99988642   24599999999999999999999999   99999999999999999999999999875322111  111


Q ss_pred             eecCcccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          432 VMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ....||+.|+|||.+.     ...++.++||||||+++|||++|..||...+....      ........ ..       
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~-~~-------  240 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSD-PP-------  240 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC-CC-------
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhccC-Cc-------
Confidence            2234899999999883     56789999999999999999999999976543211      01111100 00       


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ....+...+..+.+++.+||+.||++|||++++++
T Consensus       241 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          241 ----TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ----CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ----ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                00112233457899999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.4e-40  Score=340.61  Aligned_cols=248  Identities=12%  Similarity=-0.020  Sum_probs=176.5

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhc--CCCcEEeee-------eeeeeC---
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL--HHPNLVAVK-------GCCYDH---  337 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~H~niv~l~-------g~~~~~---  337 (557)
                      .+.||+|+||.||++... +|+.||||++.....   ...+.+.+|+.++..+  +||||++++       +++...   
T Consensus        67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~  146 (371)
T 3q60_A           67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP  146 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred             eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence            456899999999999964 689999999987532   3456677885555444  699988754       343332   


Q ss_pred             --------------CceEEEEecCCCCChHHHhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCeeecC
Q 008698          338 --------------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR------MKVATTLAQGIAFLHDKVKPHVVHRD  397 (557)
Q Consensus       338 --------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ivH~D  397 (557)
                                    ...++||||++ |+|.+++...   +..+++..+      ..++.||+.||+|||++   +|+|||
T Consensus       147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrD  219 (371)
T 3q60_A          147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH  219 (371)
T ss_dssp             SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCc
Confidence                          23799999998 8999999753   123455556      78889999999999999   999999


Q ss_pred             CCCCCeeeCCCCCcEEeeccCCccCCccccccceeecCccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008698          398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQ  475 (557)
Q Consensus       398 lk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~el~tG~~p~~  475 (557)
                      |||+|||++.++.+||+|||+++......     ....+|+.|+|||++.+  ..++.++|||||||++|||+||+.||.
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999998654321     12236799999999987  679999999999999999999999998


Q ss_pred             CCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          476 AVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .........        ..............    ........+..+.+++.+||+.||++|||+.++++
T Consensus       295 ~~~~~~~~~--------~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          295 LVTPGIKGS--------WKRPSLRVPGTDSL----AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             BCCTTCTTC--------CCBCCTTSCCCCSC----CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CcCcccccc--------hhhhhhhhcccccc----chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            764321110        00000000000000    00001134567899999999999999999999975

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.4e-40  Score=326.96  Aligned_cols=248  Identities=23%  Similarity=0.389  Sum_probs=181.9

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhH-HHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRK-KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~-~~~~-~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||.||++.. .+|+.||||+++... .... ..+.++...+..++||||+++++++.+.+..++||||++ |
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~   90 (290)
T 3fme_A           12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-T   90 (290)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-E
T ss_pred             HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-c
Confidence            45689999999999996 468999999997642 2222 334455556788899999999999999999999999996 5


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++.........+++..+..++.|++.||+|||++.  +|+||||||+|||++.++.+||+|||++.........  
T Consensus        91 ~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  166 (290)
T 3fme_A           91 SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--  166 (290)
T ss_dssp             EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------------
T ss_pred             chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccccccc--
Confidence            888877643334567999999999999999999999842  8999999999999999999999999999866443222  


Q ss_pred             eeecCccccccccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          431 TVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~----~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                       ....||+.|+|||.+    .+..++.++||||||+++|||+||+.||....... ..+.    ......         .
T Consensus       167 -~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~----~~~~~~---------~  231 (290)
T 3fme_A          167 -DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQLK----QVVEEP---------S  231 (290)
T ss_dssp             ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHHH----HHHHSC---------C
T ss_pred             -cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHHH----HHhccC---------C
Confidence             222489999999996    45678999999999999999999999997543211 1111    111100         0


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ...+....+..+.+++.+||+.||++|||++|+++
T Consensus       232 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          232 ----PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ----CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                11111223456899999999999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.9e-39  Score=332.01  Aligned_cols=254  Identities=20%  Similarity=0.338  Sum_probs=199.4

Q ss_pred             HHhhcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccch--------hhHHHHHHHHHHHhhc-CCCcEEeeeee
Q 008698          264 RSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARL-HHPNLVAVKGC  333 (557)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~H~niv~l~g~  333 (557)
                      ..+..+|.. .+.||+|+||.||++... +|+.||||+++....        ...+.+.+|+.++.++ +||||++++++
T Consensus        90 ~~~~~~y~~-~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           90 KEFYQKYDP-KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhccc-ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            334444443 356799999999999975 699999999865421        1245688999999999 79999999999


Q ss_pred             eeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEE
Q 008698          334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL  413 (557)
Q Consensus       334 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl  413 (557)
                      +...+..++||||+++++|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999964    24699999999999999999999999   9999999999999999999999


Q ss_pred             eeccCCccCCccccccceeecCccccccccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHH
Q 008698          414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE  487 (557)
Q Consensus       414 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~  487 (557)
                      +|||++.........   ....||+.|+|||++.+      ..++.++|||||||++|||+||..||.......   ...
T Consensus       242 ~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~  315 (365)
T 2y7j_A          242 SDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---MLR  315 (365)
T ss_dssp             CCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH
T ss_pred             EecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---HHH
Confidence            999999866533221   22348999999998863      357899999999999999999999997654321   111


Q ss_pred             hhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       488 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..    ..... ....+..         ...+..+.+++.+||+.||++|||++++++
T Consensus       316 ~i----~~~~~-~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          316 MI----MEGQY-QFSSPEW---------DDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HH----HHTCC-CCCHHHH---------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HH----HhCCC-CCCCccc---------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00    00000 0000000         012356889999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.3e-40  Score=336.83  Aligned_cols=275  Identities=19%  Similarity=0.258  Sum_probs=196.7

Q ss_pred             HHHHHHhhcCCCCCCeeecccCceEEEEEEeCCCCEEEEEEecccch-----------hhHHHHHHHHHHHhhcCCCcEE
Q 008698          260 TEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-----------QRKKEFYSEIGRFARLHHPNLV  328 (557)
Q Consensus       260 ~~el~~~~~~~~~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~H~niv  328 (557)
                      ..++..+.++|.. .+.||+|+||.||++...+|+.||||++.....           ...+.+.+|+.++.+++||||+
T Consensus        14 ~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           14 IAELHAMQSPYTV-QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHTTCSCEE-EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHhccceEE-eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            3466666666655 456799999999999988899999999864321           1237899999999999999999


Q ss_pred             eeeeeeeeC-----CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 008698          329 AVKGCCYDH-----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV  403 (557)
Q Consensus       329 ~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Ni  403 (557)
                      ++++++...     ...++||||+. |+|.+++..   ....+++..+..++.||+.||.|||++   +|+||||||+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  165 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI  165 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence            999998543     35799999997 688888864   235699999999999999999999999   999999999999


Q ss_pred             eeCCCCCcEEeeccCCccCCccccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 008698          404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW  482 (557)
Q Consensus       404 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~  482 (557)
                      |++.++.+||+|||+++........   ....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+....
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  242 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ  242 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             EEcCCCCEEEEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999999754433221   22348899999999877 6789999999999999999999999987543221


Q ss_pred             h-hHHHhhhhh-------hhccccccccCcccccCCCCC---CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          483 Q-SIFEWATPL-------VQSHRYLELLDPLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       483 ~-~~~~~~~~~-------~~~~~~~~~~d~~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      . .+.+.....       .......+.+...........   ........+.+++.+||+.||++|||++|+++
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            1 111100000       000000011111110000000   00112456889999999999999999999997

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-39  Score=332.89  Aligned_cols=264  Identities=20%  Similarity=0.257  Sum_probs=194.1

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccchhh-----HHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR-----KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      ..+.||+|+||.||++... +|+.||||++.......     ...+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus        14 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   93 (346)
T 1ua2_A           14 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   93 (346)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             EEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEc
Confidence            3457899999999999974 58999999997542211     24688999999999999999999999999999999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++ +|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        94 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           94 MET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             CSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             CCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            975 88888864   235688899999999999999999999   99999999999999999999999999998764332


Q ss_pred             cccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhhhhcccccc---c
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLE---L  501 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~---~  501 (557)
                      ..  .....+|+.|+|||.+.+. .++.++|||||||++|||++|.+||...+..... .+.+..... ......+   .
T Consensus       167 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~  243 (346)
T 1ua2_A          167 RA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP-TEEQWPDMCSL  243 (346)
T ss_dssp             CC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC-CTTTSSSTTSS
T ss_pred             cc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC-ChhhhhhhccC
Confidence            21  1223489999999998764 5899999999999999999999998765432111 111100000 0000000   0


Q ss_pred             cCcccccCCCCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          502 LDPLISSLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       502 ~d~~l~~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                      .+..........+    ....+..+.+++.+||+.||++|||++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000000000000    01234678999999999999999999999973

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.8e-39  Score=330.88  Aligned_cols=265  Identities=18%  Similarity=0.246  Sum_probs=194.2

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeee--------CCceEE
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYD--------HGDRYI  342 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--------~~~~~l  342 (557)
                      .+.||+|+||.||++.. .+|+.||||++.....  .....+.+|+.++..++||||+++++++..        .+..++
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l  101 (351)
T 3mi9_A           22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL  101 (351)
T ss_dssp             EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred             EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence            45689999999999997 5689999999865432  234678899999999999999999999987        346899


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      ||||++ |+|.+.+...   ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       102 v~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A          102 VFDFCE-HDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             EEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeccC-CCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence            999996 4777777542   24599999999999999999999999   9999999999999999999999999999865


Q ss_pred             Ccccc--ccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccc-
Q 008698          423 PWEVM--QERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY-  498 (557)
Q Consensus       423 ~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  498 (557)
                      .....  ........||+.|+|||.+.+ ..++.++|||||||++|||+||..||...+.................... 
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  254 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  254 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            43221  111223348999999999876 45799999999999999999999999876543221111111000000000 


Q ss_pred             ----ccccCcccccCCCCCCcHH------HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          499 ----LELLDPLISSLSSDIPEAG------VVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       499 ----~~~~d~~l~~~~~~~~~~~------~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          .+..+.............+      ....+.+|+.+||+.||++|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence                0000000000000000011      1345889999999999999999999987

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.5e-39  Score=345.88  Aligned_cols=244  Identities=23%  Similarity=0.326  Sum_probs=195.8

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||+||++... +|+.||||++....  ......+.+|+.++.+++||||+++++++.+.+..++||||+++|
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~  106 (486)
T 3mwu_A           27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG  106 (486)
T ss_dssp             EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence            457899999999999974 68999999986432  234578999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCcEEeeccCCccCCcccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      +|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+||+|||+++.......
T Consensus       107 ~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  179 (486)
T 3mwu_A          107 ELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (486)
T ss_dssp             BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence            99998864    24599999999999999999999999   999999999999995   456799999999986543321


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                         .....||+.|+|||++.+ .++.++|||||||++|||++|..||...+....   ....    .......  +    
T Consensus       180 ---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i----~~~~~~~--~----  242 (486)
T 3mwu_A          180 ---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKRV----ETGKYAF--D----  242 (486)
T ss_dssp             -----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHTCCCS--C----
T ss_pred             ---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HhCCCCC--C----
Confidence               122348999999999875 589999999999999999999999987543221   1111    1110000  0    


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          .......+..+.+++.+||+.||++|||+.++++
T Consensus       243 ----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          243 ----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             ----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                0001223456889999999999999999999997

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-39  Score=334.03  Aligned_cols=253  Identities=21%  Similarity=0.311  Sum_probs=189.0

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC------ceEEEE
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~lV~  344 (557)
                      .+.||+|+||.||++.. .+|+.||||++...  .....+++.+|+.+++.++||||+++++++...+      ..++||
T Consensus        30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~  109 (367)
T 1cm8_A           30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM  109 (367)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence            45689999999999996 46999999999653  2334577899999999999999999999987653      459999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+ +++|.+++..     ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       110 e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          110 PFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             ECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            999 8899999875     4589999999999999999999999   999999999999999999999999999986543


Q ss_pred             cccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhh-------hhhc
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATP-------LVQS  495 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~-------~~~~  495 (557)
                      ..     ....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+...... +......       ....
T Consensus       181 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          181 EM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             SC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            21     12348999999999887 678999999999999999999999998765422111 1110000       0000


Q ss_pred             cccccc---c----CcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          496 HRYLEL---L----DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       496 ~~~~~~---~----d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ......   +    .......     ....+..+.+|+.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASI-----LTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGT-----CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCHHHH-----CCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            000000   0    0000000     0123456889999999999999999999998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.3e-39  Score=331.54  Aligned_cols=261  Identities=19%  Similarity=0.256  Sum_probs=187.6

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||+||++.. .+|+.||||+++....  .....+.+|+.++.+++||||+++++++.+.+..++||||++ |
T Consensus        39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~  117 (329)
T 3gbz_A           39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-N  117 (329)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred             EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-C
Confidence            45679999999999985 4688999999975532  224567899999999999999999999999999999999997 5


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-----CCCCcEEeeccCCccCCcc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-----EEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~-----~~~~~kl~Dfgl~~~~~~~  425 (557)
                      +|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++     .++.+||+|||+++.....
T Consensus       118 ~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          118 DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            99999875    24599999999999999999999999   999999999999994     4555999999999765432


Q ss_pred             ccccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhhhhhcccccc--c
Q 008698          426 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRYLE--L  501 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~  501 (557)
                      ...  .....+|+.|+|||.+.+. .++.++|||||||++|||++|..||...+...... +.+.. ..........  .
T Consensus       191 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  267 (329)
T 3gbz_A          191 IRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL-GLPDDTTWPGVTA  267 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-CCCCTTTSTTGGG
T ss_pred             ccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh-CCCchhhhhhhhh
Confidence            211  1223379999999999874 48999999999999999999999997654422111 11100 0000000000  0


Q ss_pred             c---CcccccCCCCC----CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          502 L---DPLISSLSSDI----PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       502 ~---d~~l~~~~~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +   ...........    .+......+.+|+.+||+.||++|||++|+++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0   00000000000    00113457889999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.6e-39  Score=325.53  Aligned_cols=255  Identities=19%  Similarity=0.258  Sum_probs=194.6

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEEeeeeeeee--CCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYD--HGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++.. .+++.||||+++..   ..+.+.+|+.++.+++ ||||+++++++.+  ....++||||+++
T Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  117 (330)
T 3nsz_A           41 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN  117 (330)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred             EEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence            45789999999999985 56899999999754   3467899999999997 9999999999987  6678999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CcEEeeccCCccCCccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~  428 (557)
                      ++|.+++..       +++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++........
T Consensus       118 ~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~  187 (330)
T 3nsz_A          118 TDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY  187 (330)
T ss_dssp             CCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred             hhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence            999998853       88999999999999999999999   999999999999999776 7999999999865433221


Q ss_pred             cceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhh--------hhccc--
Q 008698          429 ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL--------VQSHR--  497 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~--------~~~~~--  497 (557)
                         ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..+.......        .....  
T Consensus       188 ---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          188 ---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             ---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             ---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhcCCchhhhHHHHhccc
Confidence               22348899999999887 678999999999999999999999996543221 1111100000        00000  


Q ss_pred             ----cccccC----cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          498 ----YLELLD----PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       498 ----~~~~~d----~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ..+.+.    ...............+..+.+++.+||+.||++|||++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                000000    000000011112224567899999999999999999999997

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6e-39  Score=341.52  Aligned_cols=190  Identities=22%  Similarity=0.349  Sum_probs=149.5

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-----CceEEEE
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVY  344 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~  344 (557)
                      ..+.||+|+||.||++... +|+.||||++...  .....+.+.+|+.+|.+++||||+++++++...     +..|+||
T Consensus        57 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  136 (458)
T 3rp9_A           57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL  136 (458)
T ss_dssp             ECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred             EeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEE
Confidence            3456799999999999864 6899999999653  334557899999999999999999999998543     5689999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+ +|+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++....
T Consensus       137 e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          137 EIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             CCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             ecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            998 6789998864    35699999999999999999999999   999999999999999999999999999987643


Q ss_pred             cccc-------------------------cceeecCcccccccccccc-CCCCCchhhHHHHHHHHHHHHcC
Q 008698          425 EVMQ-------------------------ERTVMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSG  470 (557)
Q Consensus       425 ~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwS~Gvil~el~tG  470 (557)
                      ....                         .......||+.|+|||++. ...++.++|||||||++|||+||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            2111                         1112234799999999864 56799999999999999999993

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.7e-39  Score=348.15  Aligned_cols=245  Identities=24%  Similarity=0.342  Sum_probs=198.6

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      ..+.||+|+||.||++... +|+.||||++....   ......+.+|+.++.+++||||+++++++.+.+..++||||+.
T Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  109 (484)
T 3nyv_A           30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT  109 (484)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence            3457899999999999975 68999999996542   3456789999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCcEEeeccCCccCCcc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      +|+|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||+   +.++.+||+|||+++.....
T Consensus       110 ~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          110 GGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             SCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            9999998864    34699999999999999999999999   99999999999999   56788999999999765433


Q ss_pred             ccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      ...   ....||+.|+|||++.+ .++.++|||||||++|||++|.+||...+....   ....    ......    . 
T Consensus       183 ~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i----~~~~~~----~-  246 (484)
T 3nyv_A          183 KKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI---LKKV----EKGKYT----F-  246 (484)
T ss_dssp             CSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHCCCC----C-
T ss_pred             ccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH----HcCCCC----C-
Confidence            221   12348999999999865 689999999999999999999999987544221   1111    111000    0 


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                           ........+..+.+++.+||+.+|++|||++|+++
T Consensus       247 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          247 -----ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -----CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                 00001224467889999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.1e-39  Score=332.07  Aligned_cols=256  Identities=19%  Similarity=0.312  Sum_probs=198.5

Q ss_pred             CCeeecccCceEEEEEEeCCCCEEEEEEecccchhh-----------------HHHHHHHHHHHhhcCCCcEEeeeeeee
Q 008698          273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR-----------------KKEFYSEIGRFARLHHPNLVAVKGCCY  335 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~H~niv~l~g~~~  335 (557)
                      ..+.||+|+||.||++.. +|+.||||++.......                 ...+.+|+.++.+++||||+++++++.
T Consensus        35 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~  113 (348)
T 2pml_X           35 IIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT  113 (348)
T ss_dssp             EEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred             EEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            345689999999999999 99999999997542211                 178999999999999999999999999


Q ss_pred             eCCceEEEEecCCCCChHHH------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCC
Q 008698          336 DHGDRYIVYEFVVNGPLDRW------LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEE  408 (557)
Q Consensus       336 ~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~~~  408 (557)
                      +.+..++||||+++|+|.++      +..  .....+++..+..++.||+.||.|||+ .   +++||||||+|||++.+
T Consensus       114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          114 NYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKN  188 (348)
T ss_dssp             SSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTT
T ss_pred             eCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCC
Confidence            99999999999999999998      442  224679999999999999999999998 8   99999999999999999


Q ss_pred             CCcEEeeccCCccCCccccccceeecCccccccccccccCC-CCCc-hhhHHHHHHHHHHHHcCCCCCCCCCcccchhHH
Q 008698          409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTT-KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF  486 (557)
Q Consensus       409 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~  486 (557)
                      +.+||+|||++......    ......|+..|+|||.+.+. .++. ++||||||+++|||++|..||......  ..+.
T Consensus       189 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~  262 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VELF  262 (348)
T ss_dssp             SCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHHH
T ss_pred             CcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHH
Confidence            99999999999865433    12233489999999999877 6666 999999999999999999999865441  1111


Q ss_pred             Hhhhhhhhcccccc------ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          487 EWATPLVQSHRYLE------LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       487 ~~~~~~~~~~~~~~------~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ....    .....-      ...+.. ...........+..+.+++.+||+.||++|||++|+++
T Consensus       263 ~~i~----~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          263 NNIR----TKNIEYPLDRNHFLYPLT-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHT----SCCCCCCCSSSSSTTTTC-C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHh----ccCcCCccchhhhhcccc-ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111    010000      000000 00000001224467899999999999999999999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=334.07  Aligned_cols=254  Identities=20%  Similarity=0.369  Sum_probs=193.9

Q ss_pred             CCCeeecccCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ...+.||+|+||.||+|...+  .||+|+++...  ....+.+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus        36 ~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~  113 (319)
T 2y4i_B           36 EIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG  113 (319)
T ss_dssp             ECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCS
T ss_pred             EEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccC
Confidence            344578999999999998743  49999986542  22335678899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc--
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--  427 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--  427 (557)
                      ++|.+++..   ....+++..+..++.||+.||+|||++   +++||||||+|||++ ++.+||+|||++........  
T Consensus       114 ~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~  186 (319)
T 2y4i_B          114 RTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR  186 (319)
T ss_dssp             EEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred             CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence            999999964   234689999999999999999999999   999999999999998 67999999999876532211  


Q ss_pred             -ccceeecCccccccccccccC---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          428 -QERTVMAGGTYGYLAPEFVYR---------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       428 -~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                       ........|++.|+|||.+.+         ..++.++||||||+++|||+||+.||.......   ...   . .... 
T Consensus       187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~---~-~~~~-  258 (319)
T 2y4i_B          187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---IIW---Q-MGTG-  258 (319)
T ss_dssp             -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH---HHH---H-HHTT-
T ss_pred             cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-hccC-
Confidence             112223348899999999874         357889999999999999999999997654321   111   0 0001 


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                          ..+..       .....+..+.+++.+||+.||++|||+++|++.|+++.+.
T Consensus       259 ----~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          259 ----MKPNL-------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             ----CCCCC-------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             ----CCCCC-------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence                11111       0111234588999999999999999999999999988764

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.3e-39  Score=358.32  Aligned_cols=250  Identities=27%  Similarity=0.374  Sum_probs=199.1

Q ss_pred             CeeecccCceEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|+||.||+|....    +..||||+++.. .....+.+.+|+.++.+++||||+++++++. .+..++||||++
T Consensus       395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~  473 (656)
T 2j0j_A          395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT  473 (656)
T ss_dssp             EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCC
Confidence            4568999999999998642    457999998754 3344578999999999999999999999985 466899999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++...   ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++........
T Consensus       474 ~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~  547 (656)
T 2j0j_A          474 LGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  547 (656)
T ss_dssp             TCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred             CCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence            99999999752   34689999999999999999999999   9999999999999999999999999999876543322


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .. ....+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+.....   .....   .. ..          
T Consensus       548 ~~-~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i---~~-~~----------  609 (656)
T 2j0j_A          548 KA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI---EN-GE----------  609 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH---HH-TC----------
T ss_pred             ec-cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH---Hc-CC----------
Confidence            21 22336789999999998899999999999999999997 999998654321   11111   00 00          


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                         ....+..++..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus       610 ---~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          610 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence               00011234467899999999999999999999999998764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.3e-39  Score=359.36  Aligned_cols=242  Identities=23%  Similarity=0.319  Sum_probs=198.2

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|+||.||++... +++.||||++++..   ....+.+..|..++..+ +||||+++++++.+.+..|+||||++
T Consensus       346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~  425 (674)
T 3pfq_A          346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN  425 (674)
T ss_dssp             EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred             EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence            457899999999999965 58899999997542   23346788899999988 79999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++....... 
T Consensus       426 gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~-  497 (674)
T 3pfq_A          426 GGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-  497 (674)
T ss_dssp             SCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC-
T ss_pred             CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCc-
Confidence            99999999752    4599999999999999999999999   999999999999999999999999999985432222 


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                       ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+   +....            +...+  
T Consensus       498 -~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~~~~i------------~~~~~--  559 (674)
T 3pfq_A          498 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSI------------MEHNV--  559 (674)
T ss_dssp             -CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH------------HSSCC--
T ss_pred             -ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---HHHHH------------HhCCC--
Confidence             2223459999999999999999999999999999999999999998754321   11111            11100  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM-----SHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~-----~evl~  545 (557)
                          ..+...+..+.+|+.+||+.||++||++     +||++
T Consensus       560 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 ----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                1112344678999999999999999998     77764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.8e-39  Score=340.73  Aligned_cols=257  Identities=18%  Similarity=0.240  Sum_probs=201.2

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC-CcEEeeeeeeeeCCceEEEEecCCC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ...+.||+|+||.||++.. .+++.||||++.....  ..++.+|+.++..++| ++|..+..+..+.+..++||||+ +
T Consensus        10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g   86 (483)
T 3sv0_A           10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G   86 (483)
T ss_dssp             ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence            3345679999999999996 5699999999865432  2358899999999976 56666666777888899999999 9


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCcEEeeccCCccCCccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      ++|.+++...   ...+++.+++.++.||+.||.|||++   +|+||||||+||||   +.++.+||+|||+++......
T Consensus        87 ~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           87 PSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             CCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            9999999742   24699999999999999999999999   99999999999999   688999999999998765432


Q ss_pred             ccc-----ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccc
Q 008698          427 MQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  501 (557)
Q Consensus       427 ~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (557)
                      ...     ......||+.|+|||.+.+..++.++|||||||+||||++|+.||...........+........    ...
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----~~~  236 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----ATS  236 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH----HSC
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc----ccc
Confidence            211     11234489999999999999999999999999999999999999987655433322222111111    111


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ++...         ..++.++.+++..||+.+|++||++++|++.|+.+
T Consensus       237 ~~~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          237 IEALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            11100         11235689999999999999999999999999876

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=328.58  Aligned_cols=245  Identities=24%  Similarity=0.402  Sum_probs=190.2

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeee------CCceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD------HGDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~------~~~~~lV~E  345 (557)
                      .+.||+|+||.||++.. .+|+.||||++.... .....+.+|+.++.++ +||||+++++++..      .+..++|||
T Consensus        29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e  107 (326)
T 2x7f_A           29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME  107 (326)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred             EEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence            45789999999999997 468999999997543 3456789999999999 89999999999986      467899999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      |+++|+|.+++...  ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus       108 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  182 (326)
T 2x7f_A          108 FCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  182 (326)
T ss_dssp             CCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred             cCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence            99999999999753  235689999999999999999999999   9999999999999999999999999999865432


Q ss_pred             ccccceeecCcccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          426 VMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      ...  .....|++.|+|||.+.     +..++.++||||||+++|||+||..||........  +.    .... ...  
T Consensus       183 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~-~~~--  251 (326)
T 2x7f_A          183 VGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--LF----LIPR-NPA--  251 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH----HHHH-SCC--
T ss_pred             ccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--HH----Hhhc-Ccc--
Confidence            211  12234899999999987     45689999999999999999999999976543211  10    0000 000  


Q ss_pred             ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         +..       .....+..+.+++.+||+.||++|||++++++
T Consensus       252 ---~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          252 ---PRL-------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ---CCC-------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---ccC-------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence               000       01122356889999999999999999999987

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.9e-39  Score=344.82  Aligned_cols=244  Identities=22%  Similarity=0.314  Sum_probs=191.8

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||+||++... ++..||||++....  ......+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus        42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  121 (494)
T 3lij_A           42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG  121 (494)
T ss_dssp             EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence            456899999999999975 68899999997643  233577899999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCcEEeeccCCccCCcccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~~  427 (557)
                      +|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.+   +.+||+|||++........
T Consensus       122 ~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~  194 (494)
T 3lij_A          122 ELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK  194 (494)
T ss_dssp             BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence            99988864    24589999999999999999999999   99999999999999764   4599999999986543322


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                         .....||+.|+|||++. ..++.++|||||||++|||++|..||...+....   ....    ..... ....+.. 
T Consensus       195 ---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i----~~~~~-~~~~~~~-  261 (494)
T 3lij_A          195 ---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI---LRKV----EKGKY-TFDSPEW-  261 (494)
T ss_dssp             ---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHTCC-CCCSGGG-
T ss_pred             ---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HhCCC-CCCchhc-
Confidence               12234899999999876 5689999999999999999999999987654221   1111    00000 0000000 


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                              ...+..+.+++.+||+.||++|||+.++++
T Consensus       262 --------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          262 --------KNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             --------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                    123456889999999999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.5e-39  Score=320.63  Aligned_cols=245  Identities=21%  Similarity=0.310  Sum_probs=196.6

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---------hhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEE
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---------FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~l  342 (557)
                      .+.||+|+||.||++... +|+.||||+++...         ....+.+.+|+.++.+++ ||||+++++++...+..++
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  101 (298)
T 1phk_A           22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL  101 (298)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence            456899999999999975 58899999996542         122467889999999995 9999999999999999999


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      ||||+++++|.+++..    ...+++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||++...
T Consensus       102 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A          102 VFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            9999999999999975    24689999999999999999999999   9999999999999999999999999999765


Q ss_pred             CccccccceeecCcccccccccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcc
Q 008698          423 PWEVMQERTVMAGGTYGYLAPEFVY------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  496 (557)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (557)
                      ......   ....+++.|+|||.+.      ...++.++||||||+++|||++|..||........   ..   .... .
T Consensus       175 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~---~~~~-~  244 (298)
T 1phk_A          175 DPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---LR---MIMS-G  244 (298)
T ss_dssp             CTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHH-T
T ss_pred             CCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH---HH---HHhc-C
Confidence            433221   2234899999999885      45688999999999999999999999976543211   11   0000 0


Q ss_pred             ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       497 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .. ..         ........+..+.+++.+||+.||++|||++++++
T Consensus       245 ~~-~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          245 NY-QF---------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CC-CC---------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             Cc-cc---------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            00 00         00011234467899999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4e-39  Score=332.53  Aligned_cols=263  Identities=20%  Similarity=0.248  Sum_probs=195.6

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-----CceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~  346 (557)
                      .+.||+|+||.||++... +++.||||++.... ......+.+|+.++.+++||||+++++++...     ...++||||
T Consensus        32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~  111 (364)
T 3qyz_A           32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL  111 (364)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred             EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence            456899999999999864 58899999997543 33457889999999999999999999998755     368999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +. |+|.+++..     ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus       112 ~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          112 ME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             CS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             cC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            96 699998865     3599999999999999999999999   99999999999999999999999999998765432


Q ss_pred             ccc-ceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCc
Q 008698          427 MQE-RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  504 (557)
Q Consensus       427 ~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  504 (557)
                      ... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...+........................+.
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            221 1122348999999998765 45899999999999999999999999876543221111000000000000000000


Q ss_pred             c----cccC-C-CCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          505 L----ISSL-S-SDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       505 ~----l~~~-~-~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .    .... . ...+    ....+..+.+|+.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0    0000 0 0000    0112456889999999999999999999997

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1e-39  Score=327.41  Aligned_cols=262  Identities=21%  Similarity=0.332  Sum_probs=183.0

Q ss_pred             CCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .+...+.||+|+||.||++... +++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++||||+
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   95 (303)
T 2vwi_A           16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL   95 (303)
T ss_dssp             CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred             hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence            3444567899999999999853 68999999986543 234567889999999999999999999999999999999999


Q ss_pred             CCCChHHHhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          348 VNGPLDRWLHHI----PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       348 ~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      ++++|.+++...    ......+++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||++....
T Consensus        96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  172 (303)
T 2vwi_A           96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA  172 (303)
T ss_dssp             TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred             cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence            999999998631    11235689999999999999999999999   99999999999999999999999999987654


Q ss_pred             cccc---ccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          424 WEVM---QERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       424 ~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ....   ........||+.|+|||.+.+ ..++.++||||||+++|||+||+.||.........  ..    .... ...
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~----~~~~-~~~  245 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--ML----TLQN-DPP  245 (303)
T ss_dssp             ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HH----HHTS-SCC
T ss_pred             cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--HH----Hhcc-CCC
Confidence            3211   111122348999999999876 56899999999999999999999999875442211  00    0000 000


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      . +.....   ........+..+.+++.+||+.||++|||++++++
T Consensus       246 ~-~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          246 S-LETGVQ---DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             C-TTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             c-cccccc---cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0 000000   00001112356889999999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.3e-39  Score=337.37  Aligned_cols=195  Identities=22%  Similarity=0.319  Sum_probs=161.2

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-----CceEEEE
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVY  344 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~  344 (557)
                      ..+.||+|+||.||++... +|+.||||+++..  .....+.+.+|+.+|.+++||||+++++++...     +..++||
T Consensus        30 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  109 (432)
T 3n9x_A           30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL  109 (432)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred             EEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEE
Confidence            3457899999999999964 5789999999754  334457899999999999999999999998766     5789999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+. |+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       110 e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          110 EIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             ECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             ecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            9985 699999864    35699999999999999999999999   999999999999999999999999999987643


Q ss_pred             cccc--------------------cceeecCccccccccccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008698          425 EVMQ--------------------ERTVMAGGTYGYLAPEFV-YRNELTTKSDVYSFGVLLLEIVSGRRPAQ  475 (557)
Q Consensus       425 ~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDVwS~Gvil~el~tG~~p~~  475 (557)
                      ....                    .......||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            3211                    112334589999999986 45679999999999999999998655543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.1e-39  Score=330.77  Aligned_cols=258  Identities=19%  Similarity=0.263  Sum_probs=187.9

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC------ceEEEE
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~lV~  344 (557)
                      .+.||+|+||.||++... +|+.||||++...  .......+.+|+.+++.++||||+++++++...+      ..++||
T Consensus        30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~  109 (371)
T 2xrw_A           30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM  109 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred             eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence            456899999999999864 5889999999753  3344577899999999999999999999987654      679999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||++ |+|.+++.      ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       110 e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          110 ELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             ECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             EcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            9996 57888875      3489999999999999999999999   999999999999999999999999999986543


Q ss_pred             cccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhh--------------
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWA--------------  489 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~--------------  489 (557)
                      ...   .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.+..... .+....              
T Consensus       180 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  256 (371)
T 2xrw_A          180 SFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  256 (371)
T ss_dssp             -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred             ccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            221   12234899999999999989999999999999999999999999875432110 000000              


Q ss_pred             -hhhhhcc------ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          490 -TPLVQSH------RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       490 -~~~~~~~------~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       .......      .....+...... ............+.+|+.+||+.||++|||++|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          257 VRTYVENRPKYAGYSFEKLFPDVLFP-ADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHHHHSSCCCCCCCHHHHSCGGGSC-CSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhCccccccchhhhcccccCc-ccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence             0000000      000000000000 000011234678999999999999999999999997

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.4e-38  Score=335.51  Aligned_cols=196  Identities=18%  Similarity=0.238  Sum_probs=167.4

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc------CCCcEEeeeeeeeeCCceEEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL------HHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      +..+.||+|+||.||++... +++.||||+++.. .....++.+|+.++..+      +|+||+++++++...+..++||
T Consensus       100 ~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~  178 (429)
T 3kvw_A          100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF  178 (429)
T ss_dssp             EEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence            33457899999999999864 4889999999764 23346677888888777      5779999999999999999999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC--cEEeeccCCccC
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--AHLMGVGLSKFV  422 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgl~~~~  422 (557)
                      ||+. ++|.+++....  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.  +||+|||++...
T Consensus       179 e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~  252 (429)
T 3kvw_A          179 ELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE  252 (429)
T ss_dssp             CCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             eccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence            9995 69999887632  34599999999999999999999999   9999999999999999887  999999999754


Q ss_pred             CccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q 008698          423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS  479 (557)
Q Consensus       423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~  479 (557)
                      ....     ....||+.|+|||++.+..++.++|||||||++|||+||.+||...+.
T Consensus       253 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          253 HQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             TCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            3221     123489999999999999999999999999999999999999987654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.4e-39  Score=324.34  Aligned_cols=245  Identities=19%  Similarity=0.297  Sum_probs=189.7

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcC--CCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++...+++.||||++...  .......+.+|+.++.+++  ||||+++++++.+.+..++||| +.+
T Consensus        33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~  111 (313)
T 3cek_A           33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN  111 (313)
T ss_dssp             EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred             EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence            4568999999999999888999999999654  3345678999999999996  5999999999999999999999 568


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      ++|.+++..    ...+++..+..++.||++||.|||+.   +|+||||||+|||+++ +.+||+|||++..........
T Consensus       112 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~  183 (313)
T 3cek_A          112 IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV  183 (313)
T ss_dssp             EEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence            899999975    24689999999999999999999999   9999999999999965 789999999998765433322


Q ss_pred             ceeecCccccccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccc
Q 008698          430 RTVMAGGTYGYLAPEFVYR-----------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  498 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (557)
                      ......|++.|+|||.+.+           ..++.++||||||+++|||++|+.||....... ..+    .        
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~----~--------  250 (313)
T 3cek_A          184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKL----H--------  250 (313)
T ss_dssp             ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHH----H--------
T ss_pred             cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-HHH----H--------
Confidence            2223348999999999875           468889999999999999999999997543210 000    0        


Q ss_pred             ccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       499 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       ..+++...    ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       251 -~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          251 -AIIDPNHE----IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             -HHHCTTSC----CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHhcccc----cCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence             11111110    0001112346889999999999999999999997

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=328.38  Aligned_cols=271  Identities=21%  Similarity=0.283  Sum_probs=192.7

Q ss_pred             CeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeee--------------eCC
Q 008698          274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY--------------DHG  338 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~--------------~~~  338 (557)
                      .+.||+|+||.||++.... |+.||||++........+++.+|+.++++++||||+++++++.              +.+
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~   95 (320)
T 2i6l_A           16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN   95 (320)
T ss_dssp             EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred             EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence            4568999999999999764 8999999998776667788999999999999999999998873              346


Q ss_pred             ceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCcEEeecc
Q 008698          339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVG  417 (557)
Q Consensus       339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfg  417 (557)
                      ..++||||++ |+|.+++..     ..+++..+..++.||+.||+|||++   +|+||||||+|||++ +++.+||+|||
T Consensus        96 ~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           96 SVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             EEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             ceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCc
Confidence            7899999997 699999853     4589999999999999999999999   999999999999997 56789999999


Q ss_pred             CCccCCccccc-cceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhc
Q 008698          418 LSKFVPWEVMQ-ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS  495 (557)
Q Consensus       418 l~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~  495 (557)
                      +++........ .......++..|+|||.+.+ ..++.++||||||+++|||+||+.||...+............+....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE  246 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred             cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence            99876432211 11122337889999998875 67899999999999999999999999876542211111000000000


Q ss_pred             cccccc---c----CcccccCCCC--CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcccCC
Q 008698          496 HRYLEL---L----DPLISSLSSD--IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLAQP  553 (557)
Q Consensus       496 ~~~~~~---~----d~~l~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~~~  553 (557)
                      ....+.   +    ..........  ......+..+.+++.+||+.||++|||++|+++  .+.....|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence            000000   0    0000000000  000123467899999999999999999999987  45544433

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.1e-38  Score=324.92  Aligned_cols=265  Identities=21%  Similarity=0.248  Sum_probs=201.7

Q ss_pred             CCCeeecccCceEEEEEEe--CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC------cEEeeeeeeeeCCceEEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL--PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP------NLVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~--~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~------niv~l~g~~~~~~~~~lV  343 (557)
                      +..+.||+|+||.||++..  .+|+.||||+++.. ....+.+.+|+.++..++|+      +++++++++...+..++|
T Consensus        17 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv   95 (339)
T 1z57_A           17 EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV   95 (339)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEE
Confidence            3345689999999999986  36889999999754 23456788999999888665      499999999999999999


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC----------------
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE----------------  407 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~----------------  407 (557)
                      |||+ +++|.+++...  ....+++..+..++.||+.||+|||++   +|+||||||+|||++.                
T Consensus        96 ~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~  169 (339)
T 1z57_A           96 FELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER  169 (339)
T ss_dssp             EECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred             EcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccc
Confidence            9999 89999999763  234689999999999999999999999   9999999999999987                


Q ss_pred             ---CCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh
Q 008698          408 ---EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS  484 (557)
Q Consensus       408 ---~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~  484 (557)
                         ++.+||+|||++.......     ....||+.|+|||.+.+..++.++||||||+++|||+||..||...+......
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          170 TLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             EESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             cccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence               6689999999997644321     22348999999999999899999999999999999999999998765432221


Q ss_pred             HHHhhhhh-----hhcccccc---------------------ccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC
Q 008698          485 IFEWATPL-----VQSHRYLE---------------------LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP  538 (557)
Q Consensus       485 ~~~~~~~~-----~~~~~~~~---------------------~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP  538 (557)
                      ........     ........                     ...+.. .  ........+..+.+++.+||+.||++||
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK-E--FMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGG-G--GCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchh-h--hcccchhhHHHHHHHHHHHhCcCccccc
Confidence            11111000     00000000                     000000 0  0112334677899999999999999999


Q ss_pred             CHHHHHHH--Hhccc
Q 008698          539 RMSHVVHQ--LQQLA  551 (557)
Q Consensus       539 t~~evl~~--L~~~~  551 (557)
                      |++|+++.  ++.++
T Consensus       322 t~~ell~hp~f~~~~  336 (339)
T 1z57_A          322 TLREALKHPFFDLLK  336 (339)
T ss_dssp             CHHHHTTSGGGGGGG
T ss_pred             CHHHHhcCHHHHHHh
Confidence            99999863  44443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.6e-39  Score=343.31  Aligned_cols=256  Identities=23%  Similarity=0.299  Sum_probs=188.9

Q ss_pred             hcCCCCCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEe
Q 008698          267 TKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      .+++....++||+|+||+||.+...+|+.||||++...   ..+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            34455556778999999998766668999999998654   245678999999887 89999999999999999999999


Q ss_pred             cCCCCChHHHhccCCCCCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-------------C
Q 008698          346 FVVNGPLDRWLHHIPRGGRS---LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------------F  409 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~-------------~  409 (557)
                      |+. |+|.+++.........   .++..+..++.||+.||+|||++   +|+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCce
Confidence            995 7999999753322111   13334678999999999999999   99999999999999754             4


Q ss_pred             CcEEeeccCCccCCcccccc--ceeecCccccccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCc
Q 008698          410 GAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS  479 (557)
Q Consensus       410 ~~kl~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~  479 (557)
                      .+||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||+| |..||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            79999999998765432211  1223359999999999975       568999999999999999999 9999975432


Q ss_pred             ccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          480 VCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .. ..+       .....  . .. ..    ........+..+.+++.+||+.||++|||+.+|++
T Consensus       246 ~~-~~i-------~~~~~--~-~~-~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          246 RE-SNI-------IRGIF--S-LD-EM----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HH-HHH-------HHTCC--C-CC-CC----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hH-HHH-------hcCCC--C-cc-cc----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            11 011       00000  0 00 00    11223456788999999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=9.2e-39  Score=324.20  Aligned_cols=258  Identities=21%  Similarity=0.300  Sum_probs=193.1

Q ss_pred             CeeecccCceEEEEEEe--CCCCEEEEEEecccch--hhHHHHHHHHHHHhhc---CCCcEEeeeeeee-----eCCceE
Q 008698          274 NRLLGDSKTGGTYSGIL--PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCY-----DHGDRY  341 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~--~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~g~~~-----~~~~~~  341 (557)
                      .+.||+|+||.||++..  .+|+.||||+++....  .....+.+|+.++..+   +||||+++++++.     .....+
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   95 (326)
T 1blx_A           16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   95 (326)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred             eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence            45679999999999997  4688999999865422  1223566777766665   8999999999987     456789


Q ss_pred             EEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      +||||+. |+|.+++....  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus        96 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~  169 (326)
T 1blx_A           96 LVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI  169 (326)
T ss_dssp             EEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             EEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCccccc
Confidence            9999997 69999997632  34589999999999999999999999   999999999999999999999999999987


Q ss_pred             CCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhhhhccccc-
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYL-  499 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~-  499 (557)
                      ......   .....||..|+|||.+.+..++.++||||||+++|||+||+.||...+..... .+.............. 
T Consensus       170 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (326)
T 1blx_A          170 YSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  246 (326)
T ss_dssp             CCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             ccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence            653321   12234899999999999989999999999999999999999999876442211 1111000000000000 


Q ss_pred             -----cccC----cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          500 -----ELLD----PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       500 -----~~~d----~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                           ..+.    ..+...     ....+..+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          247 VALPRQAFHSKSAQPIEKF-----VTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CSSCGGGSCCCCCCCGGGT-----CCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccchhhhcccCcchhhhc-----cccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                 0000    000000     1123456889999999999999999999995

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1e-38  Score=343.72  Aligned_cols=244  Identities=25%  Similarity=0.355  Sum_probs=193.5

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch-------------hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-------------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD  339 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~  339 (557)
                      .+.||+|+||+||++... +++.||||++.....             ...+.+.+|+.++.+++||||+++++++.+.+.
T Consensus        41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  120 (504)
T 3q5i_A           41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY  120 (504)
T ss_dssp             EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            456799999999999975 578999999975421             234678999999999999999999999999999


Q ss_pred             eEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CcEEeec
Q 008698          340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGV  416 (557)
Q Consensus       340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Df  416 (557)
                      .++||||+++|+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++   .+||+||
T Consensus       121 ~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          121 FYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            9999999999999998865    24599999999999999999999999   999999999999998775   6999999


Q ss_pred             cCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcc
Q 008698          417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  496 (557)
Q Consensus       417 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~  496 (557)
                      |++........   .....||+.|+|||++. +.++.++|||||||++|||++|..||...+....   ....    ...
T Consensus       194 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i----~~~  262 (504)
T 3q5i_A          194 GLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI---IKKV----EKG  262 (504)
T ss_dssp             TTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHC
T ss_pred             CCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HcC
Confidence            99987654322   12234899999999886 5689999999999999999999999987554221   1111    111


Q ss_pred             ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       497 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...  ++..        .....+..+.+++.+||+.||++|||++|+++
T Consensus       263 ~~~--~~~~--------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          263 KYY--FDFN--------DWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             CCC--CCHH--------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCC--CCcc--------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            000  0000        00123456899999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-39  Score=337.53  Aligned_cols=263  Identities=21%  Similarity=0.257  Sum_probs=191.0

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-------------
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-------------  337 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-------------  337 (557)
                      ...+.||+|+||.||++.. .+|+.||||++.....    ...+|+.+++.++||||+++++++...             
T Consensus        10 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~   85 (383)
T 3eb0_A           10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD   85 (383)
T ss_dssp             EEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred             EEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence            3345789999999999986 5689999999865422    234799999999999999999998543             


Q ss_pred             -------------------------CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 008698          338 -------------------------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH  392 (557)
Q Consensus       338 -------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  392 (557)
                                               ...++||||++ |+|.+.+.........+++..+..++.||+.||+|||+.   +
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---g  161 (383)
T 3eb0_A           86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---G  161 (383)
T ss_dssp             ------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---T
T ss_pred             cccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---c
Confidence                                     33789999997 588877764333456799999999999999999999999   9


Q ss_pred             eeecCCCCCCeeeC-CCCCcEEeeccCCccCCccccccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcC
Q 008698          393 VVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSG  470 (557)
Q Consensus       393 ivH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG  470 (557)
                      |+||||||+|||++ .++.+||+|||+++........   ....+|+.|+|||.+.+. .++.++|||||||++|||++|
T Consensus       162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  238 (383)
T 3eb0_A          162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG  238 (383)
T ss_dssp             EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence            99999999999998 6888999999999866433222   123478999999998775 489999999999999999999


Q ss_pred             CCCCCCCCcccch-hHHHhhhhhh------hccccccccCcccccC-CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 008698          471 RRPAQAVDSVCWQ-SIFEWATPLV------QSHRYLELLDPLISSL-SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH  542 (557)
Q Consensus       471 ~~p~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~d~~l~~~-~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~e  542 (557)
                      +.||...+..+.. .+........      ......+..-+.+... .....+...+..+.+|+.+||+.||++|||+.|
T Consensus       239 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  318 (383)
T 3eb0_A          239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE  318 (383)
T ss_dssp             SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            9999876543211 1111000000      0000000000000000 000011223456899999999999999999999


Q ss_pred             HHH
Q 008698          543 VVH  545 (557)
Q Consensus       543 vl~  545 (557)
                      +++
T Consensus       319 ~l~  321 (383)
T 3eb0_A          319 AMA  321 (383)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-38  Score=323.39  Aligned_cols=245  Identities=24%  Similarity=0.340  Sum_probs=189.1

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEE
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      .+.||+|+||.||++... +++.||||++.....        .....+.+|+.++.+++||||+++++++...+ .++||
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~   93 (322)
T 2ycf_A           15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVL   93 (322)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEE
T ss_pred             eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEE
Confidence            456899999999999964 578999999865421        22345889999999999999999999987654 89999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---cEEeeccCCcc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSKF  421 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgl~~~  421 (557)
                      ||+++|+|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.   +||+|||++..
T Consensus        94 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           94 ELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             ECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            99999999998864    35699999999999999999999999   9999999999999987654   99999999987


Q ss_pred             CCccccccceeecCcccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccc
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  498 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (557)
                      .......   ....||+.|+|||.+.   ...++.++||||||+++|||++|..||.......  .+....    .....
T Consensus       167 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~----~~~~~  237 (322)
T 2ycf_A          167 LGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----TSGKY  237 (322)
T ss_dssp             CCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH----HHTCC
T ss_pred             ccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH----HhCcc
Confidence            6533211   1223899999999874   4678999999999999999999999997654321  111111    00000


Q ss_pred             ccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       499 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       . ..+..        ....+..+.+++.+||+.||++|||++++++
T Consensus       238 -~-~~~~~--------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          238 -N-FIPEV--------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -C-CCHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -c-cCchh--------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             0 00000        0113456889999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.2e-39  Score=338.71  Aligned_cols=265  Identities=22%  Similarity=0.310  Sum_probs=191.3

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC------ceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~lV~E~  346 (557)
                      .+.||+|+||.||++... +|+.||||++....    ..+.+|+.+|++++||||+++++++....      ..++||||
T Consensus        59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~  134 (420)
T 1j1b_A           59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  134 (420)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred             eeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence            457899999999999975 58999999986542    22347999999999999999999985421      25799999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCcEEeeccCCccCCcc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~  425 (557)
                      +++ +|.+.+.........+++..+..++.||+.||+|||++   +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus       135 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~  210 (420)
T 1j1b_A          135 VPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  210 (420)
T ss_dssp             CCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             ccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence            975 66666543323346799999999999999999999999   99999999999999965 56799999999865433


Q ss_pred             ccccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhh-------hh--c
Q 008698          426 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL-------VQ--S  495 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~-------~~--~  495 (557)
                      ...   ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+  .+.+.....       +.  .
T Consensus       211 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          211 EPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             CCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHHHC
T ss_pred             CCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhC
Confidence            221   123489999999998764 78999999999999999999999998754321  111111100       00  0


Q ss_pred             cccccccCcccccCC-CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhccc
Q 008698          496 HRYLELLDPLISSLS-SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLA  551 (557)
Q Consensus       496 ~~~~~~~d~~l~~~~-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~  551 (557)
                      ....+...+.+.... ........+..+.+|+.+||+.||++|||+.|+++  .++++.
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence            000111001000000 00001123457899999999999999999999986  344443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=341.06  Aligned_cols=203  Identities=18%  Similarity=0.327  Sum_probs=154.6

Q ss_pred             CCCCCeeecccCceEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeee--CCceEEEE
Q 008698          270 FSEGNRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVY  344 (557)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~g~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~  344 (557)
                      |....+.||+|+||.||++...   +++.||||++....  ....+.+|+.+|.+++||||+++++++..  ....++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            4444556899999999999965   47899999997553  23468899999999999999999999954  67789999


Q ss_pred             ecCCCCChHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCcEEee
Q 008698          345 EFVVNGPLDRWLHHIP-----RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMG  415 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~D  415 (557)
                      ||+. |+|.+++....     .....+++..+..++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|
T Consensus       100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            9996 57877775311     1223599999999999999999999999   99999999999999    7788999999


Q ss_pred             ccCCccCCccccc-cceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008698          416 VGLSKFVPWEVMQ-ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVD  478 (557)
Q Consensus       416 fgl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~  478 (557)
                      ||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            9999876533211 122233489999999999874 58999999999999999999999997653

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.3e-39  Score=331.43  Aligned_cols=281  Identities=24%  Similarity=0.294  Sum_probs=190.8

Q ss_pred             HHHHhhcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc-
Q 008698          262 ELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-  339 (557)
Q Consensus       262 el~~~~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~-  339 (557)
                      +.....++|.. .+.||+|+||.||++... +|+.||||++.... .....+.+++..+..++||||+++++++...+. 
T Consensus        17 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           17 RSRKEMDRFQV-ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHTTEEE-C----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hchhhccceEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            34444555544 446799999999999974 58999999986542 233456788888999999999999999976443 


Q ss_pred             ------eEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeeecCCCCCCeeeCC-CCC
Q 008698          340 ------RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH--DKVKPHVVHRDIRASNVLLDE-EFG  410 (557)
Q Consensus       340 ------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~Dlk~~Nill~~-~~~  410 (557)
                            .++||||+++ +|...+.........+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence                  7899999975 555544432234467899999999999999999999  77   9999999999999997 899


Q ss_pred             cEEeeccCCccCCccccccceeecCccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHh
Q 008698          411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEW  488 (557)
Q Consensus       411 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~  488 (557)
                      +||+|||+++........   ....||+.|+|||++.+.. ++.++|||||||++|||+||+.||...+...... +...
T Consensus       171 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  247 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV  247 (360)
T ss_dssp             EEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence            999999999876543222   2234899999999987654 8999999999999999999999998765432111 1110


Q ss_pred             hhh-------hhh-ccccccccCcc---cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcccC
Q 008698          489 ATP-------LVQ-SHRYLELLDPL---ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLAQ  552 (557)
Q Consensus       489 ~~~-------~~~-~~~~~~~~d~~---l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~~  552 (557)
                      ...       ... ........+..   .... ........+..+.+|+.+||+.||++|||+.|+++  .++++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNV-FSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHH-TTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             cCCCCHHHHHhcccchhhccccccccCCcccc-cchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            000       000 00000000000   0000 00001124567999999999999999999999997  3454433

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.2e-39  Score=333.46  Aligned_cols=257  Identities=20%  Similarity=0.305  Sum_probs=178.5

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC------CceEEEE
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lV~  344 (557)
                      .+.||+|+||.||++.. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      +..++|+
T Consensus        34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~  113 (367)
T 2fst_X           34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  113 (367)
T ss_dssp             EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred             eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence            45689999999999985 46889999999653  334557889999999999999999999998654      5679999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      |++ +++|.+++..     ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       114 e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          114 HLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             ECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             ccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            999 7899888853     4599999999999999999999999   999999999999999999999999999986542


Q ss_pred             cccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhh-------hhhc
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATP-------LVQS  495 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~-------~~~~  495 (557)
                      .     .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+...... +......       ....
T Consensus       185 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          185 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             c-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            2     122348999999999887 678999999999999999999999998765422111 1110000       0000


Q ss_pred             cccccccCcccccCCCCCC---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          496 HRYLELLDPLISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       496 ~~~~~~~d~~l~~~~~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ......+.. +........   .......+.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          260 ESARNYIQS-LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHHHHHT-SCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhc-cCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            000000000 000000000   0012356889999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.2e-38  Score=325.30  Aligned_cols=254  Identities=17%  Similarity=0.245  Sum_probs=172.7

Q ss_pred             hhcCCCCCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeee----CCce
Q 008698          266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDR  340 (557)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~  340 (557)
                      +.++|....++||+|+||.||++... +|+.||||++.... .   ...+....+..++||||+++++++..    .+..
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            44555555667899999999999975 58999999996542 1   11222334566799999999999876    4457


Q ss_pred             EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCcEEeecc
Q 008698          341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVG  417 (557)
Q Consensus       341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfg  417 (557)
                      ++||||+++|+|.+++...  ....+++.++..++.||+.||.|||++   +|+||||||+|||++.   ++.+||+|||
T Consensus       102 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            9999999999999999752  235699999999999999999999999   9999999999999986   4559999999


Q ss_pred             CCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       418 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                      ++........    ....+|+.|+|||++.+..++.++||||||+++|||++|..||...........   ...      
T Consensus       177 ~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~------  243 (336)
T 3fhr_A          177 FAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKR------  243 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cceecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHH------
Confidence            9976543221    223479999999999888899999999999999999999999976543211000   000      


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        .+..... .. ........+..+.+++.+||+.||++|||++|+++
T Consensus       244 --~~~~~~~-~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          244 --RIRLGQY-GF-PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ----------CC-CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --hhhcccc-cc-CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              0000000 00 00001223457889999999999999999999998

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-38  Score=327.45  Aligned_cols=259  Identities=20%  Similarity=0.238  Sum_probs=193.6

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-----CceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~  346 (557)
                      .+.||+|+||.||++... +|+.||||++.... ......+.+|+.++.+++||||+++++++...     +..++||||
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~   95 (353)
T 2b9h_A           16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL   95 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred             eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence            456899999999999975 58899999997543 33456788999999999999999999988754     678999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +. |+|.+++..     ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus        96 ~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           96 MQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             CS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             cC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            96 699998865     4599999999999999999999999   99999999999999999999999999998765332


Q ss_pred             ccc--------ceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          427 MQE--------RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       427 ~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                      ...        ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+......   ..........
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~  243 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFGIIGTPH  243 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCC
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhCCCc
Confidence            111        1112348999999998765 678999999999999999999999998764321111   0000000000


Q ss_pred             ----c--------ccccCcccccCCCCC---CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          498 ----Y--------LELLDPLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       498 ----~--------~~~~d~~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          .        .+.+.. +.......   .....+..+.+++.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKS-LPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHT-SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccccchhhHHhhc-ccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                0        000000 00000000   00123456889999999999999999999997

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.5e-39  Score=333.23  Aligned_cols=264  Identities=20%  Similarity=0.290  Sum_probs=191.1

Q ss_pred             CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc------eEEEEec
Q 008698          273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------RYIVYEF  346 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~------~~lV~E~  346 (557)
                      ..+.||+|+||.||++...++..||+|++.....    ...+|+.+++.++||||+++++++...+.      .++||||
T Consensus        44 ~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~  119 (394)
T 4e7w_A           44 NCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY  119 (394)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred             EeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence            3457899999999999987777899998865421    22369999999999999999999865443      7899999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCcEEeeccCCccCCcc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~  425 (557)
                      ++++.+. .+.........+++..+..++.||+.||+|||++   +|+||||||+|||++ .++.+||+|||+++.....
T Consensus       120 ~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          120 VPETVYR-ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             CSEEHHH-HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             cCccHHH-HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence            9765443 3332122345799999999999999999999999   999999999999999 7899999999999876433


Q ss_pred             ccccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc-------
Q 008698          426 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR-------  497 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  497 (557)
                      ...   ....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+....  +...... .....       
T Consensus       196 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~-~g~p~~~~~~~~  269 (394)
T 4e7w_A          196 EPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKV-LGTPSREQIKTM  269 (394)
T ss_dssp             CCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHH-HCCCCHHHHHHH
T ss_pred             CCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHH-hCCCCHHHHHhh
Confidence            222   123489999999998764 589999999999999999999999987654221  1111110 00000       


Q ss_pred             cccccCcccccCCCCC----CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhcc
Q 008698          498 YLELLDPLISSLSSDI----PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQL  550 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~--L~~~  550 (557)
                      .....+..........    .+...+..+.+|+.+||+.||++|||+.|+++.  ++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence            0000000000000000    011234578999999999999999999999973  4444

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.6e-38  Score=329.65  Aligned_cols=263  Identities=16%  Similarity=0.204  Sum_probs=196.7

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC--------CCcEEeeeeeee----eCC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH--------HPNLVAVKGCCY----DHG  338 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------H~niv~l~g~~~----~~~  338 (557)
                      ...+.||+|+||.||++.. .+++.||||+++.. ....+.+.+|+.++..++        |+||+++++++.    +..
T Consensus        40 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~  118 (397)
T 1wak_A           40 HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGT  118 (397)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEE
T ss_pred             EEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCc
Confidence            3445689999999999985 45889999999754 344577889999999985        788999999987    556


Q ss_pred             ceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---------
Q 008698          339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---------  409 (557)
Q Consensus       339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~---------  409 (557)
                      ..++||||+ +++|.+++...  ....+++..+..++.||+.||+|||+++  +|+||||||+|||++.++         
T Consensus       119 ~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~  193 (397)
T 1wak_A          119 HICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAE  193 (397)
T ss_dssp             EEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred             eEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhh
Confidence            789999999 66676666542  2356999999999999999999999853  899999999999999775         


Q ss_pred             ----------------------------------------CcEEeeccCCccCCccccccceeecCccccccccccccCC
Q 008698          410 ----------------------------------------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN  449 (557)
Q Consensus       410 ----------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  449 (557)
                                                              .+||+|||++.......     ....||+.|+|||++.+.
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~  268 (397)
T 1wak_A          194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEVLIGS  268 (397)
T ss_dssp             HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHHHHTS
T ss_pred             hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChhhcCC
Confidence                                                    79999999998664321     123489999999999999


Q ss_pred             CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh---HHHhhhhhhh--------ccc-cccccCcc--cccCC-----
Q 008698          450 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS---IFEWATPLVQ--------SHR-YLELLDPL--ISSLS-----  510 (557)
Q Consensus       450 ~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~---~~~~~~~~~~--------~~~-~~~~~d~~--l~~~~-----  510 (557)
                      .++.++|||||||++|||+||+.||...+......   ..........        ... ..+.+...  +....     
T Consensus       269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (397)
T 1wak_A          269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW  348 (397)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred             CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence            99999999999999999999999998655432211   1110000000        000 00000000  00000     


Q ss_pred             --------CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          511 --------SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       511 --------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                              ....+......+.+|+.+||+.||++|||++||++
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                    01123567788999999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3e-38  Score=314.80  Aligned_cols=245  Identities=23%  Similarity=0.329  Sum_probs=195.2

Q ss_pred             CCeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ..+.||+|+||.||++... +++.||||++....  ......+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        26 i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  105 (287)
T 2wei_A           26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG  105 (287)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             eeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCC
Confidence            3457899999999999975 68999999986542  23467899999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCcEEeeccCCccCCccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~  426 (557)
                      ++|.+++..    ...+++..+..++.||+.||.|||++   +++||||||+|||++.+   ..+||+|||++.......
T Consensus       106 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~  178 (287)
T 2wei_A          106 GELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (287)
T ss_dssp             CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence            999998864    24589999999999999999999999   99999999999999764   469999999997654332


Q ss_pred             cccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ..   ....+++.|+|||.+.+ .++.++||||||+++|||++|..||...+....   ...    ........  +  .
T Consensus       179 ~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~----~~~~~~~~--~--~  243 (287)
T 2wei_A          179 KM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKR----VETGKYAF--D--L  243 (287)
T ss_dssp             SC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH----HHHCCCCC--C--S
T ss_pred             cc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHH----HHcCCCCC--C--c
Confidence            21   11237899999998865 589999999999999999999999976543211   111    11111000  0  0


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                            ......+..+.+++.+||+.||++|||++++++
T Consensus       244 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          244 ------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             ------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                  000123456889999999999999999999997

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.2e-38  Score=329.74  Aligned_cols=256  Identities=19%  Similarity=0.273  Sum_probs=190.5

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCce------EEEE
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR------YIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~------~lV~  344 (557)
                      .+.||+|+||.||++... +|+.||||++...  .......+.+|+.+++.++||||+++++++...+..      ++||
T Consensus        47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  126 (371)
T 4exu_A           47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM  126 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred             EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence            456899999999999864 5899999999764  233457889999999999999999999999877655      9999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+. ++|.+++.      ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       127 e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          127 PFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             ECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             cccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence            9996 68888774      3499999999999999999999999   999999999999999999999999999986543


Q ss_pred             cccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhhh----hh---c
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPL----VQ---S  495 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~~----~~---~  495 (557)
                      .     .....||+.|+|||.+.+ ..++.++||||||+++|||+||+.||...+..+... +.......    ..   .
T Consensus       197 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  271 (371)
T 4exu_A          197 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  271 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred             C-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence            2     122348999999999987 678999999999999999999999998754322111 11000000    00   0


Q ss_pred             cccccccCcccccCCCCCC---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          496 HRYLELLDPLISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       496 ~~~~~~~d~~l~~~~~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ......+.. +........   ....+..+.+|+.+||+.||++|||++|+++
T Consensus       272 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          272 KAAKSYIQS-LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHHHHHH-SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhhc-cCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            000000000 000000000   0123467899999999999999999999987

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.5e-38  Score=314.46  Aligned_cols=246  Identities=20%  Similarity=0.313  Sum_probs=186.1

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeee-------------CCc
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-------------HGD  339 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-------------~~~  339 (557)
                      .+.||+|+||.||++... +|+.||||++... ....+.+.+|+.++.+++||||+++++++.+             .+.
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~   89 (303)
T 1zy4_A           11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST   89 (303)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred             hheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence            356799999999999964 6899999999654 3455789999999999999999999998865             356


Q ss_pred             eEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCC
Q 008698          340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS  419 (557)
Q Consensus       340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~  419 (557)
                      .++||||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~  163 (303)
T 1zy4_A           90 LFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLA  163 (303)
T ss_dssp             EEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcch
Confidence            79999999999999999752   34578899999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCcccc------------ccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHH
Q 008698          420 KFVPWEVM------------QERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF  486 (557)
Q Consensus       420 ~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~  486 (557)
                      ........            ........|++.|+|||.+.+. .++.++||||||+++|||++   |+.....  .....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~--~~~~~  238 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME--RVNIL  238 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHHHH
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--HHHHH
Confidence            86543210            1112233488999999999764 68999999999999999998   4432111  00111


Q ss_pred             HhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       487 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..    ....      ....    ........+..+.+++.+||+.||++|||++++++
T Consensus       239 ~~----~~~~------~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          239 KK----LRSV------SIEF----PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HH----HHST------TCCC----CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Hh----cccc------cccc----CccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            10    0000      0000    01112233456889999999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.2e-37  Score=323.52  Aligned_cols=196  Identities=18%  Similarity=0.248  Sum_probs=164.8

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CC-----cEEeeeeeeeeCCceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HP-----NLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~g~~~~~~~~~lV~E~  346 (557)
                      .+.||+|+||+||++... +++.||||+++.. .....++.+|+.++..++ |+     +|+++++++...+..++||||
T Consensus        59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~  137 (382)
T 2vx3_A           59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM  137 (382)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEec
Confidence            456899999999999865 5789999999754 234567778888888884 55     499999999999999999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCCcEEeeccCCccCCc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--EEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Dfgl~~~~~~  424 (557)
                      +. |+|.+++....  ...+++..+..++.||+.||.|||++ ..+|+||||||+|||++  .++.+||+|||+++....
T Consensus       138 ~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~  213 (382)
T 2vx3_A          138 LS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ  213 (382)
T ss_dssp             CC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             CC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence            95 59999997632  24589999999999999999999953 23899999999999995  477899999999986643


Q ss_pred             cccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS  479 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~  479 (557)
                      ..     ....||+.|+|||++.+..++.++|||||||++|||+||+.||...+.
T Consensus       214 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          214 RI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             CC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            21     123489999999999999999999999999999999999999987654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.4e-38  Score=322.62  Aligned_cols=254  Identities=19%  Similarity=0.258  Sum_probs=190.3

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc------eEEEE
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------RYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~------~~lV~  344 (557)
                      .+.||+|+||.||++... +|+.||||++...  .......+.+|+.++.+++||||+++++++...+.      .++||
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  108 (353)
T 3coi_A           29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM  108 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred             eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence            456899999999999964 5899999999654  23345678999999999999999999999987654      49999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+. ++|.+++.      ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       109 e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          109 PFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             ECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             cccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence            9996 68887763      3489999999999999999999999   999999999999999999999999999986542


Q ss_pred             cccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhc--------
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS--------  495 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~--------  495 (557)
                      .     .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+....   ..........        
T Consensus       179 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          179 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHHHTT
T ss_pred             C-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHH
Confidence            2     122348999999999887 6789999999999999999999999987543211   1111000000        


Q ss_pred             ---cccccccCcccccCC--CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          496 ---HRYLELLDPLISSLS--SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       496 ---~~~~~~~d~~l~~~~--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ......+........  ........+..+.+++.+||+.||++|||++++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               000000000000000  00011234567899999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.2e-38  Score=321.90  Aligned_cols=251  Identities=22%  Similarity=0.371  Sum_probs=173.7

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHH-HHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      .+.||+|+||.||++... +|+.||||+++... .....++..|+. +++.++||||+++++++.+.+..++||||+++ 
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-  105 (327)
T 3aln_A           27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-  105 (327)
T ss_dssp             -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred             hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence            456799999999999974 68999999997653 334456666666 67778999999999999999999999999974 


Q ss_pred             ChHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          351 PLDRWLHHIP-RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       351 sL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      +|.+++.... .....+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||+++........ 
T Consensus       106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-  182 (327)
T 3aln_A          106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-  182 (327)
T ss_dssp             EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------
T ss_pred             ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccccc-
Confidence            8877765311 1235689999999999999999999984  28999999999999999999999999999866433221 


Q ss_pred             ceeecCccccccccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          430 RTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~----~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                        ....||+.|+|||.+    .+..++.++||||||+++|||++|+.||.......     +.         ....+...
T Consensus       183 --~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~---------~~~~~~~~  246 (327)
T 3aln_A          183 --TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQ---------LTQVVKGD  246 (327)
T ss_dssp             -------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------CCCCCSC
T ss_pred             --ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HH---------HHHHhcCC
Confidence              122489999999998    45678999999999999999999999997543210     00         00111110


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .... ........+..+.+++.+||+.||++|||+++|++
T Consensus       247 ~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          247 PPQL-SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCC-CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCC-CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            0000 00001123456899999999999999999999976

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.4e-37  Score=318.89  Aligned_cols=262  Identities=18%  Similarity=0.216  Sum_probs=195.7

Q ss_pred             CCCeeecccCceEEEEEEeC-CC-CEEEEEEecccchhhHHHHHHHHHHHhhcCCCc------EEeeeeeeeeCCceEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DG-SRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN------LVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~g~~~~~~~~~lV  343 (557)
                      ...+.||+|+||.||++... ++ +.||||+++.. ....+.+.+|+.++.+++|+|      ++.+++++...+..++|
T Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv  100 (355)
T 2eu9_A           22 EIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIA  100 (355)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred             EEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEE
Confidence            33456899999999999964 34 68999999754 344567888999999997766      89999999999999999


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee------------------
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL------------------  405 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill------------------  405 (557)
                      |||+ +++|.+++...  ....+++.++..++.||+.||+|||++   +|+||||||+|||+                  
T Consensus       101 ~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~  174 (355)
T 2eu9_A          101 FELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEK  174 (355)
T ss_dssp             EECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred             Eecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccccc
Confidence            9999 66777777652  234699999999999999999999999   99999999999999                  


Q ss_pred             -CCCCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh
Q 008698          406 -DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS  484 (557)
Q Consensus       406 -~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~  484 (557)
                       +.++.+||+|||+++......     ....||+.|+|||++.+..++.++||||||+++|||+||..||...+......
T Consensus       175 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (355)
T 2eu9_A          175 SVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV  249 (355)
T ss_dssp             EESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             ccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence             567899999999997643221     22348999999999999999999999999999999999999998755432111


Q ss_pred             HHHhhhhh-----hhcccccccc-C----------------ccccc-CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 008698          485 IFEWATPL-----VQSHRYLELL-D----------------PLISS-LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS  541 (557)
Q Consensus       485 ~~~~~~~~-----~~~~~~~~~~-d----------------~~l~~-~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~  541 (557)
                      ........     .......... .                ..... .............+.+|+.+||+.||++|||++
T Consensus       250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  329 (355)
T 2eu9_A          250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA  329 (355)
T ss_dssp             HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence            11110000     0000000000 0                00000 000111234566899999999999999999999


Q ss_pred             HHHH
Q 008698          542 HVVH  545 (557)
Q Consensus       542 evl~  545 (557)
                      |+++
T Consensus       330 e~l~  333 (355)
T 2eu9_A          330 EALL  333 (355)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=327.87  Aligned_cols=244  Identities=24%  Similarity=0.308  Sum_probs=181.6

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .++||+|+||+||.....+|+.||||++.....   ..+.+|+.+|..+ +||||+++++++.+.+..++||||+. |+|
T Consensus        29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L  104 (432)
T 3p23_A           29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL  104 (432)
T ss_dssp             EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred             CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence            457899999996655556899999999965432   2356899999999 89999999999999999999999995 699


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-----CCCcEEeeccCCccCCcccc
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-----EFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      .+++....   ..+.+..+..++.||+.||+|||+.   +|+||||||+|||++.     ...+||+|||+++.......
T Consensus       105 ~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          105 QEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             HHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             HHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence            99997532   2344455678999999999999999   9999999999999953     34578999999987653321


Q ss_pred             c-cceeecCcccccccccccc---CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhcccccccc
Q 008698          428 Q-ERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  502 (557)
Q Consensus       428 ~-~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (557)
                      . .......||+.|+|||++.   ...++.++|||||||++|||+| |..||.......    .   ....... .   .
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~---~~~~~~~-~---~  247 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----A---NILLGAC-S---L  247 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----H---HHHTTCC-C---C
T ss_pred             ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----H---HHHhccC-C---c
Confidence            1 1222345999999999997   4567889999999999999999 899986433211    0   0000000 0   0


Q ss_pred             CcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       503 d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +       ...+.......+.+|+.+||+.||++|||+++|++
T Consensus       248 ~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          248 D-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             T-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            0       11122334566889999999999999999999984

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-37  Score=320.58  Aligned_cols=263  Identities=16%  Similarity=0.228  Sum_probs=193.7

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-----------CCcEEeeeeeeeeCC-
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----------HPNLVAVKGCCYDHG-  338 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~g~~~~~~-  338 (557)
                      ...+.||+|+||.||++.. .+++.||||++... ......+.+|+.++.+++           ||||+++++++...+ 
T Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~  100 (373)
T 1q8y_A           22 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP  100 (373)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred             EEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCC
Confidence            3345789999999999996 46889999999754 334567889999998886           899999999988654 


Q ss_pred             ---ceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC------CCC
Q 008698          339 ---DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD------EEF  409 (557)
Q Consensus       339 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~------~~~  409 (557)
                         ..++||||+ +++|.+++....  ...+++..+..++.||+.||+|||+++  +|+||||||+|||++      .++
T Consensus       101 ~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A          101 NGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             TEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred             CCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcc
Confidence               689999999 899999997632  345999999999999999999999842  899999999999994      444


Q ss_pred             CcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh---HH
Q 008698          410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS---IF  486 (557)
Q Consensus       410 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~---~~  486 (557)
                      .+||+|||++.......     ....||+.|+|||++.+..++.++||||||+++|||+||..||...+......   ..
T Consensus       176 ~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          176 QIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             EEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            79999999998664321     12248999999999999999999999999999999999999998654322111   00


Q ss_pred             Hhhhhhhh--------cccc-ccccCc-----cccc----------CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 008698          487 EWATPLVQ--------SHRY-LELLDP-----LISS----------LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH  542 (557)
Q Consensus       487 ~~~~~~~~--------~~~~-~~~~d~-----~l~~----------~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~e  542 (557)
                      ........        .... ...++.     .+..          ......+...+..+.+|+.+||+.||++|||++|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            00000000        0000 000000     0000          0011234567888999999999999999999999


Q ss_pred             HHH
Q 008698          543 VVH  545 (557)
Q Consensus       543 vl~  545 (557)
                      |++
T Consensus       331 ll~  333 (373)
T 1q8y_A          331 LVN  333 (373)
T ss_dssp             HHT
T ss_pred             Hhh
Confidence            997

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=319.49  Aligned_cols=241  Identities=23%  Similarity=0.335  Sum_probs=187.3

Q ss_pred             hhcCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccch------hhHHHHHHHHHHHhhc----CCCcEEeeeeee
Q 008698          266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF------QRKKEFYSEIGRFARL----HHPNLVAVKGCC  334 (557)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~H~niv~l~g~~  334 (557)
                      ..++| ...+.||+|+||.||++.. .+++.||||++.....      .....+.+|+.++.++    +||||+++++++
T Consensus        29 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           29 FEAEY-RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             ----C-EEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhce-EEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            33444 3456789999999999986 4688999999975432      1233466799999998    899999999999


Q ss_pred             eeCCceEEEEec-CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCcE
Q 008698          335 YDHGDRYIVYEF-VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAH  412 (557)
Q Consensus       335 ~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~k  412 (557)
                      ...+..++|||+ +.+++|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++ .++.+|
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence            999999999999 789999999975    24589999999999999999999999   999999999999999 788999


Q ss_pred             EeeccCCccCCccccccceeecCccccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhh
Q 008698          413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP  491 (557)
Q Consensus       413 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~  491 (557)
                      |+|||++........    ....|+..|+|||.+.+..+. .++||||||+++|||++|+.||.....     ..     
T Consensus       181 l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~-----  246 (312)
T 2iwi_A          181 LIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----IL-----  246 (312)
T ss_dssp             ECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HH-----
T ss_pred             EEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----Hh-----
Confidence            999999987654322    123489999999998876664 589999999999999999999864211     00     


Q ss_pred             hhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       492 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        .         ...      ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       247 --~---------~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          247 --E---------AEL------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             --H---------TCC------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --h---------hcc------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0         000      001123456889999999999999999999997

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.3e-38  Score=322.88  Aligned_cols=236  Identities=21%  Similarity=0.327  Sum_probs=192.0

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchh------hHHHHHHHHHHHhhcC--CCcEEeeeeeeeeCCceEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~l  342 (557)
                      ...+.||+|+||.||++.. .+|+.||||+++.....      ....+.+|+.++.+++  ||||+++++++.+.+..++
T Consensus        46 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~l  125 (320)
T 3a99_A           46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL  125 (320)
T ss_dssp             EEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEE
Confidence            4456789999999999985 46889999999754321      2345778999999996  5999999999999999999


Q ss_pred             EEecCCC-CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCcEEeeccCCc
Q 008698          343 VYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSK  420 (557)
Q Consensus       343 V~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgl~~  420 (557)
                      |||++.+ ++|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++ +++.+||+|||+++
T Consensus       126 v~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          126 ILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             EEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            9999976 899999865    24689999999999999999999999   999999999999999 78899999999998


Q ss_pred             cCCccccccceeecCccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      .......    ....||+.|+|||.+.+..+ +.++||||||+++|||+||+.||.....     .       ....   
T Consensus       199 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~-------~~~~---  259 (320)
T 3a99_A          199 LLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-------IRGQ---  259 (320)
T ss_dssp             ECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------HHCC---
T ss_pred             ccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h-------hccc---
Confidence            7653322    12348999999999987665 6789999999999999999999865311     0       0000   


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..+            +...+..+.+++.+||+.||++|||+++|++
T Consensus       260 ~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          260 VFF------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCC------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000            0112356889999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.1e-37  Score=310.80  Aligned_cols=244  Identities=21%  Similarity=0.362  Sum_probs=173.0

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch-hhH-HHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRK-KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~-~~~-~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|+||.||++... +|+.||||++..... ... +.+.++..++..++||||+++++++.+.+..++||||+ ++.
T Consensus        31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~  109 (318)
T 2dyl_A           31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTC  109 (318)
T ss_dssp             EEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEE
T ss_pred             ceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCc
Confidence            46799999999999975 689999999976532 222 33444555678889999999999999999999999999 555


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +..+...   ....+++..+..++.||+.||.|||+ .   +++||||||+|||++.++.+||+|||++.........  
T Consensus       110 ~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--  181 (318)
T 2dyl_A          110 AEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--  181 (318)
T ss_dssp             HHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             HHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc--
Confidence            5555432   13568999999999999999999998 5   8999999999999999999999999999765433221  


Q ss_pred             eeecCcccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          431 TVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                       ....+++.|+|||.+.     ...++.++||||||+++|||++|+.||......  ....   .......      .+.
T Consensus       182 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~---~~~~~~~------~~~  249 (318)
T 2dyl_A          182 -DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVL---TKVLQEE------PPL  249 (318)
T ss_dssp             ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHH---HHHHHSC------CCC
T ss_pred             -cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHH---HHHhccC------CCC
Confidence             1234899999999984     456889999999999999999999999764321  1111   1111110      000


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +    .  .....+..+.+++.+||+.||.+|||+++|++
T Consensus       250 ~----~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          250 L----P--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             C----C--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C----C--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0    0  00113356889999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2e-37  Score=337.88  Aligned_cols=260  Identities=20%  Similarity=0.311  Sum_probs=196.0

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeee------CCceEEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD------HGDRYIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~------~~~~~lV  343 (557)
                      ...+.||+|+||.||++.. .+|+.||||+++.. .....+.+.+|+.++.+++||||+++++++..      .+..++|
T Consensus        17 ~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LV   96 (676)
T 3qa8_A           17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA   96 (676)
T ss_dssp             CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCE
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEE
Confidence            3445679999999999986 45899999998764 34456789999999999999999999998765      6678999


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---cEEeeccCCc
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSK  420 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgl~~  420 (557)
                      |||+++|+|.+++.... ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.   +||+|||++.
T Consensus        97 mEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           97 MEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             EECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            99999999999997533 234588999999999999999999999   9999999999999997765   8999999998


Q ss_pred             cCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccc--
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY--  498 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  498 (557)
                      ........   ....||+.|+|||.+.+..++.++||||||+++|||+||..||......     ..|..........  
T Consensus       173 ~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          173 ELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEHI  244 (676)
T ss_dssp             BTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------C
T ss_pred             cccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchhh
Confidence            76543322   2234899999999999999999999999999999999999999754221     1111111000000  


Q ss_pred             --ccccCcccc--c--CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 008698          499 --LELLDPLIS--S--LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV  543 (557)
Q Consensus       499 --~~~~d~~l~--~--~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev  543 (557)
                        .+.......  .  ..........+..+.+++.+||+.||++|||++++
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence              000110000  0  00111234467789999999999999999999873

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.5e-36  Score=301.04  Aligned_cols=229  Identities=17%  Similarity=0.282  Sum_probs=177.9

Q ss_pred             hcCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHH-hhcCCCcEEeeeeeeee----CCce
Q 008698          267 TKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRF-ARLHHPNLVAVKGCCYD----HGDR  340 (557)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~g~~~~----~~~~  340 (557)
                      ..+|....++||+|+||.||++.. .+++.||||+++..     ..+.+|+.++ ..++||||+++++++..    .+..
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            344555456789999999999996 46899999999643     3567888887 55599999999999876    6778


Q ss_pred             EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCcEEeecc
Q 008698          341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVG  417 (557)
Q Consensus       341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfg  417 (557)
                      ++||||+++|+|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            9999999999999999762  234699999999999999999999999   9999999999999998   7889999999


Q ss_pred             CCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       418 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                      ++....                        +..++.++||||||+++|||+||..||..........             
T Consensus       166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------------  208 (299)
T 3m2w_A          166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------------  208 (299)
T ss_dssp             TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------------
T ss_pred             cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------------
Confidence            986432                        2446789999999999999999999997654321000             


Q ss_pred             cccccCcccccCCCCCCc---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          498 YLELLDPLISSLSSDIPE---AGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        . +...+.......+.   ...+..+.+++.+||+.||++|||++|+++
T Consensus       209 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          209 --G-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             --C-SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --H-HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              0 00000000001111   123567899999999999999999999997

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.2e-36  Score=301.47  Aligned_cols=229  Identities=14%  Similarity=0.081  Sum_probs=180.0

Q ss_pred             CCCCeeecccCceEEEEEEeCC-CCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          271 SEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      +...+.||+|+||.||++.... |+.||||++....   ....+.+.+|+..+.+++||||+++++++.+.+..++||||
T Consensus        33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  112 (286)
T 3uqc_A           33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW  112 (286)
T ss_dssp             EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence            3444678999999999999754 8999999997653   23347899999999999999999999999999999999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++++|.+++..      .....++..++.||+.||+|||++   +|+||||||+|||++.++.+||++++         
T Consensus       113 ~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          113 IRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             CCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             cCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            999999999853      135567889999999999999999   99999999999999999999997443         


Q ss_pred             cccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                                   |++|       ++.++||||||+++|||+||+.||...+.......   +         ...+....
T Consensus       175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~---------~~~~~~~~  222 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---A---------ERDTAGQP  222 (286)
T ss_dssp             -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---C---------CBCTTSCB
T ss_pred             -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---H---------HHHhccCC
Confidence                         3333       68899999999999999999999987544211000   0         00000000


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      ..  ......+.+..+.+++.+||+.||++| |++|+++.|+++..
T Consensus       223 ~~--~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          223 IE--PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             CC--HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             CC--hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            00  000011234568999999999999999 99999999987654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-36  Score=338.40  Aligned_cols=234  Identities=22%  Similarity=0.249  Sum_probs=187.9

Q ss_pred             CCCeeecccCceEEEEEEeC--CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc-----eEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILP--DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-----RYIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~--~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~-----~~lV  343 (557)
                      ...+.||+|+||.||++...  +|+.||||++... .......+.+|+.++.+++||||+++++++...+.     .++|
T Consensus        83 ~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv  162 (681)
T 2pzi_A           83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIV  162 (681)
T ss_dssp             EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEE
Confidence            33457899999999999975  5899999998654 33455678999999999999999999999987765     6999


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      |||+++++|.+++.      ..+++.+++.++.||+.||.|||++   +|+||||||+|||++.+ .+||+|||+++...
T Consensus       163 ~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          163 MEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             EEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            99999999988764      2599999999999999999999999   99999999999999986 89999999998664


Q ss_pred             ccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccC
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  503 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  503 (557)
                      ..      ....||+.|+|||++.+.. +.++|||||||++|||++|.+|+........                     
T Consensus       233 ~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------------  284 (681)
T 2pzi_A          233 SF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------------  284 (681)
T ss_dssp             CC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------------
T ss_pred             cC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---------------------
Confidence            32      2234899999999987654 8999999999999999999888764211100                     


Q ss_pred             cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHhc
Q 008698          504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVHQLQQ  549 (557)
Q Consensus       504 ~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-~~evl~~L~~  549 (557)
                            ....+.......+.+++.+||+.||++||+ ++++.+.|..
T Consensus       285 ------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          285 ------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                  011112234467889999999999999995 6666666654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=9.5e-37  Score=320.05  Aligned_cols=237  Identities=18%  Similarity=0.163  Sum_probs=175.9

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCC-CcEE---------------ee---
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHH-PNLV---------------AV---  330 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H-~niv---------------~l---  330 (557)
                      .++||+|+||.||++.. .+|+.||||+++...   ....+.+.+|+.++..++| +|..               .+   
T Consensus        83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  162 (413)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred             ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence            35689999999999995 469999999987432   2235779999999999987 3211               11   


Q ss_pred             ---eeeeee-----CCceEEEEecCCCCChHHHhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 008698          331 ---KGCCYD-----HGDRYIVYEFVVNGPLDRWLHHI---PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR  399 (557)
Q Consensus       331 ---~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk  399 (557)
                         ..+...     ....+++|+++ +++|.+++...   ......+++..++.++.||+.||+|||++   +|+|||||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiK  238 (413)
T 3dzo_A          163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR  238 (413)
T ss_dssp             --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred             CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcc
Confidence               111111     12356777765 78999888421   12345688889999999999999999999   99999999


Q ss_pred             CCCeeeCCCCCcEEeeccCCccCCccccccceeecCccccccccccc----------cCCCCCchhhHHHHHHHHHHHHc
Q 008698          400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----------YRNELTTKSDVYSFGVLLLEIVS  469 (557)
Q Consensus       400 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDVwS~Gvil~el~t  469 (557)
                      |+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||++|||+|
T Consensus       239 p~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          239 PVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            99999999999999999998765432     223347 999999999          55568899999999999999999


Q ss_pred             CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          470 GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       470 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      |+.||...+....                   .+..+.. ...     .+..+.+|+.+||+.||++|||+.++++
T Consensus       313 g~~Pf~~~~~~~~-------------------~~~~~~~-~~~-----~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          313 ADLPNTDDAALGG-------------------SEWIFRS-CKN-----IPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             SSCCCCTTGGGSC-------------------SGGGGSS-CCC-----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCcchhhh-------------------HHHHHhh-ccc-----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999976543211                   1111110 011     2356899999999999999999877754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-35  Score=302.90  Aligned_cols=237  Identities=14%  Similarity=0.141  Sum_probs=177.3

Q ss_pred             CCeeecccCceEEEEEEeCCCCEEEEEEecccc--------hhhHHHHHHHHHHHhhcC---------CCcEEeeeeee-
Q 008698          273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--------FQRKKEFYSEIGRFARLH---------HPNLVAVKGCC-  334 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------H~niv~l~g~~-  334 (557)
                      ..+.||+|+||+||++.. +|+.||||+++...        ....+.+.+|+.+++.++         ||||+++.+++ 
T Consensus        24 ~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~  102 (336)
T 2vuw_A           24 RCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHC  102 (336)
T ss_dssp             TCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEE
T ss_pred             heeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeE
Confidence            345789999999999998 78999999997542        223477889999888885         67766666653 


Q ss_pred             ----------------ee-------------CCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 008698          335 ----------------YD-------------HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL  385 (557)
Q Consensus       335 ----------------~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL  385 (557)
                                      .+             .+..++||||+++|++.+.+..     ..+++..+..++.||+.||+||
T Consensus       103 ~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A          103 VQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH
Confidence                            22             6789999999999977666632     4589999999999999999999


Q ss_pred             h-cCCCCCeeecCCCCCCeeeCCCC--------------------CcEEeeccCCccCCccccccceeecCccccccccc
Q 008698          386 H-DKVKPHVVHRDIRASNVLLDEEF--------------------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE  444 (557)
Q Consensus       386 H-~~~~~~ivH~Dlk~~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE  444 (557)
                      | ++   +|+||||||+|||++.++                    .+||+|||+++.....       ...||+.|+|||
T Consensus       178 H~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE  247 (336)
T 2vuw_A          178 EASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDED  247 (336)
T ss_dssp             HHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSG
T ss_pred             HHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChh
Confidence            9 88   999999999999999887                    8999999999865422       124899999999


Q ss_pred             cccCCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHH
Q 008698          445 FVYRNELTTKSDVYSFGVL-LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVV  523 (557)
Q Consensus       445 ~~~~~~~s~~sDVwS~Gvi-l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~  523 (557)
                      ++.+.. +.++||||||++ .+++++|..||.....  ...+.+   .......    ...    ..........+..+.
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~---~~~~~~~----~~~----~~~~~~~~~~s~~~~  313 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTD---KMLKQMT----FKT----KCNTPAMKQIKRKIQ  313 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHH---HHHHTCC----CSS----CCCSHHHHHHHHHHH
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHH---hhhhhhc----cCc----ccchhhhhhcCHHHH
Confidence            998766 889999998777 7788889998743100  000000   0000000    000    001111345778899


Q ss_pred             HHHHHhcCCCCCCCCCHHHHH
Q 008698          524 DLVYACTQHVPSMRPRMSHVV  544 (557)
Q Consensus       524 ~l~~~Cl~~~P~~RPt~~evl  544 (557)
                      +|+.+||+.|     |++|++
T Consensus       314 dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          314 EFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHhccC-----CHHHHH
Confidence            9999999966     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=8.2e-30  Score=276.94  Aligned_cols=183  Identities=17%  Similarity=0.088  Sum_probs=128.0

Q ss_pred             cccCceEEEEEE-eCCCCEEEEEEecccc----------hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEe
Q 008698          278 GDSKTGGTYSGI-LPDGSRVAVKRLKRSS----------FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       278 g~G~~g~Vy~g~-~~~g~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      +.|++|.+..+. .-.|+.+|||++....          ....++|.+|+++|+++ +|+||+++++++++++..|||||
T Consensus       243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME  322 (569)
T 4azs_A          243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME  322 (569)
T ss_dssp             C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred             ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence            455555444333 2248889999996541          22346799999999999 79999999999999999999999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      |++|++|.++|..    ..+++..   +|+.||+.||+|+|++   +||||||||+||||++++.+||+|||+++.....
T Consensus       323 yv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          323 KLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             CCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             cCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999974    2456654   4789999999999999   9999999999999999999999999999876543


Q ss_pred             ccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 008698          426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP  473 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p  473 (557)
                      ....  ....||+.|||||.+.+ .+..++|+||+|++++++.++..+
T Consensus       393 ~~~~--~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CSWP--TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCS--HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             Cccc--cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            3221  22349999999999865 467789999999998887665443

>1ypq_A Oxidised low density lipoprotein (lectin-like) receptor 1; oxidized low density lipoprotein receptor, LOX-1, CTLD, C- type lectin like domain; 1.40A {Homo sapiens} SCOP: d.169.1.1 PDB: 1ypu_A 1yxk_A 3vlg_A 1ypo_A 1yxj_A

Probab=99.95  E-value=6.6e-28  Score=212.09  Aligned_cols=129  Identities=19%  Similarity=0.441  Sum_probs=111.0

Q ss_pred             CCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCee
Q 008698           49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW  128 (557)
Q Consensus        49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w  128 (557)
                      .+..||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++......+||||+  +...++.|
T Consensus         5 ~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w   80 (135)
T 1ypq_A            5 CSAPCPQDWI--WHGENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSSFPFWMGLS--RRNPSYPW   80 (135)
T ss_dssp             CCCSSCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHTTCCCCEEEEEE--ESSTTSCC
T ss_pred             cCCcCCcccE--EcCCEEEEEECCccCHHHHHHHHHhCCCEEeEeCCHHHHHHHHHHHhccCCCEEEecc--ccCCCCCe
Confidence            3478999999  8999999999999999999999999999999999999999999999755678999999  55556999


Q ss_pred             EEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccc
Q 008698          129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       129 ~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      +|+||+++..+.+|..++|++         ..+.++|+.+..  +.|++..|....+|||+.+.
T Consensus        81 ~W~dg~~~~~~~~w~~g~P~~---------~~~~~~Cv~~~~--~~w~~~~C~~~~~fICe~~~  133 (135)
T 1ypq_A           81 LWEDGSPLMPHLFRVRGAVSQ---------TYPSGTCAYIQR--GAVYAENCILAAFSICQKKA  133 (135)
T ss_dssp             EETTSCBCCTTSCCEEESCSC---------CCTTCEEEEEET--TEEEEEETTSCBEEEEEEEC
T ss_pred             EeCCcCccCcccccccCCCCC---------CCCCCCeeEEeC--CcEEccCCCCCeeeEeeecC
Confidence            999999996556666666554         234678988864  57999999999999999754

>3vpp_A C-type lectin domain family 9 member A; dendritic cell, C-type lectin-like domain, membrane, immune; 1.64A {Homo sapiens}

Probab=99.95  E-value=1.2e-27  Score=209.61  Aligned_cols=127  Identities=24%  Similarity=0.461  Sum_probs=104.8

Q ss_pred             CCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCe
Q 008698           50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~  127 (557)
                      |.+||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++...  ...+||||+  +...++.
T Consensus         1 c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   76 (132)
T 3vpp_A            1 SSPCPNNWI--QNRESCYYVSEIWSIWHTSQENCLKEGSTLLQIESKEEMDFITGSLRKIKGSYDYWVGLS--QDGHSGR   76 (132)
T ss_dssp             -CCSCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHTTSSSCCEEEEEEE--ECTTTCC
T ss_pred             CCCCCccce--EeCCEEEEEECCccCHHHHHHHHHhcCCEEeEECCHHHHHHHHHHHhccCCCccEEEEec--ccCCCCc
Confidence            579999999  8999999999999999999999999999999999999999999988642  457999999  5555699


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccccC
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN  194 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~s  194 (557)
                      |+|+||+++.+.+ |..++|+           .+.++|+.+..  +.|++..|....+|||+.+...
T Consensus        77 w~W~dg~~~~~~~-w~~~~p~-----------~~~~~C~~~~~--~~w~~~~C~~~~~fiCe~~~~~  129 (132)
T 3vpp_A           77 WLWQDGSSPSPGL-LPAERSQ-----------SANQVCGYVKS--NSLLSSNCDTWKYFICEKYALR  129 (132)
T ss_dssp             EEETTSCCCCTTS-CCCC-----------------CEEEEEET--TEEEEEESSSCBEEEEEEECC-
T ss_pred             eEecCCCcCChhh-cccCCCC-----------CCCCceEEEEC--CeEeccCCCCCceEECCccccc
Confidence            9999999987654 5555543           24578998864  5699999999999999987543

>2py2_A Antifreeze protein type II; type II antifreeze protein; 1.70A {Clupea harengus}

Probab=99.94  E-value=2.7e-27  Score=208.44  Aligned_cols=129  Identities=22%  Similarity=0.503  Sum_probs=107.9

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEE
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW  130 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W  130 (557)
                      ..||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++......+||||+  +...++.|+|
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W   77 (136)
T 2py2_A            2 DECPTDWK--MFNGRCFLFNPLQLHWADAQESCMKEGANLASIHSLEESTFVKELTSADLIPSWIGGT--DCQVSTRWFW   77 (136)
T ss_dssp             --CCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTTCEECCCCSHHHHHHHHTTSTTTTCCEEEEEE--CCSSTTCCEE
T ss_pred             CCCCcCce--ecCCEEEEEECCCcCHHHHHHHHhhCCCEEeeeCCHHHHHHHHHHHHcCCCCEeEeeE--cCCCCCceEe
Confidence            47999999  8999999999999999999999999999999999999999999998744478999999  6656799999


Q ss_pred             ccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecC-CCceeccccCCCCCccccccccC
Q 008698          131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVEHEN  194 (557)
Q Consensus       131 ~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~~~~~s  194 (557)
                      +||+++.|.+|. .++|++          .+.++|+.+... .+.|++..|....+|||+.+.+.
T Consensus        78 ~dG~~~~y~~W~-~geP~~----------~~~~~Cv~~~~~~~~~W~d~~C~~~~~fIC~~~~~~  131 (136)
T 2py2_A           78 MDSTSMDYADWC-AAQPDT----------TLTECCIQMNVGIGKCWNDTPCTHLHSSICAKPLKH  131 (136)
T ss_dssp             TTCCCCCCCCBC-TTCCCC----------CGGGCEEEEEETTTTEEEEECTTSCEEEEEEEECC-
T ss_pred             CCCCCcccCCCC-CCCCCC----------CCCCCCeEEccCCCCeEcCCCCCCCccEEeeECccc
Confidence            999999776654 444443          122788887654 56799999999999999987654

>3rs1_A C-type lectin domain family 2 member I; C-type lectin-like, ligand of NK receptor, natural killer CE receptors, surface of activated T lymphocytes; 1.94A {Mus musculus}

Probab=99.94  E-value=8.3e-27  Score=201.27  Aligned_cols=119  Identities=23%  Similarity=0.444  Sum_probs=103.5

Q ss_pred             CCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCe
Q 008698           48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~  127 (557)
                      ..+++||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++.  ...+||||+  +...++.
T Consensus         3 ~~~~~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~   76 (122)
T 3rs1_A            3 KTYAACSKNWT--GVGNKCFYFSGYPRNWTFAQAFCMAQEAQLARFDNEEELIFLKRFKG--DFDSWIGLH--RESSEHP   76 (122)
T ss_dssp             BSSSSCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCSSHHHHHHHHHHTT--TSCEEEEEE--CSSTTSC
T ss_pred             cccCCCChhhe--ecCCEEEEEECCccCHHHHHHHHHhcCCEEeeeCCHHHHHHHHHhcC--CCCEEEEEE--ecCCCCc
Confidence            34579999999  89999999999999999999999999999999999999999999986  458999999  6556799


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |+|+||+++.+.+|.                 .+.++|+.+...  .|++..|....+|||+++
T Consensus        77 w~W~dg~~~~~~~w~-----------------~~~~~C~~~~~~--~w~~~~C~~~~~fICekp  121 (122)
T 3rs1_A           77 WKWTNNTEYNNMNPI-----------------LGVGRYAYLSSD--RISSSRSYINRMWICSKL  121 (122)
T ss_dssp             CEETTCCBCCCCSCC-----------------CSSCSEEEEETT--EEEEECSCSCBCBEEEEE
T ss_pred             eECCCCCcCCccccC-----------------CCCCceEEEeCC--cEeccccCCCCCeeeecC
Confidence            999999998776641                 123578877653  699999999999999875

>2b6b_D CD209 antigen; cryo EM dengue CRD DC-SIGN, icosahedral virus, virus-recepto; 25.00A {Homo sapiens} SCOP: d.169.1.1

Probab=99.94  E-value=1.8e-26  Score=211.90  Aligned_cols=135  Identities=24%  Similarity=0.481  Sum_probs=114.0

Q ss_pred             cCCCCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCC
Q 008698           45 MNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV  124 (557)
Q Consensus        45 ~~~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~  124 (557)
                      .....|..||.||.  .|+++||+|+.+.++|.+|+.+|+++||+||+|+|++|++||..++......+||||+  +...
T Consensus        19 ~~~~~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~--~~~~   94 (175)
T 2b6b_D           19 SHMRLCHPCPWEWT--FFQGNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNRFTWMGLS--DLNQ   94 (175)
T ss_pred             ccccccCCCCcCcE--EeCCEEEEEECCccCHHHHHHHHhhCCCEEeeeCCHHHHHHHHHHhccCCCcEEEeeE--ccCC
Confidence            34567789999999  8999999999999999999999999999999999999999999877545678999999  6556


Q ss_pred             CCeeEEccCCCCCC--cCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccccCcc
Q 008698          125 GLSWKWSDNMSKWN--ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKC  196 (557)
Q Consensus       125 ~~~w~W~Dg~~~~~--~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~s~c  196 (557)
                      ++.|+|+||+++.+  +..|..++|++          .+.++|+.+...  .|++..|....+|||+.+.. .|
T Consensus        95 ~~~w~W~dGs~~~~~~~~~W~~geP~~----------~~~~~Cv~~~~~--gW~d~~C~~~~~fICe~~~~-~C  155 (175)
T 2b6b_D           95 EGTWQWVDGSPLLPSFKQYWNRGEPNN----------VGEEDCAEFSGN--GWNDDKCNLAKFWICKKSAA-SC  155 (175)
T ss_pred             CCcEEeCCCCCcccccccCCCCCCCCC----------CCCCCeeEEcCC--ceEccCCCCCeeEEEEECCC-CC
Confidence            79999999999875  35566666553          245788887654  39999999999999998765 44

>2bpd_A Dectin-1; receptor, beta-glucan, fungal recognition, C-type lectin-like domain, CTLD, carbohydrate; 1.5A {Mus musculus} PDB: 2bph_A 2bpe_A 2cl8_A*

Probab=99.94  E-value=6.2e-27  Score=207.74  Aligned_cols=130  Identities=22%  Similarity=0.483  Sum_probs=108.3

Q ss_pred             CCCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCC
Q 008698           47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVG  125 (557)
Q Consensus        47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~  125 (557)
                      .+....||.||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++... ...+||||+  +...+
T Consensus        11 ~~~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~WIGl~--~~~~~   86 (142)
T 2bpd_A           11 GGFSQSCLPNWI--MHGKSCYLFSFSGNSWYGSKRHCSQLGAHLLKIDNSKEFEFIESQTSSHRINAFWIGLS--RNQSE   86 (142)
T ss_dssp             ----CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHGGGTTSEEEEEEE--CSSTT
T ss_pred             CCCCCCCCccce--ecCCEEEEEECCCCCHHHHHHHHHHcCCEEeeeCCHHHHHHHHHHHhccCCCCEEEEee--cCCCC
Confidence            344578999999  8999999999999999999999999999999999999999999998643 467999999  66667


Q ss_pred             CeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       126 ~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      +.|+|+||+++.+.+|....++++         ..+.++|+.+..  +.|++..|....+|||+.+
T Consensus        87 ~~w~W~dg~~~~~~~w~~~~~~~~---------~~~~~~Cv~~~~--~~W~d~~C~~~~~fICe~~  141 (142)
T 2bpd_A           87 GPWFWEDGSAFFPNSFQVRNAVPQ---------ESLLHNCVWIHG--SEVYNQICNTSSYSICEKE  141 (142)
T ss_dssp             SCCEETTSCBCCSSSCCEECCCCS---------CCSCCCEEEEET--TEEEEECTTSCEEEEEEEC
T ss_pred             CCeEeCCCCccccccccccCCCCC---------CCCCCCCcEEcC--CeEECcCCCCCceeeeeee
Confidence            999999999998877665533332         235678988864  5799999999999999874

>1sl6_A C-type lectin DC-signr; sugar binding protein; HET: GAL NDG FUC; 2.25A {Homo sapiens} SCOP: d.169.1.1 PDB: 1xar_A

Probab=99.94  E-value=1e-26  Score=215.61  Aligned_cols=130  Identities=22%  Similarity=0.443  Sum_probs=111.0

Q ss_pred             CCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCe
Q 008698           48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~  127 (557)
                      ..|..||.||+  .|+++||+|+.+.++|.+|+.+|+++||+||+|+|.+|++||..++......+||||+  +...++.
T Consensus        48 ~~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~--~~~~~~~  123 (184)
T 1sl6_A           48 RLCRHCPKDWT--FFQGNCYFMSNSQRNWHDSVTACQEVRAQLVVIKTAEEQNFLQLQTSRSNRFSWMGLS--DLNQEGT  123 (184)
T ss_dssp             TTCCBCCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHTTCCEEEEEE--CCSSTTC
T ss_pred             CcCCCCCCCcE--EECCEEEEEECCCCCHHHHHHHHHhcCCEEEEeCCHHHHHHHHHHhccCCccEEEEEE--ccCCCCC
Confidence            35679999999  8999999999999999999999999999999999999999999876434568999999  6556799


Q ss_pred             eEEccCCCCCC--cCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccccc
Q 008698          128 WKWSDNMSKWN--ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE  193 (557)
Q Consensus       128 w~W~Dg~~~~~--~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~  193 (557)
                      |.|+||+++.+  ++.|..++|++          .+.++|+.+...  .|++..|....+|||+.+..
T Consensus       124 w~W~DGs~~~~~~~~~W~~geP~~----------~~~~~Cv~~~~~--gW~d~~C~~~~~fICe~~~~  179 (184)
T 1sl6_A          124 WQWVDGSPLSPSFQRYWNSGEPNN----------SGNEDCAEFSGS--GWNDNRCDVDNYWICKKPAA  179 (184)
T ss_dssp             CEETTSCBCCGGGGGGBCTTCCCC----------TTSCCEEEEETT--EEEEECTTSCBEEEEEEECB
T ss_pred             eEecCCCccCCcccCCCCCCCCCC----------CCCCCceEEeCC--cEEccCCCCCeeEEEeECCc
Confidence            99999999875  35576666553          256789888764  49999999999999998765

>3kqg_A Langerin, C-type lectin domain family 4 member K; trimer, NECK and CRD, coiled coil, immune system; 2.30A {Homo sapiens}

Probab=99.94  E-value=1.1e-26  Score=215.12  Aligned_cols=129  Identities=19%  Similarity=0.345  Sum_probs=109.8

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEE
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW  130 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W  130 (557)
                      ..||+||.  .|+++||+|+.++++|.+|+.+|+++||+||+|+|.+|++||.+++.  ...+||||+  +...+|.|+|
T Consensus        47 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~w~W  120 (182)
T 3kqg_A           47 QVVSQGWK--YFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAG--GLIYWIGLT--KAGMEGDWSW  120 (182)
T ss_dssp             HHHTTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHT--TCCEEEEEE--ECSTTCCEEE
T ss_pred             ccCCCCCE--EeCCEEEEEECCCCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhcC--CCcEEEEeE--ccCCCCceEe
Confidence            36999999  89999999999999999999999999999999999999999999986  458999999  5455699999


Q ss_pred             ccCCCCCC---cCccccCCCCCCCCCCCCccccccCceeEeecCC-CceeccccCCCCCccccccccC
Q 008698          131 SDNMSKWN---ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICMVEHEN  194 (557)
Q Consensus       131 ~Dg~~~~~---~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~-~~w~~~~C~~~~~~iC~~~~~s  194 (557)
                      +||+++.+   +..|..++|++         ..+.++|+.+...+ +.|++..|....+|||+.+..+
T Consensus       121 ~dG~~~~~~~~~~~W~~geP~~---------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~~~~  179 (182)
T 3kqg_A          121 VDDTPFNKVQSARFWIPGEPNN---------AGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVP  179 (182)
T ss_dssp             TTCCCCCHHHHTTTBCTTCCCC---------TTSCCCEEEECSSSSSCEEEECTTSCBEEEEEEECCC
T ss_pred             CCCCccccccccCCCCCCCCCC---------CCCCCCeeEEecCCCCCEeCcCCCCCeeEEeccCCCC
Confidence            99999983   45566666554         23457898886644 5799999999999999987543

>3bdw_A Natural killer cells antigen CD94; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 3cdg_J 1b6e_A 3cii_G

Probab=99.94  E-value=4.1e-27  Score=203.54  Aligned_cols=121  Identities=16%  Similarity=0.386  Sum_probs=103.8

Q ss_pred             CCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCee
Q 008698           49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW  128 (557)
Q Consensus        49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w  128 (557)
                      .|.+||+||+  .|+++||+++.++++|.+|+.+|+++||+||+|+|++|++||.++    ...+||||+  +...++.|
T Consensus         1 ~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~----~~~~WIGl~--~~~~~~~w   72 (123)
T 3bdw_A            1 DCCSCQEKWV--GYRCNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSSS----QQFYWIGLS--YSEEHTAW   72 (123)
T ss_dssp             CCCCCTTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCSCGGGGGGGTTC----CCCEECSEE--EETTTTEE
T ss_pred             CCCCCCCCce--EECCEEEEEeCCCCCHHHHHHHHHHCCCeeEEECCHHHHHHHHhC----cCCEEeeee--cCCCCCcE
Confidence            4789999999  899999999999999999999999999999999999999999886    458999999  54556999


Q ss_pred             EEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       129 ~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      +|+||+++.+.+|....|             .+.++|+.+... +.|++..|....+|||+.+
T Consensus        73 ~W~dg~~~~~~~w~~~~~-------------~~~~~C~~~~~~-~~w~d~~C~~~~~fICe~~  121 (123)
T 3bdw_A           73 LWENGSALSQYLFPSFET-------------FNTKNCIAYNPN-GNALDESCEDKNRYICKQQ  121 (123)
T ss_dssp             EETTSCBCCTTTSGGGGG-------------CCTTSEEEEETT-TEEEEECTTSCBEEEEEEC
T ss_pred             EeeCCCcCCcccccccCC-------------CCCCCCcEEcCC-CcEEccCCCCCCeeeEeEe
Confidence            999999988776543322             134689887654 5799999999999999875

>3m9z_A Killer cell lectin-like receptor subfamily B MEMB; C-type lectin-like domain, domain swapping, disulfide bond, transmembrane protein; 1.70A {Mus musculus} SCOP: d.169.1.0 PDB: 3t3a_A

Probab=99.94  E-value=6.3e-27  Score=206.90  Aligned_cols=125  Identities=26%  Similarity=0.557  Sum_probs=108.9

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEE
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW  130 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W  130 (557)
                      ..||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++......+||||+  +...++.|+|
T Consensus         4 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W   79 (139)
T 3m9z_A            4 LECPQDWL--SHRDKCFHVSQVSNTWEEGLVDCDGKGATLMLIQDQEELRFLLDSIKEKYNSFWIGLR--YTLPDMNWKW   79 (139)
T ss_dssp             CCCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCCHHHHHHHHHHHTCSSSCEEEEEE--EECCCCCCBC
T ss_pred             CCCCccce--ecCCEEEEEECCcCCHHHHHHHHHhcCCeEeeeCCHHHHHHHHHHhcccCccEEEEEe--ccCCCCCeEe
Confidence            68999999  8999999999999999999999999999999999999999999999855668999999  4445689999


Q ss_pred             ccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccccC
Q 008698          131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN  194 (557)
Q Consensus       131 ~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~s  194 (557)
                      +||+++.+.+|+..++++             .++|+.+..  +.|++..|....+|||+.+...
T Consensus        80 ~dg~~~~~~~~~~~~~~~-------------~~~Cv~~~~--~~w~~~~C~~~~~fICe~~~~~  128 (139)
T 3m9z_A           80 INGSTLNSDVLKITGDTE-------------NDSCAAISG--DKVTFESCNSDNRWICQKELYH  128 (139)
T ss_dssp             TTSCBCCHHHHTTSSCTT-------------CEEEEEEET--TEEEEEETTSCBEEEEEEECC-
T ss_pred             CCCCcCCcCccccCCCCC-------------CCCeeEEeC--CcEEeCCCCCCCceEeeecCcc
Confidence            999999888877655432             358888864  5799999999999999987554

>3c22_A C-type lectin domain family 4 member K; coiled coil, glycoprotein, membrane, signal-anchor, transmembrane, immune system, sugar binding protein; 1.50A {Homo sapiens} PDB: 3p5g_A* 3p5d_A* 3p5f_A* 3p5e_A* 3p5h_A* 3p5i_A* 3p7g_A* 3p7f_A* 3p7h_A* 3bc7_A* 3bbs_A* 3bc6_A*

Probab=99.94  E-value=1.7e-26  Score=208.36  Aligned_cols=132  Identities=20%  Similarity=0.339  Sum_probs=108.1

Q ss_pred             CCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCe
Q 008698           48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~  127 (557)
                      ..+..||+||+  .|+++||+|+.+.++|.+|+.+|+++||+||+|+|++|++||.+++.  ...+||||+  +...++.
T Consensus        18 ~~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~   91 (156)
T 3c22_A           18 DILQVVSQGWK--YFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAG--GLIYWIGLT--KAGMEGD   91 (156)
T ss_dssp             ------CCCCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHT--TCCEEEEEE--EETTTTE
T ss_pred             hhhccCCCCCE--EcCCEEEEEECCCCCHHHHHHHHHhCCCEEeecCCHHHHHHHHHhhc--CCcEEEeee--ccCCCCc
Confidence            34468999999  89999999999999999999999999999999999999999999987  568999999  4445699


Q ss_pred             eEEccCCCCCC---cCccccCCCCCCCCCCCCccccccCceeEeecCC-CceeccccCCCCCccccccccC
Q 008698          128 WKWSDNMSKWN---ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICMVEHEN  194 (557)
Q Consensus       128 w~W~Dg~~~~~---~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~-~~w~~~~C~~~~~~iC~~~~~s  194 (557)
                      |+|+||+++.+   +..|..++|++         ..+.++|+.+.... +.|++..|....+|||+.+..+
T Consensus        92 w~W~dG~~~~~~~~~~~W~~geP~~---------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~~~~  153 (156)
T 3c22_A           92 WSWVDDTPFNKVQSARFWIPGEPNN---------AGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVP  153 (156)
T ss_dssp             EEETTCCCCCHHHHGGGBCTTCCCC---------GGGCCCEEEECSSSSSCEEEECTTSCBEEEEEEECCC
T ss_pred             eEeCCCCccccccccCcCCCCCCCC---------CCCCCCceEECCCCCCcEECCCCCCCeeEEEeeCCcC
Confidence            99999999986   45676666554         22567888876543 6799999999999999986543

>3bx4_B Aggretin beta chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_B

Probab=99.94  E-value=1e-26  Score=207.31  Aligned_cols=119  Identities=24%  Similarity=0.536  Sum_probs=102.5

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL  126 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~  126 (557)
                      ..||+||.  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...  ...+||||+  +...++
T Consensus        23 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~   98 (146)
T 3bx4_B           23 ADCPSGWS--SYEGHCYKPFNEPKNWADAERFCKLQPKHSHLVSFQSAEEADFVVKLTRPRLKANLVWMGLS--NIWHGC   98 (146)
T ss_dssp             --CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHSSSCCEECCCSSHHHHHHHHHHHTTTTTTSEEECSCC--CTTSSS
T ss_pred             CCCCcCcE--eeCCEEEEEECCCcCHHHHHHHHhccCCCceEeccCCHHHHHHHHHHHhhcCCCCCEEEecc--cCCCCC
Confidence            37999999  8999999999999999999999999  599999999999999999998754  468999999  665679


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      .|+|+||+++.|.+|.  ++|                +|+.+....+.|++..|....+|||+.+
T Consensus        99 ~~~W~dg~~~~~~~W~--g~P----------------~C~~~~~~~g~w~~~~C~~~~~~ICe~~  145 (146)
T 3bx4_B           99 NWQWSDGARLNYKDWQ--EQS----------------ECLAFRGVHTEWLNMDCSSTCSFVCKFK  145 (146)
T ss_dssp             CEEETTCCCCCSCCBC--SCC----------------EEEEEETTCCCEEEEETTSCEEEEEEEE
T ss_pred             ceEeCCCCcccccCcC--CCC----------------CceEEECCCCeEecCCCCCCcceEEeec
Confidence            9999999998777655  433                5777766556899999999999999874

>3bdw_B NKG2-A/NKG2-B type II integral membrane protein; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} PDB: 3cdg_K 3cii_H

Probab=99.93  E-value=1.8e-26  Score=198.61  Aligned_cols=118  Identities=19%  Similarity=0.388  Sum_probs=100.9

Q ss_pred             CCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCe
Q 008698           48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~  127 (557)
                      ..|+.||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.++..    .+||||+  +...++.
T Consensus         2 ~~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~----~~WIGl~--~~~~~~~   73 (120)
T 3bdw_B            2 RHCGHCPEEWI--TYSNSCYYIGKERRTWEESLLACTSKNSSLLSIDNEEEMKFLSIISP----SSWIGVF--RNSSHHP   73 (120)
T ss_dssp             CCCTTSCTTCE--ESSSSEEEEEEEEECHHHHHHHHHHTTSEECCCCCHHHHHHHHHHCS----EEEEEEE--CSSTTSC
T ss_pred             CcCCCCCCCce--EECCEEEEEECCccCHHHHHHHHHhCCCEEceeCCHHHHHHHHHcCC----CEeEEEE--ecCCCCc
Confidence            45789999999  89999999999999999999999999999999999999999999863    8999999  6666799


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~  190 (557)
                      |+|+||+++.+.+ |   +|++           +.++|+.+...  .|++..|....+|||+.
T Consensus        74 w~W~dg~~~~~~~-~---~p~~-----------~~~~C~~~~~~--~w~~~~C~~~~~fICe~  119 (120)
T 3bdw_B           74 WVTMNGLAFKHEI-K---DSDN-----------AELNCAVLQVN--RLKSAQCGSSIIYHCKH  119 (120)
T ss_dssp             CEETTSSBCCSCC-C------------------CCCCEEEEESS--SEEEECTTSCEEEEEEC
T ss_pred             eEeCCCCccCccC-c---CCCC-----------CCCCccEEeCC--ceECCCCCCCcceeeee
Confidence            9999999987653 1   2221           34689888664  49999999999999986

>2c6u_A CLEC1B protein; lectin, rhodocytin, aggretin, C-type lectin-like, platelets, thrombosis; 1.6A {Homo sapiens}

Probab=99.93  E-value=7.7e-27  Score=201.50  Aligned_cols=121  Identities=18%  Similarity=0.411  Sum_probs=104.6

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEE
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW  130 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W  130 (557)
                      ++||+||+  .|+++||+++.++++|.+|+.+|+++||+||+|+|++|++||.+++.   ..+||||+  +...++.|+|
T Consensus         1 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~L~~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~~~W   73 (122)
T 2c6u_A            1 SPCDTNWR--YYGDSCYGFFRHNLTWEESKQYCTDMNATLLKIDNRNIVEYIKARTH---LIRWVGLS--RQKSNEVWKW   73 (122)
T ss_dssp             CCSCTTEE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHTTCC---SCEEEEEE--CSSTTSCCBC
T ss_pred             CCCCccce--EeCCEEEEEECCcCCHHHHHHHHHhCCCeEeeECCHHHHHHHHHhhc---CCEEEEee--ecCCCCCeEe
Confidence            37999999  89999999999999999999999999999999999999999999886   36899999  6556799999


Q ss_pred             ccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccc
Q 008698          131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       131 ~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      +||+++.+ + |.+++|++          .+.++|+.+.  .+.|++..|....+|||+.+.
T Consensus        74 ~dg~~~~~-~-W~~~~P~~----------~~~~~C~~~~--~g~w~~~~C~~~~~~ICe~~~  121 (122)
T 2c6u_A           74 EDGSVISE-N-MFEFLEDG----------KGNMNCAYFH--NGKMHPTFCENKHYLMCERKA  121 (122)
T ss_dssp             TTSCBCCG-G-GGGGBCCC----------CTTCCEEEEE--TTEEEEECTTSCEEEEEEEEC
T ss_pred             CCCCccCc-C-cccCCCCC----------CCCCCeeEEc--CCeEEeccCCCCceEeeeecC
Confidence            99999987 5 55554443          2457898884  368999999999999998754

>1gz2_A Ovocleidin-17, OC-17 ovocleidin; structural protein, CTLD, eggshell structural protein, phosphoprotein, sugar-binding protein, glycoprotein; HET: SEP; 1.5A {Gallus gallus} SCOP: d.169.1.1

Probab=99.93  E-value=1.8e-26  Score=204.67  Aligned_cols=126  Identities=25%  Similarity=0.555  Sum_probs=106.4

Q ss_pred             CCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC----------CCCeEEee
Q 008698           50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----------VNGCWVGG  117 (557)
Q Consensus        50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~----------~~~~WiGl  117 (557)
                      |..||+||+  .|+++||+++.++++|.+|+.+|++  +||+||+|+|++|++||.+++...          ...+||||
T Consensus         2 ~~~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~~~~~~WIGl   79 (142)
T 1gz2_A            2 PDGCGPGWV--PTPGGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASRGGDGSGEGADGRVWIGL   79 (142)
T ss_dssp             --CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCTTEEECCCCSHHHHHHHHHHHHCSSCCSSSCCCCSSCEEEEE
T ss_pred             CCCCCcccE--EcCCEEEEEcCCCcCHHHHHHHHhccCCCceECccCCHHHHHHHHHHHHhcccccccccccCCCEEEEe
Confidence            468999999  8999999999999999999999999  999999999999999999998643          46799999


Q ss_pred             eecCCCCCCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCC--ceeccccCCCCCcccccc
Q 008698          118 RSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVE  191 (557)
Q Consensus       118 ~~~~~~~~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~--~w~~~~C~~~~~~iC~~~  191 (557)
                      +  +...++.|+|+||+++.|.+|. .++|++          . .++|+.+...+.  .|++..|....+|||+.+
T Consensus        80 ~--~~~~~~~w~W~dg~~~~~~~W~-~~~P~~----------~-~~~C~~~~~~~~~~~w~~~~C~~~~~fICe~~  141 (142)
T 1gz2_A           80 H--RPAGSRSWRWSDGTAPRFASWH-RTAKAR----------R-GGRCAALRDEEAFTSWAARPCTERNAFVCKAA  141 (142)
T ss_dssp             E--CCTTCSSCEETTSCCCCCCCBC-SSSGGG----------C-SCSEEEECTTTTSSCEEEECTTCCEEEEEEEE
T ss_pred             e--cCCCCCCcEeCCCCccCccCcC-CCCCCC----------C-CCCCeEEecCCCCCeEecCCCCCCceeEEeec
Confidence            9  6666799999999998776654 444443          1 568888876553  799999999999999874

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=1.7e-26  Score=249.50  Aligned_cols=184  Identities=16%  Similarity=0.165  Sum_probs=146.7

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEe
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      .++||+|+||.||++.. .++.+++|+......        ...+++.+|+.++.+++||||+++..++...+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            34689999999999955 688999998643211        123568999999999999999977777778888899999


Q ss_pred             cCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      |+++++|.+++..            +..++.|+++||+|||++   +|+||||||+|||++.  .+||+|||+++.....
T Consensus       420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            9999999999863            458999999999999999   9999999999999999  9999999999987643


Q ss_pred             cccc-----ceeecCccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008698          426 VMQE-----RTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQ  475 (557)
Q Consensus       426 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~el~tG~~p~~  475 (557)
                      ....     ......||+.|||||++..  ..|+..+|+||..+-..+.+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2211     1123348999999999986  567888999999999999888777663

>1dv8_A Asialoglycoprotein receptor 1; C-type lectin CRD, signaling protein; 2.30A {Homo sapiens} SCOP: d.169.1.1

Probab=99.93  E-value=5.5e-26  Score=197.82  Aligned_cols=125  Identities=22%  Similarity=0.525  Sum_probs=104.8

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEcc
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD  132 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~D  132 (557)
                      ||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++.  ...+||||+  +.  ++.|+|+|
T Consensus         1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~--~~~~~W~d   72 (128)
T 1dv8_A            1 CPVNWV--EHERSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIG--PVNTWMGLH--DQ--NGPWKWVD   72 (128)
T ss_dssp             CCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CT--TSSCEETT
T ss_pred             CCCcce--ecCCEEEEEECCCcCHHHHHHHHhhCCCEEcccCCHHHHHHHHHhhC--CCCEEeeEE--cC--CCcEEeCC
Confidence            999999  89999999999999999999999999999999999999999999997  468999999  54  59999999


Q ss_pred             CCCC--CCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          133 NMSK--WNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       133 g~~~--~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |+++  .|.+ |.+++|++...    +...+.++|+.+.. .+.|++..|....+|||+.+
T Consensus        73 g~~~~~~~~~-W~~g~P~~~~~----~~~~~~~~C~~~~~-~g~W~~~~C~~~~~fICe~~  127 (128)
T 1dv8_A           73 GTDYETGFKN-WRPEQPDDWYG----HGLGGGEDCAHFTD-DGRWNDDVCQRPYRWVCETE  127 (128)
T ss_dssp             CCCSTTSCCC-BCTTCCCCCCT----TSSSSCCCEEEECT-TSCEEEECTTSCBEEEEEEE
T ss_pred             CCcCCccccc-CCCCCCCCccc----ccCCCCCcCceecC-CCcCCCccCCCCcceeeeeC
Confidence            9998  5555 45555454211    01235788998864 46899999999999999874

>1tdq_B Aggrecan core protein; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: d.169.1.1

Probab=99.93  E-value=3.1e-26  Score=199.93  Aligned_cols=124  Identities=23%  Similarity=0.440  Sum_probs=106.2

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEE
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW  130 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W  130 (557)
                      ..||+||+  .|+++||+++.++++|.+|+.+|+++||+||+|+|++|++||.+++.   ..+||||+  +...++.|+|
T Consensus         5 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~~~W   77 (130)
T 1tdq_B            5 EQCEEGWT--KFQGHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQEFVNKNAQ---DYQWIGLN--DRTIEGDFRW   77 (130)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC---SCEEEEEE--CSSSTTCCEE
T ss_pred             cCCCcccE--EeCCEEEEEECCCCCHHHHHHHHHhcCCEEeeeCCHHHHHHHHhccC---CCEEEeee--cCCCCCEEEe
Confidence            58999999  89999999999999999999999999999999999999999999885   47999999  6556799999


Q ss_pred             ccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeec-CCCceeccccCCCCCccccc
Q 008698          131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       131 ~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~-~~~~w~~~~C~~~~~~iC~~  190 (557)
                      +||+++.|.+|. .++|++.        ..+.++|+.+.. ..+.|++..|....+|||+.
T Consensus        78 ~dg~~~~~~~W~-~~~P~~~--------~~~~~~C~~~~~~~~~~w~~~~C~~~~~fICe~  129 (130)
T 1tdq_B           78 SDGHSLQFEKWR-PNQPDNF--------FATGEDCVVMIWHERGEWNDVPCNYQLPFTCKK  129 (130)
T ss_dssp             TTCCCCCCCCBC-TTCCCCC--------STTTEEEEEEETTTTTEEEEEETTSCEEEEEEE
T ss_pred             cCCCcCCccccC-CCCCCCc--------cCCCCCeEEEccCCCCcccCcCCCCCeeeeeec
Confidence            999999876654 4444431        135678988763 45689999999999999986

>2afp_A Protein (SEA raven type II antifreeze protein); recombinant SEA raven protein, solution backbone fold, C- type lectin; NMR {Hemitripterus americanus} SCOP: d.169.1.1

Probab=99.93  E-value=1.6e-26  Score=201.50  Aligned_cols=125  Identities=26%  Similarity=0.497  Sum_probs=105.3

Q ss_pred             CCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCee
Q 008698           49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW  128 (557)
Q Consensus        49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w  128 (557)
                      .+..||+||+  .|+++||+++.++++|.+|+.+|+++||+||+|+|++|++||.++ .  ...+||||+  +...++.|
T Consensus         3 ~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~-~--~~~~WIGl~--~~~~~~~~   75 (129)
T 2afp_A            3 AGPNCPAGWQ--PLGDRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTL-N--AGVVWIGGS--ACLQAGAW   75 (129)
T ss_dssp             CCCSSCSSSC--CCSSSEECCCCSCCCHHHHHHHHHHHSCEECCCSSSHHHHHHHHH-C--SSCBCCSCB--CSSSSSCC
T ss_pred             ccCCCCcCcE--EcCCEEEEEECCcCCHHHHHHHHHHcCCEECCcCCHHHHHHHHhc-C--CCCEEEccc--ccCCCCce
Confidence            4578999999  899999999999999999999999999999999999999999999 3  568999999  65567999


Q ss_pred             EEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCC-ceeccccCCCCCcccccc
Q 008698          129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR-SLVTERCNTSHPFICMVE  191 (557)
Q Consensus       129 ~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~-~w~~~~C~~~~~~iC~~~  191 (557)
                      +|+||+++.|.+|. .++|++.          +.++|+.+..... .|++..|....+|||+.+
T Consensus        76 ~W~dg~~~~~~~W~-~~~P~~~----------~~~~C~~~~~~~~~~w~~~~C~~~~~~iCe~~  128 (129)
T 2afp_A           76 TWSDGTPMNFRSWC-STKPDDV----------LAACCMQMTAAADQCWDDLPCPASHKSVCAMT  128 (129)
T ss_dssp             BSSSSCCCCCCCSS-SCCSCCS----------TTCCBCCBCCSSSSCBCCBCSCCCCCCCEEEC
T ss_pred             EeCCCCccccCCcC-CCccCCC----------CCCCCeEEccCCCCEEeCCCCCCCcceEEeee
Confidence            99999999776654 4444431          1267877765544 599999999999999874

>2kv3_A Regenerating islet-derived protein 4; GISP, C-type lectin, REG IV, disulfide bond, glycoPro lectin, secreted, sugar binding protein; NMR {Homo sapiens}

Probab=99.93  E-value=3e-26  Score=200.24  Aligned_cols=123  Identities=24%  Similarity=0.617  Sum_probs=105.8

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhC--CCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCe
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~  127 (557)
                      .||+||+  .|+++||+++.++++|.+|+.+|+++  ||+||+|+|++|++||.+++...  ...+||||+  +...++.
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   77 (131)
T 2kv3_A            2 SCAPGWF--YHKSNCYGYFRKLRNWSDAELECQSYGNGAHLASILSLKEASTIAEYISGYQRSQSIWIGLH--DPQKRQQ   77 (131)
T ss_dssp             CSCTTCC--EETTEEEEEEEEEECHHHHHHHHHTTSSSCEECCCSSHHHHHHHHHHHTCTTSCCCCBCSEE--CSSSSSC
T ss_pred             cCCcccE--EcCCEeEEEECCCCCHHHHHHHHhccCCCceEeeeCCHHHHHHHHHHHHhcCCCCCEEEecc--CCCCCCC
Confidence            6999999  89999999999999999999999999  99999999999999999999754  468999999  6656799


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCC--ceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~--~w~~~~C~~~~~~iC~~~  191 (557)
                      |+|+||+++.|.+|..++|             .+.++|+.+...++  .|++..|....+|||+.+
T Consensus        78 ~~W~dg~~~~~~~W~~~~P-------------~~~~~C~~~~~~~~~~~W~~~~C~~~~~~iCe~~  130 (131)
T 2kv3_A           78 WQWIDGAMYLYRSWSGKSM-------------GGNKHCAEMSSNNNFLTWSSNECNKRQHFLCKYR  130 (131)
T ss_dssp             CEETTCCCCSSCCCSSCCC-------------TTCTTEEEECTTCTTCCEEEECTTCCEEEEEEEC
T ss_pred             eEeCCcCcccccccCCCCC-------------CCCCCceEEECCCCcCceecCCCCCCceEEEeeC
Confidence            9999999997766544433             13467888766544  599999999999999875

>1wmz_A Lectin CEL-I, N-acetyl-D-galactosamine-specific C-type; C-type lectin, N-acetylgalactosamine, invertebrate, sugar binding protein; HET: NGA A2G; 1.70A {Cucumaria echinata} SCOP: d.169.1.1 PDB: 1wmy_A*

Probab=99.93  E-value=1.9e-26  Score=203.98  Aligned_cols=128  Identities=13%  Similarity=0.343  Sum_probs=108.8

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHh-------hCCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeec
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCK-------EIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSI  120 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~-------~~~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~  120 (557)
                      ++||+||+  .|+++||+++.++++|.+|+.+|+       ..||+||+|+|++|++||.+++...   ...+||||+  
T Consensus         1 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--   76 (140)
T 1wmz_A            1 NQCPTDWE--AEGDHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNYWRGIDSQAGQLWIGLY--   76 (140)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCBGGGTEEEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--
T ss_pred             CcCCCcce--ecCCEEEEEECCCcCHHHHHHhhhhhccCCCCCCcEEcccCCHHHHHHHHHHHhhccCCCCCEEEeee--
Confidence            37999999  899999999999999999999999       9999999999999999999988632   468999999  


Q ss_pred             CCCCCCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCC-ceeccccCCCCCccccccc
Q 008698          121 NTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR-SLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       121 ~~~~~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~-~w~~~~C~~~~~~iC~~~~  192 (557)
                      +...++.|+|+||+++.|.+|. .++|++         ..+.++|+.+....+ .|++..|....+|||+.+.
T Consensus        77 ~~~~~~~~~W~dg~~~~~~~W~-~~~P~~---------~~~~~~Cv~~~~~~~~~W~~~~C~~~~~fICe~~~  139 (140)
T 1wmz_A           77 DKYNEGDFIWTDGSKVGYTKWA-GGQPDN---------WNNAEDYGQFRHTEGGAWNDNSAAAQAKYMCKLTF  139 (140)
T ss_dssp             CSSSTTCCEETTCCCCCCCCBC-TTCCCC---------GGGCEEEEEECSSTTTCEEEEETTCCEEEEEEEEE
T ss_pred             ecCCCCeeEECCcCcccccCcC-cccCCC---------CCCcCCcEEEccCCCCCEeCCCCCCCceEEEEEec
Confidence            6556799999999999776644 444443         235678998876655 7999999999999998753

>1hq8_A NKG2-D; homodimer, CIS-proline, apoptosis; 1.95A {Mus musculus} SCOP: d.169.1.1 PDB: 1jsk_A 1kcg_A*

Probab=99.93  E-value=9.3e-27  Score=201.29  Aligned_cols=120  Identities=23%  Similarity=0.547  Sum_probs=103.0

Q ss_pred             CCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCee
Q 008698           49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW  128 (557)
Q Consensus        49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w  128 (557)
                      .|.+||+||.  .|+++||+++.++++|.+|+.+|+++||+||+|+|++|++||..+.    ..+||||+  +...++.|
T Consensus         2 ~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~fl~~~~----~~~WIGl~--~~~~~~~w   73 (123)
T 1hq8_A            2 YCGPCPNNWI--CHRNNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEEQDFLKLVK----SYHWMGLV--QIPANGSW   73 (123)
T ss_dssp             CCCCCSTTCE--EETTEEEEEEEEEECHHHHHHHHHTTTCEECCCSCTTTTGGGGGCC----SCEEEEEE--ECTTTCCE
T ss_pred             cCCCCCcccE--EcCCEEEEEeCCccCHHHHHHHHHhcCCEecccCCHHHHHHHHhcc----CCEEEEee--ecCCCCCe
Confidence            4689999999  8999999999999999999999999999999999999999998753    47999999  55556999


Q ss_pred             EEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       129 ~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      +|+||+++.+.+|..++| +             .++|+.+... +.|++..|....+|||+.+
T Consensus        74 ~W~dg~~~~~~~w~~~~p-~-------------~~~C~~~~~~-~~w~~~~C~~~~~fICe~~  121 (123)
T 1hq8_A           74 QWEDGSSLSYNQLTLVEI-P-------------KGSCAVYGSS-FKAYTEDCANLNTYICMKR  121 (123)
T ss_dssp             EETTSCBCCTTTCEEECC-T-------------TCCEEEECST-TEEEEECTTSCEEEEEEEC
T ss_pred             EeCCCCCccccccccCCC-C-------------CCCcEEEecc-CCEeccCCCCCceeEeeee
Confidence            999999988776554443 2             2578877654 5799999999999999875

>2ox9_A Collectin placenta 1; C-type lectin, sugar binding protein; HET: GAL NAG FUC; 1.95A {Mus musculus} PDB: 2ox8_A

Probab=99.93  E-value=8.2e-26  Score=200.00  Aligned_cols=132  Identities=22%  Similarity=0.442  Sum_probs=109.1

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEE
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW  130 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W  130 (557)
                      ..||+||.  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++.. ...+||||+  +...++.|+|
T Consensus         3 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~-~~~~WIGl~--~~~~~~~~~W   77 (140)
T 2ox9_A            3 NGCPPHWK--NFTDKCYYFSLEKEIFEDAKLFCEDKSSHLVFINSREEQQWIKKHTVG-RESHWIGLT--DSEQESEWKW   77 (140)
T ss_dssp             -CCCTTCE--EETTEEEEECSCCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHTCCS-SSCEEEEEE--CSSSTTCCEE
T ss_pred             CCCCcCce--EcCCEEEEEECCCcCHHHHHHHHHhcCCEEeeeCCHHHHHHHHHHhcC-CCCEEeeeE--eCCCCCceEe
Confidence            47999999  899999999999999999999999999999999999999999998863 568999999  6556799999


Q ss_pred             ccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccccC
Q 008698          131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN  194 (557)
Q Consensus       131 ~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~s  194 (557)
                      +||+++.|.+|.. ++|++..     +...+.++|+.+.. .+.|++..|....+|||+.+...
T Consensus        78 ~dg~~~~~~~W~~-~~P~~~~-----~~~~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~~~~~  134 (140)
T 2ox9_A           78 LDGSPVDYKNWKA-GQPDNWG-----SGHGPGEDCAGLIY-AGQWNDFQCDEINNFICEKEREA  134 (140)
T ss_dssp             TTSCBCCSCCBCT-TCCCCTT-----TTTSSCCCEEEECG-GGCEEEECTTSCBEEEEEEECC-
T ss_pred             CCcCcCCccCcCC-cCCCCcc-----cCCCCCCCCceECC-CCeEeccCCCCCceeEEeecCCC
Confidence            9999987766544 4444421     11245688988765 36799999999999999987543

>1egg_A Macrophage mannose receptor; C-type lectin, sugar binding protein; 2.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1egi_A

Probab=99.93  E-value=4.3e-26  Score=203.45  Aligned_cols=129  Identities=25%  Similarity=0.531  Sum_probs=104.6

Q ss_pred             CCCCccC--cccCCCCeeeEEec----CCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecC
Q 008698           51 APCPPDW--IINEEKSKCFGYIG----NFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSIN  121 (557)
Q Consensus        51 ~~Cp~~w--~~~~~~~~Cy~~~~----~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~~  121 (557)
                      ..||+||  .  .|+++||+|+.    +.++|.+|+.+|+++||+||+|+|++|++||.+++...   ...+||||+  +
T Consensus         3 ~~Cp~gw~~~--~~~~~CY~~~~~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~   78 (147)
T 1egg_A            3 PKCPEDWGAS--SRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLITASGSYHKLFWLGLT--Y   78 (147)
T ss_dssp             --CCTTCEEC--SSSSCEEEEECSCGGGCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--C
T ss_pred             CCCCCCCccc--cCCCEEEEEeccCCccccCHHHHHHHHHHcCCEECccCCHHHHHHHHHHHHhccCCCCcEEEeee--c
Confidence            5799999  8  89999999999    99999999999999999999999999999999887532   368999999  6


Q ss_pred             CCCCCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecC-CCceeccccCCCCCcccccccc
Q 008698          122 TTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVEHE  193 (557)
Q Consensus       122 ~~~~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~~~~~  193 (557)
                      ...++.|+|+||+++.|.+|.. ++|++         ..+.++|+.+... ++.|++..|....+|||+.+..
T Consensus        79 ~~~~~~w~W~dg~~~~~~~W~~-g~P~~---------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~~~  141 (147)
T 1egg_A           79 GSPSEGFTWSDGSPVSYENWAY-GEPNN---------YQNVEYCGELKGDPTMSWNDINCEHLNNWICQIQKG  141 (147)
T ss_dssp             C----CCCCTTSCCCCCCCCCT-TCSCG---------GGSCCEEEEEECSTTCCEEEEETTSCBEEEEECCC-
T ss_pred             CCCCCcEEecCCCCcccCccCC-CCCCC---------CCCCCCCeEECCCCCCceeccCCCCCccEEeeCCCC
Confidence            5557999999999987766544 44443         2356789888765 5789999999999999998653

>2yhf_A C-type lectin domain family 5 member A; immune system; 1.90A {Homo sapiens}

Probab=99.93  E-value=6.4e-26  Score=194.48  Aligned_cols=117  Identities=22%  Similarity=0.420  Sum_probs=99.8

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEc
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS  131 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~  131 (557)
                      +||+||.  .|+++||+++.++++|.+|+.+|+++||+||+|+|++|++||.+++.  ...+||||+  +...++.|+|+
T Consensus         1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~w~W~   74 (118)
T 2yhf_A            1 MCPKDWE--FYQARCFFLSTSESSWNESRDFCKGKGSTLAIVNTPEKLKFLQDITD--AEKYFIGLI--YHREEKRWRWI   74 (118)
T ss_dssp             CCCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--EETTTTEEEET
T ss_pred             CCCCCcE--EeCCEEEEEeCCCCCHHHHHHHHhhcCCEEEEeCCHHHHHHHHHhhC--CCcEEEecc--ccCCCCcEEEe
Confidence            5999999  89999999999999999999999999999999999999999999987  468999999  44456999999


Q ss_pred             cCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       132 Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      ||+++.+   |..+++             +.++|+.+... +.|++..|....+|||+.+
T Consensus        75 dg~~~~~---~~~~~~-------------~~~~C~~~~~~-~~w~~~~C~~~~~fICe~~  117 (118)
T 2yhf_A           75 NNSVFNG---NVTNQN-------------QNFNCATIGLT-KTFDAASCDISYRRICEKN  117 (118)
T ss_dssp             TTEECCS---CEESCC-------------TTCCEEEESSS-SSEEEECTTSCBEEEEEEE
T ss_pred             CCCcCCC---CccCCC-------------CCCCeeEEcCC-CcCccccCCCCceeeeccc
Confidence            9998542   333321             23678887643 6799999999999999874

>2xr6_A CD209 antigen; sugar binding protein, carbohydrate binding, mannose; HET: MAN 07B; 1.35A {Homo sapiens} PDB: 1sl4_A* 2it6_A* 1k9i_A* 2xr5_A* 1sl5_A* 2it5_A* 1xph_A 1k9j_A*

Probab=99.93  E-value=3.5e-26  Score=209.33  Aligned_cols=133  Identities=23%  Similarity=0.474  Sum_probs=108.3

Q ss_pred             CCCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCC
Q 008698           47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL  126 (557)
Q Consensus        47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~  126 (557)
                      ...|..||.||.  .|+++||+++.+.++|.+|+.+|+++||+||+|+|++|++||..++......+||||+  +...++
T Consensus        16 ~~~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~--~~~~~~   91 (170)
T 2xr6_A           16 ERLSHPCPWEWT--FFQGNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNRFTWMGLS--DLNQEG   91 (170)
T ss_dssp             -----CCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCCEEEEEE--EEEETT
T ss_pred             ccccCCCCcCcE--EeCCEEEEEECCcCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHHhccCCCCEEeccc--cCCCCC
Confidence            445678999999  8999999999999999999999999999999999999999999866433568999999  434469


Q ss_pred             eeEEccCCCCCC--cCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccccCcc
Q 008698          127 SWKWSDNMSKWN--ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKC  196 (557)
Q Consensus       127 ~w~W~Dg~~~~~--~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~s~c  196 (557)
                      .|+|+||+++.+  +..|..++|++          .+.++|+.+...  +|++..|....+|||+.... .|
T Consensus        92 ~w~W~dG~~~~~~~~~~W~~geP~~----------~~~~~Cv~~~~~--gW~d~~C~~~~~fICe~~~~-~C  150 (170)
T 2xr6_A           92 TWQWVDGSPLLPSFKQYWNRGEPNN----------VGEEDCAEFSGN--GWNDDKCNLAKFWICKKSAA-SS  150 (170)
T ss_dssp             EEEETTSCBCCGGGGGGBCTTCCCC----------TTCCCEEEEETT--EEEEECTTSCBEEEEEEETT-TC
T ss_pred             eEEeCCCCCcccccccCCCCCCCCC----------CCCCCCeEEeCC--cEEccccCCCccEEEEECCC-CC
Confidence            999999999875  35566666553          246789888764  49999999999999998765 45

>1qdd_A Lithostathine; pancreatic stone inhibitor, metal binding protein; HET: SIA NDG GAL; 1.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1lit_A

Probab=99.93  E-value=5.9e-26  Score=201.83  Aligned_cols=126  Identities=18%  Similarity=0.468  Sum_probs=106.8

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhC-CCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL  126 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~  126 (557)
                      ..||+||.  .|+++||+|+.+.++|.+|+.+|+.+ ||+||+|+|++|++||.+++...   ...+||||+  +...++
T Consensus        12 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~gg~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~~   87 (144)
T 1qdd_A           12 ISCPEGTN--AYRSYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKESGTDDFNVWIGLH--DPKKNR   87 (144)
T ss_dssp             TSCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSCEECCCCSHHHHHHHHHHHHHTTCCCSEEEEEEE--CTTSSS
T ss_pred             CCCCCCce--ecCCEeEEEeCCCcCHHHHHHHhhccCCceECccCCHHHHHHHHHHHHhcCCCCCCEEEeeE--cCCCCC
Confidence            58999999  89999999999999999999999998 89999999999999999988642   457999999  665679


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCcccccc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~  191 (557)
                      .|+|+||+++.|.+|. +++|++          .+.++|+.+....  +.|++..|....+|||+.+
T Consensus        88 ~~~W~dg~~~~~~~W~-~~~P~~----------~~~~~Cv~~~~~~~~~~W~d~~C~~~~~fICe~~  143 (144)
T 1qdd_A           88 AWHWSSGSLVSYKSWG-IGAPSS----------VNPGYCVSLTSSTGFQKWKDVPCEDKFSFVCKFK  143 (144)
T ss_dssp             CCEETTCCCCCCCCBC-TTCSCS----------SSCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEE
T ss_pred             eEEeCCCCCcCcCccC-CCCcCC----------CCCCCcEEEEecCCCCeEeCCCCCCCceeeeeec
Confidence            9999999998776654 444442          2457898886543  4799999999999999874

>1jzn_A Galactose-specific lectin; C-type lectin, protein-disaccharide complex, sugar binding P; HET: BGC GAL; 2.20A {Crotalus atrox} SCOP: d.169.1.1 PDB: 1muq_A*

Probab=99.93  E-value=4.9e-26  Score=199.92  Aligned_cols=126  Identities=21%  Similarity=0.588  Sum_probs=106.2

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCC
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL  126 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~  126 (557)
                      +||+||.  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...   ...+||||+  +...++
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~~   77 (135)
T 1jzn_A            2 NCPLDWL--PMNGLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAEYISDYHKGQENVWIGLR--DKKKDF   77 (135)
T ss_dssp             CSCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSSSEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--CTTSSS
T ss_pred             cCCCCce--eeCCEEEEEECCccCHHHHHHHHhccCCCCEECccCCHHHHHHHHHHHHhcccCCCCEEEeeE--cCCcCC
Confidence            6999999  8999999999999999999999999  699999999999999999887532   358999999  665679


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCcccccc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~  191 (557)
                      .|+|+||+++.|.+|. .++|++         ..+.++|+.+....  +.|++..|....+|||+.+
T Consensus        78 ~~~W~dg~~~~~~~W~-~~~P~~---------~~~~~~C~~~~~~~~~~~w~~~~C~~~~~~ICe~~  134 (135)
T 1jzn_A           78 SWEWTDRSCTDYLTWD-KNQPDH---------YQNKEFCVELVSLTGYRLWNDQVCESKDAFLCQCK  134 (135)
T ss_dssp             CCEETTCCCCCCCCBC-TTCCCC---------GGGCCCEEEECGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred             ceEECCCCccCcCcCC-cCCCCC---------CCCCCCceEEECCCCCCcCCCcCCCCCCceeeeec
Confidence            9999999998776654 444443         23467888876543  4799999999999999874

>1oz7_B Echicetin B-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1

Probab=99.93  E-value=6.3e-26  Score=195.99  Aligned_cols=118  Identities=20%  Similarity=0.474  Sum_probs=102.7

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCe
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~  127 (557)
                      +||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...  ...+||||+  +...++.
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   76 (123)
T 1oz7_B            1 NCLPDWS--VYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPMLKNDLVWIGLT--DYWRDCN   76 (123)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCCSSHHHHHHHTSSTTTTCSEEEEEEE--CCCCGGG
T ss_pred             CCCCCcE--EcCCEEEEEECCccCHHHHHHHHhccCCCcEECCcCCHHHHHHHHHHHHhcCCCCCEEEeee--eCCCCCC
Confidence            5999999  8999999999999999999999999  899999999999999999998753  468999999  6656799


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |+|+||+++.+.+|.  ++|                +|+.+....+.|++..|....+|||+.+
T Consensus        77 ~~W~dg~~~~~~~W~--g~P----------------~C~~~~~~~g~w~~~~C~~~~~~ICe~~  122 (123)
T 1oz7_B           77 WEWSDGAQLDYKAWD--NER----------------HCFIYKNTDNQWTRRDCTWTFSFVCKCP  122 (123)
T ss_dssp             EEETTCCCCCSCCBC--SST----------------TEEEEEGGGTEEEEECTTSCEEEEEEEE
T ss_pred             EEEcCCCcccccCCC--CCC----------------CeEEEECCCCcEeCCCCCCCeeEEEeEe
Confidence            999999998777655  443                4666655456899999999999999874

>1jwi_B Platelet aggregation inducer; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_B

Probab=99.93  E-value=4.3e-26  Score=197.69  Aligned_cols=119  Identities=24%  Similarity=0.503  Sum_probs=101.6

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHh--hCCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCK--EIGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL  126 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~--~~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~  126 (557)
                      ..||+||.  .|+++||+++.++++|.+|+.+|+  ..||+||+|+|++|++||.+++...  ...+||||+  +...++
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~   77 (125)
T 1jwi_B            2 EGCLPDWS--SYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKMRIVLVWIGLS--HFWRIC   77 (125)
T ss_dssp             -CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHTTCCCEEEEEEE--ECGGGS
T ss_pred             CCCCCCCE--ecCCEEEEEECCCcCHHHHHHHhhccCCCceECccCCHHHHHHHHHHHHhcCCCCCEEEeee--cCCCCC
Confidence            47999999  899999999999999999999999  8999999999999999999988642  568999999  555569


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      .|+|+||+++.|.+|. +++                 .|+.+...++.|++..|....+|||+.+
T Consensus        78 ~~~W~dg~~~~~~~W~-~g~-----------------pC~~~~~~~~~W~~~~C~~~~~~iCe~~  124 (125)
T 1jwi_B           78 PLRWTDGARLDYRALS-DEP-----------------ICFVAESFHNKWIQWTCNRKKSFVCKYR  124 (125)
T ss_dssp             CEEETTCCCCCSCCSC-CSC-----------------EEEEEETTTCCEEEEETTSCEEEEEEEE
T ss_pred             ceEeeCcCcCccCCcC-CCC-----------------CeEEEECCCCeEecCCCCCCCcEEEeEe
Confidence            9999999998776544 332                 1777766557899999999999999874

>2e3x_C Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis}

Probab=99.93  E-value=1e-25  Score=194.43  Aligned_cols=117  Identities=25%  Similarity=0.579  Sum_probs=101.2

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCe
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~  127 (557)
                      +||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...  ...+||||+  +...++.
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   77 (122)
T 2e3x_C            2 DCPSGWL--SYEQHCYKGFNDLKNWTDAEKFCTEQKKGSHLVSLHSREEEKFVVNLISENLEYPATWIGLG--NMWKDCR   77 (122)
T ss_dssp             CCCSSCE--EETTEEEEECCCCBCHHHHHHHHHHHSTTCCBCCCSSHHHHHHHHHHHHHHCSSSEEEEEEE--STTSSSC
T ss_pred             CCCcchh--hhCCEeEEEECCCcCHHHHHHHHhccCCCCEECccCCHHHHHHHHHHHHhcCCCCCEEEeee--ecCCCCc
Confidence            6999999  8999999999999999999999999  899999999999999999987532  368999999  6656799


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~  190 (557)
                      |+|+||+++.+.+|.  ++|                +|+.+....+.|++..|....+|||+.
T Consensus        78 ~~W~dg~~~~~~~W~--~~P----------------~C~~~~~~~g~w~~~~C~~~~~~ICe~  122 (122)
T 2e3x_C           78 MEWSDRGNVKYKALA--EES----------------YCLIMITHEKVWKSMTCNFIAPVVCKF  122 (122)
T ss_dssp             EEETTSCCCCCCCBC--SCC----------------EEEEEETTTCCEEEEETTSCBCCEEC-
T ss_pred             eEeCCCCcccccccC--CCC----------------CCEEEECCCCcEeCCCCCCCCceeecC
Confidence            999999998776654  443                577776655689999999999999974

>1fvu_B Botrocetin beta chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_C 1u0n_C 1u0o_B

Probab=99.92  E-value=7.5e-26  Score=196.07  Aligned_cols=120  Identities=23%  Similarity=0.527  Sum_probs=101.7

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCe
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~  127 (557)
                      +||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...  ...+||||+  +...++.
T Consensus         1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   76 (125)
T 1fvu_B            1 DCPPDWS--SYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEMLKGDVVWIGLS--DVWNKCR   76 (125)
T ss_dssp             CCSTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHTTCTTSCTTCCEECSCC--CCSTTSC
T ss_pred             CcCCccE--EcCCEEEEEeCCCCCHHHHHHHHhccCCCcEECccCCHHHHHHHHHHHHhcCCCCCEEEeee--ecCCCCc
Confidence            5999999  8999999999999999999999999  899999999999999999988754  468999999  6556799


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |+|+||+++.|.+|.. ++|+               +|+.+....+.|++..|....+|||+.+
T Consensus        77 ~~W~dg~~~~~~~w~~-~~P~---------------~C~~~~~~~g~w~~~~C~~~~~~iCe~~  124 (125)
T 1fvu_B           77 FEWTDGMEFDYDDYYL-IAEY---------------ECVASKPTNNKWWIIPCTRFKNFVCEFQ  124 (125)
T ss_dssp             EEETTSCCCCC----C-CSCC---------------EEEEEETTTTEEEEEETTSCEEEEEEEC
T ss_pred             eEecCCCccCccccCC-CCCC---------------CceEEECCCCcEeCCcCCCCCcEEEeec
Confidence            9999999987766544 4332               5777776556899999999999999874

>1umr_C Convulxin beta, CVX beta; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_B

Probab=99.92  E-value=8.9e-26  Score=195.61  Aligned_cols=119  Identities=24%  Similarity=0.562  Sum_probs=103.4

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL  126 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~  126 (557)
                      ..||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...  ...+||||+  +...++
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~   77 (125)
T 1umr_C            2 FCCPSHWS--SYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSLKSTFFWIGAN--NIWNKC   77 (125)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHTTCSSSEEECSCC--CTTTSS
T ss_pred             CCCCCCCE--EcCCEeEEEECCCcCHHHHHHHHhccCCcceECccCCHHHHHHHHHHHHhcCCCCCEEEeeE--eCCCCC
Confidence            37999999  8999999999999999999999999  899999999999999999988643  368999999  665679


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      .|+|+||+++.|.+|.  ++|                +|+.+....+.|++..|....+|||+.+
T Consensus        78 ~~~W~dg~~~~~~~W~--g~P----------------~C~~~~~~~g~w~~~~C~~~~~fICe~~  124 (125)
T 1umr_C           78 NWQWSDGTKPEYKEWH--EEF----------------ECLISRTFDNQWLSAPCSDTYSFVCKFE  124 (125)
T ss_dssp             CEEETTSCCCSSCCBC--CCC----------------EEEEEESSCSCEEEEETTSCEEEEEEEE
T ss_pred             eeEeCCcCccCcccCC--CCC----------------CcEEEECCCCcEeCCCCCCCcceEEeec
Confidence            9999999998777655  433                5777766556899999999999999874

>1mpu_A NKG2-D type II integral membrane protein; C-type lectin-like domain, immune system; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 1hyr_B

Probab=99.92  E-value=2.9e-26  Score=202.34  Aligned_cols=122  Identities=23%  Similarity=0.521  Sum_probs=103.9

Q ss_pred             CCCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCC
Q 008698           47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL  126 (557)
Q Consensus        47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~  126 (557)
                      ...|..||.||.  .|+++||+++.++++|.+|+.+|+++||+||+|+|++|++||..+.    ..+||||+  +...++
T Consensus        15 ~~~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~fl~~~~----~~~WIGl~--~~~~~~   86 (138)
T 1mpu_A           15 ESYCGPCPKNWI--CYKNNCYQFFDESKNWYESQASCMSQNASLLKVYSKEDQDLLKLVK----SYHWMGLV--HIPTNG   86 (138)
T ss_dssp             CCCCCCCCTTCE--ECSSCEEEEEEEEECHHHHHHHHHHTSCEECCCCCTTTCGGGGGCC----SEEEEEEE--ECTTTC
T ss_pred             CCccCCCChhhe--EeCCEEEEEECCCCCHHHHHHHHHhcCCEEeeeCCHHHHHHHHhcc----CCEeEeee--ccCCCC
Confidence            455678999999  8999999999999999999999999999999999999999998653    48999999  555679


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      .|.|+||+++.+.+|..++| +             .++|+.+... +.|++..|....+|||+.+
T Consensus        87 ~w~W~dG~~~~~~~w~~~~p-~-------------~~~C~~~~~~-~~w~~~~C~~~~~fICe~~  136 (138)
T 1mpu_A           87 SWQWEDGSILSPNLLTIIEM-Q-------------KGDCALYASS-FKGYIENCSTPNTYICMQR  136 (138)
T ss_dssp             CEEETTSCBCCTTSCEEECS-S-------------CCSEEEEETT-TEEEEECTTSCEEEEEEEC
T ss_pred             ceEeCCCCcCCccccccCCC-C-------------CCCCeEEECC-CcEEccCCCCCCeEcccCc
Confidence            99999999988766554443 2             2578877654 5799999999999999875

>1fm5_A Early activation antigen CD69; C-type lectin-like domain, natural killer cell receptor, lectin, C-type lectin, immune system; 2.27A {Homo sapiens} SCOP: d.169.1.1

Probab=99.92  E-value=1.6e-25  Score=209.94  Aligned_cols=118  Identities=25%  Similarity=0.556  Sum_probs=99.0

Q ss_pred             CCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCe
Q 008698           48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~  127 (557)
                      ..+..||+||.  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++.  ...+||||+  +.. ++.
T Consensus        80 ~~~~~Cp~gW~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~--~~~~WIGl~--~~~-~~~  152 (199)
T 1fm5_A           80 SHVSSCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAG--REEHWVGLK--KEP-GHP  152 (199)
T ss_dssp             C----CCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CCT-TSC
T ss_pred             CCCCCCCCCcE--EECCEEEEEeCCccCHHHHHHHHhhcCCEEEecCCHHHHHHHHHhhC--CCCEEeeeE--ECC-CCC
Confidence            45578999999  89999999999999999999999999999999999999999999997  468999999  554 799


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |.|+||+++  .+ |.  +            ..+.++|+.+..  +.|++..|....+|||+.+
T Consensus       153 w~W~DGs~~--~~-W~--~------------~~~~~~Cv~l~~--~~W~d~~C~~~~~fICe~~  197 (199)
T 1fm5_A          153 WKWSNGKEF--NN-WF--N------------VTGSDKCVFLKN--TEVSSMECEKNLYWICNKP  197 (199)
T ss_dssp             CEETTSCBC--CC-SS--C------------CCSSSSEEEECS--SCEEEECTTSCBEEEEEEE
T ss_pred             eEECCCCcc--cc-cc--C------------CCCCCCceEEEC--CCEEEecCCCCEEEEcccc
Confidence            999999974  23 32  1            224568888765  5799999999999999875

>1j34_B Coagulation factor IX-binding protein B chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_B 1ixx_B* 1j35_B* 1x2t_B* 1x2w_B 1wt9_B 1iod_B 1y17_B

Probab=99.92  E-value=6.6e-26  Score=195.86  Aligned_cols=118  Identities=23%  Similarity=0.556  Sum_probs=102.5

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCe
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~  127 (557)
                      +||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...  ...+||||+  +...++.
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   76 (123)
T 1j34_B            1 DCPSDWS--SYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTFGHSIFWMGLS--NVWNQCN   76 (123)
T ss_dssp             CCCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--SCSTTSC
T ss_pred             CcCCccc--ccCCEEEEEECCCcCHHHHHHHHhccCCCcEEcccCCHHHHHHHHHHHHhcCCCCCEEEeeE--cCCCCCe
Confidence            5999999  8999999999999999999999999  899999999999999999987632  368999999  6656799


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |+|+||+++.+.+|.  ++|                +|+.+....+.|++..|....+|||+.+
T Consensus        77 ~~W~dg~~~~~~~W~--g~P----------------~C~~~~~~~g~w~~~~C~~~~~~iCe~~  122 (123)
T 1j34_B           77 WQWSNAAMLRYKAWA--EES----------------YCVYFKSTNNKWRSRACRMMAQFVCEFQ  122 (123)
T ss_dssp             EEETTCCCCCCCCBS--CSC----------------EEEEEETTSCCBEEEETTSCEEEEEEEE
T ss_pred             eEeCCCCCcCccCcC--CCC----------------CcEEEECCCCCCcCCCCCCCCcEEEeec
Confidence            999999998776654  433                5777766556899999999999999874

>2h2t_B Low affinity immunoglobulin epsilon FC receptor ( IGE receptor) (FC-epsilon-RII)...; C-type lectin, calcium-bound, lectin domain; 1.30A {Homo sapiens} PDB: 2h2r_A 1t8c_A 1t8d_A

Probab=99.92  E-value=9.9e-26  Score=207.25  Aligned_cols=128  Identities=20%  Similarity=0.415  Sum_probs=105.2

Q ss_pred             CCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCe
Q 008698           48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~  127 (557)
                      ..+..||.||.  .|+++||+|+.+.++|.+|+.+|+++||+||+|+|++|++||.+++.  ...+||||++  ...++.
T Consensus        12 ~~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~--~~~~WIGl~~--~~~~~~   85 (175)
T 2h2t_B           12 FVCNTCPEKWI--NFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKRAS--HTGSWIGLRN--LDLKGE   85 (175)
T ss_dssp             --CCBCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHTTCC--TTCEEEEEEE--ETTTTE
T ss_pred             ccCCCCCcccE--EeCCEEEEEeCCccCHHHHHHHHhhcCCEEeecCCHHHHHHHHHHhc--CCcEEeccee--cCCCCC
Confidence            44578999999  89999999999999999999999999999999999999999999886  4689999994  445699


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCC-Cccccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH-PFICMVEH  192 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~-~~iC~~~~  192 (557)
                      |+|+||+++.|.+|. .++|++         ..+.++|+.+.. .+.|++..|.... +|||+...
T Consensus        86 w~W~dG~~~~y~~W~-~geP~~---------~~~~~~Cv~~~~-~g~W~d~~C~~~~~~fICe~~~  140 (175)
T 2h2t_B           86 FIWVDGSHVDYSNWA-PGEPTS---------RSQSEDCVMMRG-SGRWNDAFCDRKLGAWVCDRLA  140 (175)
T ss_dssp             EEETTSCCCSSCCBC-TTCCCC--------------CEEEECT-TSCEEEECTTCCEEEEEEEEEC
T ss_pred             eEeCCCCcccCcCcC-CCCCCC---------CCCCCCceEEcC-CCcEEECCCCCcCcceEEeECC
Confidence            999999998776654 444443         235678988764 4689999999999 99999865

>3ff7_C Killer cell lectin-like receptor subfamily G member 1; KLRG1-cadherin complex, calcium, cell adhesion, cell junction, cell membrane; 1.80A {Homo sapiens} SCOP: d.169.1.0

Probab=99.92  E-value=1.4e-25  Score=190.46  Aligned_cols=112  Identities=21%  Similarity=0.539  Sum_probs=97.7

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEcc
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD  132 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~D  132 (557)
                      ||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++.  ...+||||++     ++.|+|+|
T Consensus         1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WiGl~~-----~~~~~W~d   71 (112)
T 3ff7_C            1 CPDRWM--KYGNHCYYFSVEEKDWNSSLEFCLARDSHLLVITDNQEMSLLQVFLS--EAFSWIGLRN-----NSGWRWED   71 (112)
T ss_dssp             CCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHTTCC--SSCEEEEEEE-----SSSEEETT
T ss_pred             CCccce--EeCCEEEEEeCCccCHHHHHHHHhhcCCeEeeECCHHHHHHHHHhcc--CCCEEEeeec-----CCceEeCC
Confidence            999999  89999999999999999999999999999999999999999999887  4579999993     37899999


Q ss_pred             CCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccc
Q 008698          133 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       133 g~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~  190 (557)
                      |+++.+.+|. ++              .+.++|+.+...  .|++..|....+|||++
T Consensus        72 g~~~~~~~w~-~~--------------~~~~~C~~~~~~--~w~~~~C~~~~~fICek  112 (112)
T 3ff7_C           72 GSPLNFSRIS-SN--------------SFVQTCGAINKN--GLQASSCEVPLHWVCKK  112 (112)
T ss_dssp             SCBCCSSCEE-CS--------------STTCCEEEEETT--EEEEECTTSCBEEEEEC
T ss_pred             CCccccceec-CC--------------CCCCCCeEEeCC--CcccCCCCCCCceeecC
Confidence            9999876653 21              124678888653  59999999999999974

>1uv0_A Pancreatitis-associated protein 1; lectin, C-type, secreted, inflammatory response, acute phase; 1.78A {Homo sapiens} SCOP: d.169.1.1 PDB: 2go0_A

Probab=99.92  E-value=1.9e-25  Score=199.78  Aligned_cols=126  Identities=20%  Similarity=0.405  Sum_probs=106.2

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhC-CCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL  126 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~  126 (557)
                      ..||+||+  .|+++||+|+.+.++|.+|+.+|+++ ||+||+|+|++|++||.+++...   ...+||||+  +...++
T Consensus        12 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--~~~~~~   87 (149)
T 1uv0_A           12 IRCPKGSK--AYGSHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGNSYSYVWIGLH--DPTQGT   87 (149)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHTTSTTCEECCCCSHHHHHHHHHHHTTSCTTCCEEEEEEE--CTTTTC
T ss_pred             CCCCcccc--ccCCEEEEEECCCCCHHHHHHHhhcCCCccEeEeCCHHHHHHHHHHHHhhccCCCCEEEeeE--ccCCCC
Confidence            58999999  89999999999999999999999998 89999999999999999999753   467999999  555555


Q ss_pred             e-----eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCcccccc
Q 008698          127 S-----WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       127 ~-----w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~  191 (557)
                      .     |+|+||+++.|.+|. .++|++          .+.++|+.+....  +.|++..|....+|||+.+
T Consensus        88 ~~~~~~w~W~dg~~~~~~~W~-~~~P~~----------~~~~~Cv~~~~~~~~~~W~d~~C~~~~~fICe~~  148 (149)
T 1uv0_A           88 EPNGEGWEWSSSDVMNYFAWE-RNPSTI----------SSPGHCASLSRSTAFLRWKDYNCNVRLPYVCKFT  148 (149)
T ss_dssp             C--CCCCEETTCCCCCCCCBS-SCGGGS----------SSCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred             ccCCCccEECCCCccCccCcC-CCCcCC----------CCCCCCEEEEcCCCCCeEeCcCCCCCCceEEeec
Confidence            5     999999998776654 444332          2457888886543  4799999999999999874

>1tn3_A Tetranectin; plasminogen binding, kringle 4, C-type lectin, carbohydrate recognition domain; 2.00A {Homo sapiens} SCOP: d.169.1.1 PDB: 1rjh_A 3l9j_C

Probab=99.92  E-value=4.3e-26  Score=200.87  Aligned_cols=126  Identities=16%  Similarity=0.318  Sum_probs=104.9

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCe
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~  127 (557)
                      ..||+||.   |+++||+++.++++|.+|+.+|+++||+||+|+|++|++||.+++...   ...+||||+  +...++.
T Consensus         4 ~~Cp~gw~---~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~~~   78 (137)
T 1tn3_A            4 TVCLKGTK---VHMKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGNEAEIWLGLN--DMAAEGT   78 (137)
T ss_dssp             CEEEECSS---SSEEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--EEEETTE
T ss_pred             CCCCCCeE---ECCEEEEEeCCCCCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHHHhhcCCCCCEEEeeE--ccCCCce
Confidence            57999997   789999999999999999999999999999999999999999887532   468999999  4444699


Q ss_pred             eEEccCCCCCCcCccc--cCCCCCCCCCCCCccccccCceeEeec-CCCceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHA--VGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~--~~~~~~~~~~~~c~~~~~~~~C~~~~~-~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |.|+||+++.|.+|..  +++|+          +.+.++|+.+.. ..+.|++..|....+|||+.+
T Consensus        79 w~W~dg~~~~~~~W~~~~~g~P~----------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fiCe~~  135 (137)
T 1tn3_A           79 WVDMTGARIAYKNWETEITAQPD----------GGKTENCAVLSGAANGKWFDKRCRDQLPYICQFG  135 (137)
T ss_dssp             EEETTSCBCSCCCBCCTTTCSSC----------CGGGCCEEEEETTTTTEEEEECTTSCEEEEEEEE
T ss_pred             EEeCCcCCCcccccCcCCCCcCC----------CCCccCCcEEccCCCCeEeCcCCCCCccceEeEe
Confidence            9999999987766541  34433          234578988864 357799999999999999875

>3gpr_C Rhodocetin subunit gamma; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma}

Probab=99.92  E-value=6.6e-26  Score=198.95  Aligned_cols=121  Identities=24%  Similarity=0.517  Sum_probs=102.6

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhC--CCeEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCCC
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTVG  125 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~s~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~~  125 (557)
                      +||+||+  .|+++||+++.++++|.+|+.+|+++  ||+||+|+|++|++||.+++...    ...+||||+  +...+
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~G~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~--~~~~~   77 (134)
T 3gpr_C            2 NCLPGWS--AYDQHCYQAFNEPKTWDEAERFCTEQAKRGHLVSIGSDGEADFVAQLVTNNIKRPELYVWIGLR--DRRKE   77 (134)
T ss_dssp             CCCTTCE--ESSSCEEEECSCCBCSHHHHHHHTTSSSCCEECCCCCHHHHHHHHHHHHHHHCSSCCBCCCSCB--CCSST
T ss_pred             cCCCcce--eeCCEEEEEeCCCcCHHHHHHHHHhhCCCceEeeeCCHHHHHHHHHHHHhhccCCCCcEEEeeE--ecCCC
Confidence            6999999  89999999999999999999999998  89999999999999999988632    268999999  65567


Q ss_pred             Ce-e-EEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCC--ceeccccCCCCCccccccc
Q 008698          126 LS-W-KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       126 ~~-w-~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~--~w~~~~C~~~~~~iC~~~~  192 (557)
                      +. | +|+||+++.|.+|.. ++|               ++|+.+....+  .|++..|....+|||+.+.
T Consensus        78 ~~~w~~W~dG~~~~~~~W~~-~~~---------------~~Cv~~~~~~~~~~W~~~~C~~~~~fICe~~~  132 (134)
T 3gpr_C           78 QQCSSEWSMSASIIYVNWNT-GES---------------QMCQGLARWTGFRKWDYSDCQAKNPFVCKFSS  132 (134)
T ss_dssp             TSCSCEETTCCCSCCBCBSS-CEE---------------CCEECCBCSSSSCBBCEECTTCCBCCEEEECC
T ss_pred             CCcCCEeCCcCcccccccCC-CCC---------------CcceEEeccCCCCcCcCCCCCCCCcEEeCcCC
Confidence            99 9 999999998766543 321               45766655433  7999999999999999864

>1c3a_B Flavocetin-A: beta subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_B

Probab=99.92  E-value=9.5e-26  Score=195.44  Aligned_cols=119  Identities=19%  Similarity=0.410  Sum_probs=102.9

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL  126 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~  126 (557)
                      ..||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...  ...+||||+  +...++
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~   77 (125)
T 1c3a_B            2 FCCPLGWS--SYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPILKYDFVWIGLS--NVWNEC   77 (125)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--CTTTSS
T ss_pred             CCCCCcce--ecCCEEEEEECCCCCHHHHHHHhhccCCCcEECccCCHHHHHHHHHHHHhcCCCCCEEEeeE--cCCCCC
Confidence            37999999  8999999999999999999999999  899999999999999999987532  468999999  665679


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      .|+|+||+++.+.+|.  ++|                +|+.+....+.|++..|....+|||+.+
T Consensus        78 ~~~W~dg~~~~~~~w~--~~P----------------~C~~~~~~~g~w~~~~C~~~~~fiCe~~  124 (125)
T 1c3a_B           78 TKEWSDGTKLDYKAWS--GGS----------------DCIVSKTTDNQWLSMDCSSKYYVVCKFQ  124 (125)
T ss_dssp             CEEETTCCCCCSCCBC--CCC----------------EEEEEESSSSCEEEEETTSCEEEEEEEE
T ss_pred             ceEeCCCCcccccccC--CCC----------------CcEEEECCCCCEeCCCCCCCCeeEEeee
Confidence            9999999998777655  432                4777765556899999999999999874

>3ff9_A Killer cell lectin-like receptor subfamily G member 1; natural killer cell receptor KLTG1, glycoprotein, membrane, phosphoprotein, signal-anchor; 1.80A {Mus musculus} SCOP: d.169.1.0 PDB: 3ff8_C

Probab=99.92  E-value=1.2e-25  Score=191.85  Aligned_cols=113  Identities=22%  Similarity=0.516  Sum_probs=98.0

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEc
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS  131 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~  131 (557)
                      .||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++.  ...+||||+  +   ++.|+|+
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~---~~~w~W~   71 (115)
T 3ff9_A            1 MCPILWT--RNGSHCYYFSMEKKDWNSSLKFCADKGSHLLTFPDNQGVKLFGEYLG--QDFYWIGLR--N---IDGWRWE   71 (115)
T ss_dssp             CCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCTTSCCHHHHHTTCC--SSCEEEEEE--E---SSSEEET
T ss_pred             CCCccce--ecCCEEEEEEcCCcCHHHHHHHHHhcCCeeeeeCCHHHHHHHHHhhC--CCcEEEeee--e---CCceEeC
Confidence            4999999  89999999999999999999999999999999999999999999887  458999999  4   3789999


Q ss_pred             cCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       132 Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      ||+++.+ ++    +|+           .+.++|+.+...  .|++..|....+|||+.+
T Consensus        72 dg~~~~~-~~----~p~-----------~~~~~C~~~~~~--~w~~~~C~~~~~fICe~~  113 (115)
T 3ff9_A           72 GGPALSL-RI----LTN-----------SLIQRCGAIHRN--GLQASSCEVALQWICKKV  113 (115)
T ss_dssp             TSCBCCS-CC----BCS-----------STTCCEEEEETT--EEEEECTTSCBEEEEEEE
T ss_pred             CCCcccc-cc----cCC-----------CCCCCCeEEcCC--CcccccCCCCCceEEEEe
Confidence            9999876 22    111           145689888763  599999999999999875

>3hup_A Early activation antigen CD69; C-type lectin-like domain, disulfide bond, glycoprotein, LEC membrane, phosphoprotein, signal-anchor, transmembrane; 1.37A {Homo sapiens} SCOP: d.169.1.1 PDB: 1e87_A 1e8i_A 3cck_A

Probab=99.92  E-value=3.3e-25  Score=193.44  Aligned_cols=117  Identities=25%  Similarity=0.543  Sum_probs=99.8

Q ss_pred             CCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCee
Q 008698           49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW  128 (557)
Q Consensus        49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w  128 (557)
                      .+..||+||+  .|+++||+++.++++|.+|+.+|+++||+||+|+|++|++||.+++.  ...+||||++  . .++.|
T Consensus        12 ~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~~--~-~~~~w   84 (130)
T 3hup_A           12 HVSSCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAG--REEHWVGLKK--E-PGHPW   84 (130)
T ss_dssp             CCBCCCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHT--TSCEEEEEEE--C-TTSCE
T ss_pred             CCCCCChhhe--ecCCEEEEEECCccCHHHHHHHHHhcCCEEeecCCHHHHHHHHHhhC--CCCEEEEEEe--C-CCCeE
Confidence            3478999999  89999999999999999999999999999999999999999999987  4589999994  2 36899


Q ss_pred             EEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       129 ~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      +|+||+++  .+ |..              ..+.++|+.+..  ..|++..|....+|||+.+
T Consensus        85 ~W~dg~~~--~~-w~~--------------~~~~~~Cv~~~~--~~w~~~~C~~~~~fICe~~  128 (130)
T 3hup_A           85 KWSNGKEF--NN-WFN--------------VTGSDKCVFLKN--TEVSSMECEKNLYWICNKP  128 (130)
T ss_dssp             EETTSCBC--CC-CSC--------------CCSSCSEEEEET--TEEEEECTTSCBEEEEEEE
T ss_pred             EeCCCCcc--cC-ccC--------------CCCCCCceEEeC--CCcccCCCCCCccEEeccC
Confidence            99999983  23 321              224568888865  3699999999999999875

>3ubu_B Agglucetin subunit beta-2; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus}

Probab=99.92  E-value=1.7e-25  Score=194.03  Aligned_cols=119  Identities=24%  Similarity=0.490  Sum_probs=102.7

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL  126 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~  126 (557)
                      ..||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...  ...+||||+  +...++
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~   77 (126)
T 3ubu_B            2 FCCPLRWS--AYEGHCYLVVKEKKTWDDAEKFCTEQRKGGHLVSVHSREEADFLVHLAYPILDLSLIWMGLS--NMWNDC   77 (126)
T ss_dssp             CSCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHHCSCEEEEEEE--CTTTSS
T ss_pred             CCCCCCCe--EcCCEeEEEeCCCCCHHHHHHHHhccCCCcEECccCCHHHHHHHHHHHhhccCCCcEEEeEE--cCCCCC
Confidence            37999999  8999999999999999999999999  999999999999999999987532  348999999  655679


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC-CceeccccCCCCCcccccc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~-~~w~~~~C~~~~~~iC~~~  191 (557)
                      .|+|+||+++.+.+|..                  .++|+.+.... ..|++..|....+|||+.+
T Consensus        78 ~~~W~dg~~~~~~~W~~------------------~~~Cv~~~~~~~~~W~~~~C~~~~~fICe~~  125 (126)
T 3ubu_B           78 KREWSDGTKLDFKSWAK------------------TSDCLIGKTDGDNQWLNMDCSKKHYFVCKFK  125 (126)
T ss_dssp             EEEETTCCCCCCCCBCC------------------CCCEEEEESSTTCCEEEECTTSCEEEEEEEE
T ss_pred             ceEecCCCeeeeeccCC------------------CCCeEEEecCCCCcCcCCCCCCCceeEEeee
Confidence            99999999987766432                  24677776654 5799999999999999875

>3alu_A Lectin CEL-IV, C-type; C-type lectin, raffinose, sugar binding protein; HET: RAF; 1.65A {Cucumaria echinata} PDB: 3als_A* 3alt_A*

Probab=99.92  E-value=7.1e-26  Score=204.53  Aligned_cols=128  Identities=22%  Similarity=0.380  Sum_probs=107.8

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--C---------CCeEeeeCCHHHHHHHHHHhCCC-------C--
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--I---------GGHLAALTSYEEEHSAQKLCGKN-------V--  110 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~---------~~~L~~i~s~~e~~f~~~~~~~~-------~--  110 (557)
                      ..||+||+  .|+++||+++.++++|.+|+.+|++  .         ||+||+|+|++|++||.+++...       .  
T Consensus         3 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~~~~~~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~~   80 (157)
T 3alu_A            3 TSCPPLWT--GFNGKCFRLFHNHLNFDNAENACRQFGLASCSGDELATGHLASIHSAESQAFLTELVKTSLPDLITGGWA   80 (157)
T ss_dssp             CEECTTCE--EETTEEEEEEEEEECHHHHHHHHTTEEEEETTSCEEEECEECCCCSHHHHHHHHHHHHHHCGGGCCSSSC
T ss_pred             CCCCCCcE--eeCCEEEEEECCccCHHHHHHHhhccccccccCCCCCCeEEcccCCHHHHHHHHHHHHhcccccccccCC
Confidence            57999999  8999999999999999999999999  8         99999999999999999987532       1  


Q ss_pred             CCeEEeeeecCCCCCCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC-CceeccccCCCCCcccc
Q 008698          111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICM  189 (557)
Q Consensus       111 ~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~-~~w~~~~C~~~~~~iC~  189 (557)
                      ..+||||+  +...++.|+|+||+++.|.+|. +++|++         ..+.++|+.+.... +.|++..|....+|||+
T Consensus        81 ~~~WIGl~--~~~~~~~w~W~dG~~~~y~~W~-~g~P~~---------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe  148 (157)
T 3alu_A           81 PQVYIGMK--VGSTNSDQTWTDGSSVDYDGWV-SGEPNN---------GPNSRGAIAAGDYSRGFWADVYSNNNFKYICQ  148 (157)
T ss_dssp             SEEEEEEE--ECSSTTCEEETTCCCCCCCCBC-TTCCCS---------CSSEEEEEECSTTTTTCEEEECTTCCEEEEEE
T ss_pred             CCEEEeee--eCCCCCCeEeCCCCCCCccCcC-CCCCCC---------CCCCCCeEEEecCCCCeEcCCCCCCccceEec
Confidence            67999999  5555699999999998776654 444443         22467898876543 68999999999999999


Q ss_pred             ccc
Q 008698          190 VEH  192 (557)
Q Consensus       190 ~~~  192 (557)
                      .+.
T Consensus       149 ~~~  151 (157)
T 3alu_A          149 LPC  151 (157)
T ss_dssp             CCC
T ss_pred             ccc
Confidence            864

>2zib_A Type II antifreeze protein; thermal hysteresis, lectin; 1.34A {Brachyopsis rostratus}

Probab=99.92  E-value=4.2e-25  Score=193.58  Aligned_cols=123  Identities=26%  Similarity=0.523  Sum_probs=105.8

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEE
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW  130 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W  130 (557)
                      .++|.+|.  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++.   ..+||||+  +...++.|+|
T Consensus         8 ~~~~~~~~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~w~W   80 (133)
T 2zib_A            8 LVCPAGWT--LHGQRCFYSEATAMTWDLAEANCVNKGGHLASIHSLEEQLYIKDIVA---GIVWIGGS--ACKVAGAWSW   80 (133)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHCS---SCEEEEEE--CCSSTTCCEE
T ss_pred             eeCCCCEE--EeCCEEEEEECCccCHHHHHHHHHHCCCEECccCCHHHHHHHHHhhc---cCEEEccE--ecCCCCceEE
Confidence            47899999  89999999999999999999999999999999999999999999987   58999999  6556799999


Q ss_pred             ccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCC-ceeccccCCCCCcccccc
Q 008698          131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR-SLVTERCNTSHPFICMVE  191 (557)
Q Consensus       131 ~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~-~w~~~~C~~~~~~iC~~~  191 (557)
                      +||+++.|.+|. .++|++.         .+ ++|+.+...++ .|++..|....+|||+.+
T Consensus        81 ~dG~~~~y~~W~-~g~P~~~---------~~-~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~  131 (133)
T 2zib_A           81 TDGTPVDYRTWC-PTKPNDI---------LS-DCCMQMTAAVDKCWDDLPCPASHASICAKA  131 (133)
T ss_dssp             TTCCCCCCCCBC-TTCCCCC---------TT-SCEEEECSSTTCCEEEECTTCCEEEEEEEE
T ss_pred             CCCCCcccCCcC-CCCCCCC---------CC-CCceEEecCCCCcEeCCCCCCCeeEEEeEc
Confidence            999999776654 4444431         22 78988876554 599999999999999875

>3ubu_A Agglucetin subunit alpha-1; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus}

Probab=99.92  E-value=1.1e-25  Score=196.66  Aligned_cols=123  Identities=23%  Similarity=0.546  Sum_probs=102.5

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhC--CCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL  126 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~  126 (557)
                      ..||+||+  .|+++||+++.++++|.+|+.+|+++  ||+||+|+|++|++||.+++...  ...+||||++.....++
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~G~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~~~~~~~~~   79 (131)
T 3ubu_A            2 VDCLPGWS--AYDQSCYRVFKLLKTWDDAEKFCTERPKGGHLVSIESAGERDFVAQLVSENKQTDNVWLGLKIQSKGQQC   79 (131)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTSTTCCEECCCCSHHHHHHHHHHHHHTTCCSCEEEEEEEECSSSSS
T ss_pred             cCCCccCE--ecCCEeeEEcCCCcCHHHHHHHHhccCCCceEceeCCHHHHHHHHHHHHhcCCCCCEEEeEecCCCCCCC
Confidence            37999999  89999999999999999999999998  89999999999999999988643  34899999954332269


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCC--ceeccccCCCCCcccccc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVE  191 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~--~w~~~~C~~~~~~iC~~~  191 (557)
                      .|.|+||+++.|.+|.. +++               ++|+.+....+  .|++..|....+|||+.+
T Consensus        80 ~~~W~dg~~~~~~~w~~-~~~---------------~~Cv~~~~~~~~~~W~~~~C~~~~~fiCe~~  130 (131)
T 3ubu_A           80 STEWTDGSSVSYENFSE-YQS---------------KKCFVLEKNTGFRTWLNLNCGSEYSFVCKSP  130 (131)
T ss_dssp             CCBCTTSCBCCCCCBCT-TTC---------------CCEEEECGGGTSCSEEEECTTCCEEEEEEEC
T ss_pred             ceEeCCCCccceeccCC-CCC---------------CCcEEEeCCCCCCeEcCCCCCCCceeEEecC
Confidence            99999999988766543 321               46777765433  799999999999999875

>1c3a_A Flavocetin-A: alpha subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_A

Probab=99.92  E-value=1.5e-25  Score=196.86  Aligned_cols=124  Identities=23%  Similarity=0.468  Sum_probs=103.9

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTV  124 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~  124 (557)
                      ..||+||+  .|+++||+++.+.++|.+|+.+|++  .||+||+|+|++|++||.+++...   .. .+||||+..+...
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~   79 (135)
T 1c3a_A            2 FDCIPGWS--AYDRYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKIKTSFQYVWIGLRIQNKEQ   79 (135)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCSCCSEEEEEEEECCCSS
T ss_pred             cCCCCcCE--ecCCeeEEEeCCCcCHHHHHHHHhhcCCCCEECeeCCHHHHHHHHHHHhhccccCCCcEEecccccCCCC
Confidence            37999999  8999999999999999999999999  899999999999999999988642   24 7999998434445


Q ss_pred             CCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCccccccc
Q 008698          125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       125 ~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~  192 (557)
                      ++.|.|+||+++.|.+|..++ |+               +|+.+....  +.|++..|....+|||+.++
T Consensus        80 ~~~~~W~dg~~~~~~~W~~~~-P~---------------~C~~~~~~~~~~~W~d~~C~~~~~fICe~~~  133 (135)
T 1c3a_A           80 QCRSEWSDASSVNYENLVKQF-SK---------------KCYALKKGTELRTWFNVYCGTENPEVCKYTP  133 (135)
T ss_dssp             SCCCBCTTSCBCCCCCBCGGG-CC---------------CEEEEETTSCSCSBEEECTTSCEEEEEEECC
T ss_pred             CCceEECCCCcccccccCCCC-CC---------------cceEEeccCCCCeEccCCCCCCccEEcccCC
Confidence            699999999998777655443 33               466665544  57999999999999999865

>1sb2_A Rhodocetin alpha subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_A

Probab=99.92  E-value=2.1e-25  Score=195.39  Aligned_cols=123  Identities=24%  Similarity=0.514  Sum_probs=103.4

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCCC
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTVG  125 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~~  125 (557)
                      +||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...    ...+||||+..+...+
T Consensus         1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~   78 (133)
T 1sb2_A            1 DCPDGWS--STKSYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNFENKIYRSWIGLKIENKGQR   78 (133)
T ss_dssp             CCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHTSSSCCEECCCSSHHHHHHHHHHHHHHTTTCCEEEEEEEEEECSSTT
T ss_pred             CcCCCcE--EcCCEeEEEECCcCCHHHHHHHHhhhCCCcEEeeECCHHHHHHHHHHHHhhccCccCCEEEeeeccCCCCC
Confidence            5999999  8999999999999999999999999  899999999999999999987532    3579999982233346


Q ss_pred             CeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCccccccc
Q 008698          126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       126 ~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~  192 (557)
                      +.|.|+||+++.|.+|.. +|               .++|+.+....  +.|++..|....+|||+.+.
T Consensus        79 ~~~~W~dg~~~~~~~W~~-~P---------------~~~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~  131 (133)
T 1sb2_A           79 SNLEWSDGSSISYENLYE-PY---------------MEKCFLMDHQSGLPKWHTADCEEKNVFMCKFQL  131 (133)
T ss_dssp             SSEEETTCCCCCCCCBSS-CC---------------CEEEEEEEESSSSCEEEEECTTSCEEEEEEEEC
T ss_pred             CceEECCCCcccccccCc-CC---------------CCCcEEEEecCCCCeEccCCCCCCceeEecccC
Confidence            999999999988776555 43               24677776554  57999999999999999864

>1ukm_B EMS16 B chain, EMS16 subunit B; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_B*

Probab=99.92  E-value=1.9e-25  Score=194.42  Aligned_cols=120  Identities=28%  Similarity=0.545  Sum_probs=101.2

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCee
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLSW  128 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~w  128 (557)
                      ||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...  ...+||||+  +...++.|
T Consensus         1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~~   76 (128)
T 1ukm_B            1 CPLGWS--SFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKALKFTSMWIGLN--NPWKDCKW   76 (128)
T ss_dssp             CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCSSCEEEEEEE--CTTTTCCE
T ss_pred             CCCcCE--ecCCEeEEEECCccCHHHHHHHHhccCCccEEcccCCHHHHHHHHHHHHhcCCcCcEEEecc--cCCCCCce
Confidence            999999  8999999999999999999999999  899999999999999999987632  368999999  65567999


Q ss_pred             EEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecC--CCceeccccCCCCCccccccccC
Q 008698          129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEHEN  194 (557)
Q Consensus       129 ~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~--~~~w~~~~C~~~~~~iC~~~~~s  194 (557)
                      +|+||+++.+.+|.  ++|                +|+.+...  .+.|++..|....+|||+.+..+
T Consensus        77 ~W~dg~~~~~~~W~--g~P----------------~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~~~  126 (128)
T 1ukm_B           77 EWSDNARFDYKAWK--RRP----------------YCTVMVVKPDRIFWFTRGCEKSVSFVCKFLTDP  126 (128)
T ss_dssp             EETTCCCCCCCCBC--CCC----------------EEEEEEECSSCEEEEEEETTSCEEEEEEEEC--
T ss_pred             EeCCCCccccCCCC--CCC----------------CcEEEeCCCCCCeEeCCCCCCCcCeEeeecCCC
Confidence            99999998777654  443                46565443  26799999999999999987543

>1hup_A Mannose-binding protein; alpha-helical coiled-coil, C-type lectin; 2.50A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1

Probab=99.92  E-value=1.8e-25  Score=198.08  Aligned_cols=122  Identities=15%  Similarity=0.155  Sum_probs=105.7

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEc
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS  131 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~  131 (557)
                      .||+||.  .++++||+++.++++|.+|+.+|+++||+||+|+|++|++||.+++.   ..+||||+  +...++.|.|+
T Consensus        19 ~~~~~w~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~w~W~   91 (141)
T 1hup_A           19 LTFSLGK--QVGNKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAENGAIQNLIK---EEAFLGIT--DEKTEGQFVDL   91 (141)
T ss_dssp             HHHHTSE--EETTEEEEEEEEEEEHHHHHHHHHHTTCEECCCCSHHHHHHHHHHCS---SCEEEEEE--CSSSTTCCEET
T ss_pred             hhcCCeE--EECCEEEEEeCCCcCHHHHHHHHHhCCCEECccCCHHHHHHHHHHhc---CCEEEeee--ecCcCCcEEEC
Confidence            6899999  89999999999999999999999999999999999999999999886   68999999  66667999999


Q ss_pred             cCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       132 Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      ||+++.|.+|. +++|++         ..+.++|+.+.. .+.|++..|....+|||+.+
T Consensus        92 dG~~~~~~~W~-~g~P~~---------~~~~~~Cv~~~~-~g~W~~~~C~~~~~fICe~~  140 (141)
T 1hup_A           92 TGNRLTYTNWN-EGEPNN---------AGSDEDCVLLLK-NGQWNDVPCSTSHLAVCEFP  140 (141)
T ss_dssp             TSCBCSCCCBC-TTCCCC---------GGGCCCEEEECT-TSCEEEECTTSEEEEEEEEE
T ss_pred             CcCCCcCCCCC-CCCCCC---------CCCCCCeEEECC-CCcEeccCCCCCccEEEEEE
Confidence            99999776654 444443         235678988863 46899999999999999875

>1fvu_A Botrocetin alpha chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_B 1u0n_B 1u0o_A

Probab=99.92  E-value=1.6e-25  Score=196.23  Aligned_cols=123  Identities=26%  Similarity=0.551  Sum_probs=103.7

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHH-HHHHHHHHhCCC----CCCeEEeeeecCCCC
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYE-EEHSAQKLCGKN----VNGCWVGGRSINTTV  124 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~-e~~f~~~~~~~~----~~~~WiGl~~~~~~~  124 (557)
                      +||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++ |++||.+++...    ...+||||+..+...
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~   78 (133)
T 1fvu_A            1 DCPSGWS--SYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKNIQSSDLYAWIGLRVENKEK   78 (133)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCTTSTHHHHHHHHHHHHCCSSCCEEEEEEEECCSSS
T ss_pred             CcCCCcE--EcCCeeEEEECCCcCHHHHHHHHhccCCCcEEeeecChHHHHHHHHHHHhhccccCCCCEEEeeecccCCC
Confidence            5999999  8999999999999999999999999  799999999999 999999988532    367999998323334


Q ss_pred             CCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCccccccc
Q 008698          125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       125 ~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~  192 (557)
                      ++.|+|+||+++.|.+|.. +| +              ++|+.+....  +.|++..|....+|||+.+.
T Consensus        79 ~~~w~W~dg~~~~~~~W~~-~P-~--------------~~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~  132 (133)
T 1fvu_A           79 QCSSEWSDGSSVSYENVVE-RT-V--------------KKCFALEKDLGFVLWINLYCAQKNPFVCKSPP  132 (133)
T ss_dssp             SSCCBCTTSCBCCCCCBCG-GG-C--------------CCEEEEETTTTSCSEEEECTTCCEEEEEEECC
T ss_pred             CCccEeCCCCcccccCccc-CC-C--------------CCcEEEEecCCCCeEecCCCCCCCCEEeeecC
Confidence            6999999999988777655 43 3              4677776654  57999999999999999764

>1jwi_A Bitiscetin; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_A

Probab=99.92  E-value=1.7e-25  Score=195.48  Aligned_cols=121  Identities=29%  Similarity=0.593  Sum_probs=99.6

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCCCCCCe
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTVGLS  127 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~~~~  127 (557)
                      .||+||+  .|+++||+++.++++|.+|+.+|+++||+||+|+|++|++||.+++...   .. .+||||+..+...++.
T Consensus         3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~~~   80 (131)
T 1jwi_A            3 GCLPDWS--SYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTKFVYDAWIGLRDESKTQQCS   80 (131)
T ss_dssp             -CCTTSE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHC--CCSCEEEEEEECCSSSSSC
T ss_pred             CCCCCCE--EeCCEeEEEECCCcCHHHHHHHHHHcCCeECccCCHHHHHHHHHHHhhcccccCccEEEeeeecCCCCCCc
Confidence            6999999  8999999999999999999999999999999999999999999987532   24 8999998333334699


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCccccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~  192 (557)
                      |+|+||+++.+.+|.  +| +               +|+.+....  +.|++..|....+|||+.+.
T Consensus        81 ~~W~dg~~~~~~~W~--~P-~---------------~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~  129 (131)
T 1jwi_A           81 PQWTDGSSVVYENVD--EP-T---------------KCFGLDVHTEYRTWTDLPCGEKNPFICKSRL  129 (131)
T ss_dssp             SBCTTSCBCCSCCBS--SC-C---------------CEEEECGGGTTSSEEEECTTSCEEEEEEC--
T ss_pred             eEEeCcCcccCcCCC--CC-C---------------CceEEecCCCCCeEcCcCCCCCcceeeCcCC
Confidence            999999998777654  33 2               466655443  67999999999999999864

>3bx4_A Aggretin alpha chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_A

Probab=99.92  E-value=3e-25  Score=195.27  Aligned_cols=123  Identities=26%  Similarity=0.515  Sum_probs=102.4

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC--C---CCeEEeeeecCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--V---NGCWVGGRSINTT  123 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~--~---~~~WiGl~~~~~~  123 (557)
                      ..||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...  .   ..+||||+..+..
T Consensus         3 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~WIGl~~~~~~   80 (136)
T 3bx4_A            3 EDCDFGWS--PYDQHCYQAFNEQKTWDEAEKFCRAQENGAHLASIESNGEADFVSWLISQKDELADEDYVWIGLRAQNKE   80 (136)
T ss_dssp             -CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTSTTTCEECCCCSHHHHHHHHHHHHTCGGGTTCCEEEEEEEECCCS
T ss_pred             CCCCCCCE--ecCCEEEEEECCCcCHHHHHHHHhccCCCcEEcccCCHHHHHHHHHHHHhhcccCccCCEEEeeeccCCC
Confidence            47999999  8999999999999999999999999  799999999999999999988643  2   5799999843444


Q ss_pred             CCCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCcccccc
Q 008698          124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       124 ~~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~  191 (557)
                      .++.|+|+||+++.|.+|.. ++|+               +|+.+....  +.|++..|....+|||+.+
T Consensus        81 ~~~~~~W~dg~~~~~~~W~~-~~P~---------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~  134 (136)
T 3bx4_A           81 QQCSSEWSDGSSVSYENLID-LHTK---------------KCGALEKLTGFRKWVNYYCEQMHAFVCKLL  134 (136)
T ss_dssp             SSSCCBCTTSCBCCCCCCTT-CCCC---------------CEEEEEGGGTTTSEEEECTTSCEEEEEEEC
T ss_pred             CCCceEeCCCCccCcccccC-CCCC---------------ccEEEEecCCCCeEeCCCCCCCcceEEeec
Confidence            56999999999987776544 4333               466665443  5799999999999999875

>3gpr_D Rhodocetin subunit delta; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma}

Probab=99.92  E-value=7.5e-26  Score=195.80  Aligned_cols=117  Identities=23%  Similarity=0.571  Sum_probs=100.2

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhhC--CCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCee
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLSW  128 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~w  128 (557)
                      ||+||+  .|+++||+++.++++|.+|+.+|+++  ||+||+|+|++|++||.+++...  ...+||||+  +...++.|
T Consensus         1 Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~~   76 (124)
T 3gpr_D            1 CPLHWS--SYNGYCYRVFSELKTWEDAESFCYAQHKGSRLASIHSREEEAFVGKLASQTLKYTSMWLGLN--NAWAACKW   76 (124)
T ss_dssp             CCSSCC--CSSSEEEEEEEEEEESHHHHHHHHHHSTTCBSCCCCSHHHHHHHHHHHHHSCSSCCBCCSEE--CCSSCSSC
T ss_pred             CCCcce--ecCCEeEEEeCCCcCHHHHHHHHHhcCCCCEEcccCCHHHHHHHHHHHHhcCCCCCEEEEeE--cCCCCCce
Confidence            999999  89999999999999999999999999  99999999999999999988632  368999999  66667999


Q ss_pred             EEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCcccccc
Q 008698          129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       129 ~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~  191 (557)
                      .|+||+++.|.+|.. +|                 +|+.+....  +.|++..|....+|||+.+
T Consensus        77 ~W~dg~~~~~~~W~~-~p-----------------~C~~~~~~~~~~~W~~~~C~~~~~fiCe~p  123 (124)
T 3gpr_D           77 EWSDDAKLDYKVWLR-RA-----------------YCAVMVVKTDRIFWYNRGCEKTVSFLCKFY  123 (124)
T ss_dssp             SSSSCCCSCCBCCCS-CC-----------------CEECCBCCSSSCBBCEECTTSEEEEEEEEE
T ss_pred             EECCCCcccccccCC-CC-----------------CcEEEEcCCCCCcEeCCCCCCCccEEeeec
Confidence            999999997766543 21                 455554443  5799999999999999875

>1ukm_A EMS16 A chain, EMS16 subunit A; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_A*

Probab=99.91  E-value=2.2e-25  Score=195.52  Aligned_cols=123  Identities=24%  Similarity=0.517  Sum_probs=102.3

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTV  124 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~  124 (557)
                      ..||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...   .. .+||||++.....
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~   79 (134)
T 1ukm_A            2 FDCPSDWT--AYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFMHRSEIYVWIGLRDRREEQ   79 (134)
T ss_dssp             -CCSTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHTGGGGGSSCCEEEEEEEECCSSS
T ss_pred             cCCCCccE--ecCCEEEEEECCCcCHHHHHHHHhhcCCCcEECccCCHHHHHHHHHHHhhhccCCCCCEEEeeecCCCCC
Confidence            37999999  8999999999999999999999999  899999999999999999988643   25 8999999431155


Q ss_pred             CCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCcccccc
Q 008698          125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       125 ~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~  191 (557)
                      ++.|+|+||+++.|.+|.. ++|+               +|+.+....  +.|++..|....+|||+.+
T Consensus        80 ~~~~~W~dg~~~~~~~W~~-g~P~---------------~C~~~~~~~~~~~W~~~~C~~~~~~ICe~~  132 (134)
T 1ukm_A           80 QCNPEWNDGSKIIYVNWKE-GESK---------------MCQGLTKWTNFHDWNNINCEDLYPFVCKFS  132 (134)
T ss_dssp             CSCCBCTTSCBCCCCCBCT-TCCC---------------CEEEEEGGGTSCSEEEECTTSCEEEEEEEE
T ss_pred             CCceEEcCcCccccceECC-CcCc---------------cceEEEecCCCCeeecCCCCCCceeEEeEc
Confidence            6999999999987766544 4333               466665443  6799999999999999875

>3c8j_A Natural killer cell receptor LY49C; MHC, virus, immune system; 2.60A {Mus musculus} SCOP: d.169.1.1 PDB: 3c8k_D 1p4l_D 1ja3_A 1p1z_D

Probab=99.91  E-value=2.4e-25  Score=209.24  Aligned_cols=125  Identities=18%  Similarity=0.341  Sum_probs=105.5

Q ss_pred             CCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCe
Q 008698           48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~  127 (557)
                      ..+++||+||.  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++.  ...+||||+  +...++.
T Consensus        75 ~~~~~Cp~gW~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~LasI~s~~E~~fl~~~~~--~~~~WIGl~--~~~~~~~  148 (203)
T 3c8j_A           75 RDTGRGVKYWF--CYSTKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHVI--PGNYWIGLS--YDKKKKE  148 (203)
T ss_dssp             --CCCCCEEEE--EEETEEEEEEEEEECHHHHHHHHHHTTCCBCCCCSHHHHHHHHHHSC--SSCEEEEEE--EETTTTE
T ss_pred             cCCCCCCCCcE--EeCCEEEEEECCCCCHHHHHHHHHhCCCEeeeeCCHHHHHHHHHhcC--CCCEEEeee--ecCCCCc
Confidence            34578999999  89999999999999999999999999999999999999999999987  568999999  4445699


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE  193 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~  193 (557)
                      |.|+||+++.+ +| ..++|+           .+.++|+.+..  ..|++..|....+|||+.+..
T Consensus       149 w~W~DGs~~~~-~w-~~~~pn-----------~~~~~Cv~l~~--~~W~d~~C~~~~~fICe~~~~  199 (203)
T 3c8j_A          149 WAWIDNGPSKL-DM-KIKKMN-----------FKSRGCVFLSK--ARIEDIDCNIPYYCICGKKLD  199 (203)
T ss_dssp             EEETTSCCCTT-HH-HHHTTC-----------CCSSSEEEECS--SCEEEECTTSCEEEEEEEECS
T ss_pred             eEECCCCCCCC-CC-CCCCCC-----------CCCCCcEEEEC--CcEECcCCCCCEEEEEeECCc
Confidence            99999999874 44 444432           24578988764  469999999999999998653

>1rtm_1 Mannose-binding protein-A; lectin; 1.80A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1 PDB: 1kwu_A* 1kwv_A* 1kwt_A* 1kwx_A* 1kwy_A* 1kx1_A* 1kww_A 1kwz_A* 1kx0_A* 3kmb_1* 1kmb_1* 2kmb_1* 4kmb_1* 1afb_1* 1afa_1* 1afd_1 1bch_1* 1bcj_1* 1fif_A 1fih_A*

Probab=99.91  E-value=3.2e-25  Score=198.31  Aligned_cols=122  Identities=14%  Similarity=0.186  Sum_probs=105.4

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEc
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS  131 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~  131 (557)
                      .||++|.  .++++||+++.++++|.+|+.+|++.||+||+|+|++|++||.+++.   ..+||||+  +...++.|.|+
T Consensus        27 ~~~~~w~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~w~W~   99 (149)
T 1rtm_1           27 HAFSMGK--KSGKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYV   99 (149)
T ss_dssp             HHHHTTC--CTTSCEEEEEEEEEEHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHS---SCEEEEEE--CSSSTTCCEET
T ss_pred             hcCCCeE--EeCCEEEEEeCCCCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHHhc---CCEEEEee--ccCcCCeEEEC
Confidence            5789999  89999999999999999999999999999999999999999999985   57999999  66667999999


Q ss_pred             cCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       132 Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      ||+++.|.+|. +++|++         ..+.++|+.+.. .+.|++..|....+|||+.+
T Consensus       100 dg~~~~~~~W~-~g~P~~---------~~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~~  148 (149)
T 1rtm_1          100 TGGRLTYSNWK-KDEPND---------HGSGEDCVTIVD-NGLWNDISCQASHTAVCEFP  148 (149)
T ss_dssp             TSSBCCSCCBC-TTCCCC---------CTTCCCEEEECG-GGCEEEECTTSEEEEEEEEC
T ss_pred             CCCCccccCcC-CCCCCC---------CCCCCCeEEECC-CCCEeCCCCCCCeeEEEEee
Confidence            99999776654 444443         235678988863 45899999999999999874

>1umr_A Convulxin alpha, CVX alpha; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_A

Probab=99.91  E-value=2.6e-25  Score=195.45  Aligned_cols=124  Identities=24%  Similarity=0.487  Sum_probs=103.0

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTV  124 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~  124 (557)
                      ..||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...   .. .+||||+..+...
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~   79 (135)
T 1umr_A            2 LHCPSDWY--YYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNIEESFSHVSIGLRVQNKEK   79 (135)
T ss_dssp             CSSCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCTTCCEEECSEEECCSSS
T ss_pred             CCCCCCCE--EcCCEeEEEECCCCCHHHHHHHHHccCCCceECccCCHHHHHHHHHHHHhhcccCCCCEEEeccccCCCC
Confidence            37999999  8999999999999999999999999  899999999999999999987642   24 8999998323334


Q ss_pred             CCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCccccccc
Q 008698          125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       125 ~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~  192 (557)
                      ++.|.|+||+++.|.+|..++ |+               +|+.+....  +.|++..|....+|||+.+.
T Consensus        80 ~~~w~W~dg~~~~~~~W~~g~-P~---------------~C~~~~~~~~~g~W~~~~C~~~~~~ICe~~~  133 (135)
T 1umr_A           80 QCSTKWSDGSSVSYDNLLDLY-IT---------------KCSLLKKETGFRKWFVASCIGKIPFVCKFPP  133 (135)
T ss_dssp             SSCCBCTTSCBCCCCCBCGGG-CC---------------CEEEEEGGGTTCSBEEECTTCCEEEEEEECC
T ss_pred             CCccCcCCCCeecccccCCCC-CC---------------ccEEEecCCCCCeEecCCCCCCCcEEeCccC
Confidence            699999999998877655443 33               466665543  57999999999999999864

>2vuv_A Codakine; sugar-binding protein, C-type, lectin, mannose, invertebrate; HET: CIT; 1.3A {Codakia orbicularis} PDB: 2vuz_A*

Probab=99.91  E-value=3.9e-25  Score=192.72  Aligned_cols=123  Identities=23%  Similarity=0.467  Sum_probs=103.2

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC--CCCe--EEeeeecCCCCCCe
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN--VNGC--WVGGRSINTTVGLS  127 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~--~~~~--WiGl~~~~~~~~~~  127 (557)
                      +||+||.  .|+++||+++.++++|.+|+.+|+++||+||+|+|++|++||.+++...  ...+  ||| . ..  .++.
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WiG-~-~~--~~~~   74 (129)
T 2vuv_A            1 GCPDGWT--QFLDLCYIYQSAKASWASAQSSCQALGGILAEPDTACENEVLIHMCKENGDAGSFGPWLG-G-QK--VGGA   74 (129)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHTTCCSSSCCEEE-E-EE--ETTE
T ss_pred             CCCcchh--hhCCEEEEEECCCcCHHHHHHHHHhcCCEECccCCHHHHHHHHHHHHhccCCCCcccccC-C-CC--CCCe
Confidence            5999999  8999999999999999999999999999999999999999999988643  3567  999 3 23  3589


Q ss_pred             eEEcc-CCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccc
Q 008698          128 WKWSD-NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       128 w~W~D-g~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      |+|+| |+++.+.+|. +++|++         ..+.++|+.+...+  |++..|....+|||+.+.
T Consensus        75 ~~W~d~g~~~~~~~W~-~~~P~~---------~~~~~~C~~~~~~~--w~~~~C~~~~~~ICe~~~  128 (129)
T 2vuv_A           75 WQWSSSGAAFDYLRWG-PNEPNN---------SGGNEDCLHYNWLS--WNDLRCHYQASYLCQRAA  128 (129)
T ss_dssp             EEETTTCCBCSSCCBC-TTCSCC---------TTSCCCEEEEETTE--EEEECTTSCEEEEEEEEC
T ss_pred             EEEcCCCCccccCCcC-CCCCCC---------CCCCCCccEEcCCc--ccCCCCCCCcceEeeecC
Confidence            99999 9999776654 444443         23567899887754  999999999999998754

>1oz7_A Echicetin A-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1

Probab=99.91  E-value=2.5e-25  Score=194.39  Aligned_cols=120  Identities=27%  Similarity=0.589  Sum_probs=102.3

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCC--C
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTT--V  124 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~~~~--~  124 (557)
                      +||+||+  .|+++||+++.+.++|.+|+.+|+.  .||+||+|+|++|++||.+++...   ...+||||+  +..  .
T Consensus         1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~~   76 (131)
T 1oz7_A            1 MCPPGWS--SNGVYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENIGKMYKIWTGLS--ERSKEQ   76 (131)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCCCSEEEEEEE--ECCCGG
T ss_pred             CcCCCcE--EeCCEEEEEECCCCCHHHHHHHHHhcCCCCEECccCCHHHHHHHHHHHHhhcCCCCCEEEeee--CCCCCC
Confidence            5999999  8999999999999999999999999  899999999999999999988532   367999999  444  5


Q ss_pred             CCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCccccccc
Q 008698          125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       125 ~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~  192 (557)
                      ++.|.|+||+++.|.+|.. + |+               +|+.+....  +.|++..|....+|||+.+.
T Consensus        77 ~~~~~W~dg~~~~~~~W~~-~-P~---------------~Cv~~~~~~~~~~w~~~~C~~~~~fICe~~~  129 (131)
T 1oz7_A           77 HCSSRWSDGSFFRSYEIAI-R-YS---------------ECFVLEKQSVFRTWVATPCENTFPFMCKYPV  129 (131)
T ss_dssp             GSCCBCSSSBCCSCCCCCC-S-CC---------------CEEEEEGGGTTCSEEEECTTSCEEEEEEECT
T ss_pred             CCceEECCCCeeccccccC-C-CC---------------CeEEEEccCCCCeEeecCCCCCCcEEeeecC
Confidence            6999999999988776555 3 33               466665543  57999999999999999864

>2ls8_A C-type lectin domain family 4 member D; structural genomics, NEW YORK structural genomics research consortium, nysgrc, PSI-biology, immune system; NMR {Homo sapiens}

Probab=99.85  E-value=2.5e-26  Score=207.26  Aligned_cols=128  Identities=20%  Similarity=0.434  Sum_probs=106.8

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEc
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS  131 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~  131 (557)
                      .||+||.  .|+++||+++.+.++|.+|+.+|+++||+||+|+|++|++||.+++.. ...+||||+  +...++.|+|+
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~-~~~~WIGl~--~~~~~~~w~W~   76 (156)
T 2ls8_A            2 VCPIDWR--AFQSNCYFPLTDNKTWAESERNCSGMGAHLMTISTEAEQNFIIQFLDR-RLSYFLGLR--DENAKGQWRWV   76 (156)
Confidence            6999999  899999999999999999999999999999999999999999999863 457999999  66567999999


Q ss_pred             cCCCCC-CcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCccccccccC
Q 008698          132 DNMSKW-NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEHEN  194 (557)
Q Consensus       132 Dg~~~~-~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~~s  194 (557)
                      ||+++. .+..|..++|++          .+.++|+.+....  +.|++..|....+|||+.+...
T Consensus        77 dG~~~~~~~~~W~~g~P~~----------~~~~~Cv~l~~~~~~~~W~d~~C~~~~~fICe~~~~~  132 (156)
T 2ls8_A           77 DQTPFNPRRVFWHKNEPDN----------SQGENCVVLVYNQDKWAWNDVPCNFEASRICKIPGTT  132 (156)
Confidence            999984 234455555443          2456787776543  3799999999999999987544

>1j34_A Coagulation factor IX-binding protein A chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_A* 1j35_A* 1x2t_A* 1x2w_A 1ixx_A 1y17_A 1wt9_A 1iod_A*

Probab=99.91  E-value=4.4e-25  Score=192.24  Aligned_cols=121  Identities=27%  Similarity=0.582  Sum_probs=100.0

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCCCCC
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTVG  125 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~~  125 (557)
                      +||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...   .. .+||||+..+...+
T Consensus         1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~   78 (129)
T 1j34_A            1 DCPSGWS--SYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENIQNTKSYVWIGLRVQGKEKQ   78 (129)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCCTTCCEEEEEEECSSCSC
T ss_pred             CCCCCcE--EeCCEEEEEECCCCCHHHHHHHHhccCCCCEECccCCHHHHHHHHHHHhhcccCCCCCEEEeeecCCCCCC
Confidence            5999999  8999999999999999999999999  899999999999999999987542   24 89999982233346


Q ss_pred             CeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCccccc
Q 008698          126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMV  190 (557)
Q Consensus       126 ~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~  190 (557)
                      +.|+|+||+++.|.+|..++ |+               +|+.+....  +.|++..|....+|||+.
T Consensus        79 ~~~~W~dg~~~~~~~W~~~~-P~---------------~C~~~~~~~~~~~w~~~~C~~~~~fiCe~  129 (129)
T 1j34_A           79 CSSEWSDGSSVSYENWIEAE-SK---------------TCLGLEKETGFRKWVNIYCGQQNPFVCEA  129 (129)
T ss_dssp             SCCBCTTSCBCCCCCBCGGG-SC---------------CEEEECGGGTTCSBEEECTTSCEEEEEEC
T ss_pred             CceEECCcCccceeccCCCC-CC---------------cceEEEccCCCCeEccCCCCCCCceEeeC
Confidence            99999999998777655443 33               466654433  579999999999999974

>1buu_A Protein (mannose-binding protein A); lectin, HOST defense, metalloprotein, sugar binding protein; 1.90A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1

Probab=99.91  E-value=7.5e-25  Score=199.85  Aligned_cols=122  Identities=14%  Similarity=0.186  Sum_probs=106.0

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEc
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS  131 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~  131 (557)
                      .||++|.  .++++||+++.+.++|.+|+.+|+++||+||+|+|++|++||.+++.   ..+||||+  +...++.|+|+
T Consensus        46 ~~~~~~~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--d~~~~g~w~W~  118 (168)
T 1buu_A           46 HAFSMGK--KSGKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYV  118 (168)
T ss_dssp             HHHHTTC--CTTSCEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHC---SCEECSEE--CSSSTTCCEET
T ss_pred             ccCCCeE--EECCEEEEEeCCccCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHHhc---CCEEeeee--cCCcCCCEEeC
Confidence            6899999  89999999999999999999999999999999999999999999985   58999999  66667999999


Q ss_pred             cCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       132 Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      ||+++.|.+|. .++|++         ..+.++|+.+.. .+.|++..|....+|||+.+
T Consensus       119 dG~~~~y~~W~-~geP~~---------~~~~e~Cv~~~~-~g~W~d~~C~~~~~~ICe~~  167 (168)
T 1buu_A          119 TGGRLTYSNWK-KDEPND---------HGSGEDCVTIVD-NGLWNDISCQASHTAVCEFP  167 (168)
T ss_dssp             TSSBCSCCCBS-SSSCCC---------TTSCCCEEEECT-TSCEEEECTTSCEEEEEEEC
T ss_pred             CCCCcCCCCCC-CCCCCC---------CCCCCCeEEECC-CCCEEccCCCCCEEEEEEec
Confidence            99999776654 444443         235678988873 46899999999999999874

>3g8l_A Lectin-related NK cell receptor LY49L1; natural killer cell receptor, immune system; 2.50A {Mus musculus}

Probab=99.91  E-value=7.1e-25  Score=204.06  Aligned_cols=125  Identities=17%  Similarity=0.324  Sum_probs=105.3

Q ss_pred             CCCCCCCc-cCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCC
Q 008698           48 DWKAPCPP-DWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL  126 (557)
Q Consensus        48 ~~~~~Cp~-~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~  126 (557)
                      ..++.||+ ||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++.  ...+||||+  +...++
T Consensus        61 ~~~~~Cp~~gW~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~LasI~s~~e~~fl~~~~~--~~~~WIGl~--~~~~~~  134 (190)
T 3g8l_A           61 QHTGRGFEKYWF--CYGIKCYYFVMDRKTWSGCKQTCQISSLSLLKIDNEDELKFLKLLVP--SDSYWIGLS--YDNKKK  134 (190)
T ss_dssp             SSTTCEEEEEEE--EEETEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHSC--SSCEEEEEE--EETTTT
T ss_pred             CCCCCCCCCCcE--EECCEEEEEEcccCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhhC--cCCEEEEEE--cCCCCC
Confidence            44578999 999  89999999999999999999999999999999999999999999987  468999999  444569


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccccc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE  193 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~  193 (557)
                      .|+|+||+++.+.. |..++            +.+.++|+.+..  +.|++..|....+|||+.+..
T Consensus       135 ~w~W~DGs~~~~~~-~~~~~------------~~~~~~Cv~l~~--~~W~d~~C~~~~~fICek~~~  186 (190)
T 3g8l_A          135 DWAWINNGPSKLAL-NTMKY------------NIRDGGCMLLSK--TRLDNDNCDKSFICICGKRLD  186 (190)
T ss_dssp             EEEETTTBCCCCCC-CGGGC------------CGGGCSEEEECS--SCEEEECTTSCEEEEEEEECC
T ss_pred             ceEeCCCCcccccc-cCCCC------------CCCCCCeEEEeC--CcEECCCCCCCeeEEEeeCCC
Confidence            99999999876654 43332            224567888754  479999999999999998653

>2e3x_B Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis}

Probab=99.91  E-value=4.1e-25  Score=193.84  Aligned_cols=123  Identities=26%  Similarity=0.513  Sum_probs=102.2

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCCC---C-CeEEeeeecCCCCC
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV---N-GCWVGGRSINTTVG  125 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~~---~-~~WiGl~~~~~~~~  125 (557)
                      +||+||+  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++....   . .+||||+..+...+
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~   79 (134)
T 2e3x_B            2 DCPPDSS--LYRYFCYRVFKEHKTWEAAERFCMEHPNNGHLVSIESMEEAEFVAKLLSNTTGKFITHFWIGLMIKDKEQE   79 (134)
T ss_dssp             CCTTTSE--EETTEEEEEEEEEEEHHHHHHHHTSTTTTCCBCCCCSHHHHHHHHHHHHTCC----CEEECCEEECSSCTT
T ss_pred             CCCCCCE--EeCCEeeEEeCCCcCHHHHHHHHhccCCCcEEcccCCHHHHHHHHHHHHhhccCCCCCEEEeeeecCCCCC
Confidence            6999999  8999999999999999999999999  8999999999999999999887542   4 89999982233346


Q ss_pred             CeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCccccccc
Q 008698          126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       126 ~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~  192 (557)
                      +.|.|+||+++.|.+|..+ +|+               +|+.+....  +.|++..|....+|||+.+.
T Consensus        80 ~~~~W~dg~~~~~~~W~~~-~P~---------------~C~~~~~~~~~~~w~~~~C~~~~~~ICe~~~  132 (134)
T 2e3x_B           80 CSSEWSDGSSVSYDKLGKQ-EFR---------------KCFVLEKESGYRMWFNRNCEERYLFVCKVPP  132 (134)
T ss_dssp             TTCCCTTSCCCCCCCBCGG-GCC---------------CEEEEEGGGTTCCBEEECTTSEEEEEEEECC
T ss_pred             CccEeCCCCcccccccCCC-CCC---------------CeEEEEecCCCCcCCCCCCCCCcceEeCccC
Confidence            9999999999877765444 333               466665543  57999999999999999864

>1sb2_B Rhodocetin beta subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_B

Probab=99.91  E-value=5.4e-25  Score=191.84  Aligned_cols=118  Identities=22%  Similarity=0.451  Sum_probs=100.2

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTV  124 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~  124 (557)
                      ..||+||.  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...    ...+||||+      
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WiGl~------   73 (129)
T 1sb2_B            2 FRCPTTWS--ASKLYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNFDKQRYRAWTGLT------   73 (129)
T ss_dssp             CCCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHC---CCCEEEEEE------
T ss_pred             CCCCCCCE--EeCCEeEEEECCCcCHHHHHHHHhhcCCCceECccCCHHHHHHHHHHHHhhcccCCCCEeEeec------
Confidence            47999999  8999999999999999999999999  899999999999999999987532    468999998      


Q ss_pred             CCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCC--ceeccccCCCCCccccccc
Q 008698          125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       125 ~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~--~w~~~~C~~~~~~iC~~~~  192 (557)
                      ++.|+|+||+++.+.+|. .++|+               +|+.+....+  .|++..|....+|||+.+.
T Consensus        74 ~~~~~W~dg~~~~~~~W~-~~~P~---------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~~  127 (129)
T 1sb2_B           74 ERNLKWTNGASVSYENLY-EPYIR---------------KCFVVQPWEGKSKWYKADCEEKNAFLCKFPK  127 (129)
T ss_dssp             ECCCBCTTSCBCCSCCBS-SCCCC---------------CEEEEEEETTEEEEEEECTTSCEEEEEEEEC
T ss_pred             CCccEECCCCcccccccC-CCCCC---------------CeEEEEecCCCCeEeCcCCCCCcceEecccC
Confidence            489999999998776654 44333               4666655444  7999999999999999864

>1htn_A Tetranectin; plasminogen binding, kringle 4, alpha-helical coiled coil, C-type lectin, carbohydrate recognition domain; 2.80A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1

Probab=99.91  E-value=4.3e-25  Score=204.32  Aligned_cols=126  Identities=16%  Similarity=0.323  Sum_probs=105.6

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCe
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~  127 (557)
                      ..||.||.   |+++||+|+.+.++|.+|+.+|+++||+||+|+|++|++||.+++...   ...+||||+  +...++.
T Consensus        49 ~~Cp~gw~---~~~~CY~~~~~~~tw~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~g~  123 (182)
T 1htn_A           49 TVCLKGTK---VHMKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGNEAEIWLGLN--DMAAEGT  123 (182)
T ss_dssp             HHHHHSEE---ETTEEEEEEEEEECHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHHTCSSCEEEEEEE--CSSSTTC
T ss_pred             CCCCCCcE---ECCEEEEEECCCcCHHHHHHHHhhCCCEEeeeCCHHHHHHHHHHHHhccCCCCcEEEeeE--CCCCCCe
Confidence            47999998   679999999999999999999999999999999999999999887532   467999999  6666799


Q ss_pred             eEEccCCCCCCcCccc--cCCCCCCCCCCCCccccccCceeEeec-CCCceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHA--VGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~--~~~~~~~~~~~~c~~~~~~~~C~~~~~-~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |.|+||+++.|.+|..  .++|++          .+.++|+.+.. ..+.|++..|....+|||+.+
T Consensus       124 w~W~dG~~~~y~nW~~~~~geP~~----------~~~~~Cv~l~~~~~g~W~d~~C~~~~~fICe~~  180 (182)
T 1htn_A          124 WVDMTGARIAYKNWETEITAQPDG----------GKTENCAVLSGAANGKWFDKRCRDQLPYICQFG  180 (182)
T ss_dssp             CBCTTSCBCCCCCBCCSSSCSCCC----------TTTCCEEEEETTTTTEEEEECTTSCEEEEEEEE
T ss_pred             EEeCCCCCccCCCCCCCCCCcCCC----------CCCCCCEEEccCCCCCEECCCCCCCeeEEEEEe
Confidence            9999999997766541  444332          34678988864 457899999999999999875

>2msb_A Mannose-binding protein-A; lectin; HET: BMA MAN; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1msb_A 1ytt_A*

Probab=99.90  E-value=6.4e-24  Score=181.06  Aligned_cols=113  Identities=15%  Similarity=0.235  Sum_probs=95.3

Q ss_pred             CCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCCCcCcc
Q 008698           63 KSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIH  142 (557)
Q Consensus        63 ~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~~~  142 (557)
                      +++||+++.++++|.+|+.+|+++||+||+|+|++|++||.++++   ..+||||+  +...++.|.|+||+++.|.+|.
T Consensus         2 g~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~w~W~dg~~~~~~~W~   76 (115)
T 2msb_A            2 GKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYVTGGRLTYSNWK   76 (115)
T ss_dssp             --CEEEEEEEEECHHHHHHHHHHTTCEECCCSSHHHHHHHHHHHS---SCEEEEEE--CSSSTTCCEETTSSBCCSCCBC
T ss_pred             CCEEEEEeCCCcCHHHHHHHHHhCCCEEeccCCHHHHHHHHHhhc---CCEEEeeE--cCCCCCcEEECCCCEeeecCcC
Confidence            678999999999999999999999999999999999999999986   58999999  6666799999999999776654


Q ss_pred             ccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          143 AVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       143 ~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                       +++|++         ..+.++|+.+.. .+.|++..|....+|||+.+
T Consensus        77 -~~~P~~---------~~~~~~C~~~~~-~g~W~~~~C~~~~~fiCe~~  114 (115)
T 2msb_A           77 -KDEPND---------HGSGEDCVTIVD-NGLWNDISCQASHTAVCEFP  114 (115)
T ss_dssp             -TTCCCC---------CTTCCCEEEECT-TSCEEEECTTSCEEEEEEEC
T ss_pred             -CCCCCC---------CCCCCCeEEECC-CCCEECcCCCCCeEEEEeEc
Confidence             444443         235678988873 46899999999999999874

>1wk1_A Hypothetical protein YK1067A12; lectin C-type domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Caenorhabditis elegans} SCOP: d.169.1.1

Probab=99.90  E-value=9.8e-24  Score=188.91  Aligned_cols=120  Identities=18%  Similarity=0.321  Sum_probs=99.9

Q ss_pred             cCCCCeeeEEecCC---CChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCC
Q 008698           60 NEEKSKCFGYIGNF---RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSK  136 (557)
Q Consensus        60 ~~~~~~Cy~~~~~~---~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~  136 (557)
                      +.|+++||+|+.+.   ++|.+|+.+|+++||+||+|+|++|++||.+++.  ...+||||+  + ..++.|+|+||+++
T Consensus         1 ~~~~~~CY~~~~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~-~~~~~w~W~dg~~~   75 (150)
T 1wk1_A            1 GSSGSSGVKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAA--NTQFWIGLF--K-NSDGQFYWDRGQGI   75 (150)
T ss_dssp             CCCSSCCCCSSSCCSSCBCHHHHHHHHHHHTCEECCCCSHHHHHHHHHHTT--TCEEEEEEE--E-CSSSCEEECCSSSS
T ss_pred             CccCCEEEEEEecCCCccCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhhc--cCCEEEEEE--e-CCCCcEEeCCCCcc
Confidence            36899999999999   9999999999999999999999999999999997  347999999  4 55699999999998


Q ss_pred             C------CcCccccCCCCCCCCCCCCccccccCceeEee----cCCCceeccccCCCCCccccccccC
Q 008698          137 W------NESIHAVGSFNSSCTSLPCHVHATVDLCTLVS----NGSRSLVTERCNTSHPFICMVEHEN  194 (557)
Q Consensus       137 ~------~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~----~~~~~w~~~~C~~~~~~iC~~~~~s  194 (557)
                      .      .++.|..++|++          .+.++|+.+.    ...+.|++..|....+|||+.+...
T Consensus        76 ~~~~~~~~y~~W~~geP~~----------~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~~~~  133 (150)
T 1wk1_A           76 NPDLLNQPITYWANGEPSN----------DPTRQCVYFDGRSGDKSKVWTTDTCATPRPFICQKHRYD  133 (150)
T ss_dssp             CCEECCCSCCCBCTTCSCC----------CSSCCEEEEESSCSCGGGCEEEECTTSCBCCCEECCCCC
T ss_pred             ccccccCCcCCCCCCCCCC----------CCCCCcEEEeCccCCCCCEEeCcCcCCCeeEEEeecCCC
Confidence            3      344455555442          3467898887    3446799999999999999986533

>1h8u_A MBP, eosinophil granule major basic protein 1; lectin, eosinophil granule protein, EMBP; 1.8A {Homo sapiens} SCOP: d.169.1.1 PDB: 2brs_A*

Probab=99.90  E-value=1.1e-23  Score=180.11  Aligned_cols=114  Identities=17%  Similarity=0.316  Sum_probs=94.9

Q ss_pred             ee-eEEecCCCChHHHHHHHhh-CCCeEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCeeEEccCCCCCCcCc
Q 008698           65 KC-FGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESI  141 (557)
Q Consensus        65 ~C-y~~~~~~~~w~~a~~~C~~-~~~~L~~i~s~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~~  141 (557)
                      +| |+++.++++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||++.+...++.|+|+||+++.|.+|
T Consensus         1 ~C~Y~~~~~~~tw~~A~~~C~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~WIGl~~~~~~~~~~~~W~dg~~~~y~~W   80 (117)
T 1h8u_A            1 TCRYLLVRSLQTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSGRCRRFQWVDGSRWNFAYW   80 (117)
T ss_dssp             --CEEEEEEEECHHHHHHHHHHHHSSEECCCCSHHHHHHHHHHHTTCSSSEEEEEEEEECSSSCCEEEETTCCCCCCCCB
T ss_pred             CeEEEEeCCccCHHHHHHHhccCCCCeEEeecCHHHHHHHHHHHhccCCCCEEEcccccCCCCCCccEeCCCCcCCccCc
Confidence            59 9999999999999999999 999999999999999999998743 45799999965445679999999999877665


Q ss_pred             cccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccc
Q 008698          142 HAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       142 ~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~  190 (557)
                      .. ++|++           +.++|+.+....+.|++..|....+|||+.
T Consensus        81 ~~-~~P~~-----------~~~~C~~~~~~~g~W~~~~C~~~~~fiCe~  117 (117)
T 1h8u_A           81 AA-HQPWS-----------RGGHCVALCTRGGYWRRAHCLRRLPFICSY  117 (117)
T ss_dssp             CS-SSCCT-----------TSCSEEEEETTTTCEEEECTTSCEEEEEEC
T ss_pred             CC-CCCCC-----------CCCCCeEEECCCCcCCCCCCCCCcceeEeC
Confidence            44 44442           247899888766789999999999999973

>1rdl_1 SUB-MBP-C, mannose-binding protein-C; C-type lectin, calcium-binding protein; HET: MMA; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1rdj_1* 1rdk_1* 1rdi_1* 1rdm_1* 1rdn_1* 1rdo_1 1bv4_A 1kza_1* 1kzb_1* 1kzc_1* 1kzd_1* 1kze_1*

Probab=99.89  E-value=2.6e-23  Score=176.64  Aligned_cols=112  Identities=14%  Similarity=0.198  Sum_probs=94.8

Q ss_pred             CeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCCCcCccc
Q 008698           64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHA  143 (557)
Q Consensus        64 ~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~~~~  143 (557)
                      ++||+++.++++|.+|+.+|+++||+||+|+|++|++||.+++   ...+||||+  +...++.|.|+||+++.|.+| .
T Consensus         1 ~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~---~~~~WIGl~--~~~~~~~~~W~dg~~~~y~~W-~   74 (113)
T 1rdl_1            1 KKYFMSSVRRMPLNRAKALCSELQGTVATPRNAEENRAIQNVA---KDVAFLGIT--DQRTENVFEDLTGNRVRYTNW-N   74 (113)
T ss_dssp             -CEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHC---SSCEEEEEE--CSSSTTCCEETTSCBCCCCCB-C
T ss_pred             CeEEEEeCCccCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHh---cCCEEEEeE--CCCCCCcEEECCCCEeecCCC-C
Confidence            3799999999999999999999999999999999999999988   358999999  655679999999999977665 4


Q ss_pred             cCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          144 VGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       144 ~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      +++|++         ..+.++|+.+.. .+.|++..|....+|||+.+
T Consensus        75 ~~~P~~---------~~~~~~Cv~~~~-~g~w~~~~C~~~~~~ICe~~  112 (113)
T 1rdl_1           75 EGEPNN---------VGSGENCVVLLT-NGKWNDVPCSDSFLVVCEFS  112 (113)
T ss_dssp             TTCCCC---------CTTCCCEEEECT-TSCEEEECTTSCBEEEEEEC
T ss_pred             CCcCCC---------CCCCCCeeEECC-CCcEeccCCCCCceEEEeeC
Confidence            444443         235678988864 46899999999999999874

>1pwb_A SP-D, PSP-D, pulmonary surfactant-associated protein D; collectin, C-type lectin, alpha-helical coiled coil, carbohydrate recognition domain; HET: GLC; 1.40A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 PDB: 1pw9_A* 3ikn_A* 3ikp_A* 3ikq_A* 3ikr_A* 2rie_A* 2ggx_A* 2ggu_A* 2ork_A* 2orj_A* 2ria_A* 2rib_A* 2ric_A* 2rid_A* 2os9_A* 3dbz_A 3g81_A* 3g83_A* 1b08_A 3g84_A* ...

Probab=99.89  E-value=4.4e-24  Score=196.62  Aligned_cols=124  Identities=16%  Similarity=0.247  Sum_probs=105.2

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEc
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS  131 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~  131 (557)
                      .|+++|.  .++++||+++.+.++|.+|+.+|+++||+||+|+|++|++||.+++......+||||+  +...++.|.|+
T Consensus        54 ~~~~~~~--~~~~~Cy~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W~  129 (177)
T 1pwb_A           54 ELFPNGQ--SVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMT--DSKTEGKFTYP  129 (177)
T ss_dssp             HHTTTEE--EETTEEEEEEEEEEEHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHHTCCEECSCB--CSSSTTCCBCT
T ss_pred             hcCCCeE--EECCEEEEEcCCccCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHHhcCCCcEEEEEe--ccCcCCceEeC
Confidence            5778999  8999999999999999999999999999999999999999999988533468999999  66667999999


Q ss_pred             cCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccc
Q 008698          132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       132 Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~  190 (557)
                      ||+++.|.+|. .++|++         ..+.++|+.+.. ++.|++..|....+|||+.
T Consensus       130 dG~~~~y~~W~-~geP~~---------~~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~  177 (177)
T 1pwb_A          130 TGESLVYSNWA-PGEPND---------DGGSEDCVEIFT-NGKWNDRACGEKRLVVCEF  177 (177)
T ss_dssp             TSCBCSCCCBC-TTCCCC---------GGGCCCEEEECT-TSCEEEECTTSEEEEEEEC
T ss_pred             CcCCcccCCcC-CCcCCC---------CCCCCCcEEECC-CCcEeCCCCCCCeeEEEeC
Confidence            99999776644 444443         235678988864 4689999999999999973

>1byf_A TC14, protein (polyandrocarpa lectin); C-type lectin, galactose-specific, sugar binding protein; 2.00A {Polyandrocarpa misakiensis} SCOP: d.169.1.1 PDB: 1tlg_A*

Probab=99.88  E-value=4.4e-23  Score=178.59  Aligned_cols=118  Identities=15%  Similarity=0.260  Sum_probs=95.7

Q ss_pred             CCeeeEEecCCCChHHHHHHHhhCCCeEee--eCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCe--eEEccCCCC-C
Q 008698           63 KSKCFGYIGNFRSWDESETYCKEIGGHLAA--LTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS--WKWSDNMSK-W  137 (557)
Q Consensus        63 ~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~--i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~--w~W~Dg~~~-~  137 (557)
                      +++||+|+.++++|.+|+.+|+++||+||+  |+|++|++||.++.......+|||| +...  ++.  |+|+||+++ .
T Consensus         1 g~~Cy~~~~~~~~w~~A~~~C~~~g~~La~~~i~s~~e~~~l~~~~~~~~~~~WIGl-~~~~--~~~~~w~W~dg~~~~~   77 (125)
T 1byf_A            1 MDYEILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGA-DNLQ--DGAYNFLWNDGVSLPT   77 (125)
T ss_dssp             -CEEEEEEEEEECHHHHHHHHHTTTCEESCGGGGSHHHHHHHHHHHHHHTCCEEEEE-ESTT--TCTTCCEETTSCBCCT
T ss_pred             CCeEEEEeCCCCCHHHHHHHHHHcCCEeeecCCCCHHHHHHHHHhcCCCCCCEEEec-ccCC--CCceeEEECCCCCCcc
Confidence            478999999999999999999999999999  9999999999998211256899999 5443  488  999999998 6


Q ss_pred             CcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccc
Q 008698          138 NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       138 ~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      |...|.+++|++         ..+.++|+.+....+.|++..|....+|||+.+.
T Consensus        78 ~~~~W~~~~P~~---------~~~~~~Cv~~~~~~~~W~d~~C~~~~~fICe~~~  123 (125)
T 1byf_A           78 DSDLWSPNEPSN---------PQSWQLCVQIWSKYNLLDDVGCGGARRVICEKEL  123 (125)
T ss_dssp             TCTTBCTTCSCS---------CTTSCCEEEEETTTTEEEEECSCSCEEEEEEEEC
T ss_pred             cccCcCCCcCCC---------CCCCCCceEEECCCCcEECcCCCCceeEEEeeeC
Confidence            651455555554         2356789988855568999999999999999864

>3pbf_A Pulmonary surfactant-associated protein A; collectin, carbohydrate binding, lectin, mannose, sugar BIND protein; 1.80A {Rattus norvegicus} PDB: 1r14_A* 1r13_A* 3paq_A* 3par_A 3pak_A

Probab=99.88  E-value=3.5e-23  Score=184.84  Aligned_cols=115  Identities=17%  Similarity=0.233  Sum_probs=97.4

Q ss_pred             CCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCCCcC
Q 008698           61 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNES  140 (557)
Q Consensus        61 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~  140 (557)
                      .++++||+++.++++|.+|+.+|+.+||+||+|+|.+|++||.+++......+||||+  +...++.|.|+||+++.|.+
T Consensus        33 ~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W~dg~~~~~~~  110 (148)
T 3pbf_A           33 SVGDKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYLGMI--EDQTPGDFHYLDGASVSYTN  110 (148)
T ss_dssp             EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTSCEEEEEE--ECSSTTCEEETTSCBCCSCC
T ss_pred             eeCCEEEEEcCCccCHHHHHHHHhhcCCEEeeeCCHHHHHHHHHHHHhCCCCEEEEeE--ecCCCCceEeCCCCCcccCC
Confidence            7999999999999999999999999999999999999999999988643458999999  54456999999999997766


Q ss_pred             ccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccc
Q 008698          141 IHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM  189 (557)
Q Consensus       141 ~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~  189 (557)
                      |.. ++|++          .+.++|+.+.. .+.|++..|....+|||+
T Consensus       111 W~~-~~P~~----------~~~~~Cv~~~~-~g~W~~~~C~~~~~fICe  147 (148)
T 3pbf_A          111 WYP-GEPRG----------QGKEKCVEMYT-DGTWNDRGCLQYRLAVCE  147 (148)
T ss_dssp             BCT-TCCCS----------TTSCCEEEECT-TSCEEEECSCSCEEEEEE
T ss_pred             cCC-CccCc----------CCCCCceEECC-CCcEecCCCCCCeeEeee
Confidence            554 44443          14568888765 467999999999999997

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=2.7e-23  Score=206.09  Aligned_cols=141  Identities=18%  Similarity=0.143  Sum_probs=115.1

Q ss_pred             CCeeecccCceEEEEEEeCCCCEEEEEEecccch------------------hhHHHHHHHHHHHhhcCCCcEEeeeeee
Q 008698          273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF------------------QRKKEFYSEIGRFARLHHPNLVAVKGCC  334 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~H~niv~l~g~~  334 (557)
                      ..+.||+|+||.||++...+|+.||||+++....                  .....+.+|+.++.+++  | +++.+++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~  170 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred             ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence            3467899999999999997799999999964321                  13567899999999999  5 6666655


Q ss_pred             eeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEe
Q 008698          335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM  414 (557)
Q Consensus       335 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  414 (557)
                      .. +..++||||+++|+|.+ +..          .....++.||+.||.|||+.   +|+||||||+|||++ ++.+||+
T Consensus       171 ~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~  234 (282)
T 1zar_A          171 AW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWII  234 (282)
T ss_dssp             EE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEEC
T ss_pred             ec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEE
Confidence            43 56699999999999988 421          12346999999999999999   999999999999999 9999999


Q ss_pred             eccCCccCCccccccceeecCcccccccccccc
Q 008698          415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY  447 (557)
Q Consensus       415 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  447 (557)
                      |||+++.               +..++|||++.
T Consensus       235 DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          235 DFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             CCTTCEE---------------TTSTTHHHHHH
T ss_pred             ECCCCeE---------------CCCCCHHHHHH
Confidence            9999863               34578999874

>1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A

Probab=99.84  E-value=6.3e-21  Score=171.94  Aligned_cols=114  Identities=19%  Similarity=0.349  Sum_probs=94.2

Q ss_pred             eeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCC--CcCccc
Q 008698           66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKW--NESIHA  143 (557)
Q Consensus        66 Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~--~~~~~~  143 (557)
                      ||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++......+||||+  +.  ++.|+|+||+...  .++.|.
T Consensus         2 ~Y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~--~~~~~W~dg~~~~~~~y~~W~   77 (157)
T 1g1t_A            2 SYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIR--KV--NNVWVWVGTQKPLTEEAKNWA   77 (157)
T ss_dssp             EEEECSSCBCHHHHHHHHHHHSSEECCCCSHHHHHHHHHHSCCCTTCEEESEE--EE--TTEEEETTTCCBCCTTTCCBC
T ss_pred             ceEeCCCccCHHHHHHHHHHCCCEEcccCCHHHHHHHHHHhccCCCCEEEEEE--CC--CCeeEEeCCCccCCcccCCCC
Confidence            89999999999999999999999999999999999999999755668999999  43  4899999998532  244466


Q ss_pred             cCCCCCCCCCCCCccccccCceeEeec----CCCceeccccCCCCCccccccc
Q 008698          144 VGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       144 ~~~~~~~~~~~~c~~~~~~~~C~~~~~----~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      +++|++         ..+.++|+.+..    ..+.|++..|....+|||+.+.
T Consensus        78 ~geP~~---------~~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~~  121 (157)
T 1g1t_A           78 PGEPNN---------RQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAA  121 (157)
T ss_dssp             TTCCCC---------CSTTCCEEEECTTCSSSTTCEEEECTTSCBEEEEEECC
T ss_pred             CCcCCC---------CCCCCCceEEeCcCCCCCCccccCCCCCCcceEeCcCC
Confidence            665554         234678888764    2467999999999999999864

>3cfw_A L-selectin; EGF, cell adhesion, EGF-like domain, glycoprotein, membrane, sushi, transmembrane; HET: NAG MAN BMA; 2.20A {Homo sapiens}

Probab=99.84  E-value=4.3e-21  Score=174.35  Aligned_cols=114  Identities=16%  Similarity=0.336  Sum_probs=94.7

Q ss_pred             eeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCC--CcCccc
Q 008698           66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKW--NESIHA  143 (557)
Q Consensus        66 Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~--~~~~~~  143 (557)
                      ||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++......+||||++  .  ++.|+|+||+...  .+..|.
T Consensus         2 cY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~~--~--~~~~~W~dg~~~~~~~y~~W~   77 (164)
T 3cfw_A            2 TYHYSEKPMNWQRARRFCRDNYTDLVAIQNKAEIEYLEKTLPFSRSYYWIGIRK--I--GGIWTWVGTNKSLTEEAENWG   77 (164)
T ss_dssp             EEEEEEEEECHHHHHHHHHHHSSEECCCCSHHHHHHHHHHSCCCTTCEEESEEE--E--TTEEEETTTCCBCCTTTCCBC
T ss_pred             eEEEecCCcCHHHHHHHHHHCCCEECccCCHHHHHHHHHHhccCCccEEEeEEC--C--CCEEEECCCCcccccccCCCC
Confidence            999999999999999999999999999999999999999997556789999994  3  4899999998533  244566


Q ss_pred             cCCCCCCCCCCCCccccccCceeEeec----CCCceeccccCCCCCccccccc
Q 008698          144 VGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       144 ~~~~~~~~~~~~c~~~~~~~~C~~~~~----~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      +++|++         ..+.++|+.+..    ..+.|++..|....+|||+.+.
T Consensus        78 ~geP~~---------~~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~~  121 (164)
T 3cfw_A           78 DGEPNN---------KKNKEDCVEIYIKRNKDAGKWNDDACHKLKAALCYTAS  121 (164)
T ss_dssp             TTCCCC---------GGGCCCEEEECTTCSSSTTCEEEECTTSCEEEEEEECC
T ss_pred             CCCCCC---------CCCCccceeeeccCCCCCCceeCCCCCCCcEeEEccCC
Confidence            565554         234678988864    3467999999999999999864

>1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A

Probab=99.84  E-value=6e-21  Score=172.99  Aligned_cols=113  Identities=19%  Similarity=0.324  Sum_probs=94.1

Q ss_pred             eeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCC-CC-CcCccc
Q 008698           66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMS-KW-NESIHA  143 (557)
Q Consensus        66 Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~-~~-~~~~~~  143 (557)
                      ||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++......+||||++  .  ++.|+|+||++ +. .+..|.
T Consensus         2 ~Y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~~--~--~~~~~W~dg~~~~~~~~~~W~   77 (162)
T 1g1s_A            2 TYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIRK--N--NKTWTWVGTKKALTNEAENWA   77 (162)
T ss_dssp             EEEEEEEEECHHHHHHHHHHHSSEECCCCCHHHHHHHHHHSCCCTTCEEEEEEE--E--TTEEEETTTCCBCCTTTCCBC
T ss_pred             eEEEecCCcCHHHHHHHHHhcCCEEeeeCCHHHHHHHHHHhccCCCCEEEeEEC--C--CCCeEECCCCccCCcccCccC
Confidence            899999999999999999999999999999999999999998556789999994  3  48999999974 43 245566


Q ss_pred             cCCCCCCCCCCCCccccccCceeEeec----CCCceeccccCCCCCcccccc
Q 008698          144 VGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       144 ~~~~~~~~~~~~c~~~~~~~~C~~~~~----~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      +++|++         ..+.++|+.+..    ..+.|++..|....+|||+..
T Consensus        78 ~geP~~---------~~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~  120 (162)
T 1g1s_A           78 DNEPNN---------KRNNEDCVEIYIKSPSAPGKWNDEHCLKKKHALCYTA  120 (162)
T ss_dssp             TTCCCC---------TTSCCCEEEECTTCSSSTTCEEEECTTSCEEEEEEEC
T ss_pred             CCCCCC---------CCCCcceEEEeccCCCCCCeEECCCCCCCCCEEEEeC
Confidence            665554         234678988764    346799999999999999986

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=3.7e-19  Score=173.99  Aligned_cols=135  Identities=13%  Similarity=0.116  Sum_probs=104.4

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCE--EEEEEecccchh------------------------hHHHHHHHHHHHhhcCC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSR--VAVKRLKRSSFQ------------------------RKKEFYSEIGRFARLHH  324 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~H  324 (557)
                      .....||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+..|.+++|
T Consensus        50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  129 (258)
T 1zth_A           50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE  129 (258)
T ss_dssp             EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence            3456789999999999997 68989  999987543111                        12368899999999988


Q ss_pred             CcE--EeeeeeeeeCCceEEEEecCCC-C----ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeec
Q 008698          325 PNL--VAVKGCCYDHGDRYIVYEFVVN-G----PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-DKVKPHVVHR  396 (557)
Q Consensus       325 ~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~  396 (557)
                      +++  +.++++    +..+|||||+.+ |    +|.++...       .++..+..++.|++.||.||| +.   +|+||
T Consensus       130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givHr  195 (258)
T 1zth_A          130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVHA  195 (258)
T ss_dssp             TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred             CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence            764  333332    356899999942 4    67666532       224456789999999999999 88   99999


Q ss_pred             CCCCCCeeeCCCCCcEEeeccCCccC
Q 008698          397 DIRASNVLLDEEFGAHLMGVGLSKFV  422 (557)
Q Consensus       397 Dlk~~Nill~~~~~~kl~Dfgl~~~~  422 (557)
                      ||||+|||++.  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.62  E-value=1.3e-16  Score=162.62  Aligned_cols=137  Identities=14%  Similarity=0.078  Sum_probs=97.2

Q ss_pred             CCCCCeeecccCceEEEEEEeCCCCEEEEEEecccch--------------hhHH--------HHHHHHHHHhhcCCCcE
Q 008698          270 FSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------------QRKK--------EFYSEIGRFARLHHPNL  327 (557)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~--------------~~~~--------~~~~e~~~l~~l~H~ni  327 (557)
                      .+.....||.|++|.||+|...+|+.||||+++....              ....        ...+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3555677899999999999998999999998753210              0011        12346666666655443


Q ss_pred             EeeeeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 008698          328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE  407 (557)
Q Consensus       328 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~  407 (557)
                      ....-+..  +..+|||||+++++|..+..        .+  ....++.||+.+|.|||+.   +||||||||.|||+++
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~~--~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------VP--DPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE  240 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCC--------CS--CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhcc--------cH--HHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence            22111111  22379999999988865432        11  2346789999999999999   9999999999999988


Q ss_pred             CC----------CcEEeeccCCcc
Q 008698          408 EF----------GAHLMGVGLSKF  421 (557)
Q Consensus       408 ~~----------~~kl~Dfgl~~~  421 (557)
                      ++          .+.|+||+-+..
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCcccccccccceEEEEeCCccc
Confidence            76          378999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.25  E-value=1.5e-11  Score=119.92  Aligned_cols=135  Identities=12%  Similarity=0.026  Sum_probs=105.4

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEecCCCCChHH
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  354 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  354 (557)
                      .++.|+.+.||+... +++.+++|+...........+.+|+.++..+. |.++.+++++..+.+..++||||++|.+|.+
T Consensus        21 ~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   99 (263)
T 3tm0_A           21 DTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE   99 (263)
T ss_dssp             CCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred             eccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhh
Confidence            457778899999876 47899999987532223346888999999884 6778889999888889999999999999987


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 008698          355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK----------------------------------------------  388 (557)
Q Consensus       355 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------  388 (557)
                      .+..         ......++.+++.+|..||+.                                              
T Consensus       100 ~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  170 (263)
T 3tm0_A          100 EYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL  170 (263)
T ss_dssp             HCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred             ccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence            6421         112346788999999999981                                              


Q ss_pred             ----------CCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          389 ----------VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       389 ----------~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                                ..+.++|+|++|.|||++++..+.|+||+.+.
T Consensus       171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                      01359999999999999876666799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.11  E-value=7.9e-11  Score=114.18  Aligned_cols=128  Identities=16%  Similarity=0.141  Sum_probs=97.1

Q ss_pred             cccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc--EEeeeeeeeeCCceEEEEecCCCCChHHH
Q 008698          278 GDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAVKGCCYDHGDRYIVYEFVVNGPLDRW  355 (557)
Q Consensus       278 g~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~  355 (557)
                      +.|..+.||+....+|+.+++|.....   ....+.+|+.++..+++.+  +.+++++....+..++||||+++.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            355669999998777889999997654   2245778899998885444  456888887777889999999998884  


Q ss_pred             hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------------
Q 008698          356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV----------------------------------------------  389 (557)
Q Consensus       356 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------------  389 (557)
                      ...       .+   ...++.+++..|..||+..                                              
T Consensus       104 ~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          104 SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence            211       12   2356788888888888752                                              


Q ss_pred             ---------CCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          390 ---------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       390 ---------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                               ...++|+|++|.|||++++..++|.||+.+.
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                     1139999999999999887667799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.02  E-value=8.7e-10  Score=112.59  Aligned_cols=141  Identities=18%  Similarity=0.220  Sum_probs=105.7

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEec--ccc-hhhHHHHHHHHHHHhhcC--CCcEEeeeeeeeeC---CceEEEEec
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLK--RSS-FQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDH---GDRYIVYEF  346 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~E~  346 (557)
                      +.++.|.++.||+.... +..+++|+..  ... ......+.+|+.++..++  +..++++++++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            35799999999998874 5688899876  332 123457888999999986  45578888888766   448999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-------------------------------------  389 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------  389 (557)
                      +++.++.+..      -..++..++..++.+++..|..||+..                                     
T Consensus       123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9988774321      134778889999999999999999731                                     


Q ss_pred             ------------------CCCeeecCCCCCCeeeCCCCC--cEEeeccCCccC
Q 008698          390 ------------------KPHVVHRDIRASNVLLDEEFG--AHLMGVGLSKFV  422 (557)
Q Consensus       390 ------------------~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgl~~~~  422 (557)
                                        .+.++|+|+++.|||++.++.  +.|.||+.+...
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                              247999999999999997754  589999988753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.89  E-value=8e-10  Score=110.11  Aligned_cols=185  Identities=16%  Similarity=0.173  Sum_probs=121.2

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCc--EEeeeeeeeeCC---ceEEEEecCCC
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPN--LVAVKGCCYDHG---DRYIVYEFVVN  349 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~n--iv~l~g~~~~~~---~~~lV~E~~~~  349 (557)
                      .++.|....||+..    ..+++|+....  .....+.+|+..|..+ .+..  +.+++......+   ..|+|||+++|
T Consensus        27 ~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           27 ISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             EEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             ecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            46999999999852    56889986533  3456788999999888 3333  334444433332   34899999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK-----------------------------------------  388 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----------------------------------------  388 (557)
                      .+|.+...      ..++..++..++.+++..|+.||+.                                         
T Consensus       101 ~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          101 VPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             EECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             eECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            88865332      2367788888899999999999861                                         


Q ss_pred             --------------CCCCeeecCCCCCCeeeCC--CCCcEEeeccCCccCCccccccceeec---Cc---------cccc
Q 008698          389 --------------VKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVPWEVMQERTVMA---GG---------TYGY  440 (557)
Q Consensus       389 --------------~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~~~~~---~g---------t~~y  440 (557)
                                    ..+.++|+|++|.||++++  +..+.|.||+.+........-......   .+         .++.
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                          1245899999999999998  456789999988654321100000000   00         0111


Q ss_pred             cc-cccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008698          441 LA-PEFVYRNELTTKSDVYSFGVLLLEIVSGRRPA  474 (557)
Q Consensus       441 ~a-PE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~  474 (557)
                      .. |+....  .....+.|++|.++|.+.+|..+|
T Consensus       255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11 222111  112368999999999999998765

>3k7b_A Protein A33; C-type lectin-like domain, homodimer, poxvirus, EEV, EV, VIR protein; 2.10A {Vaccinia virus WR}

Probab=98.77  E-value=8.3e-10  Score=86.91  Aligned_cols=46  Identities=7%  Similarity=0.161  Sum_probs=43.3

Q ss_pred             CCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhC
Q 008698           61 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCG  107 (557)
Q Consensus        61 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~  107 (557)
                      .|+++||+|+.++++|.||+..|.++|++|++|++.++ .||..++.
T Consensus        15 ~f~~~CY~f~~~pkTW~eA~~~C~~~G~~Lpsi~s~~~-~wL~~YL~   60 (96)
T 3k7b_A           15 YYQGSCYILHSDYQMFSDAAANCTAESSTLPNKSDVMI-TWLIDYVE   60 (96)
T ss_dssp             EETTEEEEEEEEEECHHHHHHHHHHTTCBCCCHHHHTT-STTHHHHB
T ss_pred             eeCCeeEEEeCCCCCHHHHHHHHHHcCCccCCcccchh-HHHHHHHh
Confidence            48999999999999999999999999999999999988 89988875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.39  E-value=2.1e-06  Score=85.36  Aligned_cols=136  Identities=17%  Similarity=0.109  Sum_probs=95.8

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC---cEEeeeeeee-eCCceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP---NLVAVKGCCY-DHGDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~E~~~~g  350 (557)
                      ..++.|....||+.    |..++||+...  ......+.+|..+|..+.+.   .+.+++.+.. ..+..++|||+++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            34688888899987    57788888532  23456789999999999642   2455666653 345678999999998


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK------------------------------------------  388 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------  388 (557)
                      +|.+...      ..++..++..++.+++..|..||+.                                          
T Consensus        99 ~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           99 ILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             ECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             ECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            8876321      1245555666666666666666643                                          


Q ss_pred             ---------------CCCCeeecCCCCCCeeeCC---CCC-cEEeeccCCccC
Q 008698          389 ---------------VKPHVVHRDIRASNVLLDE---EFG-AHLMGVGLSKFV  422 (557)
Q Consensus       389 ---------------~~~~ivH~Dlk~~Nill~~---~~~-~kl~Dfgl~~~~  422 (557)
                                     ..+.++|+|+.+.|||++.   ++. ..|.||+.+...
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           2235799999999999997   455 489999987653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.31  E-value=3.5e-06  Score=81.82  Aligned_cols=133  Identities=18%  Similarity=0.128  Sum_probs=93.3

Q ss_pred             ecccCce-EEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          277 LGDSKTG-GTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       277 lg~G~~g-~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      +..|..| .||+.... ++..++||+-...   ....+.+|...|..+. +--+.++++++.+.+..++|||++++.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            3555554 68987754 4678999987543   3456788998888884 434667888888889999999999998876


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK---------------------------------------------  388 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------------  388 (557)
                      +....        .......+..+++..|.-||+.                                             
T Consensus       109 ~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          109 QVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             ccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            65432        1112234555555666666532                                             


Q ss_pred             ----------CCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          389 ----------VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       389 ----------~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                                ..+.++|+|+.+.|||++++..+-|.||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                      01237999999999999987767799998774

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.15  E-value=3.2e-06  Score=85.76  Aligned_cols=78  Identities=5%  Similarity=-0.051  Sum_probs=53.4

Q ss_pred             ee-cccCceEEEEEEeC-------CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcC-C--CcEEeeeeeeeeC---C
Q 008698          276 LL-GDSKTGGTYSGILP-------DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLH-H--PNLVAVKGCCYDH---G  338 (557)
Q Consensus       276 ~l-g~G~~g~Vy~g~~~-------~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-H--~niv~l~g~~~~~---~  338 (557)
                      .| +.|....+|+....       ++..+++|......   ......+.+|+.++..+. +  -.+.++++++.+.   +
T Consensus        27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g  106 (357)
T 3ats_A           27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG  106 (357)
T ss_dssp             EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred             ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence            46 78888999988764       26789999875432   111245677888887773 2  3466777776554   3


Q ss_pred             ceEEEEecCCCCChH
Q 008698          339 DRYIVYEFVVNGPLD  353 (557)
Q Consensus       339 ~~~lV~E~~~~gsL~  353 (557)
                      ..++||||+++.++.
T Consensus       107 ~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          107 TPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SCEEEEECCCCBCCC
T ss_pred             CceEEEEecCCCChh
Confidence            568999999887664

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.88  E-value=7.7e-05  Score=74.73  Aligned_cols=140  Identities=19%  Similarity=0.243  Sum_probs=78.2

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-----CCcEEeee-e--eeeeCCceEEEEecC
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----HPNLVAVK-G--CCYDHGDRYIVYEFV  347 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~-g--~~~~~~~~~lV~E~~  347 (557)
                      .|+.|..+.||+....+| .+++|+.... .   ..+..|..++..+.     .|.++... |  +....+..++||||+
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            356677899999887554 5899998753 1   23334444444442     34443311 1  123456789999999


Q ss_pred             CCCChH--------------HHhccCCC----C-C-----CCCCHHHH-------------------------------H
Q 008698          348 VNGPLD--------------RWLHHIPR----G-G-----RSLDWAMR-------------------------------M  372 (557)
Q Consensus       348 ~~gsL~--------------~~l~~~~~----~-~-----~~l~~~~~-------------------------------~  372 (557)
                      ++.++.              .-++....    . .     ....|...                               .
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986542              11111100    0 0     01123211                               0


Q ss_pred             HHHHHHHHHHHHHhc----------CCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          373 KVATTLAQGIAFLHD----------KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       373 ~i~~~ia~gL~yLH~----------~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      .+..++..++++|+.          .....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            111224456667763          124589999999999999888889999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.78  E-value=8.2e-05  Score=76.52  Aligned_cols=74  Identities=14%  Similarity=0.020  Sum_probs=48.0

Q ss_pred             eeecccCceEEEEEEeC-CCCEEEEEEecccch-------hhHHHHHHHHHHHhhcCC--Cc-EEeeeeeeeeCCceEEE
Q 008698          275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-------QRKKEFYSEIGRFARLHH--PN-LVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~H--~n-iv~l~g~~~~~~~~~lV  343 (557)
                      +.+|.|..+.||++... +++.++||.......       .....+..|..+|..+..  +. +.+++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            45799999999999754 468999998653211       123456778888887732  33 3345543  44556899


Q ss_pred             EecCCCC
Q 008698          344 YEFVVNG  350 (557)
Q Consensus       344 ~E~~~~g  350 (557)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.74  E-value=0.00016  Score=71.64  Aligned_cols=137  Identities=19%  Similarity=0.222  Sum_probs=90.5

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC---CCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .|+.|....+|+... ++..++||+....   ....+..|+..|..|.   ...+++++++....+..++||||+++.++
T Consensus        43 ~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           43 KLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            469999999999886 5778999987643   3567888988888873   35677888888777889999999998764


Q ss_pred             H--------H---HhccCCC-C-----------------CCCCCHHHHH---HHH----------------HHHHHH-HH
Q 008698          353 D--------R---WLHHIPR-G-----------------GRSLDWAMRM---KVA----------------TTLAQG-IA  383 (557)
Q Consensus       353 ~--------~---~l~~~~~-~-----------------~~~l~~~~~~---~i~----------------~~ia~g-L~  383 (557)
                      .        .   -|+.... .                 ...-+|....   ++.                ..+... ..
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            2        1   1222211 0                 0012454321   111                111111 22


Q ss_pred             HHhc-CCCCCeeecCCCCCCeeeCCCCCcEEeecc
Q 008698          384 FLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVG  417 (557)
Q Consensus       384 yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  417 (557)
                      .|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3432 2356899999999999999887 8888873

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.74  E-value=0.00013  Score=71.57  Aligned_cols=74  Identities=26%  Similarity=0.222  Sum_probs=53.4

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CC--cEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HP--NLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~--niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      ..+|.|..+.||+....||+.|.||+...........|..|+..|+.|. ..  -+.+++++    +..++||||++.+.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence            3469999999999999999999999876554344456788998888874 21  23344443    23478999998765


Q ss_pred             h
Q 008698          352 L  352 (557)
Q Consensus       352 L  352 (557)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.63  E-value=0.00017  Score=74.72  Aligned_cols=79  Identities=9%  Similarity=0.109  Sum_probs=50.4

Q ss_pred             CCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceeecCccccccccccccCC---CCCchhhHHHHHHHHHH
Q 008698          390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLE  466 (557)
Q Consensus       390 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDVwS~Gvil~e  466 (557)
                      .+.++|+|++|.|||++.+. +++.||+.+........-. .....-...|.+|+.....   ......++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            34899999999999998876 9999999887543221100 0000012356777655421   11234566788888888


Q ss_pred             HHcC
Q 008698          467 IVSG  470 (557)
Q Consensus       467 l~tG  470 (557)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.18  E-value=0.0047  Score=61.25  Aligned_cols=161  Identities=15%  Similarity=0.126  Sum_probs=89.3

Q ss_pred             ccCHHHHHHhhcCCCC----CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC--cEEee
Q 008698          257 VFTTEELRSITKNFSE----GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP--NLVAV  330 (557)
Q Consensus       257 ~~~~~el~~~~~~~~~----~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l  330 (557)
                      ..+.+++..+...+..    .-..++ |....||+....+|+.+++|...... .....+..|..++..+...  .++++
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence            3455666555544422    123456 77889999877778789999986431 1344566777777776321  23444


Q ss_pred             eee-----eeeCCceEEEEecCCCCChH-----H------H---hcc----CCC-CCCCCCHHHH----HH---------
Q 008698          331 KGC-----CYDHGDRYIVYEFVVNGPLD-----R------W---LHH----IPR-GGRSLDWAMR----MK---------  373 (557)
Q Consensus       331 ~g~-----~~~~~~~~lV~E~~~~gsL~-----~------~---l~~----~~~-~~~~l~~~~~----~~---------  373 (557)
                      +..     ....+..++|||++++.++.     .      .   ++.    ... ....+++...    ..         
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            443     12244568899999875432     0      1   111    000 0011222111    00         


Q ss_pred             ------HHHHHHHHHHHHhc----CCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          374 ------VATTLAQGIAFLHD----KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       374 ------i~~~ia~gL~yLH~----~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                            +...+...++.+..    .....++|+|+.+.|||++ + .+.|.||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                  01111122333322    1234789999999999999 4 899999987754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.16  E-value=0.0059  Score=60.38  Aligned_cols=160  Identities=14%  Similarity=0.173  Sum_probs=87.8

Q ss_pred             cCHHHHHHhhcCCCCCC----eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc--EEeee
Q 008698          258 FTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAVK  331 (557)
Q Consensus       258 ~~~~el~~~~~~~~~~~----~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~  331 (557)
                      ++.+++..+...|....    +.|+.|....+|+....+| .+++|......  ....+..|+.++..+....  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            55677777776654421    2356788889999887655 68899886531  1234455666666663212  23333


Q ss_pred             ee------eeeCCceEEEEecCCCCChHH--------------HhccC----CCCC-CCC---CHHHHHH----------
Q 008698          332 GC------CYDHGDRYIVYEFVVNGPLDR--------------WLHHI----PRGG-RSL---DWAMRMK----------  373 (557)
Q Consensus       332 g~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~----~~~~-~~l---~~~~~~~----------  373 (557)
                      ..      ....+..+++|+|+++.++..              -++..    .... ...   .|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      122356789999998765321              01111    0000 001   1222110          


Q ss_pred             --HHHHHHHHHHHHhcC----CCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          374 --VATTLAQGIAFLHDK----VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       374 --i~~~ia~gL~yLH~~----~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                        +...+...+++++..    ....++|+|+.+.|||++++..+.|.||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              011244455566532    23479999999999999987656899998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.96  E-value=0.0037  Score=62.30  Aligned_cols=33  Identities=27%  Similarity=0.255  Sum_probs=28.0

Q ss_pred             CCCeeecCCCCCCeeeCCC----CCcEEeeccCCccC
Q 008698          390 KPHVVHRDIRASNVLLDEE----FGAHLMGVGLSKFV  422 (557)
Q Consensus       390 ~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgl~~~~  422 (557)
                      ...++|||+.+.|||++.+    ..+.|.||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4489999999999999875    67899999988654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.93  E-value=0.0019  Score=63.46  Aligned_cols=70  Identities=7%  Similarity=-0.022  Sum_probs=41.2

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcE-EeeeeeeeeCCceEEEEecC-CCCCh
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEFV-VNGPL  352 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~-~~gsL  352 (557)
                      +.|+.|....+|+.     ..+++|+....... .....+|+..+..+....+ .+++++  +.+..++++||+ ++.+|
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence            45688999999998     56888887643211 1122456666666532122 344443  344457899999 55444

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.84  E-value=0.0028  Score=65.73  Aligned_cols=71  Identities=14%  Similarity=0.161  Sum_probs=47.6

Q ss_pred             eecccCceEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcE-EeeeeeeeeCCceEEEEec
Q 008698          276 LLGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~  346 (557)
                      .|+.|....+|+....+        +..+++|+.....  ....+.+|..++..+...++ .++++.+.+    .+|+||
T Consensus        80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            46888889999998753        5789999884421  12455678888888743333 456665432    389999


Q ss_pred             CCCCCh
Q 008698          347 VVNGPL  352 (557)
Q Consensus       347 ~~~gsL  352 (557)
                      +++.+|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            976443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.58  E-value=0.011  Score=61.83  Aligned_cols=72  Identities=10%  Similarity=-0.096  Sum_probs=45.4

Q ss_pred             eecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcE-EeeeeeeeeCCceEEEEecCCCCCh
Q 008698          276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .|+.|-...+|+....+ +..+++|+...... ......+|..++..|...++ .++++++.  +  .+||||+++.+|
T Consensus       115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            46888889999998765 47888998754321 11112478888888864444 45666652  2  259999987544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.49  E-value=0.0064  Score=61.80  Aligned_cols=141  Identities=16%  Similarity=0.159  Sum_probs=80.9

Q ss_pred             eecccCceEEEEEEeC--------CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEec
Q 008698          276 LLGDSKTGGTYSGILP--------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~--------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      .+..|-...+|+....        +++.+++|+.... ......+.+|..+++.+. +.-..++++++.+    -+||||
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            4577778889998864        2578999986332 223456678888888773 3223556665543    289999


Q ss_pred             CCCCChHHH-----------------hccCCC-CCCCCC--HHHHHHHHHHHHH-------------------HHHHHh-
Q 008698          347 VVNGPLDRW-----------------LHHIPR-GGRSLD--WAMRMKVATTLAQ-------------------GIAFLH-  386 (557)
Q Consensus       347 ~~~gsL~~~-----------------l~~~~~-~~~~l~--~~~~~~i~~~ia~-------------------gL~yLH-  386 (557)
                      +++.+|..-                 |+.... ..+...  +.++.++..++..                   .+..|. 
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            987654310                 111110 112222  3444444443321                   233332 


Q ss_pred             ---cC-CCCCeeecCCCCCCeeeCCC----CCcEEeeccCCcc
Q 008698          387 ---DK-VKPHVVHRDIRASNVLLDEE----FGAHLMGVGLSKF  421 (557)
Q Consensus       387 ---~~-~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgl~~~  421 (557)
                         .. ....++|+|+.+.|||++.+    +.+.++||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               21 23479999999999999876    6889999988753

>3fd4_A Glycoprotein GP42; C type lectin, virus entry, membrane fusion, HOST-virus interaction, lectin, membrane, transmembrane, viral protein; 2.40A {Human herpesvirus 4} PDB: 1kg0_C

Probab=96.43  E-value=0.017  Score=49.38  Aligned_cols=121  Identities=19%  Similarity=0.292  Sum_probs=79.9

Q ss_pred             CCCCCCCCCcc-CcccCCCCeeeEEecCCCChHHHHHHHhhCC-CeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCC
Q 008698           46 NKDWKAPCPPD-WIINEEKSKCFGYIGNFRSWDESETYCKEIG-GHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT  123 (557)
Q Consensus        46 ~~~~~~~Cp~~-w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~-~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~  123 (557)
                      ..+.|.-|+.- -++ .+++.||+|..++-+|+..-.+|++.. -.-.-=-.+..+-++.+.++ ..++.|||..+. . 
T Consensus        63 ~k~~C~~C~~r~~tF-s~~~~CyYftp~kytf~~CF~aCa~ls~C~yfY~Pq~~~~PiV~~NLk-~~eslWVGifK~-~-  138 (191)
T 3fd4_A           63 TKANCTYCNTREYTF-SYKGCCFYFTKKKHTWNGCFQACAELYPCTYFYGPTPDILPVVTRNLN-AIESLWVGVYRV-G-  138 (191)
T ss_dssp             CCCCSCCCCTTTCSE-EETTEEEEECSSCBCTTHHHHHHHHHSTTEEECCCCTTTHHHHHTTSC-TTCEEEECCEEC-T-
T ss_pred             CCCCCeecCcceeEE-EecceEEEeCcccccHHHHHHHHHhhcCeeEEecCCccCChhhhcccC-CcCcEEEEEEEc-C-
Confidence            56788889965 332 599999999999999999999999852 22222223345677887776 357899999843 2 


Q ss_pred             CCCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCC-ceeccccCCCCCccccc
Q 008698          124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR-SLVTERCNTSHPFICMV  190 (557)
Q Consensus       124 ~~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~-~w~~~~C~~~~~~iC~~  190 (557)
                       ++.|+=.||+  ++.- |.  ....              .|+-+...+. -|....|...++=.|..
T Consensus       139 -~~~W~sLDn~--n~~V-~D--i~gS--------------yCaYvt~~S~~P~s~~eC~~~K~CLC~s  186 (191)
T 3fd4_A          139 -EGNWTSLDGG--TFKV-YQ--IFGS--------------HCTYVSKFSTVPVSHHECSFLKPCLCVS  186 (191)
T ss_dssp             -TCCEEETTEE--EECC-BC--SSSS--------------SCEEEESSCSSCEECSCTTSCBCBEEEE
T ss_pred             -ccceEEccCC--ceEE-EE--eccC--------------eeeEEecccccccceeeccccceeEEee
Confidence             3889888866  2222 21  1122              4555444333 37777888887766644

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=96.36  E-value=0.0028  Score=42.07  Aligned_cols=32  Identities=34%  Similarity=0.335  Sum_probs=20.0

Q ss_pred             eEEeehhHHHHHHHHHHHHHHHHHHHhhhccc
Q 008698          204 EYLITLGVVSGLILLTTFAIVIWLLAYRRSKR  235 (557)
Q Consensus       204 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~r~k~  235 (557)
                      ...|+.+++.|++++++++++++++.+||+++
T Consensus        10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           10 IPSIATGMVGALLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             SSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence            34477777777877766666555555554443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.21  E-value=0.029  Score=56.00  Aligned_cols=31  Identities=26%  Similarity=0.290  Sum_probs=27.6

Q ss_pred             CCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       391 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      ..++|+|+.+.||+++.++.+.|.||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999987754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.06  E-value=0.035  Score=51.16  Aligned_cols=102  Identities=13%  Similarity=0.137  Sum_probs=65.0

Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      -||.+.|..   .+.++++.++..++.|.+.+|.-+-.... . ..+=+.|..|++..+|.+...+ +.+.         
T Consensus        33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence            368888874   34789999999999999999877622100 1 1223456889999999887653 1110         


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRR  472 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~  472 (557)
                           .....+.|||... ...+.+.=|||+|+++|.-+- |-+
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                 0223466888763 345778899999999998886 443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.03  E-value=0.0098  Score=60.14  Aligned_cols=72  Identities=13%  Similarity=0.080  Sum_probs=41.4

Q ss_pred             eecccCceEEEEEEeCC---------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc-EEeeeeeeeeCCceEEEEe
Q 008698          276 LLGDSKTGGTYSGILPD---------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN-LVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~---------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E  345 (557)
                      .++.|....+|+....+         +..+++|+...... .......|..++..+...+ ..++++..  .  .++|||
T Consensus        40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            45778888999988654         26899998754321 1112356777777763223 33555443  2  368999


Q ss_pred             cCCCCCh
Q 008698          346 FVVNGPL  352 (557)
Q Consensus       346 ~~~~gsL  352 (557)
                      |+++.++
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987543

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=95.87  E-value=0.0055  Score=40.49  Aligned_cols=28  Identities=25%  Similarity=0.558  Sum_probs=13.4

Q ss_pred             ehhHHHHHHHHHHHHHHHHHHHhhhccc
Q 008698          208 TLGVVSGLILLTTFAIVIWLLAYRRSKR  235 (557)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~r~k~  235 (557)
                      +++.++|++++++++++++++.+||+.+
T Consensus        14 Ia~~vVGvll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           14 IISAVVGILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred             hHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence            4444555554444444444444444443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=95.72  E-value=0.0066  Score=40.19  Aligned_cols=32  Identities=28%  Similarity=0.515  Sum_probs=19.2

Q ss_pred             EEeehhHHHHHHHHHHHHHHHHHHHhhhcccc
Q 008698          205 YLITLGVVSGLILLTTFAIVIWLLAYRRSKRR  236 (557)
Q Consensus       205 ~~i~~~~~~~~~~~~~~~~~~~~~~~~r~k~~  236 (557)
                      ..|+.+++.|++++++++++++++.+||++++
T Consensus        10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~   41 (44)
T 2l2t_A           10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred             ceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence            34667777777776666655555555544443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.13  E-value=0.31  Score=50.00  Aligned_cols=72  Identities=13%  Similarity=0.065  Sum_probs=44.7

Q ss_pred             eecccCceEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEec
Q 008698          276 LLGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      .+..|-...+|+....+        ++.+++++..... .......+|..+++.+. +.-..++++.+  .  .++||||
T Consensus        77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef  151 (424)
T 3mes_A           77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF  151 (424)
T ss_dssp             EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred             EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence            45778888999988753        6889999875432 11112346777777663 22233445432  2  3789999


Q ss_pred             CCCCCh
Q 008698          347 VVNGPL  352 (557)
Q Consensus       347 ~~~gsL  352 (557)
                      +++.+|
T Consensus       152 I~G~~l  157 (424)
T 3mes_A          152 IDGEPL  157 (424)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.16  E-value=1.1  Score=45.55  Aligned_cols=30  Identities=27%  Similarity=0.414  Sum_probs=24.6

Q ss_pred             CeeecCCCCCCeee------CCCCCcEEeeccCCcc
Q 008698          392 HVVHRDIRASNVLL------DEEFGAHLMGVGLSKF  421 (557)
Q Consensus       392 ~ivH~Dlk~~Nill------~~~~~~kl~Dfgl~~~  421 (557)
                      .++|+|+.+.|||+      +++..+.++||-.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4566789999988754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.42  E-value=1.1  Score=41.01  Aligned_cols=116  Identities=12%  Similarity=0.158  Sum_probs=78.5

Q ss_pred             CCCcEEeeeeeeeeCCceEEEEecCCCC-ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 008698          323 HHPNLVAVKGCCYDHGDRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS  401 (557)
Q Consensus       323 ~H~niv~l~g~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~  401 (557)
                      .||+.++. .+-.+.+...+.|+.-+.+ ++.. +       +.++...+++++..|+.-..+++..     +|--|.|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~  108 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD  108 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence            68888765 4555666665666654322 2322 3       3478899999999999888666644     78889999


Q ss_pred             CeeeCCCCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008698          402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA  476 (557)
Q Consensus       402 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~  476 (557)
                      |++++.++.+++.-.|+...+.                   |.     ..+...=.-.+=+++..+++++..|..
T Consensus       109 NL~f~~~~~p~i~~RGik~~l~-------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNVVD-------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             GEEECTTSCEEESCCEETTTBS-------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             eEEEcCCCCEEEEEccCccCCC-------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            9999999999998877654322                   22     112222233566788889999888753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.10  E-value=1.8  Score=39.77  Aligned_cols=83  Identities=12%  Similarity=0.173  Sum_probs=59.3

Q ss_pred             CCCcEEeeeeeeeeCCceEEEEecCCCC-ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeeecCCCC
Q 008698          323 HHPNLVAVKGCCYDHGDRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA-FLHDKVKPHVVHRDIRA  400 (557)
Q Consensus       323 ~H~niv~l~g~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~ivH~Dlk~  400 (557)
                      .||..  -...-.+.+...+.++.-+++ ++. .+       +.++...+++++..|+.-.. +++     .-+|--|.|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P  112 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCP  112 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeC
Confidence            67877  233345666766767755333 333 33       24788899999999887666 555     457888999


Q ss_pred             CCeeeCCCCCcEEeeccCCc
Q 008698          401 SNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       401 ~Nill~~~~~~kl~Dfgl~~  420 (557)
                      +|+++|.++.+++.-.|+-.
T Consensus       113 ~NL~f~~~~~p~i~hRGi~~  132 (219)
T 4ano_A          113 ENLMFNRALEPFFLHVGVKE  132 (219)
T ss_dssp             GGEEECTTCCEEESCCEETT
T ss_pred             ceEEEeCCCcEEEEEcCCcc
Confidence            99999999999998887654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	557
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-57
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-51
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-51
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-50
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-48
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-48
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-48
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-48
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-46
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-46
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-45
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-45
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-45
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-45
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-45
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-44
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-44
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-44
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-44
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-43
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-43
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-41
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-41
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-40
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-40
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-40
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-39
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-38
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-35
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-34
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-34
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-32
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-32
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-32
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-31
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-30
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-30
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-29
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-29
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-28
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-27
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-26
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-26
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-22
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-21
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-13
d1ypqa1	131	d.169.1.1 (A:140-270) Oxidised low density lipopro	3e-12
d1egga_	136	d.169.1.1 (A:) Macrophage mannose receptor, CRD4 {	4e-11
d1g1sa1	118	d.169.1.1 (A:1-118) P-selectin, C-lectin domain {H	2e-10
d1e87a_	117	d.169.1.1 (A:) CD69 {Human (Homo sapiens) [TaxId:	3e-10
d1xpha1	130	d.169.1.1 (A:265-394) DC-SIGNR (DC-SIGN related re	1e-09
d1wk1a_	150	d.169.1.1 (A:) Hypothetical protein F28B4.3 {Caeno	2e-09
d1hq8a_	123	d.169.1.1 (A:) NK cell-activating receptor nkg2d {	2e-09
d1qo3c_	133	d.169.1.1 (C:) NK cell receptor {Mouse (Mus muscul	2e-09
d3c8ja1	122	d.169.1.1 (A:138-259) NK cell receptor {Mouse (Mus	3e-09
d1tdqb_	126	d.169.1.1 (B:) Aggrecan core protein {Rat (Rattus	1e-08
d1g1ta1	118	d.169.1.1 (A:1-118) E-selectin, C-lectin domain {H	1e-08
d1dv8a_	128	d.169.1.1 (A:) H1 subunit of the asialoglycoprotei	2e-08
d1h8ua_	115	d.169.1.1 (A:) Eosinophil major basic protein {Hum	5e-08
d1kg0c_	136	d.169.1.1 (C:) EBV gp42 {Epstein-Barr virus [TaxId	2e-07
d1r13a1	119	d.169.1.1 (A:110-228) Surfactant protein, lectin d	5e-07
d2msba_	112	d.169.1.1 (A:) Mannose-binding protein A, C-lectin	7e-07
d1pwba1	121	d.169.1.1 (A:235-355) Surfactant protein, lectin d	7e-07
d1oz7b_	123	d.169.1.1 (B:) Snake coagglutinin beta chain {Saw-	8e-07
d1tn3a_	137	d.169.1.1 (A:) Tetranectin {Human (Homo sapiens) [	8e-07
d1t8da1	143	d.169.1.1 (A:1-143) Low affinity immunoglobulin ep	9e-07
d1v7pb_	127	d.169.1.1 (B:) Snake coagglutinin beta chain {Snak	1e-06
d1wmza_	140	d.169.1.1 (A:) Lectin CEL-I {Cucumaria echinata [T	2e-06
d1c3ab_	125	d.169.1.1 (B:) Snake coagglutinin beta chain {Habu	2e-06
d1hupa1	117	d.169.1.1 (A:112-228) Mannose-binding protein A, C	2e-06
d3bdwa1	121	d.169.1.1 (A:59-179) CD94 {Human (Homo sapiens) [T	3e-06
d1jwia_	124	d.169.1.1 (A:) Snake coagglutinin alpha chain {Puf	4e-06
d1gz2a_	139	d.169.1.1 (A:) Ovocleidin-17 {Chicken (Gallus gall	8e-06
d1oz7a_	131	d.169.1.1 (A:) Snake coagglutinin alpha chain {Saw	9e-06
d1uv0a_	140	d.169.1.1 (A:) Pancreatitis-associated protein 1 {	9e-06
d1rdl1_	111	d.169.1.1 (1:) Mannose-binding protein A, C-lectin	1e-05
d1jwib_	123	d.169.1.1 (B:) Snake coagglutinin beta chain {Puff	2e-05
d1jzna_	135	d.169.1.1 (A:) Galactose-specific C-type lectin {W	2e-05
d2afpa_	129	d.169.1.1 (A:) Type II antifreeze protein {Sea rav	3e-05
d1qdda_	144	d.169.1.1 (A:) Lithostathine, inhibitor of stone f	4e-05
d1umrc_	125	d.169.1.1 (C:) Snake coagglutinin beta chain {Sout	5e-05
d1v7pa_	134	d.169.1.1 (A:) Snake coagglutinin alpha chain {Sna	6e-05
d1c3aa_	135	d.169.1.1 (A:) Snake coagglutinin alpha chain {Hab	8e-05
d1byfa_	123	d.169.1.1 (A:) Lectin TC14 {Tunicate (Polyandrocar	9e-05
d1j34b_	123	d.169.1.1 (B:) Snake coagglutinin beta chain {Habu	1e-04
d1fvub_	125	d.169.1.1 (B:) Snake coagglutinin beta chain {Jara	2e-04
d1umra_	135	d.169.1.1 (A:) Snake coagglutinin alpha chain {Sou	2e-04
d1sb2a1	132	d.169.1.1 (A:1-132) Snake coagglutinin alpha chain	2e-04
d1fvua_	133	d.169.1.1 (A:) Snake coagglutinin alpha chain {Jar	2e-04
d1sb2b1	127	d.169.1.1 (B:2-128) Snake coagglutinin beta chain	5e-04
d1j34a_	129	d.169.1.1 (A:) Snake coagglutinin alpha chain {Hab	7e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 3e-57
 Identities = 63/283 (22%), Positives = 122/283 (43%), Gaps = 29/283 (10%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKG 332
           + +G    G  Y G       VAVK L  ++   Q+ + F +E+G   +  H N++   G
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
                    IV ++     L   LH         +    + +A   AQG+ +LH K    
Sbjct: 72  YS-TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK---S 124

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RN 449
           ++HRD++++N+ L E+    +   GL+          +     G+  ++APE +    +N
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184

Query: 450 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509
             + +SDVY+FG++L E+++G+ P   +++             +        L P +S +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ----------IIFMVGRGYLSPDLSKV 234

Query: 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
            S+ P+A     +  L+  C +     RP    ++  ++ LA+
Sbjct: 235 RSNCPKA-----MKRLMAECLKKKRDERPLFPQILASIELLAR 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 2e-51
 Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 27/274 (9%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
             LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD+RA+N+L+ +     +   GL++ +       R   A     + APE +     T K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTFTIK 190

Query: 455 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514
           SDV+SFG+LL EIV+  R      +                    E++  L        P
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMT------------------NPEVIQNLERGYRMVRP 232

Query: 515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
           +    +++  L+  C +  P  RP   ++   L+
Sbjct: 233 D-NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 6e-51
 Identities = 59/278 (21%), Positives = 120/278 (43%), Gaps = 27/278 (9%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           + +G  + G  + G   +  +VA+K ++  +   +++F  E     +L HP LV + G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
            +     +V+EF+ +G L  +L               + +   + +G+A+L +     V+
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 123

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD+ A N L+ E     +   G+++FV  +     +        + +PE    +  ++K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 182

Query: 455 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514
           SDV+SFGVL+ E+ S  +                     ++    E+++ + +      P
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPY------------------ENRSNSEVVEDISTGFRLYKP 224

Query: 515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                  V  ++  C +  P  RP  S ++ QL ++A+
Sbjct: 225 R-LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-50
 Identities = 60/276 (21%), Positives = 113/276 (40%), Gaps = 27/276 (9%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           + LG  + G    G       VA+K +K  S   + EF  E      L H  LV + G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 +I+ E++ NG L  +L               +++   + + + +L  K     +
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 122

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD+ A N L++++    +   GLS++V  +     +V +     +  PE +  ++ ++K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181

Query: 455 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514
           SD+++FGVL+ EI S  +             +E  T    +    + L      L+S+  
Sbjct: 182 SDIWAFGVLMWEIYSLGKM-----------PYERFTNSETAEHIAQGLRLYRPHLASE-- 228

Query: 515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
                 KV  ++Y+C       RP    ++  +  +
Sbjct: 229 ------KVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  168 bits (426), Expect = 2e-48
 Identities = 67/314 (21%), Positives = 133/314 (42%), Gaps = 43/314 (13%)

Query: 258 FTTEELRSITKNFSEGN--------RLLGDSKTGGTYSGILPDGSR----VAVKRLKRS- 304
           FT E+     + F++          +++G  + G   SG L    +    VA+K LK   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 305 SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR 364
           + +++++F SE     +  HPN++ ++G         I+ EF+ NG LD +L        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDG 123

Query: 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
                  + +   +A G+ +L D    + VHRD+ A N+L++      +   GLS+F+  
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 425 EVMQE---RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 480
           +         +       + APE +   + T+ SDV+S+G+++ E++S G RP   + + 
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240

Query: 481 CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM 540
                              ++++ +        P       +  L+  C Q   + RP+ 
Sbjct: 241 -------------------DVINAIEQDYRLPPPM-DCPSALHQLMLDCWQKDRNHRPKF 280

Query: 541 SHVVHQLQQLAQPP 554
             +V+ L ++ + P
Sbjct: 281 GQIVNTLDKMIRNP 294

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 3e-48
 Identities = 57/296 (19%), Positives = 113/296 (38%), Gaps = 25/296 (8%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
             +G  + G  + G    G  VAVK       +R     +EI +   L H N++      
Sbjct: 9   ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 335 YDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV- 389
                     ++V ++  +G L  +L+       ++     +K+A + A G+A LH ++ 
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 390 ----KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAP 443
               KP + HRD+++ N+L+ +     +  +GL+                  GT  Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 444 EFVYRN------ELTTKSDVYSFGVLLLEIVSGRRP-AQAVDSVCWQSIFEWATPLVQSH 496
           E +  +      E   ++D+Y+ G++  EI           D          + P V+  
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
           R +     L  ++ +       ++ +  ++  C     + R     +   L QL+Q
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 4e-48
 Identities = 61/294 (20%), Positives = 112/294 (38%), Gaps = 35/294 (11%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKG 332
             LG    G  +     P G  +A K +        + +   E+      + P +V   G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71

Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
             Y  G+  I  E +  G LD+ L    R    +   +  KV+  + +G+ +L +K K  
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKHK-- 125

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
           ++HRD++ SN+L++      L   G+S  +   +         GT  Y++PE +     +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYS 181

Query: 453 TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF-----------------------EWA 489
            +SD++S G+ L+E+  GR P    D+   + +F                        + 
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
                     ELLD +++     +P      +  D V  C    P+ R  +  +
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 4e-48
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 27/280 (9%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
             LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +    
Sbjct: 23  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 81

Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
                 YIV E++  G L  +L      G+ L     + +A  +A G+A++      + V
Sbjct: 82  S-EEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 135

Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
           HRD+RA+N+L+ E     +   GL++ +       R         + APE       T K
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 194

Query: 455 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514
           SDV+SFG+LL E+ +  R             +             E+LD +        P
Sbjct: 195 SDVWSFGILLTELTTKGRV-----------PYPGMVN-------REVLDQVERGYRMPCP 236

Query: 515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
                + + DL+  C +  P  RP   ++   L+      
Sbjct: 237 P-ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  166 bits (421), Expect = 6e-48
 Identities = 74/279 (26%), Positives = 119/279 (42%), Gaps = 27/279 (9%)

Query: 275 RLLGDSKTGGTYSGILPDGSR-VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
             LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 81

Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
           C      YI+ EF+  G L  +L       + +   + + +AT ++  + +L    K + 
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE---KKNF 136

Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 453
           +HRD+ A N L+ E     +   GLS+ +  +        A     + APE +  N+ + 
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNKFSI 195

Query: 454 KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513
           KSDV++FGVLL EI +                              ++ + L      + 
Sbjct: 196 KSDVWAFGVLLWEIATYGM------------------SPYPGIDLSQVYELLEKDYRMER 237

Query: 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
           PE G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 238 PE-GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 3e-47
 Identities = 69/277 (24%), Positives = 115/277 (41%), Gaps = 33/277 (11%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
           + +G  + G    G    G++VAVK +K  +    + F +E     +L H NLV + G  
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 335 YDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
            +     YIV E++  G L  +L    RG   L     +K +  + + + +L      + 
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 124

Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 453
           VHRD+ A NVL+ E+  A +   GL+K                   + APE +   + +T
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALREKKFST 179

Query: 454 KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513
           KSDV+SFG+LL EI S  R       +                   +++  +      D 
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPL------------------KDVVPRVEKGYKMDA 221

Query: 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
           P+ G    V +++  C     +MRP    +  QL+ +
Sbjct: 222 PD-GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 5e-46
 Identities = 73/297 (24%), Positives = 126/297 (42%), Gaps = 36/297 (12%)

Query: 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSR----VAVKRLKRSSFQRK-KEFYSEIGRF 319
           S+  +F+E   ++G    G  Y G L D        AVK L R +   +  +F +E    
Sbjct: 26  SLIVHFNE---VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82

Query: 320 ARLHHPNLVAVKGCCYDH-GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
               HPN++++ G C    G   +V  ++ +G L  ++ +      +      +     +
Sbjct: 83  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQV 139

Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--G 436
           A+G+ FL  K     VHRD+ A N +LDE+F   +   GL++ +  +         G   
Sbjct: 140 AKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196

Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH 496
              ++A E +   + TTKSDV+SFGVLL E+++   P          + F+    L+Q  
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-----DVNTFDITVYLLQGR 251

Query: 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
           R   LL P         P+      + +++  C      MRP  S +V ++  +   
Sbjct: 252 R---LLQP------EYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 9e-46
 Identities = 65/303 (21%), Positives = 122/303 (40%), Gaps = 36/303 (11%)

Query: 259 TTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR-----VAVKRLKRSSFQR-KKEF 312
           TTE   S     +   +++G  + G  Y G+L   S      VA+K LK    ++ + +F
Sbjct: 1   TTEIHPS---CVTRQ-KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF 56

Query: 313 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
             E G   +  H N++ ++G    +    I+ E++ NG LD     +            +
Sbjct: 57  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALD---KFLREKDGEFSVLQLV 113

Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
            +   +A G+ +L      + VHRD+ A N+L++      +   GLS+ +  +     T 
Sbjct: 114 GMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 170

Query: 433 MAG-GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP 491
             G     + APE +   + T+ SDV+SFG+++ E+++                  W   
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER------------PYWELS 218

Query: 492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551
                   E++  +        P       +  L+  C Q   + RP+ + +V  L +L 
Sbjct: 219 NH------EVMKAINDGFRLPTPM-DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271

Query: 552 QPP 554
           + P
Sbjct: 272 RAP 274

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 1e-45
 Identities = 64/305 (20%), Positives = 117/305 (38%), Gaps = 49/305 (16%)

Query: 275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNL 327
           R +G+   G  +    P        + VAVK LK  +    + +F  E    A   +PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLH--------------------HIPRGGRSLD 367
           V + G C       +++E++  G L+ +L                         G   L 
Sbjct: 79  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138

Query: 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427
            A ++ +A  +A G+A+L    +   VHRD+   N L+ E     +   GLS+ +     
Sbjct: 139 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195

Query: 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 487
            +          ++ PE ++ N  TT+SDV+++GV+L EI S                + 
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-----------PYY 244

Query: 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
                       E++  +        PE     ++ +L+  C   +P+ RP    +   L
Sbjct: 245 GMAH-------EEVIYYVRDGNILACPE-NCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

Query: 548 QQLAQ 552
           Q++ +
Sbjct: 297 QRMCE 301

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 1e-45
 Identities = 61/277 (22%), Positives = 104/277 (37%), Gaps = 29/277 (10%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVK 331
             +G    G         DG  +  K L   S     K+   SE+     L HPN+V   
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 332 GCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK- 388
               D  +   YIV E+   G L   +    +  + LD    ++V T L   +   H + 
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 389 -VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
                V+HRD++ +NV LD +    L   GL++ +  +    +  +  GT  Y++PE + 
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV--GTPYYMSPEQMN 187

Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507
           R     KSD++S G LL E+ +   P            F   +    + +  E     I 
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPP------------FTAFSQKELAGKIREGKFRRIP 235

Query: 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
              SD        ++ +++          RP +  ++
Sbjct: 236 YRYSD--------ELNEIITRMLNLKDYHRPSVEEIL 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-45
 Identities = 63/301 (20%), Positives = 114/301 (37%), Gaps = 35/301 (11%)

Query: 261 EELRSITKNFSEGNR-----LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYS 314
           E+LRSI        +      +G   +G  Y+ + +  G  VA++++      +K+   +
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66

Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
           EI       +PN+V          + ++V E++  G L   +         +D      V
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAV 121

Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
                Q + FLH      V+HRDI++ N+LL  +    L   G    +  E  Q +    
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTM 176

Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 494
            GT  ++APE V R     K D++S G++ +E++ G  P            +    PL  
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP------------YLNENPLRA 224

Query: 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQLQQLAQP 553
            +       P + +    +          D +  C       R     ++ HQ  ++A+P
Sbjct: 225 LYLIATNGTPELQN-PEKLSAI-----FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

Query: 554 P 554
            
Sbjct: 279 L 279

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 2e-45
 Identities = 59/295 (20%), Positives = 114/295 (38%), Gaps = 31/295 (10%)

Query: 261 EELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR---VAVKRLKRSSFQR-KKEFYSEI 316
           ++L     N    +  LG    G    G+     +   VA+K LK+ + +   +E   E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
               +L +P +V + G C       +V E    GPL ++L         +  +   ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLH 116

Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV-PWEVMQERTVMAG 435
            ++ G+ +L +K   + VHRD+ A NVLL     A +   GLSK +   +          
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495
               + APE +   + +++SDV+S+GV + E +S  +             ++        
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-----------YKKMKG---- 218

Query: 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
               E++  +      + P      ++  L+  C  +    RP    V  +++  
Sbjct: 219 ---PEVMAFIEQGKRMECPP-ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 8e-45
 Identities = 62/300 (20%), Positives = 110/300 (36%), Gaps = 43/300 (14%)

Query: 275 RLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPN 326
           + LG    G                  VAVK LK S+    ++   SE+   + L +H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH--------------IPRGGRSLDWAMRM 372
           +V + G C   G   ++ E+   G L  +L                +     +LD    +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
             +  +A+G+AFL  K   + +HRD+ A N+LL       +   GL++ +  +       
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 492
            A     ++APE ++    T +SDV+S+G+ L E+ S          V  +         
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------- 256

Query: 493 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
                       +        PE     ++ D++  C    P  RP    +V  +++   
Sbjct: 257 --------FYKMIKEGFRMLSPE-HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-44
 Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 35/289 (12%)

Query: 268 KNFSEGNRLLGDSKTGGTYSGILPD---GSRVAVKRLKRSSFQR--KKEFYSEIGRFARL 322
           K  +  ++ LG    G    G          VAVK LK  +     K E  +E     +L
Sbjct: 6   KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 65

Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
            +P +V + G C +     +V E    GPL+++L       R +     +++   ++ G+
Sbjct: 66  DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGM 120

Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-GTYGYL 441
            +L +    + VHRD+ A NVLL  +  A +   GLSK +  +    +    G     + 
Sbjct: 121 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177

Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500
           APE +   + ++KSDV+SFGVL+ E  S G++P + +                      E
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------------------E 218

Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
           +   L        P  G  +++ DL+  C  +    RP  + V  +L+ 
Sbjct: 219 VTAMLEKGERMGCPA-GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-44
 Identities = 68/302 (22%), Positives = 121/302 (40%), Gaps = 43/302 (14%)

Query: 268 KNFSEGNRLLGDSKTGGTYSGILPDGSR---VAVKRLKR-SSFQRKKEFYSEIGRFARL- 322
            +    + ++G+   G      +         A+KR+K  +S    ++F  E+    +L 
Sbjct: 10  NDIKFQD-VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68

Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH------------HIPRGGRSLDWAM 370
           HHPN++ + G C   G  Y+  E+  +G L  +L                    +L    
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 371 RMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430
            +  A  +A+G+ +L    +   +HRD+ A N+L+ E + A +   GLS+     V   +
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---K 182

Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 490
             M      ++A E +  +  TT SDV+S+GVLL EIVS         +           
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------- 232

Query: 491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
                    EL + L      + P      +V DL+  C +  P  RP  + ++  L ++
Sbjct: 233 --------AELYEKLPQGYRLEKPL-NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

Query: 551 AQ 552
            +
Sbjct: 284 LE 285

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  157 bits (397), Expect = 3e-44
 Identities = 65/311 (20%), Positives = 119/311 (38%), Gaps = 44/311 (14%)

Query: 252 PPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK- 309
           P   ++F  ++     K FS+   + G    G  Y    + +   VA+K++  S  Q   
Sbjct: 2   PDVAELFFKDD---PEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 57

Query: 310 --KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLD 367
             ++   E+    +L HPN +  +GC       ++V E+ +    D    H     + L 
Sbjct: 58  KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQ 113

Query: 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427
                 V     QG+A+LH     +++HRD++A N+LL E     L   G +  +     
Sbjct: 114 EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---- 166

Query: 428 QERTVMAGGTYGYLAPEFV---YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS 484
              + +  GT  ++APE +      +   K DV+S G+  +E+   + P           
Sbjct: 167 PANSFV--GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----------- 213

Query: 485 IFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                  +   +   +   P +   S    E        + V +C Q +P  RP    ++
Sbjct: 214 -LFNMNAMSALYHIAQNESPALQ--SGHWSEY-----FRNFVDSCLQKIPQDRPTSEVLL 265

Query: 545 -HQLQQLAQPP 554
            H+     +PP
Sbjct: 266 KHRFVLRERPP 276

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 3e-44
 Identities = 65/338 (19%), Positives = 121/338 (35%), Gaps = 48/338 (14%)

Query: 238 KSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR-- 295
           +  +++  + +      ++ +  +      +   E  ++LG    G   +      S+  
Sbjct: 6   QMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTG 65

Query: 296 ----VAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349
               VAVK LK  +    ++   SE+    +L  H N+V + G C   G  Y+++E+   
Sbjct: 66  VSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCY 125

Query: 350 GPLDRWLH-------------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
           G L  +L                            L +   +  A  +A+G+ FL  K  
Sbjct: 126 GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-- 183

Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
              VHRD+ A NVL+       +   GL++ +  +        A     ++APE ++   
Sbjct: 184 -SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 242

Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
            T KSDV+S+G+LL EI S                     P             + +   
Sbjct: 243 YTIKSDVWSYGILLWEIFSLGVN-----------------PYPGIPVDANFYKLIQNGFK 285

Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
            D P     +++  ++ +C       RP   ++   L 
Sbjct: 286 MDQPF-YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-43
 Identities = 53/290 (18%), Positives = 105/290 (36%), Gaps = 36/290 (12%)

Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQR--KKEFYSEIGRFA 320
            S    F + +  +G       Y G+  +    VA   L+     +  ++ F  E     
Sbjct: 4   MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63

Query: 321 RLHHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
            L HPN+V                 +V E + +G L  +L       + +   +      
Sbjct: 64  GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCR 119

Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQERTVMAG 435
            + +G+ FLH +  P ++HRD++  N+ +    G   +  +GL+        +       
Sbjct: 120 QILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---- 174

Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495
           GT  ++APE +Y  +     DVY+FG+ +LE+ +   P    +      I+      V S
Sbjct: 175 GTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRR----VTS 227

Query: 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545
                  D +               +V +++  C +     R  +  +++
Sbjct: 228 GVKPASFDKVAI------------PEVKEIIEGCIRQNKDERYSIKDLLN 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (389), Expect = 1e-43
 Identities = 66/274 (24%), Positives = 104/274 (37%), Gaps = 36/274 (13%)

Query: 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
           R LG  K G  Y          +A+K L ++  ++     +   E+   + L HPN++ +
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
            G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H K  
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK-- 125

Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
             V+HRDI+  N+LL       +   G S   P      R     GT  YL PE +    
Sbjct: 126 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRM 180

Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
              K D++S GVL  E + G+ P            FE  T      R   +       ++
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPP------------FEANTYQETYKRISRVEFTFPDFVT 228

Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
                        DL+    +H PS RP +  V+
Sbjct: 229 EG---------ARDLISRLLKHNPSQRPMLREVL 253

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 6e-43
 Identities = 58/286 (20%), Positives = 117/286 (40%), Gaps = 32/286 (11%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 328
           ++LG    G  Y G+ +P+G +    VA+K L+ + S +  KE   E    A + +P++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            + G C       ++ + +  G L   L ++     ++     +     +A+G+ +L D+
Sbjct: 75  RLLGICLT-STVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
               +VHRD+ A NVL+       +   GL+K +  E  +           ++A E +  
Sbjct: 131 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187

Query: 449 NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508
              T +SDV+S+GV + E+++        D +    I      +++    L         
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISS----ILEKGERLP-------- 233

Query: 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
                P       V  ++  C       RP+   ++ +  ++A+ P
Sbjct: 234 ----QPP-ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-42
 Identities = 57/275 (20%), Positives = 99/275 (36%), Gaps = 32/275 (11%)

Query: 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
             LGD   G  Y     +     A K +   S +  +++  EI   A   HPN+V +   
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
            Y   + +I+ EF   G +D     +    R L  +    V       + +LHD     +
Sbjct: 78  FYYENNLWILIEFCAGGAVD---AVMLELERPLTESQIQVVCKQTLDALNYLHDN---KI 131

Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-- 451
           +HRD++A N+L   +    L   G+S      + +  + +  GT  ++APE V       
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKD 189

Query: 452 ---TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508
                K+DV+S G+ L+E+     P                 P+    +  +   P ++ 
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPP------------HHELNPMRVLLKIAKSEPPTLAQ 237

Query: 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
            S             D +  C +     R   S +
Sbjct: 238 PSRWSSNF------KDFLKKCLEKNVDARWTTSQL 266

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 3e-41
 Identities = 66/283 (23%), Positives = 110/283 (38%), Gaps = 36/283 (12%)

Query: 284 GTYSGILPDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY 341
           G         ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y
Sbjct: 36  GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 95

Query: 342 IVYEFVVNGPLDRWLHHIPRGG------------RSLDWAMRMKVATTLAQGIAFLHDKV 389
           ++ E+   G L  +L      G              L     +  A  +A+G+ +L  K 
Sbjct: 96  VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK- 154

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
               +HRD+ A NVL+ E+    +   GL++ +      ++T        ++APE ++  
Sbjct: 155 --KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212

Query: 450 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509
             T +SDV+SFGVLL EI +          V                   EL   L    
Sbjct: 213 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------------------EELFKLLKEGH 254

Query: 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
             D P      ++  ++  C   VPS RP    +V  L ++  
Sbjct: 255 RMDKPS-NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 3e-41
 Identities = 65/283 (22%), Positives = 111/283 (39%), Gaps = 32/283 (11%)

Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVA 329
           R +G+ + G  + GI          VA+K  K  +    +E F  E     +  HP++V 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           + G   ++   +I+ E    G L      +     SLD A  +  A  L+  +A+L  K 
Sbjct: 73  LIGVITEN-PVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 127

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
               VHRDI A NVL+       L   GLS+++       +         ++APE +   
Sbjct: 128 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFR 184

Query: 450 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509
             T+ SDV+ FGV + EI+                         Q  +  +++  + +  
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPF------------------QGVKNNDVIGRIENGE 226

Query: 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
              +P       +  L+  C  + PS RPR + +  QL  + +
Sbjct: 227 RLPMPP-NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 4e-41
 Identities = 59/292 (20%), Positives = 120/292 (41%), Gaps = 35/292 (11%)

Query: 275 RLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNL 327
           R LG    G  Y G+          +RVA+K +  ++  R + EF +E       +  ++
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS------LDWAMRMKVATTLAQG 381
           V + G         ++ E +  G L  +L  +     +         +  +++A  +A G
Sbjct: 86  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145

Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           +A+L+       VHRD+ A N ++ E+F   +   G+++ +       +         ++
Sbjct: 146 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202

Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501
           +PE +     TT SDV+SFGV+L EI +                ++  +         ++
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----------YQGLSN-------EQV 244

Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
           L  ++     D P+      + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 245 LRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  149 bits (377), Expect = 5e-41
 Identities = 50/272 (18%), Positives = 91/272 (33%), Gaps = 29/272 (10%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
             LG    G  +  +    G     K +       K    +EI    +LHHP L+ +   
Sbjct: 35  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94

Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
             D  +  ++ EF+  G L      I      +  A  +       +G+  +H+     +
Sbjct: 95  FEDKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SI 148

Query: 394 VHRDIRASNVLLDEEFGAH--LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
           VH DI+  N++ + +  +   ++  GL+  +  +   E   +   T  + APE V R  +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPV 205

Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511
              +D+++ GVL   ++SG  P            F     L                  S
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSP------------FAGEDDLETLQNVKRCDWEFDEDAFS 253

Query: 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
            +          D +    Q  P  R  +   
Sbjct: 254 SVSPE-----AKDFIKNLLQKEPRKRLTVHDA 280

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  148 bits (375), Expect = 1e-40
 Identities = 50/272 (18%), Positives = 92/272 (33%), Gaps = 29/272 (10%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
             LG    G  +       G+  A K +       K+    EI   + L HP LV +   
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
             D  +  ++YEF+  G L      +      +     ++    + +G+  +H+    + 
Sbjct: 92  FEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NY 145

Query: 394 VHRDIRASNVLLDEEFGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
           VH D++  N++   +    L  +  GL+  +     ++   +  GT  + APE      +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPV 202

Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511
              +D++S GVL   ++SG  P            F                  +  S  S
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSP------------FGGENDDETLRNVKSCDWNMDDSAFS 250

Query: 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
            I E        D +       P+ R  +   
Sbjct: 251 GISED-----GKDFIRKLLLADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 3e-40
 Identities = 52/283 (18%), Positives = 96/283 (33%), Gaps = 32/283 (11%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
           ++LG+           L      A+K L++    ++        E    +RL HP  V +
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
                D    Y    +  NG L +++  I       D          +   + +LH    
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLH---G 126

Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
             ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  Y++PE +    
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
               SD+++ G ++ ++V+G  P            F      +   + ++L         
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPP------------FRAGNEYLIFQKIIKLEYDFPEKFF 234

Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
                        DLV        + R     +       A P
Sbjct: 235 PK---------ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 4e-40
 Identities = 54/272 (19%), Positives = 100/272 (36%), Gaps = 28/272 (10%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRL-KRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
           + LG+   G     +       VAVK +  + +    +    EI     L+H N+V   G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
              +   +Y+  E+   G L   +         +      +    L  G+ +LH      
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---G 123

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL- 451
           + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+APE + R E  
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511
               DV+S G++L  +++G  P            ++  +   Q +   +     ++    
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELP------------WDQPSDSCQEYSDWKEKKTYLN---- 227

Query: 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
             P   +    + L++      PS R  +  +
Sbjct: 228 --PWKKIDSAPLALLHKILVENPSARITIPDI 257

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 5e-39
 Identities = 53/271 (19%), Positives = 92/271 (33%), Gaps = 29/271 (10%)

Query: 284 GTYSGILPDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
           G +         VAVK LK       +   +F  E+     L H NL+ + G        
Sbjct: 27  GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85

Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
            +V E    G L   L  + +           + A  +A+G+ +L  K     +HRD+ A
Sbjct: 86  KMVTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAA 139

Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEV-MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
            N+LL       +   GL + +P               + + APE +     +  SD + 
Sbjct: 140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 199

Query: 460 FGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVV 519
           FGV L E+ +  +             +         H+  +  +        D P+    
Sbjct: 200 FGVTLWEMFTYGQE-----------PWIGLNGSQILHKIDK--EGERLPRPEDCPQ---- 242

Query: 520 QKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
             + +++  C  H P  RP    +   L + 
Sbjct: 243 -DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 9e-39
 Identities = 69/299 (23%), Positives = 106/299 (35%), Gaps = 42/299 (14%)

Query: 275 RLLGDSKTGGTYSGI------LPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFAR-LHHPN 326
           + LG    G                  VAVK LK  +     +   SE+       HH N
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 327 LVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHH------------IPRGGRSLDWAMRMK 373
           +V + G C   G    ++ EF   G L  +L                     L     + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
            +  +A+G+ FL  +     +HRD+ A N+LL E+    +   GL++ +  +    R   
Sbjct: 139 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV 493
           A     ++APE ++    T +SDV+SFGVLL EI S               I E     +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRL 250

Query: 494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
           +    +   D                 ++   +  C    PS RP  S +V  L  L Q
Sbjct: 251 KEGTRMRAPD-------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  140 bits (353), Expect = 2e-38
 Identities = 58/286 (20%), Positives = 108/286 (37%), Gaps = 34/286 (11%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
            +LG       +    L     VAVK L+    +       F  E    A L+HP +VAV
Sbjct: 13  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72

Query: 331 KGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
                         YIV E+V    L   +H        +     ++V     Q + F H
Sbjct: 73  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSH 128

Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV-MQERTVMAGGTYGYLAPEF 445
                 ++HRD++ +N+++       +M  G+++ +        +T    GT  YL+PE 
Sbjct: 129 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

Query: 446 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505
              + +  +SDVYS G +L E+++G  P            F   +P+  +++++      
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPP------------FTGDSPVSVAYQHVREDPIP 233

Query: 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVHQLQQL 550
            S+    +        +  +V       P  R +  + +   L ++
Sbjct: 234 PSARHEGLSAD-----LDAVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 3e-36
 Identities = 39/267 (14%), Positives = 84/267 (31%), Gaps = 30/267 (11%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
             LG  + G  +  +          K +K     +      EI       H N++ +   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHES 69

Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
                +  +++EF+    +   ++        L+    +     + + + FLH     ++
Sbjct: 70  FESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NI 123

Query: 394 VHRDIRASNVLLDEEFGAH--LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
            H DIR  N++      +   ++  G ++ +      +   +      Y APE    + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511
           +T +D++S G L+  ++SG  P            F   T        +            
Sbjct: 181 STATDMWSLGTLVYVLLSGINP------------FLAETNQQIIENIMNAEYTFDEEAFK 228

Query: 512 DIPEAGVVQKVVDLVYACTQHVPSMRP 538
           +I         +D V          R 
Sbjct: 229 EISIE-----AMDFVDRLLVKERKSRM 250

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 4e-35
 Identities = 52/301 (17%), Positives = 111/301 (36%), Gaps = 31/301 (10%)

Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
            +I  ++   +++LG    G            + A+K L+        +   E+    R 
Sbjct: 7   NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRA 61

Query: 323 -HHPNLVAVKGCCYD----HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
              P++V +     +         IV E +  G L   +    RG ++       ++  +
Sbjct: 62  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKS 119

Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
           + + I +LH     ++ HRD++  N+L   +    ++ +    F               T
Sbjct: 120 IGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176

Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497
             Y+APE +   +     D++S GV++  ++ G  P  +       +I       ++  +
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKTRIRMGQ 233

Query: 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQ-LQQLAQPPV 555
           Y E  +P  S +S +         V  L+    +  P+ R  ++  + H  + Q  + P 
Sbjct: 234 Y-EFPNPEWSEVSEE---------VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283

Query: 556 T 556
           T
Sbjct: 284 T 284

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  132 bits (334), Expect = 7e-35
 Identities = 53/282 (18%), Positives = 102/282 (36%), Gaps = 38/282 (13%)

Query: 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRK------KEFYSEIGRFAR 321
           +FS   R++G    G  Y     D G   A+K L +   + K            +   + 
Sbjct: 5   DFSVH-RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
              P +V +    +       + + +  G L   L            A     A  +  G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILG 119

Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
           +  +H++    VV+RD++ +N+LLDE     +  +GL+        +++   + GT+GY+
Sbjct: 120 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYM 172

Query: 442 APEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500
           APE + +     + +D +S G +L +++ G  P +   +     I             L 
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---------RMTLT 223

Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH 542
           +   L  S S +         +  L+    Q   + R     
Sbjct: 224 MAVELPDSFSPE---------LRSLLEGLLQRDVNRRLGCLG 256

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  130 bits (328), Expect = 1e-34
 Identities = 52/271 (19%), Positives = 90/271 (33%), Gaps = 26/271 (9%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKG 332
            +LG                  VA+K + + + + K+    +EI    ++ HPN+VA+  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
                G  Y++ + V  G L   +                ++   +   + +LHD    H
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLGIVH 130

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
              +        LDE+    +   GLSK    E        A GT GY+APE + +   +
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYS 187

Query: 453 TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512
              D +S GV+   ++ G  P            F          + L+      S    D
Sbjct: 188 KAVDCWSIGVIAYILLCGYPP------------FYDENDAKLFEQILKAEYEFDSPYWDD 235

Query: 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
           I ++       D +    +  P  R      
Sbjct: 236 ISDS-----AKDFIRHLMEKDPEKRFTCEQA 261

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 8e-34
 Identities = 55/269 (20%), Positives = 90/269 (33%), Gaps = 35/269 (13%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFAR-LHHPNLVA 329
           ++LG    G  +           A+K LK+       +      E    +    HP L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
           +        + + V E++  G L   +          D +     A  +  G+ FLH K 
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK- 122

Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
              +V+RD++  N+LLD++    +   G+ K       +  T    GT  Y+APE +   
Sbjct: 123 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAPEILLGQ 178

Query: 450 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509
           +     D +SFGVLL E++ G+ P            F         H            L
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSP------------FHGQDEEELFHSIRMDNPFYPRWL 226

Query: 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
             +           DL+       P  R 
Sbjct: 227 EKE---------AKDLLVKLFVREPEKRL 246

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  128 bits (323), Expect = 9e-34
 Identities = 54/268 (20%), Positives = 95/268 (35%), Gaps = 37/268 (13%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV 330
           R LG    G  +      +G   A+K LK+    R K+      E    + + HP ++ +
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
            G   D    +++ +++  G L   L                      A+    L     
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYAAEVCLALEYLHS 122

Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
             +++RD++  N+LLD+     +   G +K+VP     + T    GT  Y+APE V    
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKP 177

Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
                D +SFG+L+ E+++G  P            F  +  +    + L          +
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTP------------FYDSNTMKTYEKILNAELRFPPFFN 225

Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRP 538
            D+          DL+        S R 
Sbjct: 226 EDVK---------DLLSRLITRDLSQRL 244

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  126 bits (317), Expect = 4e-33
 Identities = 45/287 (15%), Positives = 90/287 (31%), Gaps = 30/287 (10%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
           R +G    G  Y G  +  G  VA+K     +  +  + + E   +  +     +     
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
           C   GD  ++   ++   L+   +      R       + +A  +   I ++H K   + 
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NF 124

Query: 394 VHRDIRASNVL---LDEEFGAHLMGVGLSKFVPWE-----VMQERTVMAGGTYGYLAPEF 445
           +HRD++  N L     +    +++  GL+K          +         GT  Y +   
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 446 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505
               E + + D+ S G +L+    G           WQ +              + +   
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSL--------PWQGLKAATKRQKYERISEKKMSTP 236

Query: 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
           I  L    P           +  C       +P  S++    + L  
Sbjct: 237 IEVLCKGYPSE-----FATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  124 bits (312), Expect = 1e-32
 Identities = 42/290 (14%), Positives = 90/290 (31%), Gaps = 34/290 (11%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKG 332
           R +G+   G  + G  L +  +VA+K   R S     +   E   +  L     +  V  
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
              +     +V + +           +   GR          A  +   +  +H+K    
Sbjct: 69  FGQEGLHNVLVIDLLGPS----LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---S 121

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKF----------VPWEVMQERTVMAGGTYGYLA 442
           +V+RDI+  N L+      +   + +  F              +         GT  Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502
                  E + + D+ + G + +  + G  P Q + +   +  +E      QS       
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS------- 234

Query: 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
              +  L +  PE          ++          P   ++     ++ +
Sbjct: 235 -TPLRELCAGFPEE-----FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-32
 Identities = 57/296 (19%), Positives = 108/296 (36%), Gaps = 20/296 (6%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKG 332
             +G+   G   S     +  RVA+K++     Q   +    EI    R  H N++ +  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
                    +   ++V   +   L+ + +    L           + +G+ ++H     +
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSA---N 129

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
           V+HRD++ SN+LL+      +   GL++   P             T  Y APE +  ++ 
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189

Query: 452 TTKS-DVYSFGVLLLEIVSGRRP----------AQAVDSVCWQSIFEWATPLVQSHRYLE 500
            TKS D++S G +L E++S R               +  +   S  +    +    R   
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249

Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQ-LQQLAQPP 554
           L  P  + +  +        K +DL+       P  R  +   + H  L+Q   P 
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-32
 Identities = 51/298 (17%), Positives = 98/298 (32%), Gaps = 42/298 (14%)

Query: 257 VFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR------K 309
           VF  E   ++   +  G   LG  +            G + A K +K+   +       +
Sbjct: 2   VFRQE---NVDDYYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57

Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
           ++   E+     + HPN++ +     +  D  ++ E V  G L  +L        SL   
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEE 113

Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA----HLMGVGLSKFVPWE 425
              +    +  G+ +LH      + H D++  N++L +         ++  GL+  +   
Sbjct: 114 EATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-- 168

Query: 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI 485
                     GT  ++APE V    L  ++D++S GV+   ++SG  P            
Sbjct: 169 -FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP------------ 215

Query: 486 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
           F   T          +         S+           D +       P  R  +   
Sbjct: 216 FLGDTKQETLANVSAVNYEFEDEYFSNTSAL-----AKDFIRRLLVKDPKKRMTIQDS 268

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  123 bits (309), Expect = 3e-32
 Identities = 56/286 (19%), Positives = 102/286 (35%), Gaps = 44/286 (15%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF---------QRKKEFYSEIGRFARLH- 323
            +LG   +      I  P     AVK +  +           + ++    E+    ++  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
           HPN++ +K     +   ++V++ +  G L  +L        +L      K+   L + I 
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVIC 124

Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 443
            LH     ++VHRD++  N+LLD++    L   G S  +      E+     GT  YLAP
Sbjct: 125 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREVCGTPSYLAP 178

Query: 444 EFVYRNEL------TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497
           E +  +          + D++S GV++  +++G  P            F     ++    
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------------FWHRKQMLMLRM 226

Query: 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
            +       S    D  +      V DLV       P  R      
Sbjct: 227 IMSGNYQFGSPEWDDYSDT-----VKDLVSRFLVVQPQKRYTAEEA 267

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 1e-31
 Identities = 53/292 (18%), Positives = 109/292 (37%), Gaps = 29/292 (9%)

Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
           R    ++++  +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L
Sbjct: 16  RPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKL 70

Query: 323 HHPNLVAVKGCCYDHGDR------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
            H N+V ++   Y  G++       +V ++V         H+  R  ++L          
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQTLPVIYVKLYMY 129

Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH-LMGVGLSKFVPWEVMQERTVMAG 435
            L + +A++H      + HRDI+  N+LLD +     L   G +K +         +   
Sbjct: 130 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 184

Query: 436 GTYGYLAP-EFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQSIF 486
            +  Y AP       + T+  DV+S G +L E++ G+        V           +  
Sbjct: 185 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
                 +  +        + +   + +       + + L     ++ P+ R 
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 2e-30
 Identities = 46/284 (16%), Positives = 93/284 (32%), Gaps = 21/284 (7%)

Query: 275 RLLGDSKTGGTYSG--ILPDGSRVAVKRLKRSSFQRKKEFY-----SEIGRFARLHHPNL 327
             +G+   G  +    +   G  VA+KR++  + +           + +       HPN+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRW--LHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
           V +   C            +V   +D+    +        +       +   L +G+ FL
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
           H      VVHRD++  N+L+       L   GL++   +++     V    T  Y APE 
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYRAPEV 186

Query: 446 VYRNELTTKSDVYSFGVLLLEIVSGRRP------AQAVDSVCWQSIFEWATPLVQSHRYL 499
           + ++   T  D++S G +  E+   +           +  +             +     
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
                  S+   +     + +   DL+  C    P+ R      
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 5e-30
 Identities = 55/278 (19%), Positives = 94/278 (33%), Gaps = 23/278 (8%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-----FYSEIGRFARLHHPNLV 328
             LG+ +    Y          VA+K++K       K+        EI     L HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
            +        +  +V++F+           I      L  +          QG+ +LH  
Sbjct: 64  GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
               ++HRD++ +N+LLDE     L   GL+K            +   T  Y APE ++ 
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRAPELLFG 174

Query: 449 NEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQSIFE--WATPLVQSHRYLELLDP 504
             +     D+++ G +L E++           +     IFE        Q      L D 
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 505 LISSLSSDIPEAGVVQKV----VDLVYACTQHVPSMRP 538
           +       IP   +        +DL+       P  R 
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 272

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 8e-30
 Identities = 59/293 (20%), Positives = 105/293 (35%), Gaps = 22/293 (7%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 331
             +G+   G  Y       G  VA+K+++  +           EI     L+HPN+V + 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
              +     Y+V+EF+              G   +   +       L QG+AF H     
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFCHSH--- 121

Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE- 450
            V+HRD++  N+L++ E    L   GL++     V      +   T  Y APE +   + 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILLGCKY 179

Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQSIFEWATPLVQSHRYLELL 502
            +T  D++S G +  E+V+ R        +           +  E   P V S    +  
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQ-LQQLAQP 553
            P  +          + +    L+     + P+ R      + H   Q + +P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-29
 Identities = 58/270 (21%), Positives = 88/270 (32%), Gaps = 34/270 (12%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV 330
           +LLG    G          G   A+K L++     K E     +E        HP L A+
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
           K     H     V E+   G L   L       R             +   + +LH +  
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-- 124

Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
             VV+RDI+  N++LD++    +   GL K    +          GT  YLAPE +  N+
Sbjct: 125 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDND 181

Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
                D +  GV++ E++ GR P            F            L        +LS
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP------------FYNQDHERLFELILMEEIRFPRTLS 229

Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRM 540
            +            L+    +  P  R   
Sbjct: 230 PE---------AKSLLAGLLKKDPKQRLGG 250

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 2e-29
 Identities = 54/280 (19%), Positives = 96/280 (34%), Gaps = 48/280 (17%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE------FYSEIGRFARLH--HP 325
            LLG    G  YSGI + D   VA+K +++       E         E+    ++     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
            ++ +           ++ E          L        +L   +       + + +   
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHC 126

Query: 386 HDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
           H+     V+HRDI+  N+L+D   G   L+  G    +   V  +      GT  Y  PE
Sbjct: 127 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPE 179

Query: 445 FVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503
           ++  +    +S  V+S G+LL ++V G  P            FE    +++   +     
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP------------FEHDEEIIRGQVFFR--- 224

Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
                +SS+            L+  C    PS RP    +
Sbjct: 225 ---QRVSSE---------CQHLIRWCLALRPSDRPTFEEI 252

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  113 bits (282), Expect = 1e-28
 Identities = 51/280 (18%), Positives = 98/280 (35%), Gaps = 20/280 (7%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKG 332
             +G+   G  Y      G   A+K+++              EI     L H N+V +  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
             +      +V+E +           +      L+          L  GIA+ HD+    
Sbjct: 68  VIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---R 120

Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-L 451
           V+HRD++  N+L++ E    +   GL++     V +    +   T  Y AP+ +  ++  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI--VTLWYRAPDVLMGSKKY 178

Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQSIFEWATPLVQSHRYLELLD 503
           +T  D++S G +  E+V+G      V              +      P V      +   
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
            +   L  +    G+ +  +DL+    +  P+ R      
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  113 bits (283), Expect = 3e-28
 Identities = 56/268 (20%), Positives = 99/268 (36%), Gaps = 37/268 (13%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV 330
           + LG    G          G+  A+K L +    + K+     +E      ++ P LV +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
           +    D+ + Y+V E+V  G +   L  I R             A  +     +LH    
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL-- 160

Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
             +++RD++  N+L+D++    +   G +K      ++ RT    GT   LAPE +    
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKG 214

Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
                D ++ GVL+ E+ +G  P            F    P+    + +       S  S
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP------------FFADQPIQIYEKIVSGKVRFPSHFS 262

Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRP 538
           SD+          DL+    Q   + R 
Sbjct: 263 SDLK---------DLLRNLLQVDLTKRF 281

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 1e-27
 Identities = 45/297 (15%), Positives = 95/297 (31%), Gaps = 23/297 (7%)

Query: 258 FTTEELRSITKNFSEGNRL---LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KE 311
           F  +E+           R    +G    G   S +    G++VA+K+L R        K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 312 FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR 371
            Y E+     + H N++ +              +F +  P              L     
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 372 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431
             +   + +G+ ++H      ++HRD++  N+ ++E+    ++  GL++        E T
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMT 176

Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQ 483
                 +       +     T   D++S G ++ E+++G+   +  D +           
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236

Query: 484 SIFEWATPLVQSHRYLELLDPLISSLSSDIPE--AGVVQKVVDLVYACTQHVPSMRP 538
           +        +QS      +  L      D            V+L+          R 
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 4e-27
 Identities = 45/289 (15%), Positives = 95/289 (32%), Gaps = 32/289 (11%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 331
             +G    G  +       G +VA+K++   + +         EI     L H N+V + 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 332 GCCYDH--------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
             C           G  Y+V++F  +       + + +   +L    R+     +   + 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRV-----MQMLLN 128

Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 441
            L+   +  ++HRD++A+NVL+  +    L   GL++        +         T  Y 
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 442 APEFV-YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH---- 496
            PE +    +     D++  G ++ E+ +     Q        ++       +       
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 497 -------RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
                    LEL+      +   +         +DL+       P+ R 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 4e-26
 Identities = 57/279 (20%), Positives = 96/279 (34%), Gaps = 36/279 (12%)

Query: 275 RLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSSFQRK----KEFYSEIGRFARL-HHP 325
           ++LG    G  +          G   A+K LK+++  +K    +   +E      +   P
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
            LV +          +++ +++  G L   L    R                +   +  L
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHL 145

Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
           H      +++RDI+  N+LLD      L   GLSK        ER     GT  Y+AP+ 
Sbjct: 146 HKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEYMAPDI 201

Query: 446 VYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503
           V   +       D +S GVL+ E+++G  P        +    E  +    S R L+   
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASP--------FTVDGEKNSQAEISRRILKSEP 253

Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH 542
           P    +S+            DL+       P  R     
Sbjct: 254 PYPQEMSAL---------AKDLIQRLLMKDPKKRLGCGP 283

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (261), Expect = 9e-26
 Identities = 48/283 (16%), Positives = 95/283 (33%), Gaps = 24/283 (8%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 331
             +G+   G  +          VA+KR++              EI     L H N+V + 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
              +      +V+EF           +       LD  +       L +G+ F H +   
Sbjct: 68  DVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--- 120

Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
           +V+HRD++  N+L++      L   GL++      ++  +      +             
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-----------SIFEWATPLVQSHRYLE 500
           +T  D++S G +  E+ +  RP    + V  Q           +  +W +          
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
            + P  +SL + +P+  +     DL+    +  P  R      
Sbjct: 240 PMYPATTSLVNVVPK--LNATGRDLLQNLLKCNPVQRISAEEA 280

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 98.0 bits (243), Expect = 5e-23
 Identities = 51/286 (17%), Positives = 100/286 (34%), Gaps = 37/286 (12%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKG 332
           R LG  K    +  I + +  +V VK LK     +KK+   EI     L   PN++ +  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLAD 97

Query: 333 CCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
              D   R   +V+E V N    +         ++L           + + + + H    
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM-- 148

Query: 391 PHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
             ++HRD++  NV++D E     L+  GL++F      QE  V     Y       V   
Sbjct: 149 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDYQ 205

Query: 450 ELTTKSDVYSFGVLLLEIVSGRRP-----------AQAVDSVCWQSIFEWAT--PLVQSH 496
                 D++S G +L  ++  + P            +    +  + ++++     +    
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 497 RYLELLDPLISSLSSDIPEAGVVQKV----VDLVYACTQHVPSMRP 538
           R+ ++L             +     V    +D +    ++    R 
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.0 bits (235), Expect = 6e-22
 Identities = 44/277 (15%), Positives = 89/277 (32%), Gaps = 20/277 (7%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVK 331
             +G    G   +      G RVAVK+L R   S    K  Y E+     + H N++ + 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
                        +  +   L     +     + L       +   + +G+ ++H     
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA--- 140

Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
            ++HRD++ SN+ ++E+    ++  GL++        E T      +       +     
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHY 196

Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQSIFEWATPLVQSHRYLELLD 503
               D++S G ++ E+++GR      D +           +        + S      + 
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256

Query: 504 PLISSLSSDIPEA--GVVQKVVDLVYACTQHVPSMRP 538
            L      +      G     VDL+          R 
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.3 bits (228), Expect = 5e-21
 Identities = 39/208 (18%), Positives = 77/208 (37%), Gaps = 22/208 (10%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 331
           + +G    G   +         VA+K+L R    +   K  Y E+     ++H N++++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 332 GCC------YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
                     +  D Y+V E +           +              +   +  GI  L
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHL 135

Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
           H      ++HRD++ SN+++  +    ++  GL++      M    V    T  Y APE 
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEV 189

Query: 446 VYRNELTTKSDVYSFGVLLLEIVSGRRP 473
           +         D++S G ++ E+V  +  
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 90.5 bits (223), Expect = 3e-20
 Identities = 31/228 (13%), Positives = 79/228 (34%), Gaps = 17/228 (7%)

Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
           R LG       +    + + + VA+K ++      +     EI    R++  +       
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSM 77

Query: 334 CYDHGDRYIVYE------------FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
             +H  + + +                    +          R +      +++  L  G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
           + ++H +    ++H DI+  NVL++      +L+ + ++         E    +  T  Y
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
            +PE +        +D++S   L+ E+++G    +  +   +    + 
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 66.0 bits (160), Expect = 4e-13
 Identities = 40/209 (19%), Positives = 71/209 (33%), Gaps = 40/209 (19%)

Query: 275 RLLGDSKTGGTYSGILPDGSRVAVK--RLKRSSFQ--------RKKEFYSEIGRFARLHH 324
           +L+G+ K    ++          VK  ++  +SF+            F     R AR   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 325 PNLVAVKGCC----YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
             L  ++G      Y      ++ E +    L R     P            +V   + +
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPD-----------EVLDMILE 114

Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGT 437
            +A  + +    +VH D+   NVL+  E G  ++    S  V    W  + ER V    T
Sbjct: 115 EVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170

Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
           Y        +     T+ D+ S    +L+
Sbjct: 171 Y--------FSRTYRTEKDINSAIDRILQ 191

>d1ypqa1 d.169.1.1 (A:140-270) Oxidised low density lipoprotein {Human (Homo sapiens) [TaxId: 9606]} Length = 131

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Oxidised low density lipoprotein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.9 bits (149), Expect = 3e-12
 Identities = 28/138 (20%), Positives = 48/138 (34%), Gaps = 15/138 (10%)

Query: 51  APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
           APCP DWI +     C+ +     +W++S+  C  +   L  + S  +    Q+    + 
Sbjct: 3   APCPQDWIWHG--ENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSS 60

Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
              W+G    N      W W D            G+ + +  S           C  +  
Sbjct: 61  FPFWMGLSRRNP--SYPWLWEDGSPLMPHLFRVRGAVSQTYPS---------GTCAYIQR 109

Query: 171 GSRSLVTERCNTSHPFIC 188
           G  ++  E C  +   IC
Sbjct: 110 G--AVYAENCILAAFSIC 125

>d1egga_ d.169.1.1 (A:) Macrophage mannose receptor, CRD4 {Human (Homo sapiens) [TaxId: 9606]} Length = 136

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Macrophage mannose receptor, CRD4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.7 bits (140), Expect = 4e-11
 Identities = 28/143 (19%), Positives = 53/143 (37%), Gaps = 12/143 (8%)

Query: 53  CPPDWIINEEKSKCFGYIGNF----RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGK 108
           CP DW  +   S CF          ++W ES  +C+ +GG LA++ + EE+ +  +L   
Sbjct: 1   CPEDWGASSRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLITA 60

Query: 109 NVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
           + +   +    +            + S  +    A G  N+      C          L 
Sbjct: 61  SGSYHKLFWLGLTYGSPSEGFTWSDGSPVSYENWAYGEPNNYQNVEYC--------GELK 112

Query: 169 SNGSRSLVTERCNTSHPFICMVE 191
            + + S     C   + +IC ++
Sbjct: 113 GDPTMSWNDINCEHLNNWICQIQ 135

>d1g1sa1 d.169.1.1 (A:1-118) P-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} Length = 118

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: P-selectin, C-lectin domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.3 bits (134), Expect = 2e-10
 Identities = 23/123 (18%), Positives = 39/123 (31%), Gaps = 7/123 (5%)

Query: 66  CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125
            + Y     SW+ S  YC+     L A+ +  E     K+     +  W+G R  N T  
Sbjct: 2   TYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIRKNNKTW- 60

Query: 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHP 185
            +W  +           A    N+   +  C     V++     +       E C     
Sbjct: 61  -TWVGTKKALTNEAENWADNEPNNKRNNEDC-----VEIYIKSPSAPGKWNDEHCLKKKH 114

Query: 186 FIC 188
            +C
Sbjct: 115 ALC 117

>d1e87a_ d.169.1.1 (A:) CD69 {Human (Homo sapiens) [TaxId: 9606]} Length = 117

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: CD69
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.6 bits (133), Expect = 3e-10
 Identities = 28/138 (20%), Positives = 52/138 (37%), Gaps = 26/138 (18%)

Query: 51  APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
           + C  DW+    + KC+      RSW  ++  C E G  LA + S ++ +  ++  G+  
Sbjct: 1   SSCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGREE 58

Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
           +   +         G  WKWS+   ++N   +  GS                  C  + N
Sbjct: 59  HWVGL-----KKEPGHPWKWSNG-KEFNNWFNVTGSDK----------------CVFLKN 96

Query: 171 GSRSLVTERCNTSHPFIC 188
               + +  C  +  +IC
Sbjct: 97  T--EVSSMECEKNLYWIC 112

>d1xpha1 d.169.1.1 (A:265-394) DC-SIGNR (DC-SIGN related receptor) {Human (Homo sapiens) [TaxId: 9606]} Length = 130

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: DC-SIGNR (DC-SIGN related receptor)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.3 bits (129), Expect = 1e-09
 Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 14/137 (10%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
            CP DW   +    C+    + R+W +S T C+E+   L  + + EE++  Q    ++  
Sbjct: 3   HCPKDWTFFQ--GNCYFMSNSQRNWHDSVTACQEVRAQLVVIKTAEEQNFLQLQTSRSNR 60

Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
             W+G   +N      W     +S   +     G  N+S            + C   S  
Sbjct: 61  FSWMGLSDLNQEGTWQWVDGSPLSPSFQRYWNSGEPNNSGN----------EDCAEFSGS 110

Query: 172 SRSLVTERCNTSHPFIC 188
                  RC+  + +IC
Sbjct: 111 --GWNDNRCDVDNYWIC 125

>d1wk1a_ d.169.1.1 (A:) Hypothetical protein F28B4.3 {Caenorhabditis elegans [TaxId: 6239]} Length = 150

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Hypothetical protein F28B4.3
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 54.6 bits (130), Expect = 2e-09
 Identities = 19/126 (15%), Positives = 39/126 (30%), Gaps = 7/126 (5%)

Query: 64  SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
            K      +  S  ++  +C   GG+LA     ++ +    +         +   S    
Sbjct: 8   VKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAANTQFWIGLFKNSDGQF 67

Query: 124 VGLSW-KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNT 182
                   + ++     +  A G  ++  T    +            + S+   T+ C T
Sbjct: 68  YWDRGQGINPDLLNQPITYWANGEPSNDPTRQCVYFDGR------SGDKSKVWTTDTCAT 121

Query: 183 SHPFIC 188
             PFIC
Sbjct: 122 PRPFIC 127

>d1hq8a_ d.169.1.1 (A:) NK cell-activating receptor nkg2d {Mouse (Mus musculus) [TaxId: 10090]} Length = 123

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: NK cell-activating receptor nkg2d
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 53.8 bits (128), Expect = 2e-09
 Identities = 27/137 (19%), Positives = 48/137 (35%), Gaps = 23/137 (16%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
           PCP +WI +   + C+ +    ++W++S+  C      L  + S EE+   + +      
Sbjct: 5   PCPNNWICHR--NNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEEQDFLKLVK----- 57

Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
             +     +      SW+W D  S     +  V     SC                 S+ 
Sbjct: 58  -SYHWMGLVQIPANGSWQWEDGSSLSYNQLTLVEIPKGSC-------------AVYGSSF 103

Query: 172 SRSLVTERCNTSHPFIC 188
                TE C   + +IC
Sbjct: 104 --KAYTEDCANLNTYIC 118

>d1qo3c_ d.169.1.1 (C:) NK cell receptor {Mouse (Mus musculus), ly49-a [TaxId: 10090]} Length = 133

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: NK cell receptor
species: Mouse (Mus musculus), ly49-a [TaxId: 10090]

 Score = 53.7 bits (128), Expect = 2e-09
 Identities = 20/137 (14%), Positives = 37/137 (27%), Gaps = 21/137 (15%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
                W       KC+ ++ + ++W   +  C+     L  +   +E    Q +   +  
Sbjct: 13  GDKVYWF--CYGMKCYYFVMDRKTWSGCKQTCQSSSLSLLKIDDEDELKFLQLVVPSDSC 70

Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
              +   +        W W DN               S         +     C L+S  
Sbjct: 71  WVGLSYDNKKK----DWAWIDNRP-------------SKLALNTRKYNIRDGGCMLLSKT 113

Query: 172 SRSLVTERCNTSHPFIC 188
              L    C+     IC
Sbjct: 114 --RLDNGNCDQVFICIC 128

>d3c8ja1 d.169.1.1 (A:138-259) NK cell receptor {Mouse (Mus musculus), ly49-c [TaxId: 10090]} Length = 122

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: NK cell receptor
species: Mouse (Mus musculus), ly49-c [TaxId: 10090]

 Score = 53.0 bits (126), Expect = 3e-09
 Identities = 22/136 (16%), Positives = 38/136 (27%), Gaps = 21/136 (15%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
               W      +KC+ +I N  +W   +  C+  G  +  +   +E    Q+        
Sbjct: 2   GVKYWFCYS--TKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHVIPGNYW 59

Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
             +            W W DN     +      +F S               C  +S   
Sbjct: 60  IGLSYDKKKKE----WAWIDNGPSKLDMKIKKMNFKSRG-------------CVFLSKA- 101

Query: 173 RSLVTERCNTSHPFIC 188
             +    CN  +  IC
Sbjct: 102 -RIEDIDCNIPYYCIC 116

>d1tdqb_ d.169.1.1 (B:) Aggrecan core protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 126

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Aggrecan core protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.6 bits (122), Expect = 1e-08
 Identities = 26/137 (18%), Positives = 48/137 (35%), Gaps = 15/137 (10%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
            C   W   + +  C+ +  +  +W ++E  C+E   HL+++ + EE+        KN  
Sbjct: 2   QCEEGWT--KFQGHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQE----FVNKNAQ 55

Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
                G +  T  G  ++WSD         H++                  D   ++ + 
Sbjct: 56  DYQWIGLNDRTIEG-DFRWSDG--------HSLQFEKWRPNQPDNFFATGEDCVVMIWHE 106

Query: 172 SRSLVTERCNTSHPFIC 188
                   CN   PF C
Sbjct: 107 RGEWNDVPCNYQLPFTC 123

>d1g1ta1 d.169.1.1 (A:1-118) E-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} Length = 118

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: E-selectin, C-lectin domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (121), Expect = 1e-08
 Identities = 23/115 (20%), Positives = 41/115 (35%), Gaps = 7/115 (6%)

Query: 74  RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133
            ++DE+  YC++   HL A+ + EE      +   + +  W+G R +N      W  +  
Sbjct: 10  MTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVW--VWVGTQK 67

Query: 134 MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
                    A G  N+      C     V++             ERC+     +C
Sbjct: 68  PLTEEAKNWAPGEPNNRQKDEDC-----VEIYIKREKDVGMWNDERCSKKKLALC 117

>d1dv8a_ d.169.1.1 (A:) H1 subunit of the asialoglycoprotein receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 128

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: H1 subunit of the asialoglycoprotein receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.6 bits (119), Expect = 2e-08
 Identities = 23/142 (16%), Positives = 45/142 (31%), Gaps = 18/142 (12%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP +W+  E +  C+ +  + ++W +++ YC+    HL  +TS+EE+   Q   G     
Sbjct: 1   CPVNWV--EHERSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIGPVNTW 58

Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLP---CHVHATVDLCTLVS 169
                              +   KW +       F +     P                 
Sbjct: 59  MG-------------LHDQNGPWKWVDGTDYETGFKNWRPEQPDDWYGHGLGGGEDCAHF 105

Query: 170 NGSRSLVTERCNTSHPFICMVE 191
                   + C   + ++C  E
Sbjct: 106 TDDGRWNDDVCQRPYRWVCETE 127

>d1h8ua_ d.169.1.1 (A:) Eosinophil major basic protein {Human (Homo sapiens) [TaxId: 9606]} Length = 115

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Eosinophil major basic protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (116), Expect = 5e-08
 Identities = 18/117 (15%), Positives = 37/117 (31%), Gaps = 14/117 (11%)

Query: 74  RSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGK-NVNGCWVGGRSINTTVGLSWKWS 131
           +++ ++   C+    G+L ++ ++   +  Q      N    W+GGR   +     ++W 
Sbjct: 9   QTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSGRCRRFQWV 68

Query: 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
           D          A   ++                C  +           C    PFIC
Sbjct: 69  DGSRWNFAYWAAHQPWSRG------------GHCVALCTRGGYWRRAHCLRRLPFIC 113

>d1kg0c_ d.169.1.1 (C:) EBV gp42 {Epstein-Barr virus [TaxId: 10376]} Length = 136

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: EBV gp42
species: Epstein-Barr virus [TaxId: 10376]

 Score = 48.3 bits (114), Expect = 2e-07
 Identities = 14/138 (10%), Positives = 28/138 (20%), Gaps = 23/138 (16%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
                      K  CF +     +W+     C E            +           + 
Sbjct: 18  NTREYTF--SYKGCCFYFTKKKHTWNGCFQACAEKYPCTYFYGPTPDILPVVTRNLNAIE 75

Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
             WVG   +      +W   D    +                             +    
Sbjct: 76  SLWVG---VYRVGEGNWTSLDG-GTFKVYQIFGSHC-----------------TYVSKFS 114

Query: 172 SRSLVTERCNTSHPFICM 189
           +  +    C+   P +C+
Sbjct: 115 TVPVSHHECSFLKPCLCV 132

>d1r13a1 d.169.1.1 (A:110-228) Surfactant protein, lectin domain {Rat (Rattus norvegicus), SP-A [TaxId: 10116]} Length = 119

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Surfactant protein, lectin domain
species: Rat (Rattus norvegicus), SP-A [TaxId: 10116]

 Score = 46.6 bits (109), Expect = 5e-07
 Identities = 18/125 (14%), Positives = 37/125 (29%), Gaps = 14/125 (11%)

Query: 64  SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
            K F   G   ++D  +  C   GG++A   + EE  +   +  K  N  ++        
Sbjct: 7   DKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYL-------- 58

Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
                        ++    A  S+ +     P           + ++G  +     C   
Sbjct: 59  ---GMIEDQTPGDFHYLDGASVSYTNWYPGEPRG-QGKEKCVEMYTDG--TWNDRGCLQY 112

Query: 184 HPFIC 188
              +C
Sbjct: 113 RLAVC 117

>d2msba_ d.169.1.1 (A:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 112

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Mannose-binding protein A, C-lectin domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.7 bits (107), Expect = 7e-07
 Identities = 17/125 (13%), Positives = 36/125 (28%), Gaps = 18/125 (14%)

Query: 65  KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN-GCWVGGRSINTT 123
           K F        + + +  C E+ G +A   + EE  + Q++   +   G           
Sbjct: 2   KFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAKTSAFLGITDEVTEGQFM 61

Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
                + + +  K +E        +  C ++                 +       C  S
Sbjct: 62  YVTGGRLTYSNWKKDEPNDHGSGED--CVTI---------------VDNGLWNDISCQAS 104

Query: 184 HPFIC 188
           H  +C
Sbjct: 105 HTAVC 109

>d1pwba1 d.169.1.1 (A:235-355) Surfactant protein, lectin domain {Human (Homo sapiens), SP-D [TaxId: 9606]} Length = 121

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Surfactant protein, lectin domain
species: Human (Homo sapiens), SP-D [TaxId: 9606]

 Score = 46.2 bits (108), Expect = 7e-07
 Identities = 22/125 (17%), Positives = 40/125 (32%), Gaps = 13/125 (10%)

Query: 64  SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
            K F   G  + + E++  C + GG LA+  S  E  + Q+L        ++        
Sbjct: 8   EKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFL-------- 59

Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
              S   S    K+         +++     P     + D   + +NG        C   
Sbjct: 60  ---SMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNG--KWNDRACGEK 114

Query: 184 HPFIC 188
              +C
Sbjct: 115 RLVVC 119

>d1oz7b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]} Length = 123

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]

 Score = 46.2 bits (108), Expect = 8e-07
 Identities = 25/142 (17%), Positives = 43/142 (30%), Gaps = 30/142 (21%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
           C PDW     +  C+       +W ++E +C +    GHL +  + +E      L    +
Sbjct: 2   CLPDWS--VYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPML 59

Query: 111 NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
               V     +     +W+WSD        W+   H                      C 
Sbjct: 60  KNDLVWIGLTDYWRDCNWEWSDGAQLDYKAWDNERH----------------------CF 97

Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
           +  N         C  +  F+C
Sbjct: 98  IYKNTDNQWTRRDCTWTFSFVC 119

>d1tn3a_ d.169.1.1 (A:) Tetranectin {Human (Homo sapiens) [TaxId: 9606]} Length = 137

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Tetranectin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (108), Expect = 8e-07
 Identities = 18/137 (13%), Positives = 39/137 (28%), Gaps = 11/137 (8%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN- 111
           C     ++    KCF      +++ E+   C   GG L+   +  E  +  +   ++V  
Sbjct: 6   CLKGTKVH---MKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGN 62

Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
              +     +     +W          ++     +                    L    
Sbjct: 63  EAEIWLGLNDMAAEGTWVDMTGARIAYKNWETEITAQPDGGKTENCAV-------LSGAA 115

Query: 172 SRSLVTERCNTSHPFIC 188
           +     +RC    P+IC
Sbjct: 116 NGKWFDKRCRDQLPYIC 132

>d1t8da1 d.169.1.1 (A:1-143) Low affinity immunoglobulin epsilon Fc receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 143

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Low affinity immunoglobulin epsilon Fc receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (109), Expect = 9e-07
 Identities = 26/138 (18%), Positives = 46/138 (33%), Gaps = 18/138 (13%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
            CP  WI    + KC+ +    + W  +   C ++ G L ++ S EE+    K      +
Sbjct: 7   TCPEKWI--NFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGS 64

Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
              +    +       + W D  S  + S  A G   S      C          ++  G
Sbjct: 65  WIGLRNLDLKGE----FIWVDG-SHVDYSNWAPGEPTSRSQGEDC----------VMMRG 109

Query: 172 SRSLVTERCNTS-HPFIC 188
           S       C+     ++C
Sbjct: 110 SGRWNDAFCDRKLGAWVC 127

>d1v7pb_ d.169.1.1 (B:) Snake coagglutinin beta chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]} Length = 127

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]

 Score = 45.8 bits (107), Expect = 1e-06
 Identities = 33/142 (23%), Positives = 46/142 (32%), Gaps = 28/142 (19%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W        C+      ++W E+E  C +   G  LA++ S EEE    KL  K +
Sbjct: 1   CPLGWS--SFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKAL 58

Query: 111 NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
               +     N      W+WSDN       W             CT +            
Sbjct: 59  KFTSMWIGLNNPWKDCKWEWSDNARFDYKAWKR--------RPYCTVM------------ 98

Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
           +V        T  C  S  F+C
Sbjct: 99  VVKPDRIFWFTRGCEKSVSFVC 120

>d1wmza_ d.169.1.1 (A:) Lectin CEL-I {Cucumaria echinata [TaxId: 40245]} Length = 140

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Lectin CEL-I
species: Cucumaria echinata [TaxId: 40245]

 Score = 45.6 bits (106), Expect = 2e-06
 Identities = 17/148 (11%), Positives = 36/148 (24%), Gaps = 17/148 (11%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGG-------HLAALTSYEEEHSAQKL 105
           CP DW    E   C+ +     +W+ +   C             L ++ S  E+      
Sbjct: 3   CPTDWE--AEGDHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNY 60

Query: 106 CGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLC 165
                +        +            + SK   +  A G  ++   +            
Sbjct: 61  WRGIDSQAGQLWIGLYDKYNEGDFIWTDGSKVGYTKWAGGQPDNWNNAEDY--------G 112

Query: 166 TLVSNGSRSLVTERCNTSHPFICMVEHE 193
                   +           ++C +  E
Sbjct: 113 QFRHTEGGAWNDNSAAAQAKYMCKLTFE 140

>d1c3ab_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]} Length = 125

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]

 Score = 45.1 bits (105), Expect = 2e-06
 Identities = 22/142 (15%), Positives = 42/142 (29%), Gaps = 30/142 (21%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W        C+       +W+++E +C +   G HL +  S EE           +
Sbjct: 4   CPLGWS--SYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPIL 61

Query: 111 NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
              +V     N     + +WSD        W+                          C 
Sbjct: 62  KYDFVWIGLSNVWNECTKEWSDGTKLDYKAWSGGSD----------------------CI 99

Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
           +        ++  C++ +  +C
Sbjct: 100 VSKTTDNQWLSMDCSSKYYVVC 121

>d1hupa1 d.169.1.1 (A:112-228) Mannose-binding protein A, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} Length = 117

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Mannose-binding protein A, C-lectin domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (105), Expect = 2e-06
 Identities = 18/125 (14%), Positives = 41/125 (32%), Gaps = 16/125 (12%)

Query: 64  SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
           +K F   G   ++++ +  C +    +A   +  E  + Q L  +     ++G     T 
Sbjct: 5   NKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAENGAIQNLIKEEA---FLGITDEKTE 61

Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
                      ++   +    G  N++ +   C +             +       C+TS
Sbjct: 62  G---QFVDLTGNRLTYTNWNEGEPNNAGSDEDCVLL----------LKNGQWNDVPCSTS 108

Query: 184 HPFIC 188
           H  +C
Sbjct: 109 HLAVC 113

>d3bdwa1 d.169.1.1 (A:59-179) CD94 {Human (Homo sapiens) [TaxId: 9606]} Length = 121

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: CD94
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (104), Expect = 3e-06
 Identities = 20/137 (14%), Positives = 40/137 (29%), Gaps = 22/137 (16%)

Query: 52  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
            C   W+       C+      ++W+ES   C      L  L + +E             
Sbjct: 2   SCQEKWVGYR--CNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSSSQQFYWI 59

Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
           G         +    +W W +  S  ++ +       ++            +      NG
Sbjct: 60  GLS------YSEEHTAWLWENG-SALSQYLFPSFETFNTK-----------NCIAYNPNG 101

Query: 172 SRSLVTERCNTSHPFIC 188
             + + E C   + +IC
Sbjct: 102 --NALDESCEDKNRYIC 116

>d1jwia_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]} Length = 124

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]

 Score = 44.3 bits (103), Expect = 4e-06
 Identities = 36/144 (25%), Positives = 54/144 (37%), Gaps = 30/144 (20%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN- 111
           C PDW     K  C+       +W+++E +C E  GHLA++ S EE     KL  + +  
Sbjct: 1   CLPDWS--SYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTK 58

Query: 112 ---GCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
                W+G R  + T   S +W+D         +E         + C  L  H       
Sbjct: 59  FVYDAWIGLRDESKTQQCSPQWTDGSSVVYENVDE--------PTKCFGLDVH------- 103

Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
                   R+     C   +PFIC
Sbjct: 104 -----TEYRTWTDLPCGEKNPFIC 122

>d1gz2a_ d.169.1.1 (A:) Ovocleidin-17 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 139

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Ovocleidin-17
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 43.7 bits (101), Expect = 8e-06
 Identities = 24/137 (17%), Positives = 35/137 (25%), Gaps = 4/137 (2%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-GHLAALTSYEEEHSAQKLCGKNVN 111
           C P W+       C G+     SW  +E++C+  G G   A      E            
Sbjct: 2   CGPGWV--PTPGGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASR 59

Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
           G    G   +  V +          W  S      F S   +                  
Sbjct: 60  GGDGSGEGADGRVWIGLHRPAGSRSWRWSDGTAPRFASWHRTAKAR-RGGRCAALRDEEA 118

Query: 172 SRSLVTERCNTSHPFIC 188
             S     C   + F+C
Sbjct: 119 FTSWAARPCTERNAFVC 135

>d1oz7a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]} Length = 131

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]

 Score = 43.2 bits (100), Expect = 9e-06
 Identities = 26/136 (19%), Positives = 44/136 (32%), Gaps = 12/136 (8%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CPP W  N     C+      ++WDE+E +C + G     L+   ++             
Sbjct: 2   CPPGWSSNG--VYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDI----VV 55

Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
               G+      GLS +  +             S  S   S    +  +        +  
Sbjct: 56  SENIGKMYKIWTGLSERSKEQHCSSRW------SDGSFFRSYEIAIRYSECFVLEKQSVF 109

Query: 173 RSLVTERCNTSHPFIC 188
           R+ V   C  + PF+C
Sbjct: 110 RTWVATPCENTFPFMC 125

>d1uv0a_ d.169.1.1 (A:) Pancreatitis-associated protein 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 140

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Pancreatitis-associated protein 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 9e-06
 Identities = 18/136 (13%), Positives = 38/136 (27%), Gaps = 4/136 (2%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP         S C+    + +SW +++  C++             E S      K++  
Sbjct: 5   CPKGSK--AYGSHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGN 62

Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
            +              + +    +W  S   V ++ +   +               S   
Sbjct: 63  SYSYVWIGLHDPTQGTEPNGEGWEW--SSSDVMNYFAWERNPSTISSPGHCASLSRSTAF 120

Query: 173 RSLVTERCNTSHPFIC 188
                  CN   P++C
Sbjct: 121 LRWKDYNCNVRLPYVC 136

>d1rdl1_ d.169.1.1 (1:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 111

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Mannose-binding protein A, C-lectin domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.4 bits (98), Expect = 1e-05
 Identities = 16/124 (12%), Positives = 34/124 (27%), Gaps = 16/124 (12%)

Query: 65  KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
           K F         + ++  C E+ G +A         +A++          V    I    
Sbjct: 1   KYFMSSVRRMPLNRAKALCSELQGTVATP------RNAEENRAIQNVAKDVAFLGITDQR 54

Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH 184
             +       ++   +    G  N+  +   C          +V   +       C+ S 
Sbjct: 55  TENVFEDLTGNRVRYTNWNEGEPNNVGSGENC----------VVLLTNGKWNDVPCSDSF 104

Query: 185 PFIC 188
             +C
Sbjct: 105 LVVC 108

>d1jwib_ d.169.1.1 (B:) Snake coagglutinin beta chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]} Length = 123

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]

 Score = 42.3 bits (98), Expect = 2e-05
 Identities = 29/138 (21%), Positives = 49/138 (35%), Gaps = 22/138 (15%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
           C PDW     K  C+      ++W ++E +CKE+  GGHL ++ S EE     KL  + +
Sbjct: 2   CLPDWS--SYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKM 59

Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
               V     +       +W+D                     L     +   +C +  +
Sbjct: 60  RIVLVWIGLSHFWRICPLRWTDG------------------ARLDYRALSDEPICFVAES 101

Query: 171 GSRSLVTERCNTSHPFIC 188
                +   CN    F+C
Sbjct: 102 FHNKWIQWTCNRKKSFVC 119

>d1jzna_ d.169.1.1 (A:) Galactose-specific C-type lectin {Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]} Length = 135

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Galactose-specific C-type lectin
species: Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]

 Score = 42.1 bits (97), Expect = 2e-05
 Identities = 21/137 (15%), Positives = 44/137 (32%), Gaps = 9/137 (6%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           CP DW+       C+      ++W+++E +C++        + +    S +         
Sbjct: 3   CPLDWL--PMNGLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAE------ 54

Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS-NG 171
                      V +  +       W  +  +   + +   + P H         LVS  G
Sbjct: 55  YISDYHKGQENVWIGLRDKKKDFSWEWTDRSCTDYLTWDKNQPDHYQNKEFCVELVSLTG 114

Query: 172 SRSLVTERCNTSHPFIC 188
            R    + C +   F+C
Sbjct: 115 YRLWNDQVCESKDAFLC 131

>d2afpa_ d.169.1.1 (A:) Type II antifreeze protein {Sea raven (Hemitripterus americanus) [TaxId: 8094]} Length = 129

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Type II antifreeze protein
species: Sea raven (Hemitripterus americanus) [TaxId: 8094]

 Score = 41.6 bits (96), Expect = 3e-05
 Identities = 25/138 (18%), Positives = 40/138 (28%), Gaps = 17/138 (12%)

Query: 51  APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
             CP  W       +C  Y     +W  +ET C ++GGHLA++ S EE    Q L    V
Sbjct: 5   PNCPAGWQ--PLGDRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTLNAGVV 62

Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
                                 + +  N         +    +             + + 
Sbjct: 63  WIGGSACLQAG------AWTWSDGTPMNFRSWCSTKPDDVLAA---------CCMQMTAA 107

Query: 171 GSRSLVTERCNTSHPFIC 188
             +      C  SH  +C
Sbjct: 108 ADQCWDDLPCPASHKSVC 125

>d1qdda_ d.169.1.1 (A:) Lithostathine, inhibitor of stone formation {Human (Homo sapiens) [TaxId: 9606]} Length = 144

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Lithostathine, inhibitor of stone formation
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.7 bits (96), Expect = 4e-05
 Identities = 18/140 (12%), Positives = 41/140 (29%), Gaps = 11/140 (7%)

Query: 50  KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 109
           +  CP        +S C+ +  +  +W +++ YC+ +          + E +      K 
Sbjct: 11  RISCPEGTN--AYRSYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKE 68

Query: 110 VNGCWVGGRSINTTVGLSWKWSD-NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
                            +  W   + S  +     +G+ +S        + +        
Sbjct: 69  SGTDDFNVWIGLHDPKKNRAWHWSSGSLVSYKSWGIGAPSSVNPGYCVSLTS-------- 120

Query: 169 SNGSRSLVTERCNTSHPFIC 188
           S G +      C     F+C
Sbjct: 121 STGFQKWKDVPCEDKFSFVC 140

>d1umrc_ d.169.1.1 (C:) Snake coagglutinin beta chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]} Length = 125

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]

 Score = 40.9 bits (94), Expect = 5e-05
 Identities = 25/142 (17%), Positives = 49/142 (34%), Gaps = 30/142 (21%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W        C+       +W ++E +C +   G HL +  S EE     K+  +++
Sbjct: 4   CPSHWS--SYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSL 61

Query: 111 NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
              +    + N     +W+WSD       +W+E                         C 
Sbjct: 62  KSTFFWIGANNIWNKCNWQWSDGTKPEYKEWHEEFE----------------------CL 99

Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
           +        ++  C+ ++ F+C
Sbjct: 100 ISRTFDNQWLSAPCSDTYSFVC 121

>d1v7pa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]} Length = 134

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]

 Score = 40.9 bits (94), Expect = 6e-05
 Identities = 29/142 (20%), Positives = 47/142 (33%), Gaps = 22/142 (15%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGK-- 108
           CP DW        C+  IG  ++W E+E +C E    GHL ++ S EE +   +L     
Sbjct: 4   CPSDWT--AYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFM 61

Query: 109 --NVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
             +    W+G R        + +W+D       +     S      +             
Sbjct: 62  HRSEIYVWIGLRDRREEQQCNPEWNDGSKIIYVNWKEGESKMCQGLT------------- 108

Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
                        C   +PF+C
Sbjct: 109 -KWTNFHDWNNINCEDLYPFVC 129

>d1c3aa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]} Length = 135

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]

 Score = 40.5 bits (93), Expect = 8e-05
 Identities = 15/136 (11%), Positives = 37/136 (27%), Gaps = 10/136 (7%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
           C P W        C+      ++W+++E++C+E       ++                  
Sbjct: 4   CIPGWS--AYDRYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKI 61

Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
                           +  +   +   S  +  ++ +         +A            
Sbjct: 62  KTSFQYVWIGLR---IQNKEQQCRSEWSDASSVNYENLVKQFSKKCYALKK-----GTEL 113

Query: 173 RSLVTERCNTSHPFIC 188
           R+     C T +P +C
Sbjct: 114 RTWFNVYCGTENPEVC 129

>d1byfa_ d.169.1.1 (A:) Lectin TC14 {Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]} Length = 123

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Lectin TC14
species: Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]

 Score = 40.2 bits (92), Expect = 9e-05
 Identities = 19/124 (15%), Positives = 38/124 (30%), Gaps = 9/124 (7%)

Query: 66  CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV-NGCWVGGRSINTTV 124
              +     ++ ++ TYC+  G  L +    +       L    V    +  G       
Sbjct: 3   EILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGADNLQDG 62

Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH 184
             ++ W+D +S   +S     +  S+  S    V         + +    L    C  + 
Sbjct: 63  AYNFLWNDGVSLPTDSDLWSPNEPSNPQSWQLCVQ--------IWSKYNLLDDVGCGGAR 114

Query: 185 PFIC 188
             IC
Sbjct: 115 RVIC 118

>d1j34b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]} Length = 123

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]

 Score = 39.7 bits (91), Expect = 1e-04
 Identities = 27/142 (19%), Positives = 45/142 (31%), Gaps = 30/142 (21%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
           CP DW     +  C+      ++W ++E +C +   GGHL +  S EE     KL  +  
Sbjct: 2   CPSDWS--SYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTF 59

Query: 111 NGCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
                     N     +W+WS+        W E  +                      C 
Sbjct: 60  GHSIFWMGLSNVWNQCNWQWSNAAMLRYKAWAEESY----------------------CV 97

Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
              + +    +  C     F+C
Sbjct: 98  YFKSTNNKWRSRACRMMAQFVC 119

>d1fvub_ d.169.1.1 (B:) Snake coagglutinin beta chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]} Length = 125

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]

 Score = 39.1 bits (89), Expect = 2e-04
 Identities = 26/138 (18%), Positives = 44/138 (31%), Gaps = 20/138 (14%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
           CPPDW     +  C+ +   +  WD++E +C E   G HL +  S EE    + L  + +
Sbjct: 2   CPPDWS--SYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEML 59

Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
            G  V     +      ++W+D              +             T         
Sbjct: 60  KGDVVWIGLSDVWNKCRFEWTDG------MEFDYDDYYLIAEYECVASKPT--------- 104

Query: 171 GSRSLVTERCNTSHPFIC 188
            +       C     F+C
Sbjct: 105 -NNKWWIIPCTRFKNFVC 121

>d1umra_ d.169.1.1 (A:) Snake coagglutinin alpha chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]} Length = 135

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]

 Score = 39.3 bits (90), Expect = 2e-04
 Identities = 26/140 (18%), Positives = 48/140 (34%), Gaps = 18/140 (12%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
           CP DW        C+       +W+++E +C +   G HL ++ S +E      +  +N+
Sbjct: 4   CPSDWY--YYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNI 61

Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS- 169
              +            S        +  E   +    + S  S    +   +  C+L+  
Sbjct: 62  EESF------------SHVSIGLRVQNKEKQCSTKWSDGSSVSYDNLLDLYITKCSLLKK 109

Query: 170 -NGSRSLVTERCNTSHPFIC 188
             G R      C    PF+C
Sbjct: 110 ETGFRKWFVASCIGKIPFVC 129

>d1sb2a1 d.169.1.1 (A:1-132) Snake coagglutinin alpha chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]} Length = 132

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]

 Score = 39.3 bits (90), Expect = 2e-04
 Identities = 25/138 (18%), Positives = 41/138 (29%), Gaps = 14/138 (10%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W     KS C+      ++W+E+E +C E     HL ++ +  E      +   N 
Sbjct: 2   CPDGWS--STKSYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNF 59

Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
                           SW      +K   S       +S         +          +
Sbjct: 60  ENKIYR----------SWIGLKIENKGQRSNLEWSDGSSISYENLYEPYMEKCFLMDHQS 109

Query: 171 GSRSLVTERCNTSHPFIC 188
           G     T  C   + F+C
Sbjct: 110 GLPKWHTADCEEKNVFMC 127

>d1fvua_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]} Length = 133

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]

 Score = 39.3 bits (90), Expect = 2e-04
 Identities = 24/138 (17%), Positives = 41/138 (29%), Gaps = 13/138 (9%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG--GHLAALTSYEEEHSAQKLCGKNV 110
           CP  W     +  C+ +     +W ++E +C E    GHL ++  Y +E           
Sbjct: 2   CPSGWS--SYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKN 59

Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
                    I   V    K   +      S+    S+ +          A          
Sbjct: 60  IQSSDLYAWIGLRVENKEKQCSSEWSDGSSV----SYENVVERTVKKCFALEK-----DL 110

Query: 171 GSRSLVTERCNTSHPFIC 188
           G    +   C   +PF+C
Sbjct: 111 GFVLWINLYCAQKNPFVC 128

>d1sb2b1 d.169.1.1 (B:2-128) Snake coagglutinin beta chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]} Length = 127

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]

 Score = 38.2 bits (87), Expect = 5e-04
 Identities = 22/138 (15%), Positives = 39/138 (28%), Gaps = 20/138 (14%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W     K  C+      ++W E+E +C +    GHL ++ S  E      +   N 
Sbjct: 3   CPTTWS--ASKLYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNF 60

Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
           +               +W      +    +  +V   N          +           
Sbjct: 61  DKQR----------YRAWTGLTERNLKWTNGASVSYENLY------EPYIRKCFVVQPWE 104

Query: 171 GSRSLVTERCNTSHPFIC 188
           G        C   + F+C
Sbjct: 105 GKSKWYKADCEEKNAFLC 122

>d1j34a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]} Length = 129

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]

 Score = 37.8 bits (86), Expect = 7e-04
 Identities = 29/140 (20%), Positives = 51/140 (36%), Gaps = 18/140 (12%)

Query: 53  CPPDWIINEEKSKCFGYIGNFRSWDESETYC--KEIGGHLAALTSYEEEHSAQKLCGKNV 110
           CP  W     +  C+     +++WD++E +C  +  GGHL ++ S  E     +L  +N+
Sbjct: 2   CPSGWS--SYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENI 59

Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
                            + W     +  E   +    + S  S    + A    C  +  
Sbjct: 60  QNTKS------------YVWIGLRVQGKEKQCSSEWSDGSSVSYENWIEAESKTCLGLEK 107

Query: 171 --GSRSLVTERCNTSHPFIC 188
             G R  V   C   +PF+C
Sbjct: 108 ETGFRKWVNIYCGQQNPFVC 127

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	557
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1hq8a_	123	NK cell-activating receptor nkg2d {Mouse (Mus musc	99.94
d1ypqa1	131	Oxidised low density lipoprotein {Human (Homo sapi	99.94
d1xpha1	130	DC-SIGNR (DC-SIGN related receptor) {Human (Homo s	99.93
d1t8da1	143	Low affinity immunoglobulin epsilon Fc receptor {H	99.93
d1tdqb_	126	Aggrecan core protein {Rat (Rattus norvegicus) [Ta	99.93
d1oz7b_	123	Snake coagglutinin beta chain {Saw-scaled viper (E	99.93
d1fvub_	125	Snake coagglutinin beta chain {Jararaca (Bothrops	99.92
d1dv8a_	128	H1 subunit of the asialoglycoprotein receptor {Hum	99.92
d1gz2a_	139	Ovocleidin-17 {Chicken (Gallus gallus) [TaxId: 903	99.92
d1j34b_	123	Snake coagglutinin beta chain {Habu snake (Trimere	99.92
d1jwib_	123	Snake coagglutinin beta chain {Puff adder (Bitis a	99.92
d1jwia_	124	Snake coagglutinin alpha chain {Puff adder (Bitis	99.92
d1c3ab_	125	Snake coagglutinin beta chain {Habu snake (Trimere	99.92
d1sb2a1	132	Snake coagglutinin alpha chain {Malayan pit viper	99.92
d1umrc_	125	Snake coagglutinin beta chain {South american ratt	99.91
d1qdda_	144	Lithostathine, inhibitor of stone formation {Human	99.91
d2afpa_	129	Type II antifreeze protein {Sea raven (Hemitripter	99.91
d1tn3a_	137	Tetranectin {Human (Homo sapiens) [TaxId: 9606]}	99.91
d3c8ja1	122	NK cell receptor {Mouse (Mus musculus), ly49-c [Ta	99.91
d1wmza_	140	Lectin CEL-I {Cucumaria echinata [TaxId: 40245]}	99.91
d1e87a_	117	CD69 {Human (Homo sapiens) [TaxId: 9606]}	99.91
d3bdwa1	121	CD94 {Human (Homo sapiens) [TaxId: 9606]}	99.91
d1jzna_	135	Galactose-specific C-type lectin {Western diamondb	99.91
d1qo3c_	133	NK cell receptor {Mouse (Mus musculus), ly49-a [Ta	99.91
d1c3aa_	135	Snake coagglutinin alpha chain {Habu snake (Trimer	99.91
d1umra_	135	Snake coagglutinin alpha chain {South american rat	99.91
d1v7pb_	127	Snake coagglutinin beta chain {Snake (Echis multis	99.91
d1sb2b1	127	Snake coagglutinin beta chain {Malayan pit viper (	99.9
d1egga_	136	Macrophage mannose receptor, CRD4 {Human (Homo sap	99.9
d1j34a_	129	Snake coagglutinin alpha chain {Habu snake (Trimer	99.9
d1fvua_	133	Snake coagglutinin alpha chain {Jararaca (Bothrops	99.9
d1oz7a_	131	Snake coagglutinin alpha chain {Saw-scaled viper (	99.9
d1uv0a_	140	Pancreatitis-associated protein 1 {Human (Homo sap	99.9
d1v7pa_	134	Snake coagglutinin alpha chain {Snake (Echis multi	99.9
d1pwba1	121	Surfactant protein, lectin domain {Human (Homo sap	99.89
d2msba_	112	Mannose-binding protein A, C-lectin domain {Rat (R	99.89
d1hupa1	117	Mannose-binding protein A, C-lectin domain {Human	99.88
d1r13a1	119	Surfactant protein, lectin domain {Rat (Rattus nor	99.88
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1rdl1_	111	Mannose-binding protein A, C-lectin domain {Rat (R	99.87
d1h8ua_	115	Eosinophil major basic protein {Human (Homo sapien	99.87
d1kg0c_	136	EBV gp42 {Epstein-Barr virus [TaxId: 10376]}	99.85
d1g1ta1	118	E-selectin, C-lectin domain {Human (Homo sapiens)	99.82
d1wk1a_	150	Hypothetical protein F28B4.3 {Caenorhabditis elega	99.81
d1g1sa1	118	P-selectin, C-lectin domain {Human (Homo sapiens)	99.8
d1byfa_	123	Lectin TC14 {Tunicate (Polyandrocarpa misakiensis)	99.75
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.38
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.69
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.23
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.8
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.9
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.77

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-53  Score=415.07  Aligned_cols=251  Identities=24%  Similarity=0.408  Sum_probs=197.7

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|+||+||+|.+.+++.||||+++... ...++|.+|+.++++++|||||+++|++.+.+..++||||+++|+|.
T Consensus        10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~   88 (263)
T d1sm2a_          10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS   88 (263)
T ss_dssp             EEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred             EEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHH
Confidence            34689999999999999888999999997653 44578999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++..   ....+++..++.++.|||.||+|||++   +|+||||||+|||+++++.+||+|||+++........... .
T Consensus        89 ~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~-~  161 (263)
T d1sm2a_          89 DYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-G  161 (263)
T ss_dssp             HHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred             HHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeec-c
Confidence            99874   235689999999999999999999999   9999999999999999999999999999876544332222 2


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ..||+.|+|||++.+..++.++|||||||++|||+|+ .+|+...+..   .+......    .     .        ..
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~~----~-----~--------~~  221 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIST----G-----F--------RL  221 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHHH----T-----C--------CC
T ss_pred             eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHHh----c-----C--------CC
Confidence            3489999999999999999999999999999999995 5555443221   11111111    0     0        01


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      ..+..++.++.+++.+||+.||++||||+||++.|+++++
T Consensus       222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            1122344678999999999999999999999999998764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=416.19  Aligned_cols=258  Identities=24%  Similarity=0.420  Sum_probs=201.2

Q ss_pred             CCCeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      ...+.||+|+||+||+|+++  ..||||+++..  +....+.|.+|+.+|.+++|||||+++|++.+ +..++||||+++
T Consensus        11 ~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~   87 (276)
T d1uwha_          11 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG   87 (276)
T ss_dssp             CCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred             EEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCC
Confidence            34457899999999999864  36999998654  34456789999999999999999999998754 568999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++...   ...+++.+++.++.|||+||+|||++   +||||||||+||||+.++.+||+|||+|+.........
T Consensus        88 g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          88 SSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             EEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred             CCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence            9999999642   34699999999999999999999999   99999999999999999999999999998765443333


Q ss_pred             ceeecCccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          430 RTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ......||+.|||||++.+   ..++.++|||||||++|||+||+.||.+.+...  .+..    .....    ...+.+
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~----~~~~~----~~~p~~  231 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIF----MVGRG----YLSPDL  231 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHH----HHHHT----SCCCCG
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHH----HHhcC----CCCCcc
Confidence            3334459999999999864   358999999999999999999999998754421  1111    11111    111111


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ...     +.+++..+.+|+.+||+.||++||||+||++.|+.+++.
T Consensus       232 ~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         232 SKV-----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             GGS-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hhc-----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            111     122446789999999999999999999999999988753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-53  Score=422.87  Aligned_cols=270  Identities=25%  Similarity=0.444  Sum_probs=205.3

Q ss_pred             CHHHHHHhhcCCCCC--------CeeecccCceEEEEEEeCC-C---CEEEEEEeccc-chhhHHHHHHHHHHHhhcCCC
Q 008698          259 TTEELRSITKNFSEG--------NRLLGDSKTGGTYSGILPD-G---SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHP  325 (557)
Q Consensus       259 ~~~el~~~~~~~~~~--------~~~lg~G~~g~Vy~g~~~~-g---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~  325 (557)
                      +++++..++.+|...        .++||+|+||+||+|.+.. |   ..||||.+... .....++|.+|+.+|++++||
T Consensus         8 t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~Hp   87 (299)
T d1jpaa_           8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP   87 (299)
T ss_dssp             GSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCT
T ss_pred             CHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCC
Confidence            344455555554322        3578999999999999743 3   26899998654 344567899999999999999


Q ss_pred             cEEeeeeeeeeCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 008698          326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL  405 (557)
Q Consensus       326 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill  405 (557)
                      |||+++|++.+.+..++||||+++|+|.+++..   ....+++.+++.++.|||+||+|||++   +|+||||||+||||
T Consensus        88 nIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl  161 (299)
T d1jpaa_          88 NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV  161 (299)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CCccEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence            999999999999999999999999999998874   235699999999999999999999999   99999999999999


Q ss_pred             CCCCCcEEeeccCCccCCcccccc---ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 008698          406 DEEFGAHLMGVGLSKFVPWEVMQE---RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVC  481 (557)
Q Consensus       406 ~~~~~~kl~Dfgl~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~  481 (557)
                      +.++.+||+|||+++.........   ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.+.....
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~  241 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD  241 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999998765432221   1122337899999999999999999999999999999998 899998754321


Q ss_pred             chhHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          482 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                         +....    ..+       .      ....+.+++..+.+|+.+||+.||++||||+||++.|+++.+.|
T Consensus       242 ---~~~~i----~~~-------~------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         242 ---VINAI----EQD-------Y------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             ---HHHHH----HTT-------C------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ---HHHHH----HcC-------C------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence               11111    100       0      01112335567999999999999999999999999999876654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=413.04  Aligned_cols=250  Identities=26%  Similarity=0.421  Sum_probs=201.4

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|+||+||+|.+++++.||||+++... ...++|.+|+.++.+++|||||+++|++.+ +..++||||+++|+|.
T Consensus        18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~   95 (272)
T d1qpca_          18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLV   95 (272)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHH
T ss_pred             eEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHH
Confidence            45689999999999999888999999997653 345789999999999999999999998754 5679999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      +++...  ....+++..++.++.|||+||+|||++   +|+||||||+||||++++.+||+|||+|+........... .
T Consensus        96 ~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~-~  169 (272)
T d1qpca_          96 DFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-G  169 (272)
T ss_dssp             HHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT-T
T ss_pred             HHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccccc-c
Confidence            987642  234599999999999999999999999   9999999999999999999999999999877544332222 2


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  513 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  513 (557)
                      ..||+.|||||++.++.++.++|||||||++|||+||..|+......  ..+....    ...     ..+        .
T Consensus       170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i----~~~-----~~~--------~  230 (272)
T d1qpca_         170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNL----ERG-----YRM--------V  230 (272)
T ss_dssp             CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH----HTT-----CCC--------C
T ss_pred             cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHH----Hhc-----CCC--------C
Confidence            34889999999999889999999999999999999966554432221  1111111    000     011        1


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       514 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      .+..++..+.+|+.+||+.||++||||++|++.|+.+
T Consensus       231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            1223456789999999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.5e-52  Score=411.99  Aligned_cols=254  Identities=28%  Similarity=0.439  Sum_probs=207.7

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||+||+|.+. +|+.||||+++... ...++|.+|+.+|++++|||||+++|++.+.+..++||||+++|+|
T Consensus        22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l  100 (287)
T d1opja_          22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL  100 (287)
T ss_dssp             EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             eeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcch
Confidence            456899999999999975 48899999997653 3467899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .+++...  ....+++..++.++.|||.||+|||++   +|+||||||+||||+.++.+||+|||+++........... 
T Consensus       101 ~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~-  174 (287)
T d1opja_         101 LDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-  174 (287)
T ss_dssp             HHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET-
T ss_pred             HHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceeec-
Confidence            9999752  346799999999999999999999999   9999999999999999999999999999876544332222 


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ...|++.|+|||++.+..++.++|||||||++|||+||..|+....+.  ..+.+..    ..+     .        ..
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~i----~~~-----~--------~~  235 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELL----EKD-----Y--------RM  235 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHH----HTT-----C--------CC
T ss_pred             cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHHH----hcC-----C--------CC
Confidence            223789999999999999999999999999999999977665433221  1111111    111     0        00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                      ..+..++..+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus       236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            11223456799999999999999999999999999987653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=406.39  Aligned_cols=247  Identities=23%  Similarity=0.358  Sum_probs=202.4

Q ss_pred             ecccCceEEEEEEeC---CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          277 LGDSKTGGTYSGILP---DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       277 lg~G~~g~Vy~g~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ||+|+||+||+|.+.   ++..||||+++... ....++|.+|+++|++++|||||+++|++.+ +..++||||+++|+|
T Consensus        17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L   95 (285)
T d1u59a_          17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPL   95 (285)
T ss_dssp             EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEH
T ss_pred             EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcH
Confidence            799999999999863   35579999997653 3446789999999999999999999999864 568999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc-cce
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-ERT  431 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~  431 (557)
                      .+++..   ....+++.++..++.|||+||+|||++   +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus        96 ~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  169 (285)
T d1u59a_          96 HKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  169 (285)
T ss_dssp             HHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred             HHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccc
Confidence            999854   235699999999999999999999999   9999999999999999999999999999876544322 222


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      ....||+.|+|||++.++.++.++|||||||++|||+| |+.||...+..+   +...    +..+.             
T Consensus       170 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~----i~~~~-------------  229 (285)
T d1u59a_         170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAF----IEQGK-------------  229 (285)
T ss_dssp             CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHH----HHTTC-------------
T ss_pred             cccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCC-------------
Confidence            33458999999999999999999999999999999998 999998765432   1111    11110             


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ....+..++.++.+|+.+||+.||++||||.+|++.|+..
T Consensus       230 ~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            0111233556799999999999999999999999988753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=399.84  Aligned_cols=249  Identities=23%  Similarity=0.382  Sum_probs=207.7

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCChH
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  353 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  353 (557)
                      .+.||+|+||+||+|++++++.||||+++.... ..++|.+|+.++.+++||||++++|++.+.+..++||||+++|+|.
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~   87 (258)
T d1k2pa_           9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL   87 (258)
T ss_dssp             CCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred             eEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence            346799999999999998888999999986543 4578999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccceee
Q 008698          354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  433 (557)
Q Consensus       354 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  433 (557)
                      .++..   ....+++..+.+++.|||+||+|||++   +|+||||||+|||+++++.+||+|||+++.......... ..
T Consensus        88 ~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-~~  160 (258)
T d1k2pa_          88 NYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-VG  160 (258)
T ss_dssp             HHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC-CC
T ss_pred             Hhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee-cc
Confidence            98764   235689999999999999999999999   999999999999999999999999999987654433222 22


Q ss_pred             cCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCCC
Q 008698          434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  512 (557)
Q Consensus       434 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  512 (557)
                      ..+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...+..+....       +...     .        ..
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~-------i~~~-----~--------~~  220 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-------IAQG-----L--------RL  220 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-------HHTT-----C--------CC
T ss_pred             cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH-------HHhC-----C--------CC
Confidence            348999999999999999999999999999999998 8999987654321111       1110     0        01


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       513 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ..+..++..+.+|+.+||+.||++||||++|++.|.++
T Consensus       221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            11223446789999999999999999999999999764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=405.46  Aligned_cols=256  Identities=23%  Similarity=0.390  Sum_probs=198.8

Q ss_pred             CeeecccCceEEEEEEeCCC-----CEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILPDG-----SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .++||+|+||+||+|.+.++     ..||||+++.. ......+|.+|+.++++++|||||+++|++.+.+..++||||+
T Consensus        12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~   91 (283)
T d1mqba_          12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM   91 (283)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence            45789999999999997542     37999999754 3344567999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      .+|++.+++...   ...+++.+++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++.......
T Consensus        92 ~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          92 ENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             TTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             ccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence            999999887642   35699999999999999999999999   999999999999999999999999999987654322


Q ss_pred             c-cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 Q-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      . .......||+.|||||++.++.++.++|||||||++|||+||..|+......  ..+....    ..+     .    
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i----~~~-----~----  230 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAI----NDG-----F----  230 (283)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH----HTT-----C----
T ss_pred             cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHH----hcc-----C----
Confidence            2 1222334899999999999999999999999999999999966655432221  1111111    110     0    


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                          ....+.+++..+.+|+.+||+.||++||||.||++.|+++.+.|
T Consensus       231 ----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         231 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             ----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence                01112234567999999999999999999999999999876654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=403.45  Aligned_cols=248  Identities=27%  Similarity=0.389  Sum_probs=199.6

Q ss_pred             eeecccCceEEEEEEeCC---CCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          275 RLLGDSKTGGTYSGILPD---GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~---g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      +.||+|+||+||+|.+.+   ++.||||+++...  ....++|.+|+.+|++++|||||+++|+|.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            468999999999998643   4689999997542  2345789999999999999999999999864 567999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc-
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-  428 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  428 (557)
                      |+|.+++..    ...+++.+++.++.|||.||+|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999999975    35699999999999999999999999   9999999999999999999999999999876544322 


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      .......||++|||||.+.+..++.++|||||||++|||+| |+.||.+.+...   +...    +..+.          
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~----i~~~~----------  227 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAM----LEKGE----------  227 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHH----HHTTC----------
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHHH----HHcCC----------
Confidence            22233458999999999999999999999999999999998 899998754321   1111    11110          


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                         ....+..++.++.+|+.+||+.||++||||++|++.|+..
T Consensus       228 ---~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         228 ---RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence               0111223456789999999999999999999999988753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-51  Score=400.52  Aligned_cols=247  Identities=22%  Similarity=0.324  Sum_probs=198.9

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||+||++.. .+|+.||||+++... ....+++.+|+.+|++++||||+++++++.+.+..++||||+++|+
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~   89 (271)
T d1nvra_          10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   89 (271)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence            45789999999999997 468999999997553 2334678999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |.+++..    ...+++.++..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+|+...........
T Consensus        90 L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          90 LFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             GGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            9999864    34699999999999999999999999   9999999999999999999999999999876544333333


Q ss_pred             eecCccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          432 VMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      ....||+.|||||++.+..+ +.++|||||||++|||+||+.||........ ......    ....             
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~~~----~~~~-------------  224 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKT-------------  224 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHHHH----TTCT-------------
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHHHh----cCCC-------------
Confidence            34459999999999988776 5789999999999999999999976543211 111000    0000             


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ...+....+.++.+|+.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            01111223456889999999999999999999976

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=400.56  Aligned_cols=246  Identities=21%  Similarity=0.350  Sum_probs=204.6

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +..+.||+|+||+||++.. .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..++||||+++|
T Consensus        23 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg  102 (293)
T d1yhwa1          23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG  102 (293)
T ss_dssp             CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCC
Confidence            4445689999999999996 469999999998765556778999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++..     ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........  
T Consensus       103 ~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~--  172 (293)
T d1yhwa1         103 SLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--  172 (293)
T ss_dssp             BHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--
T ss_pred             cHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc--
Confidence            99998864     3599999999999999999999999   9999999999999999999999999999876543222  


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                      .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+....  +.    .......      +      
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~----~~~~~~~------~------  234 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LY----LIATNGT------P------  234 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH----HHHHHCS------C------
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--HH----HHHhCCC------C------
Confidence            2233599999999999999999999999999999999999999976543211  11    1111100      0      


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ....+...+..+.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00112234567899999999999999999999986

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=394.28  Aligned_cols=240  Identities=26%  Similarity=0.358  Sum_probs=200.8

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||+||++... +|+.||||++.+..   ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~   90 (263)
T d2j4za1          11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL   90 (263)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence            456899999999999974 58999999987542   23457789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..    ...+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        91 g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---  160 (263)
T d2j4za1          91 GTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---  160 (263)
T ss_dssp             CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---
T ss_pred             CcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc---
Confidence            999999964    24699999999999999999999999   99999999999999999999999999998665332   


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                       .....||+.|||||++.+..++.++|||||||++|||+||+.||...+...   +....    ....      .     
T Consensus       161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i----~~~~------~-----  221 (263)
T d2j4za1         161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRI----SRVE------F-----  221 (263)
T ss_dssp             -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH----HTTC------C-----
T ss_pred             -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHHHH----HcCC------C-----
Confidence             223459999999999999999999999999999999999999997654321   11111    0000      0     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ..+...++++.+|+.+||+.||++|||++|+++
T Consensus       222 ---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence               011223456889999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=412.16  Aligned_cols=255  Identities=25%  Similarity=0.363  Sum_probs=202.0

Q ss_pred             CCCeeecccCceEEEEEEeCC-C-----CEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILPD-G-----SRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~-g-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV  343 (557)
                      +..+.||+|+||+||+|.... +     ..||||.+... .......+.+|+.+|.++ +|||||++++++.+.+..++|
T Consensus        40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv  119 (325)
T d1rjba_          40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI  119 (325)
T ss_dssp             EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEE
Confidence            345678999999999998643 2     36999998654 333456799999999998 899999999999999999999


Q ss_pred             EecCCCCChHHHhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008698          344 YEFVVNGPLDRWLHHIPR-------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL  404 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nil  404 (557)
                      |||+++|+|.++|+....                   ....+++..++.++.||++||+|||++   +|+||||||+|||
T Consensus       120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nil  196 (325)
T d1rjba_         120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVL  196 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEE
T ss_pred             EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhccc
Confidence            999999999999975321                   124589999999999999999999999   9999999999999


Q ss_pred             eCCCCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccch
Q 008698          405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQ  483 (557)
Q Consensus       405 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~  483 (557)
                      ++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||.+.+...  
T Consensus       197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~--  274 (325)
T d1rjba_         197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA--  274 (325)
T ss_dssp             EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred             cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH--
Confidence            99999999999999987654433322223347999999999999999999999999999999998 899997654321  


Q ss_pred             hHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008698          484 SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  548 (557)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~  548 (557)
                      .+...    ....     .        ....+..+++.+.+|+.+||+.||++||||+||++.|.
T Consensus       275 ~~~~~----~~~~-----~--------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         275 NFYKL----IQNG-----F--------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HHHHH----HHTT-----C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHH----HhcC-----C--------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            11111    1111     0        00112234567999999999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=400.58  Aligned_cols=250  Identities=23%  Similarity=0.301  Sum_probs=190.7

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeee--CCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~  348 (557)
                      .+.||+|+||+||++.. .+|+.||||.++...  ....+.+.+|+++|++++|||||++++++.+  .+..++||||++
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~   88 (269)
T d2java1           9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE   88 (269)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence            35689999999999986 468999999997653  3345678999999999999999999999865  456899999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +|+|.+++.........+++..+..++.||+.||+|||+..  ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        89 ~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  168 (269)
T d2java1          89 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT  168 (269)
T ss_dssp             TEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC----
T ss_pred             CCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC
Confidence            99999998654334467999999999999999999999861  1249999999999999999999999999998765432


Q ss_pred             cccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ..  .....||+.|||||++.+..++.++|||||||++|||+||+.||...+..+   +...    .......       
T Consensus       169 ~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~----i~~~~~~-------  232 (269)
T d2java1         169 SF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGK----IREGKFR-------  232 (269)
T ss_dssp             ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH----HHHTCCC-------
T ss_pred             Cc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHH----HHcCCCC-------
Confidence            22  123348999999999999999999999999999999999999998654321   1111    1111100       


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                            ..+...++++.+|+.+||+.||++|||++|+++
T Consensus       233 ------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 ------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                  011223457899999999999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=399.93  Aligned_cols=248  Identities=23%  Similarity=0.343  Sum_probs=202.9

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +..+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++||||+++|
T Consensus        15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g   94 (288)
T d2jfla1          15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence            4345689999999999996 468999999998776666788999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|.+++...   ...+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+|+.......  .
T Consensus        95 ~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--~  166 (288)
T d2jfla1          95 AVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R  166 (288)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--H
T ss_pred             cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc--c
Confidence            999987642   35699999999999999999999999   999999999999999999999999999976543221  1


Q ss_pred             eeecCcccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          431 TVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      .....||+.|||||++.     ...++.++|||||||++|||+||+.||.+.+....   ..   ...... .     + 
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~---~i~~~~-~-----~-  233 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LL---KIAKSE-P-----P-  233 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HH---HHHHSC-C-----C-
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HH---HHHcCC-C-----C-
Confidence            22344999999999984     45689999999999999999999999987654321   11   011100 0     0 


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                           ....+...+.++.+|+.+||+.||++|||++|+++
T Consensus       234 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         234 -----TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -----CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 01112234567899999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=398.55  Aligned_cols=254  Identities=25%  Similarity=0.366  Sum_probs=199.7

Q ss_pred             CCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +..+.||+|+||+||+|...+++.||||+++... ...+.|.+|+.++.+++|||||+++|++.+ +..++||||+++|+
T Consensus        20 ~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~   97 (285)
T d1fmka3          20 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS   97 (285)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred             EEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCc
Confidence            3345689999999999999888899999997553 456789999999999999999999999854 56899999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |..++...  ....+++.+++.++.|||.||+|||++   +|+||||||+|||||.++.+||+|||+++.......... 
T Consensus        98 l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-  171 (285)
T d1fmka3          98 LLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-  171 (285)
T ss_dssp             HHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred             hhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee-
Confidence            99988652  234699999999999999999999999   999999999999999999999999999987654433222 


Q ss_pred             eecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ....||+.|+|||++..+.++.++|||||||++|||+||..|+......  ..+.....    ..     ..        
T Consensus       172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~----~~-----~~--------  232 (285)
T d1fmka3         172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVE----RG-----YR--------  232 (285)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----TT-----CC--------
T ss_pred             ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHH----hc-----CC--------
Confidence            2234899999999999999999999999999999999976665443221  11211111    00     00        


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      ...+..+++++.+++.+||+.||++||||++|++.|+....
T Consensus       233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            01122345678999999999999999999999999987654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-50  Score=393.48  Aligned_cols=246  Identities=20%  Similarity=0.351  Sum_probs=194.1

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeee----CCceEEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVY  344 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lV~  344 (557)
                      +..+.||+|+||+||+|... +++.||+|++...  .....+.|.+|+++|++++|||||++++++.+    .+..++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            33446899999999999974 5889999998754  33445679999999999999999999999865    34579999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCcEEeeccCCccCC
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~  423 (557)
                      ||+++|+|.+++..    ...+++..+..++.||++||+|||++ +++|+||||||+|||++ +++.+||+|||+++...
T Consensus        92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999965    24699999999999999999999998 12299999999999996 57899999999998654


Q ss_pred             ccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccC
Q 008698          424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  503 (557)
Q Consensus       424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  503 (557)
                      ....    ....||+.|||||++.+ .++.++|||||||++|||+||+.||......  ..+....    ....     .
T Consensus       167 ~~~~----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~~i----~~~~-----~  230 (270)
T d1t4ha_         167 ASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRV----TSGV-----K  230 (270)
T ss_dssp             TTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHH----TTTC-----C
T ss_pred             CCcc----CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHHHHH----HcCC-----C
Confidence            3222    23459999999998865 6999999999999999999999999754332  1111111    1000     0


Q ss_pred             cccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       504 ~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      +       ...+...++++.+|+.+||+.||++|||++|+++
T Consensus       231 ~-------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 P-------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             C-------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C-------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            0       0011122346889999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-50  Score=401.07  Aligned_cols=258  Identities=25%  Similarity=0.412  Sum_probs=207.9

Q ss_pred             CCCeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEE
Q 008698          272 EGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~  344 (557)
                      +..+.||+|+||+||+|+..      +++.||||+++... ....++|.+|+.+|++++||||+++++++.+.+..++||
T Consensus        16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~   95 (301)
T d1lufa_          16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF   95 (301)
T ss_dssp             EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence            44456799999999999863      35789999997653 334578999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008698          345 EFVVNGPLDRWLHHIPR--------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL  404 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nil  404 (557)
                      ||+++|+|.+++.....                    ....+++..++.++.|+|.||+|||++   +||||||||+|||
T Consensus        96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NIL  172 (301)
T d1lufa_          96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL  172 (301)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceE
Confidence            99999999999964321                    124589999999999999999999999   9999999999999


Q ss_pred             eCCCCCcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCcccch
Q 008698          405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR-RPAQAVDSVCWQ  483 (557)
Q Consensus       405 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~-~p~~~~~~~~~~  483 (557)
                      ||.++.+||+|||+++...............+++.|+|||.+.+..+|.++|||||||++|||++|. +||...+..+. 
T Consensus       173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~-  251 (301)
T d1lufa_         173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV-  251 (301)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-
T ss_pred             ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH-
Confidence            9999999999999998765444333344455889999999999999999999999999999999985 67766544321 


Q ss_pred             hHHHhhhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          484 SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       484 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                        ...    +..+...             ..+..++.++.+|+.+||+.+|++||||.||+++|+++.+
T Consensus       252 --~~~----v~~~~~~-------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         252 --IYY----VRDGNIL-------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             --HHH----HHTTCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --HHH----HHcCCCC-------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence              111    1111110             0122344578999999999999999999999999998864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-50  Score=395.51  Aligned_cols=245  Identities=22%  Similarity=0.312  Sum_probs=198.6

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +..+.||+|+||+||++.. .+|+.||||+++...   ....+.+.+|+.+|++++||||+++++++.+.+..++||||+
T Consensus        11 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~   90 (288)
T d1uu3a_          11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA   90 (288)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEcc
Confidence            3346789999999999996 468999999997542   234567999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++.......
T Consensus        91 ~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          91 KNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             TTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             CCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            99999998864    24699999999999999999999999   999999999999999999999999999987754433


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                      ........||+.|||||++.+..++.++|||||||++|||+||+.||...+...   +....   .. ..        . 
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i---~~-~~--------~-  227 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQKI---IK-LE--------Y-  227 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HT-TC--------C-
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HHHHH---Hc-CC--------C-
Confidence            333334459999999999999999999999999999999999999998654321   11110   00 00        0 


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV  544 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl  544 (557)
                          . .+...++.+.+|+.+||+.||++|||++|++
T Consensus       228 ----~-~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         228 ----D-FPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             ----C-CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ----C-CCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence                0 1122345688999999999999999999863

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-50  Score=404.38  Aligned_cols=261  Identities=22%  Similarity=0.362  Sum_probs=200.2

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      .+.||+|+||+||++.. .+|+.||+|+++.. ......++.+|+.+|++++|||||++++++.+.+..++||||+++|+
T Consensus        11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~   90 (322)
T d1s9ja_          11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   90 (322)
T ss_dssp             EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence            35689999999999996 46899999999754 33445789999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      |.+++.+    ...+++..+..++.||+.||+|||+ +   +|+||||||+|||++.++.+||+|||+|+......    
T Consensus        91 L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----  159 (322)
T d1s9ja_          91 LDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----  159 (322)
T ss_dssp             HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT----
T ss_pred             HHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc----
Confidence            9999965    2459999999999999999999996 5   89999999999999999999999999998653221    


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhh-hhhh---------------
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT-PLVQ---------------  494 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~-~~~~---------------  494 (557)
                      .....||+.|||||++.+..++.++|||||||++|||+||+.||...+............ ....               
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            123359999999999999999999999999999999999999997654432111100000 0000               


Q ss_pred             -------ccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          495 -------SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       495 -------~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                             .....+.++..........+....+.++.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                   000000000000000011111223456889999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-50  Score=391.30  Aligned_cols=247  Identities=28%  Similarity=0.428  Sum_probs=195.6

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeee-CCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||.||+|.+ .|+.||||+++...  ..++|.+|++++++++||||++++|++.+ .+..++||||+++|+|
T Consensus        12 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L   88 (262)
T d1byga_          12 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL   88 (262)
T ss_dssp             EEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred             eEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence            34689999999999998 68899999997653  45789999999999999999999999865 4568999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      .++|...  ....+++..+++++.|||.||+|||+.   +|+||||||+|||++.++.+|++|||+++......     .
T Consensus        89 ~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~  158 (262)
T d1byga_          89 VDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D  158 (262)
T ss_dssp             HHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred             HHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-----c
Confidence            9999652  223589999999999999999999999   99999999999999999999999999998654321     2


Q ss_pred             ecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCCC
Q 008698          433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  511 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  511 (557)
                      ...+|..|+|||++.+..++.++|||||||++|||+| |++|+...+..   ++.....    .+     ..+       
T Consensus       159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~----~~-----~~~-------  219 (262)
T d1byga_         159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE----KG-----YKM-------  219 (262)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHT----TT-----CCC-------
T ss_pred             cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----cC-----CCC-------
Confidence            2337899999999999999999999999999999999 67777665432   2222111    11     011       


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       512 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                       ..+...+.++.+|+.+||+.||++||||.+|++.|++++..
T Consensus       220 -~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         220 -DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence             11123446789999999999999999999999999988653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-49  Score=396.13  Aligned_cols=239  Identities=23%  Similarity=0.401  Sum_probs=195.9

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +.||+|+||+||+|.. .+|+.||||+++...   ....+.+.+|+.+|++++|||||++++++.+.+..++||||+++|
T Consensus        21 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g  100 (309)
T d1u5ra_          21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS  100 (309)
T ss_dssp             EEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCC
Confidence            4579999999999986 468899999997543   233467899999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      +|..++..    ...+++.++..++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++......    
T Consensus       101 ~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~----  169 (309)
T d1u5ra_         101 ASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----  169 (309)
T ss_dssp             HHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC----
T ss_pred             chHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCCC----
Confidence            99876654    35699999999999999999999999   99999999999999999999999999998654322    


Q ss_pred             eeecCccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccc
Q 008698          431 TVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  507 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  507 (557)
                        ...||+.|||||++.+   ..++.++|||||||++|||++|..||.+.....  .+    .......      .    
T Consensus       170 --~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--~~----~~i~~~~------~----  231 (309)
T d1u5ra_         170 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--AL----YHIAQNE------S----  231 (309)
T ss_dssp             --CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH----HHHHHSC------C----
T ss_pred             --ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--HH----HHHHhCC------C----
Confidence              2349999999999864   458999999999999999999999997654321  11    1111100      0    


Q ss_pred             cCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       508 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                         ....+...++.+.+|+.+||+.||++|||++|+++
T Consensus       232 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         232 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence               01111223457899999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=397.75  Aligned_cols=251  Identities=22%  Similarity=0.369  Sum_probs=199.1

Q ss_pred             CeeecccCceEEEEEEeC-CCC----EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      .++||+|+||+||+|.+. +|+    +||||+++.. +....++|.+|+.++++++|||||+++|+|.+. ..++++||+
T Consensus        14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~   92 (317)
T d1xkka_          14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM   92 (317)
T ss_dssp             EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred             eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEec
Confidence            357899999999999864 344    6899988654 344567899999999999999999999999865 567889999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      .+|+|.+++...   ...+++..++.++.|||.||+|||++   +|+||||||+||||+.++.+||+|||+++.......
T Consensus        93 ~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          93 PFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             TTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             cCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence            999999988752   35699999999999999999999999   999999999999999999999999999987765444


Q ss_pred             ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCccc
Q 008698          428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  506 (557)
Q Consensus       428 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  506 (557)
                      ........||+.|||||++.++.++.++|||||||++|||+| |.+||...+.......+.       .+.         
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-------~~~---------  230 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE---------  230 (317)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-------HTC---------
T ss_pred             cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC---------
Confidence            333334458999999999999999999999999999999999 788887665432211111       110         


Q ss_pred             ccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       507 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                          ....+..++..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus       231 ----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         231 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence                00112234567899999999999999999999999987664

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=390.78  Aligned_cols=252  Identities=27%  Similarity=0.377  Sum_probs=194.3

Q ss_pred             CCCeeecccCceEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          272 EGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      +..+.||+|+||.||+|.+..    +..||||.++.. .....+.|.+|+.+|++++||||++++|++. .+..++||||
T Consensus        10 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~   88 (273)
T d1mp8a_          10 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL   88 (273)
T ss_dssp             EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEe
Confidence            345678999999999998643    356999998654 3344578999999999999999999999985 4678999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++|+|.+++...   ...+++..++.++.||++||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        89 ~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          89 CTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             CTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             ccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            9999999987642   35699999999999999999999999   99999999999999999999999999998765433


Q ss_pred             cccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      ... .....||+.|+|||.+.+..++.++|||||||++|||+| |.+||...+..+   +....    ..+.        
T Consensus       163 ~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i----~~~~--------  226 (273)
T d1mp8a_         163 YYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENGE--------  226 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTC--------
T ss_pred             cee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcCC--------
Confidence            222 223348999999999999999999999999999999998 899998765432   11111    1110        


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                           ....+..++..+.+|+.+||+.||++|||++||++.|+.+.
T Consensus       227 -----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         227 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                 00112234567999999999999999999999999998764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-49  Score=392.77  Aligned_cols=248  Identities=20%  Similarity=0.292  Sum_probs=186.9

Q ss_pred             CCCCeeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      ++..+.||+|+||+||++... +|+.||||++..... .....+.+|+.+|++++|||||++++++.+.+..++||||++
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~   90 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS   90 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            344567899999999999964 589999999976532 334678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCcEEeeccCCccCCcc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgl~~~~~~~  425 (557)
                      +|+|.+++..    ...+++.++..++.||+.||+|||++   +|+||||||+|||++   +++.+||+|||+++.....
T Consensus        91 gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          91 GGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             SCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             CCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            9999999964    35699999999999999999999999   999999999999995   5788999999999865433


Q ss_pred             ccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      ..   .....||+.|||||++.+..++.++|||||||++|||+||+.||.+.....   +....   ....       ..
T Consensus       164 ~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i---~~~~-------~~  227 (307)
T d1a06a_         164 SV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQI---LKAE-------YE  227 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH---HTTC-------CC
T ss_pred             Ce---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHH---hccC-------CC
Confidence            22   122349999999999999999999999999999999999999998654321   11111   1100       00


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .    ........++.+.+|+.+||+.||++|||++|+++
T Consensus       228 ~----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         228 F----DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             C----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C----CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            0    00011223456899999999999999999999997

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=389.85  Aligned_cols=255  Identities=26%  Similarity=0.415  Sum_probs=202.2

Q ss_pred             CeeecccCceEEEEEEeCCC----CEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-CceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGILPDG----SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~  347 (557)
                      +++||+|+||+||+|.+.++    ..||||+++.. +....++|.+|+++|++++||||++++|++.+. +..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            35789999999999997542    26899999753 445568899999999999999999999998764 5789999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++..   ....+++..++.++.|+|.||.|||+.   +|+||||||+||||++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            99999999874   235688899999999999999999999   999999999999999999999999999987654422


Q ss_pred             cc--ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          428 QE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       428 ~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      ..  ......||+.|+|||.+.++.++.++||||||+++|||+||..|+......  .++..   ......+        
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~---~i~~g~~--------  252 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITV---YLLQGRR--------  252 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH---HHHTTCC--------
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHH---HHHcCCC--------
Confidence            21  112234899999999999999999999999999999999988777543221  11111   1111110        


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  553 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  553 (557)
                           . ..+..++..+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus       253 -----~-~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         253 -----L-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             -----C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----C-CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                 0 01122345789999999999999999999999999877543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.3e-48  Score=394.18  Aligned_cols=248  Identities=19%  Similarity=0.289  Sum_probs=203.8

Q ss_pred             CCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      ..+.||+|+||.||++.. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||+++|+
T Consensus        30 i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~  109 (350)
T d1koaa2          30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE  109 (350)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence            345689999999999996 4689999999987766677889999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--CCCcEEeeccCCccCCcccccc
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |.+++..   ....+++..+..++.||+.||+|||++   +|+||||||+|||++.  ++.+||+|||+++........ 
T Consensus       110 L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~-  182 (350)
T d1koaa2         110 LFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-  182 (350)
T ss_dssp             HHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE-
T ss_pred             HHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccccc-
Confidence            9999864   234699999999999999999999999   9999999999999964  678999999999876543322 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..+   +....   .... . . ..      
T Consensus       183 --~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i---~~~~-~-~-~~------  245 (350)
T d1koaa2         183 --KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNV---KSCD-W-N-MD------  245 (350)
T ss_dssp             --EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHTC-C-C-SC------
T ss_pred             --ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHH---HhCC-C-C-CC------
Confidence              23449999999999999999999999999999999999999998654321   11111   1000 0 0 00      


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                        .......+..+.+|+.+||+.||++|||++|+++.
T Consensus       246 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         246 --DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             --CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             --cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              00112234568899999999999999999999973

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=394.82  Aligned_cols=259  Identities=26%  Similarity=0.346  Sum_probs=195.6

Q ss_pred             CCCeeecccCceEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeC-CceEE
Q 008698          272 EGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-GDRYI  342 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~-~~~~l  342 (557)
                      +..+.||+|+||.||+|...      +++.||||+++.. .....+.+.+|...+.++ +|+||+.+++++.+. +..++
T Consensus        16 ~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~i   95 (299)
T d1ywna1          16 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV   95 (299)
T ss_dssp             EEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred             EEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEE
Confidence            44567899999999999853      3468999999754 334456788898888887 799999999988765 46899


Q ss_pred             EEecCCCCChHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 008698          343 VYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG  410 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~  410 (557)
                      ||||+++|+|.++++....            ....+++.+++.++.||++||+|||++   +|+||||||+||||+.++.
T Consensus        96 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~  172 (299)
T d1ywna1          96 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNV  172 (299)
T ss_dssp             EEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCc
Confidence            9999999999999975321            124589999999999999999999999   9999999999999999999


Q ss_pred             cEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCcccchhHHHhh
Q 008698          411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR-RPAQAVDSVCWQSIFEWA  489 (557)
Q Consensus       411 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~-~p~~~~~~~~~~~~~~~~  489 (557)
                      +||+|||+|+...............||+.|||||.+.+..++.++|||||||++|||+||. +||.......  .+..  
T Consensus       173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--~~~~--  248 (299)
T d1ywna1         173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR--  248 (299)
T ss_dssp             EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHHH--
T ss_pred             EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--HHHH--
Confidence            9999999998765444333333445999999999999999999999999999999999964 5776544321  1111  


Q ss_pred             hhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       490 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                        ....+.     .+        ..+..++.++.+++.+||+.||++||||+||++.|+++.+
T Consensus       249 --~~~~~~-----~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         249 --RLKEGT-----RM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             --HHHHTC-----CC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHhcCC-----CC--------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence              111110     00        1112234568999999999999999999999999988753

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.4e-48  Score=393.54  Aligned_cols=248  Identities=19%  Similarity=0.269  Sum_probs=204.2

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  350 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  350 (557)
                      +..+.||+|+||.||++.. .+|+.||||+++.........+.+|+.+|++++|||||++++++.+.+..++||||+++|
T Consensus        32 ~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg  111 (352)
T d1koba_          32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG  111 (352)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            4456789999999999996 469999999998776666778999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCCcEEeeccCCccCCccccc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--EEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|.+++..   ....+++.++..++.||+.||+|||++   +|+||||||+||||+  .++.+||+|||+|+....... 
T Consensus       112 ~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~-  184 (352)
T d1koba_         112 ELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-  184 (352)
T ss_dssp             BHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred             hHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence            99888753   235699999999999999999999999   999999999999998  578899999999987654322 


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                        .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+...   +....    ....      ...  
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i----~~~~------~~~--  247 (352)
T d1koba_         185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNV----KRCD------WEF--  247 (352)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH----HHCC------CCC--
T ss_pred             --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HhCC------CCC--
Confidence              223448999999999999999999999999999999999999998754422   11111    0000      000  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        ........+..+.+|+.+||+.||.+|||++|+++
T Consensus       248 --~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         248 --DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             --CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00011223456889999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=389.08  Aligned_cols=259  Identities=22%  Similarity=0.375  Sum_probs=209.5

Q ss_pred             CCeeecccCceEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEe
Q 008698          273 GNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  345 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  345 (557)
                      ..+.||+|+||+||+|.+.      +++.||||+++.. .......|.+|+.++++++||||++++|++...+..++|||
T Consensus        24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e  103 (308)
T d1p4oa_          24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME  103 (308)
T ss_dssp             EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence            3456899999999999863      3578999999754 33445679999999999999999999999999999999999


Q ss_pred             cCCCCChHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCC
Q 008698          346 FVVNGPLDRWLHHIP------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS  419 (557)
Q Consensus       346 ~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~  419 (557)
                      |+++|+|.+++....      .....+++..+.+++.|+|+||.|||++   +|+||||||+|||++.++++||+|||++
T Consensus       104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla  180 (308)
T d1p4oa_         104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT  180 (308)
T ss_dssp             CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred             ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccc
Confidence            999999999886421      1224579999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCcccchhHHHhhhhhhhcccc
Q 008698          420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR-RPAQAVDSVCWQSIFEWATPLVQSHRY  498 (557)
Q Consensus       420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (557)
                      +...............+|+.|+|||.+.+..++.++||||||+++|||+||. +||...+...   .....    .... 
T Consensus       181 ~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---~~~~i----~~~~-  252 (308)
T d1p4oa_         181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLRFV----MEGG-  252 (308)
T ss_dssp             CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHHHH----HTTC-
T ss_pred             eeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HhCC-
Confidence            8765544333333334899999999999999999999999999999999985 6776543321   11111    1111 


Q ss_pred             ccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008698          499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  554 (557)
Q Consensus       499 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  554 (557)
                             .    . ..+..++..+.+++.+||+.+|++||||++|++.|++..+|.
T Consensus       253 -------~----~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         253 -------L----L-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             -------C----C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             -------C----C-CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence                   1    0 011234467999999999999999999999999999887764

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=389.00  Aligned_cols=268  Identities=21%  Similarity=0.278  Sum_probs=196.7

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC----ceEEEEecCCCC
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----DRYIVYEFVVNG  350 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~~~~g  350 (557)
                      +.||+|+||.||+|++ +|+.||||+++.... ....+..|+..+..++||||++++|++.+.+    ..++||||+++|
T Consensus         9 ~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g   86 (303)
T d1vjya_           9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG   86 (303)
T ss_dssp             EEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred             EEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence            4689999999999997 789999999975432 2222344566667889999999999998654    579999999999


Q ss_pred             ChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcc
Q 008698          351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  425 (557)
Q Consensus       351 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  425 (557)
                      +|.++|+.     ..+++.+++.++.|+|.||+|||+..     .++|+||||||+||||+.++.+||+|||+++.....
T Consensus        87 ~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~  161 (303)
T d1vjya_          87 SLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             BHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence            99999975     35999999999999999999999631     349999999999999999999999999999866433


Q ss_pred             ccc--cceeecCccccccccccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh--HHH--hhhhhh
Q 008698          426 VMQ--ERTVMAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS--IFE--WATPLV  493 (557)
Q Consensus       426 ~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~--~~~--~~~~~~  493 (557)
                      ...  .......||+.|+|||++.+.      .++.++|||||||+||||+||..|+..........  ...  ......
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T d1vjya_         162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM  241 (303)
T ss_dssp             TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred             CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence            221  122334599999999998754      25779999999999999999998875433221100  000  000000


Q ss_pred             hccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       494 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      ......+.+++.+   .......+.+..+.+|+.+||+.||++||||.||++.|+++.+
T Consensus       242 ~~~~~~~~~~p~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         242 RKVVCEQKLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHTTSCCCCCC---CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhccccCCCC---CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            0000011111111   0111233466779999999999999999999999999987754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-48  Score=386.23  Aligned_cols=249  Identities=18%  Similarity=0.283  Sum_probs=201.3

Q ss_pred             CCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccch------hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEE
Q 008698          270 FSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l  342 (557)
                      +++..+.||+|+||+||++.. .+|+.||||++++...      ...+.+.+|+.+|++++|||||++++++.+.+..++
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            344456789999999999997 4699999999965421      235789999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CcEEeeccC
Q 008698          343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGL  418 (557)
Q Consensus       343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgl  418 (557)
                      ||||+++|+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++    .+|++|||+
T Consensus        91 v~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          91 ILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999965    24699999999999999999999999   999999999999998776    489999999


Q ss_pred             CccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccc
Q 008698          419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  498 (557)
Q Consensus       419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  498 (557)
                      +.........   ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+   .....    .....
T Consensus       164 a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i----~~~~~  233 (293)
T d1jksa_         164 AHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANV----SAVNY  233 (293)
T ss_dssp             CEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HTTCC
T ss_pred             hhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHHHH----HhcCC
Confidence            9876543222   22348999999999999999999999999999999999999998654321   11100    00000


Q ss_pred             ccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       499 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       . ....        .....+..+.+|+.+||+.||++|||++|+++
T Consensus       234 -~-~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 -E-FEDE--------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -C-CCHH--------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -C-CCch--------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0 0000        01123456889999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-49  Score=386.28  Aligned_cols=250  Identities=24%  Similarity=0.314  Sum_probs=191.9

Q ss_pred             eeecccCceEEEEEEeCC--C--CEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecC
Q 008698          275 RLLGDSKTGGTYSGILPD--G--SRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  347 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~--g--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  347 (557)
                      +.||+|+||.||+|++..  +  ..||||+++..   .....++|.+|+.+|++++||||++++|++.+ +..++||||+
T Consensus        14 ~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~   92 (273)
T d1u46a_          14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELA   92 (273)
T ss_dssp             EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             EEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeee
Confidence            457999999999998632  3  37999998754   23445789999999999999999999999976 4678999999


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      ++|+|.+++...   ...+++..++.++.|||.||.|||++   +|+||||||+||||+.++.+||+|||+++.......
T Consensus        93 ~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~  166 (273)
T d1u46a_          93 PLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD  166 (273)
T ss_dssp             TTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred             cCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence            999999887642   24599999999999999999999999   999999999999999999999999999997654433


Q ss_pred             cc-ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          428 QE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       428 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      .. ......||..|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+   .....   .....        
T Consensus       167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i---~~~~~--------  232 (273)
T d1u46a_         167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKI---DKEGE--------  232 (273)
T ss_dssp             EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH---HTSCC--------
T ss_pred             cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHH---HhCCC--------
Confidence            22 2223347889999999999999999999999999999998 899997654321   11111   11110        


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                           ....+..++..+.+|+.+||+.||++||||++|++.|++.
T Consensus       233 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 -----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                 0011123345789999999999999999999999999764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-49  Score=393.33  Aligned_cols=258  Identities=24%  Similarity=0.382  Sum_probs=206.6

Q ss_pred             CCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV  343 (557)
                      +..+.||+|+||.||+|++      .+++.||||+++... .....+|.+|+.++.++ +|||||+++|++.+.+..++|
T Consensus        26 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lv  105 (311)
T d1t46a_          26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI  105 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEE
Confidence            3456789999999999985      346789999997653 34556899999999999 799999999999999999999


Q ss_pred             EecCCCCChHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008698          344 YEFVVNGPLDRWLHHIPR--------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  409 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~  409 (557)
                      |||+++|+|.++++....              ....+++..+..++.|||.||+|||++   +++||||||+|||++.++
T Consensus       106 mE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~  182 (311)
T d1t46a_         106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGR  182 (311)
T ss_dssp             EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTT
T ss_pred             EEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccC
Confidence            999999999999975321              224689999999999999999999999   999999999999999999


Q ss_pred             CcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHh
Q 008698          410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEW  488 (557)
Q Consensus       410 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~  488 (557)
                      .+|++|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+|+...+..+  .+.. 
T Consensus       183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--~~~~-  259 (311)
T d1t46a_         183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--KFYK-  259 (311)
T ss_dssp             EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--HHHH-
T ss_pred             cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH--HHHH-
Confidence            999999999997765443333334458999999999999999999999999999999999 555555443321  1111 


Q ss_pred             hhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       489 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                         ....+     ..+        ..+...+..+.+|+.+||+.||++||||++|+++|+++.
T Consensus       260 ---~i~~~-----~~~--------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         260 ---MIKEG-----FRM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             ---HHHHT-----CCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHhcC-----CCC--------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence               11111     000        111223457899999999999999999999999998653

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=389.35  Aligned_cols=257  Identities=25%  Similarity=0.405  Sum_probs=203.8

Q ss_pred             CCCeeecccCceEEEEEEeCC--------CCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceE
Q 008698          272 EGNRLLGDSKTGGTYSGILPD--------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY  341 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~~--------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~  341 (557)
                      +..+.||+|+||.||+|+...        +..||||+++... .....++.+|...+.++ +|||||++++++.+++..+
T Consensus        16 ~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~   95 (299)
T d1fgka_          16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY   95 (299)
T ss_dssp             EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEE
Confidence            344678999999999998522        3479999997654 34457899999999998 8999999999999999999


Q ss_pred             EEEecCCCCChHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008698          342 IVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  409 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~  409 (557)
                      +||||+++|+|.+++.....            ....+++.+++.++.|||.||+|||++   +||||||||+|||++.++
T Consensus        96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~  172 (299)
T d1fgka_          96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDN  172 (299)
T ss_dssp             EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTC
T ss_pred             EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCC
Confidence            99999999999999975421            235689999999999999999999999   999999999999999999


Q ss_pred             CcEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccchhHHHh
Q 008698          410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEW  488 (557)
Q Consensus       410 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~t-G~~p~~~~~~~~~~~~~~~  488 (557)
                      .+||+|||+++...............+|+.|+|||.+.++.++.++|||||||++|||+| |.+||...+..   .+.+.
T Consensus       173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~~~~~  249 (299)
T d1fgka_         173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---ELFKL  249 (299)
T ss_dssp             CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH
T ss_pred             CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---HHHHH
Confidence            999999999987765544444444558999999999999999999999999999999998 68888755432   11111


Q ss_pred             hhhhhhccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008698          489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  551 (557)
Q Consensus       489 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  551 (557)
                          +..+.     .        ...+..++..+.+|+.+||+.||++|||++||++.|+++.
T Consensus       250 ----i~~~~-----~--------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         250 ----LKEGH-----R--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             ----HHTTC-----C--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHcCC-----C--------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence                11110     0        0111223457899999999999999999999999998763

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-48  Score=387.88  Aligned_cols=253  Identities=27%  Similarity=0.444  Sum_probs=200.6

Q ss_pred             CeeecccCceEEEEEEeCC-CC--EEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILPD-GS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~-g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|+||+||+|.+.+ |.  .||||+++.. .....+.|.+|+++|.++ +|||||+++|++.+.+..++||||++
T Consensus        15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~   94 (309)
T d1fvra_          15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   94 (309)
T ss_dssp             EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence            4578999999999999754 43  5788888644 333456899999999999 79999999999999999999999999


Q ss_pred             CCChHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeec
Q 008698          349 NGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  416 (557)
Q Consensus       349 ~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  416 (557)
                      +|+|.++|+...            .....+++.++..++.|||.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~Df  171 (309)
T d1fvra_          95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF  171 (309)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCT
T ss_pred             CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEccc
Confidence            999999997531            2346799999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCcccchhHHHhhhhhhhc
Q 008698          417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR-RPAQAVDSVCWQSIFEWATPLVQS  495 (557)
Q Consensus       417 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~-~p~~~~~~~~~~~~~~~~~~~~~~  495 (557)
                      |+++........   ....||..|+|||.+.+..++.++|||||||++|||++|. +||...+...   +...+.   ..
T Consensus       172 G~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~i~---~~  242 (309)
T d1fvra_         172 GLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLP---QG  242 (309)
T ss_dssp             TCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHGG---GT
T ss_pred             cccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHHHH---hc
Confidence            999865433222   2334899999999999999999999999999999999976 4666543321   111111   00


Q ss_pred             cccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008698          496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  552 (557)
Q Consensus       496 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  552 (557)
                      .              ....+..+++++.+|+.+||+.||++||||+||++.|+++.+
T Consensus       243 ~--------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         243 Y--------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             C--------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C--------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            0              011122345679999999999999999999999999987654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-47  Score=381.05  Aligned_cols=242  Identities=24%  Similarity=0.274  Sum_probs=200.7

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||.||++.. .+|+.||||++++..   ....+.+.+|+.+|++++||||+++++++.+.+..++||||+++
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g   89 (337)
T d1o6la_          10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   89 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCC
Confidence            45789999999999996 469999999997542   23457789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+........ 
T Consensus        90 g~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~-  161 (337)
T d1o6la_          90 GELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-  161 (337)
T ss_dssp             CBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC-
T ss_pred             Cchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCcc-
Confidence            999999875    35689999999999999999999999   9999999999999999999999999999865433221 


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                       .....||+.|+|||++.+..++.++||||+||++|||++|++||.+.+...   +....    ....        +   
T Consensus       162 -~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~i----~~~~--------~---  222 (337)
T d1o6la_         162 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELI----LMEE--------I---  222 (337)
T ss_dssp             -BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCC--------C---
T ss_pred             -cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHHH----hcCC--------C---
Confidence             222349999999999999999999999999999999999999998765422   11111    0000        0   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~  545 (557)
                         ..+...+.++.+|+.+||+.||++||+     ++|+++
T Consensus       223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               011223456889999999999999995     788876

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-46  Score=377.20  Aligned_cols=239  Identities=22%  Similarity=0.326  Sum_probs=199.0

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||+||++.. .+|+.||||++++..   ....+.+.+|+.+|++++||||+++++++.+.+..++||||+++
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g   88 (316)
T d1fota_           9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG   88 (316)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCC
Confidence            35679999999999996 469999999997542   23457899999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|..++..    ...+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+......   
T Consensus        89 g~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~---  158 (316)
T d1fota_          89 GELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---  158 (316)
T ss_dssp             CBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB---
T ss_pred             ccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc---
Confidence            999998865    35688899999999999999999999   99999999999999999999999999998765332   


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+....   ..   .... ..        .   
T Consensus       159 --~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~---~i~~-~~--------~---  218 (316)
T d1fota_         159 --YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YE---KILN-AE--------L---  218 (316)
T ss_dssp             --CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH---HHHH-CC--------C---
T ss_pred             --ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH---HH---HHHc-CC--------C---
Confidence              224599999999999999999999999999999999999999987543211   11   1111 00        0   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                         ..+...+..+.+++.+||+.||.+||     |++++++
T Consensus       219 ---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence               01112345688999999999999996     8999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1e-46  Score=372.01  Aligned_cols=256  Identities=23%  Similarity=0.307  Sum_probs=198.3

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCc----eEEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD----RYIV  343 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~----~~lV  343 (557)
                      +..+.||+|+||+||++.. .+|+.||||+++...   ......|.+|+.++++++||||+++++++...+.    .|+|
T Consensus        10 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lv   89 (277)
T d1o6ya_          10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV   89 (277)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEE
Confidence            4456789999999999996 469999999997543   3345679999999999999999999999876543    7899


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      |||+++|+|.+++..    ...+++.+++.++.||+.||+|||++   +|+||||||+|||++.++..+++|||.+....
T Consensus        90 mE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          90 MEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             EECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             EECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhc
Confidence            999999999998864    24699999999999999999999999   99999999999999999999999999987654


Q ss_pred             cccc-ccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccccc
Q 008698          424 WEVM-QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  502 (557)
Q Consensus       424 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (557)
                      .... ........||+.|||||++.+..++.++|||||||++|||+||+.||...+..+.      .........    .
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~----~  232 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP----I  232 (277)
T ss_dssp             ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCC----C
T ss_pred             cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCC----C
Confidence            3322 2222334599999999999999999999999999999999999999986543211      111111110    0


Q ss_pred             CcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhccc
Q 008698          503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-RMSHVVHQLQQLA  551 (557)
Q Consensus       503 d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-t~~evl~~L~~~~  551 (557)
                      .+..       ...+.+..+.+++.+||+.||++|| |++++++.|.++.
T Consensus       233 ~~~~-------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 PPSA-------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CGGG-------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCch-------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            0000       0112345688999999999999999 8999999998764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=380.26  Aligned_cols=253  Identities=17%  Similarity=0.242  Sum_probs=197.9

Q ss_pred             hcCCCCCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEEeeeeeeee----CCce
Q 008698          267 TKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD----HGDR  340 (557)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~----~~~~  340 (557)
                      .++|....++||+|+||.||++.. .+|+.||||+++..     ..+.+|+.++.++ +|||||++++++.+    .+..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            345544456789999999999996 56899999999643     4577899887665 89999999999865    4568


Q ss_pred             EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCcEEeecc
Q 008698          341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVG  417 (557)
Q Consensus       341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfg  417 (557)
                      |+||||+++|+|.++|..  .....+++.++..++.||+.||+|||++   +|+||||||+|||++.   ++.+||+|||
T Consensus        85 ~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence            999999999999999975  2345699999999999999999999999   9999999999999986   4569999999


Q ss_pred             CCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccc
Q 008698          418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  497 (557)
Q Consensus       418 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~  497 (557)
                      +++........   ....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+.......   ...      
T Consensus       160 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~------  227 (335)
T d2ozaa1         160 FAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKT------  227 (335)
T ss_dssp             TCEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred             eeeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHH------
Confidence            99876543322   234499999999999999999999999999999999999999976543221100   000      


Q ss_pred             cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       498 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                        .+...... . ........++++.+|+.+||+.||++|||++|+++
T Consensus       228 --~i~~~~~~-~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         228 --RIRMGQYE-F-PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             --CCCSCSSS-C-CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HHhcCCCC-C-CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              00000000 0 01111245677999999999999999999999987

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.7e-46  Score=368.01  Aligned_cols=247  Identities=22%  Similarity=0.307  Sum_probs=199.4

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccch---------hhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCce
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---------QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDR  340 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~  340 (557)
                      +..+.||+|+||+||+++. .+|+.||||+++....         ...+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus         6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~   85 (277)
T d1phka_           6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF   85 (277)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence            3356789999999999996 5689999999975421         12356889999999996 99999999999999999


Q ss_pred             EEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      ++||||+++|+|.+++..    ...+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          86 FLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence            999999999999999965    24699999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccccccceeecCccccccccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhh
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYR------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ  494 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~  494 (557)
                      ........   ....||+.|+|||.+.+      ..++.++||||+||++|||+||+.||.+.+.....   ..    ..
T Consensus       159 ~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~---~~----i~  228 (277)
T d1phka_         159 QLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML---RM----IM  228 (277)
T ss_dssp             ECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH----HH
T ss_pred             EccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH---HH----HH
Confidence            76543222   22348999999998863      34688999999999999999999999876542211   10    11


Q ss_pred             ccccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       495 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..... .         ........++++.+|+.+||+.||++|||++||++
T Consensus       229 ~~~~~-~---------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         229 SGNYQ-F---------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HTCCC-C---------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hCCCC-C---------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11100 0         01111234567999999999999999999999976

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=374.46  Aligned_cols=266  Identities=20%  Similarity=0.243  Sum_probs=196.0

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccchhh-----HHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR-----KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      ++||+|+||+||+|.. .+|+.||||+++......     .+.+.+|+.+|++++|||||++++++.+.+..++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            4689999999999996 458999999997543221     2468899999999999999999999999999999999998


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      ++++..+..    ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........
T Consensus        84 ~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          84 TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             chHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            887766653    245688999999999999999999999   9999999999999999999999999999876543322


Q ss_pred             cceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhhhhhccc--cccccCc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHR--YLELLDP  504 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~d~  504 (557)
                      .  ....||+.|+|||++... .++.++|||||||++|||+||.+||...+..+... +.+..........  .......
T Consensus       157 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         157 Y--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             C--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             c--cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence            1  223489999999998754 57999999999999999999999998765432111 1110000000000  0000000


Q ss_pred             -ccccCCCCCCc----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcc
Q 008698          505 -LISSLSSDIPE----AGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQL  550 (557)
Q Consensus       505 -~l~~~~~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~  550 (557)
                       ..... ...+.    ....+.+.+|+.+||+.||++|||++|+++  .|.+.
T Consensus       235 ~~~~~~-~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         235 VTFKSF-PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCC-CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             hhhccC-CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence             00000 00000    112456889999999999999999999997  46543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.7e-46  Score=380.47  Aligned_cols=243  Identities=20%  Similarity=0.250  Sum_probs=193.9

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHH---HHHHHhhcCCCcEEeeeeeeeeCCceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYS---EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~---~~~~~~~~---e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  346 (557)
                      .++||+|+||.||++... +|+.||||++.+...   .....+.+   |+.+++.++|||||++++++.+.+..++||||
T Consensus         9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~   88 (364)
T d1omwa3           9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL   88 (364)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence            457899999999999964 699999999864321   22233444   46677778899999999999999999999999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      +++|+|.++|..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        89 ~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~  161 (364)
T d1omwa3          89 MNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  161 (364)
T ss_dssp             CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred             cCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence            999999999965    24688999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcc
Q 008698          427 MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  505 (557)
Q Consensus       427 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  505 (557)
                      .    ....||+.|+|||++.. ..++.++|||||||++|||+||+.||..........+....            ... 
T Consensus       162 ~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~------------~~~-  224 (364)
T d1omwa3         162 P----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------------LTM-  224 (364)
T ss_dssp             C----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS------------SSC-
T ss_pred             c----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------ccC-
Confidence            2    23349999999999975 46899999999999999999999999875543221111100            000 


Q ss_pred             cccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008698          506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  545 (557)
Q Consensus       506 l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~  545 (557)
                           ....+...++.+.+|+.+||+.||++|||     ++|+++
T Consensus       225 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 -----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                 00011223456899999999999999999     688875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.5e-46  Score=376.53  Aligned_cols=239  Identities=21%  Similarity=0.271  Sum_probs=198.8

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      -+.||+|+||.||++.. .+|+.||||+++...   ....+.+.+|+.+|+.++||||+++++++.+.+..++||||+.+
T Consensus        46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~  125 (350)
T d1rdqe_          46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG  125 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccc
Confidence            35689999999999996 469999999996542   23356789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  429 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  429 (557)
                      |+|..++..    ...+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+|||+++......   
T Consensus       126 g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~---  195 (350)
T d1rdqe_         126 GEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---  195 (350)
T ss_dssp             CBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---
T ss_pred             cchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc---
Confidence            999999865    24699999999999999999999999   99999999999999999999999999998764322   


Q ss_pred             ceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccC
Q 008698          430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  509 (557)
Q Consensus       430 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  509 (557)
                        ....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+...   +....   .. ..        .   
T Consensus       196 --~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i---~~-~~--------~---  255 (350)
T d1rdqe_         196 --WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKI---VS-GK--------V---  255 (350)
T ss_dssp             --CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH-CC--------C---
T ss_pred             --ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHHHH---hc-CC--------C---
Confidence              12349999999999999999999999999999999999999998654321   11111   00 00        0   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          510 SSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       510 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                         ..+...+..+.+++.+||+.||.+|+     |++++++
T Consensus       256 ---~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               01122345688999999999999994     8999986

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=371.62  Aligned_cols=245  Identities=17%  Similarity=0.206  Sum_probs=198.9

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      .+.||+|+||+||++... +|+.||||+++... .....+.+|+++|++++||||+++++++.+.+..|+||||+++|+|
T Consensus        10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L   88 (321)
T d1tkia_          10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI   88 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcH
Confidence            456899999999999974 58899999997654 3346788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC--CCcEEeeccCCccCCccccccc
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--FGAHLMGVGLSKFVPWEVMQER  430 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~Dfgl~~~~~~~~~~~~  430 (557)
                      .+++..   .+..+++.++..++.||+.||+|||++   +|+||||||+|||++.+  ..+||+|||+++........  
T Consensus        89 ~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~--  160 (321)
T d1tkia_          89 FERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--  160 (321)
T ss_dssp             HHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE--
T ss_pred             HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCcc--
Confidence            999964   234699999999999999999999999   99999999999999854  57899999999876543322  


Q ss_pred             eeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCcccccCC
Q 008698          431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  510 (557)
Q Consensus       431 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  510 (557)
                       ....+|+.|+|||.+.+..++.++|||||||++|||++|..||...+...   +....   .... .  .++...    
T Consensus       161 -~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~~i---~~~~-~--~~~~~~----  226 (321)
T d1tkia_         161 -RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENI---MNAE-Y--TFDEEA----  226 (321)
T ss_dssp             -EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---HHTC-C--CCCHHH----
T ss_pred             -cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HHHHH---HhCC-C--CCChhh----
Confidence             22348999999999999999999999999999999999999998754321   11111   1000 0  000000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       511 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                          ....+.++.+|+.+||+.||++|||++|+++
T Consensus       227 ----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         227 ----FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0113456889999999999999999999997

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-46  Score=373.90  Aligned_cols=242  Identities=23%  Similarity=0.327  Sum_probs=196.8

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHh-hcCCCcEEeeeeeeeeCCceEEEEecCC
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFA-RLHHPNLVAVKGCCYDHGDRYIVYEFVV  348 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~H~niv~l~g~~~~~~~~~lV~E~~~  348 (557)
                      .+.||+|+||+||+|+.. +|+.||||++++..   ....+.+..|..++. .++||||+++++++.+.+..|+||||++
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~   86 (320)
T d1xjda_           7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN   86 (320)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence            457899999999999974 58999999997542   233456777777765 6899999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccc
Q 008698          349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  428 (557)
                      +|+|.+++..    ...+++.++..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++........
T Consensus        87 ~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          87 GGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             TCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             CCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccccc
Confidence            9999999975    24589999999999999999999999   9999999999999999999999999999865433222


Q ss_pred             cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccccCccccc
Q 008698          429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  508 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  508 (557)
                        .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+...   +....    ...      .+    
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i----~~~------~~----  220 (320)
T d1xjda_         160 --TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSI----RMD------NP----  220 (320)
T ss_dssp             --BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHC------CC----
T ss_pred             --ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHH----HcC------CC----
Confidence              222349999999999999999999999999999999999999998755421   11111    111      01    


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 008698          509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVVH  545 (557)
Q Consensus       509 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~-evl~  545 (557)
                          ..+...+..+.+|+.+||+.||++|||+. ++++
T Consensus       221 ----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 ----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                01122345688999999999999999995 6753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=367.93  Aligned_cols=272  Identities=21%  Similarity=0.302  Sum_probs=199.0

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|+||+||+|.. .+|+.||||+++....  ...+++.+|+.+|++++|||||++++++.+.+..++||||+.++ 
T Consensus         8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~-   86 (298)
T d1gz8a_           8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-   86 (298)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE-
T ss_pred             cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCc-
Confidence            4679999999999996 5699999999965432  23568999999999999999999999999999999999999654 


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      +.+++..  .....+++..+..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.........  
T Consensus        87 ~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~--  159 (298)
T d1gz8a_          87 LKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--  159 (298)
T ss_dssp             HHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT--
T ss_pred             hhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcccc--
Confidence            4444433  2345699999999999999999999999   99999999999999999999999999997654332221  


Q ss_pred             eecCccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCcccch-hHHHhhhhhhhccccccc--c---Cc
Q 008698          432 VMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLEL--L---DP  504 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~---d~  504 (557)
                      ....||+.|+|||.+.... ++.++|||||||++|||++|+.||...+..+.. ........ ..+......  .   ..
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~  238 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT-PDEVVWPGVTSMPDYKP  238 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSTTGGGSTTCCT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC-Cchhhcccccccccccc
Confidence            1234899999999887765 588999999999999999999999865432211 11100000 000000000  0   00


Q ss_pred             ccccCCCCCC---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcccCCCCC
Q 008698          505 LISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLAQPPVT  556 (557)
Q Consensus       505 ~l~~~~~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~~~~~~  556 (557)
                      ..........   ....+..+.+|+.+||+.||++|||++|+++.  |+++.+| +|
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p-~p  294 (298)
T d1gz8a_         239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP-VP  294 (298)
T ss_dssp             TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC-CC
T ss_pred             ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC-CC
Confidence            0000000000   01223568899999999999999999999984  7777554 44

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.5e-45  Score=359.97  Aligned_cols=262  Identities=21%  Similarity=0.260  Sum_probs=195.0

Q ss_pred             eeecccCceEEEEEEeCCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      +.||+|+||+||+|...+|+.||||+++....  ...+++.+|+.+|++++||||+++++++.+.+..+++|||+.++.+
T Consensus         8 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~   87 (286)
T d1ob3a_           8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK   87 (286)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHH
T ss_pred             cEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhH
Confidence            45799999999999998999999999976532  2357899999999999999999999999999999999999987766


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccccccee
Q 008698          353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  432 (557)
Q Consensus       353 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  432 (557)
                      ..+...    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++.........  ..
T Consensus        88 ~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~  158 (286)
T d1ob3a_          88 KLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YT  158 (286)
T ss_dssp             HHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             HHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc--cc
Confidence            666542    36699999999999999999999999   9999999999999999999999999999765433221  22


Q ss_pred             ecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhhhhhc--cccccc--cCccc
Q 008698          433 MAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQS--HRYLEL--LDPLI  506 (557)
Q Consensus       433 ~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~--~d~~l  506 (557)
                      ...+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+... ...........  ......  .+...
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            23488999999998764 56899999999999999999999998654322111 11000000000  000000  00000


Q ss_pred             ccCCC---CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          507 SSLSS---DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       507 ~~~~~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      .....   .......+..+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000   0001123456889999999999999999999984

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=361.58  Aligned_cols=269  Identities=19%  Similarity=0.236  Sum_probs=192.7

Q ss_pred             CeeecccCceEEEEEEe-CC-CCEEEEEEecccch--hhHHHHHHHHHHHhhc---CCCcEEeeeeeeee-----CCceE
Q 008698          274 NRLLGDSKTGGTYSGIL-PD-GSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCYD-----HGDRY  341 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~-g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~-----~~~~~  341 (557)
                      .+.||+|+||+||++.. .+ ++.||||+++....  .....+.+|+.+|+.+   +||||+++++++..     ....+
T Consensus        12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~   91 (305)
T d1blxa_          12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   91 (305)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred             EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence            44679999999999996 34 56799999865422  1223456677766655   89999999999853     34679


Q ss_pred             EEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      ++|||+.++++.....   .....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          92 LVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             EEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             EEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence            9999998877654443   2345689999999999999999999999   999999999999999999999999999986


Q ss_pred             CCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhhhhhhccc---
Q 008698          422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHR---  497 (557)
Q Consensus       422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~~~~~~~~---  497 (557)
                      ......   .....||+.|+|||++.+..++.++||||+||++|||+||+.||...+..+... +............   
T Consensus       166 ~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         166 YSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence            543322   223459999999999999999999999999999999999999998765432111 1111000000000   


Q ss_pred             --cccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhccc
Q 008698          498 --YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLA  551 (557)
Q Consensus       498 --~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~  551 (557)
                        .....................++.+.+|+.+||+.||++|||++|+++.  |+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence              0000000000000000111234568899999999999999999999873  55443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=362.76  Aligned_cols=241  Identities=21%  Similarity=0.323  Sum_probs=193.0

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccch------hhHHHHHHHHHHHhhcC--CCcEEeeeeeeeeCCceEE
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF------QRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYI  342 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~l  342 (557)
                      +..++||+|+||+||+|.. .+|+.||||+++....      ....++.+|+.+|++++  ||||+++++++.+.+..++
T Consensus         7 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~l   86 (273)
T d1xwsa_           7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL   86 (273)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEE
Confidence            4456789999999999996 4689999999875421      12234678999999996  9999999999999999999


Q ss_pred             EEecCCC-CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCcEEeeccCCc
Q 008698          343 VYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSK  420 (557)
Q Consensus       343 V~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~~  420 (557)
                      ||||+.+ +++.+++..    ...+++.++..++.||++||+|||++   +|+||||||+|||++.+ +.+||+|||+++
T Consensus        87 v~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          87 ILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccce
Confidence            9999976 577777754    24699999999999999999999999   99999999999999854 789999999998


Q ss_pred             cCCccccccceeecCccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      .......    ....||+.|+|||++.+..+ +.++|||||||++|||+||+.||...+.     +       ....   
T Consensus       160 ~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i-------~~~~---  220 (273)
T d1xwsa_         160 LLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-------IRGQ---  220 (273)
T ss_dssp             ECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------HHCC---
T ss_pred             ecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H-------hhcc---
Confidence            6543322    22349999999999987765 5678999999999999999999975311     0       0000   


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcc
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQL  550 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~  550 (557)
                      ..+            +...+.++.+++.+||+.||++|||++|+++  .|+++
T Consensus       221 ~~~------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         221 VFF------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CCC------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             cCC------------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            001            1112356889999999999999999999987  35544

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-43  Score=352.60  Aligned_cols=264  Identities=17%  Similarity=0.209  Sum_probs=190.7

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeee--------CCceEEE
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--------HGDRYIV  343 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--------~~~~~lV  343 (557)
                      +.||+|+||+||+|.. .+|+.||||++....  .....++.+|+.+|++++||||+++++++..        .+..++|
T Consensus        16 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv   95 (318)
T d3blha1          16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV   95 (318)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEE
T ss_pred             EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEE
Confidence            4679999999999996 479999999986542  2335678999999999999999999998855        3457999


Q ss_pred             EecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCC
Q 008698          344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  423 (557)
Q Consensus       344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~  423 (557)
                      |||+.++.+..+..    ....++...+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        96 ~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~  168 (318)
T d3blha1          96 FDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS  168 (318)
T ss_dssp             EECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeecc
Confidence            99998877665543    235689999999999999999999999   99999999999999999999999999997665


Q ss_pred             ccccc--cceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccc
Q 008698          424 WEVMQ--ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  500 (557)
Q Consensus       424 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  500 (557)
                      .....  .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+......................
T Consensus       169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  248 (318)
T d3blha1         169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN  248 (318)
T ss_dssp             C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence            33221  122223489999999998765 689999999999999999999999987654332222111111000000000


Q ss_pred             cc----CcccccCCCCCC-c------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          501 LL----DPLISSLSSDIP-E------AGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       501 ~~----d~~l~~~~~~~~-~------~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                      ..    ...+........ .      ......+.+|+.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            00    000000000000 1      111345678999999999999999999997

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-43  Score=356.38  Aligned_cols=268  Identities=21%  Similarity=0.254  Sum_probs=191.6

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC------CceEEEEec
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYIVYEF  346 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~  346 (557)
                      .++||+|+||+||+++.. +|+.||||+++....    .+.+|+.+|++++||||+++++++...      ...++||||
T Consensus        25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey  100 (350)
T d1q5ka_          25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  100 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred             eeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence            357899999999999974 599999999976532    234799999999999999999998643      346899999


Q ss_pred             CCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CcEEeeccCCccCCcc
Q 008698          347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWE  425 (557)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~  425 (557)
                      ++++.+.. +.........+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++.....
T Consensus       101 ~~~~~~~~-l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_         101 VPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             CSEEHHHH-HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred             cCCccHHH-HHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence            97664433 322222345799999999999999999999999   999999999999999775 8999999999876543


Q ss_pred             ccccceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhhh----hhhh--ccc
Q 008698          426 VMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWAT----PLVQ--SHR  497 (557)
Q Consensus       426 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~~----~~~~--~~~  497 (557)
                      ....   ...||..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+... +.....    ....  ...
T Consensus       177 ~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         177 EPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             SCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             cccc---cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            3222   2348999999998875 468999999999999999999999997654322111 110000    0000  000


Q ss_pred             cccccCccccc-CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcccC
Q 008698          498 YLELLDPLISS-LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLAQ  552 (557)
Q Consensus       498 ~~~~~d~~l~~-~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~~  552 (557)
                      ..+..-+.... ..........++.+.+|+.+||+.||++|||++|+++  .|+++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            00000000000 0000011123456889999999999999999999996  3555544

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.5e-43  Score=347.78  Aligned_cols=257  Identities=18%  Similarity=0.247  Sum_probs=191.9

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEE-eeeeeeeeCCceEEEEecCCC
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLV-AVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      +..+.||+|+||.||+|.. .+|+.||||++....  ...++.+|+++++.++|+|++ .+.++..+.+..++||||+ +
T Consensus        10 ~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~   86 (299)
T d1ckia_          10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G   86 (299)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence            3445789999999999986 468999999987543  234678899999999776655 5555567778889999999 5


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCcEEeeccCCccCCccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKFVPWEV  426 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgl~~~~~~~~  426 (557)
                      ++|.+.+..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+|+......
T Consensus        87 ~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          87 PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            667666653   235699999999999999999999999   999999999999985   45679999999998765432


Q ss_pred             cc-----cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccccc
Q 008698          427 MQ-----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  501 (557)
Q Consensus       427 ~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  501 (557)
                      ..     .......||+.|||||.+.+..++.++|||||||++|||+||+.||.......................    
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~----  236 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP----  236 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC----
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC----
Confidence            21     112233599999999999999999999999999999999999999987544322111111100000000    


Q ss_pred             cCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       502 ~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      . +.+        ...++.++.+++..||+.+|++||+++++.+.|+.+
T Consensus       237 ~-~~~--------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         237 I-EVL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             H-HHH--------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             h-hHh--------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            0 000        012345689999999999999999999998888754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-43  Score=355.21  Aligned_cols=263  Identities=18%  Similarity=0.222  Sum_probs=191.3

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC----ceEEEEecC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----DRYIVYEFV  347 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~~  347 (557)
                      .+.||+|+||+||+|.. .+|+.||||+++... ....+.+++|+.+|+.++||||+++++++....    ..+++++|+
T Consensus        13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~   92 (345)
T d1pmea_          13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL   92 (345)
T ss_dssp             EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred             EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence            35689999999999985 579999999997543 344568899999999999999999999987553    234555667


Q ss_pred             CCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCcccc
Q 008698          348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  427 (557)
Q Consensus       348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  427 (557)
                      .+|+|.+++..     ..+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.......
T Consensus        93 ~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          93 MGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             CCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             cCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            79999999964     3599999999999999999999999   999999999999999999999999999987654432


Q ss_pred             cc-ceeecCccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccc-------
Q 008698          428 QE-RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY-------  498 (557)
Q Consensus       428 ~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  498 (557)
                      .. ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||...+....................       
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence            21 2233458999999999855 46789999999999999999999999775432211111000000000000       


Q ss_pred             -ccccCcccccCCCCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008698          499 -LELLDPLISSLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  546 (557)
Q Consensus       499 -~~~~d~~l~~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~  546 (557)
                       ...... .... ...+    ......++.+|+.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~-~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         245 ARNYLLS-LPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHT-SCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhccccc-CCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             000000 0000 0000    01123468899999999999999999999973

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-42  Score=344.34  Aligned_cols=257  Identities=18%  Similarity=0.232  Sum_probs=200.3

Q ss_pred             CCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCC-CcEEeeeeeeeeCCceEEEEecCCC
Q 008698          272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVVN  349 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~  349 (557)
                      +..+.||+|+||+||+|+.. +|+.||||+++...  ....+.+|++.+..++| +|++.+++++.+....++||||+ +
T Consensus         8 ~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~   84 (293)
T d1csna_           8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G   84 (293)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence            34457899999999999964 68999999986543  23457788999999965 89999999999999999999998 7


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-----CCCcEEeeccCCccCCc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-----EFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~Dfgl~~~~~~  424 (557)
                      ++|.+++...   +..++..++..++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||+|+....
T Consensus        85 ~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          85 PSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             CCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            8999988652   35699999999999999999999999   9999999999999975     56799999999987643


Q ss_pred             cccc-----cceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhccccc
Q 008698          425 EVMQ-----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  499 (557)
Q Consensus       425 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (557)
                      ....     .......||+.|||||.+.+..++.++|||||||++|||+||+.||.........................
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  238 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence            3221     12223459999999999999999999999999999999999999998765433222221111111100000


Q ss_pred             cccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008698          500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  550 (557)
Q Consensus       500 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~  550 (557)
                      ++    .         ..+++++.+++..|++.+|++||+++.+.+.|+++
T Consensus       239 ~l----~---------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         239 EL----C---------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HH----T---------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             Hh----c---------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            00    0         11235688999999999999999999998887764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-42  Score=343.27  Aligned_cols=267  Identities=19%  Similarity=0.232  Sum_probs=201.5

Q ss_pred             eeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCCceEEEEecCCCCC
Q 008698          275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  351 (557)
Q Consensus       275 ~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  351 (557)
                      +.||+|+||+||+|+. .+|+.||||+++...  .....++.+|+.+|+.++||||+++++++.+.+..++|+|++.+++
T Consensus         8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~   87 (292)
T d1unla_           8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL   87 (292)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred             eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence            4679999999999996 468999999996543  3346789999999999999999999999999999999999999998


Q ss_pred             hHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCccccccce
Q 008698          352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  431 (557)
Q Consensus       352 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  431 (557)
                      |..++..    .+.+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.++.........  
T Consensus        88 l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~--  158 (292)
T d1unla_          88 KKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--  158 (292)
T ss_dssp             HHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC--
T ss_pred             ccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCccc--
Confidence            8887753    35689999999999999999999999   99999999999999999999999999998765433221  


Q ss_pred             eecCccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcc---c---cccccCc
Q 008698          432 VMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH---R---YLELLDP  504 (557)
Q Consensus       432 ~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~d~  504 (557)
                      ....++..|+|||.+.... ++.++|||||||++|||++|+.||.......  +............   .   .....+.
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            2223778899999987665 6899999999999999999999975543321  1111111110000   0   0000000


Q ss_pred             -----ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcccC
Q 008698          505 -----LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLAQ  552 (557)
Q Consensus       505 -----~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~~  552 (557)
                           .................+.+|+.+|++.||++|||++||++  .|+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                 00000011111233456889999999999999999999997  4655544

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=353.02  Aligned_cols=259  Identities=21%  Similarity=0.297  Sum_probs=190.7

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeCC------ceEEEE
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~lV~  344 (557)
                      .+.||+|+||+||+|.. .+|+.||||+++..  .....+.+.+|+.+|+.++|||||++++++...+      ..++||
T Consensus        23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  102 (346)
T d1cm8a_          23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM  102 (346)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence            35689999999999996 46999999999754  2334567899999999999999999999997654      469999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+ +.+|..++..     ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||+++....
T Consensus       103 e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_         103 PFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             ECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCC
Confidence            999 6678777654     4599999999999999999999999   999999999999999999999999999987643


Q ss_pred             cccccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhh-----hhcc--
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL-----VQSH--  496 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~-----~~~~--  496 (557)
                      ..     ....||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+.+..............     ....  
T Consensus       174 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         174 EM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             SC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence            32     223489999999998764 5689999999999999999999999876442211111000000     0000  


Q ss_pred             --------ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhccc
Q 008698          497 --------RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLA  551 (557)
Q Consensus       497 --------~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~  551 (557)
                              ...+.-...+...     .......+.+|+.+||+.||++|||++|+++.  |+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASI-----LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGT-----CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhhhhccCCcccccchHHh-----ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                    0000000000000     11223467899999999999999999999983  66554

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6e-42  Score=346.12  Aligned_cols=256  Identities=19%  Similarity=0.244  Sum_probs=192.2

Q ss_pred             CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEEeeeeeeee--CCceEEEEecCCC
Q 008698          274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYD--HGDRYIVYEFVVN  349 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~E~~~~  349 (557)
                      .+.||+|+||+||+|+. .+|+.||||+++...   .+++.+|+.+|.+++ ||||+++++++..  .+..++||||+.+
T Consensus        40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~  116 (328)
T d3bqca1          40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN  116 (328)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCS
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCC
Confidence            35689999999999996 468999999997543   467889999999995 9999999999874  3568999999999


Q ss_pred             CChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CcEEeeccCCccCCccccc
Q 008698          350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQ  428 (557)
Q Consensus       350 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~  428 (557)
                      ++|..+.       +.+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+|+........
T Consensus       117 ~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~  186 (328)
T d3bqca1         117 TDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY  186 (328)
T ss_dssp             CBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred             CcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence            9987654       3599999999999999999999999   999999999999998755 5899999999876543222


Q ss_pred             cceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccch--hHHHhhh-----hhhhc-----
Q 008698          429 ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ--SIFEWAT-----PLVQS-----  495 (557)
Q Consensus       429 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~--~~~~~~~-----~~~~~-----  495 (557)
                         ....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||....+....  .+.....     .....     
T Consensus       187 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         187 ---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             ---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             ---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence               233489999999998775 4799999999999999999999999765442111  0100000     00000     


Q ss_pred             -cccccccCc----ccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          496 -HRYLELLDP----LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       496 -~~~~~~~d~----~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       .........    ..............+.++.+|+.+||+.||++|||++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000000000    00000111122334567889999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-42  Score=346.56  Aligned_cols=247  Identities=19%  Similarity=0.237  Sum_probs=195.6

Q ss_pred             CeeecccCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhcCC-CcEEeeeeeeeeCCceEEEE
Q 008698          274 NRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lV~  344 (557)
                      .+.||+|+||+||++..    .+|+.||||+++...    ....+.+.+|+.+|++++| |||+++++++.+.+..++||
T Consensus        29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~  108 (322)
T d1vzoa_          29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL  108 (322)
T ss_dssp             EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence            45689999999999984    247899999986532    2234678899999999965 89999999999999999999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+.+|+|.+++..    ...+++.....++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       109 e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         109 DYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             CCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             ecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            99999999999865    24578889999999999999999999   999999999999999999999999999987654


Q ss_pred             cccccceeecCccccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhhcccccccc
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  502 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  502 (557)
                      ....... ...|++.|+|||.+.+.  .++.++|||||||+||||+||+.||.............  .....        
T Consensus       182 ~~~~~~~-~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~~--------  250 (322)
T d1vzoa_         182 DETERAY-DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILK--------  250 (322)
T ss_dssp             GGGGGGC-GGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHH--------
T ss_pred             ccccccc-ccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhccc--------
Confidence            4333222 23489999999999764  46889999999999999999999998765433221111  00000        


Q ss_pred             CcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008698          503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  545 (557)
Q Consensus       503 d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~  545 (557)
                       .      ....+...+..+.+++.+||+.||.+||     |++|+++
T Consensus       251 -~------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         251 -S------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -C------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -C------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence             0      0001123456789999999999999999     4789886

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-41  Score=344.47  Aligned_cols=258  Identities=19%  Similarity=0.243  Sum_probs=185.9

Q ss_pred             CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEEeeeeeeee------CCceEEEE
Q 008698          274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD------HGDRYIVY  344 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~------~~~~~lV~  344 (557)
                      .+.||+|+||+||+|... +|+.||||+++...  .....++.+|+.+|++++||||+++++++..      .+..|+||
T Consensus        22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~  101 (355)
T d2b1pa1          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM  101 (355)
T ss_dssp             EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred             EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence            346899999999999964 69999999997542  3345678999999999999999999999863      36789999


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      ||+.++.+. .+.      ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++..|++|||+++....
T Consensus       102 Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1         102 ELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             ECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             eccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcccc
Confidence            999665444 443      3589999999999999999999999   999999999999999999999999999886544


Q ss_pred             cccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh-HHHhh--------------
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWA--------------  489 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~-~~~~~--------------  489 (557)
                      ....   ....+|+.|+|||++.+..++.++||||+||+++||++|+.||.+.+...... +....              
T Consensus       172 ~~~~---~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         172 SFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             cccc---ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            3222   22348999999999999999999999999999999999999997654322111 10000              


Q ss_pred             -hhhhhcc------ccccccCcccccCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008698          490 -TPLVQSH------RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  545 (557)
Q Consensus       490 -~~~~~~~------~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~  545 (557)
                       .......      .....+...... .........+..+.+|+.+|++.||++|||++||++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFP-ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSC-CSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhhcCcccccccccccccccccc-ccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             0000000      000011000100 011112345678899999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-41  Score=343.65  Aligned_cols=265  Identities=18%  Similarity=0.251  Sum_probs=192.2

Q ss_pred             CCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEEeeeeeeeeC-----CceEEEE
Q 008698          273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVY  344 (557)
Q Consensus       273 ~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~  344 (557)
                      ..+.||+|+||+||++.. .+|+.||||+++..  +....+++.+|+.+|++++||||+++++++...     ...++++
T Consensus        22 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~  101 (348)
T d2gfsa1          22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV  101 (348)
T ss_dssp             EEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEE
Confidence            345689999999999995 56999999999754  234456789999999999999999999998633     3346677


Q ss_pred             ecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEeeccCCccCCc
Q 008698          345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  424 (557)
Q Consensus       345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~  424 (557)
                      +|+.+|+|.+++..     +.+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++.....
T Consensus       102 ~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1         102 THLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             EECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             EeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc
Confidence            77889999999853     4599999999999999999999999   999999999999999999999999999976543


Q ss_pred             cccccceeecCccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchhHHHhhhhhhh----ccc--
Q 008698          425 EVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ----SHR--  497 (557)
Q Consensus       425 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~~~~~~~~~~~----~~~--  497 (557)
                      ..     ....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+................    ...  
T Consensus       174 ~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         174 EM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             GG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred             cc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence            22     223488999999987765 468899999999999999999999987654322111100000000    000  


Q ss_pred             --cccccCcccccCCCCCC---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhccc
Q 008698          498 --YLELLDPLISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLA  551 (557)
Q Consensus       498 --~~~~~d~~l~~~~~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~  551 (557)
                        ....... +........   .......+.+|+.+||+.||++|||++|+++  .|.+..
T Consensus       249 ~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         249 ESARNYIQS-LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HHHHHHHTT-SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhhh-cccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence              0000000 000000000   0113456889999999999999999999997  455443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.9e-36  Score=306.11  Aligned_cols=264  Identities=17%  Similarity=0.191  Sum_probs=184.7

Q ss_pred             CCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-----------CCcEEeeeeeeeeC--
Q 008698          272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----------HPNLVAVKGCCYDH--  337 (557)
Q Consensus       272 ~~~~~lg~G~~g~Vy~g~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~g~~~~~--  337 (557)
                      +..+.||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+.++++++           |+||+++++++...  
T Consensus        16 ~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~   94 (362)
T d1q8ya_          16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP   94 (362)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence            4456789999999999996 5699999999976532 3457788888888775           57899999887643  


Q ss_pred             CceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCC------
Q 008698          338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFG------  410 (557)
Q Consensus       338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~~~~~------  410 (557)
                      ...++++++...+........ ......+++..+..++.||++||+|||+ .   +|+||||||+|||++.++.      
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          95 NGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             TEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccce
Confidence            455677776655543322221 1334668999999999999999999998 6   8999999999999986654      


Q ss_pred             cEEeeccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccchh----HH
Q 008698          411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS----IF  486 (557)
Q Consensus       411 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~el~tG~~p~~~~~~~~~~~----~~  486 (557)
                      +|++|||.+.......     ....||+.|+|||.+....++.++||||+||+++||++|+.||...+......    +.
T Consensus       171 ~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         171 IKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence            8999999987654322     22348999999999999999999999999999999999999997653321111    11


Q ss_pred             Hhhhhh-------hhc-cccccccCc-----ccccC----------CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 008698          487 EWATPL-------VQS-HRYLELLDP-----LISSL----------SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV  543 (557)
Q Consensus       487 ~~~~~~-------~~~-~~~~~~~d~-----~l~~~----------~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev  543 (557)
                      ......       ... .......+.     .+...          ............+.+|+.+|++.||.+|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            100000       000 000000000     00000          0112235667889999999999999999999999


Q ss_pred             HH
Q 008698          544 VH  545 (557)
Q Consensus       544 l~  545 (557)
                      ++
T Consensus       326 L~  327 (362)
T d1q8ya_         326 VN  327 (362)
T ss_dssp             HT
T ss_pred             hc
Confidence            87

>d1hq8a_ d.169.1.1 (A:) NK cell-activating receptor nkg2d {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: NK cell-activating receptor nkg2d
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.94  E-value=7.1e-28  Score=206.23  Aligned_cols=120  Identities=24%  Similarity=0.553  Sum_probs=103.0

Q ss_pred             CCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCee
Q 008698           49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW  128 (557)
Q Consensus        49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w  128 (557)
                      .|++||+||+  .|+++||+++.++++|.+|+.+|+++||+||+|+|++|++||+..    ...+||||+  +...++.|
T Consensus         2 ~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~fl~~~----~~~~WiGl~--~~~~~~~w   73 (123)
T d1hq8a_           2 YCGPCPNNWI--CHRNNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEEQDFLKLV----KSYHWMGLV--QIPANGSW   73 (123)
T ss_dssp             CCCCCSTTCE--EETTEEEEEEEEEECHHHHHHHHHTTTCEECCCSCTTTTGGGGGC----CSCEEEEEE--ECTTTCCE
T ss_pred             cCCCCCccCE--EECCEEEEEECcccCHHHHHHHHhhccCccceEehHHHHHHHhhh----hhceeeeee--ecCCCCce
Confidence            5789999999  899999999999999999999999999999999999999999654    347999999  55556999


Q ss_pred             EEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       129 ~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      +|+||+++.+.+|...+|+++              +|+.+. ....|.+..|....+|||+++
T Consensus        74 ~W~dgs~~~~~~w~~~~~~~~--------------~c~~~~-~~~~w~~~~C~~~~~~ICek~  121 (123)
T d1hq8a_          74 QWEDGSSLSYNQLTLVEIPKG--------------SCAVYG-SSFKAYTEDCANLNTYICMKR  121 (123)
T ss_dssp             EETTSCBCCTTTCEEECCTTC--------------CEEEEC-STTEEEEECTTSCEEEEEEEC
T ss_pred             EECCCCcccccccCCCCCCCC--------------CEEEEE-CCCeEEEeCCCCCEeEEEEEc
Confidence            999999998888776665432              455554 346799999999999999875

>d1ypqa1 d.169.1.1 (A:140-270) Oxidised low density lipoprotein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Oxidised low density lipoprotein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=7.2e-27  Score=202.16  Aligned_cols=127  Identities=20%  Similarity=0.451  Sum_probs=109.7

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEE
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW  130 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W  130 (557)
                      ++||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++......+||||+  +...++.|+|
T Consensus         3 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~w~w   78 (131)
T d1ypqa1           3 APCPQDWI--WHGENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSSFPFWMGLS--RRNPSYPWLW   78 (131)
T ss_dssp             CSSCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHTTCCCCEEEEEE--ESSTTSCCEE
T ss_pred             CCCCCCCE--EECCEEEEEECCccCHHHHHHHHHHcCCeeccchhhhhhhhhhhhhhccCCceEEEEE--ecCCCCceEe
Confidence            68999999  8999999999999999999999999999999999999999999998766668999999  5556699999


Q ss_pred             ccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccc
Q 008698          131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       131 ~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      +||+++.+..||..++++.         ..+.++|+.+..  +.|.+..|....+|||+++.
T Consensus        79 ~dg~~~~~~~~~~~~~~~~---------~~~~~~C~~~~~--~~w~~~~C~~~~~~ICek~a  129 (131)
T d1ypqa1          79 EDGSPLMPHLFRVRGAVSQ---------TYPSGTCAYIQR--GAVYAENCILAAFSICQKKA  129 (131)
T ss_dssp             TTSCBCCTTSCCEEESCSC---------CCTTCEEEEEET--TEEEEEETTSCBEEEEEEEC
T ss_pred             CCCCCccccccccCCCCCC---------CCCCCCEEEEEC--CeEEEeCCCCCEeEEEeEEC
Confidence            9999988877766555443         334568887753  57999999999999999853

>d1xpha1 d.169.1.1 (A:265-394) DC-SIGNR (DC-SIGN related receptor) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: DC-SIGNR (DC-SIGN related receptor)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.6e-26  Score=199.77  Aligned_cols=127  Identities=22%  Similarity=0.454  Sum_probs=108.8

Q ss_pred             CCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeE
Q 008698           50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK  129 (557)
Q Consensus        50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~  129 (557)
                      |.+||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++|+..++......+|||+.  +...++.|+
T Consensus         1 c~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~gg~La~i~s~~~~~~~~~~~~~~~~~~wig~~--~~~~~~~~~   76 (130)
T d1xpha1           1 CRHCPKDWT--FFQGNCYFMSNSQRNWHDSVTACQEVRAQLVVIKTAEEQNFLQLQTSRSNRFSWMGLS--DLNQEGTWQ   76 (130)
T ss_dssp             SCBCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCCEEEEEE--CCSTTCCCE
T ss_pred             CCCCCCCCE--EECCEEEEEECcccCHHHHHHHHhhcCCeEeeeCCHHHhhhhhhhhccccceeeeeee--ccCcccceE
Confidence            679999999  8999999999999999999999999999999999999999999988755678999999  666679999


Q ss_pred             EccCCCCCC--cCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccc
Q 008698          130 WSDNMSKWN--ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       130 W~Dg~~~~~--~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      |+||+++.+  +..|..++|++          .+.++|+.+..  ..|++..|....+|||+++.
T Consensus        77 W~dg~~~~~~~~~~W~~~~P~~----------~~~~~Cv~~~~--~~w~~~~C~~~~~fICe~pA  129 (130)
T d1xpha1          77 WVDGSPLSPSFQRYWNSGEPNN----------SGNEDCAEFSG--SGWNDNRCDVDNYWICKKPA  129 (130)
T ss_dssp             ETTSCBCCGGGGGGBCTTCCCC----------CTTCCEEEEET--TEEEEECTTSCBEEEEEEEC
T ss_pred             eccccccccccccccCCcCCCC----------CCCCcEEEEEC--CEEEECCCCCCEEEEEEEeC
Confidence            999998753  44566666542          34467988854  57999999999999999863

>d1t8da1 d.169.1.1 (A:1-143) Low affinity immunoglobulin epsilon Fc receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Low affinity immunoglobulin epsilon Fc receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=6.4e-26  Score=199.33  Aligned_cols=133  Identities=20%  Similarity=0.393  Sum_probs=110.2

Q ss_pred             CCCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCC
Q 008698           47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL  126 (557)
Q Consensus        47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~  126 (557)
                      +..|.+||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.++..  ...+||||+  +...++
T Consensus         2 g~~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~--~~~~wiGl~--~~~~~~   75 (143)
T d1t8da1           2 GFVCNTCPEKWI--NFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHAS--HTGSWIGLR--NLDLKG   75 (143)
T ss_dssp             CCSSCCCCSSSE--ECSSEEEEEEECCSSHHHHHHHHHHHTSBCCCCCSHHHHHHHHHHCS--SSCEEEEEE--ESSSSS
T ss_pred             CCcCCCCCcccE--EECCEEEEEECcccCHHHHHHHhhhcCCEEeeecCHHHhhhcccccc--cccccccce--ecCCCC
Confidence            456789999999  89999999999999999999999999999999999999999999887  457999999  545569


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCC-CCccccccccCcc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS-HPFICMVEHENKC  196 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~-~~~iC~~~~~s~c  196 (557)
                      .|.|+||++..+.+|.. ++|+.         ..+.++|+.+.. .+.|++..|... .+|||++.....+
T Consensus        76 ~~~w~dg~~~~~~~w~~-~~P~~---------~~~~~~Cv~~~~-~g~W~~~~C~~~~~~fICek~~~~~~  135 (143)
T d1t8da1          76 EFIWVDGSHVDYSNWAP-GEPTS---------RSQGEDCVMMRG-SGRWNDAFCDRKLGAWVCDRLATCTP  135 (143)
T ss_dssp             CEEETTSCBCSSCCBSS-SCCCS---------CCSCCSEEEEET-TTEEEEECSCSCCCEEEEEEECSCCC
T ss_pred             ccEeCCCCccccccccc-cCCCC---------CCCCCCEEEEcC-CCEEEeeCCCCCccCeEEEECCCCCC
Confidence            99999999987776544 44443         234568988765 467999999866 5799998655433

>d1tdqb_ d.169.1.1 (B:) Aggrecan core protein {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Aggrecan core protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.93  E-value=4.5e-26  Score=195.71  Aligned_cols=123  Identities=23%  Similarity=0.450  Sum_probs=104.9

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEc
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS  131 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~  131 (557)
                      .||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.++..   ..+||||+  +...++.|+|+
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~sw~~A~~~C~~~g~~La~i~~~~e~~~l~~~~~---~~~wigl~--~~~~~~~~~W~   74 (126)
T d1tdqb_           2 QCEEGWT--KFQGHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQEFVNKNAQ---DYQWIGLN--DRTIEGDFRWS   74 (126)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC---SCEEEEEE--CSSSTTCCEET
T ss_pred             CCCCCCe--eeCCEEEEEECcccCHHHHHHHHHhhCcEEeEECChhHhhhhhcccc---ceeeeecc--cccCCCccCcC
Confidence            6999999  89999999999999999999999999999999999999999999875   47999999  65667999999


Q ss_pred             cCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeec-CCCceeccccCCCCCccccc
Q 008698          132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       132 Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~-~~~~w~~~~C~~~~~~iC~~  190 (557)
                      ||+++.+.+|.+.+| ++.        ..+.++|+.+.. ..+.|++..|....+|||++
T Consensus        75 dg~~~~~~~w~~~~p-~~~--------~~~~~~C~~~~~~~~~~W~~~~C~~~~~fICek  125 (126)
T d1tdqb_          75 DGHSLQFEKWRPNQP-DNF--------FATGEDCVVMIWHERGEWNDVPCNYQLPFTCKK  125 (126)
T ss_dssp             TCCCCCCCCBCTTCC-CCC--------STTTEEEEEEETTTTTEEEEEETTSCEEEEEEE
T ss_pred             CCCCcccccccccCC-Ccc--------ccCCcceEEEEeCCCCeEEecCCCCCEEEEeee
Confidence            999998877666554 321        234567877654 44679999999999999985

>d1oz7b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]

Probab=99.93  E-value=2.3e-26  Score=196.74  Aligned_cols=118  Identities=20%  Similarity=0.467  Sum_probs=101.6

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCe
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~  127 (557)
                      .||+||.  .|+++||+|+.++++|.+|+.+|+.  .||+||+|+|++|++||.+++...  ...+||||+  +...+|.
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   76 (123)
T d1oz7b_           1 NCLPDWS--VYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPMLKNDLVWIGLT--DYWRDCN   76 (123)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCCSSHHHHHHHTSSTTTTCSEEEEEEE--CCCCGGG
T ss_pred             CCCccCE--eECCEEEEEeCcccCHHHHHHHHhhccCCCcccccCCHHHhhhceeeeeecccceeEEEEee--ccCcccc
Confidence            4999999  8999999999999999999999975  489999999999999999987653  456899999  6666799


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |+|+||+++.|.+| .+                 +++|+.+...++.|++..|....+|||+.+
T Consensus        77 ~~W~dg~~~~y~nW-~~-----------------~~~C~~~~~~~~~W~~~~C~~~~~fICe~P  122 (123)
T d1oz7b_          77 WEWSDGAQLDYKAW-DN-----------------ERHCFIYKNTDNQWTRRDCTWTFSFVCKCP  122 (123)
T ss_dssp             EEETTCCCCCSCCB-CS-----------------STTEEEEEGGGTEEEEECTTSCEEEEEEEE
T ss_pred             eeccCCCEeecccc-CC-----------------CCCEEEEECCCCEEEeeCCCCcEEEEEEEc
Confidence            99999999887664 21                 246777776667899999999999999875

>d1fvub_ d.169.1.1 (B:) Snake coagglutinin beta chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]

Probab=99.92  E-value=3.1e-26  Score=196.45  Aligned_cols=120  Identities=23%  Similarity=0.548  Sum_probs=101.1

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCe
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~  127 (557)
                      .||+||+  .|+++||+|+.++++|.+|+.+|+.  .||+||+|+|++|++||.++++..  ...+||||+  +...++.
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~t~~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~   76 (125)
T d1fvub_           1 DCPPDWS--SYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEMLKGDVVWIGLS--DVWNKCR   76 (125)
T ss_dssp             CCSTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHTTCTTSCTTCCEECSCC--CCSTTSC
T ss_pred             CCCCCCE--eeCCEEEEEeCccCCHHHHHHhhhhccCCceecccCCHHHcccccccccccccceeEEeeee--ccCcccc
Confidence            4999999  8999999999999999999999964  589999999999999999988654  346999999  6667799


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |+|+||+++.+.+|...+                .++|+.+...++.|++..|....+|||+.+
T Consensus        77 ~~W~dg~~~~~~~w~~~~----------------~~~Cv~~~~~~~~W~~~~C~~~~~fICe~~  124 (125)
T d1fvub_          77 FEWTDGMEFDYDDYYLIA----------------EYECVASKPTNNKWWIIPCTRFKNFVCEFQ  124 (125)
T ss_dssp             EEETTSCCCCC----CCS----------------CCEEEEEETTTTEEEEEETTSCEEEEEEEC
T ss_pred             cEecCCCccccCCCCCCC----------------CcceEEEEcCCCEEEeeCCCCCEEEEEEEc
Confidence            999999999888765433                236888877778899999999999999874

>d1dv8a_ d.169.1.1 (A:) H1 subunit of the asialoglycoprotein receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: H1 subunit of the asialoglycoprotein receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.5e-25  Score=191.60  Aligned_cols=126  Identities=21%  Similarity=0.490  Sum_probs=104.7

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEcc
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD  132 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~D  132 (557)
                      ||+||.  .|+++||+++.++++|.+|+.+|+++||+||+|+|++|++||.+++.  ...+||||+  +.  ++.|+|+|
T Consensus         1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~~~~e~~~i~~~~~--~~~~WiG~~--~~--~~~~~W~d   72 (128)
T d1dv8a_           1 CPVNWV--EHERSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIG--PVNTWMGLH--DQ--NGPWKWVD   72 (128)
T ss_dssp             CCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CT--TSSCEETT
T ss_pred             CCCCCE--EECCEEEEEECCccCHHHHHHHHhhcCCEEeeecccchhhhhhcccc--ceeeeeecc--cc--CCceEEee
Confidence            999999  89999999999999999999999999999999999999999999997  558999999  54  38999999


Q ss_pred             CCCCC-CcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          133 NMSKW-NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       133 g~~~~-~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |++.. .+..|.+++|++.-..    ...+.++|+.+.. ++.|++..|....+|||+++
T Consensus        73 gs~~~~~~~~W~~~~P~~~~~~----~~~~~~~C~~~~~-~~~w~~~~C~~~~~fICe~~  127 (128)
T d1dv8a_          73 GTDYETGFKNWRPEQPDDWYGH----GLGGGEDCAHFTD-DGRWNDDVCQRPYRWVCETE  127 (128)
T ss_dssp             CCCSTTSCCCBCTTCCCCCCTT----SSSSCCCEEEECT-TSCEEEECTTSCBEEEEEEE
T ss_pred             ccccCCcceeeccCCCCccccc----cCCCCcceEEECC-CCEEEeEcCCCCEEEEEEEE
Confidence            98764 3455666665542211    1345678987754 46799999999999999874

>d1gz2a_ d.169.1.1 (A:) Ovocleidin-17 {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Ovocleidin-17
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.92  E-value=1.5e-25  Score=195.88  Aligned_cols=124  Identities=25%  Similarity=0.575  Sum_probs=101.2

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhC--CCeEeeeCCHHHHHHHHHHhCCC----------CCCeEEeeee
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN----------VNGCWVGGRS  119 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~s~~e~~f~~~~~~~~----------~~~~WiGl~~  119 (557)
                      .||+||+  .|+++||+|+.++++|.+|+.+|+.+  ||+||+|+|++|++||.+++...          ...+||||+ 
T Consensus         1 gCp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~L~~i~s~~e~~~i~~~l~~~~~~~~~~~~~~~~~WiGl~-   77 (139)
T d1gz2a_           1 GCGPGWV--PTPGGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASRGGDGSGEGADGRVWIGLH-   77 (139)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCTTEEECCCCSHHHHHHHHHHHHCSSCCSSSCCCCSSCEEEEEE-
T ss_pred             CCCCCCE--eECCEEEEEeCeecCHHHHHhhhhcccCCceecchhhHHHHHHHHHHHHhhccccccccccccceeeeee-
Confidence            4999999  89999999999999999999999864  99999999999999999987432          346999999 


Q ss_pred             cCCCCCCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCcccccc
Q 008698          120 INTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       120 ~~~~~~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~  191 (557)
                       +...++.|+|+||+++.|.+|...+ |++           ..+.|+.+....  ..|++..|....+|||+.+
T Consensus        78 -~~~~~~~w~W~dgs~~~y~~W~~~~-p~~-----------~~~~C~~l~~~~~~~~W~~~~C~~~~~fiCe~~  138 (139)
T d1gz2a_          78 -RPAGSRSWRWSDGTAPRFASWHRTA-KAR-----------RGGRCAALRDEEAFTSWAARPCTERNAFVCKAA  138 (139)
T ss_dssp             -CCTTCSSCEETTSCCCCCCCBCSSS-GGG-----------CSCSEEEECTTTTSSCEEEECTTCCEEEEEEEE
T ss_pred             -ecccCCceEeccCCcceeecccCCC-CCC-----------CCCcEEEEEecCCCCcEEecCCCCCEeEEEEEc
Confidence             6666799999999998887755444 332           123455554332  4699999999999999875

>d1j34b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]

Probab=99.92  E-value=6.2e-26  Score=194.00  Aligned_cols=118  Identities=24%  Similarity=0.566  Sum_probs=101.5

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCe
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~  127 (557)
                      .||+||.  .|+++||+++.++++|.+|+.+|++  .||+||+|+|++|++||.+++...  ...+||||+  +...+|.
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~   76 (123)
T d1j34b_           1 DCPSDWS--SYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTFGHSIFWMGLS--NVWNQCN   76 (123)
T ss_dssp             CCCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--SCSTTSC
T ss_pred             CCCCCCE--eECCEEEEEEccccCHHHHHHHHHhccCCCcccccCCHhHhhhhhhhhccccceeEEeecee--cccccce
Confidence            4999999  8999999999999999999999975  489999999999999999987532  457999999  6667799


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |+|+||+++.+.+| .+                 +|+|+.+...++.|++..|....+|||+.+
T Consensus        77 w~W~dg~~~~y~~W-~~-----------------~~~Cv~~~~~~~~W~~~~C~~~~~fiCe~~  122 (123)
T d1j34b_          77 WQWSNAAMLRYKAW-AE-----------------ESYCVYFKSTNNKWRSRACRMMAQFVCEFQ  122 (123)
T ss_dssp             EEETTCCCCCCCCB-SC-----------------SCEEEEEETTSCCBEEEETTSCEEEEEEEE
T ss_pred             eecCCCCcccccCC-CC-----------------CCCeEEEECCCCEEEeeCCCCCEeEEEEEc
Confidence            99999999876653 22                 246888877778899999999999999874

>d1jwib_ d.169.1.1 (B:) Snake coagglutinin beta chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]

Probab=99.92  E-value=9.2e-26  Score=192.91  Aligned_cols=118  Identities=25%  Similarity=0.526  Sum_probs=99.8

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhC--CCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCe
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~  127 (557)
                      .||+||+  .|+++||+|+.++++|.+|+.+|+++  ||+||+|+|++|++||.+++...  ...+||||+  +...++.
T Consensus         1 gCp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~   76 (123)
T d1jwib_           1 GCLPDWS--SYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKMRIVLVWIGLS--HFWRICP   76 (123)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHTTCCCEEEEEEE--ECGGGSC
T ss_pred             CCCCCcE--eeCCEEEEEeCcccCHHHHHHHhhhccCCccccccCCHHHhhhhhhheeccccccceEeeee--ccCccce
Confidence            4999999  89999999999999999999999874  89999999999999999877533  456899999  5556699


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |+|+||+++.|.+ |..+                 .+|..+....+.|++..|....+|||+.+
T Consensus        77 ~~W~dgs~~~y~~-w~~~-----------------~~c~~~~~~~~~W~~~~C~~~~~fiCe~k  122 (123)
T d1jwib_          77 LRWTDGARLDYRA-LSDE-----------------PICFVAESFHNKWIQWTCNRKKSFVCKYR  122 (123)
T ss_dssp             EEETTCCCCCSCC-SCCS-----------------CEEEEEETTTCCEEEEETTSCEEEEEEEE
T ss_pred             eEccCCCCccccc-CCCC-----------------CCEEEEECCCCeEEecCCCCCEeEEEeEE
Confidence            9999999987755 3222                 24666666667899999999999999875

>d1jwia_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]

Probab=99.92  E-value=4.2e-26  Score=195.36  Aligned_cols=119  Identities=32%  Similarity=0.628  Sum_probs=97.6

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCC----CCCCeEEeeeecCCCCCCee
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVGLSW  128 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~~~w  128 (557)
                      ||+||+  .|+++||+|+.++++|.||+.+|+++||+||+|+|++|++||.+++..    ....+||||++.....++.|
T Consensus         1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~i~~~~~~~~~~~~~~~WiGl~~~~~~~~~~~   78 (124)
T d1jwia_           1 CLPDWS--SYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTKFVYDAWIGLRDESKTQQCSP   78 (124)
T ss_dssp             CCTTSE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHC--CCSCEEEEEEECCSSSSSCS
T ss_pred             CCCCCE--eeCCEEEEEECcccCHHHHHHHHHhcCCeeeeeehHHHHHHHHHHHhccccccccceeeEeeeccCCCccce
Confidence            999999  899999999999999999999999999999999999999999987642    24579999997666667889


Q ss_pred             EEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccc
Q 008698          129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM  189 (557)
Q Consensus       129 ~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~  189 (557)
                      .|+||+++.|.+|   ++|+ +|.+.            ......+.|++..|....+|||+
T Consensus        79 ~W~dgs~~~y~n~---~~p~-~c~~~------------~~~~~~~~W~~~~C~~~~~fICe  123 (124)
T d1jwia_          79 QWTDGSSVVYENV---DEPT-KCFGL------------DVHTEYRTWTDLPCGEKNPFICK  123 (124)
T ss_dssp             BCTTSCBCCSCCB---SSCC-CEEEE------------CGGGTTSSEEEECTTSCEEEEEE
T ss_pred             ecCCCCcccccCC---CCCC-ccEEE------------EEecCCCCEEccCCCCCEeeEeC
Confidence            9999999887664   3322 34322            11123457999999999999997

>d1c3ab_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]

Probab=99.92  E-value=1.1e-25  Score=193.03  Aligned_cols=118  Identities=19%  Similarity=0.422  Sum_probs=100.8

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCe
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~  127 (557)
                      .||+||+  .|+++||+|+.++++|.+|+.+|++  .||+||+|+|++|++||.+++...  ...+||||+  +...++.
T Consensus         3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~   78 (125)
T d1c3ab_           3 CCPLGWS--SYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPILKYDFVWIGLS--NVWNECT   78 (125)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--CTTTSSC
T ss_pred             CCCCCCE--EECCEEEEEECcccCHHHHHHhhccccCCCeecccCCHHHhhhhhhhhhccCCceeEEEEec--ccCccee
Confidence            6999999  8999999999999999999999964  589999999999999999877532  456999999  6667799


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |+|+||+++.|.+| .++                 |+|+.+....+.|++..|....+|||+.+
T Consensus        79 ~~W~dGs~~~y~~W-~~~-----------------e~Cv~~~~~~~~W~~~~C~~~~~fICe~~  124 (125)
T d1c3ab_          79 KEWSDGTKLDYKAW-SGG-----------------SDCIVSKTTDNQWLSMDCSSKYYVVCKFQ  124 (125)
T ss_dssp             EEETTCCCCCSCCB-CCC-----------------CEEEEEESSSSCEEEEETTSCEEEEEEEE
T ss_pred             eEeCCCCeeecccc-CCC-----------------CceEEEECCCCeEEeeCCCCCEEEEEEEe
Confidence            99999999877654 222                 35777776677899999999999999864

>d1sb2a1 d.169.1.1 (A:1-132) Snake coagglutinin alpha chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]

Probab=99.92  E-value=1.6e-25  Score=193.98  Aligned_cols=123  Identities=24%  Similarity=0.499  Sum_probs=103.2

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCC----CCCCeEEeeeecCCCCC
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVG  125 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~  125 (557)
                      .||+||+  .|+++||+|+.++++|.+|+.+|++  .||+||+|+|++|++||.+++..    ....+||||++.+...+
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~g~~L~~i~s~~e~~~i~~~~~~~~~~~~~~~WiGl~~~~~~~~   78 (132)
T d1sb2a1           1 DCPDGWS--STKSYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNFENKIYRSWIGLKIENKGQR   78 (132)
T ss_dssp             CCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHTSSSCCEECCCSSHHHHHHHHHHHHHHTTTCCEEEEEEEEEECSSTT
T ss_pred             CCCCcCE--EECCEEEEEECcccCHHHHHHHHhhccCCccccccCCHHHHHHHHHHHhcccccccchhhhhhhccccccc
Confidence            4999999  8999999999999999999999975  58999999999999999988752    24468999997777778


Q ss_pred             CeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCccccccc
Q 008698          126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       126 ~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~  192 (557)
                      +.|+|+||+++.|.+|+.++                .++|+.+....  ..|++..|....+|||+.+.
T Consensus        79 ~~~~W~dG~~~~y~n~~~~~----------------~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~~~  131 (132)
T d1sb2a1          79 SNLEWSDGSSISYENLYEPY----------------MEKCFLMDHQSGLPKWHTADCEEKNVFMCKFQL  131 (132)
T ss_dssp             SSEEETTCCCCCCCCBSSCC----------------CEEEEEEEESSSSCEEEEECTTSCEEEEEEEEC
T ss_pred             cceecccCCcccceecCCCC----------------CccEEEEEcCCCCCcEEecCCCCCEeEEEEEeC
Confidence            99999999999988876432                13577664433  46999999999999998764

>d1umrc_ d.169.1.1 (C:) Snake coagglutinin beta chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]

Probab=99.91  E-value=1.7e-25  Score=191.74  Aligned_cols=118  Identities=22%  Similarity=0.512  Sum_probs=101.5

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhC--CCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCe
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~  127 (557)
                      .||+||+  .|+++||+++.++++|.+|+.+|+++  ||+||+|+|++|++||.+++...  ...+||||+  +...++.
T Consensus         3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~gg~La~i~~~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   78 (125)
T d1umrc_           3 CCPSHWS--SYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSLKSTFFWIGAN--NIWNKCN   78 (125)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHTTCSSSEEECSCC--CTTTSSC
T ss_pred             CCCccCE--EECCEEEEEECCccCHHHHHHhhcccCCCCcccccCCHHHhhhhhhhhcccccceeEEEeee--ccccccc
Confidence            5999999  89999999999999999999999764  89999999999999999988643  456999999  6667799


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |+|+||+++.|.+| .++                 ++|+.+....+.|++..|....+|||+.+
T Consensus        79 w~W~dgs~~~y~~w-~~~-----------------~~c~~~~~~~~~W~~~~C~~~~~fICe~~  124 (125)
T d1umrc_          79 WQWSDGTKPEYKEW-HEE-----------------FECLISRTFDNQWLSAPCSDTYSFVCKFE  124 (125)
T ss_dssp             EEETTSCCCSSCCB-CCC-----------------CEEEEEESSCSCEEEEETTSCEEEEEEEE
T ss_pred             eEecCCCcccccCc-CCc-----------------CCeeEEECCCCeEEeeCCCCCEEEEEEEe
Confidence            99999999877654 221                 35777777778899999999999999874

>d1qdda_ d.169.1.1 (A:) Lithostathine, inhibitor of stone formation {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Lithostathine, inhibitor of stone formation
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2.5e-25  Score=195.77  Aligned_cols=126  Identities=18%  Similarity=0.447  Sum_probs=102.8

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhC-CCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL  126 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~  126 (557)
                      ..||+||+  .|+++||+|+.++++|.+|+.+|+++ ||+||+|+|++|++||.++++..   ...+||||+  +...++
T Consensus        12 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~gg~L~~i~s~~e~~~l~~~l~~~~~~~~~~WiGl~--~~~~~~   87 (144)
T d1qdda_          12 ISCPEGTN--AYRSYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKESGTDDFNVWIGLH--DPKKNR   87 (144)
T ss_dssp             TSCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSCEECCCCSHHHHHHHHHHHHHTTCCCSEEEEEEE--CTTSSS
T ss_pred             CcCCCCCE--EECCEEEEEECCccCHHHHHHHHHhccccccceEEeeecchhhhhccccccccccceeeeee--cccccc
Confidence            47999999  89999999999999999999999986 78999999999999999987533   346899999  666679


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecC--CCceeccccCCCCCcccccc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~--~~~w~~~~C~~~~~~iC~~~  191 (557)
                      .|+|+||+++.|.+|.. ++|++          .+.++|+.+...  ...|++..|....+|||+.+
T Consensus        88 ~w~W~dGs~~~y~~W~~-~~P~~----------~~~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~k  143 (144)
T d1qdda_          88 AWHWSSGSLVSYKSWGI-GAPSS----------VNPGYCVSLTSSTGFQKWKDVPCEDKFSFVCKFK  143 (144)
T ss_dssp             CCEETTCCCCCCCCBCT-TCSCS----------SSCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEE
T ss_pred             eeEecCCCeeecccccC-CCCCC----------CCCccEEEEEccCCCCcEEecCCCCCeEEEEEEC
Confidence            99999999988776554 44432          223456665432  24699999999999999874

>d2afpa_ d.169.1.1 (A:) Type II antifreeze protein {Sea raven (Hemitripterus americanus) [TaxId: 8094]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Type II antifreeze protein
species: Sea raven (Hemitripterus americanus) [TaxId: 8094]

Probab=99.91  E-value=1.7e-25  Score=192.93  Aligned_cols=122  Identities=26%  Similarity=0.524  Sum_probs=102.7

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEE
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW  130 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W  130 (557)
                      ..||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||+++..   ..+||||+  +...++.|+|
T Consensus         5 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~fl~~~~~---~~~Wig~~--~~~~~~~w~W   77 (129)
T d2afpa_           5 PNCPAGWQ--PLGDRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTLNA---GVVWIGGS--ACLQAGAWTW   77 (129)
T ss_dssp             CSSCSSSC--CCSSSEECCCCSCCCHHHHHHHHHHHSCEECCCSSSHHHHHHHHHCS---SCBCCSCB--CSSSSSCCBS
T ss_pred             CCCCCCCE--EECCEEEEEECcccCHHHHHHHHHhcCCeEeeeeehhcchhhccccc---Cceeeeee--cccccceeec
Confidence            35999999  89999999999999999999999999999999999999999999865   46999999  6666799999


Q ss_pred             ccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecC-CCceeccccCCCCCccccc
Q 008698          131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       131 ~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~~  190 (557)
                      +||+++.|.+|. +++|++          ...++|+.+... ...|++..|....+|||+.
T Consensus        78 ~dgs~~~y~~W~-~~~P~~----------~~~~~c~~~~~~~~~~W~~~~C~~~~~~ICe~  127 (129)
T d2afpa_          78 SDGTPMNFRSWC-STKPDD----------VLAACCMQMTAAADQCWDDLPCPASHKSVCAM  127 (129)
T ss_dssp             SSSCCCCCCCSS-SCCSCC----------STTCCBCCBCCSSSSCBCCBCSCCCCCCCEEE
T ss_pred             cCCCeeeccccc-CCCCCC----------CCCCcEEEEECCCCCcEEeeCCCCCEeEEEEE
Confidence            999998877654 444432          234567666543 3569999999999999986

>d1tn3a_ d.169.1.1 (A:) Tetranectin {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Tetranectin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.2e-25  Score=196.03  Aligned_cols=128  Identities=16%  Similarity=0.295  Sum_probs=104.2

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCC---CCCCeEEeeeecCCCCCCe
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGK---NVNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~---~~~~~WiGl~~~~~~~~~~  127 (557)
                      ..||+||.   ++++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.++++.   ....+||||+  +...++.
T Consensus         4 t~C~~G~~---~~~~CY~~~~~~~tw~~A~~~C~~~gg~La~i~s~~e~~~l~~~l~~~~~~~~~~WiGl~--~~~~~~~   78 (137)
T d1tn3a_           4 TVCLKGTK---VHMKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGNEAEIWLGLN--DMAAEGT   78 (137)
T ss_dssp             CEEEECSS---SSEEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--EEEETTE
T ss_pred             CcCCCCeE---ECCEEEEEeCccCCHHHHHHHHHHcCCccccccchHhcccccccccccccccccEeeeec--cCCcccc
Confidence            57999997   78999999999999999999999999999999999999999988743   2557999999  4445699


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeec-CCCceeccccCCCCCcccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~-~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |.|+||+++.|.+|....| .     +  +++.+.++|+.+.. .++.|++..|....+|||+..
T Consensus        79 w~w~dg~~~~y~~w~~~~p-~-----~--p~~~~~~~C~~~~~~~~~~W~~~~C~~~~~fICe~~  135 (137)
T d1tn3a_          79 WVDMTGARIAYKNWETEIT-A-----Q--PDGGKTENCAVLSGAANGKWFDKRCRDQLPYICQFG  135 (137)
T ss_dssp             EEETTSCBCSCCCBCCTTT-C-----S--SCCGGGCCEEEEETTTTTEEEEECTTSCEEEEEEEE
T ss_pred             cEeCCCCeeeeeeeccccc-c-----C--CCCCCcceeEEEEeCCCCEEEeeCCCCCEEEEEEEe
Confidence            9999999988776533222 1     0  22345678888764 346799999999999999875

>d3c8ja1 d.169.1.1 (A:138-259) NK cell receptor {Mouse (Mus musculus), ly49-c [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: NK cell receptor
species: Mouse (Mus musculus), ly49-c [TaxId: 10090]

Probab=99.91  E-value=1.9e-25  Score=190.67  Aligned_cols=120  Identities=18%  Similarity=0.312  Sum_probs=101.5

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEc
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS  131 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~  131 (557)
                      .|+.+|+  .|+++||+|+.+++||.+|+.+|+++||+||+|+|++|++||.+++.  ...+||||+  +...++.|+|+
T Consensus         1 ~~~k~W~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fi~~~~~--~~~~WIGl~--~~~~~~~w~W~   74 (122)
T d3c8ja1           1 RGVKYWF--CYSTKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHVI--PGNYWIGLS--YDKKKKEWAWI   74 (122)
T ss_dssp             CCCEEEE--EEETEEEEEEEEEECHHHHHHHHHHTTCCBCCCCSHHHHHHHHHHSC--SSCEEEEEE--EETTTTEEEET
T ss_pred             CCCcccE--EECCEEEEEeCCcCCHHHHHHHHHhCCCcccceehHHHhhhhhhhhe--eeeeEEEEE--EcCCCCcEEEC
Confidence            3899999  89999999999999999999999999999999999999999999987  458999999  44456999999


Q ss_pred             cCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccc
Q 008698          132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       132 Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      ||+++.+..++.+++             .+.++|+.+..  ..|++..|....+|||+++.
T Consensus        75 dg~~~~~~~~~~~~~-------------~~~~~Cv~~~~--~~w~~~~C~~~~~~ICek~l  120 (122)
T d3c8ja1          75 DNGPSKLDMKIKKMN-------------FKSRGCVFLSK--ARIEDIDCNIPYYCICGKKL  120 (122)
T ss_dssp             TSCCCTTHHHHHTTC-------------CCSSSEEEECS--SCEEEECTTSCEEEEEEEEC
T ss_pred             CCCcccccccCCCCC-------------CCCCCEEEEEC--CEEEEcCCCCCEeEEEeEEC
Confidence            999987665554332             12356887743  47999999999999998764

>d1wmza_ d.169.1.1 (A:) Lectin CEL-I {Cucumaria echinata [TaxId: 40245]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Lectin CEL-I
species: Cucumaria echinata [TaxId: 40245]

Probab=99.91  E-value=2.4e-25  Score=194.86  Aligned_cols=126  Identities=14%  Similarity=0.361  Sum_probs=105.0

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCC-------CeEeeeCCHHHHHHHHHHhCC---CCCCeEEeeeecC
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-------GHLAALTSYEEEHSAQKLCGK---NVNGCWVGGRSIN  121 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~-------~~L~~i~s~~e~~f~~~~~~~---~~~~~WiGl~~~~  121 (557)
                      .||+||.  .|+++||+|+.++++|.+|+.+|+++|       ||||+|++++|++||.+++..   ....+||||+  +
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~g~~l~~~~~~L~~i~~~~e~~~~~~~~~~~~~~~~~~WiGl~--~   77 (140)
T d1wmza_           2 QCPTDWE--AEGDHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNYWRGIDSQAGQLWIGLY--D   77 (140)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCBGGGTEEEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--C
T ss_pred             CCCCCCE--eeCCEEEEEECccCCHHHHHHHHHHhhcccccccceeeeeCCHHHHHhhhhhhccccccccceeeeee--e
Confidence            6999999  899999999999999999999999987       669999999999999988753   2457999999  6


Q ss_pred             CCCCCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeec-CCCceeccccCCCCCcccccc
Q 008698          122 TTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       122 ~~~~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~-~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      ...++.|+|+||+++.|.+| .+++|++         ..+.++|+.+.. ..+.|++..|....+|||+.+
T Consensus        78 ~~~~~~w~W~dG~~~~y~~W-~~g~P~~---------~~~~~~c~~~~~~~~~~W~~~~C~~~~~fICe~~  138 (140)
T d1wmza_          78 KYNEGDFIWTDGSKVGYTKW-AGGQPDN---------WNNAEDYGQFRHTEGGAWNDNSAAAQAKYMCKLT  138 (140)
T ss_dssp             SSSTTCCEETTCCCCCCCCB-CTTCCCC---------GGGCEEEEEECSSTTTCEEEEETTCCEEEEEEEE
T ss_pred             ccccceeeecCCcccccccc-ccccccc---------CCCCccEEEEEeCCCCEEEeeCCCCCEeEEEEEe
Confidence            66679999999999987765 4444443         234567877754 446799999999999999875

>d1e87a_ d.169.1.1 (A:) CD69 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: CD69
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=3.9e-25  Score=187.16  Aligned_cols=115  Identities=25%  Similarity=0.545  Sum_probs=96.8

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEE
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW  130 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W  130 (557)
                      ++||+||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||..++.  ...+||||+  +. .++.|+|
T Consensus         1 ssCp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~L~~i~s~~e~~~l~~~~~--~~~~WiGl~--~~-~~~~w~w   73 (117)
T d1e87a_           1 SSCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAG--REEHWVGLK--KE-PGHPWKW   73 (117)
T ss_dssp             CCSCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CC-TTSCCEE
T ss_pred             CCCCCCCE--EECCEEEEEECcccCHHHHHHHHhhcCCEEeeecCHHHHHHHhhhhc--cceeecccc--cc-ccCccEe
Confidence            37999999  89999999999999999999999999999999999999999999987  457999998  43 3478999


Q ss_pred             ccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       131 ~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      +||+++.  + |...              .+.++|+.+..  +.|++..|....+|||+++
T Consensus        74 ~dg~~~~--~-w~~~--------------~~~~~C~~l~~--~~w~~~~C~~~~~~ICekp  115 (117)
T d1e87a_          74 SNGKEFN--N-WFNV--------------TGSDKCVFLKN--TEVSSMECEKNLYWICNKP  115 (117)
T ss_dssp             TTSCBCC--C-SSCC--------------BSSCSEEEEET--TEEEEECTTSCBEEEEEEE
T ss_pred             CCCCccc--C-ccCC--------------CCCCcEEEEEC--CEEEEecCCCCEEEEEEEe
Confidence            9998743  3 2211              12346887753  5799999999999999975

>d3bdwa1 d.169.1.1 (A:59-179) CD94 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: CD94
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2e-25  Score=190.23  Aligned_cols=118  Identities=16%  Similarity=0.398  Sum_probs=99.0

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEc
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS  131 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~  131 (557)
                      +||.||+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||..    ....+||||+  +...++.|+|+
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~~~~fl~~----~~~~~WiGl~--~~~~~~~w~w~   73 (121)
T d3bdwa1           2 SCQEKWV--GYRCNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSS----SQQFYWIGLS--YSEEHTAWLWE   73 (121)
T ss_dssp             CCTTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCSCGGGGGGGTT----CCCCEECSEE--EETTTTEEEET
T ss_pred             cCCCCcE--EECCEEEEEEccccCHHHHHHHHhhcCCcccceeeeeeeeEeee----cccceEEEEe--ecCccceeEeC
Confidence            7999999  89999999999999999999999999999999999999999854    2458999999  44456999999


Q ss_pred             cCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       132 Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      ||+++.+.. |..++|++            .++|+.+.. .+.|.+..|....+|||+++
T Consensus        74 dg~~~~~~~-w~~~~~~~------------~~~C~~~~~-~g~w~~~~C~~~~~fICek~  119 (121)
T d3bdwa1          74 NGSALSQYL-FPSFETFN------------TKNCIAYNP-NGNALDESCEDKNRYICKQQ  119 (121)
T ss_dssp             TSCBCCTTT-SGGGGGCC------------TTSEEEEET-TTEEEEECTTSCBEEEEEEC
T ss_pred             CCCcccccc-cCCCCCCC------------CCCEEEEEC-CCEEEeeCCCCCEEEEEeEE
Confidence            999987765 44444332            246777654 36799999999999999875

>d1jzna_ d.169.1.1 (A:) Galactose-specific C-type lectin {Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Galactose-specific C-type lectin
species: Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]

Probab=99.91  E-value=3.4e-25  Score=192.63  Aligned_cols=126  Identities=21%  Similarity=0.592  Sum_probs=104.5

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhhC--CCeEeeeCCHHHHHHHHHHhCC---CCCCeEEeeeecCCCCCC
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGK---NVNGCWVGGRSINTTVGL  126 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~s~~e~~f~~~~~~~---~~~~~WiGl~~~~~~~~~  126 (557)
                      .||+||.  .++++||+|+.++++|.+|+.+|+++  |++||+|+|.+|++||...+..   ....+||||+  +...++
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~L~~i~s~~e~~~i~~~l~~~~~~~~~~WiGl~--~~~~~~   77 (135)
T d1jzna_           2 NCPLDWL--PMNGLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAEYISDYHKGQENVWIGLR--DKKKDF   77 (135)
T ss_dssp             CSCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSSSEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--CTTSSS
T ss_pred             CCCCCCE--eECCEEEEEECcccCHHHHHHHhhhccccccccccCCHHHHHHHHHhhhhccCCCccEEEEEe--ecCccc
Confidence            6999999  89999999999999999999999875  7999999999999999987643   2457999999  666679


Q ss_pred             eeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecC--CCceeccccCCCCCcccccc
Q 008698          127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       127 ~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~--~~~w~~~~C~~~~~~iC~~~  191 (557)
                      .|+|+||+++.+.+|.. ++|++         ..+.++|+.+...  ...|++..|....+|||+++
T Consensus        78 ~~~W~dg~~~~~~~W~~-~~P~~---------~~~~~~Cv~~~~~~~~~~W~~~~C~~~~~fiCe~k  134 (135)
T d1jzna_          78 SWEWTDRSCTDYLTWDK-NQPDH---------YQNKEFCVELVSLTGYRLWNDQVCESKDAFLCQCK  134 (135)
T ss_dssp             CCEETTCCCCCCCCBCT-TCCCC---------GGGCCCEEEECGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred             ceeecCCceeeccccCC-CCCCC---------CCCCCCEEEEEecCCCCcEEeeCCCCCEEEEeeec
Confidence            99999999988776544 44443         3456688877532  34799999999999999874

>d1qo3c_ d.169.1.1 (C:) NK cell receptor {Mouse (Mus musculus), ly49-a [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: NK cell receptor
species: Mouse (Mus musculus), ly49-a [TaxId: 10090]

Probab=99.91  E-value=4.4e-25  Score=191.28  Aligned_cols=124  Identities=19%  Similarity=0.325  Sum_probs=98.7

Q ss_pred             CCCCCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCe
Q 008698           48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~  127 (557)
                      .....||.+|+  .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||+.++.  ...|||||++  ...++.
T Consensus         9 ~~~~~c~~~W~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~~--~~~~~~   82 (133)
T d1qo3c_           9 HTGRGDKVYWF--CYGMKCYYFVMDRKTWSGCKQTCQSSSLSLLKIDDEDELKFLQLVVP--SDSCWVGLSY--DNKKKD   82 (133)
T ss_dssp             C-----CEEEE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHSC--SSCEEEEEEE--EGGGTE
T ss_pred             cCCCCCCCceE--EECCEEEEEECccCCHHHHHHHHHhcCCEEeEEeecceeeehhcccc--cceeEEEEEE--cCCCCC
Confidence            34468999999  89999999999999999999999999999999999999999999987  4579999994  445699


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      |+|+||+++.+.. |...+            +...++|+.+..  ..|++..|....+|||+++.
T Consensus        83 w~W~dg~~~~~~~-~~~~~------------~~~~~~C~~l~~--~~w~~~~C~~~~~~ICek~l  132 (133)
T d1qo3c_          83 WAWIDNRPSKLAL-NTRKY------------NIRDGGCMLLSK--TRLDNGNCDQVFICICGKRL  132 (133)
T ss_dssp             EEETTSCCCSSCC-CTTSS------------CGGGCSEEEECS--SCEEEECTTSCEEEEEEEEC
T ss_pred             EEECCCCcccccc-ccCCC------------CCCCCCEEEEEC--CEEEEcCCCCCEEEEEeEEC
Confidence            9999999865533 32221            123456887743  47999999999999998753

>d1c3aa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]

Probab=99.91  E-value=3.2e-25  Score=192.78  Aligned_cols=123  Identities=24%  Similarity=0.494  Sum_probs=100.4

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCC----CCCCeEEeeeecCCCCC
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVG  125 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~  125 (557)
                      .||+||.  .|+++||+|+..+++|.+|+.+|++  .||+||+|+|++|++||.+++..    ....+||||++.+.+..
T Consensus         3 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WiGl~~~~~~~~   80 (135)
T d1c3aa_           3 DCIPGWS--AYDRYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKIKTSFQYVWIGLRIQNKEQQ   80 (135)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCSCCSEEEEEEEECCCSSS
T ss_pred             CCCCCCE--eECCEEEEEECcccCHHHHHHHHhhccccccccccCCHHHHHHHHHhhhccccccccccceeeeecCCccc
Confidence            6999999  8999999999999999999999986  49999999999999999987742    24468999996665556


Q ss_pred             CeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecC--CCceeccccCCCCCccccccc
Q 008698          126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       126 ~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~--~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      +.|.|+||+++.|.+|....|  +              +|+.+...  .+.|++..|....+|||+.++
T Consensus        81 ~~~~W~dgs~~~y~nw~~~~p--~--------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~P  133 (135)
T d1c3aa_          81 CRSEWSDASSVNYENLVKQFS--K--------------KCYALKKGTELRTWFNVYCGTENPEVCKYTP  133 (135)
T ss_dssp             CCCBCTTSCBCCCCCBCGGGC--C--------------CEEEEETTSCSCSBEEECTTSCEEEEEEECC
T ss_pred             ccccccccCcccccccCCCCC--C--------------CeEEEEecCCCCCEEccCCCCCEeEEEEECC
Confidence            789999999988777544332  2              35555432  246999999999999999754

>d1umra_ d.169.1.1 (A:) Snake coagglutinin alpha chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]

Probab=99.91  E-value=1.7e-25  Score=194.47  Aligned_cols=123  Identities=24%  Similarity=0.503  Sum_probs=101.2

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCC----CCCCeEEeeeecCCCCC
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVG  125 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~  125 (557)
                      .||+||.  .|+++||+|+.++++|.+|+.+|++  .||+||+|+|++|++||.+++..    ....+||||++.+...+
T Consensus         3 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~fl~~~~~~~~~~~~~~~WiGl~~~~~~~~   80 (135)
T d1umra_           3 HCPSDWY--YYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNIEESFSHVSIGLRVQNKEKQ   80 (135)
T ss_dssp             SSCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCTTCCEEECSEEECCSSSS
T ss_pred             CCCCCCE--EECCEEEEEECcccCHHHHHHHhhccCCCcceeeehhhhhhHHHHHHhhcccCCCCcceeeeeeeeccccc
Confidence            6999999  8999999999999999999999976  48999999999999999987643    24568999987777777


Q ss_pred             CeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeec--CCCceeccccCCCCCccccccc
Q 008698          126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN--GSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       126 ~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~--~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      +.|+|+||+++.|.+|....|  +              +|+.+..  ....|++..|....+|||+.++
T Consensus        81 ~~~~W~dGs~~~y~nw~~~~~--~--------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~pP  133 (135)
T d1umra_          81 CSTKWSDGSSVSYDNLLDLYI--T--------------KCSLLKKETGFRKWFVASCIGKIPFVCKFPP  133 (135)
T ss_dssp             SCCBCTTSCBCCCCCBCGGGC--C--------------CEEEEEGGGTTCSBEEECTTCCEEEEEEECC
T ss_pred             CccccccCCcccccccCCCCC--C--------------CEEEEEeeCCCCcEEecCCCCCEeEEEeECC
Confidence            899999999988777544332  2              3545443  2356999999999999999864

>d1v7pb_ d.169.1.1 (B:) Snake coagglutinin beta chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]

Probab=99.91  E-value=8.2e-25  Score=188.04  Aligned_cols=118  Identities=28%  Similarity=0.560  Sum_probs=97.4

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCC--CCCCeEEeeeecCCCCCCee
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK--NVNGCWVGGRSINTTVGLSW  128 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~--~~~~~WiGl~~~~~~~~~~w  128 (557)
                      ||+||+  .|+++||+|+.++++|.+|+.+|+.  .||+||+|+|++|++||.+++..  ....+||||+  +...++.|
T Consensus         1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~w   76 (127)
T d1v7pb_           1 CPLGWS--SFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKALKFTSMWIGLN--NPWKDCKW   76 (127)
T ss_dssp             CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCSSCEEEEEEE--CTTTTCCC
T ss_pred             CCCCCE--eeCCEEEEEECcccCHHHHHHhhcccCCCCcccchhhhhhhhhhceeecccccceeEEeeee--ccCcccee
Confidence            999999  8999999999999999999999965  57999999999999999998753  2457999999  66677999


Q ss_pred             EEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeec--CCCceeccccCCCCCccccccc
Q 008698          129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN--GSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       129 ~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~--~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      +|+||+++.|.+| .+++                 +|+.+..  ....|++..|....+|||+...
T Consensus        77 ~W~dg~~~~y~~W-~~~~-----------------~c~~~~~~~~~~~W~~~~C~~~~~fiCe~~~  124 (127)
T d1v7pb_          77 EWSDNARFDYKAW-KRRP-----------------YCTVMVVKPDRIFWFTRGCEKSVSFVCKFLT  124 (127)
T ss_dssp             EETTCCCCCCCCB-CCCC-----------------EEEEEEECSSCEEEEEEETTSCEEEEEEEEC
T ss_pred             EecCCCccccccc-CCCC-----------------CcEEEEEECCCCeEEecCCCCCEEEEEEEcC
Confidence            9999999877664 3221                 3444332  2246999999999999998864

>d1sb2b1 d.169.1.1 (B:2-128) Snake coagglutinin beta chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]

Probab=99.90  E-value=4e-25  Score=190.04  Aligned_cols=117  Identities=22%  Similarity=0.484  Sum_probs=95.8

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCC----CCCCeEEeeeecCCCCC
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVG  125 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~  125 (557)
                      .||+||+  .|+++||+|+.++++|.+|+.+|++  .||+||+|+|++|++||.+++..    ....+||||+  +    
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~gg~La~i~s~~e~~fl~~~~~~~~~~~~~~~WiGl~--~----   73 (127)
T d1sb2b1           2 RCPTTWS--ASKLYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNFDKQRYRAWTGLT--E----   73 (127)
T ss_dssp             CCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHC---CCCEEEEEE--E----
T ss_pred             cCCCCCe--ecCCEEEEEECeecCHHHHHHHHHhhcCCcccccccCHHHHHHHHHHHhhhccccccceeeeec--c----
Confidence            5999999  8999999999999999999999976  49999999999999999988742    2456999998  4    


Q ss_pred             CeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEee--cCCCceeccccCCCCCccccccc
Q 008698          126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS--NGSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       126 ~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~--~~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      +.|+|+||+++.|.+|..+++  +              +|+.+.  ...+.|++..|....+|||+.+.
T Consensus        74 ~~~~W~dGs~~~y~nw~~~~~--~--------------~c~~~~~~~~~~~W~~~~C~~~~~fICe~Pk  126 (127)
T d1sb2b1          74 RNLKWTNGASVSYENLYEPYI--R--------------KCFVVQPWEGKSKWYKADCEEKNAFLCKFPK  126 (127)
T ss_dssp             CCCBCTTSCBCCSCCBSSCCC--C--------------CEEEEEEETTEEEEEEECTTSCEEEEEEEEC
T ss_pred             cceeecccCCccccccCCCCC--c--------------ceeEEEEeCCCCCEEecCCCCCEEEEEEEcC
Confidence            569999999998888754332  2              344433  23346999999999999999864

>d1egga_ d.169.1.1 (A:) Macrophage mannose receptor, CRD4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Macrophage mannose receptor, CRD4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=1.2e-24  Score=189.23  Aligned_cols=127  Identities=26%  Similarity=0.537  Sum_probs=100.7

Q ss_pred             CCccCcccCCCCeeeEE----ecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCC
Q 008698           53 CPPDWIINEEKSKCFGY----IGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVG  125 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~----~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~  125 (557)
                      ||+||..+.++++||++    ..++++|.+|+.+|+++||+||+|+|++|++||.++++..   ...+||||+  +...+
T Consensus         1 Cp~gW~~~~~~~~CY~~~~~~~~~~~~w~~A~~~C~~~gg~L~~i~s~~e~~~i~~~l~~~~~~~~~~wiG~~--~~~~~   78 (136)
T d1egga_           1 CPEDWGASSRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLITASGSYHKLFWLGLT--YGSPS   78 (136)
T ss_dssp             CCTTCEECSSSSCEEEEECSCGGGCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--CC---
T ss_pred             CCCCCeeCCCCCEEEEEEecCCCcccCHHHHHHHHHHCCCEEeEEecchhhhhhhhhcccccccccccccccc--ccccc
Confidence            99999755778999988    4567899999999999999999999999999999987532   456899999  66667


Q ss_pred             CeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecC-CCceeccccCCCCCcccccc
Q 008698          126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       126 ~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~~~  191 (557)
                      +.|.|+||+++.|.+| .+++|++         ..+.++|+.+... ...|++..|....+|||+.+
T Consensus        79 ~~~~W~dg~~~~y~~W-~~g~P~~---------~~~~~~C~~~~~~~~~~W~~~~C~~~~~fICe~~  135 (136)
T d1egga_          79 EGFTWSDGSPVSYENW-AYGEPNN---------YQNVEYCGELKGDPTMSWNDINCEHLNNWICQIQ  135 (136)
T ss_dssp             -CCCCTTSCCCCCCCC-CTTCSCG---------GGSCCEEEEEECSTTCCEEEEETTSCBEEEEECC
T ss_pred             eeeeeecCCcceeecc-cCCCCCC---------CCCCcceEEEEcCCCCeEEecCCCCcEeEEEEEe
Confidence            9999999999877664 4444443         2345678877644 45799999999999999874

>d1j34a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]

Probab=99.90  E-value=4.3e-25  Score=190.34  Aligned_cols=121  Identities=27%  Similarity=0.584  Sum_probs=97.6

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCCHHHHHHHHHHhCC----CCCCeEEeeeecCCCCC
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVG  125 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~  125 (557)
                      .||+||.  .|+++||+|+..+++|.+|+.+|+.  .||+||+|+|++|++||.+++..    ....+||||++.+.+..
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~g~~L~~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~   78 (129)
T d1j34a_           1 DCPSGWS--SYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENIQNTKSYVWIGLRVQGKEKQ   78 (129)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCCTTCCEEEEEEECSSCSC
T ss_pred             CCCCcCE--eeCCEEEEEECcccCHHHHHHhhhhccCCccccccCCHHHHHHHHhhhccccccccceEEeeeeccccccc
Confidence            4999999  8999999999999999999999965  69999999999999999987642    24569999996665555


Q ss_pred             CeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeec--CCCceeccccCCCCCccccc
Q 008698          126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN--GSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       126 ~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~--~~~~w~~~~C~~~~~~iC~~  190 (557)
                      +.|+|+||+++.|.+|.+++ |+ +              |+.+..  ....|++..|....+|||+.
T Consensus        79 ~~~~W~dgs~~~y~~W~~~e-p~-~--------------c~~~~~~~~~~~W~~~~C~~~~~fICea  129 (129)
T d1j34a_          79 CSSEWSDGSSVSYENWIEAE-SK-T--------------CLGLEKETGFRKWVNIYCGQQNPFVCEA  129 (129)
T ss_dssp             SCCBCTTSCBCCCCCBCGGG-SC-C--------------EEEECGGGTTCSBEEECTTSCEEEEEEC
T ss_pred             cceecCCCCcccccccCCCC-CC-c--------------EEEEEccCCCCCEEecCCCCCcceEecC
Confidence            78999999999887755444 33 3              333322  23469999999999999973

>d1fvua_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]

Probab=99.90  E-value=8.7e-25  Score=189.47  Aligned_cols=123  Identities=24%  Similarity=0.514  Sum_probs=98.8

Q ss_pred             CCCccCcccCCCCeeeEEecCCCChHHHHHHHhh--CCCeEeeeCC-HHHHHHHHHHhCC----CCCCeEEeeeecCCCC
Q 008698           52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTS-YEEEHSAQKLCGK----NVNGCWVGGRSINTTV  124 (557)
Q Consensus        52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~s-~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~  124 (557)
                      .||+||.  .|+++||+|+.++++|.+|+.+|++  .||+||+|++ ++|++||..++..    ....+||||++.+...
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~~~~e~~~~~~~~~~~~~~~~~~~~WIGl~~~~~~~   78 (133)
T d1fvua_           1 DCPSGWS--SYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKNIQSSDLYAWIGLRVENKEK   78 (133)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCTTSTHHHHHHHHHHHHCCSSCCEEEEEEEECCSSS
T ss_pred             CCCCCCE--EECCEEEEEECcccCHHHHHHHHhhccccccccccCCHHHHHHHHHhhhhccccCccccceEEEeeccccc
Confidence            4999999  8999999999999999999999975  5899999975 6788888887642    2456899998766666


Q ss_pred             CCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCccccccc
Q 008698          125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       125 ~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~  192 (557)
                      .+.|.|+||+++.|.+|...+| +               +|+.+....  ..|++..|....+|||+.++
T Consensus        79 ~~~w~W~dGs~~~y~~w~~~~p-~---------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~P  132 (133)
T d1fvua_          79 QCSSEWSDGSSVSYENVVERTV-K---------------KCFALEKDLGFVLWINLYCAQKNPFVCKSPP  132 (133)
T ss_dssp             SSCCBCTTSCBCCCCCBCGGGC-C---------------CEEEEETTTTSCSEEEECTTCCEEEEEEECC
T ss_pred             ccccccccCCcccccccCCCCC-C---------------CeEEEEecCCCCeEEccCCCCCEEEEEEECc
Confidence            6889999999988877544332 2               255554433  46999999999999999865

>d1oz7a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]

Probab=99.90  E-value=8.7e-25  Score=188.94  Aligned_cols=122  Identities=25%  Similarity=0.556  Sum_probs=97.4

Q ss_pred             CCccCcccCCCCeeeEEecCCCChHHHHHHHhhCC--CeEeeeCCHHHHHHHHHHhCC---CCCCeEEeeeecCCCCCCe
Q 008698           53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG--GHLAALTSYEEEHSAQKLCGK---NVNGCWVGGRSINTTVGLS  127 (557)
Q Consensus        53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~--~~L~~i~s~~e~~f~~~~~~~---~~~~~WiGl~~~~~~~~~~  127 (557)
                      ||+||+  .|+++||+++.++++|.+|+.+|+++|  |+||+|+|++|++||.+++..   ....+||||++...+....
T Consensus         2 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~g~L~~i~s~~e~~fi~~~~~~~~~~~~~~WIGl~~~~~~~~~~   79 (131)
T d1oz7a_           2 CPPGWS--SNGVYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENIGKMYKIWTGLSERSKEQHCS   79 (131)
T ss_dssp             CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCCCSEEEEEEEECCCGGGSC
T ss_pred             CCCCCE--EECCEEEEEECcccCHHHHHhhhhccCCCccccccCCHHHhhhhhhheecccCCCccEEEEEEecCcccccc
Confidence            999999  899999999999999999999999876  999999999999999988742   2457999999554443456


Q ss_pred             eEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecC--CCceeccccCCCCCcccccccc
Q 008698          128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEHE  193 (557)
Q Consensus       128 w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~--~~~w~~~~C~~~~~~iC~~~~~  193 (557)
                      |+|+||+++.+.+++.                 +.++|+.+...  ...|++..|....+|||+++.+
T Consensus        80 ~~W~dgs~~~~~~~~~-----------------~~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~~~p  130 (131)
T d1oz7a_          80 SRWSDGSFFRSYEIAI-----------------RYSECFVLEKQSVFRTWVATPCENTFPFMCKYPVP  130 (131)
T ss_dssp             CBCSSSBCCSCCCCCC-----------------SCCCEEEEEGGGTTCSEEEECTTSCEEEEEEECTT
T ss_pred             cccCCCCcccCCccCC-----------------CCCCEEEEEecCCCCcEEecCCCCCEeEEEeEeCC
Confidence            9999998865544332                 12356665432  3469999999999999998753

>d1uv0a_ d.169.1.1 (A:) Pancreatitis-associated protein 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Pancreatitis-associated protein 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=5.2e-24  Score=186.12  Aligned_cols=128  Identities=19%  Similarity=0.373  Sum_probs=102.4

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhC-CCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCC---
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTT---  123 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~s~~e~~f~~~~~~~~---~~~~WiGl~~~~~~---  123 (557)
                      ..||+||.  .|+++||+|+.++++|.+|+.+|+++ ||+||+|+|.+|++||.++++..   ...+||||++....   
T Consensus         3 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~gg~La~i~s~~e~~~l~~~l~~~~~~~~~~WiGl~~~~~~~~~   80 (140)
T d1uv0a_           3 IRCPKGSK--AYGSHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGNSYSYVWIGLHDPTQGTEP   80 (140)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHTTSTTCEECCCCSHHHHHHHHHHHTTSCTTCCEEEEEEECTTTTCC-
T ss_pred             CccCcCcE--eeCCEEEEEECCccCHHHHHHhhhccccceecccCCHHHHHHHHHhhhccccccceeEEeeecccccccC
Confidence            58999999  89999999999999999999999875 89999999999999999998653   45699999854322   


Q ss_pred             CCCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCC--CceeccccCCCCCcccccc
Q 008698          124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       124 ~~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~  191 (557)
                      ....|.|+||+++.+.+|. .+||+          ..+.++|+.+....  ..|++..|....+|||+..
T Consensus        81 ~~~~w~w~dg~~~~~~~w~-~~~~~----------~~~~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~t  139 (140)
T d1uv0a_          81 NGEGWEWSSSDVMNYFAWE-RNPST----------ISSPGHCASLSRSTAFLRWKDYNCNVRLPYVCKFT  139 (140)
T ss_dssp             -CCCCEETTCCCCCCCCBS-SCGGG----------SSSCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred             CCCceEccCCCcccccccC-CCCCC----------CCCCCCEEEEEccCCCCeEEecCCCCCEeEEEEEC
Confidence            1246999999998877654 44432          23446787765433  4699999999999999863

>d1v7pa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]

Probab=99.90  E-value=1.2e-24  Score=188.74  Aligned_cols=125  Identities=25%  Similarity=0.478  Sum_probs=98.1

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhC--CCeEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCC
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTV  124 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~s~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~  124 (557)
                      ..||+||.  .|+++||+|+.++++|.+|+.+|+.+  ||+||+|+|++|++||.+++...    ...+||||++...+.
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~~g~La~i~s~~e~~fi~~~~~~~~~~~~~~~WIGl~~~~~~~   79 (134)
T d1v7pa_           2 FDCPSDWT--AYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFMHRSEIYVWIGLRDRREEQ   79 (134)
T ss_dssp             TTSCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHTGGGGGSSCSEEEEEEECCCSSS
T ss_pred             CCCCCCCE--EECCEEEEEECcccCHHHHHHhhcccCCCccccccCCHHHhHHHHhhcccccccccchhhhhccccCCcc
Confidence            36999999  89999999999999999999999764  89999999999999999988642    345999999444443


Q ss_pred             CCeeEEccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       125 ~~~w~W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      ...|+|+||+++.|.+ |.+++|+ +|.+.            ......+.|++..|....+|||+.+
T Consensus        80 ~~~~~W~dgs~~~y~~-W~~~~p~-~~~~~------------~~~~~~~~W~~~~C~~~~~fICe~~  132 (134)
T d1v7pa_          80 QCNPEWNDGSKIIYVN-WKEGESK-MCQGL------------TKWTNFHDWNNINCEDLYPFVCKFS  132 (134)
T ss_dssp             CSCCBCTTSCBCCCCC-BCTTCCC-CEEEE------------EGGGTTCSEEEECTTSCEEEEEEEE
T ss_pred             eeeeeecCCCcccccc-cCCCCCC-ceeEE------------EEecCCCcEEeeCCCCCEEEEEEEe
Confidence            3467899999987776 4445443 33211            1223446799999999999999875

>d1pwba1 d.169.1.1 (A:235-355) Surfactant protein, lectin domain {Human (Homo sapiens), SP-D [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Surfactant protein, lectin domain
species: Human (Homo sapiens), SP-D [TaxId: 9606]

Probab=99.89  E-value=1.4e-24  Score=184.79  Aligned_cols=120  Identities=18%  Similarity=0.274  Sum_probs=100.8

Q ss_pred             CccCcccCCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccC
Q 008698           54 PPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN  133 (557)
Q Consensus        54 p~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg  133 (557)
                      |.|+.   ++++||+++.+++||.+|+.+|+++||+||+|+|++|++||.+++......+||||+  +...++.|.|.||
T Consensus         1 P~g~~---~g~~cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~~~w~dg   75 (121)
T d1pwba1           1 PNGQS---VGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMT--DSKTEGKFTYPTG   75 (121)
T ss_dssp             TTEEE---ETTEEEEEEEEEEEHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHHTCCEECSCB--CSSSTTCCBCTTS
T ss_pred             CCcEE---ECCEEEEEeCeeECHHHHHHHHHHcCCEecceeechhhhhhhhccccceeeeeeeee--ccCccceeeeccc
Confidence            45554   899999999999999999999999999999999999999999987654668999999  6666799999999


Q ss_pred             CCCCCcCccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccc
Q 008698          134 MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM  189 (557)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~  189 (557)
                      +++.+.+| .+++|++         ..+.++|+.+.. ++.|++..|....+|||+
T Consensus        76 ~~~~~~~W-~~~eP~~---------~~~~~~C~~~~~-~~~W~~~~C~~~~~fICe  120 (121)
T d1pwba1          76 ESLVYSNW-APGEPND---------DGGSEDCVEIFT-NGKWNDRACGEKRLVVCE  120 (121)
T ss_dssp             CBCSCCCB-CTTCCCC---------GGGCCCEEEECT-TSCEEEECTTSEEEEEEE
T ss_pred             ccccccee-cCCCCCC---------CCCceeEEEECC-CCEEEeeCCCCCEEEEEe
Confidence            99887665 4444443         335678988764 467999999999999997

>d2msba_ d.169.1.1 (A:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Mannose-binding protein A, C-lectin domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.89  E-value=1.4e-23  Score=175.74  Aligned_cols=111  Identities=15%  Similarity=0.246  Sum_probs=94.8

Q ss_pred             eeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCCCcCcccc
Q 008698           65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV  144 (557)
Q Consensus        65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~~~~~  144 (557)
                      +||+++.++++|.+|+.+|+++||+||+|+|++|++||.++..   ..+||||+  +...+|.|+|+||+++.|.+|.. 
T Consensus         2 k~y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~g~~~w~dg~~~~y~~W~~-   75 (112)
T d2msba_           2 KFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYVTGGRLTYSNWKK-   75 (112)
T ss_dssp             CEEEEEEEEECHHHHHHHHHHTTCEECCCSSHHHHHHHHHHHS---SCEEEEEE--CSSSTTCCEETTSSBCCSCCBCT-
T ss_pred             cEEEECCcEeCHHHHHHHHHhCCCEEeeEcCHHHhhhhhhccc---ceEEEEEe--ecCcccccccccccccccccccc-
Confidence            6999999999999999999999999999999999999999986   36999999  66667999999999998777554 


Q ss_pred             CCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          145 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       145 ~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      ++|++         ..+.++|+.+.. .+.|++..|....+|||+.|
T Consensus        76 ~eP~~---------~~~~~~Cv~~~~-~~~W~~~~C~~~~~fICe~P  112 (112)
T d2msba_          76 DEPND---------HGSGEDCVTIVD-NGLWNDISCQASHTAVCEFP  112 (112)
T ss_dssp             TCCCC---------CTTCCCEEEECT-TSCEEEECTTSCEEEEEEEC
T ss_pred             CCCCC---------CCCCCCEEEEeC-CCEEEEeCCCCcEEEEEecC
Confidence            44443         234568888754 46799999999999999864

>d1hupa1 d.169.1.1 (A:112-228) Mannose-binding protein A, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Mannose-binding protein A, C-lectin domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=2.1e-23  Score=176.34  Aligned_cols=115  Identities=15%  Similarity=0.198  Sum_probs=98.1

Q ss_pred             CCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCCCcC
Q 008698           61 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNES  140 (557)
Q Consensus        61 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~  140 (557)
                      .++++||+++.++++|.+|+.+|+++||+||+|+|++|++||.+++.   ..+||||+  +...+|.|+|.||+++.+.+
T Consensus         2 ~vG~~~y~~~~~~~tw~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~w~w~dg~~~~~~~   76 (117)
T d1hupa1           2 QVGNKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAENGAIQNLIK---EEAFLGIT--DEKTEGQFVDLTGNRLTYTN   76 (117)
T ss_dssp             EETTEEEEEEEEEEEHHHHHHHHHHTTCEECCCCSHHHHHHHHHHCS---SCEEEEEE--CSSSTTCCEETTSCBCSCCC
T ss_pred             cccCEEEEEcCEEECHHHHHHHHHHCCCEEcccCCHHHHHHHhhccc---ceEEEEee--ccCcccceeecccccccccc
Confidence            46889999999999999999999999999999999999999999986   47999999  55566999999999998877


Q ss_pred             ccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccccc
Q 008698          141 IHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       141 ~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |...+| ++         ..+.++|+.+.. ++.|++..|....+|||+.|
T Consensus        77 w~~~~p-~~---------~~~~~~Cv~~~~-~~~W~~~~C~~~~~fICe~P  116 (117)
T d1hupa1          77 WNEGEP-NN---------AGSDEDCVLLLK-NGQWNDVPCSTSHLAVCEFP  116 (117)
T ss_dssp             BCTTCC-CC---------GGGCCCEEEECT-TSCEEEECTTSEEEEEEEEE
T ss_pred             cCCCCC-CC---------CCCcCCeEEECC-CCeEEeeCCCCCEEEEEEEe
Confidence            665544 32         234678887754 46899999999999999875

>d1r13a1 d.169.1.1 (A:110-228) Surfactant protein, lectin domain {Rat (Rattus norvegicus), SP-A [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Surfactant protein, lectin domain
species: Rat (Rattus norvegicus), SP-A [TaxId: 10116]

Probab=99.88  E-value=3.8e-23  Score=175.12  Aligned_cols=115  Identities=17%  Similarity=0.227  Sum_probs=97.8

Q ss_pred             CCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCCCcC
Q 008698           61 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNES  140 (557)
Q Consensus        61 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~  140 (557)
                      ..+++||+++.++++|.+|+.+|+++||+||+|+|++|++||.+++......+||||+  +...++.|.|.||+++.+.+
T Consensus         4 ~vG~~cy~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~w~w~dg~~~~y~~   81 (119)
T d1r13a1           4 SVGDKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYLGMI--EDQTPGDFHYLDGASVSYTN   81 (119)
T ss_dssp             EETTEEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHTTSCEEEEEE--ECSSTTCEEETTSCBCCSCC
T ss_pred             cCccEEEEECCEEECHHHHHHHhhhCCCEEeEEeehHHhhhhhhcccccceEEEEEee--cCCcceeeeeecccccccce
Confidence            5789999999999999999999999999999999999999999998755678999999  55567999999999987766


Q ss_pred             ccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCcccc
Q 008698          141 IHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM  189 (557)
Q Consensus       141 ~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~  189 (557)
                      |. +++|++          .++++|+.+.. ++.|++..|....+|||+
T Consensus        82 W~-~~~P~~----------~~~~~Cv~~~~-~~~W~~~~C~~~~~~ICe  118 (119)
T d1r13a1          82 WY-PGEPRG----------QGKEKCVEMYT-DGTWNDRGCLQYRLAVCE  118 (119)
T ss_dssp             BC-TTCCCC----------SSCCCEEEECT-TSCEEEECSCSCEEEEEE
T ss_pred             EE-eeccCC----------CCCCCEEEEcC-CCEEEecCCCCCEeEEEe
Confidence            54 444442          24567887764 467999999999999997

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=4.8e-23  Score=189.99  Aligned_cols=167  Identities=18%  Similarity=0.162  Sum_probs=118.3

Q ss_pred             CeeecccCceEEEEEEeCCCCEEEEEEecccch------------------hhHHHHHHHHHHHhhcCCCcEEeeeeeee
Q 008698          274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF------------------QRKKEFYSEIGRFARLHHPNLVAVKGCCY  335 (557)
Q Consensus       274 ~~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~H~niv~l~g~~~  335 (557)
                      ++.||+|+||+||+|...+|+.||||+++....                  .......+|...+.++.|++++..+++. 
T Consensus         5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~-   83 (191)
T d1zara2           5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE-   83 (191)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred             CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence            457899999999999988999999998753210                  1123456788899999999998877652 


Q ss_pred             eCCceEEEEecCCCCChHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCcEEee
Q 008698          336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG  415 (557)
Q Consensus       336 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  415 (557)
                         ..+++|||++++.+..           ++......++.|++.+|+|||++   +|+||||||+|||++++ .++|+|
T Consensus        84 ---~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          84 ---GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ---TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred             ---CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence               2379999998765533           23334567899999999999999   99999999999999965 589999


Q ss_pred             ccCCccCCccccccceeecCccccccccccccCCCCCchhhHHHHHHHH
Q 008698          416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL  464 (557)
Q Consensus       416 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil  464 (557)
                      ||.|.....+.......   ..... -.|. ....|+.++|+||..--+
T Consensus       146 FG~a~~~~~~~~~~~l~---rd~~~-~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWREILE---RDVRN-IITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHHHHHH---HHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcHHHHH---HHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence            99997654322111000   00000 0111 235678889999976433

>d1rdl1_ d.169.1.1 (1:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Mannose-binding protein A, C-lectin domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.87  E-value=2.4e-22  Score=167.95  Aligned_cols=110  Identities=15%  Similarity=0.206  Sum_probs=93.3

Q ss_pred             eeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCCCcCcccc
Q 008698           65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV  144 (557)
Q Consensus        65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~~~~~  144 (557)
                      +||+++.++++|.||+.+|+++||+||+|+|++|++||.+++.   ..+||||+  +...+|.|.|+||+++.|.+ |.+
T Consensus         1 kyy~~~~~~~~~~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~~~w~dG~~~~y~~-W~~   74 (111)
T d1rdl1_           1 KYFMSSVRRMPLNRAKALCSELQGTVATPRNAEENRAIQNVAK---DVAFLGIT--DQRTENVFEDLTGNRVRYTN-WNE   74 (111)
T ss_dssp             CEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHCS---SCEEEEEE--CSSSTTCCEETTSCBCCCCC-BCT
T ss_pred             CEEEECCcEeCHHHHHHHHHHcCCEEEEECCHHHhHHHhhccc---ceeeEEee--ecCccceeeecccccceeee-ccc
Confidence            5899999999999999999999999999999999999999875   46999999  66667999999999988766 455


Q ss_pred             CCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccc
Q 008698          145 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       145 ~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~  190 (557)
                      ++|++         .++.++|+.+.. ++.|++..|....+|||+.
T Consensus        75 geP~~---------~~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~  110 (111)
T d1rdl1_          75 GEPNN---------VGSGENCVVLLT-NGKWNDVPCSDSFLVVCEF  110 (111)
T ss_dssp             TCCCC---------CTTCCCEEEECT-TSCEEEECTTSCBEEEEEE
T ss_pred             cCCCC---------CCCcceEEEECC-CCEEEeeCCCCCEEEEEEE
Confidence            55443         335568988754 4679999999999999985

>d1h8ua_ d.169.1.1 (A:) Eosinophil major basic protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Eosinophil major basic protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=1.9e-22  Score=169.66  Aligned_cols=112  Identities=16%  Similarity=0.285  Sum_probs=93.6

Q ss_pred             eEEecCCCChHHHHHHHhh-CCCeEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCeeEEccCCCCCCcCcccc
Q 008698           67 FGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV  144 (557)
Q Consensus        67 y~~~~~~~~w~~a~~~C~~-~~~~L~~i~s~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~~~~~~~  144 (557)
                      |+++.+++||.+|+.+|++ +|||||+|+|++|++||.+++... ...+||||...+...++.|+|+||+++.|.+|-.+
T Consensus         2 Y~~~~~~~tw~~A~~~C~~~~gg~L~sI~s~~e~~~i~~~~~~~~~~~~WIGl~~~~~~~~~~~~W~dGs~~~y~~W~~~   81 (115)
T d1h8ua_           2 YLLVRSLQTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSGRCRRFQWVDGSRWNFAYWAAH   81 (115)
T ss_dssp             EEEEEEEECHHHHHHHHHHHHSSEECCCCSHHHHHHHHHHHTTCSSSEEEEEEEEECSSSCCEEEETTCCCCCCCCBCSS
T ss_pred             eEEECCccCHHHHHHHhhcccCCcCcccCHHHHHHHHHHHHhhcCCCcEEEEEEecCCCCcceEEEecCceeecccccCC
Confidence            8899999999999999987 799999999999999999998754 45799998755666678999999999887775444


Q ss_pred             CCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccc
Q 008698          145 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  190 (557)
Q Consensus       145 ~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~  190 (557)
                       +|++           ..++|+.+...++.|++..|....+|||+.
T Consensus        82 -~P~~-----------~~~~Cv~~~~~~g~W~~~~C~~~~~fICe~  115 (115)
T d1h8ua_          82 -QPWS-----------RGGHCVALCTRGGYWRRAHCLRRLPFICSY  115 (115)
T ss_dssp             -SCCT-----------TSCSEEEEETTTTCEEEECTTSCEEEEEEC
T ss_pred             -CCCC-----------CCCCEEEEECCCCEEEeeCCCCCEeeEEeC
Confidence             4332           234788887777789999999999999973

>d1kg0c_ d.169.1.1 (C:) EBV gp42 {Epstein-Barr virus [TaxId: 10376]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: EBV gp42
species: Epstein-Barr virus [TaxId: 10376]

Probab=99.85  E-value=5.9e-22  Score=171.07  Aligned_cols=116  Identities=16%  Similarity=0.212  Sum_probs=94.0

Q ss_pred             CCCCccCcccCCCCeeeEEecCCCChHHHHHHHhhC-CCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeE
Q 008698           51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK  129 (557)
Q Consensus        51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~  129 (557)
                      ..||.+|.  .|+++||+|+.+++||.+|+.+|++. +++|++|++++|++||..++.. .+.|||||++ +  .+|.|+
T Consensus        17 c~~~~~~~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~~~L~~i~~~~e~~fl~~~~~~-~~~~WIGL~~-~--~~~~W~   90 (136)
T d1kg0c_          17 CNTREYTF--SYKGCCFYFTKKKHTWNGCFQACAEKYPCTYFYGPTPDILPVVTRNLNA-IESLWVGVYR-V--GEGNWT   90 (136)
T ss_dssp             CCTTTCSE--EETTEEEEECSSCBCTTHHHHHHHHHSTTCEECCCCTTTHHHHHHTSCS-SCCEECSEEE-S--SSSSEE
T ss_pred             CCCCCCeE--eECCEEEEEEcccCcHHHHHHHHhcCCCCcEeccCCHHHHHHHHHhcCC-CCcEEEEEEe-c--CCCceE
Confidence            35699999  89999999999999999999999886 5699999999999999998763 4579999984 2  358999


Q ss_pred             EccCCCCCCcCccccCCCCCCCCCCCCccccccCceeEeec-CCCceeccccCCCCCcccccc
Q 008698          130 WSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE  191 (557)
Q Consensus       130 W~Dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~-~~~~w~~~~C~~~~~~iC~~~  191 (557)
                      |+||+++.+.++                   .+++|+.+.. ....|++..|....++||+..
T Consensus        91 W~Dgs~~~~~~~-------------------~~~~C~~l~~~~~~~w~~~~C~~~~~~IC~~~  134 (136)
T d1kg0c_          91 SLDGGTFKVYQI-------------------FGSHCTYVSKFSTVPVSHHECSFLKPCLCVSQ  134 (136)
T ss_dssp             ETTCSCCCCBCS-------------------SCTTCEEECTTCSSCEECSCTTSCBCBEEEEE
T ss_pred             ECCCCccccccc-------------------cccceEEEEecCCCcEeecCCCCCcceEEEEe
Confidence            999998644321                   1135665543 335799999999999999864

>d1g1ta1 d.169.1.1 (A:1-118) E-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: E-selectin, C-lectin domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=1.7e-20  Score=158.45  Aligned_cols=110  Identities=20%  Similarity=0.373  Sum_probs=89.4

Q ss_pred             eeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCC--CcCccc
Q 008698           66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKW--NESIHA  143 (557)
Q Consensus        66 Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~--~~~~~~  143 (557)
                      ||+|+.+++||.+|+.+|++.||+||+|+|++|++||.+++......+||||++  .  ++.|.|+||+...  .+..|.
T Consensus         2 ~Y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~~--~--~~~~~w~~~~~~~~~~~~~W~   77 (118)
T d1g1ta1           2 SYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRK--V--NNVWVWVGTQKPLTEEAKNWA   77 (118)
T ss_dssp             EEEECSSCBCHHHHHHHHHHHSSEECCCCSHHHHHHHHHHSCCCTTCEEESEEE--E--TTEEEETTTCCBCCTTTCCBC
T ss_pred             EEEEeCCccCHHHHHHHHHHCCCEEeEEccHHHhHHHHhccccccceeeecccc--c--ceeeeeecCCCCccccccccC
Confidence            799999999999999999999999999999999999999997667789999994  3  3789999987542  344566


Q ss_pred             cCCCCCCCCCCCCccccccCceeEee----cCCCceeccccCCCCCccc
Q 008698          144 VGSFNSSCTSLPCHVHATVDLCTLVS----NGSRSLVTERCNTSHPFIC  188 (557)
Q Consensus       144 ~~~~~~~~~~~~c~~~~~~~~C~~~~----~~~~~w~~~~C~~~~~~iC  188 (557)
                      +++|++         ..+.++|+.+.    ...+.|++..|....+|||
T Consensus        78 ~~eP~~---------~~~~~~Cv~l~~~~~~~~~~W~d~~C~~~~~fIC  117 (118)
T d1g1ta1          78 PGEPNN---------RQKDEDCVEIYIKREKDVGMWNDERCSKKKLALC  117 (118)
T ss_dssp             TTCCCC---------CSTTCCEEEECTTCSSSTTCEEEECTTSCBEEEE
T ss_pred             CCCccC---------CCCCCCeEEEEecCCCCCCeEeccCCCCCeeEEc
Confidence            666554         23446788763    2335799999999999999

>d1wk1a_ d.169.1.1 (A:) Hypothetical protein F28B4.3 {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Hypothetical protein F28B4.3
species: Caenorhabditis elegans [TaxId: 6239]

Probab=99.81  E-value=5.1e-20  Score=162.32  Aligned_cols=119  Identities=18%  Similarity=0.318  Sum_probs=92.4

Q ss_pred             CCCCeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCCCC--
Q 008698           61 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWN--  138 (557)
Q Consensus        61 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~~~--  138 (557)
                      ..+.+||.+..+.++|.+|+.+|+++||+||+|++++|++||.++..  ...|||||++  . .+|.|+|+||+++..  
T Consensus         5 ~~g~~~~~~~~~~~s~~~A~~~C~~~gg~La~i~~~~e~~fi~~~~~--~~~~WiGl~~--~-~~g~w~W~dg~~~~~~~   79 (150)
T d1wk1a_           5 SSGVKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAA--NTQFWIGLFK--N-SDGQFYWDRGQGINPDL   79 (150)
T ss_dssp             SCCCCSSSCCSSCBCHHHHHHHHHHHTCEECCCCSHHHHHHHHHHTT--TCEEEEEEEE--C-SSSCEEECCSSSSCCEE
T ss_pred             CCCcEEEEEeCCccCHHHHHHHHHhCCCEEeeeCCHHHHHHhhhccc--ccceeEeeee--c-ccccccccccccccccc
Confidence            45666777888999999999999999999999999999999999987  5689999984  2 358999999998752  


Q ss_pred             ----cCccccCCCCCCCCCCCCccccccCceeEeecCC----CceeccccCCCCCccccccccC
Q 008698          139 ----ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS----RSLVTERCNTSHPFICMVEHEN  194 (557)
Q Consensus       139 ----~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~----~~w~~~~C~~~~~~iC~~~~~s  194 (557)
                          +..|..++|++          .+.++|+.+....    ..|++..|....+|||++....
T Consensus        80 ~~~~~~~W~~~eP~~----------~~~~~C~~~~~~~~~~~~~W~~~~C~~~~~fICe~~~~~  133 (150)
T d1wk1a_          80 LNQPITYWANGEPSN----------DPTRQCVYFDGRSGDKSKVWTTDTCATPRPFICQKHRYD  133 (150)
T ss_dssp             CCCSCCCBCTTCSCC----------CSSCCEEEEESSCSCGGGCEEEECTTSCBCCCEECCCCC
T ss_pred             cccccccccCCCCCC----------CCCcceEEEeccCCCCCCceEccCCCCCEeEEEEECCCC
Confidence                23355544443          2345566654332    3599999999999999876433

>d1g1sa1 d.169.1.1 (A:1-118) P-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: P-selectin, C-lectin domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=1.4e-20  Score=158.90  Aligned_cols=109  Identities=19%  Similarity=0.343  Sum_probs=88.3

Q ss_pred             eEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCeeEEccCCCC--CCcCcccc
Q 008698           67 FGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSK--WNESIHAV  144 (557)
Q Consensus        67 y~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg~~~--~~~~~~~~  144 (557)
                      |+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++......+||||++  ..  +.|+|+||+..  ..++.|.+
T Consensus         3 Y~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~fl~~~~~~~~~~~WiGl~~--~~--~~~~W~~~~~~~~~~~~~W~~   78 (118)
T d1g1sa1           3 YHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIRK--NN--KTWTWVGTKKALTNEAENWAD   78 (118)
T ss_dssp             EEEEEEEECHHHHHHHHHHHSSEECCCCCHHHHHHHHHHSCCCTTCEEEEEEE--ET--TEEEETTTCCBCCTTTCCBCT
T ss_pred             EEEECCccCHHHHHHHHHHcCCEEeEEeCHHHHHHHHhhhccccccchhhccc--cc--cccceecCCCCccceecccCC
Confidence            89999999999999999999999999999999999999987666789999994  33  78999987654  33445666


Q ss_pred             CCCCCCCCCCCCccccccCceeEeec----CCCceeccccCCCCCccc
Q 008698          145 GSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFIC  188 (557)
Q Consensus       145 ~~~~~~~~~~~c~~~~~~~~C~~~~~----~~~~w~~~~C~~~~~~iC  188 (557)
                      ++|++         ..+.++|+.+..    ..+.|++..|....+|||
T Consensus        79 ~eP~~---------~~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fIC  117 (118)
T d1g1sa1          79 NEPNN---------KRNNEDCVEIYIKSPSAPGKWNDEHCLKKKHALC  117 (118)
T ss_dssp             TCCCC---------TTSCCCEEEECTTCSSSTTCEEEECTTSCEEEEE
T ss_pred             CCCCC---------CCCCCCeEEEEccCCCCCCeEEeeCCCCCEeEEc
Confidence            66554         335567877632    235699999999999999

>d1byfa_ d.169.1.1 (A:) Lectin TC14 {Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Lectin TC14
species: Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]

Probab=99.75  E-value=8.2e-19  Score=148.92  Aligned_cols=118  Identities=18%  Similarity=0.291  Sum_probs=94.4

Q ss_pred             CeeeEEecCCCChHHHHHHHhhCCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCC-CeeEEccCCCCCC-c
Q 008698           64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVG-LSWKWSDNMSKWN-E  139 (557)
Q Consensus        64 ~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~s~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~-~~w~W~Dg~~~~~-~  139 (557)
                      ++.|+|+.+++||.+|+.+|++.||+||+|.+++|+.|+..+....  ...+|||++  +...+ ..|.|.||+++.+ .
T Consensus         1 ~y~~~f~~~~~tw~~A~~~C~~~g~~La~i~~~~~~~~~~~~~~~~~~~~~~WiG~~--~~~~~~~~w~~~~~~~~~~~~   78 (123)
T d1byfa_           1 DYEILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGAD--NLQDGAYNFLWNDGVSLPTDS   78 (123)
T ss_dssp             CEEEEEEEEEECHHHHHHHHHTTTCEESCGGGGSHHHHHHHHHHHHHHTCCEEEEEE--STTTCTTCCEETTSCBCCTTC
T ss_pred             CeEEEEECcEeCHHHHHHHHHHCCCCCCccCCHHHHHHHHHHHhccCCCccEEEeec--cccccccccccccCCcccccc
Confidence            3679999999999999999999999999999999999988765322  557999998  43333 4699999998754 4


Q ss_pred             CccccCCCCCCCCCCCCccccccCceeEeecCCCceeccccCCCCCccccccc
Q 008698          140 SIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  192 (557)
Q Consensus       140 ~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~  192 (557)
                      ++|..++|++         ..+.++|+.+....+.|++..|....+|||+++.
T Consensus        79 ~~~~~~~p~~---------~~~~~~Cv~l~~~~~~W~~~~C~~~~~fICe~~~  122 (123)
T d1byfa_          79 DLWSPNEPSN---------PQSWQLCVQIWSKYNLLDDVGCGGARRVICEKEL  122 (123)
T ss_dssp             TTBCTTCSCS---------CTTSCCEEEEETTTTEEEEECSCSCEEEEEEEEC
T ss_pred             cccccccccc---------ccCcceeEEEecCCCeEeeeCCCCCEeEEEEEcc
Confidence            5555555443         2356789988877788999999999999998753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.38  E-value=6.4e-07  Score=84.33  Aligned_cols=130  Identities=12%  Similarity=0.048  Sum_probs=89.3

Q ss_pred             CceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEEeeeeeeeeCCceEEEEecCCCCChHHHhccC
Q 008698          281 KTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI  359 (557)
Q Consensus       281 ~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  359 (557)
                      +.+.||+... +++.+.||+...........+.+|...+..+. +--+.+++.+..+.+..++||+++++.++.+.....
T Consensus        26 s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~  104 (263)
T d1j7la_          26 SPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE  104 (263)
T ss_dssp             SSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred             CCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence            3468998865 66778889886554444456777888877773 433567777778888899999999988876543210


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------------------
Q 008698          360 PRGGRSLDWAMRMKVATTLAQGIAFLHDKV--------------------------------------------------  389 (557)
Q Consensus       360 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------------  389 (557)
                               .....++.+++..|+.||+..                                                  
T Consensus       105 ---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (263)
T d1j7la_         105 ---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK  175 (263)
T ss_dssp             ---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred             ---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence                     112234455555555555321                                                  


Q ss_pred             ------CCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          390 ------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       390 ------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                            .+.++|+|+.|.|||++++....|.||+.+.
T Consensus       176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                  1237899999999999987667799998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.69  E-value=0.0001  Score=68.20  Aligned_cols=72  Identities=15%  Similarity=0.105  Sum_probs=51.3

Q ss_pred             cccC-ceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC--CCcEEeeeeeeeeCCceEEEEecCCCCCh
Q 008698          278 GDSK-TGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEFVVNGPL  352 (557)
Q Consensus       278 g~G~-~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL  352 (557)
                      ..|. ...||+...+++..+++|.......   ..+..|...+..+.  .-.+.+++++..+.+..++||+++++.++
T Consensus        19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             SCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             CCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4444 3678999887788899998765532   23566777776663  33356677877888889999999987655

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.23  E-value=0.00044  Score=68.50  Aligned_cols=74  Identities=15%  Similarity=-0.002  Sum_probs=46.4

Q ss_pred             eecccCceEEEEEEeCC-CCEEEEEEeccc------c-hhhHHHHHHHHHHHhhc-CC--CcEEeeeeeeeeCCceEEEE
Q 008698          276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRS------S-FQRKKEFYSEIGRFARL-HH--PNLVAVKGCCYDHGDRYIVY  344 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~-g~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l-~H--~niv~l~g~~~~~~~~~lV~  344 (557)
                      -||.|....||+....+ ++.|+||.-...      + .....+...|...|..+ .+  ..+++++.+  +.+..++||
T Consensus        33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvm  110 (392)
T d2pula1          33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM  110 (392)
T ss_dssp             ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred             EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEE
Confidence            46999999999998654 678999975421      1 11223445677777666 23  334555543  555678999


Q ss_pred             ecCCCCC
Q 008698          345 EFVVNGP  351 (557)
Q Consensus       345 E~~~~gs  351 (557)
                      |++.+..
T Consensus       111 E~L~~~~  117 (392)
T d2pula1         111 EDLSHLK  117 (392)
T ss_dssp             CCCTTSE
T ss_pred             eccCCcc
Confidence            9997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.80  E-value=0.0033  Score=60.13  Aligned_cols=136  Identities=15%  Similarity=0.144  Sum_probs=77.7

Q ss_pred             eEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcE--Eeeee-----eeeeCCceEEEEecCCCCChH--
Q 008698          283 GGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL--VAVKG-----CCYDHGDRYIVYEFVVNGPLD--  353 (557)
Q Consensus       283 g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~E~~~~gsL~--  353 (557)
                      -.||+...++|+.|++|+.+.. ....+++..|...+..|....+  +..+.     .....+..+.++++++|..+.  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            5899999999999999998754 2345667788888877743222  11111     123445678899998764321  


Q ss_pred             ---H------Hh---c----cCCC-CCCCCCH-------------------H---HHHHHHHHHHHHHHHH-hcCCCCCe
Q 008698          354 ---R------WL---H----HIPR-GGRSLDW-------------------A---MRMKVATTLAQGIAFL-HDKVKPHV  393 (557)
Q Consensus       354 ---~------~l---~----~~~~-~~~~l~~-------------------~---~~~~i~~~ia~gL~yL-H~~~~~~i  393 (557)
                         .      .+   +    .... ....+++                   .   .....+.++...+.-. .+....++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               0      00   1    0000 0011111                   1   1122223333332222 12234579


Q ss_pred             eecCCCCCCeeeCCCCCcEEeeccCCcc
Q 008698          394 VHRDIRASNVLLDEEFGAHLMGVGLSKF  421 (557)
Q Consensus       394 vH~Dlk~~Nill~~~~~~kl~Dfgl~~~  421 (557)
                      ||+|+.+.|||++++  ..+.||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  46899998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.90  E-value=0.026  Score=53.11  Aligned_cols=160  Identities=13%  Similarity=0.083  Sum_probs=83.3

Q ss_pred             cCHHHHHHhhcCCCCCC----eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcE--Eeee
Q 008698          258 FTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL--VAVK  331 (557)
Q Consensus       258 ~~~~el~~~~~~~~~~~----~~lg~G~~g~Vy~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni--v~l~  331 (557)
                      .+.+|+..+...|..+.    +.|..|---+.|+.+.++|+ +++|+.....  ..+++..|+..+..|.+.++  ...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            46788888888876532    12346666888998886654 8999986532  12334445666666532222  1111


Q ss_pred             e------eeeeCCceEEEEecCCCCChHH--------------Hhcc----C--CCCCCCC-----------------CH
Q 008698          332 G------CCYDHGDRYIVYEFVVNGPLDR--------------WLHH----I--PRGGRSL-----------------DW  368 (557)
Q Consensus       332 g------~~~~~~~~~lV~E~~~~gsL~~--------------~l~~----~--~~~~~~l-----------------~~  368 (557)
                      -      +....+....++.+..+.....              .++.    .  .......                 ..
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      1122344566777665533210              0000    0  0000000                 00


Q ss_pred             HHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCcEEeeccCCc
Q 008698          369 AMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  420 (557)
Q Consensus       369 ~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~  420 (557)
                      ......+..+...+.-.+. ....++||+|+.+.||+++.+...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            0111222233333333332 234489999999999999998877899999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.77  E-value=0.014  Score=57.26  Aligned_cols=71  Identities=14%  Similarity=0.168  Sum_probs=46.8

Q ss_pred             eecccCceEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcE-EeeeeeeeeCCceEEEEec
Q 008698          276 LLGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEF  346 (557)
Q Consensus       276 ~lg~G~~g~Vy~g~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~  346 (557)
                      .|+.|-.-.+|+...++        ++.|.+++....  .......+|..+++.+.-.++ .++++++.+    .+|+||
T Consensus        49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            46888889999988654        356777776532  223445678888887743343 466776542    589999


Q ss_pred             CCCCCh
Q 008698          347 VVNGPL  352 (557)
Q Consensus       347 ~~~gsL  352 (557)
                      +++.+|
T Consensus       123 i~g~~l  128 (395)
T d1nw1a_         123 IPSRPL  128 (395)
T ss_dssp             CCEEEC
T ss_pred             eccccC
Confidence            986544